P01282450A01
Pain_NN management_NN ,_, nutritional_JJ support_NN ,_, and_CC psychosocial_JJ support_NN are_VBB fundamental_JJ services_NNS that_PNR enhance_VVB patients_NNS '_GE ability_NN to_TO cope_VVI with_II their_PNG cancer_NN and_CC its_PNG therapy_NN ._.
P01350716A05
Seven_MC trials_NNS of_II beta-blockers_NNS and_CC 15_MC of_II sclerotherapy_NN were_VBD published_VVN as_II full_JJ papers_NNS ._.
P01421653A15
CONCLUSIONS_NNS :_: Although_CS more_RR well-designed_VVNJ clinical_JJ trials_NNS comparing_VVG pamidronate_NN with_II standard_JJ therapies_NNS and_CC other_JJ available_JJ agents_NNS are_VBB necessary_JJ ,_, initial_JJ results_NNS indicate_VVB that_CST pamidronate_NN is_VBZ an_DD effective_JJ and_CC promising_VVGJ alternative_NN for_II use_NN in_II the_DD treatment_NN of_II HCM_NN ._.
P01462793A01
BACKGROUND_NN :_: More_RR than_CSN 11_MC million_MC people_NNS in_II the_DD United_VVNJ States_NNS have_VHB moderate_JJ or_CC severe_JJ migraine_NN resulting_VVG in_II much_DD suffering_VVGN and_CC millions_NNS of_II lost_VVNJ work_NN days_NNS annually_RR ._.
P01533416A11
Thirty-eight_MC of_II 44_MC effect_NN sizes_NNS indicated_VVD that_CST SMT_NN was_VBD better_JJR than_CSN the_DD comparison_NN treatment_NN ._.
P01538563A14
There_EX has_VHZ been_VBN an_DD exponential_JJ increase_NN in_II knowledge_NN regarding_VVG the_DD interactions_NNS among_II the_DD components_NNS of_II the_DD stress_NN system_NN and_CC between_II the_DD stress_NN system_NN and_CC other_JJ brain_NN elements_NNS involved_VVN in_II the_DD regulation_NN of_II emotion_NN ,_, cognitive_JJ function_NN ,_, and_CC behavior_NN ,_, as_CC+ well_CC+ as_CC with_II the_DD axes_NNS responsible_JJ for_II reproduction_NN ,_, growth_NN ,_, and_CC immunity_NN ._.
P01595772A01
Gastroesophageal_JJ reflux_NN disease_NN (_( GERD_NN )_) remains_VVZ a_DD ubiquitous_JJ problem_NN ,_, although_CS therapeutic_JJ options_NNS continue_VVB to_TO evolve_VVI ._.
P01616217A13
Medical_JJ interventions_NNS that_PNR effectively_RR halt_VVB the_DD progression_NN or_CC prevent_VVB the_DD development_NN of_II diabetic_JJ retinopathy_NN are_VBB needed_VVN ._.
P01658404A08
Because_CS PID_NN is_VBZ polymicrobial_JJ in_II cause_NN ,_, recommended_VVNJ antimicrobial_JJ regimens_NNS are_VBB broad-spectrum_NN in_II coverage_NN ._.
P01726215A18
The_DD modest_JJ ,_, reversible_JJ risk_NN of_II neutropenia_NN ,_, affecting_VVG less_RR than_CSN 1_MC %_SYM of_II patients_NNS ,_, makes_VVZ the_DD benefit_NN :_SYM risk_NN ratio_NN a_DD reasonable_JJ one_PN ._.
P01767696A02
Central_JJ to_II the_DD debate_NN are_VBB the_DD results_NNS of_II the_DD major_JJ placebo-controlled_VVNJ clinical_JJ trials_NNS of_II pharmacologic_JJ treatment_NN of_II hypercholesterolemia_NN ._.
P01828529A09
In_II the_DD case_NN of_II comparative_JJ studies_NNS the_DD relative_JJ risks_NNS of_II severe_JJ reactions_NNS in_II low-risk_NN versus_CC high-risk_NN patients_NNS and_CC with_II LOCM_NN compared_VVN with_II HOCM_NN were_VBD treated_VVN for_II homogeneity_NN ,_, and_CC pooled_VVNJ odds_NNS ratios_NNS and_CC 95_MC %_SYM confidence_NN intervals_NNS (_( CI_NN )_) were_VBD calculated_VVN by_II combining_VVGN the_DD logarithms_NNS of_II the_DD odds_NNS ratios_NNS weighted_VVN by_II their_PNG variances_NNS ._.
P01934395A12
The_DD consensus_NN was_VBD that_CST a_DD very_RR restrictive_JJ and_CC cautious_JJ attitude_NN to_II the_DD newer_JJR settings_NNS is_VBZ appropriate_JJ at_II this_DD time_NN ._.
P02050423A02
Although_CS there_EX are_VBB differences_NNS in_II pathogens_NNS by_II age_NN ,_, the_DD importance_NN of_II nosocomial_JJ pneumonia_NN is_VBZ apparent_JJ in_II the_DD adult_NN population_NN as_CC+ well_CC+ as_CC in_II the_DD pediatric_JJ patient_NN groups_NNS ._.
P02206035A07
In_II the_DD United_VVNJ States_NNS ,_, lovastatin_NN will_VM be_VBB used_VVN in_II a_DD double-blind_JJ ,_, placebo-controlled_VVNJ ,_, primary_JJ prevention_NN trial_NN involving_VVG 8,000_MC patients_NNS without_II clinical_JJ evidence_NN of_II CAD_NN ,_, slight_JJ to_II moderate_JJ elevations_NNS of_II total_JJ cholesterol_NN ,_, and_CC low-_JJ and_CC high-density_NN lipoprotein_NN cholesterol_NN to_TO establish_VVI whether_CST 5_MC years_NNS of_II treatment_NN will_VM decrease_VVB the_DD rate_NN of_II fatal_JJ CAD_NN or_CC nonfatal_JJ myocardial_JJ infarction_NN ._.
P02491421A14
In_II many_DD patients_NNS with_II renal_JJ disease_NN ,_, ACE_NN inhibitors_NNS dramatically_RR reduce_VVB proteinuria_NN ,_, but_CC whether_CST they_PN also_RR reduce_VVB the_DD rate_NN of_II progression_NN of_II renal_JJ disease_NN remains_VVZ unproved_VVN ._.
P02656825A15
7._MC Finally_RR ,_, in_II this_DD era_NN of_II quality_NN assurance_NN ,_, professional_JJ review_NN and_CC cost_NN containment_NN ,_, it_PN behooves_VVZ each_DD physician_NN to_TO ask_VVI whether_CST the_DD data_NNS provided_VVN by_II the_DD particular_JJ tests_NNS were_VBD worth_II the_DD cost_NN ,_, inconvenience_NN and_CC risk_NN for_II that_DD particular_JJ patient_NN ._.
P02864682A09
The_DD success_NN of_II captopril_NN ,_, the_DD first_JJ oral_JJ agent_NN of_II this_DD class_NN ,_, promises_VVZ to_TO hold_VVI true_JJ for_II other_JJ ACE_NN inhibitors_NNS (_( such_II+ as_II enalapril_NN )_) ,_, which_PNR have_VHB similar_JJ activities_NNS but_CC differing_VVGJ pharmacokinetic_JJ properties_NNS and_CC will_VM soon_RR be_VBB available_JJ for_II clinical_JJ use_NN ._.
P03414608A08
The_DD ATP_NN 's_GE report_NN established_VVD criteria_NNS that_PNR define_VVB candidates_NNS with_II high_JJ blood_NN cholesterol_NN levels_NNS who_PNR should_VM receive_VVB medical_JJ intervention_NN and_CC provided_VVD guidelines_NNS on_II how_CST to_TO detect_VVI ,_, set_VVI goals_NNS ,_, treat_VVI ,_, and_CC monitor_VVI these_DD patients_NNS over_II time_NN ._.
P07474194A07
CONCLUSIONS_NNS --_: Sympathetic_JJ nervous_JJ system_NN activation_NN in_II patients_NNS with_II chronic_JJ heart_NN failure_NN is_VBZ a_DD major_JJ contributor_NN to_II the_DD severity_NN of_II disease_NN as_CC+ well_CC+ as_CC its_PNG progression_NN over_II time_NN ._.
P07486487A12
The_DD pooled_VVNJ sensitivity_NN was_VBD 66_MC %_SYM (_( 95_MC %_SYM CI_NN ,_, 57_MC %_SYM to_II 74_MC %_SYM )_) ,_, and_CC the_DD pooled_VVNJ specificity_NN was_VBD 98_MC %_SYM (_( CI_NN ,_, 96_MC %_SYM to_II 99.5_MC %_SYM )_) ._.
P07503088A01
Some_DD aspects_NNS of_II thyroid_NN nodule_NN evaluation_NN and_CC management_NN remain_VVB controversial_JJ ._.
P07527326A07
Titrating_VVGN quinapril_NN dosages_NNS from_II 10_MC to_II 40_MC mg_NN /_SYM day_NN increased_VVD response_NN rates_NNS without_II increasing_VVGN the_DD incidence_NN or_CC severity_NN of_II adverse_JJ events_NNS ._.
P07563563A09
Thereafter_RR ,_, the_DD panel_NN resolved_VVD conflicting_VVGJ recommendations_NNS and_CC released_VVD a_DD revised_VVNJ statement_NN at_II the_DD end_NN of_II the_DD conference_NN ._.
P07587242A08
Experts_NNS in_II closed_VVNJ loop_NN systems_NNS were_VBD then_RR added_VVN to_II the_DD group_NN to_TO review_VVI the_DD summary_NN provided_VVN by_II the_DD task_NN force_NN ._.
P07596718A18
Five_MC trials_NNS reporting_VVG deaths_NNS from_II tuberculosis_NN showed_VVD a_DD BCG_NN protective_JJ effect_NN of_II 0.65_MC (_( 95_MC %_SYM CI_NN ,_, 0.12_MC to_II 0.86_MC )_) ,_, five_MC studies_NNS reporting_VVG on_II meningitis_NN showed_VVD a_DD protective_JJ effect_NN of_II 0.64_MC (_( 95_MC %_SYM CI_NN ,_, 0.30_MC to_II 0.82_MC )_) ,_, and_CC three_MC studies_NNS of_II disseminated_VVNJ tuberculosis_NN showed_VVD a_DD protective_JJ effect_NN of_II 0.78_MC (_( 95_MC %_SYM CI_NN ,_, 0.58_MC to_II 0.88_MC )_) ._.
P07606076A04
DATA_NNS EXTRACTION_NN :_: The_DD most_RRT recent_JJ clinical_JJ trials_NNS that_PNR evaluated_VVD cytotoxic_JJ chemotherapy_NN or_CC hormonal_JJ therapy_NN in_II patients_NNS with_II node-negative_JJ breast_NN cancer_NN were_VBD chosen_VVN ._.
P07639445A03
Five_MC major_JJ areas_NNS were_VBD identified_VVN and_CC searched_VVN :_: cardiomyopathies_NNS ,_, atrial_JJ fibrillation_NN ,_, the_DD long_JJ QT_NN syndrome_NN ,_, cardiac_JJ transplantation_NN ,_, and_CC vasovagal_JJ syncope_NN ._.
P07650455A11
One_MC technique_NN ,_, atherectomy_NN ,_, has_VHZ been_VBN shown_VVN to_TO be_VBI no_RR more_RR effective_JJ ,_, and_CC more_RR expensive_JJ ,_, than_CSN conventional_JJ balloon_NN angioplasty_NN ._.
P07663033A01
OBJECTIVE_NN :_: To_TO discuss_VVI the_DD role_NN of_II amiodarone_NN for_II the_DD maintenance_NN of_II normal_JJ sinus_NN rhythm_NN in_II patients_NNS with_II atrial_JJ fibrillation_NN (_( AF_NN )_) and_CC review_VVI the_DD clinical_JJ trial_NN data_NNS evaluating_VVG the_DD efficacy_NN and_CC safety_NN of_II amiodarone_NN in_II patients_NNS with_II AF_NN ._.
P07674695A10
The_DD most_RRT recent_JJ data_NNS from_II the_DD 4S_NN trial_NN have_VHB unequivocally_RR demonstrated_VVN the_DD benefits_NNS of_II treatment_NN with_II HMG_NN coenzyme-A_NN reductase_NN inhibitors_NNS in_II reducing_VVGN the_DD risk_NN of_II future_JJ coronary_JJ events_NNS and_CC improving_VVGN the_DD overall_JJ survival_NN in_II patients_NNS with_II established_VVNJ CHD_NN ._.
P07700062A05
Are_VBB ACE_NN inhibitors_NNS beneficial_JJ in_II mild-to-moderate_JJ heart_NN failure_NN ?_.
P07726699A06
To_II our_PNG knowledge_NN ,_, no_DD randomized_VVNJ ,_, placebo-controlled_VVNJ trials_NNS of_II amiodarone_NN therapy_NN for_II atrial_JJ fibrillation_NN have_VHB been_VBN published_VVN ._.
P07752668A09
There_EX are_VBB also_RR promising_VVGJ data_NNS suggesting_VVG that_CST beta-blockade_NN is_VBZ useful_JJ in_II endothelial_JJ protection_NN and_CC atheroma_NN prevention_NN ,_, and_CC benefits_VVZ patients_NNS with_II hypertrophic_JJ cardiomyopathy_NN and_CC heart_NN failure_NN ._.
P07786840A10
More_RR recently_RR ,_, preliminary_JJ results_NNS from_II the_DD third_JJ Gruppo_NN Italiano_NN per_II lo_DD Studio_NN della_II Sopravvivenza_NN nell'Infarto_NN Miocardico_NN (_( GISSI-3_NN )_) ,_, the_DD Fourth_JJ International_JJ Study_NN of_II Infarct_NN Survival_NN (_( ISIS-4_NN )_) ,_, and_CC the_DD Chinese_NN Captopril_NN Trial_NN suggested_VVD that_CST angiotensin-converting_VVGJ enzyme_NN (_( ACE_NN )_) inhibitor_NN mortality_NN benefits_NNS post-myocardial_JJ infarction_NN would_VM be_VBB detected_VVN in_II these_DD megatrials_NNS as_II early_JJ as_II 35_MC days_NNS after_II the_DD event_NN ._.
P07805271A02
The_DD American_JJ Heart_NN Association_NN assembled_VVD a_DD group_NN of_II experts_NNS in_II a_DD multidisciplinary_JJ consensus_NN conference_NN to_TO develop_VVI this_DD statement_NN ._.
P07826548A10
The_DD panel_NN believes_VVZ that_CST whereas_CS many_DD different_JJ drugs_NNS can_VM produce_VVB effective_JJ blood_NN pressure_NN reduction_NN ,_, the_DD modern_JJ primary_JJ goal_NN of_II antihypertensive_JJ drug_NN therapy_NN is_VBZ to_TO select_VVI a_DD regimen_NN most_RRT likely_RR to_TO prolong_VVI the_DD quality_NN and_CC duration_NN of_II life_NN ._.
P07850886A09
Peluso_NNP and_CC colleagues_NNS (_( 1993_MC )_) have_VHB performed_VVN a_DD recent_JJ meta-analysis_NN of_II available_JJ therapies_NNS in_II fibromyalgia_NN syndrome_NN and_CC found_VVD that_CST the_DD effect-size_NN (_( a_DD standardized_VVNJ measure_NN of_II the_DD efficacy_NN of_II a_DD given_VVNJ therapy_NN )_) of_II several_JJ non-medication_NN therapies_NNS such_II+ as_II electroacupuncture_NN exceeded_VVD that_PND of_II traditional_JJ medication_NN therapies_NNS ._.
P07867364A10
CONCLUSION_NN :_: Recommendations_NNS for_II the_DD design_NN ,_, conduct_NN and_CC analysis_NN of_II future_JJ trials_NNS of_II sepsis_NN therapies_NNS were_VBD summarized_VVN ._.
P07882203A09
At_II the_DD conclusion_NN ,_, the_DD students_NNS will_VM have_VHB encountered_VVN all_DB the_DD information_NN necessary_JJ to_TO solve_VVI the_DD case_NN and_CC ,_, in_II so_RR doing_VVGN ,_, will_VM have_VHB gained_VVN knowledge_NN that_PNR in_II a_DD conventional_JJ curriculum_NN would_VM usually_RR have_VHB been_VBN disseminated_VVN by_II lecture_NN ._.
P07905143A11
This_DD overview_NN indicates_VVZ that_CST fibrinolytic_JJ therapy_NN is_VBZ beneficial_JJ in_II a_DD much_RR wider_JJR range_NN of_II patients_NNS than_CSN is_VBZ currently_RR given_VVN such_DD treatment_NN routinely_RR ._.
P07922426A04
These_DD considerations_NNS have_VHB led_VVN to_II pressure-limited_VVNJ mechanical_JJ ventilation_NN strategies_NNS ,_, including_VVG pressure-controlled_VVNJ ,_, inverse-ratio_NN ventilation_NN ._.
P07939748A04
The_DD presentation_NN of_II advanced_VVNJ disease_NN is_VBZ also_RR unusual_JJ ,_, in_II that_CST the_DD vast_JJ majority_NN of_II patients_NNS do_VDB not_RR have_VHB measurable_JJ disease_NN suitable_JJ for_II traditional_JJ studies_NNS of_II new_JJ chemotherapy_NN agents_NNS ._.
P07966873A01
OBJECTIVE_NN --_: This_DD article_NN reviews_VVZ the_DD incidence_NN of_II arterial_JJ thromboembolism_NN in_II patients_NNS with_II heart_NN failure_NN who_PNR are_VBB not_RR receiving_VVG anticoagulants_NNS ._.
P08011827A20
More_RR reliable_JJ administration_NN of_II antimicrobial_JJ agents_NNS according_II+ to_II recognized_VVNJ guidelines_NNS should_VM prevent_VVB some_DD postoperative_JJ wound_NN infections_NNS while_CS lowering_VVG the_DD total_JJ quantity_NN of_II these_DD drugs_NNS used_VVN ._.
P08017749A09
The_DD clinical_JJ presentations_NNS of_II nonvalvular_JJ endovascular_JJ infections_NNS are_VBB subtle_JJ and_CC diagnoses_NNS are_VBB difficult_JJ to_TO make_VVI ,_, often_RR requiring_VVG not_RR only_RR a_DD high_JJ index_NN of_II suspicion_NN but_CC also_RR the_DD use_NN of_II sophisticated_VVNJ radiologic_JJ techniques_NNS ._.
P08055409A10
The_DD clinical_JJ judgment_NN of_II the_DD practising_VVGJ clinician_NN ,_, however_RR ,_, must_VM always_RR be_VBB incorporated_VVN into_II any_DD diagnostic_JJ or_CC therapeutic_JJ decision_NN ._.
P08080494A10
Unfortunately_RR ,_, these_DD conditions_NNS are_VBB extremely_RR frequent_JJ and_CC carry_VVB high_JJ mortality_NN rates_NNS ._.
P08085692A07
Single_JJ and_CC combined_VVNJ chemotherapeutic_JJ agents_NNS produce_VVB high_JJ response_NN rates_NNS ._.
P08120703A06
DATA_NNS SYNTHESIS_NN :_: The_DD spontaneous_JJ rate_NN of_II primary_JJ control_NN --_: without_II antibiotics_NNS or_CC tympanocentesis_NN --_: was_VBD 81_MC %_SYM (_( 95_MC %_SYM confidence_NN interval_NN ,_, 69_MC %_SYM to_II 94_MC %_SYM )_) ._.
P08147551A11
Perhaps_RR more_RR accurate_JJ clinical_JJ and_CC laboratory_NN predictors_NNS are_VBB needed_VVN to_TO identify_VVI patients_NNS who_PNR may_VM benefit_VVB from_II a_DD given_VVNJ treatment_NN strategy_NN ._.
P08173141A17
Failure_NN to_TO respond_VVI to_II treatment_NN of_II recurrent_JJ ventricular_JJ tachycardia_NN /_SYM fibrillation_NN to_II usual_JJ antiarrhythmic_JJ therapy_NN in_II patients_NNS with_II acute_JJ myocardial_JJ infarction_NN ,_, idiopathic_JJ dilated_VVNJ cardiomyopathy_NN ,_, and_CC congestive_JJ heart_NN failure_NN should_VM alert_VVB the_DD clinician_NN to_TO consider_VVI administering_VVG intravenous_JJ Mg_NN ._.
P08207176A07
EVIDENCE_NN :_: Many_DD prospective_JJ ,_, randomized_VVNJ ,_, controlled_VVNJ trials_NNS comparing_VVG placebo_NN with_II antibiotic_NN and_CC comparing_VVG one_MC antibiotic_NN with_II another_PND have_VHB been_VBN conducted_VVN ._.
P08221424A15
The_DD CMA_NN 's_GE guidelines_NNS on_II this_DD topic_NN should_VM be_VBB evaluated_VVN to_TO see_VVI whether_CST they_PN are_VBB effective_JJ in_II controlling_VVGN physician-industry_NN interactions_NNS ._.
P08234776A08
The_DD creation_NN of_II this_DD ideal_JJ ICD_NN will_VM obviously_RR require_VVB continued_VVNJ technological_JJ advances_NNS ;_: however_RR ,_, given_VVN the_DD tremendous_JJ improvements_NNS realized_VVN over_II the_DD first_JJ three_MC generations_NNS of_II ICD_NN systems_NNS ,_, optimism_NN for_II the_DD future_NN seems_VVZ warranted_VVN ._.
P08281682A07
Data_NNS on_II each_DD procedure_NN were_VBD recorded_VVN on_II a_DD unique_JJ modular_JJ database_NN that_PNR captured_VVD the_DD reason_NN for_II (_( and_CC interim_JJ result_NN after_II )_) each_DD device_NN use_NN ._.
P08305784A06
Clinical_JJ trials_NNS were_VBD assessed_VVN primarily_RR for_II comparative_JJ efficacy_NN and_CC toxicity_NN ._.
P08329800A23
Based_VVN on_II the_DD CONSENSUS_NN II_MC results_NNS ,_, enalapril_NN therapy_NN immediately_RR following_VVG AMI_NN can_VM not_RR be_VBB recommended_VVN ._.
P08357116A08
For_II most_DD patients_NNS ,_, therapy_NN can_VM be_VBB initiated_VVN with_II a_DD full_JJ replacement_NN dosage_NN (_( 1.6_MC micrograms_NNS /_SYM kg_NN body_NN weight_NN )_) ,_, which_PNR is_VBZ usually_RR 75_MC to_II 100_MC micrograms_NNS /_SYM day_NN for_II women_NNS and_CC 100_MC to_II 150_MC micrograms_NNS /_SYM d_NN for_II men_NNS ._.
P08379605A13
After_II one_MC negative_JJ result_NN of_II a_DD 3-year_NN examination_NN ,_, the_DD interval_NN can_VM be_VBB increased_VVN to_II 5_MC years_NNS ._.
P08410406A02
DESIGN_NN AND_CC DATA_NNS IDENTIFICATION_NN :_: English-language_NN literature_NN search_NN using_VVG MEDLINE_NN ,_, Index_NN Medicus_NN ,_, and_CC bibliographic_JJ reviews_NNS of_II texts_NNS and_CC all_DD pertinent_JJ articles_NNS to_TO perform_VVI a_DD quantitative_JJ and_CC methodologic_JJ analysis_NN of_II all_DD studies_NNS from_II 1983_MC (_( the_DD original_JJ publication_NN )_) assessing_VVG the_DD association_NN under_II study_NN ._.
P08439699A08
Trials_NNS were_VBD assessed_VVN by_II design_NN ,_, sample_NN size_NN ,_, types_NNS of_II seizures_NNS of_II the_DD subjects_NNS ,_, and_CC clinical_JJ response_NN ._.
P08472581A13
In_II recognition_NN of_II these_DD complex_JJ issues_NNS (_( including_VVG potential_JJ conflicts_NNS among_II ICUs_NNS ,_, hospital_NN administration_NN ,_, individual_JJ physicians_NNS ,_, and_CC the_DD various_JJ medical_JJ and_CC surgical_JJ programs_NNS feeding_VVG patients_NNS into_II special_JJ care_NN units_NNS )_) ,_, the_DD Society_NN of_II Critical_JJ Care_NN Medicine_NN has_VHZ organized_VVN a_DD Task_NN Force_NN on_II the_DD legal_JJ and_CC ethical_JJ justification_NN for_II triage_NN ._.
P08520092A11
CONCLUSIONS_NNS :_: Desogestrel_NN ,_, norgestimate_NN ,_, and_CC gestodene_NN appear_VVB to_TO offer_VVI clinical_JJ advantages_NNS because_II+ of_II their_PNG decreased_VVNJ androgenicity_NN ._.
P08544272A14
Sucralfate_NN may_VM be_VBB as_RR effective_JJ in_II reducing_VVGN bleeding_VVGN as_II gastric_JJ pH-altering_VVGJ drugs_NNS and_CC is_VBZ associated_VVN with_II lower_JJR rates_NNS of_II pneumonia_NN and_CC mortality_NN ._.
P08564995A04
Much_DD progress_NN has_VHZ been_VBN made_VVN in_II altering_VVGN practices_NNS such_II+ as_II under-prescribing_VVGN and_CC underdosing_VVGN that_PNR have_VHB adversely_RR affected_VVD adequate_JJ control_NN of_II pain_NN in_II children_NNS ._.
P08576513A20
Research_NN questions_NNS might_VM be_VBB guided_VVN by_II the_DD biopsychosocial_JJ conceptual_JJ context_NN described_VVN above_RR ._.
P08591547A22
The_DD candidate_NN obtains_VVZ information_NN by_II "_`` mouse-clicking_VVGN ,_, "_'' so_CS it_PN is_VBZ not_RR necessary_JJ to_TO be_VBI a_DD computer_NN expert_NN to_TO use_VVI the_DD system_NN ._.
P08593127A12
Possible_JJ adverse_JJ effects_NNS of_II the_DD fibric-acid_NN derivatives_NNS include_VVB abdominal_JJ discomfort_NN ,_, nausea_NN ,_, flatulence_NN ,_, increased_VVNJ lithogenicity_NN of_II bile_NN ,_, liver_NN enzyme_NN elevations_NNS and_CC creatine_NN kinase_NN elevations_NNS ._.
P08601930A08
RESULTS_NNS :_: A_DD total_NN of_II 8676_MC admissions_NNS with_II unstable_JJ angina_NN or_CC non-Q-wave_NN MI_NN were_VBD enumerated_VVN and_CC ,_, of_II these_PND ,_, 3318_MC patients_NNS were_VBD selected_VVN for_II the_DD prospective_JJ study_NN ._.
P08604723A17
Other_JJ treatment_NN modalities_NNS ,_, including_VVG tissue_NN transplants_NNS and_CC cytokine-modulating_VVGJ drugs_NNS ,_, are_VBB emerging_VVG for_II the_DD potential_JJ therapy_NN of_II OA_NN ._.
P08608668A13
Patients_NNS who_PNR present_VVB 1-6_MC months_NNS after_II angioplasty_NN with_II typical_JJ anginal_JJ symptoms_NNS have_VHB a_DD high_JJ likelihood_NN of_II having_VVGN angiographic_JJ restenosis_NN ._.
P08615705A02
It_PN is_VBZ unknown_VVN how_CST the_DD effectiveness_NN and_CC costs_NNS of_II such_DB an_DD approach_NN (_( "_`` stepped_VVNJ care_NN "_'' )_) compare_VVB in_II typical_JJ clinical_JJ practice_NN to_II those_PND of_II initial_JJ therapy_NN with_II lovastatin_NN ._.
P08625645A02
To_TO examine_VVI the_DD available_JJ evidence_NN that_PNR supports_VVZ or_CC refutes_VVZ goal-directed_VVNJ therapy_NN toward_II supranormal_JJ oxygen_NN transport_NN in_II optimizing_VVGN the_DD outcome_NN of_II critically_RR ill_JJ sepsis_NN syndrome_NN patients_NNS ._.
P08633831A06
RESULTS_NNS :_: Forty-two_MC studies_NNS were_VBD reviewed_VVN for_II possible_JJ inclusion_NN ._.
P08653655A03
At_II the_DD same_JJ time_NN ,_, many_DD interventions_NNS are_VBB associated_VVN with_II increased_VVNJ risks_NNS in_II the_DD elderly_NN ,_, so_CS+ that_CS individualization_NN of_II treatment_NN is_VBZ essential_JJ in_II all_DD patients_NNS ._.
P08658222A21
A_DD large_JJ American_JJ intergroup_NN trial_NN is_VBZ underway_VVN testing_VVG the_DD concept_NN of_II postoperative_JJ adjuvant_NN chemoradiation_NN ._.
P08673987A05
The_DD role_NN of_II cyclooxygenase-2_NN (_( COX-2_NN )_) versus_CC COX-1_NN inhibiting_VVGJ agents_NNS was_VBD also_RR examined_VVN ._.
P08677863A05
Clinicians_NNS must_VM therefore_RR decide_VVB what_DB their_PNG practice_NN will_VM be_VBB on_II the_DD basis_NN of_II data_NNS that_PNR are_VBB currently_RR available_JJ ._.
P08686979A02
The_DD review_NN consists_VVZ of_II two_MC parts_NNS ._.
P08703521A03
AIM_NN :_: The_DD aim_NN of_II the_DD study_NN was_VBD to_TO assess_VVI the_DD effectiveness_NN of_II corticosteroid_NN injections_NNS in_II the_DD treatment_NN of_II lateral_JJ epicondylitis_NN (_( tennis_NN elbow_NN )_) by_II systematic_JJ review_NN of_II the_DD available_JJ randomized_VVNJ clinical_JJ trials_NNS ._.
P08729587A01
Both_CC the_DD European_JJ Atherosclerosis_NN Society_NN and_CC the_DD US_NNP National_JJ Cholesterol_NN Education_NN Program_NN have_VHB issued_VVN revised_VVNJ guidelines_NNS for_II the_DD prevention_NN of_II coronary_JJ heart_NN disease_NN (_( CHD_NN )_) ,_, based_VVN on_II a_DD multitude_NN of_II recent_JJ epidemiological_JJ and_CC angiographic_JJ studies_NNS ._.
P08736614A24
In_II comparison_NN with_II haloperidol_NN ,_, it_PN appears_VVZ to_TO be_VBI associated_VVN with_II a_DD lower_JJR prevalence_NN of_II acute_JJ extrapyramidal_JJ adverse_JJ effects_NNS in_II dosages_NNS <_SYM or_CC =_SYM 10_MC mg_NN /_SYM day_NN ,_, the_DD most_RRT potentially_RR important_JJ component_NN of_II which_PNR is_VBZ its_PNG reportedly_RR insignificant_JJ likelihood_NN of_II promoting_VVGN akathisia_NN ._.
P08754362A14
Amiodarone_NN unlike_II other_JJ antiarrhythmic_JJ drugs_NNS does_VDZ not_RR seem_VVB depress_VVI left_VVD ventricular_JJ function_NN ,_, and_CC may_VM be_VBB the_DD best_JJT drug_NN in_II patients_NNS with_II CHF_NN and_CC symptomatic_JJ arrhythmias_NNS ._.
P08780375A04
The_DD literature_NN was_VBD searched_VVN through_II Medline_NN and_CC an_DD extensive_JJ bibliography_NN of_II references_NNS was_VBD provided_VVN to_II the_DD panel_NN and_CC the_DD conference_NN audience_NN ._.
P08792953A07
DATA_NNS SYNTHESIS_NN :_: Production_NN of_II viscous_JJ respiratory_JJ secretion_NN is_VBZ a_DD hallmark_NN phenomenon_NN of_II cystic_JJ fibrosis_NN ,_, leading_VVG to_II a_DD variety_NN of_II symptoms_NNS ._.
P08826564A01
OBJECTIVE_NN :_: To_TO review_VVI the_DD pathophysiology_NN of_II hypertension_NN and_CC complications_NNS in_II patients_NNS with_II diabetes_NN mellitus_NN ,_, specifically_RR focusing_VVG on_II diabetic_JJ nephropathy_NN ;_: to_TO evaluate_VVI the_DD current_JJ clinical_JJ literature_NN regarding_VVG the_DD appropriate_JJ management_NN of_II hypertension_NN in_II this_DD patient_NN group_NN ;_: and_CC to_TO offer_VVI treatment_NN recommendations_NNS ._.
P08827194A19
And_CC it_PN would_VM be_VBB even_RR more_RR peculiar_JJ if_CS various_JJ other_JJ antidepressant_NN medications_NNS chemically_RR unrelated_VVN to_II fluoxetine_NN also_RR ,_, by_II chance_NN alone_JJ ,_, benefited_VVD all_PND of_II these_DD same_JJ disorders_NNS via_II still_RR other_JJ independent_JJ mechanisms_NNS ._.
P08837541A11
RECOMMENDATIONS_NNS :_: Bone_NN mineral_NN density_NN should_VM be_VBB measured_VVN only_RR to_TO assist_VVI in_II making_VVGN a_DD clinical_JJ management_NN choice_NN ._.
P08841011A01
Role_NN of_II ACE_NN inhibitors_NNS in_II the_DD management_NN of_II asymptomatic_JJ or_CC symptomatic_JJ left_JJ ventricular_JJ (_( LV_NN )_) dysfunction_NN after_II acute_JJ myocardial_JJ infarction_NN (_( AMI_NN )_) is_VBZ well_RR established_VVN ._.
P08853610A07
Although_CS successful_JJ for_II some_PND ,_, this_DD approach_NN increases_VVZ risk_NN for_II ineffective_JJ interventions_NNS accompanied_VVN by_II side_NN effects_NNS ._.
P08873639A05
OUTCOMES_NNS :_: Prevention_NN of_II loss_NN of_II bone_NN mineral_NN density_NN and_CC fracture_NN ;_: increased_VVNJ bone_NN mass_NN ;_: and_CC improved_VVNJ quality_NN of_II life_NN ._.
P08876861A08
The_DD attenuation_NN of_II ventricular_JJ remodeling_VVGN that_PNR occurs_VVZ with_II ACE_NN inhibition_NN does_VDZ not_RR fully_RR explain_VVB the_DD results_NNS of_II clinical_JJ trials_NNS in_II patients_NNS after_II MI_NN ._.
P08888782A14
Early_JJ intervention_NN has_VHZ been_VBN shown_VVN to_TO reduce_VVI the_DD rate_NN of_II vertebral_JJ and_CC hip_NN fractures_NNS by_II 50_MC -_CC 70_MC %_SYM ._.
P08893123A27
Therapy_NN must_VM be_VBB individualized_VVN according_II+ to_II the_DD patient_NN 's_GE disease_NN course_NN and_CC other_JJ patient-specific_JJ factors_NNS ._.
P08900335A03
Most_PND of_II the_DD atherosclerotic_JJ regression_NN trials_NNS were_VBD too_RR small_JJ and_CC of_II too_RR short_JJ duration_NN to_TO demonstrate_VVI a_DD significant_JJ difference_NN in_II hard_JJ coronary_JJ events_NNS between_II patients_NNS receiving_VVG cholesterol-lowering_VVGJ intervention_NN and_CC controls_NNS ._.
P08903273A12
Return_NN to_II sinus_NN rhythm_NN may_VM be_VBB difficult_JJ to_TO achieve_VVI early_JJ after_II surgery_NN ,_, so_CS opting_VVGN for_II rate_NN control_NN is_VBZ the_DD best_RRT initial_JJ approach_NN ._.
P08913409A03
;_: published_VVNJ articles_NNS and_CC abstracts_NNS ;_: and_CC review_NN chapters_NNS from_II medical_JJ textbooks_NNS ._.
P08918275A05
The_DD population_NN studied_VVN comprised_VVD subgroups_NNS of_II patients_NNS with_II atherosclerotic_JJ vascular_JJ disease_NN manifested_VVN as_II either_CC recent_JJ ischaemic_JJ stroke_NN ,_, recent_JJ myocardial_JJ infarction_NN ,_, or_CC symptomatic_JJ peripheral_JJ arterial_JJ disease_NN ._.
P08934387A13
Lipid-lowering_VVGJ drugs_NNS improve_VVB endothelium-dependent_JJ vasodilation_NN in_II the_DD coronary_JJ and_CC forearm_NN circulation_NN of_II patients_NNS with_II hyperlipidemia_NN and_CC atherosclerosis_NN ._.
P08968429A04
It_PN is_VBZ our_PNG opinion_NN ,_, however_RR ,_, that_CST there_EX are_VBB no_DD data_NNS that_PNR support_VVB the_DD extrapolation_NN of_II these_DD untoward_JJ effects_NNS to_II the_DD more_RR contemporary_JJ ,_, long-acting_VVGJ dihydropyridines_NNS (_( eg_NN ,_, amlodipine_NN )_) or_CC ,_, especially_RR ,_, to_II the_DD non-dihydropyridine_NN (_( heart_NN rate-lowering_VVGN )_) calcium_NN antagonists_NNS ,_, such_II+ as_II diltiazem_NN or_CC verapamil_NN ._.
P08974727A09
Weight-bearing_VVGJ exercise_NN is_VBZ important_JJ throughout_II life_NN ._.
P08990407A06
TIMI_NN grade_NN 2_MC or_CC 3_MC flow_NN at_II 90_MC minutes_NNS when_CS compared_VVN with_II accelerated_VVNJ alteplase_NN ._.
P09002496A13
CONCLUSIONS_NNS :_: The_DD results_NNS of_II this_DD meta-analysis_NN indicate_VVB that_CST in_II patients_NNS undergoing_VVG CABG_NN surgery_NN ,_, treatment_NN with_II acadesine_NN before_II and_CC during_II surgery_NN can_VM reduce_VVB early_RR cardiac_JJ death_NN ,_, MI_NN ,_, and_CC combined_VVNJ adverse_JJ cardiovascular_JJ outcomes_NNS ._.
P09023821A08
The_DD panel_NN composed_VVD a_DD draft_JJ statement_NN that_PNR was_VBD read_VVN in_II its_PNG entirety_NN and_CC circulated_VVN to_II the_DD experts_NNS and_CC the_DD audience_NN for_II comment_NN ._.
P09029428A15
Simply_RR developing_VVGN and_CC publishing_VVGN guidelines_NNS has_VHZ not_RR resulted_VVN in_II improvement_NN in_II practice_NN ._.
P09036802A07
Platelet_NN hyperactivity_NN ,_, reduced_VVNJ fibrinolytic_JJ capacity_NN ,_, increased_VVNJ concentrations_NNS of_II hemostatic_JJ proteins_NNS ,_, and_CC endothelial_JJ dysfunction_NN promote_VVB thrombosis_NN at_II the_DD site_NN of_II plaque_NN rupture_NN ._.
P09054283A09
Educational_JJ interventions_NNS with_II physicians_NNS led_VVD to_II increased_VVNJ use_NN of_II patient_NN preferences_NNS ,_, but_CC sophisticated_VVNJ educational_JJ techniques_NNS were_VBD needed_VVN to_TO motivate_VVI physicians_NNS to_TO change_VVI their_PNG behavior_NN ._.
P09063282A02
STUDY_NN SELECTION_NN /_SYM DATA_NNS ABSTRACTION_NN :_: MEDLINE_NN searches_NNS for_II literature_NN on_II prevention_NN and_CC screening_VVGN with_II regard_NN to_II older_JJR adults_NNS as_CC+ well_CC+ as_CC each_DD individual_JJ condition_NN reviewed_VVN ;_: bibliographical_JJ reviews_NNS of_II textbooks_NNS ,_, journal_JJ articles_NNS ,_, government_NN and_CC advocacy_NN organization_NN task_NN force_NN reports_NNS ,_, and_CC recommendations_NNS ._.
P09072935A03
STUDY_NN SELECTION_NN :_: Probabilities_NNS for_II individual_JJ clinical_JJ outcomes_NNS were_VBD derived_VVN from_II various_JJ sources_NNS ,_, including_VVG the_DD largest_JJT screening_VVGJ study_NN of_II community_NN volunteers_NNS to_II data_NNS ,_, analyses_NNS of_II Medicare_NN claims_NNS ,_, and_CC recently_RR published_VVNJ meta-analyses_NNS of_II the_DD outcomes_NNS of_II alternative_JJ treatment_NN strategies_NNS ._.
P09092324A01
PURPOSE_NN :_: To_TO review_VVI the_DD literature_NN on_II risk_NN stratification_NN after_II acute_JJ myocardial_JJ infarction_NN in_II the_DD reperfusion_NN era_NN and_CC to_TO propose_VVI an_DD algorithm_NN for_II early_JJ and_CC continual_JJ risk_NN assessment_NN ._.
P09101399A10
For_II example_NN ,_, in_II the_DD GISSI_NN 3_MC study_NN ,_, treatment_NN with_II lisinopril_NN was_VBD associated_VVN with_II a_DD decreased_VVNJ 6-week_NN mortality_NN in_II both_CC IDD_NN (_( 11.8_MC %_SYM versus_CC 21.1_MC ,_, p_NN <_SYM 0.05_MC )_) and_CC non-IDD_NN (_( 8.0_MC %_SYM versus_CC 10.6_MC %_SYM ,_, p_NN <_SYM 0.05_MC )_) patients_NNS corresponding_VVG to_II a_DD 44.1_MC %_SYM and_CC 24.5_MC %_SYM reduction_NN ,_, respectively_RR ._.
P09110119A02
For_II example_NN 1_MC out_II+ of_II 5_MC ,_, and_CC even_RR as_RR many_JJ as_CSN 1_MC out_II+ of_II 3_MC ,_, fatal_JJ cardiovascular_JJ events_NNS can_VM be_VBB prevented_VVN by_II some_DD treatments_NNS ._.
P09112710A23
These_DD impressions_NNS justify_VVB additional_JJ research_NN efforts_NNS on_II this_DD topic_NN ._.
P09118820A13
Evidence_NN is_VBZ now_RR available_JJ to_TO show_VVI a_DD beneficial_JJ effect_NN of_II bezafibrate_NN on_II retarding_VVGN atherosclerotic_JJ processes_NNS and_CC in_II reducing_VVGN risk_NN of_II coronary_JJ heart_NN disease_NN ._.
P09132880A12
However_RR ,_, there_EX are_VBB still_RR many_DD methodological_JJ questions_NNS regarding_VVG the_DD validity_NN and_CC sensitivity_NN of_II quality_NN of_II life_NN measurement_NN an_DD optimal_JJ study_NN design_NN calls_VVZ for_II caution_NN in_II the_DD interpretation_NN of_II current_JJ results_NNS and_CC makes_VVZ refinement_NN of_II methodological_JJ issues_NNS a_DD desirable_JJ goal_NN ._.
P09158559A12
Of_II the_DD 639_MC patients_NNS who_PNR may_VM have_VHB received_VVN electrolyte-free_JJ solutions_NNS ,_, 16_MC patients_NNS (_( 2.5_MC %_SYM )_) reported_VVD adverse_JJ effects_NNS ,_, 8_MC of_II which_PNR were_VBD severe_JJ ._.
P09165992A16
The_DD results_NNS of_II the_DD 26_MC randomised_VVNJ trials_NNS that_PNR have_VHB been_VBN carried_VVN out_II to_II date_NN ,_, suggest_VVB that_CST NSAIDs_NNS might_VM be_VBB effective_JJ for_II short-term_NN symptomatic_JJ relief_NN in_II patients_NNS with_II uncomplicated_VVNJ low_JJ back_NN pain_NN ,_, but_CC are_VBB less_RR effective_JJ or_CC ineffective_JJ in_II patients_NNS with_II low_JJ back_NN pain_NN with_II sciatica_NN and_CC patients_NNS with_II sciatica_NN with_II nerve_NN root_NN symptoms_NNS ._.
P09187830A14
Pilot_NN studies_NNS suggest_VVB that_CST QOL_NN can_VM be_VBB enhanced_VVN prior_II+ to_II transplant_NN ,_, and_CC that_CST health-related_VVNJ QOL_NN prior_II+ to_II transplant_NN may_VM predict_VVB survival_NN and_CC clinical_JJ outcomes_NNS ._.
P09198254A06
Estrogen_NN replacement_NN therapy_NN is_VBZ associated_VVN with_II decreased_VVNJ atherosclerosis_NN in_II several_JJ animal_NN models_NNS ._.
P09207617A10
When_CS all_DD 17_MC reports_NNS were_VBD combined_VVN ,_, beta-blockade_NN significantly_RR reduced_VVD all-cause_NN mortality_NN (_( random_JJ effect_NN odds_NNS ratio_NN [_( OR_NN ]_) 0.69_MC ,_, 95_MC %_SYM confidence_NN interval_NN [_( CI_NN ]_) 0.54_MC to_II 0.88_MC )_) ._.
P09214253A08
For_II acute_JJ mono-_JJ and_CC oligoarthritis_NN ,_, rheumatologists_NNS performed_VVD arthrocentesis_NN more_RR appropriately_RR than_CSN nonrheumatologists_NNS and_CC produced_VVD shorter_JJR durations_NNS of_II hospitalization_NN ._.
P09220052A08
A_DD pharmacoeconomic_JJ analysis_NN estimated_VVD that_CST continuation_NN of_II digoxin_NN in_II patients_NNS with_II stable_JJ congestive_JJ heart_NN failure_NN could_VM save_VVB the_DD healthcare_NN system_NN an_DD estimated_VVNJ $_SYM 400_MC million_MC ,_, based_VVN on_II costs_NNS from_II one_MC hospital_NN ._.
P09222261A05
Physician_NN advice_NN to_TO stop_VVI smoking_VVGN substantially_RR increases_VVZ the_DD likelihood_NN of_II smoking_VVGJ cessation_NN and_CC long-term_NN abstinence_NN ._.
P09230868A09
The_DD ABCs_NNS recently_RR have_VHB been_VBN seriously_RR challenged_VVN on_II the_DD basis_NN of_II results_NNS of_II both_CC experimental_JJ and_CC clinical_JJ studies_NNS ._.
P09235072A20
The_DD primary_JJ outcome_NN is_VBZ the_DD development_NN of_II NIDDM_NN according_II+ to_II WHO_NN criteria_NNS (_( fasting_VVGJ plasma_NN glucose_NN level_NN 140_MC mg_NN /_SYM dL_NN or_CC 2-hour_NN plasma_NN glucose_NN 200_MC mg_NN /_SYM dL_NN after_II a_DD 75_MC g_NN OGTT_NN )_) ._.
P09257080A08
Since_CS causes_NNS of_II sudden_JJ death_NN are_VBB heterogeneous_JJ ,_, the_DD clinician_NN should_VM pursue_VVB a_DD multifactorial_JJ approach_NN to_II its_PNG prevention_NN ._.
P09264420A10
Treatment_NN of_II this_DD population_NN is_VBZ likely_RR to_TO realize_VVI the_DD greatest_JJT cumulative_JJ long-term_NN benefit_NN in_II the_DD prevention_NN of_II acute_JJ major_JJ coronary_JJ events_NNS ._.
P09274899A01
PURPOSE_NN :_: To_TO review_VVI information_NN on_II the_DD implications_NNS of_II insulin_NN resistance_NN for_II type_NN II_MC diabetes_NN mellitus_NN (_( non-insulin-dependent_JJ diabetes_NN mellitus_NN )_) and_CC coronary_JJ heart_NN disease_NN ,_, and_CC to_TO derive_VVI guidance_NN from_II this_DD information_NN for_II the_DD management_NN of_II these_DD conditions_NNS ._.
P09286833A06
DATA_NNS SYNTHESIS_NN :_: While_CS nearly_RR all_DD medical_JJ schools_NNS offer_VVB some_DD formal_JJ teaching_VVGN about_II end-of-life_NN care_NN ,_, there_EX is_VBZ considerable_JJ evidence_NN that_CST current_JJ training_VVGN is_VBZ inadequate_JJ ,_, most_RRT strikingly_RR in_II the_DD clinical_JJ years_NNS ._.
P09294665A11
To_II date_NN ,_, no_DD other_JJ antiarrhythmic_JJ drug_NN has_VHZ shown_VVN benefit_NN ,_, while_CS several_PND have_VHB been_VBN shown_VVN to_TO be_VBI harmful_JJ ._.
P09299869A10
EVIDENCE_NN AND_CC INFORMATION_NN SOURCES_NNS :_: The_DD method_NN used_VVN for_II preparing_VVGN this_DD review_NN was_VBD an_DD informal_JJ consensus_NN development_NN ._.
P09309458A20
Attention_NN to_II factors_NNS that_PNR may_VM predispose_VVB an_DD individual_NN to_TO fall_VVI ,_, such_II+ as_II her_PNG balance_NN ,_, eyesight_NN ,_, stairs_NNS ,_, and_CC bathtubs_NNS that_PNR are_VBB difficult_JJ to_TO get_VVI into_II and_CC out_II+ of_II ,_, are_VBB all_PND items_NNS that_PNR need_VVB attention_NN ._.
P09327800A07
VALUES_NNS :_: High_JJ priority_NN was_VBD given_VVN to_II prevention_NN of_II adverse_JJ maternal_JJ and_CC neonatal_JJ outcomes_NNS in_II pregnancies_NNS with_II established_VVNJ hypertension_NN and_CC in_II those_PND at_II high_JJ risk_NN of_II gestational_JJ hypertension_NN through_II the_DD provision_NN of_II effective_JJ nonpharmacologic_JJ management_NN ._.
P09337293A02
All_DD organizations_NNS recommend_VVB against_II any_DD efforts_NNS to_TO detect_VVI early_JJ lung_NN cancer_NN because_CS each_PND of_II four_MC randomized_VVNJ controlled_VVNJ trials_NNS (_( RCTs_NNS )_) has_VHZ failed_VVN to_TO demonstrate_VVI a_DD significant_JJ reduction_NN in_II lung_NN cancer_NN mortality_NN as_II a_DD result_NN of_II screening_VVGN ._.
P09337449A02
DATA_NNS SOURCES_NNS :_: A_DD MEDLINE_NN search_NN encompassing_VVG the_DD years_NNS 1966-1996_MC was_VBD used_VVN to_TO identify_VVI pertinent_JJ literature_NN for_II discussion_NN ._.
P09347000A13
Caution_NN is_VBZ warranted_VVN in_II interpreting_VVGN these_DD results_NNS because_RR :_: 1_MC )_) the_DD treatment_NN is_VBZ not_RR blinded_VVN and_CC this_PND could_VM affect_VVB some_DD outcomes_NNS ;_: 2_MC )_) except_II+ for_II one_MC small_JJ trial_NN postneonatal_JJ survival_NN ,_, lung_NN function_NN ,_, and_CC neurodevelopment_NN have_VHB not_RR been_VBN reported_VVN from_II HVS_NN trials_NNS ;_: and_CC 3_MC )_) the_DD benefits_NNS and_CC disadvantages_NNS have_VHB not_RR been_VBN reported_VVN in_II infants_NNS born_VVN at_II different_JJ gestational_JJ ages_NNS or_CC different_JJ birth_NN weights_NNS ._.
P09357708A02
Small_JJ groups_NNS of_II senior_JJ medical_JJ students_NNS under_II the_DD direction_NN of_II a_DD multidisciplinary_JJ team_NN (_( behavioral_JJ scientist_NN ,_, information_NN specialist_NN ,_, physician_NN )_) facilitate_VVB discussions_NNS of_II clinical_JJ articles_NNS using_VVG checklists_NNS designed_VVN to_TO evaluate_VVI their_PNG quality_NN ._.
P09366779A08
Finally_RR ,_, the_DD relevance_NN of_II this_DD information_NN (_( or_CC lack_NN thereof_RR )_) to_II clinical_JJ practice_NN needs_VVZ to_TO be_VBI determined_VVN ._.
P09374952A01
OBJECTIVES_NNS :_: To_TO review_VVI prospective_JJ epidemiological_JJ studies_NNS and_CC randomized_VVNJ clinical_JJ trials_NNS regarding_VVG the_DD role_NN of_II antioxidant_NN vitamins_NNS (_( vitamins_NNS E_NN and_CC C_NN and_CC beta-carotene_NN )_) in_II the_DD prevention_NN of_II cardiovascular_JJ diseases_NNS ._.
P09388153A11
As_II a_DD result_NN ,_, society_NN could_VM expect_VVB to_TO gain_VVI 1.7_MC million_MC new_JJ quitters_NNS at_II an_DD average_JJ cost_NN of_II $_SYM 3779_MC per_II quitter_NN ,_, $_SYM 2587_MC per_II life-year_NN saved_VVN ,_, and_CC $_SYM 1915_MC for_II every_DD QALY_NN saved_VVN ._.
P09393381A02
Studies_NNS were_VBD identified_VVN through_II a_DD MEDLINE_NN search_NN of_II all_DD English-language_NN publications_NNS between_II 1970_MC and_CC 1996_MC in_II which_PNR the_DD words_NNS estrogen_NN and_CC cognition_NN or_CC estrogen_NN and_CC memory_NN appeared_VVD ._.
P09397232A11
Primary_JJ angioplasty_NN may_VM have_VHB a_DD role_NN in_II selected_VVNJ patients_NNS ._.
P09414540A11
The_DD inclusion_NN criteria_NNS were_VBD fairly_RR broad_JJ because_II+ of_II the_DD quality_NN of_II the_DD studies_NNS located_VVN ._.
P09416913A03
The_DD fact_NN that_CST many_DD practitioners_NNS do_VDB not_RR pursue_VVB a_DD proven_VVNJ treatment_NN strategy_NN in_II patients_NNS who_PNR qualify_VVB must_VM be_VBB redressed_VVN through_II education_NN and_CC reinforcement_NN of_II existing_VVGJ recommendations_NNS ._.
P09426711A02
The_DD experimental_JJ observation_NN that_CST low-fat_NN diets_NNS and_CC soy_NN protein_NN extracts_NNS may_VM influence_VVB the_DD progression_NN of_II established_VVNJ tumors_NNS ,_, rather_II+ than_II inhibiting_VVGN etiologic_JJ factors_NNS ,_, is_VBZ particularly_RR intriguing_VVG because_CS it_PN may_VM serve_VVB to_TO help_VVI explain_VVI the_DD paradox_NN whereby_CST the_DD incidence_NN of_II clinical_JJ prostate_NN cancer_NN shows_VVZ wide_JJ geographic_JJ variation_NN ,_, yet_CC the_DD evidence_NN persists_VVZ that_CST the_DD incidence_NN of_II microfocal_JJ tumors_NNS is_VBZ essentially_RR the_DD same_JJ worldwide_JJ ._.
P09438745A03
Additional_JJ data_NNS sources_NNS included_VVD bibliographies_NNS of_II papers_NNS identified_VVN on_II MEDLINE_NN and_CC bibliographies_NNS in_II textbooks_NNS on_II substance_NN abuse_NN ._.
P09445511A09
The_DD risk_NN of_II methemoglobinemia_NN (_( defined_VVN as_II methemoglobin_NN concentration_NN >_SYM 5_MC %_SYM and_CC requiring_VVGN medical_JJ intervention_NN )_) was_VBD estimated_VVN from_II all_DD prospective_JJ studies_NNS ._.
P09457159A16
Individuals_NNS infected_VVN with_II the_DD hepatitis_NN C_NN virus_NN should_VM not_RR donate_VVB blood_NN ,_, organs_NNS ,_, tissues_NNS ,_, or_CC semen_NN ._.
P09469146A07
DATA_NNS EXTRACTION_NN :_: The_DD following_VVGJ information_NN was_VBD extracted_VVN from_II the_DD 11_MC studies_NNS :_: characteristics_NNS of_II the_DD study_NN population_NN ,_, number_NN of_II participants_NNS (_( and_CC number_NN followed_VVN to_II completion_NN )_) ,_, length_NN of_II follow-up_NN ,_, type_NN of_II intervention_NN ,_, outcome_NN measures_NNS and_CC results_NNS ._.
P09476302A01
Improvement_NN of_II symptoms_NNS and_CC ,_, accordingly_RR ,_, quality_NN of_II life_NN ,_, as_CC+ well_CC+ as_CC prolongation_NN of_II life_NN ,_, are_VBB the_DD objectives_NNS of_II drug_NN therapy_NN in_II congestive_JJ heart_NN failure_NN patients_NNS ._.
P09479406A11
Designing_VVG tolerable_JJ ,_, effective_JJ regimens_NNS will_VM require_VVB careful_JJ monitoring_VVGN for_II compliance_NN ,_, adverse_JJ effects_NNS ,_, and_CC potential_JJ drug_NN interactions_NNS ._.
P09483156A06
To_TO make_VVI recommendations_NNS for_II the_DD future_JJ development_NN and_CC organisation_NN of_II neonatal_JJ screening_VVGN for_II inborn_NN errors_NNS of_II metabolism_NN in_II the_DD UK_NNP ._.
P09483159A28
Other_JJ studies_NNS that_PNR provide_VVB some_DD natural_JJ history_NN data_NNS suggest_VVB that_CST mild_JJ degrees_NNS of_II amblyopia_NN may_VM resolve_VVB spontaneously_RR ._.
P09483162A02
To_TO try_VVI to_TO identify_VVI the_DD optimal_JJ time_NN at_II which_PNR to_TO start_VVI assessing_VVGN new_JJ and_CC fast-evolving_VVGJ health_NN technologies_NNS ._.
P09483436A22
But_CC what_PND is_VBZ the_DD better_JJR solution_NN for_II thrombosis_NN and_CC which_PND for_II plaque_NN disruption_NN ?_.
P09484275A08
For_II accurate_JJ staging_VVGN and_CC to_TO reduce_VVI the_DD risk_NN of_II recurrence_NN in_II the_DD axilla_NN ,_, level_NN 1_MC and_CC level_NN 2_MC nodes_NNS should_VM be_VBB removed_VVN ._.
P09484278A18
Tamoxifen_NN should_VM normally_RR be_VBB administered_VVN daily_RR for_II 5_MC years_NNS ._.
P09484281A18
Intramuscular_JJ administration_NN of_II opioids_NNS is_VBZ not_RR recommended_VVN ._.
P09496407A07
It_PN is_VBZ most_RRT commonly_RR caused_VVN by_II dermatophytes_NNS ,_, but_CC yeasts_NNS and_CC molds_NNS can_VM also_RR be_VBB involved_VVN ._.
P09499674A15
Finally_RR ,_, the_DD Italian_JJ Federation_NN of_II Centers_NNS for_II the_DD Surveillance_NN of_II Anticoagulant_NN (_( FCSA_NN )_) therapies_NNS was_VBD founded_VVN in_II 1989_MC ._.
P09505959A06
Scientific_JJ evidence_NN was_VBD given_VVN precedence_NN over_II clinical_JJ anecdotal_JJ experience_NN ._.
P09516096A11
If_CS applied_VVN appropriately_RR ,_, they_PN can_VM ensure_VVB that_CST management_NN of_II patients_NNS is_VBZ based_VVN on_II clinically_RR useful_JJ diagnostic_JJ tests_NNS and_CC treatments_NNS that_PNR have_VHB been_VBN shown_VVN to_TO be_VBI effective_JJ and_CC not_RR harmful_JJ ._.
P09526814A02
The_DD diabetic_JJ dyslipidemia_NN in_II these_DD patients_NNS is_VBZ characterized_VVN by_II moderately_RR high_JJ levels_NNS of_II (_( 1_MC )_) serum_NN cholesterol_NN and_CC triglycerides_NNS ;_: (_( 2_MC )_) small_JJ ,_, dense_JJ low-density_NN lipoprotein_NN (_( LDL_NN )_) particles_NNS ;_: and_CC (_( 3_MC )_) low_JJ high-density_NN lipoprotein_NN (_( HDL_NN )_) cho-lesterol_NN concentrations_NNS ._.
P09537220A13
A_DD short-term_NN reduction_NN on_II markers_NNS like_II ventricular_JJ ectopic_JJ beats_NNS ,_, for_II example_NN ,_, does_VDZ not_RR translate_VVB into_II a_DD long-term_NN decrease_NN in_II arrhythmia-related_VVNJ mortality_NN ._.
P09539499A08
The_DD currently_RR available_JJ data_NNS concerning_VVG the_DD efficacy_NN ,_, safety_NN ,_, and_CC cost_NN provide_VVB a_DD compelling_VVGJ argument_NN for_II embracing_VVGN abciximab_NN therapy_NN in_II the_DD treatment_NN of_II patient_NN subsets_NNS where_PNR it_PN will_VM be_VBB a_DD cost-saving_VVGJ or_CC cost-neutral_JJ adjunct_NN to_II percutaneous_JJ coronary_JJ intervention_NN ._.
P09550500A02
The_DD Scandinavian_NN Simvastatin_NN Survival_NN Study_NN (_( 4S_NN )_) ,_, the_DD West_NN of_II Scotland_NNP Coronary_JJ Prevention_NN Study_NN (_( WOSCOPS_NN )_) ,_, and_CC the_DD Cholesterol_NN and_CC Recurrent_JJ Events_NNS (_( CARE_NN )_) trial_NN ,_, as_CC+ well_CC+ as_CC numerous_JJ other_JJ investigations_NNS ,_, have_VHB established_VVN that_CST decreasing_VVGN elevated_VVNJ levels_NNS of_II low-density_NN lipoprotein_NN (_( LDL_NN )_) cholesterol_NN will_VM result_VVB in_II a_DD reduction_NN in_II CAD_NN risk_NN ._.
P09560079A08
Older_JJR age_NN was_VBD also_RR sometimes_NNS associated_VVN with_II decreased_VVNJ participation_NN in_II research_NN ._.
P09578541A02
Patients_NNS and_CC doctors_NNS seek_VVB evidence-based_VVNJ clinical_JJ information_NN ,_, regulatory_JJ agencies_NNS look_VVB for_II efficacy_NN and_CC safety_NN ,_, and_CC the_DD health-care_NN industry_NN demands_VVZ data_NNS on_II the_DD risk-benefit_NN ratio_NN attached_VVN to_II a_DD product_NN ._.
P09586593A16
Transurethral_JJ microwave_NN thermotherapy_NN of_II the_DD prostate_NN (_( TUMT_NN )_) and_CC radiofrequency_NN transurethral_JJ needle_NN ablation_NN (_( TUNA_NN )_) are_VBB minimally_RR invasive_JJ ,_, safe_JJ new_JJ therapies_NNS ._.
P09597223A04
The_DD published_VVNJ literature_NN was_VBD reviewed_VVN and_CC classified_VVN into_II one_MC of_II four_MC categories_NNS ,_, according_II+ to_II study_NN design_NN and_CC scientific_JJ value_NN ._.
P09606473A06
Cumulative_JJ outcomes_NNS were_VBD considered_VVN up_II+ to_II 6_MC months_NNS after_II initial_JJ PTCA_NN ._.
P09615298A03
With_II funding_VVGN from_II the_DD Office_NN of_II Alternative_JJ Medicine_NN ,_, National_JJ Institutes_NNS of_II Health_NN ,_, our_PNG goal_NN was_VBD to_TO identify_VVI the_DD type_NN and_CC prevalence_NN of_II complementary_JJ and_CC alternative_JJ treatments_NNS for_II asthma_NN in_II use_NN in_II the_DD United_VVNJ States_NNS in_II order_NN to_TO establish_VVI a_DD research_NN agenda_NN for_II the_DD study_NN of_II the_DD most_RRT promising_VVGJ therapies_NNS ._.
P09625664A03
DATA_NNS SOURCES_NNS :_: Published_VVNJ reports_NNS of_II clinical_JJ studies_NNS were_VBD found_VVN by_II searching_VVGN MEDLINE_NN and_CC selected_VVNJ bibliographies_NNS ._.
P09636826A08
DATA_NNS SYNTHESIS_NN :_: Specialized_VVNJ centres_NNS /_SYM clinicians_NNS fared_VVD better_RRR both_CC when_CS process_NN and_CC outcome_NN indicators_NNS were_VBD used_VVN ._.
P09644351A25
Provision_NN of_II quality_NN ,_, cost-effective_JJ care_NN for_II patients_NNS requiring_VVG prolonged_VVNJ ventilation_NN is_VBZ a_DD true_JJ clinical_JJ challenge_NN ._.
P09649257A02
It_PN is_VBZ associated_VVN with_II a_DD considerable_JJ burden_NN of_II suffering_VVGN ._.
P09663319A04
The_DD interventional_JJ therapies_NNS include_VVB permanent_JJ pacing_VVGN for_II bradyarrhythmias_NNS ,_, arrhythmia_NN surgery_NN for_II arrhythmias_NNS ,_, percutaneous_JJ catheter_NN ablation_NN and_CC implantable_JJ devices_NNS for_II tachyarrhythmias_NNS ._.
P09676168A16
STUDY_NN IMPLICATIONS_NNS :_: The_DD trial_NN will_VM demonstrate_VVB whether_CST the_DD use_NN of_II a_DD heparin-bonded_VVNJ stent_NN can_VM improve_VVB long_JJ term_NN patency_NN and_CC clinical_JJ outcome_NN in_II patients_NNS undergoing_VVG clinically_RR indicated_VVNJ PTCA_NN of_II totally_RR occluded_VVNJ coronary_JJ arteries_NNS ._.
P09684847A09
This_DD collective_JJ new_JJ knowledge_NN provides_VVZ the_DD basis_NN for_II a_DD shift_NN in_II the_DD management_NN of_II CAD_NN from_II an_DD invasive_JJ ,_, procedure-oriented_VVNJ viewpoint_NN currently_RR dominant_JJ in_II cardiology_NN toward_II a_DD noninvasive_JJ orientation_NN that_PNR views_VVZ the_DD problem_NN as_II a_DD graded_VVNJ ,_, continuous_JJ ,_, heterogeneously_RR diffuse_JJ disease_NN process_NN for_II which_PNR reversal_NN treatment_NN is_VBZ optimal_JJ ._.
P09705684A07
RESULTS_NNS :_: A_DD total_NN of_II 10,948_MC patients_NNS were_VBD enrolled_VVN between_II November_NN 1995_MC and_CC January_NN 1997_MC ._.
P09707957A04
Major_JJ hypertension_NN texts_NNS were_VBD also_RR reviewed_VVN for_II information_NN on_II combination_NN therapy_NN ._.
P09712593A15
Benefits_NNS were_VBD not_RR restricted_VVN to_II particular_JJ patient_NN groups_NNS ._.
P09727542A04
The_DD primary_JJ efficacy_NN end_NN point_NN was_VBD death_NN ,_, reinfarction_NN ,_, or_CC any_DD (_( urgent_JJ or_CC elective_JJ )_) target_NN vessel_NN revascularization_NN (_( TVR_NN )_) at_II 6_MC months_NNS by_II intention-to-treat_NN (_( ITT_NN )_) analysis_NN ._.
P09738589A07
Panel_NN members_NNS also_RR considered_VVD the_DD effect_NN of_II CID_NN on_II quality_NN of_II life_NN and_CC the_DD cost-effectiveness_NN and_CC efficacy_NN of_II different_JJ pharmacologic_JJ approaches_NNS ._.
P09743780A08
As_II a_DD first_JJ step_NN ,_, many_DD medical_JJ schools_NNS introduce_VVB students_NNS to_II on-line_NN databases_NNS ,_, most_RRT notably_RR MEDLINE_NN ._.
P09753529A08
Level_NN 1_MC :_: Evidence_NN from_II at_RR+ least_RR one_MC randomized_VVNJ ,_, controlled_VVNJ trial_NN ._.
P09759577A09
For_II patients_NNS with_II local-regional_JJ disease_NN (_( stage_NN III_MC ,_, satellites_NNS ,_, and_CC local_JJ recurrence_NN )_) ,_, a_DD selective_JJ approach_NN to_II imaging_VVGJ studies_NNS is_VBZ warranted_VVN ._.
P09765748A16
Most_PND of_II the_DD patients_NNS with_II local_JJ recurrence_NN in_II these_DD trials_NNS underwent_VVD mastectomy_NN ._.
P09765759A19
Therefore_RR ,_, if_CS the_DD outcome_NN of_II interest_NN is_VBZ a_DD reduction_NN in_II the_DD frequency_NN of_II local_JJ tumour_NN recurrence_NN ,_, radiotherapy_NN is_VBZ recommended_VVN ._.
P09765768A25
Patient_NN or_CC tumour_NN factors_NNS (_( number_NN of_II involved_VVNJ sites_NNS ,_, location_NN of_II involved_VVNJ sites_NNS or_CC level_NN of_II pain_NN control_NN )_) that_PNR are_VBB relative_JJ contraindications_NNS to_II the_DD use_NN of_II multiple_JJ single_JJ fields_NNS of_II radiation_NN as_II an_DD alternative_NN ._.
P09777140A08
Recent_JJ trials_NNS have_VHB been_VBN performed_VVN in_II patients_NNS with_II unstable_JJ angina_NN ,_, and_CC trials_NNS of_II adjunctive_JJ therapy_NN are_VBB currently_RR underway_VVB in_II patients_NNS receiving_VVG thrombolysis_NN for_II AMI_NN ,_, and_CC for_II secondary_JJ prevention_NN ._.
P09783489A08
Each_PND of_II the_DD guidelines_NNS acknowledged_VVD the_DD important_JJ effect_NN of_II associated_VVNJ cardiovascular_JJ disease_NN (_( CVD_NN )_) risk_NN factors_NNS on_II the_DD likely_JJ benefits_NNS of_II treatment_NN ,_, but_CC did_VDD not_RR expand_VVB on_II the_DD magnitude_NN of_II this_DD effect_NN ._.
P09793596A02
DATA_NNS SOURCES_NNS :_: A_DD MEDLINE_NN search_NN (_( January_NN 1960-April_NN 1998_MC )_) ,_, Current_JJ Contents_NNS search_NN ,_, additional_JJ references_NNS listed_VVN in_II articles_NNS ,_, and_CC unpublished_VVNJ data_NNS obtained_VVN from_II the_DD manufacturer_NN were_VBD used_VVN to_TO identify_VVI data_NNS from_II scientific_JJ literature_NN ._.
P09794095A02
The_DD radiologist_NN who_PNR performs_VVZ percutaneous_JJ breast_NN biopsies_NNS assumes_VVZ an_DD increased_VVNJ level_NN of_II responsibility_NN for_II the_DD patient_NN regarding_VVG patient_NN selection_NN ,_, lesion_NN selection_NN ,_, performance_NN of_II the_DD biopsy_NN procedure_NN ,_, interpretation_NN of_II results_NNS ,_, and_CC patient_NN follow-up_NN ._.
P09794982A06
The_DD goals_NNS of_II such_DD studies_NNS would_VM be_VBB to_TO understand_VVI better_RRR the_DD acute_JJ HHE_NN event_NN and_CC to_TO evaluate_VVI the_DD possibility_NN of_II long-term_NN sequelae_NNS ._.
P09806109A02
Primarily_RR ,_, the_DD drug_NN inhibits_VVZ platelet_NN aggregation_NN ,_, but_CC it_PN may_VM also_RR have_VHB anticoagulant_NN activity_NN and_CC other_JJ beneficial_JJ effects_NNS ,_, such_II+ as_II inhibiting_VVGN migration_NN and_CC promoting_VVGN apoptosis_NN of_II smooth_JJ muscle_NN cells_NNS ._.
P09809771A17
An_DD automatic_JJ implantable_JJ cardioverter-defibrillator_NN should_VM be_VBB used_VVN in_II persons_NNS who_PNR have_VHB a_DD history_NN of_II ventricular_JJ fibrillation_NN or_CC serious_JJ sustained_VVNJ ventricular_JJ tachycardia_NN or_CC who_PNR are_VBB at_II very_RR high_JJ risk_NN for_II developing_VVGN sudden_JJ cardiac_JJ death_NN ._.
P09819098A02
Abundant_JJ clinical_JJ trial_NN evidence_NN supports_VVZ the_DD importance_NN of_II LDL_NN cholesterol-lowering_VVGN in_II decreasing_VVGN CAD_NN risk_NN ,_, both_CC in_II angiographic_JJ trials_NNS ,_, which_PNR measure_VVB CAD_NN progression_NN ,_, and_CC in_II trials_NNS with_II morbidity_NN and_CC mortality_NN endpoints_NNS ._.
P09821012A05
However_RR ,_, the_DD extent_NN of_II LDL-C_NN reduction_NN achieved_VVN often_RR fell_VVB short_JJ of_II LDL-C_NN treatment_NN targets_NNS recommended_VVN in_II national_JJ and_CC international_JJ guidelines_NNS ._.
P09825877A13
Drug_NN interactions_NNS involving_VVG atorvastatin_NN can_VM be_VBB expected_VVN to_TO parallel_VVI those_PND of_II other_JJ statins_NNS metabolized_VVN via_II CYP3A4_NN ._.
P09832669A05
In_II addition_NN ,_, emerging_VVGJ evidence_NN suggests_VVZ a_DD future_JJ role_NN for_II GP_NN IIb_NN /_SYM IIIa_NN receptor_NN inhibitors_NNS as_II an_DD adjunct_NN to_II low-dose_NN fibrinolytic_JJ therapy_NN in_II patients_NNS with_II acute_JJ MI_NN ._.
P09852937A05
Multiple_JJ randomized_VVNJ and_CC nonrandomized_VVNJ trials_NNS indicate_VVB that_CST prehospital_JJ care_NN providers_NNS (_( including_VVG paramedics_NNS ,_, nurses_NNS and_CC doctors_NNS )_) are_VBB able_JJ to_TO acquire_VVI prehospital_JJ ECGs_NNS with_II negligible_JJ increases_NNS in_II on-scene_NN time_NN ,_, ranging_VVG from_II 30_MC s_NNS to_II 7_MC mins_NNS ._.
P09858958A03
Currently_RR ,_, pneumonia_NN patients_NNS are_VBB classified_VVN as_II having_VVGN either_CC community-acquired_VVNJ or_CC hospital-acquired_VVNJ infection_NN rather_II+ than_II typical_JJ versus_CC atypical_JJ ._.
P09861792A05
Review_NN of_II meta-analyses_NNS of_II clinical_JJ trials_NNS showed_VVD that_CST ERT_NN /_SYM HRT_NN ever-users_NNS (_( patients_NNS who_PNR have_VHB ever_RR used_VVN ERT_NN /_SYM HRT_NN )_) did_VDD not_RR have_VHB an_DD increased_VVNJ risk_NN of_II breast_NN cancer_NN ,_, but_CC current_JJ users_NNS did_VDD have_VHB an_DD increased_VVNJ risk_NN ,_, with_II some_DD studies_NNS reporting_VVGN increasing_VVGJ risk_NN with_II duration_NN of_II ERT_NN ._.
P09870124A01
OBJECTIVE_NN :_: To_TO review_VVI and_CC recognize_VVI how_CST presentation_NN ,_, investigation_NN ,_, risk_NN factor_NN modification_NN ,_, and_CC treatment_NN of_II coronary_JJ artery_NN disease_NN (_( CAD_NN )_) is_VBZ different_JJ for_II women_NNS than_CSN for_II men_NNS ._.
P09878986A07
There_EX was_VBD no_DD reduction_NN in_II the_DD rate_NN of_II death_NN at_II day_NN 30_MC or_CC nonfatal_JJ MI_NN in_II patients_NNS who_PNR received_VVD lamifiban_NN ;_: however_RR ,_, at_II 6_MC months_NNS a_DD significant_JJ treatment_NN effect_NN was_VBD seen_VVN in_II patients_NNS who_PNR received_VVD low_JJ dose_NN lamifiban_NN (_( 13.7_MC %_SYM ,_, p_NN =_SYM 0.02_MC )_) but_CC not_RR high_JJ dose_NN lamifiban_NN (_( 16.4_MC %_SYM ,_, p_NN =_SYM 0.38_MC )_) compared_VVN with_II those_PND who_PNR received_VVD heparin_NN alone_JJ (_( 18.1_MC %_SYM )_) ._.
P09891161A21
If_CS more_RR rigorous_JJ study_NN designs_NNS were_VBD required_VVN for_II publication_NN ,_, radiology_NN outcomes_NNS research_NN would_VM probably_RR improve_VVB drastically_RR ._.
P09915665A22
At_II the_DD same_JJ time_NN ,_, it_PN is_VBZ presently_RR unknown_VVN whether_CST improved_VVNJ glycemic_JJ control_NN decreases_VVZ coronary_JJ artery_NN disease_NN risk_NN in_II such_DD patients_NNS ._.
P09920227A05
DATA_NNS EXTRACTION_NN :_: Study_NN design_NN ,_, inclusion_NN and_CC exclusion_NN criteria_NNS ,_, setting_VVGN ,_, sample_NN size_NN ,_, response_NN rate_NN ,_, mean_NN age_NN ,_, method_NN of_II medication_NN verification_NN and_CC fall_NN assessment_NN ,_, fall_NN definition_NN ,_, and_CC the_DD number_NN of_II fallers_NNS and_CC non-fallers_NNS taking_VVG specific_JJ classes_NNS of_II psychotropic_JJ drugs_NNS ._.
P09924156A18
CONCLUSIONS_NNS :_: The_DD results_NNS of_II this_DD study_NN demonstrate_VVB that_CST GP_NN IIb_NN /_SYM IIIa_NN antagonists_NNS are_VBB able_JJ to_TO prevent_VVI vessel_NN occlusion_NN after_II PTCA_NN complicated_VVN by_II subsequent_JJ threatened_VVNJ or_CC abrupt_JJ vessel_NN closure_NN ._.
P09934917A14
Crystalloid_NN resuscitation_NN is_VBZ associated_VVN with_II a_DD lower_JJR mortality_NN in_II trauma_NN patients_NNS ._.
P09972388A08
CONCLUSIONS_NNS :_: In_II general_NN ,_, the_DD small_JJ amount_NN of_II published_VVNJ literature_NN supports_VVZ the_DD empirical_JJ use_NN of_II levodopa_NN /_SYM carbidopa_NN as_II a_DD safe_JJ and_CC effective_JJ therapy_NN to_TO manage_VVI the_DD distressing_VVGJ symptoms_NNS of_II RLS_NN in_II a_DD hemodialysis_NN population_NN ._.
P10026768A08
Men_NNS with_II high-grade_NN tumors_NNS (_( Gleason_NNP score_NN >_SYM or_CC =_SYM 7_MC )_) or_CC with_II seminal_JJ vesicle_NN or_CC lymph_NN node_NN involvement_NN in_II whom_PNR disease_NN recurs_VVZ within_II 2_MC years_NNS of_II radical_JJ prostatectomy_NN are_VBB most_RRT appropriately_RR observed_VVN or_CC treated_VVN with_II early_JJ hormonal_JJ therapy_NN ._.
P10047618A08
Sotalol_NN was_VBD 1_MC of_II 2_MC drugs_NNS selected_VVN for_II comparison_NN with_II implantable_JJ defibrillators_NNS in_II the_DD recent_JJ National_JJ Institutes_NNS of_II Health_NN Antiarrhythmics_NNS versus_CC Implantable_JJ Defibrillator_NN (_( AVID_NN )_) study_NN ._.
P10069357A02
The_DD traditional_JJ management_NN of_II type_NN 2_MC diabetes_NN has_VHZ been_VBN ineffective_JJ in_II altering_VVGN this_DD dismal_JJ prognosis_NN ._.
P10079780A01
OBJECTIVE_NN :_: To_TO estimate_VVI the_DD magnitude_NN of_II the_DD clinical_JJ benefits_NNS that_PNR may_VM result_VVB from_II use_NN of_II abciximab_NN at_II the_DD time_NN of_II angioplasty_NN and_CC the_DD cost_NN of_II achieving_VVGN them_PN ._.
P10082589A23
The_DD structured_VVNJ review_NN provides_VVZ a_DD concise_JJ analysis_NN of_II these_DD books_NNS to_TO allow_VVI readers_NNS to_TO determine_VVI application_NN of_II these_DD publications_NNS to_II their_PNG needs_NNS ._.
P10085198A03
In_II contrast_NN to_II other_JJ major_JJ chronic_JJ diseases_NNS such_II+ as_II heart_NN disease_NN and_CC cancer_NN ,_, medical_JJ treatments_NNS for_II COPD_NN have_VHB not_RR made_VVN decisive_JJ inroads_NNS into_II its_PNG morbidity_NN or_CC death_NN rates_NNS over_II the_DD last_JJ 20_MC years_NNS ,_, resulting_VVG in_II continuing_VVGJ efforts_NNS to_TO reduce_VVI disability_NN in_II patients_NNS with_II established_VVNJ disease_NN ._.
P10089844A12
Nevertheless_RR ,_, in_II comparison_NN with_II amiodarone_NN ,_, treatment_NN of_II MADIT_NN patients_NNS with_II ICDs_NNS seems_VVZ to_TO be_VBI cost-effective_JJ ,_, especially_RR if_CS ICDs_NNS are_VBB implanted_VVN transvenously_RR and_CC have_VHB the_DD improved_VVNJ battery_NN longevity_NN of_II the_DD current_JJ devices_NNS ._.
P10092711A02
The_DD most_RRT common_JJ pathology_NN of_II vascular_JJ diseases_NNS is_VBZ occlusion_NN ._.
P10094222A03
This_DD review_NN was_VBD undertaken_VVN to_TO evaluate_VVI the_DD relationship_NN of_II allergic_JJ rhinitis_NN to_II these_DD diseases_NNS and_CC to_TO provide_VVI support_NN for_II proposing_VVGN national_JJ guidelines_NNS for_II managing_VVGN rhinitis_NN ._.
P10103321A17
The_DD probability_NN of_II UTI_NN in_II each_PND of_II these_DD groups_NNS depends_VVZ not_RR only_RR on_II the_DD sensitivity_NN and_CC specificity_NN of_II the_DD test_NN ,_, but_CC also_RR on_II the_DD prior_JJ probability_NN of_II the_DD UTI_NN among_II the_DD children_NNS being_VBG tested_VVN ._.
P10140233A08
Rates_NNS of_II performance_NN of_II tasks_NNS of_II smoking_VVGJ cessation_NN by_II healthcare_NN professionals_NNS ,_, including_VVG offering_VVGN counselling_VVGN ,_, setting_VVGN dates_VVZ to_TO stop_VVI smoking_VVGN ,_, giving_VVGN follow_NN+ up_NN appointments_NNS ,_, distributing_VVGN self_PN help_NN materials_NNS ,_, and_CC recommending_VVGN nicotine_NN gum_NN ._.
P10147240A19
(_( ABSTRACT_NN TRUNCATED_VVD AT_II 400_MC WORDS_NNS )_)
P10160469A15
Although_CS limited_VVNJ formulary_NN choices_NNS have_VHB been_VBN used_VVN in_II the_DD hospital_NN setting_VVGN for_II years_NNS ,_, and_CC are_VBB now_RR becoming_VVG popular_JJ in_II managed_VVNJ care_NN ,_, there_EX is_VBZ no_DD proof_NN that_CST this_DD mechanism_NN saves_VVZ money_NN when_CS looking_VVG at_II the_DD overall_JJ picture_NN ._.
P10169000A05
If_CS current_JJ clinical_JJ information_NN is_VBZ unreliable_JJ ,_, then_RR healthcare_NN risk_NN management_NN strategies_NNS for_II LBP_NN must_VM be_VBB revised_VVN ._.
P10172669A12
In_II subgroup_NN analyses_NNS ,_, alteplase_NN was_VBD a_DD cost-effective_JJ treatment_NN option_NN for_II all_DD elderly_JJ patients_NNS (_( >_SYM 60_MC years_NNS of_II age_NN )_) and_CC all_DD patients_NNS >_SYM 40_MC years_NNS of_II age_NN with_II anterior_JJ infarction_NN ._.
P10182193A02
Some_DD preventive_JJ approaches_NNS are_VBB both_CC inexpensive_JJ and_CC effective_JJ ;_: others_NNS are_VBB expensive_JJ while_CS their_PNG effectiveness_NN is_VBZ slight_JJ or_CC unproven_VVN ._.
P10186462A18
These_DD benefits_NNS come_VVB at_II a_DD substantial_JJ economic_JJ cost_NN ,_, but_CC one_MC that_PNR is_VBZ in_II line_NN with_II accepted_VVNJ costs_NNS for_II other_JJ medical_JJ interventions_NNS ._.
P10190758A06
Of_II these_DD nine_MC ,_, four_MC controlled_VVNJ studies_NNS were_VBD chosen_VVN based_VVN upon_II their_PNG large_JJ patient_NN populations_NNS and_CC their_PNG consistency_NN in_II brand_NN and_CC dosage_NN of_II St._NN John_NN 's_GE wort_NN used_VVN ._.
P10196487A01
EXECUTIVE_NN SUMMARY_NN The_DD "_`` Guideline_NN for_II Prevention_NN of_II Surgical_JJ Site_NN Infection_NN ,_, 1999_MC "_'' presents_VVZ the_DD Centers_NNS for_II Disease_NN Control_NN and_CC Prevention_NN (_( CDC_NN )_) 's_GE recommendations_NNS for_II the_DD prevention_NN of_II surgical_JJ site_NN infections_NNS (_( SSIs_NNS )_) ,_, formerly_RR called_VVN surgical_JJ wound_NN infections_NNS ._.
P10203636A07
Participants_NNS reported_VVD using_VVGN EBM_NN in_II their_PNG clinical_JJ practice_NN always_RR (_( 33_MC ,_, 11_MC %_SYM )_) ,_, often_RR (_( 173_MC ,_, 59_MC %_SYM )_) ,_, sometimes_NNS (_( 80_MC ,_, 27_MC %_SYM )_) ,_, or_CC rarely_RR /_SYM never_RR (_( 8_MC ,_, 3_MC %_SYM )_) ._.
P10209667A20
Many_DD patients_NNS will_VM have_VHB primary_JJ refractory_JJ of_II relapsing_VVGJ disease_NN in_II whom_PNR survival_NN is_VBZ short_JJ despite_II all_DD current_JJ therapeutic_JJ modalities_NNS ._.
P10220238A03
A_DD good_JJ example_NN is_VBZ the_DD concern_NN about_II using_VVGN oral_JJ cobalamin_NN when_CS treating_VVG pernicious_JJ anemia_NN ._.
P10228456A11
CONSENSUS_NN PROCESS_NN :_: The_DD panel_NN ,_, answering_VVG predefined_VVNJ questions_NNS ,_, developed_VVD their_PNG conclusions_NNS based_VVN on_II the_DD scientific_JJ evidence_NN presented_VVN in_II open_JJ forum_NN and_CC the_DD scientific_JJ literature_NN ._.
P10321422A13
In_II adapting_VVGN the_DD findings_NNS on_II cholesterol-lowering_VVGJ efficacy_NN from_II this_DD analysis_NN to_II our_PNG lipid_NN clinic_NN ,_, we_PN concluded_VVD that_CST the_DD most_RRT cost-effective_JJ treatment_NN approach_NN is_VBZ to_TO individualize_VVI the_DD selection_NN of_II an_DD HMG-CoA_NN reductase_NN inhibitor_NN based_VVN on_II both_CC coronary_JJ risk_NN and_CC the_DD LDL-C_NN reduction_NN required_VVN to_TO achieve_VVI NCEP_NN ATP-II_NN goals_NNS ._.
P10332429A12
For_II prostate_NN cancer_NN strong_JJ evidence_NN exists_VVZ for_II a_DD preventive_JJ effect_NN of_II reduced_VVNJ fat_NN intake_NN ,_, vitamin_NN E_NN ,_, selenium_NN and_CC soy_NN proteins_NNS ._.
P10333848A16
(_( 2_MC )_) To_TO reduce_VVI blood_NN pressure_NN in_II the_DD population_NN at_JJ+ large_JJ ,_, it_PN is_VBZ recommended_VVN that_CST Canadians_NNS attain_VVB and_CC maintain_VVB a_DD healthy_JJ BMI_NN (_( 20-25_MC )_) ._.
P10333852A14
(_( 2_MC )_) For_II normotensive_JJ people_NNS obtaining_VVG on_II average_NN 60_MC mmol_NN of_II potassium_NN daily_RR through_II dietary_JJ intake_NN ,_, potassium_NN supplementation_NN is_VBZ not_RR recommended_VVN as_II a_DD means_NNS of_II preventing_VVGN an_DD increase_NN in_II blood_NN pressure_NN ._.
P10340840A14
Treatment_NN alone_JJ is_VBZ not_RR enough_PND ;_: treatment_NN to_II goal_NN blood_NN pressure_NN is_VBZ an_DD essential_JJ first_JJ step_NN towards_II optimal_JJ target-organ_NN protection_NN ._.
P10346425A02
US_NNP National_JJ Cholesterol_NN Education_NN Program_NN (_( NCEP_NN )_) guidelines_NNS recommend_VVB aggressive_JJ lipid-modifying_VVGJ therapy_NN for_II individuals_NNS at_II highest_JJT risk_NN for_II CHD_NN ._.
P10353983A05
The_DD therapeutic_JJ approaches_NNS considered_VVN included_VVD continuous_JJ anticonvulsant_JJ therapies_NNS ,_, intermittent_JJ therapy_NN ,_, or_CC no_DD anticonvulsant_JJ therapy_NN ._.
P10359204A09
RESULTS_NNS :_: As_II+ of_II March_NN 1_MC ,_, 1998_MC ,_, there_EX are_VBB 9,373_MC references_NNS ,_, excluding_VVG citations_NNS of_II letters_NNS or_CC comments_NNS ,_, contained_VVD in_II the_DD core_NN pediatric_JJ surgery_NN literature_NN ,_, as_CS provided_VVN through_II Medline_NN ._.
P10365602A08
In_II patients_NNS with_II symptomatic_JJ CHF_NN due_II+ to_II systolic_JJ dysfunction_NN the_DD addition_NN of_II diuretics_NNS and_CC digoxin_NN appears_VVZ to_II reducing_VVGN worsening_VVGJ CHF_NN without_II improving_VVGN survival_NN ._.
P10366798A05
RESULTS_NNS :_: In_II patients_NNS with_II symptoms_NNS or_CC signs_NNS suggestive_JJ of_II DVT_NN ,_, compression_NN ultrasound_NN (_( CUS_NN )_) appears_VVZ to_TO be_VBI the_DD diagnostic_JJ test_NN of_II first_JJ choice_NN ,_, since_CS it_PN is_VBZ a_DD noninvasive_JJ test_NN with_II high_JJ specificity_NN and_CC sensitivity_NN for_II proximal_JJ DVT_NN (_( about_RR 97_MC %_SYM )_) ._.
P10372678A04
With_II the_DD recognition_NN of_II that_DD reality_NN comes_VVZ a_DD variety_NN of_II challenges_NNS to_II clinicians_NNS and_CC investigators_NNS ._.
P10381989A12
When_CS these_DD data_NNS were_VBD combined_VVN using_VVG effect_NN size_NN as_II a_DD common_JJ measure_NN ,_, the_DD use_NN of_II ipratropium_NN was_VBD associated_VVN with_II a_DD summary_NN effect_NN size_NN of.38_MC (_( 95_MC %_SYM CI.27_MC to.48_MC )_) ._.
P10387403A01
BACKGROUND_NN :_: Although_CS the_DD randomised_VVNJ controlled_VVNJ trial_NN (_( RCT_NN )_) is_VBZ regarded_VVN as_II the_DD '_`` gold_NN standard_NN '_'' in_II terms_NNS of_II evaluating_VVGN the_DD effectiveness_NN of_II interventions_NNS ,_, it_PN is_VBZ susceptible_JJ to_II challenges_NNS to_II its_PNG external_JJ validity_NN if_CS those_PND participating_VVG are_VBB unrepresentative_JJ of_II the_DD reference_NN population_NN for_II whom_PNR the_DD intervention_NN in_II question_NN is_VBZ intended_VVN ._.
P10387985A21
The_DD methods_NNS used_VVN to_TO detect_VVI responses_NNS in_II solid_JJ tumours_NNS and_CC metastases_NNS are_VBB crude_JJ ,_, and_CC it_PN is_VBZ likely_JJ that_CST many_DD useful_JJ drugs_NNS are_VBB missed_VVN ._.
P10387991A14
He_PN first_RR came_VVD to_II the_DD NCI_NN as_II a_DD Clinical_JJ Associate_NN in_II 1967_MC ._.
P10388002A33
Further_RR ,_, the_DD list_NN above_JJ does_VDZ not_RR include_VVB his_PNG personal_JJ labortory_NN and_CC clinical_JJ accomplishments_NNS ,_, some_PND of_II which_PNR are_VBB :_: *_SYM Development_NN of_II the_DD principles_NNS of_II use_NN of_II important_JJ antimetabolites_NNS ,_, such_II+ as_II methotrexate_NN ._.
P10388010A16
The_DD survey_NN of_II 20_MC patients_NNS conducted_VVN by_II Dr._NN Quah_NN represents_VVZ a_DD substantial_JJ portion_NN of_II the_DD literature_NN on_II the_DD subject_NN of_II alternative_JJ therapy_NN use_NN for_II children_NNS with_II cancer_NN ._.
P10388013A07
As_II the_DD famed_VVNJ radiotherapist_NN and_CC Founding_VVGJ Editor_NN ,_, Eli_NNP Glatstein_NNP ,_, summarized_VVD ,_, "_`` The_DD Oncologist_NN emphasizes_VVZ the_DD interpretation_NN rather_II+ than_II the_DD data._NNS "_'' The_DD Oncologist_NN to_II date_NN has_VHZ published_VVN more_RR than_CSN forty_MC manuscripts_NNS from_II international_JJ authorities_NNS ._.
P10388030A26
In_II fact_NN ,_, the_DD growth_NN of_II radiosurgery_NN has_VHZ made_VVN radiation_NN oncologists_NNS re-think_VVB their_PNG own_JJ practice_NN of_II conventional_JJ radiation_NN therapy_NN ._.
P10388041A16
This_PND explains_VVZ the_DD difficulties_NNS one_PN encounters_VVZ in_II the_DD correct_JJ evaluation_NN of_II relevant_JJ data_NNS of_II one_MC specific_JJ patient_NN ._.
P10388095A19
The_DD preferred_VVNJ sequence_NN of_II treatment_NN has_VHZ been_VBN suggested_VVN to_TO be_VBI tamoxifen_NN followed_VVN by_II selective_JJ aromatase_NN inhibitor_NN and_CC then_RR a_DD progestin_NN ._.
P10388128A06
How_CST far_RR this_DD lymph_NN node_NN dissection_NN is_VBZ directly_RR therapeutic_JJ is_VBZ a_DD source_NN of_II controversy_NN ._.
P10391814A03
With_II appropriate_JJ multidisciplinary_JJ care_NN ,_, pain_NN can_VM be_VBB controlled_VVN in_II 90_MC %_SYM of_II patients_NNS who_PNR have_VHB advanced_VVNJ malignant_JJ conditions_NNS ,_, and_CC 90_MC %_SYM of_II ambulatory_JJ patients_NNS with_II spinal_JJ cord_NN compression_NN can_VM remain_VVB ambulatory_JJ ._.
P10404937A01
OBJECTIVE_NN :_: To_TO review_VVI the_DD prognosis_NN and_CC management_NN of_II ventricular_JJ arrhythmias_NNS (_( VA_NN )_) in_II persons_NNS with_II and_CC without_II heart_NN disease_NN ,_, with_II emphasis_NN on_II older_JJR adults_NNS ._.
P10410186A01
OBJECTIVE_NN :_: To_TO briefly_RR discuss_VVI the_DD pathophysiology_NN of_II acute_JJ coronary_JJ syndromes_NNS (_( ACS_NN )_) and_CC to_TO present_VVI the_DD clinical_JJ data_NNS currently_RR available_JJ regarding_VVG the_DD use_NN of_II platelet_NN glycoprotein_NN (_( GP_NN )_) IIb_NN /_SYM IIIa_NN inhibitors_NNS in_II the_DD management_NN of_II ACS_NN ._.
P10412759A09
RESULTS_NNS :_: Most_DD studies_NNS showed_VVD that_CST 3-hydroxy-3-methylglutaryl_NN coenzyme_NN A_NN (_( HMG-CoA_NN )_) reductase_NN inhibitors_NNS reduce_VVB cholesterol-rich_JJ apolipoprotein_NN (_( apo_NN )_) B-containing_VVGJ lipoproteins_NNS with_II no_DD effects_NNS on_II renal_JJ function_NN or_CC proteinuria_NN among_II patients_NNS with_II progressive_JJ renal_JJ disease_NN ._.
P10423049A14
Symptomatic_JJ measures_NNS in_II addition_NN to_II specific_JJ treatments_NNS for_II the_DD underlying_VVGJ cancer_NN and/or_CC other_JJ pulmonary_JJ and_CC cardiovascular_JJ diseases_NNS are_VBB indicated_VVN ._.
P10426859A15
It_PN is_VBZ hoped_VVN that_CST advances_NNS in_II molecular_JJ approach_NN to_II cardiovascular_JJ disease_NN ,_, molecular_JJ genetics_NNS and_CC transgenic_JJ techniques_NNS will_VM allow_VVB better_RRR understanding_VVGN and_CC more_RR effective_JJ therapeutic_JJ strategies_NNS to_TO prevent_VVI and_CC control_VVI IHD_NN ._.
P10433350A16
Combined_VVNJ therapy_NN with_II sulphonylureas_NNS may_VM be_VBB more_RR expensive_JJ and_CC clear_JJ clinical_JJ advantages_NNS have_VHB not_RR been_VBN consistently_RR demonstrated_VVN ._.
P10439825A01
To_TO help_VVI family_NN physicians_NNS manage_VVB patients_NNS with_II irritable_JJ bowel_NN syndrome_NN (_( IBS_NN )_) ,_, a_DD consensus_NN conference_NN was_VBD convened_VVN in_II June_NN 1997_MC at_II which_PNR 5_MC internationally_RR recognized_VVNJ experts_NNS in_II IBS_NN presented_VVD position_NN papers_NNS on_II selected_VVNJ topics_NNS previously_RR circulated_VVN to_II the_DD conference_NN participants_NNS ._.
P10448335A02
METHODS_NNS :_: Articles_NNS were_VBD selected_VVN from_II a_DD review_NN of_II Medline_NN ,_, accessed_VVN with_II the_DD OVID_NN search_NN engine_NN ._.
P10449891A06
Certain_JJ inotropic_JJ drugs_NNS may_VM reduce_VVB symptoms_NNS but_CC shorten_VVB life_NN expectancy_NN ._.
P10453829A22
The_DD data_NNS at_II present_NN are_VBB not_RR robust_JJ enough_RR to_TO address_VVI the_DD issue_NN of_II safety_NN ._.
P10467222A11
It_PN is_VBZ essential_JJ that_CST future_JJ intervention_NN strategies_NNS focus_VVB on_II improving_VVGN adoption_NN of_II new_JJ therapies_NNS into_II clinical_JJ practice_NN ._.
P10473016A03
In_II addition_NN ,_, morbidity_NN and_CC mortality_NN benefits_NNS have_VHB been_VBN suggested_VVN ,_, specifically_RR with_II the_DD non-selective_JJ vasodilating_VVGJ agent_NN ,_, carvedilol_NN ._.
P10474762A17
The_DD evidence_NN supports_VVZ the_DD use_NN dexrazoxane_NN to_TO provide_VVI protection_NN against_II the_DD cardiotoxicity_NN associated_VVN with_II conventional-dose_NN epirubicin_NN in_II patients_NNS with_II advanced_VVNJ but_CC anthracycline-sensitive_JJ cancer_NN ,_, in_II whom_PNR the_DD continued_VVNJ use_NN of_II anthracycline-containing_VVGJ chemotherapy_NN is_VBZ indicated_VVN in_II the_DD opinion_NN of_II the_DD treating_VVGJ physicians_NNS ._.
P10484239A04
According_II+ to_II estimates_NNS based_VVN on_II phase-2_NN NHANES_NN III_MC data_NNS (_( 1991-1994_MC )_) ,_, only_RR 1.4_MC million_MC (_( 6.6_MC %_SYM )_) of_II 21.1_MC million_MC American_JJ adults_NNS eligible_JJ for_II cholesterol-lowering_VVGJ drug_NN therapy_NN by_II NCEP_NN guidelines_NNS were_VBD receiving_VVG such_DD therapy_NN ,_, including_VVG 14_MC %_SYM of_II those_PND eligible_JJ in_II secondary_JJ prevention_NN and_CC 4_MC %_SYM of_II those_PND eligible_JJ in_II primary_JJ prevention_NN ._.
P10488367A02
The_DD target_NN group_NN for_II guideline_NN use_NN included_VVD general_JJ practitioners_NNS and_CC other_JJ primary_JJ health_NN care_NN providers_NNS in_II the_DD public_JJ and_CC private_JJ sectors_NNS ._.
P10494519A04
The_DD primary_JJ goal_NN of_II these_DD analyses_NNS is_VBZ to_TO maximize_VVI value_NN and_CC efficiency_NN ,_, not_RR necessarily_RR to_TO decrease_VVI spending_VVGN ._.
P10502233A06
Over_II the_DD past_JJ 2_MC years_NNS ,_, 4_MC major_JJ trials_NNS involving_VVG more_RR than_CSN 18,000_MC patients_NNS have_VHB evaluated_VVN the_DD therapeutic_JJ potential_NN of_II 3_MC small-molecule_NN ,_, intravenous_JJ GP_NN IIb-IIIa_NN inhibitors_NNS as_II a_DD component_NN of_II first-line_NN management_NN of_II unstable_JJ angina_NN or_CC non-ST-segment_NN elevation_NN myocardial_JJ infarction_NN ._.
P10505286A09
In_II this_DD registry_NN ,_, the_DD success_NN rate_NN of_II direct_JJ PTCA_NN was_VBD 87_MC %_SYM as_CS defined_VVN by_II a_DD final_JJ TIMI-grade_NN 3_MC perfusion_NN of_II the_DD infarct_NN vessel_NN which_PNR is_VBZ close_JJ to_II the_DD data_NNS of_II the_DD MITI-registry_NN and_CC the_DD GUSTO_NN IIb_NN study_NN ._.
P10507632A04
DATA_NNS SYNTHESIS_NN :_: In_II the_DD ICU_NN ,_, life_NN and_CC death_NN decisions_NNS are_VBB often_RR made_VVN in_II a_DD crisis_NN mode_NN or_CC in_II the_DD face_NN of_II uncertainty_NN ,_, and_CC may_VM necessitate_VVB the_DD withholding_VVGN and_CC withdrawal_NN of_II life-supporting_VVGJ technologies_NNS ._.
P10516909A07
In_II contrast_NN ,_, when_CS clinical_JJ improvement_NN has_VHZ not_RR occurred_VVN and_CC chest_NN radiographs_NNS are_VBB unchanged_VVN or_CC worse_JJ ,_, a_DD more_RR aggressive_JJ approach_NN is_VBZ warranted_VVN ._.
P10517720A07
DATA_NNS EXTRACTION_NN :_: The_DD sample_NN size_NN and_CC number_NN of_II subjects_NNS who_PNR developed_VVD preeclampsia_NN in_II the_DD calcium_NN supplementation_NN group_NN vs_CC a_DD control_NN group_NN were_VBD recorded_VVN and_CC analyzed_VVN on_II an_DD intent-to-treat_NN basis_NN ._.
P10526699A07
Beta_NN blockers_NNS can_VM also_RR improve_VVB the_DD intrinsic_JJ contractile_JJ function_NN of_II cardiomyocytes_NNS and_CC have_VHB also_RR been_VBN shown_VVN to_TO improve_VVI myocardial_JJ energetics_NNS in_II HF_NN ,_, possibly_RR through_II desirable_JJ changes_NNS in_II substrate_NN utilization_NN ._.
P10533351A07
Because_II+ of_II its_PNG short_JJ half-life_NN ,_, zaleplon_NN will_VM be_VBB useful_JJ in_II patients_NNS experiencing_VVG difficulty_NN in_II falling_VVGN asleep_JJ and_CC in_II those_PND who_PNR wake_VVB up_II at_II night_NN and_CC have_VHB trouble_JJ falling_VVGN back_II to_TO sleep_VVI ._.
P10534233A11
Pharmacological_JJ stress_NN testing_VVGN has_VHZ high_JJ clinical_JJ use_NN for_II risk_NN stratifying_VVGJ patients_NNS with_II known_VVNJ or_CC suspected_VVNJ CAD_NN ,_, in_II patients_NNS after_II myocardial_JJ infarction_NN ,_, and_CC in_II patients_NNS needing_VVG noncardiac_JJ surgery_NN ._.
P10538854A11
A_DD mini-pharmacoeconomic_JJ analysis_NN based_VVN on_II claims_NNS data_NNS over_II a_DD 6-month_NN period_NN from_II HMO_NN Colorado_NNP ,_, a_DD health_NN maintenance_NN organization_NN ,_, shows_VVZ that_CST switching_VVGN patients_NNS on_II dual_JJ therapy_NN with_II a_DD calcium_NN channel_NN blocker_NN and_CC an_DD ACE_NN inhibitor_NN to_II 1-pill_NN combination_NN therapy_NN with_II both_CC agents_NNS can_VM result_VVB in_II substantial_JJ cost_NN savings_NNS ._.
P10545862A18
There_RR have_VHB already_RR been_VBN several_JJ visits_NNS from_II senior_JJ NCI_NN personnel_NN to_II Ireland_NNP including_VVG Dr._NN Klausner_NN ,_, the_DD Director_NN of_II the_DD NCI_NN ,_, to_TO determine_VVI the_DD potential_JJ impact_NN of_II this_DD agreement_NN and_CC to_TO identify_VVI the_DD most_RRT productive_JJ areas_NNS of_II interaction_NN between_II the_DD NCI_NN and_CC the_DD Irish_NN Cancer_NN Community_NN ._.
P10550165A06
RESULTS_NNS :_: The_DD lack_NN of_II a_DD clearly_RR defined_VVNJ treatment_NN approach_NN to_II patients_NNS with_II locally_RR advanced_VVNJ prostate_NN cancer_NN stems_VVZ from_II multiple_JJ factors_NNS ,_, including_VVG ambiguities_NNS in_II clinical_JJ staging_VVGN ,_, inadequate_JJ knowledge_NN of_II the_DD natural_JJ history_NN of_II the_DD cancer_NN ,_, and_CC a_DD dearth_NN of_II comparative_JJ randomized_VVNJ trials_NNS evaluating_VVG efficacy_NN of_II different_JJ therapies_NNS ._.
P10551433A04
These_DD benefits_NNS are_VBB sustained_VVN at_II 6_MC months_NNS ._.
P10561236A04
EVIDENCE_NN :_: A_DD comprehensive_JJ ,_, formal_JJ literature_NN review_NN was_VBD conducted_VVN for_II tamoxifen_NN and_CC raloxifene_NN on_II the_DD following_VVGJ topics_NNS :_: breast_NN cancer_NN risk_NN reduction_NN ;_: tamoxifen_NN side_NN effects_NNS and_CC toxicity_NN ,_, including_VVG endometrial_JJ cancer_NN risk_NN ;_: tamoxifen_NN influences_NNS on_II nonmalignant_JJ diseases_NNS ,_, including_VVG coronary_JJ heart_NN disease_NN and_CC osteoporosis_NN ;_: and_CC decision_NN making_VVGN by_II women_NNS at_II risk_NN for_II breast_NN cancer_NN ._.
P10568677A14
Pharmacologic_JJ therapy_NN is_VBZ likely_RR to_TO be_VBI dominated_VVN by_II compounds_NNS that_PNR exert_VVB their_PNG predominant_JJ effect_NN by_II prolonging_VVGN atrial_JJ repolarization_NN ._.
P10577465A08
In_II addition_NN ,_, intramural_JJ delivery_NN of_II enoxaparin_NN to_TO achieve_VVI a_DD locally_RR high_JJ concentration_NN is_VBZ being_VBG investigated_VVN for_II the_DD prevention_NN of_II restenosis_NN after_II coronary_JJ stenting_VVGN ._.
P10583795A03
Various_JJ surveys_NNS have_VHB shown_VVN that_CST residents_NNS are_VBB under-trained_VVN in_II managed_VVNJ care_NN principles_NNS and_CC practice_NN ._.
P10588173A08
Other_JJ patient_NN characteristics_NNS that_PNR may_VM be_VBB useful_JJ in_II the_DD future_NN in_II deciding_VVGN suitability_NN for_II a_DD trial_NN ,_, or_CC predicting_VVGN response_NN ,_, include_VVB symptom_NN pattern_NN ,_, length_NN of_II symptom_NN history_NN ,_, whether_CST the_DD condition_NN was_VBD triggered_VVN by_II enteric_JJ infection_NN ,_, whether_CST a_DD patient_NN is_VBZ in_II primary_JJ ,_, secondary_JJ ,_, or_CC tertiary_JJ care_NN ,_, psychological_JJ characteristics_NNS ,_, a_DD history_NN of_II physical_JJ or_CC sexual_JJ abuse_NN ,_, and_CC possibly_RR visceral_JJ sensitivity_NN testing_VVGN or_CC autonomic_JJ dysfunction_NN ._.
P10591384A09
MAIN_JJ OUTCOME_NN MEASURES_NNS :_: Primary_JJ efficacy_NN was_VBD an_DD excellent_JJ neurologic_JJ recovery_NN at_II day_NN 90_MC (_( National_JJ Institutes_NNS of_II Health_NN Stroke_NN Scale_NN [_( NIHSS_NN ]_) score_NN of_II <_SYM or_CC =1_MC )_) ;_: secondary_JJ end_NN points_NNS included_VVD excellent_JJ recovery_NN on_II functional_JJ outcome_NN measures_NNS (_( Barthel_NNP index_NN ,_, modified_VVNJ Rankin_NNP scale_NN ,_, and_CC Glasgow_NNP Outcome_NN Scale_NN )_) at_II days_NNS 30_MC and_CC 90_MC ._.
P10595286A07
RESULTS_NNS :_: Twenty-two_MC trials_NNS ,_, including_VVG a_DD total_NN of_II 1042_MC patients_NNS (_( median_NN 36_MC ,_, range_NN 10-150_MC )_) ,_, met_VVD the_DD inclusion_NN criteria_NNS ._.
P10599376A25
It_PN was_VBD extremely_RR effective_JJ ,_, and_CC most_DD dermatologists_NNS who_PNR used_VVD it_PN have_VHB patients_NNS who_PNR consider_VVB it_PN the_DD most_RRT effective_JJ therapy_NN in_II the_DD last_JJ year_NN ._.
P10605194A03
Over_II the_DD last_JJ two_MC decades_NNS ,_, a_DD marked_VVNJ shift_NN in_II the_DD spectrum_NN of_II causative_JJ organisms_NNS towards_II a_DD gram-positive_JJ predominance_NN has_VHZ been_VBN the_DD main_JJ factor_NN influencing_VVG therapeutic_JJ approaches_NNS ._.
P10612273A05
Unfortunately_RR ,_, adverse_JJ effects_NNS may_VM limit_VVB compliance_NN in_II some_DD patients_NNS ._.
P10624417A04
The_DD choice_NN of_II a_DD specific_JJ antihypertensive_JJ drug_NN is_VBZ dependent_JJ upon_II the_DD severity_NN of_II the_DD hypertension_NN and_CC the_DD presence_NN of_II other_JJ cardiovascular_JJ risk_NN factors_NNS and_CC concurrent_JJ diseases_NNS ._.
P10630795A01
OBJECTIVE_NN :_: To_TO determine_VVI the_DD effect_NN of_II reamed_VVNJ versus_CC nonreamed_VVNJ intramedullary_JJ (_( IM_NN )_) nailing_VVGN of_II lower_JJR extremity_NN long_JJ bone_NN fractures_NNS on_II the_DD rates_NNS of_II nonunion_NN ,_, implant_NN failure_NN ,_, malunion_NN ,_, compartment_NN syndrome_NN ,_, pulmonary_JJ embolus_NN ,_, and_CC infection_NN ._.
P10632305A04
METHODS_NNS :_: We_PN conducted_VVD a_DD retrospective_JJ cohort_NN study_NN using_VVG the_DD SAGE_NN database_NN ,_, a_DD long-term_NN care_NN database_NN linking_VVG patient_NN information_NN with_II drug_NN utilization_NN data_NNS ._.
P10635046A21
The_DD explosive_JJ expansion_NN of_II information_NN now_RR available_JJ to_II ,_, and_CC frequently_RR quoted_VVN by_II ,_, HCV_NN patients_NNS seeking_VVG treatment_NN will_VM increasingly_RR make_VVB this_DD option_NN less_RR acceptable_JJ to_II a_DD great_JJ many_PND of_II this_DD group_NN ._.
P10646698A02
The_DD clinical_JJ goal_NN of_II peri-menopause_NN therapy_NN is_VBZ to_TO optimize_VVI the_DD woman_NN 's_GE health_NN during_II and_CC after_II this_DD transitional_JJ period_NN ._.
P10651602A03
This_DD paper_NN reviews_VVZ the_DD clinical_JJ characteristics_NNS of_II normal_JJ grief_NN and_CC clinical_JJ depression_NN and_CC explains_VVZ strategies_NNS for_II differential_JJ diagnosis_NN ._.
P10653213A12
The_DD methodologic_JJ quality_NN of_II all_DD trials_NNS was_VBD assessed_VVN ._.
P10665250A03
STUDY_NN SELECTION_NN :_: Clinical_JJ trials_NNS and_CC pertinent_JJ review_NN articles_NNS that_PNR discussed_VVD the_DD pharmacology_NN ,_, pharmacokinetics_NNS ,_, efficacy_NN ,_, and_CC safety_NN of_II PPIs_NNS in_II the_DD management_NN of_II acid-related_VVNJ disease_NN ._.
P10674059A08
Patient-reported_VVNJ outcomes_NNS were_VBD more_RR optimistic_JJ for_II sleep_NN latency_NN ;_: those_PND randomized_VVN to_II benzodiazepine_NN treatment_NN estimated_VVD a_DD sleep_NN latency_NN decrease_NN of_II 14.3_MC minutes_NNS (_( 95_MC %_SYM CI_NN 10.6_MC to_II 18.0_MC )_) ._.
P10678340A04
DATA_NNS COLLECTION_NN /_SYM ANALYSIS_NN :_: Abstracts_NNS of_II trials_NNS were_VBD reviewed_VVN independently_RR by_II 2_MC members_NNS of_II the_DD study_NN team_NN ._.
P10682170A01
Insulin_NN resistance_NN syndrome_NN (_( IRS_NN )_) ,_, also_RR termed_VVN syndrome_NN X_NN ,_, is_VBZ a_DD distinctive_JJ constellation_NN of_II risk_NN factors_NNS for_II the_DD development_NN of_II type_NN 2_MC diabetes_NN mellitus_NN and_CC cardiovascular_JJ disease_NN ._.
P10689260A04
Patients_NNS were_VBD randomly_RR assigned_VVN to_TO receive_VVI a_DD bolus_NN and_CC infusion_NN of_II either_CC eptifibatide_NN or_CC placebo_NN in_II addition_NN to_II standard_JJ therapy_NN ._.
P10695704A08
Inpatient_NN medical_JJ records_NNS from_II a_DD 254-bed_NN Brown_NNP University-affiliated_VVNJ teaching_VVGJ hospital_NN were_VBD also_RR evaluated_VVN for_II lipid_NN profile_NN ,_, achievement_NN of_II NCEP_NN II_MC goal_NN ,_, and_CC use_NN of_II lipid-lowering_VVGJ medication_NN on_II admission_NN and_CC discharge_NN ._.
P10699540A02
Controversy_NN also_RR exists_VVZ concerning_VVG its_PNG effectiveness_NN in_II the_DD chronically_RR ill_NN ._.
P10711239A12
Tamoxifen_NN also_RR reduced_VVD the_DD incidence_NN of_II contralateral_JJ breast_NN cancer_NN ,_, as_CC+ well_CC+ as_CC tumour_NN in_II the_DD ipsilateral_JJ breast_NN following_VVG lumpectomy_NN ._.
P10715310A06
The_DD panel_NN addressed_VVD which_DD patients_NNS to_TO treat_VVI and_CC when_PNR in_II their_PNG course_NN of_II disease_NN ,_, specific_JJ drug_NN delivery_NN issues_NNS ,_, duration_NN of_II therapy_NN ,_, management_NN of_II bony_JJ metastases_NNS with_II other_JJ therapies_NNS ,_, and_CC the_DD public_JJ policy_NN implications_NNS ._.
P10727363A05
RESULTS_NNS :_: a_DD total_NN of_II 34_MC articles_NNS were_VBD found_VVN ,_, but_CC only_RR 10_MC were_VBD reports_NNS of_II randomised_VVNJ controlled_VVNJ trials_NNS ._.
P10731376A14
It_PN should_VM be_VBB used_VVN early_RR after_II symptom_NN onset_NN and_CC in_II conjunction_NN with_II a_DD more_RR specific_JJ marker_NN of_II myocardial_JJ damage_NN ._.
P10733260A02
CHF_NN is_VBZ thought_VVN to_TO progress_VVI as_II a_DD result_NN of_II activation_NN of_II endogenous_JJ neurohormonal_JJ systems_NNS which_PNR are_VBB activated_VVN by_II the_DD initial_JJ myocardial_JJ injury_NN ._.
P10744594A07
DATA_NNS EXTRACTION_NN :_: Two_MC independent_JJ reviewers_NNS abstracted_VVD each_DD article_NN by_II following_VVGN a_DD prospectively_RR designed_VVNJ protocol_NN ._.
P10750936A03
Meta-analysis_NN of_II randomized_VVNJ ,_, placebo_NN controlled_VVNJ trials_NNS ._.
P10755326A12
While_CS waiting_VVG for_II a_DD donor_NN ,_, patients_NNS have_VHB been_VBN bridged_VVN with_II various_JJ intravenous_JJ agents_NNS ,_, most_RRT often_RR inotropes_NNS ,_, but_CC symptom_NN relief_NN is_VBZ associated_VVN with_II risk_NN of_II increased_VVNJ mortality_NN due_II+ to_II these_DD drugs_NNS ._.
P10767115A09
There_EX may_VM be_VBB a_DD role_NN for_II IV_NN IgG_NN and_CC steroids_NNS ,_, especially_RR for_II cases_NNS of_II thrombocytopenia_NN that_PNR are_VBB immune-mediated_VVN ;_: however_RR ,_, further_JJ investigations_NNS are_VBB necessary_JJ ._.
P10772302A07
DATA_NNS SYNTHESIS_NN :_: Six_MC randomized_VVNJ controlled_VVNJ trials_NNS were_VBD included_VVN in_II the_DD review_NN ,_, 4_MC of_II which_PNR used_VVD crossover_NN design_NN ._.
P10783421A08
A_DD recent_JJ meta-analysis_NN analyzed_VVD 10_MC prospective_JJ studies_NNS comparing_VVG primary_JJ angioplasty_NN with_II intravenous_JJ fibrinolytic_JJ therapy_NN and_CC found_VVD that_CST the_DD mortality_NN rate_NN for_II 30_MC days_NNS or_CC less_PND was_VBD 4.4_MC %_SYM for_II 1,290_MC patients_NNS treated_VVN with_II primary_JJ angioplasty_NN compared_VVN with_II 6.5_MC %_SYM for_II 1,316_MC patients_NNS treated_VVN with_II fibrinolytic_JJ agents_NNS (_( 95_MC %_SYM confidence_NN intervals_NNS 0.46_MC to_II 0.49_MC ,_, P_NN =.02_MC )_) ._.
P10789664A04
OBJECTIVE_NN :_: To_TO compare_VVI the_DD effect_NN of_II doxazosin_NN ,_, an_DD alpha-blocker_NN ,_, with_II chlorthalidone_NN ,_, a_DD diuretic_NN ,_, on_II incidence_NN of_II CVD_NN in_II patients_NNS with_II hypertension_NN as_II part_NN of_II a_DD study_NN of_II 4_MC types_NNS of_II antihypertensive_JJ drugs_NNS :_: chlorthalidone_NN ,_, doxazosin_NN ,_, amlodipine_NN ,_, and_CC lisinopril_NN ._.
P10792162A04
RESULTS_NNS :_: In_II all_PND ,_, 444_MC men_NNS were_VBD enrolled_VVN in_II two_MC placebo-controlled_VVNJ and_CC two_MC comparative_JJ trials_NNS lasting_VVG 12-24_MC weeks_NNS ._.
P10796129A07
Expert_NN informant_NN 's_GE search_NN in_II the_DD Japanese_JJ language_NN was_VBD made_VVN by_II Prof._NN Y_NN ._.
P10796197A13
Further_JJ research_NN should_VM evaluate_VVB the_DD practice_NN of_II supplementation_NN of_II human_NN milk_NN with_II fat_NN ._.
P10796208A12
Data_NNS were_VBD entered_VVN into_II the_DD Review_NN Manager_NN software_NN and_CC double_RR checked_VVN ._.
P10796252A17
There_EX is_VBZ a_DD compelling_VVGJ need_NN for_II the_DD long_JJ term_NN follow-up_NN and_CC reporting_VVGN of_II late_JJ outcomes_NNS ,_, especially_RR neurologic_JJ and_CC developmental_JJ outcomes_NNS ,_, among_II surviving_VVGJ infants_NNS who_PNR participated_VVD in_II all_DD randomized_VVNJ trials_NNS of_II early_JJ postnatal_JJ corticosteroid_NN treatment_NN ._.
P10796264A19
Chronic_JJ administration_NN of_II furosemide_NN improves_VVZ both_CC oxygenation_NN and_CC lung_NN compliance_NN ._.
P10796274A21
Large_JJ studies_NNS are_VBB needed_VVN to_TO assess_VVI (_( 1_MC )_) whether_CST chronic_JJ diuretic_NN administration_NN improves_VVZ mortality_NN ,_, duration_NN of_II oxygen_NN dependency_NN ,_, ventilator_NN dependency_NN ,_, length_NN of_II hospital_NN stay_NN and_CC long-term_NN outcome_NN in_II patients_NNS without_II long-term_NN toxicity_NN and_CC (_( 2_MC )_) whether_CST adding_VVGN spironolactone_NN to_II thiazides_NNS or_CC adding_VVGN metolazone_NN to_II furosemide_NN has_VHZ any_DD beneficial_JJ effect_NN ._.
P10796282A11
MAIN_JJ RESULTS_NNS :_: Five_MC randomised_VVNJ trials_NNS with_II data_NNS for_II 3954_MC participants_NNS were_VBD included_VVN ._.
P10796300A12
The_DD five_MC included_VVNJ trials_NNS involved_VVD 1068_MC patients_NNS ._.
P10796306A30
The_DD significance_NN of_II these_DD results_NNS is_VBZ therefore_RR questionable_JJ ._.
P10796329A14
Two_MC trials_NNS used_VVD intra-arterial_JJ administration_NN but_CC the_DD rest_NN used_VVD the_DD intravenous_JJ route_NN ._.
P10796337A10
The_DD drugs_NNS analyzed_VVN were_VBD :_: nimodipine_NN (_( eight_MC trials_NNS ,_, 1574_MC patients_NNS )_) ,_, nicardipine_NN (_( two_MC trials_NNS ,_, 954_MC patients_NNS )_) ,_, and_CC AT877_NN (_( one_MC trial_NN ,_, 276_MC patients_NNS )_) ._.
P10796343A06
SELECTION_NN CRITERIA_NNS :_: Unconfounded_VVNJ truly_RR or_CC quasi_RR randomised_VVNJ controlled_VVNJ trials_NNS in_II dysphagic_JJ patients_NNS with_II acute_JJ /_SYM subacute_JJ (_( within_II 3_MC months_NNS )_) stroke_NN ._.
P10796350A16
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: Data_NNS in_II this_DD review_NN are_VBB too_RR inconclusive_JJ to_TO guide_VVI those_PND wishing_VVG to_II uphold_VVI or_CC refute_VVI the_DD effect_NN of_II intercessory_JJ prayer_NN on_II health_NN care_NN outcomes_NNS ._.
P10796364A18
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: There_EX is_VBZ insufficient_JJ information_NN on_II the_DD use_NN of_II rescue_NN HFOV_NN to_TO make_VVI recommendations_NNS for_II practice_NN ._.
P10796390A01
BACKGROUND_NN :_: Although_CS medication_NN is_VBZ the_DD mainstay_NN of_II treatment_NN for_II schizophrenia_NN ,_, always_RR ,_, some_DD sort_NN of_II informal_JJ or_CC formal_JJ talking_VVGJ therapy_NN is_VBZ indicated_VVN ._.
P10796398A11
DATA_NNS COLLECTION_NN AND_CC ANALYSIS_NN :_: All_DD data_NNS were_VBD abstracted_VVN by_II two_MC independent_JJ and_CC trained_VVNJ reviewers_NNS (_( DF_NNP ,_, AT_NNP )_) ,_, and_CC verified_VVN by_II a_DD third_JJ reviewer_NN (_( JP_NNP )_) ._.
P10796404A01
BACKGROUND_NN :_: Hallux_NN valgus_NN is_VBZ classified_VVN as_II an_DD abnormal_JJ deviation_NN of_II the_DD great_JJ toe_NN (_( hallux_NN )_) towards_II the_DD midline_NN of_II the_DD foot_NN ._.
P10796407A03
Non-nutritive_JJ sucking_VVGN has_VHZ been_VBN considered_VVN to_TO be_VBI a_DD benign_JJ intervention_NN ,_, although_CS it_PN has_VHZ the_DD potential_JJ to_TO have_VHI a_DD negative_JJ effect_NN on_II breastfeeding_VVGN or_CC on_II the_DD incidence_NN of_II later_RR oral_JJ aversion_NN ._.
P10796414A11
For_II continuous_JJ data_NNS Weighted_VVNJ Mean_NN Differences_NNS (_( WMD_NN )_) were_VBD calculated_VVN ._.
P10796420A08
Specifically_RR ,_, we_PN required_VVD that_CST trials_NNS be_VBB randomized_VVN or_CC cross-over_NN and_CC report_VVB at_RR+ least_RR one_MC of_II the_DD following_VVGJ outcome_NN measures_NNS in_II a_DD quantitative_JJ manner_NN :_: joint_NN tenderness_NN ,_, joint_NN swelling_VVGN ,_, grip_NN strength_NN ,_, or_CC erythrocyte_NN sedimentation_NN rate_NN (_( ESR_NN )_) ._.
P10796428A05
Date_NN of_II the_DD most_RRT recent_JJ search_NN :_: April_NN 1999_MC ._.
P10796432A07
For_II practical_JJ reasons_NNS only_RR those_PND in_II English_NN were_VBD included_VVN ,_, but_CC all_DD languages_NNS will_VM be_VBB retrieved_VVN and_CC translated_VVN for_II future_JJ updates_NNS ._.
P10796439A06
All_PND randomized_VVNJ controlled_VVNJ trials_NNS which_PNR compared_VVD pain_NN response_NN to_II venepuncture_NN vs._CC heel_NN lance_NN were_VBD searched_VVN using_VVG MEDLINE_NN ,_, Embase_NN ,_, CINAHL_NN ,_, the_DD Cochrane_NNP Library_NN ,_, reference_NN lists_NNS of_II identified_VVNJ trials_NNS and_CC personal_JJ files_NNS ._.
P10796442A16
There_EX were_VBD no_DD clear_JJ differences_NNS between_II the_DD two_MC preparations_NNS ._.
P10796457A03
It_PN has_VHZ been_VBN shown_VVN that_CST bone_NN mineral_NN loss_NN at_II the_DD hip_NN averages_VVZ 14_MC %_SYM in_II the_DD first_JJ year_NN after_II starting_VVGN corticosteroid_NN therapy_NN ._.
P10796461A07
The_DD pooled_VVNJ analysis_NN was_VBD performed_VVN using_VVG standardized_VVNJ mean_NN differences_NNS (_( SMDs_NNS )_) for_II joint_NN counts_NNS ,_, pain_NN and_CC global_JJ assessments_NNS ._.
P10796480A03
OBJECTIVES_NNS :_: The_DD objective_NN of_II this_DD review_NN was_VBD to_TO assess_VVI the_DD effects_NNS of_II adding_VVGN inhaled_VVNJ anti-cholinergics_NNS to_II beta2-agonists_NNS in_II acute_JJ paediatric_JJ asthma_NN ._.
P10796491A09
Six_MC of_II seven_MC trials_NNS that_PNR measured_VVD health_NN professional_JJ practice_NN demonstrated_VVD some_DD improvement_NN for_II at_RR+ least_RR one_MC outcome_NN variable_NN ,_, and_CC in_II two_MC trials_NNS ,_, the_DD results_NNS were_VBD statistically_RR significant_JJ and_CC clinically_RR important_JJ ._.
P10796506A11
Methodological_JJ quality_NN was_VBD assessed_VVN independently_RR by_II two_MC reviewers_NNS ._.
P10796515A21
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: For_II acute_JJ maxillary_JJ sinusitis_NN confirmed_VVN radiographically_RR or_CC by_II aspiration_NN ,_, current_JJ evidence_NN is_VBZ limited_VVN but_CC supports_VVZ penicillin_NN or_CC amoxicillin_NN for_II 7_MC to_II 14_MC days_NNS ._.
P10796525A05
The_DD Cochrane_NNP Controlled_VVNJ Trials_NNS Register_NN and_CC the_DD Inflammatory_JJ Bowel_NN Disease_NN Review_NN Group_NN Trials_NNS Register_NN were_VBD also_RR searched_VVN ._.
P10796528A16
Outcomes_NNS analysed_VVN included_VVD improvement_NN in_II menstrual_JJ blood_NN loss_NN ,_, satisfaction_NN ,_, change_NN in_II quality_NN of_II life_NN ,_, duration_NN of_II surgery_NN and_CC hospital_NN stay_NN ,_, time_NN to_TO return_VVI to_II work_NN ,_, adverse_JJ events_NNS and_CC requirement_NN for_II repeat_NN surgery_NN because_II+ of_II failure_NN of_II the_DD initial_JJ surgical_JJ treatment_NN ._.
P10796534A12
DATA_NNS COLLECTION_NN AND_CC ANALYSIS_NN :_: Data_NNS were_VBD extracted_VVN independently_RR by_II the_DD reviewers_NNS ,_, pooled_VVN where_CS appropriate_JJ and_CC possible_JJ ,_, and_CC the_DD pooled_VVNJ odds_NNS ratios_NNS (_( 95_MC %_SYM CI_NN )_) or_CC the_DD average_JJ differences_NNS (_( 95_MC %_SYM CI_NN )_) were_VBD estimated_VVN ._.
P10796541A09
Other_JJ sources_NNS including_VVG personal_JJ communications_NNS ,_, ongoing_VVGJ trials_NNS ,_, conference_NN proceedings_NNS ,_, handsearching_VVGN and_CC reference_NN lists_NNS of_II published_VVNJ papers_NNS and_CC books_NNS were_VBD all_PND searched_VVN for_II relevant_JJ randomized_VVNJ controlled_VVNJ trials_NNS ._.
P10796544A21
The_DD individual_JJ patient_NN data_NNS review_NN will_VM yield_VVB further_JJ evidence_NN on_II the_DD effects_NNS of_II selegiline_NN compared_VVN to_II control_NN as_CS would_VM additional_JJ studies_NNS evaluating_VVG the_DD use_NN of_II selegiline_NN for_II the_DD endpoints_NNS of_II standardised_VVNJ cognitive_JJ scales_NNS ,_, clinician_NN impression_NN of_II global_JJ change_NN ,_, dependency_NN and_CC caregiver_NN quality_NN of_II life_NN ._.
P10796550A06
DATA_NNS COLLECTION_NN AND_CC ANALYSIS_NN :_: Two_MC reviewers_NNS independently_RR assessed_VVD trial_NN quality_NN and_CC extracted_VVD data_NNS ._.
P10796567A08
Specialist_NN advice_NN was_VBD sought_VVN to_TO categorise_VVI interventions_NNS ._.
P10796576A07
The_DD main_JJ outcome_NN was_VBD the_DD rate_NN of_II tracheal_JJ re-intubation_NN after_II extubation_NN ._.
P10796587A01
BACKGROUND_NN :_: Excessively_RR heavy_JJ menstrual_JJ bleeding_VVGN (_( HMB_NN )_) or_CC menorrhagia_NN is_VBZ an_DD important_JJ cause_NN of_II ill_JJ health_NN in_II women_NNS ._.
P10796594A27
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: Treatment_NN of_II patients_NNS with_II COPD_NN with_II long_RR acting_VVGJ beta2-agonists_NNS produces_VVZ only_RR small_JJ increases_NNS in_II FEV1_NN ._.
P10796603A10
The_DD objective_NN of_II the_DD review_NN is_VBZ to_TO assess_VVI the_DD effects_NNS of_II RT_NN for_II dementia_NN ._.
P10796607A18
For_II the_DD risk_NN of_II leaving_VVGN the_DD study_NN early_RR ,_, there_EX was_VBD also_RR a_DD trend_NN for_II benefit_NN to_II those_PND allocated_VVN to_II zuclopenthixol_NN decanoate_NN ._.
P10796617A02
Although_CS beneficial_JJ effects_NNS upon_II clinically_RR relevant_JJ outcomes_NNS have_VHB been_VBN demonstrated_VVN in_II randomised_VVNJ controlled_VVNJ trials_NNS ,_, there_RR remains_VVZ a_DD risk_NN of_II severe_JJ and_CC sometimes_NNS fatal_JJ anaphylaxis_NN ._.
P10796622A05
To_TO evaluate_VVI the_DD relative_JJ efficacy_NN of_II different_JJ types_NNS of_II fatty_JJ acid_NN supplementation_NN ._.
P10796639A16
Change_NN in_II cognitive_JJ outcome_NN was_VBD towards_II being_VVGN in_II favour_NN of_II treatment_NN ._.
P10796650A09
Studies_NNS were_VBD included_VVN if_CS patients_NNS presented_VVD with_II acute_JJ asthma_NN and_CC were_VBD treated_VVN with_II IV_NN magnesium_NN sulfate_NN vs_CC placebo_NN ._.
P10796661A05
We_PN hand_NN searched_VVD relevant_JJ journals_NNS and_CC conference_NN proceedings_NNS ,_, and_CC contacted_VVD Hoechst_NNP (_( the_DD manufacturer_NN of_II the_DD drug_NN )_) and_CC experts_NNS in_II the_DD field_NN ._.
P10796671A04
SEARCH_NN STRATEGY_NN :_: Electronic_JJ searches_NNS of_II Biological_JJ Abstracts_NNS (_( 1980-1999_MC )_) ,_, CINAHL_NN (_( 1982-1999_MC )_) ,_, The_DD Cochrane_NNP Library_NN (_( Issue_NN 1_MC ,_, 1999_MC )_) ,_, The_DD Cochrane_NNP Schizophrenia_NN Group_NN 's_GE Register_NN (_( January_NN 1999_MC )_) ,_, EMBASE_NN (_( 1980-1999_MC )_) ,_, Dialog_NN Corporation_NN Datastar_NN service_NN (_( 1999_MC )_) ,_, MEDLINE_NN (_( 1966-1999_MC )_) ,_, and_CC PsycLIT_NN (_( 1974-1999_MC )_) were_VBD undertaken_VVN ._.
P10796678A02
From_II its_PNG beginnings_NNS telemedicine_NN has_VHZ been_VBN used_VVN in_II a_DD variety_NN of_II health_NN care_NN fields_NNS ,_, although_CS widespread_JJ interest_NN among_II healthcare_NN providers_NNS has_VHZ only_RR now_RR become_VVB apparent_JJ with_II the_DD development_NN of_II more_RR sophisticated_VVNJ technology_NN ._.
P10796688A13
Cardiovascular_JJ mortality_NN was_VBD reduced_VVN from_II 69_MC to_II 50_MC deaths_NNS (_( 95_MC %_SYM CI_NN of_II the_DD difference_NN 9_MC to_II 31_MC )_) ._.
P10796704A14
Levodopa_NN dose_NN was_VBD reduced_VVN more_RR in_II those_PND receiving_VVG pergolide_NN (_( 235_MC mg_NN v_CC 51_MC mg_NN ;_: p_NN <_SYM 0._MC 001_MC )_) ._.
P10796711A20
Trial_NN design_NN characteristics_NNS ._.
P10796715A21
No_DD increase_NN in_II endometrial_JJ cancer_NN was_VBD seen_VVN in_II any_PND of_II the_DD treatment_NN groups_NNS during_II the_DD limited_VVNJ duration_NN (_( maximum_NN of_II 3_MC years_NNS )_) of_II these_DD trials_NNS ._.
P10796723A15
Subgroup_NN analysis_NN was_VBD performed_VVN according_II+ to_II type_NN of_II control_NN group_NN ,_, no_DD pre-treatment_NN or_CC placebo_NN ,_, and_CC for_II some_DD outcomes_NNS there_EX were_VBD additional_JJ subgroup_NN analyses_NNS according_II+ to_II size_NN of_II the_DD uterus_NN in_II gestational_JJ weeks_NNS ._.
P10796730A20
MAIN_JJ RESULTS_NNS :_: Outcomes_NNS were_VBD evaluated_VVN separately_RR for_II unopposed_VVNJ oestrogen_NN and_CC oestrogen_NN /_SYM progestogen_NN regimens_NNS ._.
P10796739A23
Additional_JJ randomized_VVNJ placebo_NN and_CC active-controlled_VVNJ trials_NNS are_VBB needed_VVN to_TO evaluate_VVI the_DD long-term_NN clinical_JJ effectiveness_NN and_CC safety_NN of_II Cernilton_NN ._.
P10796750A10
Studies_NNS where_PNR less_RR than_CSN 50_MC %_SYM of_II patients_NNS had_VHD a_DD spinal_JJ cord_NN injury_NN were_VBD excluded_VVN ._.
P10796754A20
In_II order_NN to_TO detect_VVI a_DD realistic_JJ treatment_NN advantage_NN ,_, larger_JJR trials_NNS will_VM have_VHB to_TO be_VBI conducted_VVN ._.
P10796760A02
In_II Australia_NNP ,_, the_DD United_VVNJ Kingdom_NN and_CC the_DD United_VVNJ States_NNS ,_, it_PN is_VBZ the_DD second_JJ commonest_JJT cancer_NN for_II women_NNS after_II breast_NN cancer_NN (_( age-standardised_VVNJ incidence_NN 22-33_MC per_II 100,000_MC )_) ,_, and_CC men_NNS after_II prostate_NN or_CC lung_NN cancer_NN (_( age-standardised_VVNJ incidence_NN 31-47_MC per_II 100,000_MC )_) (_( Jeffs_NNP et_CC al_NN ,_, 1996_MC ;_: Parkin_NNP et_CC al_NN ,_, 1992_MC )_) ._.
P10796766A17
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: The_DD results_NNS of_II non-randomised_VVNJ studies_NNS have_VHB concluded_VVN that_CST a_DD phenylalanine_NN restricted_VVNJ diet_NN is_VBZ effective_JJ in_II reducing_VVGN blood_NN phenylalanine_NN levels_NNS and_CC improving_VVGN intelligence_NN quotient_NN and_CC neuropsychological_JJ outcome_NN ._.
P10796777A09
SELECTION_NN CRITERIA_NNS :_: We_PN included_VVD randomized_VVNJ controlled_VVNJ trials_NNS using_VVG any_DD antibiotic_NN compared_VVN with_II a_DD placebo_NN ._.
P10796785A17
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: Gabapentin_NN has_VHZ efficacy_NN as_II an_DD add-on_NN treatment_NN in_II patients_NNS with_II drug-resistant_JJ partial_JJ epilepsy_NN ._.
P10796793A05
Additional_JJ studies_NNS were_VBD identified_VVN from_II the_DD reference_NN lists_NNS of_II retrieved_VVNJ reports_NNS ._.
P10796799A16
No_DD significant_JJ differences_NNS were_VBD found_VVN between_II any_PND of_II the_DD other_JJ outcomes_NNS measured_VVN ._.
P10796805A08
Information_NN was_VBD collected_VVN on_II death_NN ,_, disability_NN ,_, and_CC incidence_NN of_II infection_NN ._.
P10796814A05
SELECTION_NN CRITERIA_NNS :_: All_DD randomised_VVNJ and_CC pseudorandomised_VVNJ trials_NNS (_( published_VVN or_CC unpublished_VVN )_) comparing_VVG any_DD influenza_NN vaccine_NN with_II a_DD placebo_NN or_CC with_II another_DD type_NN of_II influenza_NN vaccine_NN ._.
P10796818A17
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: There_EX still_RR remains_VVZ considerable_JJ uncertainty_NN about_II which_PNR forms_NNS of_II psychosocial_JJ and_CC physical_JJ treatments_NNS of_II self-harm_NN patients_NNS are_VBB most_RRT effective_JJ ,_, inclusion_NN of_II insufficient_JJ numbers_NNS of_II patients_NNS in_II trials_NNS being_VBG the_DD main_JJ limiting_VVGJ factor_NN ._.
P10796830A20
However_RR ,_, there_EX are_VBB only_RR limited_VVNJ data_NNS examining_VVG a_DD more-important_JJ longer-term_NN effect_NN on_II the_DD prevention_NN of_II unplanned_VVNJ pregnancies_NNS ._.
P10796838A14
Differences_NNS were_VBD resolved_VVN by_II discussion_NN ._.
P10796845A04
OBJECTIVES_NNS :_: The_DD aim_NN of_II this_DD review_NN is_VBZ to_TO examine_VVI the_DD evidence_NN for_II the_DD safety_NN and_CC effectiveness_NN of_II photodynamic_JJ therapy_NN in_II the_DD treatment_NN of_II neovascular_JJ age-related_VVNJ macular_JJ degeneration_NN ._.
P10796856A05
As_CS most_DD acne_NN prescribing_VVGN is_VBZ undertaken_VVN by_II general_JJ practitioners_NNS ,_, it_PN is_VBZ important_JJ that_CST guidelines_NNS issued_VVN to_II them_PN are_VBB based_VVN on_II the_DD best_RRT available_JJ evidence_NN rather_II+ than_II personal_JJ judgements_NNS ._.
P10796860A04
SEARCH_NN STRATEGY_NN :_: The_DD following_VVGJ electronic_JJ databases_NNS were_VBD searched_VVN :_: MEDLINE_NN to_II June_NN 1997_MC ;_: AMED_NN ;_: ASSIA_NN ;_: BIDS_NN ;_: BIOSIS_NN Previews_NNS (_( 1985-1996_MC )_) ;_: CINAHL_NN ;_: DHSS_NN Data_NNS ;_: EMBASE_NN (_( 1974_MC to_II June_NN 1997_MC )_) ;_: PsycLIT_NN and_CC SIGLE_NN ._.
P10796862A31
Some_DD women_NNS treated_VVN with_II cones_NNS stop_VVB treatment_NN early_RR so_CS cones_NNS may_VM only_RR be_VBB useful_JJ for_II those_PND who_PNR find_VVB them_PN acceptable_JJ ._.
P10799082A02
While_CS the_DD need_NN for_II randomized_VVNJ trials_NNS is_VBZ evident_JJ ,_, conducting_VVGN these_DD trials_NNS is_VBZ becoming_VVG increasingly_RR difficult_JJ and_CC complex_NN ._.
P10804811A08
Traditional_JJ laboratories_NNS which_PNR are_VBB unwilling_VVN to_TO adapt_VVI themselves_PN to_II the_DD new_JJ environment_NN will_VM not_RR survive_VVB in_II this_DD country_NN ._.
P10815085A01
OBJECTIVE_NN :_: Assays_NNS for_II drug_NN resistance_NN testing_VVGN in_II human_NN immunodeficiency_NN virus_NN type_NN 1_MC (_( HIV-1_NN )_) infection_NN are_VBB now_RR available_JJ and_CC clinical_JJ studies_NNS suggest_VVB that_CST viral_JJ drug_NN resistance_NN is_VBZ correlated_VVN with_II poor_JJ virologic_JJ response_NN to_II new_JJ therapy_NN ._.
P10819705A06
No_DD studies_NNS of_II computerized_VVNJ screening_VVGN were_VBD included_VVN ._.
P10824405A14
An_DD "_`` Optimal_JJ Volume_NN Strategy_NN "_'' with_II HFOV_NN was_VBD utilized_VVN to_TO recruit_VVI alveoli_NNS and_CC optimize_VVI lung_NN volume_NN ._.
P10828751A02
Resistance_NN is_VBZ an_DD ongoing_VVGJ problem_NN with_II antimicrobial_JJ therapy_NN but_CC considerable_JJ progress_NN has_VHZ now_RR been_VBN made_VVN into_II understanding_VVGN the_DD underlying_VVGJ genetic_JJ mechanisms_NNS of_II this_DD process_NN ._.
P10849468A02
Despite_II this_PND ,_, asthma_NN morbidity_NN and_CC mortality_NN rates_NNS are_VBB rising_VVG ._.
P10853406A23
The_DD guideline_NN is_VBZ endorsed_VVN by_II the_DD South_NN African_JJ Medical_JJ Association_NN ._.
P10858490A01
Cardiovascular_JJ disease_NN mortality-rate_NN reductions_NNS have_VHB slowed_VVN in_II the_DD United_VVNJ States_NNS in_II the_DD last_JJ decade_NN ,_, suggesting_VVG that_CST additional_JJ strategies_NNS are_VBB needed_VVN to_TO reduce_VVI rates_NNS further_RR ._.
P10860137A09
Leflunomide_NN has_VHZ been_VBN shown_VVN to_TO be_VBI equal_JJ to_II or_CC less_RR efficacious_JJ than_CSN methotrexate_NN ,_, and_CC may_VM be_VBB beneficial_JJ as_II a_DD second-line_NN disease-modifying_VVGJ antirheumatic_JJ drug_NN (_( DMARD_NN )_) ._.
P10863884A19
CONCLUSIONS_NNS :_: There_EX is_VBZ evidence_NN to_TO support_VVI the_DD role_NN of_II citalopram_NN as_II a_DD well-tolerated_VVNJ and_CC effective_JJ SSRI_NN antidepressant_NN ._.
P10872016A11
Smaller_JJR estrogen_NN dosages_NNS were_VBD associated_VVN with_II lower_JJR risk_NN (_( P=.01_NN for_II trend_NN )_) ,_, but_CC risk_NN was_VBD significantly_RR elevated_VVN for_II all_DD dosages_NNS ._.
P10874909A17
CONCLUSIONS_NNS :_: Traumatic_JJ Brain_NN Injury_NN (_( TBI_NN )_) results_VVZ principally_RR from_II vehicular_JJ incidents_NNS ,_, falls_NNS ,_, acts_NNS of_II violence_NN ,_, and_CC sports_NNS injuries_NNS ,_, and_CC is_VBZ more_RR than_CSN twice_RR as_RR likely_JJ in_II males_NNS as_CS in_II females_NNS ._.
P10890271A05
The_DD evidence_NN that_CST diet_NN alone_JJ improves_VVZ survival_NN is_VBZ poor_JJ ,_, although_CS specifically_RR increasing_VVGN intake_NN of_II polyunsaturated_VVNJ fatty_JJ acid_NN (_( including_VVG n-3_NN fatty_JJ acids_NNS )_) relative_JJ to_II saturated_VVNJ fatty_JJ acid_NN intake_NN may_VM provide_VVB some_DD clinical_JJ benefit_NN in_II the_DD secondary_JJ prevention_NN of_II coronary_JJ heart_NN disease_NN ._.
P10901828A07
OUTCOMES_NNS :_: The_DD main_JJ potential_JJ outcomes_NNS considered_VVN were_VBD :_: to_TO reduce_VVI morbidity_NN and_CC mortality_NN by_II correct_JJ diagnosis_NN of_II asthma_NN ,_, to_TO achieve_VVI the_DD best_JJT quality_NN of_II life_NN for_II the_DD child_NN with_II asthma_NN ,_, to_II minimise_VVI side-effects_NNS from_II medication_NN and_CC to_TO prevent_VVI development_NN of_II permanently_RR abnormal_JJ lung_NN function_NN ._.
P10908464A08
These_PND include_VVB acute_JJ phase_NN reactants_NNS ,_, disability_NN ,_, pain_NN ,_, patient_NN global_JJ assessment_NN ,_, physician_NN global_JJ assessment_NN ,_, swollen_JJ joint_NN count_NN ,_, tender_NN joint_NN count_NN and_CC radiographic_JJ changes_NNS of_II joints_NNS in_II any_DD trial_NN of_II one_MC year_NN or_CC longer_JJR [_( Tugwell_NNP 1993_MC ]_) ,_, and_CC the_DD change_NN in_II pooled_VVNJ disease_NN index_NN (_( DI_NN )_) ._.
P10908475A02
Although_CS payment_NN systems_NNS may_VM be_VBB used_VVN to_TO achieve_VVI policy_NN objectives_NNS (_( e.g._II improving_VVGN quality_NN of_II care_NN ,_, cost_NN containment_NN and_CC recruitment_NN to_II under-served_VVNJ areas_NNS )_) ,_, little_PND is_VBZ known_VVN about_II the_DD effects_NNS of_II different_JJ payment_NN systems_NNS in_II achieving_VVGN these_DD objectives_NNS ._.
P10908485A02
The_DD condition_NN usually_RR results_VVZ in_II an_DD increase_NN in_II symptoms_NNS ,_, a_DD greater_JJR reliance_NN on_II corticosteroids_NNS to_TO control_VVI the_DD disease_NN process_NN and_CC may_VM lead_VVB to_II a_DD progressive_JJ decline_NN in_II lung_NN function_NN ._.
P10908489A16
One_MC large_JJ study_NN (_( 106_MC patients_NNS )_) showed_VVD an_DD improvement_NN in_II PEFR_NN and_CC reduction_NN in_II rescue_NN bronchodilator_NN use_NN ._.
P10908496A18
Dose-response_NN studies_NNS examining_VVG survival_NN for_II either_DD agent_NN could_VM not_RR be_VBB identified_VVN ._.
P10908505A01
BACKGROUND_NN :_: Stress_NN is_VBZ considered_VVN an_DD important_JJ precipitating_VVGJ factor_NN for_II seizures_NNS ._.
P10908512A12
Overall_RR the_DD methodological_JJ quality_NN of_II the_DD studies_NNS included_VVN in_II our_PNG review_NN was_VBD rather_RR low_JJ ._.
P10908517A33
Its_PNG adverse_JJ events_NNS profile_NN is_VBZ similar_JJ to_II that_PND of_II other_JJ drugs_NNS ,_, but_CC it_PN may_VM have_VHB a_DD lower_JJR level_NN of_II extrapyramidal_JJ problems_NNS ._.
P10908521A18
All_PND found_VVD withdrawal_NN to_TO be_VBI less_RR severe_JJ in_II the_DD buprenorphine_JJ treatment_NN group_NN ._.
P10908538A10
The_DD majority_NN of_II the_DD studies_NNS lacked_VVD sample_NN size_NN calculations_NNS and_CC randomization_NN procedure_NN remained_VVD unclear_JJ in_II three_MC trials_NNS ._.
P10908543A08
Interventions_NNS were_VBD continuous_JJ distending_VVGJ airway_NN pressure_NN including_VVG continuous_JJ positive_JJ airway_NN pressure_NN (_( CPAP_NN )_) by_II mask_NN ,_, nasal_JJ prong_NN ,_, nasopharnygeal_JJ tube_NN ,_, or_CC endotracheal_JJ tube_NN ,_, or_CC continuous_JJ negative_JJ pressure_NN (_( CNDP_NN )_) via_II a_DD chamber_NN enclosing_VVG the_DD thorax_NN and_CC lower_JJR body_NN ,_, compared_VVN with_II standard_JJ care_NN ._.
P10908549A17
The_DD odds_NNS ratio_NN for_II '_`` same_JJ or_CC worse_JJ '_'' vs_CC '_`` improved_VVNJ symptoms_NNS '_'' at_II the_DD end_NN of_II treatment_NN was_VBD 0.34_MC (_( 95_MC %_SYM CI_NN 0.10_MC ,_, 1.19_MC )_) ,_, thus_RR showing_VVG no_DD statistically_RR significant_JJ difference_NN between_II the_DD two_MC interventions_NNS ._.
P10908555A03
OBJECTIVES_NNS :_: The_DD aims_NNS of_II this_DD review_NN study_NN are_VBB to_TO compare_VVI the_DD safety_NN and_CC efficacy_NN of_II anti-leukotriene_NN agents_NNS with_II inhaled_VVNJ glucocorticoids_NNS and_CC to_TO determine_VVI the_DD dose-equivalence_NN of_II anti-leukotrienes_NNS in_II mcg_NN of_II inhaled_VVNJ corticosteroids_NNS in_II the_DD management_NN of_II chronic_JJ asthma_NN ._.
P10912869A20
Our_PNG results_NNS cast_VVB serious_JJ doubt_NN on_II the_DD existing_VVGJ policies_NNS on_II VT_NN prophylaxis_NN ,_, and_CC we_PN call_VVB for_II a_DD large_JJ ,_, high-quality_NN ,_, multicenter_NN trial_NN that_PNR can_VM provide_VVB definitive_JJ answers_NNS ._.
P10920183A07
Whether_CST cases_NNS existed_VVD in_II Japan_NNP before_RR that_DD time_NN is_VBZ currently_RR under_II study_NN ._.
P10928402A04
STUDY_NN SELECTION_NN :_: Prospective_JJ ,_, randomized_VVNJ ,_, controlled_VVNJ studies_NNS ;_: prospective_JJ ,_, nonrandomized_VVNJ ,_, controlled_VVNJ studies_NNS ;_: prospective_JJ ,_, nonrandomized_VVNJ ,_, uncontrolled_VVNJ studies_NNS ;_: retrospective_JJ studies_NNS ;_: clinical_JJ experience_NN reports_NNS ;_: case_NN reports_NNS ;_: in_JJ+ vitro_JJ studies_NNS ;_: and_CC letters_NNS were_VBD evaluated_VVN for_II relevant_JJ information_NN ._.
P10934310A01
OBJECTIVE_NN :_: To_TO review_VVI the_DD development_NN of_II intracoronary_JJ ultrasound_NN ,_, its_PNG current_JJ utility_NN and_CC the_DD impetus_NN for_II its_PNG continued_VVNJ development_NN as_II a_DD coronary_JJ imaging_VVGJ modality_NN ._.
P10939145A19
The_DD expert_NN group_NN identified_VVD 16_MC key_JJ topics_NNS for_II a_DD national_JJ hypertension_NN guideline_NN ._.
P10949779A16
Results_NNS of_II trials_NNS with_II CIN3_NN as_II an_DD endpoint_NN are_VBB arguably_RR more_RR persuasive_JJ than_CSN those_PND from_II intervention_NN studies_NNS with_II HPV_NN infection_NN endpoints_NNS ._.
P10966006A08
Later_JJR reports_NNS have_VHB not_RR noted_VVN increased_VVNJ bleeding_VVGN when_CS incorporating_VVGN these_DD modifications_NNS plus_II early_JJ platelet_NN transfusion_NN ,_, if_CS required_VVN ._.
P10977460A06
The_DD angiotensin_NN II_MC receptor_NN blockers_NNS (_( ARBs_NNS )_) share_VVB many_PND of_II the_DD organ-protective_JJ effects_NNS of_II ACE_NN inhibitors_NNS when_CS studied_VVN in_II animal_NN models_NNS ._.
P10982214A02
DATA_NNS SOURCES_NNS :_: All_DD English_JJ language_NN MEDLINE_NN articles_NNS that_PNR cross-referenced_VVD allergy_NN ,_, fungal_JJ ,_, and_CC sinusitis_NN from_II 1983-present_NN ._.
P11000650A04
DATA_NNS SOURCES_NNS :_: A_DD MEDLINE_NN search_NN was_VBD performed_VVN to_TO identify_VVI all_DD English-language_NN articles_NNS regarding_VVG use_NN of_II Gp_NN IIb_NN /_SYM IIIa_NN inhibitors_NNS in_II ACSs_NNS published_VVN between_II 1966_MC and_CC June_NN 2000_MC ._.
P11005773A09
All_DD economic_JJ evaluations_NNS comprised_VVD analytical_JJ studies_NNS containing_VVG a_DD decision_NN tree_NN ._.
P11016488A07
Some_DD patients_NNS ,_, however_RR ,_, have_VHB symptomatic_JJ and_CC hemodynamic_JJ rebound_NN to_II worsened_VVNJ heart_NN failure_NN states_NNS during_II or_CC shortly_RR after_II inotrope_NN weaning_VVGN ._.
P11025346A05
The_DD recent_JJ introduction_NN of_II direct_JJ thrombin_NN inhibitors_NNS ,_, platelet_NN fibrinogen_NN receptor_NN antagonists_NNS and_CC low-molecular-weight_NN heparins_NNS (_( LMWHs_NNS )_) has_VHZ offered_VVN an_DD opportunity_NN to_TO develop_VVI more_RR aggressive_JJ antithrombotic_JJ regimens_NNS ._.
P11030020A09
Clinical_JJ trial_NN results_NNS provide_VVB evidence_NN that_CST some_DD ACE_NN inhibitors_NNS have_VHB renoprotective_JJ and_CC vasculoprotective_JJ effects_NNS and_CC improve_VVB outcomes_NNS of_II patients_NNS with_II a_DD variety_NN of_II cardiovascular_JJ disorders_NNS ;_: differences_NNS among_II the_DD ACE_NN inhibitors_NNS should_VM be_VBB considered_VVN in_II formulary_JJ decision-making_VVGN ._.
P11034667A06
We_PN also_RR contacted_VVD investigators_NNS in_II the_DD field_NN ._.
P11034678A09
MAIN_JJ RESULTS_NNS :_: Nine_MC trials_NNS involving_VVG over_II 750_MC patients_NNS aged_VVN eight_MC to_II over_RR 65_MC and_CC including_VVG smokers_NNS and_CC non-smokers_NNS were_VBD included_VVN ._.
P11034682A16
There_EX is_VBZ some_DD evidence_NN that_CST discharge_NN planning_VVGN may_VM lead_VVB to_II reduced_VVNJ hospital_NN length_NN of_II stay_NN ,_, and_CC in_II some_DD cases_NNS reduced_VVNJ readmission_NN to_II hospital_NN ._.
P11034686A17
Progestogen_NN (_( Medroxyprogesterone_NN acetate_NN )_) was_VBD associated_VVN with_II a_DD reduction_NN of_II pain_NN during_II treatment_NN ._.
P11034695A04
SEARCH_NN STRATEGY_NN :_: The_DD Cochrane_NNP Dementia_NN and_CC Cognitive_JJ Impairment_NN Group_NN Register_NN of_II Clinical_JJ Trials_NNS has_VHZ been_VBN searched_VVN ,_, as_CS have_VHB the_DD electronic_JJ databases_NNS MEDLINE_NN ,_, EMBASE_NN ,_, Psychlit_NN ,_, ISI_NN and_CC Current_JJ Contents_NNS ._.
P11034699A06
Subsequently_RR ,_, guidelines_NNS for_II their_PNG use_NN can_VM be_VBB made_VVN on_II a_DD sound_JJ evidence_NN base_NN ._.
P11034705A04
Several_JJ other_JJ cholinesterase_NN inhibitors_NNS ,_, including_VVG rivastigmine_NN ,_, with_II superior_JJ properties_NNS in_II terms_NNS of_II specificity_NN of_II action_NN and_CC low_JJ risk_NN of_II adverse_JJ effects_NNS ,_, have_VHB now_RR been_VBN introduced_VVN ._.
P11034709A15
In_II cross-over_NN studies_NNS ,_, evening_NN peak_JJ flow_NN was_VBD better_JJR with_II regular_JJ treatment_NN ,_, weighted_VVNJ mean_NN difference_NN (_( WMD_NN )_) 13.1_MC l_NN /_SYM min_NN (_( 95_MC %_SYM confidence_NN interval_NN 24.3_MC ,_, 1.9_MC )_) ._.
P11034713A03
OBJECTIVES_NNS :_: The_DD object_NN of_II this_DD review_NN was_VBD to_TO determine_VVI the_DD efficacy_NN and_CC safety_NN of_II corticosteroids_NNS or_CC ACTH_NN in_II reducing_VVGN the_DD short_JJ and_CC long_JJ term_NN morbidity_NN from_II MS_NN ._.
P11034719A10
Toxicity_NN was_VBD evaluated_VVN with_II pooled_VVNJ odds_NNS ratios_NNS for_II withdrawals_NNS and_CC adverse_JJ reactions_NNS ._.
P11034725A03
OBJECTIVES_NNS :_: The_DD objective_NN of_II this_DD review_NN was_VBD to_TO determine_VVI the_DD efficacy_NN of_II any_DD form_NN of_II surface_NN ES_NN in_II the_DD prevention_NN and/or_CC treatment_NN of_II pain_NN around_II the_DD shoulder_NN at_II any_DD time_NN after_II stroke_NN ._.
P11034730A01
BACKGROUND_NN :_: Preterm_NN infants_NNS experience_VVB a_DD range_NN of_II morbidity_NN related_VVN to_II the_DD immaturity_NN of_II their_PNG organ_NN systems_NNS and_CC to_II concurrent_JJ disease_NN states_NNS ._.
P11034734A11
MAIN_JJ RESULTS_NNS :_: Four_MC randomized_VVNJ controlled_VVNJ trials_NNS met_VVD the_DD inclusion_NN criteria_NNS ._.
P11034739A05
OBJECTIVES_NNS :_: The_DD objective_NN of_II this_DD review_NN was_VBD to_TO evaluate_VVI the_DD efficacy_NN and_CC safety_NN of_II long-term_NN treatment_NN of_II symptomatic_JJ venous_JJ thromboembolism_NN with_II low-molecular-weight_NN heparins_NNS compared_VVN with_II vitamin_NN K_NN antagonists_NNS ._.
P11034748A13
A_DD dose_NN response_NN relationship_NN was_VBD not_RR seen_VVN with_II duodenal_JJ ulcers_NNS ._.
P11034753A16
The_DD doses_NNS of_II aminophylline_NN and_CC other_JJ medications_NNS and_CC the_DD severity_NN of_II asthma_NN varied_VVD between_II studies_NNS ._.
P11034757A18
There_EX needs_VVZ to_TO be_VBI a_DD greater_JJR standardisation_NN of_II management_NN so_CS+ that_CS comparisons_NNS between_II different_JJ series_NN can_VM be_VBB made_VVN ._.
P11034764A02
It_PN is_VBZ important_JJ to_TO quantify_VVI the_DD drop-out_NN rates_NNS of_II different_JJ antidepressant_NN drugs_NNS in_II order_NN to_TO have_VHI a_DD better_JJR understanding_VVGN of_II the_DD relative_JJ tolerability_NN of_II these_DD drugs_NNS ._.
P11034770A15
Patients_NNS reported_VVD that_CST they_PN preferred_VVD heat_NN therapy_NN to_II no_DD therapy_NN (_( 94_MC %_SYM like_VVB heat_NN therapy_NN better_JJR than_CSN no_DD therapy_NN )_) ._.
P11034777A07
Date_NN of_II last_JJ search_NN :_: June_NN 2000_MC ._.
P11041454A12
A_DD multicenter_NN international_JJ study_NN has_VHZ shown_VVN that_CST serum_NN Tg_NN measurements_NNS alone_JJ are_VBB not_RR as_RR sensitive_JJ in_II the_DD identification_NN of_II patients_NNS with_II persistent_JJ or_CC recurrent_JJ tumor_NN as_CSN are_VBB rhTSH-stimulated_VVNJ serum_NN Tg_NN determinations_NNS ._.
P11048901A13
The_DD target_NN hemoglobin_NN level_NN is_VBZ 12_MC g_NN /_SYM dL_NN for_II men_NNS and_CC 11_MC g_NN /_SYM dL_NN for_II women_NNS ._.
P11051137A17
The_DD nail_NN lacquer_NN is_VBZ a_DD cost_NN effective_JJ agent_NN compared_VVN with_II the_DD oral_JJ antifungal_JJ therapies_NNS ,_, terbinafine_NN ,_, itraconazole_NN ,_, fluconazole_NN ,_, and_CC griseofulvin_NN ._.
P11059357A16
The_DD best_NN would_VM be_VBB records_NNS of_II the_DD progression_NN of_II a_DD disease-state_NN in_II untreated_VVNJ patients_NNS ._.
P11060248A14
Moreover_RR ,_, the_DD notion_NN that_CST coronary_JJ artery_NN disease_NN can_VM be_VBB considered_VVN to_TO be_VBI an_DD inflammatory_JJ condition_NN in_II its_PNG own_JJ right_NN has_VHZ opened_VVN new_JJ and_CC challenging_VVGJ avenues_NNS for_II research_NN ._.
P11062301A10
Investigators_NNS should_VM also_RR be_VBB encouraged_VVN to_TO combine_VVI their_PNG individual_JJ patient_NN data_NNS in_II meta-analyses_NNS to_TO obtain_VVI a_DD more_RR robust_JJ assessment_NN of_II the_DD value_NN of_II DWI_NN and_CC PI_NN from_II larger_JJR sample_NN sizes_NNS ._.
P11073480A02
The_DD administration_NN of_II thrombolytic_JJ therapy_NN for_II acute_JJ myocardial_JJ infarction_NN is_VBZ a_DD particularly_RR high-risk_NN situation_NN for_II emergency_NN physicians_NNS ._.
P11074393A21
Manufacturers_NNS '_GE submissions_NNS to_II the_DD National_JJ Institute_NN for_II Clinical_JJ Excellence_NN were_VBD searched_VVN ._.
P11074396A17
(_( 4_MC )_) Caregiver_NN 's_GE and_CC child_NN 's_GE QoL_NN ._.
P11076126A11
Patients_NNS who_PNR were_VBD discharged_VVN on_II a_DD statin_NN showed_VVD a_DD 50_MC %_SYM reduction_NN in_II mortality_NN over_II those_PND who_PNR did_VDD not_RR receive_VVB statin_NN therapy_NN independent_JJ of_II lipid_NN level_NN ._.
P11083694A01
STUDY_NN OBJECTIVES_NNS :_: Tracheostomy_NN is_VBZ one_MC of_II the_DD most_RRT commonly_RR performed_VVNJ procedures_NNS in_II the_DD patient_NN receiving_VVG long-term_NN mechanical_JJ ventilation_NN ._.
P11086757A01
OBJECTIVE_NN :_: To_TO critically_RR review_VVI the_DD current_JJ data_NNS concerning_VVG the_DD efficacy_NN of_II preventive_JJ measures_NNS described_VVN in_II the_DD literature_NN ,_, on_II the_DD incidence_NN of_II lateral_JJ ankle_NN ligament_NN injuries_NNS ._.
P11095158A13
In_II the_DD early_JJ 21st_JJ century_NN ,_, the_DD patient_NN with_II type_NN 2_MC diabetes_NN will_VM need_VVB to_TO be_VBI the_DD specific_JJ focus_NN for_II use_NN of_II these_DD preventive_JJ treatment_NN modalities_NNS due_II+ to_II the_DD geometric_JJ risk_NN in_II the_DD international_JJ incidence_NN of_II this_DD disease_NN ._.
P11096522A15
This_PND has_VHZ significant_JJ clinical_JJ relevance_NN because_CS the_DD presence_NN of_II these_DD disorders_NNS guides_VVZ treatment_NN specific_JJ to_II the_DD disorder_NN (_( s_NN )_) ._.
P11098244A20
Meta-analysis_NN of_II the_DD limited_VVNJ data_NNS available_JJ shows_VVZ a_DD statistically_RR significant_JJ difference_NN in_II survival_NN at_II 5_MC years_NNS that_PNR favors_VVZ combined_VVNJ androgen_NN blockade_NN ._.
P11100995A02
In_II the_DD last_JJ two_MC decades_NNS ,_, the_DD rediscovery_NN of_II H._NN pylori_NN ,_, development_NN of_II potent_JJ ulcer-healing_VVGJ drugs_NNS and_CC specific_JJ Cox-II_NN inhibitors_NNS have_VHB opened_VVN new_JJ horizons_NNS in_II the_DD management_NN of_II NSAID_NN toxicity_NN ._.
P11105180A07
Mortality_NN and_CC morbidity_NN from_II CHD_NN were_VBD derived_VVN from_II published_VVNJ meta-analyses_NNS and_CC recent_JJ studies_NNS ._.
P11109039A06
Evidence_NN for_II risk_NN stratification_NN of_II patients_NNS with_II non-ST_NN segment_NN acute_JJ coronary_JJ syndromes_NNS and_CC the_DD results_NNS of_II clinical_JJ trials_NNS for_II the_DD individual_JJ antithrombotic_JJ and_CC antiplatelet_NN agents_NNS were_VBD reviewed_VVN ._.
P11115025A04
Seven_MC trials_NNS (_( 286_MC children_NNS in_II total_NN )_) compared_VVD cisapride_NN with_II placebo_NN ._.
P11122746A01
The_DD advent_NN of_II statin_NN therapy_NN has_VHZ revolutionized_VVN the_DD ability_NN of_II the_DD clinician_NN to_TO manage_VVI patients_NNS at_II risk_NN for_II the_DD development_NN of_II an_DD ischemic_JJ event_NN due_II+ to_II dyslipidemia_NN ._.
P11129126A04
Recent_JJ evidence_NN indicates_VVZ that_CST budesonide_NN inhalation_NN suspension_NN is_VBZ significantly_RR more_RR effective_JJ than_CSN nebulised_VVNJ sodium_NN cromoglycate_NN in_II improving_VVGN control_NN of_II asthma_NN in_II young_JJ children_NNS with_II persistent_JJ asthma_NN ._.
P11130523A01
BACKGROUND_NN :_: This_DD programme_NN of_II overviews_NNS of_II randomised_VVNJ trials_NNS was_VBD established_VVN to_TO investigate_VVI the_DD effects_NNS of_II angiotensin-converting-enzyme_NN (_( ACE_NN )_) inhibitors_NNS ,_, calcium_NN antagonists_NNS ,_, and_CC other_JJ blood-pressure-lowering_VVGJ drugs_NNS on_II mortality_NN and_CC major_JJ cardiovascular_JJ morbidity_NN in_II several_JJ populations_NNS of_II patients_NNS ._.
P11134919A10
OBJECTIVES_NNS :_: The_DD objectives_NNS of_II this_DD scoping_VVGJ review_NN are_VBB two-fold_NN ._.
P11138871A02
The_DD purpose_NN of_II this_DD study_NN was_VBD to_TO observe_VVI potential_JJ risk_NN factors_NNS and_CC diagnostic_JJ tests_NNS for_II VTE_NN ,_, and_CC prophylaxis_NN against_II VTE_NN in_II medical-surgical_JJ ICU_NN patients_NNS ._.
P11141646A03
There_EX is_VBZ large_JJ evidence_NN from_II observational_JJ studies_NNS that_CST HRT_NN reduces_VVZ the_DD risk_NN of_II cardiovascular_JJ mortality_NN and_CC morbidity_NN in_II postmenopausal_JJ women_NNS ._.
P11145762A06
These_DD studies_NNS ,_, however_RR ,_, were_VBD either_CC uncontrolled_VVN or_CC poorly_RR controlled_VVN ,_, unblinded_VVN or_CC only_RR single-blinded_VVN ,_, and_CC enrolled_VVD small_JJ numbers_NNS of_II patients_NNS ._.
P11152019A04
After_II 50_MC weeks_NNS '_GE treatment_NN ,_, plasma_NN HIV_NN RNA_NN levels_NNS were_VBD below_II the_DD limit_NN of_II detection_NN (_( LOD_NN ;_: <_SYM 50_MC copies_NNS /_SYM ml_NN )_) for_II 40_MC %_SYM of_II patients_NNS receiving_VVG triple_JJ therapy_NN but_CC for_II only_RR 6_MC %_SYM of_II those_PND receiving_VVG dual_JJ NRTI_NN therapy_NN ._.
P11153637A07
SETTING_VVGN :_: A_DD ten-bed_NN surgical_JJ ICU_NN in_II an_DD academic-affiliated_VVNJ community_NN hospital_NN ._.
P11159653A07
There_EX were_VBD five_MC randomised_VVNJ controlled_VVNJ trials_NNS published_VVN between_II 1989-99_MC ._.
P11174359A01
BACKGROUND_NN :_: In_II the_DD context_NN of_II a_DD comprehensive_JJ population_NN strategy_NN to_TO reduce_VVI tobacco_NN use_NN ,_, encourage_VVI healthy_JJ food_NN choices_NNS ,_, and_CC increase_VVI physical_JJ activity_NN for_II the_DD whole_JJ population_NN ,_, the_DD medical_JJ priority_NN is_VBZ to_TO focus_VVI on_II those_PND who_PNR have_VHB developed_VVN symptoms_NNS of_II coronary_JJ heart_NN disease_NN (_( CHD_NN )_) or_CC other_JJ major_JJ atherosclerotic_JJ disease_NN ,_, and_CC those_PND who_PNR are_VBB at_II high_JJ risk_NN of_II developing_VVGN such_DD diseases_NNS in_II the_DD future_NN ._.
P11179262A07
The_DD risk_NN of_II major_JJ bleeding_VVGN balanced_VVD the_DD reduction_NN in_II cardiovascular_JJ events_NNS when_CS cardiovascular_JJ event_NN risk_NN was_VBD 0.22_MC %_SYM /_SYM year_NN ._.
P11190039A05
Methods_NNS of_II epithelial_JJ cauterization_NN and_CC curettage_NN were_VBD grouped_VVN as_II relatively_RR equivalent_JJ physicochemical_JJ therapy_NN ,_, and_CC solution_NN and_CC ointment_NN formulations_NNS of_II a_DD given_VVNJ topical_JJ antiviral_JJ agent_NN were_VBD combined_VVN ._.
P11192359A05
This_DD was_VBD so_RR prevalent_JJ as_RR to_TO allow_VVI the_DD conduct_NN of_II a_DD substantial_JJ study_NN ,_, the_DD ATLAS_NN trial_NN ,_, to_TO compare_VVI high_JJ and_CC low_JJ dose_NN ACE_NN inhibition_NN ._.
P11195408A01
These_DD guidelines_NNS propose_VVB a_DD treatment_NN algorithm_NN in_II which_PNR patients_NNS are_VBB evaluated_VVN regularly_RR for_II fatigue_NN ,_, using_VVG a_DD brief_JJ screening_VVGJ instrument_NN ,_, and_CC are_VBB treated_VVN as_CS indicated_VVN by_II their_PNG fatigue_NN level_NN ._.
P11199101A10
In_II patients_NNS with_II severe_JJ disease_NN ,_, reduction_NN in_II operating_VVGJ lung_NN volumes_NNS is_VBZ more_RR important_JJ than_CSN '_`` bronchodilitation_NN '_'' and_CC is_VBZ better_JJR sustained_VVN by_II long_JJ acting_VVGJ beta_NN agonists_NNS and_CC anticholinergics_NNS ._.
P11206593A01
BACKGROUND_NN :_: This_DD review_NN summarizes_VVZ and_CC evaluates_VVZ clinical_JJ experience_NN with_II citalopram_NN ,_, the_DD latest_JJT selective_JJ serotonin_NN reuptake_NN inhibitor_NN (_( SSRI_NN )_) to_TO be_VBI approved_VVN for_II the_DD treatment_NN of_II depression_NN in_II the_DD United_VVNJ States_NNS ._.
P11220287A09
Other_JJ novel_JJ antidiabetic_JJ agents_NNS are_VBB currently_RR under_II development_NN ,_, including_VVG pramlintide_NN (_( an_DD amylin_NN analogue_NN )_) and_CC glucagon-like_JJ peptide_NN ._.
P11224885A01
STUDY_NN DESIGN_NN :_: A_DD systematic_JJ review_NN of_II randomized_VVNJ and_CC nonrandomized_VVNJ controlled_VVNJ trials_NNS ._.
P11230834A10
The_DD use_NN of_II eptifibatide_NN independently_RR predicted_VVD a_DD lower_JJR risk_NN of_II events_NNS (_( adjusted_VVNJ RR_NN 0.31_MC ,_, 95_MC %_SYM CI_NN 0.10_MC to_II 0.93_MC ,_, p_NN =_SYM 0.04_MC )_) ._.
P11232362A29
Only_RR in_II this_DD way_NN can_VM the_DD challenges_NNS of_II the_DD present_NN and_CC the_DD future_NN be_VBB met_VVN ._.
P11236168A11
Likewise_RR ,_, TEE_NN also_RR may_VM prove_VVB to_TO be_VBI useful_JJ in_II identifying_VVGN patients_NNS with_II a_DD low-clinical_JJ risk_NN profile_NN who_PNR may_VM be_VBB treated_VVN with_II aspirin_NN alone_JJ and_CC patients_NNS in_II whom_PNR warfarin_NN may_VM be_VBB superior_JJ ._.
P11242429A03
OBJECTIVE_NN :_: To_TO explore_VVI disagreement_NN for_II serious_JJ adverse_JJ safety_NN (_( intracranial_JJ hemorrhage_NN [_( ICH_NN ]_) )_) and_CC efficacy_NN outcomes_NNS between_II meta-analysis_NN of_II phase_NN 2_MC (_( small_JJ )_) vs_CC meta-analysis_NN of_II phase_NN 3_MC (_( large_JJ )_) randomized_VVNJ controlled_VVNJ trials_NNS comparing_VVG the_DD efficacy_NN of_II bolus_NN thrombolytic_JJ therapy_NN with_II infusion_NN for_II acute_JJ myocardial_JJ infarction_NN (_( AMI_NN )_) ._.
P11249510A12
Fewer_JJR studies_NNS have_VHB investigated_VVN statins_NNS '_GE effects_NNS on_II the_DD quality_NN of_II lipoprotein_NN particles_NNS ,_, the_DD activities_NNS of_II cholesteryl_NN ester_NN transfer_NN protein_NN and_CC lecithin_NN :_: cholesterol_NN acyltransferase_NN as_CC+ well_CC+ as_CC their_PNG possible_JJ synergistic_JJ effects_NNS with_II n-3_NN fatty_JJ acids_NNS ,_, anti-oxidants_NNS and_CC aspirin_NN in_II reducing_VVGN cardiovascular_JJ events_NNS ._.
P11255426A03
DATA_NNS SOURCES_NNS :_: Studies_NNS with_II English-language_NN abstracts_NNS identified_VVN in_II MEDLINE_NN (_( 1966-August_NN 2000_MC )_) ,_, HealthSTAR_NN (_( 1975-August_NN 2000_MC ,_, PsychINFO_NN (_( 1984-August_NN 2000_MC )_) ;_: Cochrane_NNP Library_NN databases_NNS ;_: and_CC articles_NNS listed_VVN in_II reference_NN lists_NNS of_II key_JJ articles_NNS ._.
P11255880A19
For_II this_DD reason_NN ,_, guidelines_NNS for_II such_DD patients_NNS are_VBB aimed_VVN at_II keeping_VVGN the_DD other_JJ risk_NN factors_NNS under_II strict_JJ control_NN in_II order_NN to_II significantly_RR reduce_VVI their_PNG effect_NN ._.
P11261530A05
STUDY_NN SELECTION_NN AND_CC DATA_NNS EXTRACTION_NN :_: Prospective_JJ ,_, randomized_VVNJ ,_, double-blind_JJ ,_, placebo-controlled_VVNJ ,_, human_NN trials_NNS were_VBD selected_VVN for_II review_NN and_CC discussion_NN ._.
P11262422A02
Policy_NN documents_NNS have_VHB advocated_VVN the_DD importance_NN of_II public_JJ views_NNS as_II one_MC such_DD criterion_NN ._.
P11270126A05
The_DD anticoagulation_NN target_NN for_II AF_NN is_VBZ INR_NN 2_MC to_II 3_MC with_II INR_NN 2.5_MC as_II the_DD specific_JJ goal_NN ._.
P11276294A08
A_DD total_NN of_II 18_MC trials_NNS involving_VVG 2939_MC men_NNS were_VBD reviewed_VVN ._.
P11279681A08
Additional_JJ information_NN was_VBD sought_VVN from_II all_DD trialists_NNS ._.
P11279687A04
SEARCH_NN STRATEGY_NN :_: We_PN searched_VVD the_DD The_DD Cochrane_NNP Library_NN ,_, Issue_NN 32000_MC ;_: MEDLINE_NN ,_, EMBASE_NN ,_, LILACS_NN ,_, Current_JJ Contents_NNS ,_, Dissertation_NN Abstracts_NNS ,_, and_CC Index_NN to_II UK_NNP Theses_NNS to_II August_NN 2000_MC ._.
P11279691A04
SEARCH_NN STRATEGY_NN :_: We_PN searched_VVD the_DD Cochrane_NNP Musculoskeletal_JJ Injuries_NNS Group_NN trials_NNS register_NN ,_, MEDLINE_NN ,_, PubMed_NN ,_, the_DD Cochrane_NNP Controlled_VVNJ Trials_NNS Register_NN ,_, CINAHL_NN ,_, the_DD National_JJ Research_NN Register_NN and_CC bibliographies_NNS of_II trial_NN reports_NNS ._.
P11279699A02
When_CS it_PN affects_VVZ one_MC side_NN of_II the_DD mouth_NN the_DD lower_JJR jaw_NN may_VM have_VHB to_TO move_VVI to_II one_MC side_NN to_TO allow_VVI the_DD back_II teeth_NN to_TO meet_VVI together_RR ._.
P11279702A14
The_DD effect_NN remained_VVD statistically_RR significant_JJ when_CS the_DD results_NNS from_II studies_NNS with_II less_RR rigorous_JJ methodology_NN were_VBD excluded_VVN in_II a_DD sensitivity_NN analysis_NN ._.
P11279713A01
BACKGROUND_NN :_: Asthma_NN is_VBZ one_MC of_II the_DD most_RRT common_JJ reasons_NNS for_II paediatric_JJ admissions_NNS to_II hospital_NN ,_, with_II substantial_JJ cost_NN to_II the_DD community_NN ._.
P11279716A25
PFMT_NN may_VM be_VBB more_RR effective_JJ than_CSN some_DD types_NNS of_II electrical_JJ stimulation_NN but_CC there_EX were_VBD problems_NNS in_II combining_VVGN the_DD data_NNS from_II these_DD trials_NNS ._.
P11279720A01
BACKGROUND_NN :_: Long_JJ term_NN levodopa_NN therapy_NN in_II Parkinson_NN 's_GE disease_NN is_VBZ associated_VVN with_II the_DD development_NN of_II motor_NN complications_NNS including_VVG abnormal_JJ involuntary_JJ movements_NNS and_CC a_DD shortening_VVGJ response_NN to_II each_DD dose_NN (_( wearing_VVG off_II phenomenon_NN )_) ._.
P11279723A14
The_DD clinical_JJ trial_NN registers_NNS of_II the_DD National_JJ Cancer_NN Institute_NN and_CC the_DD Radiation_NN Therapy_NN Oncology_NN Group_NN were_VBD consulted_VVN for_II ongoing_VVGJ trials_NNS ._.
P11279726A23
Low_JJ dose_NN corticosteroids_NNS (_( <_SYM or_CC =_SYM 80_MC mg_NN /_SYM day_NN of_II methylprednisolone_NN or_CC <_SYM or_CC =_SYM 400_MC mg_NN /_SYM day_NN of_II hydrocortisone_NN )_) appear_VVB to_TO be_VBI adequate_JJ in_II the_DD initial_JJ management_NN of_II these_DD adult_NN patients_NNS ._.
P11279735A01
BACKGROUND_NN :_: Concerns_NNS regarding_VVG the_DD safety_NN of_II transfused_VVNJ blood_NN have_VHB prompted_VVN re-consideration_NN of_II the_DD use_NN of_II allogeneic_JJ (_( blood_NN from_II an_DD unrelated_VVNJ donor_NN )_) blood_NN transfusion_NN ._.
P11279739A08
DATA_NNS COLLECTION_NN AND_CC ANALYSIS_NN :_: No_DD controlled_VVNJ trials_NNS of_II suitable_JJ quality_NN were_VBD identified_VVN for_II inclusion_NN in_II the_DD review_NN ._.
P11279745A18
These_DD results_NNS should_VM be_VBB interpreted_VVN with_II caution_NN ._.
P11279752A01
BACKGROUND_NN :_: Coronary_JJ artery_NN bypass_NN surgery_NN (_( CABG_NN )_) may_VM be_VBB life_NN saving_VVGN ,_, but_CC known_VVNJ side_NN effects_NNS include_VVB neurological_JJ damage_NN and_CC cognitive_JJ impairment_NN ._.
P11279758A01
BACKGROUND_NN :_: Prevalence_NN studies_NNS show_VVB that_CST behaviour_NN problems_NNS in_II children_NNS are_VBB quite_RR common_JJ (_( 10-15_MC %_SYM in_II preschoolers_NNS )_) ._.
P11279762A08
Data_NNS were_VBD excluded_VVN where_CS more_RR than_CSN 50_MC %_SYM of_II participants_NNS in_II any_DD group_NN were_VBD lost_VVN to_II follow_NN+ up_NN ._.
P11279766A16
Suitable_JJ outcome_NN measures_NNS should_VM be_VBB chosen_VVN so_CS+ that_CS the_DD efficacy_NN and_CC effectiveness_NN of_II non-pharmacological_JJ swallowing_VVGJ therapy_NN can_VM be_VBB assessed_VVN and_CC an_DD economic_JJ analysis_NN performed_VVN ._.
P11279772A04
OBJECTIVES_NNS :_: To_TO assess_VVI whether_CST computer_NN support_NN for_II drug_NN dosage_NN benefits_VVZ patients_NNS and_CC hence_RR whether_CST it_PN should_VM be_VBB more_RR widely_RR available_JJ ._.
P11279781A19
Further_JJ reviews_NNS comparing_VVG the_DD effective_JJ interventions_NNS and_CC studies_NNS that_PNR include_VVB cost-effectiveness_NN ,_, women_NNS 's_GE satisfaction_NN and_CC equity_NN issues_NNS are_VBB needed_VVN ._.
P11279789A16
More_DD research_NN is_VBZ needed_VVN to_TO investigate_VVI the_DD effects_NNS of_II these_DD and_CC other_JJ related_VVNJ interventions_NNS ._.
P11281087A04
Risk_NN is_VBZ highest_JJT in_II smokers_NNS with_II chronic_JJ obstructive_JJ pulmonary_JJ disease_NN ._.
P11286095A05
Our_PNG current_JJ quality_NN improvement_NN initiative_NN ,_, developed_VVN through_II the_DD Occupational_JJ Health_NN Services_NNS Project_NN ,_, synthesizes_VVZ what_PND was_VBD learned_VVN from_II the_DD MCP_NN and_CC other_JJ pilot_NN studies_NNS to_TO make_VVI delivery_NN system_NN improvements_NNS ._.
P11288383A16
The_DD guideline_NN was_VBD developed_VVN by_II the_DD Executive_NN Committee_NN of_II the_DD Southern_JJ African_JJ Hypertension_NN Society_NN with_II consensus_NN meeting_VVGJ endorsement_NN ,_, and_CC is_VBZ endorsed_VVN by_II the_DD South_NN African_JJ Medical_JJ Association_NN Guideline_NN Commitee_NN ._.
P11293649A02
Nocturnal_JJ and_CC early_JJ morning_NN symptoms_NNS are_VBB quite_RR common_JJ among_II patients_NNS with_II asthma_NN ._.
P11296189A01
STUDY_NN OBJECTIVES_NNS :_: To_TO critically_RR review_VVI the_DD available_JJ data_NNS on_II the_DD diagnostic_JJ evaluation_NN ,_, risk_NN stratification_NN ,_, and_CC therapeutic_JJ management_NN of_II patients_NNS with_II acute_JJ exacerbations_NNS of_II COPD_NN ._.
P11302109A09
Mainly_RR because_II+ of_II the_DD on-course_NN modification_NN of_II the_DD study_NN protocol_NN ,_, 402_MC /_SYM 2133_MC (_( 18.8_MC %_SYM )_) patients_NNS in_II the_DD control_NN group_NN started_VVD a_DD cholesterol-lowering_VVGJ treatment_NN during_II follow-up_NN ._.
P11303413A02
The_DD total_JJ economic_JJ cost_NN of_II COPD_NN in_II the_DD US_NNP in_II 1993_MC was_VBD estimated_VVN to_TO be_VBI over_RR $_SYM US15.5_NN billion_MC ,_, with_II $_SYM US6.1_NN billion_MC for_II hospitalisation_NN ,_, $_SYM US4.4_NN billion_MC for_II physician_NN and_CC other_JJ fees_NNS ,_, $_SYM US2.5_NN billion_MC for_II drugs_NNS ,_, $_SYM US1.5_NN billion_MC for_II nursing_VVGJ home_NN care_NN and_CC $_SYM US1.0_NN billion_MC for_II home_NN care_NN ._.
P11306234A15
Four_MC high-risk_NN studies_NNS reported_VVD results_NNS for_II preterm_NN delivery_NN less_RR than_CSN 34_MC weeks_NNS ._.
P11308231A14
There_EX was_VBD no_DD difference_NN in_II studies_NNS that_PNR provided_VVD lipids_NNS as_II a_DD component_NN of_II TPN_NN when_CS compared_VVN with_II studies_NNS that_PNR did_VDD not_RR ._.
P11315826A04
This_DD study_NN will_VM help_VVB clarify_VVI the_DD treatment_NN of_II HTN_NN in_II the_DD setting_VVGN of_II diabetes_NN ._.
P11318073A04
OBJECTIVE_NN :_: This_DD article_NN reviews_VVZ the_DD pharmacologic_JJ properties_NNS and_CC clinical_JJ usefulness_NN of_II linezolid_NN ._.
P11319991A09
METHODS_NNS -_: DATA_NNS EXTRACTION_NN (_( NON-HEALTH_NN TECHNOLOGY_NN ASSESSMENT_NN LITERATURE_NN SEARCH_NN )_) :_: The_DD new_JJ statistical_JJ techniques_NNS identified_VVN were_VBD categorised_VVN into_II four_MC subgroups_NNS of_II increasing_VVGJ complexity_NN :_: exploratory_JJ data_NNS analysis_NN ;_: simple_JJ series_NN data_NNS analysis_NN ;_: complex_JJ data_NNS structure_NN analysis_NN ,_, generic_JJ techniques_NNS ._.
P11331734A30
Continued_VVNJ scientific_JJ efforts_NNS need_VVB to_TO be_VBI directed_VVN to_II the_DD identification_NN of_II the_DD causes_NNS of_II ASD_NN ._.
P11346064A05
STUDY_NN SELECTION_NN :_: Clinical_JJ efficacy_NN data_NNS were_VBD extracted_VVN from_II clinical_JJ trials_NNS ,_, case_NN reports_NNS ,_, and_CC abstracts_NNS that_PNR mentioned_VVD linezolid_NN ._.
P11349622A03
Moreover_RR ,_, the_DD mechanisms_NNS leading_VVG to_II the_DD instability_NN of_II an_DD atherosclerotic_JJ plaque_NN are_VBB complex_JJ themselves_PN ._.
P11359552A12
Actual_JJ patient_NN harm_NN from_II serious_JJ errors_NNS was_VBD rarely_RR recorded_VVN ._.
P11373981A04
The_DD total_JJ CK_NN level_NN is_VBZ far_RR too_RR insensitive_JJ and_CC nonspecific_JJ a_DD test_NN to_TO be_VBI used_VVN to_TO diagnose_VVI AMI_NN ._.
P11376301A09
CONCLUSIONS_NNS :_: The_DD potential_JJ clinical_JJ impact_NN of_II the_DD PRINCE_NN trial_NN is_VBZ substantial_JJ because_CS nearly_RR 50_MC %_SYM of_II myocardial_JJ infarctions_NNS in_II the_DD United_VVNJ States_NNS occur_VVB in_II persons_NNS with_II normal_JJ cholesterol_NN levels_NNS ,_, and_CC inflammatory_JJ markers_NNS such_II+ as_II hs-CRP_NN may_VM provide_VVB a_DD means_NNS to_TO detect_VVI such_DD individuals_NNS at_II high_JJ risk_NN who_PNR do_VDB not_RR currently_RR qualify_VVB for_II statin_NN therapy_NN ._.
P11381277A07
Reference_NN lists_NNS were_VBD scanned_VVN ,_, experts_NNS were_VBD polled_VVN ,_, and_CC the_DD personal_JJ files_NNS of_II the_DD subgroup_NN members_NNS and_CC authors_NNS were_VBD used_VVN to_TO identify_VVI other_JJ studies_NNS ._.
P11394560A08
However_RR ,_, the_DD discriminating_VVGJ power_NN of_II specific_JJ variables_NNS from_II the_DD medical_JJ history_NN and_CC exercise_NN test_NN remains_VVZ unclear_JJ because_II+ of_II inadequate_JJ study_NN design_NN and_CC differences_NNS in_II study_NN populations_NNS ._.
P11399237A21
Quality_NN assessment_NN was_VBD conducted_VVN independently_RR by_II two_MC reviewers_NNS ._.
P11401736A02
STUDY_NN DESIGN_NN :_: A_DD systematic_JJ review_NN was_VBD performed_VVN with_II meta-analysis_NN where_CS appropriate_JJ ._.
P11405951A11
The_DD meta-analysis_NN shows_VVZ that_CST the_DD use_NN of_II natural_JJ surfactant_NN rather_II+ than_II synthetic_JJ surfactant_NN results_VVZ in_II a_DD significant_JJ reduction_NN in_II the_DD risk_NN of_II pneumothorax_NN (_( typical_JJ relative_JJ risk_NN 0.63_MC ,_, 95_MC %_SYM CI_NN 0.53_MC ,_, 0.75_MC ;_: typical_JJ risk_NN difference_NN -0.04_MC ,_, 95_MC %_SYM CI_NN -0.06_MC ,_, -0.03_MC )_) and_CC the_DD risk_NN of_II mortality_NN (_( typical_JJ relative_JJ risk_NN 0.87_MC ,_, 95_MC %_SYM CI_NN 0.76_MC ,_, 0.98_MC ;_: typical_JJ risk_NN difference_NN -0.02_MC ,_, 95_MC %_SYM CI_NN -0.05_MC ,_, 0.00_MC )_) ._.
P11405961A13
Where_CS possible_JJ ,_, intention-to-treat_NN data_NNS were_VBD used_VVN ._.
P11405964A11
To_TO avoid_VVI duplication_NN of_II data_NNS in_II the_DD reviews_NNS ,_, the_DD labour_NN induction_NN methods_NNS have_VHB been_VBN listed_VVN in_II a_DD specific_JJ order_NN ,_, from_II one_MC to_II 25_MC ._.
P11405971A01
OBJECTIVES_NNS :_: To_TO determine_VVI the_DD clinical_JJ efficacy_NN of_II piracetam_NN for_II the_DD features_NNS of_II dementia_NN or_CC cognitive_JJ impairment_NN ,_, classified_VVN according_II+ to_II the_DD major_JJ subtypes_NNS of_II dementia_NN :_: vascular_JJ ,_, Alzheimer_NNP 's_GE disease_NN or_CC mixed_VVNJ vascular_JJ and_CC Alzheimer_NNP 's_GE disease_NN ,_, or_CC unclassified_VVNJ dementia_NN ,_, or_CC cognitive_JJ impairment_NN not_RR fulfilling_VVG the_DD criteria_NNS for_II dementia_NN ._.
P11405980A21
Frequency_NN of_II STIs_NNS :_: In_II both_CC Mwanza_NNP and_CC Rakai_NNP ,_, there_EX was_VBD no_DD significant_JJ reduction_NN in_II gonorrhoea_NN ,_, chlamydia_NN ,_, urethritis_NN ,_, or_CC reported_VVNJ STI_NN symptoms_NNS among_II intervention_NN communities_NNS ._.
P11405986A05
OBJECTIVES_NNS :_: To_TO assess_VVI the_DD effectiveness_NN of_II prophylactic_JJ antibiotic_JJ administration_NN before_II IUD_NN insertion_NN in_II reducing_VVGN IUD-related_VVNJ complications_NNS and_CC discontinuations_NNS within_II three_MC months_NNS of_II insertion_NN ._.
P11405990A23
For_II this_DD outcome_NN there_EX was_VBD statistically_RR significant_JJ between_II study_NN heterogeneity_NN (_( for_II RR_NN ,_, p=0.02_NN ;_: for_II RD_NN ,_, p=0.0001_NN )_) ._.
P11405998A15
Any_DD disagreement_NN was_VBD resolved_VVN by_II discussion_NN ._.
P11406004A03
OBJECTIVES_NNS :_: To_TO review_VVI evidence_NN for_II the_DD efficacy_NN of_II speleotherapy_NN in_II the_DD treatment_NN of_II asthma_NN ._.
P11406016A11
In_II DDAVP-treated_VVNJ patients_NNS the_DD relative_JJ risk_NN of_II requiring_VVGN re-operation_NN due_II+ to_II bleeding_VVGN was_VBD 0.56_MC (_( 95_MC %_SYM CI_NN :_: 0.18_MC to_II 1.73_MC )_) ._.
P11406027A01
BACKGROUND_NN :_: Reduced_VVNJ perfusion_NN of_II organs_NNS such_II+ as_II the_DD brain_NN ,_, heart_NN ,_, kidneys_NNS and_CC the_DD gastrointestinal_JJ tract_NN may_VM lead_VVB to_II acute_JJ dysfunction_NN and_CC be_VBB associated_VVN with_II permanent_JJ injury_NN ._.
P11406033A10
SELECTION_NN CRITERIA_NNS :_: Randomized_VVNJ controlled_VVNJ trials_NNS in_II patients_NNS with_II localized_VVNJ esophageal_JJ cancer_NN ,_, with_II one_MC arm_NN employing_VVGN radiotherapy_NN alone_JJ ,_, and_CC one_MC arm_NN employing_VVGN combination_NN radiotherapy_NN chemotherapy_NN were_VBD included_VVN ._.
P11406037A17
MAIN_JJ RESULTS_NNS :_: In_II general_NN ,_, media-based_VVNJ therapies_NNS for_II behavioural_JJ disorders_NNS in_II children_NNS had_VHD a_DD moderate_JJ effect_NN when_CS compared_VVN with_II both_CC no-treatment_NN controls_NNS and_CC with_II standard_JJ care_NN ._.
P11406045A11
These_DD methodological_JJ problems_NNS could_VM potentially_RR lead_VVN to_II bias_NN from_II a_DD number_NN of_II sources_NNS ._.
P11406055A16
The_DD trials_NNS included_VVD 584_MC patients_NNS ._.
P11406061A14
Authors_NNS ,_, other_JJ experts_NNS in_II the_DD field_NN and_CC pharmaceutical_JJ companies_NNS were_VBD contacted_VVN for_II knowledge_NN of_II suitable_JJ trials_NNS ,_, published_VVN or_CC unpublished_VVN ._.
P11406065A10
SELECTION_NN CRITERIA_NNS :_: Randomised_VVNJ or_CC quasi-randomised_VVNJ controlled_VVNJ clinical_JJ trials_NNS involving_VVG preterm_NN infants_NNS ._.
P11406071A15
An_DD adequately_RR powered_VVNJ randomised_VVNJ controlled_VVNJ trial_NN would_VM be_VBB useful_JJ to_TO determine_VVI if_CST the_DD use_NN of_II extra-amniotic_JJ prostaglandins_NNS would_VM lower_VVB the_DD rate_NN of_II caesarean_NN section_NN ._.
P11419424A09
These_DD data_NNS support_VVB a_DD policy_NN involving_VVG broader_JJR use_NN of_II the_DD early_JJ inhibition_NN of_II glycoprotein_NN IIb_NN /_SYM IIIa_NN in_II combination_NN with_II an_DD early_JJ invasive_JJ strategy_NN in_II such_DD patients_NNS ._.
P11427188A08
It_PN reports_VVZ a_DD series_NN of_II case_NN studies_NNS ,_, each_PND describing_VVG the_DD development_NN of_II a_DD clinical_JJ guideline_NN ;_: each_DD case_NN study_NN illustrates_VVZ different_JJ issues_NNS in_II incorporating_VVGN these_DD different_JJ types_NNS of_II evidence_NN ._.
P11434828A06
INTERVENTIONS_NNS :_: Participants_NNS in_II the_DD double-blind_JJ primary_JJ prevention_NN trial_NN were_VBD randomly_RR assigned_VVN to_TO receive_VVI 40_MC mg_NN /_SYM d_NN of_II pravastatin_NN (_( n_NN =_SYM 865_MC )_) or_CC placebo_NN (_( n_NN =_SYM 837_MC )_) for_II 24_MC weeks_NNS ._.
P11441927A13
These_PND constitute_VVB about_II 75_MC %_SYM ,_, of_II all_DD haematological_JJ malignancies_NNS ._.
P11441935A03
This_DD synthesis_NN of_II the_DD literature_NN on_II chemotherapy_NN in_II patients_NNS with_II acute_JJ myeloid_NN leukaemia_NN (_( AML_NN )_) is_VBZ based_VVN on_II 129_MC scientific_JJ articles_NNS :_: one_MC meta-analysis_NN ,_, 51_MC randomised_VVNJ trials_NNS ,_, 39_MC prospective_JJ and_CC 18_MC retrospective_JJ studies_NNS ,_, and_CC 20_MC other_JJ articles_NNS ._.
P11441937A21
High-dose_NN infusional_JJ regimens_NNS with_II modulated_VVNJ fluorouracil_NN may_VM turn_VVB out_II to_TO be_VBI superior_JJ to_II conventional_JJ bolus_NN regimens_NNS ,_, since_CS they_PN result_VVB in_II more_DD tumour_NN regressions_NNS ,_, longer_JJR times_NNS to_II disease_NN progression_NN and_CC possibly_RR longer_JJR survival_NN ._.
P11441940A22
Thus_RR ,_, there_EX are_VBB preliminary_JJ data_NNS supporting_VVG the_DD substitution_NN of_II cisplatin_NN with_II carboplatin_NN ._.
P11445744A10
These_DD studies_NNS reported_VVD variable_JJ hospital_NN and_CC intensive_JJ care_NN unit_NN (_( ICU_NN )_) occurrence_NN rates_NNS ,_, ranging_VVG from_II 2_MC %_SYM to_II 11_MC %_SYM of_II all_DD hospital_NN or_CC ICU_NN admissions_NNS ._.
P11449817A12
Although_CS many_PND of_II these_DD studies_NNS can_VM be_VBB cited_VVN for_II various_JJ methodologic_JJ flaws_NNS ,_, the_DD most_RRT consistent_JJ problem_NN is_VBZ that_CST sample_NN sizes_NNS are_VBB too_RR small_JJ to_TO detect_VVI difference_NN between_II two_MC or_CC more_DD active_JJ treatments_NNS ._.
P11455747A08
Incidence_NN is_VBZ 5_MC %_SYM to_II 40_MC %_SYM in_II high-risk_NN surgical_JJ patients_NNS ._.
P11464448A13
However_RR ,_, recent_JJ retrospective_JJ real-life_NN clinical_JJ studies_NNS show_VVB that_CST only_RR 38_MC %_SYM of_II patients_NNS receiving_VVG some_DD form_NN of_II lipid-lowering_VVGJ therapy_NN achieved_VVD NCEP-defined_VVNJ LDL-C_NN target_NN levels_NNS ,_, demonstrating_VVG the_DD need_NN for_II the_DD use_NN of_II more_RR aggressive_JJ treatment_NN ._.
P11469927A01
The_DD continued_VVNJ widespread_JJ prevalence_NN of_II breast_NN cancer_NN supports_VVZ placing_VVGN a_DD high_JJ priority_NN on_II research_NN aimed_VVN at_II its_PNG primary_JJ prevention_NN ,_, particularly_RR among_II women_NNS who_PNR are_VBB at_II increased_VVNJ risk_NN for_II developing_VVGN this_DD disease_NN ._.
P11478189A12
4._MC Work_VVB at_II building_VVGN a_DD reputation_NN for_II general_JJ objectivity_NN ,_, reliance_NN on_II multiple_JJ data_NNS sources_NNS ,_, reaching_VVGN opinions_NNS only_RR after_II reviewing_VVGN complete_JJ information_NN from_II both_CC sides_NNS ,_, and_CC completing_VVGN the_DD evaluation_NN ._.
P11483848A16
The_DD presumed_VVNJ efficacy_NN is_VBZ based_VVN on_II a_DD collection_NN of_II animal_NN and_CC human_NN data_NNS concerning_VVG occupational_JJ ,_, perinatal_JJ ,_, and_CC nonoccupational_JJ exposures_NNS to_II HIV_NN ._.
P11495374A06
Mammograms_NNS miss_VVB approximately_RR 12_MC %_SYM to_II 37_MC %_SYM of_II cancers_NNS ,_, generate_VVB false-positive_JJ results_NNS ,_, and_CC cause_VVB anxiety_NN while_CS abnormal_JJ results_NNS are_VBB evaluated_VVN ._.
P11501601A06
Subgroup_NN analyses_NNS have_VHB demonstrated_VVN that_CST the_DD efficacy_NN of_II statins_NNS extends_VVZ to_II specific_JJ subgroups_NNS of_II patients_NNS ,_, including_VVG women_NNS ,_, people_NNS with_II diabetes_NN ,_, and_CC older_JJR individuals_NNS ._.
P11509058A04
DESIGN_NN AND_CC SETTING_VVGN :_: Cost-effectiveness_NN analysis_NN using_VVG the_DD Coronary_JJ Heart_NN Disease_NN Policy_NN Model_NN ,_, a_DD validated_VVNJ ,_, state-transition_NN model_NN of_II CHD_NN events_NNS in_II adults_NNS aged_VVN 35_MC through_CC 84_MC years_NNS ._.
P11512506A07
The_DD panel_NN composed_VVD a_DD draft_JJ statement_NN that_PNR was_VBD read_VVN in_II its_PNG entirety_NN and_CC circulated_VVN to_II the_DD experts_NNS and_CC the_DD audience_NN for_II comment_NN ._.
P11520256A09
There_EX are_VBB no_DD clearcut_NN advantages_NNS to_TO distinguish_VVI these_DD antihistamines_NNS ,_, although_CS for_II children_NNS under_II 5_MC years_NNS of_II age_NN ,_, only_RR cetirizine_NN and_CC loratadine_NN are_VBB approved_VVN ._.
P11524642A04
Antiplatelet_NN ,_, antithrombin_NN ,_, and_CC fibrinolytic_JJ agents_NNS unknown_VVN in_II clinical_JJ practice_NN as_RR recently_RR as_CSN 5_MC years_NNS ago_RR have_VHB secured_VVN places_NNS in_II the_DD emergency_NN physician_NN 's_GE armamentarium_NN for_II treating_VVGN acute_JJ coronary_JJ syndrome_NN ._.
P11529246A05
This_DD pathology_NN results_VVZ in_II focal_JJ changes_NNS in_II the_DD function_NN of_II several_JJ deep_JJ brain_NN nuclei_NNS ,_, which_PNR have_VHB been_VBN well-characterized_VVN in_II humans_NNS and_CC animal_NN models_NNS and_CC which_PNR account_VVB for_II many_PND of_II the_DD motor_NN symptoms_NNS of_II PD_NN ._.
P11530420A04
Whether_CST or_CC not_RR individuals_NNS with_II TS_NN have_VHB significant_JJ discrepancies_NNS between_II their_PNG verbal_JJ and_CC nonverbal_JJ abilities_NNS remains_VVZ unclear_JJ ._.
P11532236A23
This_PND was_VBD not_RR a_DD cohesive_JJ group_NN ,_, however_RR ._.
P11532238A38
METHODS_NNS -_: DATA_NNS SYNTHESIS_NN :_: For_II all_DD comparisons_NNS ,_, the_DD primary_JJ outcome_NN was_VBD the_DD number_NN of_II clients_NNS who_PNR were_VBD in_II competitive_JJ employment_NN at_II various_JJ time_NN points_NNS ._.
P11532240A03
In_II addition_NN ,_, the_DD research_NN :_: (_( 1_MC )_) explored_VVD the_DD '_`` diagnostic_JJ accuracy_NN '_'' of_II initial_JJ clinical_JJ investigation_NN of_II the_DD knee_NN by_II an_DD orthopaedic_JJ trainee_NN ,_, consultant_NN knee_NN specialist_NN and_CC consultant_NN radiologist_NN ;_: (_( 2_MC )_) considered_VVD the_DD variability_NN and_CC diagnostic_JJ accuracy_NN of_II interpretations_NNS of_II knee_NN MRI_NN investigations_NNS between_II radiologists_NNS ;_: (_( 3_MC )_) measured_VVD the_DD strength_NN of_II preference_NN for_II the_DD potential_JJ diagnostic_JJ /_SYM therapeutic_JJ impact_NN of_II knee_NN MRI_NN (_( i.e._II the_DD avoidance_NN of_II surgery_NN )_) ._.
P11533360A28
Policy-level_NN changes_NNS at_II the_DD state_NN and_CC community_NN led_VVD to_II lasting_VVGJ changes_NNS in_II the_DD organization_NN and_CC financing_VVGN of_II care_NN ,_, which_PNR enabled_VVD changes_NNS in_II clinical_JJ services_NNS to_TO take_VVI place_NN ._.
P11535983A08
The_DD results_NNS of_II ICON3_NN ,_, in_II accordance_NN with_II GOG132_NN study_NN ,_, appear_VVB to_TO contradict_VVI the_DD earlier_JJR positive_JJ results_NNS seen_VVN for_II PTX_NN and_CC CP_NN in_II the_DD GOG-111_NN and_CC OV10_NN trials_NNS and_CC suggested_VVD that_CST single_JJ agent_NN carboplatin_NN ,_, CY-adriamycin-CP_NN are_VBB safe_JJ and_CC effective_JJ first-line_NN treatments_NNS for_II women_NNS requiring_VVG chemotherapy_NN for_II ovarian_JJ cancer_NN ._.
P11550833A02
The_DD objective_NN of_II this_DD review_NN was_VBD to_TO assess_VVI the_DD effectiveness_NN of_II the_DD various_JJ methods_NNS of_II immobilisation_NN for_II acute_JJ ankle_NN sprain_NN ._.
P11557249A01
Patients_NNS admitted_VVN with_II suspicion_NN of_II an_DD acute_JJ coronary_JJ syndrome_NN (_( ACS_NN )_) still_RR constitute_VVB a_DD diagnostic_JJ ,_, prognostic_JJ and_CC therapeutic_JJ challenge_NN for_II the_DD treating_VVGJ physician_NN ._.
P11561607A05
Specialized_VVNJ centers_NNS have_VHB reported_VVN improved_VVNJ hospital_NN morbidity_NN ,_, mortality_NN and_CC survival_NN after_II pancreaticoduodenectomy_NN ;_: however_RR ,_, disease-specific_JJ survival_NN after_II surgical_JJ resection_NN remains_VVZ dismal_JJ ._.
P11567728A09
The_DD continuing_VVGJ elucidation_NN of_II pathophysiological_JJ pathways_NNS relevant_JJ in_II rheumatoid_JJ arthritis_NN ,_, coupled_VVN with_II continuing_VVGJ advances_NNS in_II biotechnology_NN and_CC rational_JJ drug_NN design_NN ,_, offer_VVB substantial_JJ hope_NN for_II the_DD continued_VVNJ development_NN of_II increasingly_RR potent_JJ and_CC specific_JJ pharmacotherapy_NN for_II treatment_NN of_II rheumatoid_JJ arthritis_NN ._.
P11570305A01
OBJECTIVE_NN :_: To_TO help_VVI family_NN physicians_NNS who_PNR care_VVB for_II patients_NNS with_II acute_JJ stroke_NN or_CC who_PNR are_VBB involved_VVN in_II planning_VVGN service_NN delivery_NN or_CC resource_NN allocation_NN to_TO understand_VVI recent_JJ developments_NNS in_II acute_JJ stroke_NN care_NN ._.
P11575024A05
Scientific_JJ evidence_NN was_VBD given_VVN precedence_NN over_II clinical_JJ anecdotal_JJ experience_NN ._.
P11581453A18
Ethically_RR sound_JJ ,_, specific_JJ policies_NNS for_II storage_NN ,_, ownership_NN ,_, and_CC use_NN in_II future_JJ studies_NNS of_II archived_VVNJ samples_NNS remaining_VVG from_II PKU_NN testing_VVGN should_VM be_VBB established_VVN ._.
P11587008A09
CONCLUSIONS_NNS :_: Consensus_NN recommendations_NNS were_VBD used_VVN to_TO create_VVI an_DD algorithm_NN for_II evaluating_VVGN women_NNS with_II postmenopausal_JJ bleeding_VVGN ._.
P11589256A11
Finally_RR ,_, risedronate_NN has_VHZ been_VBN associated_VVN with_II a_DD lower_JJR incidence_NN of_II gastric_JJ ulcers_NNS than_CSN alendronate_NN ._.
P11595196A06
The_DD Beyond_II Endorsed_VVNJ Lipid_NN Lowering_VVGN with_II EBCT_NN Scanning_VVGN (_( BELLES_NN )_) trial_NN will_VM use_VVB EBCT_NN to_TO compare_VVI the_DD effects_NNS of_II 12_MC months_NNS of_II treatment_NN with_II aggressive_JJ or_CC moderate_JJ statin_NN therapy_NN on_II the_DD progression_NN of_II coronary_JJ atherosclerosis_NN ._.
P11669360A03
Prior_JJ evidence_NN has_VHZ been_VBN limited_VVN regarding_VVG effective_JJ diagnostic_JJ strategies_NNS for_II the_DD assessment_NN of_II symptomatic_JJ women_NNS ._.
P11680099A07
reports_NNS and_CC opinion_NN of_II expert_NN committees_NNS and_CC working_VVGJ teams_NNS ._.
P11685852A02
Routine_JJ ultrasound_NN in_II late_JJ pregnancy_NN (_( after_II 24_MC weeks_NNS gestation_NN )_) (_( Cochrane_NNP Review_NN )_) ._.
P11686052A60
The_DD proposed_VVNJ treatments_NNS for_II the_DD other_JJ disorders_NNS are_VBB conventional_JJ :_: haloperidol_NN and_CC lithium_NN for_II bipolar_JJ disorders_NNS ,_, fluvoxamine_NN for_II obsessive_JJ compulsive_JJ disorders_NNS and_CC neuroleptics_NNS for_II psychotic_JJ disorders_NNS ._.
P11686949A17
No_DD completed_VVNJ studies_NNS of_II interventions_NNS to_TO raise_VVI blood_NN pressure_NN were_VBD identified_VVN ._.
P11686953A16
Higher_JJR doses_NNS of_II nicotine_NN patch_NN may_VM produce_VVB small_JJ increases_NNS in_II quit_NN rates_NNS ._.
P11686957A20
~bullet~Home_NN hazard_NN modification_NN in_II association_NN with_II advice_NN on_II optimising_VVGN medication_NN (_( 1_MC trial_NN ,_, 658_MC participants_NNS )_) ,_, or_CC in_II association_NN with_II an_DD education_NN package_NN on_II exercise_NN and_CC reducing_VVGN fall_NN risk_NN (_( 1_MC trial_NN ,_, 3182_MC participants_NNS )_) ._.
P11686965A09
SELECTION_NN CRITERIA_NNS :_: Two_MC reviewers_NNS independently_RR assessed_VVD citations_NNS or_CC papers_NNS and_CC selected_VVD all_DD randomised_VVNJ trials_NNS that_PNR included_VVD people_NNS with_II serious_JJ mental_JJ illnesses_NNS and_CC compared_VVD zuclopenthixol_NN acetate_NN with_II other_JJ drug_NN regimes_NNS ._.
P11686970A06
OBJECTIVES_NNS :_: To_TO determine_VVI the_DD effects_NNS of_II vaginal_JJ misoprostol_NN for_II third_JJ trimester_NN cervical_JJ ripening_VVGN or_CC induction_NN of_II labour_NN ._.
P11686975A11
Measured_VVD clinically_RR relevant_JJ outcomes_NNS ._.
P11686981A15
Further_JJ trials_NNS -_: one_MC of_II them_PN very_RR large_JJ -_: are_VBB currently_RR in_II progress_NN ._.
P11686989A13
Method_NN to_TO ascertain_VVI cases_NNS was_VBD similar_JJ in_II one_MC study_NN and_CC not_RR similar_JJ in_II the_DD other_JJ ._.
P11686996A23
Two_MC women_NNS in_II the_DD Goretex_NN group_NN had_VHD late_JJ sling_NN erosion_NN of_II the_DD urethra_NN requiring_VVG removal_NN of_II the_DD Goretex_NN ,_, although_CS their_PNG incontinence_NN remained_VVD cured_VVN ._.
P11687000A13
MAIN_JJ RESULTS_NNS :_: Seven_MC eligible_JJ controlled_VVNJ trials_NNS were_VBD included_VVN in_II the_DD analysis_NN representing_VVG 924_MC randomized_VVNJ pediatric_JJ patients_NNS ._.
P11687004A09
PPIs_NNS were_VBD significantly_RR more_RR effective_JJ than_CSN both_CC H2RA_NN s_NNS and_CC antacids_NNS ._.
P11687013A33
JAPANESE_JJ HERBAL_JJ COMBINATION_NN :_: One_MC small_JJ trial_NN showed_VVD the_DD herbal_JJ combination_NN to_TO be_VBI more_RR effective_JJ for_II pain_NN relief_NN than_CSN placebo_NN ,_, and_CC less_DD additional_JJ pain_NN medication_NN was_VBD taken_VVN by_II the_DD treatment_NN group_NN ._.
P11687024A14
The_DD two_MC in-hospital_NN studies_NNS were_VBD very_RR different_JJ in_II quality_NN (_( A_NN and_CC C_NN )_) and_CC size_NN (_( 773_MC and_CC 53_MC patients_NNS )_) ._.
P11687028A02
The_DD role_NN of_II the_DD occupational_JJ therapist_NN is_VBZ to_TO support_VVI the_DD patient_NN and_CC help_VVB them_PN maintain_VVI their_PNG usual_JJ level_NN of_II self-care_NN ,_, work_NN and_CC leisure_NN activities_NNS for_II as_RR long_RR as_CSN possible_JJ ._.
P11687033A13
The_DD conclusions_NNS are_VBB also_RR limited_VVN by_II some_PND of_II the_DD methodological_JJ deficiencies_NNS of_II the_DD included_VVNJ studies_NNS ._.
P11687038A06
SELECTION_NN CRITERIA_NNS :_: All_DD randomized_VVNJ controlled_VVNJ trials_NNS (_( RCTs_NNS )_) and_CC controlled_VVNJ clinical_JJ trials_NNS (_( CCTs_NNS )_) comparing_VVG therapeutic_JJ ultrasound_NN against_II placebo_NN or_CC another_DD active_JJ intervention_NN in_II patients_NNS with_II OA_NN were_VBD selected_VVN ._.
P11687043A01
BACKGROUND_NN :_: :_: Two_MC recent_JJ clinical_JJ reports_NNS describe_VVB an_DD association_NN between_II statin_NN therapy_NN and_CC a_DD reduction_NN in_II the_DD occurrence_NN of_II Alzheimer_NNP 's_GE disease_NN by_II as_RR much_PND as_CSN 70_MC %_SYM ._.
P11687048A19
Because_CS alternative_JJ antidepressants_NNS exist_VVB which_PNR have_VHB been_VBN proven_VVN to_TO be_VBI effective_JJ and_CC safe_JJ the_DD clinical_JJ usefulness_NN of_II 5-HTP_NN and_CC tryptophan_NN is_VBZ limited_VVN at_II present_NN ._.
P11687053A20
MAIN_JJ RESULTS_NNS :_: One_MC eligible_JJ study_NN was_VBD found_VVN dealing_VVG with_II prevention_NN of_II CLD_NN ;_: this_DD study_NN used_VVD salbutamol_NN and_CC enrolled_VVD 173_MC infants_NNS ._.
P11687058A09
SELECTION_NN CRITERIA_NNS :_: All_DD randomised_VVNJ or_CC quasi-randomised_VVNJ clinical_JJ trials_NNS comparing_VVG different_JJ haemodialysis_NN membrane_NN material_NN in_II patients_NNS with_II ESRD_NN ._.
P11687061A18
Amniotomy_NN and_CC intravenous_JJ oxytocin_NN resulted_VVD in_II more_DD postpartum_NN haemorrhage_NN than_CSN vaginal_JJ prostaglandins_NNS (_( RR_NN 5.5_MC ,_, CI_NN 1.26-24.07_MC )_) ._.
P11687078A12
95_MC %_SYM confidence_NN intervals_NNS were_VBD used_VVN ._.
P11687084A23
There_EX is_VBZ a_DD possible_JJ reduction_NN in_II the_DD severity_NN of_II chronic_JJ lung_NN disease_NN (_( shortened_VVNJ duration_NN of_II assisted_VVNJ ventilation_NN )_) ._.
P11687092A17
van_NNP Wassenaer_NNP 1997_MC found_VVD no_DD significant_JJ differences_NNS in_II the_DD Bayley_NNP MDI_NN and_CC PDI_NN at_II 24_MC months_NNS ,_, incidence_NN of_II cerebral_JJ palsy_NN (_( RR_NN 0.72_MC ,_, 95_MC %_SYM CI_NN 0.28_MC ,_, 1.84_MC )_) ,_, death_NN and_CC cerebral_JJ palsy_NN (_( RR_NN 0.70_MC ,_, 95_MC %_SYM CI_NN 0.43_MC ,_, 1.14_MC )_) or_CC the_DD RAKIT_NN IQ_NN score_NN (_( WMD_NN -2.10_MC ,_, 95_MC %_SYM CI_NN -7.91_MC ,_, 3.71_MC )_) at_II 5.7_MC years_NNS of_II age_NN ._.
P11687098A08
Trial_NN quality_NN was_VBD scored_VVN by_II the_DD Cochrane_NNP assessment_NN of_II allocation_NN concealment_NN &_CC the_DD Jadad_NNP scale_NN of_II methodological_JJ quality_NN ._.
P11687106A17
Manual_JJ muscle_NN testing_VVGN was_VBD assessed_VVN in_II three_MC studies_NNS (_( 54_MC patients_NNS )_) ,_, with_II 29_MC patients_NNS (_( 54_MC %_SYM )_) improving_VVGN in_II at_RR+ least_RR one_MC muscular_JJ district_NN during_II study_NN treatment_NN versus_CC four_MC patients_NNS (_( 7_MC %_SYM )_) during_II placebo_NN (_( odds_NNS ratio_NN [_( OR_CC ]_) 14.5_MC ,_, 95_MC %_SYM confidence_NN interval_NN [_( CI_NN ]_) 4.7-43.7_MC )_) ._.
P11687114A05
SELECTION_NN CRITERIA_NNS :_: Prospective_JJ randomised_VVNJ controlled_VVNJ trials_NNS (_( RCTs_NNS )_) which_PNR evaluated_VVD educational_JJ programmes_NNS for_II the_DD prevention_NN of_II foot_NN ulcers_NNS in_II people_NNS with_II diabetes_NN mellitus_NN ._.
P11687118A03
The_DD present_JJ reviews_NNS addresses_VVZ to_II the_DD use_NN of_II hot_JJ ,_, humid_NN air_NN in_II common_JJ cold_NN ._.
P11687120A24
The_DD GnRH_NN antagonist_NN flexible_JJ regimen_NN should_VM be_VBB the_DD area_NN of_II research_NN in_II the_DD near_JJ future_NN ._.
P11687130A08
MAIN_JJ RESULTS_NNS :_: Three_MC trials_NNS were_VBD included_VVN ,_, two_MC based_VVN in_II general_JJ practice_NN and_CC one_MC in_II a_DD neurology_NN centre_NN ._.
P11687134A08
MAIN_JJ RESULTS_NNS :_: We_PN found_VVD three_MC small_JJ trials_NNS (_( 50_MC patients_NNS )_) of_II relaxation_NN therapy_NN ._.
P11687139A02
Treatment_NN is_VBZ readily_RR available_JJ and_CC puts_VVZ a_DD large_JJ demand_NN on_II healthcare_NN budgets_NNS ._.
P11687142A13
Of_II these_DD nine_MC trials_NNS ,_, four_MC were_VBD excluded_VVN ,_, two_MC at_II further_JJ investigation_NN revealed_VVD a_DD lack_NN of_II randomisation_NN and_CC two_MC included_VVD combined_VVNJ oral_JJ contraceptives_NNS that_PNR are_VBB now_RR discontinued_VVN due_II+ to_II very_RR high_JJ oestrogen_NN content_NN ._.
P11687152A20
Details_NNS of_II late_JJ morbidity_NN were_VBD sparse_JJ ._.
P11687159A18
The_DD results_NNS should_VM be_VBB viewed_VVN with_II caution_NN as_CS patient_NN numbers_NNS are_VBB small_JJ ._.
P11687164A18
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: There_EX is_VBZ a_DD need_NN for_II evaluations_NNS of_II interventions_NNS combining_VVG provider_NN training_VVGN and_CC patient_NN education_NN ,_, and_CC for_II evaluations_NNS conducted_VVN in_II developing_VVGJ countries_NNS ._.
P11687168A14
Positive_JJ urine_NN sample_NN for_II cocaine_NN metabolites_NNS was_VBD the_DD main_JJ efficacy_NN outcome_NN ,_, with_II no_DD significant_JJ results_NNS obtained_VVN regardless_RR the_DD type_NN of_II antidepressant_NN ._.
P11687174A02
In_II RA_NN this_PND resulted_VVD in_II the_DD development_NN of_II the_DD Outcome_NN Measures_NNS in_II Arthritis_NN Clinical_JJ Trials_NNS (_( OMERACT_NN )_) ,_, and_CC in_II juvenile_JJ arthritis_NN the_DD Pediatric_JJ Rheumatology_NN International_JJ Trials_NNS Organization_NN (_( PRINTO_NN )_) core_NN set_NN ._.
P11687176A13
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: :_: There_EX is_VBZ no_DD good_JJ evidence_NN to_TO recommend_VVI statins_NNS for_II reducing_VVGN the_DD risk_NN of_II Alzheimer_NNP 's_GE disease_NN ._.
P11687180A29
Thus_RR there_EX is_VBZ insufficient_JJ evidence_NN on_II the_DD total_JJ costs_NNS and_CC benefits_NNS of_II treating_VVGN pre-dialysis_NN patients_NNS with_II rHu_NN EPO_NN ._.
P11687187A12
MAIN_JJ RESULTS_NNS :_: Four_MC studies_NNS were_VBD included_VVN ._.
P11687193A20
There_EX were_VBD no_DD significant_JJ differences_NNS in_II trials_NNS where_PNR participants_NNS had_VHD primary_JJ cocaine_NN dependence_NN or_CC had_VHD additional_JJ diagnosis_NN of_II opioid_NN dependence_NN and/or_CC were_VBD in_II methadone_NN maintenance_NN treatment_NN ._.
P11687198A12
The_DD pooled_VVNJ RR_NN for_II remission_NN of_II binge_NN episodes_NNS was_VBD 0.88_MC (_( 95_MC %_SYM CI_NN 0.83-0.93_MC ;_: p_NN <_SYM 0,001_MC )_) favoring_VVG drugs_NNS ._.
P11695246A01
The_DD cyclooxygenase_NN (_( COX_NN )_) -2_MC selective_JJ inhibitors_NNS celecoxib_NN and_CC rofecoxib_NN have_VHB been_VBN found_VVN to_TO be_VBI more_RR effective_JJ than_CSN placebo_NN and_CC comparably_RR effective_JJ to_II nonselective_JJ nonsteroidal_JJ anti-inflammatory_JJ drugs_NNS (_( NSAIDs_NNS )_) in_II the_DD treatment_NN of_II patients_NNS with_II osteoarthritis_NN and_CC rheumatoid_JJ arthritis_NN ._.
P11699634A27
None_MC of_II these_DD anticipated_VVNJ advances_NNS will_VM be_VBB achieved_VVN ,_, however_RR ,_, in_II the_DD absence_NN of_II a_DD progressive_JJ ,_, third-party_NN payment_NN system_NN that_PNR acknowledges_VVZ its_PNG responsibility_NN to_TO compensate_VVI providers_NNS adequately_RR to_TO ensure_VVI that_CST the_DD next_JJ generation_NN of_II conservative_JJ therapy_NN can_VM be_VBB enjoyed_VVN by_II the_DD American_JJ people_NNS ._.
P11701099A48
Trials_NNS should_VM be_VBB undertaken_VVN in_II community_NN settings_NNS to_TO ensure_VVI the_DD generalisability_NN of_II results_NNS ._.
P11701102A23
However_RR ,_, power_NN was_VBD considerably_RR reduced_VVN for_II smaller_JJR interactions_NNS ,_, which_PNR are_VBB much_RR more_RR likely_JJ in_II practice_NN ._.
P11701786A05
Computer_NN database_NN searches_NNS were_VBD performed_VVN independently_RR by_II two_MC investigators_NNS to_TO identify_VVI all_DD potentially_RR relevant_JJ study_NN titles_NNS ._.
P11702861A16
Methods_NNS used_VVN to_TO determine_VVI the_DD extent_NN of_II resection_NN were_VBD subjective_JJ and_CC qualitative_JJ in_II almost_RR all_DD studies_NNS ._.
P11708038A04
METHODOLOGY_NN :_: The_DD MEDLINE_NN ,_, EMBASE_NN ,_, Best_JJT Evidence_NN ,_, and_CC Cochrane_NNP Systematic_JJ Review_NN databases_NNS and_CC Internet_NN Web_NN sites_NNS were_VBD searched_VVN for_II articles_NNS and_CC guidelines_NNS published_VVN between_II January_NN 1980_MC and_CC May_NN 2001_MC to_TO identify_VVI quality_NN indicators_NNS for_II CAP_NN and_CC relevant_JJ evidence_NN ._.
P11711010A09
CONCLUSIONS_NNS :_: There_EX is_VBZ no_DD evidence_NN to_TO support_VVI using_VVGN beta2-agonists_NNS in_II children_NNS with_II acute_JJ cough_NN and_CC no_DD evidence_NN of_II airflow_NN obstruction_NN ._.
P11713849A02
Blood_NN pressure_NN management_NN remains_VVZ one_MC of_II the_DD most_RRT cost-effective_JJ methods_NNS of_II cardiovascular_JJ risk_NN factor_NN reduction_NN ._.
P11715181A21
The_DD current_JJ multicenter_NN prospective_JJ trials_NNS will_VM provide_VVB much_DD needed_VVNJ guidance_NN on_II this_DD subject_NN ._.
P11720920A15
More_DD research_NN is_VBZ needed_VVN to_TO establish_VVI more_DD evidence_NN regarding_VVG situations_NNS in_II which_PNR teleadvice_NN is_VBZ beneficial_JJ and_CC efficient_JJ ._.
P11724098A06
Treatment_NN of_II these_DD underlying_VVGJ etiologies_NNS should_VM be_VBB considered_VVN ._.
P11727406A09
The_DD patients_NNS for_II whom_PNR combination_NN therapy_NN is_VBZ most_RRT commonly_RR successful_JJ are_VBB those_PND who_PNR do_VDB not_RR achieve_VVB adequate_JJ glycemic_JJ control_NN using_VVG daytime_NN oral_JJ agents_NNS but_CC who_PNR still_RR show_VVB some_DD evidence_NN of_II responsiveness_NN to_II the_DD medications_NNS ._.
P11728541A05
We_PN calculated_VVD summary_NN estimates_NNS across_II studies_NNS for_II important_JJ efficacy_NN and_CC tolerability_NN parameters_NNS ,_, and_CC separately_RR summarised_VVD direct_JJ comparator_NN trials_NNS ._.
P11735631A11
Wide_JJ variability_NN in_II ACE_NN inhibitor_NN use_NN is_VBZ noted_VVN ,_, with_II higher_JJR rates_NNS consistently_RR reported_VVN among_II patients_NNS having_VHG systolic_JJ dysfunction_NN confirmed_VVN by_II an_DD objective_JJ assessment_NN --_: an_DD apparent_JJ minority_NN of_II the_DD those_PND having_VHG CHF_NN ._.
P11735713A10
For_II diagnostic_JJ accuracy_NN ,_, sensitivity_NN was_VBD 0.81_MC to_II 1.00_MC for_II dermatologists_NNS and_CC 0.42_MC to_II 1.00_MC for_II PCPs_NNS ._.
P11747684A05
Medications_NNS analyzed_VVN include_VVB alendronate_NN ,_, either_CC 5_MC mg_NN /_SYM day_NN or_CC 5_MC mg_NN /_SYM day_NN ,_, followed_VVN by_II 10_MC mg_NN /_SYM day_NN ;_: raloxifene_NN ,_, 60_MC or_CC 120_MC mg_NN /_SYM day_NN ;_: and_CC combination_NN hormone_NN replacement_NN therapy_NN (_( HRT_NN )_) of_II four_MC different_JJ regimen_NN types_NNS ._.
P11756209A02
Thus_RR diabetes_NN not_RR only_RR increases_VVZ the_DD risk_NN of_II coronary_JJ heart_NN disease_NN but_CC also_RR increases_VVZ the_DD case_NN fatality_NN rate_NN ,_, ensuring_VVG that_CST the_DD majority_NN of_II patients_NNS die_VVB of_II cardiovascular_JJ causes_NNS ,_, often_RR before_II the_DD age_NN of_II 50_MC years_NNS ._.
P11761209A07
All_DD randomised_VVNJ controlled_VVNJ trials_NNS (_( RCTs_NNS )_) descrbiing_VVG individuals_NNS with_II diagnosed_VVNJ lateral_JJ epicondylitis_NN and_CC assessing_VVG the_DD use_NN of_II an_DD orthotic_JJ device_NN as_II a_DD treatment_NN strategy_NN were_VBD evaluatedfor_VVN inclusion_NN ._.
P11768834A10
Full_JJ reports_NNS were_VBD available_JJ for_II only_RR 6_MC of_II the_DD 11_MC studies_NNS ._.
P11772158A17
CONCLUSIONS_NNS :_: Paclitaxel_NN used_VVN in_II combination_NN with_II cisplatin_NN offers_VVZ survival_NN and_CC utility_NN gains_NNS versus_CC cyclophosphamide_NN plus_CC cisplatin_NN ,_, when_CS used_VVN as_II first-line_NN treatment_NN in_II patients_NNS with_II stage_NN III_MC or_CC IV_MC ovarian_JJ cancer_NN ._.
P11773571A24
Comparison_NN of_II final_JJ videotape_NN interpretation_NN to_II initial_JJ telemedicine_NN diagnosis_NN resulted_VVD in_II 1_MC minor_JJ diagnostic_JJ change_NN (_( membranous_JJ versus_CC inlet_RR ventricular_JJ septal_JJ defect_NN )_) ._.
P11780589A03
In_II the_DD United_VVNJ States_NNS alone_JJ ,_, the_DD uncontrolled_VVNJ epilepsy_NN represents_VVZ more_RR than_CSN 500,000_MC people_NNS ._.
P11784221A05
Patients_NNS with_II 2_MC or_CC more_DD cardiac_JJ risk_NN factors_NNS or_CC with_II documented_VVNJ coronary_JJ artery_NN disease_NN were_VBD classified_VVN as_II high_JJ risk_NN and_CC were_VBD considered_VVN eligible_JJ for_II treatment_NN with_II a_DD beta-blocker_NN if_CS they_PN had_VHD no_DD obvious_JJ contraindications_NNS to_II its_PNG use_NN ._.
P11789467A04
The_DD Dietary_JJ Supplement_NN and_CC Health_NN Education_NN Act_NN signed_VVN into_II law_NN in_II October_NN 1994_MC ,_, requires_VVZ no_DD proof_NN of_II efficacy_NN ,_, no_DD demonstration_NN of_II safety_NN ,_, and_CC sets_VVZ no_DD standards_NNS for_II quality_NN control_NN for_II the_DD products_NNS labeled_VVN as_II "_`` supplements_NNS "_'' thereby_RR increasing_VVG the_DD risk_NN of_II adverse_JJ effects_NNS of_II these_DD herbs_NNS ._.
P11791816A03
To_TO investigate_VVI the_DD effects_NNS of_II exercise_NN training_VVGN upon_II CHF_NN patients_NNS ,_, a_DD systematic_JJ literature_NN review_NN was_VBD carried_VVN out_II of_II trials_NNS (_( from_II 1966_MC to_II December_NN 2000_MC )_) which_PNR used_VVD as_II their_PNG main_JJ outcome_NN measures_NNS the_DD effects_NNS of_II exercise_NN training_VVGN upon_II :_: (_( a_NN )_) physical_JJ performance_NN ;_: or_CC (_( b_NN )_) quality_NN of_II life_NN ;_: or_CC (_( c_NN )_) morbidity_NN /_SYM mortality_NN ._.
P11793629A03
STUDY_NN SELECTION_NN AND_CC DATA_NNS EXTRACTION_NN :_: All_PND of_II the_DD articles_NNS identified_VVN from_II the_DD data_NNS sources_NNS were_VBD evaluated_VVN ._.
P11802753A13
Continued_VVNJ efforts_NNS should_VM be_VBB made_VVN in_II all_DD settings_NNS to_TO optimize_VVI the_DD use_NN of_II antithrombotic_JJ therapy_NN among_II persons_NNS at_II an_DD elevated_VVNJ risk_NN of_II atherothrombotic_JJ events_NNS ._.
P11809427A06
Total_JJ cholesterol_NN and_CC apolipoprotein_NN B_NN reductions_NNS and_CC apolipoprotein_NN A-I_NN increases_NNS were_VBD also_RR greater_JJR with_II rosuvastatin_NN ;_: triglyceride_NN reductions_NNS were_VBD similar_JJ ._.
P11813503A28
Despite_II a_DD poor_JJ virologic_JJ response_NN for_II some_PND of_II them_PN ,_, a_DD rise_NN in_II CD4_NN cell_NN count_NN was_VBD observed_VVN for_II all_DD patients_NNS during_II the_DD study_NN period_NN ._.
P11817979A04
In_II general_NN ,_, quinapril_NN provided_VVD similar_JJ blood_NN pressure_NN control_NN to_II other_JJ standard_JJ antihypertensive_JJ therapies_NNS including_VVG other_JJ ACE_NN inhibitors_NNS ,_, calcium_NN antagonists_NNS and_CC beta-adrenoceptor_NN antagonists_NNS in_II comparative_JJ clinical_JJ trials_NNS ._.
P11820489A06
First_RR ,_, the_DD topic_NN should_VM be_VBB of_II common_JJ interest_NN and_CC relevance_NN to_II family_NN practice_NN ._.
P11827558A06
Quinupristin_NN /_SYM dalfopristin_NN is_VBZ a_DD streptogramin_NN ,_, which_PNR impairs_VVZ bacterial_JJ protein_NN synthesis_NN at_II both_CC early_JJ peptide_NN chain_NN elongation_NN and_CC late_JJ peptide_NN chain_NN extrusion_NN steps_NNS ._.
P11832671A11
A_DD hybrid_NN strategy_NN using_VVG greater-than-or-equal15_NN %_SYM risk_NN ,_, or_CC 10_MC %_SYM to_II 14_MC %_SYM risk_NN with_II a_DD parental_JJ history_NN of_II premature_JJ coronary_JJ heart_NN disease_NN or_CC treated_VVNJ ,_, controlled_VVNJ hypertension_NN ,_, identified_VVD 20_MC %_SYM for_II treatment_NN :_: n=2646_NN ;_: events_NNS expected_VVN to_TO be_VBI prevented=97_NN ;_: number_NN needed_VVN to_II treat=27_NN ;_: sensitivity=0.44_NN (_( 0.40-0.47_MC )_) ;_: sensitivity_NN when_CS LDL-C_NN was_VBD greater-than-or-equal130_NN mg_NN /_SYM dL=0.66_NN ._.
P11837527A01
BACKGROUND_NN :_: Dysarthria_NN is_VBZ a_DD common_JJ sequel_NN of_II nonprogressive_JJ brain_NN damage_NN (_( typically_RR stroke_NN and_CC traumatic_JJ brain_NN damage_NN )_) ._.
P11840109A03
SUMMARY_NN OF_II BACKGROUND_NN DATA_NNS :_: Whiplash_NN constitutes_VVZ a_DD considerable_JJ problem_NN in_II health_NN care_NN ._.
P11845635A02
They_PN are_VBB not_RR absolute_JJ care_NN directives_NNS ,_, but_CC are_VBB intended_VVN to_TO facilitate_VVI individualized_VVNJ decision_NN making_VVGN related_VVN to_II patient_NN care_NN situations_NNS ._.
P11850611A14
For_II chronic_JJ treatment_NN of_II VTE_NN ,_, warfarin_NN is_VBZ the_DD treatment_NN of_II choice_NN (_( INR_NN 2.0-3.0_MC )_) ,_, also_RR in_II the_DD elderly_NN ._.
P11858225A03
High_JJ incidence_NN of_II alcohol-impaired_VVNJ driving_VVGN ._.
P11862245A14
Future_JJ trials_NNS comparing_VVG efficacy_NN of_II agents_NNS in_II high_JJ risk_NN patients_NNS and_CC rigorously_RR evaluating_VVG thromboembolic_JJ events_NNS will_VM allow_VVB unconditional_JJ recommendations_NNS ._.
P11865567A58
DISCUSSION_NN :_: The_DD diversity_NN of_II psychiatric_JJ morbidity_NN in_II SLE_NN and_CC SS_NN may_VM be_VBB due_II+ to_II differences_NNS in_II patient_NN selection_NN and_CC a_DD lack_NN of_II uniform_JJ clinical_JJ criteria_NNS ._.
P11869563A24
Given_VVN the_DD lower_JJR complication_NN rate_NN of_II the_DD SHS_NN in_II comparison_NN with_II intramedullary_JJ nails_NNS ,_, it_PN appears_VVZ that_CST for_II trochanteric_NN fractures_NNS the_DD SHS_NN is_VBZ superior_JJ ._.
P11869578A04
It_PN is_VBZ also_RR recommended_VVN for_II neonates_NNS with_II post-extubation_NN tracheal_JJ obstruction_NN and_CC stridor_NN in_II neonatal_JJ and_CC respiratory_JJ textbooks_NNS and_CC reviews_NNS ._.
P11869583A13
Continuous_JJ measures_NNS of_II outcome_NN were_VBD combined_VVN using_VVG standardised_VVNJ mean_NN differences_NNS ._.
P11869591A05
SELECTION_NN CRITERIA_NNS :_: Randomised_VVNJ trials_NNS comparing_VVG intravenous_JJ immunoglobulin_NN (_( monoclonal_JJ or_CC polyclonal_JJ )_) with_II placebo_NN or_CC no_DD intervention_NN ,_, in_II patients_NNS with_II bacterial_JJ sepsis_NN or_CC septic_JJ shock_NN ._.
P11869600A08
Eligible_JJ studies_NNS needed_VVD to_TO assess_VVI at_RR+ least_RR one_MC of_II the_DD outcome_NN variables_NNS defined_VVN a_RR+ priori_RR for_II this_DD systematic_JJ review_NN ._.
P11869609A01
BACKGROUND_NN :_: Lateral_JJ epicondylitis_NN (_( tennis_NN elbow_NN )_) is_VBZ a_DD frequently_RR reported_VVNJ condition_NN ._.
P11869615A16
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: There_EX is_VBZ weak_JJ and_CC unreliable_JJ evidence_NN that_CST the_DD absorbed_VVNJ drug_NN ,_, ketoconazole_NN ,_, may_VM eradicate_VVB oral_JJ candidiasis_NN and_CC that_CST a_DD higher_JJR dose_NN of_II the_DD partially_RR absorbed_VVNJ drug_NN ,_, clotrimazole_NN ,_, may_VM give_VVB greater_JJR benefit_NN than_CSN a_DD lower_JJR 10mg_NN dose_NN ,_, however_RR ,_, researchers_NNS may_VM wish_VVB to_TO prevent_VVI rather_CC+ than_CC treat_VVI oral_JJ candidiasis_NN ._.
P11869624A15
In_II most_DD cases_NNS ,_, the_DD first_PN or_CC corresponding_VVGJ author_NN of_II each_DD included_VVNJ trial_NN was_VBD contacted_VVN for_II additional_JJ information_NN ._.
P11869629A17
Large_JJ clinical_JJ trials_NNS underway_VVB or_CC about_RR to_TO commence_VVI are_VBB likely_RR to_TO contribute_VVI valuable_JJ further_JJ information_NN to_TO clarify_VVI these_DD areas_NNS of_II clinical_JJ uncertainty_NN ._.
P11869636A05
SELECTION_NN CRITERIA_NNS :_: Randomised_VVNJ trials_NNS in_II children_NNS and_CC adults_NNS comparing_VVG Fluticasone_NN to_II either_CC Beclomethasone_NN or_CC Budesonide_NN in_II the_DD treatment_NN of_II chronic_JJ asthma_NN ._.
P11869641A07
DATA_NNS COLLECTION_NN AND_CC ANALYSIS_NN :_: Two_MC reviewers_NNS independently_RR selected_VVD trials_NNS for_II inclusion_NN and_CC extracted_VVD data_NNS ._.
P11869648A11
MAIN_JJ RESULTS_NNS :_: The_DD initial_JJ search_NN retrieved_VVD 95_MC studies_NNS ._.
P11869655A16
~bullet~There_EX is_VBZ no_DD good_JJ evidence_NN comparing_VVG the_DD Epley_NNP manoeuvre_NN with_II other_JJ physical_JJ ,_, medical_JJ or_CC surgical_JJ therapy_NN for_II posterior_JJ canal_NN BPPV_NN ._.
P11869662A04
SEARCH_NN STRATEGY_NN :_: We_PN searched_VVD the_DD Cochrane_NNP Controlled_VVNJ Trials_NNS Register_NN ,_, issue_NN 1_MC ,_, 2001_MC ,_, MEDLINE_NN 1966_MC to_II 2001_MC ,_, EMBASE_NN 1980_MC to_II 2001_MC ,_, CANCERCD_NN 1980_MC to_II 2001_MC ,_, Science_NN Citation_NN Index_NN 1991_MC to_II 2001_MC ,_, CINAHL_NN 1982_MC to_II 2001_MC ,_, as_CC+ well_CC+ as_CC sources_NNS of_II grey_JJ literature_NN ._.
P11869665A15
The_DD percent_NN overall_JJ survival_NN at_II 1_MC ,_, 2_MC ,_, 5_MC ,_, and_CC 10_MC years_NNS for_II the_DD early_JJ treatment_NN group_NN was_VBD 88_MC %_SYM ,_, 73_MC %_SYM ,_, 44_MC %_SYM ,_, and_CC 18_MC %_SYM ._.
P11869669A02
Lateral_JJ elbow_NN pain_NN ,_, or_CC tennis_NN elbow_NN ,_, is_VBZ a_DD common_JJ condition_NN causing_VVG pain_NN in_II the_DD elbow_NN and_CC forearm_NN and_CC lack_NN of_II strength_NN and_CC function_NN of_II the_DD elbow_NN and_CC wrist_NN ._.
P11869676A03
SEARCH_NN STRATEGY_NN :_: We_PN searched_VVD the_DD Cochrane_NNP Airways_NNS Group_NN trials_NNS register_NN ,_, electronic_JJ reference_NN databases_NNS ,_, UK_NNP National_JJ Research_NN Register_NN ,_, bibliographies_NNS of_II included_VVNJ studies_NNS ,_, and_CC contacted_VVD pharmaceutical_JJ companies_NNS ._.
P11872916A02
The_DD realization_NN that_CST atherosclerosis_NN is_VBZ an_DD inflammatory_JJ disease_NN has_VHZ led_VVN to_II a_DD search_NN for_II new_JJ stroke_NN and_CC cardiovascular_JJ disease_NN risk_NN factors_NNS and_CC treatments_NNS ._.
P11884907A10
A_DD fixed_VVNJ effects_NNS model_NN was_VBD used_VVN throughout_RR for_II continuous_JJ variables_NNS ,_, except_CS where_CS heterogeneity_NN existed_VVD ,_, in_II which_DD case_NN ,_, a_DD random_JJ effects_NNS model_NN was_VBD used_VVN ._.
P11888339A06
Various_JJ migraine_NN surveys_NNS have_VHB indicated_VVN that_CST a_DD rapid_JJ onset_NN of_II therapeutic_JJ effect_NN is_VBZ a_DD highly_RR desirable_JJ attribute_NN of_II an_DD antimigraine_JJ drug_NN ._.
P11899566A04
Owing_II+ to_II their_PNG age_NN ,_, the_DD elderly_NN are_VBB more_RR afflicted_VVN with_II chronic_JJ diseases_NNS ,_, including_VVG coronary_JJ artery_NN disease_NN ._.
P11907914A04
DATA_NNS EXTRACTION_NN :_: Data_NNS extraction_NN and_CC quality_NN assessment_NN were_VBD performed_VVN in_II duplicate_NN ,_, with_II assistance_NN of_II a_DD manual_NN ._.
P11918516A04
Abstracts_NNS presented_VVN at_II infectious_JJ diseases_NNS and_CC critical_JJ care_NN meetings_NNS were_VBD also_RR reviewed_VVN ._.
P11923602A03
The_DD past_JJ decade_NN has_VHZ witnessed_VVN the_DD development_NN of_II a_DD variety_NN of_II locoregional_JJ therapies_NNS for_II HCC_NN ._.
P11925374A14
However_RR ,_, this_DD study_NN failed_VVD to_TO recruit_VVI the_DD planned_VVNJ number_NN of_II participants_NNS and_CC was_VBD consequently_RR underpowered_VVN ._.
P11929334A05
Among_II patients_NNS with_II acute_JJ ST_NN elevation_NN MI_NN ,_, randomised_VVNJ trials_NNS have_VHB demonstrated_VVN bivalirudin_NN to_TO be_VBI significantly_RR more_RR effective_JJ than_CSN heparin_NN in_II improving_VVGN early_JJ patency_NN in_II patients_NNS receiving_VVG thrombolytic_JJ therapy_NN with_II streptokinase_NN ._.
P11939601A04
IVIG_NN is_VBZ U.S_NN ._.
P11959890A08
Nevertheless_RR ,_, by_II exploring_VVGN the_DD relative_JJ effectiveness_NN of_II the_DD different_JJ intervention_NN strategies_NNS for_II each_DD outcome_NN and_CC follow-up_NN period_NN ,_, we_PN suggest_VVB the_DD specific_JJ therapies_NNS that_PNR should_VM be_VBB considered_VVN for_II further_JJ investigation_NN ._.
P11967397A06
RESULTS_NNS :_: Major_JJ deficiencies_NNS in_II treatment_NN that_PNR were_VBD identified_VVN include_VVB inappropriate_JJ dosing_VVGN with_II antipsychotic_JJ agents_NNS ,_, underutilization_NN of_II adjunctive_JJ antidepressant_NN therapy_NN ,_, very_RR low_JJ rates_NNS of_II prescription_NN of_II psychosocial_JJ interventions_NNS and_CC lack_NN of_II continuity_NN between_II inpatient_NN and_CC outpatient_JJ settings_NNS ._.
P11967417A01
BACKGROUND_NN :_: "_`` Systematic_JJ reviews_NNS "_'' have_VHB come_VVB to_TO be_VBI recognized_VVN as_II the_DD most_RRT rigorous_JJ method_NN of_II summarizing_VVGN confusing_VVGJ and_CC often_RR contradictory_JJ primary_JJ research_NN in_II a_DD transparent_JJ and_CC reproducible_JJ manner_NN ._.
P11967432A03
AIMS_NNS OF_II THE_DD STUDY_NN :_: The_DD scope_NN of_II this_DD review_NN was_VBD to_TO examine_VVI studies_NNS published_VVN in_II the_DD international_JJ literature_NN to_TO describe_VVI and_CC compare_VVI the_DD social_JJ costs_NNS of_II depression_NN in_II various_JJ countries_NNS ._.
P11967455A22
IMPLICATIONS_NNS FOR_II FURTHER_JJ RESEARCH_NN :_: Further_RR research_NN that_PNR improves_VVZ our_PNG understanding_VVGN of_II how_CST decisions_NNS regarding_VVG provider_NN choice_NN ,_, concurrent_JJ psychotherapy_NN ,_, and_CC drug_NN choice_NN are_VBB made_VVN will_VM improve_VVB our_PNG understanding_VVGN of_II the_DD effects_NNS treatment_NN choices_NNS on_II the_DD cost-effectiveness_NN of_II depression_NN care_NN ._.
P11978164A06
Clinical_JJ investigations_NNS were_VBD evaluated_VVN for_II design_NN ,_, sample_NN size_NN ,_, diagnosis_NN ,_, duration_NN ,_, and_CC outcome_NN ._.
P11982721A25
The_DD response_NN is_VBZ durable_JJ in_II approximately_RR 80_MC %_SYM of_II responders_NNS ._.
P11991548A01
OBJECTIVE_NN :_: This_DD article_NN reviews_VVZ the_DD recommendations_NNS by_II the_DD World_NN Health_NN Organization_NN 's_GE new_JJ guidelines_NNS ,_, "_`` Allergic_JJ Rhinitis_NN and_CC Its_PNG Impact_NN on_II Asthma_NN "_'' (_( ARIA_NN )_) ,_, and_CC the_DD paradigm_NN for_II treating_VVGN allergic_JJ rhinitis_NN based_VVN on_II disease_NN classification_NN ._.
P11993293A32
Few_JJ schools_NNS screen_VVB for_II processing_VVGJ problems_NNS ,_, including_VVG auditory_JJ and_CC visual_JJ motor_NN processing_VVGJ problems_NNS ,_, processing_VVGJ speed_NN ,_, comprehension_NN ,_, and_CC short-term_NN and_CC long-term_NN memory_NN problems_NNS ._.
P12004249A04
DATA_NNS SUMMARY_NN :_: Taken_VVN en_RR+ toto_RR ,_, the_DD data_NNS suggest_VVB that_CST NE_NN could_VM contribute_VVB to_II ALI_NN and_CC endothelial_JJ cell_NN injury_NN that_PNR is_VBZ relevant_JJ to_II ALI_NN ._.
P12011590A01
Although_CS the_DD manifestations_NNS of_II sickle_JJ cell_NN disease_NN (_( SCD_NN )_) do_VDB not_RR typically_RR necessitate_VVB critical_JJ care_NN management_NN ,_, several_JJ life-threatening_VVGJ complications_NNS may_VM require_VVB admission_NN to_II the_DD pediatric_JJ intensive_JJ care_NN unit_NN ._.
P12017503A04
DATA_NNS EXTRACTION_NN :_: All_DD titles_NNS (_( 4397_MC )_) ,_, articles_NNS ,_, and/or_CC abstracts_NNS (_( 1362_MC )_) were_VBD evaluated_VVN by_II 2_MC independent_JJ reviewers_NNS who_PNR extracted_VVD data_NNS on_II study_NN design_NN and_CC quality_NN ,_, sample_NN size_NN ,_, type_NN of_II intervention_NN ,_, and_CC outcomes_NNS ._.
P12020339A01
CONTEXT_NN :_: Complications_NNS of_II atherosclerosis_NN cause_VVB most_DD morbidity_NN and_CC mortality_NN in_II patients_NNS with_II diabetes_NN mellitus_NN ._.
P12022907A12
Bivalirudin_NN has_VHZ also_RR induced_VVN early_JJ patency_NN in_II patients_NNS with_II myocardial_JJ infarction_NN in_II combination_NN with_II streptokinase_NN ,_, but_CC its_PNG use_NN with_II newer_JJR thrombolytics_NNS needs_VVZ to_TO be_VBI studied_VVN ._.
P12027776A16
Treatment_NN should_VM be_VBB individualised_VVN for_II each_DD patient_NN ._.
P12034414A04
Two_MC reviewers_NNS independently_RR extracted_VVD data_NNS from_II the_DD studies_NNS ._.
P12040543A09
CONCLUSIONS_NNS :_: Further_JJ work_NN is_VBZ needed_VVN to_TO create_VVI operational_JJ definitions_NNS and_CC to_TO pilot_NN test_VVI the_DD selected_VVNJ measures_NNS ._.
P12045080A02
METHODS_NNS :_: The_DD review_NN followed_VVD the_DD methodology_NN of_II systematic_JJ reviews_NNS and_CC was_VBD facilitated_VVN through_II the_DD use_NN of_II a_DD structured_VVNJ template_NN ,_, a_DD companion_NN explanatory_JJ piece_NN ,_, and_CC a_DD grading_VVGJ and_CC methodological_JJ scoring_VVGJ system_NN based_VVN on_II published_VVNJ criteria_NNS for_II critical_JJ appraisal_NN ._.
P12049028A32
NATIONAL_JJ IMPLEMENTATION_NN OF_II THE_DD PRIMARY_JJ CARE_NN RESEARCH_NN TEAM_NN ASSESSMENT_NN :_: The_DD pilot_NN project_NN has_VHZ been_VBN very_RR successful_JJ and_CC recommendations_NNS have_VHB been_VBN made_VVN to_TO progress_VVI to_II a_DD UK_NNP scheme_NN ._.
P12053714A05
The_DD motion_NN studies_NNS afforded_VVN by_II cineangiography_NN also_RR permitted_VVD dynamic_JJ visualization_NN of_II the_DD contracting_VVGJ ventricle_NN which_PNR led_VVD to_II the_DD concept_NN of_II regional_JJ wall_NN motion_NN abnormalities_NNS being_VVGN characteristic_JJ of_II CAD_NN and_CC provided_VVD some_PND of_II our_PNG earliest_JJT understanding_VVGN of_II left_VVNJ ventricular_JJ dysfunction_NN ._.
P12057986A04
At_II the_DD time_NN of_II enrollment_NN ,_, patients_NNS were_VBD stratified_VVN according_II+ to_II diabetes_NN status_NN ._.
P12064194A14
The_DD findings_NNS of_II both_CC the_DD SPEED_NN and_CC TIMI_NN 14_MC trials_NNS were_VBD incorporated_VVN into_II the_DD design_NN of_II the_DD large_JJ (_( approximately_RR 17,000_MC patients_NNS )_) GUSTO_NN V_MC mortality_NN trial_NN ,_, which_PNR compared_VVD standard_JJ reteplase_NN therapy_NN with_II abciximab_NN plus_CC low-dose_NN reteplase_NN ._.
P12065798A03
Data_NNS from_II recently_RR completed_VVNJ phase_NN III_MC adjuvant_NN trials_NNS and_CC worldwide_JJ consensus_NN conferences_NNS document_VVB the_DD benefits_NNS of_II adjuvant_NN therapy_NN in_II improving_VVGN disease-free_JJ survival_NN and_CC overall_JJ survival_NN for_II patients_NNS diagnosed_VVN with_II invasive_JJ breast_NN cancer_NN >_SYM 1.0_MC cm_NN in_II size_NN ._.
P12072654A14
SUMMARY_NN :_: Among_II the_DD multitude_NN of_II oral_JJ ,_, intravesical_JJ ,_, interventional_JJ and_CC complementary_JJ treatments_NNS suggested_VVN few_JJ studies_NNS have_VHB high_JJ levels_NNS of_II evidence_NN ._.
P12075559A04
We_PN assess_VVB the_DD evidence_NN for_II the_DD use_NN of_II apheresis_NN ,_, the_DD optimal_JJ schedules_NNS for_II apheresis_NN ,_, and_CC the_DD replacement_NN solutions_NNS used_VVN ,_, based_VVN on_II randomized_VVNJ controlled_VVNJ trials_NNS ._.
P12076380A01
BACKGROUND_NN :_: Electroconvulsive_NN therapy_NN (_( ECT_NN )_) involves_VVZ the_DD induction_NN of_II a_DD seizure_NN (_( fit_NN )_) for_II therapeutic_JJ purposes_NNS by_II the_DD administration_NN of_II a_DD variable_JJ frequency_NN electrical_JJ stimulus_NN shock_NN via_II electrodes_NNS applied_VVN to_II the_DD scalp_NN ._.
P12076389A07
Due_II+ to_II the_DD variable_JJ methods_NNS of_II collecting_VVGN and_CC presenting_VVGN outcome_NN data_NNS ,_, no_DD statistical_JJ summary_NN measure_NN was_VBD calculated_VVN ._.
P12076395A06
This_PND included_VVD searches_NNS of_II the_DD Oxford_NNP Database_NN of_II Perinatal_JJ trials_NNS ,_, Cochrane_NNP Controlled_VVNJ Trials_NNS Register_NN (_( Cochrane_NNP Library_NN ,_, Issue_NN 4_MC ,_, 2001_MC )_) ,_, MEDLINE_NN (_( 1966-January_NN 2002_MC )_) ,_, EMBASE_NN ,_, CINAHL_NN (_( 1982-January_NN 2002_MC )_) ,_, previous_JJ reviews_NNS including_VVG cross_NN references_NNS ,_, abstracts_NNS ,_, conferences_NNS and_CC symposia_NN proceedings_NNS ,_, expert_NN informants_NNS ,_, journal_NN hand_NN searching_VVGN mainly_RR in_II the_DD English_JJ language_NN ._.
P12076403A06
(_( 2_MC )_) Women_NNS defined_VVN as_II high_JJ risk_NN of_II hypertensive_JJ disorders_NNS of_II pregnancy_NN ._.
P12076407A08
DATA_NNS COLLECTION_NN AND_CC ANALYSIS_NN :_: All_DD trials_NNS ,_, judged_VVN as_II fitting_VVGN the_DD selection_NN criteria_NNS by_II two_MC reviewers_NNS ,_, were_VBD independently_RR assessed_VVN by_II two_MC reviewers_NNS for_II methodological_JJ quality_NN by_II use_NN of_II an_DD 11_MC item_NN checklist_NN ._.
P12076411A11
We_PN performed_VVD meta-analyses_NNS with_II Review_NN Manager_NN 4.1_MC software_NN using_VVG a_DD fixed_VVNJ effects_NNS model_NN ._.
P12076414A27
The_DD pharmacology_NN and_CC toxicology_NN of_II melatonin_NN needs_VVZ systematic_JJ study_NN ,_, and_CC routine_JJ pharmaceutical_JJ quality_NN control_NN of_II melatonin_NN products_NNS must_VM be_VBB established_VVN ._.
P12076418A22
There_EX is_VBZ also_RR insufficient_JJ evidence_NN to_TO determine_VVI the_DD effects_NNS of_II early_JJ weight_NN bearing_VVGN after_II the_DD internal_JJ fixation_NN of_II an_DD intracapsular_JJ proximal_JJ femoral_JJ fracture_NN ._.
P12076423A22
Also_RR ,_, no_DD difference_NN in_II mean_NN improvement_NN on_II the_DD disability_NN scale_NN was_VBD found_VVN at_II two_MC weeks_NNS (_( effect_NN size_NN -0.12_MC ,_, 95_MC %_SYM confidence_NN interval_NN -0.68_MC to_II 0.45_MC )_) or_CC six_MC weeks_NNS (_( effect_NN size_NN -0.07_MC ,_, 95_MC %_SYM confidence_NN interval_NN -0.63_MC to_II 0.50_MC )_) between_II prednisolone_NN and_CC intravenous_JJ immunoglobulin_NN ._.
P12076426A05
SEARCH_NN STRATEGY_NN :_: The_DD following_VVGJ databases_NNS were_VBD searched_VVN :_: MEDLINE_NN ,_, Psyclit_NN ,_, EMBASE_NN ,_, Science_NN Citation_NN Index_NN ,_, Social_JJ Science_NN Citation_NN Index_NN ,_, CINAHL_NN ,_, Cochrane_NNP Controlled_VVNJ Trials_NNS Register_NN (_( CCTR_NN )_) and_CC the_DD Cochrane_NNP Heart_NN Group_NN 's_GE specialised_VVNJ register_NN from_II 1985_MC to_II July_NN 2001_MC ._.
P12076431A07
DATA_NNS COLLECTION_NN AND_CC ANALYSIS_NN :_: One_MC reviewer_NN assessed_VVD potentially_RR relevant_JJ studies_NNS for_II inclusion_NN and_CC undertook_VVD data_NNS extraction_NN ._.
P12076435A10
Endolaryngeal_JJ resection_NN of_II early_JJ glottic_JJ tumours_NNS is_VBZ becoming_VVG more_RR common_JJ and_CC a_DD well_RR designed_VVNJ multicentre_NN RCT_NN is_VBZ warranted_VVN ._.
P12076440A14
In_II the_DD two_MC trials_NNS with_II adequate_JJ allocation_NN concealment_NN ,_, death_NN was_VBD more_RR common_JJ in_II the_DD anticonvulsant_JJ group_NN (_( Relative_JJ Risk_NN 2.0_MC ;_: 95_MC %_SYM confidence_NN interval_NN 1.20_MC to_II 3.33_MC ;_: fixed_VVNJ effect_NN model_NN )_) ._.
P12076445A03
The_DD major_JJ difficulty_NN with_II IPPV_NN is_VBZ that_CST it_PN is_VBZ invasive_JJ ,_, resulting_VVG in_II airway_NN and_CC lung_NN injury_NN and_CC contributing_VVG to_II the_DD development_NN of_II chronic_JJ lung_NN disease_NN ._.
P12076453A05
The_DD hallmark_NN of_II this_DD condition_NN ,_, is_VBZ a_DD massive_JJ shift_NN of_II fluid_NN from_II the_DD intra-vascular_JJ compartment_NN to_II the_DD third_JJ space_NN resulting_VVG in_II profound_JJ intra-vascular_JJ depletion_NN and_CC hemoconcentration_NN ._.
P12076456A13
Analysis_NN included_VVD haloperidol_NN treated_VVNJ patients_NNS ,_, compared_VVN with_II placebo_NN MAIN_JJ RESULTS_NNS :_: The_DD five_MC included_VVNJ trials_NNS led_VVD to_II the_DD following_VVGJ results_NNS :_: 1_MC ._.
P12076461A03
Metformin_NN ,_, however_RR ,_, is_VBZ thought_VVN to_TO increase_VVI the_DD risk_NN of_II lactic_JJ acidosis_NN ,_, and_CC is_VBZ considered_VVN to_TO be_VBI contraindicated_VVN in_II many_DD chronic_JJ hypoxemic_JJ conditions_NNS that_PNR may_VM be_VBB associated_VVN with_II lactic_JJ acidosis_NN ,_, such_II+ as_II cardiovascular_JJ ,_, renal_JJ ,_, hepatic_JJ and_CC pulmonary_JJ disease_NN ,_, and_CC advancing_VVGJ age_NN ._.
P12076468A04
Evidence_NN is_VBZ required_VVN as_II+ to_II the_DD safest_JJT and_CC most_RRT effective_JJ means_NNS of_II preventing_VVGN chest_NN tube_NN blockage_NN and_CC preventing_VVGN cardiac_JJ tamponade_NN ._.
P12076475A11
Initial_JJ treatment_NN was_VBD conservative_JJ ,_, involving_VVG plaster_NN cast_NN immobilisation_NN ,_, in_II all_PND but_CC 20_MC patients_NNS whose_PNR fractures_NNS were_VBD fixed_VVN surgically_RR ._.
P12076479A14
Regarding_VVG the_DD studies_NNS that_PNR compare_VVB methadone_NN with_II other_JJ opioid_NN agonists_NNS ,_, in_II Sorensen_NNP 1982_MC methadyl_NN acetate_NN performed_VVD similarly_RR to_II methadone_NN on_II most_DD process_NN and_CC outcome_NN measures_NNS ,_, while_CS in_II Tennant_NNP 1975_MC ,_, methadone_NN reduced_VVD severity_NN of_II withdrawal_NN and_CC had_VHD fewer_JJR drop-outs_NNS than_CSN did_VDD a_DD propoxyphene_NN group_NN ._.
P12076484A14
However_RR ,_, the_DD effectiveness_NN of_II the_DD '_`` long-short_JJ '_'' course_NN (_( from_II 28_MC weeks_NNS in_II pregnancy_NN for_II the_DD mother_NN and_CC for_II the_DD baby_NN until_II 3_MC days_NNS old_NN )_) and_CC the_DD '_`` short-long_JJ '_'' course_NN (_( from_II 35_MC weeks_NNS in_II pregnancy_NN for_II the_DD mother_NN and_CC for_II the_DD baby_NN until_II 6_MC weeks_NNS old_NN )_) did_VDD not_RR differ_VVB from_II that_PND of_II the_DD '_`` long-long_JJ '_'' course_NN ._.
P12076491A01
BACKGROUND_NN :_: Public_JJ concerns_NNS regarding_VVG the_DD safety_NN of_II transfused_VVNJ blood_NN have_VHB prompted_VVN re-consideration_NN of_II the_DD indications_NNS for_II the_DD transfusion_NN of_II allogeneic_JJ red_JJ cells_NNS (_( blood_NN from_II an_DD unrelated_VVNJ donor_NN )_) ,_, and_CC a_DD range_NN of_II techniques_NNS designed_VVN to_TO minimise_VVI transfusion_NN requirements_NNS ._.
P12076498A03
Hence_RR ,_, there_EX may_VM be_VBB a_DD role_NN for_II some_PND of_II these_DD drugs_NNS in_II the_DD treatment_NN of_II Alzheimer_NNP 's_GE disease_NN ._.
P12076503A04
SEARCH_NN STRATEGY_NN :_: We_PN searched_VVD the_DD Musculoskeletal_JJ Review_NN Group_NN 's_GE trials_NNS register_NN database_NN ,_, the_DD Cochrane_NNP Clinical_JJ Trials_NNS Register_NN (_( Cochrane_NNP Library_NN issue_NN 2_MC ,_, 2001_MC )_) ,_, MEDLINE_NN ,_, CINAHL_NN ,_, EMBASE_NN and_CC SCISEARCH_NN up_II+ to_II June_NN 2001_MC ._.
P12082187A02
A_DD number_NN of_II procedural_JJ and_CC patient_NN factors_NNS have_VHB been_VBN shown_VVN to_TO predict_VVI the_DD occurrence_NN of_II SAT_NN ,_, including_VVG longer_JJR stent_NN length_NN ,_, smaller_JJR minimum_NN luminal_JJ diameter_NN ,_, persistent_JJ dissection_NN ,_, multivessel_NN intervention_NN ,_, and_CC possibly_RR acute_JJ coronary_JJ syndrome_NN (_( ACS_NN )_) presentation_NN ._.
P12086276A16
While_CS 15_MC %_SYM were_VBD current_JJ smokers_NNS ,_, 56_MC %_SYM were_VBD ex-smokers_NNS ._.
P12086558A02
DATA_NNS SOURCES_NNS :_: Literature_NN search_NN strategy_NN involved_VVN using_VVGN MEDLINE_NN (_( 1966-July_NN 2001_MC )_) and_CC AIDSLINE_NN (_( MEDSCAPE_NN )_) databases_NNS (_( up_II+ to_II July_NN 2001_MC )_) ._.
P12092641A08
Information_NN was_VBD then_RR organized_VVN and_CC correlated_VVN in_II order_NN to_TO provide_VVI a_DD detailed_VVNJ description_NN of_II the_DD key_JJ conditions_NNS and_CC their_PNG interrelatedness_NN ._.
P12093715A11
Limited_VVNJ data_NNS exist_VVB for_II ED-based_VVNJ practice_NN ,_, but_CC ,_, based_VVN on_II the_DD burden_NN of_II disease_NN ,_, relative_JJ ease_NN of_II intervention_NN ,_, and_CC likely_JJ efficacy_NN ,_, routine_JJ screening_VVGN of_II all_DD patients_NNS for_II tobacco_NN use_NN and_CC referral_NN of_II smokers_NNS to_II primary_JJ care_NN and_CC cessation_NN programs_NNS are_VBB recommended_VVN ._.
P12096151A09
No_DD meta-analyses_NNS were_VBD performed_VVN ,_, as_CS no_DD data_NNS were_VBD available_JJ from_II randomized_VVNJ comparisons_NNS ._.
P12105077A09
Recognition_NN of_II the_DD seizure_NN state_NN remains_VVZ the_DD foremost_RRT challenge_NN to_TO overcome_VVI ._.
P12108581A22
Strategies_NNS to_TO protect_VVI the_DD safety_NN of_II both_CC the_DD patient_NN and_CC the_DD public_JJ safety_NN worker_NN must_VM be_VBB devised_VVN and_CC tested_VVN ._.
P12114036A15
INTERPRETATION_NN :_: Adding_VVGN simvastatin_NN to_II existing_VVGJ treatments_NNS safely_RR produces_VVZ substantial_JJ additional_JJ benefits_NNS for_II a_DD wide_JJ range_NN of_II high-risk_NN patients_NNS ,_, irrespective_JJ of_II their_PNG initial_JJ cholesterol_NN concentrations_NNS ._.
P12114165A20
Quiz_NN scores_NNS confirmed_VVD that_CST the_DD residents_NNS achieved_VVD the_DD desired_VVNJ learning_VVGJ objectives_NNS ._.
P12116690A17
Two_MC novel_JJ serotonin_NN agonists_NNS are_VBB currently_RR under_II development_NN for_II constipated_VVNJ IBS_NN patients_NNS ,_, tegaserod_NN and_CC prucalopride_NN ._.
P12117354A07
These_DD criteria_NNS were_VBD applied_VVN in_II a_DD blinded_VVNJ fashion_NN by_II 2_MC independent_JJ investigators_NNS ._.
P12120485A12
Training_VVGN and_CC preparation_NN for_II contingencies_NNS experienced_VVN in_II an_DD attack_NN have_VHB the_DD potential_JJ to_TO enhance_VVI delivery_NN of_II care_NN ._.
P12130935A04
Resolution_NN of_II nosocomial_JJ pneumonia_NN ,_, in_II terms_NNS of_II improvement_NN of_II clinical_JJ parameters_NNS such_II+ as_II oxygenation_NN ,_, fever_NN ,_, leukocytosis_NN and_CC bacterial_JJ eradication_NN ,_, has_VHZ been_VBN reported_VVN ,_, and_CC these_DD data_NNS can_VM lead_VVB to_II a_DD better_JJR understanding_VVGN of_II the_DD natural_JJ course_NN of_II the_DD disease_NN ._.
P12133028A07
Bradykinin_NN ,_, a_DD potent_JJ vasodilator_NN ,_, acts_VVZ by_II stimulating_VVGN formation_NN of_II vasodilatory_JJ prostaglandins_NNS such_II+ as_II prostacyclin_NN ,_, whereas_CS aspirin_NN or_CC acetyl_NN salicylic_JJ acid_NN inhibits_VVZ the_DD enzyme_NN cyclooxygenase_NN ,_, which_PNR in_II turn_NN decreases_VVZ the_DD production_NN of_II the_DD prostaglandins_NNS ._.
P12137445A06
Reasons_NNS for_II the_DD underuse_NN may_VM include_VVB physicians_NNS '_GE and_CC patients_NNS '_GE attitudes_NNS and_CC knowledge_NN ,_, and_CC the_DD perceptions_NNS of_II physicians_NNS and_CC healthcare_NN purchasers_NNS about_II economic_JJ factors_NNS ._.
P12137608A07
References_NNS of_II all_DD identified_VVNJ studies_NNS were_VBD searched_VVN for_II further_JJ trial_NN citations_NNS ._.
P12137612A21
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: There_EX is_VBZ insufficient_JJ evidence_NN available_JJ from_II randomised_VVNJ controlled_VVNJ trials_NNS to_TO determine_VVI the_DD relative_JJ effectiveness_NN of_II surgical_JJ and_CC conservative_JJ treatment_NN for_II acute_JJ injuries_NNS of_II the_DD lateral_JJ ligament_NN complex_NN of_II the_DD ankle_NN ._.
P12137619A12
They_PN may_VM also_RR result_VVB in_II a_DD greater_JJR improvement_NN in_II long_JJ term_NN outcomes_NNS such_II+ as_II menstrual_JJ loss_NN and_CC dysmenorrhoea_NN ._.
P12137624A05
Though_CS both_DD methods_NNS are_VBB widely_RR used_VVN ,_, the_DD advantages_NNS and_CC disadvantages_NNS of_II laparoscopic_JJ sterilisation_NN compared_VVN to_II mini-laparotomy_NN have_VHB not_RR been_VBN systematically_RR evaluated_VVN ._.
P12137627A10
MAIN_JJ RESULTS_NNS :_: The_DD timing_VVGN of_II support_NN :_: early_JJ versus_CC delayed_VVNJ Of_II the_DD seven_MC trials_NNS addressing_VVG the_DD timing_VVGN of_II support_NN ,_, data_NNS on_II mortality_NN were_VBD obtained_VVN for_II all_DD seven_MC trials_NNS (_( 284_MC participants_NNS )_) ._.
P12137632A39
Longer-term_NN use_NN of_II galantamine_NN has_VHZ not_RR been_VBN assessed_VVN in_II a_DD controlled_VVNJ fashion_NN ._.
P12137636A29
Such_DD education_NN may_VM be_VBB effective_JJ in_II increasing_VVGN the_DD short-term_NN use_NN of_II contraception_NN ._.
P12137642A07
Control_NN could_VM include_VVB an_DD opiate_JJ ,_, sedative_NN or_CC non-pharmacological_JJ treatment_NN ._.
P12137653A09
Random_JJ effects_NNS meta-analyses_NNS were_VBD performed_VVN where_CS data_NNS could_VM be_VBB pooled_VVN ._.
P12137656A17
There_EX were_VBD no_DD differences_NNS between_II ACDR_NN CPR_NN and_CC STR_NN for_II mortality_NN either_CC immediately_RR (_( RR_NN 0.98_MC [_( 95_MC %_SYM CI_NN 0.94_MC -_SYM 1.03_MC ]_) )_) or_CC at_II hospital_NN discharge_NN (_( RR_NN 0.99_MC [_( 95_MC %_SYM CI_NN 0.98_MC -_SYM 1.01_MC ]_) )_) ._.
P12137667A15
Exercise_NN capacity_NN improved_VVD in_II patients_NNS treated_VVN with_II intravenous_JJ epoprostenol_NN (_( Standardised_VVNJ Mean_NN Difference_NN )_) 0.69_MC ,_, 95_MC %_SYM Confidence_NN Intervals_NNS (_( CI_NN )_) 0.40_MC ,_, 0.97_MC ._.
P12137675A18
There_EX was_VBD an_DD effect_NN on_II some_DD verbal_JJ memory_NN functions_NNS (_( immediate_JJ recall_NN )_) ,_, on_II a_DD test_NN of_II abstract_JJ reasoning_VVGN and_CC a_DD test_NN of_II speed_NN and_CC accuracy_NN in_II relatively_RR young_JJ (_( 47_MC years_NNS of_II age_NN )_) surgically_RR menopausal_JJ women_NNS who_PNR had_VHD been_VBN given_VVN a_DD bolus_NN intramuscular_JJ injection_NN of_II 10_MC mg_NN E2_NN every_DD month_NN for_II 3_MC months_NNS ._.
P12137681A08
Studies_NNS reported_VVD mainly_RR goitre_NN rates_NNS and_CC urinary_JJ iodine_NN excretion_NN as_II outcome_NN measures_NNS ._.
P12137687A22
The_DD protocols_NNS of_II two_MC of_II the_DD studies_NNS mandated_VVD the_DD use_NN of_II early_JJ exchange_NN transfusion_NN ,_, limiting_VVG the_DD generalizability_NN of_II the_DD results_NNS ._.
P12137691A05
SEARCH_NN STRATEGY_NN :_: We_PN searched_VVD MEDLINE_NN ,_, Embase_NN ,_, Amed_NN ,_, Cinahl_NN ,_, CISCOM_NN and_CC the_DD Cochrane_NNP Controlled_VVNJ Trial_NN Register_NN ._.
P12137696A15
Seven_MC infants_NNS only_RR were_VBD randomised_VVN to_II treatment_NN with_II dopamine_NN and_CC seven_MC to_TO receive_VVI placebo_NN ._.
P12137705A05
The_DD manufacturers_NNS of_II rofecoxib_NN ,_, MSD_NN ,_, were_VBD also_RR approached_VVN by_II the_DD UK_NNP National_JJ Institute_NN for_II Clinical_JJ Excellence_NN to_TO submit_VVI additional_JJ evidence_NN to_TO inform_VVI it_PN 's_GE appraisal_NN on_II the_DD use_NN of_II cyclo-oxygenase_NN inhibitors_NNS for_II arthritis_NN ._.
P12137712A13
Continuous_JJ data_NNS were_VBD pooled_VVN using_VVG weighted_VVNJ mean_NN differences_NNS and_CC dichotomous_JJ data_NNS using_VVG relative_JJ risks_NNS ._.
P12137716A05
Additional_JJ RCTs_NNS were_VBD identified_VVN from_II the_DD Cochrane_NNP Airways_NNS Group_NN 's_GE registry_NN of_II COPD_NN RCTs_NNS using_VVG the_DD strategy_NN :_: [_( exp_NN ,_, lung_NN diseases_NNS ,_, obstructive_JJ ]_) and_CC [_( exp_NN ,_, rehabilitation_NN or_CC exp_NN ,_, exercise_NN therapy_NN ]_) and_CC [_( research_NN design_NN or_CC longitudinal_JJ studies_NNS or_CC evaluation_NN study_NN or_CC randomized_VVNJ controlled_VVNJ trial_NN ]_) ._.
P12140910A02
The_DD advanced_VVNJ practice_NN nursing_VVGJ model_NN at_II Mount_NN Sinai_NN Hospital_NN is_VBZ one_MC successful_JJ care_NN delivery_NN model_NN that_PNR fills_VVZ the_DD needs_NNS of_II both_CC CCI_NN patients_NNS and_CC the_DD nurses_NNS who_PNR work_VVB with_II them_PN ._.
P12149041A08
In_II primary_JJ prevention_NN ,_, the_DD data_NNS are_VBB not_RR as_RR convincing_VVG and_CC generalisations_NNS can_VM not_RR be_VBB made_VVN as_II+ to_II whether_CST ,_, and_CC in_II which_DD subgroup_NN ,_, drug_NN therapy_NN to_TO lower_VVI low_JJ density_NN lipoprotein_NN (_( LDL_NN )_) cholesterol_NN should_VM be_VBB initiated_VVN ._.
P12150693A03
In_II both_CC ST-segment_NN elevation_NN and_CC non-ST-segment_NN elevation_NN MI_NN ,_, aspirin_NN /_SYM clopidogrel_NN ,_, heparin_NN /_SYM low_JJ molecular_JJ weight_NN heparin_NN /_SYM direct_JJ thrombin_NN inhibitors_NNS ,_, beta-blockers_NNS and_CC angiotensin_NN converting_VVGJ enzyme_NN inhibitors_NNS are_VBB part_NN of_II the_DD routine_JJ regimens_NNS ._.
P12164804A07
For_II both_DD subsets_NNS ,_, protein_NN A_NN immunoadsorption_NN is_VBZ reportedly_RR successful_JJ ._.
P12169077A13
Publication_NN bias_NN was_VBD examined_VVN using_VVG Begg_NNP modified_VVNJ funnel_NN plots_NNS and_CC formally_RR tested_VVN using_VVG the_DD Egger_NNP weighted-linear_JJ regression_NN method_NN ._.
P12175274A06
A_DD booster_NN dose_NN of_II PNCRM7_NN elicited_VVD an_DD anamnestic_JJ response_NN to_II all_DD seven_MC serotypes_NNS ._.
P12187868A06
Amiodarone_NN has_VHZ been_VBN evaluated_VVN in_II numerous_JJ clinical_JJ trials_NNS in_II patients_NNS with_II heart_NN failure_NN and_CC appears_VVZ to_TO be_VBI safe_JJ and_CC effective_JJ in_II terms_NNS of_II conversion_NN to_II sinus_NN rhythm_NN ,_, maintenance_NN of_II sinus_NN rhythm_NN as_CC+ well_CC+ as_CC control_NN of_II ventricular_JJ rate_NN ._.
P12192737A25
Dietary_JJ surveys_NNS carried_VVN out_II in_II the_DD US_NNP population_NN indicate_VVB that_CST less_RR than_CSN 12_MC percent_NN of_II US_NNP children_NNS and_CC adults_NNS meet_VVB this_DD recommended_VVNJ level_NN of_II intake_NN (_( 104_MC )_) ._.
P12196062A06
The_DD prognosis_NN is_VBZ poor_JJ ,_, with_II a_DD mean_NN survival_NN time_NN of_II 2.8_MC years_NNS after_II diagnosis_NN if_CS untreated_VVN ._.
P12196870A35
(_( III-C_NN )_) Part_NN II_MC :_: New_JJ Technologies_NNS for_II Fetal_JJ Surveillance_NN in_II Labour_NN ._.
P12196882A23
The_DD clinician_NN is_VBZ advised_VVN to_TO examine_VVI the_DD breast_NN in_II the_DD postpartum_NN period_NN if_CS the_DD woman_NN is_VBZ not_RR breastfeeding_VVG ._.
P12197448A10
Further_RR randomized_VVNJ controlled_VVNJ trials_NNS with_II larger_JJR sample_NN sizes_NNS are_VBB required_VVN to_TO demonstrate_VVI the_DD efficacy_NN of_II a_DD combination_NN antidepressant_NN strategy_NN for_II patients_NNS with_II treatment-resistant_JJ depression_NN ._.
P12202465A08
Individual_JJ studies_NNS showed_VVD similar_JJ results_NNS ,_, reflected_VVN in_II the_DD P_NN values_NNS of_II the_DD test_NN of_II heterogeneity_NN (_( P_NN =_SYM 0.99_MC for_II vertebral_JJ and_CC 0.88_MC for_II nonvertebral_JJ fractures_NNS )_) ._.
P12202471A10
At_II the_DD lumbar_JJ spine_NN and_CC forearm_NN sites_NNS ,_, hydroxylated_VVNJ vitamin_NN D_NN doses_NNS above_II 50_MC microg_NN yield_VVB larger_JJR effects_NNS than_CSN lower_JJR doses_NNS ._.
P12207806A12
In_II most_DD populations_NNS studied_VVN ,_, 60_MC %_SYM of_II people_NNS who_PNR develop_VVB diabetes_NN have_VHB either_CC IGT_NN or_CC IFG_NN 5_MC years_NNS or_CC so_RR before_RR ,_, with_II the_DD other_JJ 40_MC %_SYM having_VVGN normal_JJ glucose_NN tolerance_NN at_II that_DD time_NN ._.
P12215733A08
Beta-blockers_NNS have_VHB been_VBN shown_VVN to_TO significantly_RR reduce_VVI sudden_JJ death_NN as_CC+ well_CC+ as_CC total_JJ mortality_NN ,_, while_CS the_DD effects_NNS of_II amiodarone_NN have_VHB been_VBN less_RR decisive_JJ ._.
P12222079A20
Strategies_NNS need_VVB to_TO be_VBI developed_VVN and_CC tested_VVN to_TO enhance_VVI motivation_NN and_CC to_TO target_VVI treatment_NN efforts_NNS at_II those_DD youth_NN who_PNR are_VBB most_RRT likely_RR to_TO benefit_VVI from_II services_NNS ._.
P12227125A09
One_MC study_NN involving_VVG high-risk_NN patients_NNS reported_VVD a_DD reduction_NN in_II ulcer_NN incidence_NN (_( OR_NN 0.28_MC ,_, 95_MC %_SYM confidence_NN interval_NN [_( CI_NN ]_) 0.13-0.59_MC )_) and_CC amputation_NN rate_NN (_( OR_NN 0.32_MC ,_, 95_MC %_SYM CI_NN 0.14-0.71_MC )_) after_II 1_MC year_NN ._.
P12229053A10
To_TO prepare_VVI for_II this_DD "_`` certainty_NN ,_, "_'' radiology_NN departments_NNS must_VM answer_VVB many_DD questions_NNS ._.
P12235735A03
Diabetic_JJ individuals_NNS with_II hypertension_NN have_VHB a_DD greater_JJR risk_NN of_II macrovascular_JJ and_CC microvascular_JJ disease_NN than_CSN normotensive_JJ diabetic_JJ individuals_NNS ._.
P12241126A10
However_RR ,_, all_PND have_VHB potential_JJ serious_JJ adverse_JJ events_NNS ._.
P12269960A10
The_DD mechanism_NN of_II any_DD anti-dyspeptic_JJ action_NN is_VBZ difficult_JJ to_TO define_VVI ,_, as_CS the_DD causes_NNS of_II non-ulcer_NN dyspepsia_NN are_VBB unclear_JJ ._.
P12350192A04
DATA_NNS SOURCES_NNS :_: Relevant_JJ articles_NNS were_VBD identified_VVN through_II searches_NNS of_II the_DD Cochrane_NNP Library_NN ,_, MEDLINE_NN ,_, and_CC EMBASE_NN (_( 1984-2001_MC )_) ,_, manual_JJ searches_NNS of_II bibliographies_NNS of_II known_VVNJ primary_JJ and_CC review_NN articles_NNS ,_, and_CC contact_NN with_II manufacturers_NNS ._.
P12354487A08
Combined_VVNJ oestrogen_NN /_SYM progestagen_NN HRT_NN was_VBD used_VVN in_II three_MC trials_NNS and_CC oestrogen_NN alone_JJ in_II one_MC ._.
P12360366A10
The_DD accrual_JJ of_II breast_NN cancer_NN cases_NNS appearing_VVG during_II the_DD fourth_JJ year_NN of_II observation_NN is_VBZ similar_JJ to_II that_PND found_VVN in_II previous_JJ studies_NNS ,_, and_CC remains_VVZ inferior_JJ to_II the_DD increases_NNS related_VVN to_II lifestyle_NN factors_NNS reported_VVN in_II other_JJ studies_NNS ._.
P12369881A02
The_DD potential_NN of_II this_DD drug_NN class_NN has_VHZ yet_RR to_TO be_VBI fully_RR explored_VVN ._.
P12371014A09
Electrophysiologic_JJ studies_NNS performed_VVN during_II the_DD antiarrhythmic_JJ surgical_JJ procedure_NN can_VM not_RR provide_VVB complete_JJ information_NN ,_, and_CC their_PNG use_NN is_VBZ thus_RR restricted_VVN to_II the_DD arrhythmogenic_JJ myocardial_JJ target_NN only_RR [_( 32_MC ,_, 45_MC ]_) ._.
P12381215A07
Antihypertensive_JJ agents_NNS have_VHB been_VBN extensively_RR studied_VVN in_II the_DD primary_JJ prevention_NN of_II stroke_NN ;_: however_RR ,_, relatively_RR few_JJ trials_NNS of_II antihypertensive_JJ agents_NNS in_II the_DD secondary_JJ prevention_NN of_II stroke_NN are_VBB available_JJ ._.
P12383060A08
Out_II+ of_II 76_MC eligible_JJ clinical_JJ trials_NNS ,_, 53_MC (_( 12_MC not_RR yet_RR published_VVN )_) involving_VVG 24089_MC patients_NNS met_VVD the_DD criteria_NNS for_II inclusion_NN ._.
P12386751A21
Catheter-directed_VVNJ thrombolysis_NN is_VBZ known_VVN to_TO improve_VVI lysis_NN rates_NNS ._.
P12390557A06
The_DD dyslipidemia_NN may_VM be_VBB associated_VVN with_II lipodystrophy_NN ,_, insulin_NN resistance_NN ,_, and_CC ,_, rarely_RR ,_, frank_JJ diabetes_NN mellitus_NN ._.
P12391943A10
Cost-effectiveness_NN base_NN case_NN estimates_NNS ranged_VVD from_II 2,415_MC Pounds_NNS savings_NNS to_II 49,476_MC Pounds_NNS additional_JJ cost_NN (_( 1997_MC prices_NNS )_) per_II unit_NN of_II effect_NN for_II donepezil_NN and_CC a_DD small_JJ savings_NNS for_II rivastigmine_NN ._.
P12398573A02
DATA_NNS SOURCES_NNS :_: A_DD MEDLINE_NN search_NN (_( 1966-September_NN 2001_MC )_) was_VBD conducted_VVN using_VVG the_DD following_VVGJ terms_NNS :_: pravastatin_NN ,_, lovastatin_NN ,_, simvastatin_NN ,_, atorvastatin_NN ,_, cerivastatin_NN ,_, fluvastatin_NN ,_, statins_NNS ,_, hydroxymethylglutaryl_NN coenzyme_NN A_NN reductase_NN inhibitor_NN ,_, acute_JJ coronary_JJ syndromes_NNS ,_, unstable_JJ angina_NN ,_, and_CC myocardial_JJ infarction_NN ._.
P12406054A04
Cigarette_NN smoking_VVGN appears_VVZ to_TO be_VBI the_DD most_RRT significant_JJ environmental_JJ risk_NN factor_NN ._.
P12407856A06
We_PN believe_VVB that_CST several_JJ aspects_NNS of_II the_DD new_JJ definition_NN need_VVB to_TO be_VBI discussed_VVN before_CS the_DD new_JJ criteria_NNS for_II MI_NN are_VBB used_VVN in_II clinical_JJ practice_NN in_II Italy_NNP ._.
P12408744A39
In_II November_NN 2001_MC ,_, Genentech_NN and_CC Novartis_NN stated_VVD that_CST an_DD amended_VVNJ BLA_NN would_VM be_VBB submitted_VVN to_II the_DD FDA_NN in_II the_DD fourth_JJ quarter_NN of_II 2002_MC ._.
P12411873A05
Radionuclide_NN imaging_VVGJ techniques_NNS appear_VVB to_TO be_VBI appropriate_JJ in_II risk_NN assessment_NN ,_, prognosis_NN and_CC evaluation_NN of_II therapy_NN in_II patients_NNS after_II acute_JJ myocardial_JJ infarction_NN ._.
P12415021A14
Increasing_VVG the_DD rate_NN of_II follow-up_NN to_II diagnostic_JJ evaluation_NN from_II the_DD base-case_NN estimate_NN of_II 77_MC %_SYM to_II 100_MC %_SYM decreased_VVD the_DD incremental_JJ cost_NN of_II UNHS_NN to_II $_SYM 38000_MC per_II additional_JJ infant_NN whose_PNR deafness_NN was_VBD diagnosed_VVN by_II 6_MC months_NNS ._.
P12419477A03
The_DD update_NN was_VBD made_VVN possible_JJ by_II a_DD series_NN of_II large_JJ ,_, cholesterol-lowering_VVGJ clinical_JJ trials_NNS ._.
P12424170A02
To_TO assess_VVI whether_CST results_NNS obtained_VVN in_II secondary_JJ care_NN can_VM be_VBB extrapolated_VVN to_II primary_JJ care_NN and_CC suggest_VVI how_CST future_JJ trials_NNS should_VM be_VBB designed_VVN to_TO provide_VVI more_RR rigorous_JJ evidence_NN ._.
P12428993A13
In_II elderly_JJ patients_NNS (_( arbitrarily_RR defined_VVN as_II aged_VVNJ >_SYM 75_MC years_NNS )_) ,_, the_DD management_NN of_II atrial_JJ fibrillation_NN varies_VVZ ;_: it_PN requires_VVZ an_DD individual_JJ approach_NN ,_, which_PNR largely_RR depends_VVZ on_II comorbid_JJ conditions_NNS ,_, underlying_VVG cardiac_JJ disease_NN ,_, and_CC patient_NN and_CC physician_NN preferences_NNS ._.
P12431942A12
Generalist_NN and_CC specialist_NN pediatricians_NNS prepared_VVD clinical_JJ cases_NNS ._.
P12434275A04
With_II the_DD exception_NN of_II allogeneic_JJ stem_NN cell_NN transplantation_NN ,_, no_DD treatment_NN modality_NN has_VHZ been_VBN proven_VVN to_TO be_VBI of_II benefit_NN over_II supportive_JJ care_NN ._.
P12435257A04
PATIENTS_NNS :_: A_DD total_NN of_II 4052_MC patients_NNS with_II AF_NN randomly_RR assigned_VVN to_TO receive_VVI therapeutic_JJ doses_NNS of_II oral_JJ anticoagulant_NN or_CC aspirin_NN with_II or_CC without_II low-dose_NN oral_JJ anticoagulants_NNS ._.
P12436944A03
These_DD numbers_NNS will_VM continue_VVB to_TO climb_VVI ,_, internationally_RR ,_, since_CS the_DD leading_VVGJ associated_VVNJ risk_NN for_II diabetes_NN development_NN ,_, obesity_NN ,_, has_VHZ reached_VVN epidemic_JJ proportions_NNS ,_, globally_RR ._.
P12440233A08
The_DD low_JJ density_NN lipoprotein_NN target_NN of_II <_SYM 100_MC mg_NN was_VBD present_JJ in_II only_RR 22_MC %_SYM of_II patients_NNS before_II enrollment_NN ,_, with_II improvement_NN of_II up_RR+ to_RR 57_MC %_SYM after_II the_DD follow-up_NN period_NN ._.
P12447156A02
Despite_II the_DD compelling_VVGJ scientific_JJ evidence_NN that_CST beta-blockers_NNS reduce_VVB hospitalizations_NNS and_CC mortality_NN in_II patients_NNS with_II heart_NN failure_NN ,_, this_DD lifesaving_VVGJ therapy_NN continues_VVZ to_TO be_VBI underutilized_VVN ._.
P12457213A12
For_II ulcer_NN bleedings_NNS ,_, endoscopic_JJ treatment_NN is_VBZ the_DD established_VVNJ first_JJ choice_NN ._.
P12472045A01
Stroke_NN is_VBZ the_DD leading_VVGJ cause_NN of_II serious_JJ long-term_NN disability_NN in_II the_DD United_VVNJ States_NNS ._.
P12479763A02
OBJECTIVE_NN :_: To_TO determine_VVI whether_CST treatment_NN with_II a_DD calcium_NN channel_NN blocker_NN or_CC an_DD angiotensin-converting_VVGJ enzyme_NN inhibitor_NN lowers_VVZ the_DD incidence_NN of_II coronary_JJ heart_NN disease_NN (_( CHD_NN )_) or_CC other_JJ cardiovascular_JJ disease_NN (_( CVD_NN )_) events_NNS vs_CC treatment_NN with_II a_DD diuretic_NN ._.
P12485545A12
We_PN describe_VVB a_DD classification_NN derived_VVN from_II these_DD studies_NNS that_PNR is_VBZ based_VVN on_II the_DD actual_JJ practice_NN of_II primary_JJ care_NN and_CC provides_VVZ a_DD starting_VVGJ point_NN for_II future_JJ epidemiologic_JJ and_CC interventional_JJ research_NN ._.
P12489289A11
Immunofluorescence_NN assays_NNS have_VHB been_VBN well_RR characterized_VVN and_CC validated_VVN in_II clinical_JJ trials_NNS ,_, however_RR they_PN are_VBB not_RR universally_RR available_JJ ._.
P12495903A14
Specific_JJ recommendations_NNS for_II supportive_JJ therapy_NN ,_, including_VVG iron_NN chelation_NN ,_, were_VBD issued_VVN ._.
P12501499A17
Eleven_MC published_VVNJ trials_NNS investigating_VVG the_DD effect_NN of_II diets_NNS in_II ulcerative_JJ colitis_NN show_VVB only_RR for_II elimination_NN diet_NN a_DD positive_JJ treatment_NN effect_NN ._.
P12505250A01
Little_JJ information_NN exists_VVZ to_TO quantify_VVI the_DD functional_JJ status_NN and_CC economic_JJ consequences_NNS of_II lipid-lowering_VVGJ therapy_NN in_II elderly_JJ patients_NNS ._.
P12507182A04
Evidence_NN based_VVNJ medicine_NN is_VBZ designed_VVN to_TO discover_VVI the_DD best_JJT evidence_NN available_JJ and_CC apply_VVI it_PN in_II daily_JJ practice_NN for_II treatment_NN of_II the_DD individual_JJ patient_NN ._.
P12512406A14
Although_CS a_DD complete_JJ tendon_NN rupture_NN with_II loading_VVGN after_II steroid_NN injection_NN has_VHZ been_VBN reported_VVN ,_, no_DD reliable_JJ proof_NN exists_VVZ of_II the_DD deleterious_JJ effects_NNS of_II peritendinous_JJ injections_NNS ;_: conclusions_NNS in_II literature_NN are_VBB based_VVN mainly_RR on_II uncontrolled_VVNJ case_NN reports_NNS that_PNR fail_VVB under_II scientific_JJ scrutiny_NN ,_, whereas_CS scientifically_RR rigorous_JJ studies_NNS have_VHB not_RR been_VBN performed_VVN ._.
P12513114A11
Most_RRT successful_JJ management_NN strategies_NNS combine_VVB pharmacological_JJ and_CC nonpharmacological_JJ (_( home_NN remedies_NNS ,_, massage_NN ,_, topical_JJ agents_NNS ,_, heat_NN and_CC cold_NN packs_NNS and_CC informal_JJ cognitive_JJ strategies_NNS )_) therapies_NNS ._.
P12518268A07
Patients_NNS should_VM be_VBB informed_VVN of_II these_DD side_NN effects_NNS in_II order_NN to_TO prevent_VVI excessive_JJ BWG_NN ,_, and_CC their_PNG blood_NN glucose_NN and_CC lipids_NNS should_VM be_VBB monitored_VVN before_II treatment_NN and_CC then_RR at_II regular_JJ intervals_NNS ._.
P12519539A02
Its_PNG pathogenesis_NN has_VHZ not_RR been_VBN elucidated_VVN yet_RR ,_, but_CC may_VM be_VBB related_VVN to_II vasospasm_NN ._.
P12519543A10
Participants_NNS '_GE ages_NNS ranged_VVD from_II 40_MC to_II 85_MC ,_, and_CC both_DD sexes_NNS were_VBD equally_RR represented_VVN ._.
P12519548A02
Manual_JJ therapy_NN practitioners_NNS are_VBB also_RR varied_VVN ,_, including_VVG physiotherapists_NNS ,_, respiratory_JJ therapists_NNS ,_, chiropractic_JJ and_CC osteopathic_JJ physicians_NNS ._.
P12519554A08
Where_CS insufficient_JJ data_NNS were_VBD presented_VVN original_JJ authors_NNS were_VBD contacted_VVN for_II further_JJ details_NNS ._.
P12519563A05
SEARCH_NN STRATEGY_NN :_: Searches_NNS were_VBD conducted_VVN in_II January_NN 2002_MC ._.
P12519569A03
SEARCH_NN STRATEGY_NN :_: We_PN searched_VVD the_DD following_VVGJ databases_NNS up_II+ to_II 2001_MC ,_, inclusive_JJ :_: Cochrane_NNP Drugs_NNS and_CC Alcohol_NN Review_NN Group_NN Register_NN ,_, the_DD Cochrane_NNP Controlled_VVNJ Trials_NNS Register_NN ,_, MEDLINE_NN ,_, EMBASE_NN ,_, Current_JJ Contents_NNS ,_, Psychlit_NN ,_, CORK_NN [_( www._NN state.vt.su_NN /_SYM adap_NN /_SYM cork_NN ]_) ,_, Alcohol_NN and_CC Drug_NN Council_NN of_II Australia_NNP (_( ADCA_NN )_) [_( www.adca.org.au_NN ]_) ,_, Australian_JJ Drug_NN Foundation_NN (_( ADF_NN -VIC_NN )_) [_( www.adf.org.au_NN ]_) ,_, Centre_NN for_II Education_NN and_CC Information_NN on_II Drugs_NNS and_CC Alcohol_NN (_( CEIDA_NN )_) [_( www.ceida.net.au_NN ]_) ,_, Australian_JJ Bibliographic_JJ Network_NN (_( ABN_NN )_) ,_, and_CC Library_NN of_II Congress_NN databases_NNS ,_, available_JJ NIDA_NN monographs_NNS and_CC the_DD College_NN on_II Problems_NNS of_II Drug_NN Dependence_NN Inc_NN ._.
P12519576A10
DATA_NNS COLLECTION_NN AND_CC ANALYSIS_NN :_: The_DD methodological_JJ quality_NN of_II the_DD studies_NNS was_VBD assessed_VVN using_VVG criteria_NNS for_II blinding_VVGN of_II randomization_NN ,_, blinding_VVGN of_II intervention_NN ,_, completeness_NN of_II follow-up_NN and_CC blinding_VVGN of_II outcome_NN assessment_NN ._.
P12519586A08
SELECTION_NN CRITERIA_NNS :_: All_DD relevant_JJ ,_, unconfounded_VVNJ ,_, randomized_VVNJ ,_, double-blind_JJ controlled_VVNJ studies_NNS ,_, in_II which_PNR extracts_NNS of_II Ginkgo_NN biloba_NN at_II any_DD strength_NN and_CC over_II any_DD period_NN were_VBD compared_VVN with_II placebo_NN for_II their_PNG effects_NNS on_II people_NNS with_II acquired_VVNJ cognitive_JJ impairment_NN ,_, including_VVG dementia_NN ,_, of_II any_DD degree_NN of_II severity_NN ._.
P12519590A06
All_DD searches_NNS were_VBD performed_VVN during_II April_NN and_CC May_NN 2001_MC ._.
P12519597A01
BACKGROUND_NN :_: Sickle_JJ cell_NN disease_NN is_VBZ an_DD inherited_VVNJ disorder_NN of_II haemoglobin_NN ,_, which_PNR results_VVZ in_II abnormal_JJ red_JJ blood_NN cells_NNS ._.
P12519607A02
Research_NN suggests_VVZ that_CST parenting_VVGN has_VHZ an_DD important_JJ role_NN to_TO play_VVI in_II helping_VVGN children_NNS to_TO become_VVI well_RR adjusted_VVNJ adults_NNS ,_, and_CC that_CST the_DD first_JJ few_JJ months_NNS and_CC years_NNS of_II a_DD child_NN 's_GE life_NN are_VBB especially_RR important_JJ in_II establishing_VVGN patterns_NNS of_II emotional_JJ ,_, cognitive_JJ and_CC social_JJ functioning_VVGN which_PNR will_VM in_II turn_NN influence_VVB the_DD child_NN 's_GE future_JJ development_NN and_CC in_II particular_NN ,_, their_PNG mental_JJ health_NN ._.
P12519612A02
Tap_NN water_NN is_VBZ commonly_RR used_VVN in_II the_DD community_NN for_II cleansing_VVGN wounds_NNS because_CS it_PN is_VBZ easily_RR accessible_JJ ,_, efficient_JJ and_CC cost_NN effective_JJ ,_, however_RR ,_, there_EX is_VBZ an_DD unresolved_VVNJ debate_NN about_II its_PNG use_NN ._.
P12519615A14
The_DD differences_NNS were_VBD similar_JJ among_II the_DD studies_NNS and_CC when_CS combined_VVN :_: Weighted_VVNJ Mean_NN Difference_NN (_( WMD_NN )_) 0.0_MC liters_NNS (_( 95_MC %_SYM Confidence_NN Interval_NN (_( 95_MC %_SYM CI_NN )_) -0.19_MC ,_, 0.19_MC )_) ._.
P12519624A01
BACKGROUND_NN :_: Immunization_NN rates_NNS for_II children_NNS and_CC adults_NNS are_VBB rising_VVG ,_, but_CC coverage_NN levels_NNS have_VHB not_RR reached_VVN national_JJ goals_NNS ._.
P12520824A10
Early_JJ and_CC sustained_VVNJ antiplatelet_NN use_NN after_II atherothrombotic_JJ stroke_NN reduces_VVZ stroke_NN recurrence_NN ._.
P12527564A07
There_EX is_VBZ a_DD great_JJ deal_NN of_II evidence_NN about_II a_DD wide_JJ variety_NN of_II clinician-based_VVNJ and_CC community-based_VVNJ efforts_NNS at_II smoking_VVGJ avoidance_NN or_CC cessation_NN ._.
P12530498A03
We_PN sought_VVD the_DD opinion_NN of_II pediatric_JJ cardiologists_NNS practicing_VVG in_II U.S._NNP fellowship_NN programs_NNS on_II the_DD subject_NN by_II means_NNS of_II a_DD multiple-choice_NN survey_NN ._.
P12534856A05
It_PN is_VBZ one_MC of_II the_DD causes_NNS of_II frequent_JJ hospital_NN readmissions_NNS ,_, reflecting_VVG acute_JJ decompensation_NN and_CC compromised_VVNJ quality_NN of_II life_NN for_II patients_NNS and_CC increased_VVNJ cost_NN and_CC resource_NN use_NN for_II the_DD healthcare_NN system_NN ._.
P12535389A09
The_DD second_JJ author_NN assessed_VVD the_DD quality_NN of_II trials_NNS and_CC extracted_VVD data_NNS independently_RR ._.
P12535396A12
MAIN_JJ RESULTS_NNS :_: There_EX are_VBB 17_MC included_VVNJ trials_NNS ._.
P12535398A26
The_DD apparent_JJ increase_NN in_II uterine_JJ hyperstimulation_NN is_VBZ of_II concern_NN ._.
P12535405A10
We_PN reviewed_VVD studies_NNS in_II scope_NN for_II criteria_NNS of_II outcome_NN relevance_NN (_( measurement_NN of_II at_RR+ least_RR one_MC of_II a_DD list_NN of_II behavioral_JJ or_CC biologic_JJ outcomes_NNS ,_, e.g._II ,_, unprotected_VVNJ sex_NN or_CC incidence_NN of_II HIV_NN infections_NNS )_) and_CC methodologic_JJ rigor_NN (_( randomized_VVNJ controlled_VVNJ trials_NNS or_CC certain_JJ strong_JJ quasi-experimental_JJ designs_NNS with_II comparison_NN groups_NNS )_) ._.
P12535410A01
BACKGROUND_NN :_: In_II nephrotic_JJ syndrome_NN protein_NN leaks_VVZ from_II the_DD blood_NN to_II the_DD urine_NN through_II the_DD glomeruli_NNS resulting_VVG in_II hypoproteinaemia_NN and_CC generalised_VVNJ oedema_NN ._.
P12535413A33
The_DD data_NN suggests_VVZ less_DD persisting_VVGJ pain_NN and_CC numbness_NN following_VVG laparoscopic_JJ repair_NN ._.
P12535419A16
There_EX was_VBD no_DD evidence_NN from_II these_DD studies_NNS that_CST this_DD increase_NN in_II uptake_NN of_II tests_NNS was_VBD related_VVN to_II informed_VVNJ decision_NN making_VVGN by_II consumers_NNS ._.
P12535424A21
In_II addition_NN ,_, meta-analysis_NN of_II available_JJ data_NNS from_II two_MC studies_NNS (_( Jacqz-Aigrain_NNP 1994_MC ,_, Anand_NNP 1999_MC )_) showed_VVD a_DD statistically_RR significantly_RR longer_JJR duration_NN of_II NICU_NN stay_NN in_II the_DD midazolam_NN group_NN compared_VVN to_II the_DD placebo_NN group_NN (_( WMD_NN 5.4_MC days_NNS ,_, 95_MC %_SYM CI_NN 0.4_MC ,_, 10.5_MC )_) ._.
P12535427A22
Both_PND of_II these_PND were_VBD conducted_VVN under_II open_JJ conditions_NNS and_CC had_VHD serious_JJ methodological_JJ problems_NNS ._.
P12535430A20
New_JJ Trials_NNS with_II longer_JJR follow_NN+ up_NN are_VBB required_VVN ._.
P12535436A20
There_EX was_VBD no_DD evidence_NN of_II any_DD publication_NN bias_NN ._.
P12535440A09
Types_NNS of_II outcome_NN measures_NNS :_: Primary_JJ :_: improvement_NN in_II the_DD Neuropathy_NN Disability_NN Score_NN or_CC Modified_VVNJ Rankin_NNP Scale_NN six_MC months_NNS after_II randomisation_NN Secondary_JJ :_: Neuropathy_NN Disability_NN Score_NN and/or_CC the_DD Modified_VVNJ Rankin_NNP Score_NN 12_MC months_NNS after_II randomisation_NN ._.
P12535443A21
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: The_DD evidence_NN available_JJ indicates_VVZ that_CST Open_JJ retropubic_JJ colposuspension_NN is_VBZ the_DD most_RRT effective_JJ treatment_NN modality_NN for_II stress_NN urinary_JJ incontinence_NN especially_RR in_II the_DD long_JJ term_NN ._.
P12535453A05
Such_DB an_DD approach_NN is_VBZ not_RR ,_, however_RR ,_, without_II cost_NN and_CC the_DD actual_JJ benefit_NN of_II the_DD adoption_NN of_II routine_JJ outcome_NN and_CC needs_NNS assessment_NN in_II the_DD day-to-day_NN care_NN of_II those_PND with_II schizophrenia_NN remains_VVZ unclear_JJ ._.
P12535460A15
The_DD final_JJ total_NN of_II participants_NNS included_VVN in_II the_DD meta-analysis_NN was_VBD 224_MC ._.
P12535468A13
Four_MC RCTs_NNS evaluated_VVD the_DD beta-blockers_NNS ,_, propranolol_NN and_CC pindolol_NN ,_, one_MC RCT_NN evaluated_VVD the_DD central_JJ nervous_JJ system_NN stimulant_NN ,_, methylphenidate_NN and_CC one_MC RCT_NN evaluated_VVD amantadine_NN ,_, a_DD drug_NN normally_RR used_VVN in_II parkinsonism_NN and_CC related_VVNJ disorders_NNS ._.
P12535472A15
The_DD risk_NN of_II a_DD carry-over_JJ effect_NN into_II the_DD second_JJ arm_NN meant_VVB that_CST these_DD results_NNS were_VBD not_RR analysed_VVN ._.
P12535476A08
The_DD manufacturers_NNS of_II amantadine_NN were_VBD contacted_VVN ._.
P12535479A20
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: Budesonide_NN is_VBZ effective_JJ in_II the_DD treatment_NN of_II collagenous_JJ colitis_NN ._.
P12535486A10
Quantitative_JJ data_NNS are_VBB presented_VVN using_VVG relative_JJ risks_NNS or_CC mean_NN differences_NNS together_RR with_II 95_MC per_II cent_MC confidence_NN limits_NNS ._.
P12535495A15
Quality_NN of_II life_NN was_VBD not_RR adequately_RR evaluated_VVN in_II the_DD studies_NNS ._.
P12535501A07
DATA_NNS COLLECTION_NN AND_CC ANALYSIS_NN :_: Trial_NN inclusion_NN and_CC methodological_JJ quality_NN was_VBD assessed_VVN by_II two_MC independent_JJ reviewers_NNS according_II+ to_II predetermined_VVNJ criteria_NNS ._.
P12535505A18
There_EX was_VBD no_DD significant_JJ difference_NN in_II readmission_NN rates_NNS between_II day_NN hospital_NN patients_NNS and_CC controls_NNS (_( n=667_NN ,_, 5_MC RCTs_NNS ,_, RR_NN 0.91_MC CI_NN 0.72_MC to_II 1.15_MC )_) ._.
P12535509A08
NPPV_NN resulted_VVD in_II decreased_VVNJ mortality_NN (_( Relative_JJ Risk_NN [_( RR_NN ]_) 0.41_MC ;_: 95_MC %_SYM Confidence_NN Intervals_NNS [_( CI_NN ]_) 0.26_MC ,_, 0.64_MC )_) ,_, decreased_VVNJ need_NN for_II intubation_NN (_( RR_NN 0.42_MC ;_: 95_MC %_SYM CI_NN 0.31_MC ,_, 0.59_MC )_) ,_, reduction_NN in_II treatment_NN failure_NN (_( RR_NN 0.51_MC ;_: 95_MC %_SYM CI_NN 0.39_MC ,_, 0.67_MC )_) ,_, rapid_JJ improvement_NN within_II the_DD first_JJ hour_NN in_II pH_NN (_( Weight_NN Mean_NN Difference_NN [_( WMD_NN ]_) 0.03_MC ;_: 95_MC %_SYM CI_NN 0.02_MC ,_, 0.04_MC )_) ,_, PaCO2_NN (_( WMD_NN -0.40_MC kPa_NN ;_: 95_MC %_SYM CI_NN -0.78_MC ,_, -0.03_MC )_) and_CC respiratory_JJ rate_NN (_( WMD_NN -3.08_MC bpm_NN ;_: 95_MC %_SYM CI_NN -4.26_MC ,_, -1.89_MC )_) ._.
P12540330A04
OUTCOMES_NNS MEASURED_VVN :_: To_TO prepare_VVI the_DD data_NNS ,_, systematic_JJ reviews_NNS were_VBD performed_VVN for_II low_JJ back_NN ,_, knee_NN ,_, neck_NN ,_, and_CC shoulder_NN pain_NN ._.
P12544987A10
Both_CC univariate_JJ and_CC multivariable_JJ regression_NN analyses_NNS showed_VVD a_DD consistent_JJ relative_JJ risk_NN reduction_NN in_II 28-day_NN mortality_NN rates_NNS for_II drotrecogin_NN alfa_NN (_( activated_VVNJ )_) ._.
P12552027A05
Studies_NNS of_II side_NN effects_NNS of_II anticonvulsants_NNS commonly_RR used_VVN to_TO treat_VVI seizures_NNS in_II children_NNS are_VBB also_RR reviewed_VVN ._.
P12554124A04
Osteoarthritis_NN (_( OA_NN )_) is_VBZ one_MC of_II the_DD chronic_JJ conditions_NNS for_II which_PNR HRT_NN has_VHZ been_VBN suggested_VVN to_TO provide_VVI beneficial_JJ outcomes_NNS ._.
P12563091A04
Therefore_RR ,_, a_DD predictive_JJ marker_NN of_II PE_NN emergence_NN is_VBZ critical_JJ ._.
P12570125A11
Therapeutic_JJ modalities_NNS such_II+ as_II new_JJ drugs_NNS ,_, e.g._II epoprostenol_NN ,_, treprostinil_NN and_CC bosentan_NN ,_, and_CC surgical_JJ interventions_NNS ,_, e.g._II transplantation_NN and_CC blade_NN septostomy_NN ,_, which_PNR were_VBD unavailable_JJ several_JJ decades_NNS ago_RR ,_, have_VHB had_VHD a_DD significant_JJ impact_NN on_II prognosis_NN and_CC outcome_NN ._.
P12574007A03
The_DD authors_NNS also_RR searched_VVD the_DD citations_NNS of_II selected_VVNJ studies_NNS and_CC contacted_VVD relevant_JJ authors_NNS and_CC manufacturers_NNS ._.
P12577161A02
Sepsis_NN is_VBZ the_DD systemic_JJ inflammatory_JJ response_NN to_II infection_NN ,_, often_RR associated_VVN with_II hypoperfusion_NN followed_VVN by_II tissue_NN injury_NN and_CC organ_NN failure_NN ._.
P12578514A09
CONCLUSIONS_NNS :_: Lipid_NN therapy_NN with_II statins_NNS can_VM reduce_VVB CVD_NN morbidity_NN and_CC mortality_NN as_CS demonstrated_VVN in_II a_DD number_NN of_II clinical_JJ trials_NNS ._.
P12587942A05
The_DD data_NN for_II its_PNG effective_JJ use_NN in_II the_DD medical_JJ phase_NN of_II therapy_NN for_II patients_NNS with_II acute_JJ coronary_JJ syndromes_NNS ,_, however_RR ,_, is_VBZ not_RR as_RR consistent_JJ ._.
P12595913A04
However_RR ,_, more_DD controlled_VVNJ studies_NNS addressing_VVG this_DD issue_NN are_VBB needed_VVN ._.
P12602664A06
The_DD combination_NN of_II a_DD leukotriene_NN receptor_NN antagonist_NN and_CC an_DD antihistamine_NN has_VHZ not_RR been_VBN proven_VVN to_TO be_VBI more_RR effective_JJ than_CSN either_DD agent_NN alone_JJ ._.
P12612871A07
RESULTS_NNS :_: Documentation_NN of_II low-density_NN lipoprotein_NN (_( LDL_NN )_) cholesterol_NN was_VBD significantly_RR lower_JJR in_II patients_NNS with_II CAD+HF_NN (_( 53_MC %_SYM )_) compared_VVN with_II those_PND with_II CAD_NN alone_JJ (_( 69_MC %_SYM )_) ._.
P12617510A13
Vaccinia_NN can_VM be_VBB transmitted_VVN from_II a_DD vaccinee_NN 's_GE unhealed_VVNJ vaccination_NN site_NN to_II other_JJ persons_NNS by_II close_JJ contact_NN and_CC can_VM lead_VVB to_II the_DD same_JJ adverse_JJ events_NNS as_CSN in_II the_DD vaccinee_NN ._.
P12622601A05
The_DD quality_NN of_II retrieved_VVNJ articles_NNS was_VBD rated_VVN as_II "_`` good_JJ ,_, "_'' "_`` fair_JJ ,_, "_'' or_CC "_`` poor_JJ ,_, "_'' and_CC sensitivity_NN ,_, specificity_NN ,_, and_CC diagnostic_JJ yield_NN of_II tests_NNS were_VBD calculated_VVN ._.
P12628892A11
CONCLUSION_NN :_: Based_VVN on_II surrogate_JJ markers_NNS ,_, heliox_NN may_VM offer_VVB mild-to-moderate_JJ benefits_NNS in_II patients_NNS with_II acute_JJ asthma_NN within_II the_DD first_JJ hour_NN of_II use_NN ,_, but_CC its_PNG advantages_NNS become_VVB less_RR apparent_JJ beyond_II 1_MC h_NN ,_, as_CS most_DD conventionally_RR treated_VVNJ patients_NNS improve_VVB to_II similar_JJ levels_NNS ,_, with_II or_CC without_II it_PN ._.
P12633191A10
DATA_NNS SYNTHESIS_NN :_: Randomized_VVNJ controlled_VVNJ trials_NNS have_VHB shown_VVN that_CST fecal_JJ occult_JJ blood_NN testing_VVGN can_VM reduce_VVB colorectal_JJ cancer_NN incidence_NN and_CC mortality_NN ._.
P12637112A16
Current_JJ evidence_NN supports_VVZ their_PNG use_NN as_II adjuncts_NNS to_II lifestyle_NN modifications_NNS in_II the_DD treatment_NN of_II obesity_NN ._.
P12641480A03
However_RR ,_, until_CS recently_RR ,_, there_EX has_VHZ been_VBN uncertainty_NN about_II the_DD consistency_NN of_II such_DD benefits_NNS across_II different_JJ patient_NN groups_NNS and_CC in_II particular_NN ,_, for_II older_JJR people_NNS and_CC in_II those_PND with_II a_DD history_NN of_II stroke_NN ._.
P12644345A06
The_DD Antithrombotic_JJ Trialists_NNS '_GE Collaboration_NN found_VVD a_DD 46_MC %_SYM reduction_NN in_II vascular_JJ events_NNS with_II antiplatelet_NN therapy_NN (_( mostly_RR aspirin_NN )_) ._.
P12646338A05
Also_RR ,_, in_II comparisons_NNS with_II simvastatin_NN 20_MC mg_NN and_CC pravastatin_NN 20_MC mg_NN ,_, 86_MC %_SYM of_II patients_NNS treated_VVN with_II rosuvastatin_NN 10_MC mg_NN achieved_VVD ATP_NN III_MC goals_NNS ,_, compared_VVN with_II 64_MC %_SYM of_II simvastatin-treated_VVNJ patients_NNS and_CC 49_MC %_SYM of_II pravastatin-treated_VVNJ patients_NNS (_( p_NN <_SYM 0.001_MC )_) ._.
P12656536A01
OBJECTIVES_NNS :_: The_DD recognition_NN that_CST alveolar_JJ overdistension_NN rather_II+ than_II peak_JJ inspiratory_JJ airway_NN pressure_NN is_VBZ the_DD primary_JJ determinant_NN of_II lung_NN injury_NN has_VHZ shifted_VVN our_PNG understanding_VVGN of_II the_DD pathogenesis_NN of_II ventilator-induced_VVNJ side_NN effects_NNS ._.
P12660659A07
Despite_II the_DD overall_JJ safety_NN and_CC efficacy_NN of_II these_DD agents_NNS ,_, many_DD patients_NNS undergoing_VVG statin_NN therapy_NN fail_VVB to_TO achieve_VVI the_DD treatment_NN goals_NNS specified_VVN in_II the_DD National_JJ Cholesterol_NN Education_NN Program_NN Adult_NN Treatment_NN Panel_NN III_MC guidelines_NNS ,_, often_RR because_II+ of_II suboptimal_JJ use_NN ,_, tolerability_NN problems_NNS ,_, or_CC lack_NN of_II compliance_NN ._.
P12662126A08
In_II approximately_RR 10_MC %_SYM of_II patients_NNS ,_, however_RR ,_, severe_JJ infusion-related_VVNJ reactions_NNS develop_VVB (_( e.g._II bronchospasm_NN ,_, hypotension_NN )_) ._.
P12664086A09
Sensitivity_NN analysis_NN suggests_VVZ that_CST this_DD effect_NN is_VBZ largely_RR dependent_JJ on_II the_DD results_NNS of_II a_DD single_JJ trial_NN (_( weighted_VVNJ mean_NN difference_NN :_: -0.9_MC kg_NN ;_: 95_MC %_SYM CI_NN :_: -2.0_MC to_II 0.2_MC kg_NN ,_, n=335_NN )_) ._.
P12667273A13
Prophylactic_JJ measures_NNS include_VVB rigorous_JJ infection_NN control_NN and_CC administration_NN of_II polyclonal_JJ (_( RSV-IGIV_NN [_( respiratory_JJ syncytial_JJ virus_NN -_: immunoglobulin_NN intravenous_JJ ]_) )_) and_CC monoclonal_JJ (_( palivizumab_NN )_) antibodies_NNS ._.
P12668909A11
This_DD review_NN discusses_VVZ the_DD diagnosis_NN and_CC management_NN of_II the_DD metabolic_JJ syndrome_NN and_CC examines_VVZ the_DD potential_NN of_II future_JJ treatment_NN options_NNS ._.
P12672771A17
Safety_NN data_NNS from_II 50_MC trials_NNS yielded_VVD estimates_NNS of_II 2.2-_MC to_II 3.6-fold_NN increases_NNS in_II odds_NNS of_II psychiatric_JJ ,_, autonomic_JJ ,_, or_CC gastrointestinal_JJ symptoms_NNS ,_, and_CC heart_NN palpitations_NNS ._.
P12678337A04
We_PN included_VVD any_DD randomized_VVNJ clinical_JJ trial_NN comparing_VVG different_JJ types_NNS of_II antibiotic_JJ prophylaxis_NN with_II placebo_NN or_CC no_DD intervention_NN in_II inpatients_NNS with_II cirrhosis_NN ._.
P12685059A06
Few_JJ diagnostic_JJ strategies_NNS have_VHB been_VBN assessed_VVN in_II ICU_NN patients_NNS with_II suspected_VVNJ PE_NN ._.
P12690649A13
In_II leukemia_NN and_CC lymphoma_NN ,_, the_DD coagulopathy_NN is_VBZ typically_RR acute_JJ DIC_NN that_PNR can_VM lead_VVB to_II systemic_JJ and_CC brain_NN hemorrhages_NNS ._.
P12692171A17
However_RR ,_, they_PN should_VM remind_VVB patients_NNS of_II the_DD importance_NN of_II communicating_VVGN test_NN results_NNS to_II family_NN members_NNS ,_, as_II part_NN of_II pretest_NN counseling_VVGN and_CC informed_VVNJ consent_NN discussions_NNS ._.
P12696988A09
We_PN put_VVB forward_RR recommendations_NNS for_II relevant_JJ outcome_NN measures_NNS ,_, timeframes_NNS ,_, endpoints_NNS and_CC epidemiologic_JJ data_NNS sources_NNS ._.
P12704479A02
Although_CS quality_NN indicators_NNS have_VHB been_VBN developed_VVN in_II other_JJ countries_NNS ,_, Canadian_JJ cardiovascular_JJ disease_NN indicators_NNS do_VDB not_RR exist_VVB ._.
P12708950A01
OBJECTIVE_NN :_: To_TO review_VVI the_DD pharmacology_NN ,_, pharmacokinetics_NNS ,_, efficacy_NN ,_, and_CC tolerability_NN of_II extended-release_NN (_( ER_NN )_) metoprolol_NN succinate_NN and_CC its_PNG role_NN in_II the_DD management_NN of_II chronic_JJ heart_NN failure_NN ._.
P12710848A02
The_DD systemic_JJ nature_NN of_II the_DD disease_NN is_VBZ reflected_VVN in_II the_DD fact_NN that_CST individuals_NNS with_II PAD_NN or_CC carotid_JJ artery_NN disease_NN are_VBB more_RR likely_RR to_TO have_VHI CAD_NN than_CSN those_PND without_II ._.
P12715671A07
We_PN also_RR searched_VVD the_DD Cochrane_NNP Controlled_VVNJ trials_NNS Register_VVB (_( Cochrane_NNP Library_NN issue_NN 1_MC ,_, 2000_MC )_) the_DD Science_NN Citation_NN Index_NN ,_, BIOSIS_NN ,_, CAB-Health_NN ,_, Health_NN star_NN and_CC Economic_JJ databases_NNS ._.
P12719677A02
A_DD search_NN was_VBD conducted_VVN of_II all_DD published_VVNJ literature_NN on_II conventional_JJ search_NN engines_NNS (_( PubMed_NN ,_, EMBASE_NN ,_, the_DD Cochrane_NNP Registry_NN ,_, CINAHL_NN ,_, LILACS_NN )_) and_CC alternative_JJ medicine_NN databases_NNS (_( Natural_JJ Medicines_NNS Comprehensive_JJ Database_NN ,_, Longwood_NNP Herbal_NN Taskforce_NN ,_, and_CC Alternative_JJ Medicine_NN Alert_NN )_) ,_, for_II all_DD studies_NNS of_II the_DD five_MC most_RRT commonly_RR used_VVNJ CAM_NN treatments_NNS of_II vaginitis_NN ._.
P12725011A05
There_EX are_VBB no_DD well-conducted_VVNJ ,_, randomized_VVNJ clinical_JJ trials_NNS to_TO guide_VVI practitioners_NNS ._.
P12729427A04
DATA_NNS SOURCES_NNS :_: Accuracy_NN and_CC complications_NNS of_II diagnostic_JJ tests_NNS were_VBD estimated_VVN by_II using_VVGN meta-analysis_NN and_CC literature_NN review_NN ._.
P12735123A17
Although_CS many_DD clinicians_NNS share_VVB a_DD nihilistic_JJ view_NN regarding_VVG the_DD potential_JJ usefulness_NN of_II mechanical_JJ ventilation_NN in_II elderly_JJ patients_NNS few_JJ data_NNS warrant_VVB this_DD negative_JJ prognostication_NN and_CC more_DD outcome_NN studies_NNS are_VBB needed_VVN to_TO delineate_VVI the_DD optimum_NN application_NN of_II this_DD element_NN of_II supportive_JJ care_NN ._.
P12738981A10
In_II the_DD properly_RR selected_VVNJ woman_NN with_II symptomatic_JJ fibroids_NNS ,_, the_DD result_NN from_II the_DD selected_VVNJ treatment_NN should_VM be_VBB an_DD improvement_NN in_II the_DD quality_NN of_II life_NN ._.
P12742289A04
METHODS_NNS :_: Both_CC MEDLINE_NN (_( 1966_MC to_II December_NN 2001_MC )_) and_CC EMBASE_NN (_( 1980_MC to_II December_NN 2001_MC )_) were_VBD searched_VVN ,_, with_II supplementation_NN by_II reference_NN list_NN searches_NNS ._.
P12749504A04
METHODS_NNS :_: The_DD English-language_NN literature_NN was_VBD searched_VVN using_VVG the_DD EMBASE_NN and_CC MEDLINE_NN databases_NNS ._.
P12751912A10
Furthermore_RR ,_, the_DD total_JJ cost_NN of_II a_DD screening_VVGJ programme_NN is_VBZ difficult_JJ to_TO define_VVI since_CS it_PN extends_VVZ well_RR beyond_II the_DD initial_JJ test_NN ._.
P12759325A09
DATA_NNS SYNTHESIS_NN :_: Data_NNS were_VBD combined_VVN from_II 42_MC clinical_JJ trials_NNS that_PNR included_VVD 192478_MC patients_NNS randomized_VVN to_II 7_MC major_JJ treatment_NN strategies_NNS ,_, including_VVG placebo_NN ._.
P12769045A05
DATA_NNS EXTRACTION_NN METHODS_NNS :_: Articles_NNS were_VBD categorized_VVN as_II Intervention_NN ,_, Population_NN (_( stage_NN distribution_NN )_) ,_, or_CC Validation_NN studies_NNS ._.
P12773077A12
For_II patients_NNS undergoing_VVG primary_JJ PCI_NN for_II the_DD management_NN of_II STEMI_NN ,_, the_DD available_JJ evidence_NN supports_VVZ the_DD use_NN of_II abciximab_NN ,_, albeit_CS further_JJ investigation_NN is_VBZ warranted_VVN ._.
P12777595A16
Many_JJ characteristics_NNS of_II families_NNS have_VHB changed_VVN during_II the_DD past_NN 3_MC to_II 5_MC decades_NNS ._.
P12778842A01
Depression_NN and_CC bipolar_JJ disorder_NN are_VBB frequently_RR chronic_JJ disorders_NNS ,_, with_II onset_NN often_RR beginning_VVGN in_II childhood_NN ._.
P12781904A04
In_II the_DD Heart_NN Outcomes_NNS Prevention_NN Evaluation_NN (_( HOPE_NN )_) study_NN ,_, ramipril_NN treatment_NN in_II high-risk_NN patients_NNS was_VBD associated_VVN with_II a_DD 20_MC %_SYM reduction_NN in_II the_DD risk_NN for_II myocardial_JJ infarction_NN ;_: mean_NN reduction_NN in_II blood_NN pressure_NN was_VBD 3_MC mm_NN Hg_NN for_II systolic_JJ blood_NN pressure_NN and_CC 1_MC mm_NN Hg_NN for_II diastolic_JJ blood_NN pressure_NN ._.
P12784781A09
The_DD odds_NNS ratios_NNS for_II stenting_VVGN vs_CC CABG_NN were_VBD 0.82_MC (_( 95_MC %_SYM confidence_NN interval-CI_NN 0.57-1.18_MC ,_, p_NN =_SYM 0.3_MC )_) for_II the_DD occurrence_NN of_II death_NN ,_, non-fatal_JJ myocardial_JJ infarction_NN or_CC stroke_NN ,_, 4.6_MC (_( 95_MC %_SYM CI_NN 3.5-5.9_MC ,_, p_NN <_SYM 0.00001_MC )_) for_II repeat_NN revascularization_NN ,_, and_CC 2.3_MC (_( 95_MC %_SYM CI_NN 1.8-2.8_MC ,_, p_NN <_SYM 0.00001_MC )_) for_II symptomatic_JJ angina_NN ._.
P12788842A03
Observational_JJ studies_NNS suggest_VVB a_DD protective_JJ role_NN of_II estrogen_NN ,_, whereas_CS recent_JJ randomized_VVNJ controlled_VVNJ trials_NNS report_VVB a_DD negative_JJ role_NN for_II oral_JJ estrogen_NN in_II primary_JJ and_CC secondary_JJ prevention_NN of_II cardiovascular_JJ events_NNS ._.
P12793924A07
High-risk_NN categories_NNS include_VVB congenital_JJ and_CC acquired_VVNJ immunodeficiency_NN ,_, younger_JJR age_NN ,_, transfusion_NN of_II blood_NN donated_VVN by_II family_NN members_NNS ,_, and_CC transfusion_NN with_II fresh_JJ whole_JJ blood_NN ._.
P12796751A01
BACKGROUND_NN :_: Coronary_JJ stent_NN placement_NN has_VHZ replaced_VVN balloon_NN angioplasty_NN as_II the_DD percutaneous_JJ coronary_JJ intervention_NN (_( PCI_NN )_) method_NN of_II choice_NN ,_, primarily_RR because_II+ of_II its_PNG lower_JJR restenosis_NN rate_NN ._.
P12800564A35
When_CS historical_JJ data_NNS are_VBB not_RR available_JJ ,_, the_DD Six_MC Sigma_NN team_NN must_VM collect_VVB baseline_NN data_NNS as_II one_MC of_II their_PNG earliest_JJT tasks_NNS ._.
P12804385A15
In_II the_DD bupropion_NN trials_NNS ,_, 18_MC had_VHD a_DD placebo_NN arm_NN ,_, two_MC of_II which_PNR tested_VVD long-term_NN use_NN to_TO prevent_VVI relapse_NN ._.
P12804392A22
Clinicians_NNS should_VM weigh_VVB the_DD moderate_JJ benefits_NNS of_II antibiotic_JJ treatment_NN against_II the_DD potential_NN for_II adverse_JJ effects_NNS ._.
P12804400A08
Analysis_NN was_VBD on_II an_DD intention-to-treat_NN basis_NN ._.
P12804406A27
Combined_VVNJ oestrogen_NN and_CC progesterone_NN appeared_VVD to_TO reduce_VVI the_DD likelihood_NN of_II cure_NN or_CC improvement_NN ._.
P12804410A17
Subgroups_NNS of_II patients_NNS may_VM gain_VVB benefit_NN ,_, but_CC it_PN appears_VVZ difficult_JJ to_TO predict_VVI responders_NNS ._.
P12804416A17
REVIEWER_NN 'S_GE CONCLUSIONS_NNS :_: We_PN did_VDD not_RR find_VVB convincing_VVGJ evidence_NN that_CST BCAA_NN had_VHD a_DD significant_JJ beneficial_JJ effect_NN on_II patients_NNS with_II hepatic_JJ encephalopathy_NN ._.
P12804421A18
Since_CS no_DD clear_JJ rationale_NN exists_VVZ for_II biphasic_JJ pills_NNS and_CC since_RR extensive_JJ evidence_NN is_VBZ available_JJ for_II monophasic_JJ pills_NNS ,_, the_DD latter_NN are_VBB preferred_VVN ._.
P12804425A02
OBJECTIVES_NNS :_: To_TO determine_VVI the_DD benefit_NN of_II methylxanthines_NNS compared_VVN to_II placebo_NN for_II COPD_NN exacerbations_NNS ._.
P12804428A14
The_DD rehabilitation_NN program_NN was_VBD required_VVN to_TO be_VBI multidisciplinary_JJ ,_, i.e._CC ,_, it_PN had_VHD to_TO consist_VVI of_II a_DD physician_NN 's_GE consultation_NN plus_II either_CC a_DD psychological_JJ ,_, social_JJ or_CC vocational_JJ intervention_NN ,_, or_CC a_DD combination_NN of_II these_PND ._.
P12804436A02
OBJECTIVES_NNS :_: To_TO determine_VVI whether_CST there_EX is_VBZ evidence_NN to_TO support_VVI the_DD use_NN of_II KMC_NN in_II LBW_NN infants_NNS as_II an_DD alternative_NN to_II conventional_JJ care_NN after_II the_DD initial_JJ period_NN of_II stabilization_NN with_II conventional_JJ care_NN ._.
P12804442A20
Subgroup_NN analyses_NNS failed_VVD to_TO identify_VVI a_DD disproportionate_JJ benefit_NN of_II treatment_NN according_II+ to_II the_DD allergen_NN administered_VVN ._.
P12804447A09
An_DD update_NN search_NN was_VBD conducted_VVN on_II 12th_JJ August_NN 2002_MC ._.
P12804453A06
The_DD Cochrane_NNP Effective_JJ Practice_NN and_CC Organisation_NN of_II Care_NN Specialised_VVNJ Register_NN ,_, the_DD Cochrane_NNP Rehabilitation_NN Specialist_NN Register_NN ;_: Cochrane_NNP Controlled_VVNJ Trials_NNS Register_NN (_( CCTR_NN )_) ;_: MEDLINE_NN (_( 1966-2000_MC )_) ;_: EMBASE_NN (_( 1980-2000_MC )_) ,_, Cumulative_JJ Index_NN to_II Nursing_VVGN and_CC Allied_NN Health_NN Literature_NN (_( CINAHL_NN )_) (_( 1982-2000_MC )_) :_: Science_NN Citation_NN Index_NN (_( 1982-2000_MC )_) ;_: Social_JJ Science_NN Citation_NN Index_NN (_( 1982-2000_MC )_) ;_: Best_JJT Evidence_NN (_( 1991-2000_MC )_) ;_: HMIC_NN (_( 1979-2000_MC )_) ;_: PsycINFO_NN (_( 1967-2000_MC )_) ;_: ASSIA_NN (_( 1987-2000_MC )_) ;_: Ageline_NN (_( 1978-2000_MC )_) ;_: AgeInfo_NN (_( 1971-2000_MC )_) ;_: Sociological_JJ Abstracts_NNS (_( 1963-2000_MC )_) ;_: System_NN for_II Information_NN on_II Grey_JJ Literature_NN (_( SIGLE_NN )_) (_( 1980-2000_MC )_) ;_: UK_NNP National_JJ Research_NN Registers_NNS Project_NN Database_NN (_( Issue_NN 12001_MC )_) ;_: Architecture_NN Publication_NN Index_NN (_( 1977-2000_MC )_) ._.
P12804456A24
These_DD results_NNS were_VBD not_RR sensitive_JJ to_II the_DD assumption_NN made_VVN because_CS the_DD overall_JJ benefit_NN estimated_VVN was_VBD still_RR significant_JJ when_CS the_DD correlation_NN was_VBD assumed_VVN to_TO be_VBI less_RR than_CSN 0.1_MC ._.
P12804461A13
The_DD reviewers_NNS assumed_VVD that_CST people_NNS who_PNR died_VVD or_CC dropped_VVD out_II had_VHD no_DD improvement_NN and_CC tested_VVD the_DD sensitivity_NN of_II the_DD final_JJ results_NNS to_II this_DD assumption_NN ._.
P12804466A08
SELECTION_NN CRITERIA_NNS :_: All_DD randomised_VVNJ and_CC quasi-randomised_VVNJ trials_NNS involving_VVG agents_NNS that_PNR reduce_VVB gastric_JJ acidity_NN compared_VVN to_II placebo_NN or_CC a_DD comparator_NN treatment_NN ._.
P12804469A20
The_DD incidence_NN of_II decreased_VVNJ urine_NN output_NN (_( <_SYM 1cc_NN /_SYM kg_NN /_SYM hr_NN )_) was_VBD lower_JJR in_II the_DD ibuprofen_NN group_NN as_CS compared_VVN to_II the_DD indomethacin_NN group_NN [_( NNT_NN 9_MC (_( 95_MC %_SYM CI_NN 5-14_MC )_) ]_) ._.
P12804475A10
We_PN entered_VVD and_CC analyzed_VVD data_NNS with_II RevMan_NN 4.1_MC ._.
P12804481A11
MAIN_JJ RESULTS_NNS :_: 18_MC trials_NNS involving_VVG 1891_MC people_NNS were_VBD included_VVN ._.
P12804486A29
Neuropsychiatric_JJ and_CC cognitive_JJ adverse_JJ events_NNS occur_VVB more_RR frequently_RR on_II anticholinergics_NNS than_CSN on_II placebo_NN and_CC are_VBB a_DD more_RR common_JJ reason_NN for_II withdrawal_NN than_CSN lack_NN of_II efficacy_NN ._.
P12804493A04
Several_JJ surgical_JJ techniques_NNS have_VHB been_VBN developed_VVN to_TO regenerate_VVI periodontal_JJ tissues_NNS including_VVG guided_VVNJ tissue_NN regeneration_NN (_( GTR_NN )_) ,_, bone_NN grafting_VVGN (_( BG_NN )_) and_CC the_DD use_NN of_II enamel_NN matrix_NN derivative_NN (_( EMD_NN )_) ._.
P12804498A11
The_DD data_NNS selected_VVN would_VM reflect_VVB cognitive_JJ ,_, behavioural_JJ ,_, physical_JJ and_CC psychological_JJ domains_NNS of_II AD_NN ._.
P12804502A13
Substantial_JJ statistical_JJ heterogeneity_NN was_VBD observed_VVN (_( p_NN <_SYM 0.001_MC )_) ._.
P12804506A08
DATA_NNS COLLECTION_NN AND_CC ANALYSIS_NN :_: Two_MC trials_NNS (_( 418_MC subjects_NNS )_) met_VVD the_DD inclusion_NN criteria_NNS for_II this_DD review_NN ._.
P12804510A01
BACKGROUND_NN :_: Therapeutic_JJ exercise_NN is_VBZ used_VVN as_II one_MC modality_NN to_TO treat_VVI people_NNS with_II osteoarthritis_NN (_( OA_NN )_) ._.
P12806450A11
Participants_NNS in_II the_DD studies_NNS were_VBD primiparous_JJ women_NNS ._.
P12812622A03
Because_CS there_EX is_VBZ no_DD cure_NN for_II this_DD costly_JJ disease_NN ,_, goals_NNS of_II therapy_NN include_VVB ;_: slowing_VVGN progression_NN ,_, increasing_VVGN patient_NN survival_NN ,_, minimizing_VVGN symptoms_NNS ,_, improving_VVGN patient_NN functional_JJ capacity_NN ,_, and_CC decreasing_VVGN ER_NN visits_NNS ,_, hospital_NN admissions_NNS ,_, and_CC readmissions_NNS ._.
P12816555A02
This_DD final_JJ article_NN reviews_VVZ the_DD role_NN of_II long-term_NN HRT_NN in_II stroke_NN ,_, Alzheimer_NNP 's_GE disease_NN (_( AD_NN )_) ,_, and_CC overall_JJ mortality_NN as_CC+ well_CC+ as_CC strategies_NNS to_TO guide_VVI decision-making_VVGN for_II the_DD individual_JJ patient_NN ._.
P12820712A30
Therefore_RR ,_, for_II patients_NNS with_II sufficient_JJ cardiopulmonary_JJ reserve_NN who_PNR can_VM be_VBB clinically_RR staged_VVN as_II IA_NN or_CC IB_NN ,_, either_CC by_II good_JJ quality_NN CT_NN with_II contrast_NN or_CC increasingly_RR with_II 18-FDG_NN PET_NN ,_, the_DD initial_JJ tissue_NN diagnosis_NN may_VM be_VBB at_II the_DD time_NN of_II surgery_NN ,_, when_CS a_DD frozen_VVNJ section_NN preceding_VVG a_DD complete_JJ lobectomy_NN with_II lymph_NN node_NN sampling_VVGN will_VM combine_VVB diagnosis_NN and_CC therapy_NN ._.
P12825147A03
The_DD pharmacologic_JJ options_NNS are_VBB divided_VVN into_II initiators_NNS versus_CC conditioners_NNS and_CC central-_JJ or_CC peripheral-acting_VVGJ drugs_NNS ._.
P12829553A01
OBJECTIVES_NNS :_: To_TO determine_VVI the_DD combination_NN of_II drugs_NNS and_CC vitamins_NNS ,_, and_CC their_PNG doses_NNS ,_, for_II use_NN in_II a_DD single_JJ daily_JJ pill_JJ to_TO achieve_VVI a_DD large_JJ effect_NN in_II preventing_VVGN cardiovascular_JJ disease_NN with_II minimal_JJ adverse_JJ effects_NNS ._.
P12834569A03
Current_JJ positive_JJ inotropes_NNS (_( eg_II ,_, dobutamine_NN and_CC phosphodiesterase_NN inhibitors_NNS )_) provide_VVB symptomatic_JJ relief_NN ,_, but_CC newer_JJR agents_NNS may_VM have_VHB a_DD better_JJR adverse_JJ effect_NN profile_NN ._.
P12841826A03
OBJECTIVE_NN :_: To_TO provide_VVI a_DD concise_JJ state-of-the-art_NN review_NN of_II the_DD most_RRT commonly_RR used_VVNJ automated_VVNJ signal_NN detection_NN procedures_NNS ,_, including_VVG the_DD underlying_VVGJ statistical_JJ concepts_NNS ,_, performance_NN characteristics_NNS ,_, and_CC outstanding_VVGJ limitations_NNS ,_, and_CC issues_NNS to_TO be_VBI resolved_VVN ._.
P12848590A04
Erlotinib_NN is_VBZ undergoing_VVG clinical_JJ development_NN as_II an_DD oral_JJ tablet_NN by_II an_DD alliance_NN between_II OSI_NN Pharmaceuticals_NNS ,_, Genentech_NN and_CC Roche_NNP ._.
P12852701A02
The_DD fixed-dose_NN combination_NN of_II trandolapril_NN and_CC verapamil_NN extended_VVNJ release_NN (_( ER_NN )_) is_VBZ approved_VVN for_II the_DD treatment_NN of_II hypertension_NN only_RR ._.
P12853542A16
CONCLUSIONS_NNS :_: This_DD meta-analysis_NN of_II 3_MC months_NNS of_II NIPPV_NN in_II patients_NNS with_II stable_JJ COPD_NN showed_VVD that_CST ventilatory_JJ support_NN did_VDD not_RR improve_VVB lung_NN function_NN ,_, gas_NN exchange_NN ,_, or_CC sleep_NN efficiency_NN ._.
P12858126A05
Among_II available_JJ dyslipidemic_JJ therapies_NNS ,_, although_CS statins_NNS remain_VVB the_DD mainstay_NN for_II lowering_VVGN low-density_NN lipoprotein_NN cholesterol_NN and_CC clinical_JJ events_NNS ,_, niacin_NN is_VBZ currently_RR the_DD most_RRT effective_JJ agent_NN for_II increasing_VVGN low_JJ high-density_NN lipoprotein_NN cholesterol_NN levels_NNS ._.
P12862115A27
There_EX is_VBZ need_VVB to_TO combine_VVI data_NNS collection_NN methods_NNS ,_, such_II+ as_II interview_NN surveys_NNS ,_, hospital_NN records_NNS ,_, police_NN records_NNS ,_, focus_NN group_NN discussions_NNS and_CC key_JJ informant_NN interviews_NNS ._.
P12879083A08
Nine_MC trials_NNS evaluated_VVD protein_NN and_CC energy_NN supplementation_NN (_( five_MC oral_JJ and_CC four_MC nasogastric_JJ feeding_VVGN )_) ,_, and_CC a_DD further_JJ three_MC trials_NNS tested_VVD oral_JJ protein_NN supplementation_NN ._.P00004466A01
In_II cell-free_JJ preparations_NNS (_( washed_VVN 600_MC x_SYM g_NN pellets_NNS )_) of_II human_NN renal_JJ medulla_NN ,_, glucagon_NN produced_VVD a_DD dose-dependent_JJ stimulation_NN of_II adenylate_NN cyclase_NN ._.
P00060447A10
Histamine_NN release_NN in_II both_DD systems_NNS began_VVD after_II the_DD peak_JJ cAMP_NN levels_NNS ,_, during_II the_DD period_NN of_II rapid_JJ destruction_NN of_II cAMP_NN ._.
P00071299A04
2._MC A_DD group_NN of_II more_RR widely_RR dispersed_VVNJ ,_, relatively_RR undifferentiated_VVNJ mesenchymal_JJ cells_NNS and_CC fibroblasts_NNS ,_, some_PND of_II which_PNR are_VBB chondroblast_NN precursors_NNS that_PNR probably_RR contribute_VVB to_II appositional_JJ chondrogenesis_NN and_CC growth_NN in_II width_NN of_II the_DD epiphyseal_JJ cartilage_NN ._.
P00099945A03
3._MC The_DD population_NN of_II differentiated_VVNJ glial_JJ cells_NNS is_VBZ mostly_RR composed_VVN of_II oligodendroglia_NNS ,_, less_PND of_II astrocytes_NNS and_CC microglial_JJ cells_NNS are_VBB rare_JJ ._.
P00165315A04
The_DD process_NN depended_VVD upon_II both_CC virus_NN and_CC stimulation_NN of_II lymphocytes_NNS in_II culture_NN ._.
P00198031A02
At_II high_JJ levels_NNS of_II substrate_NN cyclic_JJ AMP_NN (_( 25_MC --_: 100_MC micrometer_NN )_) ,_, hydrolysis_NN was_VBD not_RR influenced_VVN by_II either_CC 10_MC or_CC 20_MC micrometer_NN cyclic_JJ GMP_NN but_CC the_DD fetal_JJ and_CC adult_NN series_NNS were_VBD equally_RR inhibited_VVN by_II 40_MC micrometer_NN cyclic_JJ GMP_NN ._.
P00215476A07
The_DD physiologic_JJ response_NN to_II aldosterone_NN could_VM result_VVB from_II binding_VVGN to_II either_DD or_CC both_DD sets_NNS of_II sites_NNS ._.
P00286604A04
These_DD effects_NNS of_II di-M-PGE2_NN were_VBD much_RR more_RR pronounced_VVN in_II mice_NNS receiving_VVG differentiated_VVNJ (_( DMSO-treated_VVNJ )_) FLC_NN ._.
P00350127A04
Analysis_NN of_II the_DD state_NN of_II unresponsiveness_NN induced_VVN by_II SAE_NN and_CC ALS_NN showed_VVD that_CST most_PND of_II the_DD unresponsive_JJ animals_NNS had_VHD in_II their_PNG serum_NN blocking_VVGJ factors_NNS ._.
P00448111A01
The_DD origins_NNS of_II immunoglobulin-containing_VVGJ cells_NNS in_II intestinal_JJ ,_, respiratory_JJ ,_, mammary_JJ ,_, and_CC genital_JJ tissues_NNS were_VBD studied_VVN in_II CBA_NN /_SYM J_NN female_NN mice_NNS by_II using_VVGN an_DD adoptive_JJ lymphocyte_NN transfer_NN method_NN ._.
P00529110A04
The_DD early_JJ but_CC not_RR the_DD late_JJ phase_NN is_VBZ temperature_NN dependent_JJ with_II a_DD Q10_NN of_II about_RR 3-5_MC ._.
P00591509A07
Aminoff_NN 's_GE assay_NN procedure_NN for_II sialic_JJ acid_NN was_VBD modified_VVN to_TO avoid_VVI the_DD centrifugation_NN step_NN ._.
P00721901A07
The_DD carcinoma_NN cells_NNS formed_VVD a_DD smooth_JJ border_NN with_II the_DD mesenchyme_NN even_RR in_II the_DD absence_NN of_II a_DD basal_JJ lamina_NN ._.
P00803872A05
Mouse_NN ,_, dog_NN ,_, and_CC goat_NN tissues_NNS were_VBD essentia-ly_RR devoid_II+ of_II acyltransferase_NN activity_NN ._.
P00839460A06
They_PN were_VBD also_RR absent_JJ from_II ghosts_NNS prepared_VVN at_II a_DD high_JJ lytic_JJ ratio_NN (_( 1_MC :_: 100_MC )_) or_CC obtained_VVN from_II ATP-depleted_VVNJ cells_NNS ._.
P00951182A02
Following_VVG its_PNG removal_NN by_II CHCl3_NN ,_, we_PN have_VHB identified_VVN residual_JJ inhibitory_JJ activity_NN which_PNR reduces_VVZ the_DD growth_NN of_II mouse_NN marrow_NN cells_NNS but_CC not_RR lymphoma_NN cells_NNS ._.
P01008849A07
The_DD half-life_NN of_II the_DD rapidly_RR turning-over_JJ microsomal_JJ cerebrosides_NNS was_VBD calculated_VVN to_TO be_VBI 20_MC and_CC 40_MC h_NN for_II the_DD developing_VVGJ and_CC adult_JJ animals_NNS respectively_RR ._.
P01062121A08
Kinetic_JJ data_NNS supporting_VVG this_DD conclusion_NN ,_, obtained_VVN with_II extracts_NNS of_II rat-heart_NN mitochondria_NNS containing_VVG the_DD acyl-CoA_NN dehydrogenase_NN and_CC electron-transferring_VVGJ flavoprotein_NN system_NN ,_, are_VBB presented_VVN ._.
P01100420A04
Isotope_NN uptake_NN was_VBD similar_JJ regardless_II+ of_II whether_CST 3H-thymidine_NN of_II high_JJ or_CC low_JJ specific_JJ activity_NN had_VHD been_VBN used_VVN ._.
P01158883A04
These_DD and_CC other_DD results_NNS indicate_VVB that_CST the_DD tri-_JJ and_CC disulfated_VVNJ disaccharides_NNS are_VBB linked_VVN alternately_RR ,_, in_II a_DD proportion_NN of_II 3_MC :_: 1_MC ,_, respectively_RR ._.
P01212633A07
Phospholipids_NNS possessing_VVG anionic_JJ ,_, and_CC hence_RR Ca-binding_VVGJ properties_NNS ,_, were_VBD effective_JJ in_II stabilizing_VVGN ACP_NN ;_: neutral_JJ zwitterion_NN lipids_NNS ,_, which_PNR have_VHB amphipathic_JJ properties_NNS but_CC do_VDB not_RR bind_VVB Ca_NN ,_, were_VBD not_RR ._.
P01290677A03
The_DD three_MC dimensional_JJ intracellular_JJ network_NN which_PNR resulted_VVN from_II digitonin_NN treatment_NN was_VBD found_VVN to_TO be_VBI similar_JJ in_II appearance_NN to_II the_DD structures_NNS observed_VVN by_II high_JJ voltage_NN transmission_NN electron_NN microscopy_NN of_II untreated_VVNJ cells_NNS described_VVN as_II a_DD microtrabecular_JJ lattice_NN by_II Porter_NNP and_CC Tucker_NNP (_( 1981_MC )_) ._.
P01330683A04
The_DD acidification_NN is_VBZ completely_RR inhibited_VVN by_II superoxide_NN dismutase_NN and_CC its_PNG pre-steady-state_NN kinetics_NNS correlates_VVZ with_II that_PND of_II the_DD oxoferryl_NN compound_NN (_( F_NN )_) accumulation_NN ._.
P01361023A03
The_DD HIV1-infected_VVNJ patients_NNS showed_VVD a_DD decrease_NN of_II CD4+_NN helper_NN cells_NNS and_CC CD4_NN /_SYM CD8_NN ratio_NN and_CC an_DD increase_NN of_II CD8+_NN suppressor_NN /_SYM cytotoxic_JJ cells_NNS in_II all_DD examined_VVNJ segments_NNS ._.
P01383781A07
Methodological_JJ and_CC practical_JJ aspects_NNS of_II these_DD exposure_NN models_NNS are_VBB discussed_VVN ,_, as_CC+ well_CC+ as_CC their_PNG prominent_JJ effects_NNS as_CS observed_VVN in_II cultures_NNS of_II Chinese_NN hamster_NN cell_NN lines_NNS ._.
P01443054A06
Regardless_II+ of_II histologic_JJ classification_NN ,_, TAM_NN were_VBD uniformly_RR distributed_VVN throughout_II all_DB the_DD murine_JJ neoplasms_NNS growing_VVG in_II syngeneic_JJ or_CC nude_JJ mice_NNS ._.
P01501244A01
Ion_NN channels_NNS are_VBB believed_VVN to_TO play_VVI an_DD important_JJ role_NN in_II the_DD maintenance_NN of_II lens_NN transparency_NN ._.
P01529673A08
Most_PND of_II the_DD distal_JJ dendrites_NNS were_VBD postsynaptic_JJ to_II non-labelled_VVNJ axon_NN terminals_NNS ;_: however_RR ,_, some_PND were_VBD postsynaptic_JJ to_II lightly_RR labelled_VVNJ axon_NN terminals_NNS ._.
P01567442A01
A_DD simple_JJ and_CC rapid_JJ method_NN was_VBD applied_VVN for_II direct_JJ measurement_NN of_II nitric_JJ oxide_NN (_( NO_NN )_) gas_NN produced_VVN by_II cultured_VVNJ macrophages_NNS using_VVG a_DD modified_VVNJ chemiluminescence_NN detector_NN ,_, the_DD thermal_JJ energy_NN analyzer_NN (_( TEA_NN )_) ._.
P01577618A01
In_II this_DD report_NN ,_, we_PN have_VHB employed_VVN macroautoradiography_NN to_TO compare_VVI the_DD tumor_NN targeting_VVGN of_II 125I-labeled_VVNJ anti-carcinoembryonic_JJ antigen_NN (_( CEA_NN )_) MAb_NN (_( NP-4_NN )_) to_II 125I-labeled_VVNJ anti-colon-specific_JJ antigen-p_NN (_( CSAp_NN )_) MAb_NN (_( Mu-9_NN )_) and_CC their_PNG labeled_VVNJ F_NN (_( ab_NN '_SYM )_) 2_MC and_CC Fab_NN '_SYM fragments_NNS ,_, in_II nude_JJ mice_NNS each_PND bearing_VVG large_JJ dorsal_JJ human_NN colonic_JJ tumor_NN xenografts_NNS ,_, and_CC small_JJ nodular_JJ tumors_NNS in_II the_DD liver_NN and_CC lungs_NNS ._.
P01596675A04
Following_VVG stimulation_NN with_II ET-1_NN ,_, a_DD greater_JJR proportion_NN of_II tracheal_JJ [_( 3H_NN ]_) -InsPs_NNS were_VBD generated_VVN in_II the_DD intercartilaginous_JJ region_NN (_( 49_MC %_SYM )_) than_CSN in_II either_CC the_DD airway_NN smooth_JJ muscle_NN band_NN (_( 25_MC %_SYM )_) or_CC cartilaginous_JJ region_NN (_( 26_MC %_SYM )_) ._.
P01645376A05
Very_RR low_JJ to_II background_NN levels_NNS of_II VIP_NN binding_VVGN were_VBD detected_VVN in_II the_DD ectostriatum_NN ,_, paleostriatum_NN primitivum_NN ,_, paleostriatum_NN augmentatum_NN ,_, lobus_NN parolfactorius_NN ,_, nucleus_NN accumbens_NN ,_, most_PND of_II the_DD brainstem_NN ,_, and_CC the_DD cerebellum_NN ._.
P01659029A04
Con_NN A_NN weakly_RR stimulated_VVD this_DD response_NN in_II human_NN neutrophils_NNS but_CC not_RR bovine_JJ ._.
P01672479A02
In_II addition_NN to_II acute_JJ infection_NN ,_, which_PNR leads_VVZ to_II cell_NN death_NN ,_, a_DD chronic_JJ or_CC persistent_JJ infection_NN also_RR occurs_VVZ ._.
P01688849A03
Measurement_NN of_II mannose-6-phosphatase_NN activity_NN indicate_VVB that_CST the_DD heavy_JJ metal-induced_VVNJ Ca2+_NN efflux_NN is_VBZ not_RR caused_VVN by_II a_DD general_JJ increase_NN in_II membrane_NN permeability_NN ._.
P01701248A03
In_II hyperplastic_JJ prostate_NN ,_, the_DD androgen_NN receptor_NN was_VBD stained_VVN in_II the_DD glandular_JJ and_CC the_DD stromal_JJ cells_NNS ._.
P01707104A08
The_DD ORS_NN cells_NNS below_II the_DD isthmus_NN seem_VVB to_TO move_VVI up_II to_II inner-upward_JJ direction_NN along_II the_DD hair_NN axis_NN with_II differentiation_NN ._.
P01718494A05
125I-alpha-thrombin_NN ,_, 25_MC nmol_NN /_SYM L_NN ,_, was_VBD added_VVN to_II each_DD plasma_NN (_( defibrinated_VVN with_II Arvin_NN at_II 37_MC degrees_NNS C_NN )_) ,_, and_CC 90_MC seconds_NNS later_RR the_DD free_JJ thrombin_NN and_CC thrombin-inhibitor_NN complexes_NNS were_VBD quantitated_VVN after_II sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN ,_, autoradiography_NN ,_, and_CC densitometric_JJ scanning_VVGN ._.
P01726555A06
The_DD appearance_NN of_II CD56+_NN cells_NNS was_VBD examined_VVN at_II the_DD ultrastructural_JJ level_NN using_VVG immunoelectron_NN microscopy_NN ._.
P01787643A09
There_EX was_VBD a_DD highly_RR significant_JJ correlation_NN between_II interstitial_JJ macrophage_NN infiltration_NN and_CC renal_JJ function_NN impairment_NN ,_, proteinuria_NN ,_, and_CC histologic_JJ damage_NN ._.
P01828028A03
In_II contrast_NN ,_, FI-PC24h_NN ,_, which_PNR are_VBB mainly_RR I-A_NN (_( OX6_NN )_) positive_JJ and_CC can_VM potentiate_VVB the_DD autoimmunity_NN to_II RAG_NN autoantigens_NNS ,_, have_VHB a_DD diminished_VVNJ capacity_NN to_TO reduce_VVI the_DD dye_NN and_CC a_DD diminished_VVNJ phagocytic_JJ activity_NN ._.
P01847596A09
Surprisingly_RR ,_, NO3-_NN inhibited_VVD the_DD rate_NN of_II K+_NN swelling_VVGN by_II 82_MC %_SYM ._.
P01902401A01
Clinical_JJ disease_NN phases_NNS of_II chronic_JJ relapsing_VVGJ experimental_JJ allergic_JJ encephalomyelitis_NN (_( CREAE_NN )_) in_II the_DD Biozzi_NN AB_NN /_SYM H_NN mouse_NN model_NN are_VBB associated_VVN with_II extensive_JJ cellular_JJ infiltration_NN of_II the_DD central_JJ nervous_JJ system_NN ,_, principally_RR the_DD spinal_JJ cord_NN ._.
P01936787A02
The_DD aims_NNS of_II the_DD present_JJ studies_NNS were_VBD to_TO measure_VVI gamma-aminobutyric_JJ acid_NN concentrations_NNS and_CC synthesis_NN and_CC to_TO establish_VVI cellular_JJ localization_NN and_CC uptake_NN of_II gamma-aminobutyric_JJ acid_NN by_II immunocytochemistry_NN and_CC autoradiography_NN ,_, respectively_RR ,_, within_II mucosal_JJ and_CC submucosal_JJ tissues_NNS of_II the_DD rat_NN antrum_NN ._.
P01958633A04
The_DD cancer_NN cells_NNS could_VM be_VBB heterotransplanted_VVN in_II 66_MC %_SYM of_II nude_JJ mice_NNS ._.
P01972685A06
Furthermore_RR ,_, significant_JJ cytotoxic_JJ activity_NN could_VM be_VBB induced_VVN from_II PBMC_NN using_VVG the_DD culture_NN supernatant_NN derived_VVN from_II autologous_JJ LNMC_NN in_II cancer_NN patients_NNS ._.
P02010694A01
The_DD uptake_NN of_II native_JJ and_CC modified_VVNJ low_JJ density_NN lipoprotein_NN (_( LDL_NN )_) in_II foam_NN cells_NNS in_II atherosclerotic_JJ tissue_NN was_VBD studied_VVN in_II an_DD in_JJ+ vitro_JJ perfusion_NN system_NN for_II rabbit_NN aorta_NN ._.
P02026476A03
B_NN (_( a_NN )_) P-4_NN ,_, 5-_MC and_CC 7_MC ,_, 8-dihydroepoxides_NNS completely_RR inhibited_VVD the_DD proliferative_JJ response_NN at_II concentrations_NNS exceeding_VVG 10_MC (_( -6_MC )_) M_NN ,_, but_CC lower_JJR concentrations_NNS were_VBD without_II any_DD effect_NN ._.
P02051523A08
An_DD enhanced_VVNJ growth_NN of_II C._NN jejuni_NN was_VBD obtained_VVN with_II the_DD increasing_VVGJ concentration_NN of_II FeCl3_NN supplementation_NN in_II the_DD medium_NN ._.
P02073460A04
The_DD third_JJ bacterium_NN ,_, a_DD unique_JJ Gram-negative_JJ soil_NN isolate_NN ,_, was_VBD unable_JJ to_TO nitrify_VVI deferrioxamine_NN B_NN but_CC grew_VVD well_RR when_CS the_DD siderophore_NN was_VBD employed_VVN as_II the_DD sole_JJ C_NN source_NN ._.
P02104894A10
Further_RR ,_, natural_JJ suppressor_NN cell_NN activity_NN and_CC spontaneous_JJ production_NN of_II IFN-beta_NN ,_, a_DD characteristic_NN of_II this_DD form_NN of_II GVHD_NN ,_, was_VBD absent_JJ in_II spleen_NN cells_NNS obtained_VVN from_II GVHD_NN mice_NNS treated_VVN with_II mAb_NN to_II IFN-gamma_NN ._.
P02119175A04
Nine_MC species_NNS (_( mouse_NN ,_, frog_NN ,_, rat_NN ,_, guinea_NN pig_NN ,_, rabbit_NN ,_, sheep_NN ,_, cat_NN ,_, pig_NN and_CC cow_NN )_) were_VBD examined_VVN by_II light_JJ microscopy_NN and_CC six_MC (_( mouse_NN ,_, frog_NN ,_, rat_NN ,_, guinea_NN pig_NN ,_, rabbit_NN and_CC cow_NN )_) by_II electron_NN microscopy_NN ,_, with_II the_DD use_NN of_II Alcian_NN Blue_NN or_CC Cupromeronic_NN Blue_NN in_II critical-electrolyte-concentration_NN (_( CEC_NN )_) methods_NNS to_II stain_NN proteoglycans_NNS ._.
P02150917A11
Immunosuppressed_VVNJ patients_NNS also_RR have_VHB increased_VVNJ rates_NNS of_II skin_NN cancer_NN ,_, suggesting_VVG immunologic_JJ involvement_NN in_II regulation_NN of_II cutaneous_JJ oncogenesis_NN in_II humans_NNS ._.
P02178768A02
Thirty-three_MC follicular_JJ lymphoma_NN samples_NNS and_CC 36_MC reactive_JJ samples_NNS (_( lymph_NN nodes_NNS and_CC tonsils_NNS )_) were_VBD analyzed_VVN ._.
P02272351A05
A_DD regression_NN line_NN for_II the_DD two_MC responses_NNS was_VBD obtained_VVN in_II each_DD preparation_NN ._.
P02308600A04
The_DD clearance_NN of_II IgG-coated_VVNJ (_( sensitized_VVNJ )_) autologous_JJ red_JJ cells_NNS was_VBD decreased_VVN in_II 53_MC patients_NNS ._.
P02339131A02
Also_RR ,_, 1_MC ,_, 25_MC (_( OH_NN )_) 2-16-ene-23-yne-D3_NN is_VBZ 300_MC times_NNS less_RR active_JJ in_II mediating_VVGN intestinal_JJ calcium_NN absorption_NN and_CC bone_NN calcium_NN mobilization_NN as_CS compared_VVN to_II 1_MC ,_, 25-dihydroxyvitamin_NN D3_NN [_( 1_MC ,_, 25_MC (_( OH_NN )_) 2D3_NN ]_) ,_, the_DD physiologically_RR active_JJ metabolite_NN ._.
P02369786A02
Incubation_NN of_II cells_NNS with_II NAPQI_NN (_( 400_MC microM_NN )_) resulted_VVD in_II an_DD immediate_JJ uptake_NN into_II the_DD mitochondria_NNS ,_, followed_VVN by_II both_CC reduction_NN and_CC glutathione_NN conjugation_NN of_II the_DD quinone_NN imine_NN ._.
P02386535A05
The_DD kcat_NN values_NNS decreased_VVD with_II molecular-weight_NN ,_, the_DD high-molecular-weight_NN kappa-elastin_NN peptides_NNS being_VBG hydrolyzed_VVN 3_MC to_II 5_MC times_NNS faster_JJR than_CSN the_DD low-molecular-weight_NN ones_NNS ._.
P02415239A09
These_DD results_NNS demonstrate_VVB that_CST a_DD RCC_NN restrictive_JJ monoclonal_JJ antibody_NN does_VDZ specifically_RR localize_VVB to_II RCC_NN xenografts_NNS and_CC supports_VVZ the_DD hope_NN that_CST this_DD approach_NN may_VM have_VHB clinical_JJ value_NN for_II diagnosis_NN ,_, staging_VVGN ,_, or_CC treatment_NN ._.
P02427916A07
The_DD characteristics_NNS of_II the_DD high-selectivity_NN channel_NN are_VBB :_: a_DD single-channel_NN conductance_NN of_II 1-3_MC pS_NN (_( mean_NN =_SYM 2.8_MC +/-_SYM 1.2_MC )_) ,_, the_DD current-voltage_NN relationship_NN is_VBZ markedly_RR nonlinear_JJ with_II a_DD Na+_NN /_SYM K+_NN selectivity_NN greater_JJR than_CSN 20_MC :_SYM 1_MC ._.
P02448421A03
The_DD introduction_NN of_II the_DD anilinoacridine_NN ring_NN involves_VVZ a_DD modification_NN in_II the_DD geometry_NN of_II the_DD complex_NN ._.
P02458661A02
Thirty-three_MC of_II these_DD cases_NNS were_VBD studied_VVN with_II a_DD panel_NN of_II monoclonal_JJ antibodies_NNS (_( B72.3_NN ,_, B1.1_NN ,_, AE1-AE3_NN and_CC anti-Leu-7_NN )_) directed_VVN against_II tumor-associated_VVNJ glycoprotein_NN (_( TAG-72_NN )_) ,_, carcinoembryonic_JJ antigen_NN (_( CEA_NN )_) ,_, cytokeratin_NN and_CC Leu-7_NN (_( an_DD antigen_NN common_JJ to_II natural_JJ killer_NN cells_NNS and_CC small_JJ cell_NN lung_NN carcinomas_NNS )_) to_TO assess_VVI the_DD correlation_NN between_II the_DD immunocytochemical_JJ and_CC ultrastructural_JJ evidence_NN of_II differentiation_NN in_II tumors_NNS lacking_VVG differentiation_NN at_II the_DD light_NN microscopic_JJ level_NN ._.
P02464895A05
The_DD immunogold_NN staining_VVGJ reagents_NNS were_VBD used_VVN for_II a_DD direct_JJ immunostaining_VVGJ protocol_NN of_II lymphocytes_NNS ,_, which_PNR needs_VVZ less_RR than_CSN 100_MC min_NN ._.
P02481540A02
Superior_JJ anti-A_NN and_CC anti-B_NN monoclonal_JJ reagents_NNS are_VBB each_PND prepared_VVN from_II blends_NNS of_II two_MC antibodies_NNS to_TO optimise_VVI the_DD intensity_NN of_II agglutination_NN for_II slide_NN tests_NNS and_CC the_DD potency_NN for_II detection_NN of_II the_DD weaker_JJR sub-groups_NNS ,_, including_VVG Ax_NN and_CC Bw_NN by_II tube_NN techniques_NNS ._.
P02501609A07
Difluoromethylornithine_NN pretreatment_NN did_VDD not_RR affect_VVB paraquat_NN toxicity_NN ._.
P02526681A04
Cytotoxic_JJ lines_NNS were_VBD isolated_VVN that_PNR killed_VVD autologous_JJ CML_NN targets_NNS but_CC only_RR a_DD limited_VVNJ number_NN of_II allogeneic_JJ fresh_JJ leukaemias_NNS or_CC cell_NN lines_NNS ._.
P02562314A05
Bound_VVNJ and_CC free_JJ radioactivity_NN were_VBD separated_VVN through_II glass-fibre_NN filters_NNS and_CC the_DD retained_VVNJ radioactivity_NN was_VBD counted_VVN in_II a_DD gamma-spectrometer_NN ._.
P02643614A02
With_II a_DD modified_VVNJ immunodot_NN procedure_NN ,_, an_DD immune_JJ response_NN was_VBD detected_VVN after_II experimental_JJ H._NN somnus_NN abortion_NN ,_, experimental_JJ H._NN somnus_NN pneumonia_NN ,_, or_CC vaccination_NN with_II commercial_JJ H._NN somnus_NN vaccine_NN ,_, with_II the_DD greatest_JJT titer_NN found_VVN within_II the_DD immunoglobulin_NN G2_NN isotype_NN ._.
P02715729A09
The_DD structure_NN of_II II_NN was_VBD unequivocally_RR established_VVN by_II X-ray_NN crystal_NN analysis_NN ._.
P02750783A03
The_DD total_JJ data_NNS set_NN was_VBD examined_VVN for_II relationships_NNS between_II balanced_VVNJ or_CC unbalanced_VVNJ result_NN and_CC mode_NN of_II ascertainment_NN ,_, sex_NN of_II carrier_NN parent_NN ,_, chromosomes_NNS involved_VVN ,_, and_CC (_( in_II cases_NNS of_II reciprocal_JJ translocations_NNS and_CC pericentric_JJ inversions_NNS )_) for_II potential_JJ or_CC actual_JJ chromosome_NN imbalance_NN size_NN (_( %_SYM haploid_NN autosome_NN length_NN )_) ._.
P02766364A05
In_II addition_NN ,_, we_PN describe_VVB how_CST the_DD technique_NN of_II Y-contrast_NN image_NN processing_VVGN can_VM be_VBB applied_VVN to_II IRM_NN images_NNS to_TO create_VVI a_DD three-dimensional_JJ image_NN of_II the_DD ventral_JJ cell_NN surface_NN topography_NN ._.
P02826957A04
By_II the_DD addition_NN of_II forskolin_NN ,_, cyclic_JJ AMP_NN levels_NNS did_VDD not_RR change_VVB in_II Chang_NN liver_NN cells_NNS but_CC increased_VVD in_II PBMNC_NN ._.
P02838577A03
Although_CS exogenous_JJ IFN_NN suppressed_VVD the_DD spread_NN and_CC replication_NN of_II virus_NN ,_, it_PN did_VDD not_RR cure_VVB the_DD infection_NN ,_, even_RR when_CS continuously_RR present_JJ over_II many_DD cell_NN passages_NNS ._.
P02848186A02
The_DD asymmetric_JJ carbon_NN atoms_NNS of_II stereoisomers_NNS may_VM be_VBB located_VVN at_II two_MC sites_NNS within_II type_NN I_MC drugs_NNS ._.
P02856499A03
First_JJ of_II all_PND ,_, the_DD hepatocytes_NNS were_VBD fractionated_VVN with_II parenchymal_JJ and_CC non-parenchymal_JJ cells_NNS by_II low_JJ speed_NN centrifugation_NN ._.
P02863023A06
Of_II note_NN was_VBD the_DD inability_NN to_TO induce_VVI a_DD primary_JJ antibody_NN response_NN in_II the_DD spleen_NN cell_NN cultures_NNS ._.
P02872895A02
The_DD Schild_NN plot_NN for_II cimetidine_NN was_VBD linear_JJ (_( slope_NN =_SYM 0.97_MC )_) with_II a_DD pA2_NN value_NN of_II 6.72_MC +/-_SYM 0.12_MC (_( Ki_NN =_SYM 0.18_MC microM_NN cimetidine_NN )_) ,_, suggesting_VVG competitive_JJ inhibition_NN ._.
P02888623A04
In_II contrast_NN ,_, in_II order_NN of_II each_DD compound_NN 's_GE decreasing_VVGJ effectiveness_NN to_TO destroy_VVI both_CC cytochrome_NN P-450_NN and_CC heme_NN ,_, the_DD following_VVGJ sequence_NN was_VBD obtained_VVN :_: TFE_NN greater_JJR than_CSN CDE_NN greater_JJR than_CSN TFCE_NN greater_JJR than_CSN DFE_NN ._.
P02903446A06
Neu-protein_NN expression_NN in_II lymph-node_NN metastases_NNS was_VBD the_DD same_PN as_CSN its_PNG expression_NN in_II primary_JJ tumors_NNS ._.
P02908860A04
These_DD CFU-MK_NN grew_VVD as_II large_JJ (_( greater_JJR than_CSN 20_MC cells_NNS )_) ,_, mean_NN (_( 11-20_MC cells_NNS )_) ,_, small_JJ (_( 3-10_MC cells_NNS )_) ,_, or_CC mix-MK_NN colonies_NNS (_( at_RR+ least_RR two_MC MK_NN )_) that_PNR comprised_VVD 15_MC %_SYM ,_, 23_MC %_SYM ,_, 62_MC %_SYM ,_, or_CC 5_MC %_SYM of_II all_DD MK_NN colonies_NNS in_II bone_NN marrow_NN and_CC 0_MC %_SYM ,_, 8_MC %_SYM ,_, 92_MC %_SYM ,_, or_CC 1_MC %_SYM in_II peripheral_JJ blood_NN ,_, respectively_RR ._.
P02921519A01
Wasted_VVNJ mice_NNS bear_VVB an_DD autosomal_JJ recessive_JJ mutation_NN (_( wst_NN )_) that_PNR causes_VVZ neurologic_JJ abnormalities_NNS ,_, faulty_JJ DNA_NN repair_NN in_II lymphocytes_NNS ,_, and_CC immunodeficiency_NN at_II mucosal_JJ sites_NNS ._.
P02925239A03
These_DD responses_NNS were_VBD manifested_VVN by_II the_DD presence_NN of_II large_JJ numbers_NNS of_II antibody-secreting_VVGJ cells_NNS in_II salivary_JJ glands_NNS ,_, mesenteric_JJ lymph_NN nodes_NNS ,_, and_CC spleens_NNS and_CC by_II the_DD development_NN of_II high_JJ levels_NNS of_II circulating_VVGJ antibodies_NNS ._.
P02934552A01
The_DD nature_NN of_II the_DD inhibitory_JJ activity_NN of_II sera_NNS of_II patients_NNS with_II metastatic_JJ cancer_NN on_II in_JJ+ vitro_JJ immunoassays_NNS remains_VVZ unclear_JJ ._.
P02945762A03
The_DD homologous_JJ sequences_NNS are_VBB for_II the_DD most_PND part_NN composed_VVN of_II repeated_VVNJ aa_NN ,_, the_DD most_RRT remarkable_JJ of_II which_PNR is_VBZ a_DD Gly-X-His-Y-His_NN motif_NN where_PNR X_NN and_CC Y_NN are_VBB small_JJ ,_, uncharged_VVNJ aa_NN ,_, found_VVN six_MC times_NNS in_II the_DD T4_NN protein_NN and_CC seven_MC times_NNS in_II the_DD lambda_NN ORF314_NN sequence_NN ._.
P02959591A01
Aspergillus_NN nidulans_NN has_VHZ two_MC beta-tubulin_NN genes_NNS :_: benA_NN ,_, which_PNR is_VBZ involved_VVN in_II both_CC vegetative_JJ growth_NN and_CC asexual_JJ sporulation_NN ,_, and_CC tubC_NN ,_, which_PNR is_VBZ involved_VVN mainly_RR in_II asexual_JJ sporulation_NN ._.
P02965111A04
The_DD presence_NN of_II both_CC 2-deoxy-d-glucose_NN and_CC 2_MC ,_, 4-dinitrophenol_NN usually_RR prevented_VVD the_DD reduction_NN of_II binding_VVGN in_II RPMI-1640_NN ._.
P02976479A01
Preparations_NNS of_II cardiac_JJ sarcoplasmic_JJ reticulum_NN (_( CSR_NN )_) isolated_VVN from_II the_DD rat_NN by_II differential_JJ centrifugation_NN have_VHB been_VBN widely_RR used_VVN for_II measuring_VVGN alterations_NNS in_II intracellular_JJ calcium_NN flux_NN in_II response_NN to_II metabolic_JJ and_CC pharmacologic_JJ disruptions_NNS ._.
P02981512A05
Essentially_RR all_PND of_II the_DD phosphorylation_NN observed_VVN occurred_VVD on_II serines_NNS located_VVN in_II two_MC cyanogen_NN bromide_NN fragments_NNS ,_, denoted_VVN CB-1_NN (_( Mapp_NN =_SYM 13,000_MC )_) and_CC CB-2_NN (_( Mapp_NN =_SYM 22,000_MC )_) ._.
P02985117A02
Lipid_NN peroxidation_NN ,_, stimulated_VVN by_II iron_NN or_CC carbon_NN tetrachloride_NN ,_, was_VBD assayed_VVN as_II malondialdehyde_NN formation_NN ._.
P02993519A02
At_II concentrations_NNS from_II 0.1_MC to_II 2.0_MC mM_NN ,_, db-cGMP_NN produced_VVD a_DD selective_JJ ,_, concentration-dependent_JJ increase_NN in_II Ca2+-ATPase_NN activity_NN ._.
P03001736A02
Studies_NNS of_II this_DD sort_NN usually_RR examine_VVB large_JJ regions_NNS of_II DNA_NN where_PNR many_DD evolutionary_JJ events_NNS have_VHB taken_VVN place_NN ._.
P03004579A01
The_DD ADP_NN /_SYM ATP_NN carrier_NN from_II the_DD mitochondrial_JJ inner_JJ membrane_NN was_VBD found_VVN to_TO be_VBI influenced_VVN by_II cationic_JJ substances_NNS from_II the_DD hydrophilic_JJ surroundings_NNS ._.
P03007030A01
Papavarine_NN ,_, cholera_NN toxin_NN ,_, and_CC isoproterenol_NN each_PND elevated_VVD cyclic_JJ AMP_NN in_II cultured_VVNJ rat_NN retinal_JJ pigment_NN epithelium_NN and_CC reduced_VVD the_DD phagocytosis_NN of_II isolated_VVNJ rod_NN outer_JJ segments_NNS (_( 38-66_MC %_SYM of_II controls_NNS )_) during_II a_DD 4_MC hour_NN incubation_NN ._.
P03013778A04
Intact_JJ neutrophils_NNS killed_VVD opsonized_VVNJ A._NN actinomycetemcomitans_NN under_II aerobic_JJ and_CC anaerobic_JJ conditions_NNS ,_, and_CC the_DD kinetics_NNS of_II these_DD reactions_NNS indicated_VVD that_CST both_CC oxidative_JJ and_CC nonoxidative_JJ mechanisms_NNS were_VBD operative_JJ ._.
P03023820A07
Furthermore_RR ,_, several_JJ inverted_VVNJ repeat_NN sequences_NNS ,_, partially_RR within_II these_DD conserved_VVNJ regions_NNS ,_, have_VHB been_VBN identified_VVN ._.
P03025432A11
Two_MC incubating_VVGJ conditions_NNS which_PNR decrease_VVB the_DD amount_NN of_II 45Ca2+_NN uptake_NN during_II anoxia_NN protect_VVB transmission_NN against_II long-term_NN damage_NN ._.
P03031070A05
NAD+_NN and_CC carnitine_NN uptake_NN in_II the_DD solute_NN accessible_JJ volume_NN was_VBD not_RR diminished_VVN by_II a_DD variety_NN of_II analogs_NNS and_CC inhibitors_NNS ._.
P03033151A05
The_DD results_NNS are_VBB consistent_JJ with_II a_DD qualitative_JJ or_CC quantitative_JJ defect_NN in_II the_DD function_NN of_II the_DD stimulatory_JJ guanine_NN nucleotide-binding_VVGJ protein_NN (_( Ns_NN )_) ,_, as_CC+ well_CC+ as_CC in_II the_DD beta-adrenergic_JJ receptor_NN ,_, after_II chronic_JJ ethanol_NN exposure_NN ._.
P03039167A03
Fab_NN fragments_NNS of_II the_DD previously_RR characterized_VVNJ monoclonal_JJ antibody_NN E7_NN ,_, which_PNR neutralizes_VVZ polyomavirus_NN infection_NN ,_, were_VBD used_VVN for_II immunization_NN (_( S._NNP J._NNP Marriott_NNP and_CC R._NNP A._NNP Consigli_NNP ,_, J._NN Virol._NN 56_MC :_: 365-372_MC ,_, 1985_MC )_) ._.
P03047402A02
The_DD minimal_JJ fully_RR functional_JJ substrate_NN for_II in-vitro_JJ recombination_NN in_II this_DD system_NN consists_VVZ of_II two_MC FLP_NN protein_NN binding_VVGJ sites_NNS separated_VVN by_II an_DD eight_MC base-pair_NN spacer_NN sequence_NN ._.
P03052095A11
The_DD authors_NNS hypothesize_VVB that_CST the_DD induction_NN of_II MHC_NN antigens_NNS on_II bile_NN duct_NN epithelium_NN leads_VVZ to_II rejection_NN whereas_CS the_DD expression_NN on_II hepatocytes_NNS represents_VVZ an_DD epiphenomenon_NN ._.
P03067952A06
There_EX was_VBD a_DD decreased_VVNJ pokeweed_NN mitogen-induced_VVNJ proliferation_NN of_II mononuclear_JJ cells_NNS in_II SSHI_NN treated_VVNJ patients_NNS (_( p_NN less_RR than_CSN 0.01_MC )_) at_II 12_MC weeks_NNS and_CC both_DD insulin_NN treatment_NN groups_NNS had_VHD increased_VVNJ responses_NNS to_II phytohemagglutinin_NN (_( p_NN less_RR than_CSN 0.05_MC )_) but_CC not_RR concanavalin_NN A_NN at_II 24_MC weeks_NNS ._.
P03084876A04
The_DD half_JJ lives_NNS of_II 14C-labeled_VVNJ testosterone_NN administered_VVD intravenously_RR in_II NAR_NN and_CC normal_JJ Sprague-Dawley_NN (_( SD_NN )_) rats_NNS were_VBD 4.4_MC and_CC 4.1_MC min_NN ,_, respectively_RR ._.
P03097013A07
Considering_VVG their_PNG similarity_NN to_II pro-alpha_NN 2_MC (_( I_MC )_) ,_, it_PN was_VBD surprising_VVG to_TO find_VVI that_CST the_DD N-collagens_NNS were_VBD secreted_VVN to_II the_DD same_JJ extent_NN as_CS was_VBD type_NN I_MC procollagen_NN from_II Syrian_NN hamster_NN embryo_NN cells_NNS and_CC that_CST there_EX were_VBD no_DD disulfide_NN bonds_NNS between_II N-collagen_NN chains_NNS ._.
P03104208A04
Gonococcal_JJ type_NN 1_MC IgA1_NN protease_NN was_VBD produced_VVN primarily_RR by_II N._NN gonorrhoeae_NN strains_NNS which_PNR require_VVB arginine_NN ,_, hypoxanthine_NN ,_, and_CC uracil_NN (_( AHU_NN )_) and_CC which_PNR belong_VVB to_II the_DD protein_NN IA-1_NN or_CC IA-2_NN serovar_NN ._.
P03113732A01
Inhibition_NN of_II polyamine_NN synthesis_NN in_II early_JJ chick_NN embryos_NNS blocks_VVZ their_PNG development_NN at_II gastrulation_NN ._.
P03118148A01
In_II Salmonella_NN typhimurium_NN the_DD periplasmic_JJ permeases_NNS for_II histidine_NN and_CC for_II lysine-arginine-ornithine_NN are_VBB regulated_VVN by_II nitrogen_NN availability_NN ._.
P03123616A08
This_DD 40_MC kDa_NN protein_NN is_VBZ the_DD major_JJ pertussis_NN toxin_NN substrate_NN in_II glial_JJ cells_NNS ,_, while_CS Go_NN alpha_NN is_VBZ predominant_JJ in_II neuronal_JJ membranes_NNS ._.
P03130979A05
Ultrastructural_JJ analysis_NN of_II isolated_VVNJ cells_NNS fixed_VVN with_II glutaraldehyde_NN and_CC postfixed_VVN with_II osmium_NN tetroxide_NN showed_VVD that_CST these_DD cells_NNS were_VBD similar_JJ to_II cells_NNS fixed_VVN in_II the_DD intact_JJ cochlea_NN ._.
P03137084A06
Immunoblot_NN analysis_NN showed_VVD that_CST both_DD proteins_NNS are_VBB immunologically_RR similar_JJ ,_, and_CC we_PN refer_VVB to_II both_DD proteins_NNS as_II 110K_NN protein_NN ,_, collectively_RR ._.
P03138247A14
We_PN conclude_VVB that_CST the_DD slowing_VVGN of_II protein_NN and_CC lipid_NN diffusion_NN induced_VVN by_II the_DD combination_NN of_II TNF_NN and_CC IFN-gamma_NN is_VBZ not_RR due_II+ to_II plasma_NN membrane_NN corrugations_NNS ,_, to_II anisotropic_JJ diffusion_NN barriers_NNS ,_, or_CC to_II decreased_VVNJ numbers_NNS of_II cell-cell_NN contacts_NNS ._.
P03141553A02
The_DD V_NN region_NN genes_NNS for_II the_DD kappa_NN light_JJ chains_NNS and_CC mu_NN heavy_JJ chains_NNS expressed_VVN by_II these_DD tumor_NN cells_NNS were_VBD sequenced_VVN and_CC compared_VVN ._.
P03156795A05
The_DD results_NNS indicate_VVB that_CST the_DD recA_NN protein_NN protects_VVZ phage_NN DNA_NN during_II the_DD process_NN of_II restriction_NN ._.
P03168320A07
It_PN was_VBD considered_VVN that_CST taurine-induced_VVNJ IL-1_NN would_VM play_VVB an_DD essential_JJ role_NN in_II the_DD proliferation_NN and_CC differentiation_NN of_II B_NN cells_NNS ._.
P03182812A08
Tryptic_JJ digestion_NN of_II the_DD ryanodine_NN receptor_NN /_SYM junctional_JJ Ca2+_NN release_NN channel_NN ,_, which_PNR leads_VVZ to_II complete_JJ loss_NN of_II ryanodine_NN binding_VVGJ capacity_NN ,_, has_VHZ no_DD effect_NN or_CC slightly_RR stimulates_VVZ the_DD Ca2+_NN accumulation_NN activity_NN of_II these_DD membranes_NNS ._.
P03219121A04
Using_VVG the_DD first_JJ approach_NN ,_, oligonucleotides_NNS containing_VVG units_NNS with_II altered_VVNJ configuration_NN of_II the_DD sugar_NN (_( xylo-thymidine_NN and_CC arabino-uridine_NN )_) have_VHB been_VBN obtained_VVN ._.
P03234333A03
Polypeptides_NNS were_VBD visualized_VVN by_II silver_NN staining_VVGN ._.
P03258288A02
With_II a_DD preincubation_NN period_NN of_II the_DD metal_NN salts_NNS for_II 48_MC h_NN ,_, a_DD marked_VVNJ increase_NN of_II 32P_NN label_NN into_II nonhistone_NN proteins_NNS ,_, especially_RR the_DD 30-_MC to_II 40-kilodalton_NN region_NN ,_, was_VBD found_VVN compared_VVN to_II the_DD control_NN cultures_NNS ._.
P03261592A04
Significantly_RR more_DD FS_NN patients_NNS (_( 17_MC of_II 25_MC )_) showed_VVD hybridization_NN with_II this_DD oligonucleotide_NN probe_NN ,_, compared_VVN with_II the_DD number_NN of_II DR4_NN positive_JJ non-FS_NN RA_NN patients_NNS (_( 7_MC of_II 23_MC )_) and_CC normal_JJ controls_NNS (_( 7_MC of_II 21_MC )_) ._.
P03266382A03
However_RR ,_, we_PN failed_VVD to_TO demonstrate_VVI any_DD remarkable_JJ IL-1_NN inhibitory_JJ activity_NN in_II each_DD fraction_NN after_II gel_NN filtration_NN high-performance_NN liquid_NN chromatography_NN of_II the_DD psoriatic_JJ scale_NN extracts_NNS or_CC in_II that_PND of_II extracts_NNS from_II the_DD plantar_NN callus_NN ._.
P03282552A02
Monoclonal_JJ antibody_NN ATC_NN was_VBD shown_VVN by_II indirect_JJ immunofluorescence_NN (_( IIF_NN )_) to_TO bind_VVI to_II the_DD principal_JJ piece_NN of_II the_DD flagellum_NN of_II permeabilized_VVNJ mouse_NN ,_, rat_NN ,_, and_CC hamster_NN sperm_NN ,_, but_CC not_RR to_II that_DD region_NN of_II guinea_NN pig_NN ,_, rabbit_NN ,_, or_CC human_NN sperm_NN ._.
P03286629A02
The_DD concentration_NN of_II NADP+_NN required_VVN for_II the_DD maximal_JJ stimulation_NN was_VBD approximately_RR the_DD same_PN as_CSN the_DD concentration_NN of_II the_DD enzyme_NN subunit_NN ._.
P03299380A02
In_II E._NN coli_NN the_DD protein_NN homologous_JJ to_II hsp83_NN is_VBZ a_DD heat_NN shock_NN protein_NN called_VVN C62.5_NN ._.
P03313052A04
The_DD cDNA_NN encodes_VVZ a_DD phospholipid-linked_VVNJ membrane_NN protein_NN whose_PNR extracellular_JJ domain_NN shares_VVZ significant_JJ homology_NN with_II CD2_NN ._.
P03327609A05
A_DD fast_JJ migrating_VVGJ protein_NN band_NN from_II R._NN glutinis_NN was_VBD also_RR reactive_JJ ._.
P03338621A07
The_DD other_JJ two_MC early_JJ genes_NNS ,_, (_( ErA.1_NN and_CC ErB.1_NN )_) are_VBB divergently_RR paired_VVN with_II each_DD other_PN in_II the_DD manner_NN of_II the_DD middle_JJ and_CC late_JJ chorion_NN genes_NNS ._.
P03355836A08
Ternary_JJ mixtures_NNS of_II the_DD two_MC cerebrosides_NNS with_II sphingomyelin_NN /_SYM cholesterol_NN and_CC phosphatidylcholine_NN /_SYM cholesterol_NN (_( PC_NN /_SYM Chol_NN )_) showed_VVD different_JJ miscibility_NN characteristics_NNS ._.
P03379066A03
The_DD A-_NN and_CC B-related_VVNJ precursors_NNS were_VBD each_PND cleaved_VVN in_RR+ vivo_RR to_TO yield_VVI several_JJ major_JJ and_CC minor_JJ peptides_NNS including_VVG peptides_NNS A_NN and_CC B_NN and_CC the_DD ELH-related_VVNJ peptide_NN complexes_NNS that_PNR caused_VVD egg_NN laying_VVGN ._.
P03391246A01
When_CS separated_VVNJ and_CC proliferating_VVGJ rat_NN 3T3_NN cells_NNS are_VBB treated_VVN with_II butyrate_NN (_( 6_MC mM_NN )_) ,_, DNA_NN synthesis_NN stops_VVZ within_II 24_MC h_NN ,_, while_CS RNA_NN and_CC protein_NN synthesis_NN proceed_VVB unaffected_VVN ._.
P03401244A06
These_DD effects_NNS reflect_VVB a_DD deep_JJ differential_JJ effect_NN of_II CQ_NN on_II the_DD intense_JJ phospholipid_NN metabolism_NN of_II the_DD Plasmodium-infected_VVNJ erythrocytes_NNS ,_, which_PNR might_VM involve_VVB a_DD redirecting_VVGN of_II phospholipid_NN metabolism_NN similar_JJ to_II that_PND induced_VVN by_II other_JJ cationic_JJ amphiphilic_JJ drugs_NNS ,_, and_CC a_DD compensatory_JJ synthesis_NN resulting_VVG from_II the_DD severe_JJ blockage_NN of_II phosphatidylcholine_NN synthesis_NN ._.
P03415962A09
This_DD affinity_NN chromatography_NN procedure_NN should_VM prove_VVB valuable_JJ in_II the_DD isolation_NN and_CC molecular_JJ characterization_NN of_II the_DD D1_NN dopamine_NN receptor_NN ._.
P03429864A01
It_PN has_VHZ been_VBN suggested_VVN that_CST a_DD circulating_VVGJ inhibitor_NN of_II Na_NN /_SYM K_NN ATPase_NN can_VM stimulate_VVB natriuresis_NN and_CC cause_VVB vasoconstriction_NN in_II essential_JJ hypertension_NN by_II stimulating_VVGN transmembrane_JJ Na_NN /_SYM Ca_NN exchange_NN to_TO produce_VVI increased_VVNJ cytosolic_JJ concentrations_NNS of_II ionized_VVNJ calcium_NN (_( [_( Ca++_NN ]_) i_MC )_) in_II renal_JJ tubular_JJ and_CC arteriolar_JJ smooth_JJ muscle_NN cells_NNS ._.
P03447437A05
Extraction_NN of_II these_DD fluorescent_JJ compounds_NNS with_II organic_JJ solvents_NNS (_( dichloromethane_NN ,_, ethyl_NN acetate_NN ,_, chloroform_NN :_: methanol_NN )_) could_VM not_RR be_VBB achieved_VVN after_CS ultrafiltrates_NNS were_VBD subjected_VVN to_II 6N_NN hydrochloric_JJ acid_NN (_( HC1_NN )_) hydrolysis_NN ._.
P03458193A01
The_DD bacteriophage_NN phi_NN 29_MC DNA-gene_NN product_NN 3_MC complex_NN (_( DNA-gp3_NN )_) has_VHZ been_VBN efficiently_RR packaged_VVN into_II proheads_NNS in_II a_DD completely_RR defined_VVNJ in_JJ+ vitro_JJ system_NN ._.
P03462709A06
Factors_NNS (_( proteins_NNS )_) bound_VVN to_II sites_NNS 2_MC and_CC 3_MC may_VM allow_VVB cell-specific_JJ transcription_NN ,_, but_CC the_DD additional_JJ factor_NN interaction_NN at_II site_NN 1_MC could_VM be_VBB required_VVN for_II a_DD maximal_JJ rate_NN of_II albumin_NN gene_NN transcription_NN ._.
P03480243A04
Thus_RR ,_, the_DD acrosin_NN molecule_NN combines_VVZ specific_JJ proteolytic_JJ activity_NN with_II zona-_NN and_CC carbohydrate-affinity_NN properties_NNS ,_, i.e._II previously_RR unrecognized_VVNJ properties_NNS of_II a_DD serine_NN proteinase_NN ._.
P03486464A02
TNP-M_NN phi_NN fail_VVB to_TO induce_VVI contrasuppressor_NN cells_NNS (_( Tcs_NN )_) but_CC activate_VVB efferent_JJ T_NN suppressor_NN (_( Ts_NN )_) cells_NNS ._.
P03494697A03
The_DD 1_MC ,_, 3-DMU_NN C_NN (_( 5_MC )_) -OH_NN adduct_NN 4_MC reacts_VVZ slowly_RR with_II peroxodisulphate_NN (_( k_NN =_SYM 2.1_MC X_SYM 10_MC (_( 5_MC )_) dm3_NN mol-1_NN s-1_NN )_) ._.
P03500211A11
These_DD studies_NNS suggest_VVB that_CST B7_NN antigen_NN identifies_VVZ a_DD subpopulation_NN of_II B_NN cells_NNS that_PNR are_VBB preactivated_VVN or_CC primed_VVN in_RR+ vivo_RR ,_, and_CC have_VHB an_DD accelerated_VVNJ response_NN to_II subsequent_JJ activation_NN via_II cross-linking_VVGN of_II surface_NN Ig_NN ._.
P03514666A06
In_II thymic_JJ hyperplasia_NN ,_, on_II the_DD other_JJ hand_NN ,_, the_DD cortical_JJ areas_NNS appeared_VVD somewhat_RR compressed_VVN (_( but_CC comparable_JJ to_II those_PND observed_VVN in_II normal_JJ age-matched_VVNJ samples_NNS )_) by_II enlarged_VVNJ medullary_JJ areas_NNS ._.
P03522607A13
All_DB these_DD structural_JJ changes_NNS were_VBD reversed_VVN to_II normal_JJ values_NNS during_II recovery_NN of_II PS_NN II_MC activity_NN ._.
P03542052A01
Assembly_NN of_II the_DD filamentous_JJ phage_NN fd_NN is_VBZ preceded_VVN by_II the_DD formation_NN of_II a_DD complex_NN between_II the_DD viral_JJ single-stranded_VVNJ (_( ss_NN )_) DNA_NN and_CC the_DD virally_RR coded_VVNJ gene_NN 5_MC protein_NN (_( gene_NN 5_MC protein-ssDNA_NN complex_NN )_) ._.
P03550802A01
Erythrocytes_NNS infected_VVN with_II a_DD knobby_JJ variant_NN of_II Plasmodium_NN falciparum_NN selectively_RR bind_VVB IgG_NN autoantibodies_NNS in_II normal_JJ human_NN serum_NN ._.
P03582727A08
Affinity_NN labelling_VVGN of_II the_DD receptor_NN with_II [_( 125I_NN ]_) hGH_NN revealed_VVD a_DD Mr_NN of_II 37_MC +/-_SYM 0.5_MC kDa_NN (_( n_NN =_SYM 7_MC )_) for_II the_DD binding_VVGJ subunit_NN ._.
P03607024A05
The_DD effect_NN of_II these_DD cholesterol_NN analogues_NNS was_VBD studied_VVN by_II glucose_NN permeability_NN ,_, electron_NN spin_NN resonance_NN ,_, and_CC fluorescence_NN polarization_NN spectroscopy_NN ._.
P03625772A09
Loss_NN of_II electron_NN density_NN for_II residue_NN A171_NN during_II the_DD course_NN of_II refinement_NN suggests_VVZ either_CC disorder_NN or_CC absence_NN of_II this_DD C-terminal_JJ residue_NN ._.
P03653036A11
However_RR ,_, these_DD differences_NNS can_VM not_RR be_VBB explained_VVN by_II alterations_NNS of_II transformed-induced_VVNJ membrane_NN components_NNS relevant_JJ to_II the_DD coupling_VVGN of_II hormone_NN receptors_NNS to_II adenylate_NN cyclase_NN ._.
P03657797A08
Thus_RR ,_, even_RR when_CS the_DD MAb_NN reacts_VVZ with_II greater_JJR than_CSN or_CC equal_JJ to_II 2_MC epitopes_NNS in_II CEA_NN ,_, as_CS seems_VVZ to_TO be_VBI the_DD case_NN with_II several_JJ of_II our_PNG anti-CEA_NN MAbs_NNS ,_, the_DD intrinsic_JJ K-value_NN should_VM be_VBB obtained_VVN ._.
P03689774A07
The_DD independence_NN of_II A-_NN and_CC B-receptor_NN complexes_NNS was_VBD confirmed_VVN by_II the_DD finding_VVGN that_CST purified_VVNJ ,_, transformed_VVNJ B_NN receptors_NNS bind_VVB well_RR to_II DNA-cellulose_NN ._.
P03705427A05
The_DD incubation_NN of_II E._NN falciformis_NN merozoites_NNS together_RR with_II guinea-pig_NN complement_NN resulted_VVD in_II slow_JJ lysis_NN of_II the_DD cells_NNS ._.
P03718530A04
Three_MC MFO_NN activities_NNS (_( ethylmorphine_NN N-demethylase_NN ,_, aryl_NN hydrocarbon_NN hydroxylase_NN and_CC 7-ethoxycoumarin_NN O-deethylase_NN )_) were_VBD also_RR reduced_VVN to_II 40-70_MC %_SYM of_II control_NN levels_NNS ._.
P03730297A03
Both_DD assays_NNS suggest_VVB that_CST membrane_NN lipid_NN asymmetry_NN is_VBZ disrupted_VVN in_II spicules_NNS ._.
P03745187A03
The_DD length_NN of_II the_DD lag_NN phase_NN was_VBD inversely_RR related_VVN to_II both_CC the_DD total_JJ collagen_NN concentration_NN and_CC the_DD amount_NN of_II covalently_RR cross-linked_VVNJ oligomers_NNS in_II the_DD solution_NN ._.
P03754462A04
Analyses_NNS of_II populations_NNS of_II dividing_VVGJ and_CC nondividing_VVGJ human_NN lung_NN fibroblasts_NNS revealed_VVD that_CST ,_, on_II a_DD per_JJ+ cell_JJ basis_NN ,_, the_DD nondividing_VVGJ population_NN contained_VVD twice_RR as_RR much_DD alpha_NN 1_MC (_( III_MC )_) mRNA_NN than_CSN did_VDD the_DD dividing_VVGJ population_NN ._.
P03791668A09
However_RR ,_, our_PNG studies_NNS suggest_VVB that_CST autoantibodies_NNS of_II this_DD type_NN with_II TSH_NN antagonist_NN activity_NN do_VDB not_RR occur_VVB frequently_RR in_II patients_NNS from_II the_DD Cardiff_NN region_NN with_II primary_JJ myxoedema_NN ,_, Hashimoto_NN 's_GE or_CC treated_VVNJ Graves_NN '_GE disease_NN ._.
P03816801A05
It_PN was_VBD found_VVN that_CST the_DD fractional_JJ change_NN in_II the_DD dye_NN binding_VVGN was_VBD considerably_RR greater_JJR than_CSN the_DD degree_NN of_II O2_NN saturation_NN of_II hemocyanin_NN ._.
P03828779A04
It_PN was_VBD observed_VVN that_CST not_RR only_RR were_VBD Purkinje_NN cells_NNS almost_RR completely_RR ensheathed_VVN by_II astroglia_NN ,_, but_CC there_EX was_VBD a_DD greater_JJR than_CSN 60_MC %_SYM reduction_NN in_II the_DD number_NN of_II somatic_JJ synapses_NNS compared_VVN to_II the_DD non-transplanted_VVNJ granuloprival_JJ cultures_NNS ._.
P03855353A02
Long-chain_NN fatty_JJ acyl-CoAs_NNS (_( C10-C20_NN )_) ,_, like_II certain_JJ acidic_JJ phospholipids_NNS ,_, activated_VVD the_DD ligand-receptor_NN interaction_NN ._.
P03866231A03
In_II contrast_NN ,_, glutathione_NN S-transferase_NN activity_NN ,_, measured_VVN spectrophotometrically_RR with_II 1-chloro-2_NN ,_, 4-dinitrobenzene_NN ,_, was_VBD detected_VVN predominantly_RR in_II the_DD 105,000_MC X_SYM g_NN supernatant_NN (_( 89_MC %_SYM )_) and_CC also_RR in_II the_DD microsomes_NNS (_( 7_MC %_SYM )_) ._.
P03878017A06
The_DD level_NN was_VBD also_RR detected_VVN over_II the_DD central_JJ part_NN of_II the_DD karyosphere_NN in_II close_JJ proximity_NN to_II the_DD chromosomes_NNS ._.
P03882837A02
After_II appropriate_JJ absorption_NN this_DD antiserum_NN was_VBD anti-idiotype_NN specific_JJ and_CC was_VBD used_VVN to_TO set_VVI up_II a_DD particle_NN counting_VVGJ immunoassay_NN for_II human_NN IgE_NN ._.
P03894359A04
To_TO determine_VVI how_CST the_DD amount_NN of_II MBP_NN affects_VVZ transport_NN and_CC taxis_NN ,_, we_PN utilized_VVD a_DD series_NN of_II malE_NN signal-sequence_NN mutations_NNS that_PNR interfere_VVB with_II export_NN of_II MBP_NN ._.
P03906648A04
A_DD neutral_JJ proteinase_NN in_II bovine_JJ pituitary_NN has_VHZ been_VBN reported_VVN previously_RR to_TO have_VHI similar_JJ structural_JJ characteristics_NNS ._.
P03919109A02
To_TO more_RR precisely_RR characterize_VVI this_DD observation_NN ,_, we_PN examined_VVD a_DD total_NN of_II 39_MC sequential_JJ biopsies_NNS from_II 15_MC patients_NNS both_CC before_II and_CC after_II allogeneic_JJ bone_NN marrow_NN transplantation_NN ._.
P03926777A05
In_II swainsonine-fed_VVNJ rats_NNS ,_, the_DD lysosomal_JJ system_NN is_VBZ highly_RR developed_VVN in_II hepatocytes_NNS ,_, Kupffer_NN cells_NNS ,_, and_CC cells_NNS of_II the_DD proximal_JJ convoluted_VVNJ tubules_NNS ._.
P03938690A06
Our_PNG results_NNS support_VVB the_DD notion_NN that_CST any_DD collagenous_JJ species_NN may_VM be_VBB reactive_JJ towards_II platelets_NNS provided_CS+ that_CS essential_JJ tertiary_JJ and_CC quaternary_JJ structural_JJ requirements_NNS are_VBB met_VVN and_CC in_II this_DD sense_NN ,_, therefore_RR ,_, they_PN favour_VVB more_RR the_DD idea_NN of_II multiple_JJ platelet-reactive_JJ sites_NNS in_II collagen_NN of_II relatively_RR low_JJ structural_JJ specificity_NN and_CC low_JJ affinity_NN ._.
P03944117A08
Competitive_JJ binding_VVGJ studies_NNS suggest_VVB that_CST RII-H_NN and_CC RII-B_NN bind_VVB to_II the_DD same_JJ sites_NNS on_II MAP-2_NN ._.
P03963423A06
Quantification_NN of_II junctional_JJ contacts_NNS from_II days_NNS 15-19_MC indicated_VVD that_CST the_DD number_NN of_II gap_NN junctions_NNS increases_VVZ with_II fetal_JJ age_NN ._.
P03968169A07
The_DD appearance_NN of_II sea_NN urchin_NN egg_NN alpha-actinin_NN as_CS revealed_VVN by_II electron_NN microscopy_NN using_VVG the_DD low-angle_NN rotary_JJ shadowing_VVGJ technique_NN was_VBD also_RR similar_JJ to_II that_PND of_II skeletal_JJ muscle_NN alpha-actinin_NN ._.
P03988763A05
4_MC ,_, 4'-Diisothiocyanodihydrostilbene-2_NN ,_, 2'-disulfonate_NN (_( H2DIDS_NN )_) is_VBZ known_VVN to_TO form_VVI a_DD covalent_JJ cross-link_NN between_II complementary_JJ chymotryptic_JJ fragments_NNS (_( Mr_NN 60,000_MC and_CC 35,000_MC )_) ._.
P03996483A04
The_DD experiments_NNS described_VVN here_RR show_VVB that_CST introducing_VVGN a_DD G1_NN period_NN by_II mutation_NN that_PNR lowers_VVZ the_DD rate_NN of_II protein_NN synthesis_NN does_VDZ not_RR restore_VVB to_II the_DD cell_NN any_DD competence_NN to_TO arrest_VVI in_II G1_NN and_CC enter_VVI a_DD state_NN of_II quiescence_NN ._.
P04008981A08
This_DD approach_NN can_VM be_VBB used_VVN to_TO evaluate_VVI the_DD role_NN of_II components_NNS of_II the_DD thymic_JJ microenvironment_NN at_II various_JJ stages_NNS of_II differentiation_NN on_II developing_VVGJ T_NN lymphocytes_NNS ._.
P04037797A03
Further_JJ treatment_NN with_II Sephadex_NN G-200_NN and_CC CM-Sephadex_NN yielded_VVD an_DD intensely_RR blue_JJ protein_NN judged_VVN 1572-fold_NN purer_JJR than_CSN starting_VVGJ serum_NN ._.
P04049308A02
Platelet_NN aggregation_NN and_CC [_( 14C_NN ]_) -5HT_NN release_NN induced_VVN by_II "_`` threshold_NN "_'' or_CC low_JJ concentrations_NNS of_II collagen_NN (_( 0.6_MC micrograms_NNS /_SYM ml_NN )_) in_II PRP_NN were_VBD completely_RR abolished_VVN by_II PALP_NN (_( 24_MC mM_NN )_) ,_, TFPZ_NN (_( 250_MC microM_NN )_) as_CC+ well_CC+ as_CC indomethacin_NN (_( 10_MC microM_NN )_) ._.
P04074731A03
In_II the_DD presence_NN of_II zinc_NN ,_, which_PNR shifts_VVZ Ca_NN (_( II_MC )_) -alpha-lactalbumin_NN toward_II the_DD "_`` apo-like_JJ "_'' conformation_NN [_( Musci_NNP ,_, G._NNP ,_, &_CC Berliner_NNP ,_, L.J._NNP (_( 1985_MC )_) Biochemistry_NN 24_MC ,_, 3852-3856_MC ]_) ,_, the_DD catalytic_JJ rate_NN constant_NN for_II lactose_NN synthesis_NN was_VBD identical_JJ for_II both_CC the_DD Ca_NN (_( II_MC )_) and_CC apo_NN conformers_NNS ._.
P04084628A07
Galactose_NN oxidase-NaB_NN [_( 3H_NN ]_) 4_MC labeling_VVGN of_II the_DD cultured_VVNJ caput_NN sperm_NN cell_NN surface_NN revealed_VVD a_DD Mr_NN =_SYM 23,000_MC molecule_NN that_PNR was_VBD able_JJ to_TO be_VBI immunoprecipitated_VVN with_II antiepididymal_JJ alpha-lactalbumin_NN antibody_NN ._.
P06086596A02
Southern_NN blot_NN hybridization_NN under_II stringent_JJ conditions_NNS showed_VVD that_CST the_DD homology_NN between_II MDV_NN and_CC HVT_NN is_VBZ located_VVN in_II the_DD restricted_VVNJ portion_NN of_II these_DD viral_JJ genomes_NNS ._.
P06092518A06
This_DD concentration_NN of_II cAMP_NN increased_VVD Ca2+_NN uptake_NN into_II the_DD SR_NN of_II the_DD skinned_VVNJ preparation_NN when_CS the_DD Ca2+_NN in_II the_DD SR_NN was_VBD first_RR depleted_VVN ._.
P06095843A02
Simultaneous_JJ exposure_NN to_II both_DD agents_NNS greatly_RR enhanced_VVD superoxide_NN production_NN ,_, both_CC in_II rate_NN and_CC extent_NN ._.
P06097869A13
A_DD model_NN of_II two_MC voltage-sensitive_JJ gates_NNS is_VBZ proposed_VVN for_II a_DD description_NN of_II the_DD burst_NN kinetic_NN ._.
P06127736A04
The_DD apparent_JJ Ks_NN for_II acetate_NN oxidation_NN by_II D._NN postgatei_NN as_CS determined_VVN in_RR+ vivo_RR was_VBD near_RR 0.2_MC mM_NN ._.
P06146086A04
Norepinephrine-displaceable_JJ binding_VVGN was_VBD saturable_JJ and_CC monophasic_JJ ,_, with_II a_DD KD_NN of_II 1.4_MC nM_NN ,_, in_II agreement_NN with_II rate_NN and_CC competition_NN experiments_NNS ,_, and_CC a_DD Bmax_NN of_II 200_MC fmol_NN /_SYM mg_NN protein_NN ._.
P06150576A07
The_DD findings_NNS suggest_VVB that_CST X-irradiation_NN may_VM damage_VVB certain_JJ sensitive_JJ G0_NN cells_NNS ,_, such_II+ as_II Kupffer_NN cells_NNS ,_, serous_JJ cells_NNS of_II salivary_JJ glands_NNS and_CC old_JJ macrophages_NNS ,_, which_PNR normally_RR have_VHB substantial_JJ concentrations_NNS of_II metals_NNS within_II their_PNG vacuolar_JJ apparatus_NN ,_, possibly_RR by_II lysosomal_JJ damage_NN involving_VVG .OH-mediated_VVNJ lipid_NN peroxidation_NN ._.
P06154684A08
All_DD four_MC suppressors_NNS responded_VVD to_II GAG_NN in_II addition_NN to_II GAA_NN but_CC did_VDD not_RR suppress_VVB the_DD known_VVNJ mutant_JJ codons_NNS of_II several_JJ other_JJ trpA_NN mutants_NNS ._.
P06163529A02
At_II all_DD concentrations_NNS tested_VVN or_CC after_II each_DD treatment_NN regimen_NN ,_, statistically_RR significant_JJ differences_NNS in_II viability_NN and_CC cytogenetic_JJ damage_NN were_VBD obvious_JJ ,_, with_II the_DD AT_NN cell_NN lines_NNS demonstrating_VVGN reduced_VVNJ survival_NN and_CC increased_VVNJ chromosomal_JJ breakage_NN ._.
P06167251A09
The_DD chromosomal_JJ locations_NNS of_II the_DD sequence_NN in_II M._NN rufus_NN and_CC M._NN rufogriseus_NN were_VBD in_II major_JJ blocks_NNS on_II the_DD X_NN chromosome_NN ,_, in_II association_NN with_II the_DD nucleolus_NN organizer_NN ._.
P06183169A04
One_MC of_II the_DD transformants_NNS producing_VVG high_JJ amounts_NNS of_II alpha-amylase_NN was_VBD characterized_VVN further_RR ._.
P06189259A02
HU-30_NN belonged_VVD to_II the_DD IgG2_NN subclass_NN and_CC was_VBD active_JJ in_II complement_NN dependent_JJ cytotoxicity_NN ._.
P06194617A07
The_DD advantages_NNS of_II antiprotease_NN drugs_NNS based_VVN on_II human_NN alpha-2-macroglobulin_NN are_VBB discussed_VVN ._.
P06199979A05
Most_DD small_JJ round_JJ cells_NNS in_II all_DD seven_MC retinoblastomas_NNS studied_VVN stained_VVD with_II antiserum_NN to_II neuronal-specific_JJ enolase_NN but_CC Flexner-Wintersteiner_NN rosettes_NNS stained_VVD weakly_RR or_CC not_RR at_II all_PND ._.
P06203128A05
In_II contrast_NN ,_, all_DD 450_MC normal_JJ subjects_NNS and_CC 477_MC chronic_JJ HBsAg-positive_JJ carriers_NNS had_VHD levels_NNS of_II less_RR than_CSN 20_MC ng_NN /_SYM ml_NN ._.
P06209821A02
On_II gel_NN filtration_NN of_II normal_JJ plasma_NN the_DD peak_NN of_II pentosan_NN polysulphate_NN dependent_JJ activity_NN eluted_VVD with_II a_DD higher_JJR apparent_JJ molecular_JJ weight_NN than_CSN that_PND observed_VVN with_II low_JJ concentrations_NNS of_II heparin_NN ._.
P06224843A02
Beef_NN heart_NN mitochondrial_JJ fractions_NNS were_VBD prepared_VVN by_II the_DD conventional_JJ centrifugation_NN method_NN and_CC the_DD rat_NN brain_NN synaptosomes_NNS were_VBD prepared_VVN by_II Ficoll-sucrose_NN gradient_NN centrifugation_NN method_NN ._.
P06228439A02
The_DD effect_NN of_II these_DD agents_NNS on_II secretion_NN evoked_VVN by_II known_VVNJ activators_NNS of_II C-kinase_NN has_VHZ been_VBN studied_VVN in_II human_NN platelets_NNS loaded_VVN with_II the_DD fluorescent_JJ Ca_NN indicator_NN ,_, quin2_NN and_CC preincubated_VVN with_II aspirin_NN ._.
P06235171A06
These_DD antigens_NNS will_VM induce_VVB the_DD production_NN of_II idiotype_NN ,_, and_CC will_VM prime_VVB idiotype-bearing_VVGJ B_NN cells_NNS ,_, such_CS+ that_CS idiotypic_JJ dominance_NN emerges_VVZ ._.
P06244929A08
Six_MC weak_JJ analogs_NNS appeared_VVD to_TO be_VBI more_RR potent_JJ in_II the_DD nucleus_NN accumbens_NN than_CSN in_II the_DD pituitary_NN ,_, but_CC this_PND was_VBD an_DD artifact_NN of_II their_PNG relatively_RR greater_JJR potency_NN in_II competing_VVGN for_II low_JJ affinity_NN binding_VVGJ sites_NNS which_PNR are_VBB absent_JJ in_II pituitary_NN ._.
P06254659A03
The_DD Na+_NN ,_, K+-_NN ATPase_NN reactivity_NN was_VBD localized_VVN evenly_RR along_II the_DD cytoplasmic_JJ side_NN of_II the_DD basolateral_JJ cell_NN membrane_NN of_II cells_NNS of_II proximal_JJ and_CC distal_JJ tubules_NNS and_CC in_II collecting_VVGJ ducts_NNS ._.
P06263487A08
These_DD observations_NNS support_VVB the_DD previous_JJ conclusion_NN that_CST RecA_NN protein_NN can_VM pair_VVB a_DD single_JJ strand_NN with_II its_PNG complementary_JJ strand_NN in_II duplex_NN DNA_NN in_II a_DD side-by-side_NN fashion_NN without_II a_DD free_JJ end_NN in_II any_PND of_II the_DD three_MC strands_NNS ._.
P06276466A03
The_DD injection_NN itself_PN did_VDD not_RR alter_VVB cell_NN viability_NN ,_, and_CC lymphocytes_NNS given_VVN protein_NN molecules_NNS retained_VVD intact_JJ response_NN activity_NN when_CS they_PN were_VBD stimulated_VVN with_II mitogens_NNS ._.
P06289076A06
It_PN is_VBZ concluded_VVN that_CST in_II intact_JJ human_NN platelets_NNS (_( a_NN )_) the_DD intragranular_JJ storage_NN of_II 5-hydroxytryptamine_NN and_CC noradrenaline_NN mainly_RR depends_VVZ on_II the_DD proton_NN gradient_NN across_II the_DD granular_JJ membrane_NN ,_, and_CC (_( b_NN )_) ionophores_NNS causing_VVG a_DD collapse_NN of_II H+_NN gradients_NNS induce_VVB non-exocytotic_JJ release_NN of_II 5-hydroxytryptamine_NN and_CC noradrenaline_NN from_II intracellular_JJ storage_NN granules_NNS ._.
P06299270A07
After_II hydrolysis_NN of_II the_DD beta-lactam_NN amide_NN bond_NN ,_, the_DD product_NN rearranges_VVZ into_II 2.3-dihydro-2_NN ,_, 2-dimethyl-1_NN ,_, 4-thiazine-3_NN ,_, 6-dicarboxylate_NN ,_, which_PNR exhibits_VVZ an_DD absorption_NN maximum_NN at_II 305_MC nm_NN ._.
P06304112A08
Immunolabeling_VVGN of_II Rous_NN sarcoma_NN virus-transformed_VVNJ cells_NNS with_II anti-p39_NN antibodies_NNS resulted_VVD in_II fluorescent_JJ staining_VVGJ patterns_NNS indistinguishable_JJ from_II those_PND observed_VVN in_II untransformed_VVNJ cells_NNS ._.
P06309841A03
DNA_NN fragments_NNS from_II this_DD region_NN ,_, when_CS inserted_VVN between_II the_DD E._NN coli_NN gal_NN operon_NN promoter_NN and_CC galactokinase_NN (_( galK_NN )_) gene_NN ,_, effect_VVB an_DD 80_MC %_SYM reduction_NN in_II downstream_JJ galK_NN expression_NN ._.
P06316358A09
This_PND is_VBZ probably_RR due_II+ to_II a_DD nonfunctional_JJ splice_NN junction_NN of_II DC_NN beta_NN genes_NNS ,_, causing_VVG a_DD separate_JJ cytoplasmic_JJ exon_NN to_TO be_VBI nonexpressed_VVN ._.
P06321935A03
Phosphorylation_NN of_II proteins_NNS of_II Mr=170_NN K_NN ,_, 135_MC K_NN ,_, 105_MC K_NN ,_, 88_MC K_NN ,_, and_CC 68_MC K_NN was_VBD increased_VVN after_II incubation_NN with_II the_DD hormone_NN or_CC the_DD cyclic_JJ nucleotide_NN ._.
P06329441A07
These_DD cells_NNS do_VDB not_RR exhibit_VVB calcium_NN spikes_NNS and_CC the_DD role_NN of_II their_PNG D-CaBP_NN may_VM be_VBB to_TO regulate_VVI calcium_NN released_VVN from_II intracellular_JJ stores_NNS ._.
P06334646A10
The_DD cellular_JJ composition_NN of_II the_DD samples_NNS tested_VVN in_II the_DD mitogen_NN assays_NNS were_VBD also_RR evaluated_VVN by_II fluorescent_JJ microscopy_NN using_VVG FITC-conjugated_VVNJ monoclonal_JJ antibodies_NNS directed_VVN against_II specific_JJ cell_NN surface_NN markers_NNS ._.
P06354812A07
However_RR ,_, the_DD hypoglycaemic_JJ response_NN to_II exogenous_JJ insulin_NN was_VBD not_RR altered_VVN ._.
P06368005A08
This_DD inhibitory_JJ activity_NN is_VBZ probably_RR derived_VVN from_II 2-deoxyribose_NN ._.
P06376725A08
Finally_RR ,_, the_DD increased_VVNJ expression_NN of_II NF_NN and_CC VF_NN proteins_NNS was_VBD specific_JJ for_II NGF_NN since_CS they_PN could_VM not_RR be_VBB induced_VVN by_II other_JJ hormones_NNS or_CC "_`` growth_NN "_'' factors_NNS ._.
P06386169A10
Two_MC morphologically_RR distinguishable_JJ subtypes_NNS of_II Leu_NN 7-positive_JJ cells_NNS populate_VVB different_JJ microenvironments_NNS :_: The_DD Leu_NN 7-positive_JJ large-granular_JJ lymphocyte_NN was_VBD predominantly_RR found_VVN in_II the_DD crypt_NN epithelium_NN ,_, while_CS numerous_JJ Leu_NN 7-positive_JJ cells_NNS located_VVN in_II the_DD germinal_JJ centers_NNS had_VHD the_DD appearance_NN of_II small_JJ lymphocytes_NNS ._.
P06391479A05
The_DD high_JJ sensitive_JJ fluorogenic_JJ procedure_NN could_VM be_VBB performed_VVN on_II cell_NN fractions_NNS ,_, cell_NN lysates_NNS as_CC+ well_CC+ as_CC supernatants_NNS ._.
P06405010A03
G1_NN and_CC G2_NN were_VBD shown_VVN to_TO be_VBI glycosylated_VVN by_II their_PNG ability_NN to_TO bind_VVI concanavalin_NN A_NN to_II nitrocellulose_NN transfers_NNS of_II the_DD separated_VVNJ proteins_NNS (_( '_`` Western_NN blots_NNS '_'' )_) ._.
P06415059A03
The_DD total_JJ mRNAlys_NN contained_VVD the_DD cap_NN structures_NNS m7Gpppm6Am_NN ,_, m7GpppGm_NN ,_, m7GpppAm_NN ,_, m7GpppCm_NN ,_, m7GpppA_NN ,_, and_CC m7GpppG_NN ,_, in_II decreasing_VVGJ order_NN of_II abundance_NN ._.
P06427603A01
We_PN have_VHB used_VVN a_DD series_NN of_II sequenced_VVNJ V_NN kappa_NN 21_MC L-chains_NNS produced_VVN from_II murine_JJ myelomas_NNS to_TO determine_VVI whether_CST the_DD V_NN or_CC J_NN segment_NN of_II the_DD V_NN region_NN is_VBZ responsible_JJ for_II dictating_VVGN preferential_JJ recombination_NN ._.
P06437665A02
No_DD difference_NN either_CC in_II cytochrome_NN P-450_NN content_NN or_CC microsome-mediated_VVNJ AFB1-DNA_NN was_VBD observed_VVN between_II livers_NNS from_II control_NN and_CC treated_VVNJ rats_NNS ._.
P06450746A01
A_DD procedure_NN was_VBD developed_VVN for_II introducing_VVGN the_DD coliphage_NN Mu_NN d1_NN (_( Apr_NN lac_NN )_) into_II Salmonella_NN typhimurium_NN in_II order_NN to_TO construct_VVI gene_NN fusions_NNS that_PNR place_VVB the_DD structural_JJ genes_NNS of_II the_DD lac_NN operon_NN under_II the_DD control_NN of_II the_DD promoter-regulatory_JJ region_NN of_II other_JJ genes_NNS ._.
P06461773A06
The_DD latter_JJ substance_NN produces_VVZ false_JJ positive_JJ results_NNS in_II the_DD standard_JJ [_( 3H_NN ]_) thymidine_NN assay_NN ._.
P06477956A04
Apolipoprotein_NN A-I_NN ,_, which_PNR was_VBD separated_VVN from_II the_DD inhibitor_NN by_II chromatofocusing_VVGJ chromatography_NN ,_, suppressed_VVD triacyglycerol_NN transfer_NN more_RR than_CSN cholesteryl_NN ester_NN transfer_NN ._.
P06501923A04
The_DD preparation_NN also_RR showed_VVD inhibition_NN of_II the_DD proliferation_NN of_II epidermal_JJ cells_NNS in_II cell_NN culture_NN ._.
P06514721A03
First_RR ,_, the_DD dose_NN response_NN of_II human_NN LH_NN (_( hLH_NN )_) stimulation_NN of_II testosterone_NN was_VBD studied_VVN in_II detail_NN using_VVG testicular_JJ interstitial_JJ cells_NNS from_II both_DD species_NNS ._.
P06537808A08
This_DD difference_NN was_VBD not_RR detected_VVN when_CS saturation_NN analyses_NNS were_VBD performed_VVN using_VVG varying_VVGJ dilutions_NNS of_II the_DD pituitary_NN nuclear_JJ extract_NN ._.
P06557823A04
The_DD isoacceptor_NN pattern_NN ,_, determined_VVN by_II RPC-5_NN chromatography_NN ,_, for_II methionyl-tRNAs_NNS from_II control_NN muscle_NN and_CC 5-day_NN regenerating_VVGJ muscle_NN were_VBD essentially_RR indistinguishable_JJ ,_, while_CS a_DD minor_JJ peak_NN of_II prolyl-tRNA_NN was_VBD observed_VVN in_II the_DD population_NN from_II 5-_MC ,_, 8-_MC and_CC 15-day_NN regenerates_NNS which_PNR was_VBD apparently_RR absent_JJ from_II the_DD control_NN tRNA_NN ._.
P06592359A03
The_DD synthesis_NN of_II the_DD corresponding_VVGJ ribonucleoside_NN ,_, i.e._II ,_, N-_NN [_( (_( 5-amino-1-beta-D-ribofuranosyl-1H-imidazol-4-yl_NN )_) carbonyl_NN ]_) -3-_MC (_( hydroxynitrosamino_JJ )_) -L-alanine_NN ribonucleoside_NN (_( L-alanosine_NN AICO_NN ribonucleoside_NN )_) ,_, was_VBD accomplished_VVN by_II condensation_NN of_II a_DD suitably_RR protected_VVNJ derivative_NN of_II L-alanosine_NN with_II N-succinimidyl-5-amino-1-_NN (_( 2_MC ,_, 3_MC ,_, 5-tri-O-acetyl-beta-D-ribofuranosyl_NN )_) -1H-im_NN idazole-4-carboxylate_NN followed_VVN by_II the_DD removal_NN of_II the_DD protective_JJ groups_NNS ._.
P06605576A03
Results_NNS obtained_VVN on_II the_DD Na_NN transporting_VVGJ frog_NN skin_NN epithelium_NN confirmed_VVD the_DD two-barrier_NN concept_NN of_II transepithelial_JJ Na_NN transport_NN involving_VVG a_DD passive_JJ Na_NN uptake_NN and_CC an_DD active_JJ Na_NN extrusion_NN ._.
P06643461A06
The_DD protein_NN has_VHZ a_DD molar_JJ extinction_NN coefficient_NN of_II 6,500_MC at_II 282_MC nm_NN ._.
P06672107A04
Second_NN ,_, we_PN seeded_VVD nonadherent_JJ bone_NN marrow_NN mononuclear_JJ cells_NNS onto_II established_VVNJ stromal_JJ monolayers_NNS by_II incubating_VVGN them_PN together_RR for_II 2_MC h_NN and_CC then_RR washed_VVD off_II the_DD unattached_VVNJ cells_NNS ._.
P06682714A05
Furthermore_RR ,_, if_CS the_DD platelet_NN suspension_NN was_VBD treated_VVN with_II thrombin_NN in_II the_DD presence_NN of_II calcium_NN ions_NNS ,_, protein_NN bands_NNS characteristic_JJ of_II the_DD action_NN of_II Factor_NN XIII_MC on_II fibrin_NN were_VBD observed_VVN ,_, active_JJ platelet_NN Factor_NN XIII_MC apparently_RR having_VHG been_VBN made_VVN available_JJ by_II lysis_NN of_II platelets_NNS during_II preparations_NNS ._.
P06706962A05
Addition_NN of_II excess_JJ unlabeled_VVNJ apo-B_NN (_( obtained_VVN from_II rat_NN serum_NN )_) totally_RR competed_VVD with_II the_DD specific_JJ antiserum_NN for_II this_DD radioactive_JJ protein_NN ,_, indicating_VVG it_PN was_VBD antigenically_RR related_VVN to_II apo-B_NN ._.
P06713426A07
These_DD results_NNS indicate_VVB that_CST chemical-ionization_NN mass_NN spectrometry_NN is_VBZ highly_RR useful_JJ in_II determining_VVGN the_DD complete_JJ sugar-sequence_NN of_II gangliosides_NNS ._.
P06772442A07
Substitution_NN of_II enzyme_NN resulted_VVD in_II the_DD following_VVGJ major_JJ changes_NNS ._.
P06784716A08
Examination_NN by_II immunotitration_NN and_CC CM52-cellulose_NN column_NN chromatography_NN revealed_VVD that_CST the_DD difference_NN in_II activity_NN between_II High_JJ and_CC Low_JJ lines_NNS was_VBD due_II+ to_II the_DD amount_NN of_II the_DD active_JJ enzyme_NN ,_, but_CC not_RR to_II an_DD endogeneous_JJ activator_NN or_CC inhibitor_NN ._.
P06792165A04
Lines_NNS homozygous_JJ for_II the_DD AdhF_NN allele_NN were_VBD more_RR environmentally_RR sensitive_JJ than_CSN AdhS_NN /_SYM S_NN lines_NNS ._.
P06827485A01
Sulpiride_NN ,_, a_DD substituted_VVNJ benzamide_NN antipsychotic_JJ drug_NN ,_, is_VBZ considered_VVN to_TO be_VBI a_DD selective_JJ antagonist_NN at_II dopamine_NN D-2_NN receptors_NNS ,_, largely_RR because_CS it_PN does_VDZ not_RR inhibit_VVB dopamine-stimulated_VVNJ adenylate_NN cyclase_NN activity_NN ._.
P06835236A01
The_DD mutagenic_JJ effect_NN of_II epichlorohydrin_NN (_( ECH_NN )_) on_II the_DD yeast_NN Schizosaccharomyces_NN pombe_NN was_VBD studied_VVN in_RR+ vitro_RR in_II the_DD presence_NN of_II mouse-liver_NN S9_NN mix_NN and_CC microsomal_JJ and_CC cytosolic_JJ fractions_NNS ._.
P06839015A11
The_DD remaining_VVGJ four_MC antibodies_NNS react_VVB exclusively_RR with_II factor_NN V_MC ._.
P06862442A04
There_EX was_VBD no_DD general_JJ tendency_NN for_II closer_JJR location_NN of_II chromosomes_NNS containing_VVG genes_NNS with_II related_VVNJ function_NN ._.
P06872103A02
There_EX were_VBD fewer_JJR SSB_NN in_II those_PND given_VVN the_DD 5.0_MC ppm_NN Se_NN diet_NN throughout_II the_DD experiment_NN ._.
P06891742A03
The_DD activities_NNS of_II beta-hydroxy-beta-methylglutaryl_NN coenzyme_NN A_NN (_( HMG-CoA_NN )_) reductase_NN ,_, cholesterol_NN 7_MC alpha-hydroxylase_NN ,_, acetyl-CoA_NN carboxylase_NN (_( ACX_NN )_) ,_, fatty_JJ acid_NN synthetase_NN (_( FAS_NN )_) and_CC other_JJ lipogenic_JJ enzymes_NNS in_II several_JJ tissues_NNS were_VBD determined_VVN ._.
P06929219A01
A_DD cytogenetic_JJ analysis_NN of_II melphalan-sensitive_JJ and_CC -resistant_JJ murine_JJ L1210_NN leukemia_NN cells_NNS maintained_VVN in_RR+ vivo_RR indicated_VVD that_CST the_DD drug-resistant_JJ tumor_NN had_VHD a_DD modal_JJ number_NN of_II 40_MC chromosomes_NNS while_CS the_DD sensitive_JJ tumor_NN possessed_VVD a_DD mode_NN of_II 41_MC chromosomes_NNS ._.
P06941283A06
The_DD size_NN and_CC solubility_NN properties_NNS of_II the_DD repeated_VVNJ C-C-C-C-A-A_NN DNA_NN nucleoprotein_NN complex_NN after_II micrococcal_JJ nuclease_NN digestion_NN of_II macronuclei_NNS are_VBB clearly_RR distinguishable_JJ from_II those_PND of_II nucleosomes_NNS ,_, and_CC it_PN is_VBZ inferred_VVN that_CST this_DD DNA_NN sequence_NN in_II macronuclei_NNS is_VBZ packaged_VVN in_II chromatin_NN by_II proteins_NNS other_II+ than_II histones_NNS ._.
P06961099A03
In_II all_DB these_DD cases_NNS ,_, as_CC+ well_CC+ as_CC in_II four_MC others_NNS reported_VVN in_II the_DD literature_NN ,_, the_DD i_NN (_( 17q_NN )_) is_VBZ dicentric_JJ thus_RR indicating_VVG that_CST its_PNG origin_NN is_VBZ due_II+ to_II a_DD break_NN on_II the_DD short_JJ arms_NNS followed_VVN by_II joining_VVGN of_II the_DD two_MC chromatids_NNS containing_VVG the_DD centromere_NN ._.
P06968673A05
PTH_NN responsiveness_NN correlated_VVD with_II several_JJ properties_NNS ,_, presumably_RR associated_VVN with_II the_DD osteoblastic_JJ phenotype_NN :_: elevated_VVNJ alkaline_JJ phosphatase_NN activity_NN ,_, synthesis_NN of_II the_DD gamma-carboxyglutamic_JJ acid-containing_VVGJ bone_NN protein_NN ,_, and_CC production_NN of_II mineralized_VVNJ tumors_NNS in_II host_NN rats_NNS ._.
P07001479A03
The_DD 310,000-325,000_MC Mr_NN cleavage_NN fragments_NNS exhibited_VVD prolonged_VVNJ thrombin-induced_VVNJ clotting_VVGJ activity_NN but_CC were_VBD able_JJ to_TO be_VBI coagulated_VVN ,_, whereas_CS the_DD 270,000-290,000_MC Mr_NN fragments_NNS were_VBD not_RR able_JJ to_TO be_VBI coagulated_VVN ._.
P07009228A08
We_PN attempted_VVD therefore_RR to_TO influence_VVI the_DD level_NN of_II IgG_NN in_II B10_NN mice_NNS by_II administration_NN of_II 10_MC micrograms_NNS of_II LPS_NN i.p._NN simultaneously_RR with_II SRBC_NN ._.
P07018392A04
Also_RR ,_, as_CS predicted_VVN ,_, primaquine_NN did_VDD not_RR displace_VVB the_DD [_( 14C_NN ]_) chloroquine_NN ._.
P07040334A07
The_DD activities_NNS of_II L-serine_NN and_CC D-glucose_NN transport_NN were_VBD not_RR affected_VVN by_II the_DD mutation_NN ._.
P07083392A01
The_DD chemical_JJ and_CC enzymatic_JJ oxidations_NNS of_II 6-_MC ,_, 7-_MC and_CC 10-methylbenzo_NN [_( a_NN ]_) -pyrenes_NNS ,_, 6_MC ,_, 10-_MC and_CC 7_MC ,_, 10-dimethylbenzo_NN [_( a_NN ]_) pyrenes_NNS and_CC benzo_NN [_( a_NN ]_) pyrene_NN (_( BP_NN )_) itself_PN have_VHB been_VBN investigated_VVN to_TO study_VVI the_DD effects_NNS of_II alkyl_NN substitution_NN on_II the_DD pathways_NNS of_II oxidation_NN ._.
P07138840A04
Above_II pH_NN congruent_JJ to_II 13.0_MC bleaching_VVGN takes_VVZ place_NN ,_, first_RR reversibly_RR and_CC subsequently_RR irreversibly_RR ,_, to_II a_DD species_NN absorbing_VVG around_II 365_MC nm_NN (_( bR365_NN )_) ._.
P07155128A02
Exposure_NN of_II these_DD excitable_JJ organs_NNS to_II depolarizing_VVGJ concentrations_NNS of_II K+_NN resulted_VVD in_II stimulation_NN both_CC of_II 45Ca_NN uptake_NN and_CC efflux_NN ._.
P07181947A02
On_II solubilising_VVGN the_DD enzyme_NN or_CC assaying_VVGN it_PN at_II pH_NN 6_MC these_DD inhibitors_NNS have_VHB little_DD effect_NN ._.
P07207481A01
The_DD cytotoxic_JJ effects_NNS of_II azaguanine_NN and_CC thioguanine_NN have_VHB been_VBN compared_VVN in_II two_MC wild-type_NN V79_NN cells_NNS ._.
P07256862A02
The_DD cumulative_JJ indices_NNS of_II labeled_VVNJ cells_NNS and_CC labeled_VVNJ mitosis_NN as_CC+ well_CC+ as_CC the_DD cellular_JJ DNA_NN contents_NNS were_VBD determined_VVN in_II the_DD stimulated_VVNJ cultures_NNS at_II different_JJ times_NNS of_II growth_NN until_II their_PNG entry_NN into_II the_DD stationary_JJ phase_NN of_II growth_NN ._.
P07272448A01
1H_NN ,_, 2H_NN ,_, and_CC 31P_NN NMR_NN methods_NNS have_VHB been_VBN employed_VVN in_II the_DD study_NN of_II dimyristoyl_NN lecithin_NN bilayers_NNS hydrated_VVN with_II D2O_NN in_II the_DD gel_NN (_( L_NN beta_NN '_SYM )_) ,_, intermediate_JJ (_( P_NN beta_NN '_SYM )_) and_CC liquid-crystalline_JJ (_( L_NN alpha_NN )_) phases_NNS ._.
P07294161A01
The_DD role_NN of_II extracellular_JJ Ca2+_NN ions_NNS in_II the_DD killing_VVGN of_II liver_NN cells_NNS by_II CCl4_NN was_VBD studied_VVN in_II primary_JJ cultures_NNS of_II rat_NN hepatocytes_NNS ._.
P07332351A01
The_DD microsomal_JJ ,_, mitochondrial_JJ ,_, and_CC nuclear_JJ fractions_NNS of_II cutaneous_JJ tumors_NNS have_VHB been_VBN investigated_VVN ._.
P07364051A01
Contractile_JJ performance_NN of_II cardiac_JJ and_CC skeletal_JJ muscles_NNS may_VM be_VBB regulated_VVN by_II cyclic_JJ AMP_NN or_CC Ca2+_NN ,_, two_MC second_JJ messengers_NNS that_PNR stimulate_VVB the_DD phosphorylation_NN of_II specific_JJ myofibrillar_JJ proteins_NNS ._.
P07402315A03
We_PN previously_RR reported_VVD the_DD derivation_NN of_II a_DD liver-specific_JJ metastatic_JJ variant_NN of_II a_DD Marek_NN 's_GE disease_NN (_( MD_NN )_) virus-transformed_VVNJ ,_, non-producer_NN lymphoma_NN cell_NN line_NN ._.
P07417559A10
In_II case_NN of_II ApA_NN ,_, ApC_NN and_CC CpA_NN the_DD conformers_NNS with_II C_NN (_( 3_MC '_SYM )_) -endo_JJ ,_, C_NN (_( 2_MC '_SYM )_) -endo_JJ sugar_NN combination_NN were_VBD presented_VVN ._.
P07434745A10
Based_VVN on_II the_DD foregoing_VVGJ data_NNS ,_, a_DD hypothetical_JJ scheme_NN of_II the_DD processes_NNS of_II deproteinization_NN and_CC transport_NN of_II viral_JJ structures_NNS in_II an_DD infected_VVNJ cell_NN has_VHZ been_VBN proposed_VVN ._.
P07482409A01
Several_JJ pro-inflammatory_JJ cytokines_NNS have_VHB been_VBN shown_VVN to_TO be_VBI important_JJ in_II the_DD modulation_NN of_II the_DD procoagulant_NN response_NN ._.
P07493931A04
To_TO explore_VVI that_DD possibility_NN ,_, we_PN analyzed_VVD the_DD cisacting_VVGJ sequences_NNS that_PNR convey_VVB these_DD responses_NNS ._.
P07498136A03
The_DD minicartridge_NN is_VBZ then_RR connected_VVN to_II a_DD high-performance_NN liquid_NN chromatography_NN system_NN and_CC the_DD electrotransferred_VVNJ protein_NN eluted_VVN by_II applying_VVGN an_DD acetonitrile_JJ gradient_NN ._.
P07499243A06
Western_NN analysis_NN of_II subcellular_JJ fractions_NNS localized_VVD NNE_NN primarily_RR to_II the_DD cytoplasm_NN and_CC confirmed_VVD that_CST it_PN was_VBD up-regulated_VVN 2.3-fold_NN by_II hypoxia_NN ._.
P07501116A08
Development_NN of_II this_DD body_NN of_II knowledge_NN may_VM lead_VVB to_II the_DD development_NN of_II better_JJR treatment_NN for_II these_DD aggressive_JJ tumors_NNS ._.
P07507494A05
As_CS the_DD NGR_NN sequence_NN occurs_VVZ in_II the_DD cell-binding_VVGJ region_NN of_II the_DD fibronectin_NN molecule_NN ,_, this_DD sequence_NN could_VM contribute_VVB to_II the_DD specific_JJ recognition_NN of_II fibronectin_NN by_II alpha_NN 5_MC beta_NN 1_MC ._.
P07509736A11
No_DD IGFBP-1_NN or_CC -6_MC mRNAs_NNS were_VBD detected_VVN ._.
P07511744A07
AII_NN 10_MC (_( -7_MC )_) M_NN increased_VVD the_DD synthesis_NN of_II DNA_NN and_CC protein_NN to_II 1.5_MC and_CC 1.7_MC times_II the_DD control_NN values_NNS ,_, respectively_RR ._.
P07513791A04
The_DD rate_NN of_II appearance_NN of_II starvation-associated_VVNJ mutants_NNS at_II 37_MC degrees_NNS C_NN was_VBD somewhat_RR less_RR than_CSN at_II 27_MC degrees_NNS C_NN and_CC this_PND was_VBD attributed_VVN to_II a_DD reduction_NN in_II viability_NN at_II the_DD higher_JJR temperature_NN ._.
P07515283A01
Through_II functional_JJ studies_NNS of_II mutant_JJ tRNAs_NNS ,_, we_PN have_VHB identified_VVN sequence_NN and/or_CC structural_JJ features_NNS important_JJ for_II specifying_VVGN the_DD many_JJ distinctive_JJ properties_NNS of_II E_NN coli_NN initiator_NN tRNA_NN ._.
P07518577A01
The_DD transforming_VVGJ function_NN of_II polyoma_NN virus_NN ,_, middle_JJ T_NN antigen_NN (_( MT_NN )_) ,_, interacts_VVZ with_II several_JJ cellular_JJ enzymes_NNS ,_, essential_JJ to_II its_PNG oncogenic_JJ activity_NN ._.
P07523600A06
In_II contrast_NN to_II the_DD decrease_NN in_II enkephalin_NN and_CC substance_NN P_NN mRNA_NN expression_NN ,_, somatostatin_NN mRNA-expressing_VVGJ neurons_NNS were_VBD largely_RR preserved_VVN ._.
P07526534A02
Viral_JJ polypeptides_NNS ,_, VP1_NN to_II VP4_NN ,_, were_VBD expressed_VVN as_II fusion_NN proteins_NNS in_II Escherichia_NN coli_NN ,_, and_CC were_VBD used_VVN to_TO stimulate_VVI peripheral_JJ blood_NN mononuclear_JJ cells_NNS of_II vaccinated_VVNJ animals_NNS ._.
P07528261A02
It_PN was_VBD found_VVN that_CST a_DD 40-mer_NN oligopeptide_NN (_( amino_JJ acids_NNS 2-41_MC )_) was_VBD recognized_VVN more_RR frequently_RR than_CSN other_JJ peptides_NNS even_RR in_II serum_NN samples_NNS that_PNR did_VDD not_RR react_VVB with_II the_DD C22-3_NN (_( core_NN )_) by_II the_DD recombinant_JJ immunoblot_NN assay_NN (_( RIBA-II_NN )_) ._.
P07533989A01
Recent_JJ cloning_VVGN of_II the_DD chromosome_NN breakpoint_NN regions_NNS of_II the_DD reciprocal_JJ chromosomal_JJ t_NN (_( 11_MC ;_: 22_MC )_) (_( q24_NN ;_: q12_NN )_) has_VHZ revealed_VVN that_CST the_DD breakpoints_NNS were_VBD localized_VVN within_II the_DD EWS_NN gene_NN (_( Ewings_NN sarcoma_NN gene_NN )_) on_II chromosome_NN 22_MC and_CC the_DD FLI-1_NN gene_NN on_II chromosome_NN 11_MC ._.
P07538461A02
The_DD activity_NN of_II IGF-I_NN and_CC -II_MC is_VBZ regulated_VVN by_II six_MC known_VVNJ IGF-binding_VVGJ proteins_NNS (_( IGFBPs_NNS )_) ._.
P07538758A03
The_DD protein_NN binds_VVZ N_NN omega-nitro-L-arginine_NN (_( NNA_NN )_) tightly_RR ,_, but_CC this_DD binding_VVGN is_VBZ not_RR stimulated_VVN by_II BH4_NN ._.
P07539724A12
These_DD results_NNS are_VBB consistent_JJ with_II a_DD Peptide_NN T-dependent_JJ modulation_NN of_II PTK_NN regulation_NN ,_, and_CC support_VVB the_DD potential_NN of_II gp120_NN to_TO interfere_VVI with_II T_NN lymphocyte_NN signal_NN transduction_NN in_II activated_VVNJ T_NN lymphocytes_NNS ._.
P07544810A04
Our_PNG results_NNS show_VVB that_CST the_DD steady-state_NN levels_NNS of_II CFTR_NN ,_, CK13_NN ,_, CK18_NN ,_, CK18_NN ,_, CK14_NN ,_, or_CC DP_NN 1_MC mRNA_NN transcripts_NNS in_II delta_NN F_NN 508_MC CF_NN nasal_JJ polyps_NNS were_VBD not_RR significantly_RR different_JJ from_II those_PND of_II non-CF_NN tissues_NNS ._.
P07545409A08
This_DD protocol_NN was_VBD applied_VVN to_TO quantify_VVI multidrug_NN resistance_NN gene_NN (_( MDRI_NN )_) mRNA_NN in_II malignant_JJ cells_NNS ,_, but_CC it_PN can_VM easily_RR be_VBB adapted_VVN to_II any_DD gene_NN of_II interest_NN ._.
P07548412A09
These_DD results_NNS confirm_VVB the_DD idea_NN that_CST T-helper_NN (_( Th_NN )_) function_NN is_VBZ necessary_JJ for_II the_DD class_NN switch_NN to_II IgG2a_NN subclass_NN in_II rats_NNS ._.
P07553632A06
Genetic_JJ disruption_NN of_II the_DD mutant_JJ K-ras_NN allele_NN in_II human_NN colon_NN carcinoma_NN cells_NNS was_VBD associated_VVN with_II a_DD reduction_NN in_II VEGF_NN /_SYM VPF_NN activity_NN ._.
P07559510A01
Although_CS Micrococcus_NN luteus_NN UV_NN endonuclease_NN has_VHZ been_VBN reported_VVN to_TO be_VBI an_DD 18-kDa_NN enzyme_NN with_II possible_JJ homology_NN to_II the_DD 16-kDa_NN endonuclease_NN V_NN from_II bacteriophage_NN T4_NN (_( Gordon_NNP ,_, L._NNP K._NNP ,_, and_CC Haseltine_NNP ,_, W._NNP A._NNP (_( 1980_MC )_) J._NN Biol._NN Chem._NN 255_MC ,_, 12047-12050_MC ;_: Grafstrom_NNP ,_, R._NNP H._NNP ,_, Park_NNP ,_, L._NNP ,_, and_CC Grossman_NNP ,_, L._NNP (_( 1982_MC )_) J._NN Biol._NN Chem._NN 257_MC ,_, 13465-13474_MC )_) ,_, this_DD study_NN describes_VVZ three_MC independent_JJ purification_NN schemes_NNS in_II which_PNR M._NN luteus_NN UV_NN damage-specific_JJ or_CC pyrimidine_NN dimer-specific_JJ nicking_VVGJ activity_NN was_VBD associated_VVN with_II two_MC proteins_NNS of_II apparent_JJ molecular_JJ masses_NNS of_II 31_MC and_CC 32_MC kDa_NN ._.
P07564108A06
The_DD 20_MC kD_NN CD59_NN was_VBD apparent_JJ in_II GEnC_NN ._.
P07564505A06
Results_NNS showed_VVD that_CST (_( 1_MC )_) relapsed_VVNJ ALL_NN samples_NNS were_VBD more_RR resistant_JJ to_II DNR_NN ,_, but_CC not_RR to_II VM26_NN compared_VVN to_II untreated_VVNJ samples_NNS ;_: (_( 2_MC )_) large_JJ interpatient_JJ variations_NNS existed_VVD in_II both_CC Topo_NN II_MC alpha_NN gene_NN expression_NN and_CC in_JJ+ vitro_JJ cytotoxicity_NN results_NNS ;_: (_( 3_MC )_) Topo_NN II_MC alpha_NN gene_NN expression_NN was_VBD detectable_JJ in_II 29_MC /_SYM 33_MC childhood_NN ALL_NN samples_NNS with_II a_DD median_JJ expression_NN of_II 5_MC %_SYM the_DD level_NN of_II a_DD relatively_RR chemosensitive_JJ human_NN small_JJ cell_NN lung_NN cancer_NN cell_NN line_NN ;_: (_( 4_MC )_) Topo_NN II_MC alpha_NN gene_NN expression_NN did_VDD not_RR differ_VVB between_II untreated_VVNJ and_CC relapsed_VVNJ ALL_NN ;_: (_( 5_MC )_) Topo_NN II_MC alpha_NN gene_NN expression_NN was_VBD positively_RR correlated_VVN with_II the_DD percentage_NN of_II ALL_NN cells_NNS in_II S-_NN and_CC G2M-phase_NN ,_, but_CC not_RR with_II the_DD in_JJ+ vitro_JJ cytotoxicity_NN of_II the_DD drugs_NNS tested_VVN ._.
P07567450A10
These_DD results_NNS show_VVB that_CST '_`` in_JJ+ vitro_JJ '_'' evaluation_NN using_VVG an_DD RNase_NN H_NN assay_NN allowed_VVD us_PN to_TO select_VVI an_DD antisense_NN oligonucleotide_NN which_PNR elicited_VVD a_DD selectivity_NN towards_II point-mutated_VVNJ Ha-ras_NN mRNA_NN when_CS added_VVN at_II 10_MC microM_NN concentration_NN to_II the_DD culture_NN medium_NN of_II cells_NNS expressing_VVG wild_JJ type_NN and_CC mutated_VVNJ Ha-ras_NN mRNA_NN ._.
P07576082A02
Maximal_JJ phosphorylation_NN yields_NNS of_II 5_MC and_CC 3_MC mol_NN P_NN /_SYM mol_NN protein_NN were_VBD achieved_VVN when_CS the_DD highest_JJT stoichiometries_NNS of_II POCl3_NN /_SYM arginine_NN and_CC lysine_NN were_VBD used_VVN ._.
P07577473A03
In_II order_NN to_TO investigate_VVI the_DD role_NN of_II WAF1_NN /_SYM CIP1_NN in_II the_DD pathogenesis_NN of_II primary_JJ human_NN brain_NN tumours_NNS we_PN performed_VVD single-stranded_VVNJ conformation_NN polymorphism_NN (_( SSCP_NN )_) analysis_NN and_CC direct_JJ sequencing_VVGN of_II exon_NN 2_MC of_II the_DD gene_NN in_II a_DD representative_JJ series_NN of_II 158_MC brain_NN tumours_NNS and_CC corresponding_VVGJ blood_NN samples_NNS ._.
P07583386A11
The_DD therapeutic_JJ use_NN of_II differentiating_VVGJ agent_NN combinations_NNS such_II+ as_II D3_NN and_CC RA_NN may_VM provide_VVB a_DD relatively_RR nontoxic_JJ means_NNS of_II treating_VVGN susceptible_JJ tumor_NN types_NNS ._.
P07586318A11
CONCLUSIONS_NNS :_: Through_II the_DD induction_NN of_II vWF_NN secretion_NN and_CC P-selectin_NN surface_NN expression_NN ,_, peptido-LTs_NNS are_VBB likely_RR to_TO play_VVI an_DD important_JJ role_NN in_II the_DD interrelated_VVNJ processes_NNS of_II hemostasis_NN and_CC inflammation_NN ._.
P07592856A05
Forced_VVNJ expression_NN of_II sorcin_NN in_II ryanodine_NN receptor-negative_JJ Chinese_NN hamster_NN lung_NN fibroblasts_NNS resulted_VVD in_II accumulation_NN of_II the_DD predicted_VVNJ 22-kDa_NN protein_NN as_CC+ well_CC+ as_CC the_DD unexpected_VVNJ appearance_NN of_II ryanodine_NN receptor_NN protein_NN ._.
P07601107A03
We_PN also_RR reported_VVD that_CST mu-calpain_NN plays_VVZ an_DD essential_JJ role_NN in_II morphological_JJ changes_NNS and_CC membrane_NN fusion_NN of_II erythrocytes_NNS through_II the_DD degradation_NN of_II spectrin_NN ,_, a_DD lining_VVGJ protein_NN [_( Hayashi_NNP ,_, M._NNP ,_, Saito_NNP ,_, Y._NNP &_CC Kawashima_NNP ,_, S._NNP (_( 1992_MC )_) Biochim._NN Biophys._NN Res._NN Commun._NN 182_MC ,_, 939-946_MC ]_) ._.
P07603326A04
Our_PNG results_NNS indicate_VVB that_CST O6meG_NN and_CC O6etG_NN behave_VVB like_II cholera_NN toxin_NN ,_, in_CS+ as_CS+ much_CS+ as_CS they_PN inhibit_VVB DNA_NN synthesis_NN induced_VVN by_II epidermal_JJ growth_NN factor_NN plus_CC insulin_NN in_II CHEF_NN /_SYM 18_MC cells_NNS ,_, and_CC stimulate_VVB it_PN in_II 3T3_NN cells_NNS ._.
P07612049A02
To_TO use_VVI a_DD recently_RR developed_VVNJ procedure_NN for_II analysis_NN of_II blood_NN leukocyte_NN DNA_NN to_TO detect_VVI mutations_NNS in_II the_DD gene_NN for_II type_NN II_MC procollagen_NN (_( COL2A1_NN )_) in_II patients_NNS with_II cartilage_NN diseases_NNS ranging_VVG from_II early-onset_NN familial_JJ osteoarthritis_NN (_( OA_NN )_) to_II lethal_JJ chondrodysplasias_NNS ._.
P07615658A06
Moreover_RR ,_, the_DD bends_NNS were_VBD not_RR planar_JJ ._.
P07616231A06
Autoradiography_NN revealed_VVD that_CST [_( 3H_NN ]_) PDBu_NN labeling_VVGN is_VBZ present_JJ in_II all_DD retinal_JJ layers_NNS ,_, including_VVG HCs_NNS ,_, where_PNR it_PN is_VBZ associated_VVN with_II the_DD somata_NNS ._.
P07629277A03
Addition_NN of_II 0.3M_NN trehalose_NN or_CC 0.8_MC %_SYM lactalbumin_NN and_CC 3.2_MC %_SYM sucrose_NN resulted_VVD in_II the_DD lowest_JJT loss_NN of_II activity_NN if_CS the_DD conjugated_VVNJ antibodies_NNS were_VBD freeze_NN dried_VVN in_II glass_NN vials_NNS ._.
P07638238A08
Such_DD new_JJ investigative_JJ capabilities_NNS will_VM ultimately_RR allow_VVB one_PN to_TO gain_VVI intimate_JJ knowledge_NN of_II the_DD molecular_JJ basis_NN of_II complex_JJ biological_JJ processes_NNS like_II behavior_NN and_CC development_NN ._.
P07641802A08
By_II ribonuclease_NN protection_NN analysis_NN ,_, gamma_NN GT_NN RNA_NN types_NNS IV_MC and_CC VI_MC represent_VVB about_RR 80_MC %_SYM of_II the_DD total_JJ gamma_NN GT_NN RNA_NN in_II JC-44_NN embryoid_JJ bodies_NNS ._.
P07650160A07
In_II paraffin-embedded_VVNJ sections_NNS of_II human_NN choriocarcinoma_NN ,_, staining_VVGN was_VBD confined_VVN to_II the_DD nuclei_NNS of_II malignant_JJ cells_NNS ._.
P07667103A04
Sequences_NNS in_II the_DD pre-mRNA_NN ,_, domains_NNS in_II ASF_NN /_SYM SF2_NN and_CC components_NNS of_II the_DD U1_NN snRNP_NN particle_NN are_VBB shown_VVN to_TO be_VBI required_VVN for_II complex_NN formation_NN ._.
P07669803A04
The_DD difference_NN in_II the_DD molecular_JJ mass_NN values_NNS can_VM be_VBB attributed_VVN to_II the_DD glycosylated_VVNJ nature_NN of_II the_DD protein_NN ._.
P07678642A02
Few_JJ components_NNS of_II adult_NN brain_NN ECM_NN are_VBB known_VVN ._.
P07678766A09
The_DD enzymatic_JJ activity_NN of_II a_DD gene_NN product_NN that_PNR was_VBD over-produced_VVN in_II Escherichia_NN coli_NN confirmed_VVD the_DD identity_NN of_II the_DD gene_NN ._.
P07680737A06
However_RR ,_, methylation_NN changes_NNS at_II this_DD site_NN were_VBD observed_VVN in_II DNA_NN from_II two_MC cases_NNS of_II CMML_NN ,_, in_II which_PNR hypomethylation_NN was_VBD observed_VVN and_CC in_II three_MC AML_NN cases_NNS ,_, which_PNR were_VBD completely_RR methylated_VVN at_II this_DD site_NN ._.
P07684607A09
Therefore_RR ,_, like_II some_DD proteins_NNS ,_, the_DD intron_NN RNA_NN is_VBZ modular_JJ ,_, containing_VVG a_DD separable_JJ domain_NN and_CC subdomain_NN of_II tertiary_JJ structure_NN ._.
P07687055A01
Fifteen_MC monoclonal_JJ antibodies_NNS (_( MAb_NN )_) were_VBD obtained_VVN to_II cell_NN walls_NNS (_( CW_NN )_) of_II M._NN bovinus-8_NN ,_, two_MC of_II them_PN were_VBD limited_VVN specific_JJ against_II human_NN and_CC bovine_JJ mycobacteria_NN ._.
P07690115A01
Calpain_NN ,_, a_DD calcium-activated_VVNJ neutral_JJ proteinase_NN ,_, is_VBZ ubiquitously_RR present_JJ in_II human_NN tissues_NNS ._.
P07693108A10
Second_RR ,_, treating_VVGN the_DD disease_NN at_II the_DD level_NN of_II the_DD gene_NN appears_VVZ to_TO be_VBI a_DD realistic_JJ goal_NN :_: Gene_NN transfer_NN experiments_NNS in_II cultured_VVNJ CF_NN cells_NNS have_VHB shown_VVN that_CST the_DD procedure_NN will_VM restore_VVB cAMP-dependent_JJ chloride_NN conductance_NN to_II the_DD cells_NNS ,_, laying_VVG the_DD groundwork_NN for_II somatic_JJ cell_NN gene_NN therapy_NN as_II a_DD feasible_JJ treatment_NN for_II CF_NN ._.
P07698646A02
Our_PNG analyses_NNS define_VVB the_DD TATA_NN box_NN or_CC initiator_NN sequences_NNS in_II the_DD c-myc_NN gene_NN as_II necessary_JJ components_NNS for_II the_DD establishment_NN of_II paused_VVNJ RNA_NN polymerase_NN II_MC ._.
P07701536A02
We_PN established_VVD KB_NN xenografts_NNS (_( xeKB3-1_NN and_CC xeKB8-5_NN )_) by_II inoculating_VVGN these_DD in_JJ+ vitro_JJ lines_NNS into_II nude_JJ mice_NNS ._.
P07704053A09
In_II addition_NN ,_, anionic_JJ detergents_NNS ,_, in_II contrast_NN to_II cationic_JJ ,_, zwitter-ionic_JJ or_CC non-ionic_JJ detergents_NNS ,_, could_VM prevent_VVB this_DD degradation_NN ._.
P07713897A04
Upon_II the_DD addition_NN of_II Ca_NN (_( II_MC )_) or_CC Mg_NN (_( II_MC )_) ,_, large_JJ chemical_JJ shift_NN changes_NNS were_VBD observed_VVN in_II the_DD amide_NN proton_NN and_CC methyl_NN proton_NN regions_NNS of_II the_DD spectrum_NN ,_, consistent_JJ with_II the_DD conformational_JJ transitions_NNS that_PNR metal_NN ions_NNS are_VBB known_VVN to_TO induce_VVI in_II native_JJ Factor_NN IX_MC ._.
P07716788A03
The_DD results_NNS showed_VVD that_CST 92_MC %_SYM of_II the_DD antibodies_NNS recognized_VVD an_DD epitope_NN in_II which_PNR the_DD side_NN chain_NN was_VBD a_DD major_JJ constituent_NN ,_, although_CS with_II variable_JJ contributions_NNS from_II other_JJ regions_NNS of_II the_DD molecule_NN ._.
P07726826A01
We_PN have_VHB previously_RR reported_VVN that_CST a_DD Ser300Asn_NN mutant_NN of_II the_DD Escherichia_NN coli_NN lactose_NN repressor_NN protein_NN produced_VVD a_DD temperature-sensitive_JJ phenotype_NN ._.
P07733657A10
The_DD mRNA_NN levels_NNS of_II the_DD three_MC isozymes_NNS were_VBD high_JJ in_II leaves_NNS compared_VVN with_II roots_NNS and_CC mesocotyls_NNS ._.
P07738685A04
Cross-reactivity_NN ,_, at_II the_DD level_NN of_II ligand_NN recognition_NN ,_, was_VBD observed_VVN between_II quail_NN and_CC chicken_NN VLDL_NN /_SYM vitellogenin_NN receptors_NNS ,_, and_CC immunological_JJ relatedness_NN was_VBD demonstrated_VVN by_II Western_NN blotting_VVGN with_II a_DD rabbit_NN anti-chicken_NN oocyte_NN VLDL_NN receptor_NN antibody_NN ._.
P07742922A04
This_DD antigen_NN retrieval_NN sequence_NN was_VBD helpful_JJ to_TO examine_VVI the_DD localization_NN of_II bcl-2_NN protein_NN in_II archival_JJ sections_NNS of_II normal_JJ lymphoid_JJ and_CC nonlymphoid_JJ tissues_NNS and_CC follicular_JJ lymphomas_NNS ._.
P07752241A05
The_DD results_NNS provide_VVB ,_, for_II the_DD first_JJ time_NN ,_, evidence_NN for_II the_DD transmembrane_JJ disposition_NN of_II helices_NNS F_NN and_CC G_NN of_II the_DD current_JJ eight-helix_NN cytochrome_NN b_NN model_NN ._.
P07760022A09
Immunoreactivity_NN for_II a_DD monoclonal_JJ sequence-specific_JJ antipeptide_NN antibody_NN was_VBD widespread_JJ and_CC most_RRT prominent_JJ in_II Purkinje_NN cell_NN perikarya_NNS and_CC their_PNG dendrites_NNS ,_, neuronal_JJ cell_NN bodies_NNS of_II the_DD ectostriatum_NN ,_, and_CC the_DD deep_JJ optic_JJ tectum_NN ._.
P07765157A04
A_DD standard_JJ protocol_NN utilizing_VVG the_DD hybridoma_NN 3C11_NN (_( ATCC_NN HB_NN 8511_MC )_) or_CC African_JJ green_JJ monkey_NN kidney_NN cells_NNS (_( Vero_NN cells_NNS ,_, ATCC_NN CRL_NN 1587_MC )_) was_VBD designed_VVN so_CS+ that_CS the_DD only_JJ variable_NN examined_VVN was_VBD the_DD hollow_JJ fiber_NN bioreactor_NN in_II use_NN ._.
P07769706A05
The_DD protein_NN was_VBD inactive_JJ in_II the_DD null_JJ p_NN (_( od_NN )_) 2_MC mutant_NN when_CS its_PNG first_JJ 82_MC amino_JJ acids_NNS were_VBD deleted_VVN ._.
P07775580A08
Branching_VVGJ morphogenesis_NN of_II bcl-2_NN transfectants_NNS is_VBZ also_RR observed_VVN in_II collagen_NN gels_NNS (_( in_II the_DD absence_NN of_II fibroblast_NN growth_NN factors_NNS )_) ._.
P07789186A03
Comparative_JJ mapping_VVGJ data_NN presented_VVN here_RR describes_VVZ a_DD new_JJ syntenic_JJ region_NN between_II man_NN and_CC rodents_NNS ._.
P07794888A01
A_DD form_NN of_II phosphofructokinase_NN (_( PFK_NN )_) from_II Ascaris_NN suum_NN desensitized_VVN to_II hysteresis_NN in_II the_DD reaction_NN time_NN course_NN and_CC ATP_NN allosteric_JJ inhibition_NN has_VHZ been_VBN used_VVN to_TO study_VVI the_DD activation_NN by_II fructose_NN 2_MC ,_, 6-bisphosphate_NN (_( F26P2_NN )_) at_II varied_VVNJ pH_NN in_II both_DD reaction_NN directions_NNS ._.
P07811473A02
Reports_NNS from_II our_PNG laboratory_NN and_CC other_JJ investigations_NNS have_VHB shown_VVN heterogeneity_NN in_II both_DD genes_NNS within_II three_MC regions_NNS (_( the_DD 5_MC '_SYM untranslated_VVNJ [_( 5_MC '_SYM UT_NN ]_) ,_, the_DD coding_VVGN ,_, and_CC the_DD 3_MC '_SYM untranslated_VVNJ [_( 3_MC '_SYM UT_NN ]_) regions_NNS )_) ._.
P07820939A02
In_II this_DD study_NN ,_, we_PN have_VHB evaluated_VVN the_DD physiological_JJ effect_NN of_II three_MC apo_NN A-IV_NN polymorphisms_NNS (_( Gln360-_NN >_SYM His_NN ,_, Thr347-_NN >_SYM Ser_NN and_CC XbaI_NN within_II the_DD second_JJ intron_NN of_II the_DD apo_NN A-IV_NN gene_NN )_) ,_, in_II a_DD French_NN population_NN ,_, on_II seven_MC quantitative_JJ traits_NNS :_: total_JJ cholesterol_NN and_CC triglycerides_NNS ,_, cholesterol_NN of_II HDL_NN ,_, apo_NN A-IV_NN ,_, apo_NN B_NN ,_, apo_NN A-I_NN and_CC glucose_NN ._.
P07835075A08
Analysis_NN in_II detail_NN of_II these_DD deletions_NNS over_II many_DD generations_NNS showed_VVD that_CST more_RR than_CSN a_DD single_JJ sequence_NN might_VM be_VBB involved_VVN ._.
P07842166A06
No_DD improvement_NN resulted_VVD ._.
P07856108A03
CC107_NN and_CC CC74_NN each_PND have_VHB an_DD M_NN segment_NN consisting_VVG of_II 3696_MC nucleotides_NNS with_II a_DD coding_VVGJ potential_NN of_II 1140_MC amino_JJ acids_NNS in_II the_DD virus_NN complementary-sense_NN RNA_NN (_( cRNA_NN )_) ._.
P07860430A08
PC_NN also_RR increased_VVD the_DD response_NN of_II sperm_NN to_II the_DD Ca2+_NN /_SYM H_NN (_( +_SYM )_) -exchanging_VVGJ ionophore_NN ,_, ionomycin_NN ,_, suggesting_VVG that_CST PC_NN modifies_VVZ an_DD event_NN that_PNR is_VBZ coincident_JJ with_II or_CC subsequent_II+ to_II the_DD rise_NN in_II intracellular_JJ free_JJ Ca2+_NN that_PNR is_VBZ triggered_VVN by_II progesterone_NN ._.
P07864078A01
The_DD renal_JJ K+_NN channel_NN (_( ROMK2_NN )_) was_VBD expressed_VVN in_II Xenopus_NN oocytes_NNS ,_, and_CC the_DD patch-clamp_NN technique_NN was_VBD used_VVN to_TO assess_VVI its_PNG conducting_VVGJ and_CC gating_VVGJ properties_NNS ._.
P07868689A03
Using_VVG single_JJ blastomeres_NNS from_II mouse_NN embryos_NNS as_II a_DD model_NN system_NN ,_, cell_NN recycling_VVGJ procedures_NNS detect_VVB the_DD single-copy_NN beta-haemoglobin_NN gene_NN sequence_NN at_II an_DD efficiency_NN of_II 70_MC %_SYM as_CC+ well_CC+ as_CC sex_NN chromosome_NN constitution_NN at_II an_DD efficiency_NN of_II 74_MC %_SYM in_II the_DD same_JJ single_JJ cell_NN ._.
P07876231A09
Internalization_NN of_II 125I-GRP_NN ,_, assessed_VVN using_VVG an_DD acid_NN wash_NN ,_, was_VBD maximal_JJ after_II 10-20_MC min_NN ,_, and_CC was_VBD clathrin-mediated_VVN since_CS it_PN was_VBD inhibited_VVN by_II hyperosmolar_JJ sucrose_NN and_CC phenylarsine_NN oxide_NN ._.
P07887926A01
Reversible_JJ carboxyl_NN methylation_NN of_II the_DD C-terminal_JJ geranylgeranylcysteine_NN of_II G25K_NN may_VM regulate_VVB its_PNG activity_NN and_CC cellular_JJ localization_NN ._.
P07893828A06
When_CS lysis_NN buffer_NN was_VBD replaced_VVN by_II cytoplasmic_JJ extract_NN from_II normal_JJ or_CC ras-transformed_VVNJ cells_NNS ,_, autophosphorylation_NN of_II the_DD immobilized_VVNJ PKR_NN was_VBD inhibited_VVN in_II the_DD presence_NN or_CC absence_NN of_II dsRNA_NN ,_, even_RR though_CS it_PN could_VM be_VBB shown_VVN that_CST PKR_NN remained_VVD bound_VVN and_CC intact_JJ in_II the_DD precipitate_NN ,_, and_CC able_JJ to_TO autophosphorylate_VVI if_CS rewashed_VVN with_II lysis_NN buffer_NN ._.
P07897239A06
These_DD data_NNS suggest_VVB that_CST more_RR than_CSN one_MC TCRBV-bearing_VVGJ cell_NN having_VHG the_DD affinity_NN for_II AChR-dominant_JJ peptides_NNS is_VBZ involved_VVN in_II pathogenesis_NN ._.
P07901052A03
cnox5-Hm_NN was_VBD a_DD new_JJ homeobox_NN gene_NN and_CC was_VBD very_RR similar_JJ to_II Mox1_NN in_II the_DD mouse_NN ._.
P07907501A11
Because_II+ of_II these_DD uncertainties_NNS ,_, wo_PN believe_VVB that_CST the_DD potential_NN of_II F_NN XIIIa-antibody_NN in_II obtaining_VVGN precise_JJ differential_JJ diagnostic_JJ information_NN is_VBZ limited_VVN ._.
P07910838A10
Drug-related_VVNJ malaise_NN and_CC anorexia_NN were_VBD observed_VVN more_RR frequently_RR in_II patients_NNS receiving_VVG both_DD zidovudine_NN and_CC IFN-alpha_NN ._.
P07913665A02
We_PN determined_VVD whether_CST in_JJ+ vivo_JJ UVB_NN irradiation_NN alters_VVZ the_DD ability_NN of_II hapten-bearing_VVGJ APC_NN from_II the_DD DLN_NN to_TO form_VVI clusters_NNS with_II hapten-specific_JJ T_NN lymphocytes_NNS ._.
P07915843A03
PCNA_NN ,_, in_II conjunction_NN with_II activator_NN 1_MC ,_, acts_VVZ as_II a_DD processivity_NN factor_NN for_II eukaryotic_JJ DNA_NN polymerase_NN (_( pol_NN )_) delta_NN ,_, and_CC these_DD three_MC proteins_NNS constitute_VVB the_DD pol_NN delta_NN holoenzyme_NN ._.
P07922528A05
The_DD level_NN of_II the_DD novel_JJ type_NN isozymes_NNS ,_, epsilon_NN and_CC zeta_NN ,_, was_VBD not_RR altered_VVN in_II electroshocked_VVNJ mice_NNS ._.
P07929230A02
Its_PNG primary_JJ structure_NN (_( calculated_VVNJ molecular_JJ mass_NN of_II 25,831_MC Da_NN )_) shows_VVZ the_DD presence_NN of_II two_MC hydrophobic_JJ domains_NNS of_II which_PNR one_MC is_VBZ likely_RR to_TO serve_VVI as_II a_DD transmembrane_JJ segment_NN ._.
P07937122A09
In_II this_DD report_NN we_PN characterize_VVB the_DD temporal_JJ and_CC spatial_JJ expression_NN of_II three_MC novel_JJ Xenopus_NN genes_NNS during_II early_JJ development_NN as_CC+ well_CC+ as_CC during_II bFGF-induced_VVNJ mesodermal_JJ differentiation_NN ._.
P07939633A02
The_DD Bcr-associated_VVNJ protein_NN 1_MC (_( Bap-1_NN )_) is_VBZ a_DD member_NN of_II the_DD 14-3-3_MC family_NN of_II proteins_NNS ._.
P07946534A02
The_DD teleological_JJ explanation_NN for_II this_DD unique_JJ action_NN of_II PUFAs_NNS resides_VVZ in_II their_PNG ability_NN to_TO suppress_VVI the_DD synthesis_NN of_II (_( n-9_NN )_) fatty_JJ acids_NNS ._.
P07955526A01
We_PN have_VHB previously_RR shown_VVN in_II mice_NNS and_CC monkeys_NNS that_CST mycobacterial_JJ heat_NN shock_NN proteins_NNS (_( hsp_NN )_) of_II 65_MC and_CC 70_MC kD_NN exert_VVB a_DD strong_JJ in_JJ+ vivo_JJ helper_NN effect_NN when_CS conjugated_VVN to_II synthetic_JJ peptides_NNS or_CC bacterial_JJ oligosaccharides_NNS and_CC given_VVN in_II the_DD absence_NN of_II any_DD adjuvants_NNS ._.
P07958456A08
In_II contrast_NN ,_, LHRH_NN cells_NNS emigrated_VVD exclusively_RR from_II inside_JJ olfactory_NN pit_NN areas_NNS to_II the_DD surface_NN of_II the_DD culture_NN after_II 3_MC days_NNS ._.
P07962006A06
The_DD species-specific_JJ aminoacylations_NNS correlate_VVB with_II a_DD nucleotide_NN sequence_NN difference_NN at_II a_DD location_NN in_II the_DD acceptor_NN stem_NN that_PNR is_VBZ known_VVN to_TO be_VBI critical_JJ for_II aminoacylations_NNS by_II the_DD E._NN coli_NN enzyme_NN ._.
P07978314A03
The_DD SERG_NN probe_NN can_VM be_VBB used_VVN to_TO detect_VVI DNA_NN biotargets_NNS (_( e.g._II ,_, gene_NN sequences_NNS ,_, bacteria_NN ,_, viral_JJ DNA_NN fragments_NNS )_) via_II hybridization_NN to_II DNA_NN sequences_NNS complementary_JJ to_II that_DD probe_NN ._.
P07982579A05
We_PN report_VVB here_RR the_DD molecular_JJ characterization_NN of_II the_DD lin-15_NN locus_NN ._.
P07992474A04
Selectivity_NN indices_NNS (_( 50_MC per_II cent_MC cytotoxic_JJ dose_NN [_( CD50_NN ]_) /_SYM ED50_NN )_) provided_VVD the_DD following_VVGJ order_NN of_II antiviral_JJ activity_NN :_: pyrazofuin_NN >_SYM 6-azauridine_NN >_SYM 3-deazaguanosine_NN >_SYM hygromycin_NN B_NN >_SYM fusidic_JJ acid_NN >_SYM dipyridamole_NN ._.
P08001144A04
odr-7_NN null_JJ mutants_NNS fail_VVB to_TO respond_VVI to_II all_DD odorants_NNS detected_VVN by_II the_DD AWA_NN neurons_NNS ,_, while_CS a_DD missense_NN mutation_NN in_II odr-7_NN causes_VVZ a_DD specific_JJ defect_NN in_II one_MC odorant_NN response_NN ._.
P08002249A14
Three_MC of_II four_MC Irish_NN setters_NNS affected_VVN with_II atypical_JJ ,_, relatively_RR slower_JJR disease_NN also_RR had_VHD this_DD mutation_NN ,_, but_CC one_MC dog_NN did_VDD not_RR ._.
P08004151A10
These_DD data_NNS suggest_VVB that_CST ,_, in_II this_DD model_NN of_II neutrophil_NN activation_NN ,_, the_DD pathway_NN for_II O2-_NN generation_NN is_VBZ a_DD Mac-1_NN (_( but_CC not_RR LFA-1_NN )_) -dependent_JJ pathway_NN and_CC also_RR requires_VVZ iC3b_NN ._.
P08015353A01
We_PN have_VHB recently_RR demonstrated_VVD the_DD ability_NN of_II neuropeptide_NN Y_NN to_TO augment_VVI norepinephrine-stimulated_VVNJ contractions_NNS of_II the_DD rat_NN tail_NN artery_NN ._.
P08020469A08
The_DD leucine_NN dehydrogenase_NN gene_NN (_( leudh_NN )_) consists_VVZ of_II a_DD 1098-bp_NN open_JJ reading_VVGJ frame_NN and_CC encodes_VVZ 366_MC amino_JJ acid_NN residues_NNS corresponding_VVG to_II a_DD subunit_NN (_( M_NN (_( r_NN )_) 40586_MC )_) of_II the_DD octameric_JJ enzyme_NN ._.
P08021259A03
We_PN present_VVB a_DD mathematical_JJ analysis_NN which_PNR shows_VVZ that_CST this_DD behavior_NN is_VBZ inconsistent_JJ with_II a_DD simple_JJ 2-pool_NN model_NN with_II one_MC plasma_NN membrane_NN and_CC one_MC intracellular_JJ compartment_NN ,_, but_CS+ that_CS a_DD 3-pool_NN model_NN ,_, with_II two_MC intracellular_JJ compartments_NNS ,_, can_VM simulate_VVB these_DD properties_NNS ._.
P08034621A04
The_DD scheme_NN allows_VVZ the_DD preparation_NN of_II milligram_NN quantities_NNS of_II purified_VVNJ enzyme_NN for_II elucidation_NN of_II kinetic_JJ mechanism_NN as_CC+ well_CC+ as_CC for_II structural_JJ studies_NNS ._.
P08041121A06
EBVaGC_NN was_VBD found_VVN in_II the_DD cardia_NN (_( 4_MC /_SYM 8_MC )_) or_CC body_NN (_( 4_MC /_SYM 8_MC )_) of_II the_DD stomach_NN ,_, and_CC consisted_VVN of_II 7_MC advanced_VVNJ and_CC 1_MC intramucosal_JJ carcinoma_NN ._.
P08041786A01
The_DD replication_NN of_II human_NN immunodeficiency_NN virus_NN type_NN 1_MC (_( HIV-1_NN )_) in_II nondividing_VVGJ host_NN cells_NNS such_II+ as_II those_PND of_II macrophage_NN lineage_NN is_VBZ an_DD important_JJ feature_NN of_II AIDS_NN pathogenesis_NN ._.
P08049272A09
The_DD identity_NN of_II the_DD gene_NN was_VBD confirmed_VVN by_II analyzing_VVGN the_DD function_NN of_II the_DD gene_NN product_NN ._.
P08053685A04
The_DD two_MC muscle_NN caldesmons_NNS do_VDB not_RR comigrate_VVB during_II polyacrylamide_NN gel_NN electrophoresis_NN in_II the_DD presence_NN of_II sodium_NN dodecyl_NN sulfate_NN ,_, indicating_VVG that_CST they_PN have_VHB different_JJ amino_JJ acid_NN sequences_NNS ._.
P08068243A04
This_DD work_NN studies_VVZ the_DD role_NN of_II each_PND of_II the_DD oxidation_NN products_NNS of_II spermine_NN in_II cytotoxicity_NN induced_VVN by_II purified_VVNJ bovine_JJ serum_NN amine_NN oxidase_NN ._.
P08075421A03
The_DD biochemical_JJ functions_NNS of_II most_PND of_II these_DD genes_NNS have_VHB not_RR been_VBN established_VVN ._.
P08083072A01
PURPOSE_NN :_: The_DD accuracy_NN of_II DNA_NN repair_NN may_VM play_VVB a_DD role_NN in_II determining_VVGN the_DD cytotoxic_JJ effect_NN of_II ionizing_VVGJ radiation_NN ._.
P08083983A09
Specific_JJ changes_NNS exist_VVB within_II two_MC regions_NNS of_II the_DD protein_NN ,_, one_MC of_II which_PNR is_VBZ thought_VVN to_TO be_VBI involved_VVN in_II binding_VVGN to_II host_NN cell_NN receptors_NNS ._.
P08093612A04
To_TO test_VVI this_DD hypothesis_NN we_PN studied_VVD the_DD influence_NN of_II murine_JJ Hsp25_NN ,_, human_NN Hsp27_NN ,_, and_CC bovine_JJ alpha-B-crystallin_NN (_( an_DD eye_NN lens_NN protein_NN homologous_JJ to_II sHsps_NNS )_) on_II the_DD unfolding_VVGN and_CC refolding_VVGN of_II citrate_NN synthase_NN and_CC alpha-glucosidase_NN in_RR+ vitro_RR ._.
P08096831A03
Additionally_RR ,_, antibodies_NNS recognizing_VVG the_DD HE4_NN protein_NN were_VBD shown_VVN to_TO react_VVI specifically_RR in_II the_DD epididymis_NN of_II the_DD boar_NN and_CC bull_NN ._.
P08102129A07
No_DD EGF-r_NN ,_, TGF-alpha_NN or_CC c-erbB-2_NN immunopositivity_NN was_VBD found_VVN in_II normal-appearing_VVGJ thyroid_NN tissue_NN (_( 25_MC cases_NNS )_) ,_, whereas_CS a_DD few_PND of_II the_DD non-neoplastic_JJ lesions_NNS (_( colloid_NN goitres_NNS and_CC diffuse_JJ hyperplasias_NNS )_) expressed_VVD either_CC EGF-r_NN or_CC TGF-alpha_NN ._.
P08104225A04
Immunoblotting_VVGN of_II whole_JJ cell_NN lysates_NNS of_II BFP-positive_JJ ,_, EAF-positive_JJ or_CC -negative_JJ ,_, and_CC LA-positive_JJ or_CC -negative_JJ EPEC_NN strains_NNS revealed_VVD variations_NNS in_II the_DD size_NN (_( 18,500-21,000_MC )_) of_II the_DD expressed_VVNJ structural_JJ subunit_NN of_II BFP_NN ,_, suggesting_VVG differences_NNS in_II processing_VVGN that_PNR may_VM account_VVB for_II discrepancies_NNS between_II the_DD bfpA_NN ,_, EAF_NN ,_, and_CC LA_NN ._.
P08109333A07
Moreover_RR our_PNG results_NNS suggest_VVB that_CST caldesmon_NN does_VDZ not_RR function_VVB to_TO maintain_VVI passive_JJ tension_NN ._.
P08115026A02
In_II Western_NN blots_NNS ,_, the_DD antibody_NN recognized_VVD a_DD single_JJ band_NN of_II protein_NN of_II about_RR 98_MC kD_NN from_II all_DD target_NN tissues_NNS studied_VVN to_II date_NN ._.
P08119389A04
At_II the_DD gene_NN level_NN ,_, a_DD one-base_NN substitution_NN (_( A_NN --_: >_SYM G_NN )_) changed_VVD position_NN +4_MC of_II the_DD 5_MC '_SYM donor_NN splice_NN site_NN consensus_NN sequence_NN of_II intron_NN X_MC ._.
P08121806A01
The_DD DNA_NN polymerase_NN gene_NN of_II African_JJ swine_NN fever_NN virus_NN (_( ASFV_NN )_) was_VBD mapped_VVN by_II marker_NN rescue_NN experiments_NNS using_VVG a_DD phosphonoacetic_JJ acid-resistant_JJ mutant_NN and_CC hybridization_NN with_II an_DD oligonucleotide_NN probe_NN designed_VVN from_II the_DD most_RRT conserved_VVNJ motif_NN of_II family_NN B_NN DNA_NN polymerases_NNS ._.
P08125986A03
Pause_NN transfer_NN sequences_NNS direct_VVB nascent_JJ apolipoprotein_NN B_NN to_TO pause_VVI during_II its_PNG translocation_NN ,_, resulting_VVG in_II nonintegrated_VVNJ ,_, transmembrane_JJ intermediates_NNS that_PNR become_VVB fully_RR translocated_VVN over_II time_NN ._.
P08131737A10
The_DD structure_NN of_II the_DD binding_VVGJ site_NN at_II photosystem_NN I_MC and_CC the_DD mechanism_NN of_II electron_NN transfer_NN are_VBB discussed_VVN ._.
P08137263A11
On_II the_DD contrary_NN ,_, p53_NN gene_NN changes_NNS seem_VVB to_TO represent_VVI an_DD event_NN required_VVN for_II the_DD malignancy_NN progression_NN of_II ductal_JJ tumors_NNS from_II lower_JJR to_II higher_JJR grades_NNS ._.
P08143730A08
The_DD only_JJ significant_JJ difference_NN is_VBZ strictly_RR localized_VVN near_II the_DD single_JJ amino_JJ acid_NN substitution_NN in_II the_DD presumed_VVNJ active_JJ site_NN -Trp18-Arg_NN (_( Leu_NN )_) -Tyr-_NN ,_, i.e._II Leu19_NN and_CC Tyr20_NN are_VBB more_RR precisely_RR defined_VVN in_II the_DD solution_NN structure_NN of_II [_( R19L_NN ]_) Tendamistat_NN than_CSN the_DD corresponding_VVGJ residues_NNS Arg19_NN and_CC Tyr20_NN in_II wild-type_NN Tendamistat_NN ._.
P08151290A04
Control_NN transformations_NNS were_VBD carried_VVN out_II with_II the_DD GUS-NEO_NN plasmid_NN mixed_VVN with_II the_DD AL1_NN ,_, AL2_NN or_CC AL3_NN plasmids_NNS in_II which_PNR mutations_NNS were_VBD introduced_VVN to_TO prevent_VVI translation_NN of_II the_DD open_JJ reading_VVGJ frames_NNS (_( ORFs_NNS )_) ._.
P08158131A04
An_DD intracellular_JJ Ca2+_NN antagonist_NN ,_, 3_MC ,_, 4_MC ,_, 5-trimethoxybenzoic_JJ acid_NN 8-_MC (_( N_NN ,_, N-diethylamino_JJ )_) octyl_NN ester_NN ,_, selectively_RR inhibited_VVD the_DD initial_JJ phase_NN of_II secretion_NN ._.
P08160194A05
By_II contrast_NN ,_, when_CS CEM-C12_NN cells_NNS were_VBD exposed_VVN to_II higher_JJR cadmium_NN concentrations_NNS (_( 50_MC microM_NN )_) ,_, cell_NN death_NN increased_VVD without_II concomitant_JJ chromatin_NN condensation_NN or_CC DNA_NN fragmentation_NN ._.
P08163472A10
Comparison_NN of_II the_DD deduced_VVNJ amino_JJ acid_NN sequence_NN of_II the_DD biotin_NN subunit_NN of_II beta-methylcrotonyl-CoA_NN carboxylase_NN with_II other_JJ biotin_NN enzymes_NNS suggest_VVB that_CST this_DD subunit_NN contains_VVZ the_DD biotin_NN carboxylase_NN and_CC biotin_NN carboxyl-carrier_NN domains_NNS ._.
P08170362A03
Most_DD GAS_NN strains_NNS contain_VVB one_MC to_II three_MC tandemly_RR arranged_VVNJ copies_NNS of_II emm-family_NN genes_NNS in_II the_DD cluster_NN ,_, but_CC the_DD alleles_NNS within_II the_DD cluster_NN vary_VVB among_II different_JJ strains_NNS ._.
P08175742A03
We_PN investigated_VVD the_DD contribution_NN of_II the_DD cell_NN type_NN to_II the_DD pattern_NN of_II beta_NN 3-adrenergic_JJ receptor_NN long_JJ term_NN desensitization_NN by_II studying_VVGN ,_, in_II parallel_NN ,_, two_MC cell_NN lines_NNS (_( Chinese_NN hamster_NN fibroblasts_NNS and_CC murine_JJ Ltk-_NN cells_NNS )_) expressing_VVG the_DD human_NN beta_NN 3-adrenergic_JJ receptor_NN ._.
P08176363A05
When_CS translated_VVD in_RR+ vitro_RR in_II the_DD presence_NN of_II dog_NN pancreatic_JJ microsomal_JJ membranes_NNS ,_, the_DD N28-35_NN protein_NN underwent_VVD cleavage_NN and_CC did_VDD not_RR remain_VVB anchored_VVN to_II membranes_NNS ._.
P08179907A08
The_DD translation_NN of_II these_DD transcripts_NNS ,_, therefore_RR ,_, appears_VVZ to_TO be_VBI post-transcriptionally_RR controlled_VVN ._.
P08183948A02
After_II 24_MC hr_NN in_II cell_NN culture_NN ,_, RPE_NN cells_NNS developed_VVD a_DD transient_JJ ,_, voltage-activated_VVNJ inward_JJ current_NN that_CST was_VBD never_RR observed_VVN in_II acutely_RR isolated_VVNJ cells_NNS ._.
P08196637A06
Indirect_JJ immunofluorescence_NN and_CC confocal_JJ laser_NN microscopy_NN showed_VVD that_CST the_DD activity_NN of_II NF-kappa_NN B_NN correlated_VVD with_II the_DD presence_NN of_II the_DD NF-kappa_NN B_NN subunits_NNS p50_NN and_CC RelA_NN (_( p65_NN )_) in_II nuclei_NNS of_II cultured_VVNJ neurons_NNS ._.
P08204581A04
For_II both_CC an_DD equimolar_JJ ratio_NN of_II arachidonic_JJ and_CC ferulic_JJ acids_NNS and_CC ferulic_JJ acid_NN in_II excess_NN of_II arachidonic_JJ acid_NN a_DD stimulation_NN of_II the_DD cyclooxygenase_NN reaction_NN is_VBZ observed_VVN ._.
P08207793A05
Analysis_NN of_II mRNA_NN suggested_VVD that_CST Tat_NN exerts_VVZ its_PNG effect_NN on_II IL-2_NN primarily_RR at_II the_DD transcriptional_JJ level_NN ._.
P08223435A06
Also_RR TPA-induced_VVNJ ,_, p21ras-independent_JJ ,_, activation_NN of_II raf-1_NN kinase_NN and_CC ERK2_NN is_VBZ inhibited_VVN by_II cAMP_NN ._.
P08224847A08
Partial_JJ amino_JJ acid_NN sequence_NN data_NNS obtained_VVN from_II the_DD approximately_RR 55-kD_NN component_NN of_II IBP-s_NNS indicate_VVB that_CST it_PN is_VBZ hERR1_NN ,_, an_DD orphan_NN member_NN of_II the_DD steroid-thyroid_NN hormone_NN receptor_NN superfamily_NN ._.
P08228247A12
Conversely_RR ,_, the_DD IL-1_NN beta_NN converting_VVGJ enzyme_NN inhibitor_NN ,_, Ac-Tyr-Val-Ala-Asp-CHO_NN (_( L-709,049_NN )_) and_CC the_DD anti-inflammatory_JJ agent_NN [_( 5-_MC (_( 4-pyridyl_NN )_) 6_MC (_( 4-fluorophenyl_NN )_) -2_MC ,_, 3-dihydroimidazo_NN (_( 2_MC ,_, 1-b_NN )_) thiazole_NN ]_) (_( SK_NN &_CC F_NN 86002_MC )_) inhibited_VVD IL-1_NN beta_NN release_NN in_II both_CC the_DD standard_JJ and_CC staged_VVNJ release_NN assays_NNS with_II IC50_NN of_II 1_MC microM_NN ._.
P08238481A03
GCT_NN cells_NNS were_VBD sensitive_JJ to_II bone_NN sialoprotein-II_NN (_( BSP-II_NN )_) ,_, osteopontin_NN (_( OPN_NN )_) ,_, and_CC related_VVNJ fragments_NNS ._.
P08246677A03
Ischemia_NN also_RR induced_VVD a_DD time_NN dependent_JJ decrease_NN in_II the_DD activity_NN and_CC maximum_NN velocity_NN (_( Vmax_NN )_) value_NN of_II Ca-ATPase_NN ._.
P08254738A03
A_DD form_NN of_II casein_NN kinase_NN I_MC purified_VVN from_II HeLa_NN nuclear_JJ extracts_NNS (_( T-antigen_NN kinase_NN )_) phosphorylates_VVZ T_NN antigen_NN on_II physiologic_JJ sites_NNS and_CC inhibits_VVZ its_PNG activity_NN in_II the_DD unwinding_VVGJ reaction_NN (_( A._NNP Cegielska_NNP and_CC D._NNP M._NNP Virshup_NNP ,_, Mol._NN Cell._NN Biol._NN 13_MC :_: 1202-1211_MC ,_, 1993_MC )_) ._.
P08258343A01
Peripheral_JJ blood_NN B_NN cells_NNS of_II a_DD 67-year-old_JJ person_NN were_VBD separated_VVN into_II IgM+IgD+_NN ,_, IgM+IgD-_NN ,_, and_CC IgM-IgD-_NN subsets_NNS ,_, and_CC nucleotide_NN sequences_NNS of_II expressed_VVNJ immunoglobulin_NN light_JJ chain_NN variable_NN (_( V_NN )_) regions_NNS encoded_VVN by_II V_NN kappa_NN 3_MC and_CC V_NN kappa_NN 4_MC gene_NN family_NN members_NNS were_VBD determined_VVN from_II amplified_VVNJ cDNA_NN ._.
P08263508A08
Nevertheless_RR ,_, the_DD molecular_JJ structure_NN and_CC pharmacological_JJ characterization_NN of_II high-affinity_NN kainate_NN binding_VVGN of_II the_DD humEAA1_NN expressed_VVN in_II the_DD stable_JJ cell_NN line_NN (_( ppEAA1-16_NN )_) suggest_VVB that_CST the_DD humEAA1_NN is_VBZ a_DD subunit_NN protein_NN of_II a_DD human_NN kainate_NN receptor_NN complex_NN ._.
P08269996A04
Unstretched_VVNJ cells_NNS served_VVD as_II controls_NNS ._.
P08280086A08
Cross-linking_VVGJ studies_NNS indicate_VVB that_CST the_DD specific_JJ interaction_NN between_II MH1C1_NN cells_NNS and_CC the_DD 39_MC kDa_NN protein_NN is_VBZ mediated_VVN by_II an_DD association_NN with_II the_DD LRP_NN receptor_NN ._.
P08283650A03
This_DD factor_NN is_VBZ a_DD potent_JJ mitogen_NN for_II retinal_JJ pigment_NN epithelial_JJ cells_NNS and_CC vascular_JJ smooth_JJ muscle_NN cells_NNS ._.
P08286397A02
The_DD well-known_VVNJ high-spin_NN /_SYM low-spin_NN equilibrium_NN has_VHZ been_VBN detected_VVN between_II 298_MC K_NN and_CC 220_MC K_NN ._.
P08289789A04
Expression_NN in_II CD4+_NN CD8+_NN T_NN cells_NNS was_VBD found_VVN to_TO require_VVI additional_JJ regulatory_JJ elements_NNS present_JJ in_II a_DD T-cell_NN enhancer_NN fragment_NN recently_RR identified_VVN for_II the_DD murine_JJ CD4_NN gene_NN (_( S._NNP Sawada_NNP and_CC D._NNP R._NNP Littman_NNP ,_, Mol._NN Cell._NN Biol._NN 11_MC :_: 5506-5515_MC ,_, 1991_MC )_) ._.
P08293970A02
To_TO show_VVI this_PND ,_, we_PN altered_VVD a_DD low-level_NN overexpressing_VVGJ recF+_NN plasmid_NN with_II a_DD set_NN of_II structurally_RR neutral_JJ mutations_NNS that_PNR increased_VVD the_DD rate_NN of_II expression_NN of_II recF_NN ._.
P08301138A03
Although_CS both_CC pertussis_NN toxin_NN and_CC BT-D_NN inhibited_VVD exocytosis_NN in_II FMLP-stimulated_VVNJ PMNs_NNS ,_, the_DD inhibitory_JJ effects_NNS of_II the_DD two_MC toxins_NNS were_VBD found_VVN to_TO be_VBI additive_JJ ._.
P08315389A01
The_DD gene_NN encoding_VVG a_DD highly_RR immunogenic_JJ mycobacterial_JJ heat-shock_NN protein_NN (_( hsp65_NN )_) was_VBD transfected_VVN into_II the_DD murine_JJ macrophage_NN tumor_NN cell_NN line_NN J774_NN ._.
P08320826A05
Furthermore_RR ,_, this_DD approach_NN will_VM eventually_RR identify_VVB the_DD stretch-induced_VVNJ intracellular_JJ pathways_NNS ._.
P08330339A06
Four_MC human_NN samples_NNS that_PNR contained_VVD relatively_RR high_JJ levels_NNS of_II particular_JJ P450_NN enzymes_NNS in_II their_PNG microsomes_NNS were_VBD selected_VVN and_CC used_VVN for_II further_JJ characterization_NN ._.
P08335374A06
Analysis_NN of_II whole-cell_NN extracts_NNS from_II 14_MC strains_NNS by_II sodium_NN dodecyl_NN sulfate_NN (_( SDS_NN )_) -polyacrylamide_NN gel_NN electrophoresis_NN with_II 7_MC M_NN urea_NN and_CC immunoblotting_VVGN with_II antisera_NNS to_II CBF1_NN and_CC CBF2_NN suggests_VVZ that_CST CBF_NN proteins_NNS from_II adherent_JJ and_CC nonadherent_JJ strains_NNS are_VBB different_JJ ._.
P08340353A08
These_DD results_NNS suggest_VVB that_CST calpain_NN inhibition_NN and_CC binding_VVGN to_II the_DD CaMLDs_NNS are_VBB not_RR correlated_VVN or_CC mediated_VVN by_II different_JJ subdomains_NNS of_II calpastatin_NN ._.
P08347153A01
It_PN is_VBZ widely_RR known_VVN that_CST the_DD clearance_NN of_II drugs_NNS is_VBZ often_RR compromised_VVN during_II episodes_NNS of_II infectious_JJ disease_NN via_II a_DD down-regulation_NN of_II cytochrome_NN P450_NN (_( P450_NN )_) at_II a_DD pre-translational_JJ step_NN in_II enzyme_NN synthesis_NN ._.
P08366043A12
Therefore_RR ,_, the_DD steady-state_NN level_NN of_II the_DD ilvBNC_NN and_CC ilvNC_NN messages_NNS contributes_VVZ significantly_RR to_II the_DD total_JJ activity_NN of_II the_DD single_JJ AHAS_NN ._.
P08373557A06
This_DD loop_NN displays_VVZ a_DD remarkably_RR reduced_VVNJ homology_NN of_II 64.0_MC %_SYM with_II several_JJ deletions_NNS and_CC insertions_NNS ,_, although_CS four_MC putative_JJ glycosylation_NN sites_NNS are_VBB conserved_VVN ._.
P08382496A06
In_II unitary_JJ recordings_NNS PDBu_NN produced_VVD dramatic_JJ increases_NNS in_II single_JJ N-_NN and_CC L-type_NN channel_NN activity_NN by_II sharply_RR decreasing_VVGN closed_VVNJ time_NN intervals_NNS between_II adjacent_JJ openings_NNS ,_, but_CC did_VDD not_RR alter_VVB the_DD unitary_JJ current_NN size_NN or_CC mean_NN open_JJ time_NN ._.
P08384580A04
The_DD E1B_NN 55K_NN protein_NN blocks_VVZ p53_NN tumor_NN suppressor_NN protein_NN function_NN ,_, indicating_VVG that_CST p53_NN may_VM mediate_VVB apoptosis_NN by_II E1A_NN ._.
P08388022A07
These_DD data_NNS suggest_VVB that_CST such_DB a_DD phenotype_NN is_VBZ not_RR due_II+ to_II alteration_NN of_II a_DD VP3_NN function_NN related_VVN to_II transcription_NN ._.
P08389474A06
The_DD responses_NNS to_II single_JJ flashes_NNS of_II varying_VVGJ intensities_NNS occurred_VVD with_II a_DD mean_NN latency_NN of_II 460_MC ms_NN ,_, which_PNR is_VBZ consistent_JJ with_II the_DD intermediacy_NN of_II several_JJ steps_NNS between_II alpha-receptor_NN activation_NN and_CC contraction_NN ._.
P08393883A05
BAT_NN was_VBD also_RR found_VVN to_TO contain_VVI iodothyronine_NN 5'-deiodinase_NN (_( 5'D_NN )_) ,_, which_PNR appears_VVZ to_TO be_VBI a_DD type_NN II_MC enzyme_NN ,_, based_VVN on_II high_JJ affinity_NN for_II T4_NN (_( Km_NN ,_, 2.9_MC nmol_NN /_SYM L_NN )_) and_CC insensitivity_NN to_II propylthiouracil_NN (_( 10_MC %_SYM inhibition_NN by_II 1_MC nmol_NN /_SYM L_NN )_) ._.
P08396186A02
Maximal_JJ stimulations_NNS were_VBD reached_VVN at_II 10_MC (_( -7_MC )_) M_NN of_II human_NN PTHrP-_NN (_( 1-34_MC )_) or_CC rat_NN PTH-_NN (_( 1-34_MC )_) and_CC showed_VVD a_DD 3-3.3_MC fold_NN increase_NN over_II basal_JJ activity_NN ._.
P08404325A04
It_PN does_VDZ not_RR contain_VVB the_DD other_JJ extractable_JJ antigens_NNS ,_, like_II Sm_NN ,_, RNP_NN ,_, PM-ScL_NN ,_, Scl-70_NN ,_, Jo-1_NN ,_, and_CC PCNA_NN ._.
P08409525A03
This_DD enzyme_NN exhibited_VVD a_DD marked_VVNJ acyl-group_NN specificity_NN towards_II arachidonic_JJ acid_NN ._.
P08415694A03
After_II DNA_NN packaging_VVGN terminase_NN recognizes_VVZ and_CC cuts_VVZ the_DD terminal_JJ cosN_NN ,_, an_DD event_NN that_PNR does_VDZ not_RR require_VVB a_DD wild-type_NN cosB_NN ._.
P08419159A04
Cytotoxicity_NN was_VBD also_RR assessed_VVN by_II studying_VVGN the_DD entrance_NN and_CC maintenance_NN of_II cells_NNS in_II mitosis_NN (_( mitotic_JJ index_NN )_) ._.
P08422500A08
The_DD tightest_JJT linkages_NNS were_VBD with_II :_: MYH3_NN (_( embryonic_JJ ,_, skeletal_JJ myosin_NN heavy_JJ chain_NN )_) and_CC SHBG_NN (_( sex_NN hormone-binding_VVGJ globulin_NN )_) ,_, giving_VVG 2_MC point_NN lod_NN scores_NNS of_II 20.2_MC ,_, and_CC 20.0_MC ,_, respectively_RR ._.
P08428951A02
VETF_NN is_VBZ a_DD promoter-binding_VVGJ protein_NN with_II DNA-dependent_JJ ATPase_NN activity_NN ._.
P08440361A05
By_II the_DD AC-ELISA_NN ,_, 12_MC patients_NNS were_VBD positive_JJ for_II NNKY1-32_NN and_CC 4_MC for_II NNKY5-5_NN ._.
P08450462A02
Serosal_JJ administration_NN of_II neuropeptide_NN Y_NN (_( NPY_NN )_) ,_, peptide_NN YY_NN (_( PYY_NN )_) ,_, (_( +_SYM )_) -N-cyclopropylmethyl-N-methyl-1_NN ,_, 4-_MC diphenyl-1-ethyl-but-3-en-1-ylamine_NN hydrochloride_NN (_( JO_NN 1784_MC )_) ,_, di_NN (_( ortho-tolyl_NN )_) guanidine_NN (_( DTG_NN )_) and_CC (_( +_SYM )_) -_: or_CC (_( -_SYM )_) -N-allyl-normetazocine_NN (_( NANM_NN )_) produced_VVD concentration-related_VVNJ decreases_NNS in_II short-circuit_NN current_NN (_( Isc_NN )_) without_II changes_NNS in_II tissue_NN conductance_NN ._.
P08455623A06
Initial_JJ results_NNS indicate_VVB that_CST this_DD 23S_NN pre-rRNA_NN is_VBZ the_DD same_PND as_II the_DD species_NN detected_VVN on_II depletion_NN of_II the_DD small_JJ nucleolar_JJ RNA-associated_VVNJ proteins_NNS NOP1_NN and_CC GAR1_NN and_CC in_II an_DD snr10_NN mutant_NN strain_NN ._.
P08466914A04
In_II the_DD case_NN of_II the_DD mfVSG_NN of_II the_DD variant_JJ clone_NN MITat_NN 1.4_MC (_( 470_MC amino_JJ acid_NN residues_NNS )_) ,_, fragmentation_NN occurs_VVZ close_JJ to_II the_DD COOH-terminus_NN (_( Gln433_NN or_CC Thr434_NN )_) as_CS shown_VVN by_II NH2-terminal_JJ sequencing_VVGN ,_, metabolic_JJ labeling_VVGJ experiments_NNS ,_, and_CC molecular_JJ weight_NN determinations_NNS by_II laser_NN desorption_NN /_SYM ionization_NN mass_NN spectrometry_NN ._.
P08478062A07
Although_CS H._NN ducreyi_NN penetrated_VVD between_II human_NN foreskin_NN cells_NNS ,_, internalization_NN was_VBD not_RR a_DD major_JJ component_NN ._.
P08486347A05
Under_II low-stringency_NN in_JJ+ situ_JJ hybridization_NN conditions_NNS ,_, satellite_NN I_MC is_VBZ found_VVN on_II the_DD pericentric_JJ regions_NNS of_II chromosomes_NNS 3_MC and_CC 4_MC and_CC on_II all_DB the_DD acrocentric_JJ chromosomes_NNS ._.
P08491215A04
The_DD purpose_NN of_II the_DD study_NN was_VBD to_TO evaluate_VVI whether_CST the_DD newly_RR developed_VVNJ strain_NN NM3009_NN is_VBZ highly_RR sensitive_JJ toward_II nitroarene_NN compounds_NNS ._.
P08495975A06
Cross-reactive_JJ autoantibody_NN in_II the_DD eluates_NNS immunoprecipitated_VVD a_DD rat_NN RBC_NN protein_NN that_PNR comigrated_VVD with_II band_NN 3_MC ,_, together_RR with_II two_MC bands_NNS of_II 36,000_MC MW_NN and_CC 34,000_MC MW_NN that_PNR may_VM represent_VVB minor_JJ rat_NN glycophorins_NNS ._.
P08498561A02
Arterial_JJ rings_NNS were_VBD contracted_VVN with_II endothelin-1_NN (_( ET-1_NN ;_: 10_MC (_( -10_MC )_) to_II 10_MC (_( -7_MC )_) M_NN )_) and_CC phorbol_NN 12_MC ,_, 13-dibutyrate_NN (_( PDBu_NN ;_: 10_MC (_( -7_MC )_) M_NN )_) after_CS incubating_VVG them_PN for_II 1_MC and_CC 2_MC days_NNS with_II PDBu_NN (_( 200_MC nM_NN )_) in_II the_DD presence_NN and_CC absence_NN of_II CAD_NN (_( 10_MC (_( -4_MC )_) M_NN )_) ._.
P08504767A12
Increased_VVNJ GAD65_NN synthesis_NN thus_RR accounts_VVZ for_II glucose_NN stimulation_NN of_II 64K_NN expression_NN ._.
P08507640A05
Contrary_II+ to_II that_PND for_II the_DD wild-type_NN ,_, the_DD cyanide_NN dissociation_NN rate_NN constant_NN for_II the_DD mutant_NN containing_VVG Arg_NN (_( E10_NN )_) is_VBZ essentially_RR independent_JJ of_II pH_NN (_( from_II 6_MC to_II 9_MC )_) ,_, as_CS expected_VVN on_II the_DD basis_NN of_II the_DD guanidinium_NN group_NN of_II Arg_NN having_VVGN a_DD pK_NN >_SYM 10_MC ._.
P08521814A02
A_DD recurring_VVGJ mechanism_NN for_II the_DD activation_NN of_II haemopoietin_NN receptors_NNS is_VBZ the_DD formation_NN of_II functional_JJ complexes_NNS by_II receptor_NN subunit_NN oligomerization_NN ._.
P08526905A04
T_NN to_II G_NN transversion_NN in_II 5_MC bp_NN upstream_JJ from_II a_DD junction_NN of_II intron_NN 4_MC and_CC exon_NN 5_MC was_VBD found_VVN in_II genomic_JJ DNA_NN of_II the_DD patient_NN ._.
P08528889A09
CSA_NN at_II 10_MC (_( -6_MC )_) or_CC 10_MC (_( -8_MC )_) M_NN did_VDD not_RR alter_VVB basal_JJ release_NN of_II CRH_NN ;_: however_RR ,_, addition_NN of_II either_DD concentration_NN completely_RR blocked_VVD the_DD IL-2-induced_VVNJ release_NN of_II CRH_NN ._.
P08530835A03
On_II the_DD other_JJ hand_NN ,_, all_DD 14_MC pancreatic_JJ cancer_NN tissues_NNS showed_VVD irregular_JJ immunostaining_VVGN on_II the_DD basement_NN membranes_NNS surrounding_VVG cancer_NN cells_NNS ,_, and_CC positive_JJ fibrillar_JJ immunostaining_VVGN for_II type_NN IV_MC collagen_NN in_II the_DD stroma_NN of_II the_DD carcinomatous_JJ parenchyma_NN ._.
P08534761A01
The_DD cell_NN surface_NN phenotype_NN of_II immunoregulatory_JJ lymphocytes_NNS in_II bone_NN marrow_NN (_( BM_NN )_) and_CC peripheral_JJ blood_NN (_( PB_NN )_) in_II myelodysplastic_JJ syndrome_NN (_( MDS_NN )_) ,_, a_DD stem_NN cell_NN disorder_NN ,_, was_VBD analyzed_VVN ._.
P08538171A08
Data_NNS (_( means_NNS +/-_SYM SEM_NN )_) were_VBD analyzed_VVN by_II ANOVA_NN with_II a_DD Newman-Keuls_NN posttest_NN ._.
P08541000A04
We_PN reported_VVD an_DD association_NN between_II homozygosity_NN for_II the_DD 6.3_MC kb_NN allele_NN and_CC hypertension_NN in_II blacks_NNS ._.
P08546385A07
This_DD observation_NN is_VBZ not_RR restricted_VVN to_II skeletal_JJ and_CC heart_NN muscle_NN ,_, but_CC has_VHZ been_VBN observed_VVN in_II lung_NN ,_, dermis_NN ,_, and_CC in_II undefined_VVNJ tissues_NNS following_VVG intravenous_JJ administration_NN ._.
P08550185A03
In_II this_DD study_NN ,_, we_PN have_VHB examined_VVN the_DD fibronectin-binding_VVGJ properties_NNS of_II several_JJ protein_NN F-deficient_JJ mutants_NNS cultured_VVN under_II aerobic_JJ conditions_NNS and_CC have_VHB identified_VVN a_DD second_JJ pathway_NN for_II binding_VVGN fibronectin_NN ._.
P08551577A04
A_DD number_NN of_II cis-acting_VVGJ sequences_NNS within_II the_DD RNA_NN of_II Rous_NN sarcoma_NN virus_NN play_VVB a_DD role_NN in_II preserving_VVGN a_DD large_JJ pool_NN of_II unspliced_VVNJ RNA_NN ._.
P08557038A01
One_MC way_NN in_II which_PNR wild-type_NN p53_NN is_VBZ able_JJ to_TO regulate_VVI cell_NN cycle_NN progression_NN is_VBZ thought_VVN to_TO be_VBI via_II the_DD induction_NN of_II its_PNG downstream_JJ target_NN gene_NN Waf1_NN /_SYM CIP1_NN ,_, thus_RR indirectly_RR regulating_VVG the_DD transcriptional_JJ activity_NN of_II E2F_NN ._.
P08566701A03
We_PN suggest_VVB that_CST structural_JJ changes_NNS of_II RNAIII_NN to_II a_DD translatable_JJ form_NN of_II the_DD molecule_NN precede_VVB its_PNG regulation_NN of_II target_NN gene_NN expression_NN ._.
P08581322A02
Selection_NN of_II test_NN drugs_NNS was_VBD based_VVN on_II possible_JJ interference_NN with_II ricin_NN activity_NN at_II different_JJ stages_NNS of_II the_DD toxic_JJ process_NN ._.
P08587101A01
Nucleic_JJ acids_NNS have_VHB the_DD potential_NN to_TO form_VVI intrastrand_JJ stem-loops_NNS if_CS complementary_JJ bases_NNS are_VBB suitably_RR located_VVN ._.
P08593069A01
The_DD presence_NN of_II methanogenic_JJ bacteria_NN was_VBD assessed_VVN in_II peat_NN and_CC soil_NN cores_NNS taken_VVN from_II upland_NN moors_NNS ._.
P08608599A04
Of_II the_DD LRRs_NNS ,_, 20_MC show_VVB extremely_RR conserved_VVNJ alternating_VVGJ repeats_NNS ._.
P08615665A02
The_DD use_NN of_II the_DD sensitive_JJ ,_, indirect_JJ ,_, four_MC to_II six_MC step_NN immunoperoxidase_NN or_CC alkaline_JJ phosphatase_NN conjugated_VVNJ streptavidin-biotin_NN antigen_NN detection_NN technique_NN provided_VVD excellent_JJ results_NNS ._.
P08619427A05
Six_MC cases_NNS were_VBD subsequently_RR stained_VVN for_II cyclin_NN D1_NN protein_NN ,_, and_CC all_PND showed_VVD nuclear_JJ positivity_NN ._.
P08627623A04
Recently_RR ,_, we_PN developed_VVD a_DD reporter_NN system_NN which_PNR permits_VVZ sequence_NN manipulation_NN in_II the_DD vicinity_NN of_II mutational_JJ hotspots_NNS ._.
P08631494A01
Prespore_NN and_CC prestalk_NN cells_NNS can_VM be_VBB distinguished_VVN within_II aggregates_NNS of_II Dictyostelium_NN by_II the_DD expression_NN of_II well-characterized_VVNJ cell_NN type-specific_JJ genes_NNS ._.
P08637900A12
The_DD disintegrin_NN kistrin_NN was_VBD shown_VVN by_II affinity_NN crosslinking_VVGN to_TO specifically_RR bind_VVI with_II high_JJ affinity_NN to_II alpha-V-beta3_NN and_CC not_RR to_II alpha5-beta1_NN or_CC other_JJ abundant_JJ integrins_NNS ._.
P08645278A04
Peritumor_NN and_CC serum_NN HCV_NN sequences_NNS were_VBD unaffected_VVN ._.
P08648696A08
Surprisingly_RR a_DD gag_NN phylogenetic_JJ tree_NN based_VVN on_II nucleotide_NN sequences_NNS showed_VVD that_CST the_DD African_JJ relatives_NNS closest_JJT to_II all_DD three_MC household-derived_VVNJ SIVs_NNS were_VBD HIV-2_NN subtypes_NNS D_NN and_CC E_NN from_II humans_NNS in_II the_DD same_JJ West_NN African_JJ areas_NNS ._.
P08649398A08
The_DD Tetrahymena_NN H2A_NN genes_NNS confer_VVB a_DD cold-sensitive_JJ phenotype_NN ._.
P08653694A02
The_DD zinc_NN ring_NN domain_NN of_II BRCA1_NN is_VBZ of_II particular_JJ interest_NN because_CS it_PN is_VBZ the_DD location_NN of_II significant_JJ and_CC frequently_RR occurring_VVGJ missense_NN (_( Cys_NN (_( 61_MC )_) Gly_NN ,_, Cys_NN (_( 64_MC )_) Gly_NN ,_, and_CC Cys_NN (_( 64_MC )_) Tyr_NN )_) and_CC frameshift_NN (_( 185delAG_NN )_) mutations_NNS observed_VVN in_II several_JJ high-risk_NN kindreds_NNS ._.
P08661380A05
Our_PNG results_NNS demonstrate_VVB that_CST mutations_NNS within_II the_DD first_JJ five_MC nucleotides_NNS of_II the_DD PBS_NN which_PNR disrupt_VVB base_NN paring_VVGN with_II tRNA_NN (_( Lys_NN ,_, 3_MC )_) -PBS_NN results_VVZ in_II an_DD noninfectious_JJ virus_NN ;_: a_DD G-U_NN base_NN pair_NN at_II position_NN six_MC of_II the_DD tRNA_NN (_( Lys_NN ,_, 3_MC )_) -PBS_NN complex_NN was_VBD tolerated_VVN ._.
P08664298A04
The_DD extensibility_NN varies_VVZ from_II position_NN to_II position_NN in_II a_DD sequence-dependent_JJ manner_NN ,_, being_VBG particularly_RR low_JJ at_II certain_JJ sites_NNS ,_, accordingly_RR called_VVN pause_NN sites_NNS ._.
P08669906A03
To_TO undertake_VVI SDM_NN investigations_NNS ,_, an_DD efficient_JJ ,_, cellulase-free_JJ host_NN is_VBZ required_VVN ._.
P08673848A02
HEWL_NN caused_VVD a_DD premature_JJ decline_NN in_II SRBC-specific_JJ plaque_NN forming_VVGJ cells_NNS (_( PFC_NN )_) and_CC a_DD reduction_NN in_II the_DD total_JJ amount_NN of_II these_DD cells_NNS ._.
P08684619A02
While_CS in_II peripheral_JJ basement_NN membranes_NNS the_DD laminin_NN alpha_NN 1_MC and_CC alpha_NN 2_MC chains_NNS have_VHB an_DD almost_RR mutually_RR exclusive_JJ distribution_NN ,_, the_DD present_JJ results_NNS suggest_VVB both_CC alpha_NN 1_MC and_CC alpha_NN 2_MC in_II the_DD cerebral_JJ capillary_NN basement_NN membrane_NN ._.
P08692289A05
IC50_NN (_( or_CC Ki_NN )_) values_NNS for_II inhibition_NN of_II [_( 3H_NN ]_) MPP+_NN uptake_NN by_II substrates_NNS and_CC inhibitors_NNS of_II uptake2_NN or_CC OCT1_NN were_VBD highly_RR significantly_RR correlated_VVN with_II published_VVNJ IC50_NN values_NNS for_II inhibition_NN of_II uptake2_NN but_CC not_RR with_II corresponding_VVGJ values_NNS for_II inhibition_NN of_II OCT1_NN ._.
P08702221A06
AII_NN underwent_VVD slow_JJ solvolysis_NN in_II culture_NN medium_NN to_II Z-2-chloro-1_NN ,_, 3-diphenyl-2-propen-1-ol_NN and_CC its_PNG oxidized_VVNJ form_NN Z-alpha-chlorochalcone_NN (_( ZCC_NN )_) ._.
P08703509A10
It_PN is_VBZ noteworthy_JJ that_CST some_PND of_II them_PN take_VVB part_NN in_II the_DD catabolism_NN of_II exogenously_RR supplied_VVNJ peptides_NNS and_CC are_VBB necessary_JJ for_II the_DD final_JJ steps_NNS of_II protein_NN turnover_NN ._.
P08709283A06
Finally_RR ,_, coimmunoprecipitation_NN studies_NNS confirmed_VVD that_CST the_DD 52_MC /_SYM 55-kDa_NN protein_NN and_CC IVa2_NN polypeptide_NN interact_VVB specifically_RR during_II the_DD course_NN of_II adenovirus_NN infection_NN ._.
P08713997A04
G_NN alpha_NN (_( s_NN )_) and_CC G_NN alpha_NN (_( i_NN )_) stimulate_VVB and_CC inhibit_VVB adenylyl_NN cyclase_NN ,_, respectively_RR and_CC control_NN cAMP_NN formation_NN ._.
P08723654A03
2H+_NN /_SYM K_NN (_( +_SYM )_) -exchange_NN and_CC H2_NN production_NN are_VBB destroyed_VVN ,_, but_CC H_NN (_( +_SYM )_) -K_NN (_( +_SYM )_) -exchange_NN with_II a_DD variable_JJ stoichiometry_NN for_II N_NN ,_, N'-dicyclohexyl-carbodiimide-sensitive_JJ ion_NN fluxes_NNS is_VBZ displayed_VVN in_II the_DD fdhF_NN mutant_NN E_NN ._.
P08727481A04
Both_DD peptides_NNS contain_VVB cysteine_NN residues_NNS at_II the_DD N-_NN and_CC C-terminus_NN (_( Cys35_NN and_CC Cys46_NN ,_, respectively_RR )_) ._.
P08739095A08
These_DD results_NNS suggest_VVB that_CST RGM-1_NN may_VM be_VBB a_DD useful_JJ model_NN of_II gastric_JJ mucosal_JJ cells_NNS and_CC that_CST PGE2_NN plays_VVZ a_DD role_NN on_II mucin_NN synthesis_NN in_II RGM-1_NN cells_NNS possibly_RR via_II EP4_NN receptors_NNS ._.
P08750163A07
The_DD assay_NN is_VBZ based_VVN on_II hybridization_NN of_II the_DD resulting_VVGJ polymerase_NN chain_NN reaction_NN product_NN with_II oligonucleotide_NN probes_NNS immobilized_VVN as_II parallel_JJ lines_NNS on_II membrane_NN strips_NNS ._.
P08756700A04
After_II three_MC cycles_NNS of_II biopanning_VVGN ,_, four_MC potent_JJ sequences_NNS reactive_JJ with_II TSST-1_NN were_VBD isolated_VVN (_( designated_VVN phages_NNS 2_MC ,_, 3_MC ,_, 8_MC ,_, and_CC 11_MC )_) ._.
P08764482A04
A_DD same_JJ single_JJ 16S_NN rRNA_NN sequence_NN was_VBD found_VVN in_II C._NN orbiculata_NN and_CC C._NN pectinella_NN and_CC was_VBD identical_JJ to_II that_PND found_VVN in_II C._NN orbicularis_NN and_CC Linga_NN pensylvanica_NN ,_, two_MC other_JJ lucinids_NNS living_VVG in_II the_DD same_JJ type_NN of_II environment_NN ._.
P08768732A06
These_DD findings_NNS indicated_VVD that_CST preferential_JJ inhibition_NN for_II S-enantiomer_NN serum_NN binding_VVGN was_VBD caused_VVN by_II changes_NNS that_PNR occurred_VVD during_II hemodialysis_NN ._.
P08770210A08
In_II contrast_NN ,_, the_DD permeability_NN to_II protons_NNS and_CC potassium_NN ions_NNS decreased_VVD sharply_RR by_II two_MC orders_NNS of_II magnitude_NN between_II 14_MC and_CC 18_MC carbon_NN atoms_NNS ,_, and_CC leveled_VVD off_II ,_, when_CS the_DD chain_NN length_NN was_VBD further_RR extended_VVN to_II 24_MC carbon_NN atoms_NNS ._.
P08783021A09
Based_VVN on_II these_DD observations_NNS ,_, protein_NN digest_NN strategies_NNS are_VBB described_VVN for_II the_DD generation_NN of_II 1_MC :_: 1_MC ion_NN doublets_NNS spaced_VVN either_CC by_II 2_MC or_CC 4_MC D_NN ._.
P08786396A10
These_DD data_NNS clearly_RR establish_VVB the_DD presence_NN of_II apoE_NN in_II normal_JJ neurons_NNS ,_, supporting_VVG an_DD intracellular_JJ role_NN for_II apoE_NN ._.
P08793804A02
The_DD authors_NNS '_GE recent_JJ immunohistochemical_JJ study_NN demonstrated_VVD abnormal_JJ expression_NN of_II alpha_NN 3_MC (_( IV_MC )_) and_CC alpha_NN 4_MC (_( IV_MC )_) ,_, as_CC+ well_CC+ as_CC of_II alpha_NN 5_MC (_( IV_MC )_) ,_, in_II patients_NNS with_II this_DD syndrome_NN ,_, and_CC a_DD correlation_NN between_II abnormal_JJ alpha_NN 3_MC (_( IV_MC )_) and_CC alpha_NN 4_MC (_( IV_MC )_) expression_NN and_CC severity_NN of_II the_DD disease_NN ._.
P08796776A06
The_DD results_NNS revealed_VVD that_CST cultured_VVNJ myometrial_JJ cells_NNS produced_VVD prostaglandins_NNS in_II response_NN to_II IL-1_NN beta_NN ,_, TNF-alpha_NN ,_, EGF_NN ,_, PMA_NN ,_, and_CC ionomycin_NN at_II all_DD gestational_JJ ages_NNS tested_VVN at_II a_DD significantly_RR increased_VVNJ rate_NN (_( P_NN <_SYM 0.05_MC vs_CC controls_NNS at_II and_CC above_II 10_MC ng_NN /_SYM ml_NN of_II IL-1_NN beta_NN ,_, TNF_NN alpha_NN ,_, and_CC EGF_NN ;_: 1_MC microM_NN for_II PMA_NN ,_, and_CC 5_MC microM_NN for_II ionomycin_NN )_) ._.
P08801419A04
We_PN have_VHB used_VVN a_DD comparative_JJ approach_NN to_TO study_VVI the_DD sensing_VVGJ function_NN of_II EnvZ_NN ._.
P08804722A06
These_DD results_NNS support_VVB the_DD hypothesis_NN that_CST the_DD clusterin_NN protein_NN is_VBZ synthesised_VVN in_II the_DD astrocytes_NNS ,_, secreted_VVN and_CC then_RR taken_VVN up_II by_II dying_VVGJ neurons_NNS ._.
P08818343A08
In_II producing_VVGN >_SYM 30_MC %_SYM (_( carbachol_NN )_) and_CC >_SYM 60_MC %_SYM (_( histamine_NN )_) relaxation_NN these_DD inhibitors_NNS had_VHD similar_JJ potency_NN and_CC were_VBD poor_JJ compared_VVN to_II salbutamol_NN ._.
P08821939A03
The_DD heavy_JJ subunit_NN was_VBD shown_VVN to_TO be_VBI encoded_VVN by_II a_DD family_NN of_II five_MC hgl_NN genes_NNS ,_, which_PNR were_VBD physically_RR mapped_VVN to_II five_MC distinct_JJ HindIII_NN restriction_NN fragments_NNS ._.
P08828574A10
Rat_NN ADM_NN (_( 1-50_MC )_) did_VDD not_RR raise_VVB cytosolic_JJ free_JJ calcium_NN concentrations_NNS in_II astrocytes_NNS and_CC NG108-15_NN cells_NNS ._.
P08834116A07
The_DD I_NN /_SYM V_NN curves_NNS were_VBD modeled_VVN employing_VVG the_DD "_`` Two-state_NN "_'' model_NN for_II the_DD H+_NN pump_NN (_( Hansen_NNP et_CC al._NN ,_, 1981_MC )_) ._.
P08841594A04
A_DD comparative_JJ analysis_NN of_II 64_MC aptamers_NNS that_PNR were_VBD isolated_VVN from_II the_DD 11th_JJ generation_NN revealed_VVD two_MC main_JJ sequence_NN classes_NNS ._.
P08844859A08
(_( 2_MC )_) For_II more_RR than_CSN 86_MC %_SYM (_( +/-_SYM 3_MC %_SYM )_) of_II the_DD proteins_NNS ,_, topology_NN is_VBZ predicted_VVN correctly_RR ._.
P08857859A02
BACKGROUND_NN :_: Topical_JJ application_NN of_II the_DD protein_NN PDGF-B_NN has_VHZ improved_VVN wound_NN healing_VVGN in_II experimental_JJ studies_NNS of_II healing-impaired_VVNJ wounds_NNS ._.
P08861034A03
Another_DD LPS-protein_NN complex_NN obtained_VVN by_II the_DD simple_JJ mixture_NN of_II LPS_NN preparations_NNS from_II strain_NN 503_MC and_CC a_DD 17-kDa_NN membrane_NN protein_NN from_II the_DD avirulent_JJ R-variant_NN of_II the_DD vaccine_NN strain_NN 15_MC also_RR demonstrated_VVD protective_JJ properties_NNS against_II experimental_JJ tularemia_NN in_II mice_NNS ._.
P08865127A08
Whether_CST the_DD observed_VVNJ in_JJ+ vitro_JJ antagonism_NN between_II paclitaxel_NN and_CC etoposide_NN or_CC doxorubicin_NN predicts_VVZ for_II similar_JJ interaction_NN in_II the_DD clinical_JJ use_NN of_II these_DD drugs_NNS in_II combination_NN is_VBZ unknown_VVN ._.
P08872146A03
Positive_JJ staining_VVGJ results_NNS for_II CK_NN 1_MC ,_, 5_MC ,_, 10_MC and_CC 14_MC were_VBD not_RR observed_VVN using_VVG the_DD 34_MC beta_NN E12_NN antibody_NN ._.
P08879494A05
It_PN migrated_VVD as_II a_DD 105-kDa_NN protein_NN by_II molecular_JJ sieving_VVGN under_II denaturing_VVGJ conditions_NNS ._.
P08886028A05
The_DD rate_NN constant_NN of_II decay_NN matches_VVZ the_DD rate_NN constant_NN of_II the_DD main_JJ unfolding_VVGJ transition_NN ,_, showing_VVG that_CST early_JJ in_II the_DD cold_JJ denaturation_NN reaction_NN ,_, beta-lactoglobulin_NN is_VBZ kinetically_RR trapped_VVN in_II a_DD partially_RR unfolded_VVNJ intermediate_JJ state_NN ._.
P08892528A03
In_II this_DD study_NN ,_, electron_NN paramagnetic_JJ resonance_NN spectroscopy_NN was_VBD used_VVN to_TO detect_VVI nitrosyl_NN protein_NN complexes_NNS indicating_VVG nitric_JJ oxide_NN (_( .NO_NN )_) production_NN ._.
P08900244A06
While_CS the_DD frequency_NN of_II DQB1*0302_NN on_II DR4_NN haplotypes_NNS is_VBZ dramatically_RR increased_VVN in_II DR3_NN /_SYM DR4_NN patients_NNS ,_, DR4_NN haplotypes_NNS in_II DR1_NN /_SYM DR4_NN patients_NNS exhibit_VVB frequencies_NNS of_II DQB1*0302_NN and_CC DQB1*0301_NN more_RR closely_RR resembling_VVG those_PND in_II control_NN populations_NNS ._.
P08902206A07
In_II the_DD testis_NN ,_, Pem_NN mRNA_NN levels_NNS were_VBD elevated_VVN earlier_RRR (_( between_II Days_NNS 12_MC and_CC 15_MC postpartum_NN )_) and_CC less_RR dramatically_RR than_CSN in_II epididymis_NN ._.
P08916930A09
While_CS induction_NN of_II SSAT_NN mRNA_NN by_II inhibitors_NNS of_II protein_NN synthesis_NN only_RR occurred_VVD at_II concentrations_NNS which_PNR blocked_VVD protein_NN synthesis_NN ,_, that_PND by_II DENSPM_NN took_VVD place_NN at_II concentrations_NNS which_PNR did_VDD not_RR ._.
P08922300A01
Studies_NNS suggest_VVB that_CST micronutrients_NNS such_II+ as_II the_DD tocopherols_NNS ,_, retinol_NN ,_, and_CC the_DD carotenoids_NNS have_VHB a_DD chemopreventive_JJ action_NN against_II colonic_JJ carcinogenesis_NN and_CC that_CST they_PN may_VM be_VBB essential_JJ for_II the_DD functioning_VVGN and_CC structural_JJ integrity_NN of_II the_DD gastrointestinal_JJ epithelium_NN ._.
P08936402A02
The_DD method_NN has_VHZ characteristic_JJ features_NNS ,_, a_DD single_JJ injection_NN of_II an_DD emulsified_VVNJ antigen_NN via_II the_DD rat_NN 's_GE hind_JJ footpads_NNS is_VBZ sufficient_JJ for_II immunization_NN ._.
P08945567A04
Serum_NN from_II convalescent_JJ rainbow_NN trout_NN (_( Oncorhynchus_NN mykiss_NN )_) and_CC coho_NN salmon_NN (_( Oncorhynchus_NN kisutch_NN )_) reacted_VVD with_II several_JJ minor_JJ immunoreactive_JJ protein_NN antigens_NNS between_II 10_MC and_CC 70_MC kDa_NN in_II size_NN and_CC a_DD carbohydrate_NN antigen_NN with_II a_DD relative_JJ molecular_JJ size_NN of_II approximately_RR 11_MC kDa_NN ._.
P08950710A04
In_II the_DD current_JJ study_NN ,_, high_JJ magnification_NN electron_NN microscopy_NN was_VBD used_VVN to_TO examine_VVI the_DD myelin_NN membrane_NN packing_VVGN in_II sural_JJ nerve_NN biopsies_NNS from_II patients_NNS with_II MPZ_NN mutations_NNS ._.
P08955200A05
A_DD third_JJ generation_NN of_II vaccines_NNS consisting_VVG of_II naked_JJ DNA_NN encoding_VVG the_DD Id-granulocyte-macrophage_NN colony-stimulating_VVGJ factor_NN (_( GM-CSF_NN )_) fusion_NN proteins_NNS was_VBD equally_RR effective_JJ in_II inducing_VVGN tumor_NN immunity_NN ._.
P08960294A03
Antibodies_NNS exhibited_VVD specific_JJ reaction_NN with_II native_JJ rat_NN SP-A_NN in_II Western_NN blot_NN and_CC immunohistochemical_JJ analysis_NN ._.
P08969469A06
The_DD sequence_NN and_CC distribution_NN of_II the_DD element_NN as_CC+ well_CC+ as_CC it_PN 's_GE proximity_NN to_II the_DD Adh_NN gene_NN are_VBB discussed_VVN ._.
P08981749A04
Isothermal_JJ unfolding_VVGJ kinetics_NNS from_II spectrophotometry_NN confirm_VVB this_DD result_NN ._.
P08987164A09
In_II patients_NNS association_NN between_II the_DD 4G_NN /_SYM 5G_NN genotypes_NNS and_CC PAI_NN activity_NN was_VBD observed_VVN ,_, with_II the_DD highest_JJT values_NNS in_II the_DD 4G_NN /_SYM 4G_NN genotype_NN (_( 13.3_MC U_NN /_SYM mL_NN )_) ,_, median_JJ values_NNS in_II the_DD 4G_NN /_SYM 5G_NN genotype_NN (_( 9.8_MC U_NN /_SYM mL_NN )_) and_CC the_DD lowest_JJT values_NNS in_II the_DD 5G_NN /_SYM 5G_NN genotype_NN (_( 2.0_MC U_NN /_SYM mL_NN )_) ._.
P08994437A10
Radioimmunologic_JJ measurement_NN of_II cellular_JJ cAMP_NN in_II the_DD dissociated_VVNJ myocytes_NNS showed_VVD that_CST angiotensin_NN II_MC inhibited_VVD the_DD isoproterenol-induced_VVNJ increase_NN of_II cAMP_NN ._.
P08999892A06
A_DD monoclonal_JJ antibody_NN against_II the_DD hirudin-like_JJ domain_NN of_II the_DD G-protein-linked_VVNJ receptor_NN abrogated_VVD alpha-thrombin_NN binding_VVGN to_II platelets_NNS ,_, cleavage_NN of_II TR-_NN (_( 1-41_MC )_) ,_, and_CC platelet_NN activation_NN by_II <_SYM /_SYM =1.0_MC nM_NN (_( but_CC not_RR 10_MC nM_NN )_) alpha-thrombin_NN ._.
P09007541A02
In_JJ+ vivo_JJ measurements_NNS of_II calcium_NN in_II the_DD interstitial_JJ space_NN and_CC in_II the_DD tissue_NN suggest_VVB the_DD occurrence_NN of_II a_DD posttraumatic_JJ shift_NN of_II calcium_NN from_II the_DD extracellular_JJ to_II the_DD intracellular_JJ compartment_NN at_II the_DD injury_NN site_NN ._.
P09010720A12
A_DD tight_JJ regulation_NN of_II expression_NN of_II CD40L_NN on_II T_NN cells_NNS and_CC costimulatory_JJ activity_NN on_II APC_NN would_VM prevent_VVB activation_NN of_II unwanted_VVNJ bystander_NN T_NN cells_NNS ._.
P09013974A06
Inhibition_NN of_II TNF-alpha_NN secretion_NN by_II LPS-stimulated_VVNJ THP-1-hGH_NN cells_NNS was_VBD associated_VVN with_II a_DD decrease_NN in_II nuclear_JJ translocation_NN of_II nuclear_JJ factor-kappaB_NN ._.
P09017600A05
It_PN was_VBD found_VVN that_CST approximately_RR 90_MC %_SYM of_II the_DD total_JJ cellular_JJ gelsolin_NN was_VBD found_VVN in_II the_DD Triton_NN X-100-soluble_JJ fraction_NN in_II suspended_VVNJ cells_NNS ,_, but_CS+ that_CS upon_II adherence_NN to_II either_CC fibronectin-_NN or_CC laminin-coated_VVNJ plastic_NN about_II 40_MC %_SYM of_II the_DD soluble_JJ gelsolin_NN could_VM be_VBB detected_VVN in_II the_DD insoluble_JJ fraction_NN ._.
P09031443A03
A_DD missense_NN mutation_NN ,_, G_NN to_II T_NN transversion_NN at_II codon_NN Cys598_NN ,_, and_CC two_MC different_JJ alterations_NNS ,_, leading_VVG either_CC to_II allelic_JJ exclusion_NN ,_, or_CC premature_JJ termination_NN of_II the_DD protein_NN translation_NN :_: a_DD G_NN to_II A_NN transition_NN at_II codon_NN Trp465_NN and_CC a_DD 1_MC nt_NN (_( T_NN )_) insertion_NN at_II codon_NN 265_MC ,_, were_VBD identified_VVN ._.
P09038379A05
Northern_NN blot_NN analysis_NN of_II fractionated_VVNJ testicular_JJ cells_NNS and_CC in_JJ+ situ_JJ hybridization_NN histochemistry_NN demonstrated_VVD that_CST vav-T_NN transcripts_NNS were_VBD expressed_VVN in_II the_DD differentiating_VVGJ germ_NN cells_NNS ,_, especially_RR spermatocytes_NNS ._.
P09042158A09
Isolated_VVNJ cells_NNS were_VBD aspirated_VVN into_II a_DD micropipette_NN fixed_VVN to_II a_DD second_JJ micromanipulator_NN and_CC transferred_VVN into_II a_DD PCR_NN tube_NN ._.
P09058200A04
These_DD three_MC [_( 32P_NN ]_) phosphoproteins_NNS were_VBD identified_VVN as_II calcium-binding_VVGJ proteins_NNS (_( CaBP_NN )_) 1_MC ,_, 2_MC ,_, and_CC 4_MC after_II purification_NN on_II a_DD MonoQ_NN column_NN followed_VVN by_II SDS-PAGE_NN ,_, proteolytic_JJ cleavage_NN and_CC subsequent_JJ amino_JJ acid_NN sequencing_VVGN of_II the_DD purified_VVNJ 32P-labeled_VVNJ peptides_NNS ._.
P09063728A01
In_II an_DD attempt_NN to_TO identify_VVI and_CC characterize_VVI novel_JJ Schwann_NN cell_NN surface_NN molecules_NNS with_II putative_JJ functions_NNS during_II development_NN ,_, maintenance_NN ,_, and_CC regeneration_NN of_II the_DD peripheral_JJ nervous_JJ system_NN (_( PNS_NN )_) ,_, we_PN have_VHB produced_VVN monoclonal_JJ antibodies_NNS against_II viable_JJ neonatal_JJ rat_NN Schwann_NN cells_NNS ._.
P09075674A08
A_DD significant_JJ increase_NN in_II LDH_NN leakage_NN reflecting_VVG a_DD toxic_JJ effect_NN of_II iron_NN was_VBD found_VVN in_II the_DD cell_NN medium_NN 48_MC h_NN after_II cell_NN seeding_VVGN ._.
P09085128A05
Transformed_VVNJ Escherichia_NN coli_NN TG1_NN cells_NNS were_VBD infected_VVN with_II M13K07_NN helper_NN phage_NN to_TO yield_VVI recombinant_JJ phage_NN ,_, which_PNR display_VVB ScFv_NN fragments_NNS as_II a_DD g3p_NN fusion_NN protein_NN on_II the_DD surface_NN of_II the_DD filamentous_JJ phage_NN M13_NN ._.
P09093843A02
We_PN studied_VVD gene_NN replacement_NN using_VVG a_DD related_VVNJ method_NN of_II gene_NN transfer_NN (_( transformation_NN with_II 6.5-kb_NN linear_JJ DNA_NN fragments_NNS )_) as_II an_DD experimental_JJ model_NN for_II conjugation_NN and_CC transduction_NN ._.
P09099468A05
The_DD in_JJ+ vitro_JJ design_NN described_VVN could_VM be_VBB useful_JJ to_TO evaluate_VVI compounds_NNS with_II putative_JJ immunomodulatory_JJ activities_NNS ._.
P09102198A04
After_II a_DD brief_JJ introduction_NN to_II model_NN kinetics_NNS used_VVN to_TO relate_VVI amide_NN hydrogen_NN exchange_NN rates_NNS to_II protein_NN structure_NN and_CC dynamics_NNS ,_, information_NN required_VVN to_TO understand_VVI and_CC implement_VVI a_DD new_JJ method_NN that_PNR uses_VVZ acid_NN proteases_NNS and_CC mass_NN spectrometry_NN to_TO determine_VVI amide_NN hydrogen_NN exchange_NN rates_NNS in_II proteins_NNS is_VBZ presented_VVN ._.
P09105768A04
The_DD results_NNS seem_VVB to_TO indicate_VVI that_CST myoinositol_NN ,_, in_II the_DD concentrations_NNS observed_VVN in_II uremic_JJ blood_NN serum_NN ,_, may_VM possibly_RR share_VVB the_DD responsibility_NN for_II uremic_JJ immune_JJ deficiency_NN ._.
P09114737A10
Although_CS cells_NNS expressing_VVG the_DD macrophage_NN phenotype_NN :_: CD1a-_NN DRhi_NN CD11b+_NN CD36+_NN were_VBD increased_VVN in_II UVA_NN II_MC skin_NN ,_, relative_JJ to_II C-EC_NN ,_, these_PND comprised_VVD only_RR 10.1_MC +/-_SYM 6.1_MC %_SYM of_II the_DD DR+_NN cells_NNS ,_, which_PNR is_VBZ less_RR than_CSN that_PND after_II UVB_NN exposure_NN ._.
P09119204A05
The_DD results_NNS also_RR revealed_VVD that_CST both_DD enzymes_NNS act_VVB in_II the_DD internalization_NN step_NN of_II endocytosis_NN ._.
P09130229A05
The_DD presence_NN of_II nonreciprocal_JJ recombination_NN in_II P._NN gingivalis_NN was_VBD experimentally_RR proven_VVN using_VVG suicide_NN /_SYM integration_NN plasmid_NN systems_NNS ._.
P09137451A07
CONCLUSION_NN :_: Apart_II+ from_II TGF-beta_NN ,_, MBT-2_NN cells_NNS ,_, both_CC irradiated_VVNJ and_CC nonirradiated_VVNJ ,_, may_VM also_RR secrete_VVB other_JJ suppressive_JJ factors_NNS that_PNR adversely_RR downregulate_VVB the_DD immune_JJ response_NN of_II TBM_NN which_PNR can_VM not_RR then_RR be_VBB adequately_RR reversed_VVN by_II IFN-alpha_NN ._.
P09144425A03
Efficiency_NN of_II induction_NN of_II apoptosis_NN of_II HL60_NN cells_NNS by_II irradiation_NN of_II a_DD solution_NN containing_VVG 2_MC was_VBD only_RR slightly_RR lower_JJR than_CSN that_PND by_II leucyl-leucine_NN methyl_NN ester_NN itself_PN ._.
P09149284A01
We_PN reanalyzed_VVD parasitaemia_NN profiles_NNS of_II the_DD trypanotolerant_JJ N'Dama_NN cattle_NN (_( Bos_NN taurus_NN )_) ,_, consecutively_RR infected_VVN with_II the_DD same_JJ four_MC clones_NNS of_II Trypanosoma_NN congolense_NN ._.
P09163618A03
Most_DD CD34-positive_JJ PBPC_NN are_VBB quiescent_JJ (_( <_SYM 1_MC %_SYM in_II S_NN phase_NN )_) when_CS they_PN are_VBB collected_VVN from_II the_DD bloodstream_NN of_II patients_NNS treated_VVN with_II cyclophosphamide_NN and_CC granulocyte_NN colony-stimulating_VVGJ factor_NN (_( G-CSF_NN )_) ,_, but_CC we_PN have_VHB shown_VVN that_CST they_PN are_VBB able_JJ to_TO resume_VVI proliferation_NN rapidly_RR in_RR+ vitro_RR by_II measuring_VVGN the_DD kinetics_NNS of_II CFU-GM_NN production_NN by_II primitive_JJ plastic-adherent_JJ (_( Pdelta_NN )_) cells_NNS ._.
P09166761A11
The_DD rate_NN of_II accumulation_NN of_II ppERK2_NN is_VBZ decreased_VVN by_II increasing_VVGN the_DD ERK2_NN concentration_NN ._.
P09178499A06
This_DD RT-PCR-RFLP_NN approach_NN was_VBD tested_VVN with_II Old_JJ World_NN (_( LCM_NN )_) and_CC New_JJ World_NN (_( Junin_NN and_CC Tacaribe_NN )_) arenaviruses_NNS ._.
P09182549A06
Expression_NN of_II S-AKAP84_NN in_II transfected_VVNJ HEK293_NN cells_NNS triggered_VVD a_DD redistribution_NN of_II 15_MC %_SYM of_II total_JJ RII_NN to_II mitochondria_NNS ._.
P09187078A05
To_TO further_RR define_VVI the_DD nature_NN of_II the_DD myogenic_JJ defects_NNS in_II myogenin-null_JJ mice_NNS ,_, we_PN investigated_VVD whether_CST myogenin-null_JJ myoblasts_NNS are_VBB capable_JJ of_II fusing_VVGN with_II wild-type_NN myoblasts_NNS in_RR+ vivo_RR using_VVG chimeric_JJ mice_NNS containing_VVG mixtures_NNS of_II myogenin-null_JJ and_CC wild-type_NN cells_NNS ._.
P09190912A02
G0_NN T_NN cells_NNS express_VVB high_JJ levels_NNS of_II p27Kip1_NN protein_NN and_CC specific_JJ mRNA_NN ,_, which_PNR decline_VVB rapidly_RR following_VVG activation_NN ._.
P09194315A01
In_II the_DD rabbit_NN retina_NN ,_, the_DD nuclear_JJ dye_NN ,_, 4_MC ,_, 6_MC ,_, diamidino-2-phenylindole_NN (_( DAPI_NN )_) ,_, selectively_RR labels_VVZ a_DD third_JJ type_NN of_II amacrine_NN cell_NN ,_, in_II addition_NN to_II the_DD previously_RR characterized_VVNJ type_NN a_NN and_CC type_NN b_NN cholinergic_JJ amacrine_NN cells_NNS ._.
P09198586A04
Staining_VVGN with_II avidin-horseradish_NN peroxidase_NN revealed_VVD only_RR biotin-labeled_VVNJ proteins_NNS from_II the_DD vector_NN which_PNR were_VBD bound_VVN to_II the_DD parasite_NN ._.
P09201967A06
Expression_NN of_II these_DD proteins_NNS in_II the_DD yeast_NN Saccharomyces_NN cerevisiae_NN JPY201_NN was_VBD found_VVN to_TO confer_VVI cellular_JJ resistance_NN to_II cytotoxic_JJ concentrations_NNS of_II this_DD lipid_NN by_II a_DD factor_NN of_II 4-20-fold_NN in_II a_DD growth_NN inhibition_NN assay_NN ._.
P09208437A03
The_DD incorporated_VVNJ procedure_NN included_VVD recovery_NN of_II the_DD digested_VVNJ DNA_NN with_II glassmilk_NN before_II PCR_NN ,_, which_PNR markedly_RR enhanced_VVD the_DD rate_NN of_II accurate_JJ detection_NN of_II transgenic_JJ embryos_NNS ._.
P09218217A07
These_DD results_NNS also_RR suggest_VVB that_CST the_DD cAMP_NN binding_VVGJ site_NN of_II f-channels_NNS may_VM be_VBB structurally_RR similar_JJ to_II the_DD cyclic_JJ nucleotide_NN binding_VVGJ site_NN of_II olfactory_NN receptor_NN channels_NNS ._.
P09226897A12
Two_MC trees_NNS based_VVN on_II 16S-23S_NN and_CC 23S-5S_NN ITS_NN sequences_NNS revealed_VVD distinct_JJ interspecific_JJ relationships_NNS in_II the_DD genus_NN Saccharomonospora_NN ._.
P09233596A02
Neutralizing_VVGN Abs_NNS against_II CINC_NN have_VHB been_VBN shown_VVN previously_RR to_TO be_VBI efficacious_JJ in_II several_JJ models_NNS of_II inflammation_NN ,_, indicating_VVG that_CST CINC_NN is_VBZ an_DD important_JJ proinflammatory_JJ mediator_NN in_RR+ vivo_RR ._.
P09239710A06
Immunoreactivity_NN for_II eNOS_NN and_CC iNOS_NN was_VBD not_RR present_JJ in_II endometrial_JJ stroma_NN throughout_II the_DD menstrual_JJ cycle_NN ,_, but_CC iNOS-like_JJ immunoreactivity_NN was_VBD seen_VVN in_II decidualized_VVNJ stromal_JJ cells_NNS both_CC following_VVG treatment_NN with_II exogenous_JJ progestagen_NN (_( intrauterine_JJ L-norgestrel_NN )_) and_CC in_II tissues_NNS obtained_VVN in_II the_DD first_JJ trimester_NN of_II pregnancy_NN ._.
P09246095A05
No_DD synergy_NN was_VBD demonstrated_VVN between_II transforming_VVGJ growth_NN factor-beta_NN 1_MC and_CC bone_NN morphogenetic_JJ protein-3_NN in_II the_DD ability_NN to_TO upregulate_VVI expression_NN of_II the_DD collagen_NN alpha_NN 1_MC (_( II_MC )_) gene_NN ._.
P09252410A04
2_MC )_) Casein_NN kinase_NN activity_NN co-eluted_VVD with_II MRK_NN activity_NN from_II the_DD final_JJ two_MC chromatography_NN steps_NNS in_II the_DD purification_NN of_II porcine_JJ brain_NN MRK_NN ._.
P09257876A04
We_PN have_VHB investigated_VVN the_DD phenotypic_JJ and_CC functional_JJ characteristics_NNS of_II purified_VVNJ CD2+_NN cells_NNS from_II B-CLL_NN patients_NNS at_II Binet_NN 's_GE stage_NN A_NN and_CC classified_VVN according_II+ to_II the_DD neoplastic_JJ B_NN lymphocyte_NN morphology_NN criteria_NNS :_: 32_MC patients_NNS with_II typical_JJ B-CLL_NN and_CC 12_MC patients_NNS with_II atypical_JJ B-CLL_NN ._.
P09268729A02
We_PN show_VVB here_RR that_CST this_DD tRNATyr_NN gene_NN sequence_NN is_VBZ present_JJ in_II several_JJ copies_NNS in_II the_DD mitochondrial_JJ genome_NN of_II A._NN thaliana_NN ._.
P09277513A04
VEGF120_NN and_CC VEGF164_NN were_VBD the_DD major_JJ isoforms_NNS detected_VVN in_II uterine_JJ tissues_NNS ;_: all_DD members_NNS of_II the_DD VEGF_NN family_NN (_( VEGF120_NN ,_, VEGF164_NN ,_, VEGF188_NN ,_, and_CC VEGF205_NN )_) were_VBD expressed_VVN in_II LP_NN placentas_NNS ._.
P09281409A05
Confirmatory_JJ assays_NNS were_VBD used_VVN which_PNR amplified_VVD segments_NNS of_II the_DD major_JJ outer_JJ membrane_NN gene_NN by_II PCR_NN or_CC LCR_NN ._.
P09284267A07
As_CS previously_RR described_VVN ,_, adult_NN myocytes_NNS exhibited_VVD a_DD brisk_JJ contraction_NN in_II response_NN to_II caffeine_NN ._.
P09288886A07
Adduct_NN formation_NN levelled_VVD off_II at_II higher_JJR exposure_NN levels_NNS ,_, suggesting_VVG less_RR efficient_JJ adduct_NN formation_NN ;_: decreases_NNS in_II the_DD formation_NN of_II adducts_NNS per_II unit_NN of_II exposure_NN were_VBD found_VVN in_II lymphocytes_NNS (_( r_NN (_( s_NN )_) =_SYM -0.80_MC ,_, p_NN <_SYM 0.001_MC )_) and_CC BAL_NN cells_NNS (_( r_NN (_( s_NN )_) =_SYM -0.72_MC ,_, p_NN <_SYM 0.001_MC )_) ._.
P09300677A04
Interestingly_RR ,_, a_DD drastic_JJ up-regulation_NN (_( 7-10_MC fold_NN )_) of_II RARbeta2_NN messages_NNS and_CC a_DD significant_JJ decrease_NN of_II RARbeta4_NN messages_NNS in_II AS-RARbeta1_NN /_SYM beta3_NN macrophages_NNS were_VBD observed_VVN compared_VVN with_II that_PND of_II nontransgenic_JJ macrophages_NNS ._.
P09305768A05
PCR_NN ,_, Northern_NN and_CC genomic_JJ Southern_NN analyses_NNS showed_VVD that_CST Branchiostoma_NN CaM_NN is_VBZ encoded_VVN by_II a_DD single_JJ copy_NN gene_NN ,_, while_CS fish_NN are_VBB known_VVN to_TO have_VHI at_RR+ least_RR four_MC CaM_NN genes_NNS ._.
P09312173A06
Severely_RR lipopenic_JJ islets_NNS of_II rats_NNS made_VVN chronically_RR hyperleptinemic_JJ by_II adenoviral_JJ leptin_NN gene_NN transfer_NN resisted_VVD IL-1beta_NN cytotoxicity_NN even_RR at_II 300_MC pg_NN /_SYM ml_NN ,_, the_DD maximal_JJ concentration_NN ._.
P09323490A04
Endothelial_JJ permeability_NN was_VBD monitored_VVN by_II measuring_VVGN the_DD amount_NN of_II fluorescein_NN isothiocyanate-labeled_VVNJ dextran_NN (_( FITC-Dx_NN )_) passing_VVG through_II the_DD calf_NN pulmonary_JJ arterial_JJ endothelial_JJ (_( CPAE_NN )_) cell_NN monolayer_NN ._.
P09326587A03
Here_RR we_PN report_VVB that_CST the_DD CSB_NN gene_NN product_NN enhances_VVZ elongation_NN by_II RNA_NN polymerase_NN II_MC ._.
P09332461A06
RESULTS_NNS :_: CPT_NN was_VBD extremely_RR potent_JJ against_II MDA-MB-157_NN cells_NNS with_II an_DD IC50_NN value_NN of_II 7_MC nM_NN compared_VVN with_II IC50_NN values_NNS of_II 150_MC nM_NN for_II GI_NN 101A_NN and_CC 250_MC nM_NN for_II MDA-MB-231_NN cells_NNS ._.
P09335256A09
Finally_RR ,_, the_DD peroxynitrite_NN scavenger_NN uric_JJ acid_NN protected_VVD neurons_NNS against_II apoptosis_NN induced_VVN by_II FeSO4_NN and_CC Abeta_NN ,_, and_CC suppressed_VVD peroxynitrite_NN accumulation_NN ._.
P09343337A09
At_II high_JJ rates_NNS of_II viral_JJ inoculation_NN ,_, LPS_NN had_VHD no_DD enhancing_VVGJ effect_NN on_II PCA_NN expression_NN ._.
P09352013A03
METHOD_NN OF_II STUDY_NN :_: During_II the_DD perfusion_NN of_II an_DD isolated_VVNJ cotyledon_NN from_II human_NN term_NN placenta_NN the_DD perfusate_NN was_VBD recirculated_VVN on_II both_CC maternal_JJ and_CC fetal_JJ sides_NNS ._.
P09354688A01
Malaria-parasitized_VVNJ erythrocytes_NNS have_VHB increased_VVNJ endothelial_JJ adherence_NN due_II+ to_II exposure_NN of_II previously_RR buried_VVNJ intramembranous_JJ sites_NNS of_II band_NN 3_MC ._.
P09357050A08
These_DD findings_NNS with_II the_DD snail_NN ,_, Cepaea_NN ,_, indicate_VVB that_CST NMDA_NN systems_NNS /_SYM receptors_NNS are_VBB associated_VVN with_II the_DD mediation_NN of_II the_DD nociceptive_JJ effects_NNS of_II both_CC kappa_NN opioids_NNS and_CC orphanin_NN FQ_NN ._.
P09359435A15
Molecular_JJ dynamics_NNS simulations_NNS indicated_VVD that_CST the_DD isopropyl_NN chain_VVB that_PNR is_VBZ lost_VVN interacted_VVD with_II Trp-82_NN ,_, suggesting_VVG that_CST Trp-82_NN has_VHZ a_DD role_NN in_II stabilizing_VVGN the_DD carbonium_NN ion_NN that_PNR is_VBZ released_VVN in_II the_DD dealkylation_NN step_NN ._.
P09367373A01
To_TO identify_VVI potential_JJ selection_NN pressures_NNS which_PNR lead_VVB to_II RNA_NN sequence_NN conservation_NN ,_, we_PN examined_VVD the_DD occurrence_NN rates_NNS of_II dinucleotides_NNS in_II 64_MC single-stranded_VVNJ RNA_NN virus_NN genomes_NNS ._.
P09370349A13
These_DD experiments_NNS suggest_VVB that_CST phosphatases_NNS are_VBB involved_VVN in_II the_DD rapid_JJ shut-down_NN by_II TNF-alpha_NN of_II p42_NN MAP_NN kinase_NN activity_NN ._.
P09373348A05
Expression_NN and_CC purification_NN procedures_NNS were_VBD established_VVN to_TO enable_VVI the_DD rapid_JJ production_NN of_II 1C3_NN Fab-peptide_NN epitope_NN conjugates_NNS ._.
P09376654A05
The_DD results_NNS show_VVB that_CST lectins_NNS and_CC antibodies_NNS may_VM be_VBB used_VVN as_II markers_NNS for_II the_DD detection_NN of_II basal_JJ cells_NNS in_II the_DD human_NN respiratory_JJ epithelium_NN ._.
P09384564A11
This_PND could_VM be_VBB a_DD favorable_JJ entropic_JJ factor_NN contributing_VVG to_II the_DD increased_VVNJ affinity_NN ._.
P09393441A03
Meiosis_NN and_CC sporulation_NN were_VBD defective_JJ in_II homozygous_JJ crosses_NNS between_II mus-23_NN haploids_NNS ._.
P09399698A09
Transcription_NN factors_NNS specifically_RR bound_VVN to_II this_DD sequence_NN showed_VVD a_DD dose-dependent_JJ response_NN to_II single_JJ doses_NNS of_II X_NN rays_NNS between_II 1_MC and_CC 8_MC Gy_NN ._.
P09400975A09
Taken_VVN together_RR ,_, our_PNG findings_NNS suggest_VVB that_CST there_EX is_VBZ one_MC single_JJ genotype_NN of_II HGV_NN and_CC that_CST the_DD HGV_NN genome_NN cloned_VVN from_II the_DD healthy_JJ carrier_NN is_VBZ not_RR significantly_RR different_JJ from_II those_PND derived_VVN from_II patient_NN sera_NNS ._.
P09401774A10
When_CS added_VVN alone_JJ ,_, perindoprilat_NN (_( 10_MC microM_NN )_) did_VDD not_RR alter_VVB the_DD S-I_NN efflux_NN ._.
P09408080A09
When_CS the_DD cells_NNS were_VBD prelabelled_VVN with_II [_( 3H_NN ]_) tamoxifen_NN aziridine_NN (_( [_( 3H_NN ]_) TAZ_NN )_) before_II their_PNG exposure_NN to_II E2_NN ,_, ER_NN cleavage_NN could_VM not_RR be_VBB detected_VVN due_II+ to_II the_DD lack_NN of_II activation_NN potency_NN of_II the_DD antiestrogenic_JJ ligand_NN ._.
P09415615A08
These_DD associations_NNS and_CC the_DD in_JJ+ situ_JJ divergence_NN of_II CD4_NN and_CC CD8_NN ratios_NNS suggest_VVB that_CST prognostic_JJ indicators_NNS for_II disease_NN evolution_NN could_VM be_VBB identified_VVN by_II prospective_JJ analysis_NN of_II cellular_JJ relationships_NNS and_CC response_NN to_II therapy_NN ._.
P09427029A09
Flow_NN cytometric_JJ analysis_NN revealed_VVD a_DD higher_JJR incidence_NN of_II DNA_NN aneuploidy_NN in_II 75_MC %_SYM (_( 15_MC of_II 20_MC )_) of_II p53_NN positive_JJ cases_NNS compared_VVN with_II 64.3_MC %_SYM (_( 9_MC of_II 14_MC )_) in_II the_DD diploid_NN tumors_NNS ._.
P09442079A08
Also_RR ,_, overexpression_NN of_II src_NN induced_VVD phosphorylation_NN of_II p130cas_NN ._.
P09446650A13
Studies_NNS with_II progeny_NN of_II burst-forming_VVGJ unit-erythroid_NN (_( BFU-E_NN )_) suggest_VVB that_CST the_DD FRET_NN technique_NN is_VBZ sufficiently_RR sensitive_JJ to_TO detect_VVI c-kit_NN receptor_NN dimerization_NN on_II normal_JJ human_NN hematopoietic_JJ cells_NNS ._.
P09448330A10
The_DD avrE_NN locus_NN in_II trans_NN restored_VVD pathogenicity_NN to_II dspE_NN strains_NNS of_II E._NN amylovora_NN ,_, although_CS restored_VVNJ strains_NNS were_VBD low_JJ in_II virulence_NN ._.
P09453248A08
In_II summary_NN ,_, these_DD analyses_NNS suggest_VVB that_CST genetically_RR different_JJ populations_NNS of_II HIV-1_NN may_VM be_VBB present_JJ in_II different_JJ brain_NN compartments_NNS and_CC confirm_VVB that_CST specific_JJ neurotropic_JJ variants_NNS may_VM exist_VVB ._.
P09461586A03
Sequence_NN comparison_NN of_II the_DD two_MC plant_NN cDNAs_NNS and_CC genes_NNS shows_VVZ that_CST the_DD RPL4_NN gene_NN has_VHZ acquired_VVN a_DD remarkable_JJ 3_MC '_SYM extension_NN during_II evolutionary_JJ transfer_NN to_II the_DD nuclear_JJ genome_NN ._.
P09469470A02
Transforming_VVGJ growth_NN factor-beta1_NN (_( TGF-beta1_NN )_) potently_RR suppresses_VVZ NO_NN production_NN both_CC in_RR+ vitro_RR and_CC in_RR+ vivo_RR ._.
P09475758A03
The_DD marked_VVNJ chromosome_NN contained_VVD 0_MC ,_, 3.3_MC %_SYM ,_, 13.3_MC %_SYM ,_, or_CC 33.3_MC %_SYM of_II genetic_JJ variance_NN and_CC heritability_NN was_VBD 0.25_MC or_CC 0.70_MC ._.
P09479056A06
A_DD 90-kDa_NN gonococcal_JJ protein_NN has_VHZ previously_RR been_VBN shown_VVN to_TO react_VVI with_II a_DD monoclonal_JJ antibody_NN raised_VVN against_II the_DD RpoN_NN from_II Salmonella_NN typhimurium_NN ._.
P09485210A08
It_PN is_VBZ suggested_VVN that_CST such_DD epitopes_NNS stimulate_VVB T_NN cells_NNS to_TO induce_VVI anti-p53_NN antibody_NN production_NN in_II cancer_NN patients_NNS as_CS previously_RR reported_VVN by_II others_NNS ._.
P09488674A05
Mobility_NN shift_NN assays_NNS demonstrated_VVD that_CST TGF-beta1_NN stimulated_VVD AP-1_NN protein-DNA_NN binding_VVGN to_II both_CC AP-1_NN sites_NNS ._.
P09490204A03
FC-2.15_NN is_VBZ able_JJ to_TO mediate_VVI the_DD in_JJ+ vitro_JJ lysis_NN of_II Ag-2.15+_NN cells_NNS by_II human_NN complement_NN ._.
P09493015A08
Plant_NN cells_NNS in_II which_PNR the_DD chloroplasts_NNS have_VHB suffered_VVN photo-oxidative_JJ damage_NN do_VDB not_RR express_VVB nuclear_JJ genes_NNS that_PNR encode_VVB photosynthetic_JJ protein_NN ._.
P09498569A02
We_PN first_RR performed_VVD reverse_JJ transcriptase-polymerase_NN chain_NN reaction_NN with_II oligonucleotide_NN primers_NNS corresponding_VVG to_II regions_NNS conserved_VVN among_II plastid_NN omega6_NN desaturases_NNS of_II higher_JJR plants_NNS and_CC delta12_NN desaturases_NNS of_II cyanobacteria_NN ,_, using_VVG C._NN reinhardtii_NN poly_JJ (_( A_NN )_) +_SYM RNA_NN ._.
P09506853A08
These_DD approaches_NNS could_VM be_VBB applied_VVN to_II the_DD development_NN of_II human_NN beta-cell_NN lines_NNS by_II genetic_JJ engineering_VVGN of_II isolated_VVNJ human_NN islets_NNS ._.
P09515058A03
Three_MC potential_JJ N-linked_VVNJ glycosylation_NN sites_NNS in_II the_DD alpha_NN (_( h_NN )_) FR_NN sequence_NN were_VBD disrupted_VVN by_II conservative_JJ mutation_NN of_II the_DD S_NN or_CC T_NN residues_NNS in_II the_DD consensus_NN sequence_NN (_( N-X-S_NN /_SYM T_NN )_) to_II A_NN or_CC V_NN ,_, respectively_RR ._.
P09525271A05
Allelic_JJ frequencies_NNS and_CC linkages_NNS of_II the_DD polymorphic_JJ nucleotides_NNS were_VBD determined_VVN in_II 51_MC individuals_NNS using_VVG restriction_NN fragment_NN length_NN polymorphism_NN or_CC competitive_JJ oligonucleotide_NN priming_VVGJ assays_NNS ._.
P09526508A04
The_DD identity_NN of_II CAD_NN 1-5_MC was_VBD unambiguously_RR confirmed_VVN by_II sequence_NN comparison_NN of_II the_DD cDNA_NN with_II peptide_NN sequences_NNS derived_VVN from_II purified_VVNJ CAD_NN 1_MC protein_NN and_CC by_II functional_JJ expression_NN of_II CAD_NN 1_MC recombinant_JJ protein_NN in_II Escherichia_NN coli_NN ._.
P09530095A04
Relative_JJ to_II control_NN myocytes_NNS ,_, transgenic_JJ SERCA1_NN expression_NN increased_VVD up_RR+ to_RR four_MC times_NNS the_DD rates_NNS of_II ATP-dependent_JJ (_( and_CC thapsigargin-sensitive_JJ )_) Ca2+_NN transport_NN activity_NN of_II cell_NN homogenates_NNS ._.
P09538197A03
Erythrophagocytosis_NN assays_NNS were_VBD performed_VVN in_II well_NN plates_NNS to_II which_PNR thioglycollate-induced_VVNJ peritoneal_JJ macrophages_NNS had_VHD adhered_VVN ._.
P09545153A01
We_PN attempted_VVD to_TO determine_VVI the_DD effects_NNS of_II cyclosporine_NN on_II beta-adrenergic_JJ receptors_NNS in_II bovine_JJ pulmonary_JJ artery_NN smooth_JJ muscle_NN cells_NNS ._.
P09557631A02
Infection_NN of_II LLC-PK1_NN pig_NN kidney_NN cells_NNS with_II a_DD CPV_NN CrmA_NN mutant_NN ,_, but_CC not_RR with_II wild-type_NN (_( wt_NN )_) CPV_NN ,_, results_VVZ in_II the_DD induction_NN of_II many_PND of_II the_DD morphological_JJ features_NNS of_II apoptosis_NN (_( C._NNP A._NNP Ray_NNP and_CC D._NNP J._NNP Pickup_NNP ,_, Virology_NN 217_MC :_: 384-391_MC ,_, 1996_MC )_) ._.
P09565683A03
D-DDB_NN P1_NN can_VM selectively_RR bind_VVB to_II pyrimidine_NN (_( 6-4_MC )_) pyrimidone_NN photoproducts_NNS ,_, and_CC in_II the_DD presence_NN of_II Mg++_NN ,_, D-DDB_NN P1_NN can_VM catalyze_VVB an_DD incision_NN immediately_RR on_II the_DD 3_MC '_SYM and_CC 5_MC '_SYM sides_NNS of_II the_DD (_( 6-4_MC )_) photoproduct_NN site_NN ._.
P09572051A06
At_II that_DD time_NN ,_, the_DD development_NN of_II metastases_NNS was_VBD inhibited_VVN in_II 68.75_MC %_SYM of_II IL-12-treated_VVNJ mice_NNS ._.
P09573175A04
Both_CC LamB153-YMT_NN and_CC LamB153-HMT_NN hybrids_NNS were_VBD produced_VVN in_RR+ vivo_RR as_II full-length_NN proteins_NNS ,_, without_II any_DD indication_NN of_II instability_NN or_CC proteolytic_JJ degradation_NN ._.
P09578468A08
Natural_JJ eotaxin_NN stimulated_VVD eosinophil_NN chemotaxis_NN with_II identical_JJ potency_NN and_CC efficacy_NN as_II recombinant_JJ human_NN eotaxin_NN ._.
P09585505A01
The_DD fission_NN yeast_NN Sty1_NN stress-activated_VVNJ MAP_NN kinase_NN is_VBZ crucial_JJ for_II the_DD cellular_JJ response_NN to_II a_DD variety_NN of_II stress_NN conditions_NNS ._.
P09589670A03
Maximal_JJ chronic_JJ troglitazone_NN (_( 5_MC micrograms_NNS /_SYM mL_NN for_II 4_MC days_NNS )_) increased_VVD both_CC glucose_NN uptake_NN (_( from_II 9.0_MC +/-_SYM 1.5_MC to_II 40.9_MC +/-_SYM 8.1_MC pmol_NN /_SYM mg_NN protein._NN min_NN ;_: P_NN <_SYM 0.05_MC )_) and_CC GS_NN fractional_JJ velocity_NN (_( from_II 5.4_MC +/-_SYM 0.7_MC %_SYM to_II 20.6_MC +/-_SYM 6.3_MC %_SYM ;_: P_NN <_SYM 0.05_MC )_) by_II approximately_RR 4-fold_NN ._.
P09592192A04
Although_CS 50_MC %_SYM of_II the_DD cases_NNS had_VHD chemotherapy_NN or_CC radiotherapy_NN within_II the_DD last_JJ six_MC months_NNS before_II the_DD blood_NN was_VBD drawn_VVN ,_, their_PNG gene_NN expression_NN was_VBD not_RR statistically_RR different_JJ from_II those_PND who_PNR had_VHD not_RR undergone_VVN such_DD therapies_NNS ._.
P09596554A06
Among_II them_PN ,_, aurintricarboxylic_JJ acid_NN ,_, vitamin_NN E_NN and_CC methyl-beta-cyclodextrin_NN were_VBD able_JJ to_TO prevent_VVI cholesterol_NN oxide-induced_VVNJ neurotoxicity_NN in_II a_DD dose-dependent_JJ manner_NN ._.
P09602353A04
We_PN present_VVB a_DD model_NN for_II recombination-based_VVNJ hypermutation_NN of_II the_DD immunoglobulin_NN loci_NNS which_PNR could_VM result_VVB in_II either_CC templated_VVNJ or_CC non-templated_VVNJ mutation_NN ._.
P09606178A08
Two-dimensional_JJ phosphopeptide_NN mapping_VVGN was_VBD employed_VVN to_TO identify_VVI the_DD protein_NN kinase_NN involved_VVN in_II the_DD phosphorylation_NN of_II Na+_NN ,_, K_NN (_( +_SYM )_) -ATPase_NN ._.
P09614354A06
Residual_JJ (_( i.e._II non-Type_NN II_MC )_) PLA2_NN enzymatic_JJ activity_NN was_VBD further_RR characterised_VVN by_II Western_NN blot_NN analysis_NN and_CC enzyme_NN activity_NN assay_NN ._.
P09632565A04
NH2-terminal_JJ sequencing_VVGN of_II the_DD protein_NN revealed_VVD that_CST it_PN was_VBD identical_JJ to_II the_DD previously_RR characterized_VVNJ streptococcal_JJ acid_NN glycoprotein_NN (_( SAGP_NN )_) ;_: this_DD protein_NN possesses_VVZ between_II 31.5_MC and_CC 39.0_MC %_SYM amino_JJ acid_NN identity_NN with_II arginine_NN deiminase_NN (_( AD_NN )_) from_II Mycoplasma_NN hominis_NN ,_, Mycoplasma_NN arginini_NN ,_, Pseudomonas_NN putida_NN ,_, and_CC Pseudomonas_NN aeruginosa_NN ._.
P09642212A02
Mutations_NNS (_( cki1_NN ,_, cct1_NN ,_, and_CC cpt1_NN )_) in_II the_DD CDP-choline_NN pathway_NN for_II phosphatidylcholine_NN synthesis_NN suppress_VVB the_DD sec14_NN growth_NN defect_NN (_( 2_MC )_) ,_, permitting_VVG sec14_NN (_( ts_NN )_) cki1_NN ,_, sec14_NN (_( ts_NN )_) cct1_NN ,_, and_CC sec14_NN (_( ts_NN )_) cpt1_NN strains_NNS to_TO grow_VVI at_II the_DD sec14_NN (_( ts_NN )_) restrictive_JJ temperature_NN ._.
P09643344A08
Moreover_RR ,_, the_DD hydroperoxide-reducing_VVGJ activity_NN of_II one_MC of_II the_DD fractions_NNS was_VBD inhibited_VVN almost_RR completely_RR by_II the_DD addition_NN of_II anti-apolipoprotein_NN A-I_NN antibody_NN ._.
P09651211A03
VIP_NN ,_, forskolin_NN ,_, or_CC isoproterenol_NN increased_VVD cAMP_NN accumulation_NN in_II explanted_VVNJ ganglia_NNS ._.
P09655856A03
In_II voltage-clamp_NN experiments_NNS ,_, DTG_NN and_CC (_( +_SYM )_) -pentazocine_NN elicited_VVD inward_JJ currents_NNS whose_PNR intensity_NN augmented_VVD with_II membrane_NN depolarization_NN ._.
P09657968A03
Treatment_NN of_II HeLa_NN cells_NNS with_II H2O2_NN resulted_VVD in_II a_DD time-_NN and_CC dose-dependent_JJ induction_NN of_II apoptosis_NN accompanied_VVN by_II sustained_VVNJ activation_NN of_II all_DD three_MC MAPK_NN subfamilies_NNS :_: extracellular_JJ signal-regulated_VVNJ protein_NN kinase_NN (_( ERK_NN )_) ,_, c-Jun_NN N-terminal_JJ kinase_NN /_SYM stress-activated_VVNJ protein_NN kinase_NN (_( JNK_NN /_SYM SAPK_NN )_) and_CC p38_NN ._.
P09661596A10
In_II conclusion_NN ,_, low_JJ serum_NN IGF-I_NN levels_NNS found_VVN in_II men_NNS with_II IOM_NN are_VBB associated_VVN with_II homozygosity_NN for_II a_DD specific_JJ allele_NN of_II the_DD IGF-I_NN microsatellite_NN (_( 192_MC /_SYM 192_MC )_) ,_, and_CC individual_JJ variation_NN in_II serum_NN IGF-I_NN levels_NNS is_VBZ influenced_VVN by_II genetic_JJ factors_NNS and_CC may_VM be_VBB specifically_RR influenced_VVN by_II variation_NN at_II the_DD IGF-I_NN structural_JJ locus_NN ._.
P09668357A06
Cholinergic-specific_JJ gangliosides_NNS ,_, Chol-1_NN alpha_NN ,_, were_VBD assumed_VVN to_TO participate_VVI in_II the_DD mechanism_NN of_II high-affinity_NN choline_NN uptake_NN ._.
P09677300A08
Upward_JJ shifts_NNS for_II basic_JJ residues_NNS occur_VVB because_II+ of_II favorable_JJ salt-bridge_NN interactions_NNS ,_, whilst_CS upward_JJ shifts_NNS for_II acidic_JJ residues_NNS result_VVB from_II unfavorable_JJ electrostatic_JJ interactions_NNS with_II other_JJ acidic_JJ groups_NNS ._.
P09688142A04
p53_NN mutations_NNS were_VBD detected_VVN in_II 3_MC %_SYM of_II the_DD hyperplasias_NNS ,_, 12_MC %_SYM of_II the_DD keratoacanthomas_NNS ,_, and_CC 52_MC %_SYM of_II the_DD SCCs_NNS ._.
P09693117A02
Here_RR we_PN report_VVB the_DD cloning_VVGN and_CC sequence_NN of_II human_NN tMDC_NN I_MC transcripts_NNS and_CC show_VVB that_CST they_PN are_VBB non-functional_JJ ,_, owing_II+ to_II the_DD presence_NN of_II a_DD variety_NN of_II deletions_NNS ,_, insertions_NNS and_CC in-frame_NN termination_NN codons_NNS ._.
P09705438A01
Streptococcus_NN iniae_NN is_VBZ a_DD cause_NN of_II septicemia_NN ,_, meningoencephalitis_NN ,_, and_CC death_NN in_II farmed_VVNJ fish_NN and_CC of_II cellulitis_NN in_II human_NN beings_NNS ._.
P09713497A02
There_EX is_VBZ a_DD considerable_JJ heterogeneity_NN in_II cell_NN survival_NN among_II isolated_VVNJ resistant_JJ clones_NNS (_( Rf_NN values_NNS between_II 1.4_MC to_II 2.4_MC )_) and_CC in_II the_DD propensity_NN of_II the_DD cells_NNS to_TO enter_VVI apoptosis_NN ._.
P09717704A05
A_DD small_JJ proportion_NN of_II axons_NNS (_( 4.2_MC %_SYM )_) and_CC axon_NN terminals_NNS (_( 5.3_MC %_SYM )_) showed_VVD SP_NN (_( R-i_NN )_) ,_, the_DD majority_NN of_II labeled_VVNJ axon_NN terminals_NNS ,_, amounting_VVG to_II about_RR 70_MC %_SYM of_II synapsing_VVGJ elements_NNS ,_, formed_VVD asymmetric_JJ synapses_NNS with_II dendrites_NNS ._.
P09724158A05
SSCP_NN analysis_NN confirmed_VVD the_DD sequencing_VVGJ results_NNS and_CC revealed_VVD no_DD evidence_NN for_II the_DD emergence_NN of_II new_JJ viral_JJ subpopulations_NNS before_II seroconversion_NN ._.
P09729433A02
They_PN were_VBD characterized_VVN by_II 1H-NMR_NN spectrometry_NN as_CS follows_VVZ :_: Neu5Acalpha2_NN --_: >_SYM 3Galbeta1_NN --_: >_SYM 4Glc_NN ,_, Neu5Gcalpha2_NN --_: >_SYM 6Galbeta1_NN --_: >_SYM 4Glc_NN and_CC three_MC forms_NNS of_II Neu5Gcalpha2_NN --_: >_SYM 3Galbeta1_NN --_: >_SYM 4Glc_NN ,_, namely_RR Neu5Gcalpha2_NN --_: >_SYM 3Galbeta1_NN --_: >_SYM 4Glc_NN itself_PN ,_, its_PNG lactone_NN derivative_NN between_II the_DD carboxyl_NN group_NN of_II Neu5Gc_NN and_CC Gal_NN OH-2_NN and_CC another_DD lactone_NN derivative_NN between_II the_DD carboxyl_NN group_NN and_CC Gal_NN OH-4_NN ._.
P09736045A05
Immunoblotting_VVGN revealed_VVD that_CST all_DB these_DD proteins_NNS were_VBD expressed_VVN at_II higher_JJR levels_NNS in_II tumor_NN tissues_NNS than_CSN in_II adjacent_JJ normal_JJ tissues_NNS ._.
P09748437A12
Together_RR ,_, the_DD analyses_NNS suggest_VVB that_CST PobR_NN and_CC PcaU_NN possess_VVB a_DD linear_JJ domain_NN structure_NN similar_JJ to_II that_PND of_II LysR_NN transcriptional_JJ activators_NNS which_PNR largely_RR differ_VVB in_II primary_JJ structure_NN ._.
P09755793A02
Chronic_JJ HBV_NN infection_NN ,_, frequently_RR associated_VVN with_II cirrhosis_NN and_CC eventually_RR hepatocellular_JJ carcinoma_NN (_( HCC_NN )_) ,_, represents_VVZ a_DD major_JJ health_NN problem_NN in_II the_DD world_NN ._.
P09760722A07
The_DD antibiotic_JJ activity_NN of_II these_DD antibiotics_NNS may_VM be_VBB quantitatively_RR correlated_VVN with_II their_PNG dimerization_NN constants_NNS and_CC the_DD binding_VVGJ constants_NNS through_II the_DD calculation_NN ._.
P09769335A03
To_TO test_VVI this_DD hypothesis_NN we_PN produced_VVD replication_NN deficient_JJ human_NN type_NN 5_MC adenoviruses_NNS containing_VVG cDNAs_NNS for_II the_DD rat_NN alpha1_NN and_CC beta1_NN Na_NN ,_, K-ATPase_NN subunits_NNS (_( adMRCMValpha1_NN and_CC adMRCMVbeta1_NN ,_, respectively_RR )_) ._.
P09782119A01
The_DD 40-kb_NN region_NN downstream_JJ of_II the_DD most_RRT 3_MC '_SYM immunoglobulin_NN (_( Ig_NN )_) heavy_JJ chain_NN constant_NN region_NN gene_NN (_( Calpha_NN )_) contains_VVZ a_DD series_NN of_II transcriptional_JJ enhancers_NNS speculated_VVN to_TO play_VVI a_DD role_NN in_II Ig_NN heavy_JJ chain_NN class_NN switch_NN recombination_NN (_( CSR_NN )_) ._.
P09786854A09
ZRT1_NN inactivation_NN is_VBZ a_DD relatively_RR specific_JJ response_NN to_II zinc_NN ;_: cadmium_NN and_CC cobalt_NN ions_NNS trigger_VVB the_DD response_NN but_CC less_RR effectively_RR than_CSN zinc_NN ._.
P09802898A03
We_PN show_VVB by_II nuclear_JJ run-on_NN that_CST this_DD increase_NN results_VVZ ,_, in_II part_NN ,_, from_II increased_VVNJ rates_NNS of_II transcription_NN ._.
P09810511A02
The_DD high_JJ conservation_NN of_II this_DD machinery_NN in_II the_DD different_JJ eukaryotic_JJ organisms_NNS emphasizes_VVZ its_PNG early_JJ origin_NN and_CC its_PNG importance_NN for_II life_NN ._.
P09811893A01
Germ-line_NN mutations_NNS in_II the_DD human_NN BRCA2_NN gene_NN confer_VVB susceptibility_NN to_II breast_NN cancer_NN ._.
P09813262A09
This_DD group_NN can_VM be_VBB further_RR divided_VVN into_II a_DD subgroup_NN of_II archaeal_JJ proteins_NNS and_CC two_MC subgroups_NNS of_II bacterial_JJ proteins_NNS ._.
P09819705A13
Phytanic_JJ acid_NN alpha-oxidation_NN is_VBZ thought_VVN to_TO occur_VVI partly_RR ,_, and_CC pristanic_JJ acid_NN beta-oxidation_NN exclusively_RR ,_, in_II peroxisomes_NNS (_( see_VVB Wanders_NNP et_CC al_NN 1995_MC for_II review_NN )_) ._.
P09821952A05
Our_PNG observations_NNS reported_VVD herein_RR raise_VVB the_DD possibility_NN that_CST self-association_NN of_II p202_NN may_VM provide_VVB a_DD mechanism_NN for_II the_DD regulation_NN of_II its_PNG activity_NN ._.
P09825749A09
CONCLUSION_NN :_: These_DD findings_NNS suggest_VVB that_CST bone_NN destruction_NN associated_VVN with_II local_JJ infection_NN by_II S._NN aureus_NN is_VBZ due_II+ to_II the_DD stimulation_NN of_II osteoclast_NN formation_NN induced_VVN by_II the_DD action_NN of_II the_DD easily_RR solubilized_VVNJ SAM_NN ,_, and_CC could_VM explain_VVB the_DD large_JJ numbers_NNS of_II osteoclasts_NNS found_VVN in_II infarcted_VVNJ bone_NN in_II osteomyelitis_NN ._.
P09828430A08
Growth_NN on_II glucose_NN was_VBD stimulated_VVN by_II thiosulfate_NN ,_, which_PNR was_VBD reduced_VVN to_II sulfide_NN ._.
P09829809A10
These_DD data_NNS suggest_VVB that_CST dystrophic_JJ neurites_NNS can_VM develop_VVB retrogradely_RR from_II focal_JJ plaque_NN damage_NN to_TO induce_VVI somatic_JJ and_CC dendritic_JJ degeneration_NN and_CC potentially_RR contribute_VVI to_II neurofibrillary_JJ tangle_NN formation_NN ._.
P09834853A03
Tumor_NN cells_NNS of_II 12_MC studied_VVNJ cases_NNS showed_VVD a_DD typical_JJ dose-rate_NN effect_NN on_II in_JJ+ vitro_JJ irradiation_NN with_II different_JJ X-ray_NN doses_NNS ,_, as_CS observed_VVN in_II peripheral_JJ blood_NN leukocytes_NNS ._.
P09840417A09
Pertussis_NN toxin_NN pretreatment_NN blocked_VVD the_DD CP_NN 93,129-induced_VVNJ inhibition_NN of_II FSCA_NN and_CC elevation_NN of_II [_( Ca2+_NN ]_) i_NN in_II OK_NN cells_NNS ,_, indicating_VVG the_DD involvement_NN of_II Gi_NN /_SYM o_NN proteins_NNS in_II transducing_VVGN these_DD second_JJ messenger_NN responses_NNS ._.
P09842993A02
HPE_NN is_VBZ extremely_RR heterogeneous_JJ ,_, some_DD cases_NNS being_VBG associated_VVN with_II structural_JJ anomalies_NNS of_II the_DD short_JJ arm_NN of_II chromosome_NN 3_MC ._.
P09845099A11
The_DD former_JJ group_NN reduced_VVD markedly_RR the_DD mean_NN number_NN of_II metastatic_JJ lung_NN nodules_NNS regardless_II+ of_II radiation_NN therapy_NN ._.
P09855111A09
Taken_VVN together_RR ,_, overexpression_NN of_II the_DD COOH-terminal_JJ domains_NNS does_VDZ not_RR affect_VVB the_DD regulation_NN of_II SREBP_NN processing_VVGN and_CC the_DD domains_NNS are_VBB rapidly_RR turned_VVN over_II by_II the_DD cytosolic_JJ proteolytic_JJ process_NN distinct_JJ from_II the_DD ALLN-sensitive_JJ ER_NN degradative_JJ pathway_NN ._.
P09861053A02
The_DD disappearance_NN of_II 12C18O16O_NN from_II a_DD red_JJ cell_NN suspension_NN as_CS the_DD 18O_NN exchanges_VVZ between_II labeled_VVNJ CO2_NN +_SYM HCO3-_NN and_CC unlabeled_VVNJ HOH_NN provides_VVZ a_DD measure_NN of_II the_DD carbonic_JJ anhydrase_NN (_( CA_NN )_) activity_NN (_( acceleration_NN ,_, or_CC A_NN )_) inside_II the_DD cell_NN and_CC of_II the_DD membrane_NN self-exchange_NN permeability_NN to_II HCO3-_NN (_( Pm_NN ,_, HCO-3_NN )_) ._.
P09868916A07
Finally_RR ,_, a_DD quasi-linear_JJ relationship_NN between_II particle_NN coverage_NN and_CC plasmon_NN angle_NN shift_NN is_VBZ presented_VVN ,_, thereby_RR providing_VVG for_II a_DD direct_JJ correlation_NN between_II plasmon_NN shift_NN and_CC solution_NN antigen_NN concentration_NN ._.
P09872496A01
Among_II the_DD various_JJ virulence_NN factors_NNS of_II Helicobacter_NN pylori_NN the_DD role_NN of_II its_PNG heat_NN shock_NN protein_NN 60_MC (_( HSP60_NN ,_, HspB_NN )_) in_II mucosal_JJ inflammation_NN after_II H._NN pylori_NN infection_NN was_VBD examined_VVN ._.
P09876375A08
Pathological_JJ evaluation_NN was_VBD performed_VVN in_II these_DD tissues_NNS ._.
P09882451A08
We_PN speculate_VVB that_CST this_DD segment_NN ,_, which_PNR shows_VVZ the_DD greatest_JJT variability_NN between_II species_NNS ,_, is_VBZ responsible_JJ for_II the_DD association_NN of_II the_DD enzyme_NN with_II the_DD membrane_NN ._.
P09886808A03
The_DD hormonal_JJ form_NN of_II vitamin_NN D_NN ,_, 1_MC ,_, 25-dihydroxyvitamin_NN D3_NN ,_, stimulates_VVZ transcription_NN of_II the_DD tissue-specific_JJ osteocalcin_NN (_( OC_NN )_) gene_NN in_II osteoblastic_JJ cells_NNS ._.
P09889219A05
The_DD isolates_NNS were_VBD also_RR tested_VVN for_II the_DD production_NN of_II virulent_JJ factors_NNS such_II+ as_II hemolysin_NN ,_, muramidase-released_VVNJ protein_NN (_( MRP_NN )_) ,_, and_CC extracellular_JJ factor_NN (_( EF_NN )_) ._.
P09893953A09
From_II the_DD comparative_JJ analysis_NN of_II the_DD X-ray_NN structures_NNS available_JJ for_II several_JJ families_NNS of_II proteins_NNS ,_, including_VVG at_RR+ least_RR one_MC thermophilic_JJ structure_NN in_II each_DD case_NN ,_, it_PN appears_VVZ that_CST thermal_JJ stabilization_NN is_VBZ accompanied_VVN by_II an_DD increase_NN in_II hydrogen_NN bonds_NNS and_CC salt_NN bridges_NNS ._.
P09915322A07
This_DD assay_NN derives_VVZ the_DD apparent_JJ agonist_NN affinity_NN of_II the_DD nAcChoR_NN from_II the_DD apparent_JJ rates_NNS with_II which_PNR agonists_NNS convert_VVB nAcChoRs_NNS from_II the_DD resting_VVGJ state_NN to_II the_DD desensitized_VVNJ state_NN ._.
P09921974A08
CONCLUSIONS_NNS :_: GW506U78_NN showed_VVD antileukemic_JJ activity_NN against_II Ph_NN positive_JJ T-cell_NN BP_NN CML_NN ._.
P09930966A15
This_DD recognition_NN occurs_VVZ on_II a_DD T-cell_NN level_NN as_CC+ well_CC+ as_CC on_II the_DD macrophage_NN level_NN ._.
P09973335A05
Examination_NN of_II MSHA-specific_JJ cDNAs_NNS has_VHZ localized_VVN two_MC promoters_NNS that_PNR drive_VVB expression_NN of_II these_DD genes_NNS ._.
P09988707A09
Thus_RR ,_, the_DD constitutive_JJ and_CC phorbol_NN 12-myristate_NN 13-acetate-inducible_JJ expression_NN of_II the_DD urokinase_NN receptor_NN is_VBZ mediated_VVN partly_RR through_II trans-activation_NN of_II the_DD promoter_NN via_II a_DD sequence_NN (_( -152_MC /_SYM -135_MC )_) bound_VVN with_II an_DD activator_NN protein-2alpha-related_VVNJ factor_NN ._.
P10025945A01
We_PN have_VHB isolated_VVN a_DD cDNA_NN (_( bv7-3_NN )_) encoding_VVG a_DD member_NN of_II the_DD Na+_NN ,_, Cl_NN (_( -_SYM )_) -dependent_JJ transporter_NN family_NN and_CC its_PNG short_JJ splicing_VVGJ variant_NN (_( bv7-3s_NN )_) by_II screening_VVGN a_DD bovine_JJ retina_NN cDNA_NN library_NN ._.
P10029430A04
However_RR ,_, it_PN is_VBZ not_RR known_VVN whether_CST aberrant_JJ activity_NN of_II the_DD Ras_NN pathway_NN is_VBZ also_RR a_DD prevalent_JJ molecular_JJ pathogenetic_JJ mechanism_NN in_II actual_JJ peripheral_JJ nerve_NN tumors_NNS ._.
P10037077A04
Exposure_NN of_II ventricular_JJ myocytes_NNS to_II hyperkalemic_JJ medium_NN (_( 50_MC mM_NN KCl_NN )_) in_II the_DD absence_NN of_II T3_NN increased_VVD expression_NN of_II the_DD Na_NN /_SYM K-ATPase_NN catalytic_JJ subunit_NN mRNAs_NNS ,_, alpha1_NN and_CC alpha3_NN isoforms_NNS ,_, by_II 1.9-_MC and_CC 1.5-fold_NN ,_, respectively_RR (_( p_NN <_SYM 0.01_MC )_) ,_, which_PNR were_VBD accompanied_VVN by_II similar_JJ increases_NNS (_( 1.4-_MC and_CC 1.8-fold_NN )_) in_II protein_NN content_NN ._.
P10051472A10
These_DD data_NNS indicate_VVB that_CST TIPS_NN pseudointima_NN are_VBB lined_VVN by_II hepatic_JJ sinusoidal_JJ endothelial_JJ cells_NNS ,_, which_PNR stimulate_VVB pseudointima_NN formation_NN by_II increasing_VVGN SMC_NN migration_NN and_CC proliferation_NN ._.
P10070859A02
We_PN detected_VVD allele_NN loss_NN in_II 27_MC of_II 70_MC breast_NN tumour_NN DNAs_NNS ._.
P10074179A06
Mutation_NN in_II either_DD element_NN abolished_VVD the_DD efficient_JJ binding_VVGN of_II CREB_NN ._.
P10077238A07
5._MC The_DD data_NNS clearly_RR indicate_VVB that_CST mu-opioid_NN receptor_NN gene_NN products_NNS play_VVB a_DD key_JJ role_NN in_II G-protein_NN activation_NN by_II endomorphins_NNS ,_, DAMGO_NN and_CC morphine_NN in_II the_DD mouse_NN spinal_JJ cord_NN ._.
P10079092A14
The_DD anionic_JJ detergent_NN sodium_NN dodecyl_NN sulfate_NN induced_VVD alpha-helix_NN formation_NN in_II all_DD analogues_NNS except_II the_DD loop_NN peptide_NN ,_, where_PNR it_PN induces_VVZ a_DD left-handed_VVNJ PII_NN conformation_NN ._.
P10087261A02
Vaults_NNS are_VBB multimeric_JJ protein_NN complexes_NNS with_II several_JJ copies_NNS of_II an_DD untranslated_VVNJ RNA_NN ._.
P10092212A02
Increased_VVNJ clusterin_NN expression_NN has_VHZ also_RR been_VBN found_VVN in_II tumors_NNS ,_, however_RR ,_, the_DD mechanism_NN underlying_VVG this_DD induction_NN is_VBZ not_RR known_VVN ._.
P10098495A03
The_DD results_NNS showed_VVD that_CST follicular_JJ membrane_NN AC_NN activity_NN was_VBD not_RR inhibited_VVN upon_II activation_NN of_II the_DD LH_NN /_SYM CG-R_NN despite_II evidence_NN that_CST the_DD ACs_NNS in_II follicular_JJ membranes_NNS ,_, when_CS maximally_RR activated_VVN by_II forskolin_NN ,_, could_VM be_VBB inhibited_VVN when_CS membrane_NN G_NN proteins_NNS were_VBD activated_VVN by_II guanyl-5'-yl_NN imidodiphosphate_NN ,_, and_CC that_CST pertussis_NN toxin_NN pretreatment_NN of_II membranes_NNS raised_VVD forskolin-stimulated_VVNJ AC_NN activity_NN ,_, consistent_JJ with_II a_DD tonic_JJ inhibition_NN of_II follicular_JJ membrane_NN AC_NN activity_NN ._.
P10103104A04
The_DD location_NN of_II the_DD GFP-tagged_VVNJ N-terminus_NN was_VBD confirmed_VVN to_TO be_VBI on_II the_DD extracellular_JJ side_NN by_II application_NN of_II a_DD monoclonal_JJ antibody_NN to_II nonpermeabilized_VVNJ cells_NNS ._.
P10192794A08
Immunohistochemical_JJ analyses_NNS localizing_VVG Eph_NN B3_NN protein_NN were_VBD consistent_JJ with_II the_DD mRNA_NN results_NNS ._.
P10205244A09
However_RR ,_, D1_NN receptor_NN serine_NN phosphorylation_NN in_II the_DD basal_JJ state_NN was_VBD greater_JJR in_II HT_NN than_CSN in_II NT_NN and_CC was_VBD not_RR responsive_JJ to_II fenoldopam_NN stimulation_NN in_II HT_NN ._.
P10209279A03
Here_RR we_PN set_VVB out_II to_TO determine_VVI whether_CST the_DD point_NN mutation_NN itself_PN has_VHZ any_DD effects_NNS on_II the_DD protein_NN structure_NN and_CC its_PNG stability_NN to_II pressure_NN and_CC temperature_NN in_II the_DD absence_NN of_II Ca2+_NN ._.
P10209742A16
We_PN found_VVD the_DD highest_JJT amount_NN of_II dnrE_NN transcripts_NNS in_II aerobically_RR nitrate-challenged_VVNJ cells_NNS ._.
P10222582A02
Glucose_NN repression_NN was_VBD not_RR the_DD only_JJ factor_NN affecting_VVG the_DD invertase_NN expression_NN ._.
P10226153A06
On_II the_DD other_JJ hand_NN ,_, the_DD stimulatory_JJ response_NN of_II Ca2+_NN channels_NNS to_II Gbetagamma_NN was_VBD not_RR affected_VVN by_II the_DD protein_NN kinase_NN A_NN inhibitors_NNS Rp-8-Br-cAMPS_NN and_CC KT_NN 5720_MC ,_, or_CC by_II the_DD Ca2+-dependent_JJ protein_NN kinase_NN C_NN inhibitor_NN bisindolylmaleimide_NN 1_MC ,_, but_CC was_VBD completely_RR blocked_VVN by_II the_DD protein_NN kinase_NN C_NN inhibitor_NN calphostin_NN C_NN ._.
P10235540A05
METHODS_NNS :_: Two_MC different_JJ injuries_NNS (_( a_DD linear_JJ perforation_NN wound_NN and_CC two_MC 10-0_MC nylon_NN suture_NN wounds_NNS )_) were_VBD made_VVN separately_RR on_II the_DD corneas_NNS of_II both_CC TNKO_NN and_CC congenic_JJ wild-type_NN mice_NNS ._.
P10320477A03
Whether_CST this_PND is_VBZ the_DD sole_JJ mechanism_NN of_II S_NN phase_NN inhibition_NN by_II Cdc2_NN in_II higher_JJR metazoans_NNS is_VBZ not_RR known_VVN because_CS the_DD pleiotropic_JJ functions_NNS of_II this_DD essential_JJ cell_NN cycle_NN regulator_NN make_VVB genetic_JJ analysis_NN difficult_JJ ._.
P10321563A08
CONCLUSIONS_NNS :_: The_DD results_NNS suggest_VVB that_CST therapy-resistant_JJ ,_, intractable_JJ pruritus_NN accompanied_VVN by_II hypereosinophilia_NN may_VM be_VBB used_VVN to_TO define_VVI a_DD subset_NN of_II HIV-seropositive_JJ individuals_NNS showing_VVG prototypic_JJ hyperactivation_NN of_II humoral_JJ immunity_NN ,_, and_CC in_II whom_PNR augmented_VVNJ HIV_NN viral_JJ load_NN is_VBZ present_JJ ._.
P10326726A10
Genes_NNS identified_VVN as_II being_VVGN important_JJ for_II the_DD early_JJ communication_NN between_II the_DD epithelial_JJ and_CC ectomesenchymal_JJ cells_NNS mainly_RR comprise_VVB those_PND which_PNR code_VVB for_II proteins_NNS which_PNR act_VVB as_II secreted_VVNJ signals_NNS between_II the_DD cells_NNS (_( ligands_NNS )_) and_CC those_PND that_PNR code_VVB for_II nuclear_JJ proteins_NNS that_PNR act_VVB to_TO control_VVI gene_NN expression_NN in_II response_NN to_II the_DD signals_NNS ._.
P10336642A01
It_PN is_VBZ has_VHZ been_VBN previously_RR suggested_VVN that_CST the_DD protein_NN Op18_NN /_SYM stathmin_NN may_VM interact_VVB with_II tubulin_NN via_II the_DD alpha-tubulin_NN subunit_NN [_( Larsson_NNP ,_, N._NNP ,_, Marklund_NNP ,_, U._NNP ,_, Melander_NNP Gradin_NNP ,_, H._NNP ,_, Brattsand_NNP ,_, G._NNP &_CC Gullberg_NNP ,_, M._NNP (_( 1997_MC )_) Mol._NN Cell._NN Biol._NN 17_MC ,_, 5530-5539_MC ]_) ._.
P10344234A03
We_PN have_VHB undertaken_VVN a_DD study_NN into_II the_DD potential_JJ use_NN of_II a_DD novel_JJ laser_NN capture_NN microdissection_NN (_( LCM_NN )_) system_NN to_TO isolate_VVI cells_NNS of_II interest_NN for_II subsequent_JJ proteomic_JJ analysis_NN ._.
P10361699A09
These_DD data_NNS are_VBB consistent_JJ with_II previous_JJ suggestions_NNS concerning_VVG the_DD GalT_NN acceptor_NN site_NN and_CC clearly_RR demonstrate_VVB the_DD effectiveness_NN of_II our_PNG approach_NN for_II rapid_JJ identification_NN of_II photolabeled_VVNJ peptides_NNS ._.
P10366564A02
Among_II other_JJ targets_NNS ,_, it_PN activates_VVZ the_DD Nef-associated_VVNJ kinase_NN ,_, which_PNR is_VBZ related_VVN to_II the_DD p21-activated_VVNJ kinase_NN ._.
P10374863A08
The_DD inhibitory_JJ effect_NN of_II the_DD factor_NN was_VBD neutralized_VVN by_II an_DD anti_JJ IL-6_NN neutralizing_VVGJ antibody_NN ._.
P10381090A04
DS-2_NN cell-derived_VVNJ HBsAg_NN particles_NNS were_VBD purified_VVN near_II homogeneity_NN by_II a_DD strategy_NN based_VVN on_II protein_NN concentration_NN ,_, precipitation_NN and_CC ultracentrifugation_NN ._.
P10386607A04
Comparison_NN of_II the_DD amino_JJ acids_NNS participating_VVG in_II these_DD specific_JJ and_CC essential_JJ interactions_NNS and_CC constituting_VVG the_DD folding_VVGJ nucleus_NN with_II conserved_VVNJ hydrophobic_JJ positions_NNS of_II a_DD given_VVNJ fold_NN shows_VVZ a_DD striking_VVGJ correspondence_NN ._.
P10397162A05
An_DD important_JJ signaling_VVGJ function_NN has_VHZ previously_RR been_VBN suggested_VVN for_II a_DD 65-kDa_NN protein_NN (_( p65_NN )_) ,_, whose_PNR phosphorylation_NN can_VM be_VBB detected_VVN before_II that_PND of_II other_JJ substrate_NN proteins_NNS ._.
P10403730A02
Both_CC tumour_NN necrosis_NN factor_NN alpha_NN (_( TNF-alpha_NN )_) and_CC interferon_NN gamma_NN (_( IFN-gamma_NN )_) have_VHB been_VBN implicated_VVN in_II IBD_NN ._.
P10406898A01
BACKGROUND_NN AND_CC OBJECTIVE_NN :_: 13q14_NN deletion_NN frequently_RR occurs_VVZ as_II a_DD single_JJ anomaly_NN in_II chronic_JJ lymphocytic_JJ leukemia_NN (_( CLL_NN )_) with_II favorable_JJ prognosis_NN ._.
P10413595A09
We_PN conclude_VVB that_CST a_DD promoter_NN with_II an_DD ordered_VVNJ chromatin_NN structure_NN can_VM still_RR respond_VVB to_II androgens_NNS even_RR after_CS its_PNG glucocorticoid_NN responsiveness_NN is_VBZ lost_VVN ._.
P10417056A12
These_DD data_NNS indicate_VVB that_CST acute_JJ alcohol_NN intoxication_NN may_VM directly_RR stimulate_VVB the_DD release_NN of_II reactive_JJ oxygen_NN intermediates_NNS ,_, whereas_CS chronic_JJ alcohol_NN may_VM elicit_VVB free_JJ radical_NN generation_NN through_II enhanced_VVNJ endotoxin_NN influx_NN and_CC cytokine_NN release_NN ._.
P10421271A09
CONCLUSIONS_NNS :_: The_DD elevated_VVNJ G-CSF_NN levels_NNS in_II a_DD majority_NN of_II patients_NNS during_II severe_JJ neutropenic_JJ infection_NN may_VM explain_VVB why_CST a_DD therapeutic_JJ benefit_NN of_II G-CSF_NN treatment_NN can_VM not_RR be_VBB demonstrated_VVN in_II all_DD cases_NNS ._.
P10428759A06
A_DD decrease_NN in_II insulin-induced_VVNJ receptor_NN kinase_NN activity_NN was_VBD observed_VVN for_II solubilized_VVNJ chimeric_JJ receptors_NNS ._.
P10430658A09
Western_NN blot_NN analysis_NN showed_VVD that_CST the_DD 62-65_MC kD_NN double_JJ band_NN of_II occludin_NN did_VDD not_RR change_VVB with_II these_DD treatments_NNS ._.
P10436438A03
Man_NN with_II gonococcal_JJ urethritis_NN was_VBD treated_VVN with_II oral_JJ 100_MC mg_NN levofloxacin_NN 3_MC times_NNS daily_JJ for_II 7_MC days_NNS ._.
P10446501A08
This_DD pseudo-knot_NN structures_NNS implies_VVZ a_DD highly_RR ordered_VVNJ assembly_NN pathway_NN ._.
P10449751A08
The_DD results_NNS open_VVB the_DD possibility_NN that_CST modulation_NN of_II the_DD spatial_JJ organization_NN of_II cell-cell_NN contacts_NNS may_VM play_VVB important_JJ roles_NNS in_II regulating_VVGN organization_NN and_CC physiological_JJ functions_NNS of_II epithelial_JJ tissues_NNS ._.
P10467120A05
Our_PNG results_NNS showed_VVD that_CST the_DD polypeptide_NN chains_NNS were_VBD secreted_VVN by_II insect_NN cells_NNS and_CC correctly_RR assembled_VVN into_II H_NN (_( 2_MC )_) L_NN (_( 2_MC )_) heterodimers_NNS containing_VVG N-linked_VVNJ carbohydrate_NN at_II the_DD heavy_JJ chain_NN ._.
P10473545A02
If_CS the_DD newly_RR discovered_VVNJ UCP2_NN and_CC UCP3_NN function_VVB similarly_RR ,_, they_PN will_VM enhance_VVB peripheral_JJ energy_NN expenditure_NN and_CC are_VBB potential_JJ molecular_JJ targets_NNS for_II the_DD treatment_NN of_II obesity_NN ._.
P10478844A09
Both_CC in_II the_DD presence_NN or_CC absence_NN of_II 9-cis-retinoic_JJ acid_NN receptor_NN ,_, PPARalphatr_NN did_VDD not_RR bind_VVB to_II DNA_NN in_II gel_NN shift_NN assays_NNS ._.
P10485317A08
In_II each_PND of_II L-NAME-_NN and_CC K-treated_VVNJ muscles_NNS ,_, the_DD addition_NN of_II LPC_NN (_( 20_MC microM_NN )_) further_RR impaired_VVD EDR_NN ._.
P10487707A09
DNA_NN fingerprinting_VVGN of_II codon_NN 727_MC using_VVG restriction_NN enzyme_NN NlaIII_NN and_CC genomic_JJ DNA_NN confirmed_VVD the_DD sequencing_VVGJ results_NNS in_II all_DD cases_NNS ,_, indicating_VVG that_CST the_DD sequence_NN alterations_NNS were_VBD not_RR somatic_JJ in_II nature_NN ._.
P10490661A09
Thus_RR ,_, BCL-6_NN can_VM modulate_VVB the_DD transcription_NN of_II selective_JJ Stat6-dependent_JJ IL-4_NN responses_NNS ,_, including_VVG IgE_NN class_NN switching_VVGN in_II B_NN cells_NNS ._.
P10491575A04
A_DD potential_JJ upstream_JJ mediator_NN of_II krox_NN induction_NN is_VBZ cyclic_JJ AMP-responsive_JJ element_NN binding_VVGJ protein_NN (_( CREB_NN )_) ,_, a_DD posttranslationally_RR activated_VVNJ transcription_NN factor_NN that_PNR has_VHZ been_VBN implicated_VVN in_II numerous_JJ memory_NN paradigms_NNS ._.
P10501837A06
However_RR ,_, rejection_NN of_II allografts_NNS of_II the_DD F9_NN embryonal_JJ carcinoma_NN cell_NN line_NN ,_, a_DD nullipotent_JJ cell_NN line_NN derived_VVN from_II the_DD 129_MC mouse_NN strain_NN ,_, does_VDZ not_RR appear_VVB to_TO be_VBI H2-linked_VVN ._.
P10505054A03
The_DD ability_NN of_II antiserum_NN from_II sheep_NN immunized_VVN against_II GCIF_NN to_TO reduce_VVI the_DD inhibitory_JJ effect_NN of_II GCIF_NN on_II bovine_JJ granulosa_NN cell_NN proliferation_NN in_II culture_NN was_VBD also_RR examined_VVN ._.
P10512700A05
Six_MC conformations_NNS are_VBB thus_RR characterised_VVN in_II experimental_JJ structures_NNS ._.
P10514834A15
Activation_NN of_II endogenous_JJ G_NN protein-coupled_VVNJ receptors_NNS causes_VVZ negative_JJ shifts_NNS in_II the_DD voltage_NN dependence_NN of_II sodium_NN channel_NN activation_NN and_CC inactivation_NN ._.
P10519388A06
An_DD inhibitor_NN of_II phosphorylation_NN of_II Erk-1_NN /_SYM 2_MC blocked_VVD the_DD increase_NN of_II VEGF_NN expression_NN and_CC promoter_NN activity_NN induced_VVN by_II serum_NN starvation_NN ._.
P10522861A06
RESULTS_NNS :_: There_EX was_VBD a_DD significant_JJ decrease_NN in_II transfection_NN rate_NN and_CC IGF-I_NN protein_NN expression_NN distal_JJ from_II the_DD injection_NN site_NN in_II animals_NNS receiving_VVG 1_MC injection_NN ,_, as_CS compared_VVN with_II a_DD consistent_JJ increase_NN in_II rats_NNS receiving_VVG multiple_JJ injections_NNS ._.
P10528980A06
The_DD integrity_NN and_CC immunological_JJ activity_NN of_II both_CC rF1_NN and_CC rV_NN antigens_NNS was_VBD shown_VVN to_TO be_VBI unaffected_VVN by_II the_DD microencapsulation_NN process_NN ._.
P10544078A04
Neither_CC P1_NN nor_CC P3_NN interact_VVB with_II coat_NN protein_NN (_( CP_NN )_) or_CC with_II various_JJ control_NN proteins_NNS ._.
P10547272A01
Cytokines_NNS such_II+ as_II granulocyte-macrophage_NN colony-stimulating_VVGJ factor_NN (_( GM-CSF_NN )_) and_CC IL-3_NN promote_VVB the_DD survival_NN and_CC stimulate_VVB the_DD proliferation_NN of_II haematopoietic_JJ cells_NNS ._.
P10556565A05
Infrared_JJ spectroscopy_NN ,_, however_RR ,_, revealed_VVD that_CST this_PND is_VBZ not_RR due_II+ to_II a_DD higher_JJR thermostability_NN of_II alphaA-crystallin_NN 's_GE secondary_JJ structure_NN ._.
P10559324A04
The_DD cloned_VVNJ E4orf6_NN /_SYM 7_MC collaborated_VVD with_II a_DD retinoblastoma_NN protein_NN (_( RB_NN )_) -nonbinding_VVGJ and_CC therefore_RR E2F-nonreleasing_VVGJ mutant_NN of_II Ad5_NN E1A_NN (_( dl922_NN /_SYM 947_MC )_) to_TO morphologically_RR transform_VVI primary_JJ rat_NN cells_NNS ,_, suggesting_VVG that_CST E2F_NN is_VBZ an_DD important_JJ cellular_JJ protein_NN functioning_VVG downstream_JJ of_II E1A_NN for_II transformation_NN ._.
P10564772A10
These_DD data_NNS suggest_VVB that_CST A._NN niger_NN is_VBZ capable_JJ of_II secreting_VVGN large_JJ amounts_NNS of_II a_DD single_JJ glycoprotein_NN combined_VVN with_II higher_JJR activity_NN levels_NNS of_II the_DD dolichol_NN phosphate_NN :_: glycosyltransferases_NNS without_II an_DD increase_NN in_II the_DD heterogeneity_NN of_II the_DD glycan_NN structures_NNS ._.
P10571893A10
It_PN exhibits_VVZ a_DD circadian_JJ oscillation_NN in_II constant_JJ conditions_NNS ._.
P10574797A01
BACKGROUND_NN :_: Hepatitis_NN C_NN virus_NN (_( HCV_NN )_) currently_RR infects_VVZ approximately_RR 3_MC %_SYM of_II the_DD world_NN 's_GE population_NN ._.
P10581160A01
Upon_II binding_VVGN of_II a_DD Wnt_NN to_II its_PNG receptor_NN ,_, GSK3beta_NN is_VBZ inhibited_VVN through_II an_DD unknown_VVNJ mechanism_NN involving_VVG Dishevelled_NN (_( Dsh_NN )_) ,_, resulting_VVG in_II the_DD dephosphorylation_NN and_CC stabilization_NN of_II beta-catenin_NN ,_, which_PNR translocates_VVZ to_II the_DD nucleus_NN and_CC interacts_VVZ with_II Lef_NN /_SYM Tcf_NN transcription_NN factors_NNS to_TO activate_VVI target_NN gene_NN expression_NN ._.
P10583399A07
During_II the_DD search_NN for_II potential_JJ Ca2+_NN /_SYM calmodulin-dependent_JJ protein_NN kinase_NN II_MC substrates_NNS we_PN identified_VVD different_JJ proteins_NNS associated_VVN with_II tubulovesicles_NNS ,_, such_II+ as_II synaptophysin_NN and_CC beta-tubulin_NN immunoreactivity_NN ,_, which_PNR were_VBD identified_VVN using_VVG specific_JJ antibodies_NNS ._.
P10588452A08
Median_JJ SI_NN to_II GAD_NN was_VBD higher_JJR in_II the_DD patients_NNS with_II IDDM_NN than_CSN in_II the_DD control_NN subjects_NNS (_( 3.10_MC vs._CC 1.55_MC ;_: P_NN =_SYM 0.03_MC ,_, Mann-Whitney_NN U-test_NN )_) ._.
P10593585A07
It_PN was_VBD suggested_VVN that_CST rboGM-CSF_NN enhanced_VVD bactericidal_JJ activity_NN of_II bovine_JJ neutrophils_NNS both_CC in_RR+ vitro_RR and_CC in_RR+ vivo_RR ._.
P10597302A07
Finally_RR ,_, SAHA_NN modestly_RR increased_VVD expression_NN /_SYM activation_NN of_II the_DD stress-activated_VVNJ protein_NN kinase_NN (_( SAPK_NN /_SYM JNK_NN )_) ;_: moreover_RR ,_, SAHA-related_VVNJ lethality_NN was_VBD partially_RR attenuated_VVN by_II a_DD dominant-negative_JJ c-Jun_NN mutant_NN protein_NN (_( TAM67_NN )_) ._.
P10601202A04
Using_VVG His-tagged_VVNJ recombinant_JJ HBHA_NN proteins_NNS and_CC nickel_NN chromatography_NN we_PN demonstrate_VVB that_CST HBHA_NN polypeptides_NNS which_PNR contain_VVB the_DD coiled-coil_NN region_NN form_VVB multimers_NNS ._.
P10605716A08
The_DD presence_NN of_II u-PAR_NN promotes_VVZ these_DD events_NNS because_CS the_DD extracellular_JJ domain_NN (_( s_NNS )_) of_II u-PAR_NN binds_VVZ to_II beta_NN 1_MC and_CC beta_NN 2_MC integrins_NNS and_CC the_DD GPI_NN anchor_NN of_II u-PAR_NN ,_, like_II that_PND of_II other_JJ GPI-anchored_VVNJ proteins_NNS ,_, interacts_VVZ with_II cholesterol-rich_JJ membrane_NN domains_NNS enriched_VVN in_II caveolin_NN and_CC tyrosine_NN kinases_NNS ._.
P10610815A08
The_DD electroporation_NN parameters_NNS under_II which_PNR maximum_NN transformation_NN efficiencies_NNS were_VBD obtained_VVN varied_VVD from_II strain_NN to_II strain_NN ._.
P10618275A05
This_DD sampling_VVGJ technique_NN has_VHZ successfully_RR been_VBN applied_VVN for_II collection_NN and_CC measurement_NN of_II antibody_NN in_II oral_JJ and_CC genital_JJ tract_NN secretions_NNS ._.
P10623593A01
The_DD cDNAs_NNS encoding_VVG soluble_JJ forms_NNS of_II human_NN beta-1_NN ,_, 4-galactosyltransferase_NN I_MC (_( EC_NN 2.4.1.22_MC )_) ,_, alpha-2_NN ,_, 6-sialyltransferase_NN (_( EC_NN 2.4.99.1_MC )_) ,_, and_CC alpha-1_NN ,_, 3-fucosyltransferase_NN VI_MC (_( EC_NN 2.4.1.65_MC )_) ,_, respectively_RR ,_, have_VHB been_VBN expressed_VVN in_II the_DD methylotrophic_JJ yeast_NN Pichia_NN pastoris_NN ._.
P10627464A01
Thrombomodulin_NN is_VBZ an_DD endothelial_JJ cell_NN receptor_NN for_II thrombin_NN ._.
P10628384A09
Remarkably_RR ,_, there_EX was_VBD a_DD significant_JJ staining_VVGN of_II tumor_NN cell_NN complexes_NNS undergoing_VVG lymphangiotic_JJ dissemination_NN ._.
P10631108A10
Strong_JJ staining_VVGN was_VBD observed_VVN especially_RR in_II cortical_JJ renal_JJ tubules_NNS of_II the_DD mouse_NN kidney_NN ,_, where_PNR expression_NN of_II klotho_NN transcripts_NNS overlaps_VVZ ._.
P10634193A06
In_II contrast_NN ,_, all_DD women_NNS of_II African_JJ origin_NN carried_VVD non-B_NN HIV_NN subtypes_NNS (_( subtypes_NNS A_NN ,_, C_NN ,_, D_NN ,_, or_CC G_NN )_) regardless_II+ of_II transmission_NN mode_NN ._.
P10637338A05
In_II contrast_NN to_II the_DD other_JJ type_NN I_MC element_NN binding_VVGJ factors_NNS ,_, the_DD 65_MC kDa_NN activity_NN partitions_VVZ preferentially_RR to_II the_DD nuclear_JJ fraction_NN during_II isolation_NN ._.
P10640283A03
A_DD murine-specific_JJ phosphorothioate_NN oligodeoxynucleotide_NN and_CC various_JJ control_NN sequences_NNS were_VBD each_PND passively_RR encapsulated_VVN into_II 100-nm_NN diameter_NN large_JJ unilamellar_JJ vesicles_NNS composed_VVN of_II egg_NN phosphatidylcholine_NN and_CC cholesterol_NN ._.
P10655657A04
When_CS the_DD wavelength_NN of_II the_DD incident_JJ light_NN is_VBZ far_RR away_II+ from_II the_DD optical_JJ absorption_NN bands_NNS of_II the_DD protein_NN ,_, a_DD approximately_RR 0.008_MC degree_NN decrease_NN in_II the_DD resonance_NN angle_NN ,_, due_II+ to_II a_DD conformational_JJ change_NN ,_, occurs_VVZ as_CS the_DD protein_NN is_VBZ switched_VVN from_II the_DD oxidized_VVNJ to_II reduced_VVNJ states_NNS ._.
P10659770A04
Detailed_VVNJ analysis_NN of_II 13_MC diverse_JJ silkworm_NN strains_NNS with_II a_DD representative_NN of_II 15_MC microsatellite_NN loci_NNS revealed_VVD a_DD number_NN of_II alleles_NNS ranging_VVG from_II 3_MC to_II 17_MC with_II heterozygosity_NN values_NNS of_II 0.66-0.90_MC ._.
P10666266A11
Selective_JJ mutation_NN of_II the_DD nuclear_JJ localization_NN signal_NN site_NN in_II the_DD Rev_NN portion_NN resulted_VVD in_II retargeting_VVGN of_II Rev-Tax_NN to_II TSS_NN and_CC subsequent_JJ restoration_NN of_II transcription_NN function_NN ,_, demonstrating_VVG that_CST inappropriate_JJ localization_NN preceded_VVD loss_NN of_II function_NN ._.
P10666496A09
Addition_NN of_II chondroitin_NN 4-sulfate_NN to_II the_DD sponges_NNS partially_RR or_CC totally_RR inhibited_VVD mineral_NN deposition_NN ,_, even_RR though_CS 80-90_MC %_SYM of_II the_DD compound_NN was_VBD released_VVN within_II 24_MC hours_NNS ._.
P10675238A05
Serum-deprived_VVNJ Caco-2_NN cells_NNS were_VBD employed_VVN for_II all_DD experimentation_NN ._.
P10689635A02
Evidence_NN of_II sex_NN linkage_NN was_VBD supported_VVN by_II DNA_NN analysis_NN using_VVG three_MC polymorphic_JJ markers_NNS from_II the_DD X-chromosome_NN :_: a_DD restriction_NN fragment_NN length_NN polymorphism_NN 200_MC kb_NN centromeric_JJ of_II the_DD DAX-1_NN gene_NN ,_, a_DD tetranucleotide_NN repeat_NN marker_NN in_II the_DD DAX-1_NN promoter_NN (_( DAX-P_NN )_) ,_, and_CC a_DD microsatellite_NN in_II the_DD Duchenne_NN muscular_JJ dystrophy_NN locus_NN (_( 3'-19_NN )_) ._.
P10698088A02
The_DD proliferative_JJ capacity_NN of_II T_NN cells_NNS measured_VVN in_RR+ vitro_RR as_II responses_NNS to_II antigens_NNS and_CC mitogens_NNS is_VBZ severely_RR reduced_VVN during_II HIV_NN infection_NN ._.
P10704351A01
The_DD most_RRT abundant_JJ viral_JJ transcript_NN in_II human_NN papillomavirus_NN (_( HPV_NN )_) 11-infected_VVNJ xenograft_NN tissue_NN has_VHZ been_VBN shown_VVN to_TO encode_VVI the_DD E1_NN (_( wedge_NN )_) E4_NN protein_NN ._.
P10705090A02
Mutations_NNS of_II the_DD ras_NN gene_NN family_NN is_VBZ one_MC of_II the_DD main_JJ activating_VVGJ mechanisms_NNS in_II human_NN cancer_NN ._.
P10713531A01
The_DD structure_NN of_II the_DD neutral_JJ peroxidase_NN from_II Arabidopsis_NN thaliana_NN (_( ATP_NN N_NN )_) has_VHZ been_VBN determined_VVN to_II a_DD resolution_NN of_II 1.9_MC A_NN and_CC a_DD free_JJ R_NN value_NN of_II 20.5_MC %_SYM ._.
P10719225A02
NELL2_NN protein_NN was_VBD detected_VVN as_II doublet_NN bands_NNS of_II 140_MC and_CC 90_MC kDa_NN with_II the_DD use_NN of_II the_DD specific_JJ antibodies_NNS raised_VVN against_II the_DD C-terminal_JJ region_NN of_II NELL2_NN and_CC was_VBD recognized_VVN only_RR in_II the_DD brain_NN but_CC not_RR in_II the_DD peripheral_JJ tissues_NNS ._.
P10721801A03
Norfloxacin_NN was_VBD coupled_VVN onto_II the_DD acid_NN groups_NNS present_JJ along_II the_DD polymer_NN chains_NNS ,_, and_CC conjugates_NNS were_VBD characterised_VVN by_II UV_NN ,_, TLC_NN and_CC SEC_NN ._.
P10725250A08
HGF_NN was_VBD expressed_VVN in_II the_DD branchial_JJ arches_NNS ,_, whilst_CS Met_NN ,_, which_PNR encodes_VVZ an_DD HGF_NN receptor_NN ,_, was_VBD expressed_VVN by_II subpopulations_NNS of_II cranial_JJ motor_NN neurons_NNS ._.
P10726970A08
At_II 8_MC days_NNS ,_, in_II liver_NN there_EX were_VBD no_DD significant_JJ differences_NNS in_II activities_NNS of_II all_DD enzymes_NNS between_II the_DD mice_NNS ,_, however_RR by_II 30_MC days_NNS ,_, the_DD specific_JJ activity_NN of_II GRX_NN was_VBD significantly_RR higher_JJR in_II Bcl-2-knockout_NN mice_NNS ,_, relative_JJ to_II controls_NNS ._.
P10733466A03
Two_MC loss-of-function_NN mutations_NNS of_II PAFAH_NN are_VBB associated_VVN with_II severe_JJ asthma_NN in_II Japanese_JJ individuals_NNS ._.
P10747919A02
MelR_NN stimulates_VVZ transcription_NN initiation_NN at_II the_DD melAB_NN promoter_NN by_II binding_VVGN to_II four_MC sites_NNS centered_VVN at_II positions_NNS -120.5_MC ,_, -100.5_MC ,_, -62.5_MC ,_, and_CC -42.5_MC upstream_JJ of_II the_DD transcript_NN start_NN point_NN ._.
P10751430A09
Third_RR ,_, the_DD reversal_NN of_II ATP_NN effects_NNS is_VBZ greatly_RR slowed_VVN when_CS cyclic_JJ inosine_NN 5'-monophosphate_NN is_VBZ used_VVN to_TO activate_VVI currents_NNS ,_, as_CS expected_VVN for_II slow_JJ inosine_NN 5_MC '_SYM triphosphate_NN hydrolysis_NN by_II G-proteins_NNS ._.
P10754267A03
Identification_NN and_CC quantification_NN of_II PPF_NN (_( 1_MC )_) s_NNS were_VBD achieved_VVN by_II a_DD negative_JJ ion_NN chemical_JJ ionization_NN gas_NN chromatography-mass_NN spectrometry_NN method_NN using_VVG oxygen_NN 18-labeled_VVNJ PPF_NN (_( 1_MC )_) s_NNS as_II internal_JJ standards_NNS ._.
P10757050A06
Immunohistochemistry_NN with_II a_DD monoclonal_JJ antibody_NN demonstrated_VVD the_DD IRI_NN in_II the_DD cytoplasm_NN of_II CHO_NN /_SYM I_NN cells_NNS ,_, and_CC transmission_NN electron_NN microscopic_JJ examination_NN demonstrated_VVD the_DD prominently_RR developed_VVNJ mitochondria_NNS ,_, but_CC no_DD secretion_NN granules_NNS ._.
P10758913A17
The_DD SPLP_NN were_VBD stable_JJ and_CC upon_II storage_NN at_II 4_MC degrees_NNS C_NN no_DD significant_JJ change_NN in_II the_DD transfection_NN activity_NN was_VBD observed_VVN over_II a_DD one-year_NN period_NN ._.
P10770036A04
DNA_NN from_II AH803_NN was_VBD analyzed_VVN for_II the_DD presence_NN of_II vanA_NN and_CC vanB_NN resistance_NN genes_NNS by_II polymerase_NN chain_NN reaction_NN ._.
P10781589A01
The_DD activity_NN of_II endothelial_JJ nitric-oxide_NN synthase_NN (_( eNOS_NN )_) is_VBZ regulated_VVN by_II its_PNG subcellular_JJ localization_NN ,_, phosphorylation_NN and_CC through_II its_PNG interaction_NN with_II different_JJ proteins_NNS ._.
P10786682A03
It_PN is_VBZ not_RR active_JJ against_II kinases_NNS from_II other_JJ receptor_NN families_NNS ,_, such_II+ as_II epidermal_JJ growth_NN factor_NN receptor_NN ,_, fibroblast_NN growth_NN factor_NN receptor-1_NN ,_, c-Met_NN ,_, and_CC Tie-2_NN ,_, or_CC intracellular_JJ kinases_NNS such_II+ as_II c-Src_NN ,_, c-Abl_NN ,_, and_CC protein_NN kinase_NN C-alpha_NN ._.
P10792419A03
CD28_NN and_CC CTLA-4_NN have_VHB been_VBN shown_VVN to_TO be_VBI involved_VVN as_II an_DD important_JJ costimulatory_JJ signal_NN in_II the_DD regulation_NN of_II allergic_JJ inflammation_NN and_CC TH2_NN cytokine_NN production_NN ,_, and_CC thus_RR both_DD genes_NNS are_VBB good_JJ candidate_NN genes_NNS for_II asthma_NN and_CC atopy_NN ._.
P10799543A05
The_DD lack_NN of_II effect_NN of_II gelsolin_NN on_II RCM_NN responses_NNS to_II monoclonal_JJ anti-Edg-4_NN receptor_NN antibody_NN plus_CC a_DD phorbol_NN ester_NN without_II LPA_NN attests_VVZ to_II its_PNG specificity_NN for_II LPA_NN delivery_NN and_CC the_DD absence_NN of_II post-receptor_NN effects_NNS ._.
P10806201A05
A_DD progressive_JJ age-related_VVNJ decrease_NN in_II the_DD levels_NNS of_II the_DD lysosome-associated_VVNJ membrane_NN protein_NN type_NN 2a_NN that_PNR acts_VVZ as_II a_DD receptor_NN for_II chaperone-mediated_VVNJ autophagy_NN was_VBD responsible_JJ for_II decreased_VVNJ substrate_NN binding_VVGN in_II lysosomes_NNS from_II old_JJ rats_NNS as_CC+ well_CC+ as_CC from_II late_JJ passage_NN human_NN fibroblasts_NNS ._.
P10807915A10
These_DD experiments_NNS document_VVB a_DD new_JJ event_NN in_II gamete_NN activation_NN in_II Chlamydomonas_NN and_CC reveal_VVB the_DD existence_NN of_II a_DD mechanism_NN for_II regulated_VVNJ translocation_NN of_II molecules_NNS into_II an_DD intact_JJ flagellum_NN ._.
P10810144A07
The_DD results_NNS suggest_VVB that_CST feedback_NN loops_NNS interconnect_VVB the_DD cellular_JJ machinery_NN controlling_VVG cellulose_NN and_CC pectin_NN biosynthesis_NN ._.
P10814791A02
The_DD main_JJ phagocytes_NNS in_II the_DD central_JJ nervous_JJ system_NN (_( CNS_NN )_) are_VBB microglial_JJ cells_NNS that_PNR are_VBB activated_VVN during_II CNS_NN inflammation_NN ._.
P10826556A02
The_DD cellular_JJ stress_NN response_NN is_VBZ characterized_VVN by_II the_DD expression_NN of_II specific_JJ heat_NN stress_NN genes_NNS (_( hsps_NNS )_) ,_, under_II the_DD transcriptional_JJ control_NN of_II heat_NN shock_NN transcription_NN factors_NNS (_( HSTFs_NNS )_) ._.
P10828077A05
In_II contrast_NN ,_, activation_NN of_II the_DD Ca_NN (_( 2+_MC )_) -activated_VVNJ neutral_JJ protease_NN calpain_NN I_MC was_VBD readily_RR detectable_JJ after_II the_DD exposure_NN to_II N-methyl-d-aspartate_NN ._.
P10844600A05
Extracellular_JJ matrix_NN components_NNS were_VBD analyzed_VVN by_II immunohistochemistry_NN ._.
P10848622A10
We_PN conclude_VVB that_CST processing_VVGN to_II insulin_NN ,_, facilitated_VVN by_II the_DD catalytic_JJ activities_NNS of_II granule_NN proteolytic_JJ enzymes_NNS ,_, assists_VVZ in_II the_DD targeting_VVGN (_( storage_NN )_) of_II the_DD hormone_NN ._.
P10852718A12
FA_NN binding_VVGN to_II all_DD FABPs_NNS was_VBD enthalpically_RR driven_VVN ._.
P10854671A16
These_DD results_NNS demonstrate_VVB the_DD neurotoxicity_NN and_CC the_DD genotoxicity_NN of_II B_NN [_( a_NN ]_) P_NN exposure_NN in_II the_DD mussel_NN ._.
P10859178A04
Northern_NN gel-blot_NN analysis_NN revealed_VVD what_PND appeared_VVD to_TO be_VBI a_DD single_JJ transcript_NN ,_, but_CC three_MC distinct_JJ polypeptides_NNS were_VBD detected_VVN in_II immunogel-blot_NN analyses_NNS of_II the_DD ExGases_NNS extracted_VVN from_II growing_VVGJ coleoptiles_NNS ._.
P10861219A06
Thus_RR ,_, reoxygenation_NN and_CC H_NN (_( 2_MC )_) O_NN (_( 2_MC )_) -mediated_VVNJ oxidative_JJ stress_NN share_VVB a_DD mechanism_NN of_II ERK_NN activation_NN that_PNR is_VBZ ATP-_NN or_CC mitochondrion-dependent_JJ ,_, and_CC this_DD common_JJ feature_NN suggests_VVZ that_CST the_DD reoxygenation_NN response_NN is_VBZ mediated_VVN by_II reactive_JJ oxygen_NN species_NNS ._.
P10865121A03
These_DD transporters_NNS belong_VVB to_II two_MC protein_NN families_NNS ,_, which_PNR are_VBB both_PND unrelated_VVN to_II the_DD Na_NN (_( +_SYM )_) -coupled_VVNJ neurotransmitter_NN transporters_NNS operating_VVG at_II the_DD plasma_NN membrane_NN ._.
P10869178A14
PA_NN stimulation_NN occurs_VVZ through_II both_CC a_DD C-terminal-dependent_JJ and_CC an_DD independent_JJ mechanism_NN ._.
P10875891A03
Cell_NN migration_NN induced_VVN by_II HGF_NN /_SYM SF_NN consisted_VVD of_II two_MC distinct_JJ phases_NNS ,_, initial_JJ cell_NN spreading_VVGN between_II 2_MC and_CC 9_MC h_NN after_II the_DD start_NN of_II treatment_NN ,_, and_CC the_DD scattering_VVGJ phase_NN which_PNR started_VVD approximately_RR 12_MC h_NN after_II treatment_NN ._.
P10885620A04
DNA_NN damage_NN was_VBD lowered_VVN in_II the_DD presence_NN of_II SOD_NN and_CC catalase_NN or_CC DMSO_NN ,_, indicating_VVG a_DD set_NN of_II reactions_NNS that_PNR leads_VVZ to_II oxy-radical_NN generation_NN ._.
P10892868A11
Local_JJ depletion_NN of_II macrophages_NNS in_II the_DD initiation_NN phase_NN of_II the_DD immune_JJ response_NN appears_VVZ to_TO lead_VVI to_II a_DD less_RR vigorous_JJ attack_NN on_II the_DD grafted_VVNJ tissue_NN and_CC therefore_RR to_TO promote_VVI graft_NN survival_NN ._.
P10900167A02
CARP_NN has_VHZ been_VBN identified_VVN as_II a_DD nuclear_JJ protein_NN whose_PNR mRNA_NN levels_NNS are_VBB exquisitely_RR sensitive_JJ to_II Dox_NN ._.
P10903443A05
They_PN both_PND encode_VVB putative_JJ RNA-binding_VVGJ proteins_NNS of_II the_DD RRM_NN (_( RNA_NN recognition_NN motif_NN )_) type_NN ,_, and_CC the_DD high_JJ degree_NN of_II conservation_NN of_II both_DB these_DD gene_NN families_NNS suggests_VVZ an_DD important_JJ role_NN in_II spermatogenesis_NN ._.
P10923625A08
Cytotoxicity_NN was_VBD measured_VVN by_II LDH_NN release_NN and_CC apoptotic_JJ cell_NN death_NN by_II DNA_NN fragmentation_NN analysis_NN ._.
P10930141A07
Lysozyme_NN binding_VVGN to_II PS_NN vesicles_NNS is_VBZ accompanied_VVN by_II its_PNG penetration_NN into_II the_DD PL_NN monolayer_NN ._.
P10933829A07
On_II the_DD other_JJ hand_NN ,_, use_NN of_II coexpressed_VVNJ enzymes_NNS resulted_VVD in_II 98_MC %_SYM product_NN yield_NN of_II D-hydroxyphenylglycine_NN in_II 15_MC h_NN ,_, minimizing_VVG the_DD level_NN of_II intermediates_NNS in_II the_DD reaction_NN mixture_NN ._.
P10942773A06
RGS4-stimulated_VVNJ rates_NNS could_VM be_VBB measured_VVN up_II+ to_II 5_MC s_NN (_( -1_MC )_) at_II 3_MC microm_NN ,_, giving_VVG a_DD catalytic_JJ efficiency_NN of_II 1.7-2.8_MC x_SYM 10_MC (_( 6_MC )_) m_NN (_( -1_MC )_) s_NN (_( -1_MC )_) for_II all_DD three_MC Galpha_NN subunits_NNS ._.
P10945951A05
Expression_NN of_II FABP_NN /_SYM MDGI_NN was_VBD significantly_RR high_JJ in_II NCI-H417_NN ,_, which_PNR may_VM influence_VVB mitosis_NN and_CC cell_NN growth_NN as_CS implicated_VVN in_II other_JJ tissues_NNS ,_, contrary_II+ to_II the_DD conclusion_NN drawn_VVN for_II the_DD role_NN of_II MDGI_NN in_II human_NN breast_NN cancer_NN ._.
P10947077A06
SRC-1_NN increased_VVD AhR-mediated_VVNJ ,_, TCDD-dependent_JJ reporter_NN gene_NN activity_NN three-fold_NN in_II Hepa-1_NN and_CC COS-1_NN cells_NNS ._.
P10954088A01
Plastids_NNS of_II higher_JJR plants_NNS operate_VVB with_II at_RR+ least_RR two_MC distinct_JJ DNA-dependent_JJ RNA_NN polymerases_NNS ,_, which_PNR are_VBB encoded_VVN in_II the_DD organelle_NN (_( PEP_NN )_) and_CC in_II the_DD nucleus_NN (_( NEP_NN )_) ,_, respectively_RR ._.
P10956418A04
Despite_II the_DD morphological_JJ and_CC functional_JJ differences_NNS of_II the_DD cerebella_NNS the_DD staining_VVGJ patterns_NNS of_II IP_NN (_( 3_MC )_) R1_NN labeling_VVGN in_II Purkinje_NN cells_NNS was_VBD preserved_VVN ._.
P10963363A05
The_DD higher_JJR expression_NN of_II GDNF_NN and_CC its_PNG mRNA_NN in_II developing_VVGJ brains_NNS may_VM be_VBB one_MC of_II the_DD factors_NNS responsible_JJ for_II the_DD relative_JJ resistance_NN to_II ischemia_NN of_II fetal_JJ and_CC neonatal_JJ as_CS opposed_VVN to_II adult_NN brains_NNS ._.
P10966784A03
The_DD attention_NN was_VBD focussed_VVN on_II the_DD MxM_NN form_NN of_II the_DD protein_NN ,_, in_II which_PNR the_DD two_MC subunits_NNS swap_VVB their_PNG N-terminal_JJ ends_NNS interconverting_VVG at_II equilibrium_NN with_II the_DD M=M_NN form_NN with_II no_DD interchange_NN between_II subunits_NNS ._.
P10973558A09
In_II addition_NN ,_, the_DD mRNA_NN of_II the_DD homeodomain-containing_VVGJ gene_NN Cart-1_NN began_VVD to_TO be_VBI expressed_VVN in_II prechondrogenic_JJ condensations_NNS and_CC corresponded_VVD to_II the_DD expression_NN of_II type_NN II_MC collagen_NN mRNA_NN ._.
P10997589A01
A_DD cDNA_NN encoding_VVG an_DD RNA_NN binding_VVGJ protein_NN has_VHZ been_VBN isolated_VVN from_II a_DD cDNA_NN library_NN prepared_VVN from_II larvae_NN of_II the_DD ascidian_NN Ciona_NN intestinalis_NN ._.
P11000250A10
We_PN suggest_VVB that_CST LMP-1_NN encodes_VVZ stimulatory_JJ and_CC inhibitory_JJ activities_NNS ;_: the_DD latter_NN could_VM limit_VVB signaling_VVGN in_II the_DD apparent_JJ absence_NN of_II ligand-dependent_JJ down-regulation_NN ._.
P11009062A05
The_DD forensic_JJ efficiency_NN values_NNS for_II the_DD Romany_JJ population_NN were_VBD slightly_RR different_JJ from_II those_PND found_VVN in_II the_DD Hungarian_JJ Caucasian_JJ population_NN ._.
P11015403A01
Aeromonads_NNS are_VBB causative_JJ agents_NNS of_II a_DD number_NN of_II human_NN infections_NNS ._.
P11024108A03
In_II this_DD report_NN ,_, we_PN show_VVB that_CST mutations_NNS in_II the_DD PPPY_NN sequence_NN of_II the_DD VSV_NN M_NN protein_NN reduce_VVB virus_NN yield_NN by_II blocking_VVGN a_DD late_JJ stage_NN in_II virus_NN budding_VVGN ._.
P11026693A04
Additionally_RR ,_, a_DD human_NN T-cell_NN line_NN ,_, Jurkat_NN ,_, exposed_VVN to_II astrocytoma_NN cyst_NN fluid_NN resulted_VVD in_II significantly_RR increased_VVNJ cytotoxicity_NN as_CS compared_VVN to_II controls_NNS ,_, an_DD effect_NN blocked_VVN by_II FasL_NN neutralizing_VVGJ antibodies_NNS ._.
P11031119A02
Artifactual_JJ covariations_NNS arising_VVG from_II close_JJ evolutionary_JJ relationships_NNS among_II certain_JJ sequence_NN subgroups_NNS were_VBD eliminated_VVN using_VVG empirically_RR derived_VVNJ sequence_NN diversity_NN thresholds_NNS ._.
P11033350A04
Interestingly_RR ,_, the_DD PKCdelta_NN C1b_NN domain_NN markedly_RR synergized_VVD with_II normal_JJ Ras_NN protein_NN to_TO induce_VVI oocyte_NN maturation_NN when_CS both_DD proteins_NNS were_VBD co-injected_VVN in_II oocytes_NNS ._.
P11042401A04
The_DD other_JJ set_NN comprised_VVD samples_NNS of_II blood_NN and_CC serum_NN obtained_VVN from_II virus-free_JJ or_CC CSFV-infected_VVNJ pigs_NNS ._.
P11044666A05
Since_CS monoterpenoid_NN pheromone_NN precursor_NN synthesis_NN and_CC HMG-CoA_NN reductase_NN expression_NN are_VBB under_II the_DD control_NN of_II JH_NN III_MC in_II the_DD metathorax_NN of_II Ips_NN bark_NN beetles_NNS ,_, the_DD observed_VVNJ HMG-S_NN expression_NN pattern_NN suggests_VVZ that_CST the_DD isoprenoid_NN pathway_NN is_VBZ similarly_RR important_JJ for_II semiochemical_JJ production_NN in_II D._NN jeffreyi_NN ._.
P11046012A03
To_TO determine_VVI whether_CST CCR2A_NN and_CC CCR2B_NN receptors_NNS function_VVB similarly_RR ,_, Jurkat_NN T_NN cells_NNS were_VBD stably_RR transfected_VVN with_II plasmids_NNS encoding_VVG the_DD human_NN CCR2A_NN or_CC CCR2B_NN gene_NN ._.
P11051552A04
The_DD PmrB_NN protein_NN bound_VVD iron_NN via_II its_PNG periplasmic_JJ domain_NN which_PNR harbors_VVZ two_MC copies_NNS of_II the_DD sequence_NN ExxE_NN ,_, a_DD motif_NN present_JJ in_II the_DD Saccharomyces_NN FTR1_NN iron_NN transporter_NN and_CC in_II mammalian_JJ ferritin_NN light_JJ chain_NN ._.
P11056013A08
The_DD ability_NN to_TO overcome_VVI density-dependent_JJ inhibition_NN of_II cell_NN division_NN correlated_VVD with_II elevated_VVNJ cyclin-dependent_JJ kinase-2_NN (_( CDK2_NN )_) activity_NN and_CC a_DD lower_JJR level_NN of_II induction_NN of_II the_DD CDK_NN inhibitor_NN p27_NN in_II the_DD target_NN cells_NNS ._.
P11063795A03
To_TO localize_VVI 8p11-p12_NN breakpoints_NNS in_II T-PLL_NN ,_, metaphases_NNS from_II seven_MC cases_NNS were_VBD karyotyped_VVN ._.
P11068137A12
As_II oxidative_JJ stress_NN is_VBZ thought_VVN to_TO play_VVI an_DD active_JJ role_NN in_II the_DD pathobiology_NN of_II Parkinson_NN 's_GE disease_NN ,_, these_DD data_NNS may_VM be_VBB relevant_JJ to_II our_PNG understanding_VVGN of_II the_DD disorder_NN ._.
P11073907A05
The_DD encoding_VVGJ gene_NN is_VBZ located_VVN within_II a_DD cluster_NN of_II genes_NNS for_II enzymes_NNS involved_VVN in_II the_DD further_JJ oxidation_NN of_II methylene_NN tetrahydromethanopterin_NN to_II CO_NN (_( 2_MC )_) ._.
P11081966A02
Polypeptide_NN sequences_NNS deduced_VVN from_II three_MC Ss2a_NN cDNA_NN clones_NNS share_VVB a_DD 95_MC %_SYM overall_JJ sequence_NN similarity_NN ,_, and_CC may_VM thus_RR have_VHB similar_JJ biochemical_JJ properties_NNS and_CC may_VM make_VVB identical_JJ contributions_NNS to_II starch_NN biosynthesis_NN in_II wheat_NN endosperm_NN ._.
P11086226A05
Here_RR we_PN report_VVB in_JJ+ vitro_JJ data_NNS concerning_VVG (_( a_NN )_) the_DD relative_JJ binding_VVGJ affinity_NN of_II the_DD selected_VVNJ synthetic_JJ chemicals_NNS Bisphenol_NN A_NN ,_, nonylphenol_NN ,_, p-tert-octylphenol_NN ,_, and_CC o_NN ,_, p-DDT_NN to_II the_DD estrogen_NN receptor_NN of_II RUCA-I_NN cells_NNS and_CC (_( b_NN )_) the_DD relative_JJ potency_NN of_II these_DD compounds_NNS in_II inducing_VVGN increased_VVNJ production_NN of_II complement_NN C3_NN ,_, an_DD endogenous_JJ estrogen-responsive_JJ gene_NN ._.
P11089534A07
As_CS in_II PM_NN ,_, almost_RR all_DD p85_NN was_VBD associated_VVN with_II IRS1_NN /_SYM 2_MC ._.
P11101896A03
We_PN now_RR report_VVB the_DD 1.9_MC A_NN crystal_NN structure_NN of_II DsRed_NN ,_, a_DD red_JJ fluorescent_JJ protein_NN from_II Discosoma_NN coral_NN ._.
P11106095A10
Nine_MC of_II the_DD 18_MC (_( 50_MC %_SYM )_) samples_NNS had_VHD a_DD K-ras_NN codon_NN 12_MC point_NN mutation_NN ._.
P11115065A03
METHODS_NNS :_: Human_NN umbilical_JJ vein_NN endothelial_JJ cells_NNS (_( HUVECs_NNS )_) in_II culture_NN were_VBD incubated_VVN with_II varying_VVGJ concentrations_NNS of_II DA_NN for_II different_JJ time_NN periods_NNS ._.
P11120760A09
The_DD resulting_VVGJ sperm_NNS are_VBB malformed_VVN and_CC are_VBB morphologically_RR similar_JJ to_II abnormal_JJ sperm_NN seen_VVN in_II some_DD cases_NNS of_II human_NN male_NN infertility_NN ._.
P11124832A05
We_PN discovered_VVD that_CST ,_, in_II the_DD presence_NN of_II mitogenic_JJ signal_NN ,_, HCV_NN core_NN protein_NN enhanced_VVD Elk1_NN activation_NN working_VVG downstream_JJ of_II MEK_NN without_II affecting_VVGN ERK_NN activity_NN and_CC Elk1_NN phosphorylation_NN ._.
P11130862A04
Escherichia_NN coli_NN DH5alpha_NN and_CC a_DD mutant_JJ strain_NN JRG1728_NN transformed_VVN by_II plasmid_NN carrying_VVG actX_NN manifested_VVD apparent_JJ hemolytic_JJ activity_NN on_II sheep_NN blood_NN agar_NN and_CC grew_VVD anaerobically_RR ,_, although_CS the_DD original_JJ strains_NNS did_VDD not_RR ._.
P11134582A04
METHODS_NNS :_: Wildtype_NN and_CC c-fos_NN -/-_SYM mice_NNS were_VBD exposed_VVN to_II low_JJ (_( roomlight_NN )_) or_CC high_JJ levels_NNS of_II visible_JJ light_NN for_II up_RR+ to_RR two_MC hours_NNS ._.
P11139460A05
Removal_NN of_II the_DD endothelium_NN did_VDD not_RR alter_VVB EPA-induced_VVNJ relaxations_NNS ._.
P11145742A09
Individual_JJ mutations_NNS of_II C_NN /_SYM EBP_NN and_CC Sp1_NN sites_NNS resulted_VVD in_II a_DD loss_NN of_II more_RR than_CSN 50_MC %_SYM of_II the_DD cAMP-dependent_JJ induction_NN ._.
P11151675A07
Within_II macronuclear_JJ genomes_NNS ,_, this_DD region_NN is_VBZ highly_RR under-amplified_VVN ;_: its_PNG level_NN never_RR exceeds_VVZ 20_MC %_SYM of_II that_PND of_II the_DD corresponding_VVGJ G_NN gene_NN /_SYM P_NN gene_NN region_NN in_II the_DD 11_MC cell_NN clones_NNS we_PN tested_VVD ._.
P11160651A03
This_DD effect_NN was_VBD selective_JJ for_II tumor_NN tissue_NN ,_, with_II little_DD or_CC no_DD increase_NN seen_VVN in_II nontumor_NN tissues_NNS and_CC organs_NNS ._.
P11161711A09
These_DD results_NNS suggest_VVB that_CST translocation_NN of_II CREB_NN between_II the_DD nucleus_NN and_CC the_DD cytoplasm_NN provides_VVZ an_DD important_JJ role_NN in_II CREB_NN activating_VVGJ pathways_NNS in_II VSMCs_NNS ._.
P11167927A06
The_DD extracellular_JJ domain_NN of_II the_DD exon_NN 3-retaining_VVGJ and_CC -deleted_VVNJ isoforms_NNS of_II the_DD GHR_NN are_VBB released_VVN as_II E3+GHBP_NN and_CC E3-GHBP_NN into_II the_DD peripheral_JJ circulation_NN ._.
P11180938A07
Our_PNG analytical_JJ method_NN is_VBZ very_RR useful_JJ for_II the_DD analyses_NNS of_II KS_NN in_II various_JJ biological_JJ materials_NNS and_CC for_II comparison_NN of_II the_DD degree_NN of_II sulfation_NN of_II KS_NN from_II various_JJ biological_JJ samples_NNS ._.
P11193154A03
Using_VVG this_DD assay_NN ,_, we_PN demonstrate_VVB that_CST the_DD same_JJ aspartate_NN mutations_NNS in_II PS1_NN that_PNR block_VVB APP_NN processing_VVGN also_RR prevent_VVB Notch1_NN cleavage_NN and_CC translocation_NN to_II the_DD nucleus_NN ._.
P11203697A07
Thus_RR ,_, separable_JJ regulatory_JJ elements_NNS that_PNR direct_VVB ngn2_NN expression_NN to_II distinct_JJ neural_JJ progenitor_NN populations_NNS have_VHB been_VBN defined_VVN ._.
P11207311A07
MAPK_NN kinase_NN inhibition_NN but_CC not_RR p38_NN inhibition_NN also_RR blocked_VVD FN-mediated_VVNJ F-actin_NN redistribution_NN in_II eosinophils_NNS and_CC prevented_VVD cPLA_NN (_( 2_MC )_) phosphorylation_NN caused_VVN by_II adhesion_NN to_II FN_NN ._.
P11212298A02
Neurotransmitters_NNS are_VBB released_VVN from_II the_DD presynaptic_JJ membrane_NN of_II one_MC neuron_NN ,_, and_CC bind_VVB to_II the_DD receptors_NNS accumulated_VVN at_II the_DD postsynaptic_JJ membrane_NN ,_, followed_VVN by_II the_DD activation_NN of_II the_DD other_JJ neuron_NN ._.
P11222983A09
As_CS evident_JJ from_II several_JJ examples_NNS ,_, this_DD approach_NN can_VM identify_VVB promoter_NN modules_NNS responsible_JJ for_II the_DD common_JJ regulation_NN of_II promoters_NNS solely_RR by_II the_DD application_NN of_II bioinformatics_NN methods_NNS ._.
P11226466A05
The_DD fluorescent_JJ signals_NNS of_II the_DD sandwich_NN conjugate_NN were_VBD detected_VVN by_II a_DD laser_NN confocal_JJ scanner_NN ._.
P11238881A04
Homozygous_JJ mutant_JJ H-ras_NN (_( -/-_SYM )_) mice_NNS reached_VVD sexual_JJ maturity_NN at_II the_DD same_JJ age_NN as_II their_PNG littermates_NNS ,_, and_CC both_CC males_NNS and_CC females_NNS were_VBD fertile_JJ ._.
P11244510A04
BS69_NN contains_VVZ regions_NNS of_II similarity_NN to_II the_DD PHD_NN finger_NN ,_, the_DD bromodomain_NN ,_, and_CC the_DD MYND_NN domain_NN ,_, all_PND of_II which_PNR are_VBB found_VVN in_II other_JJ proteins_NNS present_JJ in_II high_JJ molecular_JJ weight_NN complexes_NNS that_PNR regulate_VVB transcription_NN and/or_CC modify_VVB chromatin_NN structure_NN ._.
P11251388A01
Influenza_NN A_NN virus_NN with_II its_PNG two_MC major_JJ antigenic_JJ surface_NN proteins_NNS hemagglutinin_NN (_( HA_NN )_) and_CC neuraminidase_NN (_( NA_NN )_) is_VBZ a_DD widely_RR used_VVNJ model_NN to_TO study_VVI DNA_NN immunizations_NNS in_II mice_NNS and_CC other_JJ animals_NNS ._.
P11254653A03
In_II terms_NNS of_II PDGF_NN activation_NN of_II PDGF_NN receptor_NN tyrosine_NN phosphorylation_NN as_CC+ well_CC+ as_CC the_DD mitogen-activated_VVNJ protein_NN kinases_NNS Erk1_NN and_CC Erk2_NN ,_, Null_NN and_CC Null+_NN cells_NNS responded_VVD equivalently_RR ._.
P11267890A01
Juvenile_JJ hormone_NN esterase_NN (_( JHE_NN ,_, EC_NN 3.1.1.1_MC )_) from_II whole_JJ Drosophila_NN melanogaster_NN prepupae_NNS has_VHZ previously_RR been_VBN purified_VVN by_II selective_JJ precipitations_NNS ,_, isoelectric_JJ focussing_VVGN and_CC two_MC column_NN chromatography_NN steps_NNS ._.
P11275691A03
One_MC obvious_JJ reason_NN for_II the_DD difference_NN found_VVN in_II microdissected_VVNJ crypts_NNS is_VBZ their_PNG separation_NN from_II the_DD lamina_NN propria_NN milieu_NN ._.
P11281449A05
A_DD novel_JJ long-range_NN semi-nested_VVNJ polymerase_NN chain_NN reaction_NN (_( PCR_NN )_) strategy_NN was_VBD utilized_VVN in_II order_NN to_TO span_VVI two_MC different_JJ methylation_NN sites_NNS ,_, and_CC a_DD polymorphism_NN within_II SNRPN_NN was_VBD used_VVN so_CS+ that_CS allele-specific_JJ methylation_NN of_II both_DD sites_NNS could_VM be_VBB determined_VVN ._.
P11287187A02
Ad4BP_NN /_SYM SF-1_NN ,_, encoding_VVG a_DD zinc_NN finger_NN transcription_NN factor_NN ,_, plays_VVZ important_JJ roles_NNS in_II gonadogenesis_NN ._.
P11292315A08
The_DD results_NNS indicate_VVB that_CST this_DD assay_NN is_VBZ extremely_RR sensitive_JJ and_CC reproducible_JJ over_II a_DD five_MC log_NN dynamic_JJ range_NN ,_, and_CC effectively_RR quantifies_VVZ MDC_NN mRNA_NN in_II resting_VVGJ and_CC activated_VVNJ T_NN cells_NNS ._.
P11293244A08
In_II agreement_NN with_II this_DD idea_NN ,_, binding_VVGN of_II CLA_NN to_II purified_VVNJ P._NN falciparum_NN cyclophilin_NN was_VBD not_RR detected_VVN except_II+ at_II very_RR high_JJ concentrations_NNS ._.
P11296466A01
Type_NN 2_MC diabetes_NN is_VBZ a_DD multifactorial_JJ disease_NN composed_VVN of_II subtypes_NNS strongly_RR associated_VVN with_II environmental_JJ factors_NNS at_II one_MC end_NN of_II the_DD spectrum_NN and_CC highly_RR genetic_JJ forms_NNS at_II the_DD other_JJ hand_NN ._.
P11301591A06
Recombinant_JJ CsRP12-1_NN protein_NN was_VBD recognized_VVN by_II sera_NNS of_II clonorchiasis_NN patients_NNS and_CC experimental_JJ rabbits_NNS ,_, but_CC recombinant_JJ CsRP12-2_NN was_VBD not_RR ._.
P11309440A05
This_DD study_NN examined_VVD whether_CST the_DD human_NN COX2_NN locus_NN may_VM be_VBB linked_VVN to_II colon_NN neoplasia_NN in_II humans_NNS ._.
P11316371A04
The_DD deficiency_NN in_II D-arabitol_NN fermentation_NN did_VDD not_RR alter_VVB L._NN monocytogenes_NNS virulence_NN in_II the_DD BALB_NN /_SYM c_NN mouse_NN model_NN after_II intravenous_JJ and_CC intragastric_JJ inoculations_NNS ._.
P11321891A08
Water_NN extracts_NNS from_II cagA_NN negative_JJ strains_NNS stimulated_VVD gastrin_NN secretion_NN (_( p_NN <_SYM 0.05_MC )_) ._.
P11327829A13
The_DD implications_NNS of_II the_DD determined_VVNJ consensus_NN substrate_NN sequence_NN (_( Arg_NN /_SYM Lys_NN )_) /_SYM (_( Arg_NN /_SYM Lys_NN )_) -Ala_NN for_II the_DD proposed_VVNJ biological_JJ function_NN of_II OmpT_NN in_II defense_NN against_II antimicrobial_JJ peptides_NNS are_VBB discussed_VVN ._.
P11332034A08
Neither_CC AlPcS2a_NN nor_CC Photofrin_NN affects_VVZ the_DD uptake_NN of_II the_DD transfecting_VVGJ DNA_NN over_II the_DD plasma_NN membrane_NN ,_, therefore_RR photochemical_JJ permeabilization_NN of_II endocytic_JJ vesicles_NNS seems_VVZ to_TO be_VBI the_DD most_RRT likely_JJ mechanism_NN responsible_JJ for_II the_DD positive_JJ PCI_NN effect_NN on_II gene_NN transfection_NN ._.
P11341824A13
Binding_VVGN of_II bacteriochlorophyll_NN to_II these_DD PufX_NN core_NN segments_NNS is_VBZ implicated_VVN ._.
P11350945A05
Spliceosome_NN assembly_NN and_CC splicing_VVGJ catalysis_NN could_VM be_VBB restored_VVN to_II the_DD respective_JJ depleted_VVNJ extract_NN by_II the_DD addition_NN of_II recombinant_JJ 65_MC or_CC 110_MC kDa_NN protein_NN ._.
P11356414A07
Since_CS the_DD serpin-1J_NN proved_VVD to_TO be_VBI involved_VVN in_II the_DD activation_NN pathway_NN of_II the_DD prophenoloxidase_NN system_NN in_II the_DD hemolymph_NN ,_, the_DD in_JJ+ vivo_JJ function_NN of_II cuticular_JJ MsH49b_NN serpin_NN was_VBD investigated_VVN by_II prophenoloxidase_NN tests_NNS in_II native_JJ cuticular_JJ homogenates_NNS ._.
P11361343A01
The_DD role_NN of_II the_DD LexA_NN protein_NN and_CC ,_, specifically_RR ,_, its_PNG effect_NN on_II recA_NN expression_NN were_VBD analyzed_VVN in_II Xanthomonas_NN campestris_NN pathovar_NN citri_NN (_( X.c._NN pv._NN citri_NN )_) ._.
P11379284A06
Antimicrobial_JJ activity_NN of_II methanol-acetone_NN extract_NN was_VBD retained_VVN after_II heating_VVGN (_( 100_MC degrees_NNS C_NN for_II 30_MC min_NN )_) at_II pH_NN 2.5_MC to_II 6.0_MC but_CC was_VBD lost_VVN after_II treating_VVGN with_II several_JJ proteolytic_JJ enzymes_NNS at_II pH_NN 6.5_MC and_CC 7.0_MC ._.
P11387236A01
Angiogenesis_NN is_VBZ important_JJ for_II wound_NN healing_VVGN ,_, tumor_NN growth_NN ,_, and_CC metastasis_NN ._.
P11392063A11
Although_CS both_DD drugs_NNS alter_VVB membrane_NN lipids_NNS ,_, their_PNG association_NN allows_VVZ some_DD sinusoidal_JJ cell_NN responses_NNS to_TO be_VBI differentiated_VVN ._.
P11401841A03
In_II this_DD study_NN we_PN determined_VVD whether_CST COX-2_NN regulates_VVZ proliferation_NN or_CC apoptosis_NN in_II human_NN fibroblasts_NNS ._.
P11406605A06
To_TO further_RR delineate_VVI the_DD telomeric_JJ boundary_NN of_II the_DD PHP-Ib_NN locus_NN ,_, the_DD previously_RR reported_VVNJ kindred_NN F_NN ,_, in_II which_PNR patient_NN F-V_NN /_SYM 51_MC is_VBZ recombinant_JJ within_II GNAS1_NN ,_, was_VBD investigated_VVN with_II several_JJ new_JJ markers_NNS and_CC direct_JJ nucleotide_NN sequence_NN analysis_NN ._.
P11415985A01
The_DD inner_JJ membrane_NN protein_NN YidC_NN is_VBZ associated_VVN with_II the_DD preprotein_NN translocase_NN of_II Escherichia_NN coli_NN and_CC contacts_VVZ transmembrane_JJ segments_NNS of_II nascent_JJ inner_JJ membrane_NN proteins_NNS during_II membrane_NN insertion_NN ._.
P11421650A04
Twenty-six_MC taxa_NNS belonging_VVG to_II the_DD species_NN groups_NNS C._NN splendens_NN ,_, C._NN meridionalis_NN ,_, C._NN haemorrhoidalis_NN ,_, C._NN virgo_NN ,_, C._NN xanthostoma_NN ,_, and_CC C._NN exul_NN were_VBD analyzed_VVN ,_, with_II two_MC North_NN American_JJ species_NNS ,_, C._NN amata_NN and_CC C._NN aequabilis_NN ,_, as_II outgroup_NN ._.
P11423440A11
Thus_RR ,_, the_DD CA_NN protein_NN possesses_VVZ the_DD inherent_JJ ability_NN to_TO form_VVI metastable_JJ structures_NNS ,_, the_DD morphology_NN of_II which_PNR is_VBZ regulated_VVN by_II an_DD environmentally-sensitive_JJ molecular_JJ switch_NN ._.
P11431332A02
The_DD transcription_NN factor_NN runt-related_VVNJ gene_NN 2_MC (_( RUNX2_NN )_) /_SYM core_NN binding_VVGJ factoralpha-1_NN /_SYM acute_JJ myeloid_NN leukemia_NN 3_MC /_SYM polyoma_NN enhancer-binding_VVGJ protein_NN 2alphaA_NN /_SYM osteoblast-specific_JJ transcription_NN factor_NN 2_MC regulates_VVZ osteoblast_NN differentiation_NN ,_, increases_VVZ lymphomagenesis_NN in_II transgenic_JJ mice_NNS ,_, and_CC is_VBZ expressed_VVN in_II murine_JJ ECs_NNS ._.
P11435737A03
Whether_CST cathB_NN expression_NN is_VBZ regulated_VVN similarly_RR to_II prorenin_NN production_NN is_VBZ yet_RR unknown_VVN ._.
P11438441A08
Such_DD studies_NNS will_VM lead_VVB to_II advances_NNS in_II an_DD understanding_VVGN of_II the_DD relative_JJ role_NN of_II this_DD protein_NN system_NN in_II the_DD various_JJ pathways_NNS in_II which_PNR it_PN has_VHZ an_DD influence_NN ._.
P11442002A06
Flow_NN immunocytofluorometry_NN analysis_NN demonstrated_VVD that_CST the_DD G498S_NN mutant_NN resulted_VVD in_II extremely_RR low_JJ expression_NN at_II the_DD cell_NN surface_NN as_CS compared_VVN with_II the_DD wild_JJ type_NN receptor_NN and_CC the_DD R450H_NN mutant_NN ,_, in_II spite_NN of_II a_DD normal_JJ intracellular_JJ synthesis_NN ._.
P11445834A04
Oncogenesis_NN involves_VVZ aberrant_JJ interactions_NNS between_II cells_NNS and_CC the_DD extracellular_JJ matrix_NN ._.
P11455018A05
Transfection_NN of_II BAECs_NNS with_II the_DD CYP2J2_NN cDNA_NN resulted_VVD in_II increased_VVNJ CYP2J2_NN expression_NN and_CC arachidonic_JJ acid_NN epoxygenase_NN activity_NN ,_, compared_VVN with_II cells_NNS transfected_VVN with_II an_DD irrelevant_JJ green_JJ fluorescent_JJ protein_NN (_( GFP_NN )_) cDNA_NN ._.
P11468182A13
Together_RR ,_, these_DD data_NNS suggest_VVB that_CST As_NN (_( 2_MC )_) O_NN (_( 3_MC )_) and_CC AA_NN may_VM be_VBB effective_JJ antineoplastic_JJ agents_NNS in_II refractory_JJ MM_NN and_CC that_CST AA_NN might_VM be_VBB a_DD useful_JJ adjuvant_NN in_II GSH-sensitive_JJ therapies_NNS ._.
P11479624A03
Mutations_NNS in_II S6_NN or_CC integrase_NN that_PNR disrupt_VVB integrase-INI1_NN interaction_NN abrogated_VVD the_DD inhibitory_JJ effect_NN ._.
P11490348A02
Interaction_NN between_II lipopolysaccharide_NN (_( LPS_NN )_) ,_, LPS-binding_VVGJ protein_NN ,_, and_CC the_DD CD14_NN receptor_NN at_II the_DD surface_NN of_II LPS-responsive_JJ cells_NNS results_VVZ in_II inflammatory_JJ cytokine_NN release_NN and_CC internalization_NN and_CC detoxification_NN of_II LPS_NN ._.
P11500448A05
In_II contrast_NN ,_, no_DD beneficial_JJ effects_NNS were_VBD observed_VVN when_CS CTB_NN was_VBD simply_RR admixed_VVN with_II antigen_NN ._.
P11511306A09
GD1b_NN ,_, GT1b_NN ,_, and_CC GQ1b_NN reduced_VVD cAMP_NN level_NN and_CC protein_NN kinase_NN A_NN activity_NN in_II WM266-4_NN ._.
P11520620A03
The_DD major_JJ proteins_NNS expressed_VVN by_II M._NN paratuberculosis_NN were_VBD analyzed_VVN by_II two-dimensional_JJ gel_NN electrophoresis_NN ,_, and_CC a_DD superoxide_NN dismutase_NN (_( Sod_NN )_) was_VBD identified_VVN from_II this_DD protein_NN profile_NN ._.
P11525067A12
Their_PNG existence_NN in_II new_JJ cultivars_NNS of_II olive_NN is_VBZ shown_VVN ._.
P11533241A07
DNA_NN fragmentation_NN and_CC poly_JJ (_( ADP-ribose_NN )_) polymerase_NN (_( PARP_NN )_) cleavage_NN in_II LA-treated_VVNJ MCF10A_NN cells_NNS indicated_VVD progression_NN to_II the_DD execution_NN phase_NN of_II apoptosis_NN ._.
P11536051A08
Since_CS ZNF320_NN is_VBZ oriented_VVN toward_II the_DD centromere_NN of_II chromosome_NN 19_MC ,_, both_DD genes_NNS appeared_VVN on_II the_DD same_JJ derivative_NN chromosome_NN der_NN (_( 10_MC )_) ._.
P11544796A03
It_PN was_VBD found_VVN that_CST A-7_NN produced_VVD a_DD concentration-dependent_JJ (_( IC50_NN =_SYM 11.8_MC +/-_SYM 0.6_MC microM_NN )_) NMDA_NN channel_NN blocking_VVGN ._.
P11549897A05
RESULTS_NNS :_: During_II dialysis_NN with_II RC_NN ,_, Mac-1_NN expressions_NNS on_II granulocytes_NNS and_CC monocytes_NNS both_PND significantly_RR increased_VVD as_CS compared_VVN with_II predialysis_NN values_NNS and_CC across_II the_DD dialyzer_NN ._.
P11553639A09
Inhibition_NN of_II Hsp90_NN activity_NN with_II geldanamycin_NN or_CC radicicol_NN resulted_VVD in_II rapid_JJ degradation_NN of_II newly_RR synthesized_VVNJ GERp95_NN ._.
P11563557A04
The_DD demonstration_NN of_II a_DD reliable_JJ use_NN of_II time_NN dependent_JJ NOE_NN cross-peaks_NNS ,_, largely_RR available_JJ from_II NMR_NN solution_NN structure_NN determination_NN ,_, coupled_VVN to_II MCD_NN analysis_NN ,_, to_TO probe_VVI the_DD local_JJ dynamics_NNS of_II biological_JJ macromolecules_NNS ,_, is_VBZ a_DD result_NN of_II general_JJ interest_NN of_II this_DD paper_NN ._.
P11566064A08
We_PN suggest_VVB that_CST protein_NN aggregation_NN as_CC+ well_CC+ as_CC the_DD changes_NNS in_II protein_NN composition_NN and/or_CC in_II properties_NNS of_II lipid_NN bilayer_NN SR_NN membranes_NNS can_VM result_VVB in_II the_DD decrease_NN of_II enzyme_NN activity_NN during_II hibernation_NN ._.
P11576438A06
By_II using_VVGN site-directed_VVNJ mutants_NNS of_II the_DD Arabidopsis_NN ADC1_NN and_CC heterologous_JJ expression_NN in_II yeast_NN ,_, we_PN show_VVB that_CST ADC_NN ,_, like_II ODC_NN ,_, is_VBZ a_DD head-to-tail_NN homodimer_NN with_II two_MC active_JJ sites_NNS acting_VVG in_II trans_NN across_II the_DD interface_NN of_II the_DD dimer_NN ._.
P11579283A02
Proviral_JJ HIV-1_NN DNA_NN was_VBD genotyped_VVN by_II sequence_NN analysis_NN of_II the_DD C2-V3_NN env_NN region_NN ._.
P11587917A12
Future_JJ studies_NNS will_VM be_VBB aimed_VVN at_II identifying_VVGN with_II more_RR detail_NN immunologic_JJ triggers_NNS of_II inflammation_NN in_II patients_NNS ,_, and_CC at_II better_RRR defining_VVGN the_DD interplay_NN between_II effector_NN and_CC regulatory_JJ pathways_NNS both_CC in_II the_DD eye_NN and_CC in_II the_DD systemic_JJ circulation_NN ._.
P11597905A05
Quantification_NN of_II mRNA_NN expression_NN in_II the_DD remaining_VVGJ lung_NN at_II 2_MC h_NN demonstrated_VVD a_DD twofold_NN or_CC greater_JJR upregulation_NN of_II six_MC transcription_NN factors_NNS :_: early_JJ growth_NN response_NN gene-1_NN (_( Egr-1_NN )_) ,_, Nurr77_NN ,_, tristetraprolin_NN ,_, the_DD primary_JJ inhibitor_NN of_II nuclear_JJ factor-kappa_NN B_NN (_( I_MC kappa_NN B-alpha_NN )_) ,_, gut-enriched_VVNJ Kruppel-like_JJ factor_NN (_( GKLF_NN )_) ,_, and_CC LRG-21_NN ._.
P11606310A05
3._MC Three_MC approaches_NNS were_VBD employed_VVN to_TO test_VVI the_DD hypothesis_NN that_CST PAR_NN (_( 2_MC )_) receptor_NN glycosylation_NN restricts_VVZ tryptase_NN activation_NN ._.
P11666971A04
The_DD value_NN for_II C-4_NN increases_VVZ the_DD most_PND ,_, a_DD range_NN of_II 2.4_MC ppm_NN in_II this_DD series_NN ,_, whereas_CS those_PND for_II other_JJ atoms_NNS increase_VVB on_II the_DD order_NN of_II 1_MC ppm_NN ._.
P11683718A02
By_II comparison_NN with_II EMBL_NN /_SYM GenBank_NN data_NNS we_PN could_VM identify_VVB nine_MC porcine_JJ homologues_NNS to_II human_NN genes_NNS (_( TATA_NN box_NN binding_VVGJ protein_NN associated_VVNJ factor_NN B_NN TAF1B_NN ;_: B-cell_NN CLL_NN /_SYM lymphoma_NN 7B_NN BCL7B_NN ;_: pyruvate_NN dehydrogenase_NN kinase_NN ,_, isoenzyme_NN 4_MC PDK4_NN ;_: ribosomal_JJ protein_NN S10_NN RPS10_NN ;_: SPARC-like_JJ 1_MC SPARCL1_NN ;_: epithelial_JJ protein_NN lost_VVN in_II neoplasm_NN beta_NN EPLIN_NN ;_: N-myc_NN downstream-regulated_VVNJ gene_NN 2_MC NDRG2_NN ;_: pleiomorphic_JJ adenoma_NN gene_NN like_II 2_MC PLAGL_NN and_CC ,_, BCL-2_NN associated_VVNJ transcription_NN factor_NN short_JJ form_NN BTFS_NN )_) ._.
P11696220A07
MICA*008_NN ,_, *010_NN ,_, *002_NN and_CC *019_NN were_VBD highly_RR predominant_JJ with_II the_DD allele_NN frequencies_NNS of_II 21.4_MC %_SYM ,_, 18.2_MC %_SYM ,_, 17.6_MC %_SYM and_CC 15.3_MC %_SYM ,_, respectively_RR ._.
P11698482A09
Addition_NN of_II exogenous_JJ IL-17_NN or_CC IL-1beta_NN to_II synovium_NN explants_NNS increased_VVD MIP-3alpha_NN production_NN ._.
P11707779A06
This_DD alternative_JJ splicing_VVGN resulted_VVD in_II a_DD predicted_VVNJ protein_NN of_II 719_MC residues_NNS from_II the_DD smaller_JJR transcript_NN with_II four_MC more_DD terminal_JJ amino_JJ acids_NNS than_CSN the_DD 715_MC residue_NN protein_NN predicted_VVN from_II the_DD larger_JJR transcript_NN ._.
P11719221A03
A_DD cis_JJ element_NN called_VVN the_DD destruction_NN box_NN is_VBZ required_VVN for_II this_DD proteolysis_NN [_( 7-11_MC ]_) ._.
P11725058A10
We_PN have_VHB also_RR shown_VVN by_II an_DD RNA-protein_NN blotting_VVGJ assay_NN that_CST 5'-UTR_NN bound_VVD to_II the_DD HCV_NN core_NN protein_NN ,_, which_PNR can_VM be_VBB translocated_VVN to_II the_DD nuclei_NNS ._.
P11738237A02
Quadrigatus_NN venom_NN ,_, could_VM induce_VVB apoptosis_NN in_II human_NN U251_NN and_CC rat_NN C6_NN malignant_JJ glioma_NN cells_NNS and_CC transformed_VVNJ vascular_JJ endothelial_JJ ECV_NN 304_MC cell_NN lines_NNS ._.
P11743753A07
Immunochemical_JJ analysis_NN of_II the_DD heat-treated_VVNJ samples_NNS using_VVG either_PND of_II the_DD five_MC antibodies_NNS showed_VVD a_DD decrease_NN in_II the_DD quantified_VVNJ gliadin_NN ,_, in_II concordance_NN to_II the_DD loss_NN in_II the_DD extracted_VVNJ proteins_NNS ._.
P11747437A11
Moreover_RR ,_, alternative_JJ sheddases_NNS are_VBB recruited_VVN ,_, depending_VVG on_II the_DD nature_NN of_II the_DD JM_NN sequence_NN ._.
P11751961A04
This_DD Th2-associated_VVNJ repertoire_NN contains_VVZ a_DD highly_RR frequent_JJ public_JJ clonotype_NN characterized_VVN by_II preferred_VVNJ TCR_NN AV_NN and_CC BV_NN gene_NN segment_NN usage_NN along_RR with_II conserved_VVNJ sequences_NNS in_II the_DD third_JJ hypervariable_JJ regions_NNS of_II both_DD TCR_NN chains_NNS ._.
P11755787A07
Slit2_NN cleavage_NN fragments_NNS appear_VVB to_TO have_VHI different_JJ cell_NN association_NN characteristics_NNS ,_, with_II the_DD smaller_JJR C-terminal_JJ fragment_NN being_VVGN more_RR diffusible_JJ and_CC the_DD larger_JJR N-terminal_JJ and_CC uncleaved_VVNJ fragments_NNS being_VVGN more_RR tightly_RR cell_NN associated_VVN ._.
P11756363A05
There_EX was_VBD also_RR a_DD reduction_NN in_II the_DD expression_NN of_II all_DD three_MC integrins_NNS in_II the_DD glandular_JJ epithelium_NN and_CC also_RR a_DD reduced_VVNJ expression_NN of_II the_DD alpha_NN (_( v_MC )_) beta_NN (_( 3_MC )_) integrin_NN in_II the_DD luminal_JJ epithelium_NN ._.
P11762162A07
These_DD Ca2+_NN pulses_NNS trigger_VVB downstream_JJ signaling_VVGJ events_NNS that_PNR include_VVB the_DD activation_NN of_II Ca_NN (_( 2+_NN )_) -regulated_VVNJ protein_NN kinases_NNS ,_, which_PNR are_VBB required_VVN for_II stimulation_NN of_II the_DD oxidative_JJ burst_NN ._.
P11772616A07
Binding_VVGN of_II mersacidin_NN to_II intact_JJ cells_NNS was_VBD significantly_RR enhanced_VVN in_II the_DD mrsR2_NN /_SYM K2_NN knockout_NN mutant_NN ._.
P11776023A02
METHODS_NNS :_: The_DD effects_NNS of_II AGEP_NN on_II Dia_NN levels_NNS in_II cultured_VVNJ HUVEC_NN were_VBD studied_VVN with_II radio-enzymatic_JJ assay_NN ._.
P11782967A04
We_PN report_VVB that_CST the_DD expression_NN of_II Nex1_NN protein_NN is_VBZ induced_VVN after_II 5_MC hr_NN of_II NGF_NN treatment_NN and_CC reaches_VVZ maximal_JJ levels_NNS at_II 24_MC hr_NN ,_, when_CS very_RR few_JJ PC12_NN cells_NNS have_VHB begun_VVN extending_VVG neurites_NNS and_CC ceased_VVN cell_NN division_NN ._.
P11792701A04
All_DD peptides_NNS consist_VVB of_II 35_MC amino_JJ acid_NN residues_NNS and_CC are_VBB characterized_VVN by_II a_DD more_RR hydrophobic_JJ N-terminal_JJ chain_NN region_NN and_CC a_DD C_NN terminus_NN composed_VVN preferentially_RR of_II polar_JJ and_CC charged_VVNJ residues_NNS ._.
P11798529A05
Based_VVN on_II ELISA_NN assay_NN of_II IL-6_NN ,_, there_EX were_VBD remarkable_JJ differences_NNS between_II the_DD 8_MC leukemic_JJ cell_NN lines_NNS ,_, their_PNG secretion_NN of_II IL-6_NN could_VM be_VBB divided_VVN into_II 3_MC levels_NNS ,_, i.e._II high_JJ ,_, moderate_JJ and_CC low_JJ secretion_NN type_NN ._.
P11807862A02
Linkage_NN analysis_NN obtained_VVD the_DD same_JJ multipoint_NN lod_NN score_NN of_II 2.08_MC for_II two_MC intervals_NNS on_II the_DD X_NN chromosome_NN already_RR reported_VVN to_TO be_VBI linked_VVN to_II other_JJ MRX_NN and_CC syndromic_JJ X-linked_VVNJ mental_JJ retardation_NN (_( XLMR_NN )_) families_NNS :_: one_MC pericentromeric_JJ and_CC the_DD other_PN at_II Xq26_NN ._.
P11812499A09
Antibodies_NNS in_II serum_NN and_CC cerebrospinal_JJ fluid_NN from_II a_DD horse_NN with_II EPM_NN recognised_VVD a_DD 29_MC kDa_NN native_JJ protein_NN of_II S._NN neurona_NN merozoites_NNS and_CC the_DD 29_MC kDa_NN recombinant_JJ protein_NN ._.
P11817673A10
However_RR ,_, RXM_NN could_VM suppress_VVB inflammatory_JJ cytokine_NN ,_, interleukin-1beta_NN ,_, interleukin-6_NN ,_, granulocyte_NN macrophage-colony_NN stimulating_VVGJ factor_NN and_CC tumor_NN necrosis_NN factor-alpha_NN ,_, secretions_NNS induced_VVN by_II concanavalin_NN A_NN stimulation_NN at_II a_DD concentration_NN of_II as_RR little_JJ as_CSN 0.5_MC microg_NN /_SYM ml_NN ._.
P11830531A10
In_II conclusion_NN ,_, ONYX-015_NN displayed_VVD a_DD major_JJ antitumor_NN activity_NN in_II human_NN xenografts_NNS derived_VVN from_II primary_JJ malignant_JJ glioma_NN supporting_VVG its_PNG development_NN in_II the_DD treatment_NN of_II these_DD highly_RR malignant_JJ tumors_NNS ._.
P11835317A05
Analysis_NN of_II the_DD 5-HT_NN immunostaining_VVGN showed_VVD a_DD marked_VVNJ decrease_NN of_II the_DD immunoreactivity_NN in_II various_JJ brain_NN regions_NNS ,_, which_PNR was_VBD comparable_JJ at_II the_DD two_MC intervals_NNS postlesion_NN ._.
P11846397A04
Only_RR a_DD short_JJ 0.1-kb_NN segment_NN was_VBD unique_JJ to_II beta_NN ._.
P11856883A05
Comparative_JJ genome_NN maps_NNS were_VBD established_VVN by_II multi-color_NN fluorescence_NN in_JJ+ situ_JJ hybridization_NN (_( FISH_NN )_) with_II human_NN ,_, S._NN oedipus_NN and_CC Lagothrix_NN lagothricha_NN chromosome-_NN specific_JJ DNA_NN probes_NNS ._.
P11857742A10
These_DD biochemical_JJ findings_NNS suggest_VVB that_CST a_DD suboptimal_JJ enzymatic_JJ function_NN by_II the_DD PLAP_NN D_NN allozyme_NN may_VM be_VBB the_DD basis_NN for_II the_DD apparent_JJ negative_JJ selective_JJ pressure_NN of_II the_DD PLAP_NN D_NN allele_NN ._.
P11861911A02
The_DD strongest_JJT influence_NN on_II codon_NN usage_NN arises_VVZ from_II the_DD nucleotide_NN immediately_RR following_VVG the_DD codon_NN and_CC is_VBZ known_VVN as_II the_DD N1_NN context_NN ._.
P11880280A03
Addition_NN of_II activated_VVNJ PMNs_NNS to_II endothelial_JJ cells_NNS stimulated_VVD both_CC in_JJ+ vitro_JJ angiogenesis_NN in_II collagen_NN gel_NN and_CC Ets-1_NN expression_NN ._.
P11884036A01
During_II the_DD first_JJ four_MC cell_NN cycles_NNS in_II Xenopus_NN ,_, islands_NNS of_II germ_NN plasm_NN ,_, initially_RR distributed_VVN throughout_II the_DD vegetal_JJ half_NN of_II the_DD egg_NN cortex_NN ,_, move_VVB to_II the_DD vegetal_JJ pole_NN of_II the_DD egg_NN ,_, fusing_VVG with_II each_DD other_PN as_CS they_PN do_VDB so_RR ,_, and_CC form_VVB four_MC large_JJ cytoplasmic_JJ masses_NNS ._.
P11886171A07
In_II addition_NN ,_, intravenous_JJ administration_NN of_II IT9302_NN increased_VVD the_DD serum_NN levels_NNS of_II IRAP_NN ,_, an_DD IL-1beta_NN receptor_NN antagonistic_JJ cytokine_NN ._.
P11896627A05
After_II three_MC independent_JJ experiments_NNS the_DD resultant_JJ data_NN was_VBD filtered_VVN and_CC a_DD set_NN of_II genes_NNS was_VBD compiled_VVN based_VVN on_II at_RR+ least_RR threefold-altered_VVNJ expression_NN ,_, no_DD background_NN noise_NN in_II determining_VVGN expression_NN and_CC observation_NN in_II all_DD experiments_NNS ._.
P11901161A03
Here_RR we_PN show_VVB that_CST a_DD proximal_JJ 264-base_NN pair_NN fragment_NN of_II the_DD mouse_NN resistin_NN promoter_NN is_VBZ sufficient_JJ for_II expression_NN in_II adipocytes_NNS ._.
P11918814A05
Pdr3p_NN ,_, but_CC not_RR Pdr1p_NN ,_, is_VBZ required_VVN for_II normal_JJ levels_NNS of_II intracellular_JJ proteolysis_NN ,_, indicating_VVG that_CST the_DD two_MC transcription_NN factors_NNS have_VHB distinct_JJ functions_NNS in_II the_DD control_NN of_II RPN4_NN expression_NN ._.
P11921100A02
The_DD mei3_NN gene_NN is_VBZ located_VVN 0.64_MC Mb_NN from_II the_DD telomere_NN of_II the_DD left_JJ arm_NN of_II Sz_NN ._.
P11927580A04
Both_CC the_DD N_NN and_CC C_NN termini_NNS of_II gp41_NN were_VBD found_VVN to_TO lie_VVI close_JJ to_II or_CC in_II the_DD gp41-gp41_NN subunit_NN interface_NN and_CC interact_VVI with_II gp59_NN ._.
P11940484A08
The_DD patients_NNS received_VVD the_DD vaccine_NN consisting_VVG of_II their_PNG tumor_NN Ig_NN protein_NN coupled_VVN to_II keyhole_NN limpet_NN hemocyanine_NN and_CC were_VBD observed_VVN for_II toxicity_NN ,_, anti-idiotypic_JJ immune_JJ response_NN ,_, clinical_JJ outcome_NN and_CC circulating_VVGJ t_NN (_( 14_MC ;_: 18_MC )_) +_SYM tumor_NN cells_NNS ._.
P11950884A01
Schizosaccharomyces_NN pombe_NN cells_NNS have_VHB two_MC polarised_VVNJ growth_NN modes_NNS :_: an_DD intrinsic_JJ vegetative_JJ growth_NN mode_NN ,_, determined_VVN by_II an_DD internal_JJ positioning_VVGJ mechanism_NN and_CC an_DD extrinsic_JJ shmooing_VVGJ growth_NN mode_NN ,_, activated_VVN by_II external_JJ pheromone_NN ._.
P11959501A01
Considerable_JJ progress_NN has_VHZ been_VBN made_VVN during_II the_DD past_JJ year_NN on_II structural_JJ studies_NNS of_II the_DD eukaryotic_JJ and_CC bacterial_JJ transcription_NN factors_NNS that_PNR control_VVB RNA_NN polymerase_NN function_NN via_II the_DD formation_NN of_II multiprotein_NN complexes_NNS on_II promoter_NN DNA_NN ._.
P11964398A03
Xvent-1B_NN is_VBZ activated_VVN by_II Xvent-2_NN ,_, but_CC CHX_NN experiments_NNS revealed_VVD the_DD requirement_NN of_II additional_JJ factors_NNS ._.
P11972452A02
In_II the_DD meningococcus_NN ,_, this_DD uptake_NN system_NN is_VBZ dependent_JJ on_II two_MC surface-exposed_VVNJ ,_, transferrin-binding_VVGJ proteins_NNS (_( Tbps_NNS )_) ,_, TbpA_NN and_CC TbpB_NN ._.
P11979595A04
Posttranslational_JJ hydrophobic_JJ modifications_NNS of_II G-proteins_NNS are_VBB in_II most_DD cases_NNS removed_VVN for_II crystallization_NN but_CC play_VVB functional_JJ roles_NNS for_II interactions_NNS among_II G-protein_NN subunits_NNS with_II receptors_NNS ,_, as_CC+ well_CC+ as_CC membranes_NNS ._.
P11980886A12
The_DD activity_NN of_II PKC_NN determines_VVZ whether_CST tyrosine_NN kinase_NN activates_VVZ or_CC inhibits_VVZ these_DD K+_NN channels_NNS ._.
P11997261A02
AG-1478_NN rapidly_RR and_CC reversibly_RR inhibited_VVD Kv1.5_NN currents_NNS at_II 50_MC mV_NN in_II a_DD concentration-dependent_JJ manner_NN with_II an_DD IC50_NN of_II 9.82_MC microM_NN ._.
P12006089A08
The_DD expression_NN of_II multiple_JJ connexins_NNS in_II developing_VVGJ follicles_NNS is_VBZ thus_RR likely_RR to_TO reflect_VVI the_DD multiple_JJ functions_NNS served_VVN by_II gap_NN junctional_JJ communication_NN in_II folliculogenesis_NN ._.
P12015969A01
Bone_NN morphogenetic_JJ proteins_NNS (_( Bmps_NNS )_) promote_VVB ventral_JJ specification_NN in_II both_CC the_DD mesoderm_NN and_CC the_DD ectoderm_NN of_II vertebrate_NN embryos_NNS ._.
P12019215A12
The_DD protein_NN localization_NN pattern_NN of_II opticin_NN and_CC our_PNG preliminary_JJ screen_NN of_II AMD_NN patients_NNS suggest_VVB that_CST a_DD larger_JJR AMD_NN patient_NN screen_NN may_VM be_VBB warranted_VVN ._.
P12032305A03
TRPC_NN channels_NNS are_VBB assumed_VVN to_TO be_VBI composed_VVN of_II multiple_JJ TRPC_NN proteins_NNS ._.
P12042648A05
There_EX was_VBD no_DD inhibition_NN of_II class_NN I_MC antibodies_NNS to_II either_CC T_NN or_CC B_NN cells_NNS ,_, or_CC of_II class_NN II_MC antibodies_NNS to_II B_NN cells_NNS ._.
P12049293A06
After_II drying_VVGN ,_, sperms_NNS were_VBD incubated_VVN with_II FITC-PSA_NN for_II 30_MC min_NN ._.
P12054558A02
Cathepsins_NNS M_NN ,_, P_NN ,_, Q_NN ,_, and_CC R_NN ,_, are_VBB conserved_VVN in_II mice_NNS and_CC rats_NNS but_CC homologs_NNS of_II these_DD genes_NNS are_VBB not_RR found_VVN in_II human_NN or_CC rabbit_NN placenta_NN ,_, showing_VVG that_CST this_DD family_NN of_II proteases_NNS are_VBB probably_RR restricted_VVN to_II rodents_NNS ._.
P12067842A01
Brain_NN natriuretic_JJ peptide_NN (_( BNP_NN )_) is_VBZ a_DD cardiac_JJ hormone_NN constitutively_RR expressed_VVN in_II the_DD adult_NN heart_NN ._.
P12073099A04
To_TO screen_VVI for_II polymorphisms_NNS among_II the_DD 416_MC strains_NNS ,_, the_DD endonuclease_NN MaeIII_NN was_VBD used_VVN to_TO digest_VVI the_DD PCR-amplified_VVNJ mtLrRNA_NN gene_NN fragment_NN and_CC three_MC endonucleases_NNS (_( BanI_NN ,_, AluI_NN ,_, MseI_NN )_) were_VBD used_VVN to_TO digest_VVI the_DD PCR-amplified_VVNJ ND2_NN gene_NN fragment_NN ._.
P12080174A02
This_PND is_VBZ accomplished_VVN by_II the_DD rapid_JJ preliminary_JJ screening_VVGN of_II the_DD genome_NN for_II the_DD allelic_JJ association_NN with_II the_DD most_RRT common_JJ class_NN of_II polymorphic_JJ short_JJ tandem_NN repeat_NN markers_NNS ._.
P12081563A08
RESULTS_NNS :_: The_DD findings_NNS document_VVB selective_JJ storage_NN of_II protein_NN and_CC lipids_NNS ,_, progressive_JJ with_II time_NN ,_, in_II proximal_JJ tubular_JJ epithelial_JJ cells_NNS of_II nephrons_NNS draining_VVG the_DD coelomic_JJ cavity_NN ._.
P12083785A05
The_DD structural_JJ analysis_NN indicates_VVZ that_CST the_DD fragmentation_NN is_VBZ associated_VVN with_II a_DD significant_JJ change_NN of_II the_DD enzyme_NN from_II a_DD tetrameric_JJ to_II trimeric_JJ form_NN ,_, and_CC alterations_NNS in_II both_CC secondary_JJ and_CC native_JJ quaternary_JJ structures_NNS ._.
P12099698A02
However_RR ,_, little_PND is_VBZ known_VVN about_II the_DD mechanisms_NNS underlying_VVG the_DD effects_NNS of_II TGF-beta_NN on_II APP_NN expression_NN ._.
P12106089A08
The_DD 5'-flanking_VVGJ sequence_NN is_VBZ unusual_JJ in_CS+ that_CS it_PN lacks_VVZ CAAT_NN or_CC TATA_NN elements_NNS ,_, and_CC directs_VVZ RNA_NN transcription_NN initiation_NN from_II several_JJ sites_NNS ._.
P12114740A04
Frozen_VVNJ tissues_NNS collected_VVN from_II 21_MC PCs_NNS ,_, 4_MC follicular_JJ adenomas_NNS (_( FAs_NNS )_) ,_, 4_MC follicular_JJ carcinomas_NNS (_( FCs_NNS )_) ,_, and_CC 11_MC nodular_JJ hyperplasias_NNS (_( NHs_NNS )_) were_VBD stained_VVN immunohistochemically_RR for_II HlLA-D_NN antigens_NNS ,_, lymphocyte_NN ,_, and_CC macrophage_NN markers_NNS ;_: results_NNS were_VBD graded_VVN numerically_RR ._.
P12116163A01
A_DD large_JJ number_NN of_II point_NN mutations_NNS in_II the_DD p53_NN gene_NN have_VHB been_VBN detected_VVN by_II capillary_NN zone_NN electrophoresis_NN via_II single-strand_NN conformation_NN polymorphism_NN (_( SSCP_NN )_) analysis_NN ._.
P12119006A07
In_II p53-deficient_JJ cells_NNS ,_, vanadate_NN did_VDD not_RR induce_VVB any_DD observable_JJ change_NN in_II p21_NN or_CC p-cdk2_NN level_NN ._.
P12121768A08
These_DD micelles_NNS might_VM form_VVB a_DD '_`` belt_NN like_JJ '_'' structure_NN around_II the_DD enzyme_NN helping_VVG it_PN to_TO remain_VVI monodispersed_VVN in_II the_DD active_JJ form_NN ._.
P12126704A04
These_DD inhibitors_NNS differ_VVB from_II each_DD other_PN at_II their_PNG amino-terminus_NN ._.
P12144055A05
Although_CS protein_NN based_VVNJ methods_NNS such_II+ as_II isoelec-trofocusing_VVGN and_CC high_JJ performance_NN liquid_NN chromatography_NN may_VM suggest_VVB that_CST the_DD "_`` D-like_JJ "_'' variant_NN is_VBZ different_JJ from_II Hb_NN D-Los_NN Angeles_NN ,_, the_DD definitive_JJ identification_NN of_II the_DD variant_NN by_II structural_JJ analysis_NN or_CC molecular_JJ genetic_JJ methods_NNS should_VM be_VBB undertaken_VVN ,_, particularly_RR in_II newborn_NN screening_VVGJ programs_NNS when_CS the_DD variant_NN is_VBZ found_VVN in_II combination_NN with_II Hb_NN S_NN ._.
P12165734A01
BACKGROUND_NN :_: Cell_NN adhesion_NN involves_VVZ interactions_NNS of_II integrins_NNS and_CC extracellular_JJ proteins_NNS ,_, often_RR facilitated_VVN by_II the_DD RGD_NN motif_NN ._.
P12168092A11
In_II addition_NN ,_, we_PN found_VVD that_CST breast_NN cancer_NN cells_NNS abounded_VVD with_II abnormalities_NNS as_CS observed_VVN by_II M-FISH_NN and_CC CGH_NN ._.
P12177072A09
Conserved_VVNJ residues_NNS C56_NN and_CC A58_NN were_VBD identified_VVN as_II major_JJ determinants_NNS of_II 2-thiolation_NN ,_, whereas_CS tertiary_JJ interaction_NN between_II the_DD T_NN and_CC D_NN loops_NNS and_CC non-conserved_VVNJ nucleosides_NNS in_II the_DD T_NN loop_NN were_VBD revealed_VVN not_RR to_TO be_VBI important_JJ for_II the_DD reaction_NN ._.
P12192008A08
As_II a_DD result_NN ,_, the_DD heme_NN domain_NN was_VBD found_VVN to_TO be_VBI extremely_RR susceptible_JJ to_II autoxidation_NN ,_, its_PNG rate_NN being_VBG more_RR than_CSN 100_MC times_NNS higher_JJR than_CSN that_PND of_II sperm_NN whale_NN MbO2_NN ._.
P12200274A08
This_PND is_VBZ a_DD relevant_JJ phenomenon_NN for_II selection_NN of_II maltose-constitutive_JJ strains_NNS for_II baking_VVGN and_CC brewing_VVGN ._.
P12212852A04
The_DD YRA1_NN gene_NN is_VBZ essential_JJ for_II growth_NN and_CC required_VVN for_II mRNA_NN export_NN ._.
P12219037A06
Intestinal_JJ epithelial_JJ permeability_NN to_II (_( 14_MC )_) C_NN inulin_NN was_VBD assessed_VVN at_II 6_MC hours_NNS of_II reperfusion_NN ._.
P12226523A03
One_MC phytochrome_NN ,_, phytochrome_NN A_NN ,_, is_VBZ highly_RR light_NN labile_JJ ._.
P12231939A09
However_RR ,_, when_CS inoculated_VVNJ plants_NNS were_VBD incubated_VVN for_II 4_MC d_NN at_II 32_MC [_( deg_NN ]_) C_NN and_CC then_RR transferred_VVN to_II 24_MC [_( deg_NN ]_) C_NN ,_, they_PN showed_VVD a_DD 15-fold_NN increase_NN in_II BA2H_NN activity_NN and_CC a_DD 65-fold_NN increase_NN in_II free_JJ SA_NN content_NN compared_VVN with_II healthy_JJ plants_NNS incubated_VVN at_II 24_MC [_( deg_NN ]_) C_NN ._.
P12234689A03
We_PN identified_VVD the_DD minimal_JJ promoter_NN region_NN needed_VVN to_TO drive_VVI expression_NN of_II the_DD betaIII-tubulin_NN gene_NN ._.
P12243861A03
Treatment_NN of_II cells_NNS with_II phorbol_NN 12-myristate_NN 13-acetate_NN (_( PMA_NN )_) ,_, an_DD activator_NN of_II PKC_NN ,_, suppressed_VVD DNA_NN fragmentation_NN induced_VVN by_II PCBs_NNS in_II HL-60_NN cells_NNS ._.
P12324297A05
alpha_NN (_( 1_MC )_) -Antitrypsin_NN and_CC antichymotrypsin_NN concentrations_NNS were_VBD measured_VVN in_II milk_NN samples_NNS obtained_VVN longitudinally_RR (_( days_NNS 4-47_MC )_) from_II 8_MC women_NNS ._.
P12354612A02
Since_CS all_DD three_MC toxins_NNS are_VBB routed_VVN from_II the_DD cell_NN surface_NN through_II the_DD Golgi_NN apparatus_NN and_CC to_II the_DD endoplasmic_JJ reticulum_NN (_( ER_NN )_) before_II translocation_NN to_II the_DD cytosol_NN ,_, the_DD toxins_NNS are_VBB used_VVN to_TO study_VVI different_JJ endocytic_JJ pathways_NNS as_CC+ well_CC+ as_CC the_DD retrograde_JJ transport_NN to_II the_DD Golgi_NN and_CC the_DD ER_NN ._.
P12368192A01
The_DD regenerative_JJ capacity_NN of_II mammalian_JJ adult_NN liver_NN reflects_VVZ the_DD ability_NN of_II a_DD number_NN of_II cell_NN populations_NNS within_II the_DD hepatic_JJ lineage_NN to_TO take_VVI action_NN ._.
P12370426A06
Accumulated_VVNJ globotriaosylceramide_NN in_II these_DD organs_NNS was_VBD completely_RR cleared_VVN by_II 25_MC weeks_NNS after_II vector_NN injection_NN ._.
P12374793A10
Furthermore_RR ,_, MKK3_NN deficiency_NN resulted_VVD in_II a_DD selective_JJ disruption_NN of_II TGF-beta1-stimulated_VVNJ up-regulation_NN of_II pro-alpha1_NN (_( I_MC )_) collagen_NN expression_NN but_CC not_RR TGF-beta1_NN induction_NN of_II fibronectin_NN and_CC PAI-1_NN ._.
P12385625A04
Our_PNG results_NNS may_VM be_VBB summarized_VVN as_CS follows_VVZ :_: (_( 1_MC )_) S1_NN amacrine_NN cells_NNS were_VBD extensively_RR coupled_VVN and_CC their_PNG dendrites_NNS formed_VVD a_DD network_NN similar_JJ to_II but_CC less_RR dense_JJ than_CSN the_DD matrix_NN stained_VVN with_II an_DD antibody_NN to_II serotonin_NN ._.
P12388820A08
However_RR ,_, infection_NN of_II BALB_NN /_SYM c_NN mice_NNS by_II the_DD intranasal_JJ route_NN showed_VVD that_CST the_DD deletion_NN mutant_NN was_VBD attenuated_VVN and_CC induced_VVD lower_JJR weight_NN loss_NN and_CC signs_NNS of_II illness_NN compared_VVN to_II controls_NNS ._.
P12391335A04
After_II intrahepatic_JJ transfection_NN of_II chimpanzees_NNS ,_, the_DD wild-type_NN Con1_NN genome_NN was_VBD infectious_JJ and_CC produced_VVD viral_JJ titers_NNS similar_JJ to_II those_PND produced_VVN by_II other_JJ infectious_JJ HCV_NN clones_NNS ._.
P12402308A05
Therefore_RR ,_, our_PNG study_NN represents_VVZ the_DD first_JJ report_NN that_CST CD44_NN stimulation_NN induced_VVN by_II a_DD fragmented_VVNJ HA_NN results_VVZ in_II activation_NN of_II MAP_NN kinase_NN and_CC ,_, subsequently_RR ,_, enhances_VVZ uPA_NN and_CC uPAR_NN expression_NN and_CC facilitates_VVZ invasion_NN of_II human_NN chondrosarcoma_NN cells_NNS ._.
P12409222A04
However_RR ,_, in_II neonatal_JJ rat_NN nonmyocytes_NNS ,_, PACAP_NN and_CC VIP_NN showed_VVD equal_JJ potency_NN ._.
P12414803A02
In_II this_DD study_NN we_PN show_VVB that_CST in_II fetal_JJ rat_NN brown_JJ adipocyte_NN primary_JJ cultures_NNS the_DD PPARgamma_NN agonist_NN rosiglitazone_NN (_( Rosi_NN )_) ,_, as_CC+ well_CC+ as_CC retinoic_JJ acids_NNS 9-cis-retinoic_JJ acid_NN and_CC all-trans-retinoic_JJ acid_NN also_RR have_VHB "_`` extragenic_JJ "_'' effects_NNS and_CC induce_VVB p44_NN /_SYM p42_NN and_CC p38_NN mitogen-activated_VVNJ protein_NN kinase_NN (_( p38MAPK_NN )_) activation_NN ._.
P12431217A02
Because_CS resident_JJ endoneurial_JJ macrophages_NNS are_VBB slowly_RR but_CC incompletely_RR exchanged_VVN from_II the_DD blood_NN within_II 3_MC months_NNS ,_, they_PN could_VM potentially_RR comprise_VVB a_DD heterogenous_JJ cell_NN population_NN consisting_VVG of_II long-term_NN resident_JJ cells_NNS and_CC more_RR mobile_JJ cells_NNS undergoing_VVG turnover_NN ._.
P12440855A03
The_DD gene_NN transfer_NN activity_NN of_II alpha-CDE_NN conjugates_NNS (_( G2_NN ,_, G3_NN ,_, and_CC G4_NN )_) was_VBD higher_JJR than_CSN that_PND of_II the_DD corresponding_VVGJ dendrimer_NN alone_JJ in_II NIH3T3_NN and_CC RAW264.7_NN cells_NNS ._.
P12451028A10
For_II conservation_NN genetics_NNS we_PN suggest_VVB in_JJ+ situ_JJ preservation_NN areas_NNS are_VBB defined_VVN that_PNR are_VBB free_JJ of_II disturbance_NN and_CC that_PNR include_VVB populations_NNS with_II the_DD highest_JJT genetic_JJ diversity_NN ._.
P12454289A03
Here_RR we_PN used_VVD T_NN cell_NN receptor_NN (_( TCR_NN )_) transgenic_JJ animals_NNS to_TO examine_VVI the_DD role_NN of_II inducible_JJ expression_NN of_II nonlymphoid_JJ FasL_NN in_II response_NN to_II peptide_NN antigen_NN ._.
P12460670A03
The_DD monomer_NN /_SYM dimer_NN ratio_NN does_VDZ not_RR change_VVB in_II extracts_NNS from_II mitochondria_NNS subjected_VVN to_II different_JJ energy_NN conditions_NNS accompanied_VVN by_II IF1_NN binding_VVGJ modulation_NN or_CC from_II submitochondrial_JJ particles_NNS differing_VVG in_II IF1_NN content_NN ._.
P12467238A16
In_II this_DD experiment_NN ,_, NK_NN cell-depleted_VVNJ mice_NNS were_VBD injected_VVN with_II anti-NK1.1_NN IgG_NN ,_, and_CC control_NN mice_NNS were_VBD mice_NNS were_VBD treated_VVN with_II normal_JJ saline_NN ._.
P12470261A04
This_DD review_NN will_VM summarize_VVB some_PND of_II the_DD NMR-based_VVNJ efforts_NNS towards_II developing_VVGN universal_JJ ,_, rapid_JJ ,_, accurate_JJ ,_, and_CC site-specific_JJ assays_NNS for_II estimating_VVGN protein_NN binding_VVGN ._.
P12478906A10
CONCLUSION_NN :_: Relapsed_VVNJ lymphomas_NNS highly_RR express_VVB P-gp_NN and_CC mdr-1_NN mRNA_NN ._.
P12484747A09
This_DD dissociation_NN process_NN occurred_VVD on_II a_DD much_RR faster_JJR time_NN scale_NN and_CC took_VVD place_NN within_II the_DD 500_MC micros_NN response_NN time_NN of_II our_PNG detection_NN system_NN ._.
P12491803A02
Furthermore_RR ,_, epidemiological_JJ studies_NNS and_CC clinical_JJ trials_NNS for_II familial_JJ adenomatous_JJ polyposis_NN (_( FAP_NN )_) patients_NNS supported_VVD the_DD possibility_NN that_CST NSAIDs_NNS can_VM be_VBB used_VVN as_II chemopreventive_JJ agents_NNS ._.
P12500390A05
With_II time_NN lapse_NN phase-contrast_NN microscopy_NN ,_, the_DD agglutination_NN phenotype_NN on_II living_VVGJ cells_NNS was_VBD easily_RR detected_VVN by_II MTT_NN test_NN ,_, the_DD inhibition_NN rate_NN on_II EBV_NN transformed_VVNJ cells_NNS was_VBD calculated_VVN ._.
P12504597A04
The_DD neurons_NNS produced_VVN displayed_VVD molecular_JJ phenotypes_NNS similar_JJ to_II those_PND normally_RR derived_VVN from_II each_PND of_II these_DD regions_NNS in_RR+ vivo_RR ._.
P12509440A01
Before_CS fertilization_NN can_VM occur_VVB ,_, mammalian_JJ sperm_NN must_VM undergo_VVB capacitation_NN ,_, a_DD process_NN that_PNR requires_VVZ a_DD cyclic_JJ AMP-dependent_JJ increase_NN in_II tyrosine_NN phosphorylation_NN ._.
P12515386A08
Like_II noncoding_VVGJ RNAs_NNS ,_, the_DD porcine_JJ and_CC human_NN sequences_NNS have_VHB no_DD common_JJ conserved_VVNJ open_JJ reading_VVGJ frame_NN and_CC share_VVB stretches_NNS of_II high_JJ homology_NN interrupted_VVN by_II stretches_NNS with_II almost_RR no_DD homology_NN ._.
P12524230A03
METHODS_NNS AND_CC RESULTS_NNS :_: Our_PNG studies_NNS uncovered_VVD several_JJ new_JJ features_NNS that_PNR distinguish_VVB SCAP_NN ligand_NN from_II lovastatin_NN ,_, a_DD classic_JJ 3-hydroxy-3-methylglutaryl_NN coenzyme_NN A_NN (_( HMG-CoA_NN )_) reductase_NN inhibitor_NN ,_, and_CC from_II OM_NN ,_, which_PNR utilize_VVB an_DD SREBP-independent_JJ regulatory_JJ pathway_NN ._.
P12529538A06
Therefore_RR ,_, DHNs_NNS ,_, and_CC presumably_RR somewhat_RR similar_JJ plant_NN stress_NN proteins_NNS in_II the_DD late_JJ embryogenesis_NN abundant_JJ and_CC cold-regulated_VVNJ classes_NNS may_VM undergo_VVB function-related_VVNJ conformational_JJ changes_NNS at_II the_DD water_NN /_SYM membrane_NN interface_NN ,_, perhaps_RR related_VVN to_II the_DD stabilization_NN of_II vesicles_NNS or_CC other_JJ endomembrane_NN structures_NNS under_II stress_NN conditions_NNS ._.
P12537130A01
Biological_JJ and_CC molecular_JJ characteristics_NNS of_II a_DD raccoon_NN isolate_NN of_II Trypanosoma_NN cruzi_NN (_( R36_NN )_) were_VBD compared_VVN with_II those_PND of_II a_DD known_VVNJ virulent_JJ strain_NN (_( Brazil_NN )_) ._.
P12546882A02
This_DD increased_VVNJ number_NN of_II targets_NNS ,_, and_CC increasing_VVGJ knowledge_NN of_II signaling-pathway_NN networks_NNS and_CC their_PNG complexities_NNS ,_, sets_VVZ new_JJ demands_NNS for_II efficiency_NN on_II HTS_NN assay_NN technologies_NNS ._.
P12556293A02
DeltaF508-CFTR_NN is_VBZ present_JJ in_II the_DD apical_JJ membrane_NN at_II far_RR lower_JJR levels_NNS than_CSN wild-type_NN CFTR_NN ._.
P12566566A05
L._NN plantarum_NN is_VBZ a_DD species_NN that_PNR is_VBZ encountered_VVN in_II many_DD different_JJ environmental_JJ niches_NNS ,_, and_CC this_DD flexible_JJ and_CC adaptive_JJ behavior_NN is_VBZ reflected_VVN by_II the_DD relatively_RR large_JJ number_NN of_II regulatory_JJ and_CC transport_NN functions_NNS ,_, including_VVG 25_MC complete_JJ PTS_NN sugar_NN transport_NN systems_NNS ._.
P12569660A06
The_DD N-terminal_JJ region_NN had_VHD high_JJ homology_NN with_II Ran_NN BP2_NN /_SYM Nup_NN 358_MC ,_, a_DD nucleoporin_NN component_NN ,_, showing_VVG that_CST BS-63_NN was_VBD a_DD member_NN of_II the_DD NPC_NN family_NN ._.
P12571010A13
Several_JJ sequences_NNS were_VBD identified_VVN in_II the_DD library_NN for_II bacteria_NN associated_VVN with_II disease_NN in_II humans_NNS and_CC poultry_NN such_II+ as_II clostridia_NNS ,_, staphylococci_NNS ,_, and_CC Bordetella_NN spp_NN ._.
P12576309A07
Our_PNG findings_NNS indicate_VVB that_CST CRCL_NN has_VHZ prominent_JJ adjuvant_NN effects_NNS and_CC is_VBZ a_DD very_RR effective_JJ source_NN of_II tumor_NN antigen_NN for_II pulsing_VVGJ DCs_NNS ._.
P12582233A05
The_DD corresponding_VVGJ mRNA_NN of_II 3.5_MC kb_NN is_VBZ composed_VVN of_II 14_MC exons_NNS and_CC encodes_VVZ a_DD 941_MC amino_JJ acid_NN protein_NN (_( 104_MC kDa_NN )_) ._.
P12586375A07
A_DD few_JJ examples_NNS of_II heterologous_JJ expression_NN of_II membrane_NN proteins_NNS ,_, where_PNR problems_NNS of_II specific_JJ lipid_NN requirements_NNS have_VHB been_VBN noticed_VVN or_CC should_VM be_VBB thought_VVN of_II ,_, have_VHB been_VBN chosen_VVN ._.P07504457A03
A_DD MAP_NN kinase_NN activator_NN recently_RR purified_VVN and_CC cloned_VVN has_VHZ been_VBN shown_VVN to_TO be_VBI a_DD protein_NN kinase_NN (_( MAP_NN kinase_NN kinase_NN )_) that_PNR is_VBZ able_JJ to_TO induce_VVI the_DD dual_JJ phosphorylation_NN of_II MAP_NN kinase_NN on_II both_CC the_DD regulatory_JJ tyrosine_NN and_CC threonine_NN sites_NNS in_RR+ vitro_RR ._.
P07535768A04
Here_RR we_PN report_VVB the_DD cloning_VVGN and_CC characterization_NN of_II a_DD novel_JJ dual_JJ specific_JJ phosphatase_NN ,_, HVH2_NN ,_, which_PNR may_VM function_VVB in_RR+ vivo_RR as_II a_DD MAP_NN kinase_NN phosphatase_NN ._.
P07535770A05
Here_RR ,_, we_PN demonstrate_VVB that_CST p38_NN ,_, like_II JNK_NN ,_, is_VBZ activated_VVN by_II treatment_NN of_II cells_NNS with_II pro-inflammatory_JJ cytokines_NNS and_CC environmental_JJ stress_NN ._.
P07600582A03
These_DD proteins_NNS also_RR activate_VVB MAP_NN kinase_NN (_( MAPK_NN )_) cascades_NNS that_PNR regulate_VVB gene_NN expression_NN ._.
P07629120A03
Whether_CST a_DD similar_JJ antagonism_NN may_VM account_VVB for_II the_DD late_JJ inhibitory_JJ effect_NN of_II cAMP_NN in_II T_NN cell_NN was_VBD examined_VVN ._.
P07644477A07
Further_RR ,_, PD_NN 098059_MC is_VBZ an_DD invaluable_JJ tool_NN that_PNR will_VM help_VVB elucidate_VVI the_DD role_NN of_II the_DD MAPK_NN cascade_NN in_II a_DD variety_NN of_II biological_JJ settings_NNS ._.
P07716521A05
JNKK_NN also_RR activated_VVD another_DD MAPK_NN ,_, p38_NN (_( Mpk2_NN ;_: the_DD mammalian_JJ homolog_NN of_II HOG1_NN from_II yeast_NN )_) ,_, whose_PNR activity_NN is_VBZ regulated_VVN similarly_RR to_II that_PND of_II the_DD JNKs_NNS ._.
P07797573A02
This_DD activation_NN of_II MAPKs_NNS coincides_VVZ with_II the_DD formation_NN of_II superoxide_NN anion_NN ,_, which_PNR occurs_VVZ through_II the_DD activation_NN of_II a_DD multiple-component_NN NADPH_NN oxidase_NN pathway_NN ._.
P07838428A07
The_DD protein_NN expression_NN profiles_NNS were_VBD almost_RR equivalent_JJ ,_, but_CC the_DD MEK_NN expression_NN was_VBD slightly_RR advanced_VVN ,_, suggesting_VVG that_CST the_DD observed_VVNJ up-regulation_NN of_II MEK_NN was_VBD not_RR due_II+ to_II that_PND of_II ERK_NN ._.
P07839144A03
Two_MC human_NN MAP_NN kinase_NN kinases_NNS (_( MKK3_NN and_CC MKK4_NN )_) were_VBD cloned_VVN that_PNR phosphorylate_VVB and_CC activate_VVB p38_NN MAP_NN kinase_NN ._.
P07867573A01
We_PN have_VHB examined_VVN porcine_JJ granulosa_NN cells_NNS (_( pGCs_NNS )_) for_II the_DD presence_NN of_II immunodetectable_JJ mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinases_NNS (_( extracellular_JJ signal-regulated_VVNJ kinases_NNS ,_, ERK_NN )_) and_CC have_VHB further_RR studied_VVN the_DD effects_NNS of_II epidermal_JJ growth_NN factor_NN (_( EGF_NN )_) on_II the_DD activation_NN of_II these_DD kinases_NNS ._.
P07935387A05
Despite_II these_DD reports_NNS ,_, we_PN find_VVB that_CST unlike_II the_DD JNKs_NNS ,_, ERK1_NN and_CC ERK2_NN do_VDB not_RR phosphorylate_VVB the_DD N-terminal_JJ sites_NNS of_II c-Jun_NN in_RR+ vitro_RR ;_: instead_RR they_PN phosphorylate_VVB an_DD inhibitory_JJ C-terminal_JJ site_NN ._.
P07935449A01
Independent_JJ of_II its_PNG ability_NN to_TO block_VVI translation_NN ,_, anisomycin_NN intrinsically_RR initiates_VVZ intracellular_JJ signals_NNS and_CC immediate-early_JJ gene_NN induction_NN [_( L._NNP C._NNP Mahadevan_NNP and_CC D._NNP R._NNP Edwards_NNP ,_, Nature_NN (_( London_NNP )_) 349_MC :_: 747-749_MC ,_, 1991_MC ]_) ._.
P08381539A03
We_PN separated_VVD two_MC protein_NN factors_NNS from_II the_DD cytosol_NN fraction_NN of_II Xenopus_NN oocytes_NNS by_II column_NN chromatography_NN :_: one_MC was_VBD the_DD inactive_JJ form_NN of_II MAP_NN kinase_NN kinase_NN and_CC the_DD other_PN was_VBD a_DD factor_NN tentatively_RR named_VVN ras_NN p21-dependent_JJ ERK-kinase_NN stimulator_NN (_( REKS_NN )_) ._.
P08394352A06
These_DD cell-selective_JJ differences_NNS in_II MEK_NN activation_NN parallel_VVB constitutive_JJ MAPK_NN activation_NN in_II these_DD cell_NN lines_NNS ._.
P08529671A10
The_DD potential_JJ activator_NN of_II MAP_NN kinase_NN ,_, RAF-1_NN ,_, was_VBD hyperphosphorylated_VVN in_II erythropoietin-stimulated_VVNJ cells_NNS and_CC its_PNG autophosphorylation_NN activity_NN was_VBD strongly_RR increased_VVN ._.
P08530360A04
In-gel_NN JNK_NN assays_NNS confirmed_VVD activation_NN of_II two_MC renaturable_JJ JNKs_NNS of_II 46_MC and_CC 55_MC kDa_NN (_( JNK-46_NN and_CC JNK-55_NN ,_, respectively_RR )_) ._.
P08567974A03
Herein_RR we_PN provide_VVB evidence_NN that_CST two_MC distinct_JJ classes_NNS of_II MAP_NN kinases_NNS ,_, the_DD extracellular_JJ signal-regulated_VVNJ kinases_NNS (_( ERK_NN )_) and_CC the_DD c-Jun_NN NH2-terminal_JJ kinases_NNS (_( JNK_NN )_) ,_, are_VBB transiently_RR activated_VVN in_II rat_NN arteries_NNS (_( aorta_NN ,_, carotid_JJ and_CC femoral_JJ arteries_NNS )_) in_II response_NN to_II an_DD acute_JJ elevation_NN in_II blood_NN pressure_NN induced_VVN by_II either_CC restraint_NN or_CC administration_NN of_II hypertensive_JJ agents_NNS (_( i.e._II ,_, phenylephrine_NN and_CC angiotensin_NN II_MC )_) ._.
P08576169A05
Insulin_NN did_VDD not_RR enhance_VVB activation_NN of_II phospholipase_NN D_NN in_II response_NN to_II phorbol_NN ester_NN ._.
P08598210A02
CD40_NN signaling_VVGN activates_VVZ downstream_JJ effectors_NNS ,_, including_VVG the_DD tyrosine_NN protein_NN kinase_NN ,_, Lyn_NN ,_, the_DD phosphatidylinositol-3-kinase_NN (_( PI-3_NN kinase_NN )_) ,_, and_CC the_DD transcription_NN factor_NN ,_, NF-kappa_NN B_NN ._.
P08607977A08
Three_MC MAP_NN kinase_NN homologs_NNS have_VHB been_VBN identified_VVN in_II the_DD rat_NN :_: Erk1_NN ,_, Erk2_NN ,_, and_CC Erk3_NN ._.
P08626699A03
A_DD novel_JJ mitogen-activated_VVNJ protein_NN kinase_NN kinase_NN ,_, MEK6_NN ,_, was_VBD cloned_VVN and_CC characterized_VVN ._.
P08626724A01
Stimulation_NN of_II a_DD variety_NN of_II cell_NN surface_NN receptors_NNS enhances_VVZ the_DD enzymatic_JJ activity_NN of_II mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) ._.
P08631968A02
In_II particular_NN ,_, epidermal_JJ growth_NN factor_NN (_( EGF_NN )_) -stimulated_VVNJ DNA_NN synthesis_NN is_VBZ reduced_VVN in_II hepatocytes_NNS from_II aged_VVNJ rats_NNS relative_JJ to_II young_JJ rats_NNS ._.
P08645177A02
In_II each_DD case_NN ,_, there_EX is_VBZ a_DD conditional_JJ requirement_NN for_II GTP-Gs_NNS alpha_NN ._.
P08645177A13
Sphingosine_NN phosphate-stimulated_VVNJ ERK-2_NN activity_NN is_VBZ also_RR abolished_VVN by_II pertussis_NN toxin_NN ,_, indicating_VVG that_CST c-Raf-1_NN kinase_NN is_VBZ activated_VVN via_II a_DD Gi-dependent_JJ mechanism_NN ._.
P08645194A06
Moreover_RR ,_, ceramide_NN can_VM suppress_VVB growth_NN factor-_NN or_CC sphingosine-induced_VVNJ ERK_NN activation_NN as_CC+ well_CC+ as_CC proliferation_NN ._.
P08647130A10
From_II these_DD studies_NNS ,_, it_PN is_VBZ evident_JJ that_CST sphingosine_NN phosphate_NN displays_VVZ a_DD signalling_VVGJ profile_NN that_PNR is_VBZ consistent_JJ with_II it_PN mediating_VVGN part_NN of_II the_DD action_NN of_II platelet-derived_VVNJ growth_NN factor_NN ._.
P08648136A01
Stimulation_NN of_II human_NN neutrophils_NNS by_II LPS_NN is_VBZ central_JJ to_II the_DD pathogenesis_NN of_II sepsis_NN and_CC the_DD adult_NN respiratory_JJ distress_NN syndrome_NN ._.
P08663242A05
Most_RRT importantly_RR ,_, treatment_NN of_II aortic_JJ SMC_NN with_II PD_NN 98059_MC potently_RR inhibited_VVD AII-stimulated_VVNJ protein_NN synthesis_NN with_II a_DD half-maximal_JJ inhibitory_JJ concentration_NN of_II 4.3_MC microM_NN ._.
P08668180A09
These_DD findings_NNS suggest_VVB that_CST the_DD high-affinity_NN and_CC active_JJ site-independent_JJ binding_VVGN observed_VVN in_RR+ vitro_RR facilitates_VVZ signal_NN transduction_NN in_RR+ vivo_RR and_CC suggest_VVB further_RR that_CST MEK-MAPK_NN interactions_NNS may_VM utilize_VVB a_DD double-selection_NN mechanism_NN to_TO ensure_VVI fidelity_NN in_II signal_NN transmission_NN and_CC to_TO insulate_VVI one_MC signaling_VVGJ pathway_NN from_II another_PND ._.
P08668187A04
Rat_NN MAP_NN /_SYM ERK_NN kinase_NN kinase_NN 1_MC can_VM stimulate_VVB the_DD activity_NN of_II each_PND of_II these_DD MAP_NN kinases_NNS ._.
P08702674A02
Previous_JJ work_NN in_II this_DD laboratory_NN has_VHZ focused_VVN on_II elucidating_VVGN the_DD mechanism_NN of_II NOx_NN signaling_VVGN in_II cells_NNS ._.
P08703041A07
Therefore_RR ,_, inhibition_NN of_II PTP_NN activity_NN is_VBZ sufficient_JJ per_RR+ se_RR to_TO initiate_VVI a_DD complete_JJ MAP_NN kinase_NN activation_NN program_NN ._.
P08755992A04
Using_VVG the_DD isolated_VVNJ perfused_VVNJ rat_NN heart_NN ,_, we_PN show_VVB that_CST global_JJ ischemia_NN does_VDZ not_RR activate_VVB the_DD 42-_MC and_CC 44-kD_NN extracellular_JJ signal-regulated_VVNJ (_( protein_NN )_) kinase_NN (_( ERK_NN )_) subfamily_NN of_II MAPKs_NNS but_CC rather_RR stimulates_VVZ a_DD 38-kD_NN activator_NN of_II MAPK-activated_VVNJ protein_NN kinase-2_NN (_( MAPKAPK2_NN )_) ._.
P08757935A03
One_MC pathway_NN converges_VVZ on_II the_DD ERK_NN subfamily_NN known_VVN as_II the_DD "_`` stress_NN activated_VVNJ '_'' protein_NN kinases_NNS (_( SAPKs_NNS ,_, also_RR termed_VVN Jun_NN N-terminal_JJ kinases_NNS ,_, JNKs_NNS )_) ,_, whereas_CS the_DD second_JJ pathway_NN recruits_VVZ the_DD p38_NN kinases_NNS ._.
P08758915A05
Indeed_RR ,_, 4-CD3-BHTOOH_NN ,_, an_DD analogue_NN that_PNR generates_VVZ less_PND of_II the_DD metabolite_NN BHT-quinone_NN methide_NN (_( 2_MC ,_, 6-di-tert-butyl-4-methylene-2_NN ,_, 5-cyclohexadienone_NN )_) and_CC fewer_JJR tumors_NNS in_RR+ vivo_RR ,_, accordingly_RR exhibited_VVD diminished_VVNJ potency_NN for_II activating_VVGN ERK_NN ._.
P08759724A03
In_II this_DD study_NN ,_, we_PN have_VHB examined_VVN signal_NN transduction_NN events_NNS mediated_VVN by_II CD40_NN cross-linking_VVGN in_II resting_VVGJ murine_JJ splenic_JJ B_NN cells_NNS ._.
P08759733A02
These_DD pathways_NNS are_VBB disrupted_VVN by_II agonists_NNS that_PNR utilize_VVB adenylate_NN cyclase_NN and_CC cAMP-dependent_JJ protein_NN kinase_NN A_NN (_( PKA_NN )_) ._.
P08761479A09
Secondly_RR ,_, a_DD 27_MC kDa_NN protein_NN that_PNR aligns_VVZ with_II a_DD protein_NN recognized_VVN by_II anti-hsp27_NN antibody_NN is_VBZ phosphorylated_VVN upon_II LPS_NN stimulation_NN of_II intact_JJ human_NN neutrophils_NNS prelabelled_VVN with_II radioactive_JJ phosphate_NN ._.
P08766546A07
Furthermore_RR ,_, similar_JJ features_NNS of_II differential_JJ activation_NN of_II ERK_NN isoforms_NNS were_VBD observed_VVN in_II normal_JJ resting_VVGJ B_NN cells_NNS in_II CD40_NN and_CC sIgM_NN signaling_VVGN ._.
P08808707A05
Ha-RasV12_NN and_CC activated_VVNJ proteins_NNS in_II both_CC the_DD extra-cellular_JJ regulated_VVNJ kinase_NN (_( ERK_NN )_) and_CC the_DD stress-activated_VVNJ protein_NN kinase_NN (_( SAPK_NN )_) or_CC Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) cascades_NNS independently_RR stimulated_VVD PEA3-mediated_VVNJ gene_NN expression_NN ._.
P08824287A09
However_RR ,_, the_DD combined_VVNJ treatment_NN with_II PDTC_NN and_CC PMA_NN ,_, two_MC agents_NNS that_PNR synergize_VVB on_II AP-1_NN activation_NN ,_, resulted_VVD in_II the_DD persistent_JJ phosphorylation_NN of_II ERK-2_NN ._.
P08836113A08
Important_JJ concepts_NNS are_VBB that_CST signal_NN transmission_NN often_RR entails_VVZ the_DD targeted_VVNJ relocation_NN of_II specific_JJ proteins_NNS in_II the_DD cell_NN ,_, and_CC the_DD reversible_JJ formation_NN of_II protein_NN complexes_NNS by_II means_NNS of_II regulated_VVNJ protein_NN phosphorylation_NN ._.
P08855261A07
In_II the_DD case_NN of_II the_DD Jun-dependent_JJ transcription_NN ,_, this_DD effect_NN was_VBD not_RR due_II+ to_II direct_JJ phosphorylation_NN of_II c-Jun_NN by_II activated_VVNJ CaM-KIV_NN ,_, since_CS transcription_NN was_VBD blocked_VVN by_II a_DD dominant-negative_JJ JNK_NN and_CC by_II two_MC MAP_NN kinase_NN phosphatases_NNS ._.
P08855340A07
In_II addition_NN ,_, activators_NNS of_II protein_NN kinase_NN A_NN ,_, including_VVG forskolin_NN and_CC 8-Br-cAMP_NN ,_, which_PNR are_VBB known_VVN to_TO inhibit_VVI ERK-mediated_VVNJ events_NNS ,_, also_RR inhibited_VVD urea-inducible_JJ Egr-1_NN transcription_NN ._.
P08877106A02
We_PN have_VHB compared_VVN the_DD regulation_NN and_CC ,_, indirectly_RR ,_, the_DD role_NN of_II these_DD two_MC pathways_NNS in_II hepatic_JJ development_NN during_II late_JJ gestation_NN in_II the_DD rat_NN ._.
P08910292A10
Taken_VVN together_RR ,_, these_DD findings_NNS strongly_RR suggest_VVB that_CST members_NNS of_II the_DD novel_JJ MLK_NN family_NN of_II highly_RR related_VVNJ kinases_NNS link_VVB small_JJ GTP-binding_VVGJ proteins_NNS to_II the_DD JNK_NN signaling_VVGJ pathway_NN ._.
P08940179A05
The_DD putative_JJ catalytic_JJ domain_NN of_II MAPKKK5_NN shows_VVZ significant_JJ sequence_NN homology_NN to_II the_DD kinase_NN domains_NNS of_II the_DD MAPKKK_NN /_SYM MEKK_NN level_NN protein_NN kinases_NNS from_II mouse_NN MEKK2_NN and_CC -3_MC ,_, Drosophila_NN melanogaster_NN PK92B_NN ,_, Saccharomyces_NN cerevisiae_NN STE11_NN ,_, and_CC Schizosaccharomyces_NN pombe_NN BYR2_NN ._.
P08943238A07
Co-treatment_NN with_II a_DD tyrosine_NN phosphatase_NN inhibitor_NN (_( sodium_NN orthovanadate_NN )_) and_CC T-cell_NN activation_NN signals_NNS (_( phorbol_NN 12-myristate_NN 13-acetate_NN plus_CC ionomycin_NN )_) prolonged_VVD JNK_NN induction_NN ,_, followed_VVN by_II T-cell_NN apoptosis_NN ._.
P08987738A06
PD98059_NN ,_, an_DD inhibitor_NN of_II MEK_NN (_( MAP_NN kinase_NN kinase_NN )_) ,_, completely_RR abolished_VVD the_DD antiapoptotic_JJ effect_NN of_II PACAP-38_NN ,_, suggesting_VVG that_CST MAP_NN kinase_NN pathway_NN activation_NN is_VBZ necessary_JJ for_II PACAP-38_NN action_NN ._.
P08995450A06
Also_RR ,_, PTx_NN had_VHD no_DD effect_NN on_II shear-dependent_JJ activation_NN of_II JNK_NN ._.
P08999807A02
TGF-beta_NN exerts_VVZ its_PNG effects_NNS through_II a_DD heteromeric_JJ complex_NN between_II two_MC transmembrane_JJ serine_NN /_SYM threonine_NN kinase_NN receptors_NNS ,_, the_DD type_NN I_MC and_CC type_NN II_MC receptors_NNS ._.
P08999940A07
Dominant-negative_JJ SAPK_NN or_CC ERK_NN kinase-1_NN was_VBD used_VVN to_TO demonstrate_VVI that_CST JNK_NN /_SYM SAPK_NN activation_NN is_VBZ necessary_JJ for_II induction_NN of_II DSE-_NN and_CC TRE-dependent_JJ transcription_NN by_II IL-5_NN ,_, whereas_CS extracellular_JJ signal-regulated_VVNJ kinase_NN 2_MC was_VBD not_RR essential_JJ for_II TRE-_NN and_CC DSE-dependent_JJ transcription_NN ._.
P09006914A05
TNFalpha_NN stimulation_NN of_II endothelial_JJ cells_NNS induces_VVZ transient_JJ phosphorylation_NN of_II both_CC ATF-2_NN and_CC c-JUN_NN and_CC induces_VVZ marked_VVNJ activation_NN of_II the_DD c-JUN_NN N-terminal_JJ kinase_NN (_( JNK1_NN )_) and_CC p38_NN but_CC not_RR extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK1_NN )_) ._.
P09012803A08
These_DD data_NNS indicate_VVB that_CST in_II addition_NN to_II functioning_VVGN as_II a_DD positive_JJ effector_NN of_II growth_NN ,_, stimulation_NN of_II the_DD MEK_NN /_SYM MAPK_NN pathway_NN can_VM result_VVB in_II an_DD inhibition_NN of_II CDK_NN activity_NN and_CC cell_NN cycle_NN arrest_NN ._.
P09013447A09
This_DD study_NN suggests_VVZ a_DD potential_JJ mechanism_NN to_TO regulate_VVI ERK_NN activity_NN through_II feedback_NN inhibition_NN by_II demonstrating_VVGN the_DD ERK_NN cascade_NN 's_GE induction_NN of_II the_DD dual-specificity_NN PTPases_NNS CL100_NN ,_, PAC1_NN ,_, and_CC B23_NN ._.
P09015364A04
We_PN demonstrate_VVB that_CST IL-1_NN activates_VVZ three_MC MAPKs_NNS ,_, ERK_NN ,_, JNK_NN and_CC p38_NN ,_, in_II a_DD time_NN and_CC dose-dependent_JJ manner_NN ._.
P09020184A02
Like_II other_JJ MAP_NN kinases_NNS ,_, JNKs_NNS are_VBB activated_VVN via_II phosphorylation_NN on_II adjacent_JJ threonine_NN and_CC tyrosine_NN residues_NNS and_CC can_VM be_VBB inactivated_VVN by_II a_DD unique_JJ family_NN of_II dual_JJ specificity_NN phosphatases_NNS ,_, called_VVN MAP_NN kinase_NN phosphatases_NNS (_( MKPs_NNS )_) ._.
P09024981A05
Jurkat_NN ,_, but_CC not_RR EL4_NN ,_, expresses_VVZ a_DD 120-kDa_NN protein_NN recognized_VVN by_II an_DD anti-PLD_NN antibody_NN ._.
P09030549A09
Also_RR ,_, the_DD dominant_JJ negative_JJ forms_NNS of_II Ras_NN ,_, MAPK_NN ,_, and_CC JNK_NN strongly_RR inhibited_VVD Galpha12_NN (_( R203C_NN )_) -induced_VVNJ stimulation_NN of_II cyclin_NN A_NN promoter_NN activity_NN ._.
P09038212A01
Invasive_JJ and_CC metastatic_JJ cells_NNS require_VVB protease_NN expression_NN for_II migration_NN through_II the_DD extracellular_JJ matrix_NN ._.
P09044838A05
The_DD ERK2_NN isoform_NN was_VBD activated_VVN by_II 6-fold_NN within_II 10_MC min_NN of_II TGF-beta3_NN addition_NN to_II the_DD TGF-beta-sensitive_JJ BCC_NN line_NN Hs578T_NN ._.
P09045626A04
However_RR ,_, a_DD kinase_NN other_II+ than_II Raf_NN appears_VVZ responsible_JJ for_II angII-mediated_VVNJ signal_NN transduction_NN because_CS we_PN showed_VVD previously_RR that_CST treatment_NN with_II 1_MC microM_NN phorbol_NN 12_MC ,_, 13-dibutyrate_NN (_( PDBU_NN )_) for_II 24_MC h_NN completely_RR blocked_VVD Raf-Ras_NN association_NN in_II VSMC_NN but_CC did_VDD not_RR inhibit_VVB activation_NN of_II MEK_NN and_CC ERK1_NN /_SYM 2_MC by_II angII_NN ._.
P09048659A03
In_II the_DD present_JJ study_NN ,_, we_PN observed_VVD that_CST H2O2_NN in_II concentrations_NNS that_PNR induced_VVD severe_JJ fragmentation_NN of_II F-actin_NN in_II fibroblasts_NNS rather_RR induced_VVD a_DD reorganization_NN of_II F-actin_NN in_II primary_JJ cultures_NNS of_II human_NN umbilical_JJ vein_NN endothelial_JJ cells_NNS (_( HUVECs_NNS )_) that_PNR was_VBD characterized_VVN by_II the_DD accumulation_NN of_II stress_NN fibers_NNS ,_, the_DD recruitment_NN of_II vinculin_NN to_II focal_JJ adhesions_NNS ,_, and_CC the_DD loss_NN of_II membrane_NN ruffles_NNS ,_, H2O2_NN also_RR induced_VVD in_II these_DD cells_NNS a_DD strong_JJ (_( 10-_MC to_II 14-fold_NN )_) activation_NN of_II the_DD p38_NN mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN ,_, which_PNR resulted_VVD in_II activation_NN of_II MAP_NN kinase-activated_VVNJ protein_NN kinase-2_NN /_SYM 3_MC and_CC phosphorylation_NN of_II the_DD F-actin_NN polymerization_NN modulator_NN ,_, heat_NN shock_NN protein_NN 27_MC (_( HSP27_NN )_) ._.
P09067893A04
To_TO clarify_VVI this_DD point_NN ,_, we_PN examined_VVD whether_CST ET-1_NN could_VM activate_VVB JNK_NN and_CC the_DD mechanism_NN of_II activation_NN in_II cultured_VVNJ mesangial_JJ cells_NNS ._.
P09090707A05
CONCLUSIONS_NNS :_: These_DD studies_NNS show_VVB that_CST TAM_NN activates_VVZ the_DD signal_NN transduction_NN kinases_NNS ,_, JNK1_NN and_CC ERK2_NN ,_, which_PNR may_VM play_VVB important_JJ roles_NNS in_II the_DD regulation_NN of_II gene_NN expression_NN by_II TAM_NN ._.
P09096313A06
Activation_NN of_II p38_NN MAPK_NN and_CC the_DD resulting_VVGJ induction_NN of_II apoptosis_NN may_VM be_VBB important_JJ in_II the_DD demonstrated_VVNJ antineoplastic_JJ actions_NNS of_II nonsteroidal_JJ anti-inflammatory_JJ drugs_NNS ._.
P09096344A07
Therefore_RR ,_, regulation_NN of_II neutrophil_NN migration_NN appears_VVZ to_TO be_VBI largely_RR independent_JJ of_II the_DD activation_NN of_II the_DD mitogen-activated_VVNJ protein_NN kinases_NNS ._.
P09099744A10
These_DD data_NNS indicate_VVB that_CST IL-1beta_NN activates_VVZ ERK2_NN through_II an_DD oxidation-dependent_JJ pathway_NN ._.
P09111071A06
Transient_JJ transfection_NN experiments_NNS confirmed_VVD that_CST lambdaPKC_NN acts_VVZ downstream_JJ of_II Ras_NN but_CC upstream_JJ of_II mitogen-activated_VVNJ protein_NN kinase_NN /_SYM ERK_NN kinase_NN ._.
P09113418A08
Together_RR ,_, these_DD results_NNS suggest_VVB that_CST oxidants_NNS such_II+ as_II hydrogen_NN peroxide_NN stimulate_VVB tyrosine_NN phosphorylation_NN of_II receptor_NN tyrosine_NN kinases_NNS and_CC these_PND ,_, in_II turn_NN ,_, mediate_VVB the_DD down-stream_NN signalling_VVGJ events_NNS including_VVG the_DD recruitment_NN of_II Grb2_NN by_II the_DD receptor_NN ,_, activation_NN of_II ERKs_NNS and_CC induction_NN of_II c-fos_NN and_CC c-jun_NN expression_NN ._.
P09115275A01
The_DD death_NN domain_NN of_II the_DD type_NN 1_MC tumor_NN necrosis_NN factor_NN receptor_NN (_( TNFR1_NN )_) mediates_VVZ interactions_NNS with_II several_JJ proteins_NNS involved_VVN in_II signaling_VVGN the_DD downstream_JJ effects_NNS of_II TNF_NN ._.
P09120270A09
In_II a_DD model_NN of_II cartilage_NN breakdown_NN ,_, short-term_NN IL-1-stimulated_VVNJ proteoglycan_NN resorption_NN and_CC inhibition_NN of_II proteoglycan_NN synthesis_NN were_VBD unaffected_VVN by_II SB_NN 203580_MC ,_, while_CS longer_JJR term_NN collagen_NN breakdown_NN was_VBD prevented_VVN ._.
P09124279A03
We_PN now_RR report_VVB stable_JJ reduction_NN of_II extracellular_JJ signal-regulated_VVNJ kinase_NN 1_MC (_( ERK1_NN )_) protein_NN expression_NN and_CC lack_NN of_II serum-induced_VVNJ ERK1_NN activation_NN in_II alkali-dedifferentiated_VVNJ Madin-Darby_NN canine_JJ kidney-C7_NN focus_VVB (_( MDCK-C7F_NN )_) cells_NNS compared_VVN with_II their_PNG parental_JJ epithelial_JJ MDCK-C7_NN cells_NNS ._.
P09127005A07
The_DD role_NN of_II mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) pathway_NN on_II TCC-inducible_JJ mitotic_JJ signaling_VVGN was_VBD evaluated_VVN by_II assessing_VVGN DNA_NN synthesis_NN and_CC activator_NN protein_NN 1_MC (_( AP-1_NN )_) DNA-binding_VVGJ activity_NN ._.
P09144515A09
In_II the_DD presence_NN of_II the_DD MAP_NN kinase_NN kinase_NN (_( MEK_NN )_) inhibitor_NN ,_, PD_NN 098059_MC ,_, phagocytosis_NN was_VBD reduced_VVN by_II approximately_RR 50_MC %_SYM ,_, while_CS ERK1_NN and_CC ERK2_NN activity_NN was_VBD reduced_VVN by_II 85_MC to_II 90_MC %_SYM ._.
P09144545A03
Mechanical_JJ wounding_VVGN of_II IEC-6_NN cell_NN monolayers_NNS resulted_VVD in_II rapid_JJ activation_NN of_II the_DD extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) and_CC p38_NN MAP_NN kinase_NN pathways_NNS ,_, while_CS c-Jun_NN amino-terminal_JJ protein_NN kinases_NNS were_VBD not_RR significantly_RR activated_VVN ._.
P09148932A10
We_PN cotransfected_VVD either_CC one_PN of_II these_DD mutants_NNS or_CC their_PNG empty_JJ vector_NN with_II an_DD AR-ORE_NN luciferase_NN reporter_NN construct_NN and_CC compared_VVD the_DD hyperosmotically_RR induced_VVNJ increase_NN in_II luciferase_NN activity_NN with_II that_PND in_II cells_NNS lipofected_VVN with_II only_RR the_DD AR-ORE_NN luciferase_NN construct_NN ._.
P09148940A06
These_DD results_NNS suggest_VVB a_DD novel_JJ role_NN for_II Cdc42Hs_NNS in_II cell_NN cycle_NN inhibition_NN ._.
P09148971A02
The_DD induction_NN of_II immediate-early_JJ gene_NN expression_NN in_II immortalized_VVNJ mouse_NN liver_NN cells_NNS by_II the_DD PPs_NNS Wy-14_NN ,_, 643_MC ,_, monoethylhexyl_NN phthalate_NN ,_, ciprofibrate_NN ethyl_NN ester_NN ,_, and_CC clofibrate_NN suggested_VVD that_CST they_PN may_VM be_VBB activating_VVG growth-regulatory_JJ signal_NN transduction_NN pathways_NNS ._.
P09153215A09
Because_CS hyperosmolarity_NN acutely_RR activates_VVZ the_DD NHE_NN ,_, we_PN considered_VVD whether_CST the_DD resulting_VVGJ cytosolic_JJ alkalinization_NN mediates_VVZ the_DD activation_NN of_II SAPK_NN upon_II cell_NN shrinkage_NN ._.
P09155017A03
MNK1_NN ,_, but_CC not_RR Mnk2_NN ,_, also_RR binds_VVZ strongly_RR to_II the_DD stress-activated_VVNJ kinase_NN ,_, p38_NN ._.
P09159118A04
Inhibiting_VVGN activation_NN of_II ERK1_NN and_CC ERK2_NN with_II the_DD MEK1_NN /_SYM 2_MC inhibitor_NN PD98059_NN has_VHZ no_DD effect_NN on_II insulin_NN secretion_NN ,_, indicating_VVG that_CST ERK_NN activity_NN is_VBZ not_RR necessary_JJ for_II secretion_NN under_II these_DD conditions_NNS ._.
P09169474A09
Thapsigargin_NN ,_, which_PNR only_RR minimally_RR induced_VVD c-Fos_NN ,_, produced_VVD a_DD much_RR greater_JJR and_CC more_RR prolonged_VVNJ c-Jun_NN response_NN than_CSN Ang_NN II_MC ._.
P09169593A03
Nuclear_JJ localization_NN of_II MAP_NN kinase_NN is_VBZ also_RR observed_VVN in_II 3T3-F442A_NN adipocytes_NNS ,_, NIH-3T3_NN cells_NNS and_CC Fao_NN hepatoma_NN cells_NNS ,_, whereas_CS MEK_NN is_VBZ found_VVN in_II the_DD nucleus_NN only_RR in_II Fao_NN and_CC CHO_NN cells_NNS ._.
P09169613A08
The_DD activation_NN is_VBZ confirmed_VVN by_II MAP_NN kinase_NN activity_NN with_II similar_JJ kinetics_NNS to_II the_DD tyrosine_NN phosphorylation_NN ._.
P09180263A02
IFNs_NNS induce_VVB a_DD signaling_VVGJ event_NN which_PNR involves_VVZ activation_NN of_II Stat1_NN transcription_NN factor_NN ._.
P09212060A04
The_DD 63-_MC bp_NN MMP1_NN promoter_NN fragment_NN -123_MC to_II -61_MC confers_VVZ this_DD FGF2_NN response_NN on_II the_DD rous_NN sarcoma_NN virus_NN minimal_JJ promoter_NN ._.
P09212060A15
Thus_RR ,_, a_DD Ras-_NN and_CC MKP2-regulated_VVNJ MAPK_NN pathway_NN ,_, independent_JJ of_II ERK1_NN /_SYM ERK2_NN MAPK_NN activity_NN ,_, mediates_VVZ FGF2_NN transcriptional_JJ activation_NN of_II MMP1_NN in_II MC3T3-E1_NN osteoblasts_NNS ,_, converging_VVG upon_II the_DD bipartite_JJ Ets-AP1_NN element_NN ._.
P09228012A05
The_DD glutamate_NN concentration_NN effective_JJ for_II inducing_VVGN apoptosis_NN correlated_VVD with_II that_PND for_II inducing_VVGN p38_NN activation_NN ._.
P09228071A06
To_TO understand_VVI how_CST PC_NN inhibits_VVZ BCP_NN and_CC CPPD-mediated_VVNJ cellular_JJ effects_NNS ,_, we_PN have_VHB investigated_VVN the_DD mechanism_NN by_II which_PNR BCP_NN and_CC CPPD_NN transduce_VVB signals_NNS to_II the_DD nucleus_NN ._.
P09233830A07
In_II contrast_NN ,_, TAYF_NN ERK2_NN was_VBD able_JJ to_TO block_VVI EGF_NN and_CC insulin-induced_VVNJ 3TP-Lux-reporter_NN activity_NN ._.
P09242621A04
An_DD equivalent_JJ stimulation_NN is_VBZ seen_VVN in_II PC12_NN cells_NNS expressing_VVG a_DD dominant_JJ negative_JJ Ras_NN mutant_NN ._.
P09271377A07
In_II BAF3-mpl_NN cells_NNS ,_, TPO_NN triggered_VVD a_DD weak_JJ and_CC transient_JJ ERK_NN activation_NN ,_, similar_JJ to_II that_PND induced_VVN in_II UT7-mpl_NN delta3_NN cells_NNS ._.
P09287359A11
These_DD results_NNS suggest_VVB that_CST the_DD intracellular_JJ redox_NN levels_NNS may_VM be_VBB directly_RR coupled_VVN to_II tumor_NN growth_NN ,_, invasion_NN ,_, and_CC metastasis_NN via_II Elk-1-dependent_JJ induction_NN of_II c-Fos_NN controlled_VVNJ genes_NNS ._.
P09299362A04
Control_NN hearts_NNS experienced_VVD 30_MC min_NN of_II ischemia_NN only_RR ._.
P09312114A03
To_TO investigate_VVI the_DD molecular_JJ nature_NN underlying_VVG cellular_JJ responses_NNS to_II Raf-1_NN activation_NN ,_, we_PN have_VHB stably_RR transfected_VVN rat_NN salivary_JJ epithelial_JJ Pa-4_NN cells_NNS with_II human_NN Raf-1-estrogen_NN receptor_NN fusion_NN gene_NN (_( DeltaRaf-1_NN :_: ER_NN )_) and_CC used_VVD mRNA_NN differential_JJ display_NN in_II search_NN of_II messages_NNS induced_VVN by_II DeltaRaf-1_NN :_: ER_NN activation_NN ._.
P09312139A02
Purified_VVNJ Bcl-2_NN was_VBD found_VVN to_TO be_VBI phosphorylated_VVN by_II the_DD c-Jun_NN N-terminal_JJ kinase_NN /_SYM stress-activated_VVNJ protein_NN kinase_NN (_( JNK_NN /_SYM SAPK_NN )_) p54-SAPKbeta_NN ,_, and_CC this_PND is_VBZ specific_JJ insofar_CS+ as_CS the_DD extracellular_JJ signal-regulated_VVNJ kinase_NN 1_MC (_( ERK1_NN )_) and_CC p38_NN /_SYM RK_NN /_SYM CSBP_NN (_( p38_NN )_) catalyzed_VVD only_RR weak_JJ modification_NN ._.
P09322526A07
Thus_RR ,_, TUDCA_NN signaling_VVGN towards_II MAP_NN kinases_NNS is_VBZ different_JJ from_II hypo-osmotic_JJ MAP-kinase_NN activation_NN ,_, which_PNR is_VBZ sensitive_JJ to_II inhibitors_NNS of_II tyrosine_NN kinases_NNS and_CC G-protein_NN function_NN ._.
P09322943A05
The_DD inactivation_NN of_II Ras_NN ,_, Raf_NN ,_, and_CC MEK_NN directly_RR correlated_VVD with_II the_DD serine_NN /_SYM threonine_NN phosphorylation_NN of_II SOS_NN and_CC dissociation_NN of_II SOS_NN from_II Grb2_NN but_CC not_RR Grb2_NN from_II tyrosine-phosphorylated_VVNJ SHC_NN ._.
P09334169A05
NIK_NN was_VBD found_VVN to_TO be_VBI unable_JJ to_TO activate_VVI JNK_NN /_SYM SAPK_NN ,_, mitogen-activated_VVNJ protein_NN kinase_NN ,_, or_CC p38_NN kinase_NN ._.
P09337851A06
Interestingly_RR ,_, addition_NN of_II PD98059_NN or_CC dnERK-_NN ,_, but_CC not_RR dnJNK-_NN ,_, resulted_VVD in_II a_DD dramatic_JJ decrease_NN in_II cyclin_NN D1_NN protein_NN and_CC mRNA_NN levels_NNS ,_, concomitant_JJ with_II a_DD decrease_NN in_II cyclin_NN D1-cyclin-dependent_JJ kinase_NN activity_NN ._.
P09351829A07
JNK-mediated_VVNJ transcriptional_JJ activation_NN of_II AP-1_NN is_VBZ the_DD direct_JJ output_NN of_II LMP-1-triggered_VVNJ signaling_VVGN ,_, as_CS shown_VVN by_II an_DD inducible_JJ LMP-1_NN mutant_NN ._.
P09352861A06
RESULTS_NNS :_: There_EX was_VBD little_DD or_CC no_DD difference_NN in_II JNK_NN and_CC ERK_NN activity_NN in_II hyperproliferative_JJ mucosa_NN from_II DMH-treated_VVNJ animals_NNS compared_VVN with_II normal_JJ mucosa_NN from_II control_NN animals_NNS ._.
P09362525A02
Ligation_NN of_II this_DD receptor_NN leads_VVZ to_II prominent_JJ downregulation_NN of_II T_NN cell_NN proliferation_NN ,_, mainly_RR as_II a_DD consequence_NN of_II interference_NN with_II IL-2_NN production_NN ._.
P09367856A02
This_PND was_VBD followed_VVN by_II the_DD sequential_JJ activation_NN of_II mitogen-activated_VVNJ protein_NN kinase_NN kinase_NN kinase_NN (_( MAPKKK_NN )_) activity_NN of_II Raf-1_NN ,_, MAP_NN kinase_NN kinase_NN (_( MAPKK_NN )_) ,_, MAPKs_NNS (_( p44mapk_NN and_CC p42mapk_NN ,_, also_RR called_VVN extracellular_JJ signal-regulated_VVNJ protein_NN kinase_NN [_( ERK_NN ]_) 1_MC and_CC ERK2_NN ,_, respectively_RR )_) ,_, and_CC S6_NN kinase_NN (_( p90rsk_NN )_) ._.
P09370349A02
A_DD comparable_JJ TNF-alpha-mediated_VVNJ inhibition_NN of_II p42_NN /_SYM 44_MC mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN activity_NN was_VBD observed_VVN in_II 10_MC nM_NN EGF-stimulated_VVNJ cells_NNS ._.
P09372971A01
At_RR+ least_RR three_MC mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) cascades_NNS were_VBD identified_VVN in_II mammals_NNS ,_, each_PND consisting_VVG of_II a_DD well-defined_VVNJ three-kinase_NN module_NN composed_VVN of_II a_DD MAPK_NN ,_, a_DD MAPK_NN kinase_NN (_( MAPKK_NN )_) ,_, and_CC a_DD MAPKK_NN kinase_NN (_( MAPKKK_NN )_) ._.
P09374731A01
Stimulation_NN of_II cell_NN signaling_VVGJ cascades_NNS by_II oxidants_NNS may_VM be_VBB important_JJ in_II the_DD pathogenesis_NN of_II pulmonary_JJ and_CC pleural_JJ diseases_NNS ._.
P09384583A04
MKK7_NN is_VBZ most_RRT similar_JJ to_II the_DD mediator_NN of_II morphogenesis_NN ,_, hemipterous_NN (_( hep_NN )_) ,_, in_II Drosophila_NN ._.
P09388198A02
To_TO investigate_VVI the_DD regulation_NN of_II this_DD cellular_JJ response_NN ,_, we_PN isolated_VVD the_DD gene_NN for_II rhoB_NN from_II a_DD mouse_NN genomic_JJ library_NN ._.
P09389491A04
Insulin-stimulated_VVNJ phosphorylation_NN of_II the_DD alpha-subunit_NN of_II FTase_NN in_II 3T3-L1_NN fibroblasts_NNS and_CC adipocytes_NNS was_VBD blocked_VVN by_II the_DD mitogen-activated_VVNJ protein_NN /_SYM extracellular-signal_NN regulated_VVNJ kinase-kinase_NN inhibitor_NN ,_, PD98059_NN ,_, but_CC not_RR by_II wortmannin_NN or_CC bisindolylmaleimide_NN ._.
P09390997A03
In_II the_DD present_JJ investigation_NN ,_, we_PN provide_VVB evidence_NN that_CST MEK_NN is_VBZ critically_RR involved_VVN in_II regulating_VVGN APP_NN processing_VVGN by_II both_CC nerve_NN growth_NN factor_NN and_CC phorbol_NN esters_NNS ._.
P09392422A08
The_DD specific_JJ MAPK_NN pathway_NN inhibitor_NN PD98059_NN blocked_VVD TPA-induced_VVNJ ERK_NN activation_NN ._.
P09397988A03
Point_NN mutations_NNS of_II p21ras_NN have_VHB been_VBN identified_VVN in_II various_JJ tumor_NN types_NNS and_CC lead_VVB to_II constitutive_JJ activation_NN of_II this_DD protein_NN and_CC subsequent_JJ activation_NN of_II downstream_JJ pathways_NNS including_VVG the_DD MAPK_NN cascade_NN ._.
P09401960A04
In_II 3T3-L1_NN adipocytes_NNS and_CC Clone_NN 9_MC cells_NNS ,_, stimulation_NN of_II sugar_NN transport_NN by_II puromycin_NN ,_, a_DD translational_JJ inhibitor_NN that_PNR does_VDZ not_RR activate_VVB kinases_NNS ,_, was_VBD not_RR detectable_JJ until_II 90_MC min_NN after_II exposure_NN ._.
P09405407A05
A_DD TRAF2_NN mutant_NN ,_, which_PNR inhibits_VVZ both_CC TRAF2-induced_VVNJ NF-kappaB_NN and_CC SAPK_NN activation_NN ,_, blocked_VVD TNF-induced_VVNJ GCKR_NN activation_NN ._.
P09407138A08
Stably_RR transfected_VVNJ clones_NNS of_II A549_NN cells_NNS expressing_VVG c-JUN_NN (_( S63A_NN ,_, S73A_NN )_) ,_, a_DD transdominant_JJ inhibitor_NN of_II c-JUN_NN ,_, completely_RR blocked_VVD the_DD EGF-stimulated_VVNJ proliferation_NN effect_NN but_CC did_VDD not_RR alter_VVB the_DD basal_JJ proliferation_NN rate_NN ._.
P09412490A02
We_PN identified_VVD a_DD molecule_NN ,_, CEP-1347_NN (_( KT7515_NN )_) ,_, that_PNR rescues_VVZ motoneurons_NNS undergoing_VVG apoptosis_NN and_CC investigated_VVD its_PNG effect_NN on_II ERK1_NN and_CC JNK1_NN activity_NN ._.
P09415703A08
These_DD findings_NNS demonstrate_VVB that_CST reciprocal_JJ alterations_NNS in_II the_DD SAPK_NN and_CC MAPK_NN cascades_NNS are_VBB associated_VVN with_II the_DD apoptotic_JJ influence_NN of_II either_DD lipid_NN inasmuch_CS+ as_CS (_( i_MC )_) ceramide-mediated_VVNJ lethality_NN is_VBZ primarily_RR associated_VVN with_II strong_JJ stimulation_NN of_II SAPK_NN and_CC weak_JJ inhibition_NN of_II MAPK_NN ,_, whereas_CS (_( ii_MC )_) sphingosine-mediated_VVNJ lethality_NN is_VBZ primarily_RR associated_VVN with_II weak_JJ stimulation_NN of_II SAPK_NN and_CC strong_JJ inhibition_NN of_II MAPK_NN ._.
P09417090A05
However_RR ,_, unlike_II mammalian_JJ p38_NN MAPK_NN ,_, the_DD addition_NN of_II lipopolysaccharide_NN (_( LPS_NN )_) did_VDD not_RR significantly_RR affect_VVB the_DD phosphorylation_NN of_II Dp38_NN in_II the_DD LPS-responsive_JJ l_NN (_( 2_MC )_) mbn_NN cell_NN line_NN ._.
P09418855A09
In_II addition_NN ,_, these_DD results_NNS implicate_VVB the_DD p38_NN MAPK_NN as_II a_DD possible_JJ negative_JJ regulator_NN of_II TNF_NN signaling_VVGN that_PNR leads_VVZ to_II NF-kappaB_NN activation_NN ._.
P09427749A08
MLK2_NN and_CC MLK3_NN interact_VVB with_II members_NNS of_II the_DD KIF3_NN family_NN of_II kinesin_NN superfamily_NN motor_NN proteins_NNS and_CC with_II KAP3A_NN ,_, the_DD putative_JJ targeting_VVGJ component_NN of_II KIF3_NN motor_NN complexes_NNS ,_, suggesting_VVG a_DD potential_JJ link_NN between_II stress_NN activation_NN and_CC motor_NN protein_NN function_NN ._.
P09430688A03
Here_RR we_PN identify_VVB six_MC sites_NNS in_II MAPKAP-K1a_NN that_PNR become_VVB phosphorylated_VVN in_II transfected_VVNJ COS-1_NN cells_NNS ._.
P09430728A01
Inactivation_NN of_II growth_NN factor-regulated_VVNJ mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinases_NNS (_( ERK1_NN and_CC ERK2_NN )_) has_VHZ been_VBN proposed_VVN to_TO occur_VVI in_II part_NN through_II dephosphorylation_NN by_II the_DD dual_JJ specificity_NN MAP_NN kinase_NN phosphatase-1_NN (_( MKP-1_NN )_) ,_, an_DD immediate_JJ early_JJ gene_NN that_PNR is_VBZ induced_VVN by_II mitogenic_JJ signaling_VVGN ._.
P09442025A02
We_PN have_VHB examined_VVN communications_NNS between_II these_DD stress-_NN and_CC mitogen-induced_VVNJ signaling_VVGJ pathways_NNS ._.
P09443400A05
Paclitaxel_NN caused_VVD a_DD rapid_JJ and_CC transient_JJ increase_NN in_II c-Jun_NN NH2-terminal_JJ kinase_NN (_( JNK_NN )_) activity_NN ,_, a_DD proposed_VVNJ mediator_NN of_II stress_NN activation_NN pathways_NNS ._.
P09450967A04
In_II these_DD interphase-arrested_VVNJ extracts_NNS ,_, H1_NN kinase_NN activity_NN remained_VVD low_JJ ,_, Cdc2_NN was_VBD tyrosine_NN phosphorylated_VVN ,_, and_CC nuclei_NNS continued_VVD to_TO enlarge_VVI ._.
P09452444A07
Furthermore_RR ,_, we_PN clearly_RR show_VVB that_CST ,_, using_VVG a_DD nuclear_JJ Gal4_NN "_`` one-hybrid_NN "_'' system_NN ,_, the_DD MAPK_NN inhibitors_NNS SB203580_NN and_CC PD0980589_NN have_VHB a_DD direct_JJ repressive_JJ effect_NN on_II the_DD transactivation_NN potential_NN of_II the_DD p65_NN kappaB_NN subunit_NN ._.
P09452460A05
Although_CS other_JJ SAPK_NN congeners_NNS might_VM be_VBB activated_VVN upon_II microtubule_NN depolymerization_NN ,_, the_DD activation_NN of_II ERK1_NN and_CC ERK2_NN is_VBZ mandatory_JJ for_II IL-1_NN production_NN as_CS shown_VVN by_II the_DD blocking_VVGJ effect_NN of_II PD_NN 98059_MC ,_, a_DD specific_JJ MEK1_NN /_SYM 2_MC inhibitor_NN ._.
P09452512A07
After_II 15_MC min_NN ,_, livers_NNS were_VBD removed_VVN and_CC prepared_VVN for_II kinase_NN analyses_NNS ._.
P09459490A01
Vasoconstrictors_NNS ,_, such_II+ as_II angiotensin_NN II_MC (_( Ang_NN II_MC )_) ,_, are_VBB involved_VVN in_II the_DD regulatory_JJ mechanisms_NNS of_II post_RR myocardial_JJ infarction_NN (_( MI_NN )_) hypertrophy_NN ._.
P09467952A05
Inhibition_NN of_II the_DD Erk2_NN pathway_NN by_II PD98059_NN ,_, specific_JJ for_II the_DD upstream_JJ MAP_NN kinase_NN kinase_NN (_( MEK1_NN )_) ,_, abolishes_VVZ TPA-stimulated_VVNJ junB_NN but_CC not_RR insulin-induced_VVNJ c-jun_NN ._.
P09469462A03
Protein_NN phosphorylation_NN analysis_NN of_II cellular_JJ MAP_NN kinases_NNS indicates_VVZ that_CST exposure_NN of_II human_NN neutrophils_NNS to_II chemotactic_JJ factor_NN FMLP_NN as_CC+ well_CC+ as_CC granulocyte-macrophage_NN CSF_NN ,_, PMA_NN ,_, or_CC ionomycin_NN rapidly_RR induced_VVD the_DD activation_NN of_II p38_NN and_CC p44_NN /_SYM 42_MC MAP_NN kinases_NNS ,_, but_CC stimulation_NN with_II inflammatory_JJ cytokine_NN TNF-alpha_NN triggered_VVD the_DD activation_NN of_II p38_NN MAP_NN kinase_NN only_RR ._.
P09482215A08
Both_CC ,_, LPS-_NN and_CC PCW-induced_VVNJ responses_NNS of_II astrocytic_JJ cells_NNS required_VVD the_DD presence_NN of_II soluble_JJ CD14_NN (_( sCD14_NN )_) present_VVB in_II serum_NN ._.
P09501207A01
UV_NN irradiation_NN induces_VVZ apoptosis_NN in_II U937_NN human_NN leukemic_JJ cells_NNS that_PNR is_VBZ accompanied_VVN by_II the_DD activation_NN of_II both_CC the_DD stress-activated_VVNJ protein_NN kinase_NN (_( SAPK_NN )_) and_CC p38_NN mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) signal_NN transduction_NN pathways_NNS ._.
P09507015A04
Therefore_RR ,_, in_II the_DD present_JJ study_NN ,_, we_PN examined_VVD the_DD consequences_NNS of_II this_DD restriction_NN on_II IL-1-mediated_VVNJ activation_NN of_II the_DD MAP_NN kinase_NN family_NN and_CC on_II c-fos_NN expression_NN ._.
P09513050A05
IL-1_NN beta_NN preferentially_RR activated_VVD JNK_NN pathway_NN in_II a_DD dose-_NN and_CC time-dependent_JJ manner_NN and_CC had_VHD little_DD effect_NN on_II ERK_NN pathway_NN ._.
P09513899A01
The_DD in_JJ+ vivo_JJ signal_NN transduction_NN pathway_NN ,_, responsible_JJ for_II hypertension-induced_VVNJ glomerular_JJ injury_NN ,_, remains_VVZ to_TO be_VBI clarified_VVN ._.
P09515796A07
These_DD findings_NNS suggest_VVB that_CST activation_NN of_II p38_NN may_VM contribute_VVB to_II a_DD more_RR invasive_JJ phenotype_NN in_RR+ vitro_RR ,_, possibly_RR via_II the_DD expression_NN of_II MMP-9_NN ,_, and_CC that_CST targeting_VVGN of_II p38_NN using_VVG SB_NN 203580_MC may_VM provide_VVB a_DD novel_JJ means_NNS of_II controlling_VVGN invasion_NN of_II cancers_NNS in_II which_PNR this_DD MAPK_NN is_VBZ activated_VVN ._.
P09516390A05
Another_DD MAPK_NN ,_, c-Jun-N-terminal_JJ protein_NN kinase_NN (_( JNK_NN )_) ,_, was_VBD also_RR activated_VVN after_II wounding_VVGN ._.
P09516391A06
Tyrphostin_NN A46_NN treatment_NN significantly_RR inhibited_VVD ulcer_NN healing_VVGN and_CC reduced_VVD EGF-R_NN levels_NNS ,_, EGF-R_NN phosphorylation_NN ,_, and_CC ERK1_NN and_CC ERK2_NN activity_NN ._.
P09518544A09
Thus_RR ,_, growth_NN factor_NN stimulation_NN ,_, PKC_NN activation_NN and_CC protein_NN phosphatase_NN inhibition_NN induced_VVD the_DD expression_NN of_II PGHS-2_NN in_II primary_JJ amnion_NN cells_NNS by_II distinct_JJ regulatory_JJ mechanisms_NNS involving_VVG tyrosine_NN kinase_NN (_( s_NNS )_) ._.
P09518660A08
When_CS PC12D_NN cells_NNS were_VBD transfected_VVN with_II the_DD dominant_JJ inhibitory_JJ Ha-ras_NN Asn-17_NN gene_NN ,_, the_DD induction_NN of_II the_DD mutant_JJ Ras_NN protein_NN led_VVD the_DD suppression_NN of_II the_DD rapid_JJ outgrowth_NN of_II neurites_NNS in_II response_NN to_II NGF_NN but_CC not_RR to_II dibutyryl_NN cyclic_JJ AMP_NN (_( dbcAMP_NN )_) ._.
P09528766A03
NGF_NN activates_VVZ the_DD extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) ,_, which_PNR in_II turn_NN activate_VVB the_DD pp90_NN ribosomal_JJ S6_NN kinase_NN (_( RSK_NN )_) family_NN of_II Ser_NN /_SYM Thr_NN kinases_NNS ,_, all_DD three_MC members_NNS of_II which_PNR were_VBD found_VVN to_TO catalyze_VVI CREB_NN Ser-133_NN phosphorylation_NN in_RR+ vitro_RR and_CC in_RR+ vivo_RR ._.
P09533945A03
In_II this_DD study_NN ,_, we_PN further_RR examined_VVD the_DD signaling_VVGJ intermediates_NNS responsible_JJ for_II ERK_NN activation_NN by_II H2O2_NN in_II airway_NN smooth_JJ muscle_NN ,_, focusing_VVG on_II MAP_NN kinase_NN /_SYM ERK_NN kinase_NN (_( MEK_NN )_) ,_, a_DD dual-function_NN kinase_NN which_PNR is_VBZ required_VVN and_CC sufficient_JJ for_II ERK_NN activation_NN in_II bovine_JJ tracheal_JJ myocytes_NNS ;_: Raf-1_NN ,_, a_DD serine_NN /_SYM threonine_NN kinase_NN known_VVN to_TO activate_VVI MEK_NN ;_: and_CC PKC_NN ._.
P09535875A07
Involvement_NN of_II an_DD AP-1_NN site_NN in_II arsenite_NN induction_NN of_II heme_NN oxygenase-1_NN gene_NN expression_NN was_VBD studied_VVN ._.
P09535927A05
Consistent_JJ with_II a_DD role_NN for_II N-terminal_JJ binding_VVGN in_II determining_VVGN MKP-3_NN specificity_NN ,_, at_RR+ least_RR 10-fold_NN higher_JJR concentrations_NNS of_II purified_VVNJ MKP-3DeltaN_NN than_CSN full-length_NN MKP-3_NN is_VBZ required_VVN to_TO inhibit_VVI ERK2_NN activity_NN ._.
P09545341A02
To_TO establish_VVI the_DD role_NN of_II the_DD MAP_NN kinases_NNS in_II melanogenesis_NN ,_, we_PN studied_VVD the_DD effects_NNS of_II a_DD specific_JJ MAP_NN kinase_NN kinase_NN (_( MEK_NN )_) inhibitor_NN PD_NN 98059_MC on_II different_JJ melanogenic_JJ parameters_NNS ._.
P09546380A07
In_II contrast_NN ,_, PD98059_NN did_VDD not_RR block_VVB the_DD intimal_JJ cell_NN replication_NN at_II day_NN 8_MC ._.
P09547255A04
A_DD one-trial_NN in_JJ+ vitro_JJ conditioning_VVGJ procedure_NN consisting_VVG of_II light_NN (_( CS_NN )_) paired_VVN with_II the_DD application_NN of_II 5-HT_NN results_VVZ in_II the_DD increased_VVNJ incorporation_NN of_II 32PO4_NN into_II proteins_NNS detected_VVN with_II two-dimensional_JJ gel_NN electrophoresis_NN ._.
P09548470A04
Cross-linking_VVGN of_II Fas_NN on_II T_NN cells_NNS also_RR induced_VVD rapid_JJ activation_NN of_II p38_NN MAPK_NN and_CC MAPKAP_NN kinase-2_NN ._.
P09566877A06
FN-stimulated_VVNJ FAK_NN PTK_NN activity_NN was_VBD not_RR significantly_RR affected_VVN by_II herbimycin_NN A_NN treatment_NN and_CC ,_, under_II these_DD conditions_NNS ,_, FAK_NN autophosphorylation_NN promoted_VVD Shc_NN binding_VVGN to_II FAK_NN ._.
P09570551A04
Treatment_NN of_II murine_JJ macrophages_NNS with_II LAMPf_NN resulted_VVD in_II significant_JJ activation_NN of_II MAPK_NN family_NN members_NNS extracellular_JJ signal-regulated_VVNJ kinase_NN 1_MC and_CC 2_MC (_( ERK1_NN /_SYM 2_MC )_) ,_, c-Jun_NN NH2-terminal_JJ kinase_NN (_( JNK_NN )_) ,_, and_CC p38_NN ._.
P09570562A09
SB_NN 203580_MC also_RR significantly_RR reduced_VVD the_DD development_NN of_II the_DD response_NN to_II des-Arg9-BK_NN as_CS stimulated_VVN by_II IL-1_NN or_CC EGF_NN ._.
P09579682A02
The_DD patterns_NNS of_II MAPK_NN activation_NN following_VVG LPS_NN and_CC Abeta_NN treatment_NN were_VBD very_RR similar_JJ ._.
P09593727A08
Dominant-negative_JJ mutants_NNS of_II Ras_NN (_( but_CC not_RR Rac_NN or_CC Cdc42_NN )_) specifically_RR inhibited_VVD ERK_NN activation_NN by_II v-Fps_NN and_CC Myr-Fes_NN ,_, demonstrating_VVG that_CST ERK_NN activation_NN occurs_VVZ exclusively_RR downstream_JJ of_II Ras_NN ._.
P09596579A04
Neither_CC the_DD gain-of-function_NN Sevenmaker_NN ERK2_NN mutant_JJ D319N_NN nor_CC c-Jun_NN amino-terminal_JJ kinase-stress-activated_VVNJ protein_NN kinase_NN (_( JNK_NN /_SYM SAPK_NN )_) or_CC p38_NN MAP_NN kinases_NNS bound_VVD MKP-3_NN or_CC caused_VVD its_PNG catalytic_JJ activation_NN ._.
P09596671A04
Our_PNG results_NNS demonstrate_VVB that_CST p56Lck_NN and_CC CD45_NN exert_VVB a_DD negative_JJ control_NN on_II thrombin-induced_VVNJ p38_NN MAPK_NN activation_NN and_CC [_( Ca2+_NN ]_) i_NN release_NN in_II Jurkat_NN cells_NNS ._.
P09598985A02
Here_RR ,_, we_PN investigated_VVD the_DD effects_NNS of_II SB203580_NN on_II cardiac_JJ SAPKs_NNS /_SYM JNKs_NNS ._.
P09601075A09
These_DD data_NNS indicate_VVB that_CST Gq_NN /_SYM 11PCR_NN agonists_NNS activate_VVB multiple_JJ MAPK_NN signalling_VVGJ pathways_NNS in_II the_DD heart_NN ,_, all_PND of_II which_PNR may_VM contribute_VVB to_II the_DD overall_JJ response_NN (_( e.g._II the_DD development_NN of_II the_DD hypertrophic_JJ phenotype_NN )_) ._.
P09605580A08
6._MC In_II contrast_NN ,_, the_DD protein_NN tyrosine_NN kinase_NN inhibitor_NN tyrphostin_NN B42_NN (_( a_DD specific_JJ inhibitor_NN of_II interferon-gamma-activated_VVNJ janus_NN kinase_NN 2_MC )_) and_CC the_DD protein_NN tyrosine_NN kinase_NN inhibitor_NN tyrphostin_NN A25_NN both_PND reduced_VVD CM-induced_VVNJ NOS_NN II_NN mRNA_NN expression_NN in_II a_DD concentration-dependent_JJ manner_NN ._.
P09614146A04
By_II Western_NN blotting_VVGN with_II phosphospecific_JJ antibodies_NNS and_CC by_II immunocomplex_NN kinase_NN assay_NN ,_, IL-1beta_NN was_VBD shown_VVN to_TO activate_VVI extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) 1_MC /_SYM 2_MC and_CC p38_NN mitogen-activated_VVNJ protein_NN kinase_NN (_( p38_NN )_) in_II islets_NNS and_CC rat_NN insulinoma_NN cells_NNS ._.
P09626657A04
GnRH_NN as_CC+ well_CC+ as_CC tumor-promoting_VVGJ agent_NN (_( TPA_NN )_) also_RR increased_VVD c-Src_NN activity_NN ,_, which_PNR peaked_VVD at_II 2_MC min_NN after_II GnRH_NN stimulation_NN and_CC was_VBD sensitive_JJ both_CC to_II PKC_NN and_CC to_II tyrosine_NN kinase_NN inhibitors_NNS ._.
P09645711A06
FSH-induced_VVNJ GC_NN rounding_VVGN /_SYM aggregation_NN was_VBD blocked_VVN by_II pretreatment_NN with_II SB_NN 203580_MC indicating_VVG that_CST p38_NN MAPK_NN activation_NN is_VBZ necessary_JJ for_II FSH-induced_VVNJ GC_NN cell_NN shape_NN change_NN ._.
P09658404A07
Since_CS it_PN is_VBZ not_RR known_VVN whether_CST the_DD CGRP_NN enhancer_NN factors_NNS are_VBB immediate_JJ targets_NNS of_II MAP_NN kinases_NNS ,_, we_PN then_RR used_VVD EIk-1-_MC and_CC c-Jun-dependent_JJ reporter_NN genes_NNS that_PNR are_VBB directly_RR activated_VVN by_II the_DD ERK_NN (_( extracellular_JJ signal-regulated_VVNJ kinases_NNS )_) and_CC JNK_NN (_( c-Jun_NN N-terminal_JJ kinase_NN )_) MAP_NN kinases_NNS ._.
P09661668A01
The_DD c-Jun_NN N-terminal_JJ kinases_NNS (_( JNKs_NNS )_) ,_, also_RR called_VVN stress-activated_VVNJ protein_NN kinases_NNS (_( SAPKs_NNS )_) ,_, belong_VVB to_II the_DD mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) gene_NN super-family_NN ._.
P09671463A09
In_II contrast_NN ,_, neither_CC dominant_JJ negative_JJ MKK6_NN (_( or_CC SB203580_NN )_) nor_CC PD98059_NN ,_, which_PNR specifically_RR inhibit_VVB p38_NN and_CC ERK_NN MAP_NN kinase_NN pathways_NNS ,_, respectively_RR ,_, could_VM abrogate_VVB the_DD UV-induced_VVNJ effect_NN ._.
P09683913A08
AP-1_NN DNA_NN and_CC NF-kB_NN binding_VVGJ activities_NNS increased_VVD 8.7-fold_NN and_CC 7.1-fold_NN (_( P_NN <_SYM 0.01_MC )_) ,_, respectively_RR ,_, at_II 3_MC days_NNS but_CC returned_VVN to_II normal_JJ levels_NNS by_II 7_MC days_NNS after_II ligation_NN ._.
P09685422A02
In_II this_DD report_NN the_DD mechanism_NN of_II p38-activated_VVNJ transcription_NN was_VBD studied_VVN in_II cardiac_JJ myocytes_NNS where_PNR this_DD MAPK_NN is_VBZ a_DD key_JJ regulator_NN of_II the_DD cell_NN growth_NN and_CC the_DD cardiac-specific_JJ gene_NN induction_NN that_PNR occurs_VVZ in_II response_NN to_II potentially_RR stressful_JJ stimuli_NNS ._.
P09686756A01
Myocardial_JJ infarction_NN results_VVZ in_II focal_JJ areas_NNS of_II ischemia_NN ,_, hypoxia_NN ,_, necrosis_NN ,_, and_CC decreased_VVNJ contractile_JJ function_NN ._.
P09690379A01
Extracellular_JJ signal-related_VVNJ kinase_NN (_( ERK_NN )_) and_CC c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinases_NNS are_VBB highly_RR activated_VVN in_II an_DD in_JJ+ vivo_JJ rat_NN model_NN of_II colorectal_JJ carcinogenesis_NN ._.
P09694839A10
We_PN conclude_VVB that_CST the_DD carboxyl-terminal_JJ tail_NN of_II FPRs_NNS is_VBZ necessary_JJ for_II ligand-mediated_VVNJ activation_NN of_II Gi_NN proteins_NNS and_CC MAPK_NN cascades_NNS ._.
P09698157A08
CNQX_NN had_VHD no_DD effect_NN on_II PAF_NN activation_NN of_II the_DD kinases_NNS ,_, indicating_VVG that_CST PAF_NN is_VBZ downstream_JJ of_II kainate_NN activation_NN ._.
P09698606A01
Hydrogen_NN peroxide_NN (_( H2O2_NN )_) has_VHZ emerged_VVN as_II an_DD important_JJ intracellular_JJ signaling_VVGJ molecule_NN and_CC has_VHZ been_VBN shown_VVN to_TO stimulate_VVI the_DD growth_NN of_II vascular_JJ smooth_JJ muscle_NN cells_NNS ._.
P09705357A05
Selective_JJ inhibition_NN of_II COX-2_NN activity_NN suppressed_VVD the_DD production_NN of_II prostaglandin_NN E2_NN by_II >_SYM 90_MC %_SYM but_CC did_VDD not_RR alter_VVB the_DD progress_NN of_II the_DD morphological_JJ transformation_NN ._.
P09706165A03
We_PN hypothesized_VVD that_CST p38_NN MAPK_NN activity_NN is_VBZ integral_JJ to_II ICAM-1_NN up-regulation_NN on_II pulmonary_JJ endothelium_NN ._.
P09712025A09
N-acetyl-L-cysteine_NN pretreatment_NN ,_, which_PNR blocks_VVZ CD40-mediated_VVNJ JNK_NN activation_NN ,_, does_VDZ not_RR affect_VVB the_DD ability_NN of_II CD40_NN to_TO inhibit_VVI anti-IgM-mediated_VVNJ ERK2_NN activation_NN and_CC apoptosis_NN ._.
P09714186A12
We_PN conclude_VVB that_CST phosphorylation_NN of_II the_DD CD44_NN receptor_NN results_VVZ in_II an_DD increase_NN in_II tyrosine_NN phosphorylation_NN ,_, leading_VVG to_II the_DD activation_NN of_II a_DD cytoplasmic_JJ cascade_NN and_CC cell_NN proliferation_NN ;_: this_PND concurs_VVZ with_II previous_JJ work_NN ,_, which_PNR showed_VVD that_CST o-HA-induced_VVNJ proliferation_NN of_II endothelial_JJ cells_NNS is_VBZ CD44-receptor-mediated_VVNJ and_CC accompanied_VVN by_II early_JJ response_NN gene_NN activation_NN ._.
P09715266A04
Involvement_NN of_II a_DD specific_JJ MAPK_NN ,_, ERK_NN ,_, in_II LPS-stimulated_VVNJ TxB2_NN production_NN was_VBD further_RR tested_VVN using_VVG a_DD specific_JJ MAPK_NN cascade_NN inhibitor_NN ,_, PD98059_NN (_( PD_NN )_) ._.
P09716183A04
The_DD following_VVGJ results_NNS demonstrate_VVB that_CST TBP_NN phosphorylation_NN occurs_VVZ as_II a_DD result_NN of_II activation_NN of_II an_DD extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) protein_NN kinase_NN :_: (_( a_NN )_) overexpression_NN of_II mitogen-activated_VVNJ protein_NN kinase_NN phosphatase-1_NN blocks_VVZ phorbol_NN 12-myristate_NN 13-acetate_NN (_( PMA_NN )_) -induced_VVNJ phosphorylation_NN of_II TBP_NN both_CC in_RR+ vitro_RR and_CC in_RR+ vivo_RR ;_: (_( b_NN )_) pretreatment_NN with_II the_DD ERK_NN kinase_NN kinase_NN inhibitor_NN PD098059_NN also_RR blocks_VVZ PMA-induced_VVNJ phosphorylation_NN of_II TBP_NN both_CC in_RR+ vitro_RR and_CC in_RR+ vivo_RR ;_: and_CC (_( c_NN )_) phosphorylation_NN of_II TBP_NN is_VBZ observed_VVN when_CS serum-starved_VVNJ NIH_NN 3T3_NN cells_NNS are_VBB stimulated_VVN with_II fresh_JJ serum_NN ,_, another_DD activator_NN of_II the_DD ERK_NN pathway_NN ._.
P09720795A12
However_RR ,_, the_DD reduction_NN of_II c-fos_NN and_CC c-myc_NN mRNA_NN levels_NNS by_II 10_MC (_( -5_MC )_) M_NN EGC_NN did_VDD not_RR achieve_VVB significance_NN ._.
P09721723A09
Furthermore_RR ,_, stimulation_NN of_II D2_NN receptors_NNS promoted_VVD [_( 3H_NN ]_) thymidine_NN incorporation_NN with_II a_DD pattern_NN similar_JJ to_II that_PND for_II kinase_NN activation_NN ._.
P09722508A06
Furthermore_RR ,_, we_PN demonstrated_VVD that_CST Galpha11_NN Q209L_NN stimulated_VVD Src_NN family_NN kinase_NN activity_NN and_CC induced_VVD tyrosine_NN phosphorylation_NN of_II several_JJ proteins_NNS in_II HEK-293_NN cells_NNS ._.
P09729476A06
However_RR ,_, both_CC acute_JJ and_CC chronic_JJ ethanol_NN inhibited_VVD hepatocyte_NN proliferation_NN induced_VVN by_II insulin_NN and_CC epidermal_JJ growth_NN factor_NN ._.
P09730903A01
We_PN investigated_VVD the_DD effects_NNS of_II D1_NN dopamine_NN receptor_NN stimulation_NN on_II the_DD activation_NN of_II mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) in_II SK-N-MC_NN human_NN neuroblastoma_NN cells_NNS ._.
P09733758A01
Three_MC adrenergic_JJ receptor_NN families_NNS that_PNR selectively_RR activate_VVB three_MC different_JJ G_NN proteins_NNS (_( alpha1_NN /_SYM Gq_NN /_SYM 11_MC ,_, alpha2_NN /_SYM Gi_NN ,_, and_CC beta_NN /_SYM Gs_NN )_) were_VBD used_VVN to_TO study_VVI mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) activation_NN and_CC differentiation_NN in_II PC12_NN cells_NNS ._.
P09755064A05
Elimination_NN of_II the_DD Ets_NN motifs_NNS adjacent_JJ to_II key_JJ regulatory_JJ serum_NN response_NN elements_NNS in_II the_DD Egr-1_NN promoter_NN diminished_VVD the_DD effect_NN of_II hypotonicity_NN but_CC failed_VVN to_TO abolish_VVI it_PN ._.
P09758646A01
Two_MC subgroups_NNS of_II mitogen-activated_VVNJ protein_NN kinases_NNS ,_, c-jun_NN NH2-terminal_JJ kinase_NN (_( JNK_NN )_) and_CC extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) ,_, are_VBB thought_VVN to_TO be_VBI involved_VVN in_II cultured_VVNJ cardiac_JJ myocyte_NN hypertrophy_NN and_CC gene_NN expression_NN ._.
P09765228A06
Phosphorylation_NN of_II ERK_NN in_II response_NN to_II CCh_NN was_VBD mimicked_VVN by_II the_DD protein_NN kinase_NN C_NN (_( PKC_NN )_) activator_NN ,_, phorbol_NN myristate_NN acetate_NN (_( 100_MC nM_NN )_) ,_, but_CC was_VBD not_RR altered_VVN by_II the_DD PKC_NN inhibitor_NN GF_NN 109203X_NN (_( 1_MC microM_NN )_) ._.
P09765295A03
The_DD molecular_JJ events_NNS that_PNR follow_VVB and_CC that_PNR transduce_VVB signals_NNS from_II these_DD receptors_NNS to_II the_DD nucleus_NN are_VBB still_RR poorly_RR defined_VVN ._.
P09766635A04
JNKs_NNS were_VBD not_RR stimulated_VVN by_II TNF-alpha_NN or_CC GM-CSF_NN ._.
P09766656A10
Thus_RR ,_, intracellular_JJ porphyrins_NNS synthesized_VVN from_II ALA_NN are_VBB sufficient_JJ to_TO elicit_VVI activation_NN of_II p38_NN on_II photosensitization_NN ._.
P09768359A10
Nuclear_JJ export_NN of_II p38_NN and_CC MAPKAP_NN kinase-2_NN may_VM permit_VVB them_PN to_TO phosphorylate_VVI substrates_NNS in_II the_DD cytoplasm_NN ._.
P09769323A09
These_DD data_NNS are_VBB the_DD first_JJ demonstration_NN that_CST the_DD SAPKs_NNS are_VBB necessary_JJ for_II the_DD development_NN of_II agonist-induced_VVNJ cardiomyocyte_NN hypertrophy_NN ,_, and_CC suggest_VVB that_CST in_II response_NN to_II ET-1_NN ,_, they_PN transduce_VVB critical_JJ signals_NNS governing_VVG the_DD hypertrophic_JJ response_NN ._.
P09770423A05
Studies_NNS with_II selective_JJ MAPK_NN inhibitors_NNS revealed_VVD that_CST p38_NN was_VBD the_DD main_JJ inducer_NN of_II junB_NN expression_NN ,_, whereas_CS both_DD MAPK_NN pathways_NNS were_VBD involved_VVN in_II the_DD induction_NN of_II c-fos_NN ._.
P09771965A08
In_II contrast_NN ,_, agents_NNS that_PNR did_VDD not_RR have_VHB this_DD marked_VVNJ effect_NN did_VDD not_RR increase_VVB MCL1_NN ._.
P09774360A06
In_II addition_NN ,_, PD_NN 098059_MC ,_, an_DD antagonist_NN of_II MEK_NN (_( MAP_NN kinase_NN /_SYM ERK_NN kinase_NN )_) ,_, the_DD upstream_JJ kinase_NN of_II ERK_NN ,_, significantly_RR reduced_VVD the_DD PDGF-induced_VVNJ activation_NN of_II ERK_NN and_CC potently_RR inhibited_VVD the_DD expression_NN of_II MKP-1_NN after_II stimulation_NN with_II PDGF_NN ,_, thereby_RR demonstrating_VVG the_DD induction_NN of_II MKP-1_NN in_II response_NN to_II activation_NN of_II the_DD ERK_NN signaling_VVGJ cascade_NN ._.
P09774447A07
Paclitaxel_NN activated_VVD JNK_NN ,_, and_CC to_II a_DD lesser_JJR degree_NN p38_NN ,_, but_CC not_RR ERK1_NN ._.
P09776729A07
In_II contrast_NN ,_, the_DD specific_JJ p38_NN antagonist_NN SKF-86002_NN increased_VVD Na+_NN /_SYM H+_NN exchange_NN ._.
P09779822A03
We_PN found_VVD that_CST not_RR only_RR the_DD DNA_NN fragmentation_NN induced_VVN by_II 1_MC microM_NN Hg2+_NN but_CC also_RR the_DD cell_NN death_NN bypassing_VVGJ DNA_NN fragmentation_NN caused_VVN by_II 10_MC microM_NN or_CC more_DD Hg2+_NN was_VBD partly_RR inhibited_VVN by_II protein_NN kinase_NN inhibitors_NNS such_II+ as_II staurosporine_NN and_CC herbimycin_NN A_NN ._.
P09790955A02
The_DD aim_NN of_II this_DD study_NN was_VBD to_TO define_VVI the_DD role_NN of_II inducible_JJ phosphatases_NNS in_II ERK_NN MAPK_NN regulation_NN in_II cardiac_JJ myocytes_NNS ._.
P09792916A07
Thus_RR ,_, this_PND is_VBZ the_DD first_JJ report_NN showing_VVG that_CST LPA_NN induces_VVZ not_RR only_RR ERK_NN activation_NN but_CC also_RR JNK_NN activation_NN ,_, which_PNR may_VM be_VBB responsible_JJ for_II the_DD induction_NN of_II DNA_NN synthesis_NN in_II LPA-stimulated_VVNJ Swiss_NN 3T3_NN fibroblasts_NNS ._.
P09804610A04
SB_NN 203,580_MC ,_, an_DD inhibitor_NN of_II p38_NN ,_, significantly_RR attenuated_VVD phenylephrine-_NN and_CC anisomycin-induced_VVNJ ERK_NN inhibition_NN ._.
P09809995A06
Importantly_RR ,_, the_DD p36_NN MBP_NN kinase_NN was_VBD immunologically_RR different_JJ from_II MAPK_NN superfamily_NN molecules_NNS such_II+ as_II ERK1_NN ,_, JNK_NN isoforms_NNS ,_, and_CC p38_NN MAPK_NN ._.
P09811332A06
Anaplastic_JJ progression_NN in_II oligodendrogliomas_NNS resulted_VVD in_II a_DD larger_JJR number_NN of_II cells_NNS with_II active_JJ ERK_NN /_SYM MAPK_NN ._.
P09813041A01
Growth_NN hormone_NN (_( GH_NN )_) ,_, a_DD major_JJ regulator_NN of_II normal_JJ body_NN growth_NN and_CC metabolism_NN ,_, regulates_VVZ cellular_JJ gene_NN expression_NN ._.
P09815259A05
The_DD activation_NN of_II JNK_NN in_II these_DD cells_NNS appears_VVZ to_TO be_VBI mediated_VVN by_II the_DD MAP_NN kinase_NN kinase_NN MKK7_NN since_CS high_JJ levels_NNS of_II MKK7_NN and_CC low_JJ levels_NNS of_II Sek-1_NN /_SYM MKK4_NN gene_NN expression_NN were_VBD detected_VVN in_II thymocytes_NNS ._.
P09822700A09
Again_RR ,_, MHV-3_NN exposure_NN led_VVD to_II increased_VVNJ p38_NN and_CC ERK_NN tyrosine_NN phosphorylation_NN ._.
P09822710A08
These_DD results_NNS indicate_VVB that_CST cholesterol_NN or_CC cholesterol-sensitive_JJ compartments_NNS in_II the_DD plasma_NN membrane_NN play_VVB a_DD selective_JJ and_CC essential_JJ role_NN in_II activation_NN of_II ERK_NN ,_, but_CC not_RR JNK_NN ,_, by_II shear_NN stress_NN ._.
P09822758A10
It_PN was_VBD concluded_VVN that_CST ERK_NN and_CC JNK_NN are_VBB specifically_RR and_CC differentially_RR activated_VVN in_II the_DD insular_JJ cortex_NN after_II exposure_NN to_II a_DD novel_JJ taste_NN ,_, and_CC that_CST this_DD activation_NN is_VBZ required_VVN for_II consolidation_NN of_II long-term_NN taste_NN memory_NN ._.
P09832564A10
In_II contrast_NN to_II its_PNG effects_NNS on_II ERK_NN ,_, PTEN_NN expression_NN did_VDD not_RR affect_VVB c-Jun_NN NH2-terminal_JJ kinase_NN (_( JNK_NN )_) or_CC PDGF-stimulated_VVNJ Akt_NN ._.
P09837905A04
Specific_JJ inhibitors_NNS of_II cyclooxygenase-_NN ,_, lipoxygenase-_NN ,_, and_CC cytochrome_NN P450-dependent_JJ metabolism_NN did_VDD not_RR affect_VVB AA-induced_VVNJ MKP-1_NN expression_NN ,_, indicating_VVG that_CST eicosanoid_NN biosynthesis_NN was_VBD not_RR involved_VVN in_II this_DD process_NN ._.
P09845339A05
Although_CS it_PN had_VHD little_DD or_CC no_DD effect_NN on_II the_DD activity_NN of_II c-Jun_NN N-terminal_JJ kinase_NN ,_, isoproterenol_NN and_CC a_DD number_NN of_II other_JJ treatments_NNS which_PNR activated_VVD p38_NN MAPK_NN were_VBD found_VVN to_TO stimulate_VVI AMP-activated_VVNJ protein_NN kinase_NN in_II fat_NN cells_NNS ._.
P09847406A06
Reverse_JJ transcription-PCR_NN and_CC sequencing_VVGJ analysis_NN of_II the_DD respective_JJ amplicon_NN clearly_RR demonstrates_VVZ that_CST CeTRAF_NN is_VBZ in_II fact_NN transcribed_VVD in_II C._NN elegans_NN ._.
P09850168A04
IgG-SA_NN stimulated_VVD a_DD maximal_JJ ERK_NN activity_NN at_II 30_MC min_NN ,_, whereas_CS p38_NN activity_NN was_VBD maximal_JJ at_II 5_MC min_NN ._.
P09862461A02
However_RR ,_, the_DD G_NN alpha_NN i2-mediated_VVNJ mitogenic_JJ signaling_VVGJ pathways_NNS remain_VVB to_TO be_VBI elucidated_VVN ._.
P09867813A07
We_PN failed_VVD to_TO observe_VVI any_DD significant_JJ induction_NN and/or_CC modulation_NN of_II the_DD A-Raf_NN ,_, B-Raf_NN or_CC c-Raf-1_NN kinase_NN activities_NNS ,_, thus_RR suggesting_VVG the_DD existence_NN of_II a_DD MEK_NN kinase_NN different_JJ from_II the_DD classical_JJ Raf_NN kinases_NNS that_PNR directly_RR or_CC indirectly_RR can_VM be_VBB modulated_VVN by_II Ca2+_NN /_SYM calmodulin_NN ._.
P09867839A09
Importantly_RR ,_, we_PN found_VVD that_CST p38_NN MAPK_NN was_VBD essential_JJ for_II stabilizing_VVGN COX-2_NN mRNA_NN :_: when_CS cells_NNS stimulated_VVN for_II 4_MC h_NN with_II LPS_NN were_VBD treated_VVN with_II actinomycin_NN D_NN ,_, COX-2_NN mRNA_NN decayed_VVD slowly_RR ._.
P09874178A03
MAPK_NN signaling_VVGN was_VBD determined_VVN by_II assessing_VVGN MEK_NN (_( also_RR referred_VVN to_II as_II MAPK_NN kinase_NN )_) activity_NN by_II measuring_VVGN phosphorylated_VVNJ extracellular_JJ signal-regulated_VVNJ kinase_NN (_( pp44ERK_NN -_: 1_MC and_CC pp42ERK_NN -_: 2_MC )_) expression_NN ,_, and_CC ERK_NN activity_NN by_II measuring_VVGN ERK-2-dependent_JJ phosphorylation_NN of_II myelin_NN basic_JJ protein_NN (_( MBP_NN )_) ._.
P09880523A03
The_DD present_JJ study_NN was_VBD undertaken_VVN to_TO explore_VVI whether_CST TL1_NN induces_VVZ apoptosis_NN in_II endothelial_JJ cells_NNS and_CC ,_, if_CS so_RR ,_, to_TO explore_VVI its_PNG mechanism_NN of_II action_NN ._.
P09886415A08
Collectively_RR ,_, these_DD findings_NNS support_VVB the_DD involvement_NN of_II p46_NN JNK_NN /_SYM SAPK_NN and_CC its_PNG upstream_JJ kinases_NNS in_II regulating_VVGN the_DD induction_NN of_II iNOS_NN following_VVG ligation_NN of_II the_DD TNF-alpha_NN receptor_NN CD120a_NN (_( p55_NN )_) in_II the_DD presence_NN of_II IFN-gamma_NN ._.
P09890973A01
The_DD yeast_NN serine_NN /_SYM threonine_NN kinase_NN STE20_NN activates_VVZ a_DD signaling_VVGJ cascade_NN that_PNR includes_VVZ STE11_NN (_( mitogen-activated_VVNJ protein_NN kinase_NN kinase_NN kinase_NN )_) ,_, STE7_NN (_( mitogen-activated_VVNJ protein_NN kinase_NN kinase_NN )_) ,_, and_CC FUS3_NN /_SYM KSS1_NN (_( mitogen-activated_VVNJ protein_NN kinase_NN )_) in_II response_NN to_II signals_NNS from_II both_CC Cdc42_NN and_CC the_DD heterotrimeric_JJ G_NN proteins_NNS associated_VVN with_II transmembrane_JJ pheromone_NN receptors_NNS ._.
P09892211A01
Epidermal_JJ growth_NN factor_NN (_( EGF_NN )_) and_CC insulin-like_JJ growth_NN factor_NN I_MC (_( IGF-I_NN )_) are_VBB potent_JJ mitogens_NNS that_PNR regulate_VVB proliferation_NN of_II prostate_NN cancer_NN cells_NNS via_II autocrine_JJ and_CC paracrine_JJ loops_NNS and_CC promote_VVB tumor_NN metastasis_NN ._.
P09892211A13
Moreover_RR ,_, our_PNG results_NNS demonstrate_VVB that_CST selective_JJ blockade_NN of_II the_DD EGF_NN receptor_NN in_II prostate_NN cancer_NN cells_NNS does_VDZ not_RR only_RR inhibit_VVB the_DD action_NN of_II EGF_NN ,_, but_CC also_RR IGF-I-induced_VVNJ activation_NN of_II the_DD MAPK_NN pathway_NN and_CC the_DD interaction_NN with_II the_DD PKA_NN pathway_NN ._.
P09916683A04
MAPK-activated_VVNJ protein_NN kinase-2_NN (_( MAPKAPK-2_NN )_) ,_, an_DD in_JJ+ vivo_JJ substrate_NN for_II p38_NN ,_, was_VBD also_RR activated_VVN by_II T_NN cell_NN signaling_VVGN ._.
P09920737A08
The_DD levels_NNS of_II proliferating_VVGJ cell_NN nuclear_JJ antigen_NN (_( PCNA_NN )_) protein_NN as_II a_DD marker_NN for_II cell_NN proliferation_NN were_VBD induced_VVN at_II 2_MC h_NN and_CC significantly_RR increased_VVN to_II 24_MC h_NN after_II the_DD injection_NN ._.
P09923649A01
Collagenase-1_NN (_( matrix_NN metalloproteinase-1_NN ,_, MMP-1_NN )_) is_VBZ expressed_VVN by_II several_JJ types_NNS of_II cells_NNS ,_, including_VVG fibroblasts_NNS ,_, and_CC apparently_RR plays_VVZ an_DD important_JJ role_NN in_II the_DD remodeling_VVGN of_II collagenous_JJ extracellular_JJ matrix_NN in_II various_JJ physiologic_JJ and_CC pathologic_JJ situations_NNS ._.
P09927616A06
In_II addition_NN ,_, BRL_NN 37344_MC and_CC propranolol_NN ,_, ligands_NNS that_PNR act_VVB as_II agonists_NNS in_II the_DD stimulation_NN of_II cyclase_NN ,_, act_VVB as_II antagonists_NNS for_II ERK_NN activation_NN ._.
P09927621A06
The_DD Ca++_NN chelator_NN bis_JJ (_( 2-aminophenoxy_NN )_) ethane-N-N-N'-N'-tetraacetate_NN (_( BAPTA_NN )_) dose_NN dependently_RR abolished_VVD NE-stimulated_VVNJ Ca++_NN responses_NNS but_CC not_RR ERK_NN or_CC JNK_NN activation_NN ._.
P09928003A08
These_DD observations_NNS suggest_VVB that_CST PACAP_NN and_CC IL-6_NN act_VVB to_TO inhibit_VVI the_DD JNK_NN /_SYM SAPK_NN signaling_VVGJ pathway_NN ,_, thereby_RR protecting_VVG neurons_NNS against_II apoptosis_NN ._.
P09931118A06
Dominant-negative_JJ mutants_NNS of_II Ras_NN and_CC Rac_NN inhibited_VVD IL-1beta-stimulated_VVNJ hBNP_NN luciferase_NN activity_NN by_II 64_MC %_SYM and_CC 90_MC %_SYM ,_, respectively_RR ._.
P09931133A11
Furthermore_RR ,_, Ang_NN II_MC and_CC HG_NN combined_VVN had_VHD additive_JJ effects_NNS on_II AP-1_NN activity_NN ._.
P09933603A04
We_PN show_VVB that_CST ,_, like_II ERK_NN and_CC JNK_NN activation_NN ,_, activation_NN of_II p38_NN and_CC its_PNG downstream_JJ substrate_NN MAP_NN kinase-activated_VVNJ protein_NN kinase_NN 2_MC by_II interleukin-3_NN or_CC G-CSF_NN requires_VVZ Ras_NN activation_NN ._.
P09933636A06
These_DD results_NNS show_VVB for_II the_DD first_JJ time_NN that_CST SAPK2_NN /_SYM p38_NN plays_VVZ an_DD essential_JJ role_NN in_II C2C12_NN cell_NN differentiation_NN ._.
P09973482A04
Addition_NN of_II Ag_NN (_( OVA_NN )_) to_II mouse_NN bone_NN marrow-derived_VVNJ mast_JJ cells_NNS (_( BMMC_NN )_) sensitized_VVN with_II anti-OVA_NN IgE_NN triggers_VVZ the_DD activation_NN of_II three_MC members_NNS of_II the_DD mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN family_NN ,_, c-Jun_NN amino-terminal_JJ kinase_NN (_( JNK_NN )_) ,_, p38_NN MAP_NN kinase_NN (_( p38_NN )_) ,_, and_CC extracellular_JJ signal-regulated_VVNJ kinases_NNS ._.
P09988712A07
Inhibition_NN of_II receptor_NN endocytosis_NN by_II use_NN of_II sequestration-defective_JJ mutants_NNS of_II beta-arrestin1_NN and_CC dynamin_NN attenuated_VVD 5-HT1A_NN receptor-stimulated_VVNJ Erk1_NN /_SYM 2_MC activation_NN ._.
P10021319A09
Interestingly_RR ,_, there_EX is_VBZ a_DD second_JJ delayed_VVNJ peak_NN of_II p44-MAPK_NN activation_NN after_II 4-24_MC h_NN of_II stimulation_NN with_II NO_NN donors_NNS ._.
P10036133A06
The_DD assay_NN was_VBD optimized_VVN and_CC the_DD K0.5_NN value_NN for_II ATP_NN was_VBD found_VVN to_TO be_VBI 0.9_MC microM_NN and_CC the_DD Km_NN for_II stathmin_NN was_VBD determined_VVN to_TO be_VBI 16_MC microM_NN ._.
P10037715A01
Cellular_JJ ischemia_NN results_VVZ in_II activation_NN of_II a_DD number_NN of_II kinases_NNS ,_, including_VVG p38_NN mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) ;_: however_RR ,_, it_PN is_VBZ not_RR yet_RR clear_JJ whether_CST p38_NN MAPK_NN activation_NN plays_VVZ a_DD role_NN in_II cellular_JJ damage_NN or_CC is_VBZ part_NN of_II a_DD protective_JJ response_NN against_II ischemia_NN ._.
P10037749A03
Using_VVG the_DD mitogen-activated_VVNJ protein_NN kinase_NN kinase_NN (_( MEK1_NN /_SYM 2_MC )_) inhibitor_NN PD98059_NN and_CC dominant_JJ negative_JJ forms_NNS of_II Ras_NN (_( N17_NN )_) and_CC ERK1_NN (_( K71R_NN )_) ,_, we_PN found_VVD that_CST activation_NN of_II Ras_NN and_CC extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) is_VBZ necessary_JJ for_II colony-stimulating_VVGJ factor-1_NN (_( CSF-1_NN )_) -mediated_VVNJ c-Myc_NN expression_NN and_CC DNA_NN synthetic_JJ (_( S_NN )_) phase_NN entry_NN ._.
P10051431A06
Agonist-stimulated_VVNJ Ins_NN (_( 1_MC ,_, 4_MC ,_, 5_MC )_) P3_NN accumulation_NN in_II CHO-m3_NN cells_NNS was_VBD insensitive_JJ to_II pertussis_NN toxin_NN (_( PTX_NN )_) ,_, consistent_JJ with_II a_DD Gq_NN /_SYM phosphoinositide-specific_JJ phospholipase_NN C-beta_NN mediated_VVNJ pathway_NN ,_, whereas_CS a_DD significant_JJ component_NN of_II ERK_NN and_CC JNK_NN activation_NN in_II CHO-m3_NN cells_NNS was_VBD PTX-sensitive_JJ ,_, indicating_VVG Gi_NN /_SYM o_NN involvement_NN ._.
P10066377A06
VEGF_NN activated_VVD the_DD phosphorylation_NN of_II extracellular_JJ signal_NN regulated_VVNJ kinase_NN (_( ERK_NN )_) 1_MC (_( p44_NN mitogen-activated_VVNJ protein_NN kinase_NN ;_: MAPK_NN )_) and_CC ERK2_NN (_( p42_NN MAPK_NN )_) in_II a_DD time-_NN and_CC concentration-dependent_JJ manner_NN ._.
P10066421A06
PTPBR7_NN made_VVD complexes_NNS with_II ERK1_NN /_SYM ERK2_NN in_RR+ vivo_RR and_CC dephosphorylated_VVD ERK1_NN in_RR+ vitro_RR ._.
P10067836A03
GLP-1_NN increased_VVD p38_NN MAP_NN kinase_NN activity_NN 2.5-_MC and_CC 2.0-fold_NN over_II the_DD basal_JJ level_NN in_II both_CC CHO_NN /_SYM GLPR_NN cells_NNS and_CC rat_NN insulinoma_NN cells_NNS (_( RIN_NN 1046-38_MC )_) ,_, respectively_RR ._.
P10068590A03
Dose-related_VVNJ inhibition_NN of_II iNOS_NN production_NN was_VBD demonstrated_VVN when_CS inhibitors_NNS were_VBD added_VVN 1_MC h_NN before_II ,_, simultaneously_RR with_II ,_, or_CC 1_MC h_NN after_II LPS_NN plus_CC rIFN-gamma_NN stimulation_NN ._.
P10082472A04
[_( Ca2+_NN ]_) i_NN and_CC pHi_NN were_VBD measured_VVN by_II fura-2_NN and_CC BCECF_NN methodology_NN ,_, respectively_RR ,_, and_CC contraction_NN was_VBD determined_VVN by_II photomicroscopy_NN ._.
P10085241A03
This_DD phenomenon_NN occurs_VVZ even_RR though_CS HaCaT_NN cells_NNS remain_VVB proliferatively_RR responsive_JJ to_II both_DD agonists_NNS ,_, suggesting_VVG a_DD HaCaT-specific_JJ defect_NN in_II a_DD PMA-mediated_VVNJ signal_NN transduction_NN pathway_NN ._.
P10086335A09
Thus_RR ,_, we_PN suggest_VVB that_CST constitutive_JJ activation_NN of_II the_DD Raf_NN /_SYM MEK_NN /_SYM ERK_NN and_CC JNK_NN pathways_NNS is_VBZ necessary_JJ for_II Ras-induced_VVNJ transformation_NN of_II HT1080_NN but_CC not_RR DLD-1_NN cells_NNS ._.
P10089132A05
SB_NN 203580_MC ,_, a_DD selective_JJ p38_NN kinase_NN inhibitor_NN ,_, was_VBD used_VVN to_TO examine_VVI the_DD role_NN of_II p38_NN kinase_NN in_II MCP-1_NN expression_NN ._.
P10092315A02
METHODS_NNS :_: The_DD role_NN of_II mitogen-activated_VVNJ protein_NN kinases_NNS for_II proteolysis_NN control_NN was_VBD studied_VVN in_II perfused_VVNJ rat_NN liver_NN ._.
P10098852A01
Nitric_JJ oxide_NN (_( NO_NN )_) is_VBZ a_DD signaling_VVGJ molecule_NN that_PNR mediates_VVZ several_JJ physiological_JJ processes_NNS in_II a_DD range_NN of_II cell_NN and_CC tissue_NN types_NNS ._.
P10196203A09
In_II conclusion_NN ,_, this_DD study_NN demonstrates_VVZ that_CST the_DD ERK_NN pathway_NN is_VBZ required_VVN for_II AICD_NN of_II T_NN cells_NNS and_CC appears_VVZ to_TO regulate_VVI the_DD induction_NN of_II Nur77_NN and_CC FasL_NN expression_NN during_II AICD_NN ._.
P10196228A06
Using_VVG stably_RR transfected_VVNJ RAW_NN 264.7_MC cells_NNS with_II the_DD kinase-deleted_VVNJ dominant-negative_JJ mutant_NN of_II TbetaR-II_NN (_( TbetaR-IIM_NN )_) cDNA_NN ,_, we_PN demonstrate_VVB that_CST this_DD protective_JJ effect_NN by_II TGF-beta1_NN is_VBZ completely_RR abrogated_VVN ._.
P10202013A04
We_PN found_VVD that_CST amino_JJ acids_NNS 35-45_MC of_II the_DD CD40_NN cytoplasmic_JJ domain_NN constitute_VVB an_DD independent_JJ signaling_VVGJ motif_NN that_PNR is_VBZ sufficient_JJ for_II activation_NN of_II the_DD JNK_NN and_CC p38_NN MAPK_NN pathways_NNS ,_, as_CC+ well_CC+ as_CC for_II induction_NN of_II I_NN kappa_NN B_NN alpha_NN phosphorylation_NN and_CC degradation_NN ._.
P10202034A07
We_PN conclude_VVB that_CST okadaic_JJ acid-induced_VVNJ IL-6_NN gene_NN expression_NN is_VBZ at_RR+ least_RR partly_RR mediated_VVN through_II the_DD ERK1_NN /_SYM 2_MC and_CC JNK_NN pathway-dependent_JJ activation_NN of_II NF-kappa_NN B_NN transcriptional_JJ capacity_NN ._.
P10202148A06
We_PN conclude_VVB that_CST the_DD p38_NN MAP_NN kinase_NN ,_, activated_VVN through_II MKK3_NN ,_, is_VBZ required_VVN for_II the_DD production_NN of_II inflammatory_JJ cytokines_NNS by_II both_CC antigen-presenting_VVGJ cells_NNS and_CC CD4_NN (_( +_SYM )_) T_NN cells_NNS ._.
P10207024A10
These_DD data_NNS indicate_VVB that_CST constitutive_JJ beta3AR_NN coupling_VVGN to_II Gi_NN proteins_NNS serves_VVZ both_CC to_TO restrain_VVI Gs-mediated_VVNJ activation_NN of_II adenylyl_NN cyclase_NN and_CC to_TO initiate_VVI additional_JJ signal_NN transduction_NN pathways_NNS ,_, including_VVG the_DD ERK1_NN /_SYM 2_MC MAP_NN kinase_NN cascade_NN ._.
P10207619A02
The_DD multiplicity_NN of_II these_DD pathways_NNS allows_VVZ the_DD cell_NN to_TO respond_VVI to_II divergent_JJ extracellular_JJ stimuli_NNS by_II initiating_VVGN a_DD broad_JJ array_NN of_II responses_NNS ranging_VVG from_II cell_NN growth_NN to_II apoptosis_NN ._.
P10212278A06
Here_RR ,_, we_PN describe_VVB the_DD transient_JJ activation_NN of_II SAPK_NN /_SYM JNKs_NNS by_II tumor-like_JJ hypoxia_NN ,_, and_CC the_DD concurrent_JJ transcriptional_JJ activation_NN of_II MKP-1_NN ,_, a_DD stress-inducible_JJ member_NN of_II the_DD MAPK_NN phosphatase_NN (_( MKP_NN )_) family_NN of_II dual_JJ specificity_NN protein-tyrosine_NN phosphatases_NNS ._.
P10216124A05
Culture_NN of_II hepatocytes_NNS with_II glucagon_NN for_II 16_MC hours_NNS also_RR inhibited_VVD the_DD stimulation_NN by_II EGF_NN of_II activation_NN of_II ERK2_NN and_CC p70_NN (_( S6k_NN )_) (_( by_II approximately_RR 50_MC %_SYM )_) ._.
P10218497A05
Protein-bound_VVNJ 3-nitrotyrosine_NN was_VBD detected_VVN ._.
P10221768A01
The_DD expression_NN of_II the_DD p38_NN subfamily_NN of_II mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) was_VBD examined_VVN in_II rat_NN islets_NNS of_II Langerhans_NN and_CC pancreatic_JJ beta-cell_NN lines_NNS ,_, and_CC its_PNG involvement_NN in_II the_DD regulation_NN of_II insulin_NN secretion_NN was_VBD investigated_VVN ._.
P10224067A03
TGF-beta_NN treatment_NN resulted_VVD in_II a_DD time-dependent_JJ activation_NN of_II HPK1_NN ,_, which_PNR was_VBD accompanied_VVN by_II similar_JJ kinetics_NNS of_II JNK1_NN activation_NN ._.
P10224117A02
Although_CS mammalian_JJ MAPKs_NNS are_VBB most_RRT abundantly_RR expressed_VVN in_II postmitotic_JJ and_CC terminally_RR differentiated_VVNJ neuronal_JJ cells_NNS ,_, their_PNG function_NN in_II the_DD central_JJ nervous_JJ system_NN is_VBZ still_RR largely_RR undefined_VVNJ ._.
P10226075A03
Kinase_NN activity_NN for_II MEK1_NN was_VBD assessed_VVN by_II in_JJ+ vitro_JJ phosphorylation_NN assay_NN ._.
P10318806A08
Finally_RR ,_, the_DD expression_NN of_II dominant-negative_JJ Ras_NN but_CC not_RR dominant-negative_JJ Rac_NN inhibited_VVD p38_NN activation_NN by_II PDGF_NN ,_, suggesting_VVG that_CST Ras_NN is_VBZ a_DD potent_JJ mediator_NN in_II the_DD p38_NN activation_NN pathway_NN downstream_JJ of_II PDGF_NN receptors_NNS ._.
P10321726A05
To_II this_DD end_NN ,_, we_PN examined_VVD changes_NNS in_II cellular_JJ morphology_NN and_CC MAPK_NN activation_NN in_II NE-stimulated_VVNJ BEC_NN monolayer_NN ,_, and_CC the_DD effect_NN of_II PD_NN 98059_MC as_II the_DD specific_JJ inhibitor_NN for_II MAPK_NN kinase-1_NN (_( MEK-1_NN ,_, the_DD upstream_JJ regulator_NN of_II MAPK_NN )_) on_II NE-induced_VVNJ changes_NNS in_II cellular_JJ morphology_NN and_CC MAPK_NN activation_NN ._.
P10329718A01
The_DD transcription_NN factor_NN Pax6_NN is_VBZ required_VVN for_II normal_JJ development_NN of_II the_DD central_JJ nervous_JJ system_NN ,_, the_DD eyes_NNS ,_, nose_NN ,_, and_CC pancreas_NN ._.
P10329725A01
Cellular_JJ calcium_NN (_( Ca2+_NN )_) and_CC the_DD Ca2+-binding_VVGJ protein_NN calmodulin_NN (_( CaM_NN )_) regulate_VVB the_DD activities_NNS of_II Ca2+_NN /_SYM CaM-dependent_JJ protein_NN kinases_NNS and_CC protein_NN phosphatase_NN 2B_NN (_( calcineurin_NN )_) ._.
P10330143A05
The_DD efficiency_NN of_II phosphorylation_NN in_RR+ vitro_RR and_CC transcriptional_JJ activation_NN in_RR+ vivo_RR of_II MEF2A_NN and_CC MEF2C_NN by_II these_DD p38_NN subtypes_NNS requires_VVZ the_DD presence_NN of_II a_DD kinase_NN docking_VVGJ domain_NN (_( D-domain_NN )_) ._.
P10330161A02
The_DD mechanisms_NNS responsible_JJ for_II these_DD different_JJ cellular_JJ fates_NNS are_VBB unclear_JJ ._.
P10330170A08
Moreover_RR ,_, in_II addition_NN to_II JNK_NN ,_, ERK5_NN ,_, p38alpha_NN ,_, and_CC p38gamma_NN were_VBD found_VVN to_TO stimulate_VVI the_DD c-jun_NN promoter_NN by_II acting_VVGN on_II distinct_JJ responsive_JJ elements_NNS ._.
P10331432A03
TUNEL-positive_JJ cells_NNS were_VBD present_JJ at_II all_DD stages_NNS studied_VVN until_II 7_MC days_NNS after_II injury_NN ,_, and_CC percentage_NN positivity_NN for_II these_DD cells_NNS was_VBD maximal_JJ at_II 3_MC days_NNS after_II injury_NN ._.
P10334038A02
Immunoblotting_VVGN using_VVG an_DD anti-phosphoMAPK_NN antibody_NN (_( Ab_NN )_) revealed_VVD that_CST anti-IgG_NN Ab_NN induced_VVD rapid_JJ phosphorylation_NN of_II MAPK_NN in_II the_DD cells_NNS ._.
P10336426A07
Safingol_NN ,_, a_DD selective_JJ inhibitor_NN for_II PKCalpha_NN ,_, did_VDD not_RR show_VVB any_DD inhibitory_JJ effect_NN on_II UVB-induced_VVNJ mitogen-activated_VVNJ protein_NN kinase_NN activation_NN ._.
P10336565A01
The_DD family_NN of_II basic_JJ secretagogues_NNS of_II connective_JJ tissue_NN mast_JJ cells_NNS act_VVB as_II receptor_NN mimetic_JJ agents_NNS ,_, which_PNR trigger_VVB exocytosis_NN by_II directly_RR activating_VVGN G_NN proteins_NNS ._.
P10336676A09
However_RR ,_, glutamate-stimulated_VVNJ ERK_NN activation_NN remained_VVD unaffected_VVN ._.
P10339476A02
We_PN investigated_VVD whether_CST this_DD failure_NN of_II IL-4_NN to_TO promote_VVI growth_NN was_VBD because_II+ of_II its_PNG unique_JJ inability_NN to_TO activate_VVI the_DD Ras_NN /_SYM Raf_NN /_SYM Erk_NN pathway_NN ._.
P10340949A09
Together_RR ,_, these_DD data_NNS suggest_VVB that_CST in_II bovine_JJ tracheal_JJ myocytes_NNS :_: (_( 1_MC )_) activation_NN of_II MAPK_NN by_II PDGF_NN is_VBZ dependent_JJ on_II Ras_NN ;_: (_( 2_MC )_) active_JJ Ras_NN is_VBZ sufficient_JJ for_II ERK_NN activation_NN but_CC is_VBZ insufficient_JJ for_II maximal_JJ activation_NN of_II JNK_NN or_CC p38_NN ;_: (_( 3_MC )_) activation_NN of_II Rac1_NN is_VBZ sufficient_JJ for_II maximal_JJ JNK_NN activation_NN ;_: and_CC (_( 4_MC )_) Ras_NN ,_, MEK_NN ,_, and_CC ERK_NN constitute_VVB a_DD distinct_JJ pathway_NN to_II cyclin_NN D1_NN transcriptional_JJ activation_NN ._.
P10347160A03
Mutational_JJ analysis_NN of_II the_DD LMP1_NN cytoplasmic_JJ COOH_NN terminus_NN revealed_VVD that_CST p38_NN activation_NN occurs_VVZ from_II both_CC the_DD tumor_NN necrosis_NN factor_NN receptor-associated_VVNJ factor_NN (_( TRAF_NN )_) -interacting_VVGJ ,_, membrane-proximal_JJ COOH-terminal_JJ activating_VVGJ region_NN (_( CTAR_NN )_) 1_MC domain_NN (_( amino_JJ acids_NNS 186-231_MC )_) and_CC the_DD extreme_JJ tumor_NN necrosis_NN factor_NN receptor-associated_VVNJ death_NN domain_NN (_( TRADD_NN )_) binding_VVGJ CTAR2_NN region_NN (_( amino_JJ acids_NNS 351-386_MC )_) ._.
P10349832A08
These_DD contrasting_VVGJ ionic_JJ dependencies_NNS suggest_VVB a_DD mechanism_NN by_II which_PNR NMDA_NN receptor_NN activation_NN may_VM ,_, under_II distinct_JJ conditions_NNS ,_, differentially_RR regulate_VVB neuronal_JJ MAPKs_NNS and_CC their_PNG divergent_JJ functions_NNS ._.
P10354505A10
Furthermore_RR ,_, downregulation_NN of_II LPS-uptake_NN in_II LPS-tolerant_JJ macrophages_NNS was_VBD not_RR observed_VVN ._.
P10356298A04
Neurite_NN outgrowth_NN induced_VVN by_II bFGF_NN ,_, LN_NN ,_, or_CC N-cadherin_NN was_VBD strongly_RR inhibited_VVN by_II treatment_NN with_II inhibitors_NNS of_II ERK_NN kinase_NN activation_NN ,_, but_CC not_RR by_II an_DD inhibitor_NN of_II p38_NN MAPK_NN ._.
P10359012A03
The_DD activity_NN of_II JNK1_NN was_VBD also_RR significantly_RR induced_VVN ,_, with_II JNK1_NN protein_NN levels_NNS increasing_VVGN moderately_RR during_II exposure_NN to_II TPA_NN ._.
P10366004A07
The_DD time-course_NN of_II the_DD N-terminal_JJ phosphorylation_NN of_II c-Jun_NN as_CS determined_VVN by_II immunocytochemistry_NN paralleled_VVD the_DD activity_NN of_II c-Jun_NN N-terminal_JJ kinase_NN 1_MC and_CC showed_VVD a_DD compartment-specific_JJ regulation_NN between_II 3_MC and_CC 12_MC h_NN ._.
P10372920A05
The_DD phosphorylation_NN pattern_NN of_II extracellular_JJ regulated_VVNJ kinases_NNS (_( ERK_NN 1_MC /_SYM 2_MC )_) ,_, c-jun_NN N-terminal_JJ activated_VVNJ kinases_NNS (_( JNK_NN )_) and_CC p38_NN in_II PC12_NN cells_NNS is_VBZ strikingly_RR different_JJ ._.
P10374718A05
Both_DB these_DD responses_NNS were_VBD receptor_NN mediated_VVN as_II ,_, adrenomedullin-_NN (_( 22-52_MC )_) inhibited_VVD these_DD effects_NNS ._.
P10376935A10
Additional_JJ studies_NNS showed_VVD that_CST DADLE_NN stimulated_VVD an_DD increase_NN in_II cfos_NN mRNA_NN ;_: this_PND was_VBD reduced_VVN by_II the_DD inhibitor_NN of_II MAPK_NN /_SYM ERK_NN kinase_NN (_( MEK_NN )_) ,_, PD98059_NN ._.
P10380884A02
This_DD okadaic_JJ acid_NN mediated_VVNJ activation_NN of_II MAP_NN kinases_NNS correlated_VVD with_II increased_VVNJ AP-1_NN binding_VVGN to_II a_DD consensus_NN TPA_NN responsive_JJ element_NN (_( TRE_NN )_) and_CC elevated_VVNJ TRE_NN dependent_JJ transcription_NN ._.
P10381634A06
Likewise_RR ,_, activation_NN of_II JNKs_NNS was_VBD not_RR observed_VVN in_II etoposide-treated_VVNJ submandibular_JJ C6_NN cells_NNS ,_, and_CC the_DD amount_NN of_II activated_VVNJ ERK1_NN and_CC ERK2_NN decreased_VVD only_RR slightly_RR ._.
P10395291A08
Treatment_NN of_II HF_NN with_II PD98059_NN blocks_VVZ the_DD induction_NN of_II crystal-stimulated_VVNJ collagenase_NN 1_MC (_( MMP-1_NN )_) and_CC stromelysin_NN (_( MMP-3_NN )_) expression_NN ._.
P10395651A03
In_II this_DD study_NN ,_, using_VVG an_DD established_VVNJ FDC_NN line_NN ,_, HK_NN cells_NNS ,_, we_PN compared_VVD the_DD effects_NNS of_II CD40_NN and_CC TNF_NN receptor_NN triggering_VVGN on_II cytokine_NN induction_NN and_CC activation_NN of_II mitogen-activated_VVNJ protein_NN kinase_NN family_NN ._.
P10395662A05
These_DD data_NNS indicate_VVB that_CST there_EX is_VBZ discrimination_NN in_II the_DD biochemical_JJ pathways_NNS that_PNR are_VBB necessary_JJ to_TO specify_VVI CD4_NN and_CC CD8_NN lineage_NN commitment_NN and_CC can_VM reconcile_VVB previously_RR conflicting_VVGJ reports_NNS on_II the_DD influence_NN of_II MAPK_NN activation_NN in_II commitment_NN and_CC maturation_NN of_II thymocytes_NNS ._.
P10400419A03
Enhanced_VVNJ activity_NN of_II p38_NN and_CC JNK_NN was_VBD not_RR only_RR observed_VVN during_II apoptosis_NN but_CC also_RR in_II TF-1_NN cells_NNS stimulated_VVN with_II IL-1_NN ._.
P10401575A05
Both_CC endogenous_JJ and_CC over-expressed_VVNJ MEKK1_NN colocalized_VVD with_II alpha-actinin_NN along_II actin_NN stress_NN fibers_NNS and_CC at_II focal_JJ adhesions_NNS ._.
P10402237A05
We_PN found_VVD that_CST despite_II high_JJ levels_NNS of_II Ras-GTP_NN in_II each_DD cell_NN line_NN expressing_VVG mutant_JJ K-ras_NN ,_, elevated_VVNJ levels_NNS of_II active_JJ Erk1_NN and_CC Erk2_NN were_VBD not_RR detectable_JJ under_II conditions_NNS of_II exponential_JJ growth_NN or_CC serum-starvation_NN ._.
P10409243A05
In_II contrast_NN ,_, the_DD synthetic_JJ substrate_NN poly-D-lysine_NN conferred_VVD no_DD protection_NN ._.
P10413589A07
Expression_NN of_II the_DD type_NN II_MC collagen_NN gene_NN ,_, a_DD hallmark_NN of_II chondrogenesis_NN in_II vertebrates_NNS ,_, was_VBD also_RR induced_VVN by_II GDF-5_NN treatment_NN and_CC strongly_RR suppressed_VVN by_II SB202190_NN ._.
P10413591A03
The_DD effect_NN was_VBD dose-dependent_JJ in_II the_DD range_NN between_II 0.1_MC and_CC 30_MC microM_NN ._.
P10415025A10
A_DD small_JJ deletion_NN (_( aa_NN 1-46_MC )_) in_II the_DD N-terminal_JJ portion_NN of_II LC-PTP_NN or_CC Arg_NN to_II Ala_NN substitutions_NNS at_II aa_NN 41_MC and_CC 42_MC resulted_VVD in_II the_DD loss_NN of_II ERK_NN binding_VVGJ activity_NN ._.
P10428055A02
Treatment_NN with_II dibutyryl_NN cGMP_NN (_( DBcGMP_NN )_) dose-dependently_RR increased_VVD the_DD phosphorylation_NN of_II both_CC p44_NN and_CC p42_NN isoforms_NNS of_II MAPK_NN ._.
P10428774A09
Ectopic_JJ expression_NN of_II Delta_NN alpha_NN or_CC Y707A_NN resulted_VVD in_II increased_VVNJ basal_JJ phosphorylation_NN of_II pp140_NN compared_VVN with_II that_PND of_II WT_NN ,_, presenting_VVG the_DD possibility_NN that_CST pp140_NN is_VBZ a_DD novel_JJ RSK_NN substrate_NN ._.
P10432304A06
The_DD addition_NN of_II endothelin-1_NN resulted_VVD in_II the_DD phosphorylation_NN and_CC activation_NN of_II cPLA_NN (_( 2_MC )_) ._.
P10433244A08
Microinjection_NN of_II p85-SH2_NN and/or_CC catalytically_RR inactive_JJ MAP_NN kinase_NN (_( [_( K71A_NN ]_) Erk1_NN )_) GST_NN fusion_NN protein_NN gave_VVD the_DD same_JJ results_NNS as_CSN treatment_NN with_II wortmannin_NN and_CC PD98059_NN ._.
P10438726A06
Concurrent_JJ ligation_NN of_II CD22_NN and_CC BCR_NN enhanced_VVD BCR-mediated_VVNJ ERK-2_NN activation_NN without_II appreciably_RR modulating_VVGN CD22-induced_VVNJ SAPK_NN activation_NN ._.
P10440527A08
Thus_RR ,_, the_DD enhanced_VVNJ activation_NN of_II JNKs_NNS or_CC ERKs_NNS occurs_VVZ in_II various_JJ cardiovascular_JJ disease_NN models_NNS ,_, supporting_VVG the_DD notion_NN that_CST MAPKs_NNS may_VM be_VBB a_DD useful_JJ target_NN for_II treatment_NN of_II cardiovascular_JJ hypertrophy_NN and_CC remodeling_VVGN ._.
P10440934A08
Conversely_RR ,_, NIH3T3_NN and_CC K562_NN cells_NNS stably_RR overexpressing_VVG the_DD wild-type_NN ERK1_NN develop_VVB resistance_NN to_II killing_VVGN by_II heat_NN ._.
P10445668A01
We_PN report_VVB that_CST okadaic_JJ acid_NN (_( OA_NN )_) ,_, a_DD known_VVNJ inhibitor_NN of_II Ser_NN /_SYM Thr_NN phosphatases_NNS ,_, protects_VVZ pig_NN myocardium_NN against_II ischemic_JJ injury_NN in_II an_DD in_JJ+ vivo_JJ model_NN and_CC stimulates_VVZ the_DD activities_NNS of_II stress-activated_VVNJ protein_NN kinases_NNS /_SYM c-Jun_NN N-terminal_JJ kinases_NNS (_( SAPKs_NNS /_SYM JNKs_NNS )_) ._.
P10445797A03
DESIGN_NN :_: Pharmacological_JJ agents_NNS which_PNR selectively_RR interact_VVB with_II specific_JJ target_NN proteins_NNS involved_VVN in_II signal_NN transduction_NN through_II a_DD Gi-MAPK_NN pathway_NN have_VHB recently_RR become_VVB available_JJ ._.
P10447711A05
A_DD chemical_JJ inhibitor_NN of_II ERK_NN activation_NN ,_, PD_NN 098059_MC ,_, inhibits_VVZ ERK_NN activation_NN and_CC apoptosis_NN ,_, while_CS JNK_NN activation_NN is_VBZ not_RR inhibited_VVN ._.
P10454547A02
First_RR ,_, a_DD biphasic_JJ MEK_NN /_SYM ERK_NN activation_NN was_VBD evidenced_VVN in_II G_NN (_( 1_MC )_) phase_NN of_II hepatocytes_NNS from_II regenerating_VVGJ liver_NN but_CC not_RR from_II sham-operated_VVNJ control_NN animals_NNS ._.
P10454547A13
These_DD results_NNS allow_VVB us_PN to_TO point_VVI to_II a_DD growth_NN factor_NN dependency_NN in_II mid-late_JJ G_NN (_( 1_MC )_) phase_NN of_II proliferating_VVGJ hepatocytes_NNS in_RR+ vivo_RR as_CS observed_VVN in_RR+ vitro_RR in_II proliferating_VVGJ hepatocytes_NNS and_CC argue_VVB for_II a_DD crucial_JJ role_NN of_II the_DD MEK_NN /_SYM ERK_NN cascade_NN signalling_VVGJ pathway_NN ._.
P10455028A09
TGF-beta_NN (_( 1_MC )_) had_VHD no_DD effect_NN on_II the_DD expression_NN of_II c-myc_NN or_CC p27_NN (_( kip1_NN )_) and_CC weakly_RR attenuated_VVD the_DD expression_NN of_II cyclin_NN D_NN (_( 1_MC )_) ._.
P10455914A03
The_DD role_NN of_II p38_NN and_CC other_JJ MAPKs_NNS (_( ERK_NN and_CC SAPK_NN /_SYM JNK_NN )_) in_II regulating_VVGN PMN_NN apoptosis_NN after_II LPS_NN stimulation_NN is_VBZ unknown_VVN ._.
P10455916A03
Here_RR we_PN investigated_VVD the_DD effect_NN of_II mechanical_JJ injury_NN of_II endothelial_JJ cells_NNS on_II the_DD mitogen-activated_VVNJ kinase_NN signaling_VVGJ pathways_NNS ,_, extracellular-signal-regulated_VVNJ kinases_NNS (_( ERKs_NNS )_) ,_, C-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN /_SYM SAPK_NN )_) ,_, and_CC p38_NN ._.
P10471327A07
Low-dose_NN X-rays_NNS also_RR activated_VVD the_DD p38_NN MAPK_NN ._.
P10471813A01
We_PN have_VHB identified_VVN a_DD novel_JJ Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) -binding_VVGJ protein_NN ,_, termed_VVN JNKBP1_NN ,_, and_CC examined_VVN its_PNG binding_VVGJ affinity_NN for_II JNK1_NN ,_, JNK2_NN ,_, JNK3_NN ,_, and_CC extracellular_JJ signal-regulated_VVNJ kinase_NN 2_MC (_( ERK2_NN )_) in_II COS-7_NN cells_NNS ._.
P10472421A06
The_DD levels_NNS of_II a_DD dual_JJ specificity_NN tyrosine_NN phosphatase_NN ,_, MKP2_NN ,_, were_VBD significantly_RR decreased_VVN in_II cerebellar_JJ vermis_NN (_( 1716_MC +/-_SYM 465_MC versus_CC 2372_MC +/-_SYM 429_MC arbitrary_JJ units_NNS ,_, U_NN =_SYM 12_MC ,_, p_NN <_SYM .02_MC )_) from_II schizophrenic_JJ patients_NNS ._.
P10479400A08
PD98059_NN also_RR inhibited_VVD induction_NN of_II IL-2_NN by_II phorbol_NN 12-myristate_NN 13-acetate_NN (_( PMA_NN )_) ,_, and_CC AP1-linked_VVNJ reporter_NN gene_NN expression_NN in_II response_NN to_II PMA_NN but_CC not_RR IL-1_NN ._.
P10487205A02
This_PND results_VVZ in_II modification_NN of_II cellular_JJ gene_NN expression_NN ._.
P10488090A03
Treatment_NN of_II human_NN hepatoma_NN (_( HepG2_NN )_) and_CC murine_JJ hepatoma_NN (_( Hepa1c1c7_NN )_) cells_NNS with_II tert-butylhydroquinone_NN (_( tBHQ_NN )_) or_CC sulforaphane_NN (_( SUL_NN )_) ,_, two_MC potent_JJ phase_NN II_MC enzyme_NN inducers_NNS ,_, stimulated_VVD the_DD activity_NN of_II extracellular_JJ signal-regulated_VVNJ protein_NN kinase_NN 2_MC (_( ERK2_NN )_) but_CC not_RR c-Jun_NN N-terminal_JJ kinase_NN 1_MC ._.
P10488148A08
In_II contrast_NN ,_, all_PND of_II the_DD stimuli_NNS activated_VVD AP-1_NN via_II a_DD MAPK-dependent_JJ pathway_NN ._.
P10489373A04
YopJ-related_VVNJ proteins_NNS that_PNR are_VBB found_VVN in_II a_DD number_NN of_II bacterial_JJ pathogens_NNS of_II animals_NNS and_CC plants_NNS may_VM function_VVB to_TO block_VVI MKKs_NNS so_CS+ that_CS host_NN signaling_VVGJ responses_NNS can_VM be_VBB modulated_VVN upon_II infection_NN ._.
P10490955A01
Cell-cell_NN and_CC cell-matrix_NN interactions_NNS play_VVB important_JJ regulatory_JJ roles_NNS in_II lymphocyte_NN homeostasis_NN ._.
P10493750A04
Neuregulin_NN induced_VVD expression_NN of_II immediate_JJ early_JJ genes_NNS c-jun_NN and_CC c-fos_NN ,_, which_PNR followed_VVD and_CC depended_VVD on_II the_DD ERK_NN activation_NN ._.
P10496957A05
Apoptosis_NN is_VBZ antagonized_VVN by_II the_DD addition_NN of_II fetal_JJ calf_NN serum_NN or_CC the_DD simultaneous_JJ generation_NN of_II NO_NN and_CC superoxide_NN (_( O_NN (_( 2_MC )_) (_( -_SYM )_) )_) ,_, another_DD biological_JJ inflammatory_JJ mediator_NN ._.
P10498289A09
This_DD effect_NN was_VBD also_RR completely_RR inhibited_VVN by_II moexiprilat_NN (_( 10_MC (_( -7_MC )_) M_NN )_) and_CC enalaprilat_NN (_( 10_MC (_( -7_MC )_) M_NN )_) ._.
P10498647A07
Suppression_NN of_II ERK_NN activation_NN was_VBD associated_VVN with_II complete_JJ inhibition_NN of_II HSC_NN proliferation_NN and_CC with_II a_DD 57_MC %_SYM reduction_NN in_II chemotaxis_NN ._.
P10499523A05
The_DD ET-1-induced_VVNJ activation_NN of_II MAP_NN kinase_NN was_VBD reduced_VVN by_II an_DD EGFR_NN kinase_NN inhibitor_NN (_( AG1478_NN )_) but_CC not_RR by_II a_DD platelet-derived_VVNJ growth_NN factor_NN receptor_NN kinase_NN inhibitor_NN (_( AG1296_NN )_) ._.
P10501211A01
Tumor_NN necrosis_NN factor-alpha_NN (_( TNF-alpha_NN )_) is_VBZ a_DD cytokine_NN that_PNR elicits_VVZ cell_NN responses_NNS by_II activating_VVGN the_DD mitogen-activated_VVNJ protein_NN kinase_NN (_( MAP_NN kinase_NN )_) cascade_NN and_CC transcription_NN factors_NNS such_II+ as_II nuclear_JJ factor-kappaB_NN (_( NF-kappaB_NN )_) ._.
P10504489A10
The_DD activation_NN of_II the_DD p38_NN and_CC the_DD ERK1_NN ,_, 2_MC MAPKs_NNS occurred_VVD following_VVG TNF-alpha_NN stimulation_NN ._.
P10506137A02
The_DD involvement_NN of_II MAPK_NN (_( mitogen-activated_VVNJ protein_NN kinase_NN )_) pathways_NNS in_II this_DD adaptive_JJ increase_NN of_II transport_NN activity_NN was_VBD studied_VVN in_II cultured_VVNJ human_NN fibroblasts_NNS ._.
P10506143A01
c-Jun_NN N-terminal_JJ protein_NN kinase_NN (_( JNK_NN )_) ,_, a_DD member_NN of_II the_DD mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN family_NN ,_, regulates_VVZ gene_NN expression_NN in_II response_NN to_II various_JJ extracellular_JJ stimuli_NNS ._.
P10506145A02
We_PN have_VHB previously_RR shown_VVN that_CST mouse_NN Sertoli_NN cells_NNS respond_VVB to_II TNF-alpha_NN by_II increasing_VVGN interleukin-6_NN production_NN and_CC intercellular_JJ adhesion_NN molecule-1_NN (_( ICAM-1_NN )_) expression_NN (_( 1_MC )_) ._.
P10506169A03
Activation_NN of_II the_DD epidermal_JJ growth_NN factor_NN receptor_NN (_( EGFR_NN )_) signaling_VVGJ pathway_NN due_II+ to_II the_DD enhanced_VVNJ transforming_VVGJ growth_NN factor_NN alpha_NN (_( TGFalpha_NN )_) expression_NN plays_VVZ an_DD important_JJ role_NN in_II the_DD induction_NN of_II COX-2_NN by_II IFN-gamma_NN ._.
P10506481A04
In_II newborn_NN rat_NN VSMCs_NNS ,_, Ang_NN II_MC activates_VVZ extracellular_JJ signal-regulated_VVNJ protein_NN kinase_NN (_( ERK_NN )_) ,_, c-Jun_NN N-terminal_JJ protein_NN kinase_NN (_( JNK_NN )_) ,_, and_CC p38_NN mitogen-activated_VVNJ protein_NN kinase_NN ._.
P10508274A04
Wortmannin_NN ,_, an_DD inhibitor_NN of_II phosphatidylinositol_NN 3-kinase_NN ,_, partially_RR inhibited_VVD ERK2_NN and_CC p38_NN activation_NN triggered_VVN through_II the_DD B_NN cell_NN receptor_NN whereas_CS activation_NN of_II JNK1_NN and_CC p38_NN through_II CD40_NN was_VBD not_RR affected_VVN ._.
P10510396A01
Neutrophils_NNS stimulated_VVN with_II the_DD chemoattractant_NN FMLP_NN or_CC the_DD phorbol_NN ester_NN PMA_NN are_VBB known_VVN to_TO exhibit_VVI activation_NN of_II a_DD 90-kDa_NN renaturable_JJ protein_NN kinase_NN ._.
P10512765A04
These_DD compounds_NNS ,_, exemplified_VVN by_II SB_NN 203580_MC ,_, are_VBB exceptionally_RR effective_JJ in_II cell-based_VVNJ assays_NNS ,_, including_VVG the_DD inhibition_NN of_II inflammatory_JJ cytokine_NN production_NN ._.
P10512860A02
Growth_NN factors_NNS are_VBB thought_VVN to_TO regulate_VVI cyclin_NN D1_NN expression_NN because_CS they_PN stimulate_VVB sustained_VVNJ extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) activity_NN ._.
P10514426A02
Recent_JJ studies_NNS have_VHB implicated_VVN Gadd45_NN and_CC two_MC related_VVNJ proteins_NNS ,_, MyD118_NN /_SYM Gadd45beta_NN and_CC CR6_NN /_SYM Gadd45gamma_NN ,_, as_II initiators_NNS of_II JNK_NN /_SYM p38_NN signaling_VVGN via_II their_PNG interaction_NN with_II an_DD upstream_JJ kinase_NN MTK1_NN ._.
P10519165A08
HO-3_NN has_VHZ very_RR low_JJ activity_NN ;_: its_PNG physiological_JJ function_NN probably_RR involves_VVZ heme_NN binding_VVGN ._.
P10521430A03
Further_RR ,_, insulin_NN effects_NNS on_II ERK_NN were_VBD inhibited_VVN by_II kinase-inactive_JJ 3-phosphoinositide-dependent_JJ protein_NN kinase-1_NN (_( PDK-1_NN )_) ,_, and_CC by_II mutation_NN of_II Thr-410_NN in_II the_DD activation_NN loop_NN of_II PKC-zeta_NN ,_, which_PNR is_VBZ the_DD target_NN of_II PDK-1_NN and_CC is_VBZ essential_JJ for_II PI3K_NN /_SYM PDK-1-dependent_JJ activation_NN of_II PKC-zeta_NN ._.
P10521481A01
Engagement_NN of_II the_DD tumor_NN necrosis_NN factor-alpha_NN (_( TNF-alpha_NN )_) receptors_NNS by_II the_DD TNF-alpha_NN ligand_NN results_VVZ in_II the_DD rapid_JJ induction_NN of_II TNF-alpha_NN gene_NN expression_NN ._.
P10522849A07
Elastase_NN release_NN from_II PMNs_NNS was_VBD determined_VVN by_II cleavage_NN of_II the_DD substrate_NN Ala-Ala-Pro-Val-pNA_NN ._.
P10527936A09
Addition_NN of_II the_DD ATP_NN hydrolase_NN apyrase_NN to_II the_DD bath_NN greatly_RR reduced_VVD the_DD hypotonicity-induced_VVNJ Erk-1_NN /_SYM 2_MC activation_NN ,_, but_CC did_VDD not_RR affect_VVB the_DD swelling-induced_VVNJ isotope_NN efflux_NN or_CC whole-cell_NN Cl_NN (_( -_SYM )_) currents_NNS ._.
P10529371A05
However_RR ,_, the_DD inhibition_NN was_VBD partial_JJ (_( approximately_RR 50_MC %_SYM )_) ,_, while_CS inhibition_NN of_II PC_NN hydrolysis_NN was_VBD almost_RR complete_JJ ,_, suggesting_VVG a_DD concomitant_JJ inhibition_NN of_II PLA2_NN activity_NN ._.
P10531305A08
Cells_NNS deficient_JJ in_II a_DD major_JJ quinone_NN reductase_NN ,_, NQO1_NN ,_, displayed_VVD hypersensitivity_NN to_II dicoumarol_NN stress_NN inhibition_NN ,_, whereas_CS SAPK_NN in_II cells_NNS reconstituted_VVN with_II the_DD NQO1_NN gene_NN displayed_VVD relative_JJ dicoumarol_NN resistance_NN ._.
P10534331A06
Stimulation_NN with_II IL-6_NN resulted_VVD in_II proliferation_NN of_II malignant_JJ cholangiocytes_NNS ._.
P10537068A10
These_DD results_NNS indicate_VVB that_CST the_DD ERK_NN cascade_NN plays_VVZ a_DD central_JJ role_NN in_II MK-mediated_VVNJ neuronal_JJ survival_NN via_II inhibition_NN of_II caspase-3_NN activation_NN ._.
P10537140A04
PD98059_NN ,_, a_DD specific_JJ inhibitor_NN of_II the_DD upstream_JJ kinase_NN that_PNR activates_VVZ p42_NN /_SYM p44_NN MAP_NN kinase_NN ,_, inhibited_VVD the_DD IL-1alpha-induced_VVNJ IL-6_NN synthesis_NN as_CC+ well_CC+ as_CC the_DD phosphorylation_NN of_II p42_NN /_SYM p44_NN MAP_NN kinase_NN induced_VVN by_II IL-1alpha_NN ._.
P10542260A02
We_PN report_VVB here_RR studies_NNS on_II these_DD processes_NNS in_II a_DD human_NN keratinocyte_NN line_NN (_( HaCaT_NN )_) ,_, which_PNR is_VBZ a_DD constitutive_JJ producer_NN of_II tissue_NN factor_NN (_( TF_NN )_) and_CC responds_VVZ to_II both_CC FVIIa_NN and_CC FXa_NN with_II elevation_NN of_II cytosolic_JJ Ca_NN (_( 2+_MC )_) ,_, phosphorylation_NN of_II extracellular_JJ signal-regulated_VVNJ kinase_NN (_( Erk_NN )_) 1_MC /_SYM 2_MC ,_, p38_NN (_( MAPK_NN )_) ,_, and_CC c-Jun_NN N-terminal_JJ kinase_NN ,_, and_CC up-regulation_NN of_II transcription_NN of_II the_DD early_JJ growth_NN response_NN gene-1_NN (_( egr-1_NN )_) ._.
P10543994A06
Inhibition_NN of_II the_DD transient_JJ ERK_NN activation_NN by_II MEK_NN inhibitor_NN PD098059_NN attenuated_VVD the_DD H_NN (_( 2_MC )_) O_NN (_( 2_MC )_) -induced_VVNJ apoptosis_NN ._.
P10551817A07
More_RR importantly_RR ,_, we_PN demonstrate_VVB that_CST activation_NN of_II the_DD p42_NN /_SYM p44_NN MAPK_NN pathway_NN in_II quiescent_JJ cells_NNS induced_VVD the_DD phosphorylation_NN and_CC shift_NN of_II HIF-1alpha_NN ,_, which_PNR was_VBD abrogated_VVN in_II presence_NN of_II the_DD MEK_NN inhibitor_NN ,_, PD_NN 98059_MC ._.
P10551874A03
In_II HepG2_NN cells_NNS ,_, repression_NN of_II MAP_NN kinase_NN activity_NN by_II treatment_NN with_II the_DD mitogen-activated_VVNJ protein_NN kinase_NN /_SYM extracellular_JJ signal-regulated_VVNJ kinase_NN kinase_NN inhibitor_NN PD98059_NN caused_VVD a_DD 5-8-fold_NN increase_NN in_II apoCIII_NN transcriptional_JJ activity_NN ._.
P10553083A03
Compared_VVN with_II cag+_NN strains_NNS ,_, cag-_NN clinical_JJ isolates_NNS were_VBD less_RR potent_JJ in_II inducing_VVGN MAP_NN kinase_NN ,_, particularly_RR JNK_NN and_CC p38_NN ,_, activation_NN ._.
P10555036A07
The_DD cAMP_NN mimetics_NNS ,_, 3-isobutyl-1-methyl_NN xanthine_NN plus_CC forskolin_NN ,_, completely_RR blocked_VVD IL-17-induced_VVNJ NO_NN production_NN ._.
P10558995A02
The_DD specific_JJ role_NN of_II the_DD p44_NN MAPK_NN isoform_NN in_II the_DD whole_JJ animal_NN was_VBD evaluated_VVN by_II generation_NN of_II p44_NN MAPK-deficient_JJ mice_NNS by_II homologous_JJ recombination_NN in_II embryonic_JJ stem_NN cells_NNS ._.
P10559244A03
Immunoprecipitation_NN experiments_NNS with_II anti-extracellular_JJ signal-regulated_VVNJ kinase_NN 1_MC (_( ERK1_NN )_) or_CC anti-ERK2_NN antibodies_NNS followed_VVN by_II MBP_NN kinase_NN assays_NNS ,_, and_CC direct_JJ in-gel_NN kinase_NN assays_NNS for_II MBP_NN ,_, show_VVB that_CST p44_NN /_SYM ERK1_NN but_CC not_RR p42_NN /_SYM ERK2_NN is_VBZ stimulated_VVN in_II OA-treated_VVNJ spermatocytes_NNS ._.
P10562267A03
METHODS_NNS AND_CC RESULTS_NNS :_: When_CS cultured_VVNJ cardiac_JJ myocytes_NNS of_II neonatal_JJ rats_NNS were_VBD exposed_VVN to_II 1_MC micromol_NN /_SYM L_NN DM_NN for_II 24_MC hours_NNS ,_, many_DD cells_NNS became_VVD positive_JJ for_II TUNEL_NN staining_VVGN ,_, with_II morphological_JJ changes_NNS characteristic_JJ of_II apoptosis_NN ._.
P10570156A09
Finally_RR ,_, DNA_NN damage-induced_VVNJ MKK6_NN and_CC p38_NN activation_NN was_VBD diminished_VVN in_II c-Abl_NN null_JJ fibroblasts_NNS ._.
P10572244A01
We_PN previously_RR reported_VVN that_CST prostaglandin_NN F_NN (_( 2alpha_NN )_) (_( PGF_NN (_( 2alpha_NN )_) )_) activates_VVZ both_CC phosphoinositide-hydrolyzing_VVGJ phospholipase_NN C_NN and_CC phosphatidylcholine-hydrolyzing_VVGJ phospholipase_NN D_NN in_II osteoblast-like_JJ MC3T3-E1_NN cells_NNS and_CC then_RR induces_VVZ the_DD activation_NN of_II protein_NN kinase_NN C_NN (_( PKC_NN )_) ._.
P10572244A12
These_DD results_NNS indicate_VVB that_CST PGF_NN (_( 2alpha_NN )_) stimulates_VVZ the_DD induction_NN of_II HSP27_NN via_II p42_NN /_SYM p44_NN MAP_NN kinase_NN activation_NN ,_, which_PNR depends_VVZ on_II upstream_JJ PKC_NN activation_NN in_II osteoblasts_NNS ._.
P10579326A05
EGF_NN induced_VVD an_DD increase_NN in_II c-myc_NN ,_, but_CC not_RR c-fos_NN or_CC c-jun_NN ,_, mRNA_NN levels_NNS in_II subconfluent_JJ hepatocyte_NN cultures_NNS ._.
P10580747A10
These_DD results_NNS indicate_VVB that_CST TGF-beta1_NN specifically_RR activates_VVZ MEK1_NN and_CC subsequent_JJ ERK_NN pathways_NNS in_II CRAC_NN ,_, and_CC that_CST the_DD activation_NN of_II this_DD MAPK_NN pathway_NN plays_VVZ a_DD role_NN in_II the_DD mitogenic_JJ response_NN to_II TGF-beta1_NN ._.
P10580837A03
This_DD step_NN is_VBZ crucial_JJ for_II the_DD initiation_NN of_II translation_NN ._.
P10581177A02
Using_VVG human_NN helper_NN T_NN cell_NN clones_NNS ,_, we_PN examined_VVD effects_NNS of_II cAMP_NN on_II c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) and_CC extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) ,_, which_PNR are_VBB assumed_VVN to_TO play_VVI a_DD role_NN in_II T_NN cell_NN regulation_NN ._.
P10585423A12
Taken_VVN together_RR ,_, the_DD present_JJ study_NN demonstrated_VVD that_CST 1_MC ,_, 25_MC (_( OH_NN )_) (_( 2_MC )_) D_NN (_( 3_MC )_) stimulated_VVD AP-1_NN activation_NN in_II CaCo-2_NN cells_NNS by_II a_DD PKC-alpha-_NN and_CC JNK-dependent_JJ mechanism_NN leading_VVG to_II increases_NNS in_II cellular_JJ differentiation_NN ._.
P10586114A08
Despite_II the_DD fact_NN that_CST IL-3_NN did_VDD induce_VVB p38_NN and_CC ERK_NN kinase_NN activity_NN ,_, it_PN was_VBD not_RR able_JJ to_TO enhance_VVI IL-6_NN protein_NN secretion_NN ,_, which_PNR coincided_VVD with_II the_DD inability_NN of_II IL-3_NN to_TO induce_VVI NFkappaB_NN (_( nuclear_JJ factor_NN kappaB_NN )_) activation_NN and_CC IkappaB_NN (_( inhibitory_JJ protein_NN kappaB_NN )_) degradation_NN ._.
P10590051A03
Withdrawal_NN of_II EPO_NN from_II the_DD cell_NN culture_NN medium_NN resulted_VVD in_II sustained_VVNJ activation_NN of_II JNKs_NNS plus_CC p38_NN MAP_NN kinase_NN ,_, and_CC inactivation_NN of_II ERKs_NNS ,_, preceding_VVG apoptosis_NN of_II the_DD cells_NNS ._.
P10591028A10
AP-1_NN DNA_NN binding_VVGJ activities_NNS spurred_VVN by_II low_JJ or_CC high_JJ doses_NNS of_II isoproterenol_NN administration_NN increased_VVD at_II 12_MC h_NN ,_, reached_VVD their_PNG peak_NN of_II 24.1-_MC and_CC 37.1-fold_NN (_( P_NN <_SYM 0.01_MC )_) ,_, respectively_RR ,_, at_II 24_MC h_NN ,_, and_CC thereafter_RR decreased_VVD ._.
P10593906A07
Overexpression_NN of_II the_DD kinase-dead_NN mutant_JJ form_NN of_II MKK3_NN or_CC MKK6_NN demonstrated_VVD that_CST either_PND of_II these_DD two_MC mutant_JJ kinase_NN inhibited_VVD IL-1beta-induced_VVNJ p38_NN (_( MAPK_NN )_) (_( but_CC not_RR JNK_NN /_SYM SAPK_NN )_) phosphorylation_NN and_CC iNOS_NN expression_NN ._.
P10593919A01
We_PN have_VHB investigated_VVN the_DD cellular_JJ mechanisms_NNS that_PNR participate_VVB in_II reducing_VVGN insulin_NN sensitivity_NN in_II response_NN to_II increased_VVNJ oxidant_NN stress_NN in_II skeletal_JJ muscle_NN ._.
P10594022A07
Taken_VVN together_RR ,_, these_DD results_NNS demonstrate_VVB that_CST ASK1_NN is_VBZ a_DD crucial_JJ element_NN of_II NGF_NN withdrawal-induced_VVNJ activation_NN of_II the_DD Cdc42-c-Jun_NN pathway_NN and_CC neuronal_JJ apoptosis_NN ._.
P10601128A01
The_DD expression_NN of_II inducible_JJ nitric_JJ oxide_NN synthase_NN (_( iNOS_NN )_) is_VBZ a_DD characteristic_JJ response_NN to_II inflammation_NN and_CC can_VM be_VBB inhibited_VVN with_II sodium_NN salicylate_NN ._.
P10601328A05
Furthermore_RR ,_, treatment_NN of_II COS-7_NN cells_NNS with_II PKA_NN activators_NNS ,_, or_CC overexpression_NN of_II the_DD Calpha_NN catalytic_JJ subunit_NN of_II PKA_NN ,_, inhibited_VVD the_DD cytoplasmic_JJ retention_NN of_II ERK2_NN and_CC p38alpha_NN by_II wild-type_NN PTP-SL_NN ,_, but_CC not_RR by_II a_DD PTP-SL_NN S231A_NN mutant_NN ._.
P10602479A06
There_EX was_VBD no_DD effect_NN of_II HRG_NN on_II the_DD state_NN of_II phosphorylation_NN and_CC localization_NN of_II focal_JJ adhesion_NN kinase_NN ._.
P10608465A09
The_DD matching_VVGJ response_NN of_II ERK_NN activation_NN to_II TGF-1_NN in_II SHR_NN cells_NNS suggests_VVZ that_CST the_DD MAP_NN kinase-signaling_VVGJ pathway_NN remains_VVZ largely_RR unchanged_VVN in_II the_DD regulation_NN of_II vascular_JJ smooth_JJ muscle_NN growth_NN by_II TGF-1_NN in_II spontaneously_RR hypertensive_JJ rats_NNS ._.
P10611240A02
We_PN describe_VVB here_RR a_DD novel_JJ form_NN of_II dsRNA-triggered_VVNJ signaling_VVGN that_PNR leads_VVZ to_II the_DD stimulation_NN of_II the_DD p38_NN mitogen-activated_VVNJ protein_NN kinase_NN (_( p38_NN MAPK_NN )_) and_CC the_DD c-Jun_NN NH_NN (_( 2_MC )_) -terminal_JJ kinase_NN (_( JNK_NN )_) and_CC of_II their_PNG respective_JJ activators_NNS MKK3_NN /_SYM 6_MC and_CC SEK1_NN /_SYM MKK4_NN ._.
P10614711A01
A_DD novel_JJ clonal_JJ cell_NN line_NN transfected_VVN with_II the_DD delta-opioid_NN receptor_NN (_( delta-OR_NN )_) encoding_VVGJ gene_NN was_VBD used_VVN to_TO study_VVI agonist-activated_VVNJ regulation_NN of_II cell_NN proliferation_NN ._.
P10616838A05
Western_NN blot_NN analysis_NN demonstrated_VVD a_DD significant_JJ increase_NN in_II the_DD protein_NN expression_NN of_II glomerular_JJ ERK_NN and_CC JNK_NN in_II Dahl-S_NN rats_NNS fed_VVN a_DD high-salt_NN diet_NN ._.
P10617109A07
Thus_RR ,_, proteasome_NN inhibitors_NNS induce_VVB sustained_VVNJ ERK_NN activation_NN in_II a_DD Ras-dependent_JJ manner_NN ._.
P10617147A09
U0126_NN ,_, another_DD chemically_RR unrelated_VVNJ inhibitor_NN of_II the_DD MAPK_NN cascade_NN ,_, mimicked_VVD the_DD effect_NN of_II PD98059_NN on_II mu-receptor_NN phosphorylation_NN and_CC desensitization_NN ._.
P10617652A03
We_PN showed_VVD that_CST phosphorylation_NN of_II tyrosine_NN 490_MC is_VBZ required_VVN for_II activation_NN of_II phosphoinositide_NN 3-OH_NN kinase_NN ,_, whereas_CS phosphorylation_NN of_II tyrosine_NN 785_MC is_VBZ required_VVN for_II activation_NN of_II phospholipase_NN C-gamma_NN ._.
P10620499A03
However_RR ,_, whereas_CS the_DD CRE_NN is_VBZ necessary_JJ and_CC sufficient_JJ for_II promoter_NN activation_NN by_II cAMP_NN ,_, it_PN is_VBZ necessary_JJ but_CC not_RR sufficient_JJ for_II activation_NN by_II NGF_NN ._.
P10623598A08
Nonetheless_RR ,_, in_II response_NN to_II TNF_NN ,_, JNK_NN activation_NN was_VBD restored_VVN in_II the_DD TGF-beta1_NN matrix-stimulated_VVNJ cells_NNS ._.
P10625698A05
Contraction-stimulated_VVNJ phosphorylation_NN of_II ERK1_NN /_SYM 2_MC and_CC p38_NN (_( MAPK_NN )_) was_VBD completely_RR inhibited_VVN by_II pretreatment_NN with_II PD98059_NN (_( MAPK_NN kinase_NN inhibitor_NN )_) and_CC SB203580_NN (_( p38_NN (_( MAPK_NN )_) inhibitor_NN )_) ,_, respectively_RR ._.
P10627532A10
In_II contrast_NN ,_, inhibition_NN of_II stress_NN MAP_NN kinase_NN pathways_NNS does_VDZ not_RR impair_VVB the_DD ability_NN of_II Z_NN expression_NN vectors_NNS to_TO disrupt_VVI viral_JJ latency_NN ,_, presumably_RR because_CS expression_NN of_II Z_NN under_II the_DD control_NN of_II a_DD strong_JJ heterologous_JJ promoter_NN bypasses_VVZ the_DD need_NN to_TO activate_VVI Z_NN transcription_NN ._.
P10637276A03
Persistent_JJ activation_NN of_II p38_NN MAP_NN kinase_NN blocks_VVZ fetal_JJ thymocyte_NN development_NN at_II the_DD CD25_NN (_( +_SYM )_) CD44_NN (_( -_SYM )_) stage_NN in_RR+ vivo_RR ,_, and_CC results_VVZ in_II the_DD lack_NN of_II T_NN cells_NNS in_II the_DD peripheral_JJ immune_JJ system_NN of_II adult_JJ mice_NNS ._.
P10639586A02
Radiation_NN exposure_NN caused_VVD prolonged_VVN (_( approximately_RR 1_MC h_NN )_) MAPK_NN activations_NNS in_II U937_NN cells_NNS ._.
P10640438A10
Inhibitors_NNS of_II protein_NN kinase_NN C_NN (_( PKC_NN )_) (_( Ro318220_NN ,_, GF109203X_NN )_) and_CC the_DD ERK_NN cascade_NN (_( PD98059_NN )_) attenuated_VVD the_DD increase_NN in_II c-Jun_NN induced_VVN by_II IL-1_NN beta_NN ,_, but_CC LY294002_NN (_( an_DD inhibitor_NN of_II phosphatidylinositol_NN 3_MC '_SYM kinase_NN )_) and_CC SB203580_NN (_( an_DD inhibitor_NN of_II p38-MAPK_NN ,_, which_PNR also_RR inhibits_VVZ certain_JJ JNK_NN isoforms_NNS )_) had_VHD no_DD effect_NN ._.
P10640689A01
In_II rat_NN type_NN I_MC astrocytes_NNS and_CC C6_NN glioma_NN cells_NNS ,_, sphingosine_NN 1-phosphate_NN (_( S1P_NN )_) clearly_RR induced_VVD the_DD expression_NN of_II fibroblast_NN growth_NN factor-2_NN (_( FGF-2_NN )_) mRNA_NN to_II an_DD extent_NN comparable_JJ to_II that_PND achieved_VVN by_II platelet-derived_VVNJ growth_NN factor_NN (_( PDGF_NN )_) and_CC endothelin_NN ._.
P10640739A05
In_II contrast_NN ,_, the_DD phosphorylation_NN of_II LAT_NN and_CC enhanced_VVNJ association_NN with_II Grb2_NN led_VVD to_II activation_NN of_II extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) mitogen-activated_VVNJ protein_NN kinase_NN ._.
P10642305A06
In_II separate_JJ experiments_NNS ,_, 5-HT_NN (_( 10_MC nmol_NN /_SYM L_NN )_) potentiated_VVD contraction_NN in_II response_NN to_II NE_NN (_( 20_MC nmol_NN /_SYM L_NN )_) by_II approximately_RR 200_MC %_SYM to_II 300_MC %_SYM and_CC to_II ET-1_NN (_( 0.3_MC and_CC 1_MC nmol_NN /_SYM L_NN )_) by_II 640_MC %_SYM and_CC 180_MC %_SYM ,_, respectively_RR ._.
P10644049A07
These_DD results_NNS suggest_VVB that_CST ara-C-induced_VVNJ apoptotic_JJ DNA_NN fragmentation_NN and_CC loss_NN of_II clonogenicity_NN occur_VVB through_II a_DD p38-dependent_JJ pathway_NN ._.
P10644517A04
Further_JJ studies_NNS show_VVB that_CST NaCl-inducible_JJ ERK1_NN and_CC ERK2_NN (_( ERK1_NN /_SYM 2_MC )_) activation_NN is_VBZ a_DD consequence_NN of_II cPKC_NN and_CC nPKC_NN activation_NN ,_, because_CS either_CC downregulation_NN with_II 12-O-tetradecanoylphorbol_NN 13-acetate_NN or_CC selective_JJ inhibition_NN of_II cPKC_NN and_CC nPKC_NN by_II GF-109203X_NN and_CC rottlerin_NN largely_RR inhibited_VVD the_DD stimulation_NN of_II ERK1_NN /_SYM 2_MC phosphorylation_NN by_II NaCl_NN ._.
P10644575A08
Caerulein_NN hyperstimulation_NN strongly_RR activated_VVD JNK_NN ,_, p38_NN ,_, and_CC ERK_NN ._.
P10644709A09
Taken_VVN together_RR ,_, our_PNG findings_NNS strongly_RR suggest_VVB that_CST selenite_NN differentially_RR modulates_VVZ the_DD mammalian_JJ mitogen-activated_VVNJ protein_NN kinase_NN pathways_NNS and_CC that_CST it_PN can_VM repress_VVB the_DD JNK_NN /_SYM SAPK_NN signaling_VVGJ pathway_NN by_II inhibiting_VVGN JNK_NN /_SYM SAPK_NN through_II a_DD thiol_NN redox_NN mechanism_NN ._.
P10644746A05
The_DD effect_NN of_II nitric_JJ oxide_NN was_VBD mimicked_VVN by_II addition_NN of_II 8-bromo-cGMP_NN ,_, indicating_VVG that_CST activation_NN of_II soluble_JJ guanylyl_NN cyclase_NN was_VBD involved_VVN ._.
P10649432A06
Low_JJ serum_NN (_( 0.3_MC %_SYM )_) markedly_RR increased_VVD type_NN I_MC collagen_NN mRNA_NN ._.
P10650934A08
Determination_NN of_II JNK_NN activity_NN using_VVG an_DD immune_JJ complex_NN assay_NN demonstrated_VVD a_DD 3.3-_MC and_CC 3.5-fold_NN increase_NN in_II JNK1_NN and_CC -2_MC activity_NN ,_, respectively_RR ,_, 30_MC min_NN after_II treatment_NN with_II 100_MC ng_NN /_SYM ml_NN IGF-I_NN ._.
P10652360A01
Vascular_JJ endothelial_JJ cells_NNS are_VBB unique_JJ in_CS+ that_CS they_PN exit_VVB from_II the_DD cell_NN cycle_NN when_CS they_PN come_VVB into_II contact_NN with_II each_DD other_PN ._.
P10653605A01
A_DD mutant_JJ Escherichia_NN coli_NN lipopolysaccharide_NN (_( LPS_NN )_) lacking_VVG myristoyl_NN fatty_JJ acid_NN markedly_RR stimulates_VVZ the_DD activity_NN of_II manganese_NN superoxide_NN dismutase_NN (_( MnSOD_NN )_) without_II inducing_VVGN tumor_NN necrosis_NN factor_NN alpha_NN (_( TNFalpha_NN )_) production_NN by_II human_NN monocytes_NNS (_( Tian_NNP et_CC al._NN ,_, 1998_MC ,_, Am_NN J_NN Physiol_NN 275_MC :_: C740._NN )_) ,_, suggesting_VVG that_CST induction_NN of_II MnSOD_NN and_CC TNFalpha_NN by_II LPS_NN are_VBB regulated_VVN through_II different_JJ signal_NN transduction_NN pathways_NNS ._.
P10660688A01
Neuropeptide_NN Y_NN (_( NPY_NN )_) has_VHZ been_VBN shown_VVN to_TO participate_VVI in_II the_DD cardiovascular_JJ response_NN mediated_VVN by_II the_DD sympathetic_JJ system_NN ._.
P10667594A03
However_RR ,_, the_DD signaling_VVGJ mechanisms_NNS by_II which_PNR oncogenic_JJ Ras_NN controls_VVZ cancer_NN cell_NN growth_NN is_VBZ poorly_RR characterized_VVN ._.
P10668633A06
Infarct_NN size_NN (_( measured_VVN by_II triphenyltetrazolium_NN staining_VVGN )_) in_II isolated_VVNJ rabbit_NN hearts_NNS subjected_VVN to_II 30_MC min_NN regional_JJ ischemia_NN and_CC 2_MC h_NN reperfusion_NN was_VBD 31.0_MC +/-_SYM 2.6_MC %_SYM of_II the_DD risk_NN zone_NN in_II controls_NNS and_CC was_VBD 10.3_MC +/-_SYM 2.2_MC %_SYM in_II PC_NN hearts_NNS (_( p_NN <_SYM 0.001_MC )_) ._.
P10670688A02
MAPK_NN activation_NN was_VBD sphingolipid-specific_JJ in_II cells_NNS from_II both_DD species_NNS ._.
P10673361A06
These_DD results_NNS suggest_VVB that_CST the_DD susceptibility_NN to_II oxidative_JJ stress_NN in_II mutant_JJ MtPK_NN cDNA_NN transformants_NNS involves_VVZ differential_JJ signaling_VVGJ pathways_NNS evoked_VVN following_VVG oxidative_JJ stress_NN ._.
P10674496A03
We_PN also_RR demonstrate_VVB that_CST TNF-alpha-induced_VVNJ over-expression_NN of_II GFAP_NN was_VBD significantly_RR attenuated_VVN by_II the_DD MAPK_NN inhibitor_NN PD98059_NN ._.
P10677489A08
These_DD findings_NNS separate_VVB GPCR_NN endocytosis_NN from_II the_DD requirement_NN for_II clathrin-mediated_VVNJ endocytosis_NN in_II EGFR_NN transactivation-mediated_VVNJ ERK_NN activation_NN and_CC suggest_VVB that_CST it_PN is_VBZ the_DD receptor_NN tyrosine_NN kinase_NN or_CC another_DD downstream_JJ effector_NN that_PNR must_VM engage_VVB the_DD endocytic_JJ machinery_NN ._.
P10677502A03
High_JJ concentrations_NNS of_II stauro_NN of_II up_RR+ to_RR 1_MC microM_NN only_RR partially_RR inhibit_VVB IL-3-stimulated_VVNJ Bcl2_NN phosphorylation_NN but_CC completely_RR block_VVB PKC-mediated_VVNJ Bcl2_NN phosphorylation_NN in_RR+ vitro_RR ._.
P10678124A05
P42_NN /_SYM p44_NN ,_, p38_NN MAPK_NN ,_, and_CC p46_NN /_SYM p58_NN JNK_NN protein_NN expression_NN were_VBD measured_VVN by_II Western_NN blot_NN ._.
P10679516A03
AVP_NN stimulated_VVD the_DD phosphorylation_NN of_II p42_NN /_SYM p44_NN MAP_NN kinase_NN and_CC p38_NN MAP_NN kinase_NN ._.
P10683294A03
Inhibition_NN of_II either_CC xanthine_NN oxidase_NN with_II allopurinol_NN or_CC nitric_JJ oxide_NN synthase_NN with_II N_NN (_( G_NN )_) -monomethyl-l-arginine_NN produces_VVZ a_DD small_JJ but_CC significant_JJ improvement_NN in_II the_DD efficacy_NN of_II MC-CM_NN while_CS inclusion_NN of_II pyrrolidine_NN dithiocarbamate_NN ,_, a_DD hydroxyl_NN radical_NN scavenger_NN widely_RR used_VVN as_II an_DD antioxidant_NN ,_, lowers_VVZ MC-CM-induced_VVNJ ChAT_NN activity_NN ._.
P10683529A06
The_DD PMA-induced_VVNJ astrocyte_NN stellation_NN and_CC ERK1_NN /_SYM 2_MC phosphorylation_NN were_VBD blocked_VVN by_II specific_JJ PKC_NN inhibitors_NNS ,_, GF-109203X_NN (_( 0.01-1_MC microM_NN )_) and_CC calphostin_NN C_NN (_( 1_MC microM_NN )_) ._.
P10684871A03
17beta-Estradiol_NN increased_VVD B-Raf_NN activity_NN and_CC MEK_NN (_( MAP_NN kinase_NN /_SYM ERK_NN kinase_NN )_) -dependent_JJ ERK_NN phosphorylation_NN in_II cerebral_JJ cortical_JJ explants_NNS derived_VVN from_II both_CC ERKO_NN and_CC their_PNG wild-type_NN littermates_NNS ._.
P10684886A06
Immunohistochemical_JJ examination_NN of_II brain_NN sections_NNS after_II quinpirole_NN administration_NN revealed_VVD significant_JJ increases_NNS in_II ERK1_NN /_SYM 2_MC immunostaining_VVGN in_II perinuclear_JJ and_CC intranuclear_JJ areas_NNS of_II striatal_JJ neurons_NNS ._.
P10686508A03
In_II the_DD present_JJ study_NN ,_, we_PN investigated_VVD the_DD effect_NN of_II sodium_NN salicylate_NN (_( NaSal_NN )_) ,_, a_DD nonsteroidal_JJ anti-inflammatory_JJ drug_NN ,_, on_II mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPK_NN )_) and_CC apoptosis_NN of_II human_NN eosinophils_NNS ._.
P10698349A05
Analysis_NN of_II mitogen_NN activated_VVNJ protein_NN kinases_NNS (_( MAPK_NN )_) pathways_NNS induced_VVN by_II C5b-9_NN in_II aortic_JJ SMC_NN revealed_VVD that_CST extracellular_JJ signal_NN regulated_VVNJ kinase_NN (_( ERK_NN )_) 1_MC ,_, c-jun_NN NH2-terminal_JJ kinase_NN (_( JNK_NN )_) 1_MC ,_, and_CC p38_NN MAPK_NN are_VBB all_PND activated_VVN by_II C5b-9_NN ._.
P10700554A07
The_DD glutamate_NN concentration_NN effective_JJ for_II inducing_VVGN apoptotic-like_JJ cell_NN death_NN was_VBD correlated_VVN with_II that_PND for_II inducing_VVGN ERK1_NN /_SYM 2_MC diphosphorylation_NN ._.
P10704154A07
It_PN is_VBZ also_RR conceivable_JJ that_CST growth_NN factor_NN stimulation_NN of_II airway_NN smooth_JJ muscle_NN simultaneously_RR elicits_VVZ signaling_VVGN through_II negative_JJ regulatory_JJ pathways_NNS such_II+ as_II the_DD p38_NN mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN pathway_NN ,_, perhaps_RR as_II a_DD safeguard_NN against_II excessive_JJ growth_NN ._.
P10706854A04
MAP_NN kinase_NN activation_NN was_VBD studied_VVN in_II eotaxin-stimulated_VVNJ eosinophils_NNS (_( more_RR than_CSN 97_MC %_SYM purity_NN )_) by_II Western_NN blotting_VVGN and_CC immune-complex_NN kinase_NN assays_NNS ._.
P10708257A06
In_II order_NN to_TO bypass_VVI the_DD receptor-proximal_JJ age-dependent_JJ defects_NNS previously_RR described_VVN ,_, we_PN used_VVD phorbol_NN ester_NN (_( PMA_NN )_) and_CC Ca2+_NN ionophore_NN (_( A23187_NN )_) as_II co-mitogens_NNS ._.
P10708707A02
Immunoblot_NN analysis_NN with_II antibodies_NNS against_II a_DD phosphorylated_VVNJ form_NN of_II p38_NN MAPK_NN showed_VVD that_CST fMLP-stimulated_VVNJ p38_NN MAPK_NN activation_NN was_VBD dependent_JJ on_II a_DD pertussis_NN toxin-sensitive_JJ G_NN protein_NN ._.
P10712263A06
These_DD results_NNS indicate_VVB that_CST colonic_JJ smooth_JJ muscle_NN M_NN (_( 2_MC )_) receptors_NNS are_VBB coupled_VVN to_II ERK_NN and_CC p38_NN MAP_NN kinases_NNS ._.
P10712344A08
TNF-alpha_NN induced_VVD p38_NN MAP_NN kinase_NN and_CC Erk_NN phosphorylation_NN ,_, but_CC neither_CC SB_NN 203580_MC nor_CC PD_NN 98059_MC inhibited_VVD RANTES_NN production_NN ._.
P10713403A05
These_DD results_NNS suggest_VVB that_CST the_DD MEK_NN /_SYM ERK_NN signal_NN transduction_NN cascade_NN is_VBZ involved_VVN in_II the_DD neurotrophic_JJ effect_NN of_II EGF_NN ._.
P10720480A06
Delineating_VVGN the_DD signal_NN transduction_NN mechanisms_NNS regulating_VVG the_DD cellular_JJ effects_NNS of_II NT_NN will_VM provide_VVB important_JJ insights_NNS into_II the_DD molecular_JJ pathways_NNS responsible_JJ for_II NT-mediated_VVNJ effects_NNS on_II both_CC normal_JJ and_CC neoplastic_JJ cells_NNS ._.
P10722731A03
Activation_NN of_II MAP_NN kinase_NN appears_VVZ to_TO be_VBI essential_JJ for_II propagating_VVGN a_DD wide_JJ variety_NN of_II extracellular_JJ signals_NNS from_II the_DD plasma_NN membrane_NN to_II the_DD nucleus_NN ._.
P10722758A06
ERK_NN was_VBD selectively_RR activated_VVN in_II MLE-15_NN cells_NNS by_II hypertonic_JJ stress_NN ,_, and_CC inhibition_NN of_II ERK_NN activation_NN with_II two_MC distinct_JJ mitogen-activated_VVNJ extracellular_JJ regulated_VVNJ kinase_NN kinase_NN (_( MEK_NN )_) inhibitors_NNS ,_, U0126_NN and_CC PD98059_NN ,_, blocked_VVD AQP5_NN induction_NN ._.
P10727428A09
Dominant-negative_JJ Ras_NN also_RR partly_RR inhibited_VVD the_DD phenylephrine-induced_VVNJ activation_NN of_II ANF_NN promoter_NN ._.
P10727463A02
Although_CS c-Jun_NN NH2-terminal_JJ kinase_NN (_( JNK_NN )_) and_CC p38_NN mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) may_VM be_VBB involved_VVN in_II apoptosis_NN in_II various_JJ cell_NN types_NNS ,_, the_DD mode_NN of_II regulation_NN of_II FasL_NN expression_NN during_II AICD_NN in_II T_NN cells_NNS by_II these_DD two_MC MAPKs_NNS is_VBZ incompletely_RR understood_VVN ._.
P10727525A01
A_DD variety_NN of_II G_NN protein-coupled_VVNJ receptors_NNS (_( GPCRs_NNS )_) are_VBB phosphorylated_VVN by_II G_NN protein-coupled_VVNJ receptor_NN kinase_NN 2_MC (_( GRK2_NN )_) ._.
P10728664A08
Thus_RR ,_, activation_NN of_II IRF7_NN through_II the_DD JNK_NN signaling_VVGJ pathway_NN may_VM play_VVB a_DD role_NN in_II the_DD transcriptional_JJ regulation_NN of_II genes_NNS in_II response_NN to_II DNA-damaging_VVGJ agents_NNS ._.
P10733514A02
We_PN hypothesized_VVD that_CST myosin_NN light_JJ chain_NN kinase_NN (_( MLCK_NN )_) could_VM be_VBB phosphorylated_VVN and_CC activated_VVN by_II ERK_NN ,_, thereby_RR linking_VVG the_DD MAP_NN kinase_NN pathway_NN to_II the_DD activation_NN of_II cytoskeletal_JJ components_NNS required_VVN for_II pseudopod_NN formation_NN ._.
P10733575A03
The_DD DH_NN and_CC Cdc25_NN domains_NNS possess_VVB guanine_NN nucleotide_NN exchange_NN factor_NN (_( GEF_NN )_) activity_NN and_CC interact_VVB with_II Rac_NN and_CC Ras_NN ,_, respectively_RR ._.
P10735617A11
Both_CC 2-mercaptoethanol_NN and_CC a_DD p38_NN inhibitor_NN (_( SB202190_NN )_) inhibited_VVD alpha-SMA_NN expression_NN by_II day_NN 5_MC cells_NNS ._.
P10745095A03
While_CS phosphorylation_NN of_II ERK_NN and_CC JNK_NN was_VBD inhibited_VVN by_II the_DD pretreatment_NN of_II a_DD PKC_NN inhibitor_NN ,_, bisindolylmaleimide_NN I_MC ,_, activation_NN of_II p38_NN MAPK_NN was_VBD upregulated_VVN by_II the_DD same_JJ pretreatment_NN ._.
P10747973A04
As_CS cells_NNS recover_VVB from_II stress_NN ,_, the_DD punctate_JJ granules_NNS gradually_RR disappear_VVB ,_, and_CC HSF-1_NN appears_VVZ in_II a_DD diffused_VVNJ staining_VVGJ pattern_NN in_II the_DD cytoplasm_NN and_CC nucleus_NN ._.
P10749150A10
Moreover_RR ,_, a_DD dominant-negative_JJ Rac_NN (_( Rac_NN N17_NN )_) blocked_VVD serum-induced_VVNJ PTHRP_NN gene_NN expression_NN ._.
P10751227A02
We_PN tested_VVD the_DD hypothesis_NN that_CST oxidants_NNS might_VM be_VBB involved_VVN in_II the_DD signal_NN transduction_NN pathway_NN linking_VVG the_DD receptor_NN to_II extracellular_JJ signal-regulated_VVNJ protein_NN kinase_NN (_( ERK_NN )_) ._.
P10753509A06
Other_JJ blots_NNS showed_VVD the_DD specific_JJ appearance_NN of_II the_DD phosphorylated_VVNJ EGFR_NN and_CC of_II phospho-ERK-1_NN /_SYM 2_MC in_II response_NN to_II EGF_NN ._.
P10753873A05
This_DD induction_NN was_VBD mediated_VVN transcriptionally_RR through_II the_DD AP-1_NN (_( c-Fos_NN /_SYM JunD_NN )_) and_CC CCAAT_NN /_SYM enhancer-binding_VVGJ protein_NN elements_NNS as_CC+ well_CC+ as_CC through_II an_DD E-box_NN repressor_NN site_NN in_II the_DD proximal_JJ regulatory_JJ region_NN of_II the_DD FGF-BP_NN promoter_NN ._.
P10753946A10
These_DD findings_NNS describe_VVB a_DD novel_JJ inside-out_RR signaling_VVGJ pathway_NN by_II which_PNR the_DD ERK_NN cascade_NN may_VM regulate_VVB events_NNS involved_VVN in_II adhesion_NN ._.
P10764405A01
The_DD third_JJ cytoplasmic_JJ loop_NN of_II the_DD angiotensin_NN (_( Ang_NN )_) II_MC type_NN 1_MC receptor_NN (_( AT_NN (_( 1_MC )_) )_) is_VBZ important_JJ for_II receptor_NN coupling_VVGN to_II G_NN proteins_NNS and_CC activation_NN of_II downstream_JJ events_NNS ._.
P10764405A12
This_DD study_NN shows_VVZ for_II the_DD first_JJ time_NN a_DD direct_JJ link_NN between_II kinase_NN activation_NN and_CC inhibition_NN of_II apoptosis_NN dependent_JJ on_II amino_JJ acids_NNS 221_MC and_CC 222_MC in_II the_DD third_JJ cytoplasmic_JJ loop_NN of_II the_DD AT_NN (_( 1_MC )_) ._.
P10764628A03
Two_MC myeloid_NN models_NNS ,_, RAW_NN 264.7_MC murine_JJ macrophage_NN and_CC U937_NN human_NN leukemic_JJ cells_NNS were_VBD used_VVN ._.
P10764657A03
The_DD study_NN was_VBD performed_VVN to_TO further_RR characterize_VVI the_DD role_NN of_II ROS_NN in_II Ang_NN II-mediated_VVNJ MAP_NN kinase_NN activation_NN and_CC the_DD regulation_NN of_II the_DD transcription_NN factor_NN activator_NN protein-1_NN (_( AP-1_NN )_) ._.
P10766791A09
These_DD results_NNS demonstrate_VVB an_DD essential_JJ role_NN for_II Src_NN and_CC Cas_NN in_II H_NN (_( 2_MC )_) O_NN (_( 2_MC )_) -mediated_VVNJ activation_NN of_II JNK_NN and_CC suggest_VVB a_DD new_JJ redox-sensitive_JJ pathway_NN for_II JNK_NN activation_NN mediated_VVN by_II Src_NN ._.
P10770956A02
The_DD family_NN of_II mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) is_VBZ involved_VVN in_II the_DD regulation_NN of_II cardiac_JJ myocyte_NN growth_NN and_CC apoptosis_NN ._.
P10775139A05
In_II contrast_NN ,_, ramp_NN flow_NN was_VBD unable_JJ to_TO significantly_RR induce_VVI gene_NN expression_NN and_CC even_RR inhibited_VVD the_DD activation_NN of_II ERK1_NN /_SYM ERK2_NN ._.
P10781369A07
RESULTS_NNS :_: GLP-2-treated_VVNJ cells_NNS demonstrated_VVD a_DD greater_JJR than_CSN 10-fold_NN increase_NN in_II proliferation_NN ._.
P10781688A05
Although_CS K562_NN cells_NNS were_VBD very_RR resistant_JJ to_II sorbitol-induced_VVNJ apoptosis_NN ,_, DNA_NN fragmentation_NN was_VBD induced_VVN rapidly_RR in_II Jurkat_NN ,_, HL-60_NN and_CC U937_NN cells_NNS after_II exposure_NN to_II sorbitol_NN ,_, despite_II that_CST these_DD apoptosis-sensitive_JJ cells_NNS have_VHB similar_JJ or_CC lower_JJR activities_NNS of_II JNK_NN /_SYM SAPK_NN and_CC p38_NN kinase_NN compared_VVN with_II K562_NN cells_NNS after_II treatment_NN of_II sorbitol_NN ._.
P10781927A06
In_II cells_NNS pretreated_VVN with_II PMA_NN for_II 24_MC h_NN and_CC with_II either_CC the_DD PKC_NN inhibitor_NN staurosporine_NN or_CC the_DD tyrosine_NN kinase_NN inhibitor_NN genistein_NN for_II 1h_NN ,_, substantially_RR reduced_VVD the_DD [_( 3H_NN ]_) thymidine_NN incorporation_NN and_CC p42_NN /_SYM p44_NN MAPK_NN phosphorylation_NN in_II response_NN to_II OX-LDL_NN ._.
P10787425A06
Neither_CC haploids_NNS nor_CC diploids_NNS ,_, however_RR ,_, showed_VVD marked_VVNJ penetration_NN of_II agar_NN medium_NN ._.
P10788473A09
In_II a_DD third_JJ approach_NN ,_, we_PN examined_VVD the_DD activation_NN of_II MAPK_NN factors_NNS and_CC PKC_NN isoforms_NNS during_II the_DD progression_NN of_II load-induced_VVNJ hypertrophy_NN in_II aortic_JJ banded_VVNJ rats_NNS with_II or_CC without_II cyclosporine_NN ._.
P10788507A10
Expression_NN of_II Gab1DeltaPI3K_NN had_VHD no_DD apparent_JJ effect_NN on_II ERK2_NN activation_NN by_II LPA_NN and_CC EGF_NN in_II the_DD cells_NNS that_PNR we_PN have_VHB examined_VVN ._.
P10791952A11
Together_RR ,_, these_DD data_NNS suggest_VVB that_CST multivalent_JJ aggregation_NN of_II the_DD alpha_NN (_( 3_MC )_) beta_NN (_( 1_MC )_) integrin_NN regulates_VVZ proteinase_NN expression_NN ,_, matrix_NN proteolysis_NN ,_, and_CC subsequent_JJ cellular_JJ behavior_NN ._.
P10794718A04
Both_DD types_NNS of_II stimuli_NNS resulted_VVD in_II a_DD significant_JJ activation_NN of_II JNK_NN and_CC p38_NN ,_, which_PNR closely_RR paralleled_VVD the_DD time-dependent_JJ induction_NN of_II apoptosis_NN ._.
P10800946A06
Anisomycin_NN (_( 1_MC microM_NN )_) treatment_NN mimics_VVZ the_DD cytokine-induced_VVNJ enhancement_NN of_II arachidonic_JJ acid_NN production_NN and_CC activates_VVZ the_DD p38_NN MAPK_NN pathway_NN ,_, but_CC does_VDZ not_RR activate_VVB the_DD NF-kappaB_NN pathway_NN ._.
P10801798A02
The_DD group_NN I_MC germinal_JJ center_NN kinase_NN family_NN members_NNS selectively_RR activate_VVB the_DD JNK_NN pathway_NN ._.
P10807411A10
Activation_NN of_II NF-kappaB_NN occurred_VVD at_II 30_MC min_NN ,_, and_CC increased_VVNJ activity_NN continued_VVD for_II 6_MC h_NN ._.
P10807739A06
JNK_NN and_CC ERK_NN were_VBD activated_VVN by_II ET-1_NN binding_VVGN to_II a_DD single_JJ receptor_NN (_( ET-1A_NN )_) but_CC differed_VVD in_II their_PNG downstream_JJ mechanisms_NNS :_: only_RR JNK_NN activation_NN was_VBD sensitive_JJ to_II the_DD radical_NN scavenger_NN N-acetylcysteine_NN and_CC diphenylene_NN iodonium_NN ,_, an_DD inhibitor_NN of_II NADPH_NN oxidase_NN ,_, indicating_VVG a_DD role_NN for_II ROS_NN ._.
P10807911A08
The_DD prolactin-induced_VVNJ activation_NN of_II JNK_NN was_VBD prolonged_VVN and_CC accompanied_VVN by_II a_DD significant_JJ increase_NN in_II c-Jun_NN mRNA_NN abundance_NN and_CC c-Jun_NN protein_NN synthesis_NN ._.
P10807920A03
AVP_NN activated_VVD all_DD three_MC MAP_NN kinase_NN family_NN members_NNS :_: ERKs_NNS ,_, JNKs_NNS ,_, and_CC p38_NN MAP_NN kinase_NN ._.
P10807932A06
The_DD IL-1beta-induced_VVNJ increase_NN in_II the_DD number_NN of_II (_( 125_MC )_) I-PDGF-AA-binding_VVGJ sites_NNS at_II the_DD cell_NN surface_NN was_VBD reduced_VVN >_SYM 70_MC %_SYM by_II pretreatment_NN with_II SB203580_NN ._.
P10809726A04
Calphostin_NN C_NN ,_, an_DD inhibitor_NN of_II protein_NN kinase_NN C_NN ,_, blocked_VVD the_DD induction_NN of_II COX-2_NN by_II MIAs_NNS ._.
P10811116A07
Treatment_NN with_II PMA_NN increased_VVD activator_NN protein-1_NN activity_NN and_CC the_DD binding_VVGN of_II c-Jun_NN to_II the_DD cyclic_JJ AMP_NN response_NN element_NN of_II the_DD COX-2_NN promoter_NN ,_, effects_NNS that_PNR were_VBD blocked_VVN by_II ursolic_JJ acid_NN ._.
P10817569A10
CONCLUSION_NN :_: These_DD results_NNS indicate_VVB that_CST ERK-1_NN /_SYM ERK-2_NN signaling_VVGN and_CC transcriptional_JJ activation_NN through_II AP-1_NN and_CC NF-kappaB_NN are_VBB essential_JJ for_II the_DD induction_NN of_II IL-8_NN expression_NN in_II mononuclear_JJ phagocytes_NNS in_II response_NN to_II CPPD_NN and_CC MSU_NN crystals_NNS ._.
P10821851A04
By_II contrast_NN ,_, SB_NN 203580_MC ,_, an_DD inhibitor_NN of_II stress-activated_VVNJ protein_NN kinase-2_NN (_( SAPK2_NN )_) /_SYM p38_NN MAP_NN kinase_NN ,_, had_VHD no_DD effect_NN on_II any_PND of_II the_DD above_JJ parameters_NNS ,_, and_CC PPI_NN promoter_NN activity_NN and_CC PDX-1.c-myc_NN localization_NN were_VBD unaffected_VVN by_II over-expression_NN of_II the_DD upstream_JJ kinase_NN MKK6_NN (_( MAP_NN kinase_NN kinase-6_NN )_) or_CC wild-type_NN p38_NN /_SYM SAPK2_NN ,_, respectively_RR ._.
P10833473A04
Intestinal_JJ epithelial_JJ barrier_NN function_NN was_VBD characterized_VVN through_II transepithelial_JJ electrical_JJ resistance_NN and_CC mannitol_NN tracer_NN flux_NN ._.
P10840014A11
Furthermore_RR ,_, we_PN found_VVD that_CST JNK1_NN specific_JJ antisense_NN oligonucleotide_NN could_VM suppress_VVB caspase-3_NN activity_NN but_CC not_RR affect_VVB H_NN (_( 2_MC )_) O_NN (_( 2_MC )_) generation_NN and_CC could_VM block_VVB apoptosis_NN induced_VVN by_II high_JJ glucose_NN ._.
P10842159A04
The_DD antiproliferative_JJ and_CC p21_NN stimulatory_JJ effects_NNS of_II NO_NN were_VBD not_RR suppressed_VVN by_II the_DD soluble_JJ guanylate_NN cyclase_NN inhibitor_NN ODQ_NN ,_, implicating_VVG cGMP-independent_JJ signaling_VVGN ._.
P10843711A08
On_II the_DD other_JJ hand_NN ,_, PD98059_NN inhibited_VVD actin_NN polymerization_NN stimulated_VVN by_II Fc_NN gamma_NN R_NN cross-linking_VVGN ,_, while_CS SB203580_NN had_VHD no_DD effect_NN ._.
P10843887A04
We_PN tested_VVD the_DD role_NN of_II caldesmon_NN and_CC HSP27_NN phosphorylation_NN in_II the_DD contractile_JJ response_NN of_II vascular_JJ smooth_JJ muscle_NN by_II using_VVGN inhibitors_NNS of_II both_DD MAP_NN kinase_NN pathways_NNS ._.
P10845922A02
We_PN demonstrate_VVB that_CST ligation_NN of_II CD11b_NN (_( Mac-1_NN ,_, CR3_NN )_) or_CC CD11c_NN (_( p150_NN ,_, CR4_NN )_) alpha_NN chains_NNS of_II beta2_NN integrins_NNS by_II mAbs_NN or_CC soluble_JJ chimeric_JJ CD23_NN (_( sCD23_NN )_) on_II human_NN freshly_RR isolated_VVNJ monocytes_NNS rapidly_RR stimulates_VVZ high_JJ levels_NNS of_II interleukin-1beta_NN production_NN ._.
P10849439A02
Because_CS inflammatory_JJ processes_NNS are_VBB often_RR accompanied_VVN by_II hsp_NN expression_NN and_CC because_CS stress_NN and_CC cytokines_NNS share_VVB several_JJ signaling_VVGJ pathways_NNS ,_, we_PN investigated_VVD the_DD possibility_NN that_CST hsp70_NN might_VM modulate_VVB the_DD cellular_JJ response_NN to_II cytokines_NNS ._.
P10849670A04
Exposure_NN to_II moderate_JJ hypoxia_NN (_( 5_MC %_SYM O2_NN )_) was_VBD found_VVN to_TO progressively_RR stimulate_VVI phosphorylation_NN and_CC activation_NN of_II p38_NN gamma_NN in_II particular_NN ,_, and_CC also_RR p38_NN alpha_NN ,_, two_MC isoforms_NNS of_II the_DD p38_NN family_NN of_II stress-activated_VVNJ protein_NN kinases_NNS ._.
P10864142A01
The_DD signal_NN transduction_NN pathways_NNS activated_VVN by_II arachidonic_JJ acid_NN that_PNR lead_VVB to_II p38_NN mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) activation_NN in_II neutrophils_NNS remains_VVZ unclear_JJ ._.
P10864961A08
To_TO investigate_VVI possible_JJ roles_NNS of_II p38_NN in_II RGC_NN death_NN ,_, a_DD p38_NN MAP_NN kinase_NN inhibitor_NN ,_, SB203580_NN ,_, was_VBD administered_VVN intravitreally_RR at_II the_DD time_NN of_II axotomy_NN and_CC repeated_VVN at_II 5_MC and_CC 10_MC d_NN ._.
P10867029A03
Arachidonic_JJ acid_NN release_NN and_CC eicosanoid_NN production_NN induced_VVN by_II stimuli_NNS that_PNR do_VDB (_( A23187_NN ,_, zymosan_NN )_) or_CC do_VDB not_RR (_( phorbol_NN myristate_NN acetate_NN (_( PMA_NN )_) ,_, okadaic_JJ acid_NN )_) mobilize_VVB calcium_NN were_VBD quantitatively_RR suppressed_VVN in_II cPLA_NN (_( 2_MC )_) -deficient_JJ mouse_NN peritoneal_JJ macrophages_NNS ._.
P10871841A06
TPA-induced_VVNJ MEK1_NN /_SYM 2_MC and_CC Raf-1_NN phosphorylation_NN were_VBD reduced_VVN in_II these_DD cells_NNS ._.
P10874022A02
Three_MC major_JJ mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) ,_, c-JUN_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) ,_, p38_NN and_CC extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) ,_, have_VHB been_VBN shown_VVN to_TO regulate_VVI apoptosis_NN ._.
P10874022A14
Together_RR ,_, the_DD results_NNS of_II this_DD study_NN suggest_VVB that_CST JNK_NN and_CC p38_NN cooperatively_RR participate_VVB in_II apoptosis_NN induced_VVN by_II Cd_NN and_CC that_CST the_DD decreased_VVNJ ERK_NN signal_NN induced_VVN by_II low_JJ Cd_NN doses_NNS contributes_VVZ to_II growth_NN inhibition_NN or_CC apoptosis_NN ._.
P10874129A03
We_PN now_RR report_VVB that_CST cycloheximide_NN ,_, a_DD protein_NN synthesis_NN inhibitor_NN ,_, caused_VVD an_DD almost_RR complete_JJ reversion_NN of_II the_DD inhibitory_JJ effects_NNS of_II dex_NN on_II cPLA_NN (_( 2_MC )_) activation_NN ._.
P10880959A10
Leucine_NN residues_NNS in_II the_DD sequence_NN were_VBD crucial_JJ for_II the_DD NES_NN activity_NN ,_, as_CS the_DD activity_NN was_VBD lost_VVN on_II replacement_NN of_II the_DD leucines_NNS to_II alanines_NNS ._.
P10888249A04
Overexpression_NN of_II MEK1_NN EE_NN in_II MCs_NNS activated_VVD ERK1_NN /_SYM 2_MC and_CC subsequently_RR induced_VVD atrial_JJ natriuretic_JJ peptide_NN (_( ANP_NN )_) mRNA_NN expression_NN ._.
P10892858A07
EGF-induced_VVNJ PGE2_NN production_NN was_VBD suppressed_VVN by_II AACOCF3_NN ,_, a_DD phospholipase_NN A2_NN (_( cPLA2_NN )_) inhibitor_NN ._.
P10892858A19
These_DD results_NNS indicate_VVB that_CST the_DD mitogenic_JJ response_NN to_II EGF_NN in_RR+ vivo_RR in_II the_DD proliferating_VVGJ basal_JJ cell_NN layer_NN may_VM be_VBB dependent_JJ on_II the_DD level_NN of_II its_PNG PKA_NN activity_NN ._.
P10898493A09
In_II subpopulation_NN analyses_NNS ,_, synergistic_JJ activation_NN of_II Raf1_NN was_VBD consistently_RR observed_VVN in_II the_DD IgDlow_NN but_CC not_RR in_II the_DD IgDhigh_NN cells_NNS ._.
P10898517A04
In_II marked_VVNJ contrast_NN to_II ERK_NN activation_NN ,_, c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) activation_NN was_VBD observed_VVN in_II all_DD mutants_NNS when_CS co-stimulated_VVN with_II CD28_NN ._.
P10899931A09
The_DD first_PN ,_, peaking_VVG at_II 1_MC h_NN ,_, is_VBZ transient_JJ ,_, does_VDZ not_RR require_VVB protein_NN synthesis_NN ,_, and_CC is_VBZ regulated_VVN at_II the_DD transcriptional_JJ level_NN ._.
P10903502A12
The_DD Fg_NN :_: ICAM-1_NN endothelial_JJ cell_NN survival_NN pathway_NN appears_VVZ to_TO be_VBI mediated_VVN via_II the_DD activation_NN and_CC upregulation_NN of_II ERK-1_NN /_SYM 2_MC and_CC A1_NN ._.
P10903733A06
Analysis_NN of_II deletion_NN mutants_NNS of_II the_DD intracytoplasmic_JJ tail_NN of_II BCMA_NN showed_VVD that_CST the_DD 25-aa_NN protein_NN segment_NN ,_, from_II position_NN 119_MC to_II 143_MC ,_, conserved_VVN between_II mouse_NN and_CC human_NN BCMA_NN ,_, is_VBZ essential_JJ for_II its_PNG association_NN with_II the_DD TRAFs_NNS and_CC the_DD activation_NN of_II NF-kappa_NN B_NN ,_, Elk-1_NN ,_, and_CC c-Jun_NN N-terminal_JJ kinase_NN ._.
P10903806A05
When_CS added_VVN together_RR ,_, p38i_NN and_CC MEKi_NN decreased_VVD IL-1_NN beta-induced_VVNJ nitrite_NN production_NN over_II 24_MC hours_NNS by_II 60_MC %_SYM ,_, but_CC did_VDD not_RR affect_VVB IL-1_NN beta-induced_VVNJ manganese_NN superoxide_NN dismutase_NN (_( MnSOD_NN )_) mRNA_NN expression_NN ._.
P10906152A09
The_DD MAP_NN kinase_NN kinase_NN inhibitor_NN PD98059_NN completely_RR inhibits_VVZ AngII-induced_VVNJ p27_NN (_( Kip1_NN )_) expression_NN and_CC (_( 3_MC )_) [_( H_NN ]_) leucine_NN incorporation_NN into_II proteins_NNS as_II a_DD previously_RR established_VVNJ marker_NN of_II cell_NN hypertrophy_NN ._.
P10910078A07
Each_PND of_II five_MC mirk_NN transfectants_NNS proliferated_VVD when_CS switched_VVN to_II serum-free_JJ medium_NN and_CC regained_VVD rapid_JJ growth_NN when_CS serum_NN was_VBD restored_VVN ,_, whereas_CS five_MC vector_NN control_NN transfectants_NNS and_CC three_MC kinase-dead_NN mutant_JJ mirk_NN transfectants_NNS did_VDD not_RR ._.
P10910949A12
Neither_CC the_DD specific_JJ kinase_NN inhibitors_NNS nor_CC expression_NN of_II MKK7A_NN altered_VVD Cr_NN (_( VI_MC )_) -induced_VVNJ cytotoxicity_NN ._.
P10913001A02
We_PN tested_VVD the_DD hypothesis_NN that_CST this_DD coupling_VVGN is_VBZ mediated_VVN by_II enzymes_NNS of_II the_DD phosphatidylinositol_NN (_( PI_NN )_) 3-kinase_NN family_NN ._.
P10913368A01
The_DD generation_NN of_II proinflammatory_JJ eicosanoids_NNS in_II response_NN to_II tumor_NN necrosis_NN factor_NN (_( TNF_NN )_) involves_VVZ the_DD activation_NN of_II cytosolic_JJ phospholipase_NN A_NN (_( 2_MC )_) (_( cPLA_NN (_( 2_MC )_) )_) ,_, presumably_RR by_II phosphorylation_NN through_II extracellular_JJ signal-regulated_VVNJ kinases_NNS (_( ERK_NN )_) ._.
P10915907A03
Recombinant_JJ human_NN bFGF_NN (_( 0.1-10_MC ng_NN /_SYM ml_NN )_) induced_VVD phosphorylation_NN of_II p44_NN /_SYM 42_MC MAPK_NN (_( ERK1_NN /_SYM 2_MC )_) in_II a_DD concentration-_NN and_CC time-dependent_JJ manner_NN ._.
P10923358A12
CONCLUSION_NN :_: It_PN seems_VVZ likely_JJ that_CST a_DD specific_JJ interaction_NN between_II MAPK_NN and_CC p38MAPK_NN signaling_VVGJ pathway_NN may_VM be_VBB involved_VVN in_II the_DD determination_NN of_II the_DD cell_NN death_NN mechanism_NN in_II pancreatic_JJ acini_NNS subjected_VVN to_II stressful_JJ stimuli_NNS ._.
P10924699A04
Cycloheximide_NN (_( CHX_NN ,_, 20_MC microM_NN )_) ,_, a_DD protein_NN synthesis_NN inhibitor_NN ,_, alone_JJ caused_VVD increases_NNS of_II c-fos_NN and_CC c-jun_NN mRNA_NN levels_NNS ._.
P10925166A05
These_DD findings_NNS suggest_VVB that_CST PKA_NN inhibition_NN prevents_VVZ depolarization-induced_VVNJ PYK2_NN /_SYM MAP_NN kinase_NN pathway_NN activation_NN ,_, thereby_RR inhibiting_VVG the_DD early_JJ gene_NN expression_NN ._.
P10925255A06
Target_NN cell-induced_VVNJ IFN-gamma_NN and_CC FcgammaRIIIA-induced_VVNJ TNF-alpha_NN mRNA_NN accumulation_NN was_VBD similarly_RR affected_VVN under_II the_DD same_JJ conditions_NNS ._.
P10926840A03
Transport_NN was_VBD stimulated_VVN maximally_RR by_II anisomycin_NN (_( 2_MC microM_NN )_) and_CC blocked_VVN by_II SB203580_NN (_( 20_MC microM_NN )_) ,_, confirming_VVG involvement_NN of_II the_DD p38_NN pathway_NN ._.
P10930980A08
Interestingly_RR ,_, both_CC EPO_NN and_CC SCF_NN induced_VVD activation_NN of_II PI3K_NN ._.
P10935911A05
MAP_NN kinase_NN activity_NN ,_, caused_VVN by_II calcium_NN influx_NN ,_, was_VBD determined_VVN using_VVG either_CC a_DD specific_JJ synthetic_JJ peptide_NN ,_, or_CC an_DD in_JJ+ gel_JJ kinase_NN assay_NN ._.
P10940738A05
ERK_NN activation_NN was_VBD mimicked_VVN by_II cholera_NN toxin_NN ,_, forskolin_NN and_CC 8bromo-cAMP_NN ._.
P10945503A02
The_DD signalling_VVGJ pathways_NNS employing_VVG the_DD mitogen-activated_VVNJ ERK-activating_VVGJ kinase_NN (_( MEK_NN )_) and_CC the_DD extracellular-regulated_VVNJ kinase_NN (_( ERK_NN )_) are_VBB critical_JJ in_II growth_NN factors_NNS signalling_VVGN ._.
P10945608A02
Under_II nonstressed_JJ conditions_NNS ,_, increased_VVNJ expression_NN of_II GSTp_NN via_II a_DD tet-off-inducible_JJ GSTp_NN in_II NIH_NN 3T3_NN cells_NNS increased_VVD the_DD phosphorylation_NN of_II mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN kinase_NN 4_MC ,_, p38_NN ,_, extracellular_JJ receptor_NN kinase_NN (_( ERK_NN )_) ,_, and_CC inhibitor_NN of_II kappa-kinase_NN (_( IKK_NN )_) ,_, and_CC reduced_VVD phosphorylation_NN of_II MAP_NN kinase_NN kinase_NN 7_MC and_CC Jun_NN NH2-terminal_JJ kinase_NN (_( JNK_NN )_) ._.
P10953046A07
Marked_VVNJ activation_NN of_II the_DD JNK_NN pathway_NN through_II SEK1_NN and_CC apoptosis_NN signal-regulating_VVGJ kinase_NN 1_MC (_( ASK1_NN )_) ,_, an_DD upstream_JJ kinase_NN of_II SEK1_NN ,_, was_VBD demonstrated_VVN by_II the_DD transient_JJ transfection_NN of_II cDNA_NN for_II wild-type_NN SEK1_NN or_CC ASK1_NN together_RR with_II JNK_NN into_II COS-7_NN cells_NNS ._.
P10958675A08
To_TO determine_VVI if_CST Src_NN family_NN kinases_NNS (_( SFKs_NNS )_) are_VBB involved_VVN ,_, we_PN demonstrated_VVD that_CST CSF-1_NN activated_VVD Fyn_NN and_CC Lyn_NN in_II cells_NNS expressing_VVG wild-type_NN (_( WT_NN )_) or_CC DeltaKI_NN receptors_NNS ._.
P10958679A07
Development_NN of_II thermotolerance_NN was_VBD not_RR associated_VVN with_II Akt_NN or_CC ERK1_NN and_CC -2_MC regulation_NN ,_, and_CC inhibition_NN of_II these_DD kinases_NNS did_VDD not_RR reduce_VVB acquired_VVNJ thermotolerance_NN ._.
P10960082A12
Immunoblot_NN analysis_NN demonstrated_VVD the_DD translocation_NN of_II the_DD conventional_JJ isoform_NN cPKC-alpha_NN from_II cytosol_NN to_II membrane_NN following_VVG treatment_NN with_II IL-1beta_NN ._.
P10961885A06
Although_CS the_DD site_NN surrounding_VVG serine_NN 721_MC is_VBZ an_DD optimum_NN consensus_NN sequence_NN for_II mitogen-activated_VVNJ family_NN of_II protein_NN kinases_NNS (_( MAPKs_NNS )_) -mediated_VVNJ phosphorylation_NN ,_, we_PN demonstrate_VVB that_CST IL-12_NN does_VDZ not_RR induce_VVB extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) or_CC c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) activation_NN in_II T_NN and_CC natural_JJ killer_NN (_( NK_NN )_) cells_NNS and_CC that_CST IL-12-induced_VVNJ STAT4_NN transcriptional_JJ activity_NN is_VBZ not_RR affected_VVN by_II these_DD kinases_NNS ._.
P10965886A04
The_DD purpose_NN of_II the_DD present_JJ study_NN was_VBD to_TO investigate_VVI the_DD role_NN of_II the_DD MAP_NN kinase_NN pathway_NN in_II regulating_VVGN IGFBP-1_NN synthesis_NN by_II IL-1beta_NN ._.
P10969830A06
Inhibition_NN of_II ERK-1_NN /_SYM 2_MC and_CC p38_NN did_VDD not_RR prevent_VVB but_CC aggravated_VVD IL-1beta-induced_VVNJ cell_NN death_NN ._.
P10971222A01
Activation_NN of_II mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinases_NNS has_VHZ been_VBN implicated_VVN in_II the_DD signal_NN transduction_NN pathways_NNS linking_VVG exercise_NN to_II adaptive_JJ changes_NNS of_II muscle_NN protein_NN expression_NN ._.
P10972672A09
Pretreatment_NN with_II MAP_NN kinase_NN kinase_NN inhibitor_NN PD098059_NN or_CC JNK-c-Jun_NN /_SYM AP-1_NN inhibitor_NN curcumin_NN attenuated_VVD the_DD H2O2-induced_VVNJ apoptosis_NN ._.
P10989603A05
Among_II MAPK_NN ,_, extracellular-signal_NN related_VVNJ kinase_NN (_( ERK_NN )_) 1_MC /_SYM 2_MC was_VBD activated_VVN by_II UV_NN regardless_II+ of_II the_DD oxidative_JJ level_NN ,_, while_CS c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) activation_NN was_VBD inhibited_VVN in_II NAC-treated_VVNJ and_CC in_II hypoxic_JJ cultures_NNS ._.
P10994762A03
Therefore_RR ,_, the_DD present_JJ study_NN aimed_VVD to_TO determine_VVI whether_CST the_DD trophic_JJ effects_NNS of_II AngII_NN and_CC the_DD AngII-induced_VVNJ haemodynamic_JJ load_NN were_VBD associated_VVN with_II specific_JJ cardiac_JJ MAPK_NN pathways_NNS during_II the_DD development_NN of_II hypertrophy_NN ._.
P10994854A04
Peak_JJ expression_NN represented_VVD a_DD 2.7-fold_NN ,_, 3.7-fold_NN ,_, and_CC 4.8-fold_NN increase_NN in_II each_PND of_II these_DD MAPKs_NNS ,_, respectively_RR ._.
P10995825A01
Long-term_NN potentiation_NN (_( LTP_NN )_) in_II perforant_JJ path-granule_NN cell_NN synapses_NNS is_VBZ decreased_VVN in_II aged_VVNJ rats_NNS ,_, stressed_VVNJ rats_NNS ,_, and_CC rats_NNS injected_VVN intracerebroventricularly_RR with_II the_DD proinflammatory_JJ cytokine_NN interleukin-1beta_NN (_( IL-1beta_NN )_) ._.
P10997694A04
Here_RR ,_, we_PN examine_VVB the_DD role_NN of_II MAPKs_NNS in_II TGF-beta-induced_VVNJ gene_NN expression_NN of_II extracellular_JJ matrix_NN proteins_NNS in_II mesangial_JJ cells_NNS ._.
P10999952A03
Using_VVG Chinese_NN hamster_NN ovary_NN cells_NNS stably_RR transfected_VVN with_II the_DD CB_NN (_( 1_MC )_) receptor_NN cDNA_NN ,_, we_PN show_VVB here_RR that_CST Delta_NN (_( 9_MC )_) -tetrahydrocannabinol_NN (_( THC_NN )_) ,_, the_DD major_JJ active_JJ component_NN of_II marijuana_NN ,_, induces_VVZ the_DD activation_NN of_II c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) ._.
P11002425A08
These_DD results_NNS implicate_VVB ERK_NN activation_NN in_II EWS_NN /_SYM FLI-1_NN transformation_NN and_CC suggest_VVB that_CST this_DD signaling_VVGJ pathway_NN may_VM be_VBB important_JJ in_II the_DD pathogenesis_NN of_II Ewing_NN 's_GE sarcoma_NN ._.
P11003655A04
We_PN have_VHB identified_VVN the_DD guanine_NN nucleotide_NN exchange_NN factors_NNS Sos1_NN and_CC Sos2_NN as_II novel_JJ binding_VVGJ partners_NNS of_II Abi-1_NN ._.
P11004363A01
OBJECTIVE_NN :_: To_TO investigate_VVI whether_CST the_DD activity_NN of_II the_DD three_MC mitogen-activated_VVNJ protein_NN kinases_NNS (_( Jun_NN aminoterminal_JJ kinase_NN ,_, extracellular_JJ regulated_VVNJ kinase_NN ,_, and_CC p38_NN )_) is_VBZ altered_VVN in_II placental_JJ tissue_NN of_II women_NNS with_II preeclampsia_NN and_CC hemolysis_NN ,_, elevated_VVNJ liver_NN enzymes_NNS ,_, low_JJ platelets_NNS (_( HELLP_NN )_) syndrome_NN ._.
P11005808A05
A_DD MEK-specific_JJ inhibitor_NN ,_, PD98059_NN ,_, inhibited_VVD heat_NN shock_NN ERK_NN MAPK_NN activation_NN by_II >_SYM 75_MC %_SYM ._.
P11006227A08
The_DD PI-3_NN kinase_NN 85-kDa_NN subunit_NN was_VBD decreased_VVN 25_MC %_SYM in_II LY294002-treated_VVNJ tissue_NN ,_, and_CC collagen_NN binding_VVGN also_RR decreased_VVD significantly_RR in_II tissues_NNS treated_VVN with_II MEK-1_NN and_CC PI-3_NN kinase_NN inhibitors_NNS compared_VVN with_II control_NN tissues_NNS ._.
P11006268A10
The_DD protein_NN kinase_NN A_NN inhibitor_NN H89_NN inhibited_VVD the_DD stimulation_NN of_II phosphorylation_NN of_II p38-MAPKs_NNS by_II forskolin_NN ,_, whereas_CS inhibitors_NNS of_II protein_NN kinase_NN C_NN ,_, p70_NN (_( S6k_NN )_) ,_, and_CC phosphatidylinositol_NN 3-kinase_NN were_VBD ineffective_JJ ._.
P11010976A04
We_PN also_RR found_VVD that_CST the_DD preferential_JJ activation_NN of_II p38alpha_NN by_II MKK6_NN correlated_VVD with_II more_RR efficient_JJ binding_VVGN of_II MKK6_NN to_II p38alpha_NN than_CSN to_II p38gamma_NN ._.
P11012613A05
Further_RR ,_, SB_NN 203580_MC ,_, a_DD specific_JJ p38_NN MAPK_NN inhibitor_NN ,_, was_VBD additive_JJ with_II dexamethasone_NN in_II inducing_VVGN eosinophil_NN apoptosis_NN ,_, while_CS JNK1_NN /_SYM 2_MC antisense_NN phosphorothioate_NN oligodeoxynucleotides_NNS did_VDD not_RR show_VVB any_DD significant_JJ effect_NN ._.
P11012878A02
The_DD induction_NN of_II c-fos_NN in_II response_NN to_II MC_NN stretch_NN has_VHZ been_VBN shown_VVN ._.
P11012878A14
Nuclear_JJ protein_NN binding_VVGN to_II AP-1_NN was_VBD also_RR determined_VVN under_II these_DD conditions_NNS ._.
P11013043A06
The_DD ECs_NNS were_VBD then_RR subjected_VVN to_II 10_MC dyne_NN /_SYM cm_NN (_( 2_MC )_) shear_NN with_II the_DD use_NN of_II a_DD parallel_JJ flow_NN chamber_NN for_II up_RR+ to_RR 120_MC minutes_NNS ._.
P11016630A01
Methyl_NN methanesulfonate_NN (_( MMS_NN )_) ,_, a_DD direct-acting_VVGJ alkylating_VVGJ agent_NN ,_, is_VBZ a_DD strong_JJ brain_NN carcinogen_NN but_CC a_DD poor_JJ hepatocarcinogen_NN in_II rats_NNS ._.
P11018755A02
We_PN have_VHB used_VVN a_DD non-mammalian_JJ vertebrate_NN model_NN ,_, the_DD frog_NN Rana_NN esculenta_NN ,_, to_TO investigate_VVI the_DD regulation_NN of_II extracellular_JJ signal-regulated_VVNJ kinase_NN 1_MC and_CC 2_MC (_( ERK1_NN /_SYM 2_MC )_) activity_NN in_II the_DD testis_NN during_II the_DD annual_JJ sexual_JJ cycle_NN and_CC to_TO study_VVI whether_CST E_NN (_( 2_MC )_) exerts_VVZ a_DD role_NN in_II spermatogenesis_NN through_II the_DD regulation_NN of_II ERK1_NN /_SYM 2_MC activity_NN ._.
P11023661A09
These_DD studies_NNS demonstrate_VVB cooperation_NN between_II the_DD MAPK_NN and_CC NF-kappaB_NN signaling_VVGJ pathways_NNS for_II IL-1-dependent_JJ collagenase-1_NN transcription_NN ,_, and_CC they_PN define_VVB a_DD dichotomy_NN of_II IL-1-_MC and_CC TNF-elicited_VVNJ signaling_VVGN that_PNR is_VBZ relevant_JJ to_II cytokine-mediated_VVNJ connective_JJ tissue_NN disease_NN ._.
P11027277A11
The_DD results_NNS of_II this_DD study_NN suggest_VVB that_CST PI3-K_NN may_VM be_VBB required_VVN for_II the_DD signals_NNS initiated_VVN by_II TrkA_NN internalization_NN and_CC demonstrate_VVB that_CST specific_JJ endocytic_JJ events_NNS may_VM distinguish_VVB ERK_NN signaling_VVGN via_II Rap1_NN and_CC Ras_NN ._.
P11027490A07
These_DD findings_NNS establish_VVB a_DD key_JJ role_NN for_II p38_NN MAPK_NN in_II antigen_NN receptor-mediated_VVNJ apoptosis_NN of_II CH31_NN B_NN cells_NNS ._.
P11031257A02
Blockade_NN of_II the_DD ERK_NN pathway_NN by_II treatment_NN with_II PD98059_NN ,_, a_DD specific_JJ inhibitor_NN of_II mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN /_SYM ERK_NN kinase_NN (_( MEK_NN )_) ,_, completely_RR suppressed_VVD the_DD growth_NN of_II tumor_NN cells_NNS in_II which_PNR the_DD pathway_NN is_VBZ constitutively_RR activated_VVN (_( RPMI-SE_NN and_CC HT1080_NN cells_NNS )_) ._.
P11032876A05
Finally_RR ,_, transfection_NN of_II p38AGF_NN ,_, which_PNR exhibits_VVZ a_DD mutated_VVNJ activation_NN loop_NN ,_, inhibited_VVD cAMP-mediated_VVNJ neuronal_JJ differentiation_NN ._.
P11032891A03
The_DD regulation_NN of_II COX_NN expression_NN in_II neuronal_JJ cells_NNS is_VBZ only_RR partly_RR understood_VVN and_CC has_VHZ been_VBN mainly_RR linked_VVN to_II synaptic_JJ activity_NN ._.
P11035106A05
Pseudosubstrate-specific_JJ peptides_NNS with_II attached_VVNJ myristic_JJ acid_NN are_VBB cell_NN permeable_JJ and_CC can_VM be_VBB used_VVN to_TO block_VVI the_DD activity_NN of_II specific_JJ PKC_NN isoforms_NNS in_RR+ vivo_RR ._.
P11040101A10
Together_RR ,_, these_DD results_NNS indicate_VVB that_CST IL-1_NN beta_NN induces_VVZ VEGF_NN gene_NN expression_NN at_II both_DD transcriptional_JJ and_CC post-transcriptional_JJ levels_NNS ,_, and_CC IL-1_NN beta_NN evokes_VVZ p38_NN MAPK_NN and_CC JNK_NN signalings_NNS ,_, which_PNR in_II turn_NN stimulate_VVB the_DD transcription_NN of_II the_DD VEGF_NN gene_NN through_II Sp1-binding_VVGJ sites_NNS ._.
P11040243A11
These_DD data_NNS suggest_VVB that_CST the_DD activation_NN of_II Ras_NN and_CC CYP450_NN contributes_VVZ to_II the_DD development_NN of_II Ang_NN II-dependent_JJ hypertension_NN and_CC associated_VVNJ vascular_JJ pathology_NN ._.
P11041451A10
Moreover_RR ,_, Gs_NN or_CC Gi_NN /_SYM Go_NN proteins_NNS do_VDB not_RR appear_VVB to_TO participate_VVI in_II p42_NN /_SYM p44_NN MAPK_NN activation_NN ._.
P11044439A06
Finally_RR ,_, we_PN investigated_VVD the_DD molecular_JJ mechanism_NN of_II JSAP1_NN 's_GE inhibitory_JJ function_NN and_CC showed_VVD that_CST JSAP1_NN prevents_VVZ MEK1_NN phosphorylation_NN and_CC activation_NN by_II Raf-1_NN ,_, resulting_VVG in_II the_DD suppression_NN of_II the_DD activation_NN of_II ERK_NN ._.
P11048642A04
The_DD ras_NN transformed_VVNJ cells_NNS formed_VVD numerous_JJ spikes_NNS at_II the_DD edges_NNS of_II cells_NNS and_CC showed_VVD loss_NN of_II contact_NN inhibition_NN ._.
P11050008A02
An_DD improved_VVNJ understanding_VVGN of_II the_DD mechanisms_NNS of_II malarial_JJ clearance_NN may_VM facilitate_VVB the_DD development_NN of_II new_JJ therapeutic_JJ interventions_NNS ._.
P11050045A01
Persistent_JJ hepatitis_NN C_NN virus_NN (_( HCV_NN )_) infection_NN is_VBZ associated_VVN with_II the_DD development_NN of_II human_NN hepatocellular_JJ carcinoma_NN (_( HCC_NN )_) ,_, although_CS the_DD mechanism_NN of_II HCV-related_VVNJ hepatocarcinogenesis_NN remains_VVZ unclear_JJ ._.
P11053245A06
In_II contrast_NN to_II ischemia_NN ,_, brief_JJ ,_, lethal-simulated_VVNJ ischemia_NN activated_VVD only_RR p38_NN (_( 2.8_MC +/-_SYM 0.45_MC vs._CC basal_JJ ,_, P_NN <_SYM 0.01_MC )_) ,_, which_PNR was_VBD attenuated_VVN by_II expression_NN of_II active_JJ PKC-delta_NN or_CC by_II preconditioning_VVGN (_( 0.48_MC +/-_SYM 0.1_MC vs._CC ischemia_NN ,_, P_NN <_SYM 0.01_MC )_) ._.
P11053253A07
Other_JJ potential_JJ targets_NNS of_II ceramide_NN in_II the_DD control_NN of_II cell_NN fate_NN ,_, namely_RR ,_, c-Jun_NN amino-terminal_JJ kinase_NN ,_, p38_NN mitogen-activated_VVNJ protein_NN kinase_NN ,_, and_CC protein_NN kinase_NN B_NN ,_, were_VBD not_RR significantly_RR affected_VVN in_II astrocytes_NNS exposed_VVN to_II palmitate_NN ._.
P11053415A01
The_DD intensity_NN and_CC duration_NN of_II an_DD inflammatory_JJ response_NN depends_VVZ on_II the_DD balance_NN of_II factors_NNS that_PNR favor_VVB perpetuation_NN versus_CC resolution_NN ._.
P11057029A07
Their_PNG pro-apoptotic_JJ effect_NN ,_, however_RR ,_, was_VBD neither_CC mimicked_VVN nor_CC modified_VVN by_II an_DD additional_JJ inhibition_NN of_II MEK_NN /_SYM ERK_NN kinase_NN by_II 50_MC microM_NN PD_NN 98059_MC ,_, resulting_VVG in_II an_DD 80_MC %_SYM inhibition_NN of_II its_PNG initial_JJ activity_NN ._.
P11057428A08
The_DD contribution_NN of_II ERK_NN to_II cell_NN growth_NN was_VBD supported_VVN by_II the_DD observation_NN that_CST addition_NN of_II PD98059_NN ,_, a_DD specific_JJ inhibitor_NN of_II MAPK_NN kinase_NN ,_, significantly_RR attenuated_VVN the_DD increase_NN in_II endothelial_JJ cell_NN numbers_NNS induced_VVN by_II HGF_NN ,_, in_II a_DD dose-dependent_JJ manner_NN ._.
P11058801A07
These_DD findings_NNS indicate_VVB that_CST JNK_NN and_CC p38_NN MAPK_NN pathways_NNS may_VM play_VVB important_JJ roles_NNS in_II neuronal_JJ death_NN during_II brain_NN ischemia_NN ._.
P11062705A10
Genetic_JJ and_CC pharmacologic_JJ inhibition_NN of_II ERK1_NN activity_NN was_VBD sufficient_JJ to_TO reproduce_VVI the_DD effects_NNS of_II ATF-2_NN on_II cell_NN cycle_NN progression_NN and_CC proliferation_NN ._.
P11069059A07
Collectively_RR ,_, these_DD results_NNS suggest_VVB that_CST the_DD p38_NN MAPK_NN pathway_NN is_VBZ stimulated_VVN during_II the_DD development_NN of_II NK_NN cell-mediated_VVNJ cytotoxicity_NN and_CC that_CST efficient_JJ killing_VVGN is_VBZ influenced_VVN by_II both_CC p38-dependent_JJ and_CC p38-independent_JJ pathways_NNS ._.
P11069918A09
This_DD work_NN also_RR suggests_VVZ that_CST whereas_CS MAPKs_NNS utilize_VVB docking_VVGJ interactions_NNS to_TO bind_VVI substrates_NNS ,_, they_PN can_VM be_VBB weak_JJ and_CC transient_JJ in_II nature_NN ,_, providing_VVG just_RR enough_DD binding_VVGJ energy_NN to_TO promote_VVI the_DD phosphorylation_NN of_II a_DD specific_JJ substrate_NN ._.
P11071904A08
This_DD sequence_NN of_II events_NNS provides_VVZ a_DD model_NN for_II efficient_JJ cell_NN scattering_VVGN by_II SF_NN /_SYM HGF_NN at_II low_JJ cell_NN density_NN ._.
P11071910A09
Complete_JJ inhibition_NN of_II the_DD MEK_NN /_SYM ERK_NN pathway_NN causes_VVZ 50_MC %_SYM decrease_NN of_II D2_NN expression_NN ._.
P11073940A07
Activation_NN of_II BMK1_NN /_SYM ERK5_NN by_II epidermal_JJ growth_NN factor_NN and_CC H2O2_NN in_II Cos7_NN and_CC HEK293_NN cells_NNS was_VBD completely_RR blocked_VVN by_II a_DD kinase-inactive_JJ MEKK3_NN (_( MEKK3kin_NN (_( -_SYM )_) )_) ,_, whereas_CS MEKK2kin_NN (_( -_SYM )_) had_VHD no_DD effect_NN ._.
P11074940A01
Stress_NN responses_NNS induced_VVN in_II fibroblasts_NNS by_II cryopreservation_NN were_VBD compared_VVN in_II suspension_NN or_CC three-dimensional_JJ cultures_NNS at_II various_JJ times_NNS up_II+ to_II 5_MC days_NNS of_II recovery_NN ._.
P11076965A10
In_II addition_NN ,_, we_PN show_VVB that_CST the_DD polyamine_NN biosynthetic_JJ enzymes_NNS require_VVB c-Jun_NN activation_NN for_II eliciting_VVGN their_PNG biological_JJ effects_NNS ._.
P11078444A02
In_II this_DD article_NN ,_, we_PN investigated_VVD the_DD effect_NN of_II osmotic_JJ shock_NN and_CC insulin_NN on_II the_DD activation_NN of_II the_DD mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) cascades_NNS in_II differentiated_VVNJ 3T3-L1_NN adipocytes_NNS ._.
P11078444A13
Insulin_NN and_CC osmotic_JJ shock-stimulated_VVNJ glucose_NN transport_NN was_VBD not_RR inhibited_VVN by_II any_DD inhibitor_NN at_II concentrations_NNS that_PNR were_VBD shown_VVN to_TO block_VVI p38_NN MAPK_NN activity_NN ._.
P11078445A06
In_JJ+ vitro_JJ insulin_NN treatment_NN (_( 1_MC nmol_NN /_SYM l_NN over_II 4_MC min_NN )_) and_CC electrically-induced_VVNJ contraction_NN of_II isolated_VVNJ extensor_NN digitorum_NN longus_NN (_( EDL_NN )_) muscle_NN also_RR doubled_VVD the_DD kinase_NN activity_NN of_II p38_NN MAPKalpha_NN and_CC p38_NN MAPKbeta_NN ._.
P11080183A08
A_DD cause-effect_NN relationship_NN between_II agonist-dependent_JJ AA_NN release_NN and_CC stimulation_NN of_II MAPKs_NNS ,_, but_CC not_RR the_DD opposite_NN ,_, was_VBD suggested_VVN by_II activation_NN of_II JNK_NN by_II exogenous_JJ AA_NN and_CC by_II the_DD observation_NN that_CST inhibition_NN of_II MAPK_NN kinase_NN or_CC p38_NN MAPK_NN was_VBD inconsequential_JJ to_II ET-1-induced_VVNJ AA_NN release_NN ._.
P11080191A02
Because_CS neuronal_JJ mechanisms_NNS controlling_VVG these_DD responses_NNS are_VBB not_RR known_VVN ,_, these_PND were_VBD investigated_VVN in_II human_NN neuroblastoma_NN SH-SY5Y_NN cells_NNS ._.
P11082122A08
In_II contrast_NN ,_, SN50_NN failed_VVD to_TO affect_VVI the_DD release_NN of_II GM-CSF_NN from_II the_DD same_JJ monocyte_NN cultures_NNS ._.
P11082292A04
We_PN provide_VVB a_DD strong_JJ argument_NN indicating_VVG the_DD existence_NN of_II a_DD direct_JJ correlation_NN between_II JNK1_NN activation_NN and_CC cyclin_NN D2_NN stimulation_NN ._.
P11082445A05
Among_II all_DD known_VVNJ PTX-insensitive_JJ G_NN proteins_NNS ,_, G_NN (_( z_NN )_) ,_, G_NN (_( 12_MC )_) ,_, G_NN (_( 14_MC )_) ,_, and_CC G_NN (_( 16_MC )_) seemed_VVD to_TO have_VHI functional_JJ coupling_VVGN with_II the_DD ORL_NN (_( 1_MC )_) receptor_NN in_II terms_NNS of_II JNK_NN activation_NN ._.
P11085325A09
Neurotoxicant-induced_VVNJ reductions_NNS in_II striatal_JJ levels_NNS of_II DA_NN and_CC tyrosine_NN hydroxylase_NN (_( TH_NN )_) paralleled_VVD the_DD temporal_JJ profile_NN of_II GFAP_NN induction_NN ._.
P11087751A02
In_II the_DD present_JJ study_NN ,_, we_PN analyzed_VVD the_DD role_NN of_II mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinases_NNS in_II the_DD induction_NN of_II TNF-alpha_NN by_II glass_NN fibers_NNS ._.
P11089552A05
In_II DCT_NN cells_NNS ,_, stimulation_NN of_II calcium_NN entry_NN with_II ionomycin_NN did_VDD not_RR activate_VVB ERK2_NN or_CC augment_VVB PTH-stimulated_VVNJ ERK2_NN activity_NN ,_, indicating_VVG that_CST MAPK_NN activation_NN lies_VVZ upstream_JJ of_II calcium_NN entry_NN ._.
P11090594A03
Cyclic_JJ strain_NN induced_VVD activation_NN of_II extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN ;_: 1.5-fold_NN )_) ,_, c-Jun_NN NH_NN (_( 2_MC )_) -terminal_JJ protein_NN kinase_NN (_( JNK_NN ;_: 1.9-fold_NN )_) ,_, and_CC p38_NN (_( 1._MC 5-fold_NN )_) with_II a_DD peak_NN at_II 30_MC min_NN ._.
P11093788A02
Tyrosine_NN kinase_NN inhibitors_NNS (_( genistein_NN or_CC tyrphostin_NN 23_MC )_) or_CC phosphatidylcholine-specific_JJ phospholipase_NN C_NN inhibitor_NN (_( D609_NN )_) attenuated_VVD IL-1beta-induced_VVNJ ICAM-1_NN expression_NN ._.
P11093794A07
Furthermore_RR ,_, we_PN determined_VVD whether_CST the_DD RANK_NN engagement_NN of_II JNK_NN signaling_VVGJ pathways_NNS could_VM lead_VVB to_II the_DD activation_NN of_II the_DD activator_NN protein_NN 1_MC (_( AP-1_NN )_) transcription_NN factor_NN ,_, one_MC of_II the_DD potential_JJ downstream_JJ targets_NNS of_II activated_VVNJ JNK_NN ._.
P11094337A06
In_II one_MC case_NN ,_, we_PN identified_VVD a_DD compact_JJ RNA_NN structural_JJ domain_NN responsible_JJ for_II inhibition_NN ._.
P11095645A08
Overexpression_NN of_II MAPK_NN phosphatase_NN CL_NN 100_MC prevented_VVD TGF-beta1_NN promoter_NN activation_NN by_II high_JJ glucose_NN ,_, confirming_VVG the_DD involvement_NN of_II the_DD MEK-ERK_NN pathway_NN in_II response_NN to_II high_JJ glucose_NN ._.
P11101507A01
Members_NNS of_II the_DD mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) cascade_NN such_II+ as_II extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) ,_, c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) and_CC p38_NN are_VBB implicated_VVN as_II important_JJ regulators_NNS of_II cardiomyocyte_NN hypertrophic_JJ growth_NN in_II culture_NN ._.
P11103805A03
However_RR ,_, Bcl-2_NN phosphorylation_NN has_VHZ been_VBN reported_VVN to_TO occur_VVI at_II G2-M_NN in_II nonapoptotic_JJ cells_NNS ,_, raising_VVG the_DD possibility_NN that_CST this_DD and_CC perhaps_RR other_DD signaling_VVGJ pathways_NNS altered_VVN by_II microtubule_NN inhibitors_NNS reflect_VVB perturbations_NNS of_II normal_JJ mitotic_JJ events_NNS ._.
P11104828A02
LL-Z1640-2_NN ,_, a_DD macrocyclic_JJ nonaketide_NN ,_, inhibited_VVD HgCl2-induced_VVNJ JNK_NN phosphorylation_NN at_II 5-100_MC ng_NN /_SYM ml_NN ._.
P11108246A01
Tumor_NN necrosis_NN factor-alpha_NN (_( TNFalpha_NN )_) induces_VVZ apoptosis_NN and_CC cell_NN growth_NN inhibition_NN in_II primary_JJ rat_NN fetal_JJ brown_JJ adipocytes_NNS ._.
P11108246A13
These_DD results_NNS suggest_VVB that_CST p38MAPK_NN mediates_VVZ TNFalpha-induced_VVNJ apoptosis_NN and_CC cell_NN cycle_NN arrest_NN ,_, whereas_CS ERKs_NNS do_VDB the_DD opposite_NN ,_, and_CC JNKs_NNS play_VVB no_DD role_NN in_II this_DD process_NN of_II apoptosis_NN ._.
P11114188A05
ERK1_NN /_SYM 2_MC are_VBB components_NNS of_II the_DD Ras-mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) signal_NN transduction_NN pathway_NN ._.
P11118293A06
Finally_RR ,_, the_DD two_MC inhibitors_NNS suppressed_VVD [_( (_( 3_MC )_) H_NN ]_) thymidine_NN incorporation_NN into_II DNA_NN in_II MC3T3-E1_NN cells_NNS at_II a_DD normal_JJ level_NN of_II Ca_NN (_( 2+_MC )_) (_( o_NN )_) (_( 1.8_MC mM_NN )_) as_CC+ well_CC+ as_CC when_CS stimulated_VVN by_II high_JJ (_( 4.5_MC mM_NN )_) Ca_NN (_( 2+_MC )_) (_( o_NN )_) ,_, Gd_NN (_( 3+_MC )_) ,_, or_CC neomycin_NN ._.
P11121021A04
At_II 3-6_MC h_NN ,_, the_DD activities_NNS of_II ERK1_NN /_SYM 2_MC ,_, JNK_NN ,_, Cdk5_NN ,_, and_CC GSK-3beta_NN toward_II selective_JJ substrates_NNS were_VBD increased_VVN ;_: however_RR ,_, only_RR JNK_NN ,_, Cdk5_NN ,_, and_CC GSK-3beta_NN but_CC not_RR ERK1_NN /_SYM 2_MC were_VBD overactivated_VVN toward_II purified_VVNJ bovine_JJ tau_NN ._.
P11121686A05
PTH-induced_VVNJ MAPK_NN phosphorylation_NN was_VBD effectively_RR suppressed_VVN by_II the_DD tyrosine-kinase_NN inhibitors_NNS ,_, genistein_NN (_( 100microM_NN )_) and_CC herbimycin_NN (_( 2microM_NN )_) ._.
P11127202A04
SB203580_NN ,_, an_DD inhibitor_NN of_II p38_NN MAP_NN kinase_NN ,_, markedly_RR enhanced_VVD the_DD bFGF-induced_VVNJ VEGF_NN release_NN ._.
P11133526A05
Fura_NN 2_MC ratiometry_NN was_VBD used_VVN to_TO assess_VVI the_DD effect_NN of_II urea_NN treatment_NN on_II intracellular_JJ calcium_NN mobilization_NN ._.
P11134043A03
Here_RR we_PN show_VVB that_CST secretion_NN of_II tumor_NN necrosis_NN factor-alpha_NN induced_VVN by_II Treponema_NN culture_NN supernatants_NNS and_CC extracted_VVNJ LTA_NN was_VBD paralleled_VVN by_II an_DD LBP-dependent_JJ phosphorylation_NN of_II mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) p42_NN and_CC p44_NN ,_, and_CC p38_NN ,_, as_CC+ well_CC+ as_CC the_DD stress-activated_VVNJ protein_NN kinases_NNS c-Jun_NN N-terminal_JJ kinases_NNS 1_MC and_CC 2_MC ._.
P11134332A06
The_DD activation_NN of_II p38_NN by_II Irak_NN requires_VVZ Irak_NN 's_GE kinase_NN activity_NN ._.
P11135575A05
We_PN also_RR show_VVB that_CST there_EX are_VBB differences_NNS in_II the_DD signaling_VVGJ thresholds_NNS of_II the_DD three_MC mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) families_NNS ._.
P11139390A03
We_PN have_VHB used_VVN well-characterized_VVNJ inhibitors_NNS for_II proteins_NNS involved_VVN in_II different_JJ signalling_VVGJ cascades_NNS to_TO assess_VVI the_DD involvement_NN of_II these_DD pathways_NNS on_II the_DD transcriptional_JJ regulation_NN of_II glucocorticoid-stimulated_VVNJ PF2K_NN /_SYM Fru-2_NN ,_, 6-BPase_NN by_II insulin_NN ._.
P11141234A09
The_DD activity_NN of_II p38_NN was_VBD lowest_JJT immediately_RR after_II isolation_NN ,_, increasing_VVG progressively_RR with_II time_NN ._.
P11146006A02
Phosphorylation_NN of_II APPthr_NN (_( 668_MC )_) is_VBZ believed_VVN to_TO regulate_VVI APP_NN function_NN and_CC metabolism_NN ._.
P11156183A02
Recent_JJ studies_NNS of_II GTP_NN extracts_NNS showed_VVD the_DD involvement_NN of_II mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) in_II the_DD regulation_NN of_II Phase_NN II_MC enzymes_NNS gene_NN expression_NN and_CC induction_NN of_II apoptosis_NN ._.
P11156183A13
As_CS the_DD most_RRT abundant_JJ catechin_NN in_II GTP_NN extract_NN ,_, we_PN found_VVD that_CST EGCG_NN potently_RR induced_VVD ARE-mediated_VVNJ gene_NN expression_NN ,_, activated_VVD MAP_NN kinase_NN pathway_NN ,_, stimulated_VVD caspase-3_NN activity_NN ,_, and_CC induced_VVD apoptosis_NN ._.
P11158304A08
Rac1_NN may_VM stimulate_VVB the_DD ERK_NN cascade_NN either_CC by_II promoting_VVGN the_DD phosphorylation_NN of_II c-Raf_NN or_CC by_II increasing_VVGN MEK1_NN and/or_CC -2_MC association_NN with_II c-Raf_NN to_TO facilitate_VVI MEK1_NN and/or_CC -2_MC activation_NN ._.
P11159862A11
We_PN also_RR observed_VVD that_CST activation_NN of_II ERK_NN MAP_NN kinase_NN was_VBD required_VVN for_II the_DD expression_NN of_II c-fos_NN and_CC c-jun_NN mRNA_NN in_II response_NN to_II PGF2alpha_NN and_CC PMA_NN because_CS it_PN was_VBD abrogated_VVN by_II blocking_VVGN the_DD ERK_NN pathway_NN with_II PD098059_NN ._.
P11160612A09
No_DD effects_NNS of_II the_DD drug_NN were_VBD observed_VVN on_II cerebral_JJ perfusion_NN ,_, hemodynamics_NNS ,_, or_CC body_NN temperature_NN ._.
P11160653A08
Western_NN Blot_NN analysis_NN and_CC subsequent_JJ densitometry_NN corroborated_VVD these_DD observations_NNS ._.
P11160861A04
Furthermore_RR ,_, we_PN found_VVD that_CST the_DD full-length_NN MEKK1_NN was_VBD cleaved_VVN to_II a_DD 91-kDa_NN carboxyl-terminal_JJ fragment_NN at_II the_DD earlier_JJR time_NN of_II apoptosis_NN induced_VVN by_II microtubule-damaging_VVGJ agents_NNS ._.
P11161724A07
Therefore_RR ,_, the_DD early_JJ transient_JJ phase_NN of_II ERK_NN activation_NN functioned_VVD in_II signaling_VVGN chemotaxis_NN ;_: the_DD late_JJ sustained_VVNJ phase_NN of_II ERK_NN activation_NN did_VDD not_RR seem_VVB to_TO have_VHI an_DD essential_JJ role_NN ._.
P11162624A06
Furthermore_RR ,_, expression_NN of_II a_DD dual_JJ specificity_NN phosphatase_NN capable_JJ of_II inactivating_VVGN ERK_NN known_VVN as_II mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN phosphatase-2_NN (_( MKP-2_NN )_) was_VBD elevated_VVN in_II most_PND of_II the_DD pancreatic_JJ tumor_NN cell_NN lines_NNS and_CC correlated_VVN with_II the_DD presence_NN of_II active_JJ MAP_NN kinase_NN kinase_NN (_( MEK_NN )_) ._.
P11162898A11
Placental_JJ JEG-3_NN cells_NNS were_VBD treated_VVN with_II (_( D-Ala_NN (_( 6_MC )_) )_) -GnRH_NN for_II 24_MC h_NN ,_, and_CC betahCG_NN mRNA_NN level_NN was_VBD measured_VVN using_VVG Northern_NN blot_NN analysis_NN ._.
P11163183A02
LPS_NN stimulation_NN of_II peritoneal_JJ macrophages_NNS from_II these_DD mice_NNS did_VDD not_RR activate_VVB MEK1_NN ,_, ERK1_NN ,_, and_CC ERK2_NN but_CC did_VDD activate_VVB JNK_NN ,_, p38_NN MAPK_NN ,_, and_CC NF-kappaB_NN ._.
P11166122A11
That_CST 5-HT_NN (_( 7_MC )_) receptors_NNS couple_VVB to_II activation_NN of_II extracellular_JJ signal-regulated_VVNJ kinase_NN in_II hippocampal_JJ neurons_NNS suggests_VVZ a_DD possible_JJ role_NN for_II 5-HT_NN (_( 7_MC )_) receptors_NNS in_II mediating_VVGN some_PND of_II the_DD actions_NNS of_II antidepressants_NNS that_PNR increase_VVB 5-hydroxytryptamine_NN ._.
P11166517A08
These_DD results_NNS demonstrate_VVB that_CST chronic_JJ infusion_NN of_II PCP_NN in_II rats_NNS produces_VVZ a_DD differential_JJ and_CC brain_NN region-specific_JJ activation_NN of_II MAP_NN kinases_NNS ,_, suggesting_VVG a_DD role_NN for_II the_DD ERK_NN signaling_VVGJ pathway_NN in_II PCP_NN abuse_NN and_CC perhaps_RR in_II schizophrenia_NN ._.
P11169731A04
In_II the_DD first_JJ phase_NN ,_, which_PNR lasts_VVZ 24-48_MC h_NN ,_, the_DD cells_NNS continued_VVD in_II the_DD normal_JJ cell_NN cycle_NN while_CS expressing_VVG markers_NNS of_II monocytic_JJ phenotype_NN ,_, such_II+ as_II CD14_NN ._.
P11171562A09
Inhibition_NN of_II the_DD ERK_NN pathway_NN markedly_RR reduced_VVD IFN-gamma_NN +_SYM LPS-induced_VVNJ tumor_NN necrosis_NN factor-alpha_NN protein_NN expression_NN ,_, providing_VVG a_DD possible_JJ mechanism_NN by_II which_PNR ERK_NN augments_VVZ iNOS_NN expression_NN ._.
P11174007A09
This_DD finding_VVGN was_VBD confirmed_VVN by_II immunocomplex_NN JNK_NN activity_NN assay_NN using_VVG ATF-2_NN as_II substrate_NN ,_, which_PNR demonstrated_VVD a_DD significant_JJ increase_NN in_II JNK_NN activity_NN in_II the_DD left_JJ ventricle_NN of_II PHR_NN as_CS compared_VVN to_II PNR_NN (_( 6.4_MC +/-_SYM 1.5_MC vs._CC 2.5_MC +/-_SYM 0.5_MC OD_NN ;_: each_DD n_NN =_SYM 5_MC ;_: p_NN <_SYM 0.05_MC )_) ._.
P11174068A09
The_DD use_NN of_II these_DD compounds_NNS did_VDD not_RR significantly_RR alter_VVB the_DD inhibitory_JJ effects_NNS of_II GF_NN 109203X_NN or_CC calphostin_NN C_NN ._.
P11175257A04
Analysis_NN of_II PKC_NN isoform_NN expression_NN by_II immunoblot_NN shows_VVZ that_CST TPA-induced_VVNJ downregulation_NN of_II PKC_NN alpha_NN and_CC PKC_NN delta_NN is_VBZ delayed_VVN in_II cells_NNS pre-treated_VVN with_II calpeptin_NN ,_, and_CC that_CST this_PND correlates_VVZ with_II an_DD increase_NN of_II these_DD isoforms_NNS in_II the_DD membrane_NN fraction_NN of_II cells_NNS ._.
P11179198A02
However_RR ,_, additional_JJ factors_NNS appear_VVB to_TO modulate_VVI the_DD exact_JJ timing_VVGN and_CC rate_NN of_II NO-dependent_JJ apoptosis_NN ._.
P11179291A06
Inhibition_NN of_II MAP_NN kinases_NNS with_II PD98059_NN or_CC SB203580_NN did_VDD not_RR affect_VVB the_DD EPEC-induced_VVNJ decrease_NN in_II transepithelial_JJ resistance_NN or_CC actin_NN accumulation_NN beneath_II the_DD WT_NN bacteria_NN ,_, but_CC these_DD two_MC inhibitors_NNS significantly_RR decreased_VVD interleukin-8_NN (_( IL-8_NN )_) synthesis_NN ._.
P11179293A09
The_DD caspase_NN family_NN ,_, especially_RR caspase_NN 3_MC ,_, is_VBZ likely_RR to_TO play_VVI an_DD important_JJ role_NN in_II the_DD signal_NN transduction_NN for_II iNOS-mediated_VVNJ NO_NN production_NN in_II LPS-stimulated_VVNJ mouse_NN macrophages_NNS ._.
P11179444A07
Glutathione_NN ,_, a_DD neutral_JJ SMase_NN inhibitor_NN ,_, attenuated_VVD TNF-alpha-_NN or_CC SMase-induced_VVNJ activation_NN of_II MAPKs_NNS ,_, COX-2_NN expression_NN ,_, and_CC COX-2_NN promoter_NN activity_NN ._.
P11181412A01
Transforming_VVGJ growth_NN factor-beta_NN (_( 1_MC )_) (_( TGF-beta_NN (_( 1_MC )_) )_) is_VBZ a_DD potent_JJ inducer_NN of_II extracellular_JJ matrix_NN protein_NN synthesis_NN and_CC a_DD key_JJ mediator_NN of_II renal_JJ fibrosis_NN ._.
P11181412A12
Thus_RR we_PN show_VVB first_RR demonstration_NN of_II p38_NN MAPK_NN activation_NN by_II TGF-beta_NN (_( 1_MC )_) in_II mesangial_JJ cells_NNS ,_, and_CC ,_, given_VVN the_DD rapid_JJ kinetics_NNS ,_, this_DD TGF-beta_NN (_( 1_MC )_) effect_NN is_VBZ likely_JJ a_DD direct_JJ one_PN ._.
P11185956A06
Together_RR ,_, these_DD results_NNS suggest_VVB that_CST S1P_NN activates_VVZ the_DD EGF_NN receptor_NN through_II a_DD PKC-dependent_JJ pathway_NN that_PNR links_VVZ Ras_NN signaling_VVGN to_II the_DD activation_NN of_II Erk-1_NN /_SYM -2_MC in_II Rat-2_NN cells_NNS ._.
P11204428A11
Moreover_RR ,_, the_DD adhesions_NNS of_II alpha_NN (_( v_MC )_) beta3-cells_NNS to_II type_NN I_MC collagen_NN and_CC fibronectin_NN were_VBD inhibited_VVN ,_, which_PNR was_VBD attributed_VVN to_II decreased_VVNJ beta1-integrin_NN levels_NNS on_II cell_NN surface_NN ._.
P11207214A06
PDBu_NN induced_VVD (_( P_NN <_SYM 0.05_MC )_) activation_NN of_II the_DD Raf-1_NN /_SYM MEK-1_NN /_SYM ERK-1_NN /_SYM 2_MC pathway_NN ,_, which_PNR was_VBD obligatory_JJ for_II the_DD expression_NN of_II COX-2_NN and_CC secretion_NN of_II PGF_NN but_CC was_VBD not_RR altered_VVN by_II cotreatment_NN with_II rbIFN-tau_NN ._.
P11211919A05
BAPTA-AM_NN and_CC GF_NN 109203X_NN did_VDD not_RR attenuate_VVB the_DD formation_NN of_II F-actin_NN but_CC completely_RR inhibited_VVD the_DD activation_NN of_II NADPH_NN oxidase_NN ._.
P11211936A05
Neither_CC the_DD RARalpha_NN nor_CC RXR_NN selective_JJ ligands_NNS alone_JJ induced_VVD expression_NN of_II blr1_NN ,_, but_CC the_DD combination_NN of_II the_DD two_MC ligands_NNS induced_VVD the_DD expression_NN of_II blr1_NN to_II the_DD same_JJ extent_NN as_CSN RA_NN ._.
P11216996A06
RESULTS_NNS :_: The_DD ROS_NN levels_NNS in_II ET-1-_MC or_CC PE-stimulated_VVNJ myocytes_NNS were_VBD maximally_RR increased_VVN at_II 5_MC min_NN after_II stimulation_NN ._.
P11222496A03
Using_VVG human_NN monocytes_NNS and_CC the_DD human_NN monocytic_JJ cell_NN line_NN THP1_NN ,_, we_PN examined_VVD signal_NN transduction_NN events_NNS induced_VVN by_II CD40_NN engagement_NN with_II its_PNG ligand_NN ,_, CD154_NN ._.
P11222507A04
We_PN show_VVB that_CST CD28_NN co-stimulation_NN restores_VVZ normal_JJ TCR-induced_VVNJ activation_NN of_II Rac-1_NN and_CC p38_NN MAPK_NN in_II NOD_NN T_NN cells_NNS ._.
P11226388A07
Furthermore_RR ,_, adenosine_NN A_NN (_( 1_MC )_) receptor-mediated_VVNJ increases_NNS in_II p42_NN /_SYM p44_NN MAPK_NN were_VBD sensitive_JJ to_II the_DD MAPK_NN kinase_NN 1_MC inhibitor_NN PD_NN 98059_MC (_( 2'-amino-3'-methoxyflavone_NN )_) ,_, whereas_CS p38_NN MAPK_NN responses_NNS were_VBD blocked_VVN by_II the_DD p38_NN MAPK_NN inhibitor_NN SB_NN 203580_MC (_( 4-_MC (_( 4-fluorophenyl_NN )_) -2-_MC (_( 4-methylsulfinylphenyl_NN )_) -5-_MC (_( 4-pyridyl_NN )_) 1H-imidazole_NN )_) ._.
P11228094A04
H2O2_NN treatment_NN induced_VVD apoptosis_NN in_II H9c2_NN cells_NNS ,_, and_CC pretreatment_NN of_II cells_NNS with_II IGF-1_NN suppressed_VVD apoptotic_JJ cell_NN death_NN ._.
P11228545A09
We_PN conclude_VVB that_CST posttranscriptional_JJ mechanisms_NNS play_VVB an_DD important_JJ role_NN in_II the_DD regulation_NN of_II COX-2_NN expression_NN during_II carcinogenesis_NN ._.
P11230331A07
The_DD Ang_NN II-induced_VVNJ AT_NN (_( 1_MC )_) -R_NN mRNA_NN downregulation_NN was_VBD also_RR blocked_VVN by_II PD98059_NN ,_, an_DD extracellular_JJ signal-regulated_VVNJ protein_NN kinase_NN (_( ERK_NN )_) kinase_NN inhibitor_NN ._.
P11231289A02
Activation_NN by_II pI_NN :_: C_NN in_II IFN_NN alpha-primed_VVNJ cells_NNS was_VBD delayed_VVN compared_VVN to_II activation_NN with_II interleukin-1_NN beta_NN ,_, and_CC this_DD delay_NN was_VBD followed_VVN by_II high_JJ ,_, sustained_VVNJ activation_NN of_II p38_NN MAPK_NN and_CC a_DD modest_JJ elevation_NN of_II ERK_NN activation_NN ._.
P11232027A08
In_II contrast_NN ,_, MAPK_NN activation_NN was_VBD not_RR significantly_RR affected_VVN by_II pertussis_NN toxin_NN (_( 200_MC ng_NN /_SYM mL_NN ;_: a_DD G_NN (_( i_NN )_) inhibitor_NN )_) pretreatment_NN ._.
P11233147A06
An_DD intracellular_JJ Ca2+_NN chelator_NN (_( BAPTA-AM_NN )_) inhibited_VVD H2O2-induced_VVNJ phosphorylation_NN of_II SAPK_NN /_SYM JNK_NN ,_, but_CC an_DD extracellular_JJ Ca2+_NN chelator_NN (_( EDTA_NN )_) or_CC a_DD Ca2+_NN entry_NN blocker_NN (_( NiCl2_NN )_) did_VDD not_RR ._.
P11234901A10
Combined_VVNJ inhibition_NN of_II both_CC MAPK_NN and_CC IKK_NN pathways_NNS may_VM be_VBB needed_VVN for_II suppression_NN of_II the_DD signal_NN transduction_NN mechanism_NN (_( s_NNS )_) regulating_VVG VEGF_NN and_CC IL-8_NN secretion_NN and_CC angiogenesis_NN by_II human_NN HNSCC_NN ._.
P11237743A07
This_PND indicates_VVZ that_CST phorbol_NN ester-sensitive_JJ PKC_NN isoforms_NNS including_VVG PKCdelta_NN are_VBB involved_VVN in_II MAPK_NN activation_NN ._.
P11238741A06
Surprisingly_RR ,_, overexpression_NN of_II SPHK1_NN had_VHD no_DD effect_NN on_II activation_NN of_II two_MC known_VVNJ NGF-stimulated_VVNJ survival_NN pathways_NNS ,_, extracellular_JJ signal_NN regulated_VVNJ kinase_NN ERK_NN 1_MC /_SYM 2_MC and_CC Akt_NN ._.
P11243567A03
However_RR ,_, the_DD biochemical_JJ interactions_NNS of_II the_DD ACh_NN system_NN with_II the_DD immune_JJ system_NN have_VHB not_RR been_VBN elucidated_VVN in_II detail_NN ._.
P11245462A02
Here_RR ,_, the_DD relationship_NN between_II the_DD mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) response_NN and_CC apoptosis_NN in_II ML-1_NN cells_NNS treated_VVN with_II vinblastine_NN and_CC paclitaxel_NN was_VBD investigated_VVN ._.
P11245463A08
These_DD results_NNS suggest_VVB that_CST the_DD inhibition_NN of_II ERK1_NN /_SYM 2_MC phosphorylation_NN is_VBZ responsible_JJ for_II at_RR+ least_RR part_NN of_II the_DD induction_NN of_II programmed_VVNJ cell_NN death_NN by_II sulindac_NN metabolites_NNS ._.
P11245653A03
Cardiomyocytes_NNS were_VBD exposed_VVN to_II strain_NN (_( 4_MC %_SYM )_) during_II either_CC the_DD first_JJ third_NN (_( systolic_JJ phase_NN )_) or_CC last_JJ third_NN (_( diastolic_JJ phase_NN )_) of_II the_DD cardiac_JJ cycle_NN ._.
P11250939A08
VEGF_NN stimulated_VVD human_NN microvascular_JJ endothelial_JJ cells_NNS to_TO form_VVI capillary_NN tubes_NNS ,_, which_PNR was_VBD significantly_RR inhibited_VVN by_II expressing_VVGN dominant_JJ negative_JJ JNK-1_NN and_CC by_II NP_NN ._.
P11252631A07
MEK3_NN ,_, an_DD activator_NN of_II p38_NN kinase_NN ,_, was_VBD also_RR expressed_VVN in_II the_DD outer_JJ layer_NN ._.
P11254551A03
Specific_JJ pharmacologic_JJ inhibition_NN of_II the_DD extracellular-signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) or_CC NF-kappaB_NN pathway_NN revealed_VVD that_CST both_DB these_DD signaling_VVGJ cascades_NNS were_VBD required_VVN in_II gamma_NN interferon_NN (_( IFN-gamma_NN )_) -ManLAM-induced_VVNJ iNOS_NN protein_NN and_CC NO2-_MC expression_NN in_II mouse_NN macrophages_NNS ._.
P11254696A07
However_RR ,_, analysis_NN of_II the_DD dynamics_NNS of_II ERK2_NN and_CC MEK_NN suggested_VVD that_CST both_PND of_II them_PN rapidly_RR shuttle_VVB between_II the_DD cytoplasm_NN and_CC the_DD nucleus_NN and_CC that_CST MEK_NN regulates_VVZ the_DD nuclear_JJ shuttling_VVGN of_II ERK2_NN ,_, whereas_CS MEK_NN remains_VVZ mainly_RR in_II the_DD cytoplasm_NN ._.
P11255226A10
These_DD results_NNS support_VVB our_PNG proposal_NN that_CST early_JJ castration-induced_VVNJ degeneration_NN and_CC constriction_NN of_II the_DD vascular_JJ system_NN of_II the_DD rat_NN ventral_JJ prostate_NN gland_NN leads_VVZ to_II reduced_VVNJ oxygenation_NN of_II prostatic_JJ epithelial_JJ cells_NNS and_CC the_DD activation_NN of_II hypoxic_JJ cellular_JJ signaling_VVGN in_II these_DD cells_NNS through_II upregulation_NN of_II HIF-1-alpha_NN expression_NN and_CC stimulation_NN of_II the_DD JUN_NN kinase_NN signaling_VVGJ pathway_NN ._.
P11257452A05
Next_II ,_, LPS_NN is_VBZ transferred_VVN to_II the_DD transmembrane_JJ signaling_VVGJ receptor_NN toll-like_JJ receptor_NN 4_MC (_( TLR4_NN )_) and_CC its_PNG accessory_NN protein_NN MD2_NN ._.
P11262176A08
We_PN examined_VVD the_DD activation_NN of_II MAP_NN kinases_NNS during_II hemin-induced_VVNJ differentiation_NN ._.
P11266467A04
We_PN confirmed_VVD the_DD specificity_NN of_II this_DD interaction_NN in_RR+ vitro_RR by_II glutathione_NN S-transferase_NN pull-down_JJ assays_NNS and_CC by_II coimmunoprecipitation_NN ,_, cosedimentation_NN on_II glycerol_NN gradients_NNS ,_, and_CC colocalization_NN ._.
P11276120A09
On_II the_DD other_JJ hand_NN ,_, the_DD c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) and_CC p38_NN kinase_NN members_NNS of_II the_DD MAPK_NN family_NN appear_VVB to_TO regulate_VVI apoptotic_JJ events_NNS in_II OL_NN ._.
P11278318A05
Inhibition_NN of_II ERK_NN activity_NN enhanced_VVD gonadotropin-stimulated_VVNJ progesterone_NN production_NN ,_, which_PNR was_VBD correlated_VVN with_II increased_VVNJ expression_NN of_II the_DD steroidogenic_JJ acute_JJ regulatory_JJ protein_NN (_( StAR_NN )_) ,_, a_DD key_JJ regulator_NN of_II progesterone_NN synthesis_NN ._.
P11278385A07
Therefore_RR ,_, these_DD results_NNS demonstrate_VVB that_CST the_DD sequential_JJ ERK_NN /_SYM RSK1_NN /_SYM NF-kappaB_NN pathway_NN mediates_VVZ PMA-stimulated_VVNJ megakaryocytic_JJ differentiation_NN of_II K562_NN cells_NNS ._.
P11278392A04
IGF-I_NN induced_VVD a_DD rapid_JJ and_CC transient_JJ activation_NN of_II JNK_NN that_PNR peaked_VVD at_II 40_MC min_NN that_PNR was_VBD paralleled_VVN by_II a_DD transient_JJ and_CC robust_JJ phosphorylation_NN of_II c-Jun_NN ._.
P11278622A07
In_II T_NN cells_NNS ,_, MEKK2_NN was_VBD found_VVN to_TO be_VBI a_DD strong_JJ activator_NN of_II JNK_NN but_CC not_RR of_II extracellular_JJ signal-regulated_VVNJ kinase_NN MAPKs_NNS and_CC to_TO activate_VVI JNK-dependent_JJ AP-1_NN reporter_NN gene_NN expression_NN ._.
P11278768A02
These_DD mechanisms_NNS most_RRT likely_RR prevent_VVB chondrocyte_NN dedifferentiation_NN to_II fibroblast-like_JJ cells_NNS and_CC chondrocyte_NN death_NN ._.
P11278794A07
Closely_RR related_VVNJ protein_NN kinases_NNS (_( male_NN germ_NN cell-associated_VVNJ kinase_NN and_CC male_NN germ_NN cell-associated_VVNJ kinase-related_VVNJ kinase_NN )_) were_VBD also_RR found_VVN to_TO associate_VVI with_II HSP90_NN ,_, whereas_CS conventional_JJ mitogen-activated_VVNJ protein_NN kinases_NNS (_( extracellular_JJ signal-regulated_VVNJ kinase_NN ,_, p38_NN ,_, and_CC c-Jun_NN N-terminal_JJ kinase_NN /_SYM stress-activated_VVNJ protein_NN kinase_NN )_) were_VBD not_RR associated_VVN with_II HSP90_NN ._.
P11278848A07
To_TO understand_VVI the_DD events_NNS upstream_JJ of_II Sp1_NN activation_NN ,_, we_PN investigated_VVD the_DD role_NN of_II p38_NN and_CC extracellular_JJ signal-regulated_VVNJ kinase_NN mitogen-activated_VVNJ protein_NN kinases_NNS by_II using_VVGN their_PNG specific_JJ inhibitors_NNS ._.
P11278851A09
Furthermore_RR ,_, inhibition_NN of_II JNK_NN ,_, p38_NN MAPK_NN ,_, or_CC MEK_NN did_VDD not_RR alter_VVB PARP_NN cleavage_NN and_CC the_DD cell_NN death_NN induced_VVN by_II paclitaxel_NN ._.
P11279118A02
In_II this_DD study_NN ,_, we_PN examined_VVD the_DD ability_NN of_II TAO2_NN to_TO activate_VVI stress-sensitive_JJ MAP_NN kinase_NN pathways_NNS in_II cells_NNS and_CC the_DD relationship_NN between_II activation_NN of_II TAO2_NN and_CC potential_JJ downstream_JJ pathways_NNS ._.
P11279606A07
In_II agreement_NN with_II this_DD notion_NN ,_, transient_JJ expression_NN of_II active_JJ MEK1_NN prevented_VVD apoptosis_NN in_II serum-deprived_VVNJ condition_NN ._.
P11283019A09
Finally_RR ,_, p38-dependent_JJ phosphorylation_NN of_II CDX3_NN was_VBD observed_VVN in_II differentiating_VVGJ Caco-2_NN /_SYM 15_MC cells_NNS ._.
P11287413A02
In_II this_DD study_NN ,_, we_PN have_VHB further_RR investigated_VVN the_DD signal_NN transduction_NN pathways_NNS responsible_JJ for_II the_DD event_NN and_CC its_PNG role_NN in_II HGF-induced_VVNJ cell_NN scattering_VVGN ._.
P11295367A03
Treatment_NN with_II H2O2_NN (_( 100_MC microM_NN )_) ,_, superoxide_NN anion_NN (_( generated_VVN by_II 1_MC mM_NN xanthine_NN and_CC 1_MC mU_NN /_SYM ml_NN xanthine_NN oxidase_NN )_) ,_, menadione_NN ,_, and_CC phenazine_NN methosulfate_NN increased_VVD the_DD cell_NN proliferation_NN by_II approximately_RR 50_MC %_SYM ._.
P11297525A07
Surprisingly_RR ,_, constitutive_JJ ERK1_NN /_SYM 2_MC activation_NN is_VBZ MEK-independent_JJ ._.
P11298121A04
As_CS shown_VVN here_RR ,_, ERK_NN is_VBZ activated_VVN in_II K562_NN and_CC COS-7_NN cells_NNS within_II 10_MC min_NN of_II sublytic_JJ immune_JJ attack_NN and_CC then_RR shows_VVZ a_DD decline_NN and_CC a_DD second_JJ peak_NN of_II activation_NN at_II 20_MC min_NN ._.
P11303787A03
The_DD effect_NN of_II SB_NN 203580_MC on_II nitric_JJ oxide_NN (_( NO_NN )_) -_: or_CC peroxynitrite-induced_VVNJ cell_NN death_NN is_VBZ not_RR known_VVN ._.
P11306108A04
Within_II 15-30_MC min_NN after_II HNE_NN treatment_NN ,_, c-Jun_NN N-terminal_JJ protein_NN kinase_NN (_( JNK_NN )_) was_VBD maximally_RR activated_VVN ,_, before_II returning_VVGN to_II control_NN level_NN after_II 1_MC h_NN post-treatment_NN ._.
P11306514A07
In_II contrast_NN ,_, overexpression_NN of_II the_DD wild-type_NN kinases_NNS had_VHD a_DD slight_JJ proapoptotic_JJ effect_NN ._.
P11306698A03
Nuclear_JJ ARE_NN complex_NN was_VBD activated_VVN 1_MC to_II 6_MC h_NN after_II treatment_NN of_II H4IIE_NN cells_NNS with_II t-BHQ_NN ._.
P11306706A04
Here_RR ,_, we_PN demonstrate_VVB that_CST mitogen-activated_VVNJ protein_NN kinase_NN kinase-1_NN (_( MEK-1_NN )_) inhibitor_NN PD98059_NN does_VDZ not_RR change_VVB either_CC the_DD stabilization_NN or_CC DNA_NN binding_VVGJ ability_NN of_II HIF-1alpha_NN but_CC it_PN inhibits_VVZ the_DD trans-activation_NN ability_NN of_II HIF-1alpha_NN ,_, thereby_RR it_PN reduces_VVZ the_DD hypoxia-induced_VVNJ transcription_NN of_II both_CC an_DD endogenous_JJ target_NN gene_NN and_CC a_DD hypoxia-responsive_JJ reporter_NN gene_NN ._.
P11309236A08
We_PN next_RR examined_VVD the_DD effect_NN of_II AG1478_NN on_II thrombin-induced_VVNJ DNA_NN synthesis_NN ._.
P11310789A01
UV-induced_VVNJ melanogenesis_NN is_VBZ a_DD well_RR known_VVNJ physiological_JJ response_NN of_II human_NN skin_NN exposed_VVN to_II solar_JJ radiation_NN ;_: however_RR ,_, the_DD signaling_VVGJ molecules_NNS involved_VVN in_II the_DD stimulation_NN of_II melanogenesis_NN in_II melanocytes_NNS following_VVG UV_NN exposure_NN remain_VVB unclear_JJ ._.
P11310854A01
Phosphorylation_NN of_II extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) in_II response_NN to_II arachidonic_JJ acid_NN (_( AA_NN )_) was_VBD rapid_JJ and_CC transient_JJ ,_, peaking_VVG at_II 1_MC min_NN and_CC disappearing_VVG after_II 3_MC min_NN ,_, and_CC it_PN was_VBD accompanied_VVN by_II an_DD increase_NN in_II ERK_NN activity_NN in_II rat_NN neutrophils_NNS ._.
P11311983A02
However_RR ,_, our_PNG knowledge_NN of_II the_DD class_NN of_II glutamate_NN receptor_NN and_CC the_DD intracellular_JJ pathways_NNS involved_VVN derives_VVZ totally_RR from_II studies_NNS on_II embryonic_JJ neurons_NNS ,_, where_PNR the_DD mechanisms_NNS are_VBB likely_RR to_TO be_VBI totally_RR different_JJ from_II those_PND operating_VVG in_II mature_JJ neurons_NNS ._.
P11316261A08
Furthermore_RR ,_, in_II the_DD presence_NN of_II U0126_NN there_EX was_VBD no_DD aldosterone-induced_VVNJ increase_NN of_II steady-state_NN pH_NN ._.
P11316733A08
In_II contrast_NN to_II the_DD effect_NN of_II tumor_NN necrosis_NN factor-alpha_NN on_II NF-kappaB_NN activation_NN ,_, Western_NN blot_NN analyses_NNS demonstrated_VVD that_CST IGF-I_NN had_VHD no_DD effect_NN on_II IkappaB_NN phosphorylation_NN and_CC degradation_NN or_CC nuclear_JJ translocation_NN and_CC DNA_NN binding_VVGN of_II NF-kappaB_NN ._.
P11319753A08
Furthermore_RR ,_, the_DD strong_JJ correlation_NN between_II inhibition_NN of_II kinase_NN activity_NN and_CC IL-1_NN and_CC TNF-stimulated_VVNJ biological_JJ responses_NNS indicates_VVZ that_CST selective_JJ inhibition_NN of_II the_DD p38_NN MAPK_NN pathway_NN may_VM have_VHB therapeutic_JJ utility_NN in_II joint_NN diseases_NNS such_II+ as_II rheumatoid_JJ arthritis_NN (_( RA_NN )_) ._.
P11322385A06
MAPK_NN blockade_NN by_II the_DD specific_JJ MEK1_NN inhibitor_NN (_( PD98059_NN )_) decreased_VVD the_DD ability_NN of_II sodium_NN arsenite_NN to_TO increase_VVI HSP70_NN gene_NN expression_NN in_II a_DD dose-dependent_JJ manner_NN along_RR with_II dephosphorylation_NN of_II ERK1_NN /_SYM 2_MC proteins_NNS ._.
P11323408A05
SpD_NN binds_VVZ to_II the_DD ligand-binding_VVGJ site_NN of_II the_DD bombesin_NN /_SYM gastrin-releasing_VVGJ peptide_NN receptor_NN and_CC blocks_VVZ the_DD bombesin-stimulated_VVNJ increase_NN in_II [_( Ca2+_NN ]_) i_NN within_II the_DD same_JJ concentration_NN range_NN that_PNR causes_VVZ sustained_VVNJ activation_NN of_II c-Jun_NN N-terminal_JJ kinase_NN and_CC extracellular_JJ signal-regulated_VVNJ protein_NN kinase_NN (_( ERK_NN )_) ._.
P11325811A04
Both_DD groups_NNS were_VBD treated_VVN either_CC with_II SB202190_NN (_( inhibitor_NN of_II p38_NN MAP_NN kinase_NN )_) ,_, PD98059_NN (_( inhibitor_NN of_II extracellular-signal-regulated_VVNJ kinase_NN [_( ERK_NN ]_) pathway_NN )_) ,_, Ro-31-7549_NN (_( protein_NN kinase_NN C_NN [_( PKC_NN ]_) inhibitor_NN )_) ,_, LY_NN 294002_MC (_( a_DD phosphatidylinositol_NN 3-kinase_NN [_( PI_NN 3-kinase_NN ]_) inhibitor_NN )_) or_CC vehicle_NN ._.
P11327629A09
Angiotensin_NN II_MC increased_VVD c-fos_NN mRNA_NN expression_NN in_II SHR_NN and_CC had_VHD a_DD small_JJ stimulatory_JJ effect_NN in_II WKY_NN ._.
P11327635A02
Adrenomedullin_NN has_VHZ recently_RR been_VBN found_VVN to_TO enhance_VVI proliferation_NN of_II cultured_VVNJ rat_NN vascular_JJ smooth_JJ muscle_NN cells_NNS and_CC zona_NN glomerulosa_NN cells_NNS ._.
P11328854A03
Both_CC p38_NN MAPK_NN and_CC its_PNG upstream_JJ activator_NN MAPK_NN kinase-6_NN (_( MKK6_NN )_) were_VBD found_VVN to_TO be_VBI chronically_RR activated_VVN during_II the_DD luteal_JJ maturation_NN phase_NN ,_, with_II activation_NN detected_VVN by_II 24_MC h_NN post_II hCG_NN and_CC maintained_VVN through_II 4_MC days_NNS post_II hCG_NN ._.
P11331278A07
The_DD expression_NN levels_NNS of_II these_DD kinases_NNS were_VBD unaltered_VVNJ ._.
P11341985A09
AP-1_NN and_CC HSF_NN show_VVB opposite_JJ patterns_NNS of_II response_NN to_II HS_NN in_II the_DD presence_NN of_II proteasome_NN inhibitors_NNS or_CC reducing_VVGJ agents_NNS ._.
P11348889A01
Plasminogen_NN activator_NN inhibitor_NN type-1_NN (_( PAI-1_NN )_) plays_VVZ an_DD integral_JJ role_NN not_RR only_RR in_II the_DD regulation_NN of_II fibrinolytic_JJ activity_NN but_CC also_RR in_II the_DD pathogenesis_NN of_II atherosclerosis_NN and_CC hypertension_NN ._.
P11350764A01
Extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) phosphorylate_VVB caldesmon_NN in_RR+ vivo_RR ,_, but_CC the_DD function_NN of_II caldesmon_NN phosphorylation_NN in_II smooth_JJ muscle_NN physiology_NN is_VBZ controversial_JJ ._.
P11350812A01
To_TO examine_VVI signaling_VVGJ mechanisms_NNS relevant_JJ to_II cAMP_NN /_SYM protein_NN kinase_NN A_NN (_( PKA_NN )_) -dependent_JJ endothelial_JJ cell_NN barrier_NN regulation_NN ,_, we_PN investigated_VVD the_DD impact_NN of_II the_DD cAMP_NN /_SYM PKA_NN inhibitors_NNS Rp_NN diastereomer_NN of_II adenosine_NN 3_MC '_SYM ,_, 5'-cyclic_JJ monophosphorothioate_NN (_( Rp-cAMPS_NN )_) and_CC PKA_NN inhibitor_NN (_( PKI_NN )_) on_II bovine_JJ pulmonary_JJ artery_NN and_CC bovine_JJ lung_NN microvascular_JJ endothelial_JJ cell_NN cytoskeleton_NN reorganization_NN ._.
P11359446A10
These_DD results_NNS suggest_VVB that_CST DPPC_NN ,_, the_DD major_JJ component_NN of_II pulmonary_JJ surfactant_NN ,_, may_VM play_VVB a_DD role_NN in_II modulating_VVGN leucocyte_NN inflammatory_JJ responses_NNS in_II the_DD lung_NN ._.
P11359772A08
Serum-stimulated_VVNJ c-Fos_NN expression_NN is_VBZ dependent_JJ on_II MAPK_NN /_SYM Erk_NN activity_NN because_CS the_DD MEK_NN inhibitor_NN PD98059_NN suppresses_VVZ Erk_NN activity_NN and_CC c-Fos_NN expression_NN ._.
P11360180A09
These_DD data_NNS are_VBB consistent_JJ with_II a_DD model_NN where_PNR thrombin_NN induces_VVZ ERK_NN activation_NN via_II both_CC PKC-dependent_JJ and_CC independent_JJ pathways_NNS ,_, whereas_CS p38_NN MAPK_NN activation_NN requires_VVZ only_RR PTKs_NNS ._.
P11360301A10
The_DD activating_VVGJ factor_NN was_VBD shown_VVN to_TO have_VHI a_DD native_JJ size_NN of_II 50-100_MC kD_NN and_CC did_VDD not_RR signal_VVB through_II the_DD classical_JJ EGF_NN receptor_NN ._.
P11367542A02
Although_CS IL-1_NN signaling_VVGN is_VBZ known_VVN to_TO involve_VVI PI3-kinase_NN ,_, p38_NN mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN and_CC extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) ,_, the_DD crosstalk_NN of_II these_DD kinases_NNS on_II the_DD IL-1-mediated_VVNJ signal_NN transduction_NN is_VBZ not_RR clear_JJ ._.
P11372759A04
The_DD kinetics_NNS of_II activation_NN of_II Erk1_NN and_CC Erk2_NN were_VBD examined_VVN during_II erythroid_NN and_CC megakaryocytic_JJ differentiation_NN of_II UT-7_NN /_SYM GM_NN cells_NNS ._.
P11375350A10
High_JJ D-glucose_NN treatment_NN induced_VVD MEKK1_NN cleavage_NN ,_, whereas_CS caspase_NN inhibitors_NNS significantly_RR attenuated_VVD the_DD cleavage_NN ._.
P11376873A02
To_TO determine_VVI whether_CST TGF-beta_NN (_( 1_MC )_) interferes_VVZ directly_RR with_II TPO-induced_VVNJ signal_NN transduction_NN in_II hematopoietic_JJ cells_NNS ,_, we_PN compared_VVD the_DD regulatory_JJ effects_NNS in_II the_DD TPO-responsive_JJ cell_NN lines_NNS Mo-7e_NN and_CC HEL_NN ._.
P11377386A06
IFN-gamma_NN induced_VVD the_DD phosphorylation_NN of_II signal_NN transducer_NN and_CC activator_NN of_II transcription_NN 1_MC ._.
P11381075A01
PURPOSE_NN :_: To_TO determine_VVI the_DD signal_NN mediators_NNS involved_VVN in_II glycated_VVNJ human_NN serum_NN albumin_NN (_( GHSA_NN )_) stimulation_NN of_II interleukin_NN (_( IL_NN )_) -8_MC and_CC monocyte_NN chemotactic_JJ protein_NN (_( MCP_NN )_) -1_MC secretion_NN in_II human_NN retinal_JJ pigment_NN epithelium_NN (_( hRPE_NN )_) cells_NNS ._.
P11382751A09
The_DD specific_JJ inhibition_NN of_II either_CC ERK_NN or_CC p38_NN (_( MAPK_NN )_) attenuated_VVD the_DD IL-1_NN beta-_NN or_CC LIF-stimulated_VVNJ ANF_NN expression_NN by_II up_RR+ to_RR 70_MC %_SYM ._.
P11387337A09
Both_CC in_RR+ vitro_RR and_CC in_RR+ vivo_RR ,_, wild_JJ type_NN MKP-2_NN effectively_RR inactivated_VVD ERK2_NN whereas_CS MKP-2_NN mutants_NNS incapable_JJ of_II binding_VVGN to_II ERK_NN /_SYM p38_NN did_VDD not_RR ._.
P11388701A05
We_PN found_VVD that_CST thrombin_NN induced_VVD time-_NN and_CC dose-dependent_JJ activation_NN of_II p38_NN MAPK_NN ._.
P11389977A04
Both_CC the_DD TP_NN agonist_NN U46619_NN and_CC 8-epiPGF_NN (_( 2alpha_NN )_) elicited_VVD time_NN and_CC concentration_NN dependent_JJ activation_NN of_II the_DD extracellular_JJ signal_NN regulated_VVNJ kinase_NN (_( ERK_NN )_) s_NNS and_CC c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) s_NNS in_II ULTR_NN cells_NNS ._.
P11390374A06
Specifically_RR ,_, fucoidan_NN stimulates_VVZ activity_NN of_II p21-activated_VVNJ kinase_NN (_( PAK_NN )_) and_CC of_II the_DD MAPKs_NNS extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) ,_, c-Jun_NN NH_NN (_( 2_MC )_) -terminal_JJ kinase_NN (_( JNK_NN )_) ,_, and_CC p38_NN ._.
P11399523A03
NO_NN may_VM be_VBB the_DD mediator_NN of_II the_DD cytotoxic_JJ effect_NN of_II IL-1_NN beta_NN in_II rat_NN islets_NNS and_CC beta-cell_NN lines_NNS ._.
P11399647A05
In_II contrast_NN ,_, HGF_NN was_VBD unable_JJ to_TO reverse_VVI the_DD loss_NN of_II adhesion_NN of_II cells_NNS exposed_VVN to_II 99_MC %_SYM ATP_NN depletion_NN ._.
P11400118A08
Phosphorylated_VVNJ ERK1_NN /_SYM 2_MC MAP_NN kinase_NN is_VBZ thus_RR potentially_RR prognostic_JJ for_II prediction_NN of_II response_NN to_II anti-hormonal_JJ agents_NNS and_CC survival_NN ,_, data_NNS providing_VVG further_JJ evidence_NN that_CST ERK1_NN /_SYM 2_MC MAP_NN kinase_NN plays_VVZ a_DD role_NN in_II circumvention_NN of_II anti-hormonal_JJ response_NN in_II breast_NN cancer_NN ._.
P11401397A01
Retinoic_JJ acid_NN (_( RA_NN )_) ,_, a_DD potent_JJ teratogen_NN ,_, produces_VVZ a_DD characteristic_JJ set_NN of_II embryonic_JJ cardiovascular_JJ malformations_NNS similar_JJ to_II those_PND observed_VVN in_II neural_JJ crest_NN ablated_VVNJ avians_NNS ._.
P11401420A03
The_DD role_NN of_II mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) activation_NN in_II the_DD early_JJ intracellular_JJ signal_NN transduction_NN involved_VVN in_II iNOS_NN and_CC IL-6_NN transcription_NN in_II the_DD combined_VVNJ agents-stimulated_VVNJ osteoblasts_NNS has_VHZ been_VBN investigated_VVN ._.
P11401854A04
In_II this_DD study_NN ,_, we_PN report_VVB on_II the_DD interactions_NNS between_II the_DD TGF-beta_NN and_CC MAP_NN kinase_NN signaling_VVGJ pathways_NNS in_II isolated_VVNJ rat_NN pancreatic_JJ acinar_JJ cells_NNS ._.
P11401859A04
Ionomycin_NN also_RR activated_VVD (_( 2_MC microM_NN )_) and_CC primed_VVD (_( 20-200_MC nM_NN )_) the_DD PMN_NN oxidase_NN ._.
P11408609A11
Together_RR ,_, these_DD findings_NNS suggest_VVB that_CST subsequent_JJ exposure_NN of_II paclitaxel-treated_VVNJ U937_NN cells_NNS to_II MEK_NN /_SYM MAPK_NN inhibitors_NNS induces_VVZ perturbations_NNS in_II signaling_VVGJ pathways_NNS ,_, particularly_RR the_DD p42_NN /_SYM 44_MC MAPK_NN and_CC p38_NN MAPK_NN cascades_NNS ,_, that_PNR lower_VVB the_DD threshold_NN for_II mitochondrial_JJ injury_NN and_CC induction_NN of_II cell_NN death_NN ._.
P11408617A05
Selectively_RR blocking_VVGN mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) pathways_NNS by_II overexpression_NN of_II dominant-negative_JJ mutants_NNS of_II kinases_NNS attenuated_VVD the_DD AP-1_NN activation_NN by_II PMA_NN and_CC UVC_NN ._.
P11415463A03
The_DD inhibition_NN of_II MAPK_NN activity_NN induced_VVD a_DD dose-dependent_JJ growth_NN arrest_NN in_II G_NN (_( 0_MC )_) /_SYM G_NN (_( 1_MC )_) phase_NN ._.
P11422444A07
The_DD c2-ceramide_NN treatment_NN also_RR increases_VVZ levels_NNS of_II c-jun_NN ,_, c-fos_NN and_CC p53_NN mRNA_NN in_II primary_JJ cortical_JJ neuron_NN cultures_NNS ,_, but_CC this_PND is_VBZ independent_JJ of_II p38_NN activation_NN ._.
P11423664A03
We_PN show_VVB that_CST two_MC different_JJ inhibitors_NNS of_II the_DD ERK_NN pathway_NN suppress_VVB the_DD induction_NN of_II two_MC forms_NNS of_II long-term_NN potentiation_NN (_( LTP_NN )_) in_II rat_NN cortical_JJ slices_NNS and_CC that_CST their_PNG intracortical_JJ administration_NN to_II monocularly_RR deprived_VVNJ rats_NNS prevents_VVZ the_DD shift_NN in_II ocular_JJ dominance_NN towards_II the_DD nondeprived_JJ eye_NN ._.
P11423976A06
Proliferation_NN and_CC survival_NN of_II cancer_NN cells_NNS has_VHZ been_VBN linked_VVN in_RR+ vivo_RR to_II enhanced_VVNJ expression_NN of_II angiogenic_JJ growth_NN factors_NNS ._.
P11423998A01
Introduction_NN :_: We_PN report_VVB the_DD results_NNS of_II a_DD study_NN investigating_VVG signaling_VVGJ proteins_NNS in_II 26_MC cases_NNS of_II primary_JJ acute_JJ myelogenous_JJ leukemia_NN ._.
P11435219A10
However_RR ,_, phosphorylation_NN of_II PLD_NN by_II p38_NN failed_VVD to_TO affect_VVI PLD_NN activity_NN in_RR+ vitro_RR ._.
P11438570A02
It_PN has_VHZ been_VBN shown_VVN previously_RR that_CST the_DD induction_NN of_II apoptosis_NN in_II these_DD neurons_NNS at_II NGF_NN withdrawal_NN requires_VVZ both_CC the_DD activity_NN of_II the_DD small_JJ GTP-binding_VVGJ protein_NN Cdc42_NN and_CC the_DD activation_NN of_II the_DD c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) pathway_NN ._.
P11438574A02
Protein_NN kinase_NN C_NN (_( PKC_NN )_) is_VBZ known_VVN to_TO increase_VVI non-amyloidogenic_JJ alpha-secretase_NN cleavage_NN of_II APP_NN ,_, producing_VVG secreted_VVNJ APP_NN (_( sAPPalpha_NN )_) ,_, and_CC glycogen_NN synthase_NN kinase_NN (_( GSK_NN )_) -3beta_NN is_VBZ known_VVN to_TO increase_VVI tau_NN phosphorylation_NN ._.
P11443053A03
A_DD redox-cycling_VVGJ agent_NN ,_, phenazine_NN methosulfate_NN ,_, was_VBD found_VVN to_II both_CC upregulate_VVB TNF-alpha_NN (_( 5.8_MC +/-_SYM 1.0_MC fold_NN ;_: P_NN =_SYM 0.01_MC )_) and_CC increase_VVB the_DD phosphorylation_NN state_NN of_II p42_NN /_SYM 44_MC MAPK_NN (_( 3.1_MC +/-_SYM 0.2_MC fold_NN ;_: P_NN =_SYM 0.01_MC )_) in_II PMA-differentiated_VVNJ U-937_NN cells_NNS ._.
P11448861A05
It_PN did_VDD not_RR appear_VVB that_CST stimulation_NN of_II NKCC_NN activity_NN was_VBD a_DD reflection_NN of_II increased_VVNJ Na_NN (_( +_SYM )_) -K_NN (_( +_SYM )_) -ATPase_NN activity_NN because_CS insulin_NN treatment_NN did_VDD not_RR stimulate_VVB NKCC_NN activity_NN ,_, despite_II insulin_NN 's_GE well-known_VVNJ stimulation_NN of_II Na_NN (_( +_SYM )_) -K_NN (_( +_SYM )_) -ATPase_NN activity_NN ._.
P11453646A05
These_DD findings_NNS suggest_VVB that_CST Rac_NN is_VBZ activated_VVN by_II a_DD mechanism_NN that_PNR is_VBZ at_RR+ least_RR partly_RR dependent_JJ on_II PI3K_NN in_II TNFalpha_NN stimulated_VVNJ cells_NNS and_CC plays_VVZ a_DD critical_JJ role_NN in_II activation_NN of_II the_DD Erk_NN signaling_VVGJ pathway_NN ._.
P11454854A07
These_DD cells_NNS also_RR had_VHD increased_VVNJ phosphorylation_NN of_II native_JJ c-Jun_NN ,_, suggesting_VVG that_CST both_CC c-Jun_NN NH_NN (_( 2_MC )_) -terminal_JJ kinase_NN and_CC p38_NN MAP_NN kinases_NNS phosphorylate_VVB c-Jun_NN ._.
P11454948A06
Inhibition_NN of_II Akt_NN activation_NN required_VVD almost_RR complete_JJ inhibition_NN of_II ERK_NN ._.
P11455016A09
Our_PNG data_NNS confirmed_VVD additivity_NN in_II those_DD cells_NNS lines_NNS that_PNR undergo_VVB paclitaxel-induced_VVNJ ERK_NN activation_NN ,_, and_CC antagonism_NN in_II cells_NNS with_II low_JJ ERK_NN activity_NN ,_, suggesting_VVG that_CST in_II tumors_NNS with_II high_JJ ERK_NN activity_NN ,_, there_EX may_VM be_VBB an_DD application_NN for_II this_DD strategy_NN in_II therapy_NN ._.
P11455028A03
The_DD activation_NN of_II MAPKs_NNS ,_, especially_RR the_DD extracellular-regulated_VVNJ protein_NN kinase_NN subfamily_NN ,_, seems_VVZ to_TO play_VVI a_DD causal_JJ role_NN in_II death_NN of_II renal_JJ proximal_JJ tubular_JJ epithelial_JJ cells_NNS (_( LLC-PK1_NN )_) induced_VVN by_II reactive_JJ oxygen_NN species_NNS (_( ROS_NN )_) ._.
P11457751A08
Simvastatin_NN reduced_VVD LV_NN mass_NN by_II 37_MC %_SYM ,_, interventricular_JJ septal_JJ thickness_NN by_II 21_MC %_SYM ,_, and_CC posterior_JJ wall_NN thickness_NN by_II 13_MC %_SYM ._.
P11461121A10
The_DD appearance_NN of_II the_DD fragmented_VVNJ chromatin_NN visualized_VVN by_II DAPI_NN staining_VVGN ,_, and_CC DNA_NN fragments_NNS seen_VVN on_II an_DD agarose_NN gel_NN ,_, coincided_VVD with_II the_DD decrease_NN in_II ERK1_NN /_SYM 2_MC activation_NN and_CC concomitant_JJ increase_NN of_II the_DD level_NN of_II active_JJ p38_NN MAPK_NN ._.
P11464287A06
In_II contrast_NN ,_, MCF-7_NN cells_NNS expressing_VVG constitutively_RR activated_VVNJ MEK_NN show_VVB a_DD significant_JJ increase_NN in_II MAPK_NN activity_NN and_CC cell_NN migration_NN ,_, but_CC this_PND failed_VVD to_TO enhance_VVI in_JJ+ vitro_JJ invasion_NN ._.
P11466386A06
The_DD induction_NN of_II COX-2_NN was_VBD blocked_VVN by_II the_DD p38_NN MAP_NN kinase_NN inhibitor_NN SB202190_NN ,_, even_RR when_CS added_VVN 12-16_MC h_NN after_II stimulation_NN with_II Ag_NN when_CS p38_NN MAP_NN kinase_NN activity_NN had_VHD returned_VVN to_II near_RR basal_JJ ,_, but_CC still_RR minimally_RR elevated_VVN ,_, levels_NNS ._.
P11468147A02
The_DD present_JJ study_NN examines_VVZ the_DD involvement_NN of_II different_JJ intracellular_JJ signaling_VVGJ pathways_NNS and_CC their_PNG physiopathologic_JJ consequences_NNS following_VVG the_DD CD4-independent_JJ interaction_NN between_II CXCR4_NN or_CC CCR5_NN and_CC gp120_NN in_II different_JJ cell_NN types_NNS :_: primary_JJ T_NN cells_NNS ,_, CD4_NN (_( -_SYM )_) /_SYM CXCR4_NN (_( +_SYM )_) /_SYM CCR5_NN (_( +_SYM )_) T_NN cells_NNS ,_, or_CC glioma_NN cells_NNS ._.
P11468529A07
FR167653_NN significantly_RR suppressed_VVD serum_NN ALT_NN and_CC LDH_NN levels_NNS and_CC improved_VVD liver_NN tissue_NN blood_NN flow_NN after_II transplantation_NN ._.
P11472310A03
This_DD review_NN will_VM provide_VVB insight_NN on_II potential_JJ intracellular_JJ signalling_VVGJ mechanisms_NNS by_II which_PNR muscle_NN contraction_NN /_SYM exercise_NN leads_VVZ to_II changes_NNS in_II gene_NN expression_NN ._.
P11487550A07
TUDC-induced_VVNJ stimulation_NN of_II TC_NN excretion_NN was_VBD accompanied_VVN by_II a_DD p38_NN (_( MAPK_NN )_) -dependent_JJ insertion_NN of_II subcanalicular_JJ immunoreactive_JJ Bsep_NN into_II the_DD canalicular_JJ membrane_NN ._.
P11498525A10
In_II summary_NN ,_, we_PN have_VHB shown_VVN the_DD histamine_NN H_NN (_( 1_MC )_) receptor_NN activates_VVZ p42_NN /_SYM p44_NN MAPK_NN and_CC p38_NN MAPK_NN signalling_VVGJ pathways_NNS in_II DDT_NN (_( 1_MC )_) MF-2_NN smooth_JJ muscle_NN cells_NNS ._.
P11504702A05
However_RR ,_, inhibition_NN of_II either_CC ERK_NN or_CC p38_NN MAPK_NN did_VDD not_RR affect_VVB acrolein-dependent_JJ inhibition_NN of_II apoptosis_NN ._.
P11504709A03
PMA_NN and_CC TPO_NN were_VBD able_JJ to_TO modulate_VVI GPIX_NN expression_NN at_II mRNA_NN and_CC protein_NN levels_NNS ._.
P11509022A07
The_DD anisomycin_NN effect_NN was_VBD enhanced_VVN in_II the_DD presence_NN of_II 100_MC mM_NN ethanol_NN ._.
P11518563A01
Administration_NN of_II bacterial_JJ lipopolysaccharide_NN (_( LPS_NN )_) to_II laboratory_NN animals_NNS and_CC cultured_VVNJ macrophages_NNS is_VBZ known_VVN to_TO induce_VVI the_DD production_NN of_II nitric_JJ oxide_NN (_( NO_NN )_) from_II inducible_JJ nitric_JJ oxide_NN synthase_NN (_( iNOS_NN )_) ._.
P11524243A02
PGE1_NN induced_VVD the_DD phosphorylation_NN of_II both_CC p44_NN /_SYM p42_NN mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN and_CC p38_NN MAP_NN kinase_NN ._.
P11525649A04
We_PN now_RR directly_RR confirm_VVB this_DD prediction_NN by_II showing_VVGN that_CST oncogenic_JJ p21_NN induces_VVZ activating_VVGJ phosphorylation_NN of_II JNK_NN (_( JNK-P_NN )_) and_CC of_II ERK_NN (_( MAP_NN kinase_NN )_) (_( MAPK-P_NN )_) ,_, whose_PNR levels_NNS correlate_VVB with_II oocyte_NN maturation_NN ._.
P11525903A01
Mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) play_VVB a_DD critical_JJ role_NN in_II the_DD regulation_NN of_II cell_NN proliferation_NN ,_, differentiation_NN and_CC apoptosis_NN ._.
P11527089A05
Incubation_NN of_II HREC_NN in_II serum-free_JJ medium_NN caused_VVD a_DD time-dependent_JJ increase_NN in_II c-Jun_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) activity_NN ,_, and_CC continuous_JJ culture_NN of_II HREC_NN in_II the_DD presence_NN of_II IGF-I_NN or_CC vascular_JJ endothelial_JJ growth_NN factor_NN (_( VEGF_NN )_) prevented_VVD JNK_NN activation_NN and_CC arrested_VVD apoptosis_NN ._.
P11527418A01
It_PN has_VHZ been_VBN shown_VVN that_CST thyroid_NN hormone_NN stimulates_VVZ the_DD activity_NN of_II alkaline_JJ phosphatase_NN ,_, a_DD marker_NN of_II mature_JJ osteoblast_NN phenotype_NN ,_, in_II osteoblasts_NNS ._.
P11527419A01
Cannabinoids_NNS affect_VVB prostaglandin_NN (_( PG_NN )_) formation_NN in_II the_DD central_JJ nervous_JJ system_NN through_II as_RR+ yet_RR unidentified_VVNJ mechanisms_NNS ._.
P11527648A09
CONCLUSIONS_NNS :_: These_DD data_NNS demonstrate_VVB a_DD nearly_RR complete_JJ requirement_NN of_II endogenous_JJ norepinephrine_NN and_CC epinephrine_NN for_II the_DD induction_NN of_II in_JJ+ vivo_JJ pressure-overload_NN cardiac_JJ hypertrophy_NN and_CC for_II the_DD activation_NN of_II hypertrophic_JJ signaling_VVGJ pathways_NNS ._.
P11543732A06
Activation_NN of_II mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) and_CC the_DD redox-sensitive_JJ transcription_NN factors_NNS ,_, nuclear_JJ factor-kappaB_NN (_( NF-kappaB_NN )_) and_CC activator_NN protein_NN 1_MC (_( AP-1_NN )_) ,_, are_VBB key_JJ events_NNS in_II the_DD signal_NN transduction_NN pathways_NNS mediating_VVG TNF-alpha_NN induction_NN ._.
P11544323A05
Using_VVG highly_RR specific_JJ inhibitors_NNS of_II p38_NN (_( SB203580_NN )_) and_CC MAP_NN kinase_NN kinase-1_NN (_( PD98059_NN )_) ,_, we_PN found_VVD that_CST activation_NN of_II the_DD extracellular_JJ signal-regulated_VVNJ kinase_NN pathway_NN ,_, but_CC not_RR of_II p38_NN ,_, was_VBD essential_JJ for_II the_DD M._NN avium-induced_VVNJ TNF-alpha_NN formation_NN ._.
P11549715A03
This_DD stimulation_NN resulted_VVD in_II a_DD transient_JJ phosphorylation_NN of_II p42_NN MAPK_NN ,_, and_CC the_DD resulting_VVGJ LTP_NN was_VBD MAPK_NN dependent_JJ ._.
P11553284A05
However_RR ,_, blockade_NN of_II dopaminergic_JJ (_( DA_NN )_) D1_NN receptors_NNS by_II administration_NN of_II SCH_NN 23390_MC ,_, prior_II+ to_II THC_NN ,_, totally_RR prevents_VVZ ERK_NN activation_NN in_II the_DD striatum_NN ,_, thus_RR demonstrating_VVG a_DD critical_JJ involvement_NN of_II DA_NN systems_NNS in_II THC-induced_VVNJ ERK_NN activation_NN ._.
P11553563A01
Enteropathogenic_JJ Escherichia_NN coli_NN (_( EPEC_NN )_) is_VBZ an_DD extracellular_JJ bacterial_JJ pathogen_NN that_PNR infects_VVZ the_DD human_NN intestinal_JJ epithelium_NN and_CC is_VBZ a_DD major_JJ cause_NN of_II infantile_JJ diarrhea_NN in_II developing_VVGJ countries_NNS ._.
P11559033A06
G_NN (_( 2_MC )_) /_SYM M_NN was_VBD the_DD most_RRT sensitive_JJ cell_NN cycle_NN phase_NN to_II Cd_NN for_II the_DD induction_NN of_II ERK_NN and_CC p38_NN MAPK_NN activities_NNS ,_, cytotoxicity_NN ,_, apoptosis_NN ,_, micronucleus_NN ,_, and_CC intracellular_JJ peroxide_NN ;_: despite_II that_CST similar_JJ Cd_NN accumulation_NN was_VBD observed_VVN in_II G_NN (_( 1_MC )_) -_: ,_, S-_NN ,_, and_CC G_NN (_( 2_MC )_) /_SYM M-cells_NNS ._.
P11560859A02
Epidemiological_JJ studies_NNS indicate_VVB that_CST estrogen_NN replacement_NN therapy_NN is_VBZ cardioprotective_JJ ;_: the_DD mechanisms_NNS involved_VVN in_II this_DD process_NN ,_, however_RR ,_, are_VBB poorly_RR understood_VVN ._.
P11560928A09
These_DD results_NNS suggest_VVB that_CST transient_JJ activation_NN of_II ILK_NN is_VBZ required_VVN for_II neurite_NN outgrowth_NN in_II serum-starved_VVNJ N1E-115_NN cells_NNS on_II laminin_NN ._.
P11561064A01
Genistein_NN is_VBZ a_DD potent_JJ plant-derived_VVNJ isoflavone_NN displaying_VVG estrogenic_JJ activity_NN at_II low_JJ (_( nanomolar_JJ )_) concentrations_NNS and_CC antiproliferative_JJ and_CC antiangiogenic_JJ properties_NNS at_II higher_JJR concentrations_NNS (_( above_II 10-50_MC microM_NN )_) ._.
P11562426A01
Angiotensin_NN II_MC (_( Ang_NN II_MC )_) induces_VVZ vascular_JJ smooth_JJ muscle_NN cell_NN (_( VSMC_NN )_) hypertrophy_NN ,_, which_PNR results_VVZ in_II various_JJ cardiovascular_JJ diseases_NNS ._.
P11564659A07
4._MC The_DD UTP-induced_VVNJ enhancement_NN of_II the_DD growth_NN of_II C6_NN cells_NNS is_VBZ due_II+ to_II activation_NN of_II MAPK_NN by_II a_DD PPADS_NN sensitive_JJ nucleotide_NN receptor_NN ._.
P11570006A03
However_RR ,_, during_II the_DD last_JJ six_MC to_II seven_MC years_NNS this_DD view_NN has_VHZ been_VBN challenged_VVN by_II several_JJ studies_NNS demonstrating_VVG that_CST a_DD significant_JJ number_NN of_II myocytes_NNS undergo_VVB apoptosis_NN in_II myocardial_JJ infarction_NN ,_, heart_NN failure_NN ,_, myocarditis_NN ,_, arrhythmogen_NN right_JJ ventricular_JJ dysplasia_NN ,_, and_CC immune_JJ rejection_NN after_II cardiac_JJ transplantation_NN ,_, as_CC+ well_CC+ as_CC in_II other_JJ conditions_NNS of_II stress_NN ._.
P11570814A07
The_DD potential_NN of_II SNP_NN toxicity_NN directly_RR from_II NO_NN was_VBD supported_VVN by_II our_PNG finding_VVGN that_CST the_DD NO_NN scavenger_NN carboxy-PTIO_NN prevented_VVD cell_NN death_NN ._.
P11571231A06
These_DD findings_NNS suggest_VVB that_CST the_DD activation_NN of_II p38_NN kinase_NN may_VM play_VVB important_JJ roles_NNS in_II the_DD signal_NN transduction_NN mechanisms_NNS of_II hydroxyurea_NN leading_VVGN to_II erythroid_NN differentiation_NN ._.
P11571286A07
In_II contrast_NN ,_, inner_JJ retina_NN /_SYM glia_NN possess_VVB alternative_JJ ,_, cell_NN type_NN ,_, and_CC growth_NN factor-specific_JJ MEK-independent_JJ ERK1_NN /_SYM 2_MC activation_NN pathways_NNS ._.
P11573595A02
The_DD effects_NNS of_II propofol_NN on_II the_DD function_NN and_CC intracellular_JJ signal_NN transduction_NN systems_NNS of_II neutrophils_NNS is_VBZ controversial_JJ ._.
P11574421A07
Bax_NN quantity_NN also_RR increased_VVD ._.
P11577023A02
Thrombin_NN exerts_VVZ profound_JJ effects_NNS on_II endothelial_JJ function_NN ._.
P11577023A14
These_DD effects_NNS of_II thrombin_NN may_VM be_VBB important_JJ for_II endothelial_JJ dysfunction_NN in_II cardiovascular_JJ disease_NN ,_, particularly_RR during_II acute_JJ coronary_JJ episodes_NNS ._.
P11577087A01
The_DD expression_NN of_II enzymes_NNS involved_VVN in_II fatty_JJ acid_NN beta-oxidation_NN (_( FAO_NN )_) ,_, the_DD principal_JJ source_NN of_II energy_NN production_NN in_II the_DD adult_NN mammalian_JJ heart_NN ,_, is_VBZ controlled_VVN at_II the_DD transcriptional_JJ level_NN via_II the_DD nuclear_JJ receptor_NN peroxisome_NN proliferator-activated_VVNJ receptor_NN alpha_NN (_( PPARalpha_NN )_) ._.
P11579095A01
The_DD estrogen_NN receptors_NNS (_( ERs_NNS )_) are_VBB ligand-inducible_JJ transcription_NN factors_NNS that_PNR play_VVB key_JJ roles_NNS in_II the_DD control_NN of_II growth_NN and_CC differentiation_NN in_II reproductive_JJ tissues_NNS ._.
P11585923A04
A_DD similar_JJ inhibition_NN of_II the_DD Ras-MAPK_NN pathway_NN was_VBD observed_VVN on_II stimulation_NN of_II endogenous_JJ EphB2_NN in_II COS-1_NN cells_NNS ._.
P11588033A01
During_II the_DD cell_NN transformation_NN processes_NNS leading_VVG to_II erythroleukemia_NN ,_, erythroid_NN progenitors_NNS often_RR become_VVB erythropoietin_NN (_( Epo_NN )_) -independent_JJ for_II their_PNG proliferation_NN ._.
P11590318A05
METHODOLOGY_NN AND_CC RESULTS_NNS :_: We_PN established_VVD an_DD in_JJ+ vitro_JJ model_NN for_II ECM-induced_VVNJ differentiation_NN of_II poorly_RR differentiated_VVNJ pancreatic_JJ carcinoma_NN cells_NNS and_CC found_VVD that_CST a_DD specific_JJ pattern_NN of_II ECM_NN proteins_NNS resembling_VVG basal_JJ laminas_NN (_( matrigel_NN )_) induces_VVZ differentiation_NN of_II the_DD PaTu-II_NN pancreatic_JJ carcinoma_NN cell_NN line_NN to_II a_DD ductal_JJ phenotype_NN ._.
P11591707A11
Transcriptional_JJ activity_NN of_II Egr-1_NN protein_NN was_VBD enhanced_VVN by_II GnRH_NN treatment_NN ._.
P11592793A04
They_PN were_VBD treated_VVN with_II menadione_NN (_( an_DD intracellular_JJ generator_NN of_II O_NN (_( -2_MC )_) )_) and/or_CC platelet-derived_VVNJ growth_NN factor_NN homodimer_NN BB_NN (_( PDGF_NN )_) ._.
P11595733A05
Activation_NN of_II Akt_NN by_II raloxifene_NN reached_VVD a_DD plateau_NN at_II 15-30_MC min_NN and_CC declined_VVD thereafter_RR ,_, a_DD similar_JJ time_NN frame_NN to_II that_PND of_II Akt_NN activation_NN by_II 17beta-estradiol_NN ._.
P11595756A03
NO_NN donors_NNS could_VM induce_VVB the_DD neurite_NN outgrowth_NN dose-dependently_RR in_II the_DD cells_NNS ._.
P11597764A09
Since_CS cleaved_VVNJ caspase-3_NN is_VBZ not_RR expressed_VVN by_II dying_VVGJ cells_NNS in_II the_DD present_JJ paradigm_NN ,_, JNK_NN (_( P_NN )_) ,_, p38_NN (_( P_NN )_) and_CC c-Jun_NN (_( P_NN )_) expression_NN is_VBZ not_RR associated_VVN with_II caspase-3_NN activation_NN ._.
P11597988A12
Collectively_RR ,_, these_DD data_NNS indicated_VVD that_CST Ang_NN II_MC stimulated_VVD ROS_NN production_NN via_II the_DD AT1_NN receptor_NN and_CC NADH_NN /_SYM NADPH_NN oxidase_NN ,_, and_CC that_CST these_DD ROS_NN mediated_VVD activation_NN of_II MAPKs_NNS ,_, which_PNR culminated_VVD in_II IL-6_NN gene_NN expression_NN through_II a_DD CRE-dependent_JJ ,_, but_CC not_RR NF-kappaB-dependent_JJ ,_, pathway_NN in_II cardiac_JJ fibroblasts_NNS ._.
P11598011A01
The_DD oncogenic_JJ latent_JJ membrane_NN protein_NN 1_MC (_( LMP1_NN )_) of_II the_DD Epstein-Barr_NN virus_NN recruits_VVZ tumor_NN necrosis_NN factor-receptor_NN (_( TNFR_NN )_) -associated_VVNJ factors_NNS (_( TRAFs_NNS )_) ,_, the_DD TNFR-associated_VVNJ death_NN domain_NN protein_NN (_( TRADD_NN )_) and_CC JAK3_NN to_TO induce_VVI intracellular_JJ signaling_VVGJ pathways_NNS ._.
P11598045A11
ERK1_NN /_SYM 2_MC ,_, while_CS not_RR involved_VVN in_II P._NN gingivalis_NN invasion_NN of_II GECs_NNS ,_, may_VM be_VBB downregulated_VVN by_II internalized_VVNJ P._NN gingivalis_NN ._.
P11600417A05
H_NN (_( 2_MC )_) O_NN (_( 2_MC )_) (_( 50_MC microM_NN )_) caused_VVD transient_JJ activation_NN of_II ERK1_NN /_SYM 2_MC and_CC p38_NN MAP_NN kinase_NN that_PNR was_VBD detected_VVN as_RR early_RR as_CSN 5_MC min_NN ,_, was_VBD maximal_JJ at_II 20_MC min_NN (_( 9.6_MC +/-_SYM 1.2-_MC and_CC 9.0_MC +/-_SYM 1.6-fold_NN ,_, respectively_RR ,_, vs._CC control_NN )_) ,_, and_CC returned_VVD to_II baseline_NN at_II 60_MC min_NN ._.
P11600497A07
Furthermore_RR ,_, we_PN found_VVD that_CST the_DD expression_NN of_II FADD_NN and_CC caspase-8_NN was_VBD significantly_RR reduced_VVN in_II serum-starved_VVNJ cells_NNS ,_, whereas_CS the_DD level_NN of_II cFLIP_NN remained_VVD unchanged_VVNJ ._.
P11602182A05
At_II the_DD commitment_NN time_NN for_II inducing_VVGN cell_NN death_NN ,_, TT-232_NN decreased_VVD EGFR-tyrosine_NN phosphorylation_NN and_CC prevented_VVD epidermial_JJ growth_NN factor_NN (_( EGF_NN )_) -induced_VVNJ events_NNS like_II cRaf-1_NN and_CC ERK2_NN activation_NN ._.
P11603565A01
The_DD aim_NN of_II this_DD experiment_NN was_VBD to_TO examine_VVI the_DD regulation_NN of_II p38_NN mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN by_II platelet-derived_VVNJ growth_NN factor_NN (_( PDGF_NN )_) -BB_NN and_CC its_PNG biological_JJ effects_NNS on_II rat_NN cultured_VVNJ vascular_JJ smooth_JJ muscle_NN cells_NNS (_( VSMCs_NNS )_) ._.
P11604491A01
Trophic_JJ factor_NN withdrawal_NN induces_VVZ cell_NN death_NN by_II mechanisms_NNS that_PNR are_VBB incompletely_RR understood_VVN ._.
P11606371A05
In_II addition_NN ,_, we_PN show_VVB that_CST the_DD inhibition_NN of_II HER-2_NN /_SYM neu_NN signaling_VVGN with_II AG825_NN triggers_VVZ an_DD imbalance_NN between_II extracellular_JJ signal-regulated_VVNJ kinase_NN 1_MC /_SYM 2_MC and_CC p38_NN mitogen-activated_VVNJ protein_NN kinase_NN activation_NN ,_, which_PNR leads_VVZ to_II p38-dependent_JJ apoptosis_NN ._.
P11606383A08
Inhibiting_VVGN the_DD ERKs_NNS 1_MC &_CC 2_MC or_CC Akt_NN pathways_NNS with_II specific_JJ chemical_JJ inhibitors_NNS (_( PD98059_NN or_CC LY294002_NN ,_, respectively_RR )_) did_VDD not_RR affect_VVB the_DD extent_NN of_II apoptosis_NN induced_VVN by_II SDG_NN or_CC p-XSC_NN (_( with_II the_DD exception_NN of_II LY294002_NN ,_, which_PNR actually_RR enhanced_VVD the_DD level_NN of_II induction_NN of_II apoptosis_NN by_II SDG_NN )_) ._.
P11606583A02
However_RR ,_, it_PN is_VBZ unclear_JJ how_CST elevated_VVNJ endogenous_JJ p38_NN MAPK_NN activity_NN is_VBZ maintained_VVN in_II invasive_JJ breast_NN cancer_NN cells_NNS ._.
P11640950A05
However_RR ,_, in_II non-demented_VVNJ cases_NNS lacking_VVG any_DD sign_NN of_II pathology_NN (_( Braak_NN stage_NN 0_MC )_) ,_, either_CC ERK_NN alone_JJ or_CC JNK_NN /_SYM SAPK_NN alone_JJ can_VM be_VBB activated_VVN ._.
P11641266A05
Activation_NN of_II AP-1_NN with_II a_DD c-Jun_NN amino-terminal_JJ kinase_NN (_( JNK_NN )_) activator_NN (_( Ro318220_NN ,_, 10_MC microM_NN )_) provoked_VVD apoptosis_NN in_II 18.7_MC +/-_SYM 1.2_MC %_SYM cardiomyocytes_NNS ,_, which_PNR was_VBD again_RR blocked_VVN by_II intracellular_JJ scavenging_VVGN of_II AP-1_NN ._.
P11641267A08
Our_PNG data_NNS indicate_VVB that_CST p90RSK_NN downstream_JJ of_II ERK1_NN /_SYM 2_MC is_VBZ the_DD molecular_JJ target_NN for_II ROS_NN generated_VVN through_II stimulation_NN of_II purinergic_JJ receptors_NNS by_II ATP_NN ._.
P11667949A08
Time_NN course_NN experiments_NNS (_( 5-HT_NN 10_MC (_( -5_MC )_) M_NN ;_: 5_MC min_NN ,_, 15_MC min_NN ,_, 30_MC min_NN and_CC 60_MC min_NN )_) showed_VVD no_DD significant_JJ activation_NN of_II JNK_NN after_II incubation_NN with_II 5-HT_NN at_II any_DD time_NN point_NN ._.
P11677248A10
PP2_NN ,_, a_DD Src_NN family_NN kinase_NN inhibitor_NN ,_, or_CC cytochalasin_NN D_NN ,_, which_PNR selectively_RR disrupts_VVZ the_DD network_NN of_II actin_NN filaments_NNS ,_, inhibited_VVD both_CC FAK_NN phosphorylation_NN and_CC NO_NN production_NN induced_VVN by_II FN-f_NN ,_, but_CC the_DD phosphatidylinositol_NN 3-kinase_NN inhibitor_NN wortmannin_NN had_VHD no_DD effect_NN ._.
P11678615A02
Three_MC major_JJ mitogen-activation_NN protein_NN kinases_NNS (_( MAPKs_NNS )_) ,_, extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) ,_, c-JUN_NN N-terminal_JJ kinase_NN (_( JNK_NN )_) and_CC p38_NN ,_, have_VHB been_VBN shown_VVN to_TO regulate_VVI apoptosis_NN ._.
P11678615A14
Conversely_RR ,_, neither_CC SB202190_NN nor_CC PD98059_NN altered_VVD Cr_NN (_( VI_MC )_) -induced_VVNJ cytotoxicity_NN ._.
P11679966A11
Despite_II similar_JJ activators_NNS of_II TAK1_NN /_SYM JNK_NN and_CC p38_NN ,_, their_PNG functions_NNS in_II HSCs_NNS are_VBB distinct_JJ and_CC opposed_VVN ._.
P11682454A01
1._MC Although_CS accumulating_VVGJ studies_NNS have_VHB identified_VVN I_NN kappa_NN B_NN kinase_NN (_( IKK_NN )_) to_TO be_VBI essential_JJ for_II controlling_VVGN NF-kappa_NN B_NN activity_NN in_II response_NN to_II several_JJ cytokines_NNS ,_, the_DD upstream_JJ kinases_NNS that_PNR control_VVB IKK_NN activity_NN are_VBB still_RR not_RR completely_RR known_VVN ._.
P11682454A12
While_CS PKC_NN and_CC ERK_NN participate_VVB in_II IKK_NN activation_NN by_II LPS_NN and_CC UTP_NN ,_, the_DD phosphatidylinositide-phospholipase_NN C-dependent_JJ activation_NN of_II CaMK_NN plays_VVZ a_DD major_JJ role_NN in_II UTP_NN potentiation_NN of_II the_DD LPS_NN response_NN ._.
P11683179A03
In_II the_DD LMD_NN ,_, the_DD growing_VVGJ embryonic_JJ sex_NN tract_NN ,_, the_DD amount_NN of_II JNK_NN increased_VVD from_II the_DD 8th_JJ to_II 10th_JJ embryonic_JJ day_NN and_CC reached_VVD its_PNG highest_NN at_II the_DD 12th_JJ to_II 18th_JJ day_NN ._.
P11689560A07
The_DD stimulation_NN of_II apoptosis_NN by_II ERK_NN inhibition_NN was_VBD accompanied_VVN by_II increased_VVNJ p53_NN accumulation_NN and_CC caspase-3_NN activity_NN ,_, whereas_CS the_DD inhibitory_JJ effect_NN of_II p38_NN kinase_NN blockade_NN was_VBD associated_VVN with_II reduced_VVNJ p53_NN accumulation_NN and_CC caspase-3_NN activity_NN ._.
P11690563A01
The_DD mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) family_NN members_NNS have_VHB been_VBN implicated_VVN in_II cell_NN survival_NN ._.
P11692108A03
METHODS_NNS :_: The_DD levels_NNS of_II gene_NN expression_NN and_CC protein_NN production_NN for_II IL-6_NN and_CC IL-8_NN in_II IL-17-treated_VVNJ cells_NNS ,_, in_II the_DD presence_NN or_CC absence_NN of_II MAP_NN kinase_NN inhibitors_NNS ,_, were_VBD analyzed_VVN by_II RT-PCR_NN and_CC ELISA_NN ,_, respectively_RR ,_, and_CC activation_NN of_II MAP_NN kinases_NNS was_VBD determined_VVN by_II Western_NN blot_NN analyses_NNS ._.
P11694531A02
UV_NN also_RR induces_VVZ the_DD activation_NN of_II another_DD MAPK_NN member_NN ,_, extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) ,_, which_PNR is_VBZ typically_RR involved_VVN in_II a_DD growth-signaling_VVGJ cascade_NN ._.
P11697858A03
Ceramide_NN also_RR inhibited_VVD production_NN of_II PGD_NN (_( 2_MC )_) and_CC an_DD increase_NN in_II the_DD activity_NN of_II cytosolic_JJ phospholipase_NN A_NN (_( 2_MC )_) (_( cPLA_NN (_( 2_MC )_) )_) ,_, whereas_CS it_PN did_VDD not_RR influence_VVB the_DD tyrosine_NN phosphorylation_NN of_II major_JJ cellular_JJ proteins_NNS in_II response_NN to_II antigen_NN ._.
P11698257A08
We_PN conclude_VVB that_CST hypertonic_JJ activation_NN of_II Na_NN (_( +_SYM )_) /_SYM H_NN (_( +_SYM )_) exchange_NN in_II Xenopus_NN oocytes_NNS requires_VVZ Cl_NN (_( -_SYM )_) and_CC is_VBZ mediated_VVN by_II activation_NN of_II JNK_NN ._.
P11699878A04
Administration_NN of_II SB203580_NN led_VVD to_II a_DD 63.4_MC %_SYM reduction_NN in_II the_DD extent_NN of_II inflammatory_JJ involvement_NN ,_, the_DD level_NN of_II ET-1_NN fell_VVB by_II a_DD 42_MC %_SYM and_CC TNF-alpha_NN declined_VVD by_II a_DD 52.3_MC %_SYM ,_, whereas_CS PD98059_NN elicited_VVD a_DD 21.2_MC %_SYM reduction_NN in_II the_DD extent_NN of_II inflammatory_JJ involvement_NN and_CC a_DD 22.7_MC %_SYM decrease_NN in_II TNF-alpha_NN ,_, but_CC had_VHD no_DD effect_NN on_II the_DD LPS-induced_VVNJ increase_NN in_II ET-1_NN ._.
P11701758A10
Whereas_CS the_DD effect_NN of_II Z-VAD-FMK_NN on_II cell_NN survival_NN was_VBD transient_JJ ,_, the_DD effect_NN of_II MEK_NN inhibitors_NNS was_VBD long-lasting_VVGJ ._.
P11704547A01
The_DD mechanisms_NNS responsible_JJ for_II the_DD divergent_JJ physiological_JJ responses_NNS of_II endothelial_JJ cells_NNS to_II vascular_JJ endothelial_JJ growth_NN factor_NN (_( VEGF_NN )_) are_VBB incompletely_RR understood_VVN ._.
P11707695A08
The_DD transcription_NN factor_NN Ets-1_NN mediates_VVZ matrix_NN metalloproteinase_NN induction_NN required_VVN for_II tissue_NN invasion_NN by_II VSMC_NN ._.
P11709424A03
IL-1_NN beta_NN stimulated_VVD biphasic_JJ ERK_NN activation_NN in_II vascular_JJ smooth_JJ muscle_NN (_( VSM_NN )_) cells_NNS ,_, a_DD transient_JJ activation_NN that_PNR reached_VVD a_DD maximum_NN at_II 15_MC min_NN and_CC declined_VVD to_II baseline_NN levels_NNS within_II 1_MC h_NN ,_, and_CC a_DD second_JJ phase_NN of_II sustained_VVNJ ERK_NN activation_NN lasting_VVG up_RR+ to_RR 8_MC h_NN ._.
P11709707A04
The_DD expression_NN of_II matrix_NN metalloproteinases_NNS MMP-1_NN and_CC MMP-9_NN ,_, which_PNR have_VHB RRE_NN in_II their_PNG promoters_NNS ,_, were_VBD reduced_VVN by_II treatment_NN with_II malolactomycin_NN D_NN at_II the_DD translational_JJ and_CC transcriptional_JJ levels_NNS ._.
P11714824A08
A_DD similar_JJ inhibition_NN was_VBD observed_VVN with_II 20_MC mg_NN /_SYM kg_NN of_II a_DD second_JJ p38_NN inhibitor_NN SB203580_NN (_( 67_MC %_SYM ,_, p_NN <_SYM 0.05_MC )_) ._.
P11716483A10
These_DD results_NNS indicated_VVD that_CST ERK_NN activation_NN negatively_RR regulated_VVD Smad7_NN transcription_NN possibly_RR by_II inhibiting_VVGN translocation_NN of_II Smad_NN complex_NN to_II nuclei_NNS ._.
P11719557A08
TGF-beta1_NN concentrations_NNS of_II 1-2_MC ng_NN /_SYM ml_NN were_VBD significantly_RR promigratory_JJ ,_, whereas_CS lower_JJR levels_NNS (_( 0.2-0.6_MC ng_NN /_SYM ml_NN )_) were_VBD ineffective_JJ and_CC final_JJ concentrations_NNS >_SYM or_CC =5_MC ng_NN /_SYM ml_NN inhibited_VVD T2_NN cell_NN motility_NN ._.
P11724348A07
These_DD results_NNS suggest_VVB that_CST activation_NN of_II the_DD Raf-1_NN /_SYM ERK_NN module_NN of_II the_DD MAP_NN kinase_NN pathway_NN play_VVB an_DD important_JJ role_NN in_II PNETs_NNS ._.
P11731435A04
We_PN analyzed_VVD the_DD death_NN signaling_VVGJ pathways_NNS activated_VVN by_II these_DD molecules_NNS ._.
P11731569A03
This_DD Ca2+_NN signalling_VVGN was_VBD critical_JJ for_II the_DD normal_JJ regulatory_JJ volume_NN decrease_NN (_( RVD_NN )_) response_NN ._.
P11732999A06
Western_NN blot_NN analysis_NN showed_VVD that_CST phosphorylation_NN of_II ERK_NN was_VBD induced_VVN from_II 30_MC to_II 60_MC min_NN and_CC phosphorylation_NN of_II p38_NN MAPK_NN from_II 10_MC to_II 15_MC min_NN after_II the_DD addition_NN of_II CTGF_NN /_SYM Hcs24_NN in_II confluence_NN HCS-2_NN /_SYM 8_MC cells_NNS ._.
P11733514A02
We_PN employed_VVD a_DD neurofilament_NN light_JJ chain_NN (_( NFLC_NN )_) promoter-luciferase_NN (_( NFLC-Luc_NN )_) reporter_NN to_TO define_VVI the_DD role_NN of_II the_DD ERKs_NNS as_CC+ well_CC+ as_CC additional_JJ MAPK_NN pathways_NNS in_II NGF_NN induction_NN of_II this_DD neural_JJ specific_JJ gene_NN ._.
P11734304A03
Mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) signaling_VVGJ cascades_NNS trigger_VVB stimulus-specific_JJ responses_NNS in_II cells_NNS with_II ERK_NN being_VVGN associated_VVN with_II proliferation_NN and_CC differentiation_NN ,_, and_CC JNK_NN /_SYM SAPK_NN and_CC p38_NN mediating_VVGN stress_NN and_CC apoptotic_JJ responses_NNS ._.
P11734574A03
We_PN stimulated_VVD the_DD MAP_NN kinase_NN pathway_NN with_II anti-CD3_NN antibodies_NNS and_CC phorbol_NN 12-myristate_NN 13-acetate_NN (_( PMA_NN )_) ,_, which_PNR act_VVB upstream_JJ of_II the_DD MAP_NN kinase_NN (_( MAPK_NN )_) /_SYM ERK_NN kinase_NN (_( MEK_NN )_) as_II U0126_NN ,_, an_DD MEK_NN inhibitor_NN ,_, abolished_VVD the_DD actions_NNS of_II these_DD two_MC agents_NNS on_II MAP_NN kinase_NN activation_NN ._.
P11736793A02
Recent_JJ evidence_NN indicates_VVZ the_DD presence_NN of_II p21_NN Ras_NN and_CC the_DD phosphorylation_NN of_II ERK1_NN and_CC ERK2_NN ,_, suggesting_VVG the_DD occurrence_NN of_II the_DD Ras_NN /_SYM ERK_NN cascade_NN in_II mammalian_JJ spermatozoa_NNS ._.
P11739023A03
We_PN have_VHB examined_VVN the_DD possibility_NN that_CST mitogen_NN activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) may_VM play_VVB a_DD role_NN in_II mediating_VVGN the_DD effects_NNS of_II PACAP_NN on_II alpha_NN T3-1_NN gonadotrophs_NNS ._.
P11741321A06
We_PN also_RR show_VVB that_CST each_DD c-FLIP_NN variant_NN is_VBZ regulated_VVN by_II a_DD distinct_JJ molecular_JJ mechanism_NN at_II the_DD transcriptional_JJ level_NN ;_: c-FLIP_NN (_( L_NN )_) is_VBZ induced_VVN by_II Erk_NN ,_, whereas_CS c-FLIP_NN (_( S_NN )_) ,_, through_II the_DD JNK_NN activation_NN ,_, is_VBZ like_II an_DD autocrine_JJ regulatory_JJ loop_NN ._.
P11744731A04
In_II contrast_NN to_II PKC_NN alpha_NN ,_, ERK_NN activity_NN increased_VVD 15-fold_NN during_II dedifferentiation_NN ._.
P11746384A06
Five_MC hours_NNS after_II stimulation_NN ,_, neuronal_JJ retina_NN cells_NNS had_VHD an_DD apoptotic-like_JJ nuclear_JJ morphology_NN ._.
P11748143A02
To_TO determine_VVI if_CST these_DD cellular_JJ events_NNS are_VBB regulated_VVN by_II the_DD same_JJ signalling_VVGJ pathways_NNS ,_, we_PN examined_VVD the_DD role_NN of_II mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) signalling_VVGN in_II FGF-induced_VVNJ lens_NN cell_NN proliferation_NN and_CC differentiation_NN ._.
P11750912A04
U0126_NN ,_, however_RR ,_, did_VDD not_RR significantly_RR affect_VVB KCl-evoked_VVNJ glutamate_NN release_NN at_II concentrations_NNS shown_VVN to_TO inhibit_VVI ERK_NN activity_NN ._.
P11750919A11
We_PN conclude_VVB that_CST distinct_JJ receptors_NNS TNFR1_NN and_CC TNFR2_NN are_VBB expressed_VVN on_II cultured_VVNJ DRG_NN neurones_NNS and_CC that_CST they_PN are_VBB functionally_RR linked_VVD to_II intracellular_JJ Ca2+_NN mobilisation_NN ,_, a_DD response_NN that_PNR may_VM involve_VVB sphingolipid_NN signalling_VVGN ._.
P11751459A01
Bryostatin_NN 1_MC (_( bryo_NN 1_MC )_) is_VBZ known_VVN to_TO induce_VVI the_DD differentiation_NN and_CC cell_NN cycle_NN arrest_NN of_II human_NN lymphoid_JJ leukemia_NN cells_NNS in_RR+ vitro_RR ._.
P11751459A13
Our_PNG analysis_NN also_RR shows_VVZ that_CST CD11c_NN 's_GE gene_NN promoter_NN activity_NN is_VBZ augmented_VVN by_II bryo_NN 1_MC ._.
P11751895A03
The_DD mRNA_NN up-regulation_NN was_VBD seen_VVN at_II 3_MC h_NN in_II response_NN to_II MIF_NN (_( 10_MC microg_NN /_SYM ml_NN )_) ,_, reached_VVD the_DD maximum_NN level_NN at_II 6-12_MC h_NN ,_, and_CC returned_VVD to_II the_DD basal_JJ level_NN at_II 36_MC h_NN ._.
P11751976A06
However_RR ,_, hBD-2_NN induction_NN by_II F._NN nucleatum_NN was_VBD not_RR blocked_VVN by_II pretreatment_NN with_II two_MC NF-kappaB_NN inhibitors_NNS ,_, pyrrolidine_NN dithiocarbamate_NN and_CC the_DD proteasome_NN inhibitor_NN ,_, MG132_NN ._.
P11752055A08
While_CS both_CC ET-1_NN and_CC PDGF_NN displayed_VVD a_DD proliferative_JJ effect_NN on_II SC_NN ,_, treatment_NN with_II PDGF_NN did_VDD not_RR affect_VVB the_DD morphology_NN of_II these_DD cells_NNS to_II a_DD significant_JJ extent_NN ._.
P11752101A09
Therefore_RR ,_, alpha_NN (_( 1B_NN )_) -_: and_CC alpha_NN (_( 1D_NN )_) -ARs_NNS mediated_VVD similar_JJ growth_NN responses_NNS but_CC differ_VVB with_II respect_NN to_II the_DD MAPK_NN family_NN member_NN involved_VVN and_CC the_DD requirement_NN for_II agonist_NN ._.
P11756172A07
These_DD results_NNS strongly_RR indicate_VVB that_CST OxPAPC-induced_VVNJ TF_NN expression_NN is_VBZ independent_JJ of_II the_DD classical_JJ NF-kappa_NN B_NN pathway_NN ._.
P11771655A07
The_DD ability_NN of_II exogenously_RR added_VVNJ BMP-2_NN ,_, BMP-4_NN ,_, or_CC BMP-7_NN to_TO stimulate_VVI osteocalcin_NN (_( OCN_NN )_) and_CC bone_NN sialoprotein_NN (_( BSP_NN )_) mRNAs_NNS or_CC OCN_NN promoter_NN activity_NN was_VBD synergistically_RR increased_VVN in_II cells_NNS that_PNR were_VBD actively_RR synthesizing_VVG an_DD ECM_NN (_( i.e._II ,_, were_VBD grown_VVN in_II the_DD presence_NN of_II AA_NN )_) ._.
P11781373A04
To_TO further_RR define_VVI the_DD role_NN Bam32_NN plays_VVZ in_II B_NN cells_NNS ,_, we_PN generated_VVD Bam32-deficient_JJ DT40_NN cells_NNS ._.
P11782348A12
No_DD change_NN in_II nuclear_JJ factor-kappaB_NN binding_VVGJ activity_NN was_VBD found_VVN ,_, however_RR ._.
P11786558A04
Oxidative_JJ stress-induced_VVNJ apoptosis_NN was_VBD abrogated_VVN by_II dominant_JJ negative_JJ stress-activated_VVNJ protein_NN kinase_NN /_SYM extracellular_JJ signal-regulated_VVNJ kinase_NN kinase-1_NN (_( SEK1_NN )_) -mediated_VVNJ inhibition_NN of_II the_DD JNK_NN pathway_NN ,_, whereas_CS activation_NN of_II the_DD JNK_NN pathway_NN by_II constitutively_RR active_JJ SEK1_NN was_VBD sufficient_JJ to_TO cause_VVI apoptosis_NN ._.
P11788789A02
Therefore_RR these_DD kinases_NNS have_VHB been_VBN designated_VVN suitable_JJ targets_NNS for_II anti-inflammatory_JJ therapy_NN ._.
P11790788A08
Thus_RR ,_, CRH_NN promotes_VVZ PC12_NN apoptosis_NN via_II the_DD CRH_NN type_NN 1_MC receptor_NN ,_, which_PNR induces_VVZ Fas_NN ligand_NN production_NN via_II activation_NN of_II p38_NN ._.
P11795313A08
We_PN hypothesized_VVD that_CST fluid_NN shear_NN stress_NN modulates_VVZ TNF_NN effects_NNS on_II EC_NN by_II inhibiting_VVGN TNF-mediated_VVNJ activation_NN of_II MAP_NN kinases_NNS ._.
P11796002A05
The_DD effect_NN of_II MAP_NN kinase_NN inhibitors_NNS was_VBD tested_VVN using_VVG a_DD tissue_NN culture_NN model_NN ,_, the_DD fibroblast-populated_VVNJ collagen_NN lattice_NN (_( FPCL_NN )_) contraction_NN assay_NN ,_, and_CC a_DD rat_NN full-thickness_NN skin_NN defect_NN model_NN of_II wound_NN healing_VVGN ._.
P11796505A03
Subsequently_RR ,_, IGF-I_NN switches_VVZ to_II stimulating_VVGN differentiation_NN of_II these_DD cells_NNS ._.
P11796722A08
Staurosporine_NN and_CC Go6983_NN ,_, inhibitors_NNS for_II PKC_NN ,_, also_RR inhibited_VVD the_DD induction_NN of_II Prx_NN I_MC ,_, suggesting_VVG that_CST protein_NN kinase_NN Cdelta_NN is_VBZ required_VVN for_II the_DD induction_NN by_II arsenate_NN ._.
P11796740A05
H_NN (_( 2_MC )_) O_NN (_( 2_MC )_) -induced_VVNJ phosphorylation_NN of_II ERK1_NN /_SYM 2_MC ,_, Akt_NN /_SYM PKB_NN or_CC JNK_NN were_VBD unaffected_VVN by_II the_DD NMDA_NN channel_NN blocker_NN MK801_NN ._.
P11796750A08
These_DD findings_NNS suggest_VVB that_CST a_DD cell-survival_NN program_NN involving_VVG phospho-activation_NN of_II MEK1_NN /_SYM 2_MC and_CC ERK1_NN /_SYM 2_MC and_CC inactivation_NN of_II Bad_NN is_VBZ mobilized_VVN in_II hypoxic_JJ neurons_NNS ,_, and_CC may_VM help_VVB to_TO regulate_VVI neuronal_JJ fate_NN following_VVG hypoxic-ischemic_JJ injury_NN ._.
P11799073A09
Incubation_NN of_II VSMCs_NNS with_II the_DD antioxidant_NN N-acetylcysteine_NN suppressed_VVD GSA-elicited_VVNJ mRNA_NN induction_NN of_II MCP-1_NN and_CC IL-6_NN ._.
P11799150A09
These_DD results_NNS demonstrate_VVB the_DD importance_NN of_II signaling_VVGN via_II ERK_NN and_CC p38_NN in_II the_DD early_JJ host_NN response_NN to_II adenovirus_NN vectors_NNS and_CC will_VM permit_VVB the_DD development_NN of_II novel_JJ strategies_NNS to_TO improve_VVI the_DD safety_NN and_CC efficacy_NN of_II these_DD agents_NNS in_II human_NN gene_NN therapy_NN ._.
P11802792A05
To_TO investigate_VVI the_DD role_NN of_II ERK_NN activation_NN ,_, co-treatment_NN of_II RA_NN with_II PD98059_NN ,_, a_DD specific_JJ inhibitor_NN of_II the_DD ERK_NN signalling_VVGJ pathway_NN ,_, prevented_VVD both_CC adipocyte_NN formation_NN and_CC expression_NN of_II the_DD adipogenic_JJ markers_NNS ,_, adipocyte_NN lipid-binding_VVGJ protein_NN and_CC peroxisome-proliferator-activated_VVNJ receptor_NN gamma_NN ._.
P11806247A06
Treatment_NN of_II hVSMCs_NNS with_II IL-1_NN beta_NN induced_VVD VEGF_NN expression_NN in_II a_DD time-_NN and_CC concentration-dependent_JJ manner_NN and_CC increased_VVD both_CC the_DD VEGF_NN promoter_NN activity_NN and_CC the_DD mRNA_NN half-life_NN ._.
P11810403A05
Phosphorylated_VVNJ SAPK_NN /_SYM JNK_NN (_( SAPK_NN /_SYM JNK-P_NN )_) expression_NN occurs_VVZ in_II cortical_JJ neurons_NNS with_II neurofibrillary_JJ tangles_NNS in_II the_DD common_JJ form_NN of_II DLB_NN ._.
P11817656A08
Calcineurin_NN (_( or_CC protein_NN phosphatase_NN 2B_NN )_) is_VBZ activated_VVN by_II increases_NNS in_II [_( Ca2+i_NN ]_) through_II the_DD [_( Ca2+_NN ]_) -sensing_VVGJ protein_NN ,_, calmodulin_NN ._.
P11821017A11
These_DD results_NNS indicate_VVB that_CST (_( 1_MC )_) the_DD endothelin-1-induced_VVNJ mitogenic_JJ response_NN involves_VVZ both_CC ERK1_NN /_SYM 2-dependent_JJ and_CC -independent_JJ mechanisms_NNS ,_, (_( 2_MC )_) ERK1_NN /_SYM 2_MC activation_NN by_II endothelin-1_NN involves_VVZ an_DD extracellular_JJ Ca2+_NN influx-dependent_JJ cascade_NN as_CC+ well_CC+ as_CC an_DD extracellular_JJ Ca2+_NN influx-independent_JJ cascade_NN ,_, (_( 3_MC )_) because_CS endothelin-1-induced_VVNJ mitogenesis_NN is_VBZ completely_RR dependent_JJ on_II extracellular_JJ Ca2+_NN influx_NN ,_, extracellular_JJ Ca2+_NN influx_NN also_RR plays_VVZ an_DD important_JJ role_NN in_II mitogenic_JJ pathways_NNS downstream_JJ of_II ERK1_NN /_SYM 2_MC ,_, (_( 4_MC )_) extracellular_JJ Ca2+_NN influx_NN through_II NSCC-1_NN and_CC NSCC-2_NN has_VHZ an_DD important_JJ role_NN in_II the_DD extracellular_JJ Ca2+_NN influx-dependent_JJ component_NN of_II ERK1_NN /_SYM 2-dependent_JJ mitogenesis_NN ,_, (_( 5_MC )_) extracellular_JJ Ca2+_NN influx_NN through_II NSCC-2_NN has_VHZ an_DD important_JJ role_NN in_II ERK1_NN /_SYM 2-independent_JJ mitogenesis_NN ,_, and_CC (_( 6_MC )_) Ca2+_NN influx_NN through_II each_DD Ca2+_NN channel_NN may_VM play_VVB a_DD distinct_JJ role_NN in_II intracellular_JJ mitogenic_JJ cascades_NNS ._.
P11823472A03
We_PN report_VVB that_CST inhibition_NN of_II mitogen-activated_VVNJ protein_NN kinase_NN /_SYM extracellular_JJ signal-regulated_VVNJ kinase_NN kinase_NN (_( MEK_NN )_) -1_MC /_SYM 2_MC blocked_VVD BCR-induced_VVNJ activation_NN of_II extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) ._.
P11827704A04
OxLDL_NN ,_, but_CC not_RR LDL_NN ,_, increased_VVD CXCR2_NN mRNA_NN determined_VVN by_II RT-PCR_NN in_II both_DD cells_NNS ._.
P11830491A11
Together_RR ,_, these_DD results_NNS reveal_VVB Gab2_NN as_II a_DD limiting_VVGJ signaling_VVGJ component_NN for_II Erk_NN MAP_NN kinase_NN activation_NN and_CC terminal_JJ differentiation_NN of_II K562_NN CML_NN cells_NNS ._.
P11832348A07
Treatment_NN of_II the_DD p53_NN -/-_SYM VSMC_NN with_II S-nitroso-N-acetylpenicillamine_NN resulted_VVD in_II a_DD marked_VVNJ activation_NN of_II p38_NN MAPK_NN and_CC ,_, to_II a_DD lesser_JJR extent_NN ,_, of_II c-Jun_NN NH_NN (_( 2_MC )_) -terminal_JJ kinase_NN ,_, mitogen-activated_VVNJ protein_NN kinase_NN kinase_NN (_( MEK_NN )_) 1_MC /_SYM 2_MC ,_, and_CC p42_NN /_SYM 44_MC (_( extracellular_JJ signal-regulated_VVNJ kinase_NN ,_, ERK_NN )_) ._.
P11841790A08
The_DD activation_NN of_II MAP_NN kinases_NNS by_II H_NN (_( 2_MC )_) O_NN (_( 2_MC )_) and_CC NSAIDs_NNS was_VBD suppressed_VVN by_II quinone_NN reductase_NN inhibitors_NNS ,_, suggesting_VVG that_CST "_`` redox_NN cycling_VVGN "_'' was_VBD involved_VVN in_II the_DD activation_NN mechanisms_NNS of_II MAP_NN kinases_NNS by_II H_NN (_( 2_MC )_) O_NN (_( 2_MC )_) and_CC NSAIDs_NNS ._.
P11846446A07
Furthermore_RR ,_, PDGF_NN alpha-_NN ,_, but_CC not_RR PDGF_NN beta-receptor_NN protein_NN levels_NNS were_VBD reduced_VVN by_II type_NN II_MC TGF-beta_NN receptor_NN overexpression_NN ._.
P11846786A02
We_PN studied_VVD the_DD involvement_NN of_II the_DD mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) pathway_NN in_II regulating_VVGN ChAT_NN expression_NN in_II a_DD murine_JJ septal_JJ cell_NN line_NN ._.
P11849444A06
Apoptosis_NN was_VBD detected_VVN by_II the_DD TUNEL_NN method_NN ._.
P11850208A07
These_DD results_NNS indicated_VVD that_CST MAPK_NN plays_VVZ an_DD important_JJ role_NN in_II aromatase_NN activation_NN at_II the_DD post-transcriptional_JJ level_NN ._.
P11852102A03
Pretreatment_NN with_II antioxidants_NNS such_II+ as_II glutathione_NN or_CC estrogen_NN attenuated_VVD TRAIL_NN /_SYM Apo2L-induced_VVNJ apoptosis_NN through_II a_DD reduction_NN of_II ROS_NN generation_NN and_CC diminished_VVNJ p38_NN MAP_NN kinase_NN and_CC caspase_NN activation_NN ._.
P11853544A01
Chondrocyte_NN dedifferentiation_NN has_VHZ been_VBN noted_VVN in_II osteoarthritic_JJ cartilage_NN ,_, but_CC the_DD contribution_NN of_II this_DD phenomenon_NN is_VBZ poorly_RR understood_VVN ._.
P11854195A04
Therefore_RR ,_, polarized_VVNJ human_NN T84_NN intestinal_JJ epithelial_JJ cells_NNS were_VBD infected_VVN from_II the_DD basolateral_JJ surface_NN with_II either_CC wild-type_NN S._NN flexneri_NN or_CC one_MC of_II its_PNG isogenic_JJ LPS-defective_JJ strains_NNS with_II mutations_NNS in_II either_CC rfc_NN ,_, rfaL_NN ,_, or_CC galU_NN ._.
P11856743A10
JIP-1_NN specifically_RR scaffolds_VVZ JNK_NN ,_, MKK7_NN ,_, and_CC members_NNS of_II the_DD mixed-lineage_NN kinase_NN (_( MLK_NN )_) family_NN ,_, implicating_VVG these_DD kinases_NNS upstream_JJ of_II JNK_NN in_II the_DD apoptotic_JJ pathway_NN induced_VVN by_II PBOX-6_NN in_II K562_NN cells_NNS ._.
P11857775A02
Irradiation_NN of_II HLE_NN cells_NNS with_II ultraviolet_JJ B_NN and_CC ultraviolet_JJ C_NN radiation_NN activates_VVZ the_DD stress-response_NN MAPK_NN proteins_NNS ,_, p38_NN and_CC c-Jun_NN NH_NN (_( 2_MC )_) -terminal_JJ kinase_NN (_( JNK_NN )_) ,_, in_II a_DD dose-_NN and_CC time-dependent_JJ manner_NN ,_, while_CS the_DD extracellular-regulated_VVNJ signal_NN kinase_NN (_( ERK_NN 44_MC /_SYM 42_MC )_) cascade_NN was_VBD not_RR altered_VVN by_II UVR_NN exposure_NN ._.
P11861527A10
Cotransfection_NN of_II the_DD LHbeta-promoter_NN and_CC the_DD constitutively_RR active_JJ CDC42_NN stimulated_VVD basal_JJ and_CC GnRH-A-induced_VVNJ LHbeta-CAT_NN activity_NN ._.
P11867267A03
However_RR ,_, antiproliferative_JJ mechanisms_NNS of_II estrogen_NN were_VBD not_RR well_RR elucidated_VVN yet_RR ._.
P11867622A07
Coexpression_NN of_II wild_JJ type_NN JNK_NN with_II CYP_NN 2C9_NN attenuated_VVD the_DD CYP_NN 2C9-induced_VVNJ increase_NN in_II cyclin_NN D1_NN expression_NN and_CC abolished_VVD the_DD CYP_NN 2C9-induced_VVNJ proliferation_NN response_NN ._.
P11878930A01
Hepatitis_NN C_NN virus_NN (_( HCV_NN )_) core_NN protein_NN is_VBZ a_DD multifunctional_JJ protein_NN interacting_VVG with_II cellular_JJ and_CC viral_JJ proteins_NNS and_CC promoters_NNS ._.
P11880263A04
Furthermore_RR ,_, we_PN demonstrate_VVB that_CST pretreatment_NN with_II KN-93_NN or_CC a_DD CaM_NN kinase_NN II_MC inhibitor_NN peptide_NN inhibits_VVZ Ca_NN (_( 2+_MC )_) -dependent_JJ PYK2_NN activation_NN and_CC EGF_NN receptor_NN tyrosine_NN phosphorylation_NN in_II response_NN to_II ionomycin_NN ,_, ATP_NN ,_, and_CC platelet-derived_VVNJ growth_NN factor_NN but_CC has_VHZ no_DD effect_NN on_II phorbol_NN 12_MC ,_, 13-dibutyrate-_NN or_CC EGF-induced_VVNJ responses_NNS ._.
P11882602A02
Although_CS HB-EGF_NN has_VHZ been_VBN shown_VVN to_TO stimulate_VVI mitogenesis_NN and_CC chemotaxis_NN of_II vascular_JJ smooth_JJ muscle_NN cells_NNS (_( VSMC_NN )_) ,_, its_PNG signaling_VVGJ mechanism_NN remains_VVZ undefined_VVNJ ._.
P11884386A04
We_PN show_VVB that_CST aggregation_NN and_CC Me_NN (_( 2_MC )_) SO_NN treatment_NN ,_, which_PNR trigger_VVB the_DD differentiation_NN response_NN ,_, result_VVB in_II sustained_VVNJ activation_NN of_II JNK1_NN ,_, p38_NN ,_, and_CC ERK1_NN /_SYM 2_MC MAPKs_NNS and_CC acquisition_NN of_II AP-1_NN DNA_NN binding_VVGJ activity_NN ._.
P11884562A06
Infection_NN by_II UV-irradiated_VVNJ ,_, inactivated_VVNJ virus_NN capable_JJ of_II receptor_NN binding_VVGN and_CC endocytosis_NN triggered_VVD early_JJ ERK1_NN /_SYM 2_MC activation_NN ,_, but_CC was_VBD insufficient_JJ to_TO trigger_VVI late_JJ ERK1_NN /_SYM 2_MC activation_NN ._.
P11886455A05
A_DD MAPK_NN /_SYM ERK_NN kinase_NN inhibitor_NN ,_, PD098059_NN ,_, decreased_VVD the_DD basal_JJ levels_NNS of_II phospho-ERK1_NN /_SYM 2_MC and_CC prevented_VVD the_DD increase_NN in_II ERK1_NN /_SYM 2_MC phosphorylation_NN induced_VVN by_II depolarization_NN ._.
P11886529A09
This_DD study_NN provides_VVZ evidence_NN that_CST the_DD p38-MAPK_NN /_SYM SAPK_NN pathway_NN is_VBZ necessary_JJ ,_, but_CC insufficient_JJ ,_, for_II mediating_VVGN human_NN keratinocyte_NN migration_NN on_II collagen_NN ._.
P11888212A03
We_PN addressed_VVD this_DD point_NN in_II primary_JJ cultures_NNS of_II Sertoli_NN cells_NNS experimentally_RR maintained_VVN in_II suspension_NN ,_, considering_CS+ that_CS follicle-stimulating_VVGJ hormone_NN (_( FSH_NN )_) activates_VVZ ERK1_NN ,_, 2_MC in_II attached_VVNJ Sertoli_NN cells_NNS by_II acting_VVGN through_II a_DD GPCR_NN ._.
P11891438A07
These_DD findings_NNS suggest_VVB that_CST ERK_NN and_CC JNK_NN but_CC not_RR p38_NN cascades_NNS may_VM be_VBB closely_RR involved_VVN in_II signal_NN transduction_NN in_II the_DD rat_NN hippocampus_NN after_II traumatic_JJ brain_NN injury_NN ._.
P11895866A11
Together_RR ,_, the_DD data_NNS suggest_VVB that_CST an_DD inhibition_NN of_II ERK1_NN /_SYM 2_MC activation_NN and_CC an_DD increased_VVNJ activation_NN of_II JNK1_NN /_SYM 2_MC and_CC p38_NN by_II silibinin_NN could_VM be_VBB possible_JJ underlying_VVGJ molecular_JJ events_NNS involved_VVN in_II inhibition_NN of_II proliferation_NN and_CC induction_NN of_II apoptosis_NN in_II A431_NN cells_NNS ._.
P11909638A08
Retinoic_JJ acid_NN enhanced_VVD the_DD TGF-beta-induced_VVNJ increase_NN of_II mRNA_NN for_II HSP27_NN ._.
P11918731A06
PCNA_NN staining_VVGN and_CC TUNEL_NN assay_NN were_VBD performed_VVN on_II kidney_NN sections_NNS ._.
P11919515A03
Treatment_NN with_II PD98059_NN ,_, which_PNR inhibits_VVZ MAPK_NN /_SYM ERK_NN 1_MC /_SYM 2_MC ,_, the_DD upstream_JJ activator_NN of_II ERK_NN ,_, significantly_RR increased_VVD cell_NN survival_NN in_RR+ vitro_RR ._.
P11923227A04
To_TO evaluate_VVI the_DD ERK_NN mRNA_NN expression_NN level_NN ,_, semiquantitative_JJ reverse_JJ transcription-polymerase_NN chain_NN reaction_NN (_( RT-PCR_NN )_) was_VBD performed_VVN ._.
P11948398A04
Because_CS catalytically_RR active_JJ PKD_NN associates_VVZ with_II JNK_NN we_PN determined_VVD whether_CST it_PN could_VM phosphorylate_VVB the_DD c-Jun_NN N-terminus_NN as_II a_DD potential_JJ mechanism_NN by_II which_PNR it_PN suppresses_VVZ c-Jun_NN Ser_NN 63_MC phosphorylation_NN when_CS it_PN complexes_VVZ with_II JNK_NN ._.
P11953456A01
In_II this_DD report_NN we_PN describe_VVB our_PNG studies_NNS on_II intracellular_JJ signals_NNS that_PNR mediate_VVB neurite_NN outgrowth_NN and_CC long-term_NN survival_NN of_II cerebellar_JJ granule_NN cells_NNS ._.
P11956171A01
Treatment_NN of_II osteoblastic_JJ cells_NNS with_II PTH_NN initiates_VVZ dual_JJ signaling_VVGJ cascades_NNS resulting_VVG in_II activation_NN of_II both_CC PKA_NN and_CC PKC_NN ._.
P11969294A03
Here_RR we_PN show_VVB that_CST this_DD block_NN of_II G_NN (_( 1_MC )_) progression_NN is_VBZ not_RR simply_RR a_DD consequence_NN of_II inhibition_NN of_II the_DD MAPK_NN /_SYM Erk_NN pathway_NN but_CC instead_RR it_PN reveals_VVZ the_DD existence_NN of_II a_DD discrete_JJ CSK-sensitive_JJ checkpoint_NN ._.
P11971021A05
In_II contrast_NN ,_, CpG_NN DNA-mediated_VVNJ ERK_NN activation_NN was_VBD shown_VVN to_TO suppress_VVI IL-12_NN production_NN ,_, but_CC to_TO be_VBI essential_JJ for_II the_DD CpG_NN DNA-induced_VVNJ IL-10_NN production_NN ._.
P11979370A03
To_TO compare_VVI the_DD results_NNS obtained_VVN in_II the_DD 3_MC specimens_NNS ,_, the_DD average_NN percentages_NNS of_II both_DD epithelial_JJ and_CC stromal_JJ immunostained_VVNJ cells_NNS were_VBD calculated_VVN on_II immunostained_VVNJ sections_NNS ._.
P11986211A09
Inhibitors_NNS were_VBD used_VVN to_TO identify_VVI the_DD causal_JJ relationship_NN between_II signaling_VVGJ pathways_NNS and_CC PPF_NN ._.
P11991680A03
Among_II the_DD best-characterized_VVNJ pathways_NNS regulating_VVG cell_NN survival_NN and_CC cell_NN death_NN are_VBB those_PND mediated_VVN by_II the_DD mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) family_NN ._.
P11991731A06
Immunolocalization_NN in_II cultured_VVNJ cardiac_JJ myocytes_NNS followed_VVN by_II confocal_JJ microscopy_NN showed_VVD punctate_JJ ,_, non-nuclear_JJ SAPK3_NN staining_VVGN ._.
P11997322A08
These_DD findings_NNS identify_VVB a_DD novel_JJ action_NN of_II ERK_NN to_TO inhibit_VVI Na_NN (_( +_SYM )_) /_SYM H_NN (_( +_SYM )_) exchange_NN activity_NN and_CC establish_VVB a_DD role_NN for_II MAP_NN kinase_NN pathways_NNS in_II the_DD acute_JJ regulation_NN of_II Na_NN (_( +_SYM )_) /_SYM H_NN (_( +_SYM )_) exchange_NN activity_NN and_CC transepithelial_JJ acid_NN secretion_NN in_II renal_JJ tubules_NNS ._.
P12000769A06
Consistently_RR ,_, we_PN detected_VVD higher_JJR levels_NNS of_II activated_VVNJ Ras_NN in_II MEFs_NNS lacking_VVG pRB_NN ._.
P12008117A05
Neither_CC genomic_JJ DNA_NN fragmentation_NN nor_CC poly_JJ (_( ADP-ribose_NN )_) polymerase_NN cleavage_NN was_VBD observed_VVN during_II SAAD-induced_VVNJ cell_NN death_NN ._.
P12012331A03
This_DD hypothesis_NN was_VBD addressed_VVN by_II directly_RR visualizing_VVGN the_DD migration_NN of_II cultured_VVNJ human_NN HMFs_NNS into_II a_DD wound_NN ._.
P12019309A01
Despite_II the_DD characterization_NN of_II neuroprotection_NN by_II transforming_VVGJ growth_NN factor-beta1_NN (_( TGF-beta1_NN )_) ,_, the_DD signaling_VVGJ pathway_NN mediating_VVG its_PNG protective_JJ effect_NN is_VBZ unclear_JJ ._.
P12020969A03
In_II the_DD present_JJ study_NN ,_, we_PN have_VHB addressed_VVN the_DD role_NN of_II the_DD MAP-kinase_NN pathway_NN in_II the_DD signaling_VVGJ events_NNS leading_VVG to_II the_DD induction_NN of_II these_DD genes_NNS ._.
P12023682A12
Vascular_JJ structure_NN was_VBD unaltered_VVN by_II PD98059_NN ._.
P12024021A04
IB2_NN /_SYM JIP2_NN is_VBZ a_DD scaffold_NN for_II the_DD p38_NN mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN cascade_NN because_CS it_PN binds_VVZ to_II the_DD Rac_NN target_NN MLK3_NN ,_, the_DD MAP_NN kinase_NN kinase_NN MKK3_NN ,_, and_CC the_DD p38_NN MAP_NN kinase_NN ._.
P12028436A14
IL-1beta_NN was_VBD unable_JJ to_TO activate_VVI the_DD COX-2_NN promoter_NN when_CS the_DD AP-1-like_JJ site_NN was_VBD mutated_VVN ._.
P12029621A02
During_II TGF-beta1-induced_VVNJ apoptosis_NN ,_, 3_MC mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinases_NNS (_( extracellular_JJ signal-regulated_VVNJ kinase_NN [_( ERK_NN ]_) ,_, c-Jun_NN N-terminal_JJ kinase_NN [_( JNK_NN ]_) ,_, and_CC p38_NN kinase_NN )_) showed_VVD simultaneously_RR sustained_VVNJ activation_NN in_II FaO_NN rat_NN hepatoma_NN cells_NNS ._.
P12031710A04
METHODS_NNS :_: Balloon_NN angioplasty_NN was_VBD performed_VVN on_II 38_MC coronary_JJ arteries_NNS from_II 23_MC large_JJ white_JJ pigs_NNS ._.
P12032150A03
HGF_NN stimulation_NN of_II the_DD cells_NNS induces_VVZ not_RR only_RR a_DD rapid_JJ ,_, marked_VVNJ ,_, and_CC sustained_VVNJ activation_NN and_CC rapid_JJ nuclear_JJ accumulation_NN of_II ERK1_NN /_SYM 2_MC ,_, but_CC also_RR a_DD prolonged_VVNJ nuclear_JJ retention_NN of_II the_DD activated_VVNJ ERK1_NN /_SYM 2_MC ._.
P12032367A07
Burn_NN trauma_NN activated_VVD p38_NN MAPK_NN ,_, JNK_NN ,_, and_CC NF-kappaB_NN ,_, and_CC this_DD stress_NN response_NN was_VBD blocked_VVN by_II either_CC prazosin_NN or_CC propranolol_NN ._.
P12032835A01
We_PN had_VHD previously_RR shown_VVN that_CST murine_JJ macrophages_NNS expressing_VVG v-Fes_NN ,_, the_DD oncogenically_RR activated_VVNJ counterpart_NN of_II the_DD c-Fes_NN cytoplasmic_JJ tyrosine_NN kinase_NN ,_, proliferate_VVB independently_RR of_II Macrophage_NN Colony-Stimulating_VVGJ Factor_NN (_( MCSF_NN )_) and_CC that_CST the_DD Extracellular_JJ signal-Regulated_VVNJ Kinase_NN (_( ERK_NN )_) pathway_NN mediates_VVZ the_DD mitogenic_JJ effect_NN of_II v-Fes_NN ._.
P12034375A03
Berberine-induced_VVNJ IL-12_NN p40_NN production_NN and_CC activation_NN of_II p38_NN mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) in_II dose-dependent_JJ manners_NNS ,_, which_PNR were_VBD significantly_RR inhibited_VVN by_II p38_NN MAPK_NN inhibitors_NNS and_CC yohimbine_NN ,_, indicating_VVG that_CST p38_NN MAPK_NN and_CC alpha_NN (_( 2_MC )_) -adrenergic_JJ receptor_NN were_VBD involved_VVN in_II the_DD induction_NN of_II IL-12_NN p40_NN production_NN in_II mouse_NN macrophages_NNS by_II berberine_NN ._.
P12034736A05
The_DD mitochondrial_JJ pathway_NN is_VBZ involved_VVN in_II the_DD synergistic_JJ induction_NN of_II apoptosis_NN by_II Bis_NN VIII_MC and_CC TRA-8_NN ._.
P12042096A07
Western_NN blots_NNS showed_VVD that_CST phosphorylated_VVNJ extracellular_JJ signal_NN regulated_VVNJ kinase_NN (_( ERK1_NN /_SYM 2_MC )_) and_CC p38_NN were_VBD rapidly_RR upregulated_VVN in_II co-cultures_NNS after_II mechanical_JJ injury_NN ._.
P12049654A03
While_CS cells_NNS transfected_VVN with_II the_DD signalling-competent_JJ long_JJ form_NN of_II the_DD leptin_NN receptor_NN (_( ObRb_NN )_) have_VHB been_VBN used_VVN to_TO study_VVI leptin_NN signalling_VVGN ,_, these_PND are_VBB likely_RR to_TO be_VBI of_II limited_VVNJ use_NN in_II studying_VVGN STAT3_NN Ser727_NN phosphorylation_NN due_II+ to_II the_DD importance_NN of_II cell_NN background_NN in_II determining_VVGN the_DD nature_NN of_II the_DD response_NN ._.
P12051697A02
We_PN investigated_VVD the_DD role_NN of_II extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) and_CC p38_NN mitogen_NN activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) in_II the_DD disturbances_NNS in_II gastric_JJ mucin_NN synthesis_NN and_CC apoptotic_JJ processes_NNS evoked_VVN by_II H._NN pylori_NN lipopolysaccharide_NN (_( LPS_NN )_) ._.
P12051955A05
These_DD effects_NNS were_VBD investigated_VVN in_II relationship_NN to_II the_DD activation_NN of_II p38_NN mitogen_NN activated_VVNJ protein_NN kinase_NN (_( p38_NN MAPK_NN )_) and_CC c-jun_NN amino-terminal_JJ kinase_NN (_( JNK_NN )_) by_II arachidonic_JJ acid_NN in_II these_DD cell_NN lines_NNS ._.
P12057008A06
ATP_NN and_CC BzATP_NN also_RR increased_VVD the_DD tyrosine_NN phosphorylation_NN and_CC activity_NN of_II PKCdelta_NN ,_, and_CC these_DD stimuli_NNS also_RR increased_VVD extracellular_JJ signal-regulated_VVNJ protein_NN kinase_NN (_( ERK_NN )_) 1_MC /_SYM 2_MC activity_NN in_II a_DD PKC-dependent_JJ manner_NN ._.
P12058028A06
TGF-beta1_NN treatment_NN increased_VVD the_DD half-life_NN of_II p21_NN by_II 3-4-fold_NN ._.
P12060490A03
The_DD p42_NN /_SYM 44_MC MAPK_NN activation_NN was_VBD determined_VVN by_II studying_VVGN the_DD expression_NN of_II the_DD phosphorylated_VVNJ p42_NN /_SYM 44_MC MAPK_NN (_( Thr202_NN /_SYM Tyr204_NN )_) in_II the_DD MCP-1-treated_VVNJ macrophages_NNS ._.
P12072413A08
The_DD effect_NN of_II 1alpha_NN ,_, 25-_MC (_( OH_NN )_) (_( 2_MC )_) D_NN (_( 3_MC )_) required_VVD phospholipase_NN C_NN ,_, and_CC the_DD effect_NN of_II 24R_NN ,_, 25-_MC (_( OH_NN )_) (_( 2_MC )_) D_NN (_( 3_MC )_) required_VVD phospholipase_NN D_NN ._.
P12077118A07
In_II addition_NN ,_, co-transfections_NNS with_II mutants_NNS of_II Ras_NN ,_, Raf_NN ,_, and_CC MEK_NN showed_VVD that_CST the_DD induction_NN of_II MUC2_NN promoter_NN activity_NN by_II PMA_NN required_VVD these_DD three_MC signaling_VVGJ proteins_NNS ._.
P12082101A09
The_DD overexpression_NN of_II MEK1_NN enhanced_VVD substantially_RR junD_NN expression_NN in_II response_NN to_II UV_NN or_CC TPA_NN ._.
P12091247A02
We_PN have_VHB recently_RR shown_VVN that_CST phorbol_NN 13-myristate_NN 12-acetate_NN (_( PMA_NN )_) -stimulated_VVNJ SPRR1B_NN transcription_NN in_II Clara-like_JJ H441_NN cells_NNS is_VBZ mainly_RR mediated_VVN by_II activator_NN protein-1_NN (_( AP-1_NN )_) and_CC c-Jun_NN N-terminal_JJ kinase-1_NN (_( JNK1_NN )_) ._.
P12091480A03
Yet_RR ,_, the_DD role_NN of_II ERK_NN activation_NN prior_II+ to_II seizure_NN has_VHZ not_RR been_VBN evaluated_VVN ._.
P12097372A05
The_DD ability_NN of_II apoptotic_JJ cells_NNS to_TO promote_VVI survival_NN and_CC inhibit_VVI proliferation_NN appears_VVZ to_TO be_VBI the_DD result_NN of_II simultaneous_JJ activation_NN of_II Akt_NN and_CC inhibition_NN of_II the_DD mitogen-activated_VVNJ protein_NN kinases_NNS extracellular_JJ signal-regulated_VVNJ kinase_NN (_( ERK_NN )_) 1_MC and_CC ERK2_NN (_( ERK1_NN /_SYM 2_MC )_) ._.
P12105223A06
Co-transfection_NN of_II a_DD JNK_NN expression_NN plasmid_NN inhibited_VVD RXR_NN :_: RAR-mediated_VVNJ activation_NN of_II the_DD Ntcp_NN promoter_NN ,_, while_CS a_DD dominant_JJ negative_JJ JNK_NN expression_NN plasmid_NN completely_RR blocked_VVD IL-1_NN beta-mediated_VVNJ suppression_NN ._.
P12111821A11
Moreover_RR ,_, the_DD PC12-N1_NN cells_NNS may_VM be_VBB used_VVN as_II a_DD model_NN for_II investigating_VVGN molecular_JJ signaling_VVGJ mechanisms_NNS underlying_VVG neuronal_JJ differentiation_NN and_CC axonal_JJ outgrowth_NN ._.
P12114201A08
Inhibition_NN of_II integrin_NN signaling_VVGN ,_, with_II EDTA_NN or_CC RGD_NN peptides_NNS ,_, decreased_VVD LPS-induced_VVNJ MAP_NN kinase_NN activity_NN ._.
P12131776A07
The_DD activation_NN of_II mitogen-activated_VVNJ protein_NN kinases_NNS was_VBD assessed_VVN by_II Western_NN blotting_VVGN with_II use_NN of_II antiphosphospecific_JJ antibodies_NNS ._.
P12133965A07
However_RR ,_, this_PND was_VBD completely_RR blocked_VVN by_II combinations_NNS of_II the_DD inhibitors_NNS ,_, including_VVG PD98059-SB203580_NN ,_, PD98059-CAPE_NN ,_, or_CC SB203580-CAPE_NN combinations_NNS ,_, in_II both_CC LPS-_NN and_CC GBS-stimulated_VVNJ monocytes_NNS ._.
P12137564A05
The_DD mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) /_SYM extracellular_JJ signal-regulated_VVNJ protein_NN kinase_NN (_( ERK_NN )_) was_VBD rapidly_RR activated_VVN after_II 30_MC min_NN ,_, strongly_RR inhibited_VVN after_II 5_MC h_NN of_II continuous_JJ ischaemia_NN and_CC reactivated_VVN 3_MC times_NNS more_RR than_CSN control_NN during_II reoxygenation_NN ._.
P12138187A07
Consistently_RR ,_, Mekk2_NN (_( -/-_SYM )_) thymocytes_NNS were_VBD more_RR susceptible_JJ than_CSN wild-type_NN thymocytes_NNS to_II anti-CD3_NN MAb-induced_VVNJ cell_NN death_NN ._.
P12143037A07
In_RR+ vitro_RR ,_, 17_MC beta_NN estradiol-induced_VVNJ proliferation_NN of_II isolated_VVNJ normal_JJ cholangiocyte_NN was_VBD associated_VVN with_II increased_VVNJ (_( P_NN <_SYM .01_MC )_) protein_NN expression_NN of_II p-ERK1_NN /_SYM 2_MC ,_, Src_NN ,_, and_CC Shc_NN ._.
P12145102A06
4_MC :_: Inhibition_NN by_II ebselen_NN of_II H_NN (_( 2_MC )_) O_NN (_( 2_MC )_) -induced_VVNJ hydroxyl_NN radical_NN generation_NN in_II PC12_NN cells_NNS was_VBD observed_VVN using_VVG electron_NN paramagnetic_JJ resonance_NN measurements_NNS ._.
P12151271A06
Hypothermia_NN activated_VVD the_DD NF-kappaB_NN complex_NN ,_, ERK_NN 1_MC /_SYM 2_MC and_CC p38_NN MAPK_NN pathway_NN ._.
P12160213A08
These_DD results_NNS indicate_VVB that_CST MK_NN exerts_VVZ its_PNG neuroprotective_JJ actions_NNS mainly_RR via_II ERK_NN activation_NN ._.
P12161424A01
STAT6_NN functions_VVZ as_II a_DD critical_JJ mediator_NN of_II IL-4-stimulated_VVNJ gene_NN activation_NN ,_, and_CC the_DD function_NN of_II STAT6_NN is_VBZ regulated_VVN by_II both_CC tyrosine_NN and_CC serine_NN kinase_NN activities_NNS ._.
P12172379A03
The_DD increased_VVNJ levels_NNS of_II glutamate_NN receptors_NNS ,_, synaptic_JJ proteins_NNS ,_, and_CC glycolytic_JJ enzyme_NN were_VBD used_VVN to_TO track_VVI maturation_NN ._.
P12174383A07
RESULTS_NNS :_: Activity_NN of_II p38_NN MAPK_NN in_II control_NN organs_NNS decreased_VVD in_II the_DD course_NN of_II ischemia_NN and_CC reperfusion_NN by_II 85_MC %_SYM ,_, whereas_CS ANP_NN increased_VVD p38_NN activity_NN by_II up_RR+ to_RR 30-fold_NN ._.
P12176128A02
Our_PNG hypothesis_NN is_VBZ that_CST Fas_NN stimulation_NN not_RR only_RR activates_VVZ pro-apoptotic_JJ signals_NNS but_CC also_RR may_VM inhibit_VVB some_PND of_II them_PN ,_, and_CC this_DD inhibition_NN is_VBZ blocked_VVN by_II AD_NN ._.
P12181443A02
We_PN show_VVB for_II the_DD first_JJ time_NN ,_, with_II the_DD use_NN of_II both_CC pharmacological_JJ and_CC genetic_JJ inhibitors_NNS ,_, that_CST the_DD kinase_NN activity_NN and_CC S473_NN phosphorylation_NN of_II Akt_NN induced_VVN by_II LPA_NN and_CC S1P_NN requires_VVZ both_CC mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN kinase_NN (_( MEK_NN )_) and_CC p38_NN MAP_NN kinase_NN ,_, and_CC MEK_NN is_VBZ likely_RR to_TO be_VBI upstream_JJ of_II p38_NN ,_, in_II HEY_NN ovarian_JJ cancer_NN cells_NNS ._.
P12183528A09
Site-directed_VVNJ mutagenesis_NN of_II the_DD NF-kappaB_NN binding_VVGJ sites_NNS at_II positions_NNS -2640_MC to_II -2632_MC ,_, -2612_MC to_II -2603_MC in_II the_DD enhancer_NN region_NN ,_, or_CC the_DD AP-1_NN biding_VVGJ site_NN at_II position_NN -2276_MC to_II -2270_MC decreased_VVD the_DD inducible_JJ activity_NN of_II the_DD promoter_NN ._.
P12186863A08
Neutrophil_NN exposure_NN to_II the_DD Ser_NN /_SYM Thr_NN phosphatase_NN inhibitors_NNS okadaic_JJ acid_NN and_CC calyculin_NN A_NN induced_VVD JNK_NN activation_NN ._.
P12186945A11
This_PND indicates_VVZ that_CST ,_, unlike_II the_DD transient_JJ JNK_NN activation_NN that_PNR occurs_VVZ in_II the_DD TPA-mediated_VVNJ myogenic_JJ process_NN ,_, long-lasting_VVGJ JNK_NN activation_NN supports_VVZ the_DD growth-arrest_NN state_NN but_CC antagonises_VVZ p38-mediated_VVNJ myosin_NN expression_NN ._.
P12187125A04
Changes_NNS in_II diameter_NN were_VBD recorded_VVN under_II physiological_JJ levels_NNS of_II flow_NN (_( 90_MC microl_NN /_SYM min_NN )_) and_CC pressure_NN (_( 50_MC mm_NN Hg_NN )_) ._.
P12187281A03
MATERIALS_NNS AND_CC METHODS_NNS :_: Eight-week-old_JJ Wistar_NN rats_NNS underwent_VVD bilateral_JJ vasectomy_NN and_CC the_DD testes_NNS were_VBD harvested_VVN 1_MC to_II 9_MC days_NNS after_II vasectomy_NN ._.
P12187281A14
In_II contrast_NN to_II the_DD delayed_VVNJ phase_NN up_II+ to_II 24_MC weeks_NNS after_II vasectomy_NN ,_, we_PN observed_VVD hyperdynamic_JJ cellular_JJ turnover_NN ,_, spermatocyte_NN loss_NN through_II apoptosis_NN and_CC enhanced_VVNJ germ_NN cell_NN proliferation_NN transiently_RR at_II the_DD early_JJ phase_NN after_II vasectomy_NN ._.
P12193381A06
Quantitative_JJ analysis_NN of_II the_DD genomic_JJ DNA_NN showed_VVD a_DD >_SYM 5-fold_NN increase_NN (_( P_NN <_SYM 0.05_MC )_) in_II the_DD low_JJ molecular_JJ weight_NN DNA_NN fragments_NNS by_II 18_MC h_NN postinjection_NN ._.
P12193714A04
In_II this_DD study_NN ,_, we_PN report_VVB that_CST unlike_II CD28_NN ,_, ligation_NN of_II CD30_NN on_II normal_JJ effector_NN T_NN cells_NNS induces_VVZ IL-13_NN production_NN in_II the_DD absence_NN of_II concurrent_JJ TCR_NN engagement_NN ._.
P12193730A07
Conversely_RR ,_, H_NN (_( 2_MC )_) O_NN (_( 2_MC )_) activated_VVD JNK_NN ,_, whereas_CS exogenously_RR added_VVNJ AA_NN stimulated_VVD both_CC superoxide_NN production_NN and_CC JNK_NN activity_NN ._.
P12197778A01
Sphingosine-1-phosphate_NN (_( S-1-P_NN )_) has_VHZ been_VBN identified_VVN as_II an_DD extracellular_JJ mediator_NN and_CC an_DD intracellular_JJ second_JJ messenger_NN that_PNR may_VM modulate_VVB cell_NN motility_NN ,_, adhesion_NN ,_, proliferation_NN ,_, and_CC differentiation_NN and_CC cancer_NN cell_NN invasion_NN ._.
P12197778A13
However_RR ,_, pretreatment_NN with_II 10_MC microM_NN SB202190_NN or_CC SB203580_NN (_( putative_JJ p38_NN inhibitors_NNS )_) attenuated_VVD the_DD stimulation_NN of_II proliferation_NN by_II S-1-P_NN ._.
P12202534A02
Mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) are_VBB involved_VVN in_II the_DD control_NN of_II cell_NN proliferation_NN ._.
P12204895A05
Eotaxin_NN (_( 1-100_MC nM_NN )_) induced_VVD tyrosine_NN /_SYM threonine_NN phosphorylation_NN and_CC activation_NN of_II extracellular_JJ regulated_VVNJ kinase_NN (_( ERK_NN )_) 1_MC /_SYM 2_MC and_CC p38_NN in_II NCI-H_NN (_( 292_MC )_) cells_NNS and_CC normal_JJ human_NN bronchial_JJ epithelial_JJ cells_NNS ._.
P12206715A01
We_PN investigated_VVD intracellular_JJ signalling_VVGJ pathways_NNS for_II apoptosis_NN induced_VVN by_II epigallocatechin-3-gallate_NN (_( EGCG_NN )_) as_CS compared_VVN with_II those_PND induced_VVN by_II a_DD toxic_JJ chemical_JJ substance_NN (_( etoposide_NN ,_, VP16_NN )_) or_CC the_DD death_NN receptor_NN ligand_NN [_( tumour_NN necrosis_NN factor_NN (_( TNF_NN )_) ]_) ._.
P12207652A01
Mitogen-activated_VVNJ protein_NN kinases_NNS (_( MAPKs_NNS )_) appear_VVB to_TO be_VBI ubiquitously_RR involved_VVN in_II signal_NN transduction_NN during_II eukaryotic_JJ responses_NNS to_II extracellular_JJ stimuli_NNS ._.
P12208742A02
Exposure_NN of_II WB-F344_NN rat_NN liver_NN epithelial_JJ cells_NNS to_II menadione_NN (_( 50-100_MC micro_JJ M_NN )_) led_VVD to_II a_DD 50-75_MC %_SYM decrease_NN in_II GJIC_NN ._.
P12208955A03
Our_PNG model_NN is_VBZ composed_VVN of_II a_DD differentiated_VVNJ hepatocyte_NN (_( AML12_NN )_) 3pX-1_NN cell_NN line_NN that_PNR undergoes_VVZ pX-dependent_JJ transformation_NN and_CC a_DD dedifferentiated_VVNJ hepatocyte_NN (_( AML12_NN )_) 4pX-1_NN cell_NN line_NN that_PNR does_VDZ not_RR exhibit_VVB transformation_NN by_II pX_NN ._.
P12209089A11
CONCLUSION_NN :_: These_DD results_NNS demonstrate_VVB that_CST p38_NN MAPK_NN is_VBZ required_VVN for_II CD40-mediated_VVNJ class_NN switching_VVGN to_II IgE_NN ._.
P12213569A02
Most_PND ,_, if_CC not_RR all_PND ,_, the_DD biological_JJ effects_NNS of_II TCDD_NN are_VBB mediated_VVN by_II the_DD activation_NN of_II AHR_NN ,_, which_PNR is_VBZ a_DD ligand-activated_VVNJ transcription_NN factor_NN required_VVN for_II ligand-induced_VVNJ expression_NN of_II several_JJ detoxification_NN genes_NNS ,_, including_VVG those_PND encoding_VVG for_II cytochrome_NN P450_NN enzymes_NNS CYP1A1_NN ,_, CYP1A2_NN ,_, and_CC CYP1B1_NN ._.
P12218097A11
Our_PNG previous_JJ results_NNS indicate_VVB that_CST MAPK_NN /_SYM ERK_NN protects_VVZ recently_RR activated_VVNJ T_NN cells_NNS from_II Fas_NN receptor-mediated_VVNJ apoptosis_NN during_II the_DD initial_JJ phase_NN of_II an_DD immune_JJ response_NN before_CS the_DD activation-induced_VVNJ cell_NN death_NN takes_VVZ place_NN ._.
P12219008A01
BACKGROUND_NN :_: Vascular_JJ endothelial_JJ cell_NN apoptosis_NN is_VBZ central_JJ in_II atherosclerosis_NN and_CC intimal_JJ hyperplasia_NN ._.
P12219008A13
Because_CS TGF-beta1_NN is_VBZ upregulated_VVN in_II vascular_JJ remodeling_VVGN ,_, p38_NN (_( MAPK_NN )_) is_VBZ a_DD potential_JJ target_NN to_TO prevent_VVI endothelial_JJ cell_NN apoptosis_NN during_II this_DD process_NN ._.
P12219035A09
RESULTS_NNS :_: LPS_NN caused_VVD an_DD early_JJ activation_NN in_II all_DD members_NNS of_II the_DD MAPK_NN family_NN ,_, whereas_CS antecedent_JJ shock_NN both_CC delayed_VVD and_CC attenuated_VVD the_DD LPS_NN induction_NN ._.
P12220646A05
Overexpression_NN of_II inactive_JJ mutant_JJ Elk-1_NN enhanced_VVD differentiation_NN ._.
P12220664A07
Ornithine_NN decarboxylase_NN activity_NN decreased_VVD after_II etoposide_NN ,_, indicating_VVG that_CST DFMO_NN exerts_VVZ its_PNG effect_NN by_II depleting_VVGN cellular_JJ polyamines_NNS before_II induction_NN of_II apoptosis_NN ._.
P12225289A06
Nevertheless_RR ,_, ATF3_NN does_VDZ not_RR serve_VVB as_II a_DD JNK_NN substrate_NN in_RR+ vitro_RR or_CC in_RR+ vivo_RR ._.
P12225365A01
We_PN examined_VVD the_DD role_NN of_II cell_NN surface_NN clustering_VVGN of_II beta2-integrin_NN caused_VVN by_II protein_NN kinase_NN C_NN (_( PKC_NN )_) -activated-cPLA2_NN in_II adhesion_NN of_II eosinophilic_JJ AML14.3D10_NN (_( AML_NN )_) cells_NNS ._.
P12225365A13
Our_PNG data_NNS indicate_VVB that_CST PMA_NN causes_VVZ AML_NN cell_NN adhesion_NN through_II beta2-integrin_NN by_II PKC_NN activation_NN of_II cPLA2_NN ._.
P12225959A01
Lung_NN ischemia-reperfusion_NN (_( I-R_NN )_) is_VBZ an_DD important_JJ model_NN of_II oxidant-mediated_VVNJ acute_JJ lung_NN and_CC vascular_JJ injury_NN ._.
P12225989A09
PD-98059_NN ,_, an_DD inhibitor_NN of_II phosphorylation_NN of_II ERK1_NN /_SYM 2_MC ,_, caused_VVD a_DD marked_VVNJ inhibition_NN of_II HSP60-induced_VVNJ COX-2_NN and_CC NOS-2_NN expression_NN ._.
P12226747A06
Kinase_NN assays_NNS show_VVB that_CST Menin_NN overexpression_NN does_VDZ not_RR interfere_VVB with_II activation_NN of_II either_CC ERK2_NN or_CC JNK1_NN ,_, suggesting_VVG that_CST Menin_NN acts_VVZ at_II a_DD level_NN downstream_JJ of_II MAPK_NN activation_NN ._.
P12237315A06
In_II addition_NN ,_, immunoblot_NN analysis_NN revealed_VVD that_CST phosphorylation_NN of_II ERK_NN was_VBD increased_VVN by_II treatment_NN with_II the_DD p38_NN inhibitors_NNS ,_, whereas_CS the_DD MEK_NN inhibitors_NNS increased_VVD phosphorylation_NN of_II p38_NN ,_, which_PNR implies_VVZ a_DD seesaw-like_JJ balance_NN between_II ERK_NN and_CC p38_NN phosphorylation_NN ._.
P12297293A03
Phosphorylation_NN of_II p38_NN MAPK_NN was_VBD decreased_VVN in_II response_NN to_II TNF-alpha_NN ,_, and_CC the_DD specific_JJ p38_NN MAPK_NN inhibitor_NN SB203580_NN mimicked_VVD the_DD effect_NN of_II TNF-alpha_NN on_II col1a1_NN mRNA_NN levels_NNS ._.
P12297830A10
Betaine_NN supplementation_NN in_II the_DD drinking_VVGJ water_NN significantly_RR ameliorated_VVD in_JJ+ vivo_JJ hepatocyte_NN apoptosis_NN following_VVG bile_NN duct_NN ligation_NN ._.
P12354421A07
We_PN used_VVD enzyme-linked_VVNJ immunosorbent_JJ assay_NN (_( ELISA_NN )_) and_CC fluorescence-activated_VVNJ cell_NN sorting_VVGN (_( FACS_NN )_) for_II detecting_VVGN the_DD induction_NN of_II ICAM-1_NN on_II HDMEC_NN ._.
P12354565A07
Other_JJ 5-HT_NN (_( 1A_NN )_) receptor_NN agonists_NNS (_( buspirone_NN ,_, gepirone_NN and_CC ipsapirone_NN )_) also_RR reduced_VVD phospho-Erk1_NN /_SYM 2_MC levels_NNS in_II hippocampus_NN ._.
P12355484A09
Inhibitors_NNS of_II mitogen-activated_VVNJ protein_NN kinase_NN kinase_NN ,_, p38_NN ,_, and_CC JNK_NN were_VBD each_PND able_JJ to_TO inhibit_VVI increased_VVNJ MMP-13_NN production_NN ,_, while_CS the_DD interleukin-1_NN receptor_NN antagonist_NN (_( IL-1Ra_NN )_) protein_NN did_VDD not_RR ._.
P12356731A03
IEX-1_NN was_VBD isolated_VVN by_II phosphorylation_NN screening_VVGN with_II active_JJ ERK2_NN and_CC found_VVN subsequently_RR phosphorylated_VVN in_RR+ vivo_RR upon_II ERK_NN activation_NN ._.
P12359764A06
We_PN have_VHB examined_VVN the_DD response_NN of_II the_DD extracellular_JJ signal-regulated_VVNJ kinase_NN ERK1_NN /_SYM 2_MC in_II PDT-resistant_JJ (_( LFS087_NN )_) and_CC PDT-sensitive_JJ (_( GM38A_NN )_) cells_NNS after_II Photofrin-mediated_VVNJ PDT_NN ._.
P12372814A06
We_PN also_RR demonstrate_VVB that_CST upstream_JJ tyrosine_NN kinase_NN activity_NN is_VBZ involved_VVN in_II the_DD mechanotransduction_NN pathway_NN leading_VVG to_II stretch-induced_VVNJ MAPK_NN activation_NN and_CC c-fos_NN mRNA_NN expression_NN ._.
P12377734A10
CONCLUSIONS_NNS :_: Treatment_NN with_II 17betaE_NN has_VHZ a_DD dual_JJ beneficial_JJ effect_NN :_: the_DD improvement_NN of_II vascular_JJ healing_VVGN and_CC the_DD prevention_NN of_II restenosis_NN after_II angioplasty_NN ._.
P12377986A11
These_DD data_NNS provide_VVB insight_NN into_II possible_JJ general_JJ mechanisms_NNS by_II which_PNR VT_NN and_CC other_JJ trichlothecenes_NNS upregulate_VVB proinflammatory_JJ genes_NNS and_CC impart_VVB immunotoxicity_NN ._.
P12391145A02
Here_RR ,_, evidence_NN is_VBZ presented_VVN for_II VEGF_NN stimulation_NN of_II sphingosine_NN kinase_NN (_( SPK_NN )_) that_PNR affects_VVZ not_RR only_RR endothelial_JJ cell_NN signaling_VVGN but_CC also_RR tumor_NN cells_NNS expressing_VVG VEGF_NN receptors_NNS ._.
P12392577A01
In_II this_DD study_NN it_PN was_VBD shown_VVN that_CST growth_NN factor_NN receptors_NNS (_( GFR_NN )_) play_VVB a_DD crucial_JJ role_NN in_II early_JJ embryogenesis_NN of_II the_DD echinoderms_NNS Hemicentrotus_NN pulcherrimus_NN and_CC Clypeaster_NN japonicus_NN by_II transmitting_VVGN signals_NNS to_II the_DD mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) pathway_NN ._.
P12393099A01
Activation_NN of_II vascular_JJ endothelial_JJ cells_NNS (_( ECs_NNS )_) plays_VVZ an_DD important_JJ pathogenic_JJ role_NN in_II the_DD development_NN of_II atherosclerosis_NN ._.
P12393706A04
Partial_JJ inhibition_NN of_II p38_NN MAPK_NN impaired_VVD CD4_NN (_( -_SYM )_) CD8_NN (_( -_SYM )_) thymocyte_NN development_NN and_CC T-cell_NN proliferation_NN ,_, but_CC not_RR positive_JJ selection_NN ._.
P12397020A11
CO_NN may_VM act_VVB as_II an_DD important_JJ mediator_NN of_II remodeling_VVGN of_II human_NN airways_NNS in_II asthma_NN via_II its_PNG ability_NN to_TO regulate_VVI cell_NN growth_NN of_II airway_NN smooth_JJ muscle_NN cells_NNS ._.
P12406026A10
Preincubation_NN with_II SB202190_NN (_( 20_MC micro_JJ M_NN )_) ,_, a_DD specific_JJ inhibitor_NN of_II p38_NN MAPK_NN ,_, significantly_RR decreased_VVD the_DD oxLDL-induced_VVNJ VEGF_NN mRNA_NN expression_NN by_II 40_MC %_SYM ._.
P12410564A04
These_DD differing_VVGJ sensitivities_NNS at_II low_JJ concentrations_NNS correlated_VVD well_RR with_II the_DD level_NN of_II constitutive_JJ activation_NN of_II nuclear_JJ factor_NN kappa_NN B_NN (_( NFkappaB_NN )_) in_II the_DD individual_JJ cell_NN lines_NNS ._.
P12417265A06
ET-1_NN (_( 1-31_MC )_) in_II addition_NN to_II ET-1_NN increased_VVD the_DD generation_NN of_II cellular_JJ reactive_JJ oxygen_NN species_NNS (_( ROS_NN )_) in_II RASMC_NN ._.
P12421945A08
Herein_RR ,_, we_PN show_VVB that_CST CD44_NN expression_NN induced_VVN by_II the_DD LPS-mediated_VVNJ pathway_NN predominantly_RR involved_VVD JNK_NN activation_NN ._.
P12425799A04
Then_RR the_DD 542nm_NN absorption_NN value_NN was_VBD measured_VVN and_CC the_DD growth_NN curve_NN was_VBD drawn_VVN ._.
P12450322A04
MAPK_NN activities_NNS were_VBD determined_VVN by_II Western_NN immunoblotting_VVGN using_VVG specific_JJ antibodies_NNS to_II their_PNG activated_VVNJ phosphorylated_VVNJ forms_NNS ._.
P12477734A10
In_II contrast_NN ,_, forced_VVNJ MAPK_NN activation_NN diminished_VVD p27_NN expression_NN and_CC markedly_RR augmented_VVD femoral_JJ artery_NN SMC_NN proliferation_NN and_CC migration_NN ._.P00302031A02
This_DD effect_NN on_II elongating_VVGJ neurites_NNS may_VM involve_VVB alterations_NNS in_II nerve-substratum_NN interactions_NNS by_II the_DD presence_NN of_II undifferentiated_VVNJ target_NN tissues_NNS ._.
P00536696A03
The_DD preaxial_JJ response_NN to_II polarizing_VVGJ activity_NN can_VM be_VBB obtained_VVN after_II only_RR 12_MC --_: 18_MC h_NN in_II the_DD reoriented_VVNJ position_NN ._.
P00867277A02
Rabbits_NNS were_VBD killed_VVN either_DD 2-32_MC hours_NNS posttreatment_NN for_II histological_JJ analysis_NN of_II embryos_NNS or_CC at_II day_NN 29_MC for_II gross_JJ and_CC skeletal_JJ examination_NN of_II fetuses_NNS ._.
P00867277A08
Histologically_RR HU-treated_VVNJ embryos_NNS had_VHD numerous_JJ ,_, basophilic_JJ ,_, intercellular_JJ granules_NNS (_( presumably_RR cell_NN debris_NN )_) which_PNR appeared_VVD within_II two_MC to_II four_MC hours_NNS in_II the_DD limb_NN bud_NN mesenchyme_NN ,_, neural_JJ tube_NN ,_, and_CC dorsal_JJ root_NN ganglion_NN ._.
P01127402A01
In_II a_DD study_NN of_II the_DD polydactylous_JJ mutation_NN of_II the_DD domestic_JJ chicken_NN ,_, diplopodia4_NN ,_, we_PN have_VHB found_VVN that_CST the_DD genetic_JJ lesion_NN affects_VVZ primarily_RR the_DD mesoderm_NN and_CC only_RR secondarily_RR the_DD ectoderm_NN ._.
P01282859A05
In_II a_DD second_JJ series_NN of_II experiments_NNS ,_, we_PN studied_VVD the_DD expression_NN of_II TN_NN mRNA_NN and_CC protein_NN in_II combinations_NNS between_II animal_NN and_CC vegetal_JJ stage-6_NN blastomeres_NNS and_CC in_II stage-8_NN blastula_NN animal_NN caps_NNS treated_VVN with_II activin_NN A_NN or_CC basic_JJ fibroblastic_JJ growth_NN factor_NN (_( b-FGF_NN )_) ._.
P01282859A11
The_DD data_NNS further_RR show_VVB that_CST "_`` ventral_JJ mesoderm_NN "_'' induced_VVN by_II low_JJ concentrations_NNS of_II activin_NN is_VBZ distinct_JJ from_II that_PND induced_VVN by_II b-FGF_NN ,_, and_CC imply_VVB that_CST activin_NN induces_VVZ ventral_JJ mesoderm_NN of_II the_DD trunk_NN while_CS b-FGF_NN induces_VVZ posterior_JJ mesoderm_NN of_II the_DD tailbud_NN ._.
P01340474A05
The_DD ectopic_JJ expression_NN of_II hh_NN that_PNR is_VBZ normally_RR induced_VVN in_II patched_NN (_( ptc_NN )_) mutant_JJ embryos_NNS does_VDZ not_RR appear_VVB in_II ptc_NN en_NN double_JJ mutants_NNS ._.
P01354990A02
A_DD subpopulation_NN of_II cephalic_JJ neural_JJ crest_NN cells_NNS is_VBZ also_RR En-protein-positive_JJ ._.
P01354990A08
Based_VVN upon_II these_DD observations_NNS we_PN propose_VVB :_: 1_MC )_) that_CST En_NN expression_NN in_II the_DD mesoderm_NN may_VM be_VBB induced_VVN through_II interaction_NN with_II En_NN expressing_VVGJ cells_NNS in_II the_DD neuroectoderm_NN ;_: 2_MC )_) that_CST En_NN expression_NN in_II the_DD head_NN mesenchyme_NN is_VBZ associated_VVN with_II somitomere_NN 4_MC ;_: and_CC 3_MC )_) that_CST En_NN expression_NN may_VM be_VBB involved_VVN in_II epithelial-mesenchymal_JJ cell_NN transformations_NNS ._.
P01358273A05
GHox-8_NN is_VBZ expressed_VVN in_II anterior_JJ mesoderm_NN of_II normal_JJ limb_NN buds_NNS ,_, but_CC is_VBZ undetectable_JJ in_II ta2_NN limb_NN bud_NN mesoderm_NN ._.
P01358594A05
Mouse_NN neural_JJ tube_NN and_CC genital_JJ tubercle_NN grafts_NNS ,_, which_PNR give_VVB much_RR less_RR extensive_JJ changes_NNS in_II pattern_NN ,_, do_VDB not_RR activate_VVB 5'-located_VVNJ Hox-4_NN genes_NNS ._.
P01425343A01
Establishment_NN of_II mesodermal_JJ tissues_NNS in_II the_DD amphibian_JJ body_NN involves_VVZ a_DD series_NN of_II inductive_JJ interactions_NNS probably_RR elicited_VVN by_II a_DD variety_NN of_II peptide_NN growth_NN factors_NNS ._.
P01426640A04
Signals_NNS from_II all_DD three_MC types_NNS of_II facial_JJ mesenchyme_NN (_( frontonasal_JJ mass_NN ,_, mandibular_JJ ,_, and_CC maxillary_JJ )_) maintained_VVD the_DD thickened_VVNJ apical_JJ ectodermal_JJ ridge_NN of_II limb_NN epithelium_NN for_II up_RR+ to_RR 48_MC h_NN ._.
P01483395A06
We_PN find_VVB that_CST the_DD release_NN of_II morphogenetically_RR active_JJ retinoids_NNS from_II the_DD floor_NN plate_NN is_VBZ only_RR about_RR 1.5-fold_NN that_PND of_II the_DD dorsal_JJ spinal_JJ cord_NN ,_, which_PNR does_VDZ not_RR have_VHB neural_JJ tube_NN or_CC limb_NN polarizing_VVGJ activity_NN ._.
P01577190A01
It_PN has_VHZ been_VBN suggested_VVN that_CST the_DD mesonephros_NN has_VHZ a_DD role_NN in_II normal_JJ limb_NN development_NN ._.
P01577190A07
The_DD removal_NN of_II the_DD mesonephros_NN adjoining_VVG the_DD prospective_JJ limb_NN region_NN reduced_VVD the_DD number_NN of_II dividing_VVGJ cells_NNS in_II the_DD medial_JJ mesoderm_NN ._.
P01600242A02
All_DD grafts_NNS were_VBD placed_VVN solely_RR within_II the_DD confines_NNS of_II the_DD primitive_JJ streak_NN to_TO prevent_VVI confusion_NN between_II cells_NNS that_PNR had_VHD not_RR yet_RR ingressed_VVN and_CC those_PND that_PNR had_VHD already_RR ingressed_VVN ,_, and_CC transplanted_VVNJ cells_NNS were_VBD distinguished_VVN from_II host_NN cells_NNS on_II the_DD basis_NN of_II a_DD naturally_RR occurring_VVGJ cell_NN marker_NN ._.
P01600242A08
Hensen_NN 's_GE node_NN contributed_VVD cells_NNS to_II the_DD gut_NN endoderm_NN ,_, head_NN mesenchyme_NN ,_, notochord_NN ,_, and_CC median_JJ hinge-point_NN (_( MHP_NN )_) cells_NNS of_II the_DD neural_JJ tube_NN (_( future_NN floor_NN plate_NN )_) ._.
P01680378A05
GHox-8_NN encodes_VVZ an_DD mRNA_NN transcript_NN of_II about_RR 3_MC kb_NN that_PNR is_VBZ expressed_VVN at_II several_JJ early_JJ stages_NNS of_II chick_NN limb_NN development_NN ._.
P01680378A10
In_II the_DD proximal_JJ posterior_JJ periphery_NN of_II the_DD wing_NN bud_NN at_II these_DD later_JJR stages_NNS of_II development_NN ,_, expression_NN of_II GHox-8_NN is_VBZ limited_VVN to_II a_DD small_JJ region_NN in_II the_DD mid-proximal_JJ periphery_NN corresponding_VVG to_II the_DD posterior_JJ necrotic_JJ zone_NN in_II which_PNR programmed_VVNJ cell_NN death_NN is_VBZ occurring_VVG ._.
P01683800A04
Alternatively_RR ,_, retinoic_JJ acid_NN may_VM be_VBB part_NN of_II a_DD more_RR complex_JJ signalling_VVGJ system_NN ._.
P01683800A10
Results_NNS of_II recombination_NN experiments_NNS and_CC studies_NNS of_II changes_NNS in_II the_DD apical_JJ ridge_NN and_CC proliferation_NN in_II the_DD mesenchyme_NN suggest_VVB the_DD following_VVGJ scheme_NN :_: retinoic_JJ acid_NN is_VBZ involved_VVN in_II specification_NN of_II position_NN of_II mesenchyme_NN cells_NNS ;_: this_DD specification_NN determines_VVZ their_PNG local_JJ interaction_NN with_II the_DD ridge_NN that_PNR controls_VVZ ridge_NN morphology_NN ;_: the_DD thickened_VVNJ apical_JJ ridge_NN permits_VVZ local_JJ proliferation_NN in_II the_DD underlying_VVGJ mesenchyme_NN ._.
P01764996A04
Sympathetic_JJ differentiation_NN was_VBD assessed_VVN by_II catecholamine_NN fluorescence_NN after_II aldehyde_NN fixation_NN ._.
P01842349A04
The_DD floor_NN plate_NN and_CC notochord_NN appear_VVB to_TO control_VVI the_DD pattern_NN of_II cell_NN types_NNS that_PNR appear_VVB along_II the_DD dorsoventral_JJ axis_NN of_II the_DD neural_JJ tube_NN ._.
P01879338A02
Maps_NNS of_II the_DD spatial_JJ distribution_NN and_CC the_DD strength_NN of_II the_DD signal_NN within_II limb_NN buds_NNS of_II different_JJ stages_NNS are_VBB well_RR documented_VVN ._.
P01879338A08
Some_DD 6_MC to_II 8_MC h_NN later_RR at_II stage_NN 12_MC ,_, there_EX is_VBZ a_DD distinct_JJ peak_NN of_II activity_NN at_II somite_NN position_NN 18_MC ,_, the_DD middle_NN of_II the_DD wing_NN field_NN ._.
P01893873A06
Later_JJR gestation_NN embryos_NNS show_VVB expression_NN in_II developing_VVGJ limbs_NNS ,_, the_DD embryonic_JJ heart_NN ,_, the_DD facial_JJ processes_NNS and_CC condensed_VVNJ mesenchymal_JJ cells_NNS associated_VVN with_II early_JJ whisker_NN follicle_NN formation_NN ._.
P01952103A06
In_RR+ situ_RR ,_, the_DD differentiation_NN of_II the_DD floor_NN plate_NN was_VBD characterized_VVN by_II a_DD lack_NN of_II immunoperoxidase_NN staining_VVGN with_II antibody_NN to_II neurofilaments_NNS and_CC the_DD monoclonal_JJ antibody_NN HNK-1_NN throughout_II the_DD period_NN examined_VVN ._.
P01952103A12
However_RR ,_, cells_NNS staining_VVG positively_RR for_II N-CAM_NN ,_, sialylated_VVNJ N-CAM_NN and_CC the_DD glial_JJ cell_NN markers_NNS were_VBD relatively_RR sparse_JJ in_II floor_NN plate_NN cultures_NNS ,_, suggesting_VVG that_CST these_DD epitopes_NNS were_VBD not_RR retained_VVN or_CC were_VBD masked_VVN in_II cultured_VVNJ cells_NNS ._.
P01991324A03
Grafting_VVGN an_DD additional_JJ notochord_NN or_CC floor_NN plate_NN to_II ectopic_JJ positions_NNS ,_, or_CC deleting_VVGN both_DD cell_NN groups_NNS ,_, resulted_VVD in_II changes_NNS in_II the_DD fate_NN and_CC position_NN of_II neural_JJ cell_NN types_NNS ,_, defined_VVN by_II expression_NN of_II specific_JJ antigens_NNS ._.
P02186666A04
PG-M_NN is_VBZ not_RR detected_VVN in_II the_DD limb_NN mesenchyme_NN until_II after_II stage_NN 17_MC ,_, when_CS it_PN is_VBZ present_JJ in_II the_DD distal_JJ region_NN ,_, as_CS is_VBZ PNA-binding_VVGJ material_NN ._.
P02186666A09
These_DD results_NNS are_VBB considered_VVN in_II relation_NN to_II the_DD formation_NN of_II precartilage_NN aggregates_NNS ,_, and_CC indicate_VVB that_CST PNA_NN binds_VVZ to_II components_NNS in_II precartilage_NN aggregates_NNS other_II+ than_II PG-M_NN or_CC tenascin_NN ._.
P02245438A02
A_DD water-soluble_JJ extract_NN of_II bone_NN has_VHZ been_VBN shown_VVN to_TO stimulate_VVI chondrogenesis_NN in_RR+ vitro_RR in_II embryonic_JJ limb_NN mesenchymal_JJ cells_NNS (_( Syftestad_NNP ,_, Lucas_NNP &_CC Caplan_NNP ,_, 1985_MC )_) ._.
P02245438A08
Since_CS poly-L-lysine_NN (_( PL_NN )_) has_VHZ recently_RR been_VBN shown_VVN (_( San_NNP Antonio_NNP &_CC Tuan_NNP ,_, 1986_MC )_) to_TO promote_VVI chondrogensis_NN ,_, PL_NN and_CC BBE_NN were_VBD introduced_VVN together_RR in_II different_JJ doses_NNS ,_, in_II the_DD culture_NN medium_NN ,_, to_TO determine_VVI if_CST their_PNG actions_NNS were_VBD synergistic_JJ ._.
P02379136A01
Changes_NNS in_II extracellular_JJ hyaluronate_NN occur_VVB during_II the_DD onset_NN of_II cell_NN migratory_JJ stages_NNS of_II development_NN ,_, wound_NN healing_VVGN ,_, regeneration_NN ,_, and_CC tumor_NN invasion_NN ._.
P02379136A07
Human_NN LX-1_NN lung_NN carcinoma_NN cells_NNS or_CC human_NN HCV-29T_NN bladder_NN carcinoma_NN cells_NNS cultured_VVN together_RR with_II chick_NN embryo_NN limb_NN bud_NN mesoderm_NN synthesized_VVD 2-_MC to_II 4-fold_NN more_DD hyaluronate_NN than_CSN the_DD sum_NN of_II that_PND produced_VVN by_II carcinoma_NN and_CC mesoderm_NN cultures_NNS grown_VVN separately_RR ._.
P03181034A03
The_DD major_JJ active_JJ components_NNS from_II all_DD three_MC MIF_NN sources_NNS behave_VVB as_II somewhat_RR hydrophobic_JJ ,_, acid-stable_JJ molecules_NNS and_CC do_VDB not_RR bind_VVB to_II heparin_NN ._.
P03181034A09
Our_PNG study_NN shows_VVZ that_CST the_DD MIFs_NNS examined_VVN here_RR form_VVB a_DD small_JJ group_NN of_II potent_JJ agents_NNS distinct_JJ from_II the_DD HBGFs_NNS and_CC from_II other_JJ known_VVNJ growth_NN and_CC differentiations_NNS factors_NNS ._.
P03652992A01
Removal_NN of_II the_DD posterior_JJ half_NN of_II the_DD chick_NN wing_NN bud_NN between_II stages_NNS 17-22_MC results_VVZ in_II failure_NN of_II the_DD anterior_JJ distal_JJ tissue_NN to_TO survive_VVI and_CC differentiate_VVI ._.
P03652992A07
The_DD anterior_JJ half_NN went_VVD on_II to_TO develop_VVI a_DD full_JJ set_NN of_II digits_NNS and_CC zeugopod_NN parts_NNS in_II almost_RR 50_MC %_SYM of_II cases_NNS ,_, although_CS no_DD skeleton_NN resulting_VVG from_II this_DD regulation_NN of_II the_DD anterior_JJ half_NN had_VHD totally_RR size_NN regulated_VVN ._.
P03740453A03
The_DD investigation_NN is_VBZ concerned_VVN with_II analysing_VVGN why_CST this_DD mesoderm_NN fails_VVZ to_TO segment_VVI ._.
P03912458A04
At_II later_JJR stages_NNS most_PND of_II the_DD labelled_VVNJ cells_NNS were_VBD found_VVN in_II ectodermal_JJ tissues_NNS such_II+ as_II epidermis_NN ,_, head_NN mesenchyme_NN and_CC neural_JJ tube_NN (_( the_DD last_PN from_II stages_NNS 7_MC 1_MC /_SYM 2_MC and_CC 8_MC only_RR )_) ._.
P03912458A10
The_DD formation_NN of_II mesodermal_JJ tissues_NNS in_II stage-7_NN 1_MC /_SYM 2_MC combinations_NNS was_VBD confirmed_VVN by_II using_VVGN a_DD panel_NN of_II antibodies_NNS which_PNR react_VVB with_II particular_JJ tissues_NNS in_II normal_JJ tailbud-stage_NN embryos_NNS :_: anti-keratan_NN sulphate_NN for_II the_DD notochord_NN ,_, anti-myosin_NN for_II the_DD muscle_NN and_CC anti-keratin_NN for_II epidermis_NN and_CC notochord_NN ._.
P03912458A15
The_DD dorsovegetal_JJ tissue_NN induces_VVZ '_`` dorsal-type_NN '_'' mesoderm_NN (_( notochord_NN and_CC large_JJ muscle_NN masses_NNS )_) while_CS ventrovegetal_JJ tissue_NN induces_VVZ '_`` ventral-type_NN '_'' mesoderm_NN (_( blood_NN ,_, mesothelium_NN and_CC a_DD little_JJ muscle_NN )_) ._.
P06663230A04
Orthotopic_JJ grafts_NNS of_II the_DD ventral_JJ marginal_JJ zone_NN (_( the_DD tissue_NN that_PNR responds_VVZ to_II a_DD grafted_VVNJ organizer_NN )_) indicated_VVD that_CST it_PN only_RR contributes_VVZ to_II the_DD posterior_JJ half_NN of_II the_DD embryo_NN ._.
P06663230A10
The_DD neural_JJ tube_NN of_II the_DD secondary_JJ embryo_NN was_VBD also_RR unlabelled_VVNJ ,_, showing_VVG that_CST it_PN was_VBD induced_VVN by_II the_DD influence_NN of_II the_DD graft_NN on_II the_DD overlying_VVGJ ectoderm_NN ,_, which_PNR normally_RR forms_VVZ ventral_JJ epidermis_NN ._.
P06663230A16
Thus_RR ,_, our_PNG results_NNS allow_VVB us_PN to_TO conclude_VVI that_CST the_DD organizer_NN mediates_VVZ two_MC distinct_JJ interactions_NNS in_II bringing_VVGN about_II the_DD formation_NN of_II duplicated_VVNJ embryos_NNS ._.
P07477329A02
In_II vertebrate_NN embryos_NNS ,_, for_II example_NN ,_, sonic_NN hedgehog_NN expression_NN in_II the_DD notochord_NN appears_VVZ to_TO be_VBI responsible_JJ for_II the_DD local_JJ and_CC long-range_NN induction_NN of_II ventral_JJ cell_NN types_NNS within_II the_DD neural_JJ tube_NN and_CC somites_NNS (_( reviewed_VVN in_II refs_NNS 1_MC ,_, 2_MC )_) ._.
P07482777A04
We_PN review_NN the_DD induction_NN and_CC patterning_VVGN of_II the_DD nervous_JJ system_NN ,_, with_II an_DD emphasis_NN on_II molecules_NNS that_PNR might_VM play_VVB a_DD role_NN in_II these_DD interactions_NNS ._.
P07498789A01
Bone_NN morphogenetic_JJ proteins_NNS (_( BMPs_NNS )_) ,_, which_PNR have_VHB been_VBN implicated_VVN in_II the_DD patterning_VVGN of_II mesoderm_NN ,_, are_VBB members_NNS of_II the_DD transforming_VVGJ growth_NN factor-beta_NN (_( TGF-beta_NN )_) superfamily_NN ._.
P07498789A07
We_PN also_RR found_VVD that_CST expression_NN of_II Cm-XBMP-7_NN or_CC Cm-XBMP-4_NN in_II animal_NN cap_NN ectoderm_NN directly_RR induces_VVZ neuroectoderm_NN ._.
P07506139A03
The_DD level_NN of_II Evx-1_NN RNA_NN increases_VVZ during_II the_DD next_JJ 24_MC hours_NNS of_II development_NN ,_, and_CC then_RR decreases_VVZ in_II the_DD subsequent_JJ 24_MC hours_NNS ,_, such_CS+ that_CS by_II the_DD time_NN the_DD ridge_NN regresses_VVZ Evx-1_NN RNA_NN is_VBZ undetectable_JJ ._.
P07506139A08
Additional_JJ studies_NNS demonstrate_VVB that_CST the_DD effect_NN of_II FGF-4_NN on_II Evx-1_NN expression_NN is_VBZ modulated_VVN by_II BMP-2_NN ._.
P07537232A01
The_DD apical_JJ ectodermal_JJ ridge_NN (_( AER_NN )_) is_VBZ a_DD specialized_VVNJ thickening_VVGN of_II the_DD distal_JJ limb_NN mesenchyme_NN that_PNR has_VHZ been_VBN demonstrated_VVN to_TO support_VVI limb_NN outgrowth_NN and_CC proper_JJ limb_NN development_NN ._.
P07537232A06
BMP_NN 4_MC and_CC FGF_NN 2_MC can_VM also_RR maintain_VVB Msx-1_NN expression_NN in_II limb_NN mesenchyme_NN as_CC+ well_CC+ as_CC retinoic_JJ acid_NN which_PNR is_VBZ usually_RR associated_VVN with_II polarizing_VVGJ activity_NN in_II the_DD early_JJ limb_NN ._.
P07551564A03
Misexpression_NN of_II either_PND of_II these_DD genes_NNS induces_VVZ floor_NN plate_NN differentiation_NN at_II ectopic_JJ locations_NNS ._.
P07552175A01
BACKGROUND_NN :_: The_DD Drosophila_NN segment_NN polarity_NN gene_NN hedgehog_NN encodes_VVZ a_DD member_NN of_II a_DD family_NN of_II secreted_VVNJ proteins_NNS that_PNR are_VBB involved_VVN in_II a_DD variety_NN of_II patterning_VVGJ processes_NNS ,_, in_II both_CC vertebrates_NNS and_CC invertebrates_NNS ._.
P07552175A06
In_II addition_NN ,_, we_PN find_VVB that_CST increases_NNS in_II the_DD level_NN of_II expression_NN within_II the_DD normal_JJ hedgehog_NN transcriptional_JJ domain_NN of_II either_CC the_DD wild-type_NN protein_NN or_CC the_DD carboxy-terminal-deleted_VVNJ form_NN expand_VVB the_DD range_NN of_II activity_NN to_II a_DD limited_VVNJ extent_NN ,_, but_CC have_VHB only_RR minor_JJ effects_NNS on_II cell_NN identity_NN ._.
P07553857A04
BMP4_NN and_CC BMP7_NN are_VBB expressed_VVN in_II the_DD epidermal_JJ ectoderm_NN ,_, and_CC both_DD proteins_NNS mimic_VVB its_PNG inductive_JJ activity_NN ._.
P07555700A02
Grafting_VVGJ experiments_NNS were_VBD carried_VVN out_II at_II the_DD 5-somite_NN stage_NN ,_, i.e._II before_CS rhombomere_NN boundaries_NNS are_VBB visible_JJ ._.
P07555700A08
Moreover_RR ,_, the_DD fate_NN of_II the_DD cells_NNS of_II caudally_RR transplanted_VVNJ rhombomeres_NNS is_VBZ modified_VVN :_: the_DD rhombencephalic_JJ nuclei_NNS in_II the_DD graft_NN develop_VVB according_II+ to_II the_DD new_JJ location_NN as_CS shown_VVN for_II an_DD r5_NN /_SYM 6_MC to_II r8_NN transplantation_NN ._.
P07577671A06
The_DD role_NN of_II ci_NN in_II cell-cell_NN signaling_VVGN and_CC pattern_NN formation_NN was_VBD examined_VVN in_II double_JJ mutants_NNS of_II ci_NN with_II patched_NN and_CC zeste-white3_NN /_SYM shaggy_NN ._.
P07577672A06
Mox-2_NN is_VBZ expressed_VVN in_II tissues_NNS of_II the_DD tailbud_NN itself_PN that_PNR represent_VVB a_DD site_NN of_II continued_VVNJ gastrulation-like_JJ processes_NNS resulting_VVG in_II mesoderm_NN formation_NN ._.
P07577672A11
Together_RR with_II the_DD fact_NN that_CST X_NN ._.
P07583126A01
BACKGROUND_NN :_: Sonic_NN hedgehog_NN (_( Shh_NN )_) ,_, a_DD vertebrate_NN homolog_NN of_II the_DD Drosophila_NN segment_NN polarity_NN gene_NN hedgehog_NN (_( hh_NN )_) ,_, has_VHZ been_VBN implicated_VVN in_II patterning_VVGN of_II the_DD developing_VVGJ chick_NN limb_NN ._.
P07583126A07
Grafts_NNS of_II cells_NNS expressing_VVG SHH_NN protein_NN variants_NNS that_PNR correspond_VVB to_II individual_JJ cleavage_NN products_NNS demonstrate_VVB that_CST the_DD ability_NN to_TO induce_VVI patterned_VVNJ gene_NN expression_NN and_CC to_TO impose_VVI morphological_JJ pattern_NN upon_II the_DD limb_NN bud_NN is_VBZ limited_VVN to_II the_DD amino-terminal_JJ product_NN (_( SHH-N_NN )_) of_II SHH_NN proteolytic_JJ cleavage_NN ._.
P07583127A06
Likewise_RR ,_, the_DD other_JJ FGFs_NNS studied_VVD to_II date_NN are_VBB not_RR candidates_NNS for_II this_DD activity_NN ._.
P07583127A12
Moreover_RR ,_, our_PNG data_NNS suggest_VVB that_CST FGF-8_NN may_VM also_RR be_VBB an_DD ectodermally_JJ derived_VVNJ mitogen_NN that_PNR stimulates_VVZ the_DD onset_NN of_II limb_NN bud_NN outgrowth_NN (_( budding_VVGN )_) in_II the_DD absence_NN of_II a_DD morphological_JJ AER_NN ,_, and_CC indicate_VVB the_DD possible_JJ involvement_NN of_II FGF-8_NN in_II the_DD establishment_NN of_II the_DD limb_NN field_NN ._.
P07583153A01
BACKGROUND_NN :_: The_DD hedgehog_NN (_( hh_NN )_) family_NN of_II secreted_VVNJ signaling_VVGJ proteins_NNS is_VBZ responsible_JJ for_II developmental_JJ patterning_VVGN in_II a_DD variety_NN of_II systems_NNS ,_, including_VVG the_DD neural_JJ tube_NN ,_, limbs_NNS and_CC somites_NNS ._.
P07583153A07
In_II contrast_NN ,_, proximal_JJ fates_NNS were_VBD lost_VVN in_II cyclops_NN mutant_JJ embryos_NNS ,_, which_PNR lack_VVB twhh-_NN and_CC shh-expressing_VVGJ forebrain_NN cells_NNS ._.
P07588050A06
Isoforms_NNS I_MC ,_, II_MC and_CC III_MC (_( all_PND containing_VVG a_DD basic_JJ amino_JJ terminus_NN )_) are_VBB expressed_VVN in_II dorsal_JJ root_NN ganglia_NNS ,_, cranial_JJ ganglia_NNS and_CC the_DD developing_VVGJ kidney_NN including_VVG the_DD ureteric_JJ bud_NN ._.
P07588050A12
Thus_RR we_PN conclude_VVB that_CST one_MC or_CC more_DD formins_NNS are_VBB necessary_JJ to_TO initiate_VVI and/or_CC maintain_VVI fgf-4_NN production_NN in_II the_DD distal_JJ limb_NN ._.
P07589793A03
One_MC of_II these_PND ,_, Shh_NN ,_, is_VBZ expressed_VVN in_II and_CC mediates_VVZ the_DD signaling_VVGJ activities_NNS of_II several_JJ key_JJ organizing_VVGJ centers_NNS which_PNR regulate_VVB central_JJ nervous_JJ system_NN ,_, limb_NN ,_, and_CC somite_NN polarity_NN ._.
P07589793A09
Furthermore_RR ,_, we_PN have_VHB compared_VVN Hh_NN expression_NN with_II that_PND of_II a_DD second_JJ family_NN of_II signaling_VVGJ molecules_NNS ,_, the_DD Bone_NN morphogenetic_JJ proteins_NNS (_( Bmps_NNS )_) ,_, vertebrate_NN relatives_NNS of_II decapentaplegic_NN ,_, a_DD target_NN of_II the_DD Drosophila_NN Hh_NN signaling_VVGJ pathway_NN ._.
P07589799A05
This_PND suggests_VVZ that_CST these_DD genes_NNS may_VM be_VBB activated_VVN in_II response_NN to_II mesoderm_NN induction_NN ._.
P07595280A02
Examination_NN of_II the_DD expression_NN pattern_NN of_II Msx-1_NN in_II murine_JJ and_CC avian_JJ embryos_NNS suggests_VVZ that_CST this_DD gene_NN may_VM be_VBB involved_VVN in_II the_DD regionalization_NN of_II the_DD medio-lateral_JJ axis_NN during_II earlier_JJR development_NN ._.
P07600991A04
Injection_NN of_II shh_NN /_SYM vhh-1_NN RNA_NN results_VVZ in_II ectopic_JJ expression_NN of_II nk2.2_NN and_CC concomitant_JJ abnormalities_NNS in_II the_DD forebrain_NN and_CC eyes_NNS ._.
P07601005A05
Then_RR we_PN analyze_VVB expression_NN of_II these_DD genes_NNS in_II noggin-treated_VVNJ explants_NNS ._.
P07601313A05
These_DD results_NNS suggest_VVB that_CST the_DD control_NN of_II ZPA_NN function_NN during_II the_DD initial_JJ stages_NNS of_II development_NN of_II paired_VVNJ appendages_NNS has_VHZ been_VBN conserved_VVN between_II fish_NN and_CC tetrapods_NNS ._.
P07605753A03
We_PN have_VHB shown_VVN by_II library_NN screening_VVGN and_CC in_JJ+ situ_JJ hybridization_NN that_CST of_II these_DD four_MC genes_NNS ,_, BMP_NN 7_MC is_VBZ expressed_VVN earliest_RRT ,_, in_II gastrulating_VVGJ embryos_NNS ._.
P07605753A09
These_DD markers_NNS provide_VVB the_DD first_JJ molecular_JJ evidence_NN for_II dorsal_JJ /_SYM ventral_JJ polarity_NN in_II the_DD developing_VVGJ gut_NN ._.
P07617035A05
One_MC of_II the_DD dpp_NN homologues_NNS in_II vertebrates_NNS ,_, bmp-4_NN ,_, is_VBZ expressed_VVN ventrally_RR in_II Xenopus_NN and_CC promotes_VVZ ventral_JJ development_NN ._.
P07627558A03
In_II a_DD remarkably_RR similar_JJ fashion_NN ,_, the_DD function_NN and_CC expression_NN of_II the_DD sonic_NN hedgehog_NN (_( shh_NN )_) gene_NN is_VBZ closely_RR associated_VVN with_II the_DD '_`` zone_NN of_II polarizing_VVGJ activity_NN '_'' (_( ZPA_NN )_) that_PNR controls_VVZ antero-posterior_JJ patterning_VVGN of_II the_DD vertebrate_NN limb_NN ._.
P07627558A08
Varying_VVGJ levels_NNS of_II ectopic_JJ hh_NN and_CC shh_NN activity_NN can_VM differentially_RR activate_VVB transcription_NN of_II the_DD patched_NN and_CC dpp_NN genes_NNS ._.
P07630399A02
The_DD vertebrate_NN homologue_NN of_II dpp_NN is_VBZ either_CC bmp-4_NN or_CC bmp-2_NN (_( ref._NN 5_MC )_) ,_, and_CC the_DD homologue_NN os_II sog_NN is_VBZ chd_NN (_( s-chordin_NN )_) ._.
P07635045A06
In_II contrast_NN to_II an_DD experimentally_RR derived_VVNJ polydactylous_JJ transgenic_JJ mouse_NN ,_, forelimbs_NNS of_II homozygotes_NNS show_VVB a_DD normal_JJ pattern_NN of_II Hoxb-8_NN expression_NN ,_, indicating_VVG that_CST the_DD duplication_NN of_II polarizing_VVGJ tissue_NN here_RR occurs_VVZ downstream_JJ or_CC independently_RR of_II Hoxb-8_NN ._.
P07649382A03
The_DD duplicated_VVNJ patterns_NNS are_VBB also_RR formed_VVN following_VVG the_DD implantation_NN into_II the_DD center_NN of_II the_DD limb_NN bud_NN and_CC an_DD excess_JJ apical_JJ ectodermal_JJ ridge_NN (_( AER_NN )_) with_II Msx2_NN expression_NN is_VBZ induced_VVN prior_II+ to_II these_DD duplicated_VVNJ pattern_NN formulations_NNS ._.
P07671794A01
The_DD Drosophila_NN wing_NN is_VBZ formed_VVN by_II two_MC cell_NN populations_NNS ,_, the_DD anterior_JJ and_CC posterior_JJ compartments_NNS ,_, which_PNR are_VBB distinguished_VVN by_II the_DD activity_NN of_II the_DD selector_NN gene_NN engrailed_NN (_( en_NN )_) in_II posterior_JJ cells_NNS ._.
P07671794A07
Finally_RR ,_, we_PN report_VVB evidence_NN suggesting_VVG that_CST dpp_NN may_VM exert_VVB its_PNG organizing_VVGJ influence_NN by_II acting_VVGN as_II a_DD gradient_NN morphogen_NN in_II contrast_NN to_II hh_NN which_PNR appears_VVZ to_TO act_VVI principally_RR as_II a_DD short_JJ range_NN inducer_NN of_II dpp_NN ._.
P07671800A02
Here_RR we_PN show_VVB that_CST new_JJ members_NNS of_II this_DD family_NN isolated_VVN from_II Xenopus_NN laevis_NN are_VBB expressed_VVN embryonically_RR in_II patterns_NNS suggestive_JJ of_II roles_NNS in_II patterning_VVGN in_II the_DD ectoderm_NN ,_, nervous_JJ system_NN and_CC somites_NNS ._.
P07671801A05
Unexpectedly_RR ,_, an_DD internal_JJ deletion_NN of_II X-bhh_NN (_( delta_NN N-C_NN )_) was_VBD found_VVN to_TO block_VVI the_DD activity_NN of_II X-bhh_NN and_CC N_NN in_II explants_NNS and_CC to_TO reduce_VVI dorsoanterior_JJ structures_NNS in_II embryos_NNS ._.
P07671817A01
Sonic_NN hedgehog_NN (_( Shh_NN )_) encodes_VVZ a_DD signal_NN that_PNR is_VBZ implicated_VVN in_II both_CC short-_JJ and_CC long-range_NN interactions_NNS that_PNR pattern_VVB the_DD vertebrate_NN central_JJ nervous_JJ system_NN (_( CNS_NN )_) ,_, somite_NN and_CC limb_NN ._.
P07671817A07
Interestingly_RR ,_, Shh_NN expression_NN extends_VVZ beyond_II the_DD floor_NN plate_NN ,_, into_II ventrolateral_JJ regions_NNS from_II which_PNR some_DD motor_NN neuron_NN precursors_NNS are_VBB emerging_VVG ._.
P07697724A02
Fibroblast_NN growth_NN factor_NN 4_MC (_( FGF4_NN )_) and_CC Sonic_NN hedgehog_NN (_( SHH_NN )_) can_VM mediate_VVB signaling_VVGN from_II the_DD ridge_NN and_CC posterior_JJ mesenchyme_NN ,_, respectively_RR ._.
P07713429A03
We_PN extend_VVB previous_JJ observations_NNS on_II leaky_NN engrailed_NN (_( en_NN )_) mutations_NNS by_II showing_VVGN that_CST mutant_JJ clones_NNS completely_RR lacking_VVG both_CC en_NN and_CC invected_NN (_( inv_NN )_) activity_NN ectopically_RR express_VVB dpp-lacZ_NN reporter_NN genes_NNS in_II the_DD posterior_JJ compartment_NN ,_, where_PNR dpp_NN activity_NN ordinarily_RR is_VBZ repressed_VVN ._.
P07713429A09
Mutagenesis_NN of_II these_DD Engrailed_NN binding_VVGJ sites_NNS results_VVZ in_II ectopic_JJ expression_NN of_II this_DD reporter_NN gene_NN ,_, but_CC does_VDZ not_RR alter_VVB the_DD normal_JJ stripe_NN of_II expression_NN at_II the_DD A_NN /_SYM P_NN boundary_NN ._.
P07714526A05
To_TO test_VVI further_RR the_DD ability_NN of_II the_DD notochord_NN (_( and_CC floor_NN plate_NN )_) to_TO suppress_VVI En-2_NN ,_, we_PN transplanted_VVD ventral_JJ midline_NN tissues_NNS from_II HH_NN 5-9_MC quail_NN embryos_NNS beneath_II the_DD rostral_JJ neural_JJ plate_NN of_II HH_NN 4-6_MC chick_NN embryos_NNS ._.
P07720566A04
Treatments_NNS with_II pharmacological_JJ (_( beads_NNS soaked_VVN in_II 330_MC micrograms_NNS /_SYM ml_NN )_) and_CC physiological_JJ (_( beads_NNS soaked_VVN in_II 10_MC micrograms_NNS /_SYM ml_NN )_) doses_NNS of_II RA_NN are_VBB equally_RR capable_JJ of_II inducing_VVGN digit_NN pattern_NN duplication_NN ._.
P07720573A06
By_II recombining_VVGN somites_NNS and_CC neural_JJ tubes_NNS from_II different_JJ axial_JJ levels_NNS of_II the_DD embryo_NN ,_, we_PN have_VHB found_VVN that_CST a_DD second_JJ signal_NN is_VBZ necessary_JJ to_TO promote_VVI competence_NN of_II the_DD somite_NN to_TO respond_VVI to_II inducing_VVGJ signals_NNS from_II the_DD neural_JJ tube_NN ._.
P07733973A02
We_PN report_VVB here_RR that_CST an_DD additional_JJ limb_NN can_VM be_VBB formed_VVN from_II the_DD flank_NN when_CS we_PN implant_VVB fibroblast_NN growth_NN factor_NN 4_MC (_( Fgf4_NN )_) -expressing_VVGJ cells_NNS into_II the_DD lateral_JJ plate_NN mesoderm_NN at_II the_DD pre-limb_NN bud_NN stage_NN ._.
P07736596A02
We_PN have_VHB found_VVN that_CST both_CC floor_NN plate_NN cells_NNS and_CC motor_NN neurons_NNS are_VBB induced_VVN by_II the_DD amino-terminal_JJ cleavage_NN product_NN of_II SHH_NN (_( SHH-N_NN )_) ._.
P07736597A01
A_DD long-range_NN signal_NN encoded_VVN by_II the_DD Sonic_NN hedgehog_NN (_( Shh_NN )_) gene_NN has_VHZ been_VBN implicated_VVN as_II the_DD ventral_JJ patterning_VVGJ influence_NN from_II the_DD notochord_NN that_PNR induces_VVZ sclerotome_NN and_CC represses_VVZ dermomyotome_NN in_II somite_NN differentiation_NN ._.
P07750652A05
We_PN show_VVB that_CST BMP-4_NN transcripts_NNS are_VBB localized_VVN to_II the_DD ventral_JJ side_NN of_II the_DD gastrula_NN embryo_NN and_CC provide_VVB evidence_NN that_CST localized_VVNJ expression_NN of_II BMP-4_NN is_VBZ important_JJ for_II regulating_VVGN the_DD expression_NN of_II mesodermal_JJ and_CC neural_JJ genes_NNS ._.
P07753196A05
Here_RR we_PN have_VHB applied_VVN recombinant_JJ Shh_NN peptides_NNS to_II neural_JJ explants_NNS in_II serum-free_JJ conditions_NNS ._.
P07768172A03
The_DD phenotype_NN is_VBZ consistent_JJ with_II a_DD defect_NN in_II the_DD distal_JJ primitive_JJ streak_NN ._.
P07768172A09
The_DD data_NNS presented_VVN are_VBB discussed_VVN in_II terms_NNS of_II mechanisms_NNS for_II establishment_NN of_II the_DD eed_NN phenotype_NN ,_, and_CC are_VBB consistent_JJ with_II the_DD eed_NN gene_NN product_NN playing_VVGN an_DD early_JJ role_NN in_II primitive_JJ streak_NN formation_NN and/or_CC organization_NN ._.
P07789266A03
Animal_NN pole_NN explants_NNS from_II embryos_NNS injected_VVN with_II low_JJ doses_NNS of_II Xbra_NN RNA_NN differentiate_VVB into_II vesicles_NNS containing_VVG mesothelial_JJ smooth_JJ muscle_NN and_CC mesenchyme_NN ._.
P07789266A09
We_PN find_VVB that_CST co-expression_NN of_II Pintallavis_NN ,_, but_CC not_RR goosecoid_NN ,_, with_II Brachyury_NN causes_VVZ formation_NN of_II dorsal_JJ mesoderm_NN ,_, including_VVG notochord_NN ._.
P07854456A05
Here_RR we_PN present_VVB evidence_NN that_CST removing_VVGN activity_NN of_II the_DD gene_NN encoding_VVG cyclic_JJ AMP-dependent_JJ protein_NN kinase_NN A_NN (_( pka_NN )_) is_VBZ functionally_RR equivalent_JJ to_II removing_VVGN ptc_NN activity_NN or_CC to_II providing_VVGN cells_NNS with_II the_DD Hh_NN signal_NN ._.
P07873788A06
There_EX was_VBD a_DD complex_JJ relationship_NN between_II domains_NNS of_II epithelial_JJ and_CC mesenchymal_JJ Bmp-4_NN expression_NN ,_, and_CC at_II many_DD sites_NNS there_EX was_VBD an_DD inverse_JJ correlation_NN between_II epithelial_JJ and_CC mesenchymal_JJ Bmp-4_NN expression_NN ._.
P07873788A12
The_DD expression_NN of_II the_DD Bmp-4_NN and_CC Bmp-2_NN genes_NNS in_II the_DD epithelium_NN and_CC distal_JJ mesenchyme_NN of_II the_DD facial_JJ primordia_NNS suggests_VVZ that_CST BMP-4_NN and_CC BMP-2_NN may_VM be_VBB involved_VVN in_II the_DD epithelial-mesenchymal_JJ interactions_NNS that_PNR control_VVB outgrowth_NN of_II these_DD primordia_NNS ._.
P07875383A03
In_II the_DD present_JJ study_NN we_PN examined_VVD the_DD ability_NN of_II fibroblast_NN growth_NN factor_NN (_( FGF_NN )_) to_TO induce_VVI limb_NN bud_NN formation_NN in_II chicken_NN embryos_NNS ._.
P07885472A02
Proximal-distal_JJ identity_NN is_VBZ regulated_VVN by_II the_DD apical_JJ ectodermal_JJ ridge_NN (_( AER_NN )_) at_II the_DD distal_JJ tip_NN of_II the_DD growing_VVGJ limb_NN ._.
P07885472A08
In_II contrast_NN ,_, no_DD signal_NN has_VHZ yet_RR been_VBN identified_VVN for_II the_DD dorsal-ventral_JJ axis_NN ,_, although_CS Wnt-7a_NN is_VBZ expressed_VVN in_II the_DD dorsal_JJ ectoderm_NN ,_, suggesting_VVG that_CST it_PN may_VM play_VVB such_DB a_DD role_NN ._.
P07916661A03
One_MC of_II these_PND ,_, Sonic_NN hh_NN (_( Shh_NN )_) ,_, is_VBZ expressed_VVN in_II the_DD notochord_NN ,_, the_DD floor_NN plate_NN ,_, and_CC the_DD zone_NN of_II polarizing_VVGJ activity_NN ,_, signaling_VVGJ centers_NNS that_PNR are_VBB thought_VVN to_TO mediate_VVI central_JJ nervous_JJ system_NN (_( CNS_NN )_) and_CC limb_NN polarity_NN ._.
P07925288A01
In_II the_DD wing_NN imaginal_JJ disc_NN ,_, the_DD decapentaplegic_NN (_( dpp_NN )_) gene_NN is_VBZ expressed_VVN in_II a_DD stripe_NN of_II anterior_JJ cells_NNS near_II the_DD anterior-posterior_JJ compartment_NN boundary_NN ,_, and_CC it_PN is_VBZ required_VVN solely_RR in_II these_DD cells_NNS for_II the_DD entire_JJ disc_NN to_TO develop_VVI ._.
P07925288A07
This_PND strongly_RR suggests_VVZ that_CST the_DD organizating_VVGJ activity_NN of_II hh_NN is_VBZ mediated_VVN by_II dpp_NN ._.
P07935794A02
Fibroblast_NN growth_NN factor_NN (_( FGF_NN )_) can_VM replace_VVB the_DD ridge_NN and_CC ,_, because_CS Fgf4_NN RNA_NN is_VBZ localized_VVN to_II the_DD mouse_NN posterior_JJ ridge_NN ,_, we_PN proposed_VVD that_CST FGF4_NN is_VBZ the_DD endogenous_JJ ridge_NN signal_NN ._.
P07935794A08
Once_CS induced_VVN ,_, Shh_NN expression_NN can_VM be_VBB maintained_VVN by_II FGF4_NN alone_JJ ,_, thus_RR establishing_VVG a_DD positive_JJ feedback_NN loop_NN between_II ZPA_NN and_CC ridge_NN ._.
P07958460A01
Recombinant_JJ limb_NN buds_NNS constructed_VVN of_II an_DD ectodermal_JJ jacket_NN containing_VVG dissociated_VVNJ anterior_JJ wing_NN bud_NN mesoderm_NN cells_NNS form_VVB limb-like_JJ structures_NNS lacking_VVG anteroposterior_JJ polarity_NN ._.
P07958460A07
The_DD roles_NNS Msx1_NN and_CC Msx2_NN play_VVB in_II limb_NN patterning_VVGN are_VBB at_II present_NN not_RR clear_JJ ._.
P07958460A13
We_PN propose_VVB that_CST the_DD expression_NN of_II the_DD Hoxd_NN genes_NNS is_VBZ an_DD intrinsic_JJ property_NN of_II rapidly_RR growing_VVGJ limb_NN cells_NNS and_CC that_CST their_PNG expression_NN is_VBZ related_VVN to_II the_DD limb_NN bud_NN proximodistal_JJ outgrowth_NN ._.
P08001153A03
We_PN show_VVB that_CST sclerotomal_JJ markers_NNS can_VM be_VBB induced_VVN by_II a_DD diffusible_JJ factor_NN secreted_VVN by_II notochord_NN and_CC floor_NN plate_NN and_CC that_CST heterologous_JJ cells_NNS expressing_VVG Sonic_NN hedgehog_NN (_( shh_NN /_SYM vhh-1_NN )_) mimic_VVB this_DD effect_NN ._.
P08050667A05
Despite_II this_PND ,_, however_RR ,_, the_DD organization_NN of_II the_DD neural_JJ plate_NN and_CC the_DD neural_JJ keel_NN resembles_VVZ that_PND of_II other_JJ vertebrates_NNS in_II many_DD aspects_NNS ._.
P08050667A10
Expression_NN of_II axial_JJ and_CC sonic_NN hedgehog_NN is_VBZ impaired_VVN by_II the_DD cyclops_NN mutation_NN in_II the_DD midline_NN of_II the_DD neural_JJ plate_NN ._.
P08099267A01
In_II tetrapod_NN vertebrates_NNS ,_, limbs_NNS are_VBB formed_VVN as_II a_DD result_NN of_II inductive_JJ interactions_NNS between_II ectoderm_NN and_CC mesoderm_NN ._.
P08115380A01
Expression_NN patterns_NNS of_II three_MC fibroblast_NN growth_NN factor_NN receptor_NN genes_NNS ,_, FGFR1_NN (_( cek1_NN )_) ,_, FGFR2_NN (_( cek3_NN )_) and_CC FGFR3_NN (_( cek2_NN )_) ,_, were_VBD observed_VVN in_II limb_NN and_CC feather_NN morphogenesis_NN ._.
P08119128A03
The_DD polarizing_VVGJ region_NN is_VBZ a_DD group_NN of_II cells_NNS at_II the_DD posterior_JJ margin_NN of_II the_DD limb_NN bud_NN that_PNR can_VM respecify_VVB the_DD anteroposterior_JJ axis_NN of_II the_DD limb_NN when_CS grafted_VVN anteriorly_RR and_CC can_VM activate_VVB expression_NN of_II genes_NNS of_II the_DD HoxD_NN complex_NN ._.
P08119128A09
In_II support_NN of_II this_PND ,_, BMP-2_NN protein_NN does_VDZ not_RR appear_VVB to_TO have_VHI any_DD detectable_JJ polarizing_VVGJ activity_NN when_CS applied_VVN to_II the_DD wing_NN bud_NN ._.
P08124714A06
vhh-1_NN may_VM ,_, therefore_RR ,_, contribute_VVB to_II the_DD floor_NN plate_NN and_CC motor_NN neuron_NN inducing_VVGJ activities_NNS of_II the_DD notochord_NN ._.
P08136521A06
However_RR ,_, the_DD distribution_NN of_II FGF-2_NN positive_JJ cells_NNS in_II the_DD mesoderm_NN was_VBD not_RR homogeneous_JJ ._.
P08145818A01
Drosophila_NN limbs_NNS are_VBB subdivided_VVN into_II anterior_JJ and_CC posterior_JJ compartments_NNS which_PNR derive_VVB from_II adjacent_JJ cell_NN populations_NNS founded_VVN early_RR in_II development_NN ._.
P08187630A04
In_II light_NN of_II the_DD early_JJ developmental_JJ significance_NN of_II forkhead_NN in_II Drosophila_NN ,_, we_PN have_VHB compared_VVN the_DD patterns_NNS of_II expression_NN of_II HNF-3_NN alpha_NN ,_, beta_NN and_CC gamma_NN mRNAs_NNS during_II murine_JJ embryogenesis_NN ._.
P08187630A10
Furthermore_RR ,_, differential_JJ mRNA_NN expression_NN of_II HNF-3_NN alpha_NN and_CC beta_NN is_VBZ detected_VVN in_II cells_NNS of_II the_DD ventral_JJ neural_JJ epithelium_NN ,_, chordamesoderm_NN and_CC notochord_NN ._.
P08221896A05
This_PND suggests_VVZ that_CST polarizing_VVGJ activity_NN plays_VVZ a_DD role_NN in_II patterning_VVGN along_II the_DD proximodistal_JJ axis_NN ,_, in_II addition_NN to_II its_PNG well-established_VVNJ role_NN in_II anteroposterior_JJ patterning_VVGN ._.
P08223247A05
The_DD response_NN of_II neural_JJ plate_NN cells_NNS to_II inductive_JJ signals_NNS declines_VVZ with_II embryonic_JJ age_NN ,_, suggesting_VVG that_CST the_DD mediolateral_JJ extent_NN of_II the_DD floor_NN plate_NN is_VBZ limited_VVN by_II a_DD loss_NN of_II competence_NN of_II neural_JJ cells_NNS ._.
P08224541A01
The_DD anteroposterior_JJ (_( A-P_NN )_) axis_NN pattern_NN of_II the_DD chick_NN limb_NN is_VBZ likely_RR to_TO be_VBI controlled_VVN by_II a_DD small_JJ region_NN of_II mesenchyme_NN cells_NNS at_II the_DD posterior_JJ margin_NN of_II the_DD limb_NN bud_NN (_( ZPA_NN ,_, zone_NN of_II polarizing_VVGJ activity_NN )_) ._.
P08228960A01
In_II this_DD review_NN I_PN summarize_VVB recent_JJ findings_NNS on_II the_DD contributions_NNS of_II different_JJ cell_NN groups_NNS to_II the_DD formation_NN of_II the_DD basic_JJ plan_NN of_II the_DD nervous_JJ system_NN of_II vertebrate_NN embryos_NNS ._.
P08275856A05
To_TO test_VVI this_DD possibility_NN ,_, we_PN removed_VVD the_DD posterior_JJ apical_JJ ectodermal_JJ ridge_NN of_II chick_NN wing_NN buds_NNS and_CC assayed_VVD posterior_JJ mesenchyme_NN for_II polarizing_VVGJ activity_NN ._.
P08287482A01
The_DD segment_NN polarity_NN genes_NNS hedgehog_NN and_CC engrailed_NN are_VBB expressed_VVN in_II identical_JJ posterior-compartment-specific_JJ patterns_NNS in_II both_CC Drosophila_NN embryos_NNS and_CC imaginal_JJ discs_NNS ._.
P08287482A07
We_PN propose_VVB that_CST the_DD cell-cell_NN communication_NN mediated_VVN by_II hedgehog_NN links_VVZ the_DD special_JJ properties_NNS of_II compartment_NN borders_NNS with_II specification_NN of_II the_DD proximodistal_JJ axis_NN in_II imaginal_JJ development_NN ._.
P08344455A02
Although_CS RA_NN had_VHD been_VBN thought_VVN to_TO be_VBI a_DD morphogen_NN produced_VVN by_II the_DD ZPA_NN ,_, recently_RR we_PN (_( Noji_NNP et_CC al._NN ,_, 1991_MC )_) and_CC Wanek_NNP et_CC al._NN (_( 1991_MC )_) independently_RR concluded_VVD that_CST RA_NN induces_VVZ polarizing_VVGJ activity_NN in_II cells_NNS at_II the_DD anterior_JJ margin_NN of_II the_DD chick_NN limb_NN bud_NN ._.
P08344455A08
Although_CS implantation_NN of_II beads_NNS soaked_VVN in_II a_DD high_JJ concentration_NN (_( 10_MC mg_NN /_SYM ml_NN )_) of_II RA_NN did_VDD not_RR result_VVB in_II duplications_NNS but_CC rather_RR in_II truncations_NNS of_II the_DD limbs_NNS ,_, the_DD apical_JJ mesodermal_JJ cells_NNS in_II these_DD limbs_NNS were_VBD converted_VVN to_II ZPA_NN cells_NNS ,_, indicating_VVG that_CST induction_NN of_II polarizing_VVGJ activity_NN by_II RA_NN can_VM occur_VVB independently_RR of_II duplicate_NN formation_NN ._.
P08561774A05
In_JJ+ situ_JJ hybridization_NN and_CC immunolocalization_NN analyses_NNS indicate_VVB that_CST OP-1_NN is_VBZ expressed_VVN in_II the_DD neuroepithelium_NN of_II the_DD optic_JJ vesicle_NN at_II E11.5_NN ,_, is_VBZ limited_VVN to_II the_DD presumptive_JJ neural_JJ retina_NN and_CC developing_VVGJ lens_NN placode_NN ,_, and_CC is_VBZ subsequently_RR expressed_VVN in_II the_DD neural_JJ retina_NN ,_, lens_NN and_CC developing_VVGJ cornea_NN at_II E12.5-E13.5_NN ._.
P08575293A04
In_II this_DD essay_NN ,_, we_PN describe_VVB studies_NNS of_II the_DD expression_NN of_II several_JJ genes_NNS in_II the_DD mouse_NN between_II 7.5_MC (_( presomite_JJ stage_NN )_) and_CC 10.5_MC days_NNS post_II coitum_NN (_( dpc_NN )_) that_PNR provide_VVB evidence_NN for_II the_DD trajectory_NN of_II the_DD anterior-posterior_JJ axis_NN and_CC the_DD longitudinal_JJ organization_NN of_II the_DD anterior_JJ CNS_NN ._.
P08575300A01
Embryonic_JJ exposure_NN to_II the_DD vitamin_NN A_NN metabolite_NN retinoic_JJ acid_NN (_( RA_NN )_) causes_VVZ malformations_NNS in_II numerous_JJ developing_VVGJ tissues_NNS ,_, including_VVG the_DD limbs_NNS ,_, which_PNR serves_VVZ as_II a_DD model_NN system_NN of_II retinoic_JJ acid_NN action_NN ._.
P08575300A07
Heterozygous_JJ embryos_NNS are_VBB intermediate_JJ in_II sensitivity_NN to_II RA_NN ,_, suggesting_VVG the_DD importance_NN of_II RXR_NN alpha_NN gene_NN dosage_NN in_II limb_NN teratogenesis_NN ._.
P08575333A05
Anterior_JJ thirds_NNS initially_RR only_RR express_VVB the_DD 3_MC '_SYM end_NN of_II the_DD HoxD_NN cluster_NN but_CC activate_VVB the_DD more_RR 5_MC '_SYM members_NNS of_II the_DD cluster_NN sequentially_RR over_II a_DD period_NN of_II 48_MC hours_NNS ,_, a_DD period_NN during_II which_PNR Bmp-2_NN is_VBZ activated_VVN but_CC no_DD shh_NN or_CC Fgf-4_NN expression_NN could_VM be_VBB detected_VVN ._.
P08579575A02
We_PN found_VVD that_CST Shh_NN is_VBZ also_RR expressed_VVN in_II epithelia_NNS of_II the_DD developing_VVGJ whisker_NN ,_, hair_NN ,_, tooth_NN ,_, rugae_NN ,_, and_CC thyroid_NN primordium_NN of_II mouse_NN embryos_NNS ._.
P08589436A04
In_II contrast_NN ,_, levels_NNS of_II free_JJ polypeptide_NN showed_VVD a_DD dramatic_JJ increase_NN after_II stage_NN 5_MC ,_, indicating_VVG a_DD change_NN in_II the_DD dynamics_NNS of_II the_DD two_MC pools_NNS during_II development_NN ._.
P08589436A10
The_DD potential_JJ involvement_NN of_II ubiquitin_NN conjugation_NN at_II sites_NNS of_II epithelial-mesenchymal_JJ associations_NNS was_VBD further_RR analyzed_VVN in_II culture_NN using_VVG atrioventricular_JJ canal_NN (_( AV_NN )_) endothelium_NN ._.
P08620849A06
As_CS in_II Drosophila_NN ,_, ectopic_JJ expression_NN of_II Sonic_NN hedgehog_NN leads_VVZ to_II ectopic_JJ induction_NN of_II chicken_NN Patched_NN ._.
P08620849A12
Thus_RR knowing_VVGN which_PNR is_VBZ the_DD direct_JJ target_NN tissue_NN is_VBZ essential_JJ for_II unraveling_VVGN the_DD molecular_JJ patterning_VVGN of_II the_DD limb_NN ._.
P08631514A05
We_PN report_VVB that_CST BMP-2_NN promotes_VVZ formation_NN of_II cartilage_NN and_CC simultaneously_RR inhibits_VVZ development_NN of_II muscle_NN cells_NNS ._.
P08641047A04
RAR-_NN gamma_NN 2.2_MC represents_VVZ the_DD full-length_NN sequence_NN of_II a_DD receptor_NN cDNA_NN already_RR partially_RR characterized_VVN and_CC present_JJ as_II a_DD maternal_JJ transcript_NN [_( Ellinger-Ziegelbauer_NNP and_CC Dreyer_NNP (_( 1991_MC )_) ;_: Genes_NNS Dev_NN 5_MC :_: 94-104_MC ,_, (_( 1993_MC )_) :_: Mech_NN Dev_NN 41_MC :_: 31-46_MC ;_: Pfeffer_NNP and_CC DeRobertis_NNP ,_, (_( 1994_MC )_) Mech_NN Dev_NN :_: 45_MC :_: 147-153_MC ]_) ._.
P08641047A10
Using_VVG microinjection_NN techniques_NNS ,_, we_PN show_VVB that_CST changes_NNS of_II RAR-gamma_NN 2.1_MC expression_NN in_II presumptive_JJ head_NN structures_NNS occur_VVB as_II an_DD early_JJ and_CC local_JJ consequence_NN of_II retinoic_JJ acid_NN administration_NN ._.
P08645565A04
These_DD results_NNS ,_, together_RR with_II other_JJ studies_NNS of_II neuronal_JJ differentiation_NN at_II caudal_JJ levels_NNS of_II the_DD neural_JJ tube_NN ,_, suggest_VVB that_CST a_DD single_JJ inducing_VVGJ molecule_NN ,_, Shh_NN ,_, mediates_VVZ the_DD induction_NN of_II distinct_JJ ventral_JJ neuronal_JJ cell_NN types_NNS along_II the_DD entire_JJ rostrocaudal_JJ extent_NN of_II the_DD embryonic_JJ central_JJ nervous_JJ system_NN ._.
P08647801A01
Drosophila_NN patched_NN is_VBZ a_DD segment_NN polarity_NN gene_NN required_VVN for_II the_DD correct_JJ patterning_VVGN of_II larval_JJ segments_NNS and_CC imaginal_JJ discs_NNS during_II fly_NN development_NN and_CC has_VHZ a_DD close_JJ functional_JJ relationship_NN with_II hedgehog_NN ._.
P08647801A07
Human_NN PATCHED_NN maps_VVZ to_II human_NN chromosome_NN 9q22.3_NN ,_, the_DD candidate_NN region_NN for_II the_DD nevoid_JJ basal_JJ cell_NN carcinoma_NN syndrome_NN ._.
P08658135A01
Drosophila_NN limb_NN development_NN is_VBZ organized_VVN by_II interactions_NNS between_II anterior_JJ and_CC posterior_JJ compartment_NN cells_NNS ._.
P08658145A03
The_DD ptc_NN gene_NN encodes_VVZ a_DD transmembrane_JJ protein_NN that_PNR in_II Drosophila_NN acts_VVZ in_II opposition_NN to_II the_DD Hedgehog_NN signaling_VVGJ protein_NN ,_, controlling_VVG cell_NN fates_NNS ,_, patterning_VVGN ,_, and_CC growth_NN in_II numerous_JJ tissues_NNS ._.
P08660860A02
As_CS initially_RR described_VVN by_II Rutledge_NNP et_CC al._NN (_( Proc._NN Natl._NN Acad._NN Sci._NN USA_NNP 91_MC ,_, 5436_MC ,_, 1994_MC )_) ,_, we_PN have_VHB found_VVN that_CST oral_JJ administration_NN of_II all-trans_JJ retinoic_JJ acid_NN (_( 70_MC mg_NN /_SYM kg_NN body_NN weight_NN )_) at_II 5.5_MC days_NNS postcoitum_NN induced_VVD the_DD formation_NN of_II supernumerary_JJ limbs_NNS ._.
P08660860A08
This_PND is_VBZ consistent_JJ with_II the_DD reverse_JJ orientation_NN of_II most_DD supernumerary_JJ limbs_NNS at_II later_JJR stages_NNS ._.
P08660895A03
Here_RR we_PN report_VVB that_CST IGF-I_NN and_CC insulin_NN ,_, but_CC not_RR FGF-2_NN or_CC FGF-4_NN ,_, induce_VVB the_DD formation_NN of_II limb_NN bud-like_JJ structures_NNS in_RR+ vitro_RR from_II prospective_JJ limb_NN regions_NNS before_CS they_PN have_VHB acquired_VVN the_DD ability_NN to_TO form_VVI limbs_NNS independent_JJ of_II medial_JJ tissues_NNS ,_, and_CC also_RR induce_VVB the_DD formation_NN of_II limb_NN bud-like_JJ structures_NNS from_II the_DD prospective_JJ flank_NN ._.
P08660895A09
However_RR ,_, other_JJ signals_NNS are_VBB necessary_JJ to_TO promote_VVI the_DD expression_NN of_II genes_NNS such_II+ as_II sonic_NN hedgehog_NN that_PNR regulate_VVB the_DD patterning_VVGN of_II the_DD developing_VVGJ limb_NN ._.
P08662522A02
Here_RR ,_, two_MC Xenopus_NN homologs_NNS of_II the_DD Drosophila_NN gene_NN fringe_NN ,_, lunatic_NN Fringe_NN (_( lFng_NN )_) and_CC radical_NN Fringe_NN (_( rFng_NN )_) ,_, were_VBD identified_VVN and_CC the_DD protein_NN product_NN of_II lFng_NN further_RR characterized_VVN ._.
P08674409A03
At_II 11.5_MC days_NNS p.c._NN ,_, hepatocyte_NN nuclear_JJ factor-3beta_NN (_( Hnf-3beta_NN )_) is_VBZ expressed_VVN uniformly_RR throughout_II the_DD epithelium_NN ,_, while_CS Wnt-2_NN expression_NN is_VBZ confined_VVN to_II the_DD distal_JJ mesenchyme_NN ._.
P08674409A08
From_II 15.5_MC days_NNS p.c._NN ,_, transgenic_JJ lungs_NNS are_VBB smaller_JJR than_CSN normal_JJ ,_, with_II grossly_RR distended_VVNJ terminal_JJ buds_NNS and_CC ,_, at_II birth_NN ,_, contain_VVB large_JJ air-filled_VVNJ sacs_NNS which_PNR do_VDB not_RR support_VVB normal_JJ lung_NN function_NN ._.
P08674413A06
Application_NN of_II FGF-8_NN protein_NN to_II the_DD flank_NN induces_VVZ the_DD development_NN of_II additional_JJ limbs_NNS ._.
P08684485A03
In_II zebrafish_NN ,_, however_RR ,_, mutants_NNS with_II disrupted_VVNJ notochord_NN development_NN lack_VVB a_DD specific_JJ muscle_NN cell_NN type_NN ,_, the_DD muscle_NN pioneers_NNS ,_, although_CS they_PN retain_VVB the_DD ability_NN to_TO induce_VVI neural_JJ differentiation_NN ,_, raising_VVG the_DD possibility_NN that_CST neural_JJ tube_NN and_CC somite_NN patterning_VVGN may_VM be_VBB mediated_VVN by_II distinct_JJ signals_NNS ._.
P08706127A06
Based_VVN on_II its_PNG predicted_VVNJ physical_JJ characteristics_NNS and_CC on_II its_PNG position_NN in_II the_DD Hh_NN signaling_VVGJ pathway_NN ,_, we_PN suggest_VVB that_CST smo_NN encodes_VVZ a_DD receptor_NN for_II the_DD Hh_NN signal_NN ._.
P08737809A04
According_II+ to_II these_DD observations_NNS ,_, if_CS the_DD onset_NN of_II INZs_NNS is_VBZ triggered_VVN by_II the_DD cessation_NN of_II the_DD AER_NN function_NN ,_, local_JJ administration_NN of_II FGFs_NNS to_II the_DD interdigital_JJ tissue_NN prior_II+ to_II cell_NN death_NN should_VM delay_VVB or_CC inhibit_VVB interdigit_JJ degeneration_NN ._.
P08756290A01
Although_CS a_DD number_NN of_II genes_NNS have_VHB been_VBN found_VVN to_TO have_VHI restricted_VVNJ expression_NN domains_NNS in_II the_DD embryonic_JJ forebrain_NN and_CC midbrain_NN ,_, it_PN remains_VVZ largely_RR unknown_VVN how_CST the_DD expression_NN of_II these_DD genes_NNS is_VBZ regulated_VVN at_II the_DD cellular_JJ level_NN ._.
P08769111A04
These_DD results_NNS suggest_VVB that_CST Shh_NN and_CC Bmp-4_NN are_VBB involved_VVN in_II the_DD branching_VVGJ morphogenesis_NN of_II lung_NN epithelium_NN ._.
P08769644A04
Here_RR ,_, we_PN show_VVB that_CST elevated_VVNJ levels_NNS of_II Ci_NN are_VBB sufficient_JJ to_TO activate_VVI patched_NN (_( ptc_NN )_) and_CC other_JJ hh_NN target_NN genes_NNS ,_, even_RR in_II the_DD absence_NN of_II hh_NN activity_NN ._.
P08804825A01
The_DD structural_JJ classification_NN of_II proteins_NNS reveals_VVZ that_CST it_PN is_VBZ already_RR more_RR likely_RR to_TO find_VVI that_CST a_DD new_JJ protein_NN structure_NN has_VHZ similarity_NN to_II another_DD structure_NN than_CSN to_TO find_VVI that_CST it_PN has_VHZ a_DD new_JJ fold_NN ._.
P08805249A01
BACKGROUND_NN ._.
P08805249A07
Dhh_NN expression_NN is_VBZ initiated_VVN in_II Sertoli_NN cell_NN precursors_NNS shortly_RR after_II the_DD activation_NN of_II Sry_NN and_CC persists_VVZ in_II the_DD testis_NN into_II the_DD adult_NN ._.
P08805249A13
CONCLUSIONS_NNS ._.
P08812120A03
The_DD effects_NNS of_II dominant_JJ negative_JJ protein_NN kinase_NN A_NN on_II pax2_NN expression_NN appear_VVB to_TO be_VBI cell_NN nonautonomous_NN ,_, suggesting_VVG that_CST cells_NNS can_VM respond_VVB to_II regulation_NN of_II hh_NN signaling_VVGN by_II modulating_VVGN an_DD additional_JJ cell-cell_NN signaling_VVGJ pathway_NN ._.
P08812138A01
Pax1_NN and_CC Pax9_NN represent_VVB a_DD subfamily_NN of_II paired-box-containing_VVGJ genes_NNS ._.
P08812138A06
Endodermal_JJ expression_NN correlates_VVZ with_II the_DD highly_RR proliferative_JJ zones_NNS of_II the_DD folding_VVGJ foregut_NN and_CC evaginating_VVGJ pharyngeal_JJ pouches_NNS ._.
P08812138A12
Furthermore_RR ,_, paraxial_JJ head_NN mesoderm_NN shows_VVZ no_DD competence_NN to_TO express_VVI Pax1_NN ._.
P08822915A05
Over-expression_NN of_II GATA-2_NN in_II ventral_JJ mesoderm_NN leads_VVZ to_II increased_VVNJ globin_NN production_NN and_CC forced_VVNJ expression_NN of_II GATA-2_NN in_II primitive_JJ ectoderm_NN adjacent_JJ to_II ventral_JJ mesoderm_NN also_RR stimulates_VVZ globin_NN expression_NN ._.
P08823374A01
Early_JJ molecular_JJ events_NNS during_II the_DD development_NN and_CC regeneration_NN of_II skin_NN appendages_NNS were_VBD studied_VVN using_VVG cultured_VVNJ chicken_NN skin_NN explants_NNS with_II epithelial-mesenchymal_JJ recombination_NN ._.
P08823374A07
(_( i_MC )_) Placode_NN formation_NN and_CC the_DD expression_NN of_II wingless-int_NN (_( Wnt_NN )_) 7a_NN and_CC Msx-1_NN in_II the_DD placode_NN epithelium_NN are_VBB mesenchyme_NN dependent_JJ ._.
P08823374A13
These_DD results_NNS suggest_VVB an_DD order_NN for_II the_DD molecular_JJ cascade_NN during_II the_DD inductive_JJ phase_NN of_II skin_NN appendage_NN development_NN ._.
P08824192A01
Hedgehog_NN (_( Hh_NN )_) proteins_NNS comprise_VVB a_DD family_NN of_II secreted_VVNJ signaling_VVGJ molecules_NNS essential_JJ for_II patterning_VVGN a_DD variety_NN of_II structures_NNS in_II animal_NN embryogenesis_NN ._.
P08853995A02
Several_JJ FGFs_NNS are_VBB expressed_VVN by_II the_DD AER_NN and_CC appear_VVB to_TO mediate_VVI its_PNG outgrowth_NN and_CC patterning_VVGJ effects_NNS on_II the_DD subridge_NN mesoderm_NN ._.
P08853995A08
Interestingly_RR ,_, however_RR ,_, the_DD ability_NN of_II FGFs_NNS to_TO maintain_VVI the_DD expression_NN of_II the_DD homeobox_NN containing_VVGJ gene_NN Msx-1_NN by_II the_DD subridge_NN mesoderm_NN is_VBZ not_RR dependent_JJ on_II IGF-I_NN activity_NN ._.
P08861093A05
We_PN also_RR grafted_VVD cells_NNS from_II progressively_RR more_RR proximal_JJ levels_NNS of_II mouse_NN limb_NN buds_NNS to_II chick_NN wing_NN bud_NN tips_NNS beneath_II the_DD apical_JJ ridge_NN and_CC the_DD pattern_NN of_II reactivation_NN of_II Msx-1_NN expression_NN along_II the_DD proximal_JJ distal_JJ axis_NN of_II the_DD limb_NN buds_NNS was_VBD similar_JJ to_II that_PND found_VVN in_II chick_NN limb_NN buds_NNS ._.
P08887315A03
In_II the_DD eye_NN disc_NN ,_, this_DD pathway_NN drives_VVZ progression_NN of_II the_DD morphogenetic_JJ furrow_NN ,_, while_CS in_II the_DD wing_NN (_( and_CC leg_NN and_CC antennal_JJ )_) discs_NNS it_PN is_VBZ required_VVN to_TO set_VVI up_II an_DD organising_VVGJ centre_NN along_II the_DD anteroposterior_JJ compartment_NN boundary_NN ._.
P08887315A09
Moreover_RR ,_, engrailed_NN does_VDZ not_RR play_VVB an_DD essential_JJ conserved_VVNJ role_NN ._.
P08896571A05
One_MC of_II the_DD gene_NN loci_NNS ,_, HPE3_NN ,_, maps_VVZ to_II the_DD terminal_JJ band_NN of_II chromosome_NN 7_MC ._.
P08896572A01
Holoprosencephaly_NN (_( HPE_NN )_) is_VBZ a_DD common_JJ developmental_JJ defect_NN of_II the_DD forebrain_NN and_CC frequently_RR the_DD midface_NN in_II humans_NNS ,_, with_II both_CC genetic_JJ and_CC environmental_JJ causes_NNS ._.
P08896572A06
The_DD molecular_JJ basis_NN underlying_VVG HPE_NN is_VBZ not_RR known_VVN ,_, although_CS teratogens_NNS ,_, non-random_JJ chromosomal_JJ anomalies_NNS and_CC familial_JJ forms_NNS with_II autosomal_JJ dominant_JJ and_CC recessive_JJ inheritance_NN have_VHB been_VBN described_VVN ._.
P08898218A02
vent_JJ genes_NNS are_VBB related_VVN by_II sequence_NN homology_NN ,_, expression_NN pattern_NN and_CC gain-of-function_NN phenotype_NN ._.
P08898218A08
(_( 5_MC )_) Microinjection_NN of_II Xvent-2_NN mRNA_NN can_VM rescue_VVB dorsalization_NN by_II a_DD dominant-negative_JJ BMP-4_NN receptor_NN ._.
P08898238A03
Here_RR ,_, we_PN show_VVB that_CST complete_JJ removal_NN not_RR only_RR of_II the_DD node_NN but_CC also_RR of_II the_DD anterior_JJ 40_MC %_SYM of_II the_DD primitive_JJ streak_NN leads_VVZ to_II the_DD development_NN of_II normal_JJ embryos_NNS containing_VVG cells_NNS with_II all_DB the_DD fates_NNS normally_RR produced_VVN by_II the_DD node_NN ._.
P08898240A05
These_DD analyses_NNS suggest_VVB that_CST ptc_NN and_CC ci_NN are_VBB components_NNS of_II the_DD hh_NN signaling_VVGJ pathway_NN in_II the_DD germarium_NN ._.
P08906418A05
However_RR ,_, neither_CC notochord_NN nor_CC somites_NNS condensed_VVD properly_RR in_II the_DD absence_NN of_II FN_NN ._.
P08917540A06
This_PND is_VBZ surprising_VVG because_CS the_DD main_JJ functional_JJ domain_NN of_II Shh_NN had_VHD been_VBN thought_VVN to_TO be_VBI that_PND encoded_VVN by_II exon_NN 2_MC ._.
P08919748A02
Consistent_JJ with_II this_DD hypothesis_NN we_PN show_VVB that_CST ectopic_JJ application_NN of_II FGF-2_NN can_VM maintain_VVB the_DD apical_JJ ectodermal_JJ ridge_NN (_( AER_NN )_) -dependent_JJ expression_NN of_II Sonic_NN hedgehog_NN (_( Shh_NN )_) ,_, and_CC AER-dependent_JJ zone_NN of_II polarizing_VVGJ activity_NN (_( ZPA_NN )_) signaling_VVGN ._.
P08919748A08
Our_PNG data_NNS suggest_VVB that_CST FGF-2_NN is_VBZ influencing_VVG limb_NN outgrowth_NN by_II modifying_VVGN cell_NN movements_NNS and_CC subsequent_JJ position-specific_JJ cell-cell_NN interactions_NNS that_PNR are_VBB important_JJ for_II limb_NN morphogenesis_NN ._.
P08922533A06
The_DD acquisition_NN of_II polarizing_VVGJ activity_NN by_II the_DD cartilaginous_JJ structures_NNS followed_VVD clear_JJ proximo-to-distal_JJ and_CC posterior-to-anterior_JJ routes_NNS ._.
P08922533A11
In_II so_RR doing_VVGN and_CC as_II a_DD result_NN of_II their_PNG inductive_JJ activities_NNS ,_, the_DD cells_NNS may_VM also_RR have_VHB an_DD important_JJ role_NN in_II the_DD completion_NN of_II limb_NN patterning_VVGN and_CC morphogenesis_NN ._.
P08937649A04
Ihh_NN mRNA_NN was_VBD present_JJ in_II the_DD dental_JJ lamina_NN in_II both_CC incisor_NN and_CC molar_NN regions_NNS and_CC in_II the_DD developing_VVGJ whiskers_NNS (_( in-situ_JJ hybridization_NN )_) ._.
P08948572A05
Therefore_RR ,_, microsurgical_JJ approaches_NNS do_VDB not_RR permit_VVB an_DD unequivocal_JJ answer_NN to_II the_DD question_NN raised_VVN in_II this_DD and_CC the_DD earlier_JJR papers_NNS and_CC it_PN remains_VVZ a_DD reasonable_JJ possibility_NN that_CST at_RR+ least_RR up_II+ to_II stage_NN 20-21_MC the_DD polarizing_VVGJ region_NN plays_VVZ a_DD continuous_JJ role_NN in_II patterning_VVGN of_II the_DD limb_NN bud_NN during_II its_PNG development_NN ._.
P08951076A01
This_DD study_NN first_RR shows_VVZ a_DD striking_VVGJ parallel_NN between_II the_DD expression_NN patterns_NNS of_II the_DD Bmp4_NN ,_, Msx1_NN and_CC Msx2_NN genes_NNS in_II the_DD lateral_JJ ridges_NNS of_II the_DD neural_JJ plate_NN before_II neural_JJ tube_NN closure_NN and_CC later_RR on_II ,_, in_II the_DD dorsal_JJ neural_JJ tube_NN and_CC superficial_JJ midline_NN ectoderm_NN ._.
P08951076A07
Dorsalization_NN of_II the_DD neural_JJ tube_NN ,_, manifested_VVN by_II expression_NN of_II Msx_NN and_CC Pax3_NN genes_NNS in_II the_DD basal_JJ plate_NN contacting_VVG the_DD BMP-producing_VVGJ cells_NNS ,_, was_VBD also_RR observed_VVN ._.
P08971339A05
We_PN also_RR demonstrate_VVB that_CST Sonic_NN hedgehog_NN is_VBZ not_RR sufficient_JJ for_II these_DD inductions_NNS ._.
P08985186A06
Thus_RR the_DD parasegments_NNS appear_VVB to_TO be_VBI subdivided_VVN ,_, at_RR+ least_RR with_II respect_NN to_II these_DD genes_NNS ,_, a_DD subdivision_NN that_PNR depends_VVZ on_II pair-rule_NN genes_NNS such_II+ as_II even-skipped_NN (_( eve_NN )_) ._.
P08989473A03
We_PN describe_VVB 4_MC patients_NNS ,_, one_MC with_II semilobar_JJ HPE_NN and_CC three_MC others_NNS with_II less_RR complete_JJ forms_NNS of_II the_DD HPE_NN sequence_NN ,_, in_II whom_PNR we_PN have_VHB made_VVN a_DD biochemical_JJ diagnosis_NN of_II RSH_NN /_SYM SLOS_NN ._.
P08989523A06
These_DD results_NNS indicate_VVB that_CST the_DD factors_NNS affecting_VVG the_DD size_NN of_II the_DD limb_NN are_VBB already_RR involved_VVN in_II the_DD mesodermal_JJ component_NN of_II the_DD limb_NN bud_NN at_II stage_NN 20_MC of_II chick_NN embryo_NN ._.
P09004232A03
In_II all_PND of_II these_DD processes_NNS ,_, epigenetic_JJ factors_NNS affect_VVB the_DD cells_NNS '_GE developmental_JJ fate_NN but_CC it_PN is_VBZ transcription_NN factors_NNS within_II the_DD cells_NNS which_PNR function_VVB both_CC to_TO decode_VVI these_DD incoming_JJ messages_NNS and_CC then_RR to_TO effect_VVI changes_NNS in_II the_DD expression_NN of_II other_JJ genes_NNS ._.
P09007245A06
Most_DD mutants_NNS survive_VVB to_II adulthood_NN and_CC form_VVB a_DD surprisingly_RR normal_JJ complement_NN of_II adult_NN fins_NNS ._.
P09007245A12
Stein_NN und_NN bein_NN (_( sub_NN )_) has_VHZ reduced_VVNJ dorsal_JJ and_CC pelvic_JJ fins_NNS ,_, whereas_CS finless_NN (_( fls_NN )_) and_CC wanda_NN (_( wan_NN )_) mutants_NNS affect_VVB all_DD adult_NN fins_NNS ._.
P09009843A01
Members_NNS of_II the_DD Hedgehog_NN family_NN of_II signaling_VVGJ molecules_NNS mediate_VVB many_DD important_JJ short-_JJ and_CC long-range_NN patterning_VVGJ processes_NNS during_II invertebrate_NN and_CC vertebrate_NN development_NN ._.
P09012506A01
In_II chick_NN embryos_NNS homozygous_JJ for_II the_DD limbless_NN mutation_NN ,_, limb_NN bud_NN outgrowth_NN is_VBZ initiated_VVN ,_, but_CC a_DD morphologically_RR distinct_JJ apical_JJ ridge_NN does_VDZ not_RR develop_VVB and_CC limbs_NNS do_VDB not_RR form_VVB ._.
P09012506A07
These_DD observations_NNS support_VVB the_DD hypothesis_NN that_CST Fgf8_NN is_VBZ required_VVN for_II the_DD induction_NN of_II Shh_NN expression_NN during_II normal_JJ limb_NN development_NN ._.
P09012506A13
These_DD data_NNS suggest_VVB that_CST D-V_NN patterning_VVGN and_CC apical_JJ ridge_NN formation_NN are_VBB linked_VVN ,_, since_CS they_PN show_VVB that_CST the_DD limbless_NN mutation_NN affects_VVZ both_DD processes_NNS ._.
P09012508A04
We_PN have_VHB previously_RR shown_VVN that_CST overexpression_NN of_II eFGF_NN from_II the_DD start_NN of_II gastrulation_NN results_VVZ in_II a_DD posteriorised_VVNJ phenotype_NN of_II reduced_VVNJ head_NN and_CC enlarged_VVNJ proctodaeum_NN ._.
P09012508A10
This_PND suggests_VVZ that_CST this_DD aspect_NN of_II the_DD eFGF_NN overexpression_NN phenotype_NN is_VBZ caused_VVN by_II the_DD ectopic_JJ activation_NN of_II posterior_JJ genes_NNS in_II anterior_JJ regions_NNS ._.
P09019247A01
Tooth_NN development_NN involves_VVZ reciprocal_JJ epithelial-mesenchymal_JJ interactions_NNS ,_, polarized_VVNJ growth_NN ,_, mesenchyme_NN condensation_NN ,_, and_CC complex_JJ morphogenetic_JJ events_NNS ._.
P09019247A07
When_CS different_JJ portions_NNS of_II neonatal_JJ incisors_NNS were_VBD assayed_VVN ,_, a_DD clear_JJ proximo-distal_JJ gradient_NN of_II activity_NN was_VBD apparent_JJ ,_, with_II maximal_JJ activity_NN restricted_VVN to_II the_DD most_RRT proximal_JJ portion_NN where_PNR undifferentiated_VVNJ mesenchyme_NN and_CC enamel_NN organ_NN reside_VVB ._.
P09019247A13
Given_VVN its_PNG subsequent_JJ association_NN with_II differentiating_VVGJ ameloblasts_NNS ,_, Shh_NN probably_RR participates_VVZ also_RR in_II cytogenetic_JJ events_NNS during_II odontogenesis_NN ._.
P09043070A02
Mediolateral_JJ intercalation_NN begins_VVZ in_II a_DD group_NN of_II cells_NNS called_VVN the_DD vegetal_JJ alignment_NN zone_NN ,_, a_DD subpopulation_NN of_II cells_NNS in_II Spemann_NN 's_GE organizer_NN ,_, and_CC spreads_VVZ through_II much_PND of_II the_DD marginal_JJ zone_NN ._.
P09043070A08
These_DD results_NNS demonstrate_VVB that_CST microtubules_NNS are_VBB required_VVN to_TO form_VVI the_DD vegetal_JJ alignment_NN zone_NN ,_, and_CC that_CST both_CC microtubules_NNS and_CC the_DD vegetal_JJ alignment_NN zone_NN play_VVB critical_JJ roles_NNS in_II the_DD inductive_JJ and_CC morphogenetic_JJ activities_NNS of_II Spemann_NN 's_GE organizer_NN ._.
P09053330A06
Activation_NN is_VBZ also_RR achieved_VVN using_VVG the_DD Ci_NN zinc_NN finger_NN domain_NN fused_VVN to_II a_DD heterologous_JJ transactivation_NN domain_NN ._.
P09063623A03
Members_NNS of_II the_DD Msx_NN homeobox_NN gene_NN family_NN are_VBB expressed_VVN at_II sites_NNS of_II epithelial-mesenchymal_JJ interaction_NN during_II embryogenesis_NN ,_, including_VVG the_DD tooth_NN ._.
P09063623A09
Last_RR ,_, as_II a_DD unifying_VVGJ mechanism_NN to_TO explain_VVI the_DD disparate_JJ tooth_NN phenotypes_NNS in_II Msxl-_NN and_CC Msx2-deficient_JJ mice_NNS ,_, we_PN propose_VVB that_CST later_JJR steps_NNS in_II tooth_NN morphogenesis_NN molecularly_RR resemble_VVB those_PND in_II early_JJ tooth_NN development_NN ._.
P09073437A05
At_II high_JJ levels_NNS of_II BMP_NN signaling_VVGN the_DD ectoderm_NN adopts_VVZ a_DD ventral_JJ fate_NN and_CC skin_NN is_VBZ formed_VVN ._.
P09076679A04
zbmp-4_NN expression_NN ,_, however_RR ,_, was_VBD also_RR seen_VVN in_II the_DD embryonic_JJ shield_NN ,_, the_DD most_RRT dorsal_JJ mesodermal_JJ structure_NN ._.
P09076682A05
At_II the_DD highest_JJT dose_NN of_II Xdsh_NN mRNA_NN ,_, explants_NNS contained_VVD maximal_JJ amount_NN of_II HoxB9_NN transcripts_NNS and_CC developed_VVD notochord_NN and_CC somites_NNS ._.
P09076682A11
These_DD findings_NNS argue_VVB against_II induction_NN of_II the_DD entire_JJ organizer_NN by_II Xdsh_NN in_II ectodermal_JJ cells_NNS and_CC implicate_VVB signal_NN transduction_NN pathways_NNS involving_VVG Xdsh_NN in_II AP_NN axis_NN determination_NN ._.
P09078434A02
Specification_NN of_II these_DD neuroepithelial_JJ oligodendrocyte_NN precursors_NNS ,_, in_II common_JJ with_II other_JJ ventral_JJ cells_NNS such_II+ as_II motor_NN neurons_NNS ,_, depends_VVZ on_II morphogenetic_JJ signals_NNS from_II the_DD notochord_NN and/or_CC floor_NN plate_NN ._.
P09078434A08
If_CS so_RR ,_, oligodendrocyte_NN ontogeny_NN and_CC phylogeny_NN might_VM share_VVB a_DD common_JJ basis_NN ._.
P09079674A01
The_DD full-length_NN mouse_NN Indian_NN hedgehog_NN (_( Ihh_NN )_) cDNA_NN was_VBD cloned_VVN from_II an_DD embryonic_JJ 17.5-day_NN kidney_NN library_NN and_CC was_VBD used_VVN to_TO study_VVI the_DD post-translational_JJ processing_VVGN of_II the_DD peptide_NN and_CC temporal_JJ and_CC spatial_JJ expression_NN of_II the_DD transcript_NN ._.
P09079674A06
This_DD processing_VVGN required_VVD His313_NN present_JJ in_II a_DD conserved_VVNJ serine_NN protease_NN motif_NN ._.
P09102298A04
In_II addition_NN ,_, they_PN promote_VVB intense_JJ radial_JJ growth_NN of_II the_DD differentiating_VVGJ cartilages_NNS and_CC disturb_VVB the_DD formation_NN of_II joints_NNS accompanied_VVN by_II alterations_NNS in_II the_DD pattern_NN of_II Indian_NN hedgehog_NN and_CC ck-erg_NN expression_NN ._.
P09106162A04
However_RR ,_, expression_NN of_II Fgf8_NN ,_, a_DD marker_NN gene_NN for_II the_DD apical_JJ ectodermal_JJ ridge_NN (_( AER_NN )_) ,_, was_VBD delayed_VVN and_CC shortly_RR disappeared_VVD in_II the_DD wing_NN regressing_VVGJ AER_NN ._.
P09106162A10
Further_RR ,_, it_PN is_VBZ suggested_VVN that_CST the_DD AER_NN is_VBZ required_VVN for_II maintenance_NN of_II the_DD DV_NN boundary_NN and_CC the_DD polarizing_VVGJ activity_NN of_II the_DD established_VVNJ wing_NN bud_NN ._.
P09109493A04
cubitus_NN interruptus_NN (_( ci_NN )_) ,_, a_DD component_NN in_II hh_NN signalling_VVGN ,_, encodes_VVZ a_DD transcription_NN factor_NN homologous_JJ to_II the_DD Gli_NN family_NN of_II proteins_NNS and_CC is_VBZ required_VVN for_II induction_NN of_II the_DD hh-dependent_JJ expression_NN of_II patched_NN (_( ptc_NN )_) ,_, decapentaplegic_NN (_( dpp_NN )_) and_CC wingless_NN (_( wg_NN )_) ._.
P09115210A01
Mutations_NNS in_II the_DD tumor_NN suppressor_NN gene_NN PATCHED_NN (_( PTC_NN )_) are_VBB found_VVN in_II human_NN patients_NNS with_II the_DD basal_JJ cell_NN nevus_NN syndrome_NN ,_, a_DD disease_NN causing_VVG developmental_JJ defects_NNS and_CC tumors_NNS ,_, including_VVG basal_JJ cell_NN carcinomas_NNS ._.
P09118801A05
The_DD pleiotropic_JJ action_NN of_II cerebum_NN deficiencies_NNS ,_, and_CC the_DD differential_JJ response_NN of_II affected_VVNJ tissues_NNS ,_, suggest_VVB that_CST the_DD cerebum_NN gene_NN may_VM normally_RR function_VVB as_II an_DD inhibitor_NN of_II ventralizing_VVGJ signals_NNS ,_, a_DD function_NN previously_RR ascribed_VVN to_II Noggin_NN and_CC Chordin_NN in_II Xenopus_NN ._.
P09118802A02
A_DD critical_JJ event_NN for_II floor_NN plate_NN development_NN is_VBZ the_DD induction_NN of_II a_DD winged_JJ helix_NN transcription_NN factor_NN ,_, Hepatocyte_NN Nuclear_JJ Factor-3beta_NN (_( HNF-3beta_NN )_) ._.
P09118802A08
Three_MC Gli_NN genes_NNS are_VBB differentially_RR expressed_VVN in_II the_DD developing_VVGJ neural_JJ tube_NN ._.
P09118802A13
Taken_VVN together_RR ,_, these_DD findings_NNS suggest_VVB that_CST Gli_NN ,_, and_CC probably_RR also_RR Gli2_NN ,_, are_VBB good_JJ candidates_NNS for_II transcriptional_JJ activators_NNS of_II the_DD HNF-3beta_NN floor_NN plate_NN enhancer_NN ,_, and_CC the_DD binding_VVGJ site_NN for_II Gli_NN proteins_NNS is_VBZ a_DD key_JJ element_NN for_II response_NN to_II Shh_NN signalling_VVGN ._.
P09119087A04
Intramuscular_JJ transplantation_NN of_II Shh-N-RCAS-transfected_VVNJ chicken_NN fibroblasts_NNS into_II athymic_JJ mice_NNS induced_VVD ectopic_JJ bone_NN formation_NN ._.
P09133442A01
We_PN have_VHB isolated_VVN a_DD novel_JJ TGF_NN beta-like_JJ gene_NN from_II Xenopus_NN which_PNR is_VBZ highly_RR related_VVN to_II mouse_NN nodal_NN The_DD gene_NN ,_, Xnr4_NN ,_, is_VBZ expressed_VVN at_II the_DD gastrula_NN stage_NN in_II the_DD Spemann_NN organizer_NN and_CC at_II later_JJR stages_NNS in_II the_DD notochord_NN and_CC neural_JJ tube_NN ._.
P09152005A04
We_PN found_VVD that_CST Gli_NN and_CC Ptc_NN are_VBB expressed_VVN in_II similar_JJ domains_NNS in_II diverse_JJ regions_NNS of_II the_DD developing_VVGJ mouse_NN embryo_NN and_CC these_DD regions_NNS are_VBB adjacent_JJ to_II Hh_NN signals_NNS ._.
P09152007A05
Ectopic_JJ activation_NN of_II net1_NN ,_, however_RR ,_, is_VBZ restricted_VVN to_II distinct_JJ regions_NNS in_II the_DD brain_NN ._.
P09152007A11
This_PND also_RR suggests_VVZ that_CST these_DD ectopically_RR expressing_VVGJ regions_NNS have_VHB not_RR differentiated_VVN into_II floor_NN plate_NN ._.
P09152009A01
Sonic_NN hedgehog_NN (_( Shh_NN )_) expression_NN in_II the_DD developing_VVGJ limb_NN is_VBZ associated_VVN with_II the_DD zone_NN of_II polarising_VVGJ activity_NN (_( ZPA_NN )_) ,_, and_CC both_PND are_VBB restricted_VVN to_II the_DD posterior_JJ part_NN of_II the_DD limb_NN bud_NN ._.
P09181127A04
The_DD dorsal_JJ derivatives_NNS of_II the_DD somite_NN ,_, formed_VVN from_II cells_NNS in_II the_DD dermomyotome_NN ,_, are_VBB derm_NN and_CC skeletal_JJ muscle_NN ._.
P09181127A10
This_PND contributes_VVZ to_II the_DD formation_NN of_II axial_JJ muscles_NNS ._.
P09181127A16
In_II mice_NNS carrying_VVG mutations_NNS in_II both_CC MyoD_NN and_CC myf-5_NN no_DD skeletal_JJ muscle_NN forms_NNS ,_, whereas_CS myogenesis_NN can_VM take_VVB place_NN in_II the_DD absence_NN of_II either_CC MyoD_NN or_CC myf-5_NN ._.
P09181127A22
Some_DD cells_NNS localize_VVB dorsally_RR under_II the_DD epiderm_NN and_CC begin_VVB to_TO express_VVI the_DD dermal_JJ marker_NN ,_, Dermo-1_NN ._.
P09186057A03
In_II this_DD study_NN ,_, we_PN investigated_VVD the_DD expression_NN of_II Sonic_NN hedgehog_NN (_( shh_NN )_) ,_, a_DD molecular_JJ marker_NN for_II ZPA_NN ,_, in_II Xenopus_NN developing_VVGJ limb_NN buds_NNS and_CC regenerating_VVGJ blastemas_NNS by_II whole-mount_NN in_JJ+ situ_JJ hybridization_NN ._.
P09186057A09
Furthermore_RR we_PN examined_VVD shh_NN expression_NN in_II regenerating_VVGJ blastemas_NNS ._.
P09187141A04
We_PN find_VVB that_CST anteriorly_RR and_CC posteriorly_RR situated_VVNJ cells_NNS within_II the_DD A_NN compartment_NN respond_VVB in_II distinct_JJ ways_NNS to_II Hh_NN :_: they_PN express_VVB different_JJ combinations_NNS of_II genes_NNS and_CC form_VVB different_JJ cell_NN types_NNS ._.
P09199358A01
Expression_NN and_CC mutation_NN analyses_NNS in_II mice_NNS suggest_VVB that_CST the_DD homeobox-containing_VVGJ gene_NN Engrailed_NN (_( En_NN )_) plays_VVZ a_DD role_NN in_II dorsoventral_JJ patterning_VVGN of_II the_DD limb_NN ._.
P09199358A07
Furthermore_RR ,_, the_DD AER_NN is_VBZ disrupted_VVN morphologically_RR and_CC the_DD expression_NN patterns_NNS of_II the_DD AER_NN signalling_VVGJ molecules_NNS Fgf-8_NN and_CC Fgf-4_NN are_VBB altered_VVN ._.
P09205942A03
Sonic_NN hedgehog_NN is_VBZ synthesized_VVN as_II an_DD inactive_JJ precursor_NN which_PNR must_VM be_VBB proteolytically_RR cleaved_VVN and_CC modified_VVN by_II the_DD addition_NN of_II a_DD cholesterol_NN moiety_NN to_TO become_VVI active_JJ as_II a_DD signalling_VVGJ molecule_NN ._.
P09212109A02
Mutation_NN of_II the_DD only_JJ known_VVNJ HH_NN receptor_NN gene_NN ,_, Patched_NN (_( PTC_NN )_) ,_, has_VHZ recently_RR been_VBN implicated_VVN in_II inherited_VVNJ and_CC sporadic_JJ forms_NNS of_II the_DD most_RRT common_JJ human_NN cancer_NN ,_, basal_JJ cell_NN carcinoma_NN (_( BCC_NN )_) ._.
P09212109A07
LTR-SHH_NN human_NN skin_NN consistently_RR displays_VVZ the_DD abnormal_JJ specific_JJ histologic_JJ features_NNS seen_VVN in_II BCCs_NNS ,_, including_VVG downgrowth_NN of_II epithelial_JJ buds_NNS into_II the_DD dermis_NN ,_, basal_JJ cell_NN palisading_VVGN and_CC separation_NN of_II epidermis_NN from_II the_DD underlying_VVGJ dermis_NN ._.
P09216992A02
This_PND is_VBZ well_RR demonstrated_VVN in_II the_DD control_NN of_II morphogenetic_JJ furrow_NN movement_NN and_CC differentiation_NN in_II the_DD eye_NN imaginal_JJ disc_NN ._.
P09216996A02
In_II frog_NN embryos_NNS ,_, Gli1_NN is_VBZ expressed_VVN transiently_RR in_II the_DD prospective_JJ floor_NN plate_NN during_II gastrulation_NN and_CC in_II cells_NNS lateral_JJ to_II the_DD midline_NN during_II late_JJ gastrula_NN and_CC neurula_NN stages_NNS ._.
P09216996A08
Thus_RR ,_, our_PNG results_NNS identify_VVB Gli1_NN as_II a_DD midline_NN target_NN of_II Shh_NN and_CC suggest_VVB that_CST it_PN mediates_VVZ the_DD induction_NN of_II floor_NN plate_NN cells_NNS and_CC ventral_JJ neurons_NNS by_II Shh_NN acting_VVGN as_II a_DD transcriptional_JJ regulator_NN ._.
P09226442A05
This_PND suggests_VVZ that_CST the_DD forebrain_NN employs_VVZ the_DD same_JJ medial-lateral_JJ (_( ventral-dorsal_JJ )_) patterning_VVGJ mechanisms_NNS present_JJ in_II the_DD rest_NN of_II the_DD central_JJ nervous_JJ system_NN ._.
P09236238A04
We_PN found_VVD that_CST Sonic_NN hedgehog_NN and_CC Desert_NN hedgehog_NN are_VBB expressed_VVN in_II the_DD developing_VVGJ retina_NN ,_, albeit_CS at_II very_RR low_JJ levels_NNS ,_, whereas_CS Indian_NN hedgehog_NN (_( Ihh_NN )_) is_VBZ expressed_VVN in_II the_DD developing_VVGJ and_CC mature_JJ retinal_JJ pigmented_VVNJ epithelium_NN ,_, beginning_VVG at_II embryonic_JJ day_NN 13_MC ._.
P09237688A04
We_PN also_RR found_VVN that_CST two_MC types_NNS of_II ptc_NN genes_NNS ,_, potential_JJ hh_NN targets_NNS and_CC receptors_NNS ,_, were_VBD expressed_VVN in_II these_DD tissues_NNS ,_, suggesting_VVG the_DD presence_NN of_II active_JJ hh_NN signalling_VVGN there_RR ._.
P09242418A01
While_CS the_DD role_NN of_II the_DD notochord_NN and_CC floor_NN plate_NN in_II patterning_VVGN the_DD dorsal-ventral_JJ (_( D_NN /_SYM V_NN )_) axis_NN of_II the_DD neural_JJ tube_NN is_VBZ clearly_RR established_VVN ,_, relatively_RR little_PND is_VBZ known_VVN about_II the_DD earliest_JJT stages_NNS of_II D_NN /_SYM V_NN regionalization_NN ._.
P09244298A04
Like_II HH_NN ,_, the_DD kinase_NN Fused_NN and_CC the_DD transcription_NN factor_NN Cubitus_NN interruptus_NN (_( CI_NN )_) act_VVB positively_RR upon_II targets_NNS ._.
P09247329A05
gsb_NN mutants_NNS lack_VVB U_NN and_CC CQ_NN neurons_NNS ,_, have_VHB duplicated_VVNJ RP2_NN neurons_NNS ,_, and_CC display_VVB posterior_JJ commissure_NN defects_NNS ._.
P09262482A03
Mice_NNS homozygous_JJ for_II the_DD ptc_NN mutation_NN died_VVD during_II embryogenesis_NN and_CC were_VBD found_VVN to_TO have_VHI open_JJ and_CC overgrown_JJ neural_JJ tubes_NNS ._.
P09265630A02
To_TO identify_VVI potential_JJ zinc_NN ligands_NNS and_CC begin_VVI defining_VVGN the_DD active_JJ site_NN residues_NNS ,_, we_PN have_VHB mutated_VVN the_DD 2_MC cysteine_NN ,_, 5_MC histidine_NN ,_, and_CC 4_MC of_II the_DD 28_MC aspartate_NN and_CC glutamate_NN residues_NNS in_II the_DD 202_MC residue_NN VanX_NN protein_NN ._.
P09268570A02
In_II the_DD present_JJ study_NN it_PN is_VBZ demonstrated_VVN that_CST grafts_NNS of_II Hensen_NN 's_GE node_NN can_VM induce_VVB the_DD formation_NN of_II supernumerary_JJ rudimentary_JJ limbs_NNS from_II the_DD non-limb-forming_VVGJ flank_NN region_NN of_II the_DD lateral_JJ plate_NN of_II stage_NN 9-15_MC chick_NN embryos_NNS ._.
P09268573A05
The_DD most_RRT striking_VVGJ expression_NN patterns_NNS in_II the_DD head_NN are_VBB during_II neural_JJ crest_NN cell_NN migration_NN when_CS AP-2_NN transcripts_NNS follow_VVB closely_RR the_DD tracts_NNS previously_RR mapped_VVN for_II neural_JJ crest_NN cells_NNS ._.
P09268573A11
In_II addition_NN ,_, the_DD normal_JJ up-regulation_NN of_II AP-2_NN in_II the_DD frontonasal_JJ mass_NN did_VDD not_RR occur_VVB following_VVG retinoic-acid_NN treatment_NN ._.
P09268735A01
In_II this_DD study_NN we_PN asked_VVD whether_CST members_NNS of_II the_DD hedgehog_NN gene_NN family_NN are_VBB involved_VVN in_II osteogenesis_NN ._.
P09268735A07
rShh-N_NN treatment_NN did_VDD not_RR affect_VVB the_DD expression_NN levels_NNS of_II Bmp-2_NN ,_, -4_MC ,_, -5_MC ,_, -6_MC and_CC -7_MC genes_NNS ._.
P09280061A01
Sonic_NN hedgehog_NN (_( Shh_NN )_) is_VBZ a_DD secreted_VVNJ morphogen_NN that_PNR regulates_VVZ dorso-ventral_JJ patterning_VVGN within_II the_DD neural_JJ tube_NN during_II embryonic_JJ development_NN ._.
P09280061A07
Point_NN mutations_NNS introduced_VVN within_II the_DD ShhRE_NN reveal_VVB some_DD key_JJ nucleotides_NNS that_PNR are_VBB essential_JJ for_II protein_NN (_( s_NNS )_) -binding_VVGJ activity_NN ._.
P09281589A01
Pattern_NN in_II the_DD developing_VVGJ limb_NN depends_VVZ on_II signaling_VVGN by_II polarizing_VVGJ region_NN mesenchyme_NN cells_NNS ,_, which_PNR are_VBB located_VVN at_II the_DD posterior_JJ margin_NN of_II the_DD bud_NN tip_NN ._.
P09281589A07
FGF4_NN has_VHZ no_DD effect_NN on_II cultured_VVNJ anterior_JJ mesenchyme_NN ,_, suggesting_VVG that_CST any_DD effects_NNS of_II FGF4_NN on_II responding_VVGJ anterior_JJ mesenchyme_NN cells_NNS are_VBB not_RR mediated_VVN by_II a_DD change_NN in_II gap_NN junction_NN density_NN or_CC functional_JJ communication_NN through_II gap_NN junctions_NNS ._.
P09294190A01
CBP_NN is_VBZ a_DD transcriptional_JJ coactivator_NN required_VVN by_II many_DD transcription_NN factors_NNS for_II transactivation_NN ._.
P09294190A07
The_DD frequency_NN of_II the_DD different_JJ abnormalities_NNS was_VBD significantly_RR lower_JJR in_II a_DD C57BL_NN /_SYM 6-CBA_NN background_NN ,_, suggesting_VVG that_CST the_DD genetic_JJ background_NN is_VBZ an_DD important_JJ determinant_NN of_II the_DD variability_NN and_CC severity_NN of_II the_DD anomalies_NNS seen_VVN in_II Rubinstein-Taybi_NN syndrome_NN patients_NNS ._.
P09299117A02
The_DD current_JJ hypothesis_NN is_VBZ that_CST FGF-8_NN from_II the_DD mesonephros_NN induces_VVZ limb_NN initiation_NN ._.
P09299117A08
Further_JJ studies_NNS of_II axial_JJ influences_NNS on_II limb_NN initiation_NN should_VM now_RR concentrate_VVB on_II medial_JJ structures_NNS such_II+ as_II Hensen_NN 's_GE node_NN and_CC paraxial_JJ mesoderm_NN ;_: the_DD alternative_NN that_CST no_DD axial_JJ influences_NNS are_VBB required_VVN should_VM also_RR be_VBB examined_VVN ._.
P09299570A05
These_DD results_NNS suggest_VVB that_CST a_DD Sonic_NN hedgehog_NN signal_NN is_VBZ involved_VVN in_II the_DD cell_NN growth_NN of_II LK-2_NN cells_NNS ._.
P09302262A03
Here_RR we_PN describe_VVB a_DD total_NN of_II five_MC different_JJ mutations_NNS in_II the_DD processing_VVGJ domain_NN encoded_VVN by_II exon_NN 3_MC of_II SHH_NN in_II familial_JJ and_CC sporadic_JJ HPE_NN ._.
P09314535A03
Ectopic_JJ expression_NN in_II the_DD notochord_NN of_II Dorsalin-1_NN ,_, a_DD member_NN of_II the_DD TGF-beta_NN superfamily_NN ,_, inhibits_VVZ the_DD formation_NN of_II muscle_NN pioneer_NN cells_NNS ,_, demonstrating_VVG that_CST TGF-beta_NN signals_NNS can_VM antagonize_VVB the_DD induction_NN of_II muscle_NN pioneer_NN cells_NNS by_II Hedgehog_NN ._.
P09331328A03
Ablation_NN of_II the_DD notochord_NN in_II chick_NN embryos_NNS extends_VVZ the_DD domain_NN of_II Brn-3.0_NN expression_NN into_II the_DD ventral_JJ neural_JJ tube_NN ,_, while_CS ectopic_JJ grafts_NNS of_II notochord_NN tissue_NN suppress_VVB Brn-3.0_NN expression_NN ._.
P09334271A01
The_DD distribution_NN of_II Hoxb-8_NN transcripts_NNS through_II the_DD chick_NN flank_NN and_CC early_JJ forelimb_NN mirrors_VVZ the_DD distribution_NN of_II polarizing_VVGJ activity_NN in_II the_DD flank_NN at_II these_DD early_JJ stages_NNS ._.
P09334271A07
These_DD results_NNS indicate_VVB that_CST Hoxb-8_NN expression_NN may_VM be_VBB regulated_VVN by_II the_DD established_VVNJ ZPA_NN through_II a_DD negative_JJ feedback_NN loop_NN ._.
P09334279A05
These_DD results_NNS suggest_VVB that_CST changes_NNS in_II overall_JJ cell_NN death_NN or_CC cell_NN proliferation_NN rates_NNS are_VBB unlikely_RR to_TO be_VBI responsible_JJ for_II the_DD mesodermal_JJ deficits_NNS seen_VVN in_II the_DD alpha5-null_JJ embryos_NNS ._.
P09334279A11
Anteriorly_RR expressed_VVNJ HoxB_NN genes_NNS were_VBD expressed_VVN normally_RR in_II the_DD alpha5-null_JJ embryos_NNS ._.
P09334287A01
Anteroposterior_JJ polarity_NN in_II the_DD vertebrate_NN limb_NN is_VBZ thought_VVN to_TO be_VBI regulated_VVN in_II response_NN to_II signals_NNS derived_VVN from_II a_DD specialized_VVNJ region_NN of_II distal_JJ posterior_JJ mesenchyme_NN ,_, the_DD zone_NN of_II polarizing_VVGJ activity_NN ._.
P09334287A07
Increasing_VVGN the_DD time_NN of_II exposure_NN to_II Shh_NN leads_VVZ to_II specification_NN of_II additional_JJ digits_NNS ,_, firstly_RR digit_NN 2_MC ,_, then_RR 3_MC ,_, then_RR 4_MC ._.
P09334287A13
Finally_RR ,_, we_PN demonstrate_VVB that_CST when_CS Shh-N_NN is_VBZ attached_VVN to_II an_DD integral_JJ membrane_NN protein_NN ,_, cells_NNS transfected_VVN with_II this_DD anchored_VVNJ signal_NN also_RR induce_VVB mirror-image_NN pattern_NN duplications_NNS in_II a_DD dose-dependent_JJ fashion_NN similar_JJ to_II the_DD zone_NN of_II polarizing_VVGJ activity_NN itself_PN ._.
P09342041A01
The_DD semi-dominant_JJ mouse_NN mutation_NN Ulnaless_NN alters_VVZ patterning_VVGN of_II the_DD appendicular_JJ but_CC not_RR the_DD axial_JJ skeleton_NN ._.
P09342041A07
Skeletal_JJ reductions_NNS in_II the_DD proximal_JJ limb_NN may_VM be_VBB a_DD consequence_NN of_II posterior_JJ prevalence_NN ,_, whereby_RR proximal_JJ misexpression_NN of_II Hoxd-13_NN and_CC Hoxd-12_NN results_VVZ in_II the_DD transcriptional_JJ and/or_CC functional_JJ inactivation_NN of_II Hox_NN group_NN 11_MC genes_NNS ._.
P09347917A06
The_DD expression_NN of_II Brx1_NN along_RR with_II that_PND of_II Sonic_NN hedgehog_NN (_( Shh_NN )_) ,_, Nkx2.2_NN ,_, Dlx1_NN and_CC Arx_NN was_VBD examined_VVN at_II the_DD time_NN of_II the_DD formation_NN of_II ZLI_NN in_II mouse_NN embryos_NNS ._.
P09347917A12
Each_DD homeobox_NN gene_NN was_VBD also_RR expressed_VVN regionally_RR in_II the_DD nucleus_NN ,_, suggesting_VVG that_CST the_DD nucleus_NN is_VBZ comprised_VVN of_II subdivisions_NNS ._.
P09349822A06
Because_CS Gli1_NN ,_, but_CC not_RR Gli3_NN ,_, acts_VVZ as_II a_DD target_NN and_CC mediator_NN of_II Shh_NN signalling_VVGN ,_, our_PNG results_NNS suggest_VVB that_CST expression_NN of_II Gli1_NN in_II basal_JJ cells_NNS induces_VVZ BCC_NN formation_NN ._.
P09356179A01
Dorsoventral_JJ patterning_VVGN of_II somites_NNS into_II sclerotome_NN and_CC dermomyotome_NN involves_VVZ antagonistic_JJ actions_NNS of_II ventralizing_VVGJ and_CC dorsalizing_VVGJ signals_NNS originating_VVG from_II tissues_NNS surrounding_VVG the_DD somites_NNS ._.
P09367435A02
High_JJ concentrations_NNS of_II activin_NN induce_VVB dorsal_JJ and_CC anterior_JJ cell_NN types_NNS such_II+ as_II notochord_NN and_CC muscle_NN ,_, while_CS low_JJ concentrations_NNS induce_VVB ventral_JJ and_CC posterior_JJ tissues_NNS such_II+ as_II mesenchyme_NN and_CC mesothelium_NN ._.
P09367435A08
By_II contrast_NN ,_, the_DD ALK-2*_NN receptor_NN induces_VVZ only_RR ventral_JJ mesodermal_JJ markers_NNS ._.
P09367445A06
The_DD dorsalising_VVGJ factors_NNS and_CC lower_JJR levels_NNS of_II the_DD ventralising_VVGJ factors_NNS act_VVB in_II concert_NN to_TO induce_VVI the_DD myotome_NN ._.
P09373024A04
This_DD review_NN discusses_VVZ some_PND of_II the_DD recent_JJ advances_NNS in_II our_PNG knowledge_NN of_II how_CST oligodendrocytes_NNS are_VBB generated_VVN and_CC the_DD mechanisms_NNS by_II which_PNR this_PND might_VM occur_VVB in_II the_DD developing_VVGJ brain_NN and_CC spinal_JJ cord_NN ._.
P09374397A01
Correct_JJ development_NN of_II the_DD limb_NN is_VBZ dependent_JJ on_II coordination_NN between_II three_MC distinct_JJ signaling_VVGJ centers_NNS ._.
P09374397A07
The_DD polydactyly_NN is_VBZ associated_VVN with_II the_DD formation_NN of_II an_DD ectopic_JJ anterior_JJ ZPA_NN ,_, as_CS indicated_VVN by_II anterior_JJ expression_NN of_II Sonic_NN hedgehog_NN ,_, HoxD13_NN and_CC fibroblast_NN growth_NN factor-4_NN ._.
P09388780A01
Over_II the_DD past_JJ year_NN ,_, interest_NN has_VHZ focused_VVN on_II identifying_VVGN signalling_VVGJ molecules_NNS --_: including_VVG Wnts_NNS ,_, Sonic_NN hedgehog_NN ,_, BMP-4_NN ,_, and_CC noggin_NN --_: that_PNR divert_VVB somitic_JJ mesodermal_JJ cells_NNS into_II the_DD muscle_NN lineage_NN ,_, either_CC by_II induction_NN or_CC derepression_NN ._.
P09399080A05
However_RR ,_, most_PND of_II the_DD pivotal_JJ signals_NNS ,_, and_CC the_DD ways_NNS in_II which_PNR they_PN are_VBB integrated_VVN and_CC interact_VVB ,_, remain_VVB enigmatic_JJ ._.
P09399080A11
Epithelial_JJ somites_NNS are_VBB clearly_RR a_DD result_NN of_II segmentation_NN ,_, but_CC epithelialization_NN is_VBZ not_RR the_DD mechanism_NN to_TO form_VVI segments_NNS ,_, supporting_VVG the_DD idea_NN that_CST the_DD basic_JJ mechanisms_NNS that_PNR govern_VVB segmentation_NN in_II the_DD mesoderm_NN of_II vertebrates_NNS are_VBB very_RR similar_JJ in_II different_JJ species_NNS despite_II divergent_JJ types_NNS of_II resulting_VVGJ segments_NNS (_( i.e._II ,_, epithelial_JJ somites_NNS versus_CC rotated_VVNJ myotomes_NNS )_) ._.
P09399080A17
The_DD roles_NNS of_II these_DD genes_NNS have_VHB yet_RR to_TO be_VBI analyzed_VVN ._.
P09409664A01
Early_JJ dorsoventral_JJ pattern_NN formation_NN in_II vertebrate_NN embryos_NNS is_VBZ regulated_VVN by_II opposing_VVGJ activities_NNS of_II ventralizing_VVGJ bone_NN morphogenetic_JJ proteins_NNS (_( BMPs_NNS )_) and_CC dorsal-specific_JJ BMP_NN antagonists_NNS such_II+ as_II Chordin_NN ,_, Noggin_NN and_CC Follistatin_NN ._.
P09409664A07
Fertile_JJ adult_JJ mutant_JJ fish_NN were_VBD obtained_VVN ,_, showing_VVG that_CST development_NN after_II gastrulation_NN is_VBZ not_RR dependent_JJ on_II zbmp2_NN function_NN ._.
P09409670A06
Hoxd-12_NN misexpression_NN can_VM also_RR induce_VVB ectopic_JJ Sonic_NN hedgehog_NN (_( Shh_NN )_) expression_NN ,_, resulting_VVG in_II mirror-image_NN polydactyly_NN in_II the_DD limb_NN ._.
P09415428A01
Posterior_JJ neuropore_NN (_( PNP_NN )_) closure_NN coincides_VVZ with_II the_DD end_NN of_II gastrulation_NN ,_, marking_VVG the_DD end_NN of_II primary_JJ neurulation_NN and_CC primary_JJ body_NN axis_NN formation_NN ._.
P09415428A07
Patterns_NNS of_II expression_NN within_II the_DD tail_NN bud_NN ,_, neural_JJ plate_NN ,_, recently_RR closed_VVNJ neural_JJ tube_NN ,_, notochord_NN ,_, hindgut_NN ,_, mesoderm_NN ,_, and_CC surface_NN ectoderm_NN are_VBB illustrated_VVN and_CC described_VVN ._.
P09415493A05
We_PN found_VVD that_CST the_DD pattern_NN of_II Hoxd13_NN and_CC Hoxd11_NN transcripts_NNS was_VBD not_RR markedly_RR different_JJ in_II the_DD mutant_NN compared_VVN with_II the_DD normal_JJ limbs_NNS even_RR though_CS the_DD mutant_JJ limbs_NNS are_VBB narrower_JJR ._.
P09415495A02
On_II the_DD dorsal_JJ side_NN of_II the_DD embryo_NN ,_, beta-catenin_NN is_VBZ translocated_VVN into_II the_DD nuclei_NNS via_II a_DD process_NN linked_VVN to_II cortical_JJ rotation_NN ._.
P09415495A08
The_DD role_NN of_II cortical_JJ rotation_NN is_VBZ to_TO generate_VVI an_DD overlap_NN of_II the_DD region_NN with_II dorsal_JJ axis-forming_VVGJ activity_NN ,_, indicated_VVN by_II nuclear_JJ translocation_NN of_II beta-catenin_NN ,_, and_CC the_DD prospective_JJ mesoderm_NN in_II the_DD marginal_JJ zone_NN to_TO assure_VVI the_DD correct_JJ positioning_VVGN of_II the_DD Spemann_NN organizer_NN ._.
P09425144A03
Cells_NNS that_PNR migrate_VVB away_II+ from_II the_DD lateral_JJ part_NN of_II the_DD somites_NNS to_II the_DD limb_NN bud_NN do_VDB not_RR initially_RR express_VVB any_DD member_NN of_II the_DD MRF_NN family_NN ._.
P09425144A09
Addition_NN of_II SHH_NN to_II primary_JJ cultures_NNS of_II myoblasts_NNS resulted_VVD in_II an_DD increase_NN in_II the_DD proportion_NN of_II myoblasts_NNS that_PNR incorporate_VVB bromodeoxyuridine_NN ,_, resulting_VVG in_II an_DD increase_NN of_II myotube_NN number_NN ._.
P09431812A06
Here_RR we_PN demonstrate_VVB that_CST Hh_NN and_CC Patched_NN (_( Ptc_NN )_) act_VVB through_II those_DD Ci_NN binding_VVGJ sites_NNS to_TO modulate_VVI the_DD level_NN of_II Ci-dependent_JJ transcriptional_JJ activation_NN in_II S2_NN cells_NNS ._.
P09438426A04
Although_CS each_DD Gli_NN gene_NN has_VHZ its_PNG own_JJ distinct_JJ expression_NN pattern_NN in_II limb_NN buds_NNS ,_, at_II 10.5-11.5_MC dpc_NN all_DD three_MC genes_NNS were_VBD found_VVN not_RR to_TO be_VBI expressed_VVN in_II the_DD posterior_JJ region_NN ,_, the_DD presumptive_JJ Shh_NN expression_NN domain_NN ._.
P09438426A10
These_DD results_NNS strongly_RR suggest_VVB a_DD positive_JJ regulation_NN of_II Gli1_NN by_II Shh_NN and_CC a_DD negative_JJ interaction_NN between_II Shh_NN and_CC Gli3_NN ._.
P09441681A05
There_EX are_VBB several_JJ domains_NNS in_II the_DD head_NN including_VVG the_DD hatching_VVGJ gland_NN ,_, the_DD branchial_JJ clefts_NNS ,_, and_CC the_DD midbrain-hindbrain_NN border_NN ._.
P09441681A11
In_II contrast_NN to_II the_DD amniotes_NNS ,_, Xenopus_NN limb_NN buds_NNS can_VM regenerate_VVB following_VVG damage_NN ._.
P09441687A04
Injection_NN of_II zebrafish_NN chordin_NN mRNA_NN to_II the_DD ventral_JJ side_NN of_II Xenopus_NN embryos_NNS induced_VVD secondary_JJ axes_NNS ._.
P09441687A09
This_DD finding_VVGN reveals_VVZ an_DD unexpected_VVNJ function_NN for_II spadetail_NN in_II midline_NN mesoderm_NN and_CC in_II differential_JJ regulation_NN of_II chordin_NN expression_NN during_II gastrulation_NN ._.
P09442255A05
SA_NN progenitor_NN cells_NNS subsequently_RR differentiate_VVB into_II paravertebral_JJ and_CC prevertebral_JJ sympathetic_JJ neurons_NNS ,_, intra-_RR and_CC extra-adrenal_JJ chromaffin_NN cells_NNS and_CC intermediate_JJ SIF_NN (_( small_JJ intensely_RR fluorescent_JJ )_) cells_NNS ._.
P09450925A03
Furthermore_RR ,_, we_PN show_VVB that_CST the_DD BMP_NN antagonist_NN Noggin_NN is_VBZ expressed_VVN within_II the_DD dorsomedial_JJ lip_NN of_II the_DD dermomyotome_NN ,_, where_PNR Pax3-expressing_VVGJ cells_NNS first_RR initiate_VVB the_DD expression_NN of_II MyoD_NN and_CC Myf5_NN to_TO give_VVI rise_NN to_II myotomal_JJ cells_NNS in_II the_DD medial_JJ somite_NN ._.
P09452474A05
The_DD presence_NN of_II this_DD region_NN in_II the_DD GLI_NN activation_NN domain_NN provides_VVZ a_DD mechanism_NN for_II GLI-induced_VVNJ transcriptional_JJ regulation_NN ._.
P09463360A06
At_II later_JJR stages_NNS ,_, this_PND often_RR leads_VVZ to_II development_NN of_II a_DD secondary_JJ ventral_JJ AER_NN ,_, which_PNR can_VM promote_VVB formation_NN of_II an_DD ectopic_JJ digit_NN ._.
P09466889A03
We_PN have_VHB recovered_VVN a_DD spontaneous_JJ mouse_NN mutation_NN causing_VVG left_NN /_SYM right_NN patterning_VVGJ defects_NNS together_RR with_II defects_NNS in_II anteroposterior_JJ and_CC dorsoventral_JJ patterning_VVGN ._.
P09466889A09
Lefty_NN ,_, which_PNR is_VBZ normally_RR also_RR expressed_VVN in_II the_DD floorplate_NN ,_, is_VBZ not_RR found_VVN in_II the_DD prospective_JJ floor_NN plate_NN of_II nt_NN embryos_NNS ._.
P09473323A03
A_DD number_NN of_II signaling_VVGJ molecules_NNS are_VBB expressed_VVN in_II these_DD inducing_VVGJ tissues_NNS during_II times_NNS of_II active_JJ cell_NN fate_NN specification_NN ,_, including_VVG members_NNS of_II the_DD Hedgehog_NN ,_, Wnt_NN ,_, and_CC BMP_NN families_NNS ._.
P09473323A09
Delivery_NN of_II an_DD activated_VVNJ form_NN of_II beta-catenin_NN to_II somitic_JJ mesoderm_NN mimics_VVZ the_DD effects_NNS of_II Wnt-1_NN ,_, demonstrating_VVG that_CST Wnt-1_NN likely_RR acts_VVZ directly_RR on_II somitic_JJ mesoderm_NN ,_, and_CC not_RR through_II adjacent_JJ tissues_NNS via_II an_DD indirect_JJ signal_NN relay_NN mechanism_NN ._.
P09477322A01
The_DD development_NN of_II calvarial_JJ bones_NNS is_VBZ tightly_RR co-ordinated_VVN with_II the_DD growth_NN of_II the_DD brain_NN and_CC needs_VVZ harmonious_JJ interactions_NNS between_II different_JJ tissues_NNS within_II the_DD calvarial_JJ sutures_NNS ._.
P09477322A07
Msx1_NN and_CC Msx2_NN were_VBD expressed_VVN in_II the_DD sutural_JJ mesenchyme_NN and_CC the_DD dura_NN mater_NN ._.
P09477322A13
Interestingly_RR ,_, beads_NNS soaked_VVN in_II FGF4_NN accelerated_VVD sutural_JJ closure_NN when_CS placed_VVN on_II the_DD osteogenic_JJ fronts_NNS ,_, but_CC had_VHD no_DB such_DD effect_NN when_CS placed_VVN on_II the_DD mid-sutural_JJ mesenchyme_NN ._.
P09477331A05
By_II stage_NN 24_MC ,_, HOXA-11_NN expression_NN began_VVD to_TO decrease_VVI from_II the_DD posterior_JJ halves_NNS of_II the_DD muscle_NN masses_NNS ._.
P09477331A11
These_DD results_NNS suggest_VVB that_CST Hoxa-11_NN and_CC Hoxa-13_NN expression_NN in_II the_DD migrating_VVGJ premyoblasts_NNS is_VBZ under_II the_DD control_NN of_II the_DD limb_NN mesenchyme_NN and_CC the_DD polarizing_VVGJ signal_NN (_( s_NNS )_) ._.
P09482889A04
During_II embryogenesis_NN ,_, there_EX is_VBZ a_DD temporal_JJ delay_NN in_II the_DD activation_NN of_II Hoxc8_NN in_II chicken_NN compared_VVN with_II mouse_NN ._.
P09501021A02
Consequently_RR ,_, suppression_NN of_II PKA_NN activity_NN is_VBZ sufficient_JJ to_TO mimic_VVI the_DD effect_NN of_II receiving_VVGN a_DD Hedgehog_NN signal_NN ._.
P09501021A08
Thus_RR ,_, GiPs_NNS may_VM be_VBB involved_VVN in_II Hedgehog_NN signaling_VVGN in_II some_DD ,_, but_CC not_RR all_DD target_NN cells_NNS ._.
P09501024A04
Both_CC mCer-1_NN and_CC Xcer_NN appear_VVB to_TO belong_VVI to_II the_DD cystine_NN knot_NN superfamily_NN ,_, which_PNR includes_VVZ TGF_NN beta_NN s_NNS and_CC BMPs_NNS ._.
P09501024A10
In_II embryos_NNS lacking_VVG Otx2_NN ,_, a_DD homeogene_NN with_II a_DD demonstrated_VVNJ role_NN in_II anterior_JJ patterning_VVGN ,_, mCer-1_NN was_VBD still_RR expressed_VVN in_II an_DD anterior_JJ zone_NN ,_, although_CS often_RR abnormally_RR ._.
P09502725A01
Xvent-1_NN and_CC Xvent-2_NN are_VBB members_NNS of_II a_DD novel_JJ homeobox_NN subfamily_NN that_PNR have_VHB been_VBN implicated_VVN in_II dorsoventral_JJ patterning_VVGN in_II Xenopus_NN mesoderm_NN and_CC are_VBB thought_VVN to_TO function_VVI in_II BMP_NN signalling_VVGN ._.
P09502727A04
The_DD transmembrane_JJ protein_NN Patched_NN (_( Ptc_NN )_) acts_VVZ as_II a_DD negative_JJ regulator_NN of_II wg_NN expression_NN ;_: ptc-_NN embryos_NNS have_VHB ectopic_JJ wg_NN expression_NN ._.
P09502727A10
Within_II this_DD 4.5_MC kb_NN ,_, a_DD 150_MC bp_NN element_NN ,_, highly_RR conserved_VVN between_II D._NN melanogaster_NN and_CC Drosophila_NN virilis_NN ,_, is_VBZ required_VVN to_TO spatially_RR restrict_VVI wg_NN transcription_NN ._.
P09507084A06
Although_CS BMP-2_NN /_SYM -4_MC signaling_VVGN regulates_VVZ Wnt-8_NN expression_NN ,_, these_DD genes_NNS do_VDB not_RR function_VVB in_II a_DD linear_JJ pathway_NN because_CS Wnt-8_NN overexpression_NN can_VM not_RR compensate_VVB for_II an_DD inhibition_NN of_II BMP-2_NN /_SYM -4_MC function_NN ,_, but_CC rather_RR BMP-4_NN overexpression_NN rescues_VVZ ventral_JJ gene_NN expression_NN in_II embryos_NNS with_II inhibited_VVNJ Wnt-8_NN function_NN ._.
P09507096A01
In_II an_DD effort_NN to_TO define_VVI the_DD roles_NNS of_II bone_NN morphogenic_JJ proteins_NNS (_( BMPs_NNS )_) and_CC fibroblast_NN growth_NN factors_NNS (_( FGFs_NNS )_) during_II chick_NN limb_NN development_NN more_RR closely_RR ,_, we_PN have_VHB implanted_VVN beads_NNS impregnated_VVN with_II these_DD growth_NN factors_NNS into_II chick_NN limb_NN buds_NNS between_II stages_NNS 20_MC and_CC 26_MC ._.
P09507096A07
Implanting_VVGN the_DD BMP4_NN beads_NNS into_II the_DD core_NN of_II the_DD limb_NN bud_NN a_DD day_NN later_RR (_( stages_NNS 25-26_MC )_) caused_VVD intense_JJ chondrogenesis_NN rather_II+ than_II apoptosis_NN ._.
P09507106A02
Zygotic_JJ expression_NN of_II wnt11_NN was_VBD first_RR detected_VVN at_II the_DD late_JJ blastula_NN stage_NN in_II the_DD blastoderm_NN margin_NN ,_, a_DD presumptive_JJ mesoderm_NN region_NN ._.
P09507106A08
In_II later_JJR stages_NNS ,_, wnt11_NN was_VBD expressed_VVN in_II various_JJ organs_NNS ,_, such_II+ as_II the_DD somites_NNS ,_, particularly_RR in_II the_DD developing_VVGJ notochord_NN ._.
P09508065A06
We_PN report_VVB here_RR the_DD analysis_NN of_II these_DD patient_NN cell_NN lines_NNS ._.
P09510020A06
These_DD results_NNS suggest_VVB that_CST Mf2_NN ,_, like_II other_JJ murine_JJ forkhead_NN genes_NNS ,_, has_VHZ multiple_JJ roles_NNS in_II embryogenesis_NN ,_, possibly_RR mediating_VVG the_DD response_NN of_II cells_NNS to_II signaling_VVGJ molecules_NNS such_II+ as_II SHH_NN ._.
P09510022A01
The_DD axial_JJ structures_NNS ,_, the_DD notochord_NN and_CC the_DD neural_JJ tube_NN ,_, play_VVB an_DD essential_JJ role_NN in_II the_DD dorsoventral_JJ patterning_VVGN of_II somites_NNS and_CC in_II the_DD differentiation_NN of_II their_PNG many_JJ cell_NN lineages_NNS ._.
P09510022A07
The_DD effects_NNS of_II Shh_NN on_II Nkr-3.1_NN expression_NN were_VBD antagonized_VVN by_II a_DD forskolin-induced_VVNJ increase_NN in_II the_DD activity_NN of_II cyclic_JJ AMP-dependent_JJ protein_NN kinase_NN A_NN ._.
P09527877A02
Theoretical_JJ models_NNS describing_VVG these_DD phenomena_NNS have_VHB been_VBN proposed_VVN for_II feather_NN patterning_VVGN ;_: however_RR ,_, no_DD molecular_JJ candidates_NNS have_VHB been_VBN identified_VVN ._.
P09527877A08
Based_VVN on_II these_DD findings_NNS ,_, we_PN propose_VVB a_DD model_NN that_PNR involves_VVZ (_( 1_MC )_) homogeneously_RR distributed_VVNJ global_JJ activators_NNS that_PNR define_VVB the_DD field_NN ,_, (_( 2_MC )_) a_DD position-dependent_JJ activator_NN of_II competence_NN that_PNR propagates_VVZ across_II the_DD field_NN ,_, and_CC (_( 3_MC )_) local_JJ activators_NNS and_CC inhibitors_NNS triggered_VVN in_II sites_NNS of_II individual_JJ primordia_NNS that_PNR act_VVB in_II a_DD reaction-diffusion_NN mechanism_NN ._.
P09533954A04
They_PN are_VBB also_RR expressed_VVN in_II distinct_JJ patterns_NNS along_II the_DD dorsal-ventral_JJ axis_NN ._.
P09533954A06
Like_II other_JJ Nkx_NN genes_NNS ,_, expression_NN of_II Nkx-6.1_NN is_VBZ induced_VVN by_II the_DD axial_JJ mesendoderm_NN and_CC by_II sonic_NN hedgehog_NN protein_NN ._.
P09545093A02
Mendelian_JJ syndromes_NNS with_II altered_VVNJ limb_NN patterns_NNS often_RR include_VVB cardiac_JJ anomalies_NNS ,_, as_CS shown_VVN by_II limb_NN duplications_NNS (_( 34_MC %_SYM )_) ,_, deficiencies_NNS (_( 30_MC %_SYM )_) ,_, hypoplasias_NNS (_( 23_MC %_SYM )_) ,_, or_CC dysplasias_NNS (_( 9.3_MC %_SYM )_) ._.
P09545546A01
Nkx_NN homeobox_NN transcription_NN factors_NNS are_VBB expressed_VVN in_II diverse_JJ embryonic_JJ cells_NNS and_CC presumably_RR control_VVB cell-type_NN specification_NN and_CC morphogenetic_JJ events_NNS ._.
P09545546A07
The_DD dynamic_JJ expression_NN pattern_NN of_II Nkx2-9_NN in_II ventral_JJ domains_NNS of_II the_DD CNS_NN is_VBZ consistent_JJ with_II a_DD possible_JJ role_NN in_II the_DD specification_NN of_II a_DD distinct_JJ subset_NN of_II neurons_NNS ._.
P09546389A05
These_DD experiments_NNS establish_VVB the_DD time_NN of_II action_NN of_II these_DD signals_NNS to_II and_CC from_II Hensen_NN 's_GE node_NN in_II establishing_VVGN left-right_NN asymmetry_NN ._.
P09563912A02
A_DD detailed_VVNJ analysis_NN of_II Shh_NN expression_NN in_II the_DD digestive_JJ organs_NNS of_II the_DD chicken_NN embryo_NN was_VBD carried_VVN out_II ._.
P09563912A08
These_DD findings_NNS suggest_VVB that_CST Shh_NN expression_NN in_II the_DD epithelium_NN may_VM be_VBB regulated_VVN by_II surrounding_VVGJ mesenchyme_NN throughout_II organogenesis_NN of_II the_DD digestive_JJ organs_NNS and_CC is_VBZ closely_RR involved_VVN in_II epithelial-mesenchymal_JJ interactions_NNS in_II developing_VVGJ digestive_JJ organs_NNS ._.
P09570767A06
Backgrafting_VVGN either_CC the_DD ventral_JJ neural_JJ tube_NN or_CC the_DD notochord_NN allows_VVZ survival_NN of_II MyoD-_NN and_CC Pax-1-expressing_VVGJ cells_NNS ._.
P09581815A02
The_DD PTCH_NN gene_NN product_NN (_( Ptch_NN )_) functions_VVZ as_II a_DD transmembrane_JJ receptor_NN for_II the_DD Sonic_NN hedgehog_NN protein_NN (_( Shh_NN )_) and_CC interacts_VVZ with_II another_DD transmembrane_JJ protein_NN called_VVN Smoh_NN ._.
P09581815A08
Two_MC BCCs_NNS demonstrated_VVD mutations_NNS in_II both_CC SMOH_NN and_CC PTCH_NN ._.
P09584120A02
Gli_NN proteins_NNS may_VM be_VBB involved_VVN in_II these_DD processes_NNS ._.
P09584120A08
The_DD definition_NN of_II the_DD floor_NN plate_NN domain_NN ,_, therefore_RR ,_, appears_VVZ to_TO be_VBI defined_VVN by_II the_DD antagonizing_VVGJ activities_NNS of_II Gli2_NN and_CC Gli3_NN on_II Gli1_NN function_NN ._.
P09584120A14
In_II addition_NN ,_, Gli3_NN inhibits_VVZ motor_NN neuron_NN differentiation_NN by_II Gli2_NN ._.
P09585504A02
We_PN show_VVB that_CST Noggin_NN ,_, which_PNR encodes_VVZ a_DD bone_NN morphogenetic_JJ protein_NN (_( BMP_NN )_) antagonist_NN expressed_VVN in_II the_DD node_NN ,_, notochord_NN ,_, and_CC dorsal_JJ somite_NN ,_, is_VBZ required_VVN for_II normal_JJ mouse_NN development_NN ._.
P09585504A08
Addition_NN of_II BMP2_NN or_CC BMP4_NN to_II paraxial_JJ mesoderm_NN explants_NNS blocks_VVZ Shh-mediated_VVNJ induction_NN of_II Pax-1_NN ,_, a_DD sclerotomal_JJ marker_NN ,_, whereas_CS addition_NN of_II Noggin_NN is_VBZ sufficient_JJ to_TO induce_VVI Pax-1_NN ._.
P09593755A05
Cell-free_JJ palmitoylation_NN studies_NNS demonstrate_VVB that_CST radioactive_JJ palmitic_JJ acid_NN is_VBZ readily_RR incorporated_VVN into_II wild_JJ type_NN Sonic_NN hedgehog_NN ,_, but_CC not_RR into_II variant_NN forms_NNS lacking_VVG the_DD Cys-24_NN attachment_NN site_NN ._.
P09603738A03
In_II mice_NNS lacking_VVG Noggin_NN ,_, cartilage_NN condensations_NNS initiated_VVD normally_RR but_CC developed_VVD hyperplasia_NN ,_, and_CC initiation_NN of_II joint_NN development_NN failed_VVD as_CS measured_VVN by_II the_DD expression_NN of_II growth_NN and_CC differentiation_NN factor-5_NN ._.
P09609833A01
We_PN have_VHB recently_RR shown_VVN in_II mice_NNS that_CST four_MC members_NNS of_II the_DD T-box_NN family_NN of_II transcription_NN factors_NNS (_( Tbx2-Tbx5_NN )_) are_VBB expressed_VVN in_II developing_VVGJ limb_NN buds_NNS ,_, and_CC that_CST expression_NN of_II two_MC of_II these_DD genes_NNS ,_, Tbx4_NN and_CC Tbx5_NN ,_, is_VBZ primarily_RR restricted_VVN to_II the_DD developing_VVGJ hindlimbs_NNS and_CC forelimbs_NNS ,_, respectively_RR ._.
P09609833A07
To_TO investigate_VVI the_DD regulation_NN of_II T-box_NN gene_NN expression_NN during_II limb_NN development_NN ,_, we_PN employed_VVD several_JJ other_JJ embryological_JJ manipulations_NNS ._.
P09625299A03
New_JJ evidence_NN now_RR reveals_VVZ that_CST genes_NNS involved_VVN in_II hedgehog_NN signalling_VVGN are_VBB mutated_VVN in_II a_DD number_NN of_II common_JJ human_NN genetic_JJ disorders_NNS ,_, including_VVG skin_NN cancer_NN and_CC craniofacial_JJ defects_NNS ._.
P09636078A05
It_PN has_VHZ previously_RR been_VBN shown_VVN that_CST the_DD SHH_NN protein_NN arising_VVG from_II the_DD notochord_NN (_( and_CC floor_NN plate_NN )_) is_VBZ necessary_JJ for_II the_DD survival_NN and_CC further_JJ development_NN of_II Pax1_NN /_SYM Pax9-expressing_VVGJ sclerotomal_JJ cells_NNS ._.
P09655803A02
Of_II these_DD Ptc_NN ,_, Smo_NN ,_, Gli1_NN ,_, Gli2_NN and_CC Gli3_NN were_VBD expressed_VVN in_II epithelium_NN and_CC mesenchyme_NN whereas_CS Shh_NN was_VBD only_RR detected_VVN in_II epithelium_NN ._.
P09655803A08
Gli2_NN /_SYM Gli3_NN double_JJ homozygous_JJ mutants_NNS did_VDD not_RR develop_VVB any_DD normal_JJ teeth_NN and_CC did_VDD not_RR survive_VVB beyond_II embryonic_JJ day_NN 14.5_MC ;_: however_RR ,_, Gli2_NN (_( -/-_SYM )_) ;_: Gli3_NN (_( +/-_SYM )_) did_VDD survive_VVB until_II birth_NN and_CC had_VHD small_JJ molars_NNS and_CC mandibular_JJ incisors_NNS whereas_CS maxillary_JJ incisor_NN development_NN was_VBD arrested_VVN as_II a_DD rudimentary_JJ epithelial_JJ thickening_VVGN ._.
P09655805A01
The_DD wing_NN and_CC the_DD leg_NN of_II the_DD chick_NN ,_, although_CS homologous_JJ structures_NNS ,_, have_VHB characteristic_JJ patterns_NNS of_II skeletal_JJ elements_NNS ,_, muscles_NNS ,_, tendons_NNS ,_, featherbuds_NNS and_CC scales_NNS ._.
P09655805A07
We_PN have_VHB isolated_VVN and_CC characterised_VVN three_MC candidate_NN genes_NNS for_II controlling_VVGN limb_NN identity_NN in_II the_DD chick_NN ._.
P09655820A03
Embryos_NNS mutant_JJ for_II a_DD deletion_NN of_II syu_NN display_VVB defects_NNS in_II patterning_VVGN of_II the_DD somites_NNS ,_, the_DD lateral_JJ floor_NN plate_NN cells_NNS ,_, the_DD pectoral_JJ fins_NNS ,_, the_DD axons_NNS of_II motorneurons_NNS and_CC the_DD retinal_JJ ganglion_NN cells_NNS ._.
P09675051A04
In_II the_DD myotome_NN ,_, but_CC not_RR the_DD neural_JJ tube_NN ,_, netrin-1a_NN expression_NN requires_VVZ sonic_NN hedgehog_NN ._.
P09676191A04
Our_PNG results_NNS show_VVB that_CST FGFs_NNS induce_VVB the_DD production_NN of_II ectopic_JJ neural_JJ structures_NNS in_II the_DD epiblast_NN cell_NN layer_NN which_PNR are_VBB independent_JJ of_II the_DD endogenous_JJ neural_JJ tube_NN ._.
P09676195A02
Here_RR we_PN show_VVB that_CST three_MC genes_NNS in_II the_DD zebrafish_NN ,_, swirl_NN ,_, snailhouse_NN ,_, and_CC somitabun_NN ,_, function_VVB as_II critical_JJ components_NNS within_II a_DD BMP_NN pathway_NN to_TO pattern_VVI ventral_JJ regions_NNS of_II the_DD embryo_NN ._.
P09676195A08
Examination_NN of_II dorsally_RR and_CC ventrally_RR restricted_VVNJ markers_NNS during_II gastrulation_NN reveals_VVZ a_DD successive_JJ reduction_NN and_CC reciprocal_JJ expansion_NN in_II nonneural_JJ and_CC neural_JJ ectoderm_NN ,_, respectively_RR ,_, in_II snailhouse_NN ,_, somitabun_NN ,_, and_CC swirl_NN mutant_JJ embryos_NNS ,_, with_II swirl_NN /_SYM bmp2b_NN mutants_NNS exhibiting_VVGN almost_RR no_DD nonneural_JJ ectoderm_NN ._.
P09684284A06
There_EX are_VBB striking_VVGJ similarities_NNS between_II the_DD signals_NNS and_CC genes_NNS involved_VVN in_II patterning_VVGN the_DD limb_NN ectoderm_NN and_CC the_DD epithelia_NNS of_II the_DD Drosophila_NN imaginal_JJ disc_NN that_PNR gives_VVZ rise_NN to_II the_DD wing_NN ._.
P09685224A04
Our_PNG results_NNS show_VVB that_CST all_DB the_DD members_NNS of_II the_DD Igf_NN system_NN ,_, except_II Igfbp-1_NN and_CC -6_MC ,_, have_VHB specific_JJ spatio-temporal_JJ mRNA_NN expression_NN patterns_NNS ._.
P09689127A01
Neural_JJ tube_NN patterning_VVGN in_II vertebrates_NNS is_VBZ controlled_VVN in_II part_NN by_II locally_RR secreted_VVNJ factors_NNS that_PNR act_VVB in_II a_DD paracrine_JJ manner_NN on_II nearby_JJ cells_NNS to_TO regulate_VVI proliferation_NN and_CC gene_NN expression_NN ._.
P09694630A01
The_DD apical_JJ mesodermal_JJ region_NN of_II chick_NN limb_NN buds_NNS (_( progress_NN zone_NN ,_, PZ_NN )_) which_PNR is_VBZ essential_JJ for_II limb_NN pattern_NN formation_NN contains_VVZ uncommitted_VVNJ cells_NNS that_PNR change_VVB their_PNG positional_JJ values_NNS instructed_VVN by_II the_DD apical_JJ ectodermal_JJ ridge_NN (_( AER_NN )_) ._.
P09694630A07
These_DD results_NNS indicate_VVB that_CST addition_NN of_II FGF-2_NN or_CC FGF-4_NN to_II cultured_VVNJ PZ_NN cells_NNS maintains_VVZ their_PNG competence_NN for_II Hox_NN gene_NN expression_NN and_CC digit_NN formation_NN ,_, but_CC not_RR their_PNG responsiveness_NN to_II positional_JJ cues_NNS from_II the_DD ZPA_NN ._.
P09702193A02
It_PN is_VBZ also_RR a_DD key_JJ drug_NN target_NN in_II circumventing_VVGN clinical_JJ vancomycin_NN resistance_NN ._.
P09708732A04
Since_CS Pitx2_NN appears_VVZ to_TO be_VBI downstream_JJ of_II lefty-1_NN in_II the_DD mouse_NN pathway_NN ,_, we_PN examined_VVD whether_CST mouse_NN Lefty_NN proteins_NNS could_VM affect_VVB the_DD expression_NN of_II Pitx2_NN in_II the_DD chick_NN ._.
P09708733A04
Misexpression_NN of_II Pitx2_NN on_II the_DD right_JJ side_NN of_II the_DD embryo_NN is_VBZ sufficient_JJ to_TO produce_VVI reversed_VVNJ heart_NN looping_VVGN and_CC heart_NN isomerisms_NNS ,_, reversed_VVNJ body_NN rotation_NN ,_, and_CC reversed_VVNJ gut_NN situs_NN ._.
P09722173A05
This_DD mechanism_NN could_VM lead_VVB to_II the_DD establishment_NN of_II a_DD BMP4_NN activity_NN gradient_NN that_PNR would_VM produce_VVB appropriate_JJ BMP4_NN signalling_VVGN to_TO generate_VVI medial_JJ and_CC lateral_JJ somite_NN patterning_VVGN ._.
P09727360A05
Fibroblast_NN growth_NN factors_NNS (_( FGF_NN )_) have_VHB been_VBN identified_VVN as_II candidates_NNS for_II signal_NN molecules_NNS from_II the_DD AER_NN ._.
P09731531A01
Foregut_NN malformations_NNS (_( oesophageal_JJ atresia_NN ,_, tracheo-oesophageal_JJ fistula_NN ,_, lung_NN anomalies_NNS and_CC congenital_JJ stenosis_NN of_II the_DD oesophagus_NN and_CC trachea_NN )_) are_VBB relatively_RR common_JJ anomalies_NNS occurring_VVG in_II 1_MC in_II 2,000-5,000_MC live_JJ births_NNS ,_, although_CS their_PNG aetiology_NN is_VBZ poorly_RR understood_VVN ._.
P09731531A07
These_DD results_NNS indicate_VVB that_CST Gli2_NN and_CC Gli3_NN possess_VVB specific_JJ and_CC overlapping_VVGJ functions_NNS in_II Shh_NN signalling_VVGN during_II foregut_NN development_NN ,_, and_CC suggest_VVB that_CST mutations_NNS in_II GLI_NN genes_NNS may_VM be_VBB involved_VVN in_II human_NN foregut_NN malformations_NNS ._.
P09731532A03
Homozygous_JJ Shh-null_JJ mutant_JJ mice_NNS show_VVB oesophageal_JJ atresia_NN /_SYM stenosis_NN ,_, tracheo-oesophageal_JJ fistula_NN and_CC tracheal_JJ and_CC lung_NN anomalies_NNS ,_, features_NNS similar_JJ to_II those_PND observed_VVN in_II humans_NNS with_II foregut_NN defects_NNS ._.
P09735361A05
Expression_NN of_II Bix1_NN is_VBZ induced_VVN in_II an_DD immediate-early_JJ fashion_NN by_II mesoderm-inducing_VVGJ factors_NNS such_II+ as_II activin_NN as_CC+ well_CC+ as_CC by_II the_DD products_NNS of_II the_DD T-box_NN genes_NNS Xbra_NN and_CC VegT_NN (_( also_RR known_VVN as_II Antipodean_NN ,_, Brat_NN and_CC Xombi_NN )_) ._.
P09739114A01
We_PN have_VHB previously_RR cloned_VVN a_DD type_NN I_MC serine_NN /_SYM threonine_NN kinase_NN receptor_NN from_II Xenopus_NN ,_, namely_RR XTrR-I_NN ._.
P09739114A07
We_PN conclude_VVB that_CST XTrR-I_NN is_VBZ involved_VVN in_II mediating_VVGN a_DD dorsalising_VVGJ activity_NN important_JJ for_II mesoderm_NN differentiation_NN ._.
P09739117A05
The_DD Shh-expressing_VVGJ cells_NNS were_VBD found_VVN to_TO induce_VVI ectopic_JJ expression_NN of_II the_DD Shh_NN target_NN genes_NNS Patched_NN and_CC Hnf3beta_NN in_II the_DD dorsal_JJ brain_NN ,_, and_CC to_TO alter_VVI digit_NN patterning_VVGN in_II the_DD anterior_JJ limb_NN bud_NN ._.
P09744278A02
Here_RR we_PN report_VVB that_CST cyc_NN encodes_VVZ a_DD transforming_VVGJ growth_NN factor-beta_NN (_( TGF-beta_NN )_) -related_VVNJ intercellular_JJ signalling_VVGJ molecule_NN that_PNR is_VBZ similar_JJ to_II mouse_NN nodal_NN ._.
P09753682A02
We_PN isolated_VVD a_DD maternally_RR expressed_VVNJ and_CC dorsal_JJ organizer_NN localized_VVNJ member_NN of_II the_DD frizzled_NN family_NN of_II wnt_NN receptors_NNS ._.
P09767138A02
In_II cyclops_NN mutants_NNS ,_, reduction_NN in_II sonic_NN hedgehog_NN (_( shh_NN )_) expression_NN ,_, and_CC elimination_NN of_II tiggy-winkle_NN hedgehog_NN (_( twhh_NN )_) expression_NN ,_, correlated_VVD with_II reductions_NNS in_II branchiomotor_NN neuron_NN populations_NNS ._.
P09768360A02
In_II each_DD case_NN the_DD specific_JJ structure_NN (_( for_II example_NN scale_NN ,_, feather_NN or_CC hair_NN )_) arises_VVZ from_II an_DD epidermal_JJ placode_NN as_II a_DD result_NN of_II epithelial-mesenchymal_JJ interactions_NNS with_II the_DD underlying_VVGJ dermal_JJ mesenchyme_NN ._.
P09768360A08
When_CS grafted_VVN to_II nude_JJ mice_NNS (_( which_PNR lack_VVB T_NN cells_NNS )_) ,_, Shh_NN mutant_JJ skin_NN gave_VVD rise_NN to_II large_JJ abnormal_JJ follicles_NNS containing_VVG a_DD small_JJ dermal_JJ papilla_NN ._.
P09778501A03
We_PN have_VHB cloned_VVN the_DD chick_NN homologue_NN of_II Alx-4_NN and_CC investigated_VVD its_PNG expression_NN during_II limb_NN outgrowth_NN ._.
P09789036A05
Cyclopamine_NN reveals_VVZ the_DD capacity_NN of_II a_DD broad_JJ region_NN of_II the_DD posterior_JJ embryonic_JJ foregut_NN to_TO form_VVI pancreatic_JJ cells_NNS and_CC provides_VVZ a_DD means_NNS for_II expanding_VVGN embryonic_JJ pancreas_NN development_NN ._.
P09806909A02
Two_MC signals_NNS are_VBB important_JJ in_II ventral_JJ cells_NNS ,_, bone_NN morphogenetic_JJ protein-4_NN (_( BMP-4_NN )_) and_CC Wnt-8_NN ._.
P09806909A08
In_II contrast_NN ,_, the_DD expression_NN of_II Wnt-8_NN and_CC the_DD homeobox_NN gene_NN Vent-1_NN is_VBZ suppressed_VVN by_II G2en_NN ,_, whilst_CS the_DD organiser-secreted_VVNJ BMP_NN antagonist_NN chordin_NN becomes_VVZ ectopically_RR expressed_VVN ._.
P09808626A05
These_DD findings_NNS show_VVB that_CST GDF7_NN is_VBZ an_DD inductive_JJ signal_NN from_II the_DD roof_NN plate_NN required_VVN for_II the_DD specification_NN of_II neuronal_JJ identity_NN in_II the_DD dorsal_JJ spinal_JJ cord_NN and_CC that_CST GDF7_NN and_CC other_JJ BMP_NN family_NN members_NNS expressed_VVN by_II the_DD roof_NN plate_NN have_VHB non-redundant_JJ functions_NNS in_RR+ vivo_RR ._.
P09808781A03
Newly_RR migrating_VVGJ neural_JJ crest_NN cells_NNS were_VBD isolated_VVN in_II tissue_NN culture_NN ,_, labeled_VVN with_II the_DD lipophilic_JJ dye_NN DiI_NN ,_, and_CC microinjected_VVN into_II the_DD ventral_JJ portion_NN of_II the_DD neural_JJ plate_NN ._.
P09808781A09
These_DD results_NNS suggest_VVB that_CST migrating_VVGJ neural_JJ crest_NN cells_NNS are_VBB flexible_JJ in_II their_PNG fate_NN and_CC retain_VVB the_DD ability_NN to_TO form_VVI neural_JJ tube_NN derivatives_NNS even_RR after_II emigrating_VVGN from_II the_DD neural_JJ tube_NN ._.
P09811576A01
To_TO define_VVI the_DD timing_VVGN of_II neural_JJ crest_NN formation_NN ,_, we_PN challenged_VVD the_DD fate_NN of_II presumptive_JJ neural_JJ crest_NN cells_NNS by_II grafting_VVGN notochords_NNS ,_, Sonic_NN Hedgehog-_NN (_( Shh_NN )_) or_CC Noggin-secreting_VVGJ cells_NNS at_II different_JJ stages_NNS of_II neurulation_NN in_II chick_NN embryos_NNS ._.
P09811576A07
Our_PNG results_NNS suggest_VVB three_MC phases_NNS of_II neurulation_NN that_PNR relate_VVB to_II neural_JJ crest_NN formation_NN :_: (_( 1_MC )_) an_DD initial_JJ BMP-independent_JJ phase_NN that_PNR can_VM be_VBB prevented_VVN by_II Shh-mediated_VVNJ signals_NNS from_II the_DD notochord_NN ;_: (_( 2_MC )_) an_DD intermediate_JJ BMP-dependent_JJ phase_NN around_II the_DD time_NN of_II neural_JJ tube_NN closure_NN ,_, when_CS BMP-4_NN is_VBZ expressed_VVN in_II the_DD dorsal_JJ neural_JJ tube_NN ;_: and_CC (_( 3_MC )_) a_DD later_JJR pre-migratory_JJ phase_NN which_PNR is_VBZ refractory_JJ to_II exogenous_JJ Shh_NN and_CC Noggin_NN ._.
P09811578A02
Hedgehog_NN is_VBZ bound_VVN and_CC transduced_VVN by_II a_DD receptor_NN complex_NN that_PNR includes_VVZ Smoothened_NN (_( Smo_NN )_) ,_, a_DD member_NN of_II the_DD Frizzled_NN (_( Fz_NN )_) family_NN of_II seven-pass_NN transmembrane_JJ receptors_NNS ,_, as_CC+ well_CC+ as_CC the_DD multiple-pass_NN transmembrane_JJ protein_NN Patched_NN (_( Ptc_NN )_) ._.
P09811851A06
Biochemical_JJ analysis_NN of_II PTCH_NN and_CC PTCH2_NN shows_VVZ that_CST they_PN both_PND bind_VVB to_II all_DD hedgehog_NN family_NN members_NNS with_II similar_JJ affinity_NN and_CC that_CST they_PN can_VM form_VVB a_DD complex_NN with_II SMO_NN ._.
P09813177A02
In_II order_NN to_TO examine_VVI a_DD possible_JJ function_NN of_II GATA-1_NN in_II dorso-ventral_JJ patterning_VVGN of_II mesoderm_NN and_CC ectoderm_NN derivatives_NNS ,_, the_DD synthesized_VVNJ RNA_NN of_II GATA-1_NN was_VBD overexpressed_VVN in_II embryonic_JJ cells_NNS to_TO assess_VVI its_PNG biological_JJ effects_NNS ._.
P09813177A08
Therefore_RR ,_, GATA-1_NN did_VDD not_RR convert_VVB completely_RR the_DD dorsal_JJ phenotype_NN to_II the_DD ventral_JJ one_PN ._.
P09824555A06
The_DD sonic_NN hedgehog_NN gene_NN ,_, which_PNR was_VBD used_VVN as_II a_DD posterior_JJ marker_NN ,_, was_VBD expressed_VVN not_RR only_RR in_II the_DD original_JJ region_NN (_( new_JJ anterior_JJ side_NN )_) of_II the_DD graft_NN ,_, but_CC also_RR ectopically_RR in_II the_DD other_JJ region_NN (_( new_JJ posterior_JJ side_NN )_) of_II the_DD same_JJ graft_NN ._.
P09834197A02
In_II this_DD study_NN ,_, we_PN examined_VVD the_DD mechanism_NN of_II signal_NN propagation_NN of_II bone_NN morphogenetic_JJ protein_NN (_( BMP_NN )_) in_II the_DD ectodermal_JJ patterning_VVGN of_II zebrafish_NN embryos_NNS ,_, in_II which_PNR BMP_NN functions_VVZ as_II an_DD epidermal_JJ inducer_NN and_CC a_DD neural_JJ inhibitor_NN ._.
P09834197A08
Taken_VVN together_RR ,_, we_PN propose_VVB that_CST ,_, in_II ectodermal_JJ patterning_VVGN ,_, BMP_NN exerts_VVZ a_DD direct_JJ and_CC cell-autonomous_JJ effect_NN to_TO fate_VVI uncommitted_VVNJ ectodermal_JJ cells_NNS to_TO become_VVI epidermis_NN ._.
P09842713A01
Recent_JJ experiments_NNS have_VHB suggested_VVN a_DD pathway_NN of_II genes_NNS that_PNR regulate_VVB left-right_NN asymmetry_NN in_II vertebrate_NN embryogenesis_NN ._.
P09842713A07
Thus_RR we_PN examined_VVD this_DD issue_NN directly_RR ._.
P09842713A13
Thus_RR explants_NNS are_VBB not_RR isolated_VVN from_II the_DD influence_NN of_II the_DD midline_NN ._.
P09845363A01
An_DD effector_NN of_II intercellular_JJ adhesion_NN ,_, beta-catenin_NN also_RR functions_VVZ in_II Wnt_NN signaling_VVGN ,_, associating_VVG with_II Lef-1_NN /_SYM Tcf_NN DNA-binding_VVGJ proteins_NNS to_TO form_VVI a_DD transcription_NN factor_NN ._.
P09847252A02
Floor_NN plate_NN cells_NNS are_VBB induced_VVN by_II sonic_NN hedgehog_NN (_( SHH_NN )_) secreted_VVN from_II the_DD notochord_NN whereas_CS ventral_JJ midline_NN cells_NNS of_II the_DD rostral_JJ diencephalon_NN (_( RDVM_NN cells_NNS )_) appear_VVB to_TO be_VBI induced_VVN by_II the_DD dual_JJ actions_NNS of_II SHH_NN and_CC bone_NN morphogenetic_JJ protein_NN 7_MC (_( BMP7_NN )_) from_II prechordal_JJ mesoderm_NN ._.
P09847252A08
Addition_NN of_II chordin_NN to_II conjugate_JJ explant_NN cultures_NNS of_II prechordal_JJ mesoderm_NN and_CC neural_JJ tissue_NN prevents_VVZ the_DD rostralization_NN of_II ventral_JJ midline_NN cells_NNS by_II prechordal_JJ mesoderm_NN ._.
P09847253A04
This_DD isoform_NN arises_VVZ by_II alternative_JJ splicing_VVGN of_II the_DD first_JJ exon_NN of_II the_DD FHF-2_NN gene_NN and_CC is_VBZ predicted_VVN to_TO encode_VVI a_DD polypeptide_NN with_II a_DD distinct_JJ amino-terminus_NN ._.
P09847253A10
Finally_RR ,_, we_PN show_VVB that_CST a_DD secreted_VVNJ version_NN of_II cFHF-2_NN activates_VVZ the_DD expression_NN of_II HoxD13_NN ,_, HoxD11_NN ,_, Fgf-4_NN and_CC BMP-2_NN ectopically_RR ,_, consistent_JJ with_II cFHF-2_NN playing_VVGN a_DD role_NN in_II anterior-posterior_JJ patterning_VVGN of_II the_DD limb_NN ._.
P09853822A05
We_PN also_RR examine_VVB the_DD spatial_JJ localization_NN of_II Ihh_NN ,_, Bmp2_NN ,_, and_CC Bmp4_NN in_II day_NN 6.5-7.0_MC and_CC 7.5-8.0_MC embryos_NNS by_II in_JJ+ situ_JJ hybridization_NN analysis_NN ._.
P09853960A05
In_II addition_NN ,_, tooth_NN bud-like_JJ structures_NNS that_PNR resemble_VVB E13_NN tooth_NN buds_NNS in_RR+ vivo_RR both_CC morphologically_RR and_CC in_II their_PNG patterns_NNS of_II gene_NN expression_NN formed_VVD after_II 6_MC days_NNS in_II the_DD heterospecific_JJ recombinations_NNS ._.
P09858693A06
We_PN report_VVB here_RR the_DD chromosomal_JJ localization_NN of_II Ptch2_NN and_CC further_JJ analysis_NN of_II Ptch2_NN expression_NN ._.
P09878061A05
The_DD human_NN X-chromosome-linked_VVNJ inhibitor_NN of_II apoptosis_NN protein_NN (_( XIAP_NN )_) was_VBD isolated_VVN as_II a_DD TAB1-binding_VVGJ protein_NN ._.
P09882485A01
The_DD patterning_VVGJ activity_NN of_II the_DD Spemann_NN organizer_NN in_II early_JJ amphibian_JJ embryos_NNS has_VHZ been_VBN characterized_VVN by_II a_DD number_NN of_II organizer-specific_JJ secreted_VVNJ proteins_NNS including_VVG Chordin_NN ,_, Noggin_NN ,_, and_CC Follistatin_NN ,_, which_PNR all_PND share_VVB the_DD same_JJ inductive_JJ properties_NNS ._.
P09882485A07
However_RR ,_, unlike_II the_DD Xenopus_NN genes_NNS ,_, zebrafish_NN follistatin_NN and_CC noggin_NN are_VBB not_RR expressed_VVN in_II the_DD organizer_NN region_NN ,_, nor_CC are_VBB they_PN linked_VVN to_II the_DD mercedes_NN mutation_NN ._.
P09882485A13
Later_RR ,_, follistatin_NN is_VBZ expressed_VVN in_II brain_NN ,_, eyes_NNS ,_, and_CC somites_NNS ._.
P09893022A04
While_CS much_PND is_VBZ known_VVN about_II BMP_NN 's_GE expression_NN and_CC role_NN in_II patterning_VVGN the_DD marginal_JJ zone_NN ,_, little_PND is_VBZ known_VVN about_II its_PNG early_JJ role_NN in_II regulating_VVGN vegetal_JJ mesoderm_NN induction_NN centre_NN formation_NN ._.
P09893022A10
CONCLUSIONS_NNS :_: These_DD results_NNS support_VVB a_DD role_NN for_II BMP_NN signalling_VVGN in_II regulating_VVGN ventral_JJ vegetal_JJ and_CC dorsal_JJ vegetal_JJ mesoderm_NN induction_NN centre_NN formation_NN during_II early_JJ Xenopus_NN development_NN ._.
P09914417A06
A_DD single_JJ amphioxus_NN hedgehog_NN gene_NN ,_, AmphiHh_NN ,_, was_VBD identified_VVN and_CC is_VBZ probably_RR the_DD only_JJ hedgehog_NN family_NN member_NN in_II amphioxus_NN ,_, showing_VVG the_DD duplication_NN of_II hedgehog_NN genes_NNS to_TO be_VBI specific_JJ to_II the_DD vertebrate_NN lineage_NN ._.
P09914417A12
This_PND may_VM have_VHB freed_VVN Desert-type_NN and_CC Indian-type_NN hedgehog_NN genes_NNS from_II selective_JJ constraint_NN ,_, allowing_VVG them_PN to_TO diverge_VVI and_CC take_VVI on_II new_JJ roles_NNS in_II different_JJ vertebrate_NN taxa_NNS ._.
P09916808A03
To_TO define_VVI the_DD role_NN of_II Fgf10_NN ,_, we_PN generated_VVD Fgf10-deficient_JJ mice_NNS ._.
P09916808A09
Thus_RR ,_, we_PN show_VVB here_RR that_CST Fgf10_NN serves_VVZ as_II an_DD essential_JJ regulator_NN of_II lung_NN and_CC limb_NN formation_NN ._.
P09917365A04
In_II contrast_NN ,_, Kroll_NNP and_CC Amaya_NNP (_( Development_NN 122_MC ,_, 3173-3183_MC ,_, 1996_MC )_) and_CC Bang_NNP et_CC al._NN (_( Development_NN 124_MC ,_, 2075-2085_MC ,_, 1997_MC )_) proposed_VVD that_CST FGF_NN is_VBZ not_RR required_VVN for_II early_JJ neural_JJ patterning_VVGN ._.
P09917365A10
We_PN also_RR determined_VVD whether_CST FGF_NN is_VBZ required_VVN specifically_RR by_II the_DD neurectoderm_NN for_II anteroposterior_JJ neural_JJ patterning_VVGN ._.
P09918693A05
GDF-5_NN beads_NNS implanted_VVN at_II the_DD tip_NN of_II the_DD digits_NNS promote_VVB intense_JJ cartilage_NN growth_NN and_CC fail_VVB to_TO induce_VVI morphological_JJ or_CC molecular_JJ signs_NNS of_II joint_NN formation_NN ._.
P09918693A11
Potential_JJ interactions_NNS of_II GDF-5_NN with_II other_JJ signals_NNS involved_VVN in_II digits_NNS morphogenesis_NN were_VBD also_RR explored_VVN ._.
P09925646A03
Later_JJR steps_NNS in_II the_DD differentiation_NN of_II sclerotome_NN into_II cartilage_NN may_VM be_VBB independent_JJ of_II the_DD influence_NN of_II these_DD axial_JJ tissues_NNS ._.
P09925646A09
Shh_NN signals_NNS are_VBB required_VVN only_RR transiently_RR for_II somitic_JJ chondrogenesis_NN in_RR+ vitro_RR ,_, and_CC act_VVB to_TO provide_VVI a_DD window_NN of_II competence_NN during_II which_PNR time_NN BMP_NN signals_NNS can_VM induce_VVB chondrogenic_JJ differentiation_NN ._.
P09927590A04
However_RR ,_, the_DD cellular_JJ processes_NNS underlying_VVG AER_NN regression_NN remain_VVB largely_RR unclear_JJ ,_, and_CC the_DD molecular_JJ ones_NNS ,_, totally_RR unknown_VVN ._.
P09927590A10
We_PN show_VVB that_CST overall_RR the_DD AER_NN becomes_VVZ taller_JJR ,_, and_CC its_PNG anterior_JJ half_NN becomes_VVZ more_RR similar_JJ to_II a_DD normal_JJ posterior_JJ AER_NN ._.
P09927604A02
In_II this_DD study_NN we_PN have_VHB investigated_VVN how_CST this_DD balance_NN is_VBZ achieved_VVN during_II chick_NN development_NN ._.
P09927604A08
In_II contrast_NN to_II BMP-4_NN ,_, Sonic_NN hedgehog_NN (_( Shh_NN )_) locally_RR applied_VVN to_II somites_NNS arrests_VVZ muscle_NN growth_NN by_II down-regulation_NN of_II Pax-3_NN and_CC immediate_JJ up-regulation_NN of_II MyoD_NN expression_NN ._.
P09988878A05
Control_NN dams_NNS received_VVD i.p._NN saline_NN ._.
P09988878A11
Shh_NN distribution_NN was_VBD similarly_RR unaffected_VVN in_II these_DD chick_NN embryos_NNS ._.
P09990204A05
In_II the_DD limb_NN bud_NN ,_, myogenic_JJ cells_NNS proliferate_VVB under_II influence_NN of_II the_DD limb_NN ectoderm_NN and_CC congregate_NN into_II the_DD premuscle_JJ masses_NNS ._.
P09990204A11
They_PN are_VBB candidates_NNS for_II intrinsic_JJ regulator_NN of_II myogenic_JJ cells_NNS that_PNR control_VVB 1_MC )_) the_DD splitting_VVGJ processes_NNS of_II the_DD muscle_NN masses_NNS and_CC 2_MC )_) the_DD specification_NN of_II each_DD muscle_NN ._.
P10021330A03
Removal_NN of_II the_DD surface_NN ectoderm_NN resulted_VVD in_II decreased_VVNJ levels_NNS of_II Sim-1_NN and_CC Pax-2_NN mRNA_NN expression_NN in_II mesenchymal_JJ nephric_JJ duct_NN progenitors_NNS ,_, and_CC caused_VVD inhibition_NN of_II nephric_JJ duct_NN formation_NN and_CC subsequent_JJ kidney_NN development_NN ._.
P10050855A05
Hip-expressing_VVGJ cells_NNS are_VBB located_VVN next_II+ to_II cells_NNS that_PNR express_VVB each_DD Hedgehog_NN gene_NN ._.
P10051661A03
In_II the_DD developing_VVGJ rostral_JJ central_JJ nervous_JJ system_NN Sonic_NN hedgehog_NN protein_NN also_RR participates_VVZ in_II ventral_JJ regionalization_NN ;_: however_RR ,_, the_DD roles_NNS of_II BMPs_NNS in_II the_DD developing_VVGJ brain_NN are_VBB less_RR clear_JJ ._.
P10051661A09
These_DD data_NNS provide_VVB evidence_NN that_CST BMP_NN signaling_VVGN participates_VVZ in_II dorsal-ventral_JJ patterning_VVGN of_II the_DD developing_VVGJ brain_NN in_RR+ vivo_RR ,_, and_CC disturbances_NNS in_II dorsal-ventral_JJ signaling_VVGN result_VVB in_II specific_JJ malformations_NNS of_II the_DD forebrain_NN ._.
P10072786A02
The_DD mature_JJ carboxyl-terminal_JJ domain_NN encoded_VVN by_II Gdf11_NN is_VBZ most_RRT closely_RR related_VVN to_II Gdf8_NN ,_, being_VBG 90_MC %_SYM identical_JJ to_II the_DD mouse_NN gene_NN ._.
P10072789A03
Perturbation_NN of_II anterior_JJ muscle_NN pattern_NN by_II application_NN of_II Sonic_NN Hedgehog_NN protein_NN results_VVZ in_II a_DD posteriorization_NN of_II cBarx2b_NN expression_NN ._.
P10074453A06
On_II the_DD right_JJ body_NN side_NN ,_, a_DD function_NN of_II the_DD activin_NN pathway_NN is_VBZ indicated_VVN by_II the_DD right-sided_VVNJ expression_NN of_II cActRIIa_NN [_( 1_MC ]_) [_( 6_MC ]_) ._.
P10075846A05
Consistent_JJ with_II these_DD observations_NNS ,_, we_PN also_RR found_VVD that_CST injection_NN of_II mDlx5_NN mRNA_NN into_II dorsal_JJ blastomeres_NNS enhanced_VVD the_DD ventralization_NN of_II Xenopus_NN embryos_NNS ._.
P10077605A05
Based_VVN on_II the_DD correlation_NN of_II GLI3_NN truncation_NN mutations_NNS and_CC the_DD human_NN phenotypes_NNS ,_, we_PN hypothesized_VVD that_CST GLI3_NN shows_VVZ transcriptional_JJ activation_NN or_CC repression_NN activity_NN and_CC subcellular_JJ localization_NN similar_JJ to_II Ci_NN ._.
P10079222A02
Prothoracic_JJ leg_NN disc_NN fragments_NNS possess_VVB exceptional_JJ regulative_JJ capacity_NN ,_, highlighted_VVN by_II the_DD ability_NN of_II anterior_JJ cells_NNS to_TO convert_VVI to_II posterior_JJ identity_NN and_CC establish_VVI a_DD novel_JJ posterior_JJ compartment_NN ._.
P10087073A03
Whether_CST Shh_NN acts_VVZ directly_RR to_TO induce_VVI these_DD cell_NN types_NNS or_CC whether_CST their_PNG induction_NN is_VBZ mediated_VVN by_II additional_JJ factors_NNS is_VBZ unknown_VVN ._.
P10087073A09
Furthermore_RR ,_, in_II explant_NN cultures_NNS ,_, Shh-mediated_VVNJ Islet-1_NN expression_NN was_VBD blocked_VVN by_II an_DD anti-NT3_NN antibody_NN ._.
P10089144A03
Because_CS the_DD biochemical_JJ steps_NNS between_II morphogen_NN (_( s_NNS )_) and_CC gene_NN activation_NN have_VHB not_RR been_VBN elucidated_VVN ,_, there_EX is_VBZ no_DD biologically-based_VVNJ mechanism_NN for_II translating_VVGN the_DD spatio-temporal_JJ distributions_NNS of_II morphogens_NNS into_II patterns_NNS of_II gene_NN expression_NN ,_, but_CC several_JJ theoretically_RR plausible_JJ functions_NNS that_PNR bridge_VVB the_DD gap_NN are_VBB suggested_VVN ._.
P10096602A06
Ptc_NN and_CC Gli1_NN expression_NN follow_VVB a_DD pattern_NN similar_JJ to_II that_PND of_II Shh_NN ._.
P10102270A05
We_PN provide_VVB evidence_NN for_II the_DD existence_NN of_II a_DD distinct_JJ activator_NN form_NN of_II Ci_NN ,_, which_PNR does_VDZ not_RR arise_VVB by_II mere_JJ prevention_NN of_II Ci_NN proteolysis_NN ,_, but_CC rather_RR depends_VVZ on_II a_DD separate_JJ regulatory_JJ step_NN subject_JJ to_II Hh_NN control_NN ._.
P10190481A02
All_DD 5_MC had_VHD a_DD frontonasal_JJ malformation_NN of_II the_DD face_NN and_CC nasal_JJ clefting_VVGN associated_VVN with_II striking_VVGJ symmetrical_JJ preaxial_JJ polysyndactyly_NN of_II the_DD feet_NN and_CC variable_JJ tibial_JJ hypoplasia_NN ._.
P10199967A02
However_RR ,_, the_DD molecular_JJ mechanisms_NNS by_II which_PNR Shh_NN directs_VVZ anterior_JJ /_SYM posterior_JJ patterning_VVGN in_II the_DD limb_NN remain_VVB unknown_VVN ._.
P10199968A01
Formin_NN was_VBD originally_RR isolated_VVN as_II the_DD gene_NN affected_VVN by_II the_DD murine_JJ limb_NN deformity_NN (_( ld_NN )_) mutations_NNS ,_, which_PNR disrupt_VVB the_DD epithelial-mesenchymal_JJ interactions_NNS regulating_VVG patterning_VVGN of_II the_DD vertebrate_NN limb_NN autopod_NN ._.
P10199968A07
Finally_RR ,_, disruption_NN of_II the_DD epithelial-mesenchymal_JJ interactions_NNS controlling_VVG induction_NN of_II metanephric_JJ kidneys_NNS in_II ld_NN mutant_JJ embryos_NNS indicates_VVZ that_CST formin_NN might_VM function_VVB more_RR generally_RR in_II transduction_NN of_II morphogenetic_JJ signals_NNS during_II embryonic_JJ pattern_NN formation_NN ._.
P10208740A04
The_DD initial_JJ upregulation_NN of_II Shh_NN expression_NN in_II the_DD male_NN urogenital_JJ sinus_NN depends_VVZ on_II the_DD presence_NN of_II testosterone_NN ._.
P10208865A03
Indian_NN hedgehog_NN (_( Ihh_NN )_) ,_, a_DD secreted_VVNJ protein_NN expressed_VVN in_II early_JJ hypertrophic_JJ chondrocytes_NNS ,_, is_VBZ thought_VVN to_TO be_VBI involved_VVN in_II regulation_NN of_II hypertrophic_JJ conversion_NN via_II a_DD feedback_NN loop_NN through_II the_DD perichondrium_NN ._.
P10214971A04
This_DD cleavage_NN of_II the_DD yeast-derived_VVNJ NH2-terminal_JJ domain_NN of_II sonic_NN hedgehog_NN might_VM due_II+ to_II Kex_NN 2_MC ._.
P10217145A04
These_DD neuronal_JJ subtypes_NNS derive_VVB from_II distinct_JJ progenitor_NN cell_NN populations_NNS that_PNR express_VVB the_DD homeodomain_NN proteins_NNS Nkx2.2_NN or_CC Pax6_NN in_II response_NN to_II graded_VVNJ Shh_NN signalling_VVGN ._.
P10217145A09
Thus_RR ,_, Nkx2.2_NN has_VHZ an_DD essential_JJ role_NN in_II interpreting_VVGN graded_VVNJ Shh_NN signals_NNS and_CC selecting_VVGN neuronal_JJ identity_NN ._.
P10226002A02
However_RR the_DD wing_NN is_VBZ made_VVN by_II only_RR part_NN of_II one_MC A_NN and_CC part_NN of_II one_MC P_NN compartment_NN ._.
P10226002A08
First_RR ,_, we_PN show_VVB that_CST engrailed_NN acts_VVZ in_II the_DD A_NN compartment_NN :_: Hedgehog_NN leaves_VVZ the_DD P_NN cells_NNS and_CC crosses_VVZ the_DD A_NN /_SYM P_NN boundary_NN where_PNR it_PN induces_VVZ engrailed_NN in_II a_DD narrow_JJ band_NN of_II A_NN cells_NNS ._.
P10226002A14
Finally_RR ,_, we_PN find_VVB that_CST when_CS engrailed_NN is_VBZ removed_VVN from_II P_NN cells_NNS (_( of_II ,_, say_VVB ,_, segment_NN A5_NN )_) they_PN transform_VVB not_RR into_II A_NN cells_NNS of_II the_DD same_JJ segment_NN ,_, but_CC into_II A_NN cells_NNS of_II the_DD same_JJ parasegment_NN (_( segment_NN A6_NN )_) ._.
P10328918A02
Recently_RR it_PN has_VHZ been_VBN shown_VVN that_CST constitutive_JJ activation_NN of_II the_DD BMP_NN receptor-IA_NN blocks_VVZ chondrocyte_NN differentiation_NN in_II a_DD similar_JJ manner_NN as_II misexpression_NN of_II Indian_NN hedgehog_NN ._.
P10328918A08
Finally_RR ,_, we_PN use_VVB retroviral_JJ misexpression_NN of_II Noggin_NN ,_, a_DD potent_JJ antagonist_NN of_II BMP_NN signaling_VVGN ,_, to_TO gain_VVI insight_NN into_II additional_JJ roles_NNS of_II BMP_NN signaling_VVGN during_II cartilage_NN differentiation_NN ._.
P10330409A04
Whole_JJ mount_NN in_JJ+ situ_JJ hybridization_NN of_II Pax6_NN revealed_VVD a_DD normal_JJ pattern_NN while_CS staining_VVGN by_II sonic_NN hedgehog_NN (_( shh_NN )_) and_CC Brachyury_NN (_( T_NN )_) exhibited_VVD abnormal_JJ patterns_NNS in_II the_DD anterior-posterior_JJ (_( A-P_NN )_) direction_NN at_II both_CC mesencephalic_JJ and_CC thoracic_JJ levels_NNS ._.
P10331970A04
The_DD functional_JJ significance_NN was_VBD tested_VVN with_II an_DD in_JJ+ vitro_JJ feather_NN reconstitution_NN model_NN ._.
P10331970A10
This_PND was_VBD not_RR due_II+ to_II a_DD lack_NN of_II cell_NN proliferation_NN ,_, which_PNR actually_RR was_VBD increased_VVN although_CS randomly_RR distributed_VVN ._.
P10331973A04
Here_RR we_PN have_VHB characterized_VVN the_DD skin_NN and_CC hair_NN phenotypes_NNS of_II mice_NNS carrying_VVG a_DD null_JJ mutation_NN in_II the_DD PDGF-A_NN gene_NN ._.
P10331973A10
Such_JJ embryos_NNS fail_VVB to_TO form_VVI pre-papilla_NN aggregates_NNS of_II postmitotic_JJ PDGF-Ralpha-positive_JJ cells_NNS ,_, suggesting_VVG that_CST shh_NN has_VHZ a_DD critical_JJ role_NN in_II the_DD assembly_NN of_II the_DD dermal_JJ papilla_NN ._.
P10331980A04
Cells_NNS from_II this_DD region_NN will_VM subsequently_RR contribute_VVB to_II forelimb_NN and_CC intercostal_JJ muscles_NNS ._.
P10331980A10
In_II these_DD experiments_NNS ,_, Msx1_NN expression_NN in_II the_DD somite_NN depends_VVZ on_II the_DD axial_JJ position_NN of_II the_DD graft_NN ._.
P10331987A03
We_PN have_VHB shown_VVN that_CST the_DD expression_NN patterns_NNS of_II Hoxa-11_NN and_CC Hoxa-13_NN are_VBB correlated_VVN with_II muscle_NN patterning_VVGN of_II the_DD limb_NN bud_NN (_( Yamamoto_NNP et_CC al._NN ,_, 1998_MC )_) and_CC demonstrated_VVN that_CST muscular_JJ Hox_NN genes_NNS are_VBB activated_VVN by_II signals_NNS from_II the_DD limb_NN mesenchyme_NN ._.
P10331987A09
We_PN found_VVD that_CST HOXA-13_NN expression_NN in_II the_DD autopodal_JJ mesenchyme_NN was_VBD dependent_JJ on_II the_DD AER_NN but_CC not_RR on_II the_DD polarizing_VVGJ region_NN ,_, whereas_CS expression_NN of_II HOXA-13_NN in_II the_DD posterior_JJ muscle_NN masses_NNS was_VBD dependent_JJ on_II the_DD polarizing_VVGJ region_NN but_CC not_RR on_II the_DD AER_NN ._.
P10331987A15
These_DD results_NNS showed_VVD that_CST expression_NN of_II Hox_NN genes_NNS is_VBZ regulated_VVN differently_RR in_II the_DD limb_NN muscle_NN precursor_NN and_CC mesenchymal_JJ cells_NNS ._.
P10354479A06
The_DD effect_NN of_II ZPA_NN grafts_NNS can_VM be_VBB reproduced_VVN by_II application_NN of_II retinoic_JJ acid_NN (_( RA_NN )_) beads_NNS and_CC by_II grafting_VVGN sonic_NN hedgehog_NN (_( SHH_NN )_) -expressing_VVGJ cells_NNS to_II the_DD anterior_JJ margin_NN of_II the_DD limb_NN ._.
P10355946A04
Inactivation_NN of_II both_DD patched_NN alleles_NNS results_VVZ in_II the_DD formation_NN of_II tumors_NNS and_CC cysts_NNS (_( basal_JJ cell_NN carcinomas_NNS ,_, odontogenic_JJ keratocysts_NNS ,_, and_CC medulloblastomas_NNS )_) ._.
P10364424A06
The_DD morphological_JJ defects_NNS in_II Mfh1_NN /_SYM Pax1_NN double_JJ mutants_NNS strongly_RR correlate_VVB with_II the_DD reduction_NN of_II the_DD mitotic_JJ rate_NN of_II sclerotome_NN cells_NNS ._.
P10365960A04
Here_RR we_PN show_VVB that_CST Hox_NN gene_NN expression_NN domains_NNS are_VBB expanded_VVN along_II the_DD body_NN axis_NN in_II python_NN embryos_NNS ,_, and_CC that_CST this_PND can_VM account_VVB for_II both_CC the_DD absence_NN of_II forelimbs_NNS and_CC the_DD expansion_NN of_II thoracic_JJ identity_NN in_II the_DD axial_JJ skeleton_NN ._.
P10373304A01
Brain_NN factor_NN 1_MC (_( BF-1_NN )_) is_VBZ a_DD winged-helix_NN transcription_NN factor_NN with_II restricted_VVNJ expression_NN in_II the_DD anterior_JJ optic_JJ vesicle_NN and_CC in_II the_DD telencephalic_JJ neuroepithelium_NN of_II the_DD neural_JJ tube_NN ._.
P10373304A07
Sonic_NN hedgehog_NN (_( shh_NN )_) expression_NN within_II the_DD ventral_JJ telencephalic_JJ neuroepithelium_NN is_VBZ specifically_RR lost_VVN in_II the_DD BF-1_NN (_( -/-_SYM )_) mutant_NN ._.
P10375501A05
Thus_RR ,_, our_PNG findings_NNS provide_VVB a_DD molecular_JJ model_NN for_II the_DD growth_NN and_CC patterning_VVGN of_II the_DD cerebellum_NN by_II SHH_NN through_II the_DD coordination_NN of_II the_DD development_NN of_II cortical_JJ cerebellar_JJ cell_NN types_NNS ._.
P10375510A04
These_DD assays_NNS show_VVB that_CST C-terminal_JJ sequences_NNS are_VBB required_VVN for_II positive_JJ inducing_VVGJ activity_NN and_CC cytoplasmic_JJ localization_NN ,_, whereas_CS N-terminal_JJ sequences_NNS determine_VVB dominant_JJ negative_JJ function_NN and_CC nuclear_JJ localization_NN ._.
P10375510A10
In_II 10T1_NN /_SYM 2_MC cells_NNS ,_, protein_NN kinase_NN A_NN (_( PKA_NN )_) ,_, a_DD known_VVNJ inhibitor_NN of_II Hh_NN signaling_VVGN ,_, promotes_VVZ Gli3_NN repressor_NN formation_NN and_CC inhibits_VVZ Gli1_NN function_NN ._.
P10393114A06
Furthermore_RR ,_, we_PN find_VVB that_CST GDF6_NN and_CC BMP2_NN can_VM form_VVB heterodimers_NNS and_CC the_DD process_NN seems_VVZ to_TO require_VVI cotranslation_NN of_II the_DD proteins_NNS in_II the_DD same_JJ cells_NNS ._.
P10395791A01
Patched_NN (_( Ptc_NN )_) is_VBZ a_DD human_NN tumor_NN suppressor_NN protein_NN and_CC a_DD candidate_NN receptor_NN for_II Hedgehog_NN (_( Hh_NN )_) proteins_NNS ,_, which_PNR regulate_VVB growth_NN and_CC patterning_VVGN in_II embryos_NNS ._.
P10395791A07
This_PND leads_VVZ to_II partial_JJ dorsalization_NN of_II the_DD neural_JJ tube_NN and_CC a_DD wide_JJ spectrum_NN of_II neural_JJ defects_NNS ,_, ranging_VVG from_II embryonic_JJ lethality_NN to_II hydrocephaly_NN ._.
P10399918A06
These_DD findings_NNS reveal_VVB an_DD unanticipated_VVNJ Shh-independent_JJ signaling_VVGJ pathway_NN that_PNR controls_VVZ progenitor_NN cell_NN identity_NN and_CC interneuron_JJ diversity_NN in_II the_DD ventral_JJ spinal_JJ cord_NN ._.
P10403250A02
Among_II the_DD genes_NNS known_VVN to_TO be_VBI important_JJ for_II muscle_NN development_NN in_II mammalian_JJ embryos_NNS are_VBB those_PND encoding_VVG the_DD basic_JJ helix-loop-helix_NN (_( bHLH_NN )_) myogenic_JJ regulatory_JJ factors_NNS (_( MRFs_NNS ;_: MyoD_NN ,_, Myf5_NN ,_, myogenin_NN and_CC MRF4_NN )_) and_CC Pax3_NN ,_, a_DD paired-type_NN homeobox_NN gene_NN that_PNR is_VBZ critical_JJ for_II the_DD development_NN of_II limb_NN musculature_NN ._.
P10404648A02
We_PN have_VHB isolated_VVN an_DD RT-PCR_NN fragment_NN from_II the_DD axolotl_NN ,_, Ambystoma_NN mexicanum_NN ,_, that_PNR has_VHZ high_JJ identity_NN to_II other_JJ vertebrate_NN shh_NN genes_NNS ._.
P10409497A04
Within_II this_DD region_NN ,_, wg_NN and_CC dpp_NN are_VBB expressed_VVN in_II domains_NNS that_PNR are_VBB mutually_RR exclusive_JJ along_II the_DD dorso-ventral_JJ axis_NN :_: wg_NN is_VBZ expressed_VVN in_II the_DD sternite_NN and_CC medio-lateral_JJ tergite_NN ,_, whereas_CS dpp_NN expression_NN is_VBZ confined_VVN to_II the_DD pleura_NNS and_CC the_DD dorsal_JJ midline_NN ._.
P10409497A10
Second_NN ,_, Wg_NN and_CC Dpp_NN compete_VVB directly_RR with_II one_MC another_PND by_II exerting_VVGN opposite_JJ effects_NNS on_II cell_NN fate_NN ._.
P10415349A04
Using_VVG quail_NN /_SYM chick_NN chimaeras_NNS and_CC a_DD panel_NN of_II molecular_JJ markers_NNS ,_, we_PN show_VVB that_CST Hensen_NN 's_GE node_NN (_( the_DD amniote_NN organizer_NN )_) can_VM induce_VVB posterior_JJ primitive_JJ streak_NN (_( prospective_JJ lateral_JJ plate_NN )_) to_TO form_VVI somites_NNS (_( but_CC not_RR notochord_NN )_) at_II the_DD early_JJ neurula_NN stage_NN ._.
P10419691A01
We_PN have_VHB examined_VVN the_DD developmental_JJ properties_NNS of_II the_DD polydactylous_JJ chicken_NN mutant_NN ,_, talpid_NN (_( 2_MC )_) ._.
P10419691A06
However_RR ,_, a_DD Shh-expressing_VVGJ region_NN (_( zone_NN of_II polarizing_VVGJ activity_NN )_) does_VDZ not_RR reform_VVB ;_: nevertheless_RR Fgf4_NN expression_NN in_II the_DD apical_JJ ectodermal_JJ ridge_NN is_VBZ maintained_VVN ._.
P10433827A05
Similarly_RR ,_, we_PN show_VVB that_CST the_DD homeodomain_NN transcription_NN factor_NN Msx-1_NN ,_, which_PNR like_II Pax-3_NN is_VBZ an_DD early_JJ marker_NN of_II the_DD lateral_JJ neural_JJ plate_NN ,_, is_VBZ induced_VVN by_II posterior_JJ nonaxial_JJ mesoderm_NN and_CC blocked_VVN by_II dominant-negative_JJ XWnt-8_NN ._.
P10433834A05
Dlx3_NN has_VHZ little_DD ,_, if_CC any_DD ,_, effect_NN on_II these_DD anterior_JJ neural_JJ plate_NN genes_NNS ,_, instead_RR providing_VVG a_DD permissive_JJ environment_NN for_II their_PNG expression_NN while_CS repressing_VVG more_DD panneural_JJ markers_NNS ,_, including_VVG prepattern_JJ genes_NNS belonging_VVG to_II the_DD Zic_NN family_NN and_CC BF-1_NN ._.
P10437918A01
The_DD protein_NN synthetic_JJ machinery_NN is_VBZ activated_VVN by_II diverse_JJ genetic_JJ alterations_NNS during_II tumor_NN progression_NN in_RR+ vivo_RR and_CC represents_VVZ an_DD attractive_JJ target_NN for_II cancer_NN therapy_NN ._.
P10437918A07
Our_PNG results_NNS indicate_VVB that_CST sensitivity_NN to_II rapamycin_NN can_VM be_VBB induced_VVN by_II a_DD specific_JJ oncogene_NN and_CC that_CST inhibition_NN of_II global_JJ protein_NN metabolism_NN is_VBZ linked_VVN to_II the_DD rapamycin-sensitive_JJ phenotype_NN ._.
P10445498A02
In_II vertebrates_NNS ,_, they_PN are_VBB expressed_VVN in_II the_DD entire_JJ mesoderm_NN in_II early_JJ embryogenesis_NN and_CC later_RR in_II the_DD paraxial_JJ mesoderm_NN and_CC the_DD tail-bud_NN ,_, suggesting_VVG roles_NNS in_II specification_NN and_CC morphogenesis_NN of_II the_DD paraxial_JJ mesoderm_NN ._.
P10445498A07
Also_RR ,_, just_CS+ as_CS vertebrate_NN snail_NN family_NN genes_NNS are_VBB expressed_VVN in_II the_DD border_NN of_II the_DD neural_JJ plate_NN that_PNR develops_VVZ into_II dorsal_JJ neural_JJ tube_NN and_CC neural_JJ crest_NN cells_NNS ,_, so_CS Hrsna_NN expression_NN was_VBD detected_VVN in_II the_DD precursors_NNS of_II lateral_JJ and_CC dorsal_JJ regions_NNS of_II the_DD neural_JJ tube_NN ._.
P10446271A02
Fibroblast_NN growth_NN factor_NN (_( FGF_NN )_) signaling_VVGN is_VBZ an_DD essential_JJ component_NN of_II the_DD regulatory_JJ network_NN present_JJ in_II the_DD embryonic_JJ lung_NN ,_, controlling_VVG proliferation_NN ,_, differentiation_NN and_CC pattern_NN formation_NN ._.
P10457011A01
Adult_NN rat-derived_VVNJ hippocampal_JJ progenitor_NN cells_NNS express_VVB many_PND of_II the_DD molecules_NNS implicated_VVN in_II midbrain_NN dopaminergic_JJ determination_NN ,_, including_VVG FGF_NN receptors_NNS 1_MC ,_, 2_MC and_CC 3_MC ,_, the_DD sonic_NN hedgehog_NN receptor_NN components_NNS Smo_NN and_CC Ptc_NN ,_, and_CC the_DD region-specific_JJ transcription_NN factors_NNS Ptx3_NN and_CC Nurr1_NN ._.
P10457013A05
The_DD molecular_JJ basis_NN of_II these_DD differences_NNS is_VBZ still_RR largely_RR unknown_VVN ._.
P10457013A10
In_II addition_NN ,_, we_PN show_VVB that_CST the_DD morphogen_NN Hedgehog_NN can_VM pattern_VVB the_DD dorsal_JJ cuticle_NN independently_RR of_II Fused_NN ._.
P10457014A04
Shh_NN is_VBZ not_RR required_VVN for_II the_DD activation_NN of_II Myf5_NN and_CC MyoD_NN at_II any_PND of_II the_DD other_JJ sites_NNS of_II myogenesis_NN in_II the_DD mouse_NN embryo_NN ,_, including_VVG the_DD hypaxial_JJ dermomyotomal_JJ cells_NNS that_PNR give_VVB rise_NN to_II the_DD abdominal_JJ and_CC body_NN wall_NN muscles_NNS ,_, or_CC the_DD myogenic_JJ progenitor_NN cells_NNS that_PNR form_VVB the_DD limb_NN and_CC head_NN muscles_NNS ._.
P10457021A04
In_II this_DD report_NN we_PN studied_VVD the_DD molecular_JJ mechanisms_NNS of_II this_DD binary_JJ decision_NN ._.
P10457021A10
Evolutionary_JJ aspects_NNS of_II the_DD coelom_NN formation_NN are_VBB also_RR considered_VVN ._.
P10461220A01
We_PN used_VVD ultrasound_NN image-guided_VVNJ injections_NNS of_II high-titer_NN retroviral_JJ vectors_NNS to_TO obtain_VVI widespread_JJ introduction_NN of_II genes_NNS into_II the_DD mouse_NN nervous_JJ system_NN in_II utero_NN as_RR early_RR as_CSN embryonic_JJ day_NN 8.5_MC (_( E8.5_NN )_) ._.
P10462495A02
However_RR ,_, gene_NN expression_NN and_CC function_NN of_II Ihh_NN and_CC its_PNG signaling_VVGJ molecules_NNS ,_, Ptc_NN and_CC Smo_NN ,_, at_II the_DD initial_JJ stage_NN of_II fracture_NN repair_NN remain_VVB unknown_VVN ._.
P10465785A03
Analysis_NN of_II an_DD Ihh_NN null_JJ mutant_NN suggests_VVZ a_DD more_RR extensive_JJ role_NN for_II Ihh_NN in_II skeletal_JJ development_NN ._.
P10471127A06
Hence_RR ,_, we_PN propose_VVB that_CST the_DD importance_NN of_II alpha-linolenate_NN and_CC linoleate_NN for_II normal_JJ neural_JJ development_NN arises_VVZ not_RR only_RR from_II being_VVGN precursors_NNS to_II longer_JJR chain_NN polyunsaturates_NNS incorporated_VVN into_II neuronal_JJ membranes_NNS but_CC ,_, perhaps_RR equally_RR importantly_RR ,_, by_II being_VVGN ketogenic_JJ precursors_NNS needed_VVN for_II in_JJ+ situ_JJ brain_NN lipid_NN synthesis_NN ._.
P10473037A02
The_DD limb_NN is_VBZ the_DD organ_NN whose_PNR development_NN is_VBZ probably_RR best_RRT understood_VVN ._.
P10473037A08
The_DD time_NN spent_VVN in_II the_DD progress_NN zone_NN may_VM determine_VVB the_DD positional_JJ values_NNS along_II the_DD proximo-distal_JJ axis_NN ,_, that_PNR is_VBZ the_DD formation_NN of_II ,_, for_II example_NN the_DD humerus_NN ,_, then_RR the_DD radius_NN and_CC ulna_NN ._.
P10473037A14
Muscle_NN cells_NNS have_VHB a_DD separate_JJ origin_NN from_II the_DD cartilaginous_JJ cells_NNS and_CC those_PND that_PNR form_VVB connective_JJ tissue_NN and_CC tendons_NNS ,_, and_CC they_PN migrate_VVB into_II the_DD bud_NN from_II the_DD somites_NNS and_CC are_VBB patterned_VVN by_II the_DD connective_JJ tissue_NN ._.
P10475061A02
The_DD transmembrane_JJ protein_NN Patched_NN is_VBZ a_DD receptor_NN for_II the_DD morphogene_NN Sonic_NN Hedgehog_NN ._.
P10475061A08
This_DD dual_JJ role_NN is_VBZ especially_RR visible_JJ in_II humans_NNS with_II inherited_VVNJ Patched_NN mutations_NNS ._.
P10475061A14
Furthermore_RR they_PN provide_VVB important_JJ tools_NNS to_TO study_VVI the_DD Sonic_NN Hedgehog_NN /_SYM Patched_NN /_SYM Smoothened_NN signaling_VVGN at_II the_DD molecular_JJ and_CC biochemical_JJ level_NN ._.
P10477294A02
To_TO elucidate_VVI the_DD role_NN of_II retinoic_JJ acid_NN in_II the_DD primary_JJ neurogenesis_NN cascade_NN ,_, we_PN investigated_VVD whether_CST retinoic_JJ acid_NN treatment_NN of_II whole_JJ embryos_NNS could_VM change_VVB the_DD spatial_JJ expression_NN of_II a_DD set_NN of_II genes_NNS known_VVN to_TO be_VBI involved_VVN in_II neurogenesis_NN ._.
P10491258A03
We_PN find_VVB that_CST the_DD three_MC mutations_NNS are_VBB allelic_JJ and_CC that_CST the_DD locus_NN they_PN define_VVB ,_, renamed_VVN ogon_NN (_( ogo_NN )_) ,_, maps_VVZ to_II linkage_NN group_NN 25_MC ._.
P10491258A09
Thus_RR ,_, while_CS ogo_NN and_CC chordin_NN are_VBB required_VVN to_TO limit_VVI activity_NN of_II BMPs_NNS ,_, additional_JJ mechanisms_NNS must_VM exist_VVB to_TO block_VVI these_DD ventralizing_VVGJ signals_NNS ._.
P10498679A03
Sonic_NN hedgehog_NN (_( Shh_NN )_) ,_, one_MC of_II the_DD vertebrate_NN homologs_NNS of_II Hh_NN ,_, controls_VVZ patterning_VVGN and_CC growth_NN of_II the_DD limb_NN but_CC the_DD early_JJ embryonic_JJ lethality_NN of_II ptc1_NN (_( -_SYM )_) (_( /_SYM )_) (_( -_SYM )_) mice_NNS obscures_VVZ the_DD roles_NNS of_II ptc1_NN in_II later_JJR stages_NNS of_II development_NN ._.
P10508582A05
Expression_NN on_II the_DD left_JJ side_NN of_II the_DD head_NN was_VBD controlled_VVN by_II Sonic_NN hedgehog_NN (_( Shh_NN )_) acting_VVG through_II the_DD TGF-beta_NN family_NN member_NN Nodal_NN ;_: in_II the_DD flank_NN ,_, cCer_NN was_VBD also_RR regulated_VVN by_II Shh_NN ,_, but_CC independently_RR of_II Nodal_NN ._.
P10508856A03
Shh-induced_VVNJ epidermal_JJ hyperplasia_NN is_VBZ accompanied_VVN by_II continued_VVNJ cell_NN proliferation_NN in_II normally_RR growth_NN arrested_VVNJ suprabasal_JJ cells_NNS in_RR+ vivo_RR ._.
P10510326A06
Finally_RR ,_, C57BL_NN /_SYM 6_MC mice_NNS showed_VVD marked_VVNJ acceleration_NN of_II the_DD onset_NN of_II new_JJ hair_NN growth_NN in_II the_DD region_NN of_II AdShh_NN administration_NN to_II skin_NN 2_MC weeks_NNS after_II treatment_NN ,_, but_CC not_RR in_II control_NN vector-treated_VVNJ or_CC untreated_VVNJ areas_NNS ._.
P10512189A04
Shh_NN signalling_VVGN has_VHZ previously_RR been_VBN shown_VVN ,_, in_II other_JJ organs_NNS ,_, to_TO stimulate_VVI cell_NN proliferation_NN ._.
P10516314A04
Expression_NN of_II Shh_NN was_VBD maintained_VVN until_II birth_NN ,_, permitting_VVG us_PN to_TO investigate_VVI effects_NNS of_II ongoing_VVGJ exposure_NN to_II Shh_NN on_II CNS_NN precursors_NNS in_RR+ vivo_RR ._.
P10518490A04
We_PN show_VVB here_RR that_CST the_DD mouse_NN mutation_NN dominant_JJ hemimelia_NN (_( Dh_NN )_) alters_VVZ the_DD pattern_NN of_II gene_NN expression_NN in_II the_DD AER_NN such_CS+ that_CS Fgf4_NN ,_, which_PNR is_VBZ normally_RR expressed_VVN in_II a_DD posterior_JJ domain_NN ,_, and_CC Fgf8_NN ,_, which_PNR is_VBZ expressed_VVN throughout_RR are_VBB expressed_VVN in_II anterior_JJ patterns_NNS ._.
P10518503A03
In_II addition_NN ,_, teratogens_NNS such_II+ as_II jervine_NN ,_, which_PNR inhibit_VVB the_DD response_NN of_II tissues_NNS to_II SHH_NN ,_, also_RR produce_VVB cyclopia_NN ._.
P10518503A09
In_II contrast_NN ,_, excess_JJ SHH_NN leads_VVZ to_II a_DD mediolateral_JJ widening_VVGN of_II the_DD FNP_NN and_CC a_DD widening_VVGN between_II the_DD eyes_NNS ,_, a_DD condition_NN known_VVN as_II hypertelorism_NN ._.
P10524628A04
Mesenchymal_JJ Gremlin_NN expression_NN is_VBZ lost_VVN in_II limb_NN buds_NNS of_II mouse_NN embryos_NNS homozygous_JJ for_II the_DD limb_NN deformity_NN (_( Id_NN )_) mutation_NN ,_, which_PNR disrupts_VVZ establishment_NN of_II the_DD SHH_NN /_SYM FGF4_NN feedback_NN loop_NN ._.
P10525336A06
Subsequently_RR ,_, specific_JJ attenuation_NN of_II chordamesoderm_NN and_CC neural_JJ midline_NN Shh_NN expression_NN is_VBZ observed_VVN ._.
P10525354A02
Transcripts_NNS for_II the_DD putative_JJ Shh-receptor_NN genes_NNS patched_NN (_( Ptc_NN )_) and_CC smoothened_NN (_( Smo_NN )_) are_VBB expressed_VVN by_II embryonic_JJ ,_, postnatal_JJ ,_, and_CC adult_NN progenitor_NN cells_NNS ,_, suggesting_VVG that_CST Shh_NN can_VM act_VVB directly_RR on_II these_DD cells_NNS ._.
P10527664A03
They_PN include_VVB Sonic_NN hedgehog_NN (_( SHH_NN )_) ,_, ZIC2_NN ,_, and_CC SIX3_NN ._.
P10529412A06
It_PN was_VBD previously_RR thought_VVN that_CST the_DD eye_NN develops_VVZ by_II a_DD mechanism_NN distinct_JJ from_II that_PND operating_VVG in_II other_JJ imaginal_JJ discs_NNS ,_, but_CC our_PNG work_NN establishes_VVZ the_DD importance_NN of_II lineage_NN compartments_NNS in_II the_DD eye_NN and_CC thus_RR supports_VVZ their_PNG global_JJ role_NN as_II fundamental_JJ units_NNS of_II patterning_VVGN ._.
P10534614A06
We_PN conclude_VVB that_CST in_II addition_NN to_II shh_NN an_DD early_JJ ectoderm-dependent_JJ signal_NN is_VBZ required_VVN for_II the_DD establishment_NN of_II the_DD mouse_NN ZPA_NN and_CC that_CST this_DD factor_NN is_VBZ dependent_JJ on_II the_DD posterior_JJ ectoderm_NN ._.
P10536237A01
Expression_NN of_II Pax-2_NN in_II the_DD mouse_NN gastrula_NN is_VBZ the_DD first_JJ marker_NN of_II the_DD midbrain-hindbrain_NN region_NN ._.
P10536237A07
These_DD results_NNS indicate_VVB the_DD presence_NN of_II regulatory_JJ sequences_NNS upstream_JJ of_II the_DD Pax-2_NN locus_NN capable_JJ of_II directing_VVGN gene_NN expression_NN in_II the_DD developing_VVGJ midbrain_NN ,_, first_JJ rhombomere_NN of_II the_DD hindbrain_NN ,_, and_CC its_PNG principal_JJ derivative_NN ,_, the_DD cerebellum_NN ._.
P10542953A04
However_RR ,_, microsurgical_JJ experiments_NNS on_II Hensen_NN 's_GE node_NN allow_VVB to_TO think_VVI that_CST organizer_NN function_NN is_VBZ due_II+ to_II an_DD extremely_RR limited_VVNJ region_NN situated_VVN in_II the_DD caudal_JJ part_NN of_II Hensen_NN 's_GE node_NN which_PNR corresponds_VVZ to_II the_DD boundary_NN between_II prospective_JJ axial_JJ mesoderm_NN rostrally_RR and_CC paraxial_JJ mesoderm_NN caudally_RR ._.
P10542956A05
These_DD data_NNS allow_VVB us_PN to_TO draw_VVI a_DD new_JJ model_NN for_II vertebral_JJ chondrogenesis_NN ._.
P10545029A02
During_II digit_NN duplication_NN after_II implantation_NN of_II a_DD Shh-N-soaked_VVNJ bead_NN ,_, BMP-2_NN and_CC Patched_NN expression_NN was_VBD transiently_RR induced_VVN in_II the_DD anterior_JJ limb_NN mesenchyme_NN 20_MC h_NN after_II grafting_VVGN ,_, but_CC was_VBD reduced_VVN to_II the_DD basal_JJ level_NN 48_MC h_NN after_II grafting_VVGN ._.
P10545029A08
These_DD results_NNS suggest_VVB that_CST positional_JJ identity_NN is_VBZ respecified_VVN by_II Shh-N_NN activity_NN within_II the_DD first_JJ 24_MC h_NN during_II digit_NN duplication_NN ,_, and_CC that_CST Shh-N_NN on_II its_PNG own_PN is_VBZ not_RR acting_VVG as_II a_DD long-range_NN signaling_VVGJ molecule_NN to_TO determine_VVI positional_JJ identity_NN at_II a_DD distance_NN in_II the_DD limb_NN bud_NN ._.
P10545117A06
Our_PNG results_NNS indicate_VVB that_CST Xblimp1_NN is_VBZ required_VVN for_II anterior_JJ endomesodermal_JJ cell_NN fate_NN and_CC head_NN induction_NN ._.
P10556055A05
Here_RR ,_, we_PN present_VVB a_DD detailed_VVNJ description_NN of_II the_DD migration_NN of_II the_DD primordial_JJ germ_NN cells_NNS during_II the_DD first_JJ 24_MC hours_NNS of_II wild-type_NN zebrafish_NN embryonic_JJ development_NN ._.
P10556055A11
These_DD ectopic_JJ cells_NNS can_VM retain_VVB both_CC morphological_JJ and_CC molecular_JJ characteristics_NNS of_II primordial_JJ germ_NN cells_NNS ,_, suggesting_VVG that_CST ,_, in_II zebrafish_NN at_II the_DD early_JJ stages_NNS tested_VVN ,_, the_DD vasa-expressing_VVGJ cells_NNS are_VBB committed_VVN to_II the_DD germ_NN cell_NN lineage_NN ._.
P10556058A05
Cell_NN autonomous_JJ inhibition_NN of_II BMP_NN activity_NN in_II epidermis_NN with_II dominant_JJ negative_JJ ligand_NN dramatically_RR reduced_VVD the_DD amount_NN of_II (_( &agr;_NN )_) T3_NN globin_NN expression_NN ._.
P10564658A04
These_DD variants_NNS were_VBD indistinguishable_JJ from_II wild-type_NN sonic_NN hedgehog_NN in_II their_PNG ability_NN to_TO bind_VVI the_DD receptor_NN patched-1_NN ,_, but_CC failed_VVD to_TO induce_VVI the_DD hedgehog-responsive_JJ markers_NNS ,_, Gli-1_NN and_CC Ptc-1_NN ,_, and_CC failed_VVD to_TO promote_VVI hedgehog-dependent_JJ differentiation_NN of_II the_DD cell_NN line_NN ._.
P10564872A03
Treatment_NN of_II pregnant_JJ rats_NNS with_II inhibitors_NNS of_II 7-DHC_NN reductase_NN ,_, either_CC AY9944_NN or_CC BM15.766_NN ,_, has_VHZ provided_VVN a_DD valuable_JJ model_NN to_TO study_VVI the_DD pathogenesis_NN in_II SLOS_NN ._.
P10564872A09
They_PN provide_VVB further_JJ evidence_NN that_CST cholesterol-deficiency-induced_VVNJ HPE_NN originates_VVZ from_II impaired_VVNJ Shh_NN signaling_VVGJ activity_NN in_II the_DD ventral_JJ neural_JJ tube_NN ._.
P10570465A02
FGF10_NN and_CC FGF8_NN signal_VVB through_II the_DD FGFR2b_NN and_CC FGFR2c_NN alternative_JJ splice_NN isoforms_NNS ,_, respectively_RR [_( Ornitz_NNP DM_NNP ,_, et_CC al._NN 1996._MC J_NN Biol_NN Chem_NN 271_MC :_: 15292-15297_MC ;_: Igarashi_NNP M_NNP ,_, et_CC al._NN 1998._MC J_NN Biol_NN Chem_NN 273_MC :_: 13230-13235_MC ]_) ._.
P10570465A08
We_PN also_RR report_VVB that_CST transcripts_NNS for_II FGF10_NN ,_, FGFR2b_NN ,_, and_CC FGFR2c_NN are_VBB expressed_VVN normally_RR in_II the_DD limb_NN buds_NNS of_II limbless_NN mutant_NN embryos_NNS ,_, which_PNR fail_VVB to_TO form_VVI an_DD AER_NN and_CC do_VDB not_RR express_VVB FGF8_NN ._.
P10574767A06
It_PN is_VBZ not_RR well_RR understood_VVN ,_, however_RR ,_, whether_CST Shh_NN signalling_VVGN also_RR controls_VVZ the_DD activities_NNS of_II Gli_NN proteins_NNS post-translationally_RR and_CC whether_CST these_DD activities_NNS have_VHB activating_VVGJ or_CC repressing_VVGJ effects_NNS on_II target_NN genes_NNS in_RR+ vivo_RR ._.
P10586245A01
Reciprocal_JJ signaling_VVGN between_II axons_NNS and_CC Schwann_NN cells_NNS during_II development_NN is_VBZ well_RR established_VVN ._.
P10586245A07
In_II Desert_NN hedgehog_NN knockout_NN mice_NNS ,_, the_DD connective_JJ tissue_NN sheaths_NNS in_II adult_NN nerves_NNS appear_VVB highly_RR abnormal_JJ by_II electron_NN microscopy_NN ._.
P10588385A02
Yet_RR ,_, in_II the_DD embryonic_JJ spinal_JJ cord_NN ,_, the_DD oligodendrocyte_NN phenotype_NN is_VBZ induced_VVN by_II sonic_NN hedgehog_NN in_II a_DD restricted_VVNJ anterior_JJ region_NN ._.
P10588385A08
To_TO repair_VVI myelin_NN in_II adult_NN CNS_NN ,_, multipotential_JJ neural_JJ precursors_NNS ,_, rather_II+ than_II slowly_RR cycling_VVGJ OP_NN ,_, appear_VVB the_DD cells_NNS of_II choice_NN to_TO rapidly_RR generate_VVI myelin-forming_VVGJ cells_NNS ._.
P10598817A06
Despite_II extensive_JJ pedigree_NN analysis_NN of_II numerous_JJ polymorphisms_NNS ,_, as_CC+ well_CC+ as_CC complementation_NN studies_NNS in_II yeast_NN on_II one_MC of_II the_DD missense_NN mutations_NNS ,_, we_PN find_VVB no_DD evidence_NN that_CST the_DD LS_NN gene_NN is_VBZ in_II fact_NN HPE1_NN ,_, implicating_VVG another_DD gene_NN located_VVN in_II this_DD chromosomal_JJ region_NN in_II HPE_NN pathogenesis_NN ._.
P10601008A03
Recently_RR ,_, the_DD receptors_NNS and_CC the_DD post-receptor_NN pathways_NNS for_II Sonic_NN hedgehog_NN and_CC Wnts_NNS have_VHB been_VBN characterized_VVN ,_, and_CC this_PND has_VHZ opened_VVN up_II the_DD possibility_NN of_II linking_VVGN these_DD signaling_VVGJ events_NNS to_II the_DD activation_NN of_II myogenic_JJ regulatory_JJ factor_NN genes_NNS such_II+ as_II Myf5_NN and_CC MyoD_NN and_CC functionally_RR related_VVNJ genes_NNS such_II+ as_II Pax3_NN ._.
P10603350A05
Here_RR we_PN show_VVB that_CST Vitronectin_NN is_VBZ also_RR proteolitically_RR processed_VVN in_II the_DD embryonic_JJ chick_NN notochord_NN ,_, floor_NN plate_NN and_CC ventral_JJ neural_JJ tube_NN and_CC that_CST this_DD processing_VVGN is_VBZ spatiotemporally_RR correlated_VVN with_II the_DD generation_NN of_II motor_NN neurons_NNS ._.
P10625551A04
We_PN report_VVB that_CST dorsoventral_JJ patterning_VVGN of_II the_DD telencephalon_NN is_VBZ dramatically_RR disrupted_VVN in_II the_DD Xt_NN (_( J_NN )_) mutant_NN ._.
P10625563A02
One_MC feature_NN that_PNR has_VHZ been_VBN lacking_VVG in_II this_DD model_NN system_NN is_VBZ the_DD ability_NN to_II disable_NN specifically_RR targeted_VVNJ genes_NNS ._.
P10625563A08
Expression_NN of_II the_DD zebrafish_NN genes_NNS sonic_NN hedgehog_NN and_CC floating_NN head_NN was_VBD altered_VVN in_II the_DD embryos_NNS microinjected_VVN with_II the_DD Zf-T_NN double-stranded_VVNJ RNA_NN in_II a_DD manner_NN that_PNR is_VBZ remarkably_RR similar_JJ to_II the_DD zebrafish_NN no-tail_NN mutant_NN ._.
P10633866A03
Rat_NN embryos_NNS were_VBD deprived_VVN of_II RA_NN starting_VVG at_II days-postcoitum_NN (_( dpc_NN )_) 3.0_MC ,_, 5.5_MC ,_, or_CC 7.0_MC and_CC harvested_VVN at_II the_DD 35-somite_NN stage_NN (_( dpc_NN 12-12.5_MC )_) ._.
P10633866A05
Molecular_JJ analysis_NN of_II RA-deficient_JJ limb_NN buds_NNS revealed_VVD enhanced_VVNJ gli-3_NN and_CC reduced_VVNJ hoxd-12_NN ,_, hoxd-13_NN ,_, shh_NN ,_, and_CC fgf-4_NN ,_, while_CS fgf-8_NN ,_, en-1_NN ,_, and_CC wnt-7a_NN expression_NN remained_VVD unaltered_VVNJ ._.
P10633866A08
Results_NNS could_VM not_RR confirm_VVB a_DD function_NN for_II endogenous_JJ retinoids_NNS in_II limb_NN initiation_NN ,_, but_CC show_VVB they_PN are_VBB required_VVN to_TO maintain_VVI the_DD signaling_VVGJ loops_NNS between_II the_DD developing_VVGJ mesenchyme_NN and_CC AER_NN that_PNR govern_VVB limb_NN outgrowth_NN after_II the_DD initial_JJ emergence_NN of_II limb_NN bud_NN ._.
P10635458A04
The_DD functions_NNS and_CC patterns_NNS of_II expression_NN of_II different_JJ sclerotome_NN markers_NNS were_VBD discussed_VVN ._.
P10640707A01
Fli-1_NN is_VBZ an_DD ETS-domain_NN transcription_NN factor_NN whose_PNR locus_NN is_VBZ disrupted_VVN in_II Ewing_NN 's_GE Sarcoma_NN and_CC F-MuLV_NN induced_VVNJ erythroleukaemia_NN ._.
P10640707A06
Elsewhere_RR in_II the_DD embryo_NN ,_, fli-1_NN is_VBZ expressed_VVN in_II sites_NNS of_II vasculogenesis_NN ._.
P10640707A12
These_DD data_NNS indicate_VVB that_CST cloche_NN has_VHZ previously_RR unsuspected_VVNJ roles_NNS at_II multiple_JJ stages_NNS in_II the_DD formation_NN of_II the_DD vasculature_NN ._.
P10654599A05
Although_CS the_DD BMP4-producing_VVGJ cells_NNS had_VHD no_DD effect_NN on_II the_DD mature_JJ inner_JJ ear_NN structure_NN when_CS implanted_VVN alone_JJ ,_, noggin-producing_VVGJ cells_NNS implanted_VVN adjacent_JJ to_II the_DD BMP4_NN cell_NN foci_NNS prevented_VVD normal_JJ semicircular_JJ canal_NN development_NN ._.
P10654605A02
The_DD ventrally_RR located_VVNJ notochord_NN provides_VVZ the_DD ventralizing_VVGJ signals_NNS to_TO specify_VVI the_DD sclerotome_NN ,_, while_CS the_DD dorsally_RR located_VVNJ surface_NN ectoderm_NN and_CC dorsal_JJ neural_JJ tube_NN provide_VVB the_DD dorsalizing_VVGJ signals_NNS to_TO specify_VVI the_DD dermomyotome_NN ._.
P10654605A08
We_PN further_RR show_VVB that_CST SFRP2-expressing_VVGJ cells_NNS can_VM reduce_VVB the_DD dermomyotome-inducing_VVGJ activity_NN of_II WNT1_NN and_CC WNT4_NN ,_, but_CC not_RR that_PND of_II WNT3a_NN ._.
P10662638A06
This_DD conditional_JJ mutation_NN was_VBD designed_VVN so_CS+ that_CS concomitant_JJ with_II inactivation_NN of_II the_DD Fgf4_NN gene_NN by_II excision_NN of_II all_DD Fgf4-coding_VVGJ sequences_NNS ,_, a_DD reporter_NN gene_NN was_VBD activated_VVN in_II Fgf4-expressing_VVGJ cells_NNS ,_, allowing_VVG assessment_NN of_II the_DD site-specific_JJ recombination_NN reaction_NN ._.
P10662651A04
The_DD secreted_VVNJ protein_NN Sonic_NN hedgehog_NN (_( Shh_NN )_) produced_VVN in_II the_DD notochord_NN and_CC floor_NN plate_NN induces_VVZ differentiation_NN of_II ventral_JJ cell_NN types_NNS of_II the_DD central_JJ nervous_JJ system_NN ._.
P10662651A10
Moreover_RR ,_, ectopic_JJ Shh_NN induced_VVD a_DD considerable_JJ number_NN of_II SC1-positive_JJ motor_NN neurons_NNS ,_, overlapping_VVGJ markers_NNS such_II+ as_II HNF-3_NN (_( beta_NN )_) (_( floor_NN plate_NN )_) ,_, Isl-1_NN (_( postmitotic_JJ motor_NN neuron_NN )_) and_CC Lim1_NN /_SYM 2_MC ._.
P10669739A05
These_DD mutant_JJ proteins_NNS are_VBB unable_JJ to_TO transactivate_VVI a_DD reporter_NN gene_NN regulated_VVN by_II ci_NN binding_VVGJ sites_NNS and_CC have_VHB a_DD lower_JJR dCBP-stimulated_VVNJ activity_NN than_CSN wild-type_NN CI_NN ._.
P10677261A02
Upon_II reception_NN of_II these_DD signals_NNS ,_, precursor_NN cells_NNS express_VVB specific_JJ sets_NNS of_II transcription_NN factors_NNS which_PNR ,_, in_II turn_NN ,_, play_VVB critical_JJ roles_NNS in_II cell-type_NN specification_NN ._.
P10677261A08
These_DD data_NNS implicate_VVB a_DD novel_JJ class_NN of_II transcription_NN factors_NNS in_II dorsoventral_JJ cell-type_NN specification_NN in_II the_DD spinal_JJ cord_NN ._.
P10679778A02
Using_VVG the_DD expression_NN of_II O4_NN immunoreactivity_NN to_TO define_VVI cells_NNS of_II the_DD oligodendrocyte_NN lineage_NN ,_, the_DD development_NN of_II oligodendrocytes_NNS in_II different_JJ regions_NNS of_II the_DD mouse_NN spinal_JJ cord_NN was_VBD assayed_VVN ._.
P10679778A08
The_DD molecular_JJ requirements_NNS for_II the_DD dorsally-derived_VVNJ oligodendrocytes_NNS was_VBD similar_JJ to_II that_PND in_II ventral_JJ cord_NN ._.
P10683174A05
We_PN found_VVD that_CST a_DD presumptive_JJ ventral_JJ signal_NN ,_, Hh_NN signaling_VVGN ,_, acts_VVZ to_TO restrict_VVI the_DD amount_NN of_II dorsal_JJ sensory_JJ neurons_NNS and_CC trunk_NN neural_JJ crest_NN ._.
P10689616A01
Cerberus_NN encodes_VVZ for_II a_DD secreted_VVNJ protein_NN which_PNR when_CS overexpressed_VVN ventrally_RR in_II a_DD Xenopus_NN embryo_NN induces_VVZ head_NN differentiation_NN without_II trunk_NN (_( Bouwmeester_NNP et_CC al._NN ,_, 1996_MC )_) ._.
P10693670A06
Gli3_NN -/-_SYM mutants_NNS are_VBB spontaneous_JJ mutants_NNS involving_VVG the_DD Gli3_NN gene_NN ._.
P10693670A12
The_DD severity_NN of_II the_DD phenotype_NN appears_VVZ to_TO reflect_VVI the_DD gene_NN dose_NN ._.
P10693758A02
Anterior_JJ cells_NNS require_VVB reception_NN of_II the_DD Hedgehog_NN (_( Hh_NN )_) signal_NN to_TO segregate_VVI from_II P_NN cells_NNS ._.
P10693759A02
In_II Drosophila_NN ,_, Ci_NN action_NN as_II transcriptional_JJ repressor_NN or_CC activator_NN is_VBZ contingent_JJ upon_II Hedgehog-regulated_VVNJ ,_, PKA-dependent_JJ proteolytic_JJ processing_VVGN ._.
P10694427A05
Systematic_JJ mutant_NN searches_NNS in_II zebrafish_NN embryos_NNS have_VHB identified_VVN a_DD number_NN of_II genes_NNS ,_, mutations_NNS in_II which_PNR visibly_RR reduce_VVB the_DD floor_NN plate_NN ._.
P10694427A11
It_PN has_VHZ been_VBN shown_VVN previously_RR that_CST in_II the_DD zebrafish_NN shh_NN is_VBZ required_VVN for_II the_DD induction_NN of_II LFP_NN cells_NNS ,_, but_CC not_RR for_II the_DD development_NN of_II MFP_NN cells_NNS ._.
P10694427A17
The_DD number_NN of_II primary_JJ motor_NN neurons_NNS is_VBZ strongly_RR reduced_VVN in_II cyc_NN ;_: syu_NN double_JJ mutants_NNS ,_, while_CS almost_RR normal_JJ in_II single_JJ mutants_NNS ,_, suggesting_VVG that_CST the_DD two_MC different_JJ pathways_NNS have_VHB overlapping_VVGJ functions_NNS in_II the_DD induction_NN of_II primary_JJ motor_NN neurons_NNS ._.
P10704381A03
Here_RR we_PN dissect_VVB the_DD relationship_NN between_II Shh_NN and_CC Bmp_NN signalling_VVGN ._.
P10704381A09
We_PN show_VVB that_CST high-level_NN ptc_NN expression_NN is_VBZ induced_VVN rapidly_RR when_CS either_CC Shh_NN beads_NNS or_CC polarising_VVGJ regions_NNS are_VBB grafted_VVN to_II a_DD host_NN limb_NN ._.
P10704389A05
We_PN found_VVD that_CST the_DD expression_NN of_II Shh_NN and_CC Bmp2_NN is_VBZ downregulated_VVN at_II E12.5_NN and_CC E13.5_NN in_II the_DD dental_JJ epithelium_NN of_II the_DD Msx1_NN mutant_NN tooth_NN germ_NN where_PNR Bmp4_NN expression_NN is_VBZ significantly_RR reduced_VVN in_II the_DD dental_JJ mesenchyme_NN ._.
P10704389A10
TUNEL_NN assay_NN indicated_VVD that_CST this_DD suppression_NN of_II gene_NN expression_NN by_II exogenous_JJ BMP4_NN was_VBD not_RR the_DD result_NN of_II an_DD increase_NN in_II programmed_VVNJ cell_NN death_NN in_II the_DD tooth_NN germ_NN ._.
P10704389A16
Taken_VVN together_RR ,_, our_PNG data_NNS provide_VVB insight_NN into_II a_DD new_JJ regulatory_JJ mechanism_NN for_II Shh_NN expression_NN ,_, and_CC suggest_VVB that_CST this_DD BMP4-mediated_VVNJ pathway_NN in_II Shh_NN regulation_NN may_VM have_VHB a_DD general_JJ implication_NN in_II vertebrate_NN organogenesis_NN ._.
P10704868A05
Fz-10_NN is_VBZ also_RR expressed_VVN in_II the_DD feather_NN bud_NN and_CC branchial_JJ arch_NN ._.
P10710230A05
This_PND is_VBZ the_DD first_JJ molecular_JJ study_NN of_II HPE_NN in_II a_DD population-based_VVNJ sample_NN of_II patients_NNS ._.
P10719888A05
In_II developing_VVGJ mouse_NN embryos_NNS ,_, Olg_NN gene_NN expression_NN overlaps_VVZ but_CC precedes_VVZ the_DD earliest_RRT known_VVNJ markers_NNS of_II the_DD oligodendrocyte_NN lineage_NN ._.
P10725363A01
Basal_JJ cell_NN carcinoma_NN is_VBZ the_DD most_RRT prevalent_JJ cancer_NN in_II the_DD western_JJ world_NN ,_, showing_VVG a_DD rapid_JJ increase_NN in_II incidence_NN ._.
P10725363A06
These_DD findings_NNS firmly_RR establish_VVB that_CST increased_VVNJ GLI-1_NN expression_NN is_VBZ central_JJ and_CC probably_RR sufficient_JJ for_II tumor_NN development_NN and_CC suggest_VVB that_CST GLI-1-induced_VVNJ tumor_NN development_NN does_VDZ not_RR depend_VVB on_II additional_JJ p53_NN or_CC Ha_NN ras_NN mutations_NNS ._.
P10751169A02
In_II this_DD study_NN ,_, we_PN have_VHB investigated_VVN the_DD morphogenetic_JJ role_NN of_II defined_VVNJ segments_NNS of_II the_DD AML_NN by_II testing_VVGN their_PNG inductive_JJ and_CC patterning_VVGJ activity_NN and_CC by_II assessing_VVGN the_DD impact_NN of_II their_PNG ablation_NN on_II the_DD patterning_VVGN of_II the_DD neural_JJ tube_NN at_II the_DD early-somite-stage_NN ._.
P10751169A08
In_II addition_NN ,_, Nkx2.1_NN expression_NN was_VBD not_RR detected_VVN in_II the_DD ventral_JJ neural_JJ tube_NN ._.
P10751178A03
In_II this_DD study_NN ,_, to_TO test_VVI whether_CST the_DD mfp_NN is_VBZ involved_VVN in_II the_DD specification_NN of_II the_DD DV_NN polarity_NN of_II the_DD tectum_NN and_CC affects_VVZ the_DD projection_NN patterns_NNS of_II retinal_JJ fibers_NNS to_II the_DD tectum_NN along_II the_DD DV_NN axis_NN ,_, we_PN transplanted_VVD quail_NN mfp_NN into_II the_DD dorsal_JJ mesencephalon_NN of_II chick_NN embryos_NNS ,_, and_CC analyzed_VVD projection_NN patterns_NNS of_II dorsal_JJ and_CC ventral_JJ retinal_JJ fibers_NNS to_II the_DD tectum_NN ._.
P10752765A06
For_II instance_NN ,_, a_DD primary_JJ system_NN for_II pattern_NN formation_NN involving_VVG retinoic_JJ acid_NN ,_, homeobox_NN genes_NNS ,_, sonic_NN hedgehog_NN ,_, fibroblast_NN growth_NN factor_NN (_( FGF_NN )_) ,_, and_CC an_DD FGF_NN receptor_NN all_PND appear_VVB to_TO function_VVI in_II limb_NN ,_, lung_NN ,_, and_CC kidney_NN organogenesis_NN ._.
P10753513A06
Injection_NN of_II a_DD cocktail_NN of_II antisense_NN (_( alphashh_NN /_SYM alphatwhh_NN )_) oligonucleotides_NNS reduces_VVZ expression_NN of_II both_DD hh_NN genes_NNS in_II the_DD RPE_NN and_CC slows_VVZ or_CC arrests_VVZ the_DD progression_NN of_II rod_NN and_CC cone_NN photoreceptor_NN differentiation_NN ._.
P10759426A04
Differentiation_NN requires_VVZ the_DD initial_JJ commitment_NN of_II mesenchymal_JJ stem_NN cells_NNS to_II a_DD given_VVNJ lineage_NN ,_, followed_VVN by_II induction_NN of_II tissue-specific_JJ patterns_NNS of_II gene_NN expression_NN ._.
P10759426A10
A_DD cell_NN :_: ECM_NN interaction_NN mediated_VVN by_II integrin-type_NN cell-surface_NN receptors_NNS is_VBZ essential_JJ for_II the_DD induction_NN of_II osteocalcin_NN and_CC other_JJ osteoblast-related_VVNJ proteins_NNS ._.
P10771469A01
Members_NNS of_II the_DD vertebrate_NN hedgehog_NN family_NN (_( Sonic_NN ,_, Indian_NN ,_, and_CC Desert_NN )_) have_VHB been_VBN shown_VVN to_TO be_VBI essential_JJ for_II the_DD development_NN of_II various_JJ organ_NN systems_NNS ,_, including_VVG neural_JJ ,_, somite_NN ,_, limb_NN ,_, skeletal_JJ ,_, and_CC for_II male_NN gonad_NN morphogenesis_NN ._.
P10771469A07
Strikingly_RR ,_, inhibition_NN of_II body_NN coat_NN hair_NN morphogenesis_NN also_RR was_VBD observed_VVN in_II mice_NNS treated_VVN postnatally_RR with_II anti-hedgehog_NN monoclonal_JJ antibody_NN during_II the_DD growing_VVGJ (_( anagen_NN )_) phase_NN of_II the_DD hair_NN cycle_NN ._.
P10777692A03
The_DD fathead_NN minnow_NN (_( Pimephales_NN promelas_NN )_) was_VBD formalin-fixed_VVN ,_, and_CC paraffin-embedded_VVN ._.
P10777692A08
This_DD result_NN was_VBD consistent_JJ with_II that_PND of_II immunohistochemical_JJ analysis_NN with_II a_DD CYP1A1-specific_JJ monoclonal_JJ antibody_NN ._.
P10777830A05
RESULTS_NNS :_: A_DD cervical_JJ notochord_NN duplication_NN was_VBD always_RR found_VVN in_II craniorachischisis_NN (_( CRS_NN ,_, n_NN =_SYM 8_MC )_) ,_, but_CC not_RR in_II spina_NN bifida_NN (_( SB_NN ,_, n_NN =_SYM 10_MC )_) or_CC diplomyelia_NN (_( split_JJ cord_NN malformation_NN ,_, n_NN =_SYM 3_MC )_) ._.
P10777830A11
This_PND suggests_VVZ that_CST the_DD Lp_NN gene_NN could_VM be_VBB a_DD candidate_NN gene_NN for_II human_NN CRS_NN ._.
P10781055A03
We_PN describe_VVB a_DD reciprocal_JJ relationship_NN between_II the_DD expression_NN of_II Wnt-7b_NN in_II presumptive_JJ oral_JJ ectoderm_NN and_CC Shh_NN in_II presumptive_JJ dental_JJ ectoderm_NN in_II mouse_NN embryos_NNS that_PNR mark_VVB boundaries_NNS between_II these_DD cells_NNS with_II different_JJ developmental_JJ fates_NNS ._.
P10786690A06
Therefore_RR ,_, we_PN investigated_VVD ptc_NN +/-_SYM mice_NNS as_II a_DD model_NN for_II human_NN medulloblastoma_NN ._.
P10786690A12
High_JJ levels_NNS of_II glil_NN mRNA_NN and_CC protein_NN were_VBD detected_VVN in_II the_DD tumors_NNS ,_, suggesting_VVG that_CST the_DD shh_NN /_SYM ptc_NN pathway_NN was_VBD activated_VVN despite_II the_DD persistence_NN of_II ptc_NN expression_NN ._.
P10804186A01
Limb_NN outgrowth_NN and_CC patterning_VVGN of_II skeletal_JJ elements_NNS are_VBB dependent_JJ on_II complex_JJ tissue_NN interactions_NNS involving_VVG the_DD zone_NN of_II polarizing_VVGJ activity_NN (_( ZPA_NN )_) in_II the_DD posterior_JJ region_NN of_II the_DD limb_NN bud_NN and_CC the_DD apical_JJ ectodermal_JJ ridge_NN ._.
P10804186A07
Together_RR ,_, these_DD findings_NNS identify_VVB dHAND_NN as_II an_DD upstream_JJ activator_NN of_II Shh_NN expression_NN and_CC important_JJ transcriptional_JJ regulator_NN of_II limb_NN development_NN ._.
P10821773A03
We_PN have_VHB assessed_VVN the_DD function_NN of_II Sonic_NN hedgehog_NN and_CC Indian_NN hedgehog_NN genes_NNS ,_, which_PNR encode_VVB members_NNS of_II the_DD Hedgehog_NN family_NN of_II cell_NN signals_NNS ._.
P10821773A09
Indian_NN hedgehog_NN mutants_NNS show_VVB reduced_VVNJ epithelial_JJ stem_NN cell_NN proliferation_NN and_CC differentiation_NN ,_, together_RR with_II features_NNS typical_JJ of_II Hirschsprung_NN 's_GE disease_NN (_( aganglionic_JJ colon_NN )_) ._.
P10830170A02
A_DD set_NN of_II homeodomain_NN transcription_NN factors_NNS expressed_VVN by_II neural_JJ progenitors_NNS act_VVB as_II intermediaries_NNS in_II Shh-dependent_JJ neural_JJ patterning_VVGN ._.
P10838143A05
The_DD type_NN and_CC distribution_NN of_II mutations_NNS are_VBB quite_RR different_JJ between_II germline_NN ,_, sporadic_JJ and_CC XP_NN cancers_NNS ._.
P10841173A06
Using_VVG in_JJ+ situ_JJ hybridization_NN ,_, IHH_NN ,_, PTHrP_NN ,_, and_CC PTH_NN /_SYM PTHrP_NN receptor_NN mRNA_NN were_VBD detected_VVN in_II prehypertrophic_JJ and_CC hypertrophic_JJ chondrocytes_NNS in_II both_DD sexes_NNS during_II development_NN ._.
P10841173A12
Our_PNG data_NNS suggest_VVB that_CST in_II contrast_NN to_II the_DD proposed_VVNJ feedback_NN loop_NN in_II the_DD early_JJ embryonic_JJ growth_NN plate_NN ,_, which_PNR requires_VVZ the_DD presence_NN of_II the_DD perichondrium_NN ,_, a_DD feedback_NN loop_NN in_II the_DD postnatal_JJ growth_NN plate_NN can_VM be_VBB confined_VVN to_II the_DD growth_NN plate_NN itself_PN ._.
P10842364A04
A_DD similarly_RR specific_JJ requirement_NN for_II FGF-2_NN /_SYM 4_MC signaling_VVGN was_VBD revealed_VVN since_CS neither_CC FGF-7_NN ,_, activin-A_NN nor_CC insulin_NN could_VM replace_VVB this_DD activity_NN ._.
P10842364A10
These_DD findings_NNS are_VBB interpreted_VVN in_II terms_NNS of_II these_DD factors_NNS '_GE possible_JJ roles_NNS during_II cardiac_JJ specification_NN and_CC differentiation_NN ._.
P10845115A06
Several_JJ of_II these_DD transcription_NN factors_NNS serve_VVB dual_JJ roles_NNS as_II regulators_NNS of_II genes_NNS involved_VVN in_II early_JJ lung_NN development_NN and_CC in_II specialized_VVNJ functions_NNS of_II differentiated_VVNJ cells_NNS ._.
P10847682A03
acu_NN encodes_VVZ a_DD homolog_NN of_II yeast_NN cyclase-associated_VVNJ protein_NN ,_, which_PNR sequesters_VVZ monomeric_JJ actin_NN ;_: we_PN show_VVB that_CST acu_NN is_VBZ required_VVN to_TO prevent_VVI actin_NN filament_NN polymerization_NN in_II the_DD eye_NN disc_NN ._.
P10851126A06
Together_RR these_DD experiments_NNS suggest_VVB that_CST ,_, in_RR+ vivo_RR ,_, signalling_VVGN by_II anterior_JJ endoderm_NN may_VM determine_VVB the_DD extent_NN of_II prechordal_JJ mesoderm_NN ._.
P10860995A06
Finally_RR ,_, the_DD precursor_NN form_NN of_II mShh_NN that_PNR results_VVZ from_II autoprocessing_VVGJ inhibition_NN appears_VVZ to_TO accumulate_VVI as_II an_DD amide_NN rather_II+ than_II a_DD stable_JJ thioester_NN ._.
P10882517A01
The_DD Lefty_NN subfamily_NN of_II TGFbeta_NN signaling_VVGJ molecules_NNS has_VHZ been_VBN implicated_VVN in_II early_JJ development_NN in_II mouse_NN ,_, zebrafish_NN ,_, and_CC chick_NN ._.
P10882517A07
Here_RR ,_, we_PN show_VVB that_CST Xlefty_NN interacts_VVZ with_II the_DD signaling_VVGJ pathways_NNS of_II other_JJ members_NNS of_II the_DD TGFbeta_NN family_NN during_II left-right_NN development_NN ._.
P10893185A03
In_II the_DD zebrafish_NN ,_, fibres_NNS of_II the_DD slow_JJ twitch_NN class_NN arise_VVB from_II precociously_RR specified_VVNJ myoblasts_NNS that_PNR lie_VVB close_JJ to_II the_DD midline_NN whereas_CS the_DD remainder_NN of_II the_DD myotome_NN differentiates_VVZ as_II fast_JJ myosin_NN expressing_VVGJ muscle_NN ._.
P10894984A03
The_DD morphological_JJ boundary_NN between_II midbrain_NN and_CC hindbrain_NN ,_, the_DD isthmus_NN ,_, is_VBZ an_DD important_JJ tissue_NN organizer_NN that_PNR regulates_VVZ the_DD development_NN of_II both_CC the_DD midbrain_NN and_CC the_DD anterior_JJ hindbrain_NN ._.
P10899793A03
Significant_JJ etiologic_JJ heterogeneity_NN exists_VVZ in_II HPE_NN and_CC includes_VVZ both_DD genetic_JJ and_CC environmental_JJ causes_NNS ._.
P10906453A03
Such_JJ clones_NNS are_VBB associated_VVN with_II ectopic_JJ expression_NN of_II engrailed_NN ,_, hedgehog_NN ,_, patched_NN ,_, cubitus_NN interruptus_NN and_CC decapentaplegic_NN ,_, in_II a_DD compartment_NN specific_JJ manner_NN ._.
P10906454A06
Similarly_RR ,_, ectopic_JJ expression_NN of_II cFHF-4_NN is_VBZ correlated_VVN with_II a_DD local_JJ induction_NN of_II limb-like_JJ innervation_NN patterns_NNS when_CS beads_NNS containing_VVG FGF-2_NN are_VBB implanted_VVN in_II the_DD flank_NN ._.
P10921907A02
Biochemical_JJ studies_NNS in_II vertebrates_NNS indicate_VVB that_CST the_DD membrane_NN proteins_NNS Ptc_NN and_CC Smoothened_NN (_( Smo_NN )_) form_VVB a_DD receptor_NN complex_NN that_PNR binds_VVZ Hedgehog_NN (_( Hh_NN )_) morphogens_NNS ._.
P10921907A08
ptc-1_NN null_JJ mutants_NNS are_VBB sterile_JJ with_II multinucleate_JJ germ_NN cells_NNS arising_VVGN from_II a_DD probable_JJ cytokinesis_NN defect_NN ._.
P10926759A04
RT-PCR_NN analysis_NN detected_VVD insulin_NN ,_, IGF-II_NN ,_, insulin_NN receptor_NN ,_, and_CC IGF_NN receptor_NN mRNAs_NNS in_II both_CC the_DD neural_JJ tube_NN and_CC the_DD somites_NNS ,_, whereas_CS IGF-I_NN transcripts_NNS were_VBD detected_VVN in_II entire_JJ embryos_NNS but_CC not_RR in_II the_DD neural_JJ tube_NN or_CC somites_NNS ._.
P10926768A01
Mutations_NNS in_II the_DD EXT1_NN gene_NN are_VBB responsible_JJ for_II human_NN hereditary_JJ multiple_JJ exostosis_NN type_NN 1_MC ._.
P10926768A07
Immunohistochemical_JJ staining_VVGN revealed_VVD a_DD visceral_JJ endoderm_NN pattern_NN of_II Indian_NN hedgehog_NN (_( Ihh_NN )_) in_II wild-type_NN E6.5_NN embryos_NNS ._.
P10952899A05
We_PN show_VVB that_CST the_DD ability_NN of_II ectoderm_NN to_TO form_VVI an_DD apical_JJ ridge_NN in_II response_NN to_II FGF4_NN in_II both_CC mouse_NN and_CC chick_NN embryos_NNS exists_VVZ throughout_II the_DD flank_NN as_CS does_VDZ ability_NN of_II mesenchyme_NN to_TO provide_VVI a_DD polarizing_VVGJ region_NN signal_NN ._.
P10952899A11
Furthermore_RR ,_, when_CS we_PN apply_VVB simultaneously_RR a_DD polarizing_VVGJ signal_NN and_CC a_DD limb_NN induction_NN signal_NN to_II early_JJ chick_NN flank_NN ,_, this_PND leads_VVZ to_II limb_NN duplications_NNS ._.
P10970877A04
At_II many_DD axial_JJ levels_NNS there_EX is_VBZ a_DD complete_JJ block_NN in_II the_DD generation_NN of_II V2_NN interneurons_NNS and_CC motor_NN neurons_NNS and_CC a_DD compensatory_JJ ventral_JJ expansion_NN in_II the_DD domain_NN of_II generation_NN of_II V1_NN neurons_NNS ,_, demonstrating_VVG the_DD essential_JJ functions_NNS of_II Nkx6.1_NN in_II regional_JJ patterning_VVGN and_CC neuronal_JJ fate_NN determination_NN ._.
P10980429A01
Hedgehog_NN (_( Hh_NN )_) is_VBZ a_DD secreted_VVNJ signaling_VVGJ protein_NN that_PNR regulates_VVZ the_DD development_NN of_II many_DD organ_NN systems_NNS ._.
P10981962A03
Our_PNG data_NNS suggest_VVB that_CST termination_NN of_II Hh_NN signaling_VVGN is_VBZ necessary_JJ for_II differentiation_NN from_II CD4-CD8-double-negative_JJ (_( DN_NN )_) to_II CD4+CD8+_NN double-positive_JJ (_( DP_NN )_) thymocyte_NN ._.
P10983991A04
We_PN show_VVB that_CST Smoothened_NN protein_NN levels_NNS in_II Drosophila_NN embryos_NNS are_VBB regulated_VVN posttranscriptionally_RR by_II a_DD mechanism_NN dependent_JJ on_II Hedgehog_NN signaling_VVGN but_CC not_RR on_II its_PNG nuclear_JJ effector_NN Cubitus_NN interruptus_NN ._.
P10983992A06
This_DD deletion_NN has_VHZ dominant-negative_JJ activity_NN ,_, promoting_VVG target_NN gene_NN activation_NN in_II a_DD ligand-independent_JJ manner_NN ._.
P10985858A03
Here_RR we_PN have_VHB investigated_VVN the_DD hypothesis_NN that_CST Fgf4_NN is_VBZ a_DD target_NN of_II myogenic_JJ bHLH_NN factors_NNS ._.
P10985858A09
This_PND suggests_VVZ that_CST Shh_NN mediates_VVZ Fgf4_NN activation_NN in_II the_DD myotomes_NNS through_II mechanisms_NNS independent_JJ of_II its_PNG role_NN in_II the_DD activation_NN of_II myogenic_JJ factors_NNS ._.
P10994991A02
The_DD underlying_VVGJ molecular_JJ mechanisms_NNS involve_VVB the_DD oscillation_NN of_II "_`` clock-genes_NNS "_'' like_II c-hairy-1_NN and_CC lunatic_NN fringe_NN indicative_JJ of_II an_DD implication_NN of_II the_DD Notch_NN signaling_VVGJ pathway_NN ._.
P10994991A08
The_DD lateral_JJ sclerotome_NN gives_VVZ rise_NN to_II the_DD laminae_NN and_CC pedicles_NNS of_II the_DD neural_JJ arches_NNS and_CC to_II the_DD ribs_NNS ._.
P10994991A14
The_DD regionalization_NN of_II the_DD paraxial_JJ mesoderm_NN occurs_VVZ by_II a_DD combination_NN of_II functionally_RR Hox_NN genes_NNS ,_, the_DD Hox_NN code_NN ,_, and_CC determines_VVZ the_DD segment_NN identity_NN ._.
P11017081A03
We_PN show_VVB here_RR that_CST antisense_NN ,_, morpholino-modified_VVNJ oligonucleotides_NNS (_( morpholinos_NNS )_) are_VBB effective_JJ and_CC specific_JJ translational_JJ inhibitors_NNS in_II zebrafish_NN ._.
P11017081A09
We_PN showed_VVD that_CST embryos_NNS with_II reduced_VVNJ sonic_NN hedgehog_NN (_( ref._NN 9_MC )_) signalling_VVGN and_CC reduced_VVNJ tiggy-winkle_NN hedgehog_NN (_( ref._NN 10_MC )_) function_NN exhibit_VVB partial_JJ cyclopia_NN and_CC other_JJ specific_JJ midline_NN abnormalities_NNS ,_, providing_VVG a_DD zebrafish_NN genetic_JJ model_NN for_II the_DD common_JJ human_NN disorder_NN holoprosencephaly_NN ._.
P11017169A02
Shh_NN is_VBZ made_VVN in_II the_DD notochord_NN ,_, the_DD most_RRT ventral_JJ part_NN of_II the_DD spinal_JJ cord_NN ,_, and_CC in_II mice_NNS lacking_VVG Shh_NN ,_, ventral_JJ cell_NN types_NNS are_VBB reduced_VVN or_CC absent_JJ ._.
P11017169A08
Differences_NNS between_II rostral_JJ and_CC caudal_JJ regions_NNS suggest_VVB that_CST other_JJ signaling_VVGJ molecules-in_II addition_NN to_II Shh-may_VM be_VBB involved_VVN in_II specifying_VVGN ventral_JJ fates_NNS ,_, particularly_RR in_II the_DD caudal_JJ region_NN of_II the_DD spinal_JJ cord_NN ._.
P11021632A02
Facial_JJ clefts_NNS can_VM arise_VVB at_II any_DD stage_NN of_II development_NN due_II+ to_II perturbations_NNS that_PNR alter_VVB the_DD extracellular_JJ matrix_NN as_CC+ well_CC+ as_CC affect_VVB the_DD patterning_VVGN ,_, migration_NN ,_, proliferation_NN ,_, and_CC differentiation_NN of_II cells_NNS ._.
P11023863A03
We_PN have_VHB used_VVN explant_NN cultures_NNS of_II chick_NN optic_JJ vesicles_NNS to_TO study_VVI the_DD regulation_NN of_II retinal_JJ pigmented_VVNJ epithelium_NN (_( RPE_NN )_) patterning_VVGN and_CC differentiation_NN during_II early_JJ eye_NN development_NN ._.
P11023863A09
These_DD data_NNS indicate_VVB that_CST extraocular_JJ mesenchyme_NN ,_, and_CC possibly_RR an_DD activin-like_JJ signal_NN ,_, pattern_VVB the_DD domains_NNS of_II the_DD optic_JJ vesicle_NN into_II RPE_NN and_CC neural_JJ retina_NN ._.
P11023872A05
Sim2_NN encodes_VVZ a_DD basic_JJ helix-loop-helix_NN (_( bHLH-PAS_NN )_) PAS_NN domain_NN containing_VVGJ transcriptional_JJ regulator_NN whose_PNR Drosophila_NN homolog_NN ,_, single-minded_NN ,_, is_VBZ a_DD master_JJ regulator_NN of_II ventral_JJ midline_NN development_NN ._.
P11025213A01
The_DD appearance_NN of_II bottle_NN cells_NNS at_II the_DD dorsal_JJ vegetal_JJ /_SYM marginal_JJ boundary_NN of_II Xenopus_NN embryos_NNS marks_VVZ the_DD onset_NN of_II blastopore_NN formation_NN ._.
P11025213A07
In_II addition_NN ,_, fibroblast_NN growth_NN factor_NN signalling_VVGN is_VBZ an_DD essential_JJ precondition_NN for_II this_DD epithelial_JJ response_NN as_CS it_PN is_VBZ for_II mesoderm_NN formation_NN ._.
P11032829A06
Flow_NN cytometry_NN analysis_NN determined_VVD that_CST the_DD gamma-UTR_NN variant_NN expresses_VVZ a_DD heterologous_JJ reporter_NN gene_NN 14-23-fold_NN higher_JJR than_CSN the_DD alpha-UTR_NN and_CC 5-13-fold_NN higher_JJR than_CSN the_DD beta-UTR_NN in_II a_DD variety_NN of_II cell_NN types_NNS ._.
P11042037A02
To_TO explore_VVI the_DD possibility_NN that_CST hedgehog_NN signaling_VVGN is_VBZ involved_VVN in_II the_DD control_NN of_II hematopoietic_JJ differentiation_NN ,_, we_PN screened_VVD a_DD panel_NN of_II human_NN leukemia_NN cell_NN lines_NNS for_II the_DD expression_NN of_II Patched1_NN and_CC Smoothened_NN ,_, the_DD receptor_NN and_CC coreceptor_NN for_II hedgehog_NN ligands_NNS ._.
P11042037A08
Incubation_NN of_II hematopoietic_JJ progenitors_NNS with_II Shh-N_NN and_CC GM-CSF_NN resulted_VVN in_II increased_VVNJ granulocyte_NN /_SYM monocyte_NN colonies_NNS (_( P_NN <_SYM 0.01_MC )_) ;_: the_DD increase_NN was_VBD blocked_VVN by_II cyclopamine_NN ._.
P11044393A06
Sonic_NN hedgehog_NN (_( Shh_NN )_) encodes_VVZ a_DD signaling_VVGJ peptide_NN which_PNR is_VBZ present_JJ in_II the_DD oral_JJ epithelium_NN prior_II+ to_II invagination_NN and_CC in_II the_DD tooth_NN epithelium_NN throughout_II its_PNG development_NN ._.
P11044393A12
However_RR ,_, both_CC dentin-_NN and_CC enamel-specific_JJ markers_NNS are_VBB expressed_VVN and_CC a_DD large_JJ amount_NN of_II tooth-specific_JJ extracellular_JJ matrix_NN is_VBZ produced_VVN ._.
P11044396A01
The_DD polarising_VVGJ region_NN expresses_VVZ the_DD signalling_VVGJ molecule_NN sonic_NN hedgehog_NN (_( Shh_NN )_) ,_, and_CC is_VBZ an_DD embryonic_JJ signalling_VVGJ centre_NN essential_JJ for_II outgrowth_NN and_CC patterning_VVGN of_II the_DD vertebrate_NN limb_NN ._.
P11044396A07
Application_NN of_II Shh_NN protein_NN to_II late_JJ limb_NN buds_NNS also_RR caused_VVD alterations_NNS in_II digit_NN morphogenesis_NN ._.
P11044396A13
Such_DB an_DD autoregulatory_JJ process_NN based_VVN on_II cell_NN death_NN could_VM represent_VVB a_DD general_JJ way_NN for_II regulating_VVGN patterning_VVGJ signals_NNS in_II embryos_NNS ._.
P11044400A01
The_DD secretion_NN of_II Sonic_NN hedgehog_NN (_( Shh_NN )_) from_II the_DD notochord_NN and_CC floor_NN plate_NN appears_VVZ to_TO generate_VVI a_DD ventral-to-dorsal_JJ gradient_NN of_II Shh_NN activity_NN that_PNR directs_VVZ progenitor_NN cell_NN identity_NN and_CC neuronal_JJ fate_NN in_II the_DD ventral_JJ neural_JJ tube_NN ._.
P11044400A07
Conversely_RR ,_, follistatin_NN but_CC not_RR noggin_NN produces_VVZ a_DD dorsal-to-ventral_JJ switch_NN in_II progenitor_NN cell_NN identity_NN and_CC neuronal_JJ fate_NN in_II response_NN to_II Shh_NN both_CC in_RR+ vitro_RR and_CC in_RR+ vivo_RR ._.
P11044411A04
This_PND may_VM be_VBB due_II+ to_II differential_JJ WNT_NN inhibition_NN since_CS dkk1_NN ,_, unlike_II frzb_NN ,_, inhibits_VVZ Wnt3a_NN signalling_VVGN ._.
P11044411A10
Embryos_NNS treated_VVN with_II retinoic_JJ acid_NN (_( RA_NN )_) are_VBB not_RR rescued_VVN by_II dkk1_NN and_CC RA_NN affects_VVZ the_DD central_JJ nervous_JJ system_NN (_( CNS_NN )_) more_RR posterior_JJ than_CSN dkk1_NN ,_, suggesting_VVG that_CST WNTs_NNS and_CC retinoids_NNS may_VM act_VVB to_TO pattern_VVI anterior_JJ and_CC posterior_JJ CNS_NN ,_, respectively_RR ,_, during_II gastrulation_NN ._.
P11048294A01
Limbs_NNS are_VBB formed_VVN after_II a_DD series_NN of_II complex_JJ interactions_NNS between_II tissues_NNS derived_VVN from_II the_DD embryonic_JJ layers_NNS (_( surface_NN ectoderm_NN and_CC somatopleural_JJ mesoderm_NN )_) ._.
P11048294A06
So_RR ,_, the_DD definitive_JJ shape_NN of_II a_DD structure_NN could_VM depend_VVB on_II only_RR one_MC of_II its_PNG component_NN ._.
P11048294A12
The_DD family_NN of_II secreted_VVNJ FGF_NN and_CC their_PNG receptors_NNS play_VVB a_DD major_JJ role_NN in_II the_DD regulation_NN of_II the_DD development_NN of_II this_DD axis_NN ._.
P11057905A03
Functions_NNS of_II the_DD PM_NN in_II coordinating_VVGN growth_NN and_CC patterning_VVGN of_II the_DD DP_NN are_VBB unknown_VVN ._.
P11060239A05
Here_RR we_PN report_VVB the_DD identification_NN of_II two_MC chick_NN homologues_NNS of_II the_DD Cut_NN /_SYM Cux_NN /_SYM CDP_NN family_NN that_PNR are_VBB expressed_VVN in_II the_DD developing_VVGJ limb_NN bud_NN ._.
P11060239A11
These_DD results_NNS suggest_VVB that_CST Cux2_NN may_VM have_VHB a_DD role_NN in_II generating_VVGN or_CC mediating_VVGN polarizing_VVGJ activity_NN ._.
P11061432A03
DA_NN progenitors_NNS are_VBB first_RR "_`` committed_VVN "_'' to_TO give_VVI rise_NN to_II DA_NN neurons_NNS by_II the_DD action_NN of_II two_MC secreted_VVNJ factors_NNS ,_, Sonic_NN hedgehog_NN and_CC fibroblast_NN growth_NN factor_NN 8_MC (_( FGF8_NN )_) ._.
P11061432A09
Strikingly_RR ,_, the_DD in_JJ+ situ_JJ maturation_NN and_CC phenotypic_JJ specialization_NN of_II DA_NN neurons_NNS grafted_VVN into_II the_DD adult_NN striatum_NN /_SYM caudate-putamen_NN parallels_VVZ the_DD normal_JJ development_NN of_II committed_VVNJ fetal_JJ dopamine_NN neurons_NNS during_II neurogenesis_NN ._.
P11061434A05
We_PN propose_VVB the_DD possibility_NN that_CST these_DD myogenic_JJ cells_NNS are_VBB derived_VVN from_II the_DD vasculature_NN ,_, are_VBB multi-potent_JJ and_CC become_VVB committed_VVN to_II myogenesis_NN by_II local_JJ signaling_VVGN ,_, when_CS ingressing_VVG a_DD differentiating_VVGJ muscle_NN tissue_NN ._.
P11069117A02
The_DD multipass_NN membrane-spanning_VVGJ proteins_NNS Patched_NN (_( Ptc_NN )_) [_( 2-4_MC ]_) and_CC Smoothened_NN (_( Smo_NN )_) [_( 5-7_MC ]_) have_VHB been_VBN proposed_VVN to_TO act_VVI as_II subunits_NNS of_II a_DD putative_JJ Hh_NN receptor_NN complex_NN ._.
P11069117A08
Our_PNG findings_NNS suggest_VVB that_CST Smo_NN is_VBZ modified_VVN to_TO yield_VVI a_DD non-functional_JJ form_NN and_CC this_DD modification_NN is_VBZ promoted_VVN by_II Ptc_NN in_II a_DD non-stoichiometric_JJ manner_NN ._.
P11071781A05
At_II later_JJR stages_NNS ,_, the_DD lack_NN of_II opb_NN (_( +_SYM )_) causes_VVZ a_DD non-cell-autonomous_JJ expansion_NN of_II ventral_JJ cell_NN types_NNS into_II dorsal_JJ regions_NNS of_II the_DD neural_JJ tube_NN ,_, revealing_VVG that_CST opb_NN (_( +_SYM )_) controls_VVZ the_DD production_NN of_II a_DD diffusible_JJ molecule_NN that_PNR defines_VVZ the_DD domain_NN of_II Shh_NN expression_NN ._.
P11074003A01
Sonic_NN hedgehog_NN (_( Shh_NN )_) signal_NN transduction_NN via_II the_DD G-protein-coupled_VVNJ receptor_NN ,_, Smoothened_NN ,_, is_VBZ required_VVN for_II proliferation_NN of_II cerebellar_JJ granule_NN neuron_NN precursors_NNS (_( CGNPs_NNS )_) during_II development_NN ._.
P11074003A07
Analysis_NN of_II CGNPs_NNS from_II cyclinD1_NN (_( -/-_SYM )_) or_CC cyclinD2_NN (_( -/-_SYM )_) mice_NNS demonstrates_VVZ that_CST the_DD Shh_NN proliferative_JJ pathway_NN does_VDZ not_RR require_VVB unique_JJ functions_NNS of_II cyclinD1_NN or_CC cyclinD2_NN and_CC that_CST D-type_NN cyclins_NNS overlap_VVB functionally_RR in_II this_DD regard_NN ._.
P11076673A05
Hoxb-5_NN and_CC Hoxb-6_NN expression_NN domains_NNS demarcate_VVB the_DD trachea_NN ,_, bronchial_JJ tree_NN ,_, and_CC air_NN sacs_NNS ._.
P11076673A11
By_II tissue_NN recombination_NN experiments_NNS ,_, we_PN found_VVD that_CST the_DD dorsal_JJ and_CC the_DD ventral_JJ pulmonary_JJ mesenchyme_NN ,_, demarcated_VVN by_II Hoxb-6_NN expression_NN ,_, have_VHB different_JJ inductive_JJ capacities_NNS toward_II the_DD tracheal_JJ epithelium_NN ._.
P11076675A05
When_CS we_PN cultured_VVD the_DD ventral_JJ and_CC dorsal_JJ spinal_JJ cords_NNS separately_RR ,_, a_DD robust_JJ increase_NN in_II the_DD number_NN of_II O4_NN (_( +_SYM )_) cells_NNS was_VBD observed_VVN in_II the_DD ventral_JJ fragment_NN ._.
P11076756A02
Analyses_NNS of_II the_DD expression_NN and_CC targeted_VVNJ disruption_NN of_II the_DD homeobox_NN gene_NN Hoxb1_NN demonstrate_VVB that_CST it_PN is_VBZ essential_JJ for_II patterning_VVGJ progenitor_NN cells_NNS along_II the_DD entire_JJ DV_NN axis_NN of_II rhombomere_NN 4_MC (_( r4_NN )_) ._.
P11076770A04
From_II these_DD cells_NNS a_DD Hh_NN signal_NN acts_VVZ in_II both_CC anterior_JJ and_CC posterior_JJ directions_NNS ._.
P11076770A10
Hh_NN is_VBZ required_VVN for_II the_DD maintenance_NN of_II wingless_NN expression_NN before_II embryonic_JJ stage_NN 11_MC whereas_CS Ci_NN is_VBZ necessary_JJ only_RR later_RR during_II stage_NN 11_MC ._.
P11101845A01
The_DD expression_NN pattern_NN and_CC activity_NN of_II fibroblast_NN growth_NN factor-8_NN (_( FGF8_NN )_) in_II experimental_JJ assays_NNS indicate_VVB that_CST it_PN has_VHZ important_JJ roles_NNS in_II limb_NN development_NN ,_, but_CC early_JJ embryonic_JJ lethality_NN resulting_VVG from_II mutation_NN of_II Fgf8_NN in_II the_DD germ_NN line_NN of_II mice_NNS has_VHZ prevented_VVN direct_JJ assessment_NN of_II these_DD roles_NNS ._.
P11101846A02
Removal_NN of_II the_DD AER_NN in_II chick_NN results_VVZ in_II limbs_NNS lacking_VVG distal_JJ skeletal_JJ elements_NNS ._.
P11101846A08
Our_PNG data_NNS identify_VVB Fgf8_NN as_II the_DD only_JJ known_VVNJ AER-Fgf_NN individually_RR necessary_JJ for_II normal_JJ limb_NN development_NN ,_, and_CC provide_VVB insight_NN into_II the_DD function_NN of_II Fgf_NN signalling_VVGN from_II the_DD AER_NN in_II the_DD normal_JJ outgrowth_NN and_CC patterning_VVGN of_II the_DD limb_NN ._.
P11102373A04
We_PN performed_VVD a_DD mutagenesis_NN screen_NN for_II mutations_NNS that_PNR dominantly_RR suppress_VVB Hedgehog_NN overexpression_NN phenotypes_NNS in_II the_DD Drosophila_NN melanogaster_NN wing_NN ._.
P11103949A03
Several_JJ Hh-responsive_JJ genes_NNS expressed_VVN by_II cells_NNS of_II the_DD organizer_NN mediate_VVB its_PNG patterning_VVGJ activity_NN ._.
P11118005A04
Here_RR we_PN report_VVB that_CST Hhs_NNS Ihh_NN and_CC Dhh_NN and_CC their_PNG receptors_NNS patched_NN (_( Ptc_NN )_) and_CC smoothened_NN are_VBB expressed_VVN in_II the_DD endocrine_JJ islets_NNS of_II Langerhans_NN of_II the_DD fully_RR developed_VVNJ rat_NN pancreas_NN and_CC in_II the_DD clonal_JJ gamma-cell_NN line_NN INS-1_NN ._.
P11118005A10
We_PN propose_VVB that_CST Hh_NN signaling_VVGN is_VBZ not_RR restricted_VVN to_II patterning_VVGN in_II early_JJ pancreas_NN development_NN but_CC also_RR continues_VVZ to_TO signal_VVI in_II differentiated_VVNJ beta-cells_NNS of_II the_DD endocrine_JJ pancreas_NN in_II regulating_VVGN insulin_NN production_NN ._.
P11118883A01
Patterning_VVGN of_II the_DD limb_NN is_VBZ coordinated_VVN by_II the_DD complex_JJ interplay_NN of_II three_MC signaling_VVGJ regions_NNS :_: the_DD apical_JJ ectodermal_JJ ridge_NN (_( AER_NN )_) ,_, the_DD zone_NN of_II polarizing_VVGJ activity_NN (_( ZPA_NN )_) ,_, and_CC the_DD non-ridge_NN limb_NN ectoderm_NN ._.
P11118883A07
In_II contrast_NN to_II previous_JJ studies_NNS we_PN also_RR demonstrate_VVB that_CST Shh_NN signaling_VVGN is_VBZ required_VVN for_II maintenance_NN of_II normal_JJ Fgf8_NN expression_NN ,_, since_CS expression_NN of_II Fgf8_NN ,_, unlike_II some_DD other_JJ AER_NN marker_NN genes_NNS ,_, is_VBZ rapidly_RR lost_VVN from_II anterior_JJ to_II posterior_JJ after_II E10.5_NN ,_, with_II only_RR a_DD small_JJ domain_NN of_II Fgf8_NN expression_NN remaining_VVGN posteriorly_RR ._.
P11130177A03
This_DD review_NN focuses_VVZ on_II recent_JJ studies_NNS aimed_VVN at_II determining_VVGN how_CST Shh_NN signaling_VVGN is_VBZ affected_VVN by_II these_DD causes_NNS of_II holoprosencephaly_NN ,_, whether_CST they_PN involve_VVB a_DD common_JJ mechanism_NN and_CC the_DD role_NN played_VVN by_II cholesterol_NN ._.
P11144352A04
Thus_RR ,_, a_DD cellular_JJ and_CC molecular_JJ mechanism_NN that_PNR facilitates_VVZ musculoskeletal_JJ and_CC vascular_JJ development_NN elsewhere_RR in_II the_DD embryo_NN has_VHZ been_VBN adapted_VVN to_TO guide_VVI the_DD differentiation_NN of_II the_DD olfactory_NN pathway_NN in_II the_DD developing_VVGJ forebrain_NN ._.
P11152630A02
At_II early_JJ head_NN process_NN stages_NNS (_( 4+_MC to_II 6_MC ;_: Hamburger_NNP and_CC Hamilton_NNP )_) it_PN lies_VVZ beneath_II ,_, lateral_JJ to_II and_CC ahead_II+ of_II the_DD ingressed_VVNJ axial_JJ mesoderm_NN ._.
P11152630A08
Important_JJ gene_NN expressions_NNS within_II axial_JJ mesoderm_NN (_( chordin_NN ,_, Shh_NN and_CC BMP7_NN )_) appear_VVB unaffected_VVN in_II all_DD embryos_NNS ,_, including_VVG those_PND due_JJ to_TO be_VBI pattern-deleted_VVNJ ,_, during_II the_DD hours_NNS following_VVG the_DD operation_NN when_CS anterior_JJ brain_NN pattern_NN is_VBZ believed_VVN to_TO be_VBI determined_VVN ._.
P11152636A01
Pituitary_NN gland_NN development_NN serves_VVZ as_II an_DD excellent_JJ model_NN system_NN in_II which_PNR to_TO study_VVI the_DD emergence_NN of_II distinct_JJ cell_NN types_NNS from_II a_DD common_JJ primordium_NN in_II mammalian_JJ organogenesis_NN ._.
P11152636A07
Thus_RR ,_, SHH_NN appears_VVZ to_TO exert_VVI effects_NNS on_II both_CC proliferation_NN and_CC cell-type_NN determination_NN in_II pituitary_NN gland_NN development_NN ._.
P11158592A03
We_PN report_VVB here_RR the_DD expression_NN during_II implantation_NN of_II 21_MC genes_NNS encoding_VVG other_JJ signaling_VVGJ proteins_NNS ,_, including_VVG those_PND belonging_VVG to_II the_DD Bone_NN morphogenetic_JJ protein_NN (_( BMP_NN )_) ,_, fibroblast_NN growth_NN factor_NN (_( FGF_NN )_) ,_, WNT_NN ,_, and_CC Hedgehog_NN (_( HH_NN )_) pathways_NNS ._.
P11158592A09
Significantly_RR ,_, beads_NNS containing_VVG BMP-2_NN do_VDB not_RR themselves_PN elicit_VVB an_DD implantation_NN response_NN but_CC affect_VVB the_DD spacing_VVGN of_II implantation_NN sites_NNS induced_VVN by_II blastocysts_NNS cotransferred_VVN with_II the_DD beads_NNS ._.
P11159867A01
A_DD neonatal_JJ rat_NN metatarsal_JJ organ_NN culture_NN model_NN has_VHZ been_VBN employed_VVN to_TO study_VVI the_DD anabolic_JJ effects_NNS of_II Sonic_NN /_SYM Indian_NN hedgehog_NN and_CC BMP-4_NN ._.
P11159867A07
High_JJ doses_NNS of_II BMP-4_NN resulted_VVD in_II increased_VVNJ expression_NN of_II noggin_NN messenger_NN RNA_NN and_CC cotreatment_NN of_II noggin_NN and_CC Shh-N_NN resulted_VVD in_II reversal_NN of_II the_DD anabolic_JJ action_NN of_II Shh-N_NN ._.
P11160153A02
Hypertrophic_JJ chondrocytes_NNS in_II the_DD growth_NN plate_NN play_VVB a_DD pivotal_JJ role_NN in_II this_DD transition_NN ._.
P11165486A02
Two_MC transmembrane_JJ proteins_NNS associated_VVN in_II a_DD complex_NN ,_, Patched_NN (_( Ptc_NN )_) and_CC Smoothened_NN (_( Smo_NN )_) ,_, are_VBB indispensable_JJ for_II the_DD reception_NN of_II Hh_NN signals_NNS (_( Cell_NN 86_MC (_( 1996_MC )_) 221_MC ;_: Nature_NN 382_MC (_( 1996_MC )_) 547_MC ;_: Nature_NN 384_MC (_( 1996_MC )_) 176_MC ;_: Nature_NN 384_MC (_( 1996_MC )_) 129_MC )_) ._.
P11165486A08
In_II contrast_NN to_II the_DD tissue-specific_JJ expression_NN characteristics_NNS of_II XPtc1_NN ,_, XSmo_NN expression_NN appears_VVZ to_TO be_VBI ubiquitously_RR activated_VVN in_II early_JJ embryonic_JJ stages_NNS but_CC condenses_VVZ in_II the_DD terminal_JJ regions_NNS of_II the_DD embryo_NN at_II tailbud_NN stage_NN ._.
P11169584A01
Models_NNS employing_VVG gradients_NNS of_II diffusible_JJ morphogens_NNS are_VBB often_RR invoked_VVN to_TO explain_VVI regional_JJ specification_NN in_II the_DD early_JJ embryo_NN ._.
P11171336A04
We_PN find_VVB that_CST infections_NNS with_II Shh-expressing_VVGJ retrovirus_NN at_II embryonic_JJ day_NN 9.5_MC ,_, result_VVB in_II ectopic_JJ Olig2_NN and_CC PDGFR_NN (_( alpha_NN )_) expression_NN by_II mid-embryogenesis_NN ._.
P11171336A10
Further_RR supporting_VVG the_DD idea_NN that_CST Shh_NN is_VBZ required_VVN for_II the_DD in_JJ+ vivo_JJ establishment_NN of_II early_JJ oligodendrocyte_NN populations_NNS ,_, expression_NN of_II PDGFR_NN (_( alpha_NN )_) can_VM be_VBB partially_RR rescued_VVN by_II virally_RR mediated_VVNJ expression_NN of_II Shh_NN in_II the_DD Nkx2.1_NN mutant_NN telencephalon_NN ._.
P11171398A04
We_PN address_VVB the_DD question_NN of_II whether_CST the_DD Hh_NN pathway_NN is_VBZ distally_RR branched_VVN or_CC ,_, in_II other_JJ words_NNS ,_, whether_CST the_DD regulation_NN of_II Ci_NN activity_NN is_VBZ the_DD sole_JJ output_NN of_II Hh_NN signaling_VVGN ._.
P11172440A01
BACKGROUND_NN /_SYM PURPOSE_NN :_: VACTERL_NN syndrome_NN is_VBZ a_DD common_JJ surgical_JJ condition_NN affecting_VVG the_DD development_NN of_II many_DD midaxial_JJ organs_NNS ._.
P11172440A07
CONCLUSION_NN :_: To_II the_DD authors_NNS '_GE knowledge_NN ,_, these_DD mutant_JJ mice_NNS represent_VVB the_DD first_JJ animal_NN model_NN that_PNR mimics_VVZ the_DD human_NN VACTERL_NN syndrome_NN ,_, and_CC suggests_VVZ that_CST aberrations_NNS in_II Shh_NN signaling_VVGN might_VM be_VBB involved_VVN in_II the_DD VACTERL_NN syndrome_NN ._.
P11187133A02
Recent_JJ developments_NNS in_II skin_NN cancer_NN research_NN have_VHB made_VVN it_PN possible_JJ to_TO identify_VVI environmental_JJ factors_NNS involved_VVN in_II cutaneous_JJ carcinogenesis_NN and_CC to_TO describe_VVI the_DD molecular_JJ pathology_NN of_II skin_NN cancer_NN ._.
P11203695A04
Confocal_JJ laser_NN scanning_VVGJ microscopy_NN was_VBD used_VVN to_TO determine_VVI the_DD spatiotemporal_JJ relationship_NN between_II growing_VVGJ axons_NNS and_CC the_DD expression_NN pattern_NN of_II eight_MC regulatory_JJ genes_NNS in_II zebrafish_NN brain_NN ._.
P11203695A10
These_DD results_NNS suggest_VVB that_CST pioneer_NN axons_NNS in_II the_DD embryonic_JJ forebrain_NN do_VDB not_RR follow_VVB continuous_JJ pathways_NNS defined_VVN by_II the_DD borders_NNS of_II regulatory_JJ gene_NN expression_NN domains_NNS ._.
P11203700A02
Gdf11_NN null_JJ mice_NNS display_VVB skeletal_JJ abnormalities_NNS that_PNR appear_VVB to_TO represent_VVI anterior_JJ homeotic_JJ transformations_NNS of_II vertebrae_NN consistent_JJ with_II high_JJ levels_NNS of_II Gdf11_NN expression_NN in_II the_DD primitive_JJ streak_NN ,_, presomitic_JJ mesoderm_NN ,_, and_CC tail_NN bud_NN ._.
P11203700A08
When_CS beads_NNS incubated_VVN in_II GDF11_NN protein_NN were_VBD implanted_VVN into_II the_DD early_JJ wing_NN bud_NN ,_, GDF11_NN caused_VVD severe_JJ truncations_NNS of_II the_DD limb_NN that_PNR affected_VVD both_CC the_DD cartilage_NN elements_NNS and_CC the_DD muscle_NN ._.
P11222142A02
Gene_NN inactivation_NN experiments_NNS in_II mice_NNS have_VHB identified_VVN factors_NNS required_VVN for_II dorsal_JJ pancreas_NN development_NN ,_, but_CC factors_NNS that_PNR initiate_VVB the_DD ventral_JJ pancreas_NN have_VHB remained_VVN elusive_JJ ._.
P11222142A08
Cardiac_JJ mesoderm_NN or_CC FGF_NN induces_VVZ the_DD local_JJ expression_NN of_II sonic_NN hedgehog_NN ,_, which_PNR in_II turn_NN is_VBZ inhibitory_JJ to_II pancreas_NN but_CC not_RR to_II liver_NN ._.
P11229883A03
For_II structural_JJ purposes_NNS alone_JJ ,_, the_DD fetus_NN requires_VVZ 1.5_MC mg_NN of_II cholesterol_NN per_II gram_NN of_II tissue_NN ,_, not_RR including_VVG the_DD brain_NN ._.
P11237716A04
In_II animal_NN cap_NN assays_NNS ,_, the_DD antagonizing_VVGJ BMPs_NNS signal_NN was_VBD not_RR sufficient_JJ to_TO induce_VVI Xshh_NN mRNA_NN expression_NN ;_: however_RR ,_, it_PN could_VM induce_VVB Xshh_NN mRNA_NN expression_NN in_II the_DD presence_NN of_II Xnr-1_NN ._.
P11257109A05
Mutations_NNS in_II the_DD human_NN homolog_NN of_II a_DD Drosophila_NN gene_NN ,_, patched_NN ,_, underlie_VVB Gorlin_NN syndrome_NN ._.
P11277077A03
PTHrP_NN then_RR maintains_VVZ chondrocytes_NNS in_II a_DD proliferative_JJ ,_, less_RR differentiated_VVNJ state_NN ._.
P11277077A09
Thus_RR ,_, IHH_NN is_VBZ a_DD master_JJ regulator_NN of_II both_CC chondrocyte_NN and_CC osteoblast_NN differentiation_NN ._.
P11281376A02
During_II migration_NN of_II neural_JJ crest_NN cells_NNS from_II the_DD dorsal_JJ surface_NN of_II the_DD neural_JJ tube_NN to_II their_PNG destinations_NNS in_II the_DD sympathetic_JJ primordia_NNS and_CC adrenal_JJ glands_NNS ,_, precursors_NNS of_II the_DD so-called_VVNJ sympathoadrenal_JJ (_( SA_NN )_) cell_NN lineage_NN are_VBB exposed_VVN to_II signals_NNS from_II the_DD notochord_NN and_CC ventral_JJ neural_JJ tube_NN probably_RR including_VVG the_DD protein_NN ,_, Sonic_NN hedgehog_NN ._.
P11281376A08
For_II their_PNG normal_JJ development_NN ,_, these_DD neurones_NNS require_VVB signals_NNS from_II the_DD adrenal_JJ medulla_NN ,_, which_PNR include_VVB neurotrophin-4_NN ,_, a_DD major_JJ neurotrophic_JJ factor_NN of_II adrenal_JJ chromaffin_NN cells_NNS ._.
P11284692A06
Hydrophobic_JJ modifications_NNS at_II the_DD C-terminus_NN of_II Shh_NN resulted_VVD in_II only_RR a_DD 2-3-fold_NN increase_NN in_II activity_NN ,_, and_CC no_DD activation_NN was_VBD found_VVN with_II hydrophobic_JJ modification_NN at_II other_JJ surface_NN positions_NNS ._.
P11290288A04
Laminins_NNS and_CC their_PNG integrin_NN receptor_NN subunit_NN alpha6_NN accumulate_VVB in_II the_DD outer_JJ most_RRT external_JJ germinal_JJ layer_NN where_PNR proliferation_NN of_II granule_NN cell_NN precursors_NNS is_VBZ maximal_JJ ._.
P11290288A10
Taken_VVN together_RR ,_, these_DD data_NNS suggest_VVB that_CST granule_NN neuron_NN differentiation_NN is_VBZ regulated_VVN by_II the_DD vitronectin-induced_VVNJ phosphorylation_NN of_II CREB_NN ,_, a_DD critical_JJ event_NN that_PNR terminates_VVZ SHH-mediated_VVNJ proliferation_NN and_CC permits_VVZ the_DD differentiation_NN program_NN to_TO proceed_VVI in_II these_DD cells_NNS ._.
P11290296A02
We_PN report_VVB that_CST type_NN XVIII_MC collagen_NN ,_, which_PNR contains_VVZ both_CC a_DD frizzled_NN and_CC an_DD endostatin_NN domain_NN ,_, is_VBZ expressed_VVN throughout_II the_DD respective_JJ epithelial_JJ bud_NN at_II the_DD initiation_NN of_II lung_NN and_CC kidney_NN organogenesis_NN ._.
P11290296A08
Type_NN XVIII_MC collagen_NN antibody_NN blocking_VVGN also_RR led_VVD to_II a_DD notable_JJ reduction_NN in_II the_DD expression_NN of_II Wnt2_NN ,_, which_PNR is_VBZ expressed_VVN in_II the_DD lung_NN mesenchyme_NN but_CC not_RR in_II that_PND of_II the_DD kidney_NN ,_, suggesting_VVG a_DD regulatory_JJ interaction_NN between_II this_DD collagen_NN and_CC Wnt2_NN ._.
P11291852A01
Work_NN in_II amphibians_NNS indicates_VVZ that_CST inhibition_NN of_II Wnt_NN and_CC BMP_NN signals_NNS is_VBZ essential_JJ for_II head_NN development_NN and_CC that_CST head_NN induction_NN by_II the_DD Spemann-Mangold_NN organizer_NN may_VM be_VBB mediated_VVN by_II secreted_VVNJ Wnt_NN antagonists_NNS ._.
P11291852A07
Dkk1_NN thus_RR is_VBZ an_DD essential_JJ mediator_NN of_II the_DD vertebrate_NN head_NN organizer_NN ._.
P11291860A06
Conversely_RR ,_, the_DD dorsal_JJ blastoderm_NN of_II boz_NN mutants_NNS exhibits_VVZ ectopic_JJ expression_NN of_II genes_NNS normally_RR excluded_VVN from_II the_DD dorsal_JJ midline_NN such_II+ as_II wnt8_NN or_CC tbx6._. boz_NN specifies_VVZ the_DD formation_NN of_II anterior_JJ neuroectoderm_NN by_II regulating_VVGN Bmp_NN and_CC Wnt_NN pathways_NNS in_II a_DD fashion_NN consistent_JJ with_II Nieuwkoop_NN 's_GE two-step_NN neural_JJ patterning_VVGJ model_NN ._.
P11291860A12
Notably_RR ,_, Bozozok_NN appears_VVZ to_TO function_VVI by_II repressing_VVGN transcription_NN of_II target_NN genes_NNS such_II+ as_II swr_NN (_( bmp2b_NN )_) gene_NN ,_, and_CC as_II such_PND is_VBZ the_DD earliest_RRT acting_VVGJ repressor_NN that_PNR the_DD nascent_JJ dorsal_JJ axis_NN is_VBZ using_VVG to_TO antagonize_VVI ventral_JJ influences_NNS ._.
P11291868A03
Caudal_JJ node_NN cells_NNS function_VVB as_II stem_NN cells_NNS ._.
P11291868A08
Unpublished_VVNJ results_NNS indicate_VVB that_CST rescue_NN of_II the_DD posterior_JJ region_NN of_II the_DD embryo_NN can_VM be_VBB obtained_VVN by_II implantation_NN of_II Shh_NN secreting_VVGJ cells_NNS ._.
P11311154A06
Blocking_VVGN Ihh_NN function_NN in_II primitive_JJ endoderm_NN inhibits_VVZ activation_NN of_II hematopoiesis_NN and_CC vasculogenesis_NN in_II the_DD adjacent_JJ epiblast_NN ,_, suggesting_VVG that_CST Ihh_NN is_VBZ an_DD endogenous_JJ signal_NN that_PNR plays_VVZ a_DD key_JJ role_NN in_II the_DD development_NN of_II the_DD earliest_JJT hemato-vascular_JJ system_NN ._.
P11312556A06
The_DD latter_NN could_VM be_VBB amplified_VVN to_II as_RR much_PND as_CSN 30_MC %_SYM by_II increasing_VVGN the_DD concentration_NN of_II growth_NN factor_NN 10-fold_NN or_CC by_II the_DD addition_NN of_II other_JJ competent_JJ coactivators_NNS (_( IBMX_NN /_SYM forskolin_NN ,_, TPA_NN ,_, and_CC DA_NN )_) ._.
P11319862A01
The_DD Drosophila_NN Hedgehog_NN protein_NN and_CC its_PNG vertebrate_NN counterpart_NN Sonic_NN hedgehog_NN are_VBB required_VVN for_II a_DD wide_JJ variety_NN of_II patterning_VVGJ events_NNS throughout_II development_NN ._.
P11319862A07
Furthermore_RR ,_, overexpression_NN of_II the_DD mutant_JJ form_NN has_VHZ dominant_JJ negative_JJ effects_NNS on_II Hedgehog_NN signaling_VVGN ._.
P11327804A02
The_DD protocol_NN presented_VVN here_RR was_VBD established_VVN to_TO analyze_VVI the_DD role_NN and_CC dynamics_NNS of_II the_DD activated_VVNJ protein_NN kinase_NN C_NN /_SYM Rack1_NN regulatory_JJ system_NN in_II the_DD patterning_VVGN and_CC outgrowth_NN of_II limb_NN bud_NN mesenchyme_NN ._.
P11331610A03
The_DD Drosophila_NN gene_NN sprouty_NN encodes_VVZ an_DD antagonist_NN of_II FGF_NN signaling_VVGN ,_, which_PNR is_VBZ transcriptionally_RR induced_VVN by_II the_DD pathway_NN ,_, but_CC whose_PNR molecular_JJ functions_NNS are_VBB poorly_RR characterized_VVN ._.
P11332615A02
Chondrocytes_NNS infected_VVN with_II replication_NN competent_JJ avian_JJ retroviruses_NNS (_( RCAS_NN )_) viruses_NNS carrying_VVG constitutive_JJ active_JJ (_( CA_NN )_) BMPR-IA_NN and_CC BMPR-IB_NN had_VHD enhanced_VVNJ expression_NN of_II type_NN X_MC collagen_NN and_CC Ihh_NN mRNA_NN ._.
P11332615A08
To_TO determine_VVI if_CST there_EX is_VBZ an_DD autocrine_JJ role_NN for_II the_DD BMPs_NNS in_II chondrocyte_NN maturation_NN ,_, the_DD cultures_NNS were_VBD treated_VVN with_II noggin_NN and_CC follistatin_NN ,_, molecules_NNS that_PNR bind_VVB BMP-2_NN /_SYM -4_MC and_CC BMP-6_NN /_SYM -7_MC ,_, respectively_RR ._.
P11333865A03
All_DD 22_MC affected_VVNJ subjects_NNS have_VHB soft_JJ tissue_NN syndactyly_NN of_II all_DD fingers_NNS and_CC all_DD toes_NNS and_CC 14_MC also_RR have_VHB preaxial_JJ polydactyly_NN of_II the_DD hands_NNS and/or_CC feet_NN ._.
P11336495A01
Proper_JJ dorsal_JJ --_: ventral_JJ pattern_NN formation_NN of_II the_DD optic_JJ cup_NN is_VBZ essential_JJ for_II vertebrate_NN eye_NN morphogenesis_NN and_CC retinotectal_JJ topographic_JJ mapping_VVGN ._.
P11336495A07
Ectopic_JJ Shh_NN suppressed_VVD expression_NN of_II Bone_NN Morphogenetic_JJ Protein_NN 4_MC (_( BMP4_NN )_) in_II the_DD dorsal_JJ retina_NN ,_, whereas_CS reducing_VVGN endogenous_JJ Sonic_NN hedgehog_NN activity_NN resulted_VVD in_II a_DD ventral_JJ expansion_NN of_II BMP4_NN territory_NN ._.
P11395778A03
Although_CS there_EX is_VBZ much_DD data_NN (_( using_VVG soluble_JJ recombinant_JJ Shh_NN (_( ShhN_NN )_) )_) to_TO support_VVI the_DD simple_JJ diffusion_NN model_NN of_II long-range_NN Shh_NN signalling_VVGN ,_, there_EX has_VHZ been_VBN little_DD evidence_NN to_II date_NN for_II a_DD native_JJ form_NN of_II Shh_NN that_PNR is_VBZ freely_RR diffusible_JJ and_CC not_RR membrane-associated_VVN ._.
P11397007A01
Members_NNS of_II the_DD EGF-CFC_NN family_NN of_II proteins_NNS have_VHB recently_RR been_VBN implicated_VVN as_II essential_JJ cofactors_NNS for_II Nodal_NN signaling_VVGN ._.
P11397007A07
Implantation_NN of_II cells_NNS expressing_VVG human_NN or_CC mouse_NN CFC2_NN ,_, or_CC chick_NN CFC_NN on_II the_DD right_JJ side_NN of_II Hensen_NN 's_GE node_NN randomized_VVD heart_NN looping_VVGN without_II affecting_VVGN expression_NN of_II genes_NNS involved_VVN in_II left-right_NN axis_NN formation_NN ,_, including_VVG SnR_NN ,_, Nodal_NN ,_, Car_NN ,_, or_CC Pitx2_NN ._.
P11401399A03
Injection_NN of_II CHL_NN RNA_NN into_II Xenopus_NN embryos_NNS induced_VVD a_DD secondary_JJ axis_NN ._.
P11401399A09
Thus_RR ,_, CHL_NN may_VM serve_VVB as_II an_DD important_JJ BMP_NN regulator_NN for_II differentiating_VVGN mesenchymal_JJ cells_NNS ,_, especially_RR during_II skeletogenesis_NN ,_, and_CC for_II developing_VVGN specific_JJ neurons_NNS ._.
P11404418A03
The_DD stably_RR transduced_VVNJ cells_NNS were_VBD pooled_VVN and_CC designated_VVN as_II VME14_NN cells_NNS ._.
P11404418A08
This_DD monoclonal_JJ ,_, SHH-N-overexpressing_VVGJ cell_NN line_NN further_RR enhanced_VVD dopaminergic_JJ differentiation_NN of_II E11_NN rat_NN mesencephalon_NN cells_NNS ._.
P11412027A05
Sonic_NN hedgehog_NN (_( Shh_NN )_) is_VBZ also_RR expressed_VVN in_II the_DD pharyngeal_JJ arches_NNS and_CC is_VBZ necessary_JJ for_II normal_JJ craniofacial_JJ development_NN ._.
P11430830A02
To_TO assay_VVI the_DD range_NN of_II direct_JJ Shh_NN action_NN ,_, we_PN developed_VVD a_DD general_JJ method_NN for_II blocking_VVGN transduction_NN of_II Hedgehog_NN (_( Hh_NN )_) signals_NNS through_II ectopic_JJ expression_NN of_II a_DD deleted_VVNJ form_NN of_II the_DD Hh_NN receptor_NN Patched_NN (_( Ptc_NN )_) ,_, termed_VVN Ptc_NN (_( Deltaloop2_NN )_) ._.
P11440720A06
Further_RR ,_, we_PN demonstrate_VVB an_DD absolute_JJ requirement_NN for_II Hedgehog_NN signaling_VVGN in_II sclerotomal_JJ development_NN and_CC a_DD role_NN in_II cardiac_JJ morphogenesis_NN ._.
P11449277A04
The_DD organization_NN of_II ventral_JJ cell_NN types_NNS in_II Shh_NN opb_NN double_JJ mutants_NNS reveals_VVZ that_CST Shh-independent_JJ mechanisms_NNS can_VM pattern_VVB the_DD neural_JJ tube_NN along_II its_PNG dorsal-ventral_JJ axis_NN ._.
P11460262A05
The_DD resulting_VVGJ embryos_NNS were_VBD evaluated_VVN morphologically_RR and_CC by_II assaying_VVGN gene_NN expression_NN ._.
P11460262A10
DISCUSSION_NN :_: The_DD ectopic_JJ localization_NN of_II recombinant_JJ Shh_NN protein_NN in_II the_DD rostral_JJ neural_JJ tube_NN resulted_VVD in_II severe_JJ craniofacial_JJ anomalies_NNS and_CC alterations_NNS of_II gene_NN expression_NN predicted_VVN by_II other_JJ studies_NNS ._.
P11461001A05
These_DD studies_NNS demonstrated_VVD that_CST the_DD mutant_JJ gene_NN e_NN in_II the_DD axolotl_NN alters_VVZ the_DD response_NN of_II midanterior_JJ neural-plate_NN tissue_NN to_II signals_NNS from_II the_DD prechordal_JJ plate_NN ._.
P11461001A11
Thus_RR ,_, lowered_VVNJ pax-6_NN expression_NN by_II the_DD midanterior_JJ neuroectoderm_NN promotes_VVZ the_DD eyeless_JJ condition_NN by_II inhibiting_VVGN the_DD role_NN of_II pax-6_NN in_II eye_NN formation_NN ._.
P11467452A05
In_II addition_NN ,_, the_DD similarities_NNS among_II hedgehog_NN mutation-induced_VVNJ ductal_JJ dysplasias_NNS and_CC human_NN breast_NN pathologies_NNS suggest_VVB a_DD role_NN for_II altered_VVNJ hedgehog_NN signaling_VVGN in_II the_DD development_NN of_II mammary_JJ cancer_NN ._.
P11470817A06
On_II the_DD other_JJ hand_NN ,_, mice_NNS double_RR heterozygous_JJ for_II null_JJ Fbn2_NN and_CC Bmp7_NN alleles_NNS display_VVB the_DD combined_VVNJ digit_NN phenotype_NN of_II both_DD nullizygotes_NNS ._.
P11471164A02
It_PN has_VHZ been_VBN reported_VVN in_II holoprosencephaly_NN (_( HPE_NN )_) cases_NNS with_II severe_JJ facial_JJ anomalies_NNS or_CC as_II a_DD microform_NN in_II autosomal_JJ dominant_JJ HPE_NN (_( ADHPE_NN )_) ._.
P11471164A08
A_DD new_JJ missense_NN mutation_NN in_II SHH_NN (_( I111F_NN )_) ,_, segregating_VVG in_II one_MC SMMCI_NN family_NN ,_, was_VBD identified_VVN ._.
P11472891A01
Among_II the_DD bone_NN morphogenetic_JJ protein_NN (_( BMP_NN )_) family_NN ,_, which_PNR plays_VVZ a_DD crucial_JJ role_NN not_RR only_RR in_II bone_NN formation_NN but_CC also_RR in_II development_NN ,_, BMP-2_NN ,_, -4_MC ,_, and_CC -7_MC participate_VVB predominantly_RR in_II various_JJ aspects_NNS ._.
P11472891A07
The_DD transcription_NN start_NN site_NN of_II the_DD BMP-7_NN gene_NN was_VBD found_VVN to_TO be_VBI far_RR upstream_JJ (_( 764_MC bp_NN )_) of_II the_DD initiation_NN ATG_NN codon_NN ._.
P11472891A13
Our_PNG systems_NNS are_VBB helpful_JJ for_II assessment_NN of_II the_DD complicated_VVNJ interactions_NNS of_II molecules_NNS involved_VVN in_II the_DD skeletogenesis_NN and_CC developmental_JJ processes_NNS ._.
P11479882A06
RESULTS_NNS :_: At_II 24_MC hours_NNS postinjection_NN ,_, all_DD embryos_NNS were_VBD alive_JJ and_CC were_VBD imaged_VVN in_RR+ vivo_RR ._.
P11485934A06
Here_RR ,_, we_PN show_VVB that_CST mutant_JJ mice_NNS with_II various_JJ defects_NNS in_II the_DD Shh_NN signaling_VVGJ pathway_NN exhibit_VVB a_DD spectrum_NN of_II distal_JJ hindgut_NN defects_NNS mimicking_VVG human_NN anorectal_JJ malformations_NNS ._.
P11487541A02
A_DD stem_NN cell_NN located_VVN halfway_JJ up_II the_DD tubular_JJ unit_NN gives_VVZ rise_NN to_II both_CC a_DD basal_JJ gland_NN region_NN and_CC a_DD luminal_JJ pit_NN compartment_NN ,_, but_CC the_DD mechanisms_NNS responsible_JJ for_II the_DD maintenance_NN of_II this_DD asymmetry_NN are_VBB obscure_JJ ._.
P11487541A08
Inhibition_NN of_II Shh_NN markedly_RR enhanced_VVD gastric_JJ epithelial_JJ proliferation_NN and_CC affected_VVD the_DD cell_NN cycle_NN of_II gastric_JJ epithelial_JJ gland_NN cells_NNS ,_, whereas_CS pit_NN cells_NNS remained_VVD unaffected_VVN ._.
P11493520A02
We_PN report_VVB here_RR that_CST SDF-1_NN alpha_NN both_CC induces_VVZ chemotactic_JJ responses_NNS in_II granule_NN precursor_NN cells_NNS and_CC enhances_VVZ granule_NN cell_NN proliferative_JJ responses_NNS to_II Sonic_NN hedgehog_NN ._.
P11493539A01
The_DD myotome_NN is_VBZ formed_VVN by_II a_DD first_JJ wave_NN of_II pioneer_NN cells_NNS originating_VVG from_II the_DD entire_JJ dorsomedial_JJ region_NN of_II epithelial_JJ somites_NNS and_CC a_DD second_JJ wave_NN that_PNR derives_VVZ from_II all_DD four_MC lips_NNS of_II the_DD dermomyotome_NN but_CC generates_VVZ myofibers_NNS from_II only_RR the_DD rostral_JJ and_CC caudal_JJ edges_NNS ._.
P11493539A07
By_II this_DD stage_NN ,_, generation_NN of_II second-wave_NN myofibers_NNS ,_, which_PNR also_RR enter_VVB from_II the_DD extreme_JJ lips_NNS is_VBZ still_RR under_II way_NN ._.
P11493554A06
In_II this_DD report_NN ,_, we_PN show_VVB that_CST Shh_NN containing_VVG a_DD mutation_NN at_II the_DD site_NN of_II acylation_NN prevents_VVZ either_PND of_II these_DD phenotypes_NNS ._.
P11493557A03
We_PN show_VVB that_CST inactivation_NN of_II smoothened_NN by_II retroviral_JJ insertions_NNS in_II zebrafish_NN results_VVZ in_II defects_NNS that_PNR are_VBB characteristic_JJ of_II hedgehog_NN deficiencies_NNS ,_, including_VVG abnormalities_NNS in_II body_NN size_NN ,_, the_DD central_JJ nervous_JJ system_NN ,_, adaxial_JJ mesoderm_NN ,_, cartilage_NN and_CC pectoral_JJ fins_NNS ._.
P11493557A09
Taken_VVN together_RR ,_, these_DD data_NNS demonstrate_VVB the_DD conserved_VVNJ role_NN of_II vertebrate_NN smoothened_NN in_II the_DD hedgehog_NN signaling_VVGJ pathway_NN ,_, and_CC reveal_VVB similarities_NNS and_CC differences_NNS of_II hedgehog_NN function_NN between_II teleosts_NNS and_CC amniotes_NNS ._.
P11493558A05
The_DD haploinsufficiency_NN causes_VVZ a_DD variable_JJ phenotype_NN that_PNR includes_VVZ lung_NN immaturity_NN and_CC hypoplasia_NN ,_, fusion_NN of_II right_JJ lung_NN lobes_NNS ,_, narrowing_VVGN of_II esophagus_NN and_CC trachea_NN ,_, esophageal_JJ atresia_NN and_CC tracheo-esophageal_JJ fistula_NN ._.
P11493562A04
Fibroblast_NN growth_NN factor_NN (_( FGF_NN )_) also_RR induced_VVD RACK1_NN and_CC such_DD induction_NN of_II RACK1_NN expression_NN was_VBD accompanied_VVN by_II a_DD significant_JJ augmentation_NN in_II the_DD number_NN of_II active_JJ PKC_NN molecules_NNS and_CC an_DD elevation_NN of_II PKC_NN enzymatic_JJ activity_NN ._.
P11493571A02
We_PN present_VVB evidence_NN that_CST oligodendrogenesis_NN in_II the_DD anterior_JJ neural_JJ tube_NN follows_VVZ a_DD similar_JJ pattern_NN ._.
P11493571A08
However_RR ,_, OLPs_NNS did_VDD develop_VVB in_II cultures_NNS of_II Nkx2.1_NN (_( -/-_SYM )_) basal_JJ forebrain_NN and_CC this_PND was_VBD blocked_VVN by_II cyclopamine_NN ._.
P11500977A06
When_CS an_DD FGF-4-containing_VVGJ bead_NN was_VBD implanted_VVN into_II the_DD anterior_JJ region_NN of_II a_DD stage_NN 20_MC hindlimb_NN bud_NN ,_, ectopic_JJ expression_NN of_II Shh_NN was_VBD induced_VVN in_II the_DD mesenchyme_NN beneath_II the_DD anterior_JJ end_NN of_II the_DD apical_JJ ectodermal_JJ ridge_NN at_II 36_MC hr_NN after_II implantation_NN ._.
P11500977A12
These_DD results_NNS demonstrate_VVB the_DD difference_NN between_II the_DD fore-_NN and_CC hindlimb_NN buds_NNS in_II the_DD cell_NN competence_NN of_II Shh_NN induction_NN in_II response_NN to_II FGF-4_NN ,_, suggesting_VVG the_DD possibility_NN that_CST the_DD responsiveness_NN of_II mesenchymal_JJ cells_NNS in_II signaling_VVGJ molecules_NNS is_VBZ not_RR the_DD same_PND in_II the_DD fore-_NN and_CC hindlimb_NN buds_NNS ._.
P11509241A03
The_DD addition_NN of_II a_DD cholesterol_NN molecule_NN to_II the_DD C_NN terminus_NN of_II the_DD signaling_VVGJ domain_NN is_VBZ concomitant_JJ with_II cleavage_NN [_( 3_MC ]_) ._.
P11509241A08
sit_NN encodes_VVZ a_DD conserved_VVNJ transmembrane_JJ protein_NN with_II homology_NN to_II a_DD family_NN of_II membrane-bound_VVNJ acyltransferases_NNS ._.
P11511541A03
Neural_JJ precursor_NN cells_NNS always_RR express_VVB Bmpr-1a_NN ,_, but_CC Bmpr-1b_NN is_VBZ not_RR expressed_VVN until_II embryonic_JJ day_NN 9_MC and_CC is_VBZ restricted_VVN to_II the_DD dorsal_JJ neural_JJ tube_NN surrounding_VVG the_DD source_NN of_II BMP_NN ligands_NNS ._.
P11518515A05
These_DD embryos_NNS gastrulate_VVB abnormally_RR and_CC develop_VVB with_II excessive_JJ notochord_NN and_CC head_NN structures_NNS ,_, and_CC reduced_VVNJ tail_NN and_CC ventral_JJ components_NNS ._.
P11520664A01
Mutations_NNS in_II WNT_NN effector_NN genes_NNS perturb_VVB hair_NN follicle_NN morphogenesis_NN ,_, suggesting_VVG key_JJ roles_NNS for_II WNT_NN proteins_NNS in_II this_DD process_NN ._.
P11520668A04
Both_CC shh_NN and_CC presenilin_NN promoted_VVD cell_NN proliferation_NN and_CC apoptosis_NN ,_, but_CC the_DD effects_NNS of_II shh_NN were_VBD widely_RR distributed_VVN ,_, while_CS those_PND resulting_VVG from_II presenilin_NN injection_NN coincided_VVD with_II the_DD range_NN of_II shh_NN signaling_VVGN ._.
P11523056A04
Basal_JJ cell_NN naevus_JJ syndrome_NN (_( BCNS_NN )_) comprises_VVZ both_CC multiple_JJ BCCs_NNS and_CC multiple_JJ OKs_NNS ,_, in_II addition_NN to_II several_JJ other_JJ systemic_JJ manifestations_NNS ._.
P11523056A10
Although_CS moderate_JJ to_II heavy_JJ staining_VVGN with_II PTCH_NN antibody_NN was_VBD demonstrated_VVN in_II the_DD epithelium_NN of_II both_DD types_NNS of_II OK_NN (_( n=19_NN )_) ,_, a_DD quite_RR different_JJ pattern_NN of_II staining_VVGN of_II the_DD basal_JJ cell_NN layer_NN was_VBD observed_VVN in_II the_DD two_MC patient_NN groups_NNS ._.
P11533491A03
QSulf1_NN expression_NN is_VBZ induced_VVN by_II Sonic_NN hedgehog_NN in_II myogenic_JJ somite_NN progenitors_NNS in_II quail_NN embryos_NNS and_CC is_VBZ required_VVN for_II the_DD activation_NN of_II MyoD_NN ,_, a_DD Wnt-induced_VVNJ regulator_NN of_II muscle_NN specification_NN ._.
P11544187A04
Cutl1_NN mutant_JJ mice_NNS on_II inbred_VVNJ genetic_JJ backgrounds_NNS are_VBB born_VVN at_II Mendelian_JJ frequency_NN ,_, but_CC die_VVB shortly_RR after_II birth_NN because_II+ of_II retarded_VVNJ differentiation_NN of_II the_DD lung_NN epithelia_NNS ,_, which_PNR indicates_VVZ an_DD essential_JJ role_NN of_II CDP_NN in_II lung_NN maturation_NN ._.
P11545715A03
Notch_NN signaling_VVGN is_VBZ an_DD evolutionarily_RR conserved_VVNJ pathway_NN regulating_VVG the_DD differentiation_NN of_II precursor_NN cells_NNS of_II many_DD lineages_NNS ._.
P11562786A01
The_DD Hedgehog_NN (_( HH_NN )_) signaling_VVGJ pathway_NN is_VBZ involved_VVN in_II patterning_VVGN and_CC development_NN of_II a_DD variety_NN of_II organ_NN systems_NNS ,_, including_VVG the_DD nervous_JJ system_NN ,_, the_DD skeletal_JJ system_NN ,_, the_DD craniofacial_JJ structures_NNS ,_, and_CC the_DD gastrointestinal_JJ tract_NN ._.
P11562786A07
The_DD abnormalities_NNS are_VBB associated_VVN with_II congenital_JJ or_CC sporadic_JJ genetic_JJ alteration_NN affecting_VVGN function_NN of_II different_JJ components_NNS of_II the_DD HH_NN signaling_VVGJ pathway_NN ,_, including_VVG SHH_NN ,_, PTCH_NN ,_, SMOH_NN and_CC GLI_NN proteins_NNS ._.
P11566099A04
Gain-of-function_NN analysis_NN in_II transgenic_JJ mouse_NN embryos_NNS indicates_VVZ that_CST Olig_NN genes_NNS specifically_RR inhibit_VVB the_DD establishment_NN of_II Sim1-expressing_VVGJ V3_NN interneurons_NNS ._.
P11579230A01
Hedgehog_NN (_( Hh_NN )_) is_VBZ a_DD protein_NN ligand_NN that_PNR is_VBZ involved_VVN in_II early_JJ developmental_JJ patterning_VVGN ._.
P11585804A04
Resultant_JJ secondary_JJ trunks_NNS contain_VVB somite_NN and_CC neural_JJ tube_NN ,_, but_CC no_DD notochord_NN ._.
P11585804A10
Xnot_NN acts_VVZ as_II a_DD transcriptional_JJ repressor_NN within_II the_DD mesodermal_JJ region_NN ._.
P11585810A02
We_PN have_VHB found_VVN that_CST Scleraxis_NN ,_, a_DD bHLH_NN transcription_NN factor_NN ,_, is_VBZ a_DD highly_RR specific_JJ marker_NN for_II all_DB the_DD connective_JJ tissues_NNS that_PNR mediate_VVB attachment_NN of_II muscle_NN to_II bone_NN in_II chick_NN and_CC mouse_NN ,_, including_VVG the_DD limb_NN tendons_NNS ,_, and_CC show_VVB that_CST early_JJ scleraxis_NN expression_NN marks_VVZ the_DD progenitor_NN cell_NN populations_NNS for_II these_DD tissues_NNS ._.
P11585810A07
Finally_RR ,_, we_PN show_VVB that_CST the_DD endogenous_JJ expression_NN of_II noggin_NN within_II the_DD condensing_VVGJ digit_NN cartilage_NN contributes_VVZ to_II the_DD induction_NN of_II distal_JJ tendons_NNS ._.
P11592978A04
To_TO test_VVI whether_CST Sonic_NN hedgehog_NN (_( Shh_NN )_) ,_, another_DD signaling_VVGJ molecule_NN involved_VVN in_II the_DD patterning_VVGN of_II the_DD ventral_JJ neural_JJ tube_NN ,_, might_VM also_RR contribute_VVB to_II the_DD control_NN of_II the_DD adhesive_JJ and_CC migratory_JJ potential_NN of_II neuroepithelial_JJ cells_NNS ,_, we_PN analyzed_VVD the_DD effect_NN of_II ectopic_JJ Shh_NN on_II NCC_NN dispersion_NN from_II neural_JJ tube_NN explants_NNS cultured_VVN in_RR+ vitro_RR ._.
P11640898A02
Such_JJ precursors_NNS can_VM be_VBB identified_VVN by_II the_DD expression_NN of_II Olig_NN genes_NNS ,_, encoding_VVG basic_JJ helix-loop-helix_NN factors_NNS ,_, in_II the_DD spinal_JJ cord_NN and_CC brain_NN ._.
P11641224A06
SHH_NN can_VM thus_RR counteract_VVB a_DD built-in_VVNJ cell_NN death_NN program_NN and_CC thereby_RR contribute_VVB to_II organ_NN morphogenesis_NN ,_, in_II particular_NN in_II the_DD central_JJ nervous_JJ system_NN ._.
P11687485A04
The_DD analysis_NN of_II these_DD gene_NN functions_NNS has_VHZ revealed_VVN the_DD existence_NN of_II complex_JJ interactions_NNS between_II signaling_VVGJ pathways_NNS operated_VVN by_II secreted_VVNJ factors_NNS of_II the_DD HH_NN ,_, TGF-beta_NN /_SYM BMP_NN ,_, WNT_NN ,_, and_CC FGF_NN superfamilies_NNS ,_, which_PNR interact_VVB with_II many_DD other_JJ genetic_JJ networks_NNS to_TO control_VVI limb_NN positioning_VVGN ,_, outgrowth_NN ,_, and_CC patterning_VVGN ._.
P11688567A05
Transcription_NN of_II Nodal_NN is_VBZ also_RR positively_RR regulated_VVN by_II a_DD protein_NN kinase_NN A-dependent_JJ pathway_NN ._.
P11694189A03
We_PN tried_VVD to_TO utilize_VVI the_DD mitogenic_JJ effect_NN of_II Shh_NN to_TO accelerate_VVI the_DD formation_NN of_II cultured_VVNJ epithelium_NN ,_, which_PNR is_VBZ already_RR used_VVN in_II the_DD medical_JJ field_NN practically_RR ._.
P11702952A01
Previously_RR ,_, we_PN demonstrated_VVD that_CST Shh_NN acts_VVZ early_RR in_II the_DD development_NN of_II the_DD axial_JJ skeleton_NN ,_, to_TO induce_VVI a_DD prochondrogenic_JJ response_NN to_II later_JJR BMP_NN signaling_VVGN ._.
P11714671A02
We_PN generated_VVD a_DD conditional_JJ knockout_NN of_II the_DD gene_NN encoding_VVG BMPR-IA_NN (_( Bmpr_NN )_) that_PNR disrupted_VVD BMP_NN signaling_VVGN in_II the_DD limb_NN ectoderm_NN ._.
P11714671A08
This_DD study_NN demonstrates_VVZ that_CST BMPR-IA_NN signaling_VVGN plays_VVZ a_DD crucial_JJ role_NN in_II AER_NN formation_NN and_CC in_II the_DD establishment_NN of_II the_DD dorsal_JJ /_SYM ventral_JJ patterning_VVGN during_II limb_NN development_NN ._.
P11716497A02
Molecules_NNS that_PNR function_VVB downstream_JJ of_II Shh_NN ,_, however_RR ,_, still_RR remain_VVB elusive_JJ ._.
P11718263A01
Medulloblastoma_NN (_( MB_NN )_) ,_, a_DD tumor_NN of_II the_DD cerebellum_NN ,_, is_VBZ the_DD most_RRT frequent_JJ type_NN of_II malignant_JJ childhood_NN brain_NN tumor_NN ._.
P11718263A07
Mice_NNS heterozygous_JJ for_II patched_NN (_( ptc1_NN )_) mutations_NNS ,_, like_II heterozygous_JJ PTCH_NN humans_NNS ,_, have_VHB a_DD high_JJ rate_NN of_II medulloblastoma_NN as_CC+ well_CC+ as_CC other_JJ tumors_NNS ._.
P11719506A03
Comparison_NN of_II expression_NN profiles_NNS from_II GLI1-_NN and_CC Ha-ras-expressing_VVGJ cells_NNS established_VVD a_DD set_NN of_II genes_NNS unique_JJ to_II GLI1-induced_VVNJ cell_NN transformation_NN ._.
P11719506A09
Up-regulation_NN of_II cyclin_NN D2_NN and_CC down-regulation_NN of_II plakoglobin_NN were_VBD demonstrated_VVN in_II GLI1-amplified_VVNJ compared_VVN with_II non-amplified_VVNJ human_NN rhabdomyosarcoma_NN cells_NNS ._.
P11731450A01
We_PN have_VHB analyzed_VVN the_DD function_NN of_II the_DD Decapentaplegic_NN (_( Dpp_NN )_) and_CC Hedgehog_NN (_( Hh_NN )_) signaling_VVGJ pathways_NNS in_II partitioning_VVGN the_DD dorsal_JJ head_NN neurectoderm_NN of_II the_DD Drosophila_NN embryo_NN ._.
P11731450A06
Lowering_VVGN Dpp_NN levels_NNS (_( in_II dpp_NN heterozygotes_NNS or_CC hypomorphic_JJ alleles_NNS )_) results_VVZ in_II a_DD '_`` cyclops_NN '_'' phenotype_NN ,_, where_PNR mid-dorsal_JJ head_NN epidermis_NN is_VBZ transformed_VVN into_II dorsolateral_JJ structures_NNS ,_, i.e._II eye_NN /_SYM optic_JJ lobe_NN tissue_NN ,_, which_PNR causes_VVZ a_DD continuous_JJ visual_JJ primordium_NN across_II the_DD dorsal_JJ midline_NN ._.
P11731450A12
Eya_NN and_CC So_NN ,_, which_PNR are_VBB induced_VVN by_II Dpp_NN ,_, are_VBB epistatic_JJ to_II the_DD Hh_NN signal_NN ._.
P11731484A01
Mutations_NNS in_II the_DD homeobox_NN gene_NN vHnf1_NN are_VBB associated_VVN with_II human_NN diseases_NNS MODY5_NN (_( maturity-onset_NN diabetes_NN of_II the_DD young_NN ,_, type_NN V_MC )_) and_CC familial_JJ GCKD_NN (_( glomerulocystic_JJ kidney_NN disease_NN )_) ._.
P11731484A07
Complementary_JJ to_II the_DD loss-of-function_NN phenotypes_NNS ,_, overexpression_NN of_II vhnf1_NN induces_VVZ expansion_NN of_II the_DD val_NN expression_NN domain_NN in_II the_DD hindbrain_NN ._.
P11736900A06
OBJECTIVES_NNS :_: To_TO investigate_VVI the_DD cellular_JJ distribution_NN of_II beta-catenin_NN in_II skin_NN tumours_NNS ,_, in_II particular_NN ,_, in_II BCC_NN ._.
P11748145A03
In_II order_NN to_TO discern_VVI the_DD direct_JJ versus_CC indirect_JJ roles_NNS of_II Ihh_NN in_II cartilage_NN development_NN ,_, we_PN have_VHB used_VVN the_DD Cre-loxP_NN approach_NN to_TO remove_VVI Smo_NN activity_NN specifically_RR in_II chondrocytes_NNS ._.
P11748145A09
Taken_VVN together_RR ,_, the_DD present_JJ study_NN establishes_VVZ Ihh_NN as_II a_DD key_JJ mitogen_NN in_II the_DD endochondral_JJ skeleton_NN ._.
P11748147A06
Loss-of-function_NN mutations_NNS in_II cmn_NN cause_VVB similar_JJ patterning_VVGJ defects_NNS to_II those_PND caused_VVN by_II hh_NN or_CC dispatched_NN (_( disp_NN )_) mutations_NNS ._.
P11748836A06
During_II the_DD course_NN of_II gastrulation_NN ,_, both_CC the_DD neuroectodermal_JJ and_CC the_DD mesodermal_JJ admp_NN transcripts_NNS vanish_VVB in_II an_DD anterior-posterior_JJ wave_NN ._.
P11748836A12
The_DD seeming_VVGJ discrepancy_NN between_II the_DD regulative_JJ and_CC functional_JJ relationship_NN of_II boz_NN and_CC admp_NN is_VBZ discussed_VVN ,_, and_CC models_NNS are_VBB proposed_VVN according_II+ to_II which_PNR Admp_NN might_VM be_VBB part_NN of_II a_DD negative_JJ feedback_NN loop_NN to_TO pattern_VVI and_CC confine_VVI the_DD organizer_NN region_NN ._.
P11752010A01
BACKGROUND_NN :_: The_DD Sonic_NN hedgehog_NN (_( Shh_NN )_) gene_NN is_VBZ involved_VVN in_II the_DD initiation_NN of_II hair_NN growth_NN ._.
P11752010A07
All_DD statistical_JJ tests_NNS were_VBD two-sided_VVNJ ._.
P11752010A13
CONCLUSION_NN :_: Localized_VVNJ ,_, transient_JJ ,_, enhanced_VVNJ expression_NN of_II Shh_NN gene_NN in_II skin_NN ,_, mediated_VVN by_II an_DD adenovirus_NN vector_NN ,_, might_VM be_VBB a_DD future_JJ strategy_NN to_TO accelerate_VVI hair_NN follicle_NN regrowth_NN after_II chemotherapy-induced_VVNJ alopecia_NN ._.
P11754016A06
The_DD former_NN include_VVB the_DD basic_JJ sequence_NN and_CC pattern_NN of_II limb_NN chondrogenesis_NN ,_, which_PNR are_VBB typical_JJ of_II anurans_NNS generally_RR and_CC appear_VVB largely_RR unaffected_VVN by_II the_DD gross_JJ shift_NN in_II developmental_JJ timing_VVGN ;_: expression_NN of_II Distal-less_JJ protein_NN (_( Dlx_NN )_) in_II the_DD distal_JJ ectoderm_NN ;_: expression_NN of_II the_DD gene_NN Sonic_NN hedgehog_NN (_( Shh_NN )_) in_II the_DD zone_NN of_II polarizing_VVGJ activity_NN (_( ZPA_NN )_) ;_: and_CC the_DD ability_NN of_II the_DD ZPA_NN to_TO induce_VVI supernumerary_JJ digits_NNS when_CS transplanted_VVN to_II the_DD anterior_JJ region_NN of_II an_DD early_JJ host_NN limb_NN bud_NN ._.
P11755778A04
We_PN have_VHB investigated_VVN the_DD distribution_NN of_II Shh_NN signalling_VVGJ genes_NNS in_II the_DD rat_NN embryo_NN and_CC in_II the_DD adult_NN ,_, as_CC+ well_CC+ as_CC pharmacological_JJ properties_NNS of_II Shh_NN peptides_NNS ._.
P11755778A10
These_DD observations_NNS suggest_VVB that_CST in_II the_DD adult_NN brain_NN ,_, Shh_NN signals_VVZ through_II its_PNG receptor_NN complex_NN Ptc_NN /_SYM Smo_NN ,_, or_CC through_II Ptc_NN alone_JJ ._.
P11758785A01
Embryonic_JJ induction_NN of_II hair_NN follicles_NNS is_VBZ a_DD fascinating_VVGJ model_NN of_II localized_VVNJ morphogenesis_NN from_II a_DD simple_JJ homogeneous_JJ epithelial_JJ cell_NN sheet_NN ._.
P11758785A07
The_DD potential_NN of_II the_DD two_MC biological_JJ systems_NNS for_II studying_VVGN molecular_JJ mechanisms_NNS in_II hair_NN follicle_NN formation_NN ,_, particularly_RR at_II an_DD early_JJ phase_NN including_VVG Shh_NN signaling_VVGN ,_, is_VBZ discussed_VVN ._.
P11759005A02
This_PND suggests_VVZ a_DD role_NN for_II Shh_NN as_II a_DD proliferative_JJ factor_NN ,_, as_CS localized_VVNJ epithelial_JJ thickenings_NNS invaginate_VVB to_TO form_VVI a_DD tooth_NN bud_NN ._.
P11759005A08
Thus_RR ,_, Shh_NN has_VHZ dual_JJ roles_NNS in_II early_JJ odontogenesis_NN ,_, first_JJ in_II bud_NN formation_NN by_II stimulating_VVGN epithelial_JJ proliferation_NN ,_, and_CC second_JJ in_II the_DD development_NN of_II cap-stage_NN tooth_NN germs_NNS by_II increasing_VVGN epithelial_JJ cell_NN survival_NN ._.
P11763995A03
Increased_VVNJ expression_NN of_II HNF-3beta_NN precedes_VVZ activation_NN of_II its_PNG known_VVNJ target_NN genes_NNS ,_, including_VVG transthyretin_NN (_( TTR_NN )_) ,_, Sonic_NN hedgehog_NN (_( Shh_NN )_) ,_, HNF-1alpha_NN ,_, HNF-1beta_NN ,_, and_CC HNF-4alpha_NN ._.
P11782449A05
In_II previous_JJ genetic_JJ studies_NNS ,_, we_PN showed_VVD that_CST Shh_NN is_VBZ required_VVN for_II Myf5_NN expression_NN in_II the_DD specification_NN of_II dorsal_JJ somite_NN ,_, epaxial_JJ muscle_NN progenitors_NNS ._.
P11782449A11
These_DD findings_NNS establish_VVB that_CST Myf5_NN is_VBZ a_DD direct_JJ target_NN of_II long-range_NN Shh_NN signaling_VVGN through_II positive_JJ regulation_NN by_II Gli_NN transcription_NN factors_NNS ,_, providing_VVG evidence_NN that_CST Shh_NN signaling_VVGN has_VHZ a_DD direct_JJ inductive_JJ function_NN in_II cell_NN lineage_NN specification_NN ._.
P11784013A05
All_PND of_II the_DD 1,003_MC clusters_NNS were_VBD subjected_VVN to_II whole-mount_NN in_JJ+ situ_JJ hybridization_NN to_TO analyze_VVI the_DD distribution_NN of_II the_DD maternal_JJ mRNAs_NNS in_II fertilized_VVNJ eggs_NNS ,_, and_CC a_DD total_NN of_II 329_MC genes_NNS showed_VVD localized_VVNJ distribution_NN of_II the_DD mRNAs_NNS :_: 16_MC showed_VVD cortical_JJ localization_NN ,_, 12_MC showed_VVD mitochondrial-like_JJ distribution_NN ,_, 99_MC crescent-like_JJ distribution_NN ,_, 63_MC partial_JJ localization_NN ,_, and_CC 139_MC weak_JJ localization_NN ._.
P11784087A03
The_DD epithelium_NN concomitantly_RR becomes_VVZ surrounded_VVN by_II visceral_JJ mesoderm_NN and_CC is_VBZ characterized_VVN by_II distinct_JJ gene_NN expression_NN patterns_NNS that_PNR forecast_VVB the_DD development_NN of_II three_MC morphological_JJ subdomains_NNS :_: small_JJ intestine_NN ,_, large_JJ intestine_NN ,_, and_CC rectum_NN ._.
P11784093A05
However_RR ,_, by_II E18.5_NN ,_, only_RR rare_JJ patches_NNS of_II Gata4_NN (_( -/-_SYM )_) epithelium_NN were_VBD evident_JJ in_II the_DD distal_JJ stomach_NN ._.
P11784106A02
This_DD pathway_NN also_RR acts_VVZ in_II patterning_VVGN the_DD animal-vegetal_JJ axis_NN in_II sea_NN urchins_NNS ._.
P11784106A08
Thus_RR ,_, roles_NNS for_II Wnt-signaling_VVGN in_II dorso-ventral_JJ patterning_VVGN of_II embryos_NNS may_VM be_VBB a_DD vertebrate_NN innovation_NN that_PNR arose_VVD in_II connection_NN with_II the_DD evolution_NN of_II yolky_JJ eggs_NNS and_CC gastrulation_NN by_II extensive_JJ involution_NN ._.
P11788837A01
The_DD mechanisms_NNS that_PNR coordinate_VVB the_DD three-dimensional_JJ shape_NN of_II the_DD vertebrate_NN brain_NN during_II development_NN are_VBB largely_RR unknown_VVN ._.
P11790302A06
These_DD data_NNS indicate_VVB that_CST ,_, at_II neural_JJ groove_NN stages_NNS ,_, dorsally_RR derived_VVNJ BMPs_NNS affect_VVB ventral-most_JJT regions_NNS of_II the_DD neural_JJ plate_NN ,_, suggesting_VVG a_DD novel_JJ long-range_NN action_NN of_II BMPs_NNS ._.
P11795937A04
Our_PNG results_NNS indicate_VVB that_CST abdominal_JJ segments_NNS develop_VVB in_II isolation_NN from_II one_MC another_PND during_II early_JJ pupal_JJ stages_NNS ,_, and_CC that_CST some_DD patterning_VVGJ events_NNS are_VBB independent_JJ of_II hh_NN ,_, wingless_NN ,_, and_CC decapentaplegic_NN signaling_VVGN ._.
P11801325A02
Using_VVG electroporation_NN in_II chicks_NNS ,_, they_PN show_VVB that_CST ectopic_JJ expression_NN of_II Sonic_NN Hedgehog_NN (_( Shh_NN )_) in_II dorsal_JJ mesencephalon_NN can_VM recapitulate_VVB this_DD patterning_VVGN in_II its_PNG entirety_NN ._.
P11807556A06
We_PN show_VVB further_RR that_CST the_DD clinical_JJ outcome_NN of_II children_NNS with_II medulloblastomas_NNS is_VBZ highly_RR predictable_JJ on_II the_DD basis_NN of_II the_DD gene_NN expression_NN profiles_NNS of_II their_PNG tumours_NNS at_II diagnosis_NN ._.
P11813256A03
These_DD hypertrophic_JJ chondrocytes_NNS are_VBB characterized_VVN by_II their_PNG increased_VVNJ expression_NN of_II type_NN X_MC collagen_NN ,_, alkaline_JJ phosphatase_NN activity_NN ,_, and_CC apoptosis_NN ,_, as_CC+ well_CC+ as_CC by_II the_DD ability_NN of_II their_PNG extracellular_JJ matrices_NNS to_TO support_VVI mineral_NN deposition_NN ._.
P11813256A09
While_CS BMP-6_NN accelerated_VVD the_DD rate_NN of_II mineral_NN accretion_NN ,_, and_CC the_DD crystals_NNS that_PNR were_VBD formed_VVN in_II the_DD BMP-6_NN cultures_NNS were_VBD initially_RR more_RR mature_JJ ,_, by_II day_NN 21_MC the_DD crystal_NN size_NN distribution_NN in_II experimental_JJ and_CC control_NN cultures_NNS were_VBD not_RR significantly_RR different_JJ ._.
P11814561A06
Therefore_RR ,_, a_DD more_RR precise_JJ understanding_VVGN of_II the_DD molecular_JJ mechanisms_NNS that_PNR underlie_VVB the_DD different_JJ responses_NNS to_II SHH_NN signalling_VVGN is_VBZ the_DD next_JJ step_NN in_II the_DD study_NN of_II this_DD molecule_NN and_CC its_PNG role_NN in_II the_DD regulation_NN of_II neural_JJ development_NN ._.
P11820811A03
Our_PNG data_NNS show_VVB that_CST Shh_NN regulates_VVZ muscle_NN development_NN by_II repressing_VVGN the_DD terminal_JJ differentiation_NN of_II early_JJ myogenic_JJ precursor_NN cells_NNS and_CC does_VDZ not_RR function_VVB as_II a_DD myoblast_NN mitogen_NN ._.
P11830559A02
This_DD tissue_NN does_VDZ not_RR form_VVB somites_NNS ,_, yet_RR expresses_VVZ the_DD somitic_JJ markers_NNS Lbx1_NN ,_, Pax7_NN and_CC Paraxis_NN in_II a_DD regionalised_VVNJ fashion_NN ._.
P11830559A08
This_PND suggests_VVZ that_CST distinct_JJ regulatory_JJ cascades_NNS act_VVB in_II the_DD development_NN of_II trunk_NN and_CC head_NN muscles_NNS ,_, possibly_RR reflecting_VVG their_PNG distinct_JJ function_NN and_CC evolution_NN ._.
P11839821A05
Here_RR ,_, we_PN have_VHB investigated_VVN the_DD relationship_NN between_II two_MC components_NNS of_II the_DD HSC_NN ,_, the_DD serine_NN /_SYM threonine_NN protein_NN kinase_NN Fused_NN (_( Fu_NN )_) and_CC the_DD kinesin-related_VVNJ protein_NN Costal2_NN (_( Cos2_NN )_) ._.
P11839821A11
Thus_RR ,_, we_PN provide_VVB the_DD first_JJ evidence_NN that_CST Hh_NN signaling_VVGN can_VM be_VBB compromised_VVN by_II targeting_VVGN the_DD HSC_NN for_II disruption_NN ._.
P11856527A03
Overexpression_NN of_II Tiarin_NN in_II the_DD embryo_NN causes_VVZ expansion_NN of_II dorsal_JJ neural_JJ markers_NNS and_CC suppression_NN of_II ventral_JJ markers_NNS ._.
P11861468A04
In_II a_DD screen_NN for_II zygotic_JJ lethal_JJ mutations_NNS associated_VVN with_II maternal_JJ effects_NNS ,_, we_PN have_VHB identified_VVN rasp_NN ,_, a_DD novel_JJ Drosophila_NN segment_NN polarity_NN gene_NN ._.
P11867524A03
Interestingly_RR ,_, Bmp-4_NN only_RR activates_VVZ Dkk-1_NN when_CS it_PN concomitantly_RR induces_VVZ apoptosis_NN ._.
P11898849A01
The_DD development_NN of_II the_DD gastrointestinal_JJ (_( GI_NN )_) tract_NN and_CC its_PNG associated_VVNJ parenchymal_JJ organs_NNS depends_VVZ on_II Hedgehog_NN signals_NNS from_II the_DD endoderm_NN to_II the_DD surrounding_VVGJ mesoderm_NN ._.
P11900460A03
Genetic_JJ mutants_NNS of_II Shh_NN and_CC its_PNG signaling_VVGJ pathway_NN establish_VVB this_DD dependence_NN as_II specific_JJ to_II endocrine_JJ ,_, but_CC not_RR exocrine_JJ ,_, pancreas_NN ._.
P11941477A03
The_DD genetic_JJ causes_NNS of_II HPE_NN have_VHB recently_RR begun_VVN to_TO be_VBI identified_VVN ,_, and_CC we_PN have_VHB previously_RR shown_VVN that_CST HPE_NN can_VM be_VBB caused_VVN by_II haploinsufficiency_NN for_II SONIC_NN HEDGEHOG_NN (_( SHH_NN )_) ._.
P11941477A09
We_PN predict_VVB that_CST by_II enhancing_VVGN the_DD repressive_JJ activity_NN of_II PTCH_NN on_II the_DD SHH_NN pathway_NN ,_, these_DD mutations_NNS cause_VVB decreased_VVNJ SHH_NN signaling_VVGN ,_, and_CC HPE_NN results_VVZ ._.
P11955435A02
Ci-155_NN proteolysis_NN depends_VVZ on_II phosphorylation_NN at_II three_MC sites_NNS by_II Protein_NN Kinase_NN A_NN (_( PKA_NN )_) ._.
P11955708A05
However_RR ,_, decreased_VVNJ BMP_NN signaling_VVGN ,_, through_II ectopic_JJ expression_NN of_II Noggin_NN ,_, a_DD BMP-binding_VVGJ protein_NN ,_, also_RR caused_VVD decreased_VVNJ proliferation_NN and_CC hypoplasia_NN of_II the_DD telencephalic_JJ and_CC optic_JJ vesicles_NNS ,_, but_CC with_II maintenance_NN of_II Fgf8_NN and_CC Shh_NN expression_NN ,_, and_CC no_DD detectable_JJ increase_NN in_II cell_NN death_NN ._.
P11959821A04
These_DD effects_NNS appear_VVB specific_JJ ,_, as_CS they_PN can_VM be_VBB prevented_VVN by_II addition_NN of_II heparan_NN sulphate_NN to_II the_DD culture_NN medium_NN ,_, whereas_CS heparitinase-treated_VVNJ heparan_NN sulphate_NN and_CC chondroitin_NN sulphate_NN are_VBB ineffective_JJ ._.
P11959830A02
As_CS sonic_NN hedgehog_NN is_VBZ expressed_VVN in_II the_DD cerebellum_NN throughout_II life_NN it_PN is_VBZ not_RR clear_JJ why_CST proliferation_NN occurs_VVZ only_RR in_II the_DD early_JJ postnatal_JJ period_NN and_CC only_RR in_II the_DD external_JJ granule_NN cell_NN layer_NN ._.
P11959830A08
These_DD data_NNS suggest_VVB that_CST heparan_NN sulfate_NN proteoglycans_NNS ,_, synthesized_VVN by_II exostosins_NNS ,_, may_VM be_VBB critical_JJ determinants_NNS of_II granule_NN cell_NN proliferation_NN ._.
P11960025A05
Whole-organ_NN profiling_VVGN of_II the_DD developing_VVGJ cerebellum_NN was_VBD carried_VVN out_II from_II PN_NN 1_MC to_II 30_MC to_TO generate_VVI a_DD database_NN of_II temporal_JJ gene_NN regulation_NN profiles_NNS (_( TRPs_NNS )_) ._.
P11964399A02
Therefore_RR ,_, we_PN have_VHB investigated_VVN the_DD possibility_NN that_CST a_DD functional_JJ relationship_NN exists_VVZ between_II the_DD two_MC proteins_NNS ._.
P11964399A08
The_DD ability_NN of_II megalin-internalized_VVNJ N-Shh_NN to_TO bypass_VVI lysosomes_NNS may_VM relate_VVB to_II the_DD finding_VVGN that_CST the_DD interaction_NN between_II N-Shh_NN and_CC megalin_NN was_VBD resistant_JJ to_II dissociation_NN with_II low_JJ pH_NN ._.
P11973281A05
Notochordal_JJ signaling_VVGN induces_VVZ midline_NN bending_VVGN and_CC simultaneously_RR inhibits_VVZ dorsolateral_JJ bending_VVGN ._.
P11977981A05
Transcription_NN of_II Ihh_NN in_II ovariectomized_VVNJ mice_NNS is_VBZ induced_VVN by_II progesterone_NN but_CC not_RR by_II estrogen_NN ._.
P11977981A10
We_PN propose_VVB that_CST IHH_NN made_VVN by_II the_DD epithelium_NN normally_RR functions_VVZ as_II a_DD paracrine_JJ growth_NN factor_NN for_II stromal_JJ cells_NNS during_II the_DD early_JJ stages_NNS of_II pregnancy_NN ._.
P11983699A06
Reporter_NN gene_NN expression_NN driven_VVN by_II the_DD CD155_NN core_NN promoter_NN is_VBZ activated_VVN by_II Shh_NN in_II transient_JJ co-transfection_NN assays_NNS ._.
P11990870A05
In_II addition_NN to_II myelin_NN vacuolation_NN and_CC nude_JJ axons_NNS ,_, the_DD presence_NN of_II many_DD thin_JJ myelin_NN sheaths_NNS suggested_VVD remyelination_NN or_CC partial_JJ demyelination_NN ._.
P11993506A06
Epithelial_JJ Shh_NN regulates_VVZ the_DD formation_NN of_II stomach_NN glands_NNS and_CC stratification_NN of_II the_DD mesenchyme_NN into_II connective_JJ tissue_NN and_CC smooth_JJ muscle_NN ._.
P12015605A05
A_DD gain-of-function_NN ,_, calcineurin-independent_JJ active_JJ XNF-AT_NN mutation_NN (_( CA_NN XNF-AT_NN )_) inhibited_VVD anterior_JJ development_NN of_II the_DD primary_JJ axis_NN ,_, as_CC+ well_CC+ as_CC Xwnt-8-induced_VVNJ ectopic_JJ dorsal_JJ axis_NN development_NN in_II embryos_NNS ._.
P12030971A03
The_DD aim_NN of_II the_DD present_JJ study_NN was_VBD to_TO assess_VVI the_DD prevalence_NN of_II yeast_NN in_II the_DD oral_JJ cavities_NNS of_II patients_NNS suffering_VVG from_II type_NN 1_MC and_CC type_NN 2_MC diabetes_NN mellitus_NN ._.
P12030971A09
Local_JJ oral_JJ factors_NNS ,_, such_II+ as_II the_DD presence_NN of_II dentures_NNS ,_, seemed_VVD to_TO have_VHI a_DD greater_JJR influence_NN than_CSN diabetic_JJ status_NN on_II the_DD amount_NN and_CC species_NNS of_II Candida_NN isolated_VVN from_II the_DD oral_JJ cavities_NNS of_II diabetic_JJ patients_NNS ._.
P12068255A01
BACKGROUND_NN :_: Ethanol_NN is_VBZ metabolized_VVN to_II acetaldehyde_NN in_II the_DD cell_NN ,_, which_PNR is_VBZ potentially_RR deleterious_JJ because_CS it_PN can_VM react_VVB with_II cellular_JJ proteins_NNS and_CC form_NN protein-acetaldehyde_NN adducts_NNS ,_, which_PNR can_VM interfere_VVB with_II normal_JJ cellular_JJ function_NN ._.
P12068255A07
CONCLUSIONS_NNS :_: These_DD results_NNS demonstrate_VVB the_DD significant_JJ formation_NN of_II protein-acetaldehyde_NN adducts_NNS in_II rat_NN brain_NN after_II ethanol_NN ingestion_NN ._.
P12070039A04
Measurements_NNS of_II TfR_NN mRNA_NN half-life_NN indicated_VVD that_CST hyperexpression_NN in_II SCF_NN erythroblasts_NNS was_VBD due_II+ to_II a_DD massive_JJ stabilization_NN of_II transcripts_NNS even_RR in_II the_DD presence_NN of_II high_JJ iron_NN levels_NNS ._.
P12070046A02
Patients_NNS with_II paroxysmal_JJ nocturnal_JJ hemoglobinuria_NN (_( PNH_NN )_) lack_VVB GPI_NN proteins_NNS on_II the_DD surface_NN of_II somatically_RR mutated_VVNJ hematopoietic_JJ stem_NN cell_NN and_CC its_PNG progeny_NN ._.
P12072386A01
As_CS glucose-induced_VVNJ insulin_NN expression_NN is_VBZ mainly_RR regulated_VVN at_II the_DD translational_JJ level_NN ,_, and_CC such_DD regulation_NN often_RR involves_VVZ the_DD 5'-untranslated_VVNJ region_NN (_( 5'UTR_NN )_) ,_, we_PN examined_VVD the_DD human_NN proinsulin_NN gene_NN 5'UTR_NN ._.
P12072386A07
These_DD results_NNS suggest_VVB a_DD novel_JJ mechanism_NN by_II which_PNR metabolic_JJ changes_NNS can_VM modulate_VVB the_DD expression_NN of_II 5'UTR_NN SPVs_NNS and_CC thereby_RR regulate_VVB translation_NN efficiency_NN ._.
P12074503A02
There_EX is_VBZ emerging_VVG evidence_NN that_CST certain_JJ reproductive_JJ factors_NNS may_VM further_RR elevate_VVB risk_NN in_II these_DD women_NNS ._.
P12074503A08
CONCLUSIONS_NNS :_: Our_PNG findings_NNS suggest_VVB that_CST most_DD reproductive_JJ factors_NNS influence_VVB breast_NN cancer_NN risk_NN similarly_RR in_II women_NNS with_II and_CC without_II a_DD family_NN history_NN of_II breast_NN cancer_NN ._.
P12091242A02
There_EX is_VBZ also_RR in_JJ+ vitro_JJ evidence_NN that_CST SP-D_NN may_VM suppress_VVB local_JJ T_NN cell_NN responses_NNS ._.
P12091242A08
Flow_NN cytometry_NN was_VBD used_VVN to_TO determine_VVI the_DD number_NN and_CC functional_JJ activation_NN status_NN of_II intrapulmonary_JJ CD4_NN (_( +_SYM )_) and_CC CD8_NN (_( +_SYM )_) T_NN cells_NNS ,_, as_CC+ well_CC+ as_CC B_NN cells_NNS and_CC NK_NN cells_NNS ._.
P12091242A14
Of_II the_DD proinflammatory_JJ cytokines_NNS evaluated_VVN ,_, only_RR interleukin_NN (_( IL_NN )_) -12_MC and_CC IL-6_NN expression_NN were_VBD consistently_RR upregulated_VVN in_II the_DD lungs_NNS of_II SPD_NN (_( -_SYM )_) (_( /_SYM -_SYM )_) mice_NNS ._.
P12091253A06
The_DD blockade_NN of_II p38_NN with_II the_DD pharmacologic_JJ inhibitor_NN SB203580_NN abrogated_VVD IL-8_NN production_NN by_II cell_NN stretching_VVGN ,_, and_CC an_DD inhibitor_NN of_II the_DD p44_NN /_SYM 42_MC pathway_NN ,_, PD98059_NN ,_, partially_RR inhibited_VVD the_DD IL-8_NN response_NN ._.
P12117701A05
While_CS application_NN of_II these_DD technologies_NNS to_II population_NN studies_NNS will_VM still_RR require_VVB careful_JJ attention_NN to_II methodological_JJ caveats_NNS important_JJ in_II studies_NNS of_II weight_NN ,_, the_DD ability_NN to_TO separately_RR examine_VVI lean_JJ mass_NN ,_, bone_NN ,_, and_CC fat_NN should_VM shed_VVB light_NN on_II the_DD underlying_VVGJ biologic_JJ processes_NNS pertinent_JJ to_II risk_NN ._.
P12121510A05
It_PN was_VBD further_RR associated_VVN with_II decreased_VVNJ bile_NN flow_NN and_CC increased_VVNJ parenchymal_JJ cell_NN damage_NN ._.
P12128087A03
These_DD channels_NNS possess_VVB distinct_JJ physiologic_JJ characteristics_NNS that_PNR would_VM be_VBB consistent_JJ with_II their_PNG toxic_JJ properties_NNS ._.
P12128087A09
Channel_NN formation_NN by_II several_JJ other_JJ amyloid_NN peptides_NNS lends_VVZ credence_NN to_II the_DD notion_NN that_CST this_PND is_VBZ a_DD critical_JJ mechanism_NN of_II cytotoxicity_NN ._.
P12137966A04
Concentration-dependent_JJ inhibition_NN of_II the_DD agonist-driven_VVNJ CHO-Y1_NN internalization_NN was_VBD found_VVN with_II filipin_NN III_MC (_( a_DD cholesterol-complexing_VVGJ macrolide_NN )_) ,_, and_CC confirmed_VVN with_II inhibitors_NNS of_II clathrin_NN lattice_NN formation_NN ,_, phenylarsine_NN oxide_NN (_( PAO_NN )_) and_CC sucrose_NN ._.
P12140204A03
METHODS_NNS :_: This_DD clinical_JJ trial_NN was_VBD designed_VVN to_TO be_VBI randomised_VVN ,_, double_RR blinded_VVN ,_, and_CC placebo_NN controlled_VVN ._.
P12140204A09
Rose_NN bengal_NN staining_VVGN ,_, tear_NN clearance_NN ,_, and_CC corneal_JJ sensation_NN were_VBD improved_VVN although_CS this_DD increase_NN was_VBD minor_JJ ._.
P12141835A02
This_DD article_NN discusses_VVZ developmentally_RR focused_VVNJ approaches_NNS to_II providing_VVGN care_NN for_II adolescents_NNS with_II cancer_NN ._.
P12142492A05
In_II these_DD mechanisms_NNS ,_, changes_NNS in_II the_DD phospholipid_NN profile_NN and_CC extrusion_NN of_II the_DD solvents_NNS seem_VVB to_TO be_VBI shared_VVN by_II different_JJ strains_NNS ._.
P12142492A11
The_DD operation_NN of_II these_DD efflux_NN pumps_NNS seems_VVZ to_TO be_VBI coupled_VVN to_II the_DD proton_NN motive_JJ force_NN via_II the_DD TonB_NN system_NN ,_, although_CS the_DD intimate_JJ mechanism_NN of_II energy_NN transfer_NN remains_VVZ elusive_JJ ._.
P12167167A04
Each_DD fluctuation_NN cycle_NN consisted_VVD of_II a_DD phase_NN of_II increase_NN and_CC a_DD phase_NN of_II decrease_NN ._.
P12167167A10
Altering_VVGN the_DD perfusion_NN mode_NN from_II constant_JJ pressure_NN to_II constant_JJ flow_NN did_VDD not_RR prevent_VVB the_DD occurrence_NN of_II the_DD cyclic_JJ fluctuations_NNS ._.
P12167167A16
Pyruvate_NN in_II the_DD buffer_NN also_RR markedly_RR attenuated_VVD the_DD post-ischaemic_JJ deterioration_NN of_II cardiac_JJ performance_NN seen_VVN in_II this_DD mouse_NN model_NN ._.
P12167170A02
Sprague-Dawley_NN rats_NNS were_VBD assigned_VVN to_II one_MC of_II the_DD three_MC groups_NNS :_: control_NN (_( CON_NN )_) ,_, resistance_NN trained_VVNJ (_( RT_NN )_) and_CC aerobic_JJ exercise_NN trained_VVNJ (_( AT_NN )_) ._.
P12167170A08
The_DD increased_VVNJ rates_NNS of_II 3-O-methyl-d-glucose_NN transport_NN in_II the_DD skeletal_JJ muscles_NNS of_II the_DD resistance_NN trained_VVNJ and_CC aerobic_JJ exercise_NN trained_VVNJ animals_NNS appeared_VVD to_TO be_VBI ,_, in_II part_NN ,_, because_II+ of_II an_DD increased_VVNJ GLUT4_NN protein_NN concentration_NN ._.
P12175124A06
Conclusively_RR ,_, in_II amelogenesis_NN imperfecta_NN ,_, enamel_NN tissue_NN is_VBZ mostly_RR affected_VVN besides_II minor_JJ defects_NNS in_II dentinal_JJ and_CC pulpal_JJ tissue_NN ._.
P12209794A06
All_DD transformants_NNS retained_VVD large_JJ intracellular_JJ fractions_NNS of_II beta-glucosidase_NN ,_, indicative_JJ of_II an_DD intracellular_JJ bottleneck_NN ._.
P12220358A05
CONCLUSIONS_NNS :_: Results_NNS suggest_VVB that_CST collagen_NN IV_MC alpha_NN chain_NN distribution_NN in_II ameloblastoma_NN BM_NN plays_VVZ an_DD important_JJ role_NN in_II tumor_NN cytodifferentiation_NN and_CC progression_NN ._.
P12223059A02
The_DD hallmark_NN of_II the_DD family_NN is_VBZ its_PNG replicative_JJ strategy_NN ,_, essential_JJ steps_NNS of_II which_PNR include_VVB reverse_JJ transcription_NN of_II the_DD viral_JJ RNA_NN and_CC the_DD subsequent_JJ integration_NN of_II this_DD DNA_NN into_II the_DD genome_NN of_II the_DD cell_NN ._.
P12223059A08
This_DD paper_NN is_VBZ an_DD overview_NN of_II the_DD inhibitors_NNS of_II RNase_NN H_NN and_CC IN_NN and_CC describes_VVZ the_DD most_RRT promising_VVGJ inhibitors_NNS ._.
P12231267A04
Yearly_JJ direct_JJ medical_JJ costs_NNS and_CC outcomes_NNS (_( indicated_VVN by_II the_DD average_JJ Global_NN Assessment_NN of_II Functioning_VVGN score_NN )_) were_VBD assessed_VVN retrospectively_RR in_II an_DD open_JJ ,_, intent-to-treat_NN study_NN by_II abstracting_VVGN psychiatric_JJ outpatient_JJ charts_NNS ._.
P12234638A02
The_DD sensing_VVGJ elements_NNS were_VBD disk-shaped_VVN ,_, had_VHD a_DD diameter_NN of_II about_RR 1_MC microm_NN ,_, and_CC were_VBD separated_VVN from_II each_DD other_PN by_II less_RR than_CSN 15_MC microm_NN ._.
P12357531A02
Fenestrations_NNS are_VBB routinely_RR created_VVN in_II patients_NNS with_II lateral_JJ tunnel_NN or_CC extracardiac_JJ Fontan_NN ._.
P12357531A08
The_DD procedure_NN was_VBD successful_JJ in_II all_DD patients_NNS ._.
P12361503A01
Injuries_NNS to_II the_DD aorta_NN are_VBB among_II the_DD more_RR serious_JJ injuries_NNS that_PNR result_VVB from_II vehicle_NN impacts_NNS ,_, and_CC may_VM often_RR be_VBB fatal_JJ ._.
P12361503A07
It_PN was_VBD speculated_VVN that_CST the_DD anatomical_JJ asymmetry_NN of_II the_DD thorax_NN might_VM play_VVB a_DD role_NN in_II the_DD differences_NNS seen_VVN in_II injury_NN risk_NN associated_VVN with_II different_JJ impact_NN directions_NNS ._.
P12361509A02
Population-_NN based_VVNJ estimates_NNS of_II the_DD risk_NN of_II injury_NN to_II children_NNS in_II child_NN restraints_NNS and_CC a_DD description_NN of_II the_DD patterns_NNS and_CC mechanisms_NNS of_II injury_NN are_VBB necessary_JJ to_TO evaluate_VVI this_DD standard_NN and_CC identify_VVI areas_NNS of_II needed_VVNJ improvement_NN ._.
P12361512A01
The_DD objective_NN of_II this_DD study_NN was_VBD to_TO quantify_VVI the_DD relationship_NN between_II harness_NN type_NN and_CC the_DD prevalence_NN of_II child_NN restraint_NN system_NN (_( CRS_NN )_) misuse_NN ._.
P12361512A06
However_RR specific_JJ misuses_NNS were_VBD more_RR common_JJ for_II specific_JJ harness_NN types_NNS ._.
P12361514A05
Associated_VVNJ injuries_NNS ,_, such_II+ as_II mild_JJ brain_NN injuries_NNS ,_, and_CC psychosocial_JJ factors_NNS such_II+ as_II depression_NN ,_, also_RR influence_VVB the_DD long-term_NN outcome_NN ._.
P12375636A06
All_DD 14_MC DNTs_NNS were_VBD 1p_NN intact_JJ by_II FISH_NN analysis_NN ._.
P12411468A06
Sodium_NN excretion_NN only_RR decreased_VVD (_( P_NN <_SYM 0.05_MC )_) during_II the_DD first_JJ day_NN of_II COX-2_NN inhibition_NN in_II dogs_NNS with_II normal_JJ or_CC high_JJ sodium_NN load_NN ._.
P12414141A06
The_DD incidence_NN of_II brucellosis_NN in_II swine_NN and_CC sheep_NN is_VBZ very_RR rare_JJ but_CC still_RR there_EX are_VBB a_DD few_JJ outbreaks_NNS in_II some_DD regions_NNS ._.
P12417062A03
In_II spite_NN of_II the_DD evidence_NN that_CST several_JJ growth_NN factors_NNS are_VBB angiogenic_JJ in_II the_DD CAM_NN assay_NN ,_, poorly_RR investigated_VVN is_VBZ their_PNG role_NN in_II the_DD development_NN of_II the_DD CAM_NN 's_GE vascular_JJ system_NN ._.
P12419679A02
We_PN have_VHB investigated_VVN herein_RR the_DD possibility_NN to_TO obtain_VVI high_JJ resolution_NN 2D_NN MAS_NN spectra_NNS of_II cholesterol_NN embedded_VVN in_II membranes_NNS ,_, i.e._II on_II a_DD rigid_JJ molecule_NN whose_PNR dynamics_NNS is_VBZ characterized_VVN mainly_RR by_II axial_JJ diffusion_NN without_II internal_JJ segmental_JJ mobility_NN ._.
P12421100A06
The_DD results_NNS of_II 19_MC short-term_NN clinical_JJ trials_NNS using_VVG simvastatin_NN ,_, pravastatin_NN ,_, fluvastatin_NN or_CC lovastatin_NN in_II postmenopausal_JJ women_NNS are_VBB summarised_VVN and_CC discussed_VVN ._.
P12421304A04
Epitope-tagged_VVNJ gMyb2_NN localized_VVD to_II both_DD nuclei_NNS ._.
P12421304A10
gMyb2_NN is_VBZ the_DD first_JJ giardial_JJ transcription_NN factor_NN to_TO be_VBI functionally_RR identified_VVN and_CC the_DD first_PN that_PNR is_VBZ associated_VVN with_II upregulation_NN of_II encystation_NN genes_NNS ._.
P12434706A03
The_DD incidence_NN and_CC degree_NN of_II expression_NN were_VBD investigated_VVN in_II the_DD first_JJ upper_JJ permanent_JJ molars_NNS and_CC scored_VVN according_II+ to_II Dahlberg_NN 's_GE eight_MC grade_NN scale_NN classification_NN ._.
P12437102A05
The_DD Y226F_NN mutant_NN retained_VVD the_DD capacity_NN to_TO oligomerize_VVI to_II higher_JJR covalently_RR and_CC noncovalently-linked_VVNJ oligomers_NNS as_II the_DD wild_JJ type_NN ,_, whereas_CS H167A_NN was_VBD predominantly_RR a_DD monomer_NN ._.
P12440630A01
Biventricular_JJ pacing_VVGN has_VHZ been_VBN proposed_VVN recently_RR for_II treating_VVGN patients_NNS with_II medically_RR refractory_JJ heart_NN failure_NN and_CC ventricular_JJ desynchronization_NN ._.
P12443882A05
Masking_VVGN of_II the_DD cell-surface_NN CD13_NN by_II anti-CD13_NN antibody_NN WM15_NN blocked_VVD the_DD synergistic_JJ effect_NN of_II bestatin_NN and_CC ATRA_NN on_II differentiation_NN ._.
P12454837A02
It_PN is_VBZ a_DD valuable_JJ diagnostic_JJ marker_NN for_II the_DD identification_NN of_II hereditary_JJ nonpolyposis_NN colorectal_JJ cancer_NN cases_NNS and_CC may_VM be_VBB a_DD molecular_JJ predictive_JJ marker_NN for_II the_DD identification_NN of_II colon_NN cancer_NN patients_NNS who_PNR benefit_VVB from_II chemotherapy_NN ._.
P12454837A08
In_II contrast_NN ,_, all_DD MSI_NN tumors_NNS showed_VVD allelic_JJ size_NN variations_NNS in_II 3_MC or_CC more_PND of_II the_DD microsatellites_NNS ._.
P12468200A04
The_DD illumination_NN of_II HB_NN with_II visible_JJ light_NN in_II aerobic_JJ non-polar_JJ solvent_NN generated_VVD singlet_NN oxygen_NN efficiently_RR [_( Phi_NN (_( 1O_NN (_( 2_MC )_) )_) =0.76_MC ]_) which_PNR then_RR attacked_VVD the_DD sensitizer_NN HB_NN with_II formation_NN of_II an_DD endoperoxide_NN product_NN ._.
P12489133A04
The_DD time_NN from_II the_DD adult_NN molt_NN to_II the_DD maximum_NN ecdysteroid_NN titer_NN (_( E_NN (_( max_NN )_) titer_NN )_) varied_VVD in_II response_NN to_II food_NN availability_NN ,_, whereas_CS the_DD time_NN from_II E_NN (_( max_NN )_) titer_NN to_II oviposition_NN was_VBD unrelated_VVN to_II food_NN availability_NN ._.
P12489133A10
In_II contrast_NN to_II hemolymph_NN ecdysteroids_NNS ,_, ovarian_JJ ecdysteroids_NNS persisted_VVD until_II oviposition_NN ._.
P12489133A12
In_II summary_NN ,_, our_PNG studies_NNS indicate_VVB that_CST hemolymph_NN ecdysteroids_NNS in_II adult_NN females_NNS of_II the_DD lubber_NN grasshopper_NN are_VBB associated_VVN with_II the_DD timing_VVGN of_II egg_NN production_NN ,_, but_CC they_PN neither_CC regulate_VVB vitellogenesis_NN nor_CC act_VVB as_II a_DD source_NN of_II ecdysteroids_NNS for_II the_DD ovary_NN ._.
P12494717A02
This_DD study_NN reports_VVZ results_NNS from_II in-depth_NN phone_NN surveys_NNS conducted_VVN with_II 32_MC consumer_NN drop-in_JJ centers_NNS in_II Michigan_NNP ._.
P12501599A02
Radioimmunoassay_NN (_( RIA_NN )_) technique_NN was_VBD used_VVN ._.
P12501599A08
Therefore_RR ,_, in_II blood_NN ,_, the_DD uptake_NN of_II hGH-L_NN was_VBD less_RR than_CSN that_CST of_II hGH_NN ,_, the_DD removal_NN of_II hGH-L_NN was_VBD faster_JJR than_CSN the_DD removal_NN of_II hGH_NN ._.
P12501953A03
OUTCOME_NN MEASURES_NNS :_: These_PND included_VVD the_DD Color_NN Trails_NNS Test_NN ,_, Stroop_NN Colour-Word_NN Test_NN ,_, Symbol_NN Digit_NN Modalities_NNS Test_NN ,_, Word_NN Fluency_NN Test_NN ,_, Design_NN Fluency_NN Test_NN ,_, Digits_NNS Backward_NN Span_NN Test_NN and_CC Modified_VVNJ Six_MC Elements_NNS Test_NN ._.
P12501978A03
Blood_NN hormone_NN levels_NNS determinations_NNS revealed_VVD elevated_VVNJ thyroid_NN hormones_NNS ,_, TSH_NN ,_, and_CC IGF-1_NN with_II a_DD relatively_RR low_JJ GH_NN ._.
P12506970A05
The_DD breaking_VVGJ force_NN and_CC energy_NN of_II the_DD femur_NN in_II the_DD Ca-Cheese_NN group_NN were_VBD significantly_RR higher_JJR than_CSN in_II the_DD control_NN group_NN ._.
P12507857A04
At_II the_DD end_NN of_II the_DD storage_NN period_NN ,_, distributions_NNS of_II dry_JJ matter_NN ,_, pH_NN ,_, total_JJ ammoniacal_JJ nitrogen_NN and_CC total_JJ Kjeldahl_NN nitrogen_NN in_II slurry_NN were_VBD characterized_VVN ._.
P12512872A06
The_DD FasL_NN deficiency_NN reduced_VVD the_DD median_JJ time_NN to_II death_NN from_II 12.1_MC months_NNS in_II FasL_NN +/+_SYM p53_NN +/-_SYM mice_NNS to_II 9.6_MC months_NNS in_II FasL_NN -/-_SYM p53_NN +/-_SYM mice_NNS ,_, and_CC led_VVD to_II a_DD shift_NN in_II tumor_NN spectrum_NN from_II predominantly_RR sarcomas_NNS (_( 63_MC %_SYM )_) when_CS FasL_NN was_VBD present_JJ to_II a_DD large_JJ number_NN of_II lymphomas_NNS (_( 76_MC %_SYM )_) in_II FasL_NN -/-_SYM p53_NN +/-_SYM mice_NNS ._.
P12531764A06
Four_MC tibial_JJ tuberosity_NN transfer_NN procedures_NNS (_( two_MC anterior_JJ and_CC two_MC anteromedial_JJ )_) were_VBD simulated_VVN for_II each_DD patient_NN and_CC compared_VVN with_II their_PNG preoperative_JJ model_NN ._.P01284126A05
The_DD MMP-3_NN ,_, MMP-9_NN and_CC TIMP-1_NN stimulation_NN in_II response_NN to_II IL-1_NN and_CC TNF-alpha_NN treatment_NN was_VBD detected_VVN in_II some_PND of_II the_DD tumor_NN cell_NN lines_NNS and_CC HUVEC_NN ._.
P01336777A04
In_II the_DD present_JJ study_NN the_DD ability_NN of_II human_NN osteoblasts_NNS to_TO produce_VVI the_DD matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) collagenase_NN ,_, gelatinase_NN and_CC stromelysin_NN ,_, and_CC their_PNG specific_JJ inhibitors_NNS TIMPs-1_NN and_CC 2_MC ,_, was_VBD examined_VVN using_VVG highly_RR sensitive_JJ and_CC specific_JJ antisera_NNS and_CC by_II zymography_NN ._.
P01339118A05
Gelatin_NN zymography_NN revealed_VVD several_JJ lysis_NN zones_NNS amongst_II which_PNR a_DD major_JJ 92-kDa_NN band_NN shifted_VVD to_II 83-_MC and_CC 68-kDa_NN species_NNS during_II the_DD course_NN of_II implantation_NN ._.
P01379048A12
The_DD active_JJ forms_NNS generated_VVN by_II trypsin_NN were_VBD identified_VVN as_II 80_MC kDa_NN ,_, 74_MC kDa_NN and_CC 66_MC kDa_NN by_II their_PNG abilities_NNS to_TO bind_VVI to_II alpha_NN 2-macroglobulin_NN ._.
P01400481A06
The_DD proenzyme_NN is_VBZ fully_RR activated_VVN by_II cathepsin_NN G_NN ,_, trypsin_NN ,_, alpha-chymotrypsin_NN ,_, and_CC MMP-3_NN (_( stromelysin_NN 1_MC )_) but_CC not_RR by_II plasmin_NN ,_, leukocyte_NN elastase_NN ,_, plasma_NN kallikrein_NN ,_, thrombin_NN ,_, or_CC MMP-1_NN (_( tissue_NN collagenase_NN )_) ._.
P01480033A01
The_DD zymogens_NNS of_II matrix_NN metalloproteinase_NN 1_MC (_( MMP-1_NN :_: tissue_NN collagenase_NN )_) ,_, MMP-2_NN (_( gelatinase_NN /_SYM type_NN IV_MC collagenase_NN )_) and_CC MMP-3_NN (_( stromelysin_NN )_) were_VBD purified_VVN from_II the_DD culture_NN medium_NN of_II human_NN rheumatoid_JJ synovial_JJ fibroblasts_NNS and_CC the_DD mechanisms_NNS of_II activation_NN of_II each_DD zymogen_NN by_II proteinases_NNS and_CC 4-aminophenylmercuric_JJ acetate_NN (_( APMA_NN )_) were_VBD studied_VVN by_II kinetic_NN and_CC sequence_NN analyses_NNS ._.
P01645518A05
These_DD results_NNS suggest_VVB that_CST collagenolysis_NN in_II uterine_JJ cervical_JJ fibroblasts_NNS is_VBZ negatively_RR regulated_VVN by_II steroid_NN hormones_NNS via_II the_DD acceleration_NN of_II TIMP_NN production_NN and_CC the_DD suppression_NN of_II synthesis_NN of_II MMPs_NNS at_II the_DD pretranslational_JJ level_NN ._.
P01653026A13
TNF_NN alpha_NN did_VDD also_RR stimulate_VVB the_DD production_NN of_II proMMP-9_NN ,_, although_CS less_RR efficiently_RR than_CSN IL1_NN ,_, but_CC it_PN did_VDD not_RR induce_VVB ,_, or_CC very_RR poorly_RR ,_, that_PND of_II the_DD 55_MC kDa_NN proMMP-1_NN /_SYM proMMP-3_NN activity_NN ._.
P01657905A03
IL-1_NN significantly_RR augmented_VVD the_DD production_NN of_II proMMP-1_NN (_( vertebrate_NN procollagenase_NN )_) ,_, proMMP-3_NN (_( prostromelysin_NN )_) ,_, and_CC TIMP_NN without_II detectable_JJ changes_NNS in_II the_DD intracellular_JJ level_NN of_II cAMP_NN ._.
P02166509A01
We_PN have_VHB investigated_VVN the_DD effect_NN of_II interleukin_NN 6_MC (_( IL-6_NN )_) on_II the_DD synthesis_NN of_II tissue_NN inhibitor_NN of_II metalloproteinases_NNS (_( TIMP_NN )_) and_CC matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ,_, collagenase_NN (_( MMP-1_NN )_) and_CC stromelysin_NN (_( MMP-3_NN )_) using_VVG human_NN skin_NN and_CC uterine_JJ cervical_JJ fibroblasts_NNS ._.
P02174435A10
In_II contrast_NN ,_, Timp_NN gene_NN transcription_NN was_VBD reduced_VVN by_II approximately_RR 80_MC %_SYM ,_, revealing_VVG reciprocal_JJ regulation_NN of_II MMPs_NNS and_CC TIMP_NN during_II the_DD induction_NN of_II a_DD resorptive_JJ cell_NN phenotype_NN ._.
P02269296A01
Human_NN rheumatoid_JJ synovial_JJ cells_NNS in_II culture_NN secrete_VVB at_RR+ least_RR three_MC related_VVNJ metalloproteinases_NNS that_PNR digest_VVB extracellular_JJ matrix_NN macromolecules_NNS ._.
P07502710A12
After_II the_DD addition_NN of_II IL-1_NN alpha_NN ,_, a_DD very_RR rapid_JJ increase_NN in_II MMP-1_NN and_CC MMP-3_NN mRNA_NN could_VM be_VBB observed_VVN as_CC+ well_CC+ as_CC a_DD moderate_JJ increase_NN in_II TIMP-1_NN mRNA_NN ._.
P07512058A07
Two_MC inhibitors_NNS of_II MMPs_NNS ,_, the_DD naturally_RR occurring_VVGJ tissue_NN inhibitor_NN of_II metalloproteinases_NNS (_( TIMP_NN ;_: 10_MC micrograms_NNS /_SYM ml_NN )_) and_CC the_DD synthetic_JJ ,_, peptide_NN inhibitor_NN BB-94_NN (_( 1_MC microM_NN )_) were_VBD both_PND effective_JJ at_II blocking_VVGN HUVEC-mediated_VVNJ collagen_NN degradation_NN ._.
P07523391A07
These_DD studies_NNS suggest_VVB that_CST MMPs_NNS ,_, beyond_II their_PNG previously_RR described_VVNJ functions_NNS as_II extracellular_JJ degrading_VVGJ enzymes_NNS ,_, may_VM also_RR exert_VVB effects_NNS on_II cellular_JJ growth_NN and_CC proliferation_NN via_II degradation_NN of_II IGFBP-3_NN ,_, thus_RR enhancing_VVG IGF_NN bioavailability_NN ._.
P07533311A02
The_DD mRNA_NN levels_NNS for_II MMP-1_NN and_CC MMP-3_NN decreased_VVD with_II age_NN in_II STZ-induced_VVNJ diabetes_NN ._.
P07540230A04
Zymography_NN of_II medium_NN obtained_VVN from_II cells_NNS cultured_VVN in_II the_DD absence_NN of_II plasminogen_NN revealed_VVD the_DD presence_NN of_II latent_JJ matrix_NN metalloproteinase-2_NN (_( MMP-2_NN )_) which_PNR was_VBD converted_VVN to_II a_DD lower_JJR molecular_JJ weight_NN ,_, active_JJ form_NN in_II the_DD presence_NN of_II mesangial_JJ cells_NNS and_CC plasminogen_NN ._.
P07543547A06
PMA_NN stimulated_VVD the_DD production_NN of_II collagenase_NN ,_, stromelysin_NN ,_, 92-kDa_NN gelatinase_NN ,_, and_CC TIMP-1_NN in_II both_DD endothelial_JJ cell_NN types_NNS ._.
P07547939A07
The_DD results_NNS indicate_VVB that_CST weakly_RR bound_VVNJ water_NN molecules_NNS are_VBB essential_JJ to_TO mediate_VVI the_DD interaction_NN between_II substrate_NN and_CC enzyme_NN ._.
P07551259A03
Neither_CC enzyme_NN nor_CC TIMP-1_NN was_VBD detected_VVN in_II histologically_RR normal_JJ mucosa_NN ._.
P07559440A04
The_DD deduced_VVNJ protein_NN composed_VVN of_II 604_MC amino_JJ acids_NNS was_VBD closely_RR related_VVN to_II MT-MMP_NN in_II the_DD amino_JJ acid_NN sequence_NN (_( 66_MC %_SYM homology_NN at_II the_DD catalytic_JJ domains_NNS )_) and_CC has_VHZ a_DD potential_JJ TM_NN domain_NN at_II the_DD C_NN terminus_NN ._.
P07563189A10
Linear_JJ regression_NN analysis_NN ,_, Student_NN 's_GE t_NN tests_NNS ,_, and_CC chi-squared_NN analysis_NN were_VBD used_VVN to_TO evaluate_VVI the_DD data_NNS ._.
P07576228A05
Moreover_RR ,_, MMP_NN activity_NN is_VBZ post-transcriptionally_RR regulated_VVN by_II proteolytic_JJ activation_NN of_II the_DD latent_JJ proenzymes_NNS and_CC by_II interaction_NN with_II specific_JJ tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) ._.
P07586800A09
It_PN appears_VVZ ,_, therefore_RR ,_, that_CST MMP-9_NN may_VM play_VVB an_DD important_JJ role_NN in_II the_DD malignant_JJ behavior_NN of_II GCTs_NNS and_CC suggests_VVZ a_DD potential_JJ therapeutic_JJ role_NN for_II protease_NN inhibitors_NNS in_II attempting_VVGN to_TO minimize_VVI the_DD invasive_JJ behavior_NN of_II GCTs_NNS ._.
P07589989A01
Prostaglandin_NN E2_NN (_( PGE2_NN )_) and_CC leukotriene_NN B4_NN (_( LTB4_NN )_) ,_, at_II nanomolar_JJ to_II micromolar_JJ concentrations_NNS ,_, elicited_VVD migration_NN of_II human_NN blood_NN T_NN cells_NNS and_CC cultured_VVNJ T_NN lymphoblastoma_NN cells_NNS of_II the_DD Tsup-1_NN line_NN through_II a_DD layer_NN of_II Matrigel_NN basement_NN membrane_NN matrix_NN ._.
P07591310A01
We_PN have_VHB identified_VVN a_DD novel_JJ membrane-type_NN matrix_NN metalloproteinase_NN (_( MT-MMP_NN )_) expressed_VVN on_II the_DD cell_NN surface_NN and_CC inducing_VVG activation_NN of_II pro-gelatinase_NN A_NN in_RR+ vitro_RR ._.
P07593257A10
These_DD results_NNS suggested_VVD that_CST the_DD serum_NN induces_VVZ proliferation_NN as_CC+ well_CC+ as_CC expression_NN of_II MMP_NN and_CC TIMP_NN in_II HHE_NN and_CC HHF_NN cells_NNS ._.
P07601636A11
Removal_NN of_II tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMP_NN )_) from_II control_NN scleral_JJ extracts_NNS by_II reduction_NN and_CC alkylation_NN resulted_VVD in_II a_DD 222_MC %_SYM increase_NN in_II gelatinolytic_JJ activity_NN after_II APMA-activation_NN (_( P_NN <_SYM or_CC =_SYM 0.001_MC )_) ,_, whereas_CS similar_JJ treatment_NN of_II deprived_VVNJ scleral_JJ extracts_NNS resulted_VVD in_II only_RR a_DD 76_MC %_SYM increase_NN in_II gelatinolytic_JJ activity_NN (_( P_NN <_SYM or_CC =_SYM 0.001_MC )_) ._.
P07606893A08
Schwann_NN cells_NNS immortalized_VVN by_II protracted_VVNJ elevation_NN of_II cAMP_NN ,_, as_CC+ well_CC+ as_CC a_DD schwannoma_NN cell_NN line_NN (_( D6P2T_NN )_) ,_, also_RR rapidly_RR invaded_VVD a_DD reconstituted_VVNJ basement_NN membrane_NN and_CC over-expressed_VVD MMP-2_NN ._.
P07613621A04
In_II the_DD present_JJ paper_NN ,_, we_PN have_VHB studied_VVN the_DD changes_NNS occurring_VVG in_II human_NN primitive_JJ neuroectodermal_JJ cells_NNS following_VVG infection_NN with_II human_NN T_NN cell_NN lymphotropic_JJ virus_NN type_NN 1_MC (_( HTLV-I_NN )_) ,_, a_DD retrovirus_NN responsible_JJ for_II HTLV-I-associated_VVNJ myelopathy_NN ._.
P07615167A14
This_DD approach_NN may_VM prove_VVB generally_RR applicable_JJ for_II the_DD detection_NN of_II protease_NN activity_NN in_II tissue_NN sections_NNS permitting_VVG exploration_NN of_II the_DD roles_NNS of_II these_DD enzymes_NNS in_II pathobiology_NN ._.
P07616276A04
In_II five_MC human_NN glioma_NN cell_NN lines_NNS ,_, gelatinase_NN A_NN ,_, TIMP-1_NN ,_, and_CC TIMP-2_NN genes_NNS were_VBD constitutively_RR expressed_VVN in_II alll_DD cell_NN lines_NNS :_: the_DD matrilysin_NN gene_NN in_II three_MC cell_NN lines_NNS ;_: the_DD stromelysin_NN gene_NN in_II two_MC cell_NN lines_NNS ;_: and_CC the_DD interstitial_JJ collagenase_NN gene_NN in_II one_MC cell_NN line_NN ._.
P07622455A02
We_PN have_VHB reported_VVN that_CST a_DD catalytic_JJ amount_NN of_II MMP-3_NN (_( stromelysin_NN 1_MC )_) activates_VVZ pro-MMP-9_NN (_( Ogata_NNP ,_, Y._NNP ,_, Enghild_NNP ,_, J._NNP J._NNP ,_, and_CC Nagase_NNP ,_, H._NNP (_( 1992_MC )_) J._NN Biol._NN Chem._NN 267_MC ,_, 3581-3584_MC )_) ._.
P07628406A12
Gelatin_NN zymography_NN of_II follicular_JJ fluid_NN revealed_VVD bands_NNS of_II gelatinase_NN of_II 72_MC /_SYM 67_MC kilodaltons_NNS ,_, consistent_JJ with_II latent_JJ and_CC active_JJ MMP-2_NN ._.
P07629341A04
TMJ_NN discs_NNS were_VBD retrieved_VVN from_II 14-week-old_JJ male_NN NZW_NN rabbits_NNS and_CC both_CC tissue-_NN and_CC disc-derived_VVNJ cells_NNS were_VBD cultured_VVN in_II serum-free_JJ medium_NN ._.
P07639798A05
Radiologic_JJ and_CC functional_JJ joint_NN scores_NNS were_VBD based_VVN upon_II Steinbrocker_NN 's_GE criteria_NNS ._.
P07669564A07
MMP-9_NN mRNA_NN positive_JJ cells_NNS were_VBD round_JJ and_CC identified_VVN as_II macrophages_NNS by_II immunostaining_VVGN with_II an_DD anti-macrophage_NN antibody_NN (_( KP1_NN )_) ,_, while_CS TIMP-1_NN ,_, mRNA_NN was_VBD detected_VVN in_II spindle-shaped_VVNJ stromal_JJ cells_NNS ._.
P07695193A07
Upon_II stimulation_NN with_II IL1_NN or_CC TNF_NN alpha_NN ,_, SMC_NN synthesized_VVD in_II addition_NN 92_MC kDa_NN GL_NN ,_, stromelysin_NN ,_, and_CC interstitial_JJ collagenase_NN ,_, MMPs_NNS that_PNR together_RR can_VM degrade_VVB all_PND of_II the_DD ECM_NN components_NNS ._.
P07699005A08
Immunocytochemistry_NN demonstrated_VVD that_CST isolated_VVNJ rabbit_NN osteoclasts_NNS constitutively_RR expressed_VVD gelatinase_NN A_NN and_CC synthesized_VVD gelatinase_NN B_NN ,_, collagenase_NN and_CC stromelysin_NN ,_, as_CC+ well_CC+ as_CC the_DD tissue_NN inhibitor_NN of_II matrix_NN metalloproteinases-1_NN (_( TIMP-1_NN )_) following_VVG IL-1_NN alpha_NN stimulation_NN ._.
P07717983A02
An_DD antiserum_NN was_VBD prepared_VVN against_II a_DD peptide_NN conjugate_NN corresponding_VVG to_II the_DD C-terminal_JJ sequence_NN of_II the_DD matrix_NN metalloproteinase-generated_VVNJ aggrecan_NN G1_NN fragment_NN (_( Phe335-Val-Asp-Ile-Pro-Glu-Asn341_NN )_) ._.
P07734296A04
BT-20_NN cells_NNS also_RR enhanced_VVD the_DD production_NN of_II pro-MMP-2_NN and_CC TIMP-1_NN in_II the_DD dermal_JJ fibroblasts_NNS ,_, but_CC not_RR of_II pro-MMP-1_NN and_CC pro-MMP-3_NN ._.
P07743917A03
Transcripts_NNS for_II tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMP-1_NN ,_, -2_MC ,_, -3_MC )_) and_CC uPA_NN receptor_NN were_VBD detected_VVN throughout_II pre-_JJ and_CC peri-implantation_NN development_NN whilst_CS MMP-9_NN and_CC uPA_NN mRNAs_NNS were_VBD first_RR detected_VVN in_II peri-implantation_NN blastocysts_NNS associated_VVN with_II the_DD invasive_JJ phase_NN of_II implantation_NN ._.
P07772054A09
The_DD removal_NN of_II the_DD propeptide_NN of_II the_DD proMMP-2*_NN bound_VVN to_II TIMP-2_NN was_VBD also_RR observed_VVN by_II MMP-3_NN (_( stromelysin_NN 1_MC )_) ,_, but_CC not_RR by_II MMP-1_NN (_( interstitial_JJ collagenase_NN )_) ._.
P07775665A05
DOXY_NN was_VBD added_VVN to_II the_DD incubation_NN mixture_NN at_II a_DD final_JJ concentration_NN of_II 0-1000_MC microM_NN ._.
P07780609A02
Using_VVG immunohistochemistry_NN ,_, 40_MC specimens_NNS of_II colorectal_JJ cancer_NN were_VBD examined_VVN for_II the_DD presence_NN of_II TIMP-1_NN and_CC the_DD MMPs_NNS ,_, stromelysin_NN ,_, gelatinases_NNS A_NN and_CC B_NN and_CC interstitial_JJ collagenase_NN ._.
P07826345A07
Thus_RR RMCP_NN II_MC activates_VVZ proMMP-1_NN via_II a_DD mechanism_NN different_JJ from_II that_PND reported_VVN for_II the_DD stepwise_JJ processing_VVGN by_II combinations_NNS of_II other_JJ trypsin-like_JJ enzymes_NNS and_CC MMP-3_NN ._.
P07836420A05
Furthermore_RR ,_, plasma_NN membrane_NN fractions_NNS from_II these_DD cells_NNS significantly_RR enhanced_VVD the_DD rate_NN of_II cleavage_NN of_II [_( 14C_NN ]_) gelatin_NN I_MC substrate_NN by_II both_CC MMP-2_NN tissue_NN inhibitor_NN of_II metalloproteinases-2_NN (_( TIMP-2_NN )_) complex_NN (_( 2.5-8-fold_NN )_) and_CC TIMP-2-free_JJ MMP-2_NN (_( 5.9-fold_NN )_) ._.
P07840900A04
When_CS the_DD progelatinase_NN A-TIMP-2_NN complex_NN inhibits_VVZ an_DD active_JJ matrix_NN metalloproteinase_NN ,_, a_DD ternary_JJ complex_NN is_VBZ generated_VVN ._.
P07843905A15
In_JJ+ vivo_JJ injection_NN of_II cPAF_NN also_RR induced_VVD the_DD expression_NN of_II MMP-9_NN ._.
P07856724A08
Western_NN blot_NN analyses_NNS demonstrated_VVD increased_VVNJ MMP-9_NN protein_NN in_II amniochorion_NN extracts_NNS after_II onset_NN of_II labor_NN ._.
P07865092A05
Naturally_RR occurring_VVGJ inhibitors_NNS ,_, TIMPs_NNS (_( Tissue_NN Inhibitors_NNS of_II MetalloProteinases_NNS )_) ,_, are_VBB important_JJ controlling_VVGJ factors_NNS in_II the_DD actions_NNS of_II MMPs_NNS ,_, and_CC tissue_NN destruction_NN in_II disease_NN processes_NNS often_RR correlates_VVZ with_II an_DD imbalance_NN of_II MMPs_NNS over_II TIMPs_NNS ._.
P07875677A04
For_II the_DD reversibility_NN model_NN ,_, rats_NNS were_VBD treated_VVN with_II CCl4_NN three_MC times_NNS a_DD week_NN for_II 8_MC weeks_NNS and_CC killed_VVN at_II 3_MC ,_, 7_MC ,_, 14_MC ,_, 28_MC ,_, or_CC 42_MC days_NNS after_II discontinuation_NN of_II treatment_NN ._.
P07890493A07
Gelatinase_NN B_NN is_VBZ the_DD major_JJ MMP_NN expressed_VVN by_II corneal_JJ epithelial_JJ cells_NNS ,_, whereas_CS stromal_JJ fibroblasts_NNS produce_VVB gelatinase_NN B_NN along_RR with_II three_MC other_JJ MMPs_NNS :_: collagenase_NN ,_, stromelysin_NN ,_, and_CC gelatinase_NN A_NN ._.
P07890717A08
That_CST MMP-2_NN ,_, a_DD potent_JJ gelatinase_NN ,_, also_RR can_VM cleave_VVB fibrillar_JJ collagen_NN provides_VVZ an_DD alternative_NN to_II the_DD proposal_NN that_CST two_MC enzymes_NNS ,_, an_DD interstitial_JJ collagenase_NN and_CC a_DD gelatinase_NN ,_, are_VBB required_VVN for_II the_DD complete_JJ dissolution_NN of_II stromal_JJ collagen_NN during_II cellular_JJ invasion_NN ._.
P07891077A04
Enriched_VVNJ astrocyte_NN cultures_NNS were_VBD prepared_VVN from_II brains_NNS of_II 1-day-old_JJ rat_NN pups_NNS ,_, and_CC experiments_NNS were_VBD performed_VVN 13_MC days_NNS later_RR ._.
P07896811A06
On_II the_DD other_JJ hand_NN ,_, proMMP-1_NN is_VBZ activated_VVN by_II MMP-7_NN to_II an_DD activity_NN similar_JJ to_II that_PND obtained_VVN by_II APMA_NN and_CC the_DD activation_NN by_II MMP-7_NN is_VBZ enhanced_VVN up_II+ to_II approximately_RR 6.5_MC fold_NN in_II the_DD presence_NN of_II APMA_NN ._.
P07923181A06
In_II the_DD presence_NN of_II this_DD matrix_NN ,_, M24net_NN cells_NNS assume_VVB a_DD differentiated_VVNJ morphology_NN and_CC have_VHB a_DD reduced_VVNJ growth_NN rate_NN ._.
P07927938A01
The_DD 72-kDa_NN (_( MMP-2_NN ,_, gelatinase_NN A_NN )_) and_CC the_DD 92-kDa_NN (_( MMP-9_NN ,_, gelatinase_NN B_NN )_) matrix_NN metalloproteinases_NNS have_VHB been_VBN associated_VVN with_II tumor_NN cell_NN invasion_NN and_CC metastasis_NN ._.
P07944383A02
Using_VVG this_DD assay_NN we_PN were_VBD able_JJ to_TO compare_VVI the_DD native_JJ MMPs_NNS with_II the_DD respective_JJ catalytic_JJ domains_NNS in_II terms_NNS of_II inhibitor_NN affinities_NNS and_CC peptide_NN hydrolysis_NN ._.
P07945177A02
In_II particular_NN ,_, the_DD role_NN of_II the_DD matrix_NN degrading_VVGJ metalloproteinase_NN (_( MMP_NN )_) family_NN is_VBZ discussed_VVN ._.
P07989608A07
All_DD plaque_NN extracts_NNS contained_VVD activated_VVNJ forms_NNS of_II gelatinases_NNS determined_VVN zymographically_RR and_CC by_II degradation_NN of_II 3H-collagen_NN type_NN IV_MC ._.
P08006459A08
Concomitantly_RR ,_, catheptic_JJ collagenolytic_JJ activity_NN decreased_VVD in_II fibrotic_JJ fibroblast_NN extracts_NNS compared_VVN to_II controls_NNS ._.
P08013077A09
Moreover_RR ,_, since_CS these_DD mediators_NNS augment_VVB the_DD production_NN of_II MMPs_NNS without_II appreciably_RR affecting_VVGN the_DD synthesis_NN of_II TIMPs_NNS ,_, locally_RR secreted_VVNJ cytokines_NNS may_VM tip_VVB the_DD regional_JJ balance_NN of_II MMP_NN activity_NN in_II favor_NN of_II vascular_JJ matrix_NN degradation_NN ._.
P08014015A06
Nor_CC was_VBD there_EX any_DD association_NN between_II amount_NN of_II TNF_NN mRNA_NN and_CC levels_NNS of_II MMP_NN enzymes_NNS ._.
P08015284A11
However_RR ,_, the_DD PA22-2-mediated_VVNJ increase_NN in_II type_NN IV_MC collagenolytic_JJ activity_NN of_II the_DD A-2058_NN melanoma_NN line_NN remains_VVZ to_TO be_VBI elucidated_VVN ._.
P08019900A02
The_DD structures_NNS and_CC specificities_NNS of_II TIMP1_NN and_CC TIMP2_NN are_VBB described_VVN ._.
P08032535A01
We_PN have_VHB examined_VVN the_DD correlation_NN between_II matrix_NN metalloproteinase_NN (_( MMP_NN )_) expression_NN and_CC metastatic_JJ properties_NNS of_II a_DD low_JJ metastatic_JJ osteosarcoma_NN cell_NN line_NN ,_, osteosarcoma_NN takase_NN (_( OST_NN )_) ,_, under_II stimulation_NN by_II tumour_NN necrosis_NN factor_NN alpha_NN (_( TNF_NN alpha_NN )_) ._.
P08040944A02
METHODS_NNS :_: We_PN measured_VVD MMP_NN expression_NN (_( gelatin_NN ,_, casein_NN ,_, and_CC elastin_NN zymography_NN )_) by_II vascular_JJ wall_NN cells_NNS in_II balloon-injured_VVNJ carotid_JJ artery_NN during_II the_DD period_NN of_II medial_JJ SMC_NN proliferation_NN ,_, migration_NN of_II SMC_NN from_II the_DD media_NN to_II the_DD intima_NN ,_, and_CC subsequent_JJ intimal_JJ SMC_NN proliferation_NN ._.
P08063713A08
Unfortunately_RR ,_, NFF-2_NN showed_VVD little_DD discrimination_NN between_II MMP-3_NN ,_, MMP-2_NN (_( kcat_NN /_SYM Km_NN =_SYM 54,000_MC s-1_NN M-1_NN )_) ,_, and_CC MMP-9_NN (_( kcat_NN /_SYM Km_NN =_SYM 55,300_MC s-1_NN M-1_NN )_) ._.
P08083435A12
Periodontal_JJ treatment_NN reduced_VVD the_DD amount_NN of_II gelatinases_NNS dramatically_RR ._.
P08107689A07
Incubation_NN of_II the_DD extract_NN with_II both_CC serine_NN protease_NN and_CC GSSG_NN increased_VVD the_DD rate_NN of_II activation_NN 30-fold_NN ._.
P08129038A02
We_PN investigated_VVD levels_NNS and_CC cellular_JJ sites_NNS of_II gene_NN expression_NN of_II two_MC major_JJ collagen-degrading_VVGJ enzymes_NNS ,_, matrix-metalloproteinase_NN (_( MMP_NN )_) -1_MC (_( fibroblast_NN type-interstitial_JJ collagenase_NN )_) and_CC MMP-2_NN (_( 72-kd_NN gelatinase_NN ,_, type_NN IV_MC collagenase_NN )_) in_II five_MC normal_JJ and_CC 18_MC fibrotic_JJ human_NN livers_NNS as_CC+ well_CC+ as_CC in_II cultured_VVNJ human_NN hepatic_JJ fat-storing_VVGJ cells_NNS by_II Northern_NN blot_NN analysis_NN and_CC in_JJ+ situ_JJ hybridization_NN ._.
P08132824A05
Interestingly_RR ,_, in_II ulcerative_JJ colitis_NN ,_, another_DD inflammatory_JJ bowel_NN disease_NN ,_, stromelysin_NN was_VBD localised_VVN in_II the_DD lamina_NN propria_NN in_II regions_NNS of_II mucosal_JJ loss_NN ._.
P08156782A05
Basal_JJ levels_NNS of_II gelatinolytic_JJ activity_NN in_II keratoconus_NN culture_NN media_NN (_( no_DD reduction_NN ,_, alkylation_NN ,_, or_CC APMA_NN treatment_NN )_) ,_, determined_VVN by_II two_MC different_JJ assay_NN methods_NNS ,_, tended_VVD to_TO be_VBI about_RR twice_RR that_PND of_II normal_JJ cell_NN cultures_NNS ._.
P08158500A03
MMPs_NNS were_VBD observed_VVN in_II connective_JJ tissues_NNS at_II sites_NNS that_PNR histologically_RR showed_VVD signs_NNS of_II remodelling_VVGN ._.
P08166290A05
24_MC h_NN after_II instillation_NN ,_, a_DD BAL_NN was_VBD performed_VVN ,_, the_DD BAL_NN fluid_NN was_VBD separated_VVN from_II the_DD cells_NNS by_II centrifugation_NN ,_, and_CC AMACs_NNS and_CC PMNs_NNS were_VBD separately_RR cultured_VVN for_II 24_MC h_NN ._.
P08175780A05
MMP_NN inhibitors_NNS (_( MMPI_NN )_) were_VBD also_RR present_JJ in_II these_DD CM_NN and_CC were_VBD separated_VVN by_II gel_NN filtration_NN ._.
P08179336A04
Additionally_RR ,_, the_DD indomethacin-mediated_VVNJ suppression_NN of_II Con_NN A-induced_VVNJ monocyte_NN interstitial_JJ collagenase_NN and_CC 92-kDa_NN type_NN IV_MC collagenase_NN /_SYM gelatinase_NN production_NN could_VM be_VBB reversed_VVN by_II CT_NN ._.
P08219937A01
Tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) play_VVB an_DD important_JJ role_NN in_II the_DD regulation_NN of_II the_DD activity_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) such_II+ as_II collagenase_NN ,_, stromelysin_NN and_CC gelatinase_NN ._.
P08225873A04
METHODS_NNS ._.
P08280080A11
In_II human_NN vein_NN endothelial_JJ cells_NNS it_PN enhanced_VVD the_DD PMA-mediated_VVNJ induction_NN of_II MMP-9_NN ,_, whereas_CS it_PN suppressed_VVD this_DD induction_NN in_II human_NN microvascular_JJ endothelial_JJ cells_NNS and_CC in_II synovial_JJ fibroblasts_NNS ._.
P08311464A02
In_II this_DD paper_NN ,_, we_PN report_VVB that_CST both_DD peptides_NNS are_VBB efficiently_RR hydrolyzed_VVN not_RR only_RR by_II SLN_NN but_CC also_RR by_II two_MC other_JJ matrix_NN metalloproteinases_NNS ,_, collagenase_NN and_CC gelatinase_NN ,_, and_CC by_II the_DD bacterial_JJ metalloproteinase_NN thermolysin_NN ._.
P08314305A05
Tera_NN 2_MC cells_NNS can_VM be_VBB induced_VVN by_II retinoic_JJ acid_NN to_TO differentiate_VVI into_II quiescent_JJ cells_NNS ,_, of_II which_PNR many_PND express_VVB neuronal_JJ characteristics_NNS ._.
P08369572A07
Stromelysins_NNS 1_MC and_CC 3_MC mRNAs_NNS were_VBD not_RR detected_VVN in_II any_PND of_II the_DD tumors_NNS studied_VVN ._.
P08384126A01
A_DD proform_NN of_II high_JJ molecular_JJ weight_NN type_NN IV_MC collagenase_NN was_VBD isolated_VVN and_CC purified_VVN 1230-fold_NN from_II human_NN metastatic_JJ carcinoma_NN tissue_NN ._.
P08411260A02
However_RR ,_, the_DD abundance_NN of_II this_DD latent_JJ proenzyme_NN in_II normal_JJ tissues_NNS and_CC fluids_NNS suggests_VVZ that_CST MMP-2_NN proenzyme_NN utilization_NN is_VBZ limited_VVN by_II its_PNG physiological_JJ activation_NN rather_II+ than_II expression_NN alone_JJ ._.
P08425205A08
We_PN present_VVB evidence_NN which_PNR suggests_VVZ that_CST this_DD temporal_JJ relationship_NN is_VBZ imposed_VVN by_II the_DD structural_JJ architecture_NN of_II the_DD matrix_NN such_CS+ that_CS matrix_NN glycoprotein_NN serves_VVZ to_TO protect_VVI associated_VVNJ collagen_NN from_II MMP-dependent_JJ degradation_NN ._.
P08521614A08
Isolated_VVNJ THP-1_NN M_NN phi_NN s_NN produced_VVD basal_JJ levels_NNS of_II both_CC MMP-2_NN and_CC MMP-9_NN ._.
P08521615A03
Using_VVG gelatin_NN zymography_NN ,_, densitometry_NN ,_, and_CC an_DD enzyme-linked_VVNJ immunosorbent_JJ assay_NN for_II the_DD quantitative_JJ determination_NN of_II the_DD MMP-2_NN ,_, we_PN found_VVD that_CST the_DD enzyme_NN 's_GE activity_NN was_VBD significantly_RR elevated_VVN in_II malignant_JJ astrocytomas_NNS ,_, especially_RR in_II glioblastoma_NN multiforme_NN ,_, compared_VVN to_II low-grade_NN glioma_NN and_CC normal_JJ brain_NN tissues_NNS ._.
P08531210A01
Fibrillar_JJ collagens_NNS ,_, essential_JJ for_II maintaining_VVGN the_DD structural_JJ integrity_NN of_II the_DD myocardium_NN ,_, are_VBB degraded_VVN by_II matrix_NN metalloproteinase_NN (_( MMP-1_NN )_) ._.
P08542596A16
Altered_VVNJ MT-MMP_NN expression_NN might_VM contribute_VVB ,_, in_II part_NN ,_, to_II gelatinase_NN A_NN activation_NN ,_, which_PNR in_II turn_NN facilitates_VVZ invasion_NN of_II these_DD tumors_NNS ._.
P08558853A13
Sandwich_NN enzyme_NN immunoassays_NNS showed_VVD that_CST MMP-9_NN levels_NNS are_VBB significantly_RR higher_JJR in_II both_CC homogenates_NNS and_CC culture_NN media_NN of_II the_DD cup_NN and_CC stem_NN interface_NN membranes_NNS than_CSN the_DD control_NN pseudocapsule_NN ._.
P08567965A07
The_DD increase_NN of_II MMP-2_NN induced_VVN by_II P_NN withdrawal_NN was_VBD associated_VVN with_II the_DD metalloproteinase-dependent_JJ breakdown_NN of_II stromal_JJ cultures_NNS ,_, involving_VVG dissolution_NN of_II extracellular_JJ matrix_NN and_CC dissociation_NN of_II stromal_JJ cells_NNS ._.
P08576934A08
The_DD results_NNS indicated_VVD that_CST MMP_NN activity_NN was_VBD co-eluted_VVN with_II TIMP_NN activity_NN ._.
P08579123A09
These_DD results_NNS indicate_VVB the_DD production_NN of_II MMP-9_NN by_II multinucleated_VVNJ giant_JJ cells_NNS and_CC suggest_VVB that_CST the_DD metalloproteinase_NN may_VM contribute_VVB to_II proteolysis_NN associated_VVN with_II vascular_JJ invasion_NN and_CC local_JJ bone_NN resorption_NN in_II human_NN GCT_NN ._.
P08583501A04
Thus_RR ,_, it_PN was_VBD of_II interest_NN to_TO determine_VVI whether_CST activated_VVNJ microglia_NNS secrete_VVB MMPs_NNS ._.
P08594211A11
Potential_JJ treatments_NNS possible_JJ in_II this_DD second_JJ therapeutic_JJ window_NN include_VVB interfering_VVGN with_II the_DD genes_NNS that_PNR produce_VVB the_DD MMPs_NNS or_CC inhibiting_VVGN the_DD action_NN of_II the_DD gene_NN products_NNS ._.
P08594658A09
In_II addition_NN ,_, osteoclasts_NNS in_II rheumatoid_JJ subchondral_JJ bone_NN were_VBD intensively_RR stained_VVN ._.
P08600068A07
Using_VVG gelatin_NN zymography_NN ,_, active_JJ forms_NNS of_II MMP-2_NN and_CC MMP-9_NN were_VBD more_RR frequently_RR detected_VVN in_II carcinoma_NN tissue_NN ,_, and_CC the_DD activation_NN rate_NN of_II the_DD zymogen_NN of_II MMP-2_NN (_( proMMP-2_NN )_) ,_, but_CC not_RR that_PND of_II proMMP-9_NN ,_, correlated_VVD well_RR with_II degree_NN of_II local_JJ invasion_NN and_CC lymphatic_JJ permeation_NN ._.
P08608454A06
TIMP_NN levels_NNS were_VBD found_VVN to_TO be_VBI increased_VVN in_II restenotic_JJ lesions_NNS (_( 0.38_MC +/-_SYM 0.04_MC ng_NN /_SYM mL_NN )_) compared_VVN with_II normal_JJ arterial_JJ tissue_NN (_( 0.27_MC +/-_SYM 0.05_MC ng_NN /_SYM mL_NN )_) and_CC with_II tissue_NN derived_VVN from_II de_JJ+ novo_JJ (_( 0.30_MC +/-_SYM 0.02_MC ng_NN /_SYM mL_NN atherosclerotic_JJ lesions_NNS ._.
P08608561A14
The_DD average_JJ intensities_NNS of_II the_DD amplified_VVNJ gene_NN fragments_NNS from_II K-neo_NN cells_NNS ,_, KTCL-1_NN cells_NNS ,_, and_CC KTCL-14_NN cells_NNS in_II Week_NN 4_MC after_II transplantation_NN were_VBD 100_MC %_SYM ,_, 45_MC %_SYM ,_, and_CC 18_MC %_SYM ,_, respectively_RR ,_, of_II the_DD parenteral_JJ KKLS_NN cells_NNS ._.
P08611162A03
The_DD binding_VVGN of_II each_DD individual_JJ domain_NN to_II TIMP-2_NN ,_, however_RR ,_, was_VBD weak_JJ enough_RR that_CST either_DD domain_NN could_VM be_VBB fully_RR replaced_VVN by_II proMMP-2_NN through_II the_DD same_JJ binding_VVGJ sites_NNS as_CS does_VDZ proMMP-2_NN ,_, and_CC also_RR that_CST the_DD high-order_NN structure_NN of_II proMMP-2_NN allows_VVZ a_DD more_RR stable_JJ binding_VVGN to_II TIMP-2_NN ._.
P08611170A05
In_II this_DD manner_NN ,_, TIMP-2_NN may_VM assume_VVB a_DD bifunctional_JJ role_NN causing_VVGN :_: (_( i_MC )_) inhibition_NN of_II gelatinase_NN A_NN in_II the_DD extracellular_JJ compartment_NN ;_: and_CC (_( ii_MC )_) guiding_VVGN gelatinase_NN A_NN to_II activation_NN through_II a_DD membrane_NN association_NN with_II MT-MMP_NN ._.
P08625086A12
CONCLUSIONS_NNS ._.
P08625169A04
After_II local_JJ secretion_NN ,_, MMPs_NNS and_CC their_PNG complexes_NNS with_II TIMPs_NNS leach_VVB into_II the_DD blood_NN stream_NN where_PNR their_PNG concentration_NN can_VM be_VBB measured_VVN ,_, thereby_RR serving_VVG as_II surrogate_JJ markers_NNS of_II disease_NN ._.
P08631880A08
However_RR ,_, the_DD SH_NN group_NN of_II Cys75_NN of_II the_DD intermediates_NNS was_VBD not_RR modified_VVN by_II SH-reagents_NNS ,_, indicating_VVG that_CST the_DD enzymatic_JJ activity_NN generated_VVN by_II SH-reagents_NNS resulted_VVN from_II molecular_JJ perturbation_NN of_II the_DD enzyme_NN rather_II+ than_II their_PNG interaction_NN with_II Cys75_NN ._.
P08641841A15
In_II fact_NN ,_, active_JJ (_( and_CC latent_JJ )_) MMP-2_NN levels_NNS were_VBD reduced_VVN in_II recovering_VVGJ eyes_NNS even_RR below_II the_DD levels_NNS found_VVN in_II their_PNG contralateral_JJ control_NN eyes_NNS ._.
P08645587A09
Our_PNG data_NNS therefore_RR argue_VVB that_CST there_EX are_VBB remarkably_RR similar_JJ patterns_NNS of_II specific_JJ functions_NNS involved_VVN in_II ECM_NN remodelling_VVGN that_PNR correlate_VVB with_II malignancy_NN in_II different_JJ human_NN tumours_NNS of_II different_JJ histogenesis_NN ._.
P08646367A01
Immunolocalization_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC tissue_NN inhibitors_NNS of_II matrix_NN metalloproteinases_NNS (_( TIMPs_NNS )_) in_II periarticular_JJ tissues_NNS of_II beta_NN 2-microglobulin_NN amyloidosis_NN patients_NNS was_VBD investigated_VVN ._.
P08649561A06
Patients_NNS (_( n_NN =_SYM 7_MC )_) given_VVN steroids_NNS to_TO treat_VVI an_DD acute_JJ episode_NN of_II MS_NN had_VHD CSF_NN sampled_VVN before_II and_CC after_II 3_MC days_NNS of_II methylprednisolone_NN (_( 1_MC g_NN /_SYM day_NN )_) ._.
P08651985A11
The_DD combination_NN of_II antiinflammatory_JJ and_CC MMP-regulating_VVGJ properties_NNS of_II adenosine_NN or_CC adenosine-regulating_VVGJ agents_NNS suggest_VVB that_CST treatment_NN based_VVN on_II this_DD approach_NN might_VM be_VBB useful_JJ in_II rheumatoid_JJ arthritis_NN ._.
P08655631A07
IL-1_NN beta_NN ,_, IL-6_NN and_CC TGF-beta_NN did_VDD not_RR affect_VVB TIMP-2_NN expression_NN but_CC TGF-beta_NN induced_VVD TIMP-1_NN mRNA_NN in_II human_NN OA_NN chondrocytes_NNS ._.
P08663061A06
Zymography_NN showed_VVD that_CST exposure_NN of_II HBECs_NNS to_II LPS_NN induced_VVD 2-_MC and_CC 20-fold_NN increases_NNS in_II 92-kDa_NN gelatinase_NN production_NN and_CC activation_NN ,_, respectively_RR ,_, as_CC+ well_CC+ as_CC a_DD smaller_JJR increase_NN in_II activated_VVNJ 68-kDa_NN gelatinase_NN ._.
P08665498A02
delta_NN MT1_NN ,_, but_CC not_RR mutant_JJ delta_NN MT1_NN ,_, was_VBD processed_VVN to_II an_DD active_JJ form_NN and_CC exhibited_VVD gelatinolytic_JJ activity_NN as_CS seen_VVN using_VVG gelatin_NN zymography_NN ._.
P08666998A04
Although_CS a_DD significant_JJ decrease_NN in_II MMP-2_NN activity_NN was_VBD noticed_VVN in_II the_DD ALS_NN motor_NN cortex_NN ,_, statistically_RR significant_JJ increases_NNS in_II MMP-9_NN (_( 100-kDa_NN )_) activity_NN were_VBD observed_VVN in_II ALS_NN frontal_JJ and_CC occipital_JJ cortices_NNS (_( BA10_NN and_CC 17_MC )_) and_CC all_DD three_MC spinal_JJ cord_NN regions_NNS when_CS compared_VVN with_II control_NN specimens_NNS ._.
P08674412A09
We_PN conclude_VVB that_CST administration_NN of_II MMP_NN inhibitors_NNS retards_VVZ decidual_JJ remodeling_VVGN and_CC growth_NN ,_, and_CC we_PN suggest_VVB that_CST the_DD MMPs_NNS expressed_VVN in_II precursor_NN stromal_JJ cells_NNS promote_VVB their_PNG differentiation_NN and_CC expansion_NN ._.
P08675803A08
Dexamethasone_RR markedly_RR decreased_VVD the_DD amount_NN of_II MMP-2_NN mRNA_NN in_II the_DD GFs_NNS ._.
P08690299A04
MMP_NN species_NNS identical_JJ to_II those_PND secreted_VVN from_II several_JJ well-characterized_VVNJ ovarian_JJ adenocarcinoma_NN cell_NN lines_NNS were_VBD found_VVN in_II the_DD majority_NN of_II ascites_NNS :_: MMP-2-like_JJ gelatinase_NN (_( 23_MC of_II 23_MC cases_NNS )_) and_CC MMP-9-like_JJ gelatinase_NN (_( 18_MC of_II 23_MC cases_NNS )_) ,_, suggesting_VVG a_DD prevalence_NN of_II these_DD species_NNS in_II the_DD ovarian_JJ carcinoma_NN microenvironment_NN and_CC their_PNG availability_NN for_II tumor-associated_VVNJ proteolysis_NN ._.
P08691532A09
From_II these_DD data_NNS ,_, we_PN suggest_VVB SMCs_NNS may_VM be_VBB involved_VVN in_II the_DD abnormal_JJ degradation_NN of_II the_DD aortic_JJ wall_NN in_II AAA_NN through_II the_DD excessive_JJ metalloproteinase_NN activity_NN produced_VVN by_II SMCs_NNS ._.
P08698836A04
RT-PCR_NN permitted_VVD us_PN to_TO confirm_VVI the_DD observation_NN that_CST MMP-9_NN is_VBZ activated_VVN following_VVG transformation_NN and_CC also_RR to_TO observe_VVI the_DD previously_RR unreported_VVNJ activation_NN of_II MMP-7_NN in_II SV40-transformed_VVNJ cells_NNS ._.
P08706790A01
The_DD balance_NN between_II the_DD activities_NNS of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC the_DD tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) is_VBZ an_DD important_JJ control_NN point_NN in_II tissue_NN remodeling_VVGN ._.
P08706864A02
Until_II now_RR ,_, no_DD convenient_JJ and_CC sensitive_JJ MMP-activity_NN assay_NN in_II crude_JJ media_NN like_II synovial_JJ fluid_NN has_VHZ been_VBN available_JJ ._.
P08717434A09
Thus_RR ,_, in_II dilated_VVNJ failing_VVGJ human_NN hearts_NNS secondary_JJ to_II previous_JJ MI_NN or_CC DCM_NN ,_, MMP_NN activity_NN is_VBZ increased_VVN ._.
P08719871A07
The_DD migration_NN of_II TRAP+_NN cells_NNS is_VBZ completely_RR prevented_VVN by_II matrix_NN metalloproteinase_NN (_( MMP_NN )_) inhibitors_NNS ,_, but_CC not_RR by_II a_DD cysteine_NN proteinase_NN inhibitor_NN ,_, an_DD inhibitor_NN of_II carbonic_JJ anhydrase_NN ,_, or_CC a_DD bisphosphonate_NN ._.
P08726363A15
In_II transformed_VVNJ cells_NNS reducing_VVGJ agents_NNS inhibit_VVB MMP_NN expression_NN and_CC increase_VVB TIMP_NN levels_NNS ,_, which_PNR suggests_VVZ a_DD role_NN of_II antioxidants_NNS in_II preventing_VVGN tumorigenesis_NN ._.
P08738566A03
Based_VVN on_II this_DD background_NN ,_, we_PN raised_VVD monoclonal_JJ antibodies_NNS against_II human_NN gelatinase_NN (_( MMP-9_NN )_) and_CC human_NN recombinant_JJ TIMP_NN (_( TIMP-1_NN )_) ,_, and_CC immunostained_VVD these_DD two_MC components_NNS in_II skin_NN from_II patients_NNS with_II squamous_JJ cell_NN carcinoma_NN (_( SCC_NN )_) ,_, Bowen_NN 's_GE disease_NN (_( BD_NN )_) and_CC keratoacanthoma_NN (_( KA_NN )_) ._.
P08743942A08
The_DD activation_NN rate_NN of_II proMMP-2_NN was_VBD proportional_JJ to_II the_DD expression_NN of_II MMP-2_NN and_CC MT-MMP_NN ._.
P08744792A08
Preliminary_JJ findings_NNS show_VVB TIMP-1_NN mediated_VVD changes_NNS in_II morphology_NN and_CC downregulation_NN of_II MMP_NN activity_NN ._.
P08751977A06
Similar_JJ results_NNS were_VBD obtained_VVN by_II immunoprecipitation_NN ._.
P08753775A05
Moreover_RR ,_, tissue_NN inhibitor_NN of_II metalloproteinases-1_NN had_VHD at_RR+ most_RR a_DD partial_JJ effect_NN on_II the_DD in_JJ+ vivo_JJ release_NN of_II the_DD cytokine_NN in_II mice_NNS ._.
P08760357A01
Endothelial-cell-stimulating_VVGJ angiogenesis_NN factor_NN (_( ESAF_NN )_) has_VHZ been_VBN shown_VVN to_TO activate_VVI procollagenase_NN and_CC reactivate_VVB complexes_NNS of_II collagenase_NN and_CC gelatinase_NN A_NN with_II tissue_NN inhibitor_NN of_II metallo-proteinase_NN (_( TIMP_NN )_) -1_MC ._.
P08761942A13
This_PND suggests_VVZ that_CST ,_, in_II addition_NN to_II the_DD well-known_VVNJ activators_NNS and_CC inhibitors_NNS of_II MMP_NN activity_NN in_II the_DD matrix_NN ,_, differential_JJ membrane_NN distribution_NN may_VM enable_VVB more_RR precise_JJ control_NN over_II the_DD site_NN ,_, rate_NN ,_, and_CC extent_NN of_II matrix_NN degradation_NN by_II the_DD cell_NN ._.
P08771322A03
Cells_NNS of_II the_DD disc_NN synthesised_VVD all_DD three_MC classes_NNS of_II MMPs_NNS as_CC+ well_CC+ as_CC TIMP-1_NN in_II all_DD regions_NNS of_II the_DD disc_NN at_II all_DD stages_NNS examined_VVN ._.
P08779137A02
It_PN was_VBD hypothesised_VVN that_CST tuberculous_JJ lung_NN destruction_NN is_VBZ mediated_VVN ,_, at_RR+ least_RR in_II part_NN ,_, by_II the_DD participation_NN of_II matrix_NN metalloproteinases_NNS released_VVN by_II mononuclear_JJ phagocytes_NNS ._.
P08780160A03
A_DD synthetic_JJ ,_, biotinylated_VVNJ inhibitor_NN specific_JJ for_II activated_VVNJ MMP-2_NN in_II solution_NN phase_NN ,_, and_CC immunohistochemistry_NN were_VBD used_VVN to_TO detect_VVI MMP-2_NN and_CC TIMP-2_NN expression_NN in_II cell_NN lines_NNS and_CC ovarian_JJ tumors_NNS and_CC to_TO analyze_VVI the_DD surface-binding_VVGJ capacity_NN of_II the_DD inhibitors_NNS ,_, which_PNR are_VBB potential_JJ therapeutic_JJ agents_NNS ._.
P08780171A05
The_DD physiologic_JJ mechanism_NN of_II this_DD activation_NN is_VBZ not_RR well_RR understood_VVN ._.
P08783637A04
A_DD tissue-specific_JJ inhibitor_NN of_II matrix_NN metalloproteinases_NNS (_( TIMP-1_NN )_) and_CC a_DD plasma_NN proteinase_NN inhibitor_NN ,_, alpha2-macroglobulin_NN (_( alpha2M_NN )_) ,_, were_VBD used_VVN to_TO block_VVI the_DD activity_NN of_II MMPs_NNS ._.
P08806767A05
Our_PNG data_NNS demonstrate_VVB that_CST fluorescence_NN quenching_VVGN of_II the_DD proMMP-2_NN /_SYM TIMP-2_NN complex_NN by_II either_CC acrylamide_NN or_CC iodide_NN is_VBZ significantly_RR increased_VVN following_VVG mercurial_JJ activation_NN ._.
P08808829A06
Tissues_NNS were_VBD obtained_VVN at_II operation_NN after_II informed_VVNJ consent_NN was_VBD got_VVN from_II each_DD patient_NN ._.
P08808829A21
The_DD major_JJ gelatinases_NNS were_VBD those_PND with_II molecular_JJ weight_NN of_II 92_MC and_CC 72kD_NN ,_, which_PNR corresponded_VVD to_II MMP-9_NN and_CC MMP-2_NN ,_, respectively_RR ._.
P08814070A05
Immunolocalization_NN of_II MMP-9_NN in_II RA_NN ,_, OA_NN ,_, and_CC normal_JJ synovium_NN was_VBD investigated_VVN using_VVG MMP-9-specific_JJ antisera_NNS ._.
P08817668A08
Together_RR ,_, these_DD studies_NNS suggest_VVB that_CST MMPs_NNS ,_, beyond_II their_PNG previously_RR described_VVNJ roles_NNS as_II extracellular_JJ matrix_NN degrading_VVGJ enzymes_NNS ,_, may_VM also_RR exert_VVB effects_NNS on_II cellular_JJ growth_NN and_CC differentiation_NN via_II degradation_NN of_II IGFBPs_NNS ._.
P08831505A04
To_TO test_VVI this_DD hypothesis_NN ,_, we_PN developed_VVD clones_NNS of_II rat_NN SMCs_NNS that_PNR overexpress_VVB baboon_NN tissue_NN inhibitor_NN of_II matrix_NN metalloproteinase-I_NN (_( TIMP-1_NN )_) ,_, using_VVG retrovirally_RR mediated_VVNJ gene_NN transfer_NN ,_, and_CC characterized_VVD the_DD functional_JJ capacity_NN of_II these_DD cells_NNS in_RR+ vitro_RR and_CC in_RR+ vivo_RR ._.
P08841929A11
2D-zymographic_JJ analysis_NN suggested_VVD that_CST the_DD lytic_JJ band_NN at_II 66_MC kDa_NN was_VBD a_DD mixture_NN of_II two_MC neutral_JJ proteinases_NNS with_II different_JJ isoelectric_JJ point_NN ._.
P08851335A02
Cancer_NN cells_NNS are_VBB known_VVN to_TO produce_VVI various_JJ ECM-degrading_VVGJ enzymes_NNS including_VVG matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ,_, serine_NN proteinases_NNS and_CC cathepsins_NNS ._.
P08856511A10
The_DD same_JJ stromal_JJ cells_NNS could_VM synthesize_VVB MMP-1_NN ,_, MMP-2_NN (_( gelatinase_NN A_NN )_) and_CC MMP-3_NN (_( stromelysin-1_NN )_) ,_, as_CC+ well_CC+ as_CC laminin_NN ,_, and_CC did_VDD not_RR correspond_VVB to_II macrophages_NNS ._.
P08863676A01
Delayed_VVNJ re-epithelialization_NN of_II the_DD cornea_NN after_II injury_NN usually_RR precedes_VVZ stromal_JJ ulceration_NN ._.
P08867813A13
It_PN may_VM also_RR provide_VVB potential_JJ intervention_NN sites_NNS for_II the_DD therapeutic_JJ use_NN of_II inhibitors_NNS of_II aberrant_JJ MMP_NN activities_NNS which_PNR characterize_VVB chronic_JJ wounds_NNS ._.
P08872958A06
The_DD conditioned_VVNJ medium_NN from_II the_DD cystic_JJ tubules_NNS contained_VVD higher_JJR than_CSN normal_JJ levels_NNS of_II MMP-9_NN ,_, MMP-2_NN ,_, and_CC MMP-3_NN as_CC+ well_CC+ as_CC TIMP-1_NN and_CC TIMP-2_NN ._.
P08875960A10
The_DD presence_NN of_II excessive_JJ levels_NNS of_II activated_VVNJ forms_NNS of_II matrix-degrading_VVGJ enzymes_NNS at_II the_DD wound_NN surface_NN of_II pressure_NN ulcers_NNS may_VM impede_VVB the_DD healing_VVGN of_II these_DD wounds_NNS and_CC may_VM be_VBB relevant_JJ to_II the_DD development_NN of_II new_JJ rationales_NNS for_II treatment_NN ._.
P08882290A05
Matrix_NN metalloproteinase-9_NN was_VBD the_DD predominant_JJ gelatinase_NN in_II freshly_RR prepared_VVNJ granulosa_NN cells_NNS and_CC in_II culture_NN media_NN ,_, and_CC also_RR represented_VVD a_DD major_JJ metalloproteinase_NN component_NN in_II homogenates_NNS of_II early_JJ and_CC mid-luteal_JJ phase_NN samples_NNS of_II corpora_NNS lutea_NN ._.
P08884145A02
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC their_PNG inhibitors_NNS like_II tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) have_VHB been_VBN thought_VVN to_TO play_VVI major_JJ roles_NNS in_II the_DD tissue_NN metabolism_NN ._.
P08895151A03
TIMP-1_NN mRNA_NN expression_NN was_VBD analyzed_VVN by_II Northern_NN blotting_VVGN using_VVG a_DD 0.6_MC kb_NN cDNA_NN probe_NN for_II human_NN TIMP-1_NN ._.
P08911730A10
In_II RA_NN ,_, the_DD levels_NNS of_II MMP_NN and_CC TIMP_NN mRNA_NN were_VBD high_JJ ._.
P08912869A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) have_VHB been_VBN implicated_VVN in_II tumor_NN progression_NN ,_, but_CC the_DD exact_JJ roles_NNS that_PNR each_DD member_NN of_II this_DD family_NN may_VM play_VVB in_II contributing_VVGN to_II the_DD behavior_NN of_II malignant_JJ tumors_NNS are_VBB only_RR beginning_VVG to_TO be_VBI understood_VVN ._.
P08913840A07
Previous_JJ studies_NNS in_II patients_NNS with_II malignant_JJ ascites_NN have_VHB shown_VVN no_DD major_JJ toxicities_NNS at_II doses_NNS as_RR high_JJ as_CSN 1350_MC mg_NN /_SYM m2_NN ._.
P08918435A05
From_II tubular_JJ adenomas_NNS to_II villous_JJ adenomas_NNS ,_, immunolocalization_NN of_II gelatinases_NNS and_CC TIMPs_NNS showed_VVD increasing_VVG gradually_RR ,_, and_CC in_JJ+ situ_JJ carcinomas_NNS showed_VVD a_DD definite_JJ positive_JJ ,_, immunolocalization_NN of_II gelatinases_NNS and_CC TIMPs_NNS ._.
P08920930A06
Thus_RR ,_, in_II common_JJ with_II several_JJ other_JJ MMPs_NNS ,_, macrophage_NN metalloelastase_NN has_VHZ a_DD broad_JJ substrate_NN range_NN which_PNR extends_VVZ beyond_II that_PND of_II elastin_NN alone_JJ ._.
P08921246A13
The_DD induction_NN of_II gelatinase_NN activity_NN in_II rabbit_NN AH_NN preceded_VVD the_DD increase_NN in_II cell_NN number_NN during_II the_DD inflammatory_JJ process_NN in_II the_DD anterior_JJ chamber_NN ._.
P08939968A03
In_II this_DD report_NN ,_, we_PN investigated_VVD whether_CST the_DD cleavage_NN of_II the_DD RRKR_NN motif_NN of_II MT-MMP1_NN by_II Golgi-associated_VVNJ furin_NN is_VBZ analogous_JJ to_II a_DD similar_JJ enzyme_NN activation_NN mechanism_NN observed_VVN with_II stromelysin-3_NN ._.
P08941646A08
aggrecanase_NN site_NN ._.
P08953151A03
The_DD preoperative_JJ serial_JJ radiographic_JJ examinations_NNS revealed_VVD an_DD apparent_JJ clear_JJ zone_NN around_II all_DD implants_NNS ._.
P08955363A05
Our_PNG kinetic_JJ data_NNS demonstrate_VVB that_CST TIMP-2_NN is_VBZ a_DD potent_JJ inhibitor_NN for_II the_DD recombinant_JJ enzyme_NN ._.
P08956284A04
Using_VVG in_JJ+ situ_JJ hybridization_NN ,_, transcripts_NNS for_II MMP-9_NN were_VBD detected_VVN in_II trophoblast_NN cells_NNS of_II the_DD embryo_NN from_II the_DD earliest_JJT stage_NN of_II decidual_JJ formation_NN (_( day_NN 6.0_MC )_) examined_VVN ._.
P08957940A11
From_II many_DD recent_JJ studies_NNS it_PN seems_VVZ that_CST tissue_NN destruction_NN ,_, both_CC physiological_JJ and_CC pathological_JJ ,_, is_VBZ correlated_VVN with_II an_DD imbalance_NN of_II inhibitors_NNS over_II proteinases_NNS ._.
P08960389A06
To_TO further_RR identify_VVI the_DD type_NN of_II MMP_NN ,_, tissue_NN homogenates_NNS were_VBD prepared_VVN from_II collateral_JJ and_CC LAD_NN vessels_NNS and_CC analyzed_VVN by_II SDS-PAGE_NN zymography_NN ._.
P08970581A02
We_PN measured_VVD the_DD activity_NN of_II MMP-2_NN from_II 28_MC normal_JJ ,_, 12_MC benign_JJ and_CC 126_MC breast_NN cancer_NN tissues_NNS using_VVG gelatin_NN zymography_NN ._.
P08978831A07
These_DD results_NNS provide_VVB direct_JJ evidence_NN for_II cleavage_NN of_II an_DD extracellular_JJ matrix_NN molecule_NN by_II an_DD MMP_NN in_RR+ vivo_RR ._.
P08988738A06
Increased_VVNJ expression_NN of_II the_DD MT1-MMP_NN mRNA_NN transcript_NN was_VBD also_RR detected_VVN in_II eight_MC of_II eight_MC of_II these_DD tissues_NNS ._.
P08994438A12
CONCLUSIONS_NNS :_: MMP_NN expression_NN is_VBZ markedly_RR increased_VVN in_II AOD_NN and_CC AAA_NN samples_NNS ,_, and_CC an_DD imbalance_NN between_II MMPs_NNS and_CC their_PNG inhibitors_NNS results_VVZ in_II similar_JJ proteolytic_JJ activity_NN ._.
P08997658A08
Elevated_VVNJ levels_NNS of_II MMP-8_NN were_VBD further_RR detected_VVN in_II saliva_NN of_II AP_NN compared_VVN to_II LJP_NN and_CC the_DD controls_NNS ._.
P09003362A02
The_DD results_NNS indicate_VVB that_CST hyperglycaemic_JJ conditions_NNS modulate_VVB the_DD potential_JJ proteolytic_JJ activity_NN of_II the_DD enzymes_NNS secreted_VVN by_II confluent_JJ cultures_NNS of_II these_DD cells_NNS ._.
P09008612A06
RESULTS_NNS :_: In_II cultures_NNS of_II nasal_JJ cartilage_NN with_II IL-1_NN alpha_NN ,_, almost_RR all_DB the_DD proteoglycan_NN was_VBD released_VVN within_II the_DD first_JJ week_NN ,_, whereas_CS there_EX was_VBD no_DD detectable_JJ release_NN of_II type_NN II_MC collagen_NN for_II the_DD first_JJ 2_MC weeks_NNS of_II culture_NN ._.
P09009103A08
Fluorometric_JJ methods_NNS represent_VVB a_DD good_JJ alternative_NN for_II MMP_NN activity_NN measurement_NN ,_, especially_RR when_CS a_DD large_JJ number_NN of_II samples_NNS must_VM be_VBB processed_VVN ._.
P09021326A09
However_RR ,_, the_DD possibility_NN remains_VVZ that_CST MMP-8_NN plays_VVZ an_DD important_JJ role_NN in_II periodontal_JJ tissue_NN destruction_NN ,_, since_CS the_DD mRNA_NN abundance_NN and_CC not_RR the_DD enzyme_NN activity_NN was_VBD assessed_VVN ._.
P09033278A08
By_II contrast_NN ,_, these_DD cytokines_NNS induced_VVD a_DD sevenfold_NN increase_NN in_II the_DD steady-state_NN levels_NNS of_II stromelysin_NN mRNA_NN ._.
P09038230A06
In_II contrast_NN ,_, Serratia_NN 56-kDa_NN proteinase_NN and_CC Pseudomonas_NN alkaline_JJ proteinase_NN ,_, both_PND of_II which_PNR are_VBB classified_VVN as_II members_NNS of_II the_DD serralysin_NN subfamily_NN of_II zinc_NN metalloproteinases_NNS (_( family_NN M10_NN )_) ,_, and_CC Serratia_NN 73-kDa_NN thiol_NN proteinase_NN did_VDD not_RR evidence_VVB proteolytic_JJ processing_VVGN or_CC activation_NN of_II proMMP-1_NN ,_, -8_MC ,_, and_CC -9_MC under_II these_DD experimental_JJ conditions_NNS ._.
P09040053A03
Cholesterol_NN is_VBZ required_VVN for_II receptor_NN signaling_VVGN in_II the_DD plasma_NN membrane_NN ,_, but_CC a_DD role_NN of_II MMPs_NNS for_II cholesterol_NN in_II ECM_NN remodeling_VVGN has_VHZ not_RR yet_RR been_VBN shown_VVN ._.
P09043823A07
Inclusion_NN of_II gelatin_NN affinity_NN chromatography_NN did_VDD not_RR totally_RR remove_VVB the_DD gelatinases_NNS ._.
P09049977A06
High_JJ level_NN expression_NN is_VBZ driven_VVN by_II the_DD cytomegalovirus_NN major_JJ immediate_JJ early_JJ promoter_NN (_( CMV_NN IEP_NN )_) ._.
P09057654A01
We_PN have_VHB studied_VVN the_DD expression_NN of_II gelatinase_NN A_NN ,_, gelatinase_NN B_NN ,_, interstitial_JJ collagenase_NN ,_, tissue_NN inhibitor_NN of_II metalloproteinase_NN (_( TIMP_NN )_) -1_MC and_CC TIMP-2_NN in_II reactive_JJ lymphoid_JJ cells_NNS ,_, as_CC+ well_CC+ as_CC in_II a_DD series_NN of_II cell_NN lines_NNS derived_VVN from_II neoplasms_NNS of_II B-_NN and_CC T-cell_NN lineage_NN ._.
P09070604A09
These_DD findings_NNS suggest_VVB the_DD overexpression_NN of_II MMP-9_NN by_II eosinophils_NNS in_II bronchial_JJ tissues_NNS of_II asthmatic_JJ individuals_NNS ,_, and_CC the_DD participation_NN of_II MMPs_NNS in_II the_DD pathologic_JJ changes_NNS in_II asthmatic_JJ airways_NNS ._.
P09074710A02
Surgical_JJ preparative_JJ injury_NN is_VBZ an_DD important_JJ determinant_NN of_II neointimal_JJ thickening_VVGN in_II human_NN saphenous_JJ vein_NN bypass_NN grafts_NNS ._.
P09075665A08
The_DD ratios_NNS of_II serum_NN MMP-2_NN to_II TIMP-1_NN levels_NNS were_VBD significantly_RR higher_JJR in_II transient_JJ responders_NNS and_CC non-responders_NNS than_CSN in_II sustained_VVNJ responders_NNS (_( p_NN <_SYM 0.001_MC ,_, respectively_RR )_) even_RR when_CS HCV_NN RNA_NN levels_NNS were_VBD low_JJ in_II patients_NNS with_II HCV_NN genome_NN subtype_NN 1b_NN or_CC when_CS the_DD HCV_NN genome_NN subtype_NN was_VBD 2a_NN or_CC 2b_NN ._.
P09083057A09
A_DD similar_JJ activation_NN may_VM also_RR occur_VVB in_RR+ situ_RR as_CS indicated_VVN previously_RR for_II tissue-derived_VVNJ BM-40_NN ._.
P09084432A03
Using_VVG quantitative_JJ zymography_NN ,_, three_MC major_JJ neutral_JJ proteinases_NNS with_II molecular_JJ masses_NNS of_II 60_MC ,_, 95_MC ,_, and_CC 280_MC kDa_NN were_VBD readily_RR detected_VVN ._.
P09084672A07
Gelatinolytic_JJ activity_NN ,_, at_II low_JJ levels_NNS ,_, was_VBD also_RR found_VVN in_II MVs_NNS ,_, but_CC not_RR PMs_NNS or_CC conditioned_VVNJ media_NN ._.
P09086544A02
The_DD current_JJ study_NN analyzed_VVD the_DD expression_NN of_II MMP-2_NN and_CC MMP-9_NN in_II pancreatic_JJ cancer_NN tissues_NNS ._.
P09092941A01
The_DD osteoclasts_NNS are_VBB the_DD cells_NNS responsible_JJ for_II bone_NN resorption_NN ._.
P09096655A02
These_DD polypeptides_NNS regulate_VVB proliferation_NN in_II breast_NN cancer_NN cells_NNS through_II interaction_NN with_II membrane_NN receptors_NNS ._.
P09102166A12
Our_PNG results_NNS suggest_VVB that_CST at_II sites_NNS of_II vascular_JJ injury_NN ,_, thrombin_NN may_VM activate_VVB locally_RR produced_VVNJ MMP-2_NN and_CC thereby_RR facilitate_VVB cell_NN migration_NN and_CC proliferation_NN ._.
P09108368A06
Culture_NN of_II day_NN 10_MC mandibular_JJ explants_NNS with_II a_DD hydroxamic_JJ acid_NN metalloproteinase_NN inhibitor_NN ,_, but_CC not_RR with_II inhibitors_NNS of_II metalloendopeptidases_NNS (_( thiorphan_NN and_CC phosphoramidon_NN )_) ,_, serine_NN proteinases_NNS (_( aprotinin_NN )_) ,_, cysteine_NN proteinases_NNS (_( leupeptin_NN )_) and_CC urokinase_NN (_( amiloride_NN )_) ,_, altered_VVD mandibular_JJ morphogenesis_NN dramatically_RR ._.
P09113512A10
Inhibitor_NN studies_NNS and_CC gelatin_NN zymograms_NNS indicated_VVD that_CST the_DD membrane-associated_VVNJ MT-MMP_NN expressed_VVN on_II the_DD HT_NN 1080_MC cells_NNS played_VVD an_DD important_JJ role_NN in_II cleavage_NN activation_NN of_II the_DD vector_NN ._.
P09119036A01
Membrane-type-1_NN matrix_NN metalloproteinase_NN has_VHZ been_VBN identified_VVN as_II an_DD activator_NN of_II the_DD matrix_NN metalloproteinase_NN progelatinase_NN A_NN at_II cell_NN surfaces_NNS ._.
P09119983A10
Of_II the_DD other_JJ six_MC MMPs_NNS detected_VVN ,_, 92_MC kDa_NN gelatinase_NN showed_VVD a_DD modest_JJ 5_MC fold_NN increase_NN which_PNR peaked_VVN at_II the_DD onset_NN of_II clinical_JJ signs_NNS and_CC then_RR declined_VVN during_II the_DD most_RRT severe_JJ phase_NN of_II the_DD disease_NN ._.
P09131273A03
ProMMP-9_NN was_VBD expressed_VVN in_II 17.5_MC %_SYM of_II the_DD cancer_NN patients_NNS compared_VVN to_II 2.5_MC %_SYM in_II 40_MC non-cancerous_JJ tissues_NNS (_( p_NN =_SYM 0.014_MC )_) ._.
P09141525A08
Expression_NN of_II the_DD messenger_NN RNA_NN for_II TIMP-1_NN or_CC TIMP-2_NN also_RR was_VBD not_RR changed_VVN by_II P_NN withdrawal_NN ._.
P09158005A10
Activation_NN of_II proMMP-2_NN was_VBD significantly_RR higher_JJR in_II the_DD carcinoma_NN samples_NNS with_II lymph_NN node_NN or_CC distant_JJ metastasis_NN compared_VVN to_II carcinoma_NN without_II metastasis_NN ,_, normal_JJ control_NN ,_, or_CC fibrocystic_JJ disease_NN (_( P_NN <_SYM 0.05_MC )_) ._.
P09158711A11
The_DD aggressive_JJ clinical_JJ behavior_NN of_II small_JJ cell_NN carcinoma_NN may_VM be_VBB attributable_JJ ,_, at_RR+ least_RR in_II part_NN ,_, to_II a_DD loss_NN of_II the_DD inhibitory_JJ effect_NN of_II TIMP-2_NN ,_, as_CS a_DD significant_JJ proportion_NN of_II these_DD tumors_NNS showed_VVD negative_JJ or_CC low_JJ levels_NNS of_II TIMP-2_NN expression_NN ._.
P09168808A08
Both_CC mRNA_NN and_CC immunodetectable_JJ protein_NN of_II MT-MMP1_NN are_VBB increased_VVN with_II monensin_NN treatment_NN while_CS message_NN for_II the_DD protein_NN inhibitor_NN of_II gelatinase_NN A_NN ,_, TIMP-2_NN ,_, is_VBZ unchanged_VVN ._.
P09169591A06
With_II the_DD aid_NN of_II protein_NN engineering_VVGN ,_, a_DD modified_VVNJ pro-urokinase_NN has_VHZ been_VBN prepared_VVN in_II which_PNR the_DD activation_NN sequence_NN normally_RR recognized_VVN by_II plasmin_NN (_( Pro-Arg-Phe-Lys_NN upward_JJ arrowIle-Ile-Gly-Gly_NN )_) has_VHZ been_VBN replaced_VVN by_II a_DD sequence_NN expected_VVN to_TO be_VBI recognized_VVN and_CC hydrolysed_VVN by_II many_DD MMPs_NNS (_( Arg-Pro-Leu-Gly_NN upward_JJ arrowIle-Ile-Gly-Gly_NN )_) ._.
P09170840A01
The_DD matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC the_DD tissue_NN inhibitor_NN of_II metalloproteinases_NNS (_( TIMPs_NNS )_) regulate_VVB the_DD extracellular_JJ matrix_NN and_CC are_VBB important_JJ in_II the_DD process_NN of_II connective_JJ tissue_NN remodeling_VVGN ._.
P09171509A03
Matrix_NN metalloproteinases_NNS seem_VVB to_TO play_VVI a_DD key_JJ role_NN in_II physiological_JJ periodontal_JJ remodelling_VVGN and_CC pathological_JJ tissue_NN destruction_NN ._.
P09175201A05
To_TO examine_VVI whether_CST changes_NNS in_II the_DD ulcer_NN formation_NN and_CC healing_VVGJ phase_NN correlate_VVB with_II MMP_NN activity_NN ,_, Triton_NN X-100_NN /_SYM CaCl2_NN and_CC Tris_NN /_SYM CaCl2_NN (_( 60_MC degrees_NNS C_NN )_) extracts_NNS of_II stomachs_NNS were_VBD prepared_VVN from_II controls_NNS and_CC animals_NNS killed_VVN 24_MC h_NN (_( formation_NN phase_NN )_) and_CC 7_MC days_NNS (_( healing_VVGJ phase_NN )_) after_II acetic_JJ acid_NN administration_NN ._.
P09177919A01
OBJECTIVE_NN :_: To_TO clarify_VVI whether_CST gelatinases_NNS in_II the_DD synovial_JJ fluid_NN are_VBB related_VVN to_II rheumatoid_JJ arthritis_NN (_( RA_NN )_) ._.
P09180929A04
MXT_NN clones_NNS and_CC variants_NNS were_VBD selected_VVN by_II either_CC in_JJ+ vitro_JJ or_CC in_JJ+ vivo_JJ procedures_NNS ,_, and_CC they_PN differ_VVB in_II metastatic_JJ ability_NN and_CC 17_MC beta-estradiol_NN dependency_NN for_II tumor_NN growth_NN ._.
P09182725A01
The_DD active_JJ forms_NNS of_II all_PND of_II the_DD matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB inhibited_VVN by_II a_DD family_NN of_II specific_JJ inhibitors_NNS ,_, the_DD tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) ._.
P09186550A07
In_II addition_NN ,_, interaction_NN of_II MMP-2_NN with_II the_DD ovarian_JJ carcinoma_NN cell_NN surface_NN resulted_VVD in_II a_DD 2.5-_MC to_II 5-fold_NN increase_NN in_II invasiveness_NN ._.
P09188064A06
Lastly_RR ,_, this_DD report_NN examines_VVZ structure-function_NN relationships_NNS of_II TIMPs_NNS ._.
P09195290A12
Batimastat_NN (_( BB-94_NN )_) and_CC marimastat_NN (_( BB-2516_NN )_) are_VBB synthetic_JJ ,_, low-molecular_JJ weight_NN MMP_NN inhibitors_NNS ._.
P09198203A03
Thus_RR ,_, this_DD progelatinase_NN A_NN activator_NN was_VBD named_VVN membrane-type_NN matrix_NN metalloproteinase_NN (_( MT1-MMP_NN )_) ._.
P09202045A01
Membrane_NN vesicles_NNS are_VBB shed_VVN by_II tumor_NN cells_NNS both_CC in_RR+ vivo_RR and_CC in_RR+ vitro_RR ._.
P09212749A10
Plasma_NN membranes_NNS prepared_VVN from_II cultured_VVNJ chondrocytes_NNS with_II MT1-MMP_NN expression_NN and_CC those_PND directly_RR isolated_VVN from_II OA_NN cartilage_NN could_VM activate_VVB pro-MMP-2_NN ._.
P09219724A06
However_RR ,_, no_DD significant_JJ changes_NNS of_II MMP-2_NN levels_NNS were_VBD noted_VVN in_II BCNU-treated_VVNJ cells_NNS ._.
P09219732A07
The_DD enzyme_NN activity_NN from_II MDA_NN cells_NNS was_VBD not_RR influenced_VVN by_II treatment_NN with_II any_PND of_II the_DD antiestrogens_NNS ,_, whereas_CS ,_, in_II MCF_NN cells_NNS ,_, ICI_NN produced_VVD the_DD greatest_JJT enzyme_NN inhibition_NN (_( 47.93_MC %_SYM )_) ,_, followed_VVN by_II AII_NN (_( 36.51_MC %_SYM )_) and_CC TAM_NN (_( 24.05_MC %_SYM )_) ._.
P09224642A04
This_PND resulted_VVD from_II cleavage_NN of_II the_DD Val69-Cys70_NN bond_NN ._.
P09230755A03
Release_NN of_II these_DD MMPs_NNS into_II the_DD culture_NN medium_NN and_CC secretion_NN of_II neutrophil_NN elastaselike_JJ activity_NN was_VBD also_RR assessed_VVN ._.
P09232430A06
However_RR ,_, RASI-1_NN expression_NN can_VM also_RR be_VBB found_VVN in_II non-inflamed_VVNJ blood_NN vessels_NNS of_II uterine_JJ ligaments_NNS and_CC skin_NN ._.
P09234385A01
The_DD expression_NN of_II matrix_NN metalloproteinase-2_NN (_( MMP-2_NN ;_: 72_MC kDa_NN type_NN IV_MC collagenase_NN /_SYM gelatinase_NN A_NN )_) and_CC MMP-9_NN (_( 92_MC kDa_NN type_NN IV_MC collagenase_NN /_SYM gelatinase_NN B_NN )_) was_VBD immunohistochemically_RR investigated_VVN in_II 79_MC T1_NN adenocarcinomas_NNS of_II the_DD lung_NN using_VVG non-commercial_JJ polyclonal_JJ anti-MMP-2_NN and_CC -9_MC antibodies_NNS ._.
P09236138A08
Although_CS 2-week_NN losartan_NN treatment_NN of_II 65_MC ,_, 120_MC and_CC 200_MC day_NN experimental_JJ groups_NNS had_VHD no_DD significant_JJ effect_NN on_II left_JJ ventricular_JJ fibrillar_JJ collagen_NN concentration_NN or_CC collagen_NN mRNA_NN abundance_NN when_CS compared_VVN to_II vehicle-infused_VVNJ CMP_NN hamsters_NNS ,_, AT1_NN receptor_NN blockade_NN was_VBD associated_VVN with_II complete_JJ regression_NN of_II cardiac_JJ hypertrophy_NN ._.
P09238653A04
Analysis_NN of_II culture_NN medium_NN by_II zymography_NN using_VVG gelatin_NN as_II substrate_NN demonstrated_VVD the_DD presence_NN of_II metalloproteinases_NNS (_( MMP_NN )_) ,_, MMP-9_NN (_( gelatinase_NN B_NN )_) appearing_VVG as_II the_DD predominant_JJ band_NN ._.
P09260202A03
To_TO study_VVI the_DD involvement_NN of_II the_DD ECM_NN degrading_VVGJ proteases_NNS (_( matrix_NN metalloproteinases_NNS ;_: MMPs_NNS )_) and_CC their_PNG specific_JJ inhibitors_NNS in_II the_DD process_NN of_II pancreatic_JJ regeneration_NN ,_, we_PN examined_VVD the_DD expression_NN of_II these_DD genes_NNS on_II the_DD transcript_NN level_NN and_CC the_DD activation_NN of_II the_DD corresponding_VVGJ enzymes_NNS by_II use_NN of_II zymographies_NNS ._.
P09260879A04
However_RR ,_, large_JJ changes_NNS in_II cell_NN morphology_NN ,_, viability_NN and_CC expression_NN of_II MMPs_NNS and_CC MMP_NN inhibitors_NNS occurred_VVD when_CS fibroblasts_NNS were_VBD treated_VVN with_II 10_MC (_( -4_MC )_) or_CC 10_MC (_( -3_MC )_) M_NN c3Ado_NN ._.
P09268350A07
The_DD reactive_JJ site_NN identified_VVN by_II these_DD studies_NNS is_VBZ a_DD structurally_RR constrained_VVNJ but_CC elongated_VVNJ region_NN of_II TIMP_NN that_PNR can_VM fit_VVB the_DD matrix_NN metalloproteinase_NN substrate-binding_VVGJ site_NN ._.
P09269785A09
We_PN conclude_VVB that_CST the_DD increase_NN of_II MMP_NN activity_NN produced_VVN or_CC induced_VVN by_II myeloma_NN cells_NNS in_II these_DD cocultures_NNS could_VM favor_VVB bone_NN resorption_NN and_CC tumor_NN invasion_NN ._.
P09269815A02
This_DD family_NN of_II enzymes_NNS degrades_VVZ all_DD components_NNS of_II connective_JJ tissue_NN and_CC has_VHZ been_VBN implicated_VVN as_II a_DD cause_NN of_II anastomotic_JJ dehiscence_NN ._.
P09276670A05
In_II addition_NN ,_, plasminogen_NN converted_VVD the_DD pro_JJ form_NN of_II MMPs_NNS into_II the_DD active_JJ form_NN ._.
P09279657A07
Intense_JJ gelatinase_NN B_NN expression_NN was_VBD observed_VVN at_II sites_NNS of_II bone_NN resorption_NN in_II osteoclasts_NNS and_CC mononuclear_JJ cells_NNS ._.
P09284814A03
We_PN studied_VVD the_DD distribution_NN of_II 92-kd_NN gelatinase_NN B_NN (_( MMP-9_NN )_) and_CC of_II EMMPRIN_NN in_II 33_MC benign_JJ and_CC 41_MC malignant_JJ ,_, paraffin-embedded_VVNJ pigment_NN cell_NN lesions_NNS using_VVG immunohistochemistry_NN and_CC monoclonal_JJ antibodies_NNS ._.
P09285647A05
We_PN report_VVB here_RR that_CST stimulated_VVNJ human_NN T_NN lymphocytes_NNS induced_VVD the_DD expression_NN of_II the_DD matrix-degrading_VVGJ enzymes_NNS ,_, ie_II ,_, interstitial_JJ collagenase_NN (_( MMP-1_NN )_) ,_, stromelysin_NN (_( MMP-3_NN )_) ,_, gelatinase_NN B_NN (_( MMP-9_NN )_) ,_, and_CC activated_VVNJ gelatinase_NN A_NN (_( MMP-2_NN )_) ,_, in_II human_NN vascular_JJ SMCs_NNS by_II cell_NN contact_NN via_II CD40_NN ligation_NN ,_, as_CS demonstrated_VVN by_II Western_NN blot_NN analysis_NN ,_, zymography_NN ,_, and_CC antibody_NN neutralization_NN ._.
P09288131A03
This_DD study_NN proposes_VVZ to_TO quantify_VVI relative_JJ mRNA_NN levels_NNS for_II interstitial_JJ collagenase_NN (_( MMP-1_NN )_) ,_, 72_MC kd_NN type_NN IV_MC collagenase_NN (_( MMP-2_NN )_) ,_, 92_MC kd_NN type_NN IV_MC collagenase_NN (_( MMP-9_NN )_) ,_, TIMP-1_NN ,_, and_CC TIMP-2_NN in_II normal_JJ aorta_NN (_( NA_NN )_) and_CC AAA_NN to_TO provide_VVI insight_NN as_II+ to_II the_DD relative_JJ importance_NN of_II each_PND in_II aneurysm_NN formation_NN ._.
P09291433A02
Since_CS the_DD liver_NN is_VBZ a_DD main_JJ target_NN for_II metastases_NNS from_II gastrointestinal_JJ adenocarcinoma_NN ,_, we_PN have_VHB investigated_VVN MMP2_NN and_CC TIMP2_NN expression_NN by_II RT-PCR_NN ,_, in_JJ+ situ_JJ hybridization_NN and_CC zymography_NN in_II the_DD liver_NN of_II patients_NNS with_II gastrointestinal_JJ adenocarcinomas_NNS and_CC no_DD detectable_JJ hepatic_JJ metastasis_NN (_( n_NN =_SYM 12_MC )_) ,_, in_II tumoral_JJ and_CC nontumoral_JJ liver_NN from_II patients_NNS with_II hepatic_JJ metastasis_NN (_( n_NN =_SYM 9_MC )_) and_CC in_II control_NN liver_NN (_( n_NN =_SYM 4_MC )_) ._.
P09291579A08
Signals_NNS for_II MMP-9_NN mRNA_NN were_VBD first_RR detected_VVN in_II a_DD small_JJ population_NN of_II stromal_JJ cells_NNS exclusively_RR at_II the_DD site_NN of_II implantation_NN on_II day_NN 5_MC at_II the_DD antimesometrial_JJ pole_NN ._.
P09292803A05
Amounts_NNS of_II MMP-3_NN and_CC TIMP-1_NN mRNA_NN were_VBD measured_VVN by_II Northern_NN blot_NN analysis_NN ._.
P09297576A01
OBJECTIVE_NN AND_CC DESIGN_NN :_: To_TO determine_VVI whether_CST an_DD inhibitor_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ,_, administered_VVN to_II human_NN subjects_NNS in_II a_DD dental_JJ school_NN research_NN clinic_NN ,_, can_VM reduce_VVB bone-type_NN collagen_NN degradation_NN fragments_NNS in_II oral_JJ inflammatory_JJ exudates_NNS containing_VVG excessive_JJ levels_NNS of_II collagenase_NN ._.
P09300240A02
The_DD present_JJ study_NN addressed_VVD the_DD question_NN as_II+ to_II whether_CST glomerular_JJ sclerosis_NN was_VBD associated_VVN with_II alterations_NNS in_II the_DD degradation_NN of_II matrix_NN components_NNS ._.
P09301473A12
These_DD data_NNS suggest_VVB that_CST the_DD integrity_NN of_II Bruch_NN 's_GE membrane_NN may_VM serve_VVB to_TO regulate_VVI RPE_NN functions_NNS in_II MMP_NN and_CC TIMP_NN secretion_NN and_CC that_CST extracellular_JJ matrices_NNS contain_VVB signals_NNS that_PNR regulate_VVB MMP_NN and_CC TIMP_NN synthesis_NN and/or_CC secretion_NN by_II the_DD RPE_NN ._.
P09306059A05
Potential_JJ MMP-2_NN &_CC MMP-9_NN monomer_NN enzyme_NN activities_NNS were_VBD significantly_RR elevated_VVN in_II both_CC septic_JJ and_CC aseptic_JJ joint_NN disease_NN synovial_JJ fluids_NNS in_II comparison_NN to_II fluids_NNS from_II normal_JJ joints_NNS ._.
P09310250A10
Exploration_NN of_II TIMP-2_NN expression_NN is_VBZ valuable_JJ for_II the_DD discrimination_NN between_II macroscopically_RR localized_VVNJ and_CC metastatic_JJ colorectal_JJ cancer_NN ,_, but_CC it_PN can_VM not_RR predict_VVB which_PND of_II the_DD potentially_RR cured_VVNJ patients_NNS are_VBB likely_RR to_TO have_VHI micrometastases_NNS ._.
P09310982A05
METHODS_NNS :_: The_DD aneurysm_NN wall_NN was_VBD excised_VVN from_II three_MC of_II six_MC patients_NNS undergoing_VVG craniotomies_NNS for_II aneurysm_NN clipping_VVGN ._.
P09316744A05
Since_CS all_DD three_MC analytes_NNS were_VBD lower_JJR in_II heparin_NN plasma_NN than_CSN in_II serum_NN or_CC EDTA_NN plasma_NN ,_, heparin_NN plasma_NN was_VBD selected_VVN as_II the_DD specimen_NN of_II choice_NN ._.
P09325265A08
They_PN are_VBB co-expressed_VVN during_II vascular_JJ and_CC urogenital_JJ development_NN and_CC during_II the_DD development_NN of_II osteocartilaginous_JJ and_CC musculotendinous_JJ structures_NNS ._.
P09327785A04
After_II injury_NN ,_, MMP-2_NN mRNA_NN levels_NNS fell_VVB compared_VVN with_II the_DD uninjured_VVNJ arteries_NNS ;_: by_II 24_MC hours_NNS ,_, levels_NNS had_VHD increased_VVN 2-fold_NN ._.
P09328314A04
Effluents_NNS were_VBD also_RR collected_VVN from_II 17_MC human_NN donor_NN livers_NNS stored_VVN in_II UW_NN solution_NN ._.
P09328562A08
This_DD change_NN was_VBD most_RRT pronounced_VVN in_II the_DD spleen_NN ,_, while_CS liver_NN ,_, kidney_NN and_CC brain_NN showed_VVD minor_JJ or_CC no_DD changes_NNS in_II MMP_NN expression_NN ._.
P09334934A08
The_DD method_NN developed_VVN here_RR was_VBD capable_JJ of_II recovering_VVGN gelatinase_NN activities_NNS from_II rat_NN brain_NN tissue_NN over_II a_DD 4-10-fold_NN range_NN using_VVG gelatin_NN zymography_NN for_II the_DD measurement_NN of_II activity_NN ._.
P09338470A08
Production_NN of_II u-PA_NN by_II OVET_NN and_CC OVEM_NN cells_NNS was_VBD regulated_VVN by_II adhesive_JJ substratum_NN ._.
P09344045A06
There_EX was_VBD a_DD significant_JJ difference_NN in_II the_DD increase_NN of_II MMP-2_NN and_CC MMP-9_NN (_( 2.46-fold_NN and_CC 7.14-fold_NN ,_, respectively_RR ,_, at_II 0.4_MC mg_NN /_SYM ml_NN protein_NN ;_: P_NN <_SYM 0.005_MC )_) ._.
P09344465A05
Pregnancy_NN zone_NN protein_NN was_VBD cleaved_VVN at_II Thr693-Tyr694_NN and_CC alpha2-macroglobulin_NN at_II Gly679-Leu680_NN and_CC Arg696-Leu697_NN by_II matrix_NN metalloproteinase-2_NN ._.
P09348221A02
In_II wild-type_NN animals_NNS ,_, MAT_NN ,_, STR-1_NN ,_, STR-2_NN ,_, STR-3_NN ,_, and_CC gelatinase_NN A_NN were_VBD consistently_RR expressed_VVN during_II the_DD most_RRT active_JJ phases_NNS of_II the_DD estrous_JJ cycle_NN ,_, estrus_NN and_CC proestrus_NN ._.
P09352216A02
TIMP-1_NN and_CC TIMP-2_NN are_VBB capable_JJ of_II inhibiting_VVGN the_DD activities_NNS of_II all_DD known_VVNJ matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC as_II such_PND play_VVB a_DD key_JJ role_NN in_II maintaining_VVGN the_DD balance_NN between_II extracellular_JJ matrix_NN (_( ECM_NN )_) deposition_NN and_CC degradation_NN in_II different_JJ physiological_JJ processes_NNS ._.
P09352227A04
Substance_NN P_NN in_II synovial_JJ fibroblasts_NNS induced_VVD an_DD increase_NN in_II the_DD overall_JJ matrix_NN metalloproteinase_NN activity_NN towards_II the_DD dinitrophenyl-labelled_VVNJ peptide_NN by_II 85_MC %_SYM ,_, against_II an_DD increase_NN of_II 124_MC %_SYM after_II stimulation_NN with_II IL-1_NN beta_NN ._.
P09364466A09
Gelatinase-B_NN was_VBD strongly_RR expressed_VVN by_II neutrophils_NNS in_II tissue_NN from_II patients_NNS up_II+ to_II 1_MC week_NN after_II an_DD infarct_NN ,_, whereas_CS gelatinase-A_NN and_CC matrilysin_NN staining_VVGN was_VBD much_RR less_RR marked_VVN ._.
P09369533A04
Distinct_JJ spatial_JJ localisations_NNS for_II each_DD MMP_NN were_VBD observed_VVN :_: MMP-2_NN was_VBD found_VVN in_II epidermal_JJ structures_NNS ;_: MMP-9_NN was_VBD observed_VVN in_II inflammatory_JJ cells_NNS up_II+ to_II day_NN 21_MC ;_: MMP-1_NN was_VBD localised_VVN to_II keratinocytes_NNS at_II the_DD wound_NN margin_NN ._.
P09369811A05
Release_NN of_II gelatinases_NNS from_II the_DD membranes_NNS was_VBD studied_VVN with_II gelatin_NN zymography_NN ._.
P09389796A08
Endothelial_JJ cells_NNS constitutively_RR expressed_VVD gelatinases_NNS at_II Mr_NN 96,000_MC and_CC 72,000_MC ,_, consistent_JJ with_II MMP-9_NN and_CC inactive_JJ MMP-2_NN ._.
P09390324A01
It_PN is_VBZ important_JJ to_TO monitor_VVI the_DD early_JJ stages_NNS of_II postoperative_JJ wound_NN repair_NN in_II order_NN to_TO identify_VVI those_DD problems_NNS associated_VVN with_II impaired_VVNJ healing_VVGN ._.
P09393778A09
Further_JJ studies_NNS with_II PLE_NN revealed_VVD that_CST MMP-9_NN induction_NN by_II PLC_NN progressively_RR increased_VVD with_II the_DD length_NN of_II cell_NN culture_NN time_NN in_II the_DD absence_NN of_II serum_NN ._.
P09394051A05
We_PN have_VHB studied_VVN the_DD distribution_NN patterns_NNS of_II matrix_NN metalloproteinases-1_NN ,_, -2_MC ,_, -3_MC ,_, and_CC -9_MC and_CC their_PNG inhibitors_NNS TIMP-1_NN and_CC TIMP-2_NN as_CS compared_VVN to_II the_DD distribution_NN of_II their_PNG substrates_NNS along_II the_DD invasive_JJ pathway_NN of_II extravillous_JJ trophoblast_NN of_II 1st_JJ ,_, 2nd_JJ ,_, and_CC 3rd_JJ trimester_NN placentas_NNS by_II means_NNS of_II light_NN microscopy_NN on_II paraffin_NN and_CC cryostat_NN sections_NNS as_CC+ well_CC+ as_CC at_II the_DD ultrastructural_JJ level_NN (_( only_RR 3rd_JJ trimester_NN placenta_NN )_) ._.
P09395517A11
The_DD C-terminal_JJ portion_NN of_II the_DD cleaved_VVNJ HB-EGF_NN JM-AP_NN that_PNR remained_VVD attached_VVN to_II the_DD anti-AP_NN beads_NNS was_VBD N-terminally_RR sequenced_VVN and_CC the_DD MMP-3_NN cleavage_NN site_NN was_VBD determined_VVN to_TO be_VBI Glu151-Asn152_NN ,_, a_DD site_NN within_II the_DD JM_NN domain_NN ._.
P09396371A14
Those_DD evidence_NN suggest_VVB that_CST MMP-2_NN and_CC MMP-9_NN share_VVB very_RR important_JJ role_NN in_II the_DD destructive_JJ mechanism_NN of_II RDC_NN ,_, possibly_RR under_II imbalance_NN between_II TIMPs_NNS ._.
P09396633A02
SM3_NN had_VHD a_DD novel_JJ sequence_NN consisting_VVG of_II 50_MC amino_JJ acids_NNS after_II Lys407_NN instead_II+ of_II amino_JJ acids_NNS containing_VVG the_DD transmembrane_JJ domain_NN of_II MT3-MMP_NN ._.
P09397993A10
Increased_VVNJ expression_NN of_II MMP-2_NN and_CC MT1-MMP_NN was_VBD detected_VVN in_II CH_NN and_CC LC_NN ,_, while_CS dual_JJ over-expression_NN was_VBD found_VVN in_II stellate_JJ cells_NNS and_CC fibroblasts_NNS ,_, possibly_RR resulting_VVG in_II the_DD increase_NN of_II active_JJ MMP-2_NN in_II and_CC around_II these_DD cells_NNS ._.
P09407317A03
To_TO study_VVI the_DD potential_JJ involvement_NN of_II MMPs_NNS in_II retinoic_JJ acid_NN (_( RA_NN )_) regulation_NN of_II skeletal_JJ development_NN ,_, we_PN studied_VVD the_DD effect_NN of_II all-trans-RA_NN on_II MMPs_NNS levels_NNS in_II mineralizing_VVGJ chicken_NN epiphyseal_JJ chondrocyte_NN primary_JJ cultures_NNS ._.
P09409309A15
These_DD results_NNS correlate_VVB with_II the_DD MT-MMP1_NN protein_NN level_NN ,_, negatively_RR modified_VVN after_II FK_NN treatment_NN ._.
P09412577A05
Expression_NN of_II STR-3_NN and_CC TIMP-2_NN was_VBD also_RR assessed_VVN immunohistochemically_RR with_II the_DD avidin-biotin-complex_NN (_( ABC_NN )_) technique_NN ._.
P09412584A06
In_II contrast_NN ,_, analyses_NNS of_II gelatinase-B_NN (_( MMP-9_NN )_) demonstrated_VVD a_DD specific_JJ expression_NN pattern_NN ,_, with_II high_JJ expression_NN in_II exudates_NNS and_CC lack_NN of_II expression_NN in_II transudates_NNS ._.
P09417058A06
Both_CC the_DD vitronectin-induced_VVNJ MMP-2_NN production_NN and_CC vitronectin-enhanced_VVNJ invasion_NN were_VBD blocked_VVN by_II the_DD peptide_NN ligand_NN Arg-Gly-Asp-Ser_NN (_( RGDS_NN )_) ._.
P09418730A08
Substitution_NN of_II EDTA_NN for_II calcium_NN and_CC zinc_NN in_II the_DD development_NN solution_NN eliminated_VVD the_DD appearance_NN of_II these_DD bands_NNS ,_, indicating_VVG that_CST they_PN reflect_VVB MMP_NN activity_NN ._.
P09422789A04
Specific_JJ receptors_NNS for_II TIMP-2_NN were_VBD identified_VVN on_II COS-1_NN cells_NNS transfected_VVN with_II MT1-MMP_NN cDNA_NN ,_, but_CC not_RR on_II vector-transfected_VVNJ cells_NNS ._.
P09433928A04
Reverse_JJ transcription-polymerase_NN chain_NN reaction_NN (_( RT-PCR_NN )_) and_CC restriction_NN enzyme_NN analysis_NN revealed_VVD that_CST leiomyomata_NN and_CC myometrium_NN expressed_VVD MMP-1_NN ,_, -2_MC ,_, -3_MC and_CC -9_MC ,_, as_CC+ well_CC+ as_CC TIMP-1_NN and_CC -2_MC mRNA_NN ._.
P09438380A11
However_RR ,_, there_EX was_VBD a_DD dramatic_JJ difference_NN in_II level_NN of_II response_NN by_II the_DD two_MC cell_NN types_NNS with_II FSE_NN secreting_VVGN substantially_RR more_DD TIMP1_NN and_CC MMP9_NN compared_VVN to_II HUVE_NN ._.
P09462388A02
The_DD strength_NN of_II an_DD anastomosis_NN is_VBZ dependent_JJ on_II collagen_NN ,_, which_PNR is_VBZ degraded_VVN by_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ._.
P09464653A05
Using_VVG gelatin_NN zymography_NN ,_, we_PN have_VHB compared_VVN activities_NNS of_II these_DD MMPs_NNS in_II infarcted_VVNJ and_CC matched_VVNJ non-infarcted_VVNJ cerebral_JJ tissue_NN from_II eight_MC subjects_NNS dying_VVG at_II intervals_NNS of_II less_RR than_CSN 2_MC h_NN to_II several_JJ years_NNS after_II a_DD stroke_NN ._.
P09465944A08
The_DD increased_VVNJ ratio_NN of_II MMP_NN /_SYM TIMP-1_NN can_VM be_VBB interpreted_VVN as_II an_DD indicator_NN of_II the_DD imbalance_NN between_II MMP_NN and_CC TIMP_NN ,_, characteristic_JJ of_II prostate_NN carcinoma_NN tissue_NN ._.
P09466528A07
This_DD pattern_NN of_II CSF_NN gelatinase_NN activity_NN may_VM be_VBB a_DD useful_JJ marker_NN for_II neuroborreliosis_NN ._.
P09473407A02
Treatment_NN of_II cultures_NNS with_II 10_MC ng_NN /_SYM ml_NN or_CC more_PND of_II VEGF_NN significantly_RR increased_VVD cell_NN proliferation_NN ._.
P09477095A11
CONCLUSIONS_NNS :_: The_DD results_NNS of_II the_DD current_JJ study_NN indicate_VVB that_CST MMP-2_NN activation_NN plays_VVZ a_DD significant_JJ role_NN in_II tumor_NN invasion_NN and_CC metastasis_NN in_II pancreatic_JJ carcinoma_NN ._.
P09482695A01
Smooth_JJ muscle_NN cell_NN (_( SMC_NN )_) phenotypic_JJ alteration_NN ,_, followed_VVN by_II migration_NN and_CC proliferation_NN ,_, is_VBZ a_DD prominent_JJ feature_NN of_II atherogenesis_NN and_CC vascular_JJ neointimal_JJ formation_NN ._.
P09482695A16
These_DD data_NNS verify_VVB the_DD expression_NN of_II MT-MMP-1_NN in_II arterial_JJ SMC_NN and_CC suggest_VVB its_PNG importance_NN in_II MMP-2_NN activation_NN after_II balloon_NN catheter_NN de-endothelialization_NN ._.
P09486583A07
RESULTS_NNS :_: CSF_NN from_II all_DD patients_NNS with_II malignant_JJ astrocytomas_NNS or_CC brain_NN metastases_NNS contained_VVD precursor_NN gelatinase_NN A_NN (_( pMMP2_NN )_) and_CC precursor_NN gelatinase_NN B_NN (_( pMMP9_NN )_) ,_, whereas_CS control_NN CSF_NN contained_VVD only_RR pMMP2_NN ._.
P09492070A11
These_DD results_NNS demonstrate_VVB that_CST the_DD potency_NN of_II induction_NN of_II MMPs_NNS by_II IL-1_NN and_CC IL-6_NN is_VBZ closely_RR linked_VVN to_II the_DD respective_JJ bone-resorbing_VVGJ activity_NN ,_, suggesting_VVG that_CST MMP-dependent_JJ degradation_NN of_II bone_NN matrix_NN plays_VVZ a_DD key_JJ role_NN in_II bone_NN resorption_NN induced_VVN by_II these_DD cytokines_NNS ._.
P09495249A11
We_PN propose_VVB that_CST an_DD early_JJ step_NN in_II tumor_NN angiogenesis_NN involves_VVZ VEGF-induced_VVNJ thrombin_NN generation_NN and_CC increased_VVNJ MMP_NN production_NN with_II subsequent_JJ activation_NN of_II endothelial_JJ progelatinase_NN A_NN and_CC degradation_NN of_II the_DD underlying_VVGJ basement_NN membrane_NN ._.
P09499937A01
We_PN investigated_VVD whether_CST PF4_NN could_VM regulate_VVB the_DD constitutive_JJ and_CC thrombin-stimulated_VVNJ expression_NN of_II metalloproteinases_NNS (_( MMPs_NNS )_) in_II endothelial_JJ cells_NNS (_( EC_NN )_) ._.
P09502424A06
Timp2_NN and_CC Timp3_NN ,_, the_DD murine_JJ homologues_NNS of_II the_DD respective_JJ TIMP_NN genes_NNS ,_, were_VBD constitutively_RR expressed_VVN ,_, whereas_CS Timp1_NN was_VBD markedly_RR up-regulated_VVN during_II fibrosis_NN ._.
P09502791A06
TIMP-3_NN overexpression_NN induced_VVD DNA_NN synthesis_NN ,_, and_CC promoted_VVD SMC_NN death_NN by_II apoptosis_NN ,_, a_DD phenotype_NN reproduced_VVN by_II adding_VVGN TIMP-3_NN to_II uninfected_VVNJ cells_NNS ,_, but_CC not_RR by_II a_DD synthetic_JJ MMP_NN inhibitor_NN ._.
P09504769A02
We_PN investigated_VVD the_DD immunolocalization_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) in_II rabbit_NN carotid_JJ arteries_NNS after_II balloon_NN denudation_NN ._.
P09504860A08
These_DD data_NNS suggest_VVB that_CST besides_II increased_VVNJ TIMP-1_NN activity_NN ,_, altered_VVNJ MMP_NN expression_NN may_VM also_RR play_VVB a_DD part_NN in_II fibroproliferation_NN in_II liver_NN disease_NN ._.
P09506709A03
The_DD matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) have_VHB been_VBN demonstrated_VVN to_TO play_VVI a_DD significant_JJ role_NN in_II tissue_NN remodeling_VVGN in_II a_DD number_NN of_II pathological_JJ processes_NNS ._.
P09510201A07
Together_RR ,_, these_DD results_NNS demonstrate_VVB that_CST firm_JJ adhesion_NN of_II T_NN lymphoma_NN cells_NNS to_II endothelial_JJ cells_NNS participates_VVZ in_II the_DD production_NN of_II MMP-9_NN in_II both_DD cell_NN types_NNS through_II bi-directional_JJ signaling_VVGJ pathways_NNS ,_, and_CC identify_VVB intercellular_JJ adhesion_NN molecule-1_NN /_SYM LFA-1_NN as_II a_DD key_JJ interaction_NN in_II the_DD up-regulation_NN of_II MMP-9_NN in_II T_NN lymphoma_NN cells_NNS ._.
P09510291A06
At_II the_DD termination_NN of_II culture_NN ,_, MMPs_NNS were_VBD extracted_VVN from_II the_DD tissue_NN and_CC quantified_VVN by_II a_DD combination_NN of_II substrate_NN gel_NN enzymography_NN and_CC immunoblotting_VVGN ._.
P09513609A12
In_II the_DD 16_MC fluids_NNS from_II rheumatoid_JJ arthritis_NN patients_NNS ,_, levels_NNS of_II MMP-9_NN and_CC TIMP-1_NN were_VBD closely_RR correlated_VVN with_II serum_NN C-reactive_JJ protein_NN levels_NNS ._.
P09514050A04
This_DD model_NN is_VBZ composed_VVN of_II the_DD parental_JJ immortalized_VVNJ non-tumorigenic_JJ human_NN keratinocyte_NN line_NN (_( HaCaT_NN )_) ,_, and_CC three_MC activated_VVNJ c-Harvey-ras-oncogene_NN transfected_VVNJ variants_NNS (_( A-4_NN ,_, I-7_NN and_CC II-4_NN )_) ._.
P09528836A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB zinc_NN dependent_JJ endopeptidases_NNS implicated_VVN in_II cancer_NN invasion_NN and_CC metastasis_NN ._.
P09529001A02
Immunohistochemical_JJ ,_, immunoblotting_VVGJ ,_, zymographical_JJ ,_, and/or_CC Northern_NN blot_NN analyses_NNS showed_VVD that_CST MMP-2_NN and_CC -9_MC levels_NNS were_VBD much_RR higher_JJR in_II the_DD growth_NN plate_NN than_CSN in_II permanent_JJ cartilage_NN in_RR+ vivo_RR ._.
P09531484A08
This_DD cascade_NN was_VBD effectively_RR inhibited_VVN by_II tissue_NN inhibitors_NNS of_II metalloproteinases-2_NN and_CC -3_MC ._.
P09534207A07
In_JJ+ situ_JJ hybridization_NN revealed_VVD intense_JJ positive_JJ staining_VVGN for_II TIMPs_NNS in_II GCA_NN despite_II weak_JJ immunocytochemical_JJ staining_VVGN for_II TIMPs_NNS ._.
P09536819A05
By_II contrast_NN ,_, the_DD three_MC MMPs_NNS showed_VVD variable_JJ values_NNS between_II experiments_NNS in_II response_NN to_II MC_NN activation_NN ;_: no_DD reproducible_JJ trend_NN of_II either_CC an_DD increased_VVNJ or_CC decreased_VVNJ production_NN of_II each_DD MMP_NN over_II control_NN values_NNS was_VBD evident_JJ ._.
P09538225A02
To_TO clarify_VVI the_DD mechanism_NN of_II the_DD IL-1-induced_VVNJ bFGF_NN release_NN ,_, we_PN investigated_VVD the_DD production_NN and_CC gene_NN expression_NN of_II bFGF_NN ,_, matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ,_, syndecan_NN 3_MC ,_, and_CC inducible_JJ NO_NN synthase_NN (_( iNOS_NN )_) by_II IL-1-treated_VVNJ rabbit_NN articular_JJ chondrocytes_NNS ._.
P09538475A02
These_DD interactions_NNS are_VBB characterized_VVN by_II cell_NN adhesion_NN and_CC migration_NN ._.
P09543631A08
Stromal_JJ scars_NNS of_II keratoconus_NN corneas_NNS also_RR had_VHD increased_VVN staining_VVGN with_II TIMP-1_NN and_CC TIMP-2_NN antibodies_NNS ._.
P09545106A09
The_DD highest_JJT MMP-2_NN mRNA_NN levels_NNS were_VBD determined_VVN in_II thyroid-derived_VVNJ fibroblasts_NNS and_CC HTh_NN 74_MC cells_NNS ._.
P09546322A10
These_DD findings_NNS indicate_VVB that_CST 92-kd_NN gelatinase_NN and_CC matrilysin_NN are_VBB selectively_RR up-regulated_VVN during_II EAN_NN and_CC expressed_VVN in_II nerves_NNS of_II GBS_NN patients_NNS and_CC thus_RR may_VM contribute_VVB to_II the_DD pathogenesis_NN of_II inflammatory_JJ demyelination_NN of_II the_DD peripheral_JJ nervous_JJ system_NN ._.
P09546361A05
The_DD colitis_NN types_NNS studied_VVN did_VDD not_RR essentially_RR differ_VVB in_II their_PNG MMP_NN expression_NN ._.
P09549496A10
Our_PNG findings_NNS indicate_VVB that_CST 92-kDa_NN gelatinase_NN and_CC matrilysin_NN are_VBB selectively_RR upregulated_VVN during_II AT-EAE_NN and_CC thus_RR may_VM contribute_VVB to_II the_DD pathogenesis_NN of_II inflammatory_JJ diseases_NNS of_II the_DD CNS_NN ._.
P09549524A11
Prominent_JJ infiltration_NN of_II inflammatory_JJ cells_NNS into_II the_DD sciatic_JJ nerve_NN was_VBD concordant_JJ with_II a_DD significant_JJ increase_NN in_II the_DD expression_NN levels_NNS of_II matrilysin_NN and_CC macrophage_NN metalloelastase_NN ._.
P09550215A04
The_DD attenuated_VVNJ Ta-Ode_NN cells_NNS were_VBD found_VVN to_TO disseminate_VVI very_RR poorly_RR compared_VVN to_II their_PNG virulent_JJ progenitors_NNS ,_, which_PNR correlates_VVZ with_II a_DD marked_VVNJ reduction_NN in_II matrix_NN metalloproteinase_NN (_( MMP_NN )_) expression_NN ._.
P09553130A02
Previously_RR ,_, we_PN showed_VVD the_DD surface_NN association_NN of_II pro-MMP-9_NN in_II human_NN breast_NN epithelial_JJ MCF10A_NN cells_NNS ._.
P09558121A08
These_DD results_NNS suggest_VVB that_CST one_MC of_II the_DD ways_NNS in_II which_PNR TNF-alpha_NN causes_VVZ tissue_NN injury_NN in_II the_DD gut_NN is_VBZ by_II stimulating_VVGN mucosal_JJ mesenchymal_JJ cell_NN to_TO secrete_VVI matrix-degrading_VVGJ metalloproteinases_NNS ._.
P09560329A05
MMP_NN activities_NNS are_VBB regulated_VVN by_II their_PNG transition_NN from_II latent_JJ to_II activated_VVNJ forms_NNS ,_, as_CC+ well_CC+ as_CC by_II the_DD presence_NN of_II tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) ._.
P09561025A01
The_DD molecular_JJ mechanism_NN by_II which_PNR IL-10_NN inhibits_VVZ metastases_NNS was_VBD examined_VVN using_VVG a_DD SCID_NN mouse_NN model_NN ._.
P09570393A07
The_DD high_JJ level_NN of_II TIMP-1_NN appeared_VVD to_TO be_VBI related_VVN to_II malignant_JJ phenotype_NN in_II ovaries_NNS as_CC+ well_CC+ as_CC the_DD high_JJ level_NN of_II MMP-9_NN ._.
P09578462A07
ProMMP-9_NN (_( progelatinase_NN B_NN )_) is_VBZ activated_VVN by_II MMP-10_NN to_II its_PNG full_JJ activity_NN and_CC processed_VVN to_II the_DD low-Mr_NN species_NNS of_II Mr_NN 81,000_MC ,_, 65,000_MC ,_, 57,000_MC and_CC 55,000_MC ,_, the_DD former_JJ two_MC of_II which_PNR show_VVB proteolytic_JJ activity_NN on_II a_DD gelatin_NN zymography_NN ._.
P09579471A07
Gelatinase_NN A_NN was_VBD immunolocalized_VVN to_II the_DD epithelium_NN and_CC stroma_NN of_II normal_JJ corneas_NNS and_CC was_VBD predominant_JJ in_II the_DD basal_JJ epithelium_NN and_CC superficial_JJ stroma_NN at_II 3_MC and_CC 7_MC days_NNS after_II wounding_VVGN ._.
P09588507A14
This_DD enhanced_VVNJ MMP-9_NN activity_NN could_VM then_RR result_VVB in_II degradation_NN of_II the_DD ECM_NN ,_, leading_VVG to_II aneurysmal_JJ dilatation_NN ._.
P09591765A01
BACKGROUND_NN :_: One_MC of_II the_DD hallmarks_NNS of_II dilated_VVNJ cardiomyopathy_NN (_( DCM_NN )_) is_VBZ left_JJ ventricular_JJ (_( LV_NN )_) remodeling_VVGN ._.
P09596253A04
After_II focal_JJ stroke_NN ,_, there_EX is_VBZ a_DD breakdown_NN of_II the_DD BBB_NN with_II an_DD associated_VVNJ increase_NN in_II vascular_JJ permeability_NN ,_, inflammatory_JJ cell_NN influx_NN ,_, and_CC neuronal_JJ cell_NN death_NN ._.
P09598840A01
We_PN have_VHB recently_RR demonstrated_VVD that_CST the_DD blockade_NN of_II matrix_NN metalloproteinases_NNS by_II local_JJ overexpression_NN of_II the_DD intrinsic_JJ inhibitor_NN tissue_NN inhibitor_NN of_II matrix_NN metalloproteinase-1_NN (_( TIMP-1_NN )_) reduces_VVZ intimal_JJ hyperplasia_NN ._.
P09604716A04
No_DD MMP-2_NN binding_VVGN to_II fibrin_NN occurred_VVD ._.
P09605768A06
Immunohistochemical_JJ analysis_NN of_II tumor_NN tissue_NN samples_NNS indicated_VVD that_CST MMP-2_NN was_VBD present_JJ in_II both_CC tumor_NN cells_NNS and_CC stromal_JJ cells_NNS ._.
P09610608A01
OBJECTIVES_NNS :_: To_TO elucidate_VVI the_DD role_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) in_II human_NN urothelial_JJ cancers_NNS ,_, we_PN studied_VVD gene_NN expressions_NNS of_II MMPs_NNS ,_, TIMPs_NNS ,_, and_CC membrane-type_NN 1_MC matrix_NN metalloproteinase_NN (_( MT1-MMP_NN )_) in_II noninvasive_JJ or_CC invasive_JJ tumor_NN lines_NNS transplanted_VVN in_II mice_NNS with_II severe_JJ combined_VVNJ immunodeficiency_NN (_( SCID_NN )_) ._.
P09610697A02
Recently_RR ,_, GM-CSF_NN has_VHZ been_VBN demonstrated_VVN to_TO be_VBI produced_VVN by_II several_JJ tumor_NN cells_NNS and_CC also_RR to_TO be_VBI associated_VVN with_II tumor_NN growth_NN and_CC metastasis_NN ._.
P09612358A13
These_DD findings_NNS demonstrate_VVB that_CST pacing-induced_VVNJ CHF_NN leads_VVZ to_II changes_NNS in_II myocardial_JJ MMP_NN activity_NN and_CC expression_NN that_PNR may_VM be_VBB responsible_JJ for_II LV_NN remodeling_VVGN in_II CHF_NN ._.
P09620087A02
METHODS_NNS :_: Forty-two_MC vitreous_JJ samples_NNS were_VBD collected_VVN at_II the_DD time_NN of_II pars_NN plana_NN vitrectomy_NN ._.
P09627804A05
Since_RR little_PND is_VBZ known_VVN about_II the_DD actual_JJ mechanism_NN (_( s_NNS )_) involved_VVN ._.
P09639398A02
Activation_NN of_II MMP-2_NN is_VBZ RGD_NN sequence_NN dependent_JJ ,_, possibly_RR involves_VVZ anti-alphaVbeta3_NN integrins_NNS ,_, is_VBZ preceded_VVN by_II a_DD change_NN from_II spread_VVNJ to_II rounded_VVNJ cell_NN morphology_NN and_CC is_VBZ mimicked_VVN by_II the_DD actin_NN depolymerising_VVGJ agent_NN cytochalasin_NN B_NN ._.
P09639575A02
For_II these_DD studies_NNS we_PN used_VVD rAgg1mut_NN ,_, a_DD mutated_VVNJ form_NN of_II the_DD recombinant_JJ fusion_NN protein_NN (_( rAgg1_NN )_) that_PNR has_VHZ been_VBN used_VVN as_II a_DD substrate_NN to_TO monitor_VVI '_`` aggrecanase_NN '_'' catabolism_NN in_RR+ vitro_RR [_( Hughes_NNP ,_, Buttner_NNP ,_, Eidenmuller_NNP ,_, Caterson_NNP and_CC Bartnik_NNP (_( 1997_MC )_) J._NN Biol._NN Chem._NN 272_MC ,_, 20269-20274_MC ]_) ._.
P09640131A08
RESULTS_NNS :_: There_EX was_VBD little_DD difference_NN between_II the_DD amounts_NNS of_II MMP2_NN secreted_VVN by_II any_PND of_II the_DD cell_NN lines_NNS ._.
P09642234A02
Wild_JJ type_NN TIMP-3_MC was_VBD entirely_RR localized_VVN to_II the_DD ECM_NN in_II both_CC its_PNG glycosylated_VVNJ (_( 27_MC kDa_NN )_) and_CC unglycosylated_VVNJ (_( 24_MC kDa_NN )_) forms_NNS ._.
P09644306A02
These_DD enzymes_NNS are_VBB capable_JJ of_II degrading_VVGN the_DD extracellular_JJ matrix_NN ,_, including_VVG collagens_NNS ,_, laminin_NN ,_, proteoglycan_NN and_CC fibronectin_NN ._.
P09645358A04
In_II the_DD present_JJ study_NN we_PN investigated_VVD whether_CST plasma_NN cells_NNS could_VM contribute_VVB to_II matrix_NN degradation_NN by_II their_PNG expression_NN of_II MMP_. In_JJ+ situ_JJ hybridization_NN and_CC immunohistochemical_JJ analyses_NNS on_II diseased_VVNJ synovial_JJ and_CC scleral_JJ tissue_NN demonstrated_VVD the_DD expression_NN of_II stromelysin-1_NN (_( MMP-3_NN )_) and_CC gelatinase_NN B_NN (_( MMP-9_NN )_) ,_, but_CC little_DD or_CC no_DD tissue_NN inhibitor_NN of_II matrix_NN metalloproteinase_NN 1_MC (_( TIMP-1_NN )_) mRNA_NN ,_, by_II IgG-positive_JJ plasma_NN cells_NNS ._.
P09645454A01
The_DD enhanced_VVNJ expression_NN of_II matrix_NN metalloproteinases_NNS (_( MMP_NN )_) ,_, especially_RR gelatinases_NNS MMP-2_NN and_CC MMP-9_NN ,_, has_VHZ been_VBN associated_VVN with_II the_DD invasive_JJ behavior_NN of_II tumor_NN cells_NNS ._.
P09645759A04
Western_NN blotting_VVGN of_II lung_NN tissue_NN homogenates_NNS was_VBD performed_VVN for_II MMP-2_NN and_CC MMP-9_NN ._.
P09645764A01
The_DD aim_NN of_II the_DD present_JJ study_NN was_VBD to_TO investigate_VVI the_DD proteolytic_JJ potential_NN and_CC localization_NN of_II matrix_NN metalloproteinase_NN (_( MMP_NN )_) -2_MC in_II relation_NN to_II its_PNG regulatory_JJ protein_NN ,_, membrane-type-MMP_NN (_( MT1-MMP_NN )_) ,_, and_CC tissue_NN inhibitor_NN of_II metalloproteinase-2_NN (_( TIMP-2_NN )_) ,_, as_CC+ well_CC+ as_CC to_TO clarify_VVI an_DD important_JJ step_NN in_II the_DD cascade_NN of_II periprosthetic_JJ connective-tissue_NN remodeling_VVGN in_II loose_JJ total-hip_NN prostheses_NNS ._.
P09648071A05
The_DD role_NN of_II MT-1-MMP_NN in_II renal_JJ development_NN is_VBZ unknown_VVN ._.
P09648925A09
The_DD MT-MMP_NN and_CC tPA_NN activities_NNS of_II cytosol_NN and_CC membrane_NN fractions_NNS were_VBD measured_VVN by_II gelatin-_NN and_CC plasminogen-zymography_NN ,_, respectively_RR ._.
P09649139A07
TIMP-1_NN mRNA_NN was_VBD detected_VVN in_II some_DD stromal_JJ cells_NNS surrounding_VVG the_DD neoplastic_JJ islands_NNS ,_, whereas_CS the_DD mRNA_NN expression_NN for_II TIMP-2_NN was_VBD negligible_JJ ._.
P09660504A05
We_PN have_VHB investigated_VVN the_DD presence_NN of_II MMPs_NNS in_II the_DD vitreous_NN of_II patients_NNS with_II retinal_JJ detachment_NN and_CC the_DD predictive_JJ value_NN of_II MMPs_NNS for_II the_DD future_JJ development_NN of_II PVR_NN ._.
P09661630A03
Corpora_NNS lutea_NN (_( n_NN =_SYM 9_MC )_) were_VBD collected_VVN at_II hysterectomy_NN and_CC were_VBD dated_VVN by_II serial_JJ urinary_JJ LH_NN estimation_NN ._.
P09665201A02
Dissemination_NN of_II malignant_JJ cells_NNS in_II acute_JJ myeloid_NN leukemia_NN (_( AML_NN )_) may_VM be_VBB mediated_VVN by_II similar_JJ mechanisms_NNS ._.
P09666818A06
On_II gelatin_NN zymographic_JJ analysis_NN ,_, the_DD gelatinolytic_JJ activities_NNS of_II MMP-9_NN but_CC not_RR of_II MMP-2_NN were_VBD increased_VVN (_( 2.2-fold_NN )_) ._.
P09672063A10
Thus_RR ,_, the_DD unaltered_VVNJ ratios_NNS of_II active_JJ and_CC latent_JJ MMP-2_NN suggest_VVB that_CST proMMP-2_NN activation_NN may_VM occur_VVB in_II the_DD absence_NN of_II tPA_NN ,_, uPA_NN ,_, or_CC Plg_NN ,_, whereas_CS no_DD active_JJ MMP-9_NN was_VBD detected_VVN in_II the_DD absence_NN of_II Plg_NN ._.
P09678429A05
Inhibitor_NN studies_NNS showed_VVD that_CST MMPs_NNS were_VBD responsible_JJ for_II 72.2_MC %_SYM of_II the_DD degradation_NN ._.
P09679762A07
The_DD TNF_NN alpha-induced_VVNJ degradation_NN of_II IkappaB_NN alpha_NN was_VBD also_RR suppressed_VVN by_II ALLN_NN treatment_NN ,_, thus_RR implying_VVG that_CST the_DD molecule_NN linking_VVG proteasome_NN to_II MMP-9_NN production_NN should_VM be_VBB IkappaB_NN alpha_NN ._.
P09681807A04
MMP-2_NN and_CC MMP-9_NN were_VBD expressed_VVN in_II neoplastic_JJ cell_NN plasma_NN membrane_NN in_II 83.3_MC %_SYM and_CC 88_MC %_SYM of_II cases_NNS of_II AGC_NN ,_, respectively_RR with_II inter-tumoral_JJ variability_NN of_II staining_VVGJ intensity_NN ._.
P09685743A02
MT1-MMP_NN mRNA_NN was_VBD expressed_VVN in_II 8_MC cell_NN lines_NNS ,_, while_CS MT2-MMP_NN and_CC MT3-MMP_NN mRNAs_NNS were_VBD expressed_VVN in_II fewer_JJR cell_NN lines_NNS ._.
P09687303A04
Here_RR we_PN report_VVB a_DD new_JJ effect_NN of_II ascorbic_JJ acid_NN acting_VVG as_II a_DD modulator_NN of_II the_DD 72-kDa_NN type_NN IV_MC collagenase_NN (_( matrix_NN metalloproteinase-2_NN ;_: MMP-2_NN )_) ._.
P09688221A02
In_II periodontal_JJ diseases_NNS ,_, matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) may_VM play_VVB key_JJ roles_NNS in_II the_DD extracellular_JJ matrix_NN ,_, basement_NN membrane_NN ,_, serpin_NN degradation_NN ,_, and_CC modification_NN of_II cytokine_NN action_NN ._.
P09695737A08
Acetate_NN did_VDD not_RR modulate_VVB MMPs_NNS ,_, TIMP-1_NN ,_, or_CC uPA_NN ,_, but_CC stimulated_VVD TIMP-2_NN ._.
P09695744A14
ProMMP-2_NN activation_NN by_II PMN-conditioned_VVNJ medium_NN is_VBZ not_RR blocked_VVN by_II inhibitors_NNS of_II plasmin_NN ,_, cysteine-_NN ,_, acid-_NN ,_, or_CC metalloproteinases_NNS ._.
P09703281A10
Our_PNG observation_NN of_II the_DD unique_JJ presence_NN of_II the_DD active_JJ form_NN of_II MMP-9_NN within_II liver_NN metastasis_NN suggests_VVZ that_CST proMMP-9_NN activation_NN may_VM be_VBB a_DD pivotal_JJ event_NN during_II CRC_NN liver_NN metastasis_NN formation_NN ._.
P09703333A10
Competition-based_VVNJ reverse_JJ transcription-polymerase_NN chain_NN reaction_NN revealed_VVD that_CST nondiabetic_JJ and_CC diabetic_JJ HRECs_NNS expressed_VVD constitutively_RR mRNA_NN for_II MMP-2_NN ,_, MMP-9_NN ,_, tissue_NN inhibitor_NN of_II metalloproteinase_NN (_( TIMP_NN )_) -1_MC ,_, TIMP-2_NN ,_, and_CC fibronectin_NN ._.
P09706130A02
This_DD study_NN assessed_VVD the_DD feasibility_NN of_II modulating_VVGN MMP_NN activity_NN in_II hSVGs_NNS by_II adenovirus-mediated_VVNJ gene_NN transfer_NN ._.
P09706143A05
The_DD culture_NN supernatants_NNS were_VBD analyzed_VVN by_II gelatin_NN zymography_NN ._.
P09707196A11
Pretreatment_NN of_II the_DD serum_NN by_II APMA_NN (_( n_NN =_SYM 60_MC )_) lowered_VVD the_DD molecular_JJ weight_NN of_II the_DD band_NN to_II 66_MC kDa_NN ._.
P09708803A06
Moreover_RR ,_, substrate_NN gel_NN electrophoresis_NN showed_VVD that_CST the_DD activated_VVNJ forms_NNS of_II gelatinases_NNS A_NN and_CC B_NN were_VBD present_JJ in_II glioblastomas_NNS and_CC medulloblastomas_NNS ._.
P09710119A02
The_DD balance_NN between_II degradation_NN by_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) may_VM regulate_VVB plaque_NN stability_NN ._.
P09710383A06
TIMP-3_NN was_VBD abundantly_RR expressed_VVN in_II stromal_JJ fibroblast-_NN and_CC macrophage-like_JJ cells_NNS surrounding_VVG vessels_NNS and_CC sweat_NN glands_NNS in_II both_DD types_NNS of_II wounds_NNS ._.
P09711934A13
Both_CC C_NN pneumoniae_NN and_CC recombinant_JJ chlamydial_JJ HSP_NN 60_MC induced_VVD TNF-alpha_NN production_NN by_II mouse_NN macrophages_NNS in_II a_DD concentration-_NN and_CC time-dependent_JJ fashion_NN ._.
P09714179A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) play_VVB critical_JJ roles_NNS in_II tissue_NN remodeling_VVGN under_II various_JJ physiologic_JJ and_CC pathologic_JJ conditions_NNS ._.
P09716571A03
We_PN have_VHB examined_VVN the_DD interaction_NN between_II human_NN mast_JJ cells_NNS and_CC endometrial_JJ stromal_JJ cells_NNS with_II regard_NN to_II MMP_NN production_NN and_CC activation_NN ._.
P09718371A05
HT1080_NN cells_NNS cultured_VVN on_II immobilised_VVNJ antibodies_NNS to_II the_DD alpha5_NN and_CC beta1_NN integrin_NN subunits_NNS secreted_VVD levels_NNS of_II active_JJ MMP-2_NN similar_JJ to_II those_PND observed_VVN for_II full_JJ length_NN fibronectin_NN ,_, whereas_CS cells_NNS cultured_VVN on_II an_DD antibody_NN to_II the_DD alpha6_NN integrin_NN subunit_NN secreted_VVD mainly_RR proMMP-2_NN ._.
P09719036A03
We_PN performed_VVD Western_NN blot_NN analyses_NNS using_VVG MMP-specific_JJ antibodies_NNS to_TO identify_VVI MMPs_NNS in_II human_NN dental_JJ caries_NN lesions_NNS ._.
P09721888A01
We_PN assessed_VVD the_DD functional_JJ significance_NN of_II tumor_NN cell-associated_VVNJ matrix_NN metalloproteinase_NN (_( MMP_NN )_) -2_MC in_II extracellular_JJ matrix_NN remodeling_VVGN compared_VVN with_II that_PND of_II the_DD soluble_JJ enzyme_NN by_II evaluating_VVGN the_DD contraction_NN of_II three-dimensional_JJ collagen_NN lattices_NNS by_II human_NN glioma_NN U251.3_NN and_CC fibrosarcoma_NN HT-1080_NN cell_NN lines_NNS ._.
P09722003A05
RESULTS_NNS :_: MMP-2_NN and_CC MMP-9_NN were_VBD coexpressed_VVN in_II neuroblastoma_NN and_CC exhibited_VVD an_DD intratumor_JJ variability_NN of_II staining_VVGJ intensity_NN ._.
P09727371A05
Such_PND results_NNS demonstrate_VVB an_DD independent_JJ and_CC opposite_JJ regulation_NN of_II the_DD enzymes_NNS and_CC their_PNG inhibitors_NNS ._.
P09731514A10
Modulation_NN of_II TNFalpha_NN receptor_NN shedding_VVGN by_II TIMP-2_NN could_VM have_VHB important_JJ implications_NNS for_II the_DD pleiotropic_JJ effects_NNS of_II TNFalpha_NN in_II both_CC normal_JJ and_CC malignant_JJ cells_NNS and_CC for_II the_DD pharmacological_JJ activity_NN of_II synthetic_JJ MMPIs_NNS ._.
P09732233A04
The_DD use_NN of_II organomercurials_NNS revealed_VVD the_DD presence_NN of_II latent_JJ enzyme_NN in_II all_DD cases_NNS ._.
P09733107A01
The_DD roles_NNS of_II the_DD matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC their_PNG specific_JJ inhibitors_NNS ,_, the_DD tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMP_NN )_) ,_, in_II embryologic_JJ development_NN in_II general_NN ,_, and_CC in_II nephrogenesis_NN in_II particular_NN ,_, have_VHB not_RR been_VBN fully_RR elucidated_VVN ._.
P09736032A04
Lung_NN mRNAs_NNS assayed_VVN by_II Northern_NN and_CC in_JJ+ situ_JJ hybridization_NN showed_VVD an_DD up-regulation_NN of_II lung_NN gelatinases_NNS A_NN and_CC B_NN from_II the_DD 3rd_JJ day_NN on_RR ._.
P09736043A06
MT2-MMP_NN mRNA_NN was_VBD rather_RR stable_JJ in_II the_DD different_JJ groups_NNS ._.
P09736919A02
Dysregulated_VVNJ activity_NN has_VHZ long_RR been_VBN implicated_VVN in_II the_DD pathologies_NNS of_II cancer_NN and_CC arthritis_NN ,_, and_CC the_DD number_NN of_II diseases_NNS more_RR recently_RR associated_VVN with_II these_DD enzymes_NNS has_VHZ been_VBN increasing_VVG ._.
P09743373A06
Cytokine_NN stimulation_NN of_II MMP-1_NN was_VBD due_JJ ,_, at_RR+ least_RR in_II part_NN ,_, to_II an_DD increase_NN in_II the_DD release_NN of_II arachidonic_JJ acid_NN and_CC PG_NN E2_NN (_( PGE2_NN )_) ,_, because_CS inhibition_NN of_II MMP-1_NN by_II indomethacin_NN could_VM be_VBB reversed_VVN by_II exogenous_JJ PGE2_NN ._.
P09748137A04
A_DD 20_MC %_SYM risk_NN also_RR resulted_VVD from_II a_DD 1-unit_NN increment_NN in_II the_DD MT1-MMP_NN :_: MMP-2_NN ratio_NN ,_, which_PNR showed_VVD differences_NNS of_II up_RR+ to_RR 15-fold_NN ._.
P09756602A15
Treatment_NN with_II BB-1101_NN reduced_VVD BBB_NN opening_VVGN at_II 3_MC hours_NNS and_CC brain_NN edema_NN at_II 24_MC hours_NNS ,_, but_CC neither_PND was_VBD affected_VVN at_II 48_MC hours_NNS ._.
P09758100A10
Reverse_JJ zymography_NN of_II culture_NN supernatants_NNS of_II synovial_JJ fibroblasts_NNS and_CC chondrocytes_NNS gave_VVD similar_JJ results_NNS whereas_CS the_DD culture_NN supernatants_NNS from_II PMNs_NNS and_CC PBMs_NNS showed_VVD the_DD presence_NN of_II only_RR the_DD 28_MC kDa_NN protein_NN ._.
P09759652A08
In_II addition_NN to_II the_DD presence_NN of_II mRNA_NN levels_NNS ,_, the_DD level_NN of_II MT1-MMP_NN according_II+ to_II immunoblot_NN analysis_NN increased_VVD in_II the_DD emphysematous_JJ samples_NNS ._.
P09759850A08
In_II contrast_NN ,_, gelatinase_NN B_NN processed_VVD pIL-1_NN beta_NN within_II minutes_NNS ,_, resulting_VVG in_II immunoreactive_JJ products_NNS as_CC+ well_CC+ as_CC biologic_JJ activity_NN stable_JJ for_II 72_MC h_NN ._.
P09761302A08
MMP-2_NN ,_, TIMP-1_NN ,_, and_CC TIMP-2_NN mRNA_NN had_VHD a_DD similar_JJ overall_JJ distribution_NN that_PNR was_VBD relatively_RR uniform_JJ within_II the_DD vascularized_VVNJ membrane_NN stroma_NN ._.
P09763536A03
Quantitative_JJ competitive_JJ reverse_JJ transcription-polymerase_NN chain_NN reaction_NN and_CC gelatin_NN zymography_NN showed_VVD increased_VVNJ MMP-9_NN mRNA_NN and_CC protein_NN in_II both_CC AAA_NN and_CC AOD_NN tissues_NNS compared_VVN with_II those_PND in_II control_NN tissue_NN ,_, but_CC there_EX was_VBD no_DD significant_JJ difference_NN between_II AAA_NN and_CC AOD_NN ._.
P09771466A02
Immature_JJ female_NN Long-Evans_NN rats_NNS were_VBD primed_VVN with_II 15_MC IU_NN pregnant_JJ mare_NN 's_GE serum_NN gonadotropin_NN (_( PMSG_NN )_) in_II 100_MC microliters_NNS PBS_NN ._.
P09775397A05
Results_NNS show_VVB that_CST in_II normal_JJ mouse_NN muscles_NNS MMP-2_NN and_CC MMP-9_NN are_VBB localized_VVN at_II the_DD neuromuscular_JJ junctions_NNS ,_, in_II Schwann_NN cells_NNS and_CC the_DD perineurium_NN of_II the_DD intramuscular_JJ nerves_NNS ._.
P09776730A01
Vascular_JJ endothelial_JJ growth_NN factor_NN (_( VEGF_NN )_) is_VBZ a_DD critical_JJ regulator_NN of_II angiogenesis_NN that_PNR stimulates_VVZ proliferation_NN ,_, migration_NN ,_, and_CC proteolytic_JJ activity_NN of_II endothelial_JJ cells_NNS ._.
P09776730A16
These_DD data_NNS are_VBB the_DD first_PN to_TO show_VVI a_DD direct_JJ effect_NN of_II VEGF_NN on_II SMCs_NNS ._.
P09778117A05
There_EX was_VBD more_DD (_( P_NN <_SYM 0.001_MC )_) MMP-2_NN activity_NN in_II the_DD caruncle_NN versus_CC intercaruncle_NN and_CC intercotyledon_NN ,_, and_CC all_PND had_VHD greater_JJR MMP-2_NN activity_NN (_( P_NN <_SYM 0.001_MC )_) than_CSN the_DD cotyledon_NN ._.
P09778216A02
METHODS_NNS :_: Dermal_JJ fibroblasts_NNS and_CC fibroblast-like_JJ synovial_JJ cells_NNS (_( synoviocytes_NNS )_) were_VBD cultured_VVN with_II fixed_VVNJ T_NN cells_NNS ,_, isolated_VVNJ plasma_NN membranes_NNS from_II T_NN cells_NNS ,_, interleukin-1beta_NN (_( IL-1beta_NN ;_: 250_MC pg_NN /_SYM ml_NN )_) ,_, or_CC transforming_VVGJ growth_NN factor_NN beta_NN (_( TGFbeta_NN ;_: 5_MC ng_NN /_SYM ml_NN )_) ._.
P09785129A04
Eighteen_MC cervical_JJ adenocarcinomas_NNS and_CC 5_MC controls_NNS were_VBD immunohistochemically_RR analyzed_VVN for_II the_DD expression_NN of_II MMP-2_NN ,_, MMP-3_NN ,_, MMP-9_NN ,_, and_CC their_PNG inhibitors_NNS ,_, TIMP-1_NN and_CC TIMP-2_NN ,_, in_II tumor_NN cells_NNS and_CC peritumoral_JJ stromal_JJ cells_NNS ._.
P09786263A13
CONCLUSION_NN :_: A_DD decrease_NN in_II proteolytic_JJ activity_NN may_VM be_VBB responsible_JJ for_II the_DD histological_JJ and_CC structural_JJ alterations_NNS leading_VVG to_II varicose_JJ degeneration_NN of_II superficial_JJ lower_JJR extremity_NN veins_NNS ._.
P09790969A04
The_DD addition_NN of_II specific_JJ MMP_NN inhibitor_NN BB-94_NN and_CC tissue_NN inhibitor_NN MMP_NN (_( TIMP_NN )_) -2_MC but_CC not_RR TIMP-1_NN to_II such_DD collagen_NN gel_NN cultures_NNS reduced_VVD the_DD formation_NN of_II branching_VVGJ tubules_NNS induced_VVN by_II HGF_NN ._.
P09791731A02
The_DD proteinase_NN is_VBZ secreted_VVN from_II the_DD cell_NN as_II an_DD inactive_JJ zymogen_NN ._.
P09804345A02
To_TO better_RRR understand_VVI the_DD pathogenesis_NN of_II ulcer_NN formation_NN we_PN investigated_VVD the_DD expression_NN of_II matrix_NN metalloproteinases_NNS (_( MMP_NN )_) and_CC tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMP_NN )_) in_II lipodermatosclerosis_NN ._.
P09804828A01
The_DD release_NN of_II aggrecan_NN catabolites_NNS from_II cartilage_NN is_VBZ an_DD early_JJ event_NN in_II the_DD pathogenesis_NN of_II degenerative_JJ joint_NN diseases_NNS ._.
P09808534A03
To_TO address_VVI the_DD contribution_NN of_II MMP_NN activity_NN to_II the_DD development_NN of_II intestinal_JJ adenomas_NNS ,_, we_PN administered_VVD the_DD synthetic_JJ MMP_NN inhibitor_NN batimastat_NN and_CC expressed_VVD the_DD tissue_NN inhibitor_NN of_II metalloproteinases-1_NN (_( TIMP-1_NN )_) in_II the_DD gastrointestinal_JJ tract_NN of_II Min_NN mice_NNS ,_, which_PNR spontaneously_RR develop_VVB pre-malignant_JJ small_JJ and_CC large_JJ intestinal_JJ tumors_NNS ._.
P09819295A01
BACKGROUND_NN :_: Bronchial_JJ asthma_NN is_VBZ characterized_VVN by_II airway_NN structural_JJ changes_NNS ,_, including_VVG mucosal_JJ inflammation_NN and_CC subepithelial_JJ collagen_NN deposition_NN ._.
P09821179A03
Therefore_RR we_PN investigated_VVD the_DD expression_NN of_II several_JJ MMPs_NNS and_CC of_II two_MC of_II their_PNG tissue_NN inhibitors_NNS (_( TIMPs_NNS )_) in_II rat_NN pancreatic_JJ islets_NNS ._.
P09822200A07
Interestingly_RR ,_, proteolytically_RR processed_VVNJ MMP-9_NN was_VBD found_VVN in_II saliva_NN (_( vide_NN supra_NN )_) ,_, and_CC in_RR+ vivo_RR activated_VVNJ MMP-9_NN was_VBD significantly_RR higher_JJR in_II SS_NN than_CSN in_II controls_NNS (_( p=0.002_NN )_) ._.
P09823336A07
These_DD data_NNS demonstrate_VVB that_CST MMPs_NNS ,_, but_CC not_RR the_DD plasminogen_NN activator-plasmin_NN system_NN ,_, can_VM directly_RR regulate_VVB the_DD ability_NN of_II either_CC EGF-_NN or_CC SF-stimulated_VVNJ tumor_NN cells_NNS to_TO invade_VVI interstitial_JJ matrix_NN barriers_NNS ._.
P09828178A07
Menstruation_NN and_CC MMP_NN expression_NN after_II P4_NN withdrawal_NN were_VBD similar_JJ in_II both_CC the_DD presence_NN and_CC absence_NN of_II estradiol_NN ._.
P09846979A09
This_PND appears_VVZ to_TO result_VVI from_II the_DD formation_NN of_II TIMP_NN /_SYM MMP_NN complexes_NNS ._.
P09847290A07
MMP-9_NN and_CC TIMP-1_NN concentrations_NNS were_VBD greater_JJR in_II sputum_NN of_II patients_NNS with_II asthma_NN and_CC chronic_JJ bronchitis_NN than_CSN in_II control_NN subjects_NNS ._.
P09852923A03
All_DD TAAs_NNS showed_VVD cystic_JJ medial_JJ necrosis_NN (_( CMN_NN )_) ,_, with_II loss_NN of_II elastic_JJ fibers_NNS and_CC smooth_JJ muscle_NN cells_NNS ._.
P09856774A05
Kinetic_JJ inhibition_NN analysis_NN was_VBD conducted_VVN for_II stromelysin_NN ,_, gelatinase_NN A_NN ,_, and_CC gelatinase_NN B_NN with_II the_DD various_JJ inhibitors_NNS ._.
P09858432A04
METHODS_NNS :_: NOD_NN ,_, immunodeficient_JJ NOD-scid_NN ,_, and_CC nondiabetic_JJ NOD.B10.H2b_NN mice_NNS were_VBD evaluated_VVN for_II MMP_NN activity_NN in_II their_PNG saliva_NN and_CC exocrine_JJ gland_NN lysates_NNS by_II gelatin_NN zymography_NN and_CC reverse_JJ transcriptase-polymerase_NN chain_NN reaction_NN (_( RT-PCR_NN )_) ._.
P09858504A07
We_PN conclude_VVB that_CST ,_, like_II mammalian_JJ fetal_JJ membranes_NNS ,_, chick_NN embryonic_JJ membranes_NNS undergo_VVB terminal_JJ remodeling_VVGN before_II hatching_VVGN ,_, in_II part_NN as_II a_DD result_NN of_II increased_VVNJ MMP_NN activity_NN ._.
P09862695A10
These_DD results_NNS raise_VVB the_DD possibility_NN that_CST TNF-alpha_NN and_CC IFN-gamma_NN may_VM have_VHB beneficial_JJ effects_NNS in_II attenuating_VVGN astroglioma_NN invasive_JJ properties_NNS ._.
P09872414A06
Taken_VVN together_RR ,_, we_PN propose_VVB a_DD novel_JJ function_NN for_II BCL-2_NN in_II the_DD malignant_JJ phenotype_NN of_II glioma_NN cells_NNS ,_, that_PNR is_VBZ ,_, to_TO enhance_VVI migration_NN and_CC invasion_NN by_II altering_VVGN the_DD expression_NN of_II a_DD set_NN of_II metalloproteinases_NNS and_CC their_PNG inhibitors_NNS ._.
P09872597A03
Furthermore_RR ,_, treatment_NN of_II cells_NNS with_II lactose_NN (_( 30_MC mM_NN )_) ,_, which_PNR dissociated_VVD 67-kDa_NN elastin_NN binding_VVGJ protein_NN (_( EBP_NN )_) from_II cell_NN surfaces_NNS ,_, completely_RR abolished_VVD this_DD effect_NN ,_, suggesting_VVG that_CST the_DD elastin_NN receptor_NN could_VM mediate_VVB such_DB a_DD response_NN ._.
P09876398A01
OBJECTIVE_NN :_: The_DD aim_NN of_II this_DD study_NN was_VBD to_TO define_VVI the_DD relative_JJ regulation_NN of_II matrix_NN metalloproteinase-3_NN (_( MMP-3_NN )_) ,_, and_CC tissue_NN inhibitor_NN of_II metalloproteinases-1_NN (_( TIMP-1_NN )_) ,_, in_II chondrocytes_NNS and_CC synovium_NN in_II experimental_JJ osteoarthritis_NN (_( EOA_NN )_) ._.
P09881602A04
A_DD porcine_JJ MT1-MMP_NN cDNA_NN composed_VVN of_II 3284_MC bp_NN was_VBD isolated_VVN from_II an_DD enamel_NN organ-specific_JJ cDNA_NN library_NN ._.
P09882504A14
By_II in_JJ+ situ_JJ hybridization_NN we_PN localized_VVD MMP-9_NN mRNA_NN in_II inflammatory_JJ cells_NNS and_CC putative_JJ activated_VVNJ satellite_NN cells_NNS in_II injured_VVNJ muscles_NNS ._.
P09889060A11
Active_JJ MMP-2_NN was_VBD present_JJ in_II both_DD groups_NNS but_CC significantly_RR decreased_VVN in_II animals_NNS treated_VVN with_II BB-94_NN ._.
P09890433A05
Furthermore_RR ,_, it_PN was_VBD demonstrated_VVN that_CST a_DD synthetic_JJ furin_NN convertase_NN inhibitor_NN ,_, decanoyl-Arg-Val-Lys-Arg-chloromethylketone_NN ,_, decreased_VVD the_DD production_NN of_II A_NN beta-induced_VVNJ active_JJ MMP-2_NN in_II U87_NN cells_NNS ._.
P09892093A06
In_II addition_NN ,_, a_DD possible_JJ relation_NN between_II exposure_NN of_II glioma_NN cells_NNS to_II IL-10_NN and_CC invasiveness_NN of_II these_DD cells_NNS due_II+ to_II MMP_NN expression_NN was_VBD analyzed_VVN ._.
P09918213A01
Elevated_VVNJ expression_NN levels_NNS of_II matrix_NN metalloproteinase_NN (_( MMP_NN )_) -2_MC and_CC MMP-9_NN have_VHB been_VBN implicated_VVN as_II playing_VVGN important_JJ roles_NNS in_II tumor_NN invasion_NN and_CC metastasis_NN in_II various_JJ tissues_NNS ._.
P09918237A02
METHODS_NNS :_: Enzyme_NN linked_VVNJ immunoassays_NNS and_CC high_JJ performance_NN liquid_NN chromatography_NN were_VBD used_VVN ._.
P09918530A08
Indeed_RR ,_, IL-8_NN (_( 2.5_MC ng_NN /_SYM mL_NN )_) induced_VVD maximal_JJ inhibition_NN of_II TIMP-1_NN accumulation_NN (_( 30_MC %_SYM of_II control_NN )_) in_II 4_MC of_II 6_MC cell_NN preparations_NNS ._.
P09920023A11
Production_NN of_II TIMPs_NNS appears_VVZ to_TO be_VBI individually_RR linked_VVN to_II the_DD synthesis_NN of_II specific_JJ cartilage_NN molecules_NNS ._.
P09920024A04
MMP_NN activity_NN in_II the_DD medium_NN was_VBD determined_VVN using_VVG a_DD quenched_VVNJ fluorescent_JJ substrate_NN assay_NN ,_, while_CS specific_JJ collagenases_NNS were_VBD identified_VVN by_II Western_NN immunoblotting_VVGN ._.
P09923652A07
These_DD results_NNS indicate_VVB that_CST components_NNS of_II the_DD ternary_JJ MT1-MMP_NN /_SYM TIMP-2_NN /_SYM MMP-2_NN complex_NN are_VBB coexpressed_VVN in_II the_DD normal_JJ synovial_JJ lining_VVGN and_CC in_II its_PNG pathological_JJ extension_NN on_II the_DD hyaline_NN articular_JJ cartilage_NN ._.
P09927064A11
These_DD results_NNS suggest_VVB for_II the_DD first_JJ time_NN that_CST among_II seven_MC different_JJ MMPs_NNS ,_, the_DD production_NN of_II proMMP-2_NN and_CC its_PNG MT1-MMP-mediated_VVNJ activation_NN in_II the_DD carcinoma_NN cell_NN nests_NNS play_VVB an_DD important_JJ role_NN in_II the_DD lymph_NN node_NN metastasis_NN of_II human_NN invasive_JJ papillary_JJ thyroid_NN carcinomas_NNS ._.
P09927150A10
The_DD cytokine-specific_JJ regulation_NN of_II MMP_NN /_SYM TIMP_NN expression_NN in_II hepatic_JJ stellate_JJ cells_NNS suggests_VVZ that_CST the_DD initial_JJ matrix_NN breakdown_NN following_VVG liver_NN injury_NN might_VM be_VBB enhanced_VVN by_II TNF-alpha_NN ,_, while_CS diminished_VVNJ matrix_NN degradation_NN during_II chronic_JJ tissue_NN injury_NN might_VM be_VBB due_II+ to_II the_DD action_NN of_II TGF-beta1_NN through_II TIMP_NN induction_NN ._.
P09927378A11
The_DD low_JJ MMP-9_NN :_: TIMP-1_NN ratio_NN observed_VVN in_II subjects_NNS with_II little_DD or_CC no_DD FEV1_NN improvement_NN with_II CS_NN supports_VVZ the_DD hypothesis_NN that_CST ,_, in_II these_DD asthmatic_JJ subjects_NNS ,_, bronchial_JJ fibrogenesis_NN predominates_VVZ over_II inflammation_NN ._.
P09930309A06
Neointima_NN formation_NN and_CC neointimal_JJ cell_NN numbers_NNS were_VBD reduced_VVN 79_MC %_SYM and_CC 71_MC %_SYM ,_, respectively_RR (_( P_NN <_SYM 0.05_MC ;_: n_NN =_SYM 8_MC )_) ._.
P09932102A03
However_RR ,_, when_CS cultured_VVN in_II the_DD presence_NN of_II the_DD matrix_NN metalloproteinase_NN (_( MMP_NN )_) activator_NN aminophenylmercuric_JJ acetate_NN (_( APMA_NN )_) ,_, the_DD lamellae_NNS separated_VVD when_CS tension_NN was_VBD applied_VVN by_II pulling_VVGN the_DD hoof_NN wall_NN in_II an_DD opposite_JJ direction_NN to_II the_DD connective_JJ tissue_NN ._.
P09933437A05
We_PN show_VVB that_CST CD40_NN ligation_NN on_II gingival_JJ fibroblasts_NNS resulted_VVD in_II a_DD decrease_NN of_II their_PNG MMP-1_NN and_CC MMP-3_NN production_NN ,_, while_CS MMP-2_NN and_CC TIMP-1_NN production_NN were_VBD unaffected_VVN as_CS determined_VVN by_II Western_NN blot_NN ._.
P09933484A09
Thus_RR ,_, this_DD study_NN demonstrated_VVD that_CST gelatinase_NN A_NN and_CC its_PNG activator_NN might_VM contribute_VVB to_II the_DD aseptic_JJ loosening_VVGN of_II polyethylene_NN prostheses_NNS ._.
P09933646A06
A_DD triple_JJ mutation_NN ,_, K566A_NN /_SYM K568A_NN /_SYM K575A_NN ,_, having_VHG TIMP-2_NN binding_VVGN indistinguishable_JJ from_II the_DD wild-type_NN C_NN domain_NN (_( Kd_NN 3.0_MC x_SYM 10_MC (_( -8_MC )_) M_NN )_) ,_, showed_VVD that_CST simple_JJ reduction_NN of_II net_JJ positive_JJ charge_NN does_VDZ not_RR reduce_VVB TIMP-2_NN affinity_NN ._.
P09933692A07
Fourteen_MC tumors_NNS (_( 11_MC cancers_NNS ,_, 3_MC adenomas_NNS )_) were_VBD also_RR analyzed_VVN for_II collagenase-3_NN mRNA_NN ,_, but_CC no_DD expression_NN was_VBD detected_VVN ._.
P09935179A07
These_DD findings_NNS have_VHB several_JJ implications_NNS for_II investigations_NNS into_II tumor_NN metastasis_NN ,_, development_NN ,_, and_CC lymphocyte_NN function_NN ._.
P09952109A05
We_PN now_RR report_VVB on_II the_DD expression_NN of_II TIMP-1_NN ,_, the_DD inhibitor_NN of_II MMP-9_NN ,_, and_CC compare_VVB the_DD levels_NNS and_CC the_DD regulation_NN by_II cytokines_NNS of_II both_CC MMP-9_NN and_CC TIMP-1_NN ._.
P09974405A06
Zymography_NN revealed_VVD that_CST TIMP-1_NN was_VBD the_DD most_RRT abundant_JJ TIMP_NN secreted_VVN and_CC that_CST its_PNG secretion_NN increased_VVD dramatically_RR between_II 0_MC to_II 2_MC and_CC 12_MC to_II 14_MC days_NNS of_II culture_NN ._.
P09986746A07
TIMP-2_NN positive_JJ cells_NNS were_VBD observed_VVN within_II the_DD inner_JJ and_CC outer_JJ nuclear_JJ cell_NN layers_NNS of_II normal_JJ retina_NN ._.
P09988231A06
We_PN conclude_VVB that_CST in_II human_NN breast_NN cancer_NN ,_, endogenous_JJ TIMP-1_NN does_VDZ not_RR inhibit_VVB tumor_NN progression_NN but_CC may_VM enhance_VVB the_DD process_NN ._.
P10022430A01
Early_JJ human_NN trophoblast_NN shows_VVZ dramatic_JJ invasive_JJ properties_NNS during_II early_JJ pregnancy_NN ._.
P10023324A04
The_DD purpose_NN of_II this_DD study_NN was_VBD to_TO determine_VVI whether_CST MMPs_NNS play_VVB a_DD role_NN in_II aggrecan_NN catabolism_NN in_II cartilage_NN tumours_NNS ._.
P10027404A06
However_RR ,_, subcutaneous_JJ injection_NN of_II the_DD alphaPI-C-secreting_VVGJ clones_NNS resulted_VVD in_II tumors_NNS that_PNR were_VBD 1.5_MC to_II 3-fold_NN larger_JJR than_CSN those_PND of_II control_NN clones_NNS with_II an_DD increased_VVNJ tendency_NN to_II invasiveness_NN and_CC lymph_NN node_NN metastasis_NN ._.
P10029294A08
As_CS serum_NN MMP-1_NN level_NN was_VBD closely_RR associated_VVN with_II the_DD histological_JJ degree_NN of_II necroinflammation_NN ,_, we_PN examined_VVD the_DD ability_NN of_II the_DD serum_NN MMP-1_NN test_NN to_TO differentiate_VVI active_JJ and_CC inactive_JJ forms_NNS of_II hepatitis_NN with_II a_DD receiver_NN operating_VVGJ curve_NN ._.
P10048978A01
Invasiveness_NN and_CC metastatic_JJ capacity_NN of_II tumor_NN cells_NNS have_VHB been_VBN related_VVN to_II increased_VVNJ expression_NN and_CC activation_NN of_II gelatinase-A_NN (_( MMP-2_NN )_) ._.
P10051290A05
Exposure_NN to_II ox-LDL_NN (_( 10_MC to_II 50_MC microg_NN /_SYM mL_NN )_) increased_VVD MMP-9_NN mRNA_NN expression_NN as_CS analyzed_VVN by_II Northern_NN blot_NN ,_, protein_NN expression_NN as_CS measured_VVN by_II ELISA_NN and_CC Western_NN blot_NN ,_, and_CC gelatinolytic_JJ activity_NN as_CS determined_VVN by_II zymography_NN ._.
P10067990A09
In_II addition_NN ,_, the_DD active_JJ forms_NNS of_II these_DD enzymes_NNS were_VBD present_JJ in_II the_DD membranes_NNS ,_, whereas_CS there_EX was_VBD no_DD detectable_JJ level_NN of_II the_DD active_JJ forms_NNS in_II normal_JJ retinas_NNS ._.
P10068210A08
These_DD data_NNS indicate_VVB that_CST TIMP-1_NN inhibits_VVZ TAg-induced_VVNJ hepatocarcinogenesis_NN by_II altering_VVGN hepatocellular_JJ proliferation_NN and_CC tumor_NN vascularization_NN ,_, without_II any_DD effect_NN on_II hepatocyte_NN apoptosis_NN and_CC stromal_JJ composition_NN ._.
P10071915A08
In_II heterotopic_JJ bone_NN only_RR occasional_JJ low_JJ level_NN TIMP-1_NN expression_NN was_VBD detected_VVN in_II chondrocytes_NNS and_CC osteoblasts_NNS ._.
P10076570A01
We_PN recently_RR established_VVD a_DD metallothionein-I_NN (_( MT_NN )_) /_SYM RET_NN transgenic_JJ mouse_NN line_NN in_II which_PNR skin_NN melanosis_NN ,_, benign_JJ melanocytic_JJ tumor_NN and_CC malignant_JJ melanoma_NN develop_VVB stepwise_RR ._.
P10080160A10
Neither_CC plasma_NN MMP-2_NN or_CC serum_NN ALT_NN were_VBD related_VVN to_II fibrosis_NN or_CC to_II histological_JJ activity_NN index_NN ._.
P10081908A03
MATERIALS_NNS AND_CC METHODS_NNS :_: Overexpression_NN of_II MMP-1_NN ,_, MMP-2_NN and_CC MMP-9_NN was_VBD analyzed_VVN immunohistochemically_RR in_II 60_MC patients_NNS with_II transitional_JJ cell_NN carcinomas_NNS of_II the_DD urothelium_NN (_( 41_MC were_VBD pTa_NN or_CC pis_NN ,_, 19_MC were_VBD pT1-4_NN )_) ,_, and_CC compared_VVD them_PN with_II type_NN IV_MC collagen_NN expression_NN in_II tumor_NN BM_NN ._.
P10086886A02
The_DD aim_NN of_II this_DD study_NN was_VBD to_TO determine_VVI the_DD effects_NNS of_II siderophores_NNS ,_, which_PNR are_VBB iron-chelating_VVGJ molecules_NNS produced_VVN by_II a_DD variety_NN of_II microorganisms_NNS ,_, on_II the_DD activity_NN of_II MMP-2_NN ._.
P10090151A04
Via_II Northern_NN and_CC in_JJ+ situ_JJ hybridization_NN ,_, we_PN have_VHB analyzed_VVN the_DD spatio-temporal_JJ expression_NN patterns_NNS of_II members_NNS of_II the_DD MMP_NN family_NN (_( stromelysin-3_NN ,_, gelatinases_NNS A_NN and_CC B_NN )_) ,_, as_CC+ well_CC+ as_CC their_PNG inhibitors_NNS TIMP-1_NN ,_, -2_MC and_CC -3_MC in_II late_JJ murine_JJ placenta_NN (_( days_NNS 10.5_MC to_II 18.5_MC of_II gestation_NN )_) ._.
P10090824A12
RESULTS_NNS ._.
P10098765A07
Immunohistochemical_JJ study_NN showed_VVD strong_JJ TIMP-1_NN staining_VVGN in_II the_DD stroma_NN cells_NNS of_II advanced_VVNJ stages_NNS of_II carcinomas_NNS ._.
P10190278A05
This_PND includes_VVZ activation_NN ,_, assembly_NN at_II the_DD cell_NN surfaces_NNS as_II TIMP-2_NN complexes_NNS and_CC subsequent_JJ inactivation_NN by_II proteolysis_NN or_CC TIMP_NN inhibition_NN ._.
P10203333A02
We_PN report_VVB the_DD presence_NN of_II MMP-2_NN ,_, but_CC no_DD MMP-9_NN ,_, and_CC of_II all_DB the_DD four_MC known_VVNJ TIMPs_NNS in_II neuroepithelial_JJ stem_NN cells_NNS isolated_VVN from_II the_DD human_NN CNS_NN ._.
P10206300A04
Gelatinase-B_NN transcript_NN and_CC activity_NN levels_NNS were_VBD also_RR higher_JJR than_CSN in_II normal_JJ brain_NN and_CC more_RR strongly_RR correlated_VVN with_II tumour_NN grade_NN ._.
P10206578A06
RESULTS_NNS :_: Levels_NNS of_II urokinase_NN and_CC MMPs_NNS (_( MMP-2_NN and_CC MMP-9_NN )_) in_II retinas_NNS were_VBD significantly_RR increased_VVN in_II animals_NNS with_II induced_VVNJ retinal_JJ neovascularization_NN ._.
P10211985A04
MMP_NN enzyme_NN activity_NN was_VBD determined_VVN by_II gelatin_NN zymography_NN ._.
P10212153A09
The_DD deposited_VVNJ basement_NN membrane-type_NN of_II matrix_NN reproducibly_RR suppressed_VVD HDMEC_NN proliferation_NN and_CC increased_VVD HDMEC_NN adhesion_NN to_II the_DD substratum_NN ._.
P10215319A04
High_JJ levels_NNS of_II MMP-2_NN seemed_VVD to_TO result_VVI from_II increased_VVNJ expression_NN by_II the_DD cystic_JJ kidneys_NNS predominantly_RR in_II the_DD second_JJ and_CC third_JJ postnatal_JJ weeks_NNS (_( a_DD time_NN when_PNR the_DD kidneys_NNS are_VBB undergoing_VVG rapid_JJ cystic_JJ enlargement_NN )_) ._.
P10216103A06
Also_RR ,_, immunoassay_NN of_II plasma_NN cell_NN extracts_NNS showed_VVD significantly_RR higher_JJR (_( P_NN <._SYM 01_MC )_) levels_NNS of_II the_DD angiogenic_JJ basic_JJ fibroblast_NN growth_NN factor_NN (_( FGF_NN )_) -2_MC in_II the_DD active_JJ MM_NN patients_NNS than_CSN in_II nonactive_JJ MM_NN and_CC MGUS_NN patients_NNS (_( 153_MC +/-_SYM 59_MC ,_, 23_MC +/-_SYM 17_MC ,_, and_CC 31_MC +/-_SYM 18_MC pg_NN FGF-2_NN /_SYM 100_MC micrograms_NNS of_II protein_NN ,_, respectively_RR )_) ._.
P10220591A05
The_DD degradation_NN of_II proteoglycan_NN was_VBD inhibited_VVN by_II and_CC MMP_NN inhibitor_NN ,_, indicating_VVG that_CST MMPs_NNS are_VBB involved_VVN in_II the_DD degradation_NN of_II proteoglycans_NNS induced_VVN by_II high_JJ frequency_NN CTF_NN ._.
P10221718A07
There_EX was_VBD no_DD correlation_NN between_II the_DD number_NN of_II MMP-9_NN positive_JJ cells_NNS and_CC the_DD number_NN of_II bleeding_VVGJ days_NNS reported_VVN ._.
P10222217A04
The_DD animals_NNS in_II the_DD second_JJ group_NN (_( no_DD injection_NN group_NN )_) were_VBD not_RR injected_VVN after_II ACLT_NN ._.
P10223763A05
Regarding_VVG the_DD expression_NN pattern_NN of_II m-RNA_NN of_II matrix_NN metalloproteinase-2_NN and_CC tissue_NN inhibitor_NN of_II metalloproteinase-2_NN in_II normal_JJ colon_NN tissue_NN ,_, Group_NN B_NN included_VVD 24_MC cases_NNS with_II matrix_NN metalloproteinase-2_NN negative_JJ ,_, and_CC tissue_NN inhibitor_NN of_II metalloproteinase-2_NN positive_JJ (_( 24_MC /_SYM 46_MC ;_: 52.2_MC percent_NN )_) ._.
P10224058A11
The_DD activated_VVNJ MMP-9_NN enhances_VVZ the_DD invasive_JJ phenotype_NN of_II the_DD cultured_VVNJ cells_NNS as_II their_PNG ability_NN to_II both_CC degrade_VVB extracellular_JJ matrix_NN and_CC transverse_JJ basement_NN membrane_NN is_VBZ significantly_RR increased_VVN following_VVG zymogen_NN activation_NN ._.
P10226073A03
In_II this_DD study_NN we_PN examined_VVD the_DD effects_NNS of_II FGF-1_NN and_CC FGF-1_NN plus_CC heparin_NN on_II type_NN I_MC collagen_NN ,_, collagen-binding_VVGJ stress_NN protein_NN HSP47_NN ,_, interstitial_JJ collagenase_NN (_( matrix_NN metalloproteinase_NN [_( MMP_NN ]_) -1_MC )_) ,_, gelatinase_NN A_NN ,_, and_CC tissue_NN inhibitor_NN of_II metalloproteinase_NN (_( TIMP_NN )_) -1_MC and_CC TIMP-2_NN expression_NN by_II normal_JJ human_NN lung_NN fibroblasts_NNS ._.
P10232461A02
The_DD activity_NN of_II MMPs_NNS is_VBZ regulated_VVN by_II members_NNS of_II the_DD TIMP_NN (_( tissue_NN inhibitors_NNS of_II metalloproteinase_NN )_) family_NN ._.
P10235563A11
Type_NN VII_MC collagen_NN localized_VVD in_II basal_JJ epithelial_JJ cells_NNS only_RR in_II this_DD sample_NN ._.
P10319612A01
We_PN have_VHB evaluated_VVN the_DD correlation_NN between_II disc_NN herniation_NN or_CC degeneration_NN and_CC the_DD levels_NNS of_II matrix_NN metalloproteinase-3_NN (_( MMP-3_NN )_) or_CC tissue_NN inhibitor_NN of_II metalloproteinases-1_NN (_( TIMP-1_NN )_) ._.
P10321809A02
We_PN postulated_VVD that_CST the_DD repression_NN by_II synthetic_JJ progestins_NNS of_II MMP_NN production_NN from_II HESCs_NNS may_VM not_RR be_VBB fully_RR maintained_VVN in_II the_DD long_JJ term_NN ,_, and_CC that_CST this_PND may_VM account_VVB for_II the_DD disturbed_VVNJ uterine_JJ bleeding_VVGJ patterns_NNS in_II women_NNS using_VVG long-acting_VVGJ progestins_NNS ._.
P10323763A07
In_II the_DD coculture_NN experiments_NNS ,_, the_DD presence_NN of_II coronary_JJ media_NN retarded_VVD adventitial_JJ cell_NN outgrowth_NN ,_, whereas_CS medial_JJ damage_NN abrogated_VVD these_DD effects_NNS ,_, allowing_VVG for_II fibroblast_NN migration_NN (_( P_NN <_SYM 0.001_MC )_) ._.
P10330038A06
The_DD collagen_NN percentage_NN in_II deposited_VVNJ ECM_NN was_VBD increased_VVN from_II 5.8_MC +/-_SYM 0.3_MC (_( control_NN )_) to_II 9.0_MC +/-_SYM 0.5_MC and_CC 8.8_MC +/-_SYM 0.5_MC %_SYM by_II TGF-beta1_NN and_CC TGF-beta3_NN ,_, respectively_RR ._.
P10330301A09
These_DD results_NNS demonstrate_VVB that_CST MMPs_NNS and_CC TIMPs_NNS are_VBB upregulated_VVN in_II MS_NN and_CC may_VM contribute_VVB to_II the_DD pathogenesis_NN of_II the_DD disease_NN ._.
P10333542A12
Another_DD function_NN of_II MT-MMP_NN is_VBZ to_TO degrade_VVI collagen_NN types_NNS I_MC and_CC III_MC ._.
P10334190A07
By_II double_JJ immunostaining_VVGN ,_, MMP-9_NN protein_NN expression_NN was_VBD noted_VVN to_TO localize_VVI within_II areas_NNS of_II limited_VVNJ type_NN IV_MC collagen_NN staining_VVGN ._.
P10340932A02
As_II a_DD prerequisite_NN to_II understanding_VVGN which_DD specific_JJ MMPs_NNS might_VM be_VBB involved_VVN in_II the_DD injury_NN and_CC how_CST they_PN might_VM function_VVB ,_, it_PN was_VBD necessary_JJ to_TO know_VVI the_DD spectrum_NN of_II enzymes_NNS present_JJ ._.
P10343138A05
Electron-microscopic_JJ immunohistochemistry_NN of_II parietal_JJ cells_NNS showed_VVD immunolabeling_VVGN of_II MMP-2_NN and_CC TIMP-2_NN in_II the_DD cisternae_NN of_II the_DD rough_JJ endoplasmic_JJ reticulum_NN ,_, and_CC that_PND of_II MMP-1_NN and_CC MMP-9_NN in_II tubular_JJ structures_NNS in_II their_PNG cytoplasm_NN ._.
P10353410A07
However_RR ,_, renal_JJ MMP_NN expression_NN appeared_VVD to_TO be_VBI age_NN dependent_JJ ;_: the_DD highest_JJT average_JJ amounts_NNS of_II urine_NN MMP-2_NN were_VBD detected_VVN during_II adolescence_NN ,_, while_CS the_DD converse_NN was_VBD true_JJ of_II urine_NN MMP-9_NN ._.
P10357558A01
Metastatic_JJ disease_NN is_VBZ responsible_JJ for_II the_DD majority_NN of_II cancer-related_VVNJ deaths_NNS ,_, either_CC directly_RR due_II+ to_II tumor_NN involvement_NN of_II critical_JJ organs_NNS or_CC indirectly_RR due_II+ to_II complications_NNS of_II therapy_NN to_TO control_VVI tumor_NN growth_NN and_CC spread_NN ._.
P10357558A16
Therapies_NNS designed_VVN to_TO interfere_VVI with_II specific_JJ MMP_NN actions_NNS may_VM be_VBB useful_JJ in_II the_DD control_NN of_II metastatic_JJ disease_NN ._.
P10359049A06
In_II animals_NNS fed_VVN 0.4_MC %_SYM OPB-3206_NN ,_, the_DD activity_NN of_II proMMP-9_NN was_VBD increased_VVN ,_, but_CC that_PND for_II MMP-9_NN had_VHD become_VVN undetectable_JJ ._.
P10359808A08
Gelatinase_NN B-deficient_JJ mice_NNS failed_VVN to_TO show_VVI IL-10_NN production_NN at_II the_DD site_NN of_II CHS_NN ,_, an_DD essential_JJ feature_NN of_II resolution_NN in_II control_NN mice_NNS ._.
P10365570A05
In_II JRA_NN ,_, MMP-3_NN levels_NNS of_II patients_NNS with_II arthritis_NN were_VBD statistically_RR higher_JJR than_CSN those_PND of_II patients_NNS without_II arthritis_NN (_( P_NN <_SYM 0.05_MC )_) and_CC MMP-3_NN levels_NNS were_VBD correlated_VVN with_II C-reactive_JJ protein_NN (_( rs_NN =_SYM 0.465_MC ,_, P_NN <_SYM 0.05_MC )_) ,_, while_CS TIMP-1_NN did_VDD not_RR (_( rs_NN =_SYM 0.340_MC )_) ._.
P10366192A09
In_II plasma_NN ,_, only_RR MMP-9_NN increased_VVD transiently_RR at_II 2_MC hours_NNS of_II MCAO_NN ._.
P10366463A15
CONCLUSIONS_NNS :_: Both_CC MMP-2_NN and_CC TIMP-2_NN have_VHB a_DD key_JJ role_NN in_II extracellular_JJ matrix_NN invasion_NN in_II cervical_JJ carcinoma_NN ,_, largely_RR through_II their_PNG elaboration_NN by_II tumor_NN cells_NNS ._.
P10377026A01
Progesterone_NN appears_VVZ essential_JJ for_II ovulation_NN and_CC luteinization_NN of_II the_DD primate_NN follicle_NN ,_, but_CC specific_JJ gene_NN targets_NNS of_II progesterone_NN action_NN remain_VVB elusive_JJ ._.
P10377072A11
Thus_RR ,_, activation_NN of_II SMCs_NNS and_CC Mphi_NN by_II proinflammatory_JJ molecules_NNS may_VM influence_VVB extracellular_JJ matrix_NN remodeling_VVGN in_II atherosclerosis_NN by_II regulating_VVGN MT1-MMP_NN expression_NN ._.
P10377085A05
The_DD adenoviral_JJ vector_NN was_VBD delivered_VVN to_II the_DD injured_VVNJ rat_NN carotid_JJ artery_NN ,_, and_CC 4_MC days_NNS later_RR ,_, immunoreactive_JJ protein_NN was_VBD identified_VVN and_CC migration_NN of_II SMCs_NNS reduced_VVD by_II 60_MC %_SYM (_( 5.2_MC +/-_SYM 0._MC 5_MC versus_CC 12.8_MC +/-_SYM 1.5_MC cells_NNS per_II section_NN ,_, P_NN <_SYM 0.05_MC ,_, n=5_NN )_) ._.
P10385653A02
These_DD enzymes_NNS are_VBB important_JJ mediators_NNS of_II cold_NN preservation_NN injury_NN ._.
P10389763A01
Hepatocyte_NN growth_NN factor_NN /_SYM scatter_NN factor_NN (_( HGF_NN /_SYM SF_NN )_) contributes_VVZ to_II the_DD malignant_JJ progression_NN of_II human_NN gliomas_NNS ._.
P10390144A01
Bone_NN metastases_NNS are_VBB a_DD common_JJ complication_NN in_II prostate_NN and_CC breast_NN cancer_NN patients_NNS ._.
P10390419A02
The_DD accumulation_NN in_II the_DD submucosa_NN of_II fibrous_JJ proteins_NNS that_PNR are_VBB substrates_NNS of_II matrix_NN metalloproteinases_NNS (_( MMP_NN )_) ,_, and_CC the_DD demonstration_NN of_II increased_VVNJ levels_NNS of_II MMP-9_NN in_II bronchoalveolar_JJ lavage_NN fluid_NN ,_, prompted_VVD us_PN to_TO determine_VVI whether_CST there_EX was_VBD an_DD imbalance_NN between_II MMPs_NNS and_CC tissue_NN inhibitors_NNS of_II metalloproteinase_NN (_( TIMP_NN )_) in_II such_DD patients_NNS ._.
P10397688A09
Casein_NN zymography_NN and_CC in_JJ+ situ_JJ zymography_NN demonstrated_VVD that_CST increased_VVNJ caseinolytic_JJ activity_NN was_VBD confined_VVN to_II the_DD pericellular_JJ zones_NNS of_II macrophages_NNS within_II the_DD lipid_NN core_NN ,_, again_RR consistent_JJ with_II its_PNG restriction_NN by_II TIMPs_NNS ._.
P10402070A01
OBJECTIVES_NNS :_: To_TO compare_VVI plasma_NN levels_NNS of_II matrix_NN metalloproteinase_NN (_( MMP_NN )_) -3_MC ,_, MMP-9_NN and_CC tissue_NN inhibitor_NN of_II metalloproteinases-1_NN (_( TIMP-1_NN )_) between_II patients_NNS with_II knee_NN osteoarthritis_NN and_CC normal_JJ subjects_NNS ,_, to_TO investigate_VVI whether_CST the_DD degree_NN of_II knee_NN joint_NN involvement_NN is_VBZ related_VVN to_II those_DD measurements_NNS ,_, and_CC to_TO compare_VVI patients_NNS with_II and_CC without_II generalized_VVNJ osteoarthritis_NN ._.
P10402168A06
Angiogenesis_NN in_II the_DD metastatic_JJ group_NN was_VBD higher_JJR than_CSN that_PND of_II the_DD localized_VVNJ one_PN (_( p_NN <_SYM 0.05_MC )_) ._.
P10403463A06
ICC_NN results_NNS indicated_VVD that_CST 5_MC of_II the_DD 20_MC tumors_NNS coincidentally_RR produced_VVD all_DD three_MC MMPs_NNS ._.
P10405207A04
In_II this_DD study_NN ,_, it_PN is_VBZ hypothesized_VVN that_CST thrombin_NN may_VM alter_VVB the_DD production_NN and_CC the_DD degradation_NN of_II type_NN IV_MC collagen_NN ,_, which_PNR is_VBZ an_DD important_JJ component_NN of_II ECM_NN in_II the_DD glomeruli_NNS ._.
P10408538A08
RESULTS_NNS :_: The_DD production_NN of_II MMP-2_NN and_CC MMP-9_NN is_VBZ increased_VVN in_II nerve_NN tissue_NN in_II CIDP_NN and_CC NSVN_NN compared_VVN with_II NIN_NN ._.
P10409657A07
Production_NN of_II TIMP-2_NN was_VBD about_RR 10-fold_NN higher_JJR in_II low_JJ invasive_JJ cells_NNS as_CS compared_VVN with_II high_JJ invasive_JJ melanoma_NN cells_NNS and_CC was_VBD further_RR increased_VVD in_II the_DD low_JJ invasive_JJ cells_NNS upon_II contact_NN to_II collagen_NN ._.
P10411111A05
Gelatin_NN zymography_NN showed_VVD that_CST both_DD tumor_NN cell_NN lines_NNS did_VDD not_RR secrete_VVB MMP-9_NN by_II themselves_PN but_CC the_DD host_NN cells_NNS surrounding_VVG the_DD tumor_NN cells_NNS secrete_VVB MMP-9_NN in_RR+ vivo_RR ._.
P10415717A14
Batimastat_NN and_CC marimastat_NN appear_VVB not_RR to_TO interfere_VVI with_II normal_JJ wound_NN healing_VVGN ,_, but_CC only_RR in_II sutured_VVNJ surgical_JJ wounds_NNS ,_, a_DD situation_NN in_II which_PNR MMP_NN expression_NN has_VHZ practically_RR no_DD role_NN ._.
P10421601A05
CPB+LPS_NN caused_VVD severe_JJ lung_NN injury_NN ,_, as_CS demonstrated_VVN by_II a_DD significant_JJ fall_NN in_II PaO_NN (_( 2_MC )_) and_CC an_DD increase_NN in_II intrapulmonary_JJ shunt_NN compared_VVN with_II all_DD groups_NNS (_( P_NN <_SYM 0.05_MC )_) ._.
P10426384A06
The_DD addition_NN of_II recombinant_JJ IGF-1_NN to_II nondiabetic_JJ NOD-MC_NN resulted_VVD in_II a_DD decrease_NN in_II MMP-2_NN and_CC TIMP_NN activity_NN ._.
P10430840A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB implicated_VVN in_II the_DD pathogenesis_NN of_II various_JJ inflammatory_JJ diseases_NNS of_II the_DD central_JJ nervous_JJ system_NN ._.
P10433942A02
Because_CS the_DD excess_JJ matrix_NN deposition_NN is_VBZ potentially_RR reversible_JJ ,_, a_DD labile_JJ imbalance_NN between_II fibrogenesis_NN and_CC fibrolysis_NN may_VM be_VBB suspected_VVN ._.
P10434927A04
Both_CC zymography_NN and_CC ELISA_NN showed_VVD that_CST MMP-2_NN and_CC MMP-9_NN were_VBD the_DD major_JJ metalloproteinases_NNS found_VVN in_II the_DD flushings_NNS and_CC only_RR low_JJ concentrations_NNS of_II MMP-3_NN were_VBD found_VVN ._.
P10438572A11
Immunostaining_VVGN of_II keratinocytes_NNS advancing_VVG into_II the_DD wound_NN revealed_VVD that_CST MMP-2_NN was_VBD localized_VVN in_II extracellular_JJ matrix_NN contactlike_JJ structures_NNS against_II the_DD endogenously_RR produced_VVNJ laminin-5-rich_JJ matrix_NN ._.
P10443293A08
Caseinolytic_JJ bands_NNS observed_VVN were_VBD confirmed_VVN by_II Western_NN blot_NN analysis_NN to_TO be_VBI due_II+ to_II stromelysin_NN activity_NN ,_, whereas_CS matrilysin_NN was_VBD not_RR detected_VVN by_II casein_NN zymography_NN ._.
P10444506A03
Accordingly_RR ,_, isolated_VVNJ Ca_NN (_( 2+_MC )_) -tolerant_JJ LV_NN porcine_JJ myocytes_NNS (_( 10_MC (_( 5_MC )_) cells_NNS /_SYM ml_NN )_) in_II which_PNR selective_JJ disaggregation_NN and_CC resuspension_NN was_VBD performed_VVN (_( 13_MC independent_JJ experiments_NNS )_) were_VBD plated_VVN on_II basement_NN membrane_NN substrates_NNS including_VVG Matrigel_NN ,_, collagen_NN IV_MC ,_, laminin_NN ,_, and_CC fibronectin_NN as_CC+ well_CC+ as_CC poly-L-lysine_NN ._.
P10452757A07
Biopsy_NN specimens_NNS were_VBD examined_VVN for_II extent_NN of_II collagen_NN type_NN III_MC in_II the_DD subepithelial_JJ basement_NN membrane_NN by_II means_NNS of_II immunohistochemistry_NN ,_, and_CC expression_NN of_II both_CC epithelial_JJ and_CC submucosal_JJ MMP-9_NN and_CC TIMP-1_NN was_VBD quantitated_VVN ._.
P10455065A02
The_DD matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) play_VVB a_DD significant_JJ role_NN in_II extracellular_JJ remodeling_VVGN ,_, and_CC recent_JJ studies_NNS have_VHB demonstrated_VVN increased_VVNJ MMP_NN expression_NN and_CC activity_NN with_II CHF_NN ._.
P10459021A06
As_II a_DD consequence_NN of_II reduced_VVNJ IGFBP-3_NN proteolysis_NN and_CC elevated_VVNJ IGFBP-3_NN protein_NN levels_NNS ,_, dissociable_JJ IGF-II_NN levels_NNS were_VBD significantly_RR lower_JJR in_II TIMP-1-overexpressing_VVGJ animals_NNS ._.
P10465309A06
Most_PND of_II the_DD MMPs_NNS and_CC TIMPs_NNS were_VBD expressed_VVN at_II a_DD constitutive_JJ level_NN throughout_II the_DD periovulatory_JJ period_NN ._.
P10472357A01
BACKGROUND_NN :_: Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB a_DD family_NN of_II zinc-dependent_JJ metalloendopeptidases_NNS which_PNR participate_VVB in_II the_DD degradation_NN of_II collagen_NN and_CC other_JJ extracellular_JJ matrix_NN macromolecules_NNS ._.
P10474026A08
There_EX was_VBD a_DD correlation_NN between_II TIMP-2_NN immunoreactivity_NN and_CC disease_NN stage_NN (_( 42_MC %_SYM stage_NN I_MC versus_CC 88_MC %_SYM stages_NNS II_MC ,_, III_MC ,_, and_CC IV_MC )_) (_( p_NN =_SYM 0.0024_MC )_) ._.
P10474160A14
Finally_RR ,_, retinoids_NNS ,_, known_VVN for_II their_PNG dramatic_JJ effects_NNS on_II the_DD pattern_NN of_II regenerating_VVGJ limbs_NNS ,_, can_VM cause_VVB a_DD down_JJ regulation_NN of_II Mmp-9_NN expression_NN ._.
P10479141A03
The_DD M._NN avium-induced_VVNJ HIV-1_NN replication_NN was_VBD not_RR associated_VVN with_II cell_NN activation_NN or_CC differential_JJ cytokine_NN production_NN or_CC utilization_NN ._.
P10485622A05
TIMP-1_NN and_CC TIMP-2_NN expressions_NNS were_VBD localized_VVN overwhelmingly_RR to_II pericancer_NN stromal_JJ cells_NNS ,_, while_CS malignant_JJ and_CC normal_JJ mucosal_JJ cells_NNS were_VBD weak_JJ or_CC negative_JJ ._.
P10487706A04
Exposure_NN of_II these_DD cells_NNS ,_, for_II 1_MC h_NN ,_, to_II the_DD active_JJ phorbol_NN ester_NN ,_, phorbol_NN 12-myristate_NN 13-acetate_NN (_( TPA_NN ,_, 100_MC nmol_NN /_SYM L_NN )_) ,_, acting_VVG via_II protein_NN kinase_NN C_NN (_( PKC_NN )_) ,_, elicited_VVD an_DD increase_NN in_II MMP-1_NN mRNA_NN ,_, with_II a_DD peak_JJ stimulation_NN after_II a_DD 3-_MC to_II 4-h_NN culture_NN period_NN ._.
P10493528A10
The_DD clone_NN with_II the_DD lowest_JJT reduction_NN in_II S100A4_NN did_VDD not_RR demonstrate_VVB different_JJ motility_NN compared_VVN with_II control_NN cells_NNS ,_, whereas_CS transfectants_NNS with_II only_RR 5_MC %_SYM S100A4_NN mRNA_NN showed_VVD a_DD 50_MC %_SYM reduction_NN in_II motility_NN ._.
P10497310A08
These_DD results_NNS indicate_VVB that_CST tryptase_NN does_VDZ not_RR increase_VVB MMP_NN expression_NN in_II normal_JJ dermal_JJ fibroblasts_NNS ._.
P10498646A12
Similar_JJ results_NNS were_VBD obtained_VVN using_VVG membrane_NN fractions_NNS from_II cells_NNS previously_RR cultured_VVN on_II collagen_NN or_CC plastic_NN ._.
P10502722A09
In_JJ+ situ_JJ hybridization_NN showed_VVD carcinoma_NN cells_NNS selectively_RR expressing_VVG MMP-7_NN mRNA_NN ._.
P10508223A02
Using_VVG primary_JJ cultures_NNS of_II human_NN myometrial_JJ smooth_JJ muscle_NN cells_NNS we_PN found_VVD that_CST these_DD cells_NNS express_VVB MMP-1_NN ,_, MMP-3_NN ,_, TIMP-1_NN and_CC TIMP-2_NN mRNA_NN and_CC protein_NN ,_, with_II significantly_RR higher_JJR values_NNS of_II TIMP_NN than_CSN MMP_NN ._.
P10508819A03
Rats_NNS were_VBD instilled_VVN with_II 50_MC mg_NN of_II silica_NN and_CC sacrificed_VVN after_II 15_MC and_CC 60_MC d_NN ._.
P10508828A05
Ethanol_NN ingestion_NN increased_VVD (_( p_NN <_SYM 0.05_MC )_) MMP-9_NN and_CC MMP-2_NN activity_NN ,_, as_CS determined_VVN by_II zymography_NN ,_, in_II the_DD lung_NN tissue_NN and_CC lavage_NN fluid_NN compared_VVN with_II control-fed_VVNJ rats_NNS ,_, and_CC increased_VVD (_( p_NN <_SYM 0.05_MC )_) levels_NNS of_II the_DD 7S_NN fragment_NN of_II type_NN IV_MC collagen_NN in_II the_DD lung_NN lavage_NN fluid_NN ._.
P10513800A02
METHODS_NNS :_: Blood_NN was_VBD obtained_VVN from_II 20_MC RA_NN patients_NNS before_CS they_PN arose_VVD from_II a_DD night_NN 's_GE sleep_NN ,_, and_CC again_RR 1_MC and_CC 4_MC hours_NNS after_CS they_PN had_VHD begun_VVN to_TO perform_VVI moderate_JJ physical_JJ activity_NN ._.
P10516419A01
Matrix_NN metalloproteinases_NNS appear_VVB to_TO play_VVI a_DD role_NN in_II cell_NN migration_NN and_CC tissue_NN remodeling_VVGN and_CC are_VBB postulated_VVN to_TO be_VBI important_JJ in_II the_DD development_NN of_II embryos_NNS ._.
P10526099A03
Gelatinase_NN A_NN (_( MMP-2_NN )_) and_CC gelatinase_NN B_NN (_( MMP-9_NN )_) are_VBB able_JJ to_TO digest_VVI the_DD endothelial_JJ basal_JJ lamina_NN ,_, which_PNR plays_VVZ a_DD major_JJ role_NN in_II maintaining_VVGN BBB_NN impermeability_NN ._.
P10529239A07
Reduced_VVNJ chains_NNS from_II MMP-3_NN ,_, MMP-7_NN ,_, and_CC MT1-MMP_NN digests_NNS of_II Fg_NN and_CC XL-Fb_NN were_VBD subjected_VVN to_II direct_JJ sequence_NN analyses_NNS and_CC D_NN /_SYM D-dimer_NN alpha-chain_NN showed_VVD cleavage_NN at_II both_CC alpha_NN Asp_NN 97-Phe_NN 98_MC and_CC alpha_NN Asn_NN 102-Asn_NN 103_MC ._.
P10535713A07
Zymography_NN and_CC Western_NN blot_NN showed_VVD significant_JJ expression_NN of_II MMP-2_NN in_II Calu-3_NN cells_NNS ._.
P10545018A04
The_DD Immnunoblot_NN findings_NNS revealed_VVD the_DD major_JJ gelatinolytic_JJ activities_NNS to_TO be_VBI due_II+ to_II matrix_NN metalloproteinase_NN (_( MMP_NN )_) -2_MC and_CC -9_MC ._.
P10548534A12
Cultures_NNS of_II late-stage_NN OA_NN human_NN articular_JJ cartilage_NN samples_NNS indicated_VVD that_CST aggrecanase_NN activity_NN was_VBD upregulated_VVN in_II the_DD absence_NN of_II catabolic_JJ stimulation_NN when_CS compared_VVN with_II normal_JJ porcine_JJ or_CC bovine_JJ cartilage_NN ._.
P10550743A09
The_DD transcription_NN inhibitor_NN actinomycin_NN D_NN ,_, the_DD nuclear_JJ factor_NN kappaB_NN (_( NFkappaB_NN )_) inhibitor_NN N-CBZ-Leu-Leu-Leu-AL_NN ,_, the_DD protein_NN synthesis_NN inhibitor_NN cycloheximide_NN ,_, and_CC the_DD protein_NN kinase_NN C_NN inhibitor_NN H7_NN significantly_RR decreased_VVD MMP-9_NN activity_NN in_II TNF-alpha-treated_VVNJ cells_NNS ._.
P10551322A01
Membrane_NN type_NN 1_MC matrix_NN metalloproteinase_NN (_( MT1-MMP_NN )_) with_II a_DD transmembrane_JJ domain_NN is_VBZ a_DD new_JJ member_NN of_II the_DD MMP_NN gene_NN family_NN and_CC is_VBZ expressed_VVN on_II the_DD cell_NN surfaces_NNS of_II many_DD carcinoma_NN cells_NNS to_TO activate_VVI the_DD zymogen_NN of_II MMP-2_NN (_( gelatinase_NN A_NN )_) ._.
P10555745A08
None_MC of_II the_DD melanoma_NN cell_NN lines_NNS expressed_VVD MMP-9_NN ._.
P10561218A14
Increased_VVNJ tumoral_JJ expression_NN of_II MMP-3_NN ,_, -11_MC ,_, and_CC -14_MC were_VBD independent_JJ negative_JJ prognostic_JJ factors_NNS for_II survival_NN ._.
P10567441A07
Our_PNG results_NNS show_VVB that_CST EMMPRIN_NN is_VBZ an_DD important_JJ factor_NN in_II tumor_NN progression_NN by_II causing_VVGN tumor-associated_VVNJ stromal_JJ cells_NNS to_TO increase_VVI their_PNG MMP-2_NN production_NN ,_, thus_RR facilitating_VVG tumor_NN invasion_NN and_CC neoangiogenesis_NN ._.
P10579795A01
BACKGROUND_NN :_: The_DD family_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) has_VHZ been_VBN shown_VVN to_TO be_VBI involved_VVN in_II proteolytic_JJ degradation_NN of_II the_DD extracellular_JJ matrix_NN ,_, which_PNR is_VBZ an_DD essential_JJ step_NN in_II tumor_NN invasion_NN and_CC metastasis_NN ._.
P10587545A04
RESULTS_NNS :_: GLS_NN demonstrated_VVD a_DD self-induction_NN of_II mRNA_NN in_II cultured_VVNJ RA_NN FLSs_NNS ._.
P10590246A08
These_DD data_NNS are_VBB compatible_JJ with_II a_DD role_NN of_II TIMP-1_NN in_II the_DD impairment_NN of_II SMC_NN migration_NN and_CC neointima_NN formation_NN after_II vascular_JJ injury_NN ,_, as_II a_DD result_NN of_II inhibition_NN of_II MMP_NN activity_NN ._.
P10598711A01
OBJECTIVE_NN :_: To_TO determine_VVI the_DD expression_NN of_II matrix_NN metalloproteinases_NNS (_( MMP_NN )_) -1_MC ,_, -2_MC ,_, and_CC -3_MC and_CC the_DD tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMP_NN )_) -1_MC ,_, -2_MC ,_, and_CC -3_MC in_II 12_MC tissue_NN samples_NNS from_II normal_JJ pituitary_NN glands_NNS and_CC in_II 28_MC human_NN pituitary_NN tumors_NNS ranging_VVG from_II Grade_NN 0_MC to_II Grade_NN IV_MC ,_, and_CC to_TO establish_VVI a_DD correlation_NN between_II the_DD level_NN of_II expression_NN of_II MMPs_NNS and_CC TIMPs_NNS and_CC the_DD tumor_NN grade_NN ._.
P10600941A05
Northern_NN blot_NN analyses_NNS revealed_VVD a_DD single_JJ approximately_RR 4.5-kb_NN mRNA_NN transcript_NN of_II MT-1-MMP_NN ,_, and_CC its_PNG expression_NN was_VBD developmentally_RR regulated_VVN ._.
P10601286A04
Evidence_NN of_II relatively_RR slow_JJ motion_NN indicative_JJ of_II exchange_NN between_II two_MC or_CC more_DD local_JJ conformations_NNS on_II a_DD microsecond_NN to_II millisecond_NN time_NN scale_NN was_VBD also_RR found_VVN in_II the_DD free_JJ protein_NN ,_, including_VVG two_MC other_JJ regions_NNS of_II the_DD MMP_NN binding_VVGJ site_NN (_( the_DD CD_NN and_CC EF_NN loops_NNS )_) ._.
P10611071A02
Expression_NN and_CC activation_NN mechanisms_NNS for_II proMMP-2_NN differ_VVB from_II other_JJ MMPs_NNS ;_: in_II many_DD cells_NNS proMMP-2_NN is_VBZ specifically_RR activated_VVN by_II membrane-type_NN (_( MT_NN )_) -MMPs_NNS ._.
P10616801A07
In_II contrast_NN ._.
P10617637A10
On_II the_DD other_JJ hand_NN ,_, the_DD inhibition_NN was_VBD not_RR seen_VVN after_II the_DD addition_NN of_II the_DD cyclic_JJ AMP-dependent_JJ kinase_NN inhibitor_NN ,_, H-8_NN ._.
P10620188A12
CONCLUSION_NN :_: We_PN conclude_VVB that_CST NO_NN modulates_VVZ cytokine-mediated_VVNJ expression_NN of_II MMP-9_NN and_CC TIMP-1_NN in_II rat_NN MCs_NNS in_II culture_NN ._.
P10620388A08
Galardin_NN significantly_RR reduced_VVD the_DD amounts_NNS of_II collagen_NN degraded_VVN by_II P._NN aeruginosa_NN culture_NN broth_NN ,_, whether_CS keratocytes_NNS were_VBD present_JJ or_CC absent_JJ in_II the_DD gel_NN ._.
P10621835A07
METHODS_NNS :_: The_DD synthesis_NN of_II proteinases_NNS and_CC their_PNG inhibitors_NNS was_VBD compared_VVN in_II paired_VVNJ tumour_NN and_CC normal_JJ tissue_NN samples_NNS from_II patients_NNS with_II colorectal_JJ cancer_NN (_( n_NN =_SYM 24_MC )_) ._.
P10623524A05
The_DD MMP-dependent_JJ conformational_JJ changes_NNS in_II the_DD ridge_NN include_VVB a_DD dramatic_JJ bending_VVGN of_II AB_NN loop_NN residues_NNS Glu28_NN through_II Leu34_NN ,_, moderate_JJ hinge_NN bending_VVGN of_II the_DD CD-loop_NN about_II residues_NNS Ala65_NN and_CC Cys70_NN ,_, and_CC modest_JJ bending_VVGN of_II the_DD Cys1_NN through_II Pro6_NN segment_NN ._.
P10623708A08
BAY_NN 12-9566_MC was_VBD well_RR tolerated_VVN on_II all_DD dose_NN schedules_NNS ,_, and_CC there_EX was_VBD no_DD consistent_JJ dose-limiting_VVGJ toxicity_NN that_PNR precluded_VVD treatment_NN in_II the_DD range_NN of_II dose_NN schedules_NNS evaluated_VVN ._.
P10625713A01
BACKGROUND_NN AND_CC PURPOSE_NN :_: Acute_JJ disruption_NN of_II atherosclerotic_JJ plaques_NNS precedes_VVZ the_DD onset_NN of_II clinical_JJ syndromes_NNS ,_, and_CC studies_NNS have_VHB implicated_VVN a_DD role_NN for_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) in_II this_DD process_NN ._.
P10628798A02
Altered_VVNJ expression_NN of_II matrix_NN degrading_VVGJ enzymes_NNS may_VM indicate_VVB an_DD increased_VVNJ potential_NN for_II invasive_JJ growth_NN ._.
P10633007A01
Tissue_NN injury_NN and_CC pelvic_JJ inflammation_NN often_RR results_VVZ in_II peritoneal_JJ scar_NN tissue_NN formation_NN ._.
P10634397A07
These_DD results_NNS define_VVB a_DD new_JJ additional_JJ mechanism_NN for_II the_DD control_NN of_II pituitary_NN hormone_NN secretion_NN and_CC indicate_VVB new_JJ potential_JJ therapeutic_JJ targets_NNS for_II pituitary_NN adenomas_NNS ._.
P10638966A05
Zymogram_NN analysis_NN revealed_VVD that_CST the_DD effects_NNS of_II the_DD growth_NN factors_NNS depended_VVD upon_II the_DD cell_NN lines_NNS used_VVN in_II the_DD study_NN ._.
P10642509A03
Both_CC fMT1-MMP_NN and_CC sMT1-MMP_NN expressed_VVN in_II the_DD expression_NN system_NN were_VBD found_VVN not_RR to_TO contain_VVI the_DD pro-domain_NN and_CC were_VBD able_JJ to_TO activate_VVI the_DD TIMP-2-free_JJ pro-MMP-2_NN ._.
P10642956A14
Active_JJ ,_, TIMP_NN free_JJ MMP2_NN levels_NNS were_VBD increased_VVN during_II PROM_NN (_( mean_NN 233_MC pg_NN /_SYM ml_NN )_) compared_VVN to_II those_PND at_II term_NN (_( mean_NN 132_MC pg_NN /_SYM ml_NN ;_: p_NN <_SYM 0.05_MC )_) or_CC PTL_NN (_( mean_NN 132_MC pg_NN /_SYM ml_NN ;_: p_NN <_SYM 0.05_MC )_) ._.
P10645258A07
MMP-2_NN reached_VVD a_DD peak_NN on_II day_NN 3_MC ,_, whereas_CS the_DD highest_JJT expression_NN of_II MMP-7_NN occurred_VVD on_II day_NN 7_MC ._.
P10650781A05
RESULTS_NNS :_: MMP-1_NN ,_, MMP-2_NN ,_, and_CC TIMP-2_NN were_VBD detected_VVN by_II immunohistochemistry_NN in_II 74_MC %_SYM (_( 113_MC /_SYM 154_MC )_) ,_, 32_MC %_SYM (_( 49_MC /_SYM 154_MC )_) ,_, and_CC 80_MC %_SYM (_( 107_MC /_SYM 154_MC )_) of_II the_DD tumor_NN samples_NNS ,_, respectively_RR ._.
P10657374A02
METHODS_NNS :_: Quantitative_JJ reverse_JJ transcription-PCR_NN /_SYM ELISA_NN assays_NNS were_VBD performed_VVN for_II MMP_NN and_CC TIMP_NN RNA_NN ,_, and_CC corresponding_VVGJ circulating_VVGJ protein_NN concentrations_NNS were_VBD studied_VVN by_II ELISA_NN in_II 20_MC healthy_JJ controls_NNS ,_, 40_MC patients_NNS with_II CAH_NN ,_, and_CC 20_MC patients_NNS with_II hepatitis_NN C-induced_VVNJ cirrhosis_NN (_( Ci_NN )_) ._.
P10664012A06
Since_CS MMP-1_NN and_CC -2_MC are_VBB considered_VVN to_TO be_VBI major_JJ enzymes_NNS involved_VVN in_II the_DD degradation_NN of_II matrix_NN components_NNS ,_, the_DD accumulation_NN of_II elastotic_JJ materials_NNS in_II actinic_JJ elastosis_NN may_VM be_VBB related_VVN to_II the_DD degradation_NN process_NN ._.
P10664501A02
Doxycycline_NN (_( Dox_NN )_) has_VHZ direct_JJ MMP-inhibiting_VVGJ properties_NNS in_RR+ vitro_RR ,_, and_CC it_PN effectively_RR suppresses_VVZ the_DD development_NN of_II elastase-induced_VVNJ AAAs_NNS in_II rodents_NNS ._.
P10670469A02
METHODS_NNS :_: Expression_NN of_II transcripts_NNS and_CC proteins_NNS of_II MMPs_NNS ,_, TIMPs_NNS ,_, and_CC urokinase_NN plasminogen_NN activator_NN (_( uPA_NN )_) by_II cultured_VVNJ normal_JJ human_NN conjunctival_JJ and_CC conjunctivochalasis_NN fibroblasts_NNS was_VBD determined_VVN by_II Northern_NN hybridization_NN ,_, enzyme-linked_VVNJ immunosorbent_JJ assay_NN (_( ELISA_NN )_) ,_, and_CC Western_NN blot_NN analysis_NN ,_, respectively_RR ._.
P10675223A08
The_DD data_NNS show_VVB that_CST (_( 1_MC )_) MMP-9_NN activity_NN is_VBZ present_JJ in_II the_DD CSF_NN of_II patients_NNS with_II neuroborreliosis_NN ,_, (_( 2_MC )_) macrophages_NNS stimulated_VVN with_II B_NN burgdorferi_NN are_VBB a_DD possible_JJ source_NN of_II MMP-9_NN increase_NN ,_, and_CC (_( 3_MC )_) activation_NN of_II NF-kappaB_NN may_VM play_VVB a_DD part_NN in_II the_DD upregulation_NN of_II MMP-9_NN by_II B_NN burgdorferi_NN ._.
P10679106A02
Animal_NN models_NNS have_VHB shown_VVN that_CST lipoxin_NN A4_NN (_( LXA4_NN )_) down-regulates_VVZ inflammation_NN in_RR+ vivo_RR ._.
P10682680A12
In_II previous_JJ studies_NNS we_PN have_VHB shown_VVN that_CST exposure_NN of_II normal_JJ skin_NN to_II epidermal_JJ growth_NN factor_NN in_II organ_NN culture_NN induces_VVZ MMP_NN up-regulation_NN and_CC activation_NN ._.
P10689021A12
Western_NN blot_NN analysis_NN showed_VVD the_DD presence_NN of_II MMP-7_NN and_CC MMP-9_NN in_II menstrual_JJ serum_NN ._.
P10697171A07
Two_MC animals_NNS at_II a_DD time_NN were_VBD reanesthetized_VVN ,_, and_CC all_DD eight_MC wounds_NNS on_II each_DD animal_NN were_VBD excised_VVN at_II 12_MC and_CC 24_MC hours_NNS and_CC at_II 2_MC ,_, 3_MC ,_, 5_MC ,_, 7_MC ,_, 10_MC ,_, and_CC 14_MC days_NNS after_II injury_NN ._.
P10706098A10
MT6-MMP_NN was_VBD also_RR detected_VVN at_II high_JJ levels_NNS in_II SW480_NN colon_NN carcinoma_NN cells_NNS as_CC+ well_CC+ as_CC in_II some_DD anaplastic_JJ astrocytomas_NNS and_CC glioblastomas_NNS ,_, but_CC not_RR in_II normal_JJ colon_NN or_CC brain_NN or_CC in_II meningiomas_NNS ._.
P10706134A09
In_II parallel_NN with_II MMP-9_NN up-regulation_NN ,_, all_DD EGF-like_JJ ligands_NNS increased_VVD tumor_NN cell_NN invasion_NN through_II Matrigel_NN in_II in_JJ+ vitro_JJ Transwell_NN assays_NNS ._.
P10709099A05
TIMP-2_NN values_NNS could_VM not_RR be_VBB measured_VVN ._.
P10712992A01
BACKGROUND_NN :_: A_DD central_JJ feature_NN in_II the_DD pathogenesis_NN of_II COPD_NN is_VBZ the_DD inflammation_NN coexisting_VVG with_II an_DD abnormal_JJ protease_NN /_SYM antiprotease_NN balance_NN ._.
P10716770A02
Ten_MC SCI_NN subjects_NNS participated_VVN in_II an_DD 18-month_NN program_NN of_II functional_JJ electrical_JJ stimulation_NN (_( FES_NN )_) of_II their_PNG leg_NN muscles_NNS ._.
P10719361A06
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB believed_VVN to_TO be_VBI the_DD main_JJ mediators_NNS of_II ECM_NN degradation_NN ._.
P10726683A08
The_DD ratio_NN of_II MMP-2_NN /_SYM TIMP-2_NN mRNAs_NNS was_VBD significantly_RR higher_JJR in_II the_DD advanced_VVNJ stages_NNS versus_CC early_JJ stages_NNS (_( mean_NN +/-_SYM SD_NN =_SYM 1.66_MC +/-_SYM 0.65_MC and_CC 1.11_MC +/-_SYM 0.34_MC ,_, respectively_RR ;_: P_NN =_SYM .02_MC )_) and_CC in_II patients_NNS who_PNR died_VVD of_II progressive_JJ disease_NN versus_CC alive_JJ patients_NNS (_( mean_NN =_SYM 2.13_MC +/-_SYM 0.78_MC and_CC 1.21_MC +/-_SYM 0.36_MC ,_, respectively_RR ;_: P_NN =_SYM .0006_MC )_) ._.
P10727268A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB implicated_VVN in_II the_DD degradation_NN of_II extracellular_JJ matrix_NN ;_: they_PN play_VVB important_JJ roles_NNS in_II the_DD invasion_NN of_II the_DD trophoblast_NN cell_NN into_II the_DD maternal_JJ endometrium_NN during_II placentation_NN ._.
P10727268A16
The_DD same_JJ cytotrophoblast_NN cells_NNS that_PNR produced_VVD MMPs_NNS could_VM also_RR secrete_VVB various_JJ substrates_NNS for_II these_DD enzymes_NNS ._.
P10728589A03
MT1-MMP_NN expression_NN is_VBZ accompanied_VVN by_II the_DD functional_JJ activation_NN of_II integrin_NN alphaVbeta3_NN ,_, thereby_RR increasing_VVG vitronectin-mediated_VVNJ adhesion_NN and_CC migration_NN of_II MCF7_NN cells_NNS transfected_VVN with_II MT1-MMP_NN and_CC integrin_NN alphaVbeta3_NN ._.
P10731089A06
MMP_NN and_CC TIMP_NN messages_NNS were_VBD detected_VVN using_VVG RT-PCR_NN with_II specific_JJ primers_NNS to_II MMPs_NNS 2_MC ,_, 3_MC ,_, 7_MC ,_, 9_MC and_CC 13_MC and_CC TIMPs_NNS 1_MC and_CC 2_MC ._.
P10731924A08
Immunoreactivity_NN for_II COX-2_NN was_VBD predominantly_RR noted_VVN in_II macrophages_NNS and_CC smooth_JJ muscle_NN cells_NNS (_( SMCs_NNS )_) of_II the_DD intima_NN including_VVG atherosclerotic_JJ plaque_NN itself_PN and_CC the_DD medial_JJ layer_NN of_II the_DD plaque_NN base_NN ,_, as_CC+ well_CC+ as_CC in_II SMCs_NNS and_CC endothelial_JJ lining_VVGN of_II the_DD vasa_NN vasorum_NN in_II the_DD adventitia_NN ._.
P10736239A05
We_PN observed_VVD a_DD high_JJ degree_NN of_II coexpression_NN of_II MT2-MMP_NN ,_, MT1-MMP_NN and_CC MMP-2_NN mRNAs_NNS in_II single_JJ extravillous_JJ cytotrophoblasts_NNS that_PNR had_VHD invaded_VVD the_DD endometrium_NN and_CC tubal_JJ wall_NN ._.
P10737720A02
We_PN determined_VVD the_DD production_NN of_II active_JJ MMP-2_NN in_II five_MC glial_JJ (_( U138MG_NN ,_, U373MG_NN ,_, A172_NN ,_, C6_NN ,_, GOS-3_NN )_) ,_, two_MC neuronal_JJ (_( SK-N-SH_NN ,_, SK-N-MC_NN )_) ,_, and_CC two_MC pluripotent_JJ cell_NN lines_NNS with_II facultative_JJ neuronal_JJ and_CC glial_JJ differentiation_NN (_( P19_NN and_CC NT2_NN )_) by_II gelatin_NN zymography_NN ._.
P10745174A01
In_II order_NN to_TO evaluate_VVI the_DD significance_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) in_II predicting_VVGN the_DD metastatic_JJ potential_NN of_II oral_JJ squamous_JJ cell_NN carcinomas_NNS (_( SCCs_NNS )_) ,_, we_PN compared_VVD MMP-2_NN and_CC -9_MC expression_NN in_II 19_MC metastasizing_VVGJ oral_JJ SCCs_NNS with_II that_PND in_II 25_MC non-metastasizing_VVGJ cases_NNS by_II immunohistochemistry_NN and_CC gelatin_NN zymography_NN ._.
P10747288A06
The_DD p53_NN level_NN was_VBD measured_VVN by_II western_NN blot_NN analysis_NN ._.
P10760816A04
The_DD ability_NN of_II cells_NNS to_TO invade_VVI through_II Matrigel_NN was_VBD found_VVN to_TO be_VBI higher_JJR in_II the_DD EGFR_NN overexpressing_VVGJ cell_NN lines_NNS (_( p_NN <_SYM 0._MC 0001_MC )_) ._.
P10764764A08
The_DD NF-Y_NN and_CC the_DD Sp1_NN binding_VVGJ site_NN are_VBB both_PND involved_VVN in_II cAMP-dependent_JJ up-regulation_NN of_II TIMP-2_NN ._.
P10765925A14
By_II this_DD mechanism_NN ,_, CaPPS_NN may_VM be_VBB able_JJ to_TO modulate_VVI joint_NN tissue_NN destruction_NN in_II rheumatoid_JJ arthritis_NN ._.
P10766841A07
Consistently_RR ,_, TIMP-2_NN enhanced_VVD the_DD activation_NN of_II pro-MMP-2_NN by_II MT1-MMP_NN ._.
P10772252A08
The_DD addition_NN of_II cytokines_NNS to_TO stimulate_VVI bone_NN resorption_NN resulted_VVD in_II pronounced_VVNJ TRAP_NN activity_NN along_II bone_NN surfaces_NNS ,_, indicating_VVG active_JJ resorption_NN ._.
P10773235A12
MMP-8_NN and_CC MMP-14_NN protein_NN levels_NNS increased_VVD later_RR during_II heart_NN failure_NN progression_NN ._.
P10775672A06
Immunohistochemical_JJ techniques_NNS were_VBD used_VVN to_TO show_VVI the_DD pattern_NN and_CC distribution_NN of_II MMPs_NNS and_CC TIMP_NN proteins_NNS in_II the_DD muscle_NN ._.
P10780671A08
This_DD effect_NN was_VBD observed_VVN also_RR under_II conditions_NNS of_II angiogenic_JJ stimulation_NN by_II basic_JJ fibroblast_NN growth_NN factor_NN ._.
P10792961A13
Increased_VVNJ expression_NN of_II TIMP-1_NN was_VBD noted_VVN in_II vein_NN grafts_NNS from_II both_CC the_DD treated_VVNJ and_CC the_DD control_NN groups_NNS ,_, 7_MC and_CC 28_MC days_NNS following_VVG graft_NN placement_NN ._.
P10793352A09
TIMP-1_NN was_VBD expressed_VVN in_II all_DD specimens_NNS ._.
P10793622A08
Apoptosis_NN was_VBD identified_VVN by_II morphological_JJ criteria_NNS and_CC also_RR by_II TdT-mediated_VVNJ dUTP_NN nick_NN end_NN labelling_VVGN ._.
P10807502A05
Prostaglandin_NN E2_NN (_( PGE2_NN )_) was_VBD measured_VVN by_II an_DD enzyme_NN immunoassay_NN ._.
P10808169A12
It_PN was_VBD suggested_VVN that_CST overproduction_NN of_II MMP-9_NN and_CC TIMP-1_NN after_II asthma_NN exacerbation_NN might_VM contribute_VVB significantly_RR to_II airway_NN tissue_NN remodeling_VVGN and_CC that_CST TIMP-1_NN production_NN in_II acute_JJ asthma_NN might_VM not_RR be_VBB suppressed_VVN by_II glucocorticosteroid_NN ._.
P10820340A06
Localization_NN of_II gelatinase_NN activity_NN was_VBD also_RR confirmed_VVN in_II carcinoma_NN cells_NNS by_II in_JJ+ situ_JJ zymography_NN ._.
P10831344A09
CONCLUSION_NN :_: Using_VVG an_DD in_JJ+ situ_JJ hybridization_NN technique_NN ,_, we_PN disclosed_VVD a_DD direct_JJ correlation_NN between_II the_DD presence_NN of_II mRNA_NN and_CC protein_NN expression_NN for_II both_CC MMP-9_NN and_CC TIMP-1_NN ._.
P10834863A07
MMP-7_NN and_CC MMP-13_NN were_VBD detectable_JJ in_II more_RR than_CSN 45_MC %_SYM of_II RA_NN SFs_NNS and_CC in_II less_RR than_CSN 20_MC %_SYM of_II OA_NN SFs_NNS ,_, respectively_RR ._.
P10845554A01
Sixty_MC human_NN brain_NN tumors_NNS ,_, classified_VVN according_II+ to_II the_DD New_JJ World_NN Health_NN Organization_NN (_( WHO_NN )_) classification_NN including_VVG ,_, grade_NN I_MC schwannomas_NNS ,_, meningiomas_NNS and_CC pilocytic_JJ astrocytomas_NNS ,_, grade_NN II_MC astrocytomas_NNS ,_, grade_NN III_MC anaplastic_JJ astrocytomas_NNS ,_, grade_NN IV_MC glioblastomas_NNS ,_, grade_NN III_MC anaplastic_JJ oligodendrogliomas_NNS and_CC grade_NN IV_MC glioblastomas_NNS and_CC lung_NN and_CC melanoma_NN metastases_NNS were_VBD analyzed_VVN for_II the_DD expression_NN of_II three_MC matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ,_, two_MC tissue_NN inhibitors_NNS of_II MMPs_NNS (_( TIMPs_NNS )_) and_CC for_II MMP_NN activity_NN ._.
P10845563A03
In_II this_DD paper_NN we_PN examined_VVD the_DD effects_NNS of_II ligands_NNS with_II different_JJ c-erbB_NN receptor_NN specificities_NNS in_II terms_NNS of_II their_PNG stimulation_NN of_II HNSCC_NN proliferation_NN ,_, expression_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC invasion_NN ._.
P10845589A05
Cultured_VVNJ epithelial_JJ cells_NNS and_CC their_PNG supernatants_NNS were_VBD also_RR treated_VVN with_II doxycycline_NN before_CS MMP-3_NN was_VBD added_VVN ._.
P10856282A11
We_PN hypothesize_VVB a_DD potential_JJ role_NN for_II 8-iso-PGF_NN (_( 2alpha_NN )_) in_II the_DD reduced_VVNJ trophoblast_NN invasion_NN in_II preeclampsia_NN ._.
P10859268A01
Satisfactory_JJ development_NN of_II bovine_JJ follicles_NNS in_RR+ vitro_RR remains_VVZ elusive_JJ ._.
P10861227A03
Increased_VVNJ secretion_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) correlates_VVZ with_II transformation_NN of_II colon_NN epithelial_JJ cells_NNS ._.
P10861447A02
Binding_VVGN of_II MMP-2_NN to_II integrin_NN alpha_NN (_( v_MC )_) beta_NN (_( 3_MC )_) has_VHZ been_VBN implicated_VVN in_II presenting_VVGN activated_VVNJ MMP-2_NN on_II the_DD cell_NN surface_NN of_II invasive_JJ cells_NNS ,_, but_CC interactions_NNS with_II the_DD MT1-MMP-TIMP-2_NN system_NN have_VHB not_RR been_VBN considered_VVN ._.
P10861469A06
Transcripts_NNS of_II membrane-type_NN matrix_NN metalloproteinase-1_NN (_( MT1-MMP_NN )_) ,_, which_PNR is_VBZ thought_VVN to_TO be_VBI present_JJ on_II the_DD cell_NN surface_NN and_CC to_TO work_VVI as_II a_DD candidate_NN activator_NN of_II MMP-2_NN ,_, were_VBD detected_VVN in_II both_DD cancer_NN cell_NN lines_NNS ._.
P10873619A02
The_DD degradation_NN of_II the_DD extracellular_JJ matrix_NN (_( ECM_NN )_) by_II specialized_VVNJ matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) is_VBZ another_DD major_JJ step_NN in_II tumor_NN invasion_NN and_CC metastasis_NN ._.
P10878545A06
Cell_NN surface_NN expression_NN level_NN of_II MT1-MMP_NN ,_, as_CS determined_VVN by_II flow_NN cytometry_NN ,_, was_VBD similar_JJ on_II all_DD cell_NN lines_NNS ._.
P10882449A02
We_PN measured_VVD the_DD levels_NNS of_II MMPs_NNS ,_, specific_JJ tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) ,_, and_CC interleukin-6_NN (_( IL-6_NN )_) in_II synovial_JJ fluid_NN from_II the_DD knees_NNS of_II 36_MC patients_NNS with_II cartilage_NN lesions_NNS subdivided_VVN according_II+ to_II severity_NN based_VVN on_II arthroscopic_JJ findings_NNS ._.
P10885745A11
These_DD data_NNS suggest_VVB a_DD mechanism_NN by_II which_PNR Pax-6_NN may_VM direct_VVB gelB_NN expression_NN in_II an_DD eye-specific_JJ manner_NN ._.
P10889296A15
K1_NN and_CC K6_NN were_VBD negative_JJ for_II Neurokinin_NN 1_MC receptor_NN (_( NK1-R_NN )_) but_CC positive_JJ for_II Calcitonin_NN gene_NN related_VVNJ peptide_NN receptor_NN type_NN 1_MC (_( CGRP-1R_NN )_) and_CC Calcitonin_NN gene_NN related_VVNJ peptide_NN receptor_NN component_NN protein_NN (_( CGRP-RCP_NN )_) ._.
P10890358A01
The_DD human_NN retrovirus_NN HTLV-I_NN is_VBZ responsible_JJ for_II the_DD chronic_JJ progressive_JJ myelopathy_NN ,_, TSP_NN /_SYM HAM_NN ,_, characterized_VVN by_II the_DD presence_NN of_II infiltrated_VVNJ T_NN lymphocytes_NNS ,_, cytokines_NNS ,_, and_CC matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) within_II spinal_JJ cord_NN lesions_NNS ._.
P10896779A05
Since_CS MMP_NN expression_NN is_VBZ thus_RR necessary_JJ for_II myoblast_NN migration_NN ,_, we_PN have_VHB undertaken_VVN the_DD identification_NN and_CC characterization_NN of_II the_DD MMPs_NNS expressed_VVN by_II the_DD C_NN (_( 2_MC )_) C_NN (_( 12_MC )_) cell_NN line_NN ._.
P10910039A03
We_PN have_VHB called_VVN this_DD type_NN of_II movement_NN "_`` cohort_NN migration_NN "_'' and_CC developed_VVN a_DD two-dimensional_JJ in_JJ+ vitro_JJ cohort_NN migration_NN model_NN ,_, in_II which_PNR human_NN rectal_JJ well-differentiated_VVNJ adenocarcinoma_NN cells_NNS (_( L-10_NN )_) migrate_VVB from_II piled-up_JJ cell_NN islands_NNS as_II coherent_JJ sheets_NNS of_II cells_NNS when_CS stimulated_VVN with_II hepatocyte_NN growth_NN factor_NN /_SYM scatter_NN factor_NN ._.
P10913401A03
CSF_NN levels_NNS of_II MMP-9_NN were_VBD higher_JJR (_( P_NN <_SYM .05_MC )_) in_II 5_MC patients_NNS who_PNR developed_VVD hearing_VVGJ impairment_NN or_CC secondary_JJ epilepsy_NN than_CSN in_II those_PND who_PNR recovered_VVD without_II neurological_JJ deficits_NNS ._.
P10919715A09
Expression_NN of_II MMP-1_NN ,_, 2_MC ,_, 3_MC ,_, 10_MC ,_, 14_MC and_CC 17_MC showed_VVD no_DD correlation_NN to_II capacity_NN to_TO infiltrate_VVI ._.
P10922168A02
All_DD patients_NNS were_VBD fully_RR investigated_VVN ,_, by_II visual_JJ analogue_NN pain_NN scores_NNS ,_, plain_JJ radiographs_NNS and_CC double-contrast_NN arthrotomograms_NNS ._.
P10930399A09
These_DD results_NNS support_VVB the_DD hypothesis_NN of_II an_DD impaired_VVNJ thrombolytic_JJ potential_NN of_II MMP-degraded_VVNJ Factor_NN XII_MC in_RR+ vivo_RR ._.
P10935492A08
Stable_JJ expression_NN of_II this_DD construct_NN in_II ER_NN negative_JJ squamous_JJ cell_NN carcinoma_NN (_( SCC_NN )_) lines_NNS produced_VVD an_DD estradiol_NN dependent_JJ decrease_NN in_II the_DD number_NN of_II cells_NNS that_PNR migrated_VVD through_II a_DD reconstituted_VVNJ basement_NN membrane_NN ._.
P10937947A11
To_TO estimate_VVI a_DD putative_JJ role_NN of_II these_DD gelatinases_NNS ,_, several_JJ sarcomeric_JJ contractile_JJ proteins_NNS were_VBD digested_VVN in_RR+ vitro_RR by_II purified_VVNJ active_JJ MMP-9_NN ._.
P10937974A09
A_DD number_NN of_II bioactive_JJ peptides_NNS and_CC cytokines_NNS influence_VVB MMP_NN and_CC TIMP_NN expression_NN and_CC activity_NN ._.
P10946762A10
This_PND could_VM be_VBB blocked_VVN using_VVG a_DD human_NN recombinant_JJ anti-SF_NN antibody_NN ._.
P10952170A10
These_DD data_NNS are_VBB consistent_JJ with_II the_DD concept_NN that_CST regulation_NN of_II matrix_NN turnover_NN via_II MMP-9_NN may_VM be_VBB involved_VVN in_II the_DD events_NNS leading_VVG to_II myotube_NN formation_NN ,_, including_VVG migration_NN ._.
P10958381A04
In_II the_DD present_JJ study_NN ,_, we_PN investigated_VVD the_DD effect_NN of_II heparin_NN and_CC related_VVNJ glycosaminoglycans_NNS on_II PDGF-induced_VVNJ lung_NN fibroblast_NN proliferation_NN and_CC chemotactic_JJ response_NN in_RR+ vitro_RR ._.
P10960024A10
RESULTS_NNS :_: Tiludronate_NN significantly_RR inhibited_VVN both_CC MMP-1_NN and_CC MMP-3_NN activity_NN in_II a_DD concentration-dependent_JJ manner_NN ._.
P10969041A06
Efficacy_NN of_II hTIMP-1_NN gene_NN transfer_NN was_VBD assessed_VVN both_CC by_II ELISA_NN on_II bronchoalveolar_JJ lavages_NNS and_CC by_II hTIMP-1_NN immunofluorescence_NN on_II lung_NN sections_NNS ._.
P10969817A14
This_DD work_NN highlights_VVZ the_DD role_NN played_VVN by_II COX_NN in_II disturbing_VVGN the_DD balance_NN between_II MMPs_NNS and_CC TIMPs_NNS in_II prostate_NN cancer_NN cells_NNS ,_, and_CC it_PN points_VVZ to_II the_DD potential_JJ use_NN of_II COX_NN inibitors_NNS ,_, especially_RR COX-2_NN selective_JJ inhibitors_NNS ,_, in_II the_DD prevention_NN and_CC therapy_NN of_II prostate_NN cancer_NN invasion_NN ._.
P10971173A08
Gene_NN expression_NN was_VBD determined_VVN by_II band_NN densitometry_NN ._.
P10980128A13
Thus_RR ,_, the_DD present_JJ studies_NNS indicate_VVB that_CST MMPs_NNS and_CC TN-C_NN play_VVB a_DD role_NN in_II elastin-oriented_VVNJ calcification_NN ._.
P10984375A04
OBJECTIVE_NN :_: To_TO study_VVI the_DD effects_NNS of_II PAR-2-mediated_VVNJ airway_NN epithelial_JJ cell_NN activation_NN on_II the_DD production_NN of_II MMP-9_NN ._.
P10985432A10
These_DD results_NNS provide_VVB support_NN for_II the_DD idea_NN that_CST temporospatially_RR controlled_VVNJ interactions_NNS between_II MMPs_NNS and_CC their_PNG substrates_NNS may_VM be_VBB pivotal_JJ in_II modulating_VVGN events_NNS in_II palatal_JJ morphogenesis_NN ._.
P10995877A08
With_II respect_NN to_II clinical_JJ stage_NN ,_, the_DD triple_JJ diffuse_JJ positive_JJ rate_NN in_II advanced-stage_NN (_( stage_NN II_MC /_SYM III_MC /_SYM IV_MC )_) carcinomas_NNS was_VBD significantly_RR higher_JJR than_CSN that_PND in_II early-stage_NN (_( stage_NN I_MC )_) carcinomas_NNS ._.
P10997695A07
In_II contrast_NN transforming_VVGJ growth_NN factor_NN (_( TGF_NN )_) -beta_NN can_VM decrease_VVB MMP_NN expression_NN ._.
P11005153A08
Salivary_JJ MMP_NN levels_NNS and_CC activities_NNS in_II type_NN 2_MC diabetic_JJ patients_NNS were_VBD in_II general_NN similar_JJ to_II those_PND in_II the_DD control_NN group_NN ._.
P11007798A01
The_DD tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) are_VBB a_DD family_NN of_II four_MC secreted_VVNJ inhibitors_NNS of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ._.
P11007969A06
Increased_VVNJ plasma_NN membrane_NN and_CC secreted_VVNJ MMP_NN activities_NNS were_VBD found_VVN in_II primary_JJ WR_NN astrocytes_NNS ._.
P11010969A02
Biochemical_JJ and_CC immunological_JJ characterization_NN of_II the_DD purified_VVNJ enzyme_NN demonstrated_VVD that_CST it_PN is_VBZ distinct_JJ from_II the_DD chicken_NN 72-kDa_NN gelatinase_NN A_NN (_( MMP-2_NN )_) ._.
P11020282A06
Some_DD N-hydroxysulfonamides_NNS also_RR showed_VVD inhibitory_JJ properties_NNS (_( in_II the_DD micromolar_JJ range_NN )_) against_II MMP-1_NN ,_, MMP-2_NN ,_, MMP-8_NN ,_, MMP-9_NN ,_, and_CC ChC_NN ._.
P11025397A03
The_DD present_JJ study_NN investigates_VVZ the_DD effects_NNS of_II the_DD synthetic_JJ MMP_NN inhibitor_NN batimastat_NN (_( BB94_NN )_) on_II vascular_JJ SMCs_NNS ._.
P11027004A09
MMP-9_NN was_VBD not_RR detectable_JJ in_II the_DD media_NN of_II corticosteroid-treated_VVNJ explant_NN organ_NN cultures_NNS ._.
P11027427A06
HGF_NN /_SYM SF_NN stimulated_VVD the_DD expression_NN of_II MMP-1_NN ,_, 9_MC and_CC MT1-MMP_NN and_CC had_VHD a_DD slight_JJ effect_NN on_II expression_NN of_II the_DD MMP_NN inhibitor_NN TIMP-1_NN but_CC not_RR TIMP-2_NN ._.
P11033124A03
At_II 0_MC ,_, 6_MC ,_, 24_MC ,_, 48_MC ,_, and_CC 72_MC hours_NNS after_II wounding_VVGN ,_, mRNA_NN expression_NN of_II 72_MC kDa_NN type_NN gelatinase_NN (_( MMP-2_NN )_) ,_, 92_MC kDa_NN type_NN gelatinase_NN (_( MMP-9_NN )_) ,_, and_CC tissue_NN inhibitor_NN of_II matrix_NN metalloproteinases-1_NN (_( TIMP-1_NN )_) were_VBD analyzed_VVN by_II reverse_JJ transcription_NN polymerase_NN chain_NN reaction_NN in_II those_DD corneas_NNS ._.
P11038285A12
The_DD sensitivity_NN of_II this_DD ELISA-like_JJ assay_NN is_VBZ comparable_JJ to_II that_PND of_II gelatin_NN zymography_NN ,_, a_DD method_NN widely_RR used_VVN to_TO detect_VVI gelatinases_NNS ._.
P11040401A04
Palatal_JJ shelves_NNS were_VBD harvested_VVN at_II embryonic_JJ days_NNS (_( E_NN )_) 15_MC ,_, 16_MC and_CC 17_MC as_CC+ well_CC+ as_CC post-partum_NN ._.
P11042184A07
TIMP-2_NN induces_VVZ a_DD decrease_NN in_II phosphorylation_NN of_II EGFR_NN and_CC a_DD concomitant_JJ reduction_NN in_II Grb-2_NN association_NN ._.
P11044166A02
MMP-2_NN is_VBZ a_DD major_JJ protease_NN in_II the_DD wall_NN of_II small_JJ aneurysms_NNS and_CC is_VBZ produced_VVN at_II increased_VVNJ levels_NNS by_II smooth_JJ muscle_NN cells_NNS derived_VVN from_II AAAs_NNS compared_VVN with_II normal_JJ controls_NNS ._.
P11044366A01
Elevated_VVNJ expression_NN of_II type_NN IV_MC collagenases_NNS (_( MMP-2_NN and_CC MMP-9_NN )_) has_VHZ been_VBN strongly_RR correlated_VVN with_II tumour_NN progression_NN and_CC metastasis_NN in_II various_JJ tumours_NNS ._.
P11044467A08
Secretion_NN of_II the_DD tissue_NN inhibitor_NN of_II MMPs-9_NN (_( TIMP-1_NN )_) was_VBD not_RR significantly_RR different_JJ between_II untreated_VVNJ (_( 3.07_MC +/-_SYM 0.266_MC microg_NN /_SYM ml_NN /_SYM 24_MC h_NN )_) and_CC FBS-treated_VVNJ (_( 3._MC 85_MC +/-_SYM 0.24_MC microg_NN /_SYM ml_NN /_SYM 24_MC h_NN )_) cultures_NNS during_II the_DD first_JJ 4_MC days_NNS in_II culture_NN ._.
P11048298A06
Both_PND are_VBB characterized_VVN with_II the_DD accumulation_NN of_II active_JJ inflammatory_JJ cells_NNS ,_, matrix_NN remodeling_VVGN and_CC epithelial_JJ changes_NNS ._.
P11053050A01
Mammalian_JJ kidney_NN development_NN is_VBZ initiated_VVN by_II the_DD mutual_JJ interaction_NN between_II embryonic_JJ metanephric_JJ mesenchyme_NN (_( MM_NN )_) and_CC the_DD ureteric_JJ bud_NN (_( UB_NN )_) ,_, leading_VVG to_II tightly_RR controlled_VVNJ UB_NN branching_VVGJ morphogenesis_NN ._.
P11058543A04
We_PN demonstrated_VVD villous_JJ trophoblast_NN expression_NN of_II both_CC MMP-2_NN and_CC MMP-9_NN by_II in_JJ+ situ_JJ immunohistochemistry_NN and_CC by_II Western_NN blot_NN analysis_NN and_CC zymography_NN of_II lysates_NNS and_CC culture_NN supernatants_NNS of_II highly_RR purified_VVNJ villous_JJ CTs_NNS ._.
P11058950A01
OBJECTIVE_NN :_: To_TO study_VVI the_DD effect_NN of_II hypoxia_NN on_II the_DD expression_NN and_CC activity_NN of_II matrix_NN metalloproteinase-2_NN (_( MMP-2_NN )_) in_II the_DD hepatic_JJ stellate_JJ cell_NN (_( HSC_NN )_) ._.
P11062605A12
Of_II the_DD 21_MC non-RA_NN patients_NNS ,_, seven_MC had_VHD a_DD spondylarthropathy_NN and_CC 14_MC had_VHD undifferentiated_VVNJ arthritis_NN ._.
P11062605A28
Although_CS serum_NN MMP-2_NN levels_NNS were_VBD not_RR of_II prognostic_JJ value_NN ,_, high_JJ synovial_JJ tissue_NN levels_NNS of_II MMP-2_NN activity_NN were_VBD significantly_RR correlated_VVN with_II the_DD presence_NN of_II early_JJ erosions_NNS ._.
P11062755A01
Structural_JJ changes_NNS in_II the_DD extracellular_JJ matrix_NN (_( ECM_NN )_) are_VBB necessary_JJ for_II cell_NN migration_NN during_II tissue_NN remodeling_VVGN and_CC local_JJ neoplastic_JJ cell_NN invasion_NN ._.
P11069839A08
The_DD characteristic_JJ contributions_NNS of_II matrix-degrading_VVGJ proteins_NNS may_VM relate_VVB to_II the_DD distinct_JJ prognostic_JJ features_NNS of_II these_DD diseases_NNS ._.
P11075535A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB important_JJ enzymes_NNS found_VVN in_II connective_JJ tissues_NNS and_CC thought_VVN to_TO be_VBI involved_VVN in_II cartilage_NN degradation_NN ._.
P11085528A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB overexpressed_VVN in_II a_DD variety_NN of_II tumor_NN tissues_NNS and_CC cell_NN lines_NNS ,_, and_CC their_PNG expression_NN is_VBZ highly_RR correlated_VVN to_II tumor_NN invasion_NN and_CC metastasis_NN ._.
P11092396A02
We_PN investigated_VVD if_CST these_DD changes_NNS might_VM be_VBB mediated_VVN by_II remodeling_VVGN of_II ECM_NN ,_, and_CC we_PN focused_VVD our_PNG study_NN on_II the_DD neutral_JJ metalloproteinases_NNS (_( MMPs_NNS )_) ,_, known_VVNJ agents_NNS of_II matrix_NN remodeling_VVGN ,_, and_CC on_II their_PNG tissue_NN inhibitors_NNS (_( TIMPs_NNS )_) ._.
P11095607A02
The_DD purpose_NN of_II this_DD study_NN was_VBD to_TO determine_VVI the_DD expression_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC tissue_NN inhibitors_NNS of_II MMPs_NNS (_( TIMPs_NNS )_) at_II the_DD advancing_VVGJ pterygium_NN edge_NN ._.
P11095911A02
In_II the_DD present_JJ study_NN ,_, we_PN therefore_RR investigated_VVD a_DD possible_JJ role_NN of_II matrix_NN metalloproteinases_NNS in_II cataract_NN and_CC posterior_JJ capsule_NN opacification_NN ._.
P11097207A13
Alternatively_RR collagenase-1_NN production_NN by_II mast_JJ cells_NNS may_VM play_VVB a_DD critical_JJ role_NN in_II cell_NN invasion_NN and_CC migration_NN into_II sites_NNS of_II inflammation_NN ._.
P11101274A01
Rats_NNS were_VBD studied_VVN to_TO determine_VVI if_CST matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC tissue_NN inhibitors_NNS of_II MMPs_NNS (_( TIMPs_NNS )_) were_VBD detectable_JJ in_II developing_VVGJ embryonic_JJ and_CC uterine_JJ tissues_NNS during_II the_DD implantation_NN period_NN ;_: that_PND is_VBZ ,_, Days_NNS 6-8_MC of_II pregnancy_NN ._.
P11104745A10
CONCLUSIONS_NNS :_: MMP-9_NN induction_NN is_VBZ associated_VVN with_II the_DD formation_NN of_II intimal_JJ hyperplasia_NN and_CC does_VDZ not_RR require_VVB frank_JJ mechanical_JJ injury_NN ._.
P11106565A09
Proteolysis_NN was_VBD localized_VVN to_II infiltrating_VVGJ leukocytes_NNS in_II diseased_VVNJ severe_JJ combined_VVNJ immunodeficient_JJ mice_NNS ._.
P11112863A08
Importantly_RR ,_, although_CS less_RR frequently_RR detectable_JJ than_CSN pro-MMP-9_NN ,_, pro-_JJ MMP-2_NN (_( 72_MC kD_NN )_) was_VBD found_VVN more_RR frequently_RR in_II asthmatics_NNS (_( 50_MC %_SYM )_) than_CSN in_II control_NN subjects_NNS (_( 5_MC %_SYM )_) (_( p_NN <_SYM 0._MC 005_MC )_) ._.
P11115151A01
Wound_NN healing_VVGN is_VBZ a_DD complex_JJ process_NN involving_VVG the_DD interactions_NNS of_II many_DD different_JJ cell_NN types_NNS ,_, matrix_NN components_NNS and_CC biological_JJ factors_NNS ,_, including_VVG proteinases_NNS and_CC cytokines_NNS ._.
P11115618A03
In_II this_DD study_NN ,_, we_PN examined_VVD the_DD expression_NN of_II MMP_NN and_CC TIMP_NN in_II rabbit_NN aortic_JJ neointima_NN at_II a_DD relatively_RR late_JJ stage_NN of_II lesion_NN development_NN ,_, between_II 4_MC and_CC 12_MC weeks_NNS after_II initial_JJ de-endothelialization_NN ._.
P11116076A01
Tears_NNS in_II the_DD internal_JJ elastic_JJ lamina_NN (_( IEL_NN )_) can_VM be_VBB observed_VVN after_II chronic_JJ increases_NNS in_II arterial_JJ blood_NN flow_NN ,_, suggesting_VVG a_DD potential_JJ role_NN for_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) in_II flow-induced_VVNJ vascular_JJ remodeling_VVGN ._.
P11117243A02
We_PN determined_VVD whether_CST these_DD cells_NNS were_VBD able_JJ to_TO synthesize_VVI the_DD matrix_NN degrading_VVGJ enzymes_NNS ,_, matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ,_, likely_RR to_TO be_VBI responsible_JJ for_II the_DD breakdown_NN of_II this_DD membrane_NN ,_, and_CC whether_CST this_DD secretion_NN could_VM be_VBB modulated_VVN by_II cytokines_NNS involved_VVN in_II the_DD inflammatory_JJ response_NN ._.
P11120556A08
MMP-9_NN mRNA_NN expression_NN was_VBD low_JJ in_II untreated_VVNJ eyes_NNS and_CC did_VDD not_RR increase_VVB following_VVG laser_NN treatment_NN ._.
P11120638A03
The_DD aim_NN of_II this_DD study_NN was_VBD to_TO examine_VVI the_DD relationship_NN among_II shear_NN force_NN ,_, metalloproteinase_NN activity_NN ,_, and_CC intimal_JJ thickening_VVGN in_II human_NN saphenous_JJ vein_NN segments_NNS maintained_VVN in_II organ_NN culture_NN ._.
P11121376A02
We_PN tested_VVD the_DD hypothesis_NN that_CST oxidative_JJ stress_NN can_VM regulate_VVB extracellular_JJ matrix_NN in_II cardiac_JJ fibroblasts_NNS ._.
P11129784A04
Reverse_JJ transcription_NN polymerase_NN chain_NN reaction_NN showed_VVD increased_VVNJ transcription_NN of_II MMP-9_NN ._.
P11145040A14
Most_RRT important_JJ ,_, increased_VVNJ MMP_NN activity_NN stemmed_VVD from_II exocrine_JJ epithelial_JJ cells_NNS and_CC was_VBD not_RR due_II+ to_II infiltrating_VVGJ lymphocytes_NNS ._.
P11145811A10
For_II all_PND of_II the_DD enzymes_NNS ,_, there_EX was_VBD most_DD staining_VVGN in_II the_DD herniation_NN specimens_NNS and_CC least_PND in_II the_DD autopsy_NN samples_NNS ._.
P11146452A11
We_PN conclude_VVB that_CST ,_, in_II this_DD model_NN ,_, genetic_JJ increase_NN of_II TIMP-2_NN inhibits_VVZ tumor_NN growth_NN ,_, apparently_RR by_II affecting_VVGN the_DD recruitment_NN and_CC organization_NN of_II host_NN endothelial_JJ cells_NNS by_II the_DD transformed_VVNJ cells_NNS ._.
P11146729A09
CLINICAL_JJ RELEVANCE_NN :_: Overexpression_NN of_II MMP-1_NN and_CC MMP-3_NN ,_, a_DD phenotype_NN previously_RR linked_VVN with_II UV_NN exposure_NN in_II dermal_JJ fibroblasts_NNS to_TO explain_VVI the_DD pathologic_JJ finding_VVGN of_II elastotic_JJ degeneration_NN ,_, suggests_VVZ that_CST pterygium_NN head_NN fibroblasts_NNS might_VM be_VBB intrinsically_RR altered_VVN by_II UV_NN ,_, which_PNR might_VM be_VBB responsible_JJ for_II corneal_JJ invasion_NN ._.
P11148597A07
Diabetic_JJ rats_NNS were_VBD induced_VVN by_II streptozotocin_NN injection_NN ._.
P11157561A01
The_DD family_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) comprises_VVZ endopeptidases_NNS that_PNR are_VBB capable_JJ of_II degrading_VVGN all_DD extracellular_JJ matrix_NN components_NNS ._.
P11167375A02
The_DD present_JJ study_NN was_VBD conducted_VVN to_TO investigate_VVI whether_CST the_DD elevated_VVNJ amounts_NNS of_II MMP-9_NN and_CC TIMP-1_NN found_VVN in_II such_DD patients_NNS '_GE airways_NNS may_VM be_VBB linked_VVN to_II an_DD enhanced_VVNJ secretion_NN by_II granulocytes_NNS ._.
P11168235A11
Furthermore_RR ,_, peri-implantitis_NN and_CC periodontitis_NN were_VBD shown_VVN to_TO be_VBI similar_JJ inflammatory_JJ lesions_NNS in_II respect_NN to_II MMP-1_NN and_CC -8_MC and_CC collagenase_NN activities_NNS ,_, even_RR though_CS the_DD TIMP-1_NN /_SYM MMP-1_NN +_SYM MMP-8_NN ratio_NN was_VBD significantly_RR lower_JJR in_II peri-implantitis_NN than_CSN in_II periodontitis_NN ._.
P11169735A02
Myocardial_JJ tumors_NNS are_VBB rarely_RR malignant_JJ ._.
P11169735A17
The_DD reduced_VVNJ levels_NNS of_II TIMP-4_NN elicit_VVB cellular_JJ transformation_NN and_CC may_VM lead_VVB to_II adverse_JJ extracellular_JJ matrix_NN degradation_NN (_( remodeling_VVGN )_) ,_, cardiac_JJ hypertrophy_NN and_CC failure_NN ._.
P11171688A04
Collagenase_NN activity_NN was_VBD determined_VVN with_II the_DD diffuse_JJ fibril_NN assay_NN using_VVG 3H_NN acetylated_VVNJ collagen_NN ._.
P11172685A07
Using_VVG an_DD in_JJ+ vitro_JJ spectrophotometric_JJ technique_NN ,_, the_DD Zn_NN (_( ++_SYM )_) reactivity_NN of_II several_JJ CMTs_NNS was_VBD assessed_VVN and_CC found_VVN to_TO be_VBI positively_RR related_VVN to_II the_DD potency_NN of_II these_DD compounds_NNS as_II MMP_NN inhibitors_NNS ._.
P11172697A06
Biomolecular_JJ structures_NNS used_VVN in_II the_DD design_NN of_II MMP_NN inhibitors_NNS are_VBB thoroughly_RR covered_VVN ._.
P11172829A05
INTERVENTION_NN (_( S_NNS )_) :_: Prospective_JJ record_NN of_II bleeding_VVGJ patterns_NNS and_CC endometrial_JJ biopsy_NN ._.
P11174024A10
We_PN concluded_VVD that_CST increased_VVNJ MMP-9_NN and_CC TIMP-1_NN levels_NNS might_VM be_VBB associated_VVN with_II peritoneal_JJ ECM_NN remodeling_VVGN during_II peritonitis_NN ._.
P11178975A08
Interestingly_RR ,_, the_DD TIMP-4_NN protein_NN was_VBD detected_VVN by_II immunohistochemical_JJ staining_VVGN in_II infiltrating_VVGJ breast_NN carcinoma_NN cells_NNS in_II tumor_NN tissues_NNS ._.
P11179039A03
Three_MC days_NNS post-MI_NN ,_, rats_NNS were_VBD randomized_VVN to_II treatment_NN with_II the_DD ET_NN (_( A_NN )_) -selective_JJ receptor_NN antagonist_NN sitaxsentan_NN (_( n_NN =_SYM 12_MC )_) or_CC a_DD control_NN group_NN (_( n_NN =_SYM 12_MC )_) ._.
P11181900A04
Cells_NNS were_VBD treated_VVN for_II 24_MC h_NN with_II lacidipine_NN and_CC the_DD conditioned_VVNJ media_NNS were_VBD analyzed_VVN ._.
P11182067A05
However_RR ,_, there_EX is_VBZ little_JJ data_NN available_JJ on_II MMPs_NNS or_CC their_PNG tissue_NN inhibitors_NNS (_( TIMPs_NNS )_) in_II NSCLC_NN ._.
P11192834A08
The_DD enzyme_NN inhibitors_NNS ,_, TIMP-1_NN and_CC TIMP-2_NN ,_, were_VBD quantified_VVN by_II dot_NN blot_NN immunoassay_NN ._.
P11196190A04
Therefore_RR ,_, we_PN have_VHB examined_VVN the_DD role_NN of_II MMPs_NNS during_II TCIPA_NN and_CC its_PNG regulation_NN by_II nitric_JJ oxide_NN (_( NO_NN )_) in_RR+ vitro_RR ._.
P11201850A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB proteolytic_JJ enzymes_NNS that_PNR degrade_VVB components_NNS of_II the_DD extracellular_JJ matrix_NN (_( ECM_NN )_) and_CC basement_NN membrane_NN ._.
P11203734A03
METHODS_NNS :_: The_DD various_JJ types_NNS of_II MMPs_NNS and_CC TIMPs_NNS were_VBD detected_VVN by_II Western_NN blotting_VVGN with_II monoclonal_JJ antibodies_NNS and_CC gelatin_NN zymography_NN ._.
P11204422A05
1Alpha_NN ,_, 25_MC (_( OH_NN )_) 2D3_NN increased_VVD steady-state_NN messenger_NN RNA_NN (_( mRNA_NN )_) and_CC protein_NN levels_NNS of_II MMP-13_NN ._.
P11205871A06
The_DD present_JJ experiments_NNS were_VBD performed_VVN to_TO define_VVI the_DD time-course_NN ,_, isozyme_NN subtypes_NNS ,_, and_CC cellular_JJ source_NN of_II increased_VVNJ MMP_NN expression_NN that_PNR occurs_VVZ following_VVGJ MI_NN in_II an_DD experimental_JJ rabbit_NN model_NN ._.
P11212844A10
It_PN is_VBZ clear_JJ that_CST the_DD activation_NN of_II MMPs_NNS and_CC their_PNG inhibitors_NNS occurs_VVZ in_II a_DD very_RR well_RR orchestrated_VVNJ manner_NN ._.
P11213361A02
This_DD study_NN was_VBD performed_VVN to_TO examine_VVI whether_CST NO_NN modulates_VVZ the_DD production_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ,_, which_PNR degrade_VVB all_DD components_NNS of_II extracellular_JJ matrix_NN (_( ECM_NN )_) ,_, in_II rheumatoid_JJ synovial_JJ cells_NNS ._.
P11216574A15
CONCLUSIONS_NNS :_: Our_PNG results_NNS suggest_VVB that_CST high_JJ thrombin_NN levels_NNS suppress_VVB MMP-2_NN activity_NN through_II decreased_VVNJ MMP-2_NN and_CC increased_VVNJ TIMP-1_NN synthesis_NN ._.
P11222449A02
Devic_NN 's_GE neuromyelitis_NN optica_NN (_( DNO_NN )_) is_VBZ a_DD demyelinating_VVGJ syndrome_NN that_PNR involves_VVZ the_DD optic_JJ nerve_NN and_CC cervical_JJ cord_NN but_CC differs_VVZ pathologically_RR from_II multiple_JJ sclerosis_NN ._.
P11222998A04
Spontaneously_RR hypertensive_JJ rats_NNS (_( SHR_NN )_) had_VHD a_DD 90_MC min_NN middle_JJ cerebral_JJ artery_NN occlusion_NN (_( MCAO_NN )_) followed_VVD by_II reperfusion_NN for_II times_NNS from_II 3_MC h_NN to_II 21_MC days_NNS ._.
P11235952A06
In_II addition_NN ,_, the_DD expression_NN levels_NNS and_CC proMMP-2_NN activation_NN ratio_NN were_VBD remarkably_RR higher_JJR in_II glioblastomas_NNS associated_VVN with_II cerebrospinal_JJ fluid_NN (_( CSF_NN )_) dissemination_NN than_CSN in_II those_PND not_RR associated_VVN with_II CSF_NN dissemination_NN ._.
P11235993A04
MMP-3_NN ,_, and_CC MMP-13_NN in_II highly_RR invasive_JJ MDA-MB-231_NN cells_NNS ,_, but_CC not_RR in_II slightly_RR invasive_JJ cell_NN lines_NNS ._.
P11235994A02
The_DD levels_NNS of_II MMP-1_NN ,_, 2_MC ,_, 3_MC ,_, 8_MC ,_, 9_MC ,_, 13_MC and_CC TIMP-1_NN were_VBD significantly_RR higher_JJR in_II the_DD carcinoma_NN samples_NNS than_CSN in_II the_DD control_NN ._.
P11240131A03
In_II the_DD presence_NN of_II the_DD calcium_NN ionophore_NN ,_, ionomycin_NN ,_, proteolytic_JJ processing_VVGN of_II MT1_NN MMP_NN was_VBD restricted_VVN and_CC collagenolysis_NN did_VDD not_RR occur_VVB indicating_VVG that_CST the_DD 63_MC kDa_NN form_NN of_II the_DD enzyme_NN is_VBZ not_RR a_DD functional_JJ collagenase_NN ._.
P11240267A01
Stasis_NN dermatitis_NN is_VBZ a_DD common_JJ disorder_NN ,_, which_PNR is_VBZ a_DD consequence_NN of_II impaired_VVNJ venous_JJ drainage_NN of_II the_DD legs_NNS ._.
P11241738A03
In_II normal_JJ and_CC glaucomatous_JJ ONH_NN ,_, we_PN detected_VVD MMP_NN and_CC TIMP_NN expression_NN by_II immunohistochemistry_NN ._.
P11242804A01
BACKGROUND_NN :_: Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) have_VHB been_VBN implicated_VVN in_II the_DD remodelling_VVGN of_II extracellular_JJ matrix_NN (_( ECM_NN )_) ,_, including_VVG basement_NN membrane_NN ._.
P11248661A01
In_II an_DD effort_NN to_TO elucidate_VVI the_DD role_NN of_II mechanical_JJ stimuli_NNS in_II rheumatoid_JJ arthritis_NN ,_, we_PN determined_VVD mRNA_NN levels_NNS of_II matrix_NN metalloproteinase_NN (_( MMP_NN )_) -1_MC ,_, MMP-3_NN ,_, MMP-13_NN ,_, tissue_NN inhibitor_NN of_II metalloproteinase_NN (_( TIMP_NN )_) -1_MC and_CC TIMP-2_NN ,_, and_CC three_MC transcription_NN factors_NNS (_( c-fos_NN ,_, ets-1_NN ,_, and_CC ets-2_NN )_) under_II two_MC mechanical_JJ shearing_VVGJ conditions_NNS as_CC+ well_CC+ as_CC simulated_VVNJ unloading_VVGN ._.
P11263773A10
Confirmation_NN that_CST chondrocytes_NNS can_VM produce_VVB these_DD 6_MC MMPs_NNS was_VBD obtained_VVN from_II HAC_NN cultures_NNS treated_VVN with_II either_CC IL-1beta_NN ,_, TNFalpha_NN ,_, or_CC PMA_NN ;_: conditioned_VVNJ medium_NN from_II activated_VVNJ HAC_NN contained_VVD all_DB the_DD MMPs_NNS demonstrated_VVN by_II immunohistochemistry_NN ._.
P11266461A10
We_PN conclude_VVB that_CST MMPs_NNS ,_, especially_RR Str1_NN ,_, determine_VVB the_DD rate_NN of_II adipocyte_NN differentiation_NN during_II involutive_JJ mammary_JJ gland_NN remodeling_VVGN ._.
P11274235A05
Matrix_NN metalloproteinase-9_NN (_( MMP-9_NN )_) activity_NN fell_VVB in_II all_DD UUO_NN groups_NNS but_CC remained_VVD significantly_RR higher_JJR in_II the_DD timp-1_NN group_NN compared_VVN with_II the_DD Timp-1_NN group_NN ._.
P11279294A01
Polycystic_JJ ovarian_JJ syndrome_NN (_( PCOS_NN )_) involves_VVZ follicular_JJ atresia_NN ,_, formation_NN of_II multiple_JJ ovarian_JJ cysts_NNS and_CC is_VBZ frequently_RR associated_VVN with_II a_DD higher_JJR abortion_NN rate_NN ._.
P11281552A05
Non-parametric_JJ correlation_NN analysis_NN and_CC receiver_NN operating_VVGJ characteristics_NNS curves_NNS show_VVB that_CST MMP-2_NN ,_, MMP-7_NN ,_, and_CC TIMP-1_NN provide_VVB the_DD best_JJT discrimination_NN between_II cirrhosis_NN and_CC pre-cirrhotic_JJ stages_NNS ._.
P11286132A09
Thus_RR ,_, it_PN seems_VVZ that_CST the_DD stromelysins_NNS are_VBB involved_VVN in_II the_DD generalized_VVNJ growth_NN and_CC expansion_NN of_II the_DD neoplastic_JJ cell_NN mass_NN ,_, while_CS MMP-2_NN is_VBZ involved_VVN in_II the_DD neoangiogenic_JJ and_CC focal_JJ clonal_JJ selection_NN and_CC expansion_NN phenomena_NNS associated_VVN with_II in_JJ+ situ_JJ tumor_NN progression_NN ,_, invasion_NN of_II the_DD microvasculature_NN ,_, and_CC metastasis_NN ._.
P11286133A03
Expression_NN of_II MMP-2_NN ,_, -3_MC ,_, -9_MC ,_, -10_MC ,_, and_CC -13_MC was_VBD investigated_VVN in_II human_NN pancreatic_JJ adenocarcinomas_NNS employing_VVG an_DD indirect_JJ alkaline_JJ phosphatase_NN conjugated_VVNJ immunocytochemical_JJ technique_NN ._.
P11289097A07
Analysis_NN of_II TIMP-4_NN expression_NN in_II human_NN mammary_JJ specimens_NNS indicates_VVZ that_CST TIMP-4_NN protein_NN is_VBZ increased_VVN in_II mammary_JJ carcinoma_NN cells_NNS compared_VVN with_II normal_JJ mammary_JJ epithelial_JJ cells_NNS ._.
P11296850A04
MMP-9_NN expression_NN was_VBD analyzed_VVN by_II Western_NN blotting_VVGJ analysis_NN of_II microdissected_VVNJ regions_NNS of_II muscle_NN and_CC immunolabeling_VVGN of_II muscle_NN sections_NNS ._.
P11306379A07
Levels_NNS of_II MMP-2_NN and_CC MMP-9_NN correlated_VVD with_II each_DD other_PN and_CC with_II tumor_NN stage_NN and_CC grade_NN ._.
P11306704A07
A_DD dose_NN range_NN of_II 2.5_MC to_II 10_MC ng_NN /_SYM ml_NN of_II TWHF_NN was_VBD effectively_RR inhibitory_JJ for_II IL-1_NN ._.
P11308257A12
Even_RR after_II 6_MC days_NNS ,_, however_RR ,_, there_EX was_VBD only_RR a_DD low_JJ level_NN of_II gelatin-hydrolytic_JJ activity_NN and_CC no_DD measurable_JJ collagen-hydrolytic_JJ activity_NN ._.
P11310848A02
Although_CS the_DD effects_NNS of_II individual_JJ cytokines_NNS on_II monocyte_NN MMP_NN expression_NN have_VHB been_VBN studied_VVN extensively_RR ,_, few_JJ studies_NNS have_VHB examined_VVN the_DD influence_NN of_II combinations_NNS of_II cytokines_NNS ,_, which_PNR are_VBB likely_RR present_JJ at_II inflammatory_JJ sites_NNS ._.
P11315101A06
Inostamycin_NN partially_RR blocked_VVD both_CC EGF-_NN and_CC phorbol_NN 12-myristate_NN 13-acetate-stimulated_VVNJ pro-MMP-9_NN production_NN ._.
P11319136A04
We_PN examined_VVD the_DD functional_JJ roles_NNS of_II MMP-9_NN and_CC TIMP-3_NN during_II in_JJ+ vitro_JJ ECM_NN degradation_NN by_II mouse_NN embryos_NNS ._.
P11325829A07
In_II concanavalin_NN A-stimulated_VVNJ homozygous_JJ Timp2_NN -/-_SYM fibroblasts_NNS or_CC unstimulated_VVNJ MT1-MMP-transfected_VVNJ Timp2_NN -/-_SYM cells_NNS ,_, which_PNR can_VM not_RR activate_VVB progelatinase_NN A_NN ,_, activation_NN was_VBD restored_VVN by_II the_DD addition_NN of_II 0.3-5_MC nM_NN TIMP-2_NN but_CC not_RR by_II TIMP-4_NN ,_, unequivocally_RR showing_VVG the_DD TIMP-2_NN dependency_NN of_II MT1-MMP-induced_VVNJ activation_NN of_II gelatinase_NN A_NN and_CC the_DD fact_NN that_CST TIMP-4_NN can_VM not_RR support_VVB activation_NN ._.
P11326313A01
Tumor_NN cell_NN invasion_NN and_CC metastasis_NN require_VVB precise_JJ coordination_NN of_II adherence_NN to_II extracellular_JJ matrix_NN (_( ECM_NN )_) and_CC controlled_VVNJ degradation_NN of_II its_PNG components_NNS ._.
P11328721A09
After_II 11_MC days_NNS of_II MD_NN ,_, alpha1_NN (_( I_MC )_) collagen_NN mRNA_NN levels_NNS were_VBD 34_MC %_SYM lower_JJR ,_, and_CC MMP-2_NN mRNA_NN levels_NNS were_VBD 66_MC %_SYM higher_JJR in_II the_DD deprived_VVNJ eyes_NNS than_CSN in_II the_DD control_NN eyes_NNS ._.
P11339506A08
Further_JJ pharmacokinetic_JJ analysis_NN revealed_VVD IC50_NN values_NNS of_II 26_MC microM_NN and_CC 16_MC microM_NN for_II the_DD inhibition_NN of_II collagenase_NN activity_NN and_CC mRNA_NN expression_NN ,_, respectively_RR ._.
P11343173A07
Only_RR in_II the_DD case_NN of_II MT-MMP-1_NN was_VBD the_DD difference_NN between_II AAA_NN and_CC AOD_NN not_RR statistically_RR significant_JJ ._.
P11346467A08
MMP_NN inhibitor_NN BE16627B_NN (_( 66.6_MC mg_NN /_SYM kg_NN i.v._NN ,_, given_VVN 2_MC times_NNS )_) or_CC SI-27_NN (_( 10_MC mg_NN /_SYM kg_NN i.p._NN ,_, given_VVN 2_MC times_NNS )_) significantly_RR suppressed_VVD the_DD ONOO_NN (_( -_SYM )_) -induced_VVNJ EPR_NN effect_NN in_II S-180_NN tumors_NNS and_CC in_II normal_JJ skin_NN ._.
P11346728A12
The_DD elevated_VVNJ levels_NNS of_II MMP-2_NN ,_, MMP-9_NN ,_, and_CC MMP-8_NN in_II the_DD SF_NN of_II patients_NNS with_II mild_JJ TMJ-ID_NN eventually_RR reflect_VVB the_DD active_JJ phase_NN of_II TMJ_NN destruction_NN ._.
P11350830A04
Expression_NN of_II the_DD genes_NNS for_II TIMP-2_NN ,_, TIMP-3_NN ,_, and_CC interstitial_JJ collagenase_NN (_( matrix_NN metalloproteinase-13_NN )_) was_VBD unaltered_VVN in_II the_DD injured_VVNJ lung_NN ._.
P11355979A07
We_PN conclude_VVB that_CST 5-FU_NN may_VM reduce_VVB adhesions_NNS by_II limiting_VVGN the_DD migratory_JJ capacity_NN of_II synovial_JJ fibroblasts_NNS (_( extrinsic_JJ healing_VVGN )_) ._.
P11356303A04
Ischemia_NN was_VBD induced_VVN by_II intraluminal_JJ middle_JJ cerebral_JJ artery_NN occlusion_NN (_( MCAO_NN )_) in_II mice_NNS under_II halothane_NN anesthesia_NN ._.
P11368514A07
However_RR ,_, MMP-2_NN is_VBZ stabilized_VVN from_II autolysis_NN in_II the_DD presence_NN of_II type_NN I_MC collagen_NN ,_, but_CC not_RR by_II elastin_NN ,_, fibrinogen_NN ,_, or_CC laminin_NN ._.
P11373158A09
No_DD differences_NNS in_II MMP-2_NN and_CC MMP-9_NN distribution_NN could_VM be_VBB observed_VVN between_II cows_NNS with_II proper_JJ release_NN of_II fetal_JJ membranes_NNS and_CC cows_NNS with_II retained_VVNJ fetal_JJ membranes_NNS ._.
P11381054A09
Stretching_VVGN stationary_JJ organ_NN cultures_NNS or_CC stretching_VVGN TM_NN cells_NNS grown_VVN on_II membranes_NNS resulted_VVD in_II similar_JJ increases_NNS in_II gelatinase_NN A_NN without_II changes_NNS in_II gelatinase_NN B_NN or_CC stromelysin_NN levels_NNS ._.
P11382769A09
Direct_JJ interaction_NN of_II claudin-1_NN with_II MT1-MMP_NN and_CC MMP-2_NN was_VBD demonstrated_VVN by_II immunoprecipitation_NN analysis_NN ._.
P11382924A06
Known_VVNJ regulators_NNS of_II MEC_NN growth_NN and_CC differentiation_NN were_VBD evaluated_VVN for_II their_PNG ability_NN to_TO modulate_VVI gelatinase_NN activity_NN in_II primary_JJ culture_NN ._.
P11395366A03
In_II this_DD report_NN we_PN have_VHB demonstrated_VVN a_DD role_NN for_II EMMPRIN_NN in_II cancer_NN progression_NN ._.
P11398836A05
While_CS the_DD WHO_NN grade_NN I_MC and_CC II_MC tumors_NNS had_VHD MT1_NN /_SYM MT3_NN ratios_NNS below_II 1_MC ,_, the_DD malignant_JJ (_( grade_NN III_MC and_CC IV_MC )_) tumors_NNS had_VHD ratios_NNS above_II 1_MC ._.
P11400152A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC their_PNG tissue_NN inhibitors_NNS (_( TIMPs_NNS )_) play_VVB an_DD important_JJ role_NN in_II several_JJ diseases_NNS ._.
P11401321A02
The_DD regulation_NN of_II MMP-2_NN activation_NN and_CC subsequent_JJ targets_NNS is_VBZ vital_JJ to_II understanding_VVGN the_DD metastatic_JJ process_NN ._.
P11401328A05
Additionally_RR ,_, this_DD study_NN demonstrated_VVD a_DD correlation_NN between_II the_DD expression_NN of_II MMP-3_NN (_( stromelysin-1_NN )_) and_CC the_DD level_NN of_II ras_NN expressed_VVN in_II cells_NNS and_CC with_II the_DD cells_NNS '_GE ability_NN to_TO form_VVI tumors_NNS and_CC with_II malignant_JJ potential_NN ._.
P11401482A05
Treatment_NN of_II A10_NN SMC_NN conditioned_VVNJ media_NN with_II a_DD neutralising_VVGJ anti-TIMP-2_NN antibody_NN prevented_VVD the_DD suppression_NN of_II HUVEC_NN pro-MMP-2_NN activation_NN ._.
P11404174A09
We_PN evaluated_VVD lung_NN injury_NN histologically_RR ._.
P11404367A03
Gelatinase_NN B_NN activity_NN is_VBZ under_II strict_JJ control_NN at_II various_JJ levels_NNS :_: transcription_NN of_II the_DD gene_NN by_II cytokines_NNS and_CC cellular_JJ interactions_NNS ;_: activation_NN of_II the_DD pro-enzyme_NN by_II a_DD cascade_NN of_II enzymes_NNS comprising_VVG serine_NN proteases_NNS and_CC other_JJ MMPs_NNS ;_: and_CC regulation_NN by_II specific_JJ tissue_NN inhibitors_NNS of_II MMPs_NNS (_( TIMPs_NNS )_) or_CC by_II unspecific_JJ inhibitors_NNS ,_, such_II+ as_II alpha2-macroglobulin_NN ._.
P11407790A13
The_DD localization_NN of_II matrix_NN metalloproteinase-9_NN to_II damaged_VVNJ cartilage_NN matrix_NN suggested_VVD matrix_NN proteolysis_NN ,_, which_PNR was_VBD confirmed_VVN with_II DIPEN341_NN localization_NN ._.
P11412041A01
The_DD relative_JJ expression_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC tissue_NN inhibitors_NNS of_II MMPs_NNS (_( TIMPs_NNS )_) is_VBZ an_DD important_JJ determinant_NN in_II trophoblast_NN invasion_NN of_II the_DD uterus_NN and_CC tumor_NN invasion_NN and_CC metastasis_NN ._.
P11420220A04
The_DD results_NNS showed_VVD that_CST MMP-2_NN and_CC -9_MC were_VBD expressed_VVN earlier_JJR than_CSN MMP-14_NN and_CC TIMPs_NNS in_II the_DD pregnant_JJ endometrium_NN ._.
P11420245A08
The_DD expression_NN of_II MMP-14_NN was_VBD regulated_VVN in_II a_DD manner_NN similar_JJ to_II that_PND of_II MMP-2_NN ._.
P11420306A06
Electron_NN paramagnetic_JJ resonance_NN studies_NNS indicate_VVB that_CST BAECs_NNS chronically_RR grown_VVN in_II high_JJ glucose_NN conditions_NNS produce_VVB 70_MC %_SYM more_DD ROS_NN than_CSN do_VDB control_NN cells_NNS ._.
P11421072A10
The_DD large_JJ donor_NN variability_NN for_II MMP-1_NN in_II all_DB the_DD studies_NNS demonstrates_VVZ that_CST it_PN is_VBZ important_JJ to_TO analyze_VVI gene_NN expression_NN individually_RR ._.
P11425778A08
MMP9_NN expression_NN was_VBD rapidly_RR induced_VVN after_II injury_NN ,_, whereas_CS the_DD increase_NN in_II MMP2_NN expression_NN was_VBD delayed_VVN ._.
P11426939A06
This_DD gene_NN induction_NN pattern_NN corresponded_VVD to_II the_DD differential_JJ activation_NN of_II the_DD transcription_NN factor_NN nuclear_JJ factor_NN kappaB_NN (_( NF-kappaB_NN )_) regulating_VVG MMP-9_NN ,_, but_CC not_RR signal_NN transducer_NN and_CC activator_NN of_II transcription_NN 3_MC (_( STAT3_NN )_) ,_, which_PNR is_VBZ involved_VVN in_II TIMP-1_NN gene_NN regulation_NN ._.
P11448065A05
Cytochalasin-D_NN in_II the_DD presence_NN of_II PMA_NN suppressed_VVD MMP-9_NN expression_NN and_CC capillary_NN formation_NN ,_, but_CC colchicine-B_NN had_VHD no_DB such_DD effect_NN ._.
P11448356A04
DESIGN_NN :_: This_DD study_NN included_VVD 54_MC consecutive_JJ patients_NNS with_II primary_JJ HNSCC_NN ,_, 27_MC of_II which_PNR showed_VVD lymph_NN node_NN metastasis_NN ._.
P11454044A10
MMP-1_NN expression_NN in_II the_DD mucosa_NN may_VM be_VBB related_VVN to_II the_DD initial_JJ step_NN of_II ulceration_NN in_II UC_NN ._.
P11457749A15
These_DD data_NNS support_VVB both_CC the_DD systemic_JJ nature_NN of_II aneurysmal_JJ disease_NN and_CC a_DD primary_JJ role_NN of_II MMP-2_NN in_II aneurysm_NN formation_NN ._.
P11466032A10
The_DD MMP-9_NN /_SYM total_JJ protein_NN ratios_NNS in_II pleural_JJ fluid_NN were_VBD higher_JJR in_II TB_NN compared_VVN to_II CHF_NN (_( 0.4492_MC +/-_SYM 0.1633_MC vs_CC 0.0364_MC +/-_SYM 0.0145_MC ,_, P_NN <_SYM 0.005_MC )_) but_CC the_DD TIMP-1_NN ratios_NNS were_VBD lower_JJR (_( 139.0_MC +/-_SYM 28.7_MC vs_CC 517.8_MC +/-_SYM 183.7_MC ,_, P_NN <_SYM 0.0005_MC )_) ._.
P11467772A08
Interestingly_RR ,_, only_RR the_DD K562_NN cells_NNS expressed_VVD matrilysin_NN suggesting_VVG a_DD potential_JJ role_NN for_II matrilysin_NN in_II leukaemia_NN cell_NN invasion_NN ._.
P11467888A07
RESULTS_NNS :_: IL-1_NN increased_VVD the_DD expression_NN and_CC activity_NN of_II MMPs_NNS ._.
P11477554A08
Expression_NN of_II pro-MMP-9_NN protein_NN and_CC mRNA_NN was_VBD also_RR induced_VVN in_II metastatic_JJ PC-3_NN cells_NNS grown_VVN in_II human_NN fetal_JJ bone_NN implants_NNS in_II SCID_NN mice_NNS ._.
P11480246A06
RESULTS_NNS :_: Basal_JJ production_NN of_II MMPs_NNS was_VBD significantly_RR greater_JJR in_II fibroblasts_NNS grown_VVN in_II 3D_NN gels_NNS than_CSN in_II cells_NNS grown_VVN as_II monolayers_NNS ._.
P11486102A04
Therefore_RR ,_, we_PN sought_VVD to_TO determine_VVI the_DD temporal_JJ profile_NN of_II MMP_NN expression_NN in_II patients_NNS with_II acute_JJ ischemic_JJ stroke_NN and_CC to_TO investigate_VVI its_PNG relationship_NN to_II stroke_NN severity_NN ,_, location_NN of_II arterial_JJ occlusion_NN ,_, and_CC total_JJ infarct_NN volume_NN ._.
P11500442A02
To_TO investigate_VVI the_DD role_NN of_II MMPs_NNS in_II immunity_NN to_II mycobacterial_JJ infections_NNS ,_, we_PN incubated_VVD murine_JJ peritoneal_JJ macrophages_NNS with_II viable_JJ Mycobacterium_NN bovis_NN BCG_NN or_CC Mycobacterium_NN tuberculosis_NN H37Rv_NN and_CC assayed_VVD MMP_NN activity_NN in_II the_DD supernatants_NNS by_II zymography_NN ._.
P11507673A10
In_II conclusion_NN ,_, progesterone_NN increases_VVZ MT1-MMP_NN protein_NN and_CC mRNA_NN levels_NNS in_II MG-63_NN cells_NNS ,_, but_CC has_VHZ no_DD effects_NNS on_II proMMP-2_NN activation_NN ,_, which_PNR is_VBZ partly_RR attributable_JJ to_II the_DD undetectable_JJ levels_NNS of_II tissue_NN inhibitor_NN of_II metalloproteinase-2_NN (_( TIMP-2_NN )_) ._.
P11508425A10
Zymography_NN demonstrated_VVD enzyme_NN activity_NN in_II all_DD synovium_NN samples_NNS from_II all_DD 9_MC patients_NNS assessed_VVN ._.
P11509885A03
RESULTS_NNS :_: After_II 6_MC months_NNS of_II IFN-alpha_NN treatment_NN ,_, the_DD histological_JJ status_NN of_II liver_NN fibrosis_NN showed_VVD improvement_NN in_II 9_MC patients_NNS (_( IF_NN group_NN )_) and_CC no_DD change_NN or_CC a_DD worsening_VVGN in_II 18_MC patients_NNS (_( NIF_NN group_NN )_) ._.
P11511522A01
Membrane-type_NN matrix_NN metalloproteinases-1_NN and_CC -3_MC (_( MT1-_NN and_CC MT3-MMPs_NNS )_) are_VBB expressed_VVN by_II activated_VVNJ smooth_JJ muscle_NN cells_NNS (_( SMCs_NNS )_) both_CC in_RR+ vitro_RR and_CC in_RR+ vivo_RR (_( 19_MC )_) ._.
P11514263A11
Myocardial_JJ interstitial_JJ MMP_NN fluorogenic_JJ activity_NN became_VVD detectable_JJ within_II the_DD ischemic_JJ region_NN as_RR early_JJ as_CSN 10_MC min_NN after_II coronary_JJ occlusion_NN and_CC significantly_RR increased_VVD after_II 1_MC h_NN post-MI_NN ._.
P11514351A08
MMP-9_NN mRNA_NN remained_VVD predominantly_RR in_II the_DD theca_NN during_II this_DD period_NN ._.
P11518695A08
The_DD data_NNS indicate_VVB that_CST MMP_NN and_CC TIMP_NN secretion_NN by_II AGS_NN cells_NNS is_VBZ modulated_VVN by_II H._NN pylori_NN infection_NN and_CC that_CST host_NN MMP-3_NN and_CC a_DD TIMP-3_NN homolog_NN expressed_VVN by_II H._NN pylori_NN mediate_VVB at_RR+ least_RR part_NN of_II the_DD host_NN cell_NN response_NN to_II infection_NN ._.
P11520947A06
Also_RR ,_, a_DD 54-kDa_NN band_NN ,_, likely_RR to_TO be_VBI proMMP-1_NN ,_, was_VBD elevated_VVN in_II a_DD pattern_NN similar_JJ to_II MMP-2_NN and_CC -9_MC ._.
P11522674A01
Adipocyte_NN hypertrophy_NN and_CC hyperplasia_NN together_RR with_II angiogenesis_NN contribute_VVB to_II the_DD growth_NN of_II the_DD fat_NN mass_NN ._.
P11525779A02
We_PN have_VHB investigated_VVN effects_NNS of_II pirfenidone_NN ,_, antifibrotic_JJ agent_NN ,_, and_CC batimastat_NN ,_, inhibitor_NN of_II MMPs_NNS ,_, on_II gelatinase_NN activities_NNS ,_, on_II release_NN of_II tumor_NN necrosis_NN factor-alpha_NN (_( TNF-alpha_NN )_) and_CC transforming_VVGJ growth_NN factor-beta_NN (_( TGF-beta_NN )_) ,_, as_CC+ well_CC+ as_CC on_II recruitment_NN of_II inflammatory_JJ cells_NNS in_II bronchoalveolar_JJ lavage_NN (_( BAL_NN )_) fluid_NN after_II aerosol_NN administration_NN of_II lipopolysaccharide_NN (_( LPS_NN )_) in_II mice_NNS ._.
P11531282A05
MMP-9_NN immunoreactivity_NN was_VBD detected_VVN by_II immunohistochemistry_NN and_CC gelatinolytic_JJ activity_NN was_VBD localized_VVN in_II ovarian_JJ cancer_NN tissue_NN by_II in_JJ+ situ_JJ zymography_NN ._.
P11533337A03
The_DD aims_NNS of_II our_PNG study_NN were_VBD to_TO characterize_VVI the_DD presence_NN and_CC molecular_JJ weight_NN forms_NNS of_II MMP-2_NN ,_, -8_MC ,_, and_CC -9_MC and_CC their_PNG specific_JJ inhibitor_NN ,_, tissue_NN inhibitor_NN of_II metalloproteinases_NNS (_( TIMP_NN )_) -2_MC ,_, in_II lungs_NNS of_II preterm_NN infants_NNS during_II the_DD early_JJ postnatal_JJ period_NN and_CC to_TO determine_VVI whether_CST levels_NNS of_II these_DD MMPs_NNS and_CC TIMP-2_NN in_II tracheal_JJ aspirate_NN fluid_NN (_( TAF_NN )_) are_VBB associated_VVN with_II acute_JJ or_CC chronic_JJ lung_NN morbidity_NN of_II the_DD preterm_NN infant_NN ._.
P11546917A06
CONCLUSIONS_NNS :_: The_DD data_NNS do_VDB not_RR support_VVB the_DD hypothesis_NN that_CST MMP_NN gene_NN variations_NNS influence_VVB the_DD development_NN of_II intracranial_JJ aneurysms_NNS in_II the_DD population_NN studied_VVN ._.
P11551917A03
In_II the_DD present_JJ study_NN ,_, we_PN examined_VVD the_DD role_NN of_II Tiam1-Rac_NN signaling_VVGN in_II migration_NN and_CC invasion_NN of_II human_NN renal_JJ cell_NN carcinomas_NNS ._.
P11560951A04
As_RR early_JJ as_CSN 13_MC months_NNS of_II age_NN animals_NNS become_VVB moribund_JJ ._.
P11565871A06
Finally_RR ,_, using_VVG semiquantitative_JJ reverse_JJ transcriptase-polymerase_NN chain_NN reaction_NN ,_, the_DD authors_NNS demonstrated_VVD that_CST LY294002_NN decreased_VVD messenger_NN (_( m_NN )_) RNA_NN levels_NNS for_II both_DD MMPs_NNS ._.
P11577169A05
Seven_MC metalloproteinases_NNS (_( MMP-1_NN ,_, MMP-2_NN ,_, MMP-3_NN ,_, MMP-7_NN ,_, MMP-8_NN ,_, MMP-9_NN ,_, and_CC MMP-13_NN )_) were_VBD tested_VVN against_II two_MC substrates_NNS :_: gelatin_NN and_CC alpha-casein_NN ._.
P11583842A05
Incorporation_NN of_II human_NN serum_NN in_II the_DD assay_NN mixture_NN had_VHD no_DD effect_NN on_II the_DD degradation_NN of_II TIMP-1_NN by_II P._NN gingivalis_NN ,_, whereas_CS a_DD cysteine_NN proteinase_NN inhibitor_NN caused_VVD a_DD complete_JJ inhibition_NN ._.
P11585118A08
Intragroup_NN analysis_NN :_: At_II week_NN 2_MC following_VVG surgery_NN ,_, when_CS compared_VVN to_II baseline_NN all_DD parameters_NNS in_II each_DD study_NN group_NN ,_, except_II MMP-1_NN ,_, significantly_RR increased_VVD (_( p_NN <_SYM 0.05_MC )_) ._.
P11586466A05
In_II addition_NN there_EX is_VBZ a_DD marked_VVNJ increase_NN in_II expression_NN of_II TIMP-1_NN leading_VVG to_II a_DD more_RR global_JJ inhibition_NN of_II degradation_NN of_II fibrillar_JJ liver_NN collagens_NNS by_II interstitial_JJ collagenases_NNS (_( MMP-1_NN /_SYM MMP-13_NN )_) ._.
P11589731A09
GM_NN 6001_MC prevented_VVD activation_NN of_II MMP-2_NN and_CC increased_VVD latent_JJ MMP-9_NN levels_NNS ._.
P11592306A04
TGFbeta1_NN dose-dependently_RR stimulated_VVD the_DD secretion_NN of_II a_DD 68-kDa_NN gelatinase_NN ,_, which_PNR was_VBD characterized_VVN as_II an_DD MMP_NN because_CS its_PNG activity_NN was_VBD inhibited_VVN by_II a_DD metalloproteinase_NN inhibitor_NN 1_MC ,_, 10-phenanthroline_NN ,_, and_CC by_II a_DD synthetic_JJ MMP_NN inhibitor_NN BB3103_NN ._.
P11592410A05
While_CS the_DD pyrimidine-trione_NN template_NN is_VBZ used_VVN as_II the_DD zinc-chelating_VVGJ moiety_NN ,_, the_DD substituents_NNS have_VHB been_VBN optimized_VVN to_TO yield_VVI inhibitors_NNS comparable_JJ in_II their_PNG inhibition_NN efficiency_NN of_II matrix_NN metalloproteinases_NNS to_II hydroxamic_JJ acid_NN derivatives_NNS such_II+ as_II batimastat_NN ._.
P11592852A06
The_DD second_JJ wave_NN showed_VVD a_DD massive_JJ increase_NN in_II MMP-2_NN protein_NN expression_NN and_CC activation_NN by_II day_NN 4_MC ,_, which_PNR was_VBD compatible_JJ with_II abundant_JJ MMP-2_NN in_II reactive_JJ microglia_NNS /_SYM macrophages_NNS ._.
P11594775A12
The_DD results_NNS suggest_VVB that_CST activities_NNS of_II active_JJ MMP-2_NN and_CC proMMP-9_NN in_II the_DD bile_NN may_VM be_VBB useful_JJ markers_NNS for_II predicting_VVGN liver_NN metastasis_NN in_II colorectal_JJ cancer_NN ._.
P11595703A01
PURPOSE_NN :_: Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) degrade_VVB components_NNS of_II the_DD extracellular_JJ matrix_NN and_CC are_VBB implicated_VVN in_II tissue_NN remodeling_VVGN and_CC tumor_NN infiltration_NN ._.
P11641250A03
ET-1_NN [_( 1-32_MC ]_) rapidly_RR down-regulated_VVD the_DD expression_NN of_II L-selectin_NN and_CC up-regulated_VVD expression_NN of_II CD11b_NN /_SYM CD18_NN on_II the_DD neutrophil_NN surface_NN ,_, with_II EC50_NN values_NNS of_II 1-3_MC nM_NN ._.
P11642414A05
In_II these_DD patients_NNS ,_, the_DD MMP-9_NN concentration_NN was_VBD significantly_RR higher_JJR (_( p_NN <_SYM 0.05_MC )_) during_II the_DD attack_NN than_CSN during_II the_DD remission_NN ._.
P11665967A10
In_II RA_NN patients_NNS ,_, serum_NN levels_NNS of_II CRP_NN correlated_VVN with_II MMP-3_NN and_CC TIMP-1_NN levels_NNS ,_, but_CC not_RR with_II MMP-1_NN levels_NNS ._.
P11676550A07
Lung_NN permeability_NN was_VBD assayed_VVN by_II Evans_NN blue_JJ dye_NN extravasation_NN ._.
P11678909A07
MT1-MMP_NN protein_NN expression_NN on_II synovial_JJ cells_NNS was_VBD examined_VVN by_II anti-MT1-MMP_NN immunoblot_NN ._.
P11680936A06
The_DD imbalance_NN of_II MMP-9_NN dominance_NN in_II tumor_NN cells_NNS was_VBD implicated_VVN in_II liver_NN metastasis_NN ._.
P11687525A05
Trabecular_JJ protein_NN kinase_NN C_NN (_( PKC_NN )_) isoforms_NNS were_VBD identified_VVN and_CC localized_VVN by_II using_VVGN Western_NN immunoblots_NNS and_CC confocal_JJ immunohistochemistry_NN ._.
P11692106A03
One_MC reason_NN for_II this_PND might_VM be_VBB differing_VVGJ expression_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) or_CC their_PNG inhibitors_NNS (_( TIMPs_NNS )_) ._.
P11699482A09
The_DD active_JJ form_NN of_II MMP-9_NN and_CC the_DD amount_NN of_II TIMP-1_NN were_VBD positively_RR correlated_VVN with_II the_DD number_NN of_II CD22+_NN ,_, CD68+_NN ,_, and_CC TIA-1+_NN cells_NNS ._.
P11700497A13
MMP-9_NN was_VBD not_RR detected_VVN by_II IHC_NN ._.
P11704473A06
In_II all_DD LTx_NN patients_NNS ,_, MMP-9_NN and_CC the_DD MMP-9_NN :_: TIMP-1_NN ratio_NN were_VBD negatively_RR correlated_VVN with_II forced_VVNJ expiratory_JJ volume_NN in_II 1_MC second_NN values_NNS (_( rho_NN =_SYM -0.47_MC ,_, p_NN =_SYM 0.01_MC ,_, and_CC rho_NN =_SYM -0.53_MC ,_, p_NN =_SYM 0.003_MC ,_, respectively_RR )_) ._.
P11705862A04
RESULTS_NNS :_: MMP-1_NN was_VBD detected_VVN in_II urine_NN samples_NNS from_II 21_MC of_II 131_MC (_( 16_MC %_SYM )_) patients_NNS with_II bladder_NN cancer_NN but_CC was_VBD undetectable_JJ in_II samples_NNS from_II all_DD other_JJ groups_NNS (_( P_NN <_SYM 0.0001_MC )_) ._.
P11709491A09
Inhibition_NN of_II MMP_NN activity_NN was_VBD shown_VVN to_TO significantly_RR decrease_VVI liver_NN injury_NN in_II ischemic_JJ /_SYM reperfused_VVNJ liver_NN tissue_NN as_CS assessed_VVN by_II histological_JJ studies_NNS and_CC serum_NN hepatic_JJ enzyme_NN levels_NNS ._.
P11709701A06
The_DD ability_NN of_II MMAC_NN /_SYM PTEN_NN to_TO induce_VVI anoikis_NN in_II U251_NN cells_NNS was_VBD accompanied_VVN by_II a_DD significant_JJ inhibition_NN of_II in_JJ+ vitro_JJ invasion_NN (_( 70_MC %_SYM )_) ._.
P11710594A09
RESULTS_NNS :_: The_DD coprecipitation_NN of_II MMP-2_NN with_II alphavbeta3_NN by_II anti-alphav_NN antibody_NN is_VBZ a_DD strong_JJ indication_NN that_CST SiHa_NN cell_NN surface_NN alphavbeta3_NN integrin_NN is_VBZ a_DD receptor_NN for_II MMP-2_NN ._.
P11713105A08
Retinoic_JJ acid_NN attenuated_VVD the_DD induction_NN and_CC activation_NN of_II MMP-1_NN and_CC MMP-3_NN ._.
P11716072A09
These_DD data_NNS underline_VVB the_DD importance_NN of_II functional_JJ interaction_NN of_II MMPs_NNS with_II accessory_NN proteins_NNS such_II+ as_II integrins_NNS during_II invasion_NN ,_, and_CC the_DD need_NN for_II further_RR studies_NNS to_TO elucidate_VVI the_DD molecular_JJ underpinnings_NNS of_II this_DD process_NN ._.
P11716080A14
In_II addition_NN agents_NNS that_PNR target_VVB protein_NN synthesis_NN or_CC the_DD protein_NN kinase_NN C_NN pathway_NN in_II human_NN pulp_NN cells_NNS inhibit_VVB MMP-2_NN production_NN ,_, and_CC such_DD inhibition_NN may_VM contribute_VVB to_II the_DD pathogenesis_NN of_II pulpal_JJ inflammation_NN ._.
P11716537A08
Synthetic_JJ MMP_NN inhibitors_NNS CGS27023A_NN and_CC MMP_NN inhibitor_NN I_MC ,_, which_PNR inhibit_VVB MMPs_NNS 1_MC ,_, 2_MC ,_, 3_MC ,_, and_CC 9_MC ,_, markedly_RR augmented_VVD deposition_NN of_II laminin_NN 5_MC and_CC type_NN IV_MC and_CC VII_MC collagens_NNS at_II the_DD dermal-epidermal_JJ junction_NN ,_, resulting_VVG in_II formation_NN of_II continuous_JJ epidermal_JJ BM_NN ._.
P11716687A11
With_II these_DD attributes_NNS ,_, 111In-DTPA-N-TIMP-2_NN is_VBZ a_DD suitable_JJ radiopharmaceutical_NN for_II in_JJ+ vivo_JJ biological_JJ and_CC clinical_JJ investigation_NN of_II the_DD potential_JJ benefits_NNS of_II imaging_VVGN MMP_NN expression_NN ._.
P11720009A02
Stroke_NN is_VBZ associated_VVN with_II changes_NNS in_II immune_JJ responses_NNS within_II the_DD central_JJ nervous_JJ system_NN as_CC+ well_CC+ as_CC systemically_RR ._.
P11721189A04
The_DD expression_NN of_II MMP-2_NN ,_, MMP-9_NN ,_, TIMP-1_NN and_CC TIMP-2_NN was_VBD examined_VVN by_II immunohistochemistry_NN and_CC RT-PCR_NN ._.
P11726397A10
Our_PNG results_NNS suggest_VVB that_CST MMPs_NNS play_VVB an_DD important_JJ role_NN in_II the_DD development_NN of_II VILI_NN in_II rat_NN lungs_NNS and_CC that_CST the_DD MMP-inhibitor_NN Prinomastat_NN is_VBZ effective_JJ in_II attenuating_VVGN this_DD type_NN of_II lung_NN injury_NN ._.
P11726737A12
This_PND may_VM indicate_VVB that_CST decreased_VVNJ collagen_NN turnover_NN by_II fibroblasts_NNS contributes_VVZ to_II fibrosis_NN in_II BPD_NN development_NN ._.
P11728453A10
Moreover_RR ,_, a_DD non-selective_JJ COX_NN inhibitor_NN indomethacin_NN also_RR suppressed_VVD the_DD expression_NN of_II MMP-2_NN ._.
P11729853A14
In_JJ+ vitro_JJ stimulation_NN of_II the_DD cell_NN lines_NNS with_II the_DD PMA_NN increased_VVD MMP_NN production_NN ,_, particularly_RR of_II active_JJ MMP-2_NN and_CC latent_JJ MMP-9_NN ,_, resulting_VVG in_II a_DD profile_NN of_II MMP_NN production_NN similar_JJ to_II that_PND seen_VVN in_RR+ vivo_RR ._.
P11736941A07
Hence_RR ,_, we_PN concluded_VVD that_CST (_( i_MC )_) MMPs_NNS /_SYM TIMPs_NNS are_VBB secreted_VVN by_II normal_JJ human_NN bone_NN marrow_NN haematopoietic_JJ and_CC stromal_JJ cells_NNS and_CC may_VM play_VVB an_DD important_JJ role_NN in_II intercellular_JJ cross-talk_NN in_II haematopoiesis_NN ;_: and_CC (_( ii_MC )_) only_RR latent_JJ forms_NNS of_II MMPs_NNS are_VBB present_JJ under_II LTMC_NN conditions_NNS ,_, indicating_VVG that_CST the_DD specific_JJ media_NN used_VVN for_II weekly_RR re-feeding_VVGN of_II LTMC_NN can_VM block_VVB activation_NN of_II MMP-2_NN and_CC MMP-9_NN ,_, maintaining_VVG the_DD integrity_NN of_II the_DD stromal_JJ layer_NN and_CC supporting_VVG haematopoiesis_NN in_RR+ vitro_RR ._.
P11744025A01
OBJECTIVES_NNS :_: Peroxynitrite_NN (_( ONOO_NN (_( -_SYM )_) )_) mediates_VVZ in_II part_NN both_CC ischemia-reperfusion_NN and_CC pro-inflammatory_JJ cytokine-induced_VVNJ injury_NN to_II the_DD heart_NN ._.
P11745204A06
In_II contrast_NN ,_, patients_NNS with_II rectal_JJ carcinoma_NN (_( n_NN =_SYM 10_MC patients_NNS )_) had_VHD revealed_VVD the_DD same_JJ high_JJ activity_NN of_II MMP-9_NN in_II tumor_NN regions_NNS and_CC corresponding_VVGJ healthy_JJ tissue_NN ._.
P11751597A14
This_DD study_NN highlights_VVZ the_DD complex_JJ nature_NN of_II MMP_NN /_SYM TIMP_NN regulation_NN during_II reproductive_JJ tissue_NN growth_NN and_CC suggests_VVZ that_CST TIMP-1_NN and_CC TIMP-2_NN may_VM be_VBB involved_VVN in_II other_JJ aspects_NNS of_II the_DD growth_NN process_NN ._.
P11756180A02
TIMP-1_NN is_VBZ active_JJ primarily_RR in_II B_NN cells_NNS and_CC B-cell_NN lymphomas_NNS ,_, whereas_CS TIMP-2_NN expression_NN is_VBZ restricted_VVN to_II T_NN cells_NNS ._.
P11757034A05
Different_JJ expressions_NNS were_VBD also_RR observed_VVN between_II the_DD cells_NNS deriving_VVG from_II the_DD primary_JJ cell_NN cultures_NNS ,_, the_DD benign_JJ cell_NN line_NN BPH-1_NN ,_, and_CC the_DD malignant_JJ cell_NN lines_NNS LNCaP_NN ,_, D-145_NN ,_, and_CC PC-3_NN ._.
P11757634A06
MMP-2_NN and_CC -9_MC activities_NNS were_VBD elevated_VVN under_II prolonged_VVNJ hyperoxic_JJ exposure_NN ._.
P11773040A02
It_PN has_VHZ been_VBN shown_VVN that_CST matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB elevated_VVN in_II the_DD retina_NN during_II the_DD neovascularization_NN process_NN ._.
P11773040A17
Increased_VVNJ production_NN of_II MMPs_NNS by_II RMVECs_NNS does_VDZ not_RR occur_VVB directly_RR in_II response_NN to_II a_DD hypoxic_JJ stimulus_NN ._.
P11773164A11
COL-3-related_VVNJ grade_NN 3_MC or_CC 4_MC adverse_JJ events_NNS were_VBD reported_VVN by_II six_MC patients_NNS and_CC included_VVD photosensitivity_NN ,_, rash_NN ,_, and_CC headache_NN ._.
P11773278A13
MMP_NN inhibition_NN reduced_VVD proliferating_VVGJ tumor_NN cells_NNS from_II 20.8_MC %_SYM (_( 95_MC %_SYM CI_NN =_SYM 19.9_MC %_SYM to_II 21.7_MC %_SYM )_) to_II 7.4_MC %_SYM (_( 95_MC %_SYM CI_NN =_SYM 5.2_MC %_SYM to_II 9.6_MC %_SYM )_) (_( P_NN =.006_MC )_) ,_, without_II affecting_VVGN angiogenesis_NN or_CC apoptosis_NN ._.
P11775947A03
The_DD mRNA_NN expression_NN of_II MMP-9_NN ,_, MMP-2_NN ,_, TIMP-1_NN ,_, TIMP-2_NN genes_NNS were_VBD determined_VVN by_II RT-PCR_NN ._.
P11776634A07
When_CS SKOV3_NN cells_NNS were_VBD treated_VVN with_II 10_MC micrograms_NNS /_SYM ml_NN fibronectin_NN for_II 1_MC hr_NN ,_, the_DD cellular_JJ MMP-2_NN mRNA_NN dramatically_RR increased_VVD ._.
P11781293A05
Congruence_NN of_II PMN_NN and_CC MMP_NN expression_NN in_II lung_NN tissue_NN was_VBD evaluated_VVN by_II neutrophil_NN depletion_NN and_CC fluorescent_JJ immunohistochemistry_NN (_( IHC_NN )_) ._.
P11790786A02
Small_JJ molecular_JJ weight_NN synthetic_JJ inhibitors_NNS for_II these_DD enzymes_NNS are_VBB highly_RR sought_VVN for_II potential_JJ use_NN as_II anti-metastatic_JJ agents_NNS ._.
P11792884A12
The_DD analysis_NN of_II the_DD serum_NN concentrations_NNS of_II TIMP-1_NN and_CC TIMP-2_NN showed_VVD that_CST their_PNG levels_NNS were_VBD also_RR elevated_VVN in_II RA_NN patients_NNS compared_VVN with_II OA_NN patients_NNS (_( P_NN <_SYM 0.001_MC and_CC P_NN <_SYM 0.01_MC respectively_RR )_) ._.
P11795995A05
RESULTS_NNS :_: Collagenase_NN and_CC gelatinase_NN activity_NN significantly_RR increased_VVD in_II the_DD knee_NN cartilage_NN of_II rats_NNS injected_VVN with_II iodoacetate_NN with_II peak_JJ activity_NN by_II day_NN 7_MC ._.
P11796838A01
Tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) are_VBB endogenous_JJ regulators_NNS of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ._.
P11815431A10
Stromelysin-1_NN (_( MMP-3_NN )_) and_CC TIMP-3_NN were_VBD ,_, however_RR ,_, over_RR expressed_VVN in_II the_DD AAA_NN samples_NNS and_CC may_VM be_VBB involved_VVN aneurysm_NN pathogenesis_NN ._.
P11827795A03
The_DD SFD_NN mutations_NNS characterized_VVN result_VVB in_II introduction_NN of_II an_DD unpaired_VVNJ cysteine_NN residue_NN in_II the_DD C-terminal_JJ domain_NN of_II TIMP-3_NN ._.
P11839588A03
We_PN found_VVD that_CST cultured_VVNJ human_NN umbilical_JJ vein_NN endothelial_JJ cells_NNS shed_VVB vesicles_NNS (_( 300_MC to_II 600_MC nm_NN )_) originating_VVG from_II localized_VVNJ areas_NNS of_II the_DD cell_NN plasma_NN membrane_NN ,_, as_CS revealed_VVN by_II ultrastructural_JJ analysis_NN ._.
P11841363A01
BACKGROUND_NN :_: Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC tissue_NN inhibitors_NNS of_II MMPs_NNS (_( TIMPs_NNS )_) have_VHB important_JJ functions_NNS during_II skin_NN development_NN ,_, repair_NN and_CC maintenance_NN ._.
P11849655A08
The_DD immunohistochemical_JJ expression_NN of_II these_DD MMPs_NNS and_CC TIMPs_NNS were_VBD examined_VVN in_II treated_VVNJ aortic_JJ sections_NNS with_II lesions_NNS and_CC control_NN aortic_JJ sections_NNS without_II lesions_NNS ._.
P11852234A04
Collagen_NN denaturation_NN was_VBD determined_VVN by_II alpha-chymotrypsin_NN digestion_NN ._.
P11854068A10
In_II addition_NN ,_, arecoline_NN was_VBD found_VVN to_TO inhibit_VVI MMP-2_NN secretion_NN and_CC production_NN at_II the_DD concentration_NN level_NN of_II 40_MC microg_NN /_SYM ml_NN ._.
P11872217A04
PATIENT_NN (_( S_NNS )_) :_: Five_MC samples_NNS of_II hydrosalpinx_NN fluid_NN were_VBD obtained_VVN at_II the_DD time_NN of_II ovocyte_NN retrieval_NN ._.
P11872911A09
At_II 12_MC hours_NNS ,_, tPA-treated_VVNJ rats_NNS showed_VVD significantly_RR higher_JJR levels_NNS of_II pro-MMP-9_NN and_CC cleaved_VVNJ MMP-9_NN than_CSN untreated_VVNJ controls_NNS ._.
P11876751A06
The_DD levels_NNS of_II serum_NN TIMP-1_NN were_VBD significantly_RR reduced_VVN in_II AD_NN patients_NNS following_VVG conventional_JJ treatments_NNS ._.
P11878827A02
The_DD mechanisms_NNS underlying_VVG drusen_NN formation_NN are_VBB not_RR well_RR characterized_VVN ._.
P11882331A13
MMP-2_NN levels_NNS in_II the_DD coronary_JJ sinus_NN blood_NN were_VBD significantly_RR higher_JJR in_II patients_NNS with_II late_JJ restenosis_NN than_CSN in_II those_PND without_II restenosis_NN ._.
P11884904A08
RESULTS_NNS :_: In_II the_DD anulus_NN fibrosus_NN chondroitinase_NN ABC_NN and_CC interleukin-1_NN synergistically_RR increased_VVD the_DD collagenase_NN activity_NN ,_, which_PNR was_VBD at_II a_DD significantly_RR higher_JJR level_NN than_CSN the_DD increment_NN solely_RR due_II+ to_II interleukin-1_NN ._.
P11889208A03
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) are_VBB the_DD main_JJ mediators_NNS of_II ECM_NN degradation_NN ._.
P11911253A14
This_DD analysis_NN confirms_VVZ previous_JJ results_NNS obtained_VVN in_II a_DD keratinocyte_NN tumor_NN cell_NN model_NN and_CC provides_VVZ evidence_NN for_II a_DD more_RR general_JJ biological_JJ association_NN between_II MMP-expression_NN and_CC tumor_NN cell_NN growth_NN ._.
P11912288A03
Levels_NNS of_II pro-MMP-9_NN in_II choriocarcinoma_NN and_CC those_PND of_II TIMP-1_NN in_II both_CC hydatidiform_NN mole_NN and_CC choriocarcinoma_NN were_VBD also_RR increased_VVN ._.
P11918086A10
The_DD results_NNS suggest_VVB that_CST stress-activated_VVNJ protein_NN kinases_NNS like_II p38MAPK_NN are_VBB involved_VVN in_II regulation_NN of_II expression_NN of_II MMP-2_NN as_CC+ well_CC+ as_CC in_JJ+ vitro_JJ invasion_NN of_II malignant_JJ melanoma_NN cells_NNS ._.
P11920503A04
Twenty-nine_MC endometrial_JJ carcinoma_NN biopsies_NNS were_VBD investigated_VVN immunohistochemically_RR to_TO determine_VVI the_DD tissue_NN localization_NN of_II MMP-2_NN (_( gelatinase_NN A_NN )_) ,_, MMP-9_NN (_( gelatinase_NN B_NN )_) ,_, MT1-MMP_NN ,_, and_CC TIMPs_NNS 1-3_MC ._.
P11920505A02
Because_II+ of_II their_PNG ability_NN to_TO degrade_VVI extracellular_JJ matrix_NN components_NNS (_( EMC_NN )_) ,_, matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) have_VHB been_VBN implicated_VVN in_II the_DD breakdown_NN of_II basement_NN membranes_NNS and_CC underlying_VVGJ stroma_NN ,_, thereby_RR facilitating_VVG tumor_NN growth_NN and_CC invasion_NN ._.
P11925127A07
The_DD invasion_NN of_II cervical_JJ carcinoma_NN cells_NNS was_VBD suppressed_VVN by_II MMI-166_NN ._.
P11935159A14
CONCLUSIONS_NNS /_SYM INTERPRETATION_NN :_: These_DD results_NNS indicate_VVB that_CST the_DD impairment_NN of_II matrix_NN degradation_NN contributes_VVZ to_II matrix_NN accumulation_NN in_II diabetic_JJ nephropathy_NN and_CC that_CST the_DD beneficial_JJ effects_NNS of_II ACE_NN inhibition_NN could_VM in_II part_NN be_VBB mediated_VVN by_II modulation_NN of_II changes_NNS in_II matrix_NN degradative_JJ pathways_NNS ._.
P11939809A10
CONCLUSION_NN :_: Production_NN ,_, release_NN ,_, and_CC activation_NN of_II MMP-9_NN in_II hypertrophic_JJ scars_NNS could_VM be_VBB an_DD effector_NN mechanism_NN responsible_JJ for_II hypertrophy_NN regression_NN induced_VVN by_II mechanical_JJ compression_NN ._.
P11940298A09
MMP-9_NN expression_NN did_VDD not_RR correlate_VVB with_II proteinuria_NN ,_, but_CC negatively_RR correlated_VVN with_II serum_NN creatinine_NN levels_NNS (_( P_NN <_SYM 0.05_MC )_) ._.
P11949943A10
Targeting_VVGN pregnancy-associated_VVNJ factors_NNS that_PNR inhibit_VVB endometrial-specific_JJ MMP_NN expression_NN and_CC action_NN may_VM enhance_VVB the_DD effectiveness_NN of_II progestin-related_VVNJ treatments_NNS for_II endometriosis_NN ._.
P11949963A05
Although_CS most_PND of_II the_DD menstrual_JJ fluid_NN exits_VVZ the_DD body_NN ,_, reflux_NN of_II some_DD material_NN occurs_VVZ in_II most_DD women_NNS ,_, providing_VVG a_DD poorly_RR understood_VVNJ opportunity_NN for_II ectopic_JJ endometrial_JJ growth_NN and_CC establishment_NN of_II the_DD disease_NN endometriosis_NN ._.
P11955860A08
CONCLUSIONS_NNS :_: Both_CC TIMPs_NNS and_CC MMP-2_NN remained_VVD inactive_JJ during_II hypertrophy_NN ,_, per_RR+ se_RR ;_: they_PN were_VBD activated_VVN during_II the_DD transition_NN to_II CHF_NN ._.
P11956636A04
Membrane_NN type_NN 1-MMP_NN (_( MT1-MMP_NN )_) was_VBD originally_RR identified_VVN as_II an_DD activator_NN of_II MMP-2_NN ._.
P11964371A10
These_DD results_NNS demonstrate_VVB H_NN /_SYM R-mediated_VVNJ modulation_NN of_II EC_NN MMP-2_NN at_II both_CC transcriptional_JJ and_CC posttranscriptional_JJ levels_NNS ._.
P11970913A08
Dexamethasone_NN prevented_VVD the_DD increase_NN in_II MMP-9_NN release_NN ,_, and_CC increased_VVD TIMP-1_NN release_NN ._.
P11970978A11
However_RR ,_, MMP-9_NN was_VBD only_RR required_VVN for_II Langerhans_NN cell_NN migration_NN and_CC not_RR maturation_NN ,_, since_CS nonmigrating_VVGJ Langerhans_NN cells_NNS isolated_VVN from_II the_DD epidermis_NN matured_VVD normally_RR with_II regard_NN to_II morphology_NN ,_, phenotype_NN ,_, and_CC T_NN cell_NN stimulatory_JJ function_NN ._.
P11971672A10
RESULTS_NNS :_: Increasing_VVGJ concentrations_NNS of_II L-NMMA_NN produced_VVD a_DD dose-dependent_JJ decrease_NN in_II NO_NN (_( x_SYM )_) (_( 2214_MC +/-_SYM 405_MC to_II 347_MC +/-_SYM 37_MC ng_NN /_SYM mg_NN ,_, P_NN <_SYM 0.001_MC )_) ._.
P11971760A08
Finally_RR ,_, we_PN showed_VVD that_CST the_DD expression_NN of_II 1.9_MC kb_NN of_II human_NN MMP-9_NN gene_NN promoter_NN coupled_VVN with_II luciferase_NN (_( MMP-9-luc_NN )_) was_VBD increased_VVN 7.65_MC +/-_SYM 1.2-fold_NN by_II gastrin_NN ,_, via_II a_DD pathway_NN which_PNR includes_VVZ stimulation_NN of_II protein_NN kinase_NN C_NN ,_, and_CC activation_NN of_II Raf_NN and_CC the_DD mitogen-activated_VVNJ protein_NN (_( MAP_NN )_) kinase_NN pathway_NN ._.
P11984824A03
The_DD 64-kDa_NN MMP-2_NN activity_NN was_VBD the_DD highest_NN on_II day_NN 2_MC (_( P_NN <_SYM 0.01_MC )_) and_CC higher_JJR on_II day_NN 5_MC and_CC 6_MC (_( P_NN <_SYM 0.05_MC )_) ._.
P11984824A15
The_DD results_NNS suggested_VVD that_CST the_DD implanting_VVGJ rat_NN embryo_NN strongly_RR induced_VVD MMP-2_NN and_CC -9_MC proteins_NNS and_CC gene_NN expression_NN for_II decidulization_NN and_CC embryo_NN invasion_NN ,_, which_PNR were_VBD strictly_RR controlled_VVN and_CC balanced_VVN by_II the_DD simultaneous_JJ expression_NN of_II TIMP-1_NN ,_, -2_MC and_CC -3_MC ._.
P12000730A11
TGF-beta1_NN (_( 10_MC ng_NN /_SYM ml_NN )_) down-regulated_VVD MMP-9_NN by_II 54_MC %_SYM and_CC MMP-3_NN by_II 34_MC %_SYM whereas_CS TGF-beta_NN 1-neutralizing_VVGJ antibody_NN increased_VVD MMP-9_NN expression_NN by_II 39_MC %_SYM ._.
P12005365A05
Under_II the_DD stimulation_NN of_II IL-1alpha_NN ,_, heparinoid_NN increased_VVD the_DD production_NN of_II TIMP-3_NN in_II a_DD concentration-dependent_JJ manner_NN ,_, but_CC not_RR TIMP-1_NN ,_, TIMP-2_NN ,_, MMP-1_NN or_CC MMP-3_NN ._.
P12009332A03
Synovial_JJ cells_NNS were_VBD cultured_VVN on_II a_DD collagen-coated_VVNJ agar_NN block_NN and_CC exposed_VVN to_II 2_MC %_SYM cyclic_JJ strain_NN at_II 6_MC rev_NN ._.
P12009387A08
Histology_NN of_II the_DD plug_NN sites_NNS revealed_VVD good_JJ integration_NN of_II the_DD collagen_NN plug_NN without_II complete_JJ restoration_NN of_II membrane_NN integrity_NN ._.
P12010506A12
There_EX was_VBD no_DD difference_NN in_II the_DD serum_NN concentration_NN of_II TIMP-1_NN between_II patients_NNS and_CC the_DD controls_NNS ._.
P12011369A03
METHODS_NNS :_: Serum_NN samples_NNS were_VBD collected_VVN from_II 60_MC RA_NN patients_NNS at_II baseline_NN and_CC after_II 8_MC or_CC 12_MC weeks_NNS of_II treatment_NN ._.
P12011989A09
This_PND was_VBD partly_RR reproduced_VVN by_II their_PNG conditioned_VVNJ media_NN ._.
P12014920A07
All_DD quantitations_NNS were_VBD normalized_VVN to_II the_DD 18s_NN rRNA_NN values_NNS (_( endogenous_JJ control_NN )_) and_CC changes_NNS in_II gene_NN expression_NN were_VBD reported_VVN as_II fold_NN increase_NN relative_JJ to_II untreated_VVNJ controls_NNS ._.
P12021040A07
Expression_NN of_II MMP-14_NN was_VBD also_RR observed_VVN in_II the_DD granulosal_JJ layer_NN after_II the_DD gonadotropin_NN surge_NN ._.
P12027249A01
BACKGROUND_NN :_: Matrix_NN metalloproteinase-1_NN (_( MMP-1_NN )_) is_VBZ a_DD member_NN of_II a_DD family_NN of_II enzymes_NNS which_PNR are_VBB capable_JJ of_II degrading_VVGN most_DD extracellular_JJ matrix_NN macromolecules_NNS ._.
P12032297A04
The_DD present_JJ crystal_NN structure_NN of_II the_DD human_NN proMMP-2_NN /_SYM TIMP-2_NN complex_NN reveals_VVZ an_DD interaction_NN between_II the_DD hemopexin_NN domain_NN of_II proMMP-2_NN and_CC the_DD C-terminal_JJ domain_NN of_II TIMP-2_NN ,_, leaving_VVG the_DD catalytic_JJ site_NN of_II MMP-2_NN and_CC the_DD inhibitory_JJ site_NN of_II TIMP-2_NN distant_JJ and_CC spatially_RR isolated_VVN ._.
P12035934A05
These_DD data_NNS suggest_VVB that_CST thyroid_NN carcinoma_NN or_CC tumor-associated_VVNJ inflammatory_JJ cells_NNS might_VM secrete_VVB a_DD factor_NN (_( s_NNS )_) which_PNR stimulates_VVZ MMP-1_NN or_CC TIMP-1_NN expression_NN by_II surrounding_VVGJ tissues_NNS ._.
P12039803A11
Both_PND were_VBD stimulated_VVN by_II FXa_NN and_CC inhibited_VVN by_II the_DD selective_JJ FXa_NN inhibitor_NN DX-9065a_NN and_CC the_DD MMP_NN inhibitor_NN GM_NN 6001_MC but_CC not_RR by_II hirudin_NN or_CC aprotinin_NN ._.
P12042738A03
METHODS_NNS :_: Rat_NN aortic_JJ smooth_JJ muscle_NN cells_NNS were_VBD harvested_VVN from_II Sprague-Dawley_NN rats_NNS ._.
P12044662A09
Ischemic_JJ brain_NN exhibited_VVD high_JJ activity_NN lysis_NN zones_NNS within_II the_DD infarcted_VVNJ area_NN (_( detected_VVN by_II microtubuli_NNS associated_VVNJ protein-2_NN staining_VVGN )_) ._.
P12051403A13
CONCLUSION_NN :_: We_PN confirm_VVB previous_JJ observations_NNS that_CST MMPs_NNS and_CC TIMPs_NNS may_VM play_VVB an_DD important_JJ role_NN in_II various_JJ rheumatic_JJ diseases_NNS ._.
P12051699A06
Cells_NNS expressing_VVG mutant_JJ PDGF_NN receptors_NNS unable_JJ to_TO associate_VVI with_II Src_NN or_CC PLCgamma_NN ,_, retained_VVD the_DD ability_NN to_TO induce_VVI MMP-3_NN expression_NN as_II a_DD result_NN of_II PDGF-BB_NN stimulation_NN ._.
P12054499A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) play_VVB an_DD important_JJ role_NN in_II cancer_NN metastasis_NN ._.
P12058032A07
PMS-induced_VVNJ pro-MMP-2_NN activation_NN was_VBD regulated_VVN by_II the_DD receptor_NN tyrosine_NN kinases_NNS ,_, especially_RR the_DD receptors_NNS of_II platelet-derived_VVNJ growth_NN factor_NN and_CC vascular_JJ endothelial_JJ growth_NN factor_NN ,_, and_CC downstream_JJ on_II the_DD phosphatidylinositol_NN 3-kinase_NN /_SYM NF-kappa_NN B_NN pathway_NN but_CC not_RR Ras_NN ,_, cAMP-dependent_JJ protein_NN kinase_NN ,_, protein_NN kinase_NN C_NN ,_, and_CC mitogen-activated_VVNJ protein_NN kinases_NNS ._.
P12060118A10
The_DD AML_NN patients_NNS with_II lower_JJR MMP-9_NN levels_NNS (_( <_SYM or_CC =_SYM 4.4_MC ng_NN /_SYM ml_NN )_) tended_VVD to_TO have_VHI longer_JJR survival_NN time_NN than_CSN those_PND with_II higher_JJR levels_NNS (_( >_SYM 12_MC months_NNS vs_CC 4_MC months_NNS ,_, P_NN =_SYM 0.12_MC )_) ._.
P12061424A05
Both_DD enzymes_NNS induced_VVD prominent_JJ tissue_NN alterations_NNS and_CC conspicuous_JJ increments_NNS in_II interleukin_NN (_( IL_NN )_) -1beta_NN ,_, IL-6_NN and_CC a_DD number_NN of_II MMPs_NNS ,_, especially_RR gelatinase_NN MMP-9_NN ,_, rapidly_RR after_II injection_NN ._.
P12063180A04
Results_NNS showed_VVD a_DD roughly_RR constitutive_JJ TIMP-1_NN expression_NN opposed_VVN to_II an_DD inducible_JJ MMP-9_NN synthesis_NN ._.
P12064464A05
Either_DD type_NN of_II cell_NN did_VDD not_RR secrete_VVB MMP-9_NN ._.
P12076079A13
No_DD corresponding_VVGJ increase_NN in_II TIMP-1_NN and_CC TIMP-2_NN protein_NN activity_NN and_CC protein_NN level_NN was_VBD detected_VVN by_II reverse_JJ zymography_NN and_CC western_NN blot_NN ._.
P12081746A10
CONCLUSION_NN :_: Failure_NN of_II extracellular_JJ matrix_NN degradation_NN may_VM be_VBB an_DD important_JJ molecular_JJ mechanism_NN in_II the_DD pathogenesis_NN of_II chronic_JJ renal_JJ allograft_NN damage_NN ._.
P12082030A10
Immuno-localization_NN analysis_NN of_II membrane_NN type-1_NN (_( MT1_NN )_) -MMP_NN indicated_VVD that_CST migration_NN is_VBZ associated_VVN with_II the_DD redistribution_NN of_II this_DD protein_NN from_II the_DD endoplasmic_JJ reticulum_NN to_II the_DD plasma_NN membrane_NN ._.
P12084592A02
BACKGROUND_NN :_: Nitroglycerin_NN is_VBZ one_MC of_II the_DD most_RRT frequently_RR used_VVNJ therapeutic_JJ agents_NNS for_II the_DD symptomatic_JJ relief_NN of_II stable_JJ or_CC unstable_JJ coronary_JJ artery_NN disease_NN ;_: however_RR ,_, its_PNG effects_NNS on_II vascular_JJ biology_NN are_VBB poorly_RR characterized_VVN ._.
P12095558A09
Symptoms_NNS increased_VVD further_RR from_II 2_MC weeks_NNS to_II 6_MC weeks_NNS ,_, whereas_CS endoscopic_JJ and_CC cellular_JJ evidence_NN of_II proctitis_NN did_VDD not_RR ._.
P12097550A04
Infection_NN of_II immunosuppressed_VVNJ mice_NNS suggested_VVD that_CST expression_NN of_II most_DD MMP_NN ,_, TIMP_NN ,_, and_CC chemokine_NN mRNA_NN was_VBD induced_VVN primarily_RR in_II CNS-resident_NN cells_NNS ._.
P12097800A07
However_RR ,_, the_DD increased_VVNJ levels_NNS of_II MMPs_NNS seem_VVB not_RR to_TO be_VBI able_JJ to_TO overcome_VVI the_DD overproduction_NN and_CC accumulation_NN of_II the_DD exfoliative_JJ material_NN ._.
P12099554A02
METHODS_NNS :_: Two-cell_NN mouse_NN embryos_NNS were_VBD cultured_VVN for_II 96_MC h_NN in_II the_DD presence_NN or_CC absence_NN of_II various_JJ concentrations_NNS of_II TGF-alpha_NN ._.
P12103373A09
Immunostaining_VVGN for_II collagen_NN IV_MC and_CC laminin_NN was_VBD used_VVN to_TO study_VVI degradation_NN of_II basal_JJ lamina_NN ._.
P12105240A04
METHODS_NNS :_: We_PN performed_VVD immunohistochemistry_NN with_II polyclonal_JJ anti-MMP-2_NN and_CC MMP-9_NN antibodies_NNS ,_, and_CC analysed_VVD gelatin_NN zymograms_NNS of_II five_MC isolated_VVNJ glomeruli_NNS from_II various_JJ types_NNS of_II human_NN renal_JJ disease_NN ._.
P12109221A03
It_PN has_VHZ been_VBN shown_VVN that_CST overexpression_NN of_II TIMPs_NNS in_II tumors_NNS of_II various_JJ origins_NNS leads_VVZ to_II reduced_VVNJ tumor_NN growth_NN and_CC formation_NN of_II metastases_NNS ._.
P12111403A04
Basement_NN lamina_NN was_VBD present_VVB only_RR focally_RR ._.
P12113554A07
Minor_JJ gelatinolytic_JJ bands_NNS were_VBD also_RR observed_VVN at_II 92_MC kDa_NN regions_NNS that_PNR correspond_VVB to_II MMP-9_NN ._.
P12114911A06
CONCLUSIONS_NNS :_: MMP_NN levels_NNS in_II the_DD pregnant_JJ and_CC postpartum_NN rat_NN uterus_NN and_CC cervix_NN are_VBB regulated_VVN in_II part_NN by_II a_DD PGE_NN (_( 2_MC )_) -cAMP_NN mechanism_NN ._.
P12115185A02
METHODS_NNS :_: The_DD metabolic_JJ profile_NN of_II human_NN OA_NN cartilage_NN was_VBD determined_VVN at_II the_DD time_NN of_II harvest_NN and_CC after_II 24-hour_NN exposure_NN to_II n-3_NN PUFAs_NNS or_CC other_JJ classes_NNS of_II fatty_JJ acids_NNS ,_, followed_VVN by_II explant_NN culture_NN for_II 4_MC days_NNS in_II the_DD presence_NN or_CC absence_NN of_II interleukin-1_NN (_( IL-1_NN )_) ._.
P12118337A05
ACLA-differentiated_VVNJ cells_NNS exhibited_VVD an_DD increased_VVNJ proMMP-9_NN secretion_NN which_PNR has_VHZ been_VBN observed_VVN by_II gelatin_NN zymography_NN and_CC immunoassay_NN ._.
P12118680A09
The_DD potential_NN for_II physiologically_RR relevant_JJ regulation_NN of_II expression_NN of_II these_DD genes_NNS by_II PGE2_NN is_VBZ a_DD consideration_NN in_II the_DD use_NN of_II drugs_NNS that_PNR inhibit_VVB prostanoid_NN synthesis_NN in_II the_DD treatment_NN of_II equine_JJ arthropathies_NNS ._.
P12133319A06
Transcriptional_JJ levels_NNS of_II MMP-2_NN and_CC TIMP-1_NN mRNA_NN in_II the_DD lungs_NNS were_VBD assessed_VVN by_II semiquantitative_JJ reverse_JJ transcription-polymerase_NN chain_NN reaction_NN (_( RT-PCR_NN )_) ._.
P12133379A04
(_( 2_MC )_) The_DD ratio_NN of_II MMP_NN /_SYM TIMP_NN in_II trabecular_JJ meshwork_NN cells_NNS was_VBD much_RR higher_JJR than_CSN that_PND in_II ciliary_JJ muscle_NN cells_NNS ._.
P12134900A02
In_II the_DD present_JJ study_NN ,_, by_II assessing_VVGN the_DD effect_NN of_II a_DD specific_JJ p38_NN mitogen-activated_VVNJ protein_NN kinase_NN (_( MAPK_NN )_) inhibitor_NN ,_, SB203580_NN ,_, on_II the_DD secretion_NN of_II MMPs_NNS and_CC in_JJ+ vitro_JJ invasion_NN of_II various_JJ glioma_NN cells_NNS ,_, the_DD authors_NNS attempt_VVB to_TO define_VVI the_DD role_NN of_II the_DD p38_NN MAPK_NN pathway_NN in_II the_DD regulation_NN of_II MMPs_NNS and_CC tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) activated_VVN by_II phorbol_NN ester_NN (_( phorbol-12-myristate-13-acetate_NN [_( PMA_NN ]_) )_) in_II the_DD D54_NN human_NN glioblastoma_NN cell_NN line_NN ._.
P12136400A01
AIMS_NNS /_SYM HYPOTHESIS_NN :_: The_DD molecular_JJ factors_NNS that_PNR cause_VVB an_DD acute_JJ wound_NN in_II diabetic_JJ patients_NNS to_TO become_VVI chronic_JJ have_VHB not_RR yet_RR been_VBN established_VVN ._.
P12137602A08
RESULTS_NNS :_: The_DD pathological_JJ changes_NNS of_II bronchi_NNS and_CC lung_NN tissue_NN ,_, the_DD changes_NNS of_II lung_NN function_NN and_CC blood_NN gas_NN analysis_NN were_VBD similar_JJ to_II those_PND of_II the_DD COPD_NN patients_NNS ._.
P12139676A07
Serum_NN MMP-9_NN activity_NN and_CC TIMP-1_NN level_NN in_II patients_NNS with_II SSc_NN were_VBD not_RR correlated_VVN ._.
P12145178A10
Glycation_NN of_II matrix_NN decreased_VVD TGF-beta_NN mRNA_NN by_II 38.2_MC %_SYM and_CC total_JJ and_CC active_JJ TGF-beta_NN by_II 35.5_MC and_CC 21.5_MC %_SYM ,_, respectively_RR ,_, opposite_JJ the_DD effects_NNS of_II high_JJ glucose_NN concentrations_NNS ._.
P12146533A10
CONCLUSIONS_NNS :_: These_DD data_NNS strongly_RR suggest_VVB that_CST future_JJ clinical_JJ studies_NNS investigating_VVG the_DD role_NN of_II IL-6_NN in_II periodontal_JJ disease_NN must_VM also_RR determine_VVB the_DD levels_NNS of_II sIL-6r_NN within_II the_DD periodontal_JJ tissues_NNS ._.
P12147532A04
Angiotensin-converting_VVGJ enzyme_NN activity_NN was_VBD determined_VVN by_II use_NN of_II a_DD specific_JJ substrate_NN ._.
P12147614A09
TGF-beta_NN (_( 2_MC )_) also_RR stimulated_VVD MT2-MMP_NN cell_NN surface_NN expression_NN and_CC release_NN of_II TIMP-1_NN ._.
P12149192A05
The_DD closely_RR related_VVNJ chemokines_NNS MCP-1_NN ,_, MCP-2_NN ,_, and_CC MCP-4_NN were_VBD not_RR cleaved_VVN by_II MMP-2_NN or_CC MT1-MMP_NN ,_, but_CC were_VBD cleaved_VVN by_II MMP-1_NN and_CC MMP-3_NN with_II varying_VVGJ efficiency_NN ._.
P12154073A02
Endothelial_JJ tubulogenesis_NN was_VBD also_RR increased_VVN in_II co-culture_NN with_II tumour_NN cells_NNS such_II+ as_II U87_NN glioma_NN cells_NNS ,_, but_CC not_RR with_II non-tumorigenic_JJ cell_NN types_NNS such_II+ as_II Madin-Darby_NN canine_JJ kidney_NN (_( MDCK_NN )_) epithelial_JJ cells_NNS ._.
P12160135A12
S-2444_NN ,_, a_DD specific_JJ chromogenic_JJ peptide_NN ,_, was_VBD useful_JJ for_II quantitative_JJ analysis_NN of_II the_DD activity_NN of_II MMP_NN subtypes_NNS in_II this_DD study_NN ._.
P12162654A01
The_DD extracellular_JJ matrix_NN ,_, composed_VVN mainly_RR of_II collagen_NN ,_, is_VBZ considered_VVN responsible_JJ for_II the_DD residual_JJ toughness_NN of_II meat_NN ._.
P12164864A06
METHODS_NNS :_: Expression_NN of_II mRNAs_NNS for_II receptors_NNS of_II growth_NN factors_NNS (_( bFGF_NN ,_, PDGF_NN ,_, TGF-beta1_NN )_) ,_, the_DD proteinases_NNS and_CC their_PNG inhibitors_NNS in_II differentiated_VVNJ podocytes_NNS were_VBD shown_VVN by_II RT-PCR_NN ._.
P12165796A11
This_DD model_NN can_VM be_VBB applied_VVN in_II detecting_VVGN patients_NNS with_II poor_JJ prognosis_NN and_CC patients_NNS who_PNR may_VM benefit_VVB from_II MMPI_NN treatment_NN ._.
P12172142A06
In_II this_DD study_NN ,_, we_PN examined_VVD the_DD ontogeny_NN of_II ten_MC matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC their_PNG tissue_NN inhibitors_NNS (_( TIMPs_NNS )_) in_II nonwounded_VVNJ fetal_JJ rat_NN skin_NN and_CC fibroblasts_NNS as_II a_DD function_NN of_II gestational_JJ age_NN ._.
P12173379A03
RESULTS_NNS :_: We_PN found_VVD that_CST type_NN IV_MC collagenase_NN activity_NN in_II pancreatic_JJ and_CC colon_NN carcinomas_NNS with_II liver_NN metastases_NNS was_VBD significantly_RR higher_JJR than_CSN in_II pancreatic_JJ and_CC colon_NN carcinomas_NNS without_II liver_NN metastases_NNS ._.
P12174907A04
Squamous_JJ cell_NN carcinomas_NNS of_II the_DD head_NN and_CC neck_NN (_( SCCHN_NN )_) are_VBB known_VVN to_TO be_VBI highly_RR invasive_JJ tumors_NNS with_II early_JJ locoregional_JJ metastatic_JJ spread_NN ._.
P12184536A04
Specimens_NNS of_II colon_NN tumors_NNS and_CC of_II adjacent_JJ normal_JJ mucosa_NN were_VBD obtained_VVN from_II 22_MC patients_NNS at_II the_DD time_NN of_II surgical_JJ resection_NN ._.
P12185105A10
In_II conclusion_NN ,_, this_PND is_VBZ the_DD first_JJ report_NN of_II MMP_NN activity_NN in_II normal_JJ and_CC abnormal_JJ human_NN sperm_NN samples_NNS and_CC of_II TIMP_NN presence_NN in_II sperm_NN samples_NNS ._.
P12193736A04
To_TO clarify_VVI these_DD roles_NNS ,_, we_PN investigated_VVD the_DD development_NN of_II Ab-induced_VVNJ arthritis_NN ,_, one_MC of_II the_DD murine_JJ models_NNS of_II rheumatoid_JJ arthritis_NN ,_, in_II MMP-2_NN or_CC MMP-9_NN knockout_NN (_( KO_NN )_) mice_NNS ._.
P12194986A11
In_II functional_JJ studies_NNS ,_, increasing_VVGN calcium_NN enhanced_VVD MMP-dependent_JJ cellular_JJ migration_NN on_II laminin-5-rich_JJ matrix_NN using_VVG an_DD in_JJ+ vitro_JJ colony_NN dispersion_NN assay_NN ._.
P12198653A05
The_DD goal_NN of_II this_DD work_NN was_VBD to_TO determine_VVI whether_CST apoptosis_NN induction_NN in_II human_NN hepatic_JJ myofibroblasts_NNS modulates_VVZ the_DD gene_NN expression_NN of_II MMP-2_NN and/or_CC its_PNG activation_NN by_II MT1-MMP_NN ._.
P12200138A01
Release_NN and_CC activation_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) significantly_RR contribute_VVB to_II myocardial_JJ stunning_VVGJ injury_NN immediately_RR after_II ischemia_NN and_CC reperfusion_NN ,_, however_RR ,_, their_PNG role_NN in_II preconditioning_VVGN remains_VVZ unknown_VVN ._.
P12200461A09
MMP-2_NN protein_NN was_VBD prominent_JJ in_II late_JJ ,_, but_CC not_RR early_JJ CL_NN microvasculature_NN ._.
P12202125A11
However_RR ,_, failure_NN to_TO detect_VVI protein_NN expression_NN for_II MMPs_NNS 2_MC ,_, 7_MC ,_, 9_MC ,_, 13_MC and_CC TIMPs_NNS 1_MC and_CC 2_MC in_II murine_JJ chondrocytes_NNS by_II immunohistochemistry_NN indicates_VVZ that_CST the_DD changes_NNS in_II mRNA_NN levels_NNS in_II STR_NN /_SYM ort_NN mice_NNS must_VM be_VBB interpreted_VVN with_II caution_NN ._.
P12209100A08
However_RR ,_, with_II the_DD exception_NN of_II one_MC individual_NN for_II whom_PNR active_JJ MMP-9_NN was_VBD not_RR detected_VVN ,_, tear_NN fluid_NN from_II all_DD patients_NNS with_II VKC_NN contained_VVD both_CC proforms_NNS and_CC active_JJ forms_NNS of_II MMP-2_NN and_CC MMP-9_NN ._.
P12210832A02
It_PN has_VHZ been_VBN previously_RR demonstrated_VVN that_CST increased_VVNJ expression_NN of_II TGFbeta_NN has_VHZ consequences_NNS for_II the_DD levels_NNS of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC their_PNG specific_JJ inhibitors_NNS (_( tissue_NN inhibitors_NNS of_II MMPs_NNS ,_, or_CC TIMPs_NNS )_) ._.
P12231217A11
The_DD disproportional_JJ increase_NN in_II MT1-MMP_NN and_CC TIMP-2_NN might_VM contribute_VVB to_II MMP-2_NN activation_NN ._.
P12235077A06
Gene_NN array_NN analysis_NN and_CC in_JJ+ situ_JJ hybridisation_NN were_VBD performed_VVN to_TO investigate_VVI changes_NNS in_II MMP_NN gene_NN expression_NN ._.
P12237340A08
This_DD effect_NN of_II NO_NN may_VM be_VBB important_JJ in_II the_DD context_NN of_II pathophysiological_JJ conditions_NNS such_II+ as_II inflammation_NN or_CC atherogenesis_NN [_( corrected_VVN ]_) ._.
P12237942A07
Taken_VVN together_RR ,_, our_PNG results_NNS suggest_VVB that_CST MMP-2_NN and_CC TIMP-3_NN may_VM have_VHB functional_JJ roles_NNS in_II rat_NN luteal_JJ formation_NN ,_, while_CS TIMP-2_NN may_VM be_VBB implicated_VVN in_II both_CC formation_NN and_CC regression_NN of_II the_DD pregnant_JJ CL_NN ._.
P12269680A10
TIMP-2_NN levels_NNS were_VBD lower_JJR in_II serum_NN of_II subjects_NNS with_II moderate_JJ /_SYM extensive_JJ adhesions_NNS compared_VVN with_II subjects_NNS without_II adhesions_NNS ._.
P12297832A05
We_PN also_RR examined_VVD the_DD effect_NN of_II TIMP-1_NN on_II HSC_NN apoptosis_NN ._.
P12323181A02
MATERIAL_NN AND_CC METHODS_NNS :_: in_II a_DD series_NN of_II 40_MC patients_NNS with_II AAA_NN >_SYM or_CC =5cm_NN in_II maximal_JJ cross-sectional_JJ diameter_NN ,_, C._NN pneumoniae-DNA_NN was_VBD identified_VVN in_II the_DD aneurysm_NN wall_NN by_II nested_VVNJ PCR_NN in_II 14_MC (_( 35_MC %_SYM )_) patients_NNS ._.
P12351448A01
Pathological_JJ remodeling_VVGN characterized_VVN by_II extracellular_JJ matrix_NN (_( ECM_NN )_) deposition_NN contributes_VVZ to_II the_DD diabetic_JJ vascular_JJ complications_NNS ._.
P12354802A05
METHODS_NNS :_: Immunohistochemistry_NN for_II MMP-13_NN was_VBD performed_VVN on_II formalin_NN fixed_VVNJ ,_, paraffin_NN wax_NN embedded_VVNJ sections_NNS of_II a_DD large_JJ series_NN of_II colorectal_JJ cancers_NNS (_( n_NN =_SYM 249_MC )_) ,_, all_PND of_II which_PNR had_VHD uniform_JJ clinical_JJ and_CC pathological_JJ information_NN available_JJ ._.
P12359766A06
These_DD data_NNS demonstrate_VVB a_DD link_NN between_II increased_VVNJ specificity_NN of_II MMPIs_NNS and_CC enhanced_VVNJ anticancer_NN activity_NN ._.
P12361907A05
On_II the_DD protein_NN level_NN ,_, expression_NN of_II MMP-9_NN was_VBD significantly_RR higher_JJR and_CC TIMP-1_NN expression_NN was_VBD significantly_RR lower_JJR ,_, MMP-2_NN was_VBD unchanged_VVN and_CC the_DD ratios_NNS of_II MMP-2_NN and_CC MMP-9_NN to_II TIMP-1_NN were_VBD increased_VVN in_II tumor_NN tissue_NN ._.
P12370004A06
The_DD interaction_NN of_II MMPs_NNS with_II chemical_JJ mediators_NNS and_CC inflammatory_JJ cytokines_NNS has_VHZ also_RR been_VBN reported_VVN in_II some_DD recent_JJ studies_NNS ._.
P12374789A03
Myoglobin_NN was_VBD used_VVN as_II a_DD novel_JJ recombinant_JJ fusion_NN protein_NN partner_NN because_CS spectroscopic_JJ measurement_NN of_II the_DD heme_NN Soret_NN absorbance_NN at_II 408_MC nm_NN readily_RR enabled_VVD calculation_NN of_II the_DD molar_JJ equivalent_NN of_II the_DD red-colored_VVNJ recombinant_JJ protein_NN ,_, even_RR in_II complex_JJ protein_NN mixtures_NNS ._.
P12379519A02
OBJECTIVE_NN :_: To_TO examine_VVI the_DD in_JJ+ vitro_JJ invasiveness_NN of_II synoviocytes_NNS obtained_VVN from_II inflamed_VVNJ joints_NNS of_II patients_NNS with_II arthritis_NN in_II relation_NN to_II the_DD expression_NN of_II MMP_NN 1-14_MC ,_, 17_MC ,_, 19_MC ,_, cathepsin-K_NN ,_, the_DD tissue_NN inhibitors_NNS of_II matrix_NN metalloproteinases_NNS TIMP-1_NN and_CC TIMP-2_NN by_II FLS_NN ._.
P12381651A05
Increased_VVNJ MMP-2_NN was_VBD only_RR found_VVN in_II IDCM_NN (_( 3.68_MC (_( 0.41_MC )_) ng_NN /_SYM ml_NN )_) ._.
P12384502A06
In_II a_DD zymography_NN assay_NN ,_, MMP-9-PEX_NN was_VBD able_JJ to_TO inhibit_VVI MMP-9_NN activity_NN ._.
P12384564A04
In_II the_DD lung_NN metastasis_NN model_NN ,_, tumor_NN cells_NNS (_( PC14_NN ,_, PC14PE6_NN ,_, H226_NN ,_, A549_NN )_) inoculated_VVN i.v._NN into_II nude_JJ or_CC SCID_NN mice_NNS metastasized_VVD only_RR in_II the_DD lung_NN ._.
P12384920A07
Blood_NN ,_, tissue_NN samples_NNS ,_, and_CC fibroblasts_NNS were_VBD assayed_VVN for_II MMPs_NNS 1_MC ,_, 2_MC ,_, 3_MC ,_, and_CC 9_MC ,_, and_CC TIMPs_NNS 1_MC and_CC 2_MC by_II sandwich_NN enzyme_NN immunoassay_NN ._.
P12385578A02
Overexpression_NN of_II matrix_NN metalloproteinase_NN 3_MC (_( MMP-3_NN or_CC stromelysin_NN 1_MC )_) gene_NN has_VHZ been_VBN demonstrated_VVN in_II various_JJ types_NNS of_II cancers_NNS and_CC high_JJ level_NN of_II MMP-3_NN protein_NN in_II tumour_NN is_VBZ a_DD poor_JJ prognostic_JJ factor_NN for_II patients_NNS ._.
P12388270A09
The_DD collagen_NN cross-linking_VVGJ ratio_NN (_( insoluble_JJ :_: soluble_JJ collagen_NN )_) was_VBD reduced_VVN (_( P_NN =_SYM 0.003_MC )_) as_CS the_DD left_JJ ventricle_NN dilated_VVN ._.
P12390324A01
Matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) capable_JJ of_II degrading_VVGN various_JJ components_NNS of_II connective_JJ tissue_NN matrices_NNS ,_, and_CC tissue_NN inhibitor_NN metalloproteinases_NNS (_( TIMPs_NNS )_) are_VBB considered_VVN important_JJ in_II lung_NN parenchymal_JJ remodeling_VVGN and_CC repair_NN processes_NNS in_II pulmonary_JJ diseases_NNS ._.
P12393094A04
RESULTS_NNS :_: In_II viral_JJ infected_VVNJ mice_NNS ,_, both_CC mRNA_NN and_CC protein_NN abundance_NN for_II collagen_NN type_NN I_MC remained_VVD unaltered_VVN ._.
P12399724A08
RESULTS_NNS :_: There_EX was_VBD an_DD overexpression_NN of_II MMP-2_NN and_CC -9_MC in_II corneal_JJ burns_NNS versus_CC control_NN corneas_NNS ._.
P12404299A04
Inhibition_NN of_II the_DD expression_NN of_II MMP-9_NN may_VM prevent_VVB tumor_NN development_NN ._.
P12407049A06
MMP-9_NN ,_, TIMP-1_NN and_CC TIMP-2_NN were_VBD not_RR significantly_RR different_JJ in_II normozoospermia_NN and_CC azoospermia_NN ._.
P12426251A04
STUDY_NN OBJECTIVE_NN :_: s_NNS :_: To_TO determine_VVI whether_CST severe_JJ ,_, persistent_JJ asthma_NN is_VBZ associated_VVN with_II increased_VVNJ levels_NNS of_II MMP-9_NN in_II the_DD airway_NN compared_VVN with_II mild_JJ asthma_NN ,_, and_CC to_TO assess_VVI the_DD effect_NN of_II both_CC allergen_NN exposure_NN and_CC steroid_NN treatment_NN on_II MMP-9_NN and_CC TIMP-1_NN levels_NNS ._.
P12429818A10
These_DD relatively_RR rapid_JJ changes_NNS of_II the_DD MMP-2_NN status_NN can_VM not_RR be_VBB detected_VVN by_II gelatin_NN zymography_NN ._.
P12433840A04
By_II binding_VVGN to_II the_DD u-PA_NN receptor_NN this_DD protein_NN will_VM not_RR only_RR anchor_VVB the_DD TIMP-1_NN moiety_NN directly_RR to_II the_DD cell_NN surface_NN ,_, it_PN will_VM also_RR prevent_VVB the_DD local_JJ activation_NN of_II plasminogen_NN by_II blocking_VVGN the_DD binding_VVGN of_II urokinase-type_NN plasminogen_NN activator_NN (_( u-PA_NN )_) to_II its_PNG receptor_NN ._.
P12437648A01
Agnogenic_JJ myeloid_NN metaplasia_NN (_( AMM_NN )_) is_VBZ characterized_VVN by_II bone_NN marrow_NN fibrosis_NN with_II abnormal_JJ accumulation_NN of_II extracellular_JJ matrix_NN components_NNS (_( ECM_NN )_) ,_, which_PNR is_VBZ dependent_JJ on_II the_DD balance_NN between_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) and_CC tissue_NN inhibitors_NNS of_II metalloproteinases_NNS (_( TIMPs_NNS )_) ._.
P12444074A10
Therefore_RR ,_, these_DD data_NNS indicate_VVB that_CST proMMP-9_NN is_VBZ produced_VVN by_II the_DD amnion_NN but_CC not_RR the_DD chorion_NN in_II response_NN to_II LPS_NN ._.
P12447632A02
Total_JJ joint_NN replacement_NN results_VVZ in_II total_JJ resection_NN of_II cartilage_NN and_CC synovium_NN at_II the_DD joint_NN ._.
P12449177A05
Western_NN immunoblotting_VVGN revealed_VVD the_DD presence_NN of_II two_MC isoforms_NNS of_II MMP-8_NN in_II patient_NN samples_NNS ;_: an_DD 80_MC kD_NN form_NN representing_VVG latent_JJ enzyme_NN from_II polymorphonuclear_JJ neutrophils_NNS and_CC a_DD 55_MC kD_NN form_NN representing_VVG the_DD fibroblast-type_NN proform_NN ._.
P12452001A07
While_CS the_DD frequency_NN of_II the_DD serosa_NN invasion_NN and_CC lymph_NN node_NN metastasis_NN in_II the_DD group_NN of_II the_DD expression_NN of_II MMP-9_NN over_II TIMP-1_NN was_VBD significantly_RR higher_JJR than_CSN those_PND in_II the_DD groups_NNS of_II the_DD expression_NN of_II TIMP-1_NN over_II MMP-9_NN or_CC the_DD balance_NN expression_NN of_II MMP-9_NN and_CC TIMP-1_NN ._.
P12454040A05
To_TO evaluate_VVI the_DD potential_JJ role_NN of_II PKC_NN ,_, HCM_NN cells_NNS were_VBD treated_VVN with_II phorbol_NN 12-myrisate_NN 13-acetate_NN (_( PMA_NN )_) in_II the_DD absence_NN or_CC presence_NN of_II the_DD PKC_NN inhibitor_NN bisindolylmaleimide_NN I_MC (_( Bis_NN I_NN )_) or_CC the_DD PKA_NN inhibitor_NN KT5720_NN ._.
P12456342A02
The_DD chances_NNS of_II reproductive_JJ success_NN during_II each_DD cycle_NN depends_VVZ on_II appropriate_JJ ,_, cell-specific_JJ responses_NNS to_II steroids_NNS ,_, including_VVG expression_NN of_II matrix_NN metalloproteinases_NNS (_( MMPs_NNS )_) ._.
P12464265A08
As_II a_DD first_JJ step_NN ,_, human_NN fetal_JJ hepatocyte_NN (_( HFH_NN )_) and_CC HepG2_NN (_( HCC_NN origin_NN ,_, HBV_NN not_RR detected_VVN )_) cells_NNS were_VBD subjected_VVN to_II infection_NN with_II HBV_NN ,_, and_CC the_DD resulting_VVGJ infected_VVNJ cells_NNS successfully_RR established_VVD are_VBB hereafter_RR referred_VVN to_II as_II HFH-T2_NN and_CC HepG2-HBV_NN ._.
P12466243A13
TIMP-4_NN was_VBD not_RR released_VVN during_II platelet_NN aggregation_NN induced_VVN by_II HT-1080_NN cells_NNS ._.
P12468782A03
The_DD aim_NN of_II the_DD study_NN was_VBD to_TO investigate_VVI the_DD ability_NN of_II doxycycline_NN ,_, a_DD nonspecific_JJ MMP_NN inhibitor_NN ,_, to_TO reduce_VVI MMP_NN concentration_NN in_II carotid_JJ atheroma_NN ._.
P12473546A05
Abundant_JJ MT3-MMP_NN expression_NN was_VBD noted_VVN in_II medial_JJ smooth_JJ muscle_NN cells_NNS (_( SMCs_NNS )_) of_II normal_JJ arteries_NNS ._.
P12475252A07
Molecular_JJ interactions_NNS of_II TIMPs_NNS and_CC MMPs_NNS investigated_VVN by_II IAsys_NN biosensor_NN analysis_NN highlighted_VVD different_JJ modes_NNS of_II interaction_NN between_II proMMP-2-TIMP-2_NN (_( or_CC TIMP-4_NN )_) and_CC active_JJ MMP-2-TIMP-2_NN (_( or_CC TIMP-4_NN )_) complexes_NNS ._.
P12479097A06
RESULTS_NNS :_: Immunohistochemical_JJ staining_VVGN of_II tumor_NN cells_NNS for_II MMP-2_NN ,_, MMP-9_NN ,_, TIMP-1_NN ,_, and_CC TIMP-2_NN were_VBD noted_VVN 82.5_MC %_SYM ,_, 70.0_MC %_SYM ,_, 62.5_MC %_SYM ,_, and_CC 97.5_MC %_SYM in_II carcinomas_NNS ,_, 44.8_MC %_SYM ,_, 62.1_MC %_SYM ,_, 86.21_MC %_SYM ,_, and_CC 96.55_MC %_SYM in_II CIN_NN lesions_NNS respectively_RR ,_, for_II MMP-2_NN ,_, MMP-9_NN ,_, TIMP-1_NN in_II 25.0_MC %_SYM normal_JJ cervices_NNS ,_, but_CC for_II TIMP-2_NN in_II 56.25_MC %_SYM normal_JJ cervices_NNS ._.
P12483743A03
METHODS_NNS :_: We_PN administered_VVD human_NN TIMP-4_NN by_II electroporation-mediated_VVNJ intramuscular_JJ injection_NN of_II naked_JJ DNA_NN using_VVG the_DD rat_NN adjuvant-induced_VVNJ arthritis_NN (_( AIA_NN )_) model_NN ._.
P12505230A09
In_II addition_NN ,_, a_DD concomitant_JJ increase_NN in_II plasma_NN TIMP-1_NN levels_NNS did_VDD not_RR occur_VVB post-MI_NN ._.
P12506070A04
METHODS_NNS :_: Porcine_JJ TM_NN cells_NNS were_VBD treated_VVN with_II TNFalpha_NN ,_, and_CC changes_NNS in_II MMPs_NNS and_CC TIMPs_NNS were_VBD evaluated_VVN by_II zymography_NN and_CC Western_NN immunoblot_NN assay_NN ._.
P12508295A02
Female_NN Wistar_NN rats_NNS (_( 7-8_MC months_NNS old_JJ )_) had_VHD their_PNG right_JJ hindlimbs_NNS immobilized_VVN by_II an_DD external_JJ fixation_NN procedure_NN for_II 5_MC ,_, 10_MC ,_, 21_MC ,_, and_CC 30_MC days_NNS ._.
P12514782A09
Staining_VVGN for_II type_NN IV_MC collagen_NN showed_VVD focal_JJ damage_NN to_II the_DD basement_NN membranes_NNS of_II cardiac_JJ myocytes_NNS and_CC pulmonary_JJ alveoli_NNS near_II the_DD granulomas_NNS ._.
P12524413A13
RT-PCR_NN demonstrated_VVD the_DD presence_NN of_II mRNA_NN for_II metalloproteinase_NN inhibitors_NNS TIMP1_NN and_CC TIMP2_NN in_II PSCs_NNS while_CS reverse_JJ zymography_NN revealed_VVD the_DD presence_NN of_II functional_JJ TIMP2_NN in_II PSC_NN secretions_NNS ._.
P12528092A07
Interestingly_RR ,_, plasma_NN levels_NNS of_II MMP-8_NN were_VBD decreased_VVN in_II CHF_NN patients_NNS (_( 16_MC +/-_SYM 2_MC versus_CC 9_MC +/-_SYM 2_MC ng_NN /_SYM mL_NN ,_, P_NN <_SYM .05_MC )_) ._.
P12529376A05
In_II contrast_NN ,_, MMP-7_NN and_CC TIMP-3_NN mRNAs_NNS are_VBB markedly_RR decreased_VVN in_II obesity_NN ._.
P12538437A02
Several_JJ MMPs_NNS are_VBB overexpressed_VVN in_II the_DD atherosclerotic_JJ plaque_NN ,_, and_CC they_PN are_VBB believed_VVN to_TO contribute_VVI to_II the_DD expansion_NN and_CC rupture_NN of_II the_DD lesion_NN ._.
P12540195A06
After_II secretion_NN ,_, progelatinase_NN B_NN must_VM be_VBB activated_VVN through_II an_DD activation_NN network_NN ._.
P12546341A11
CONCLUSIONS_NNS :_: Our_PNG results_NNS from_II these_DD two_MC pilot_NN studies_NNS suggest_VVB that_CST increased_VVNJ MMP-9_NN and_CC decreased_VVNJ TIMP-1_NN at_II night_NN in_II NA_NN may_VM lead_VVB to_II reduced_VVNJ elastin_NN density_NN ._.
P12566130A03
METHODS_NNS AND_CC RESULTS_NNS :_: Balloon_NN angioplasty_NN was_VBD performed_VVN in_II the_DD left_JJ coronary_JJ arteries_NNS followed_VVN by_II injection_NN of_II adenovirus_NN vector_NN solution_NN encoding_VVG either_CC MMP-9_NN or_CC beta-galactosidase_NN (_( beta-gal_NN )_) gene_NN into_II the_DD injured_VVNJ coronary_JJ arteries_NNS ._.
P12566375A11
The_DD PKC-beta_NN isoform_NN played_VVD a_DD critical_JJ role_NN in_II the_DD expression_NN of_II MMPs_NNS ,_, because_CS the_DD PKC-beta_NN inhibitor_NN hispidin_NN reduced_VVD ox-LDL-induced_VVNJ activation_NN of_II PKC_NN and_CC the_DD expression_NN of_II MMPs_NNS ._.
P12566376A11
These_DD effects_NNS were_VBD not_RR observed_VVN in_II the_DD MI-only_JJ group_NN ._.
P12576963A05
INTERVENTION_NN :_: Bronchoalveolar_JJ lavages_NNS were_VBD performed_VVN on_II day_NN 0_MC of_II the_DD onset_NN of_II ARDS_NN and_CC on_II days_NNS 4_MC ,_, 8_MC ,_, and_CC 12_MC for_II unresolving_VVGJ ARDS_NN ._.
P12589095A11
MMP-2_NN ,_, MMP-9_NN ,_, and_CC TGF-beta1_NN may_VM contribute_VVB to_II eosinophil_NN and_CC mast_JJ cell_NN migrations_NNS into_II nasal_JJ polyp_NN tissue_NN ._.P07473676A02
However_RR ,_, estimates_NNS of_II the_DD prevalence_NN of_II HPV_NN infection_NN differs_VVZ among_II various_JJ detection_NN methods_NNS ._.
P07559932A09
Forty-two_MC of_II the_DD 43_MC samples_NNS that_CST did_VDD not_RR contain_VVB HPV_NN types_NNS 6_MC /_SYM 11_MC ,_, 16_MC ,_, 18_MC ,_, 31_MC ,_, 33_MC ,_, 35_MC ,_, and_CC 45_MC were_VBD also_RR negative_JJ by_II PCR-EIA_NN ,_, for_II a_DD specificity_NN of_II 97.7_MC %_SYM ._.
P07658497A11
The_DD risk_NN of_II persistent_JJ SIL_NN was_VBD associated_VVN with_II continual_JJ HPV_NN infection_NN in_II visits_NNS t_NN and_CC t_NN +_SYM 1_MC (_( HPV_NN positive_JJ by_II Southern_NN blot_NN analysis_NN :_: odds_NNS ratio_NN [_( OR_NN ]_) =_SYM 3.91_MC ,_, and_CC 95_MC %_SYM confidence_NN interval_NN [_( CI_NN ]_) =_SYM 1.58-9.65_MC ;_: HPV_NN positive_JJ by_II polymerase_NN chain_NN reaction_NN [_( PCR_NN ]_) :_: OR_NN =_SYM 2.42_MC ,_, and_CC 95_MC %_SYM CI_NN =_SYM 1.03-5.67_MC )_) and_CC a_DD persistent_JJ high_JJ viral_JJ load_NN (_( OR_NN =_SYM 4.07_MC ,_, and_CC 95_MC %_SYM CI_NN =_SYM 1.35-12.30_MC )_) ._.
P07706782A05
At_II follow-up_NN ,_, the_DD most_RRT common_JJ type_NN was_VBD HPV-16_NN (_( 2.9_MC %_SYM )_) ,_, while_CS no_DD HPV-6_NN was_VBD detected_VVN ._.
P07773937A14
Sixty-six_MC percent_NN had_VHD multicentric_JJ neoplasia_NN ._.
P07791438A10
These_DD results_NNS should_VM stimulate_VVB a_DD much_RR larger_JJR randomised_VVNJ trial_NN to_TO assess_VVI the_DD impact_NN of_II these_DD improved_VVNJ CIN_NN 2_MC /_SYM 3_MC detection_NN rates_NNS on_II the_DD subsequent_JJ incidence_NN of_II invasive_JJ cancer_NN ._.
P07862368A03
Dacron_NN swabs_NNS were_VBD used_VVN to_TO obtain_VVI samples_NNS from_II the_DD cervices_NNS of_II 371_MC women_NNS referred_VVN for_II colposcopy_NN ._.
P07871443A03
STUDY_NN DESIGN_NN :_: DNA_NN was_VBD extracted_VVN from_II paraffin-embedded_VVNJ ,_, formalin-fixed_VVNJ tissues_NNS using_VVG a_DD sonication_NN method_NN ._.
P07877628A05
The_DD high_JJ sensitivity_NN of_II the_DD in_JJ+ situ_JJ PCR_NN applicable_JJ to_II paraffin-embedded_VVNJ archival_JJ biopsies_NNS facilitated_VVD the_DD detection_NN of_II cells_NNS poorly_RR reactive_JJ by_II conventional_JJ ISH_NN ._.
P07914697A08
Contaminating_VVGJ DNA_NN was_VBD identified_VVN in_II two_MC gels_NNS where_PNR multiple_JJ samples_NNS yielded_VVD the_DD same_JJ restriction_NN pattern_NN ._.
P07927936A10
Women_NNS with_II HPV-negative_JJ tumors_NNS had_VHD a_DD higher_JJR risk_NN of_II death_NN (_( RR_NN 1.51_MC ;_: p_NN =_SYM 0.07_MC )_) ._.
P08167008A05
Five_MC percent_NN of_II biopsies_NNS were_VBD doubly_RR infected_VVN ,_, chiefly_RR with_II HPV_NN 16_MC +_SYM 18_MC ._.
P08184666A08
Our_PNG results_NNS --_: in_II accordance_NN with_II the_DD numerous_JJ data_NNS found_VVN in_II literature_NN --_: seem_VVB to_TO confirm_VVI the_DD hypothesis_NN that_CST certain_JJ HPV_NN types_NNS are_VBB greatly_RR involved_VVN in_II the_DD development_NN of_II cervical_JJ cancer_NN ._.
P08524058A10
White_JJ women_NNS presented_VVD twice_DB the_DD cervical_JJ lesions_NNS of_II mulatto_NN and_CC African_NN origin_NN women_NNS ,_, although_CS HPV_NN infection_NN rates_NNS were_VBD nearly_RR the_DD same_PND for_II the_DD three_MC groups_NNS (_( approximately_RR 50_MC %_SYM )_) ._.
P08609644A01
BACKGROUND_NN :_: Lesions_NNS that_PNR are_VBB histologically_RR classified_VVN as_II precursors_NNS of_II cervical_JJ cancer_NN ,_, which_PNR are_VBB often_RR referred_VVN to_II as_II squamous_JJ intraepithelial_JJ lesions_NNS (_( SILs_NNS )_) ,_, represent_VVB a_DD heterogeneous_JJ clinical_JJ entity_NN that_PNR can_VM be_VBB associated_VVN with_II many_DD different_JJ types_NNS of_II human_NN papillomaviruses_NNS (_( HPVs_NNS )_) and_CC have_VHB a_DD variable_JJ biologic_JJ behavior_NN ._.
P08609644A16
The_DD second_JJ types_NNS of_II low-grade_NN SIL_NN is_VBZ polyclonal_JJ and_CC is_VBZ associated_VVN with_II other_JJ types_NNS of_II HPV_NN ._.
P08613428A07
The_DD frequent_JJ alterations_NNS in_II genomic_JJ organization_NN ,_, especially_RR preferential_JJ deletion_NN of_II the_DD E1_NN or_CC E2_NN gene_NN ,_, may_VM be_VBB related_VVN to_II the_DD more_RR aggressive_JJ properties_NNS of_II HPV_NN 18-positive_JJ cervical_JJ cancers_NNS ._.
P08627038A09
The_DD high_JJ prevalence_NN of_II HPV-45_NN was_VBD notable_JJ ,_, and_CC its_PNG relation_NN to_II high_JJ cervical_JJ cancer_NN incidence_NN in_II Jamaica_NN must_VM be_VBB assessed_VVN ._.
P08635095A02
Substantial_JJ clinical_JJ ,_, epidemiologic_JJ ,_, and_CC experimental_JJ evidence_NN has_VHZ reinforced_VVN the_DD role_NN of_II high_JJ risk_NN human_NN papillomavirus_NN (_( HPV_NN )_) types_NNS in_II the_DD development_NN of_II cervical_JJ carcinoma_NN ._.
P08635095A17
HPV16_NN was_VBD detected_VVN more_RR often_RR in_II squamous_JJ cell_NN carcinoma_NN and_CC HPV18_NN was_VBD detected_VVN more_RR often_RR in_II adenocarcinoma_NN ._.
P08692513A09
CONCLUSION_NN :_: Short-term_NN HPV_NN DNA_NN detection_NN is_VBZ highly_RR variable_JJ within_II individuals_NNS ;_: therefore_RR ,_, single-point_NN measurements_NNS of_II cervical_JJ HPV_NN have_VHB limitations_NNS when_CS assessing_VVG an_DD individual_NN 's_GE HPV_NN status_NN ._.
P08699161A05
All_DD 13_MC cases_NNS harbored_VVD high_JJ copy_NN numbers_NNS of_II the_DD LR-HPV_NN genome_NN with_II an_DD average_NN of_II 926_MC copies_NNS per_II cell_NN ,_, whereas_CS the_DD other_JJ four_MC cases_NNS had_VHD an_DD average_NN of_II 12_MC copies_NNS of_II LR-HPV_NN per_II cell_NN (_( P_NN <_SYM 0.001_MC )_) ._.
P08811018A06
The_DD relatively_RR strong_JJ T_NN cell_NN proliferative_JJ responses_NNS against_II HPV-16_NN E7_NN observed_VVN in_II patients_NNS with_II a_DD persistent_JJ HPV-16_NN infection_NN and_CC progressive_JJ cervical_JJ lesions_NNS indicate_VVB that_CST the_DD effectivity_NN of_II such_DD responses_NNS can_VM not_RR be_VBB predicted_VVN and_CC apparently_RR depends_VVZ on_II additional_JJ factors_NNS ._.
P08825715A05
Overall_RR ,_, of_II the_DD total_NN 64_MC biopsies_NNS ,_, 57_MC (_( 89_MC %_SYM )_) were_VBD positive_JJ for_II HPV_NN DNA_NN sequences_NNS ._.
P08877756A05
HPV_NN DNA_NN of_II unknown_VVNJ type_NN was_VBD detected_VVN in_II 6_MC %_SYM of_II cases_NNS ,_, and_CC multiple_JJ HPV_NN infections_NNS were_VBD observed_VVN in_II 28_MC %_SYM of_II cases_NNS ._.
P08940448A04
Cervical_JJ IgA_NN antibodies_NNS to_II HPV-16_NN were_VBD also_RR more_RR common_JJ among_II patients_NNS with_II cervical_JJ intraepithelial_JJ neoplasia_NN ,_, particularly_RR among_II patients_NNS with_II cervical_JJ intraepithelial_JJ neoplasia_NN grade_NN I_MC (_( P_NN <_SYM 0.0005_MC )_) ._.
P09017005A07
The_DD following_VVGJ parameters_NNS were_VBD analyzed_VVN :_: 1_MC )_) HPV_NN infection_NN of_II the_DD cervix_NN and_CC other_JJ sites_NNS of_II the_DD lower_JJR genital_JJ tract_NN by_II colposcopic_JJ ,_, cytologic_JJ ,_, and_CC histologic_JJ examinations_NNS ;_: 2_MC )_) HPV_NN typing_VVGN ;_: 3_MC )_) in_JJ+ vitro_JJ production_NN of_II IL-2_NN by_II PBMCs_NNS in_II response_NN to_II stimulation_NN with_II soluble_JJ antigen_NN (_( influenza_NN [_( FLU_NN ]_) antigen_NN )_) or_CC to_II cell-associated_VVNJ human_NN leukocyte_NN antigen_NN (_( HLA_NN )_) alloantigen_NN ;_: and_CC 4_MC )_) in_JJ+ vitro_JJ production_NN of_II the_DD type_NN 1_MC cytokines_NNS IL-2_NN and_CC IFN_NN gamma_NN and_CC of_II the_DD type_NN 2_MC cytokines_NNS IL-4_NN and_CC IL-10_NN by_II PBMCs_NNS in_II response_NN to_II mitogen_NN stimulation_NN ._.
P09021543A02
In_II the_DD adult_NN group_NN antibodies_NNS to_II E2-16_NN and_CC VLP-16_NN were_VBD significantly_RR associated_VVN with_II CIN_NN when_CS compared_VVN to_II the_DD blood_NN donor_NN controls_NNS (_( P_NN =_SYM .039_MC and_CC P_NN =_SYM .002_MC ,_, respectively_RR )_) ._.
P09023824A01
Cervical_JJ human_NN papillomavirus_NN (_( HPV_NN )_) infections_NNS and_CC intraepithelial_JJ neoplasias_NNS are_VBB precursors_NNS to_II cervical_JJ cancer_NN ,_, the_DD second_JJ most_RRT common_JJ cancer_NN in_II women_NNS worldwide_RR ._.
P09032384A05
The_DD remaining_VVGJ 32_MC specimens_NNS (_( 7.8_MC %_SYM )_) harbored_VVD HPV-16_NN variants_NNS with_II novel_JJ hybridization_NN patterns_NNS ,_, novel_JJ nucleotide_NN changes_NNS ,_, or_CC both_PND ._.
P09049287A12
Only_RR 10_MC %_SYM of_II the_DD CIN_NN treated_VVNJ women_NNS harbored_VVD HPV_NN DNA_NN in_II the_DD cell_NN samples_NNS in_II spite_NN of_II showing_VVGN high_JJ risk_NN HPV_NN infection_NN before_II treatment_NN ._.
P09103401A07
Episomal_JJ forms_NNS of_II HPV_NN DNA_NN were_VBD detectable_JJ in_II 14_MC (_( 25.9_MC %_SYM )_) of_II 54_MC squamous_JJ cell_NN carcinomas_NNS (_( 4_MC pure_JJ episomal_JJ forms_NNS and_CC 10_MC mixed_VVNJ forms_NNS )_) ,_, whereas_CS only_RR 1_MC (_( 8.3_MC %_SYM )_) of_II 12_MC adenocarcinomas_NNS and_CC adenosquamous_JJ cell_NN carcinomas_NNS contained_VVD episomal_JJ viral_JJ DNA_NN ._.
P09155711A05
HPV18_NN /_SYM 33_MC /_SYM 45_MC /_SYM 58_MC were_VBD also_RR detected_VVN ,_, but_CC no_DD low-risk_NN or_CC multiple_JJ types_NNS ._.
P09155712A07
We_PN conclude_VVB that_CST common_JJ HPV_NN types_NNS do_VDB not_RR play_VVB an_DD important_JJ role_NN in_II the_DD pathogenesis_NN of_II bronchial_JJ carcinoma_NN ._.
P09162879A02
Molecular_JJ biology_NN has_VHZ allowed_VVN identification_NN of_II types_NNS of_II HPV_NN which_PNR seem_VVB to_TO be_VBI connected_VVN ,_, more_RR frequently_RR than_CSN others_NNS ,_, to_II dysplastic_JJ lesions_NNS ._.
P09207803A04
In_II all_DD patients_NNS ,_, information_NN on_II potential_JJ confounding_VVGJ factors_NNS for_II HPV_NN infection_NN ,_, including_VVG sociodemographic_JJ ,_, reproductive_JJ ,_, and_CC gynecologic_JJ characteristics_NNS ,_, was_VBD obtained_VVN ._.
P09217657A01
Human_NN papillomaviruses_NNS (_( HPVs_NNS )_) are_VBB associated_VVN with_II a_DD spectrum_NN of_II different_JJ diseases_NNS in_II humans_NNS ,_, including_VVG common_JJ warts_NNS and_CC genital_JJ warts_NNS ._.
P09506641A01
OBJECTIVES_NNS :_: The_DD objectives_NNS of_II this_DD study_NN were_VBD to_TO describe_VVI the_DD early_JJ natural_JJ history_NN of_II human_NN papillomavirus_NN (_( HPV_NN )_) infection_NN by_II examining_VVGN a_DD cohort_NN of_II young_JJ women_NNS positive_JJ for_II an_DD HPV_NN test_NN and_CC to_TO define_VVI within_II this_DD cohort_NN (_( 1_MC )_) the_DD probability_NN of_II HPV_NN regression_NN ,_, (_( 2_MC )_) the_DD risk_NN of_II having_VVGN a_DD squamous_JJ intraepithelial_JJ lesion_NN ,_, and_CC (_( 3_MC )_) factors_NNS that_PNR were_VBD associated_VVN with_II HPV_NN regression_NN ._.
P09515767A08
Either_CC HPV_NN DNA_NN or_CC p53-expression_NN were_VBD positive_JJ in_II 50_MC patients_NNS (_( 25_MC cases_NNS each_PND )_) ._.
P09600817A06
The_DD prevalence_NN of_II E6_NN /_SYM E7_NN spliced_VVNJ transcripts_NNS correlated_VVD with_II lesion_NN severity_NN and_CC the_DD nRT-PCR_NN protocol_NN allowed_VVD detection_NN of_II these_DD transcripts_NNS even_RR in_II nondysplastic_JJ epithelium_NN and_CC CIN_NN I_MC lesions_NNS ._.
P09622679A05
HPV_NN DNA_NN was_VBD negative_JJ in_II 81_MC %_SYM (_( 17_MC of_II 21_MC )_) of_II regressive_JJ disease_NN and_CC positive_JJ in_II 55_MC %_SYM (_( 12_MC of_II 22_MC )_) persistent_JJ and_CC progressive_JJ disease_NN ._.
P09648588A07
Two_MC amplified_VVNJ HPV_NN DNAs_NNS that_PNR were_VBD difficult_JJ to_TO type_VVI with_II various_JJ restriction_NN enzymes_NNS were_VBD cloned_VVN and_CC the_DD amplified_VVNJ regions_NNS were_VBD sequenced_VVN ._.
P09732239A07
There_EX was_VBD significant_JJ correlation_NN between_II the_DD extent_NN of_II histological_JJ abnormality_NN and_CC HPV_NN infection_NN ._.
P09738060A04
By_II the_DD reverse_JJ blot_NN strip_NN analysis_NN ,_, genotype_NN discrimination_NN of_II multiple_JJ HPV_NN types_NNS can_VM be_VBB accomplished_VVN in_II a_DD single_JJ hybridization_NN and_CC wash_NN cycle_NN ._.
P09811312A01
BACKGROUND_NN :_: Experimental_JJ models_NNS and_CC analyses_NNS of_II human_NN tumors_NNS suggest_VVB that_CST oncogenic_JJ ,_, sexually_RR transmittable_JJ human_NN papillomaviruses_NNS (_( HPVs_NNS )_) are_VBB etiologic_JJ factors_NNS in_II the_DD development_NN of_II oral_JJ squamous_JJ cell_NN carcinoma_NN (_( SCC_NN )_) ._.
P09891236A05
The_DD biopsy_NN specimens_NNS were_VBD stained_VVN with_II the_DD monoclonal_JJ antibodies_NNS p53_NN ,_, MDM2_NN ,_, and_CC p21_NN ._.
P09990815A02
A_DD multicentre_NN study_NN was_VBD organized_VVN to_TO determine_VVI the_DD prevalence_NN of_II HPV_NN in_II the_DD fertile_JJ female_NN population_NN in_II Hungary_NNP ._.
P10074522A03
Quantitative_JJ ,_, PCR-based_VVNJ fluorescent_JJ assays_NNS for_II each_PND of_II the_DD HPV_NN genotypes_NNS and_CC for_II the_DD beta-globin_NN gene_NN were_VBD used_VVN ._.
P10231038A10
RESULT_NN (_( S_NNS )_) :_: The_DD prevalence_NN of_II high-risk_NN HPVs_NNS was_VBD 7.8_MC %_SYM before_II stimulation_NN and_CC 6.8_MC %_SYM after_II stimulation_NN and_CC ,_, thus_RR ,_, was_VBD similar_JJ to_II the_DD prevalence_NN in_II controls_NNS (_( 8.4_MC %_SYM )_) ._.
P10408790A12
These_DD values_NNS were_VBD unchanged_VVN when_CS the_DD order_NN in_II which_PNR scrapes_NNS were_VBD taken_VVN was_VBD compared_VVN ._.
P10437947A10
Our_PNG results_NNS revealed_VVD infection_NN with_II HPV_NN ,_, especially_RR HPV-16_NN and_CC HPV-18_NN ,_, to_TO be_VBI strongly_RR associated_VVN with_II CIN-III_NN in_II Thai_JJ women_NNS ._.
P10446444A03
We_PN conducted_VVD a_DD population-based_VVNJ ,_, case-control_NN study_NN of_II 229_MC patients_NNS with_II different_JJ grades_NNS of_II CIN_NN and_CC invasive_JJ cervical_JJ cancer_NN and_CC 438_MC matched_VVNJ controls_NNS ._.
P10459162A02
The_DD overall_JJ HPV_NN positive_JJ rate_NN was_VBD 44.3_MC %_SYM with_II 18.6_MC %_SYM (_( 16_MC /_SYM 86_MC )_) for_II normal_JJ /_SYM inflamed_VVNJ cervices_NNS ,_, 36.4_MC %_SYM (_( 32_MC /_SYM 88_MC )_) for_II condyloma_NN ,_, 64.7_MC %_SYM (_( 33_MC /_SYM 51_MC )_) for_II cervical_JJ intraepithelial_JJ neoplasia_NN grade_NN 1_MC (_( CIN_NN 1_MC )_) ,_, 37.9_MC %_SYM (_( 11_MC /_SYM 29_MC )_) for_II CIN_NN 2_MC ,_, 68.3_MC (_( 41_MC /_SYM 60_MC )_) for_II CIN_NN 3_MC ,_, and_CC 77.8_MC %_SYM (_( 14_MC /_SYM 18_MC )_) for_II carcinoma_NN ._.
P10515799A03
In_II contrast_NN ,_, seroreactivity_NN to_II any_DD type_NN was_VBD associated_VVN with_II elevated_VVNJ seroreactivity_NN to_II all_DD others_NNS ._.
P10523544A09
Southern_NN blot_NN hybridization_NN with_II an_DD HPV-16_NN probe_NN revealed_VVD that_CST only_RR in_II these_DD two_MC cases_NNS was_VBD both_CC episomal_JJ and_CC integrated_VVNJ HPV_NN DNA_NN being_VBG carried_VVN simultaneously_RR ._.
P10523550A09
In_II summary_NN ,_, we_PN have_VHB established_VVN a_DD highly_RR sensitive_JJ and_CC comprehensive_JJ degenerate_JJ PCR_NN methodology_NN for_II detection_NN and_CC genotyping_VVGN of_II HPV_NN from_II the_DD skin_NN and_CC have_VHB demonstrated_VVN a_DD diverse_JJ spectrum_NN of_II multiple_JJ HPV_NN types_NNS in_II cutaneous_JJ warts_NNS from_II transplant_NN recipients_NNS ._.
P10604662A07
Nested_VVNJ polymerase_NN chain_NN reaction_NN was_VBD performed_VVN on_II all_DD specimens_NNS ._.
P10642935A09
These_DD findings_NNS suggest_VVB the_DD importance_NN of_II HPV_NN typing_VVGN other_II+ than_II HPV_NN 16_MC and_CC 18_MC and_CC a_DD different_JJ clinicopathologic_JJ significance_NN of_II HPV_NN 18_MC ._.
P10686023A02
The_DD enzyme-linked_VVNJ immunosorbent_JJ assay_NN (_( ELISA_NN )_) made_VVD use_NN of_II baculovirus_NN synthesised_VVNJ HPV_NN virus_NN like_JJ particles_NNS (_( VLPs_NNS )_) as_II antigen_NN ._.
P10716964A08
HPV_NN was_VBD found_VVN in_II 89_MC %_SYM of_II HSILs_NNS and_CC 88_MC %_SYM of_II cancers_NNS ,_, with_II HPV16_NN being_VBG strongly_RR predominant_JJ (_( 51_MC %_SYM and_CC 53_MC %_SYM of_II positive_JJ subjects_NNS )_) ._.
P10721654A07
E6_NN and_CC E7_NN function_VVB as_II transforming_VVGJ genes_NNS ._.
P10746674A09
Either_CC EBV_NN or_CC HPV_NN was_VBD detected_VVN in_II 61_MC %_SYM (_( 19_MC /_SYM 31_MC )_) of_II ICC_NN ,_, whereas_CS both_CC EBV_NN and_CC HPV_NN was_VBD detected_VVN in_II 39_MC %_SYM (_( 12_MC /_SYM 31_MC )_) of_II ICC_NN ._.
P10762117A08
Possible_JJ co-factors_NNS have_VHB also_RR been_VBN evaluated_VVN :_: history_NN of_II other_JJ sexually_RR transmitted_VVNJ diseases_NNS ,_, mainly_RR syphilis_NN ,_, showed_VVD to_TO be_VBI positively_RR related_VVN to_II progression_NN (_( Adjusted_VVNJ OR_NN 13.0_MC ,_, P=0.0003_NN )_) while_CS oral_JJ contraceptive_NN use_NN and_CC tobacco_NN smoking_VVGN were_VBD not_RR significantly_RR related_VVN to_II it_PN (_( P_NN >_SYM O.1_MC )_) ._.
P10815691A03
HPV_NN DNA_NN was_VBD detected_VVN and_CC typed_VVN by_II the_DD MY09_NN /_SYM 11_MC PCR_NN protocol_NN ._.
P10833983A07
RESULTS_NNS :_: The_DD rates_NNS of_II detecting_VVGN HPV_NN infection_NN cytologically_RR were_VBD higher_JJR among_II men_NNS with_II HIV_NN infection_NN (_( 50_MC %_SYM )_) than_CSN among_II their_PNG HIV-seronegative_JJ counterparts_NNS (_( 30_MC %_SYM )_) ._.
P10867192A01
We_PN established_VVD a_DD new_JJ assay_NN to_TO detect_VVI the_DD E6-E7_NN DNA_NN of_II mucosal_JJ human_NN papillomaviruses_NNS (_( HPV_NN )_) by_II a_DD PCR-based_VVNJ method_NN using_VVG four_MC pairs_NNS of_II degenerate_JJ LCR_NN and_CC E7_NN primers_NNS (_( LCR-E7_NN PCR_NN )_) ._.
P10960634A12
CONCLUSION_NN :_: Immunosuppression_NN favors_VVZ cervical_JJ high-load_NN HPV_NN infection_NN with_II oncogenic_JJ genotypes_NNS and_CC its_PNG clinical_JJ expression_NN in_II HIV-seropositive_JJ women_NNS ._.
P10962445A02
The_DD E6_NN and_CC E7_NN oncoproteins_NNS are_VBB constitutively_RR expressed_VVN in_II these_DD lesions_NNS and_CC are_VBB therefore_RR putative_JJ targets_NNS for_II the_DD immune_JJ response_NN against_II HPV_NN ._.
P11002256A01
The_DD presence_NN of_II human_NN papillomavirus_NN (_( HPV_NN )_) DNA_NN in_II almost_RR all_PND of_II the_DD cervical_JJ carcinomas_NNS is_VBZ one_MC of_II the_DD most_RRT compelling_VVGJ evidence_NN for_II the_DD viral_JJ carcinogenesis_NN ._.
P11063660A07
With_II regard_NN to_II the_DD distribution_NN of_II HPV_NN types_NNS ,_, HPV_NN type_NN 16_MC family_NN (_( types_NNS 16_MC ,_, 31_MC ,_, and_CC 35_MC )_) was_VBD identified_VVN in_II 28_MC cases_NNS (_( 50.0_MC %_SYM )_) ,_, type_NN 18_MC family_NN (_( types_NNS 18_MC ,_, 33_MC and_CC 58_MC )_) in_II 15_MC (_( 26.8_MC %_SYM )_) ,_, and_CC type_NN X_MC in_II 18_MC (_( 32.1_MC %_SYM )_) ._.
P11090752A03
At_II the_DD time_NN of_II specimen_NN collection_NN ,_, both_CC vaginal_JJ and_CC endocervical_JJ scrapes_NNS were_VBD taken_VVN from_II these_DD women_NNS ,_, and_CC tested_VVN for_II HPV_NN DNA_NN by_II PCR_NN ,_, using_VVG MY09_NN /_SYM MY11_NN primer_NN system_NN ._.
P11241459A07
To_II our_PNG knowledge_NN ,_, this_PND is_VBZ the_DD largest_JJT sequencing-based_VVNJ study_NN of_II HPV_NN ._.
P11244634A06
The_DD women_NNS with_II cytomorphologically_RR normal_JJ cervical_JJ smears_NNS but_CC which_DD who_PNR HPV-positive_JJ were_VBD reexamined_VVN six_MC months_NNS later_RR ._.
P11257210A05
Dilution_NN series_NNS of_II target_NN and_CC heterologous_JJ templates_NNS were_VBD used_VVN to_TO verify_VVI the_DD assay_NN ._.
P11265139A02
PATIENTS_NNS AND_CC METHODS_NNS :_: 223_MC cases_NNS of_II cervical_JJ cancer_NN patients_NNS included_VVN in_II this_DD retrospective_JJ study_NN underwent_VVD follow-up_NN evaluation_NN ._.
P11301343A02
p53_NN ,_, pRb_NN ,_, cyclin_NN E_NN ,_, and_CC cyclin_NN A_NN are_VBB reported_VVN to_TO be_VBI involved_VVN in_II the_DD synchronizing_VVGJ process_NN ._.
P11329141A09
In_II conclusion_NN ,_, HPV_NN infection_NN can_VM be_VBB diagnosed_VVN in_II cervical_JJ scrapes_NNS and_CC biopsy_NN specimens_NNS using_VVG the_DD SPF_NN (_( 10_MC )_) PCR-LiPA_NN system_NN ._.
P11426958A09
HPV_NN DNA_NN was_VBD detected_VVN by_II PCR_NN in_II 57_MC (_( 69_MC %_SYM )_) cases_NNS and_CC in_II 26_MC (_( 29_MC %_SYM )_) controls_NNS from_II both_DD groups_NNS (_( P_NN <_SYM 0.0001_MC )_) ._.
P11426982A05
A_DD Digene_NN II_MC kit_NN was_VBD used_VVN to_TO perform_VVI HPV_NN testing_VVGN ._.
P11531292A03
All_PND of_II them_PN were_VBD first_RR stained_VVN by_II the_DD Papanicolaou_NN (_( pap_NN )_) method_NN before_II the_DD experiments_NNS ._.
P11725224A06
Liquid-based_VVNJ cytology_NN was_VBD used_VVN to_TO screen_VVI for_II SIL_NN ._.
P11725354A06
In_II the_DD lung_NN ,_, we_PN demonstrated_VVD type_NN 16_MC /_SYM 18_MC positivity_NN in_II two_MC and_CC type_NN 6_MC /_SYM 11_MC in_II one_MC of_II the_DD HPV-positive_JJ cases_NNS ._.
P11745939A03
The_DD E2_NN protein_NN activates_VVZ and_CC represses_VVZ transcription_NN from_II different_JJ HPVs_NNS promoters_NNS ._.
P11745939A18
These_DD data_NNS suggest_VVB that_CST antibodies_NNS against_II the_DD E2_NN ,_, E6_NN ,_, and_CC E7_NN proteins_NNS are_VBB good_JJ candidates_NNS for_II use_NN as_II markers_NNS for_II monitoring_VVGN cervical_JJ HPV_NN infections_NNS ._.
P11754676A06
Incident_JJ cervical_JJ cancer_NN precursor_NN lesions_NNS ascertained_VVN by_II expert_NN review_NN of_II all_DD cytology_NN smears_NNS ._.
P11769697A10
CONCLUSION_NN :_: High-risk_NN HPV_NN infection_NN in_II female_NN genital_JJ tract_NN was_VBD the_DD major_JJ risk_NN factor_NN of_II cervical_JJ cancer_NN and_CC CIN_NN in_II the_DD areas_NNS ._.
P11816294A09
HPV_NN detection_NN could_VM be_VBB very_RR useful_JJ supplement_NN to_II Pap_NN smears_NNS ._.
P11843911A05
RESULTS_NNS :_: Of_II the_DD 127_MC participants_NNS ,_, 55_MC tested_VVD positive_JJ and_CC 72_MC tested_VVD negative_JJ for_II HPV_NN DNA_NN ._.
P11857534A07
Any_DD one_MC of_II the_DD HPV_NN types_NNS 18_MC ,_, 33_MC ,_, 35_MC ,_, 39_MC ,_, 45_MC ,_, 51_MC ,_, 52_MC ,_, 56_MC ,_, 58_MC ,_, 59_MC ,_, or_CC 66_MC was_VBD detected_VVN in_II 3.6_MC %_SYM (_( 223_MC /_SYM 6,123_MC )_) of_II the_DD women_NNS ._.
P11905599A04
This_DD process_NN results_VVZ in_II impaired_VVNJ tumour-suppressor-gene_NN function_NN ,_, involving_VVG DNA_NN repair_NN ,_, decreased_VVNJ apoptosis_NN ,_, and_CC eventual_JJ cell_NN immortalisation_NN ._.
P11920596A14
Five_MC hundred_MC twenty-five_MC women_NNS underwent_VVD HPV_NN sampling_VVGN following_VVG treatment_NN ,_, of_II whom_PNR 47_MC (_( 8.9_MC %_SYM )_) developed_VVD further_JJ CIN_NN ._.
P12001118A06
The_DD percentage_NN positive_JJ for_II HPV-16_NN E6_NN or_CC E7_NN DNA_NN in_II a_DD series_NN of_II ThinPrep_NN cervical_JJ cytologic_JJ samples_NNS (_( n_NN =_SYM 348_MC samples_NNS )_) was_VBD 0_MC %_SYM for_II negative_JJ samples_NNS (_( n_NN =_SYM 45_MC samples_NNS )_) ,_, 9.7_MC %_SYM for_II atypical_JJ squamous_JJ cells_NNS of_II undetermined_VVNJ significance_NN (_( ASCUS_NN ;_: n_NN =_SYM 144_MC samples_NNS )_) ,_, 16.9_MC %_SYM for_II low-grade_NN squamous_JJ intraepithelial_JJ lesion_NN (_( LSIL_NN ;_: n_NN =_SYM 118_MC samples_NNS )_) ,_, and_CC 51.2_MC %_SYM for_II high-grade_NN intraepithelial_JJ lesion_NN (_( HSIL_NN ;_: n_NN =_SYM 41_MC samples_NNS )_) ._.
P12023775A07
None_MC of_II the_DD men_NNS had_VHD both_CC vas_NN deferens_NN and_CC semen_NN plasma_NN samples_NNS HPV_NN positive_JJ ._.
P12082399A02
However_RR ,_, human_NN papillomaviruses_NNS (_( HPV_NN )_) have_VHB been_VBN reported_VVN to_TO be_VBI found_VVN in_II a_DD significant_JJ portion_NN of_II breast_NN cancers_NNS of_II women_NNS with_II concomitant_JJ cervical_JJ intraepithelial_JJ neoplasia_NN III_MC ._.
P12117707A04
Controls_NNS (_( n_NN =_SYM 270_MC )_) were_VBD matched_VVN on_II age_NN (_( +/-_SYM 5_MC years_NNS )_) and_CC follow-up_NN period_NN ._.
P12210419A01
Previous_JJ studies_NNS have_VHB suggested_VVN that_CST a_DD few_JJ uncommon_JJ human_NN papillomavirus_NN (_( HPV_NN )_) genotypes_NNS are_VBB prevalent_JJ in_II Chinese_NN cervical_JJ cancer_NN patients_NNS ._.
P12214730A05
The_DD sequence_NN of_II DNA_NN HPV_NN type_NN 16_MC and/or_CC 18_MC was_VBD identified_VVN with_II the_DD PCR_NN method_NN (_( polymerase_NN chain_NN reaction_NN )_) ._.
P12365959A13
The_DD strategy_NN requiring_VVG repeat_NN positive_JJ PCR_NN tests_NNS on_II 2_MC visits_NNS had_VHD a_DD sensitivity_NN of_II 84.2_MC %_SYM (_( 75.3_MC %_SYM -91.0_MC %_SYM )_) and_CC a_DD specificity_NN of_II 86.2_MC %_SYM (_( 85.1_MC %_SYM -87.3_MC %_SYM )_) ._.
P12375262A12
In_II 83_MC %_SYM of_II the_DD HPV16_NN /_SYM 18-positive_JJ CIN_NN lesions_NNS ,_, the_DD fractional_JJ area_NN of_II HPV-infected_VVNJ epithelium_NN was_VBD equal_JJ to_II ,_, or_CC larger_JJR than_CSN ,_, the_DD fractional_JJ area_NN with_II aneusomy_NN ._.
P12468350A03
Amplified_VVNJ PCR_NN products_NNS were_VBD verified_VVN and_CC typed_VVN by_II Southern_NN blot_NN analysis_NN using_VVG (_( 32_MC )_) P-labeled_VVNJ DNA_NN probes_NNS prepared_VVN from_II cloned_VVNJ HPV-16_NN and_CC -18_MC plasmids_NNS ._.P01283753A09
Among_II the_DD four_MC non-responders_NNS who_PNR were_VBD NS_NN positive_JJ during_II IFN_NN ,_, three_MC were_VBD NC_NN positive_JJ before_II IFN_NN ._.
P01309200A14
Most_PND of_II these_PND appear_VVB to_TO represent_VVI false-positive_JJ results_NNS because_CS HCV_NN RNA_NN is_VBZ usually_RR absent_JJ from_II the_DD serum_NN ._.
P01315339A03
The_DD introduction_NN of_II new_JJ epitopes_NNS ,_, particularly_RR a_DD core_NN protein_NN ,_, C22_NN (_( second-generation_NN tests_NNS )_) ,_, seems_VVZ to_TO increase_VVI the_DD sensitivity_NN of_II anti-HCV_NN detection_NN ._.
P01325035A08
Among_II the_DD organ_NN recipients_NNS ,_, the_DD prevalence_NN of_II HCV_NN RNA_NN increased_VVD after_II transplantation_NN :_: 7_MC of_II 26_MC patients_NNS (_( 27_MC percent_NN )_) had_VHD positive_JJ samples_NNS before_II transplantation_NN ,_, as_CS compared_VVN with_II 23_MC of_II 24_MC patients_NNS (_( 96_MC percent_NN )_) after_II transplantation_NN (_( P_NN less_RR than_CSN 0.001_MC )_) ._.
P01327328A04
Of_II these_DD HCV_NN antibody-positive_JJ patients_NNS 89_MC were_VBD tested_VVN for_II a_DD second_JJ time_NN ._.
P01327684A01
We_PN evaluated_VVD the_DD prevalence_NN of_II hepatitis_NN C_NN virus_NN (_( HCV_NN )_) RNA_NN and_CC antibody_NN (_( anti-HCVcore_NN )_) to_II the_DD putative_JJ HCV_NN core_NN protein_NN in_II Japanese_JJ patients_NNS with_II chronic_JJ liver_NN disease_NN ._.
P01331274A03
We_PN studied_VVD the_DD percentage_NN of_II pregnant_JJ women_NNS in_II our_PNG hospital_NN with_II antibodies_NNS to_II HCV_NN ,_, and_CC tried_VVD to_TO compare_VVI the_DD C100-3_NN antibodies_NNS with_II PHA_NN results_NNS in_II pregnant_JJ women_NNS ._.
P01331309A04
In_II contrast_NN ,_, antibody_NN reactivity_NN persisted_VVD in_II 7_MC of_II 8_MC patients_NNS with_II chronic_JJ HCV_NN infection_NN who_PNR could_VM be_VBB followed_VVN until_II 1990_MC ._.
P01332561A10
Of_II the_DD 23_MC mothers_NNS ,_, 21_MC (_( 91_MC %_SYM ;_: Cl_NN ,_, 72_MC %_SYM to_II 99_MC %_SYM )_) had_VHD a_DD reactive_JJ RIBA_NN ;_: one_MC woman_NN had_VHD an_DD indeterminate_JJ RIBA_NN and_CC was_VBD positive_JJ for_II HCV_NN RNA_NN by_II PCR_NN ._.
P01332562A07
Two_MC children_NNS had_VHD long-lasting_VVGJ alanine_NN aminotransferase_NN (_( ALT_NN )_) elevations_NNS ,_, and_CC one_MC of_II them_PN became_VVD HCV_NN RNA_NN positive_JJ ._.
P01378484A11
A_DD wide_JJ spectrum_NN of_II viral_JJ and_CC antibody_NN patterns_NNS in_II anti-HCV_NN c100-3_NN positive_JJ sera_NNS was_VBD observed_VVN in_II this_DD urban_JJ population_NN and_CC persisted_VVD for_II at_RR+ least_RR 6_MC years_NNS ._.
P01378811A06
Elevated_VVNJ alanine_NN aminotransferase_NN levels_NNS were_VBD present_JJ in_II 12.5_MC %_SYM of_II the_DD dialysis_NN patients_NNS ,_, 77_MC %_SYM of_II whom_PNR were_VBD also_RR anti-HCV_NN positive_JJ ._.
P01656140A12
However_RR ,_, not_RR all_DD anti-HCV_NN positive_JJ patients_NNS had_VHD HCV_NN positive_JJ hepatitis_NN ._.
P01667711A02
In_II these_DD subjects_NNS we_PN recorded_VVD some_DD clinical_JJ and_CC anamnestic_JJ data_NNS (_( history_NN of_II blood_NN transfusion_NN ,_, risk_NN factors_NNS of_II liver_NN disease_NN ,_, therapy_NN )_) and_CC determined_VVD ,_, besides_II a_DD few_JJ routine_JJ laboratory_NN parameters_NNS including_VVG rheumatoid_JJ factor_NN (_( RF_NN )_) ,_, AST_NN and_CC ALT_NN ,_, the_DD anti-HCV_NN serology_NN using_VVG the_DD 1st_JJ (_( EIA_NN ,_, Ortho_NN and_CC Abbott_NN ;_: Neutralization_NN test_NN ,_, Abbott_NN ;_: RIBA_NN ,_, Chiron-Ortho_NN )_) and_CC the_DD 2nd_JJ generation_NN tests_NNS (_( EIA_NN ,_, Ortho_NN ;_: RIBA_NN ,_, Chiron-Ortho_NN )_) ._.
P01724983A10
Of_II these_DD 22_MC sera_NNS plus_CC 1_MC further_RR with_II ELISA_NN OD_NN just_RR below_II cutoff_NN ,_, 8_MC were_VBD positive_JJ by_II the_DD "_`` neutralization_NN assay_NN ,_, "_'' (_( Abbott_NN Laboratories_NNS ,_, North_NN Chicago_NNP ,_, IL_NNP ,_, USA_NNP )_) and_CC 6_MC of_II these_PND ,_, including_VVG the_DD borderline_NN serum_NN ,_, were_VBD PCR_NN positive_JJ ._.
P02174157A04
HCV_NN is_VBZ a_DD small_JJ RNA_NN virus_NN with_II a_DD lipid_NN capsid_NN ,_, and_CC it_PN might_VM be_VBB indirectly_RR related_VVN to_II the_DD flaviviruses_NNS ._.
P07489343A06
Therefore_RR ,_, post-treatment_NN hepatitis_NN C_NN exacerbations_NNS show_VVB the_DD same_JJ sequence_NN of_II events_NNS seen_VVN as_CSN in_II hepatitis_NN B_NN exacerbations_NNS (_( increases_NNS of_II viraemia_NN followed_VVN by_II those_PND of_II ALT_NN and_CC IgM_NN anti-'core_NN '_'' )_) ._.
P07505079A08
Of_II the_DD 2_MC HCV-RNA_NN negative_JJ patients_NNS ,_, one_MC had_VHD been_VBN PCR_NN positive_JJ before_II interferon_NN therapy_NN ._.
P07508489A03
Results_NNS showed_VVD that_CST on_II entry_NN (_( i_MC )_) sera_NNS of_II 83_MC out_II+ of_II 272_MC members_NNS of_II the_DD cohort_NN were_VBD positive_JJ by_II the_DD HCV_NN 1st_JJ generation_NN EIA_NN (_( 30.5_MC %_SYM )_) ;_: 70_MC were_VBD confirmed_VVN by_II the_DD neutralization_NN test_NN (_( 84.3_MC %_SYM )_) ;_: (_( ii_MC )_) 115_MC of_II the_DD cohort_NN were_VBD reactive_JJ with_II the_DD 2nd_JJ generation_NN HCV_NN EIA_NN (_( 41.3_MC %_SYM )_) ;_: (_( iii_MC )_) with_II the_DD dot-blot_NN immunoassay_NN 99_MC (_( 86.1_MC %_SYM )_) of_II the_DD cohort_NN were_VBD confirmed_VVN and_CC 16_MC remained_VVD indeterminate_JJ ._.
P07508972A04
Of_II the_DD 15_MC anti-HCV-positive_JJ donors_NNS with_II normal_JJ ALT_NN ,_, only_RR five_MC (_( 33_MC %_SYM )_) were_VBD confirmed_VVN to_TO be_VBI positive_JJ by_II second-generation_NN RIBA_NN ,_, six_MC (_( 40_MC %_SYM )_) were_VBD indeterminate_JJ ,_, while_CS four_MC (_( 27_MC %_SYM )_) were_VBD RIBA_NN negative_JJ ._.
P07519631A05
Serum_NN transaminases_NNS were_VBD increased_VVN in_II 46_MC cases_NNS (_( 77_MC %_SYM )_) ,_, and_CC HCV_NN RNA_NN was_VBD detected_VVN by_II PCR_NN in_II 50_MC cases_NNS (_( 83_MC %_SYM )_) ._.
P07519818A02
METHODS_NNS :_: Sera_NNS from_II 46_MC patients_NNS were_VBD compared_VVN before_II and_CC after_II liver_NN transplantation_NN for_II markers_NNS of_II HCV_NN infection_NN ._.
P07519896A05
Although_CS the_DD Nantong_NNP area_NN is_VBZ a_DD high_JJ risk_NN region_NN for_II PHC_NN ,_, these_DD data_NNS suggest_VVB that_CST HCV_NN infection_NN is_VBZ not_RR an_DD important_JJ aetiological_JJ factor_NN for_II PHC_NN in_II this_DD area_NN ._.
P07523308A04
Anti-HCV_NN was_VBD determined_VVN by_II means_NNS of_II ELISA_NN II_MC and_CC was_VBD confirmed_VVN by_II RIBA_NN II_MC ._.
P07523676A07
Nine_MC organs_NNS from_II four_MC RIBA-positive_JJ donors_NNS were_VBD transplanted_VVN into_II eight_MC recipients_NNS of_II whom_PNR four_MC became_VVD anti-HCV_NN and_CC PCR_NN positive_JJ after_II transplantation_NN ._.
P07526275A02
In_II order_NN to_TO assess_VVI prevalence_NN and_CC risk_NN factors_NNS for_II HCV_NN infection_NN in_II CRF_NN patients_NNS on_II conservative_JJ therapy_NN we_PN tested_VVD ,_, by_II second-generation_NN assays_NNS such_II+ as_II Ortho_NN 2_MC and_CC 4-RIBA_NN ,_, 221_MC predialysis_NN CRF_NN patients_NNS attending_VVG our_PNG Department_NN ._.
P07529251A03
This_DD method_NN was_VBD compared_VVN with_II a_DD commercially_RR available_JJ second-generation_NN enzyme_NN immunoassay_NN (_( EIA_NN )_) which_PNR employed_VVD synthetic_JJ peptides_NNS corresponding_VVG to_II highly_RR antigenic_JJ segments_NNS of_II both_CC structural_JJ and_CC nonstructural_JJ portions_NNS of_II HCV_NN ._.
P07529954A02
STUDY_NN DESIGN_NN AND_CC METHODS_NNS :_: Thirty-nine_MC anti-HCV-positive_JJ donors_NNS with_II normal_JJ ALT_NN on_II four_MC determinations_NNS at_II 3-month_NN intervals_NNS were_VBD further_RR tested_VVN monthly_RR for_II 6_MC months_NNS ,_, and_CC they_PN had_VHD normal_JJ ALT_NN values_NNS ._.
P07531753A05
Fifteen_MC of_II the_DD 33_MC (_( 45.5_MC %_SYM )_) anti-HCV_NN positive_JJ patients_NNS had_VHD HCV_NN RNA_NN in_II the_DD serum_NN ._.
P07532341A03
Viraemia_NN was_VBD revealed_VVN by_II polymerase_NN chain_NN reaction_NN in_II all_DD group_NN 1_MC cases_NNS ._.
P07535737A06
Three_MC of_II the_DD HCV_NN RNA-positive_JJ and_CC none_MC of_II the_DD HCV_NN RNA-negative_JJ subjects_NNS had_VHD chronic_JJ hepatitis_NN ._.
P07539831A02
Patients_NNS were_VBD placed_VVN into_II three_MC different_JJ groups_NNS :_: 1_MC )_) patients_NNS ever_RR treated_VVN with_II large_JJ pool_NN non-hepatitis_NN C_NN virus_NN (_( HCV_NN )_) -safe_JJ concentrate_NN (_( n_NN =_SYM 179_MC )_) ;_: 2_MC )_) patients_NNS treated_VVN with_II cryoprecipitate_NN (_( n_NN =_SYM 125_MC )_) ;_: and_CC 3_MC )_) patients_NNS treated_VVN exclusively_RR with_II HCV-save_JJ concentrate_NN (_( n_NN =_SYM 12_MC )_) ._.
P07540080A07
HCV-RNA_NN was_VBD detected_VVN in_II 5_MC of_II 22_MC infants_NNS in_II the_DD fourth_JJ month_NN ._.
P07545210A09
However_RR ,_, there_EX was_VBD no_DD difference_NN in_II alanine_NN transaminase_NN (_( ALT_NN )_) levels_NNS ,_, histological_JJ lesions_NNS ,_, and_CC RIBA-2_NN patterns_NNS in_II blood_NN donors_NNS infected_VVN with_II either_CC HCV_NN genotype_NN I_MC or_CC HCV_NN genotype_NN II_MC ._.
P07554533A07
There_EX was_VBD a_DD good_JJ association_NN between_II serum_NN HCV_NN RNA_NN and_CC circulating_VVGJ anti-HCV_NN antibodies_NNS ,_, tested_VVN by_II second-generation_NN ELISA_NN and_CC RIBA_NN assays_NNS ._.
P07678638A01
Serum_NN samples_NNS from_II 103_MC blood_NN donors_NNS or_CC patients_NNS with_II slightly_RR increased_VVNJ serum_NN levels_NNS of_II liver_NN enzymes_NNS were_VBD tested_VVN for_II antibodies_NNS to_II hepatitis_NN C_NN virus_NN (_( anti-HCV_NN )_) using_VVG second_JJ generation_NN tests_NNS and_CC for_II HCV_NN RNA_NN by_II the_DD polymerase_NN chain_NN reaction_NN (_( PCR_NN )_) ._.
P07684749A04
The_DD prevalence_NN of_II HCV_NN viremia_NN ranged_VVD from_II 25.9_MC %_SYM in_II HCV_NN antibody-positive_JJ blood_NN donors_NNS to_II 92_MC %_SYM in_II HCV_NN antibody-positive_JJ hemophiliacs_NNS ._.
P07685969A04
Five_MC of_II the_DD 7_MC EIA-2-positive_JJ donors_NNS had_VHD detectable_JJ HCV_NN RNA_NN ._.
P07686741A05
During_II the_DD follow-up_NN period_NN (_( >_SYM or_CC =_SYM 6_MC months_NNS )_) ,_, acute_JJ non-A_NN ,_, non-B_NN hepatitis_NN developed_VVD in_II three_MC of_II 90_MC recipients_NNS about_RR 1_MC month_NN after_II the_DD accident_NN ._.
P07798884A01
Hepatitis_NN C_NN virus_NN (_( HCV_NN )_) is_VBZ transmitted_VVD by_II organs_NNS of_II HCV_NN antibody-positive_JJ donors_NNS to_II transplant_NN recipients_NNS ._.
P07843701A05
Clearance_NN of_II passively_RR acquired_VVNJ anti-HCV_NN antibodies_NNS was_VBD found_VVN to_TO be_VBI slower_JJR among_II babies_NNS born_VVN to_II HIV+_NN mothers_NNS (_( 22.3_MC %_SYM vs._CC 3.8_MC %_SYM at_II 12_MC months_NNS ,_, P_NN =_SYM .03_MC )_) and_CC children_NNS whose_PNR mothers_NNS showed_VVD three_MC or_CC four_MC anti-HCV_NN reactivities_NNS by_II immunoblotting_VVGN maintained_VVD anti-HCV_NN for_II longer_JJR periods_NNS compared_VVN with_II babies_NNS born_VVN to_II mothers_NNS with_II one_MC or_CC two_MC anti-HCV_NN reactivities_NNS (_( P_NN =_SYM .0001_MC )_) ._.
P07924751A03
We_PN therefore_RR performed_VVD a_DD cross-sectional_JJ study_NN to_TO determine_VVI the_DD prevalence_NN of_II HCV_NN infection_NN in_II children_NNS who_PNR had_VHD undergone_VVN liver_NN transplantation_NN ._.
P07971011A06
In_II Group_NN C_NN ,_, all_DD 13_MC patients_NNS had_VHD detectable_JJ HCV_NN RNA_NN in_II serum_NN ._.
P08023395A09
CONCLUSION_NN :_: These_DD data_NNS confirm_VVB a_DD good_JJ correlation_NN between_II RIBA-2_NN reactivity_NN and_CC the_DD detection_NN of_II HCV_NN RNA_NN in_II a_DD population_NN of_II anti-HCV-positive_JJ blood_NN donors_NNS ._.
P08042947A09
Of_II the_DD remaining_VVGJ subjects_NNS (_( seven_MC /_SYM 36_MC )_) who_PNR were_VBD anti-HCV-negative_JJ ,_, three_MC /_SYM seven_MC were_VBD HCV-RNA-positive_JJ and_CC included_VVD two_MC with_II acute_JJ post-transfusion_NN (_( PT_NN )_) NANBH_NN and_CC a_DD recent_JJ needlestick_NN victim_NN who_PNR contracted_VVD HCV_NN ._.
P08166987A01
HCV_NN infection_NN causes_VVZ serious_JJ complications_NNS in_II dialysis_NN patients_NNS that_PNR lead_VVB to_II problems_NNS in_II management_NN of_II patients_NNS in_II dialysis_NN units_NNS ._.
P08261814A05
Ten_MC ELISA2-positive_JJ women_NNS had_VHD a_DD further_JJ evaluation_NN with_II assessment_NN of_II HCV_NN infection_NN in_II their_PNG children_NNS ._.
P08264141A07
Anti-HCV_NN antibodies_NNS are_VBB frequently_RR associated_VVN with_II HCV_NN viremia_NN ,_, resulting_VVG usually_RR in_II chronic_JJ hepatitis_NN ,_, although_CS hypertransaminasemia_NN is_VBZ uncommon_JJ ._.
P08381269A09
Based_VVN on_II these_DD data_NNS ,_, we_PN anticipate_VVB that_CST screening_VVGN by_II anti-C100-3_NN in_II Taiwan_NNP will_VM exclude_VVB approximately_RR 3280_MC potentially_RR infectious_JJ donations_NNS under_II the_DD current_JJ screening_VVGJ policy_NN but_CC will_VM result_VVB in_II the_DD loss_NN of_II 6860_MC donations_NNS that_PNR will_VM be_VBB negative_JJ for_II HCV_NN RNA_NN per_II year_NN ._.
P08387411A06
Our_PNG sensitive_JJ and_CC specific_JJ PCR_NN assay_NN was_VBD unable_JJ to_TO detect_VVI HCV_NN RNA_NN in_II the_DD six_MC preparations_NNS tested_VVN ._.
P08588133A05
Of_II these_PND 11_MC were_VBD previously_RR undiagnosed_VVN ,_, and_CC seven_MC were_VBD HCV_NN RNA-positive_JJ ._.
P08637513A04
The_DD evaluations_NNS also_RR included_VVD an_DD assessment_NN of_II risk_NN factors_NNS ,_, a_DD physical_JJ examination_NN ,_, serial_JJ determinations_NNS of_II alanine_NN aminotransferase_NN levels_NNS and_CC HCV_NN serologic_JJ assays_NNS ,_, a_DD polymerase-chain-reaction_NN assay_NN for_II HCV_NN RNA_NN ,_, testing_VVGN of_II sexual_JJ contacts_NNS and_CC family_NN members_NNS ,_, and_CC liver_NN biopsies_NNS in_II some_DD participants_NNS who_PNR were_VBD HCV-positive_JJ by_II RIBA_NN ._.
P08649626A14
CONCLUSIONS_NNS ._.
P08748278A08
The_DD distribution_NN of_II HCV_NN genotypes_NNS did_VDD not_RR differ_VVB significantly_RR between_II HCV_NN RNA-positive_JJ patients_NNS with_II indeterminate_JJ or_CC positive_JJ RIBA3.0_NN results_NNS ._.
P08779139A08
In_II the_DD blood_NN donor_NN control_NN group_NN the_DD prevalence_NN of_II HCV_NN antibodies_NNS was_VBD lower_JJR (_( 0.3_MC %_SYM )_) ._.
P08784559A01
The_DD prevalence_NN of_II hepatitis_NN C_NN virus_NN (_( HCV_NN )_) infection_NN was_VBD evaluated_VVN in_II 227_MC hemodialysis_NN patients_NNS from_II four_MC units_NNS in_II Caracas_NNP ,_, Venezuela_NNP ,_, by_II using_VVGN different_JJ second-_JJ and_CC third-generation_NN enzyme_NN immunoassays_NNS (_( EIAs_NNS )_) and_CC immunoblot_NN assays_NNS ._.
P08793841A07
A_DD clear_JJ association_NN was_VBD observed_VVN between_II HCV-RNAemia_NN in_II serum_NN samples_NNS and_CC index_NN values_NNS (_( O.D._NN sample_NN /_SYM O.D._NN cut-off_NN )_) of_II the_DD screening_VVGJ EIAs_NNS as_CC+ well_CC+ as_CC with_II the_DD number_NN of_II reactive_JJ proteins_NNS in_II the_DD confirmatory_JJ assays_NNS ._.
P08818962A02
Sixteen_MC of_II 200_MC (_( 8_MC %_SYM )_) donors_NNS were_VBD positive_JJ for_II antibodies_NNS using_VVG a_DD second_JJ generation_NN enzyme-linked_VVNJ immunosorbent_JJ assay_NN (_( ELISA_NN )_) but_CC all_PND of_II the_DD children_NNS were_VBD negative_JJ ._.
P08818968A11
This_DD information_NN appears_VVZ useful_JJ for_II establishing_VVGN criteria_NNS in_II future_JJ screening_VVGJ policies_NNS ._.
P08822625A09
This_DD situation_NN was_VBD particularly_RR evidenced_VVN in_II selected_VVNJ sera_NNS from_II poor_JJ responder_NN specimens_NNS where_PNR a_DD more_RR restricted_VVNJ antibody_NN response_NN to_II core_NN peptides_NNS was_VBD observed_VVN ._.
P08837233A03
However_RR ,_, haemodialysis_NN patients_NNS and_CC haemophiliacs_NNS were_VBD at_II higher_JJR risk_NN of_II having_VVGN HCV_NN infection_NN ,_, since_CS the_DD prevalences_NNS were_VBD ,_, respectively_RR ,_, 35.1_MC and_CC 42.4_MC %_SYM in_II comparison_NN with_II the_DD blood_NN donors_NNS '_GE prevalence_NN (_( 1.1_MC %_SYM )_) ._.
P08871873A04
In_II those_PND with_II ALD_NN ,_, anti-HCV_NN and_CC HCV_NN RNA_NN were_VBD positive_JJ in_II 55.5_MC %_SYM and_CC 41.2_MC %_SYM ,_, respectively_RR ._.
P08888703A13
Chronic_JJ hepatitis_NN was_VBD diagnosed_VVN in_II 88_MC %_SYM vs_CC 43_MC %_SYM of_II donors_NNS with_II elevated_VVNJ and_CC normal_JJ alanine_NN aminotransferase_NN levels_NNS ,_, respectively_RR ._.
P08941587A06
Risk_NN factors_NNS including_VVG blood_NN transfusions_NNS were_VBD evaluated_VVN ._.
P08968936A03
This_DD study_NN was_VBD performed_VVN to_TO establish_VVI the_DD significance_NN of_II indeterminate_JJ RIBA_NN 2.0_MC results_NNS in_II relation_NN to_II HCV_NN RNA_NN detection_NN ,_, high_JJ positivity_NN for_II the_DD c22-3_NN band_NN ,_, and_CC the_DD HCV_NN genotype_NN as_CS determined_VVN by_II direct_JJ DNA_NN sequencing_VVGN ._.
P08986942A05
Sera_NNS from_II only_RR two_MC (_( 3.4_MC %_SYM )_) of_II the_DD 59_MC anti-HCV_NN negative_JJ ,_, HCV_NN RNA_NN positive_JJ patients_NNS recognised_VVD sE2_NN and_CC none_MC dE2_NN ._.
P08995939A05
RESULTS_NNS :_: Of_II 114_MC patients_NNS who_PNR were_VBD treated_VVN with_II IFN-alpha_NN for_II 24_MC weeks_NNS ,_, 22_MC of_II 29_MC patients_NNS (_( 75.9_MC %_SYM )_) who_PNR lost_VVD HCV_NN RNA_NN at_II the_DD first_JJ week_NN of_II treatment_NN ,_, 5_MC of_II 14_MC patients_NNS (_( 35.7_MC %_SYM )_) who_PNR lost_VVD HCV_NN RNA_NN at_II the_DD second_JJ week_NN ,_, and_CC 2_MC of_II 16_MC patients_NNS (_( 12.5_MC %_SYM )_) who_PNR lost_VVD HCV_NN RNA_NN at_II fourth_JJ week_NN were_VBD judged_VVN as_II sustained_VVNJ responder_NN (_( SR_NN )_) ._.
P09076628A06
Both_CC HCV-2_NN and_CC E2_NN /_SYM NS1_NN antibodies_NNS were_VBD positive_JJ at_RR+ least_RR once_NN in_II all_DD patients_NNS ._.
P09242566A05
Five_MC ID_NN patients_NNS never_RR developed_VVD HCV_NN antibodies_NNS despite_II serum_NN HCV-RNA_NN positivity_NN ._.
P09252071A06
No_DD other_JJ significant_JJ difference_NN was_VBD observed_VVN in_II any_PND of_II the_DD patients_NNS '_GE characteristics_NNS between_II IgM_NN anti-HCV_NN core_NN positive_JJ and_CC negative_JJ groups_NNS ._.
P09430360A01
The_DD risk_NN of_II perinatal_JJ transmission_NN of_II hepatitis_NN C_NN virus_NN (_( HCV_NN )_) from_II a_DD cohort_NN of_II 95_MC human_NN immunodeficiency_NN virus_NN (_( HIV_NN )_) -negative_JJ intravenous_JJ drug_NN users_NNS (_( IVDU_NN )_) is_VBZ described_VVN ,_, 89_MC of_II whom_PNR were_VBD positive_JJ for_II antibodies_NNS to_II HCV_NN (_( anti-HCV_NN )_) ._.
P09438545A01
The_DD immunoreactivity_NN profiles_NNS of_II plasma_NN samples_NNS obtained_VVN from_II patients_NNS infected_VVN with_II different_JJ hepatitis_NN C_NN virus_NN (_( HCV_NN )_) genotypes_NNS were_VBD studied_VVN using_VVG immunoblot_NN assay_NN containing_VVG multiple_JJ HCV_NN antigens_NNS ._.
P09504268A04
MATERIALS_NNS :_: From_II May_NN 1991_MC to_II August_NN 1996_MC more_RR than_CSN 4300_MC patients_NNS were_VBD tested_VVN for_II anti-HCV_NN ._.
P09592344A10
These_DD data_NNS indicate_VVB that_CST many_DD patients_NNS on_II hemodialysis_NN have_VHB hepatitis_NN C_NN or_CC B_NN viremia_NN and_CC more_DD attention_NN should_VM be_VBB paid_VVN to_II this_DD problem_NN ._.
P09619970A01
Serum_NN hepatitis_NN C_NN virus_NN (_( HCV_NN )_) RNA_NN ,_, HCV_NN genotypes_NNS and_CC liver_NN function_NN tests_NNS were_VBD evaluated_VVN in_II a_DD series_NN of_II 189_MC unselected_VVNJ ,_, consecutive_JJ anti-HCV_NN positive_JJ intravenous_JJ drug_NN users_NNS (_( IVDUs_NNS )_) ._.
P09620405A01
A_DD national_JJ survey_NN of_II hepatitis_NN C_NN virus_NN (_( HCV_NN )_) infections_NNS among_II dialysis_NN patients_NNS in_II The_DD Netherlands_NNP was_VBD performed_VVN ._.
P09620405A15
The_DD prevalence_NN of_II HCV-infected_VVNJ patients_NNS in_II Dutch_NN dialysis_NN centers_NNS ranged_VVD from_II 0_MC to_II 8_MC %_SYM ,_, suggesting_VVG the_DD existence_NN of_II local_JJ risk_NN factors_NNS for_II acquiring_VVGN HCV_NN infection_NN ._.
P09665375A08
Of_II these_PND ,_, 1_MC was_VBD RIBA_NN 2.0_MC negative_JJ (_( PCR_NN positive_JJ )_) ,_, 3_MC were_VBD indeterminate_JJ (_( 3_MC PCR_NN positive_JJ )_) ,_, and_CC 28_MC were_VBD positive_JJ (_( 23_MC PCR_NN positive_JJ )_) ._.
P09681732A02
Some_DD HD_NN patients_NNS may_VM have_VHB ,_, therefore_RR ,_, an_DD inability_NN to_TO produce_VVI detectable_JJ amounts_NNS of_II serum_NN antibodies_NNS to_II hepatitis_NN C_NN virus_NN (_( anti-HCV_NN )_) ._.
P09809407A10
High_JJ percentages_NNS of_II PCR_NN positive_JJ results_NNS among_II RIBA-3-indeterminate_JJ and_CC among_II MATRIX-indeterminate_JJ samples_NNS indicate_VVB an_DD increased_VVNJ possibility_NN of_II detecting_VVGN HCV_NN RNA_NN if_CS at_RR+ least_RR one_MC antigen_NN is_VBZ reactive_JJ ._.
P09881424A13
In_II many_DD instances_NNS there_EX was_VBD more_RR than_CSN one_MC recipient_NN per_II HCV_NN infected_VVNJ donation_NN ._.
P10068359A07
RESULTS_NNS :_: Ten_MC cases_NNS of_II infection_NN with_II acute_JJ HCV_NN genotype_NN 3a_NN occurred_VVD between_II 1990_MC and_CC 1993_MC ._.
P10094968A02
We_PN examined_VVD the_DD results_NNS of_II laboratory_NN tests_NNS for_II HCV_NN on_II a_DD cohort_NN of_II patients_NNS who_PNR received_VVD a_DD liver_NN transplant_NN between_II 1990_MC and_CC 1994_MC at_II three_MC large_JJ centers_NNS ._.
P10220737A04
Age_NN was_VBD the_DD most_RRT potential_JJ risk_NN indicator_NN for_II anti-HCV_NN positivity_NN by_II multiple_JJ stepwise_JJ regression_NN analysis_NN ._.
P10331562A08
Monitoring_VVGN anti-Core_NN 518_MC titers_NNS may_VM be_VBB helpful_JJ not_RR only_RR for_II differentiating_VVGN the_DD status_NN of_II HCV_NN infection_NN among_II patients_NNS with_II various_JJ type_NN C_NN viral_JJ liver_NN diseases_NNS ,_, but_CC also_RR for_II predicting_VVGN responses_NNS to_II IFN-alpha_NN treatment_NN ._.
P10374301A09
HCV_NN infection_NN rate_NN in_II hemodialysis_NN patients_NNS is_VBZ higher_JJR than_CSN that_PND of_II general_JJ population_NN ._.
P10438705A13
In_II all_DD 5_MC individuals_NNS ,_, independent_JJ repeats_NNS of_II the_DD experiments_NNS confirmed_VVD the_DD presence_NN of_II HCV_NN RNA_NN in_II serum_NN ,_, and_CC in_II 3_MC of_II these_DD individuals_NNS ,_, HCV-positivity_NN was_VBD confirmed_VVN in_II independently_RR collected_VVNJ plasma_NN and_CC PBMC_NN samples_NNS ._.
P10507992A02
The_DD prevalence_NN of_II anti-HCV_NN antibodies_NNS was_VBD 3.2_MC %_SYM (_( 26_MC /_SYM 820_MC )_) among_II blood_NN donors_NNS in_II Khon_NNP Kaen_NNP ,_, while_CS it_PN was_VBD 90_MC %_SYM (_( 71_MC /_SYM 79_MC )_) among_II IVDUs_NNS in_II Chiang_NNP Rai_NNP ._.
P10533794A11
Twenty-three_MC patients_NNS with_II chronic_JJ active_JJ hepatitis_NN were_VBD treated_VVN with_II interferon-alpha_NN ._.
P10534725A10
In_II some_DD patients_NNS infected_VVN with_II two_MC genotypes_NNS ,_, the_DD spontaneous_JJ loss_NN of_II the_DD 3a_NN genotype_NN was_VBD observed_VVN ._.
P10624011A02
Sex_NN ,_, age_NN ,_, duration_NN of_II dialysis_NN ,_, number_NN of_II transfusions_NNS and_CC ALT_NN were_VBD also_RR considered_VVN ._.
P10669321A06
Mean_NN ALT_NN concentrations_NNS decreased_VVD substantially_RR after_II the_DD first_JJ 2_MC years_NNS of_II life_NN ;_: 14_MC children_NNS had_VHD persistently_RR normal_JJ ALT_NN values_NNS ._.
P11059937A07
Hepatitis_NN C_NN virus-RNA_NN was_VBD detected_VVN in_II 78_MC %_SYM of_II the_DD HCV_NN antibody-positive_JJ cases_NNS ._.
P11163587A14
Nosocomial_JJ infections_NNS and_CC tattooing_VVGN were_VBD found_VVN to_TO be_VBI the_DD most_RRT important_JJ risk_NN factors_NNS for_II transmission_NN of_II HCV_NN ._.
P11179591A08
RESULTS_NNS :_: The_DD presence_NN of_II anti-HCV_NN IgG_NN was_VBD detected_VVN in_II a_DD total_NN of_II 48_MC cases_NNS (_( 1.9_MC %_SYM )_) ._.
P11189001A03
This_DD study_NN aims_VVZ to_TO investigate_VVI such_DD correlation_NN and_CC to_TO provide_VVI further_JJ evidence_NN to_II the_DD possible_JJ transmissibility_NN of_II HCV_NN via_II corneal_JJ grafts_NNS ._.
P11268963A04
The_DD relatives_NNS were_VBD 45_MC spouses_NNS ,_, 89_MC children_NNS and_CC 4_MC cohabitants_NNS who_PNR underwent_VVD detection_NN of_II serum_NN anti-HCV_NN antibodies_NNS ;_: the_DD anti-HCV-positive_JJ subjects_NNS were_VBD tested_VVN for_II serum_NN HCV-RNA_NN ._.
P11274586A08
RESULTS_NNS :_: Three_MC donations_NNS out_II+ of_II 251,737_MC were_VBD HCV_NN RNA_NN positive_JJ and_CC anti-HCV_NN negative_JJ ._.
P11318976A15
The_DD occurrence_NN of_II the_DD lesions_NNS after_II the_DD appearance_NN of_II anti-HCV_NN antibodies_NNS and_CC the_DD high_JJ HCV_NN RNA_NN levels_NNS are_VBB indicative_JJ of_II viral_JJ involvement_NN in_II the_DD pathogenesis_NN ._.
P11421370A09
Those_PND who_PNR were_VBD less_RR educated_VVN ,_, farmed_VVD ,_, provided_VVD health_NN care_NN ,_, and_CC were_VBD currently_RR married_VVN had_VHD a_DD significantly_RR higher_JJR anti-HCV_NN prevalence_NN than_CSN those_PND who_PNR were_VBD not_RR ;_: however_RR ,_, these_DD associations_NNS were_VBD not_RR significant_JJ after_II adjusting_VVGN for_II age_NN ._.P00071267A04
In_II addition_NN ,_, liver_NN biopsy_NN specimens_NNS from_II carriers_NNS with_II anti-HBe_NN were_VBD negative_JJ for_II HbcAg_NN by_II immunofluorescence_NN ,_, and_CC the_DD liver_NN histology_NN was_VBD either_CC normal_JJ or_CC revealed_VVD only_RR fatty_JJ changes_NNS ._.
P00212821A06
The_DD results_NNS indicate_VVB that_CST hepatitis_NN A_NN virus_NN is_VBZ of_II little_DD importance_NN in_II the_DD pathogenesis_NN of_II CAH_NN and_CC confirm_VVB the_DD association_NN between_II hepatitis_NN B_NN virus_NN and_CC development_NN of_II chronic_JJ active_JJ hepatitis_NN ._.
P01517947A08
Ten_MC were_VBD HBeAg_NN and_CC 19_MC anti-HBe_NN seropositive_JJ ._.
P01583107A02
New_JJ IMx_NN assays_NNS for_II HBsAg_NN and_CC immunoglobulin_NN M_NN (_( IgM_NN )_) anti-HBc_NN detection_NN were_VBD also_RR used_VVN ._.
P01663719A05
The_DD stratification_NN analysis_NN of_II interactive_JJ effects_NNS of_II HBV_NN infection_NN markers_NNS on_II the_DD development_NN of_II PHC_NN showed_VVD that_CST HBeAg_NN carrier_NN status_NN may_VM increase_VVB PHC_NN risk_NN associated_VVN with_II HBsAg_NN status_NN ._.
P02104740A08
These_DD findings_NNS suggest_VVB that_CST chronic_JJ hepatitis_NN associated_VVN with_II isolated_VVNJ anti-HBc_NN is_VBZ a_DD heterogenous_JJ pathologic_JJ entity_NN ._.
P02196336A07
Of_II specimens_NNS positive_JJ for_II anti-HBc_NN by_II EIA_NN ,_, 14.8_MC %_SYM were_VBD negative_JJ by_II RIA_NN ._.
P02227250A04
Antibody_NN to_II pre-S2_NN antigen_NN (_( anti-pre-S2_NN )_) was_VBD detected_VVN in_II 16_MC (_( 9.6_MC %_SYM )_) of_II 166_MC subjects_NNS with_II concurrent_JJ markers_NNS ,_, 15_MC of_II these_DD 16_MC carriers_NNS were_VBD positive_JJ for_II antibody_NN to_II HBeAg_NN (_( anti-HBe_NN )_) ._.
P02303802A11
The_DD levels_NNS of_II anti-HBe_NN IgG1_NN and_CC IgG3_NN were_VBD much_RR lower_JJR than_CSN the_DD levels_NNS of_II anti-HBc_NN IgG1_NN and_CC IgG3_NN ._.
P02304145A03
HBV_NN mutants_NNS with_II pre-C-region_NN defects_NNS prevailed_VVD in_II the_DD circulation_NN of_II three_MC asymptomatic_JJ carriers_NNS as_CS they_PN seroconverted_VVD from_II HBeAg_NN to_II the_DD corresponding_VVGJ antibody_NN (_( anti-HBe_NN )_) ,_, and_CC these_DD mutants_NNS finally_RR replaced_VVNJ nondefective_JJ HBV_NN ._.
P02307337A08
We_PN discussed_VVD the_DD presence_NN of_II IgM_NN anti-HBc_NN in_II association_NN with_II HBeAg_NN or_CC liver_NN damage_NN ._.
P02352457A03
HBeAg_NN /_SYM Anti-HBe_NN immune_JJ complexes_NNS were_VBD detected_VVN in_II 17_MC /_SYM 18_MC (_( 94.4_MC %_SYM )_) patients_NNS positive_JJ for_II HBV-DNA_NN ._.
P02411829A03
Antibody_NN to_II hepatitis_NN B_NN e_NN antigen_NN (_( anti-HBe_NN )_) was_VBD present_JJ in_II the_DD serum_NN of_II 93.5_MC %_SYM of_II these_DD carriers_NNS ._.
P02417111A07
To_TO define_VVI the_DD significance_NN of_II these_DD molecular_JJ forms_NNS in_II HB-VP_NN morphogenesis_NN ,_, we_PN studied_VVD the_DD effects_NNS of_II a_DD mild_JJ treatment_NN with_II a_DD chaotropic_JJ salt_NN ,_, NaSCN_NN ,_, on_II HB-VP-rich_JJ fractions_NNS (_( DNA_NN polymerase_NN positive_JJ )_) ._.
P02469730A06
T_NN cell_NN subset_NN fractionation_NN revealed_VVD that_CST CD4+_NN cells_NNS were_VBD main_JJ population_NN of_II IFN-gamma_NN production_NN specific_JJ for_II HBcAg_NN and_CC CD8+_NN cells_NNS did_VDD not_RR suppress_VVB IFN-gamma_NN production_NN of_II CD4+_NN cells_NNS ._.
P02540692A01
Sera_NNS from_II 60_MC consecutive_JJ patients_NNS with_II hepatocellular_JJ carcinoma_NN (_( HCC_NN )_) diagnosed_VVN by_II either_CC a_DD positive_JJ histology_NN or_CC at_RR+ least_RR two_MC of_II the_DD following_VVGN :_: CT_NN scan_NN ,_, hepatic_JJ ultrasound_NN ,_, hepatic_JJ angiogram_NN and_CC raised_VVNJ alpha-foetoprotein_NN levels_NNS ,_, were_VBD studied_VVN to_TO determine_VVI their_PNG Hepatitis_NN B_NN surface_NN antigen_NN (_( HBsAg_NN )_) status_NN and_CC the_DD frequency_NN of_II continuing_VVGJ viral_JJ replication_NN ._.
P02584955A04
In_II contrast_NN ,_, one_MC carrier_NN mother_NN seroconverted_VVD to_II anti-HBe_NN during_II pregnancy_NN and_CC the_DD antibody_NN persisted_VVD thereafter_RR ._.
P02656911A01
Hepatitis_NN B_NN virus_NN (_( HBV_NN )_) markers_NNS were_VBD determined_VVN in_II 821_MC patients_NNS receiving_VVG renal_JJ allografts_NNS and_CC undergoing_VVG immunosuppressive_JJ therapy_NN during_II 1970-1986_MC ._.
P02717151A06
HBeAg_NN carriers_NNS were_VBD twice_RR as_RR likely_RR to_TO be_VBI identified_VVN by_II their_PNG histories_NNS than_CSN HBsAg_NN carriers_NNS ._.
P02754427A02
Pre-S1_NN ,_, pre-S2_NN ,_, HBV_NN DNA_NN ,_, IgM_NN antihepatitis_NN core_NN antigen_NN (_( HBc_NN )_) ,_, hepatitis_NN B_NN e_NN antigen_NN (_( HBeAg_NN )_) ,_, and_CC anti-HBe_NN were_VBD detected_VVN in_II about_RR 200_MC sera_NNS serially_RR collected_VVN at_II different_JJ times_NNS for_II at_RR+ least_RR 6-12_MC months_NNS from_II the_DD onset_NN of_II clinical_JJ observation_NN ._.
P02764519A07
No_DD significant_JJ difference_NN in_II the_DD concordance_NN of_II HBV_NN infection_NN was_VBD observed_VVN in_II the_DD MZ_NN and_CC DZ_NN twins_NNS ._.
P02788545A04
Patients_NNS with_II chronic_JJ type_NN B_NN hepatitis_NN also_RR had_VHD significantly_RR higher_JJR levels_NNS of_II soluble_JJ Tac_NN peptide_NN than_CSN normal_JJ controls_NNS ,_, although_CS only_RR 63.6_MC %_SYM (_( 21_MC /_SYM 33_MC )_) of_II them_PN had_VHD a_DD level_NN greater_JJR than_CSN the_DD upper_JJ limit_NN of_II normal_NN ._.
P02800564A11
Virus_NN particles_NNS which_PNR were_VBD indistinguishable_JJ from_II Dane_NN particles_NNS were_VBD seen_VVN in_II the_DD cytoplasmic_JJ vacuoles_NNS of_II the_DD cultured_VVNJ cells_NNS by_II electron_NN microscopy_NN ._.
P02820093A12
HBVDNA_NN concentration_NN was_VBD not_RR diagnostic_JJ of_II disease_NN activity_NN on_II liver_NN biopsy_NN ._.
P02849883A02
Their_PNG prevalences_NNS were_VBD compared_VVN to_II those_PND of_II a_DD control_NN group_NN of_II 124_MC age_NN and_CC sex_NN matched_VVNJ black_NN HBV_NN carriers_NNS without_II tumor_NN ._.
P02940332A06
The_DD results_NNS suggested_VVD that_CST in_II our_PNG children_NNS ,_, most_DD HBsAg_NN carriers_NNS resulted_VVD from_II infections_NNS before_II 3_MC years_NNS of_II age_NN ,_, and_CC HBV_NN infections_NNS after_II 3_MC years_NNS of_II age_NN infrequently_RR resulted_VVD in_II a_DD carrier_NN state_NN ._.
P02947972A02
However_RR ,_, no_DD correlation_NN was_VBD observed_VVN between_II intrauterine_JJ infection_NN of_II infants_NNS and_CC the_DD presence_NN of_II antibodies_NNS of_II immunoglobulin_NN M_NN (_( IgM_NN )_) class_NN antibodies_NNS against_II hepatitis_NN B_NN core_NN antigen_NN (_( anti-HBc_NN )_) in_II maternal_JJ blood_NN ,_, nor_CC was_VBD HBeAg_NN found_VVN in_II maternal_JJ or_CC cord_NN sera_NNS ._.
P03009704A01
Antibody_NN profiles_NNS for_II cytomegalovirus_NN (_( CMV_NN )_) ,_, hepatitis_NN A_NN virus_NN (_( HAV_NN )_) ,_, hepatitis_NN B_NN virus_NN (_( HBV_NN )_) and_CC the_DD delta-agent_NN were_VBD determined_VVN on_II 55_MC serum_NN samples_NNS drawn_VVN from_II 55_MC Saudi_NN patients_NNS on_II maintenance_NN haemodialysis_NN for_II periods_NNS ranging_VVG from_II 1.5_MC months_NNS to_II 2_MC years_NNS ._.
P03360397A05
Cytoplasmic_JJ hepatitis_NN B_NN core_NN antigen_NN (_( HBcAg_NN )_) expression_NN was_VBD found_VVN in_II 9_MC out_II+ of_II 13_MC patients_NNS (_( 69_MC %_SYM )_) during_II acute_JJ exacerbation_NN ._.
P03402900A01
The_DD genome_NN of_II hepatitis_NN B_NN virus_NN (_( HBV_NN )_) contains_VVZ a_DD fourth_JJ open_JJ reading_VVGJ frame_NN (_( ORF_NN )_) ,_, designated_VVN X-region_NN ._.
P03429833A03
Pre-S_NN peptides_NNS were_VBD detected_VVN in_II the_DD serum_NN of_II 11_MC patients_NNS ,_, 10_MC of_II whom_PNR were_VBD positive_JJ for_II serum_NN HBV-DNA_NN and/or_CC liver_NN hepatitis_NN B_NN core_NN antigen_NN ._.
P03537207A02
Serial_JJ samples_NNS from_II 70_MC acutely_RR infected_VVNJ patients_NNS demonstrated_VVD that_CST anti-HBcIgM_NN may_VM detect_VVB 10_MC %_SYM more_DD positives_NNS than_CSN HBsAg_NN within_II 4_MC months_NNS after_II the_DD onset_NN of_II clinical_JJ symptoms_NNS ,_, and_CC all_PND except_II two_MC were_VBD negative_JJ for_II anti-HBcIgM_NN after_II the_DD fourth_JJ month_NN ._.
P03540211A07
Immunofluorescence_NN study_NN revealed_VVD HBsAg_NN in_II 20-30_MC %_SYM of_II hepatocytes_NNS and_CC hepatitis_NN B_NN core_NN antigen_NN (_( HBcAg_NN )_) in_II 2-3_MC %_SYM of_II the_DD cultured_VVNJ human_NN hepatocytes_NNS four_MC days_NNS after_II inoculation_NN ._.
P03585286A03
The_DD mother-infant_NN pairs_NNS were_VBD followed-up_VVD every_DD 3_MC months_NNS for_II at_RR+ least_RR 9_MC months_NNS ._.
P03616486A06
It_PN is_VBZ concluded_VVN that_CST HDV_NN superinfection_NN plays_VVZ a_DD significant_JJ role_NN in_II Taiwan_NNP in_II HBeAg_NN negative_JJ chronic_JJ hepatitis_NN B_NN patients_NNS with_II clinical_JJ "_`` exacerbation_NN "_'' ._.
P03653136A05
During_II follow-up_NN ,_, seroconversion_NN from_II HBeAg_NN to_II anti-HBe_NN with_II subsequent_JJ remission_NN of_II liver_NN disease_NN occurred_VVD in_II 82_MC %_SYM of_II patients_NNS presenting_VVG with_II detectable_JJ levels_NNS of_II anti-HBc_NN ,_, including_VVG three_MC out_II+ of_II seven_MC cases_NNS with_II chronic_JJ persistent_JJ hepatitis_NN ,_, but_CC in_II none_MC of_II the_DD cases_NNS that_PNR were_VBD initially_RR negative_JJ (_( P_NN less_RR than_CSN 0.01_MC )_) ._.
P03668273A04
None_MC of_II 9_MC HBsAg_NN positive_JJ pregnant_JJ women_NNS were_VBD carriers_NNS of_II HBeAg_NN ._.
P03669127A06
This_PND could_VM indicate_VVB an_DD important_JJ nonparenteral_JJ transmission_NN of_II HBV_NN in_II schools_NNS ._.
P03701304A03
The_DD titers_NNS correlated_VVD well_RR with_II hepatitis_NN B_NN viral_JJ DNA_NN (_( HBV_NN DNA_NN )_) and_CC hepatitis_NN B_NN e_NN antigen_NN (_( HBeAg_NN )_) in_II the_DD serum_NN ._.
P03723115A03
Our_PNG study_NN shows_VVZ that_CST perinatal_JJ transmission_NN is_VBZ relatively_RR unimportant_JJ in_II Kenya_NNP and_CC that_CST this_PND may_VM be_VBB a_DD consequence_NN of_II the_DD low_JJ levels_NNS of_II circulating_VVGJ HBV-DNA_NN in_II the_DD maternal_JJ plasma_NN ._.
P03743555A03
The_DD method_NN 's_GE detection_NN limit_NN was_VBD 10_MC (_( 5_MC )_) genome_NN equivalents_NNS or_CC 0.3_MC pg_NN DNA_NN per_II ml_NN ._.
P03765952A06
In_II sera_NNS recently_RR cleared_VVN of_II IgM_NN anti-HBc_NN ,_, mean_NN SGPT_NN activity_NN was_VBD detected_VVN twofold_NN the_DD normal_JJ value_NN in_II CPH_NN and_CC threefold_NN in_II CAH_NN patients_NNS ._.
P03784781A01
IgM_NN antibody_NN to_II hepatitis_NN B_NN core_NN antigen_NN (_( IgM_NN anti-HBc_NN )_) may_VM indicate_VVB an_DD active_JJ immune_JJ response_NN to_II persistent_JJ infection_NN with_II hepatitis_NN B_NN virus_NN (_( HBV_NN )_) ._.
P03855403A01
The_DD correlation_NN between_II serum_NN and_CC hepatic_JJ markers_NNS of_II hepatitis_NN B_NN virus_NN (_( HBV_NN )_) has_VHZ been_VBN studied_VVN in_II 70_MC subjects_NNS with_II chronic_JJ active_JJ hepatitis_NN of_II whom_PNR 18_MC were_VBD HBsAg+_NN and_CC 52_MC were_VBD HBsAg-_NN ._.
P03944482A08
Six_MC (_( 86_MC %_SYM )_) of_II seven_MC recipients_NNS of_II HBV_NN DNA-negative_JJ blood_NN units_NNS developed_VVD HBV_NN infection_NN ._.
P03956945A01
We_PN compared_VVD the_DD clinical_JJ and_CC serologic_JJ features_NNS of_II 118_MC hepatitis_NN B_NN surface_NN antigen_NN carriers_NNS with_II hepatitis_NN B_NN e_NN antibody_NN (_( anti-HBe_NN )_) followed_VVN up_II for_II 3-10_MC yr_NN (_( mean_NN 6.1_MC yr_NN )_) ,_, separated_VVN according_II+ to_II the_DD presence_NN or_CC absence_NN of_II hepatitis_NN B_NN virus-deoxyribonucleic_JJ acid_NN (_( HBV-DNA_NN )_) in_II serum_NN ._.
P03968544A01
Sera_NNS from_II four_MC groups_NNS of_II patients_NNS wtih_II different_JJ serologic_JJ markers_NNS of_II HBV_NN infection_NN were_VBD examined_VVN for_II HBV_NN DNA_NN using_VVG molecular_JJ hybridization_NN technique_NN and_CC for_II IgM_NN class_NN anti-HBc_NN using_VVG an_DD ELISA_NN based_VVN on_II the_DD antibody_NN capture_NN principle_NN ._.
P04035199A09
The_DD chi_NN 2_MC test_NN showed_VVD a_DD non_JJ significant_JJ difference_NN for_II frequencies_NNS of_II HBsAg_NN ,_, anti-HBc_NN alone_JJ ,_, anti-HBs_NNS but_CC a_DD significant_JJ one_PN for_II frequencies_NNS of_II no_DD HBV_NN markers_NNS in_II men_NNS and_CC women_NNS ._.
P04076727A02
Controls_NNS consisted_VVD of_II 90_MC patients_NNS without_II liver_NN disease_NN ._.
P06085625A01
Serum_NN samples_NNS were_VBD collected_VVN at_II the_DD time_NN of_II hospitalization_NN from_II 221_MC black_NN Africans_NNS suffering_VVG from_II cirrhosis_NN and_CC 453_MC suffering_VVG from_II hepatocellular_JJ carcinoma_NN (_( HCC_NN )_) ._.
P06100353A07
These_DD findings_NNS do_VDB not_RR support_VVB the_DD report_NN by_II Chung_NNP et_CC al._NN (_( 1983_MC ,_, J._NN Med._NN Virol._NN 11_MC :_: 99-104_MC )_) that_CST a_DD prolonged_VVNJ replicative_JJ phase_NN of_II chronic_JJ HBV_NN infection_NN is_VBZ essential_JJ for_II the_DD occurrence_NN of_II HCC_NN ._.
P06127059A02
An_DD increased_VVNJ prevalence_NN of_II anti-HBs_NNS was_VBD found_VVN in_II patients_NNS with_II systemic_JJ lupus_NN erythematosus_NN ._.
P06162990A02
Serum_NN samples_NNS from_II 102_MC PHC_NN patients_NNS and_CC from_II 100_MC control_NN individuals_NNS were_VBD tested_VVN for_II hepatitis_NN B_NN surface_NN antigen_NN (_( HBsAg_NN )_) ,_, antibody_NN to_II HBsAg_NN (_( anti-HBs_NNS )_) ,_, antibody_NN to_II hepatitis_NN B_NN core_NN antigen_NN (_( anti-HBc_NN )_) ,_, hepatitis_NN Be_NN antigen_NN (_( HBeAg_NN )_) ,_, and_CC antibody_NN to_II HBeAg_NN (_( anti-HBe_NN )_) ._.
P06188801A01
Serological_JJ evidence_NN of_II hepatitis_NN B_NN virus_NN (_( HBV_NN )_) infection_NN and_CC serum_NN alphafetoprotein_NN (_( AFP_NN )_) were_VBD assayed_VVN in_II sera_NNS from_II 112_MC Korean_JJ patients_NNS with_II primary_JJ hepatocellular_JJ carcinoma_NN (_( PHC_NN )_) and_CC from_II 63_MC age-_NN and_CC sex-matched_VVNJ controls_NNS ._.
P06204916A05
Although_CS HBsAg_NN was_VBD found_VVN in_II a_DD larger_JJR percentage_NN of_II PHC_NN patients_NNS (_( 81_MC %_SYM )_) ,_, it_PN was_VBD also_RR present_JJ in_II more_DD control_NN patients_NNS (_( 14_MC %_SYM )_) ._.
P06260695A06
Sera_NNS positive_JJ for_II any_DD HBV_NN marker_NN were_VBD also_RR tested_VVN for_II e_NN antigen_NN (_( HBeAg_NN )_) and_CC its_PNG antibody_NN (_( anti-HBe_NN )_) ._.
P06294917A03
The_DD presence_NN of_II anti-HBc_NN alone_JJ seemed_VVN to_TO denote_VVI previous_JJ hepatitis_NN B_NN virus_NN infection_NN ._.
P06313507A06
However_RR ,_, the_DD ultimate_JJ mechanism_NN regulating_VVG this_DD difference_NN awaits_VVZ further_JJ study_NN ._.
P06341197A04
In_II acute_JJ self-limited_VVNJ hepatitis_NN B_NN ,_, anti-HBc_NN IgM_NN (_( RIA_NN and_CC ELISA_NN )_) was_VBD initially_RR positive_JJ in_II all_DD 35_MC patients_NNS ._.
P06406288A09
The_DD results_NNS from_II this_DD study_NN indicate_VVB that_CST testing_VVGN for_II anti-HBc_NN IgM_NN may_VM improve_VVB serodiagnostic_JJ accuracy_NN when_CS acute_JJ NANB_NN and_CC delta-agent_NN hepatitis_NN occur_VVB in_II previously_RR unrecognized_VVNJ HBsAg_NN carriers_NNS ._.
P06475930A04
All_DD serum_NN samples_NNS were_VBD assayed_VVN by_II radioimmunoassay_NN to_TO determine_VVI presence_NN of_II HBsAg_NN ,_, antibody_NN to_II HBsAg_NN (_( anti-HBs_NNS )_) ,_, hepatitis_NN B_NN e_NN antigen_NN (_( HBeAg_NN )_) ,_, antibody_NN to_II hepatitis_NN B_NN e_NN antigen_NN (_( anti-HBe_NN )_) and_CC antibody_NN to_II hepatitis_NN B_NN core_NN antigen_NN (_( anti-HBc_NN )_) ._.
P06618432A05
All_DD six_MC were_VBD negative_JJ for_II nuclear_JJ HBcAg_NN and_CC serum_NN HBV_NN DNA_NN ,_, but_CC three_MC showed_VVD HBV_NN DNA_NN which_PNR appeared_VVD to_TO be_VBI integrated_VVN into_II unique_JJ sites_NNS in_II host_NN liver_NN DNA_NN by_II hybridization_NN analysis_NN ._.
P06637981A02
Overall_RR ,_, hepatitis_NN B_NN surface_NN antigen_NN (_( HBsAg_NN )_) was_VBD found_VVN in_II 6.4_MC %_SYM of_II those_PND tested_VVN ._.
P06693067A03
The_DD findings_NNS were_VBD correlated_VVN with_II results_NNS of_II tissue_NN immunofluorescence_NN for_II HBV_NN antigens_NNS and_CC the_DD presence_NN of_II serum_NN hepatitis_NN B_NN e_NN antigen_NN (_( HBeAg_NN )_) ,_, together_RR with_II histologic_JJ assessment_NN of_II each_DD liver_NN ._.
P07111979A11
We_PN correlate_VVB the_DD presence_NN of_II HBsAg_NN --_: regardless_II+ of_II the_DD level_NN of_II titer_NN of_II it_PN --_: with_II high_JJ titers_NNS of_II anti-HBc_NN and_CC the_DD presence_NN of_II anti-HBs_NNS with_II low_JJ titers_NNS (_( P_NN less_RR than_CSN less_RR than_CSN 0,0001_MC )_) ._.
P07229619A05
The_DD three_MC serologic_JJ parameters_NNS ,_, anti-HBc_NN ,_, anti-DNA_NN ,_, and_CC e-antigen_NN /_SYM antibody_NN ,_, should_VM together_RR prove_VVB useful_JJ for_II the_DD evaluation_NN of_II the_DD clinical_JJ status_NN of_II chronic_JJ HBsAg_NN carriers_NNS ._.
P07229621A01
A_DD new_JJ commercially_RR available_JJ radioimmunoassay_NN (_( RIA_NN )_) (_( Abbott-HBeTM_NN )_) was_VBD used_VVN for_II determination_NN of_II hepatitis_NN B_NN e-antigen_NN (_( HBeAg_NN )_) and_CC its_PNG antibody_NN (_( anti-HBe_NN )_) ._.
P07229621A14
The_DD usefulness_NN of_II HBeAg_NN /_SYM anti-HBe_NN in_II the_DD evaluation_NN of_II infectivity_NN and_CC prognosis_NN in_II hepatitis_NN B_NN has_VHZ been_VBN limited_VVN by_II the_DD low_JJ sensitivity_NN of_II the_DD earlier_JJR test_NN systems_NNS ._.
P07229626A03
In_II six_MC chimpanzees_NNS in_II which_PNR HGsAg_NN was_VBD detected_VVN for_II 16_MC weeks_NNS or_CC longer_RR ,_, HBeAg_NN was_VBD detected_VVN early_RR in_II the_DD infection_NN ;_: in_II five_MC ,_, anti-HBe_NN became_VVD detectable_JJ and_CC HBeAg_NN undetectable_JJ prior_II+ to_II the_DD clearance_NN of_II HBsAg_NN ._.
P07241093A03
The_DD significance_NN of_II relationship_NN between_II the_DD titer_NN of_II HBsAg_NN ,_, HBeAg_NN ,_, anti-HBe_NN ,_, and_CC anti-HBc_NN were_VBD statistically_RR analyzed_VVN ._.
P07348762A05
Among_II 15_MC patients_NNS with_II persistent_JJ HBsAg_NN ,_, anti-HBc_NN IgM_NN was_VBD present_JJ from_II 7_MC months_NNS to_II more_RR than_CSN 8_MC years_NNS ._.
P07508491A05
Two_MC sera_NNS from_II the_DD cases_NNS of_II acute_JJ HB_NN showed_VVD strong_JJ reactivity_NN of_II the_DD IgG3_NN isotype_NN with_II HBc_NN /_SYM eAg_NN peptides_NNS 61-85_MC ._.
P07787166A03
The_DD remaining_VVGJ 51_MC subjects_NNS (_( 58.0_MC %_SYM )_) were_VBD positive_JJ for_II anti-HBc_NN alone_JJ ;_: 50_MC of_II them_PN received_VVD a_DD four-dose_NN schedule_NN of_II hepatitis_NN B_NN (_( HB_NN )_) vaccine_NN ._.
P07897364A06
Following_VVG 1_MC month_NN of_II treatment_NN with_II interferon-alpha_NN 2b3_NN miu_NN three_MC times_NNS weekly_RR ,_, alanine_NN aminotransferases_NNS returned_VVD to_II normal_JJ levels_NNS while_CS cryoglobulins_NNS and_CC immune_JJ complexes_NNS disappeared_VVD from_II serum_NN ._.
P08294088A01
Serum_NN IgM_NN anti-HBc_NN was_VBD determined_VVN in_II 135_MC chronic_JJ HBsAg_NN carriers_NNS with_II various_JJ categories_NNS of_II histological_JJ activity_NN on_II liver_NN biopsy_NN and_CC hepatitis_NN B_NN serological_JJ profile_NN ._.
P08405860A02
The_DD aim_NN of_II this_DD study_NN was_VBD to_TO perform_VVI detailed_VVNJ serological_JJ and_CC biochemical_JJ analysis_NN during_II periods_NNS of_II active_JJ liver_NN disease_NN to_TO better_RRR understand_VVI the_DD mechanisms_NNS responsible_JJ for_II the_DD cyclic_JJ nature_NN of_II liver_NN injury_NN ._.
P08440421A07
The_DD serological_JJ profile_NN of_II HBsAg-positive_JJ /_SYM low_JJ or_CC negative_JJ anti-HBc_NN titer_NN and_CC increased_VVNJ anti-HBc_NN titer_NN with_II abnormal_JJ serum_NN ALT_NN levels_NNS are_VBB not_RR necessarily_RR exceptional_JJ in_II HBeAg-positive_JJ adolescent_NN ASC_NN ._.
P08488126A08
More_DD studies_NNS showed_VVD the_DD trans-activating_VVGJ properties_NNS of_II HBxAg_NN ;_: actually_RR the_DD X_NN protein_NN seems_VVZ to_TO be_VBI involved_VVN in_II replicative_JJ cycle_NN of_II HBV_NN ._.
P08520247A04
The_DD donor_NN follow-up_NN times_NNS ranged_VVD from_II 1.2_MC to_II 13.5_MC years_NNS ._.
P08685787A02
DESIGN_NN :_: A_DD sero-epidemiological_JJ community-based_VVNJ cross-sectional_JJ study_NN ._.
P08685787A14
However_RR ,_, standardisation_NN for_II year_NN of_II data_NNS collection_NN and_CC province_NN resulted_VVD in_II a_DD relative_JJ risk_NN of_II 2.0_MC ,_, i.e._CC the_DD risk_NN of_II being_VVGN HBsAg-positive_JJ in_II rural_JJ areas_NNS is_VBZ twice_RR as_RR high_JJ as_CSN in_II urban_JJ areas_NNS ._.
P08707245A05
Tupaias_NNS can_VM also_RR be_VBB infected_VVN with_II HBV_NN in_RR+ vivo_RR ,_, resulting_VVG in_II viral_JJ DNA_NN replication_NN and_CC gene_NN expression_NN in_II tupaia_NN livers_NNS ._.
P08835741A04
Ten_MC infants_NNS became_VVD HBsAg_NN carriers_NNS ,_, and_CC their_PNG mothers_NNS had_VHD significantly_RR lower_JJR anti-HBc_NN titers_NNS than_CSN those_PND of_II the_DD mothers_NNS of_II 182_MC infants_NNS who_PNR did_VDD not_RR become_VVB carriers_NNS (_( p_NN =_SYM 0.003_MC )_) ,_, while_CS maternal_JJ serum_NN hepatitis_NN B_NN virus_NN DNA_NN levels_NNS (_( 29.9_MC +/-_SYM 23.6_MC versus_CC 39.9_MC +/-_SYM 58.1_MC pg_NN /_SYM 10_MC ml_NN )_) did_VDD not_RR differ_VVB in_II those_DD two_MC groups_NNS (_( p_NN >_SYM 0.25_MC )_) ._.
P08931411A06
IgM_NN anti-HBc_NN and_CC HBeAg_NN levels_NNS were_VBD compared_VVN to_II initial_JJ serum_NN HBV_NN DNA_NN ,_, DNA_NN polymerase_NN ,_, serum_NN aminotransferase_NN levels_NNS ,_, and_CC demographic_JJ features_NNS ._.
P09139082A04
The_DD former_JJ group_NN of_II carrier_NN is_VBZ considered_VVN to_TO be_VBI at_II a_DD higher_JJR risk_NN of_II transmitting_VVGN HBV_NN infection_NN than_CSN the_DD latter_NN ._.
P09185774A04
The_DD median_JJ follow-up_NN period_NN was_VBD 20_MC months_NNS (_( range_NN ,_, 2-59_MC months_NNS )_) ._.
P09398007A07
Serum_NN ALT_NN remained_VVD persistently_RR normal_JJ and_CC HBV_NN DNA_NN undetectable_JJ by_II dot-blot_NN assay_NN in_II 6_MC initial_JJ responders_NNS and_CC 1_MC initial_JJ nonresponder_NN ,_, compared_VVN with_II none_MC of_II the_DD 21_MC untreated_VVNJ controls_NNS (_( sustained_VVNJ response_NN :_: 33_MC %_SYM vs._CC 0_MC ;_: P_NN <_SYM .001_MC )_) ._.
P09407340A11
The_DD mechanism_NN of_II intrahepatic_JJ shift_NN of_II HBcAg_NN from_II the_DD nucleus_NN to_II the_DD cytoplasm_NN and_CC the_DD decreased_VVNJ levels_NNS of_II viraemia_NN in_II this_DD phase_NN may_VM be_VBB ,_, at_RR+ least_RR in_II part_NN ,_, secondary_JJ to_II liver_NN damage_NN and_CC regeneration_NN ._.
P09425944A12
In_II contrast_NN ,_, HBeAg-containing_VVGJ immune_JJ complexes_NNS were_VBD still_RR detected_VVN after_II SC_NN ._.
P09493518A04
They_PN were_VBD followed-up_VVN bimonthly_RR with_II routine_JJ liver_NN function_NN tests_NNS ,_, and_CC HBcAb_NN IgM_NN titres_NNS were_VBD also_RR determined_VVN ._.
P09506393A04
After_II selecting_VVGN HEPAXPERT_NN /_SYM WWW_NN ,_, serologic_JJ test_NN results_NNS can_VM be_VBB entered_VVN and_CC will_VM be_VBB transferred_VVN as_II an_DD e-mail_NN message_NN for_II subsequent_JJ interpretation_NN which_PNR is_VBZ done_VDN off-line_NN with_II HEPAXPERT-III_NN ._.
P09715416A01
Approximately_RR 15_MC %_SYM of_II Indian_JJ patients_NNS with_II hepatitis_NN B_NN virus_NN (_( HBV_NN )_) -related_VVNJ chronic_JJ liver_NN disease_NN (_( CLD_NN )_) have_VHB infection_NN with_II precore_NN mutant_NN forms_NNS ._.
P09715416A14
This_DD study_NN concluded_VVD that_CST :_: 1_MC ._.
P09738719A10
CONCLUSIONS_NNS :_: Current_JJ immunoprophylaxis_NN strategy_NN does_VDZ not_RR protect_VVB newborns_NNS with_II surface_NN antigenemia_NN ,_, apparently_RR acquired_VVN in_II utero_NN ,_, from_II becoming_VVGN HBV_NN carriers_NNS ._.
P10607224A03
The_DD proportion_NN of_II infected_VVNJ people_NNS who_PNR become_VVB chronic_JJ carriers_NNS ranges_VVZ from_II about_RR 80_MC to_II 95_MC %_SYM for_II babies_NNS born_VVN to_II HBsAg_NN /_SYM HBeAg-positive_JJ mothers_NNS ._.
P10960459A07
Of_II the_DD 77_MC samples_NNS with_II detectable_JJ HBV-DNA_NN titers_NNS below_II 3.75_MC x_SYM 10_MC (_( 5_MC )_) copies_NNS by_II TaqMan_NN ,_, only_RR 13_MC were_VBD detected_VVN by_II bDNA_NN ._.
P11555188A12
Several_JJ other_JJ antiviral_JJ agents_NNS are_VBB currently_RR being_VBG evaluated_VVN in_II this_DD setting_VVGN with_II combined_VVNJ regimens_NNS being_VVGN the_DD most_RRT reasonable_JJ step_NN for_II the_DD near_JJ future_NN ._.
P11703579A07
In_II addition_NN ,_, we_PN analysed_VVD serum_NN samples_NNS from_II 8_MC anti-HBe-positive_JJ patients_NNS who_PNR had_VHD been_VBN receiving_VVG lamivudine_NN treatment_NN for_II more_RR than_CSN three_MC years_NNS ._.
P12239179A04
The_DD 95_MC %_SYM detection_NN limit_NN of_II the_DD method_NN amounted_VVD to_II 27.8_MC IU_NN /_SYM mL_NN ,_, consistent_JJ with_II the_DD World_NN Health_NN Organization_NN (_( WHO_NN )_) international_JJ standard_NN for_II HBV_NN DNA_NN ._.
P12421455A12
Under_II certain_JJ conditions_NNS ,_, kidneys_NNS from_II HBV-infected_VVNJ donors_NNS can_VM be_VBB safely_RR used_VVN and_CC thus_RR prevent_VVB unnecessary_JJ discarding_VVGN of_II organs_NNS ._.P00681751A04
Alternatively_RR ,_, basophils_NNS were_VBD purified_VVN from_II animals_NNS receiving_VVG repeated_VVNJ i.v._NN injections_NNS of_II sodium_NN [_( 35S_NN ]_) sulfate_NN ._.
P01339431A04
Phosphatidylinositol-specific_JJ phospholipase_NN C_NN and_CC monoclonal_JJ antibody_NN (_( mAb_NN )_) S1_NN identified_VVD the_DD 64-kDa_NN core_NN proteins_NNS as_II glypican_NN ,_, whereas_CS mAb_NN 2E9_NN ,_, which_PNR also_RR reacted_VVD with_II proteoglycan_NN from_II mouse_NN mammary_JJ epithelial_JJ cells_NNS ,_, tentatively_RR identified_VVD the_DD hybrid_NN proteoglycans_NNS as_II syndecan_NN ._.
P01443612A07
Structural_JJ analysis_NN revealed_VVD that_CST N-sulfated_VVNJ glucosamine_NN residues_NNS were_VBD present_VVB much_RR less_RR frequently_RR in_II HS_NN derived_VVN from_II these_DD cells_NNS as_CS compared_VVN with_II that_PND derived_VVN from_II wild-type_NN cells_NNS ._.
P01488123A03
In_II Alzheimer_NNP 's_GE tissue_NN ,_, however_RR ,_, the_DD number_NN and_CC intensity_NN of_II these_DD elements_NNS was_VBD more_RR extensive_JJ than_CSN in_II control_NN brains_NNS ._.
P01513088A05
In_II contrast_NN ,_, incubation_NN in_II the_DD enzyme_NN chondroitinase_NN ABC_NN did_VDD not_RR reduce_VVB the_DD number_NN of_II sites_NNS in_II the_DD LRE_NN but_CC reduced_VVD the_DD number_NN of_II sites_NNS in_II the_DD LRI_NN by_II 26_MC %_SYM ._.
P01556106A05
The_DD betaglycan_NN forms_NNS expressed_VVN in_II bFGF-treated_VVNJ osteoblasts_NNS have_VHB a_DD reduced_VVNJ content_NN of_II heparan_NN sulfate_NN GAGs_NNS ,_, without_II detectable_JJ changes_NNS in_II the_DD content_NN of_II chondroitin_NN sulfate_NN GAGs_NNS or_CC the_DD size_NN of_II the_DD core_NN protein_NN ._.
P01593846A04
Specificity_NN of_II JM-403_NN for_II HS_NN was_VBD also_RR suggested_VVN by_II results_NNS of_II inhibition_NN studies_NNS ,_, which_PNR found_VVD that_CST intact_JJ HSPG_NN and_CC HS_NN ,_, but_CC not_RR the_DD core_NN protein_NN ,_, inhibited_VVD the_DD binding_VVGN of_II JM-403_NN to_II HS_NN ._.
P01613397A01
Proteoglycan_NN production_NN was_VBD examined_VVN in_II cultures_NNS of_II thioglycollate-elicited_VVNJ peritoneal_JJ macrophages_NNS obtained_VVN from_II White_NN Carneau_NN and_CC Show_NN Racer_NN pigeons_NNS ._.
P01634336A03
These_DD filaments_NNS ,_, which_PNR were_VBD partially_RR sensitive_JJ to_II chondroitinase_NN AC_NN and_CC chondroitinase_NN B_NN ,_, were_VBD completely_RR removed_VVN by_II chondroitinase_NN ABC_NN and_CC were_VBD identified_VVN as_II chondroitin_NN /_SYM dermatan_NN sulfate_NN proteoglycans_NNS ._.
P01800132A10
We_PN conclude_VVB that_CST ,_, as_II+ for_II glomerular_JJ basement_NN membrane_NN proteoglycans_NNS ,_, biochemical_JJ alterations_NNS affect_VVB the_DD glomerular_JJ cell_NN membrane_NN proteoglycans_NNS with_II aging_VVGN ._.
P01906068A05
Large_JJ amounts_NNS of_II hyaluronic_JJ acid_NN labeled_VVN with_II 3H_NN glucosamine_NN were_VBD found_VVN in_II the_DD cell_NN layer_NN ._.
P01918055A02
Addition_NN of_II follistatin_NN to_II the_DD cultured_VVNJ cells_NNS demonstrated_VVD a_DD typical_JJ ligand-binding_VVGJ saturation_NN curve_NN ,_, suggesting_VVG that_CST granulosa_NN cells_NNS have_VHB a_DD specific_JJ binding_VVGJ site_NN for_II follistatin_NN ._.
P02022669A08
This_DD size_NN heterogeneity_NN ,_, which_PNR is_VBZ comparable_JJ to_II that_PND seen_VVN in_II the_DD lens_NN capsule_NN ,_, is_VBZ most_RRT readily_RR attributable_JJ to_II proteolytic_JJ processing_VVGN of_II a_DD precursor_NN molecule_NN ._.
P02125032A02
One_MC eye_NN received_VVD 550_MC nM_NN dexamethasone_NN in_II addition_NN to_II culture_NN medium_NN ;_: the_DD fellow_JJ eye_NN received_VVD culture_NN medium_NN only_RR ._.
P02137090A06
Membrane-associated_VVNJ proteoglycan_NN (_( MA-PG_NN )_) was_VBD further_RR purified_VVN by_II ion_NN exchange_NN and_CC gel_NN chromatography_NN ._.
P02140362A08
Thermolysin_NN fragmentation_NN of_II the_DD 125I-labeled_VVNJ proteoglycan_NN yielded_VVD glycosamino-glycan-free_JJ core_NN protein_NN fragments_NNS of_II approximately_RR 110_MC and_CC 62_MC kDa_NN which_PNR bound_VVD to_II both_CC fibronectin_NN and_CC heparin_NN columns_NNS ._.
P02143497A06
Differences_NNS in_II DEAE-chromatographic_JJ behavior_NN were_VBD obvious_JJ in_II pathological_JJ samples_NNS as_CS compared_VVN to_II controls_NNS ,_, the_DD hydrodynamic_JJ form_NN of_II HA_NN and_CC the_DD charge_NN density_NN of_II HS_NN being_VBG decreased_VVN ._.
P02144898A04
The_DD amino_JJ acid_NN sequence_NN deduced_VVN from_II the_DD isolated_VVNJ cDNAs_NNS revealed_VVD several_JJ interesting_VVGJ features_NNS ,_, including_VVG hydrophobic_JJ signal_NN and_CC transmembrane_JJ domains_NNS that_PNR flank_VVB an_DD extracellular_JJ region_NN containing_VVG six_MC potential_JJ attachment_NN sites_NNS for_II glycosaminoglycan_NN side_NN chains_NNS ._.
P02352508A08
A_DD second_JJ pericellular_JJ GAG_NN was_VBD identified_VVN as_II CS_NN in_II mature_JJ granulation_NN tissue_NN cells_NNS ,_, scar_NN cells_NNS and_CC skin_NN cells_NNS ;_: while_CS HA_NN was_VBD identified_VVN in_II the_DD pericellular_JJ matrix_NN of_II early_JJ granulation_NN tissue_NN cells_NNS ._.
P02421806A01
Proteoglycans_NNS within_II the_DD extracellular_JJ matrix_NN of_II human_NN bone_NN marrow_NN have_VHB been_VBN implicated_VVN in_II the_DD process_NN of_II hematopoiesis_NN ,_, but_CC little_PND is_VBZ known_VVN about_II the_DD structure_NN and_CC composition_NN of_II these_DD macromolecules_NNS in_II this_DD tissue_NN ._.
P02421806A15
Chondroitinase_NN ABC_NN treatment_NN of_II the_DD cultures_NNS completely_RR removed_VVD the_DD ruthenium_NN red-positive_JJ granules_NNS overlying_VVG the_DD cells_NNS and_CC resulted_VVD in_II a_DD loss_NN of_II approximately_RR 70_MC %_SYM of_II the_DD 35S-sulfate-labeled_VVNJ material_NN from_II the_DD cell_NN layer_NN ._.
P02441105A10
Their_PNG kidneys_NNS were_VBD utilized_VVN for_II labeling_VVGN of_II basement_NN membrane_NN PGs_NNS by_II employing_VVGN [_( 35S_NN ]_) -sulfate_NN as_II the_DD precursor_NN product_NN ._.
P02443472A04
In_II CB-fixed_VVNJ specimens_NNS 50_MC nm_NN long_JJ ,_, rod-like_JJ granules_NNS were_VBD found_VVN attached_VVN to_II keratinocyte_NN cell_NN surfaces_NNS ,_, while_CS the_DD RR-_NN and_CC TA-fixed_VVNJ specimens_NNS contained_VVD round_JJ granules_NNS (_( luminal_JJ diameter_NN 10_MC and_CC 30_MC nm_NN ,_, respectively_RR )_) ._.
P02472420A03
Cultures_NNS were_VBD labeled_VVN with_II 35S-sulfate_NN ,_, and_CC the_DD PGs_NNS were_VBD extracted_VVN from_II medium_NN and_CC cell_NN layer_NN ._.
P02494091A11
Characteristics_NNS of_II these_DD macromolecules_NNS differ_VVB from_II those_PND produced_VVN by_II purified_VVNJ cultures_NNS of_II chick_NN embryo_NN retina_NN neurons_NNS and_CC photoreceptors_NNS in_II terms_NNS of_II size_NN ,_, compartmental_JJ distribution_NN ,_, and_CC presence_NN of_II hyaluronic_JJ acid_NN ._.
P02498202A03
Following_VVG 24_MC h_NN incubation_NN in_II the_DD presence_NN of_II (_( 35S_NN )_) -sulfate_NN ,_, significant_JJ quantities_NNS of_II 35S-labelled_VVNJ macromolecules_NNS were_VBD detected_VVN both_CC within_II the_DD culture_NN medium_NN and_CC cells_NNS ._.
P02499495A05
Further_RR ,_, highly_RR purified_VVNJ beta-D-xyloside-initiated_VVNJ chondroitin_NN /_SYM dermatan-35SO4_NN GAGs_NNS were_VBD taken_VVN up_II by_II kidneys_NNS more_RR avidly_RR than_CSN was_VBD free_JJ [_( 35S_NN ]_) sulfate_NN ._.
P02521485A02
Analysis_NN of_II the_DD binding_VVGJ function_NN yielded_VVD an_DD association_NN constant_NN of_II 0.62_MC x_SYM 10_MC (_( 8_MC )_) M-1_NN and_CC a_DD maximum_NN binding_VVGJ capacity_NN of_II 2.1_MC micrograms_NNS /_SYM 60-mm_NN dish_NN ._.
P02521995A01
The_DD metabolic_JJ turnover_NN of_II rat_NN glomerular_JJ proteoglycans_NNS in_RR+ vivo_RR was_VBD investigated_VVN ._.
P02523890A03
The_DD binding_VVGN of_II the_DD hydrophobic_JJ HSPGs_NNS to_II membranes_NNS appears_VVZ to_TO be_VBI via_II covalently_RR linked_VVNJ phosphatidylinositol_NN based_VVN on_II the_DD observation_NN that_CST incubation_NN of_II the_DD detergent-solubilized_VVNJ protein_NN with_II purified_VVNJ phosphatidylinositol-specific_JJ phospholipase_NN C_NN significantly_RR reduces_VVZ the_DD ability_NN of_II the_DD HSPGs_NNS to_TO associate_VVI with_II phospholipid_NN vesicles_NNS in_II a_DD reconstitution_NN assay_NN ._.
P02527236A08
The_DD small_JJ keratan_NN sulfate_NN proteoglycans_NNS appear_VVB to_TO be_VBI present_JJ as_II a_DD species_NN distinct_JJ from_II the_DD small_JJ dermatan_NN sulfate_NN proteoglycans_NNS in_II these_DD cultures_NNS in_CS+ that_CS they_PN can_VM be_VBB separated_VVN on_II Q-Sepharose_NN chromatography_NN and_CC sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN ._.
P02530099A01
Heparin_NN is_VBZ known_VVN to_TO bind_VVI to_II cultured_VVNJ endothelial_JJ cells_NNS ._.
P02808381A09
Treatment_NN with_II 24_MC ,_, 25-dihydroxyvitamin_NN D3_NN did_VDD not_RR cause_VVB significant_JJ changes_NNS in_II the_DD proteoglycan_NN synthesis_NN ._.
P02840440A08
The_DD heparin_NN /_SYM heparan_NN sulfate_NN binding_VVGJ activity_NN is_VBZ a_DD protein_NN (_( s_GE )_) because_CS it_PN is_VBZ destroyed_VVN by_II treatment_NN with_II trypsin_NN ._.
P02931856A05
10_MC unit_NN /_SYM ml_NN of_II thrombin_NN released_VVD approximately_RR twice_RR as_RR much_DD amount_NN of_II 35S-glycosaminoglycans_NNS as_CSN did_VDD Hanks_NN '_GE balanced_VVNJ salt_NN solution_NN alone_JJ ._.
P02944764A02
This_DD property_NN is_VBZ mediated_VVN by_II sequences_NNS in_II the_DD core_NN protein_NN ,_, since_CS papain-or_NN alkaline_JJ borohydride-released_VVNJ heparan_NN sulfate_NN chains_NNS do_VDB not_RR bind_VVB to_II the_DD matrix_NN ._.
P02946688A08
In_II addition_NN ,_, it_PN was_VBD rapidly_RR released_VVN into_II the_DD medium_NN of_II label-chase_NN experiments_NNS after_II which_PNR it_PN migrated_VVD slightly_RR more_RR rapidly_RR than_CSN HS-tIA_NN in_II gels_NNS ,_, with_II HS_NN chains_NNS similar_JJ in_II length_NN to_II its_PNG tissue_NN counterpart_NN ._.
P02948961A04
Subsequently_RR ,_, about_RR 55_MC %_SYM was_VBD released_VVN into_II the_DD medium_NN (_( t1_NN /_SYM 2_MC approximately_RR 2.5_MC h_NN )_) where_PNR it_PN resided_VVD as_II intact_JJ macromolecule_NN and_CC was_VBD neither_CC endocytosed_VVN nor_CC degraded_VVN further_RR ._.
P02953717A01
Heparan_NN sulfate_NN proteoglycan_NN from_II the_DD Engelbreth-Holm-Swarm_NN mouse_NN tumor_NN was_VBD previously_RR separated_VVN into_II two_MC forms_NNS :_: a_DD high_JJ density_NN form_NN (_( Form_NN HD_NN )_) and_CC low_JJ density_NN form_NN (_( Form_NN LD_NN )_) ._.
P02957379A10
The_DD HSPGs_NNS released_VVN from_II the_DD cell_NN surface_NN by_II proteases_NNS were_VBD slightly_RR smaller_JJR than_CSN the_DD intact_JJ HSPGs_NNS and_CC lacked_VVD the_DD hydrophobic_JJ properties_NNS of_II the_DD latter_NN ._.
P02958485A11
A_DD variety_NN of_II experiments_NNS indicated_VVD that_CST the_DD mechanism_NN of_II this_DD inhibition_NN also_RR involved_VVD the_DD binding_VVGN of_II DS-PGs_NNS to_II only_RR substratum-bound_VVNJ CBF_NN due_II+ to_II the_DD presence_NN of_II a_DD cryptic_JJ GAG-binding_VVGJ domain_NN not_RR observed_VVN in_II the_DD soluble_JJ CBF_NN ._.
P02961930A05
The_DD staining_VVGN was_VBD absent_JJ from_II the_DD more_RR superficial_JJ layers_NNS which_PNR were_VBD invaded_VVN by_II leukocytes_NNS ._.
P02965148A07
(_( c_NN )_) Label_NN and_CC chase_NN experiments_NNS with_II and_CC without_II chloroquine_NN showed_VVD that_CST virtually_RR all_PND of_II the_DD free_JJ heparan_NN sulfate_NN glycosaminoglycan_NN chains_NNS derived_VVD from_II endocytosis_NN and_CC lysosomal_JJ degradation_NN of_II the_DD plasma_NN membrane-associated_VVNJ HSPG_NN ._.
P02967301A01
Tissue_NN culture_NN substratum_NN adhesion_NN sites_NNS from_II EGTA-detached_VVNJ Platt_NN human_NN neuroblastoma_NN cells_NNS were_VBD extracted_VVN with_II a_DD buffer_NN containing_VVG ocytlglucoside_NN ,_, NaCl_NN ,_, guanidine_NN hydrochloride_NN ,_, and_CC a_DD variety_NN of_II protease_NN inhibitors_NNS ,_, an_DD extraction_NN which_PNR resulted_VVD in_II quantitative_JJ solubilization_NN of_II the_DD 35SO4_NN =_SYM -radiolabeled_VVNJ proteoglycans_NNS and_CC 3H-leucine-radiolabeled_VVNJ proteins_NNS ._.
P02968652A04
The_DD synaptic_JJ localization_NN and_CC metabolism_NN of_II this_DD class_NN of_II proteoglycans_NNS are_VBB consistent_JJ with_II its_PNG potential_JJ involvement_NN in_II central_JJ nervous_JJ system_NN dysfunction_NN ._.
P02968986A02
Such_DD interactions_NNS play_VVB key_JJ roles_NNS in_II several_JJ biological_JJ processes_NNS ,_, such_II+ as_II cell_NN recognition_NN ,_, adhesion_NN ,_, migration_NN ,_, and_CC growth_NN ._.
P02969381A03
Adherent_JJ macrophages_NNS isolated_VVN from_II human_NN blood_NN were_VBD plated_VVN on_II [_( 35S_NN ]_) O4-prelabeled_VVNJ extracellular_JJ matrix-coated_VVNJ dishes_NNS prepared_VVN from_II cultured_VVNJ porcine_JJ aortic_JJ endothelial_JJ cells_NNS ._.
P03084487A05
After_II purification_NN by_II sequential_JJ ion-exchange_NN chromatography_NN and_CC isopycnic_JJ CsCI_NN density_NN gradient_NN ultracentrifugation_NN ,_, size-exclusion_NN high-performance_NN liquid_NN chromatography_NN showed_VVD a_DD single_JJ species_NN with_II an_DD estimated_VVNJ Mr_NN of_II 8-9_MC X_SYM 10_MC (_( 5_MC )_) ._.
P03089858A09
This_DD component_NN was_VBD not_RR found_VVN in_II glycosaminoglycan_NN preparations_NNS obtained_VVN either_CC from_II the_DD brain_NN or_CC tail_NN of_II rat_NN fetuses_NNS at_II the_DD same_JJ stages_NNS ._.
P03104227A01
The_DD synthesis_NN and_CC secretion_NN of_II glycosaminoglycans_NNS (_( GAGs_NNS )_) in_II primary_JJ cultures_NNS of_II feline_JJ retinal_JJ pigment_NN epithelium_NN (_( RPE_NN )_) was_VBD measured_VVN ._.
P03104227A15
This_DD study_NN demonstrates_VVZ that_CST the_DD profile_NN of_II radioactively-labeled_VVNJ GAGs_NNS secreted_VVN by_II primary_JJ cultures_NNS of_II feline_JJ RPE_NN is_VBZ distinct_JJ from_II that_PND retained_VVN by_II the_DD cell_NN layer_NN ._.
P03116939A02
On_II the_DD basis_NN of_II gel_NN exclusion_NN chromatography_NN the_DD prevalent_JJ CS_NN /_SYM DSPGs_NNS in_II the_DD tissue_NN were_VBD above_JJ Mr_NN 400_MC X_SYM 10_MC (_( 3_MC )_) with_II two_MC or_CC three_MC glycosaminoglycan_NN chains_NNS of_II Mr_NN 60-70_MC X_SYM 10_MC (_( 3_MC )_) ._.
P03156851A06
It_PN therefore_RR appears_VVZ that_CST there_EX are_VBB at_RR+ least_RR two_MC distinct_JJ types_NNS of_II association_NN of_II heparan_NN sulfate_NN proteoglycans_NNS with_II brain_NN membranes_NNS ._.
P03159726A01
A_DD heparan_NN sulfate-rich_JJ proteoglycan_NN is_VBZ on_II the_DD surface_NN of_II NMuMG_NN mouse_NN mammary_JJ epithelial_JJ cells_NNS apparently_RR intercalated_VVN into_II their_PNG plasma_NN membranes_NNS ._.
P03161900A01
Heparan_NN sulfate_NN and_CC heparin_NN ,_, two_MC sulfated_VVNJ glycosaminoglycans_NNS (_( GAGs_NNS )_) ,_, extracted_VVD collagen-tailed_VVNJ acetylcholinesterase_NN (_( AChE_NN )_) from_II the_DD extracellular_JJ matrix_NN (_( ECM_NN )_) of_II the_DD electric_JJ organ_NN of_II Discopyge_NN tschudii_NN ._.
P03680294A07
When_CS media_NN proteoglycans_NNS were_VBD chromatographed_VVN on_II octyl-Sepharose_NN ,_, two_MC labeled_VVNJ peaks_NNS were_VBD found_VVN ._.
P06214562A06
The_DD distribution_NN of_II chondroitin_NN sulfate_NN proteoglycan_NN was_VBD not_RR coincidental_JJ with_II that_PND of_II fibronectin_NN ._.
P06226661A04
The_DD heparan_NN sulfate_NN proteoglycan_NN ,_, which_PNR constituted_VVD approximately_RR 15_MC %_SYM of_II the_DD 35S-labeled_VVNJ proteoglycans_NNS in_II the_DD culture_NN medium_NN has_VHZ a_DD similar_JJ hydrodynamic_JJ size_NN (_( Kd_NN =_SYM 0.62_MC on_II Sepharose_NN CL-2B_NN )_) and_CC buoyant_JJ density_NN distribution_NN in_II CsCl_NN density_NN gradients_NNS as_II the_DD low_JJ buoyant_JJ density_NN dermatan_NN sulfate_NN proteoglycan_NN synthesized_VVN by_II the_DD same_JJ granulosa_NN cells_NNS and_CC described_VVN in_II the_DD accompanying_VVGJ report_NN (_( Yanagishita_NNP ,_, M._NNP ,_, and_CC Hascall_NNP ,_, V._NNP C._NNP (_( 1983_MC )_) J._NN Biol._NN Chem._NN 258_MC ,_, 12847-12856_MC )_) ._.
P06231180A05
This_DD study_NN demonstrates_VVZ the_DD existence_NN of_II heparin_NN sulfate_NN proteoglycan_NN in_II thyroid_NN tissue_NN for_II the_DD first_JJ time_NN ._.
P06235848A01
Heparan_NN sulfate_NN proteoglycans_NNS have_VHB been_VBN isolated_VVN from_II Swiss_NN mouse_NN 3T3_NN cells_NNS by_II using_VVGN two_MC nondegradative_JJ techniques_NNS :_: extraction_NN with_II 4_MC M_NN guanidine_NN or_CC 2.5_MC %_SYM 1-butanol_NN ._.
P06237102A06
Binding_VVGN requires_VVZ native_JJ collagen_NN structure_NN which_PNR may_VM be_VBB optimal_JJ when_CS the_DD collagen_NN is_VBZ in_II a_DD fibrillar_JJ configuration_NN ._.
P06415057A01
Rat_NN ovarian_JJ granulosa_NN cells_NNS were_VBD isolated_VVN from_II immature_JJ female_NN rats_NNS after_II stimulation_NN with_II pregnant_JJ mare_NN 's_GE serum_NN gonadotropin_NN and_CC maintained_VVN in_II culture_NN ._.
P06456325A08
Uridine_NN at_II the_DD dose_NN applied_VVN partially_RR reversed_VVD D-galactosamine-inhibited_VVNJ synthesis_NN of_II proteoheparan_NN sulfate_NN ._.
P06793599A11
The_DD chromatographic_JJ behavior_NN of_II the_DD extracted_VVNJ proteoglycans_NNS and_CC the_DD derived_VVNJ GAG_NN ,_, together_RR with_II the_DD fact_NN that_CST the_DD two_MC types_NNS of_II proteoglycans_NNS can_VM be_VBB partially_RR separated_VVN into_II the_DD density_NN gradient_NN ,_, suggest_VVB that_CST the_DD heparan_NN sulfate_NN and_CC chondroitin_NN sulfate_NN (_( s_NNS )_) are_VBB located_VVN on_II different_JJ core_NN proteins_NNS ._.
P07674377A06
In_II order_NN to_TO begin_VVI to_TO characterize_VVI the_DD HSPG_NN that_PNR interacts_VVZ with_II NCAM_NN ,_, we_PN initially_RR used_VVD an_DD antiserum_NN produced_VVN against_II a_DD HSPG_NN which_PNR was_VBD previously_RR shown_VVN to_TO copurify_VVI with_II NCAM_NN (_( Cole_NNP and_CC Burg_NNP :_: Exp_NN Cell_NN Res_NN 182_MC :_: 44-60_MC ,_, 1989_MC )_) ._.
P07793988A10
Overall_RR ,_, the_DD results_NNS indicate_VVB that_CST specific_JJ vascular_JJ cell-derived_VVNJ PGs_NNS differentially_RR interact_VVB with_II A_NN beta_NN ,_, and_CC that_CST the_DD interactions_NNS of_II highest_JJT affinity_NN occur_VVB between_II A_NN beta_NN and_CC binding_VVGJ sites_NNS on_II both_CC the_DD core_NN protein_NN and_CC glycosaminoglycan_NN chains_NNS of_II perlecan_NN ._.
P07807583A13
Northern_NN blot_NN analysis_NN with_II a_DD cDNA_NN to_II perlecan_NN revealed_VVD a_DD significant_JJ (_( P_NN <_SYM 0.01_MC )_) 12.7-fold_NN increase_NN in_II expression_NN of_II perlecan_NN in_II neurons_NNS (_( day_NN 9_MC )_) in_II comparison_NN to_II stem_NN cells_NNS ._.
P08035198A02
Biochemical_JJ and_CC autoradiographic_JJ results_NNS of_II 35S-amino_JJ acid_NN utilization_NN reported_VVN here_RR confirm_VVB that_CST the_DD 35SO4_NN (_( 2-_MC )_) differences_NNS seen_VVN previously_RR are_VBB accompanied_VVN by_II increased_VVNJ protein_NN synthesis_NN in_II the_DD rd_NN retina_NN ._.
P08061926A07
The_DD discrepancy_NN in_II size_NN but_CC identify_NN of_II sulfation_NN indicates_VVZ that_CST ,_, although_CS sulfation_NN takes_VVZ place_NN normally_RR on_II either_CC the_DD core_NN protein_NN or_CC the_DD xyloside_NN acceptor_NN ,_, termination_NN of_II glycosylation_NN occurs_VVZ earlier_JJR for_II xyloside-initiated_VVNJ chondroitin_NN sulfate_NN ._.
P08096145A07
These_DD results_NNS provide_VVB evidence_NN for_II participation_NN of_II cell-surface_NN HS_NN proteoglycans_NNS in_II HIV-cell_NN attachment_NN and_CC virus_NN entry_NN ._.
P08138544A06
These_DD proteoglycans_NNS were_VBD intercalated_VVN into_II phosphatidylcholine_NN liposomes_NNS ,_, suggesting_VVG that_CST they_PN are_VBB all_PND membrane-intercalated_VVNJ proteoglycans_NNS ._.
P08227171A09
Northern_NN analysis_NN reveals_VVZ that_CST a_DD panel_NN of_II macrophage-like_JJ cell_NN lines_NNS accumulate_VVB similar_JJ amounts_NNS of_II syndecan-4_NN mRNA_NN ,_, demonstrating_VVG that_CST this_DD proteoglycan_NN is_VBZ expressed_VVN by_II a_DD variety_NN of_II mature_JJ macrophage-like_JJ cells_NNS ._.
P08245966A06
The_DD ability_NN of_II both_CC A_NN beta_NN (_( 1-28_MC )_) and_CC A_NN beta_NN (_( 1-40_MC )_) to_TO bind_VVI glycosaminoglycans_NNS is_VBZ pH-dependent_JJ ,_, with_II increasing_VVGJ interaction_NN as_CS the_DD pH_NN values_NNS fall_VVB below_II neutrality_NN and_CC very_RR little_DD binding_VVGN at_II pH_NN 8.0_MC ._.
P08298962A03
Previous_JJ investigations_NNS have_VHB demonstrated_VVN high_JJ affinity_NN binding_VVGN between_II heparan_NN sulfate_NN proteoglycans_NNS and_CC the_DD amyloid_NN precursor_NN ,_, as_CC+ well_CC+ as_CC with_II the_DD A4_NN peptide_NN ._.
P08340404A01
We_PN have_VHB shown_VVN previously_RR that_CST chondroitin_NN sulfate_NN ,_, but_CC not_RR heparan_NN sulfate_NN /_SYM heparin_NN ,_, linked_VVN to_II either_CC natural_JJ core_NN proteins_NNS or_CC serum_NN albumin_NN interferes_VVZ with_II cell-to-substrate_NN adhesion_NN ,_, provided_CS+ that_CS the_DD external_JJ proteoglycans_NNS are_VBB topologically_RR immobilized_VVN on_II plastic_NN plates_NNS ._.
P08394556A04
There_EX was_VBD no_DD significant_JJ difference_NN in_II the_DD composition_NN of_II GAGs_NNS isolated_VVN from_II either_CC reeler_NN or_CC normal_JJ brain_NN ._.
P08397099A09
Plasma_NN membrane-associated_VVNJ heparan_NN sulfate_NN from_II keratinocytes_NNS differed_VVD from_II the_DD corresponding_VVGJ species_NNS of_II fibroblasts_NNS in_II quantity_NN and_CC quality_NN ._.
P08504377A08
Fluoride_NN decreased_VVD uptake_NN of_II the_DD radiolabel_NN but_CC led_VVD to_II an_DD accumulation_NN of_II glycosaminoglycan_NN within_II the_DD proteoglycan_NN of_II the_DD matrix_NN ._.
P08621634A05
A_DD minor_JJ population_NN of_II perlecan_NN apparently_RR lacks_VVZ heparan_NN sulfate_NN chains_NNS totally_RR ,_, and_CC some_PND of_II this_PND is_VBZ substituted_VVN with_II chondroitin_NN sulfate_NN ._.
P08645702A08
In_II contrast_NN ,_, exposure_NN of_II mesangial_JJ cell_NN from_II normal_JJ rats_NNS to_II elevated_VVNJ glucose_NN did_VDD not_RR lead_VVB to_II any_DD changes_NNS in_II glycosaminoglycan_NN synthesis_NN ,_, indicating_VVG that_CST this_DD short-term_NN culture_NN conditions_NNS may_VM not_RR adequately_RR simulate_VVB diabetes_NN mellitus_NN ._.
P08691728A04
Human_NN adult_NN mesangial_JJ and_CC glomerular_JJ visceral_JJ epithelial_JJ cells_NNS were_VBD cultured_VVN under_II normal_JJ (_( 5_MC mM_NN )_) and_CC high_JJ glucose_NN (_( 25_MC mM_NN )_) conditions_NNS ._.
P08792767A11
In_II comparison_NN ,_, an_DD 18-fold_NN rate_NN increase_NN was_VBD observed_VVN with_II 1_MC microgram_NN /_SYM mL_NN dermatan_NN sulfate_NN proteoglycan_NN purified_VVN from_II SMC_NN culture_NN media_NN ._.
P08824283A07
All_DD glycosaminoglycans_NNS tested_VVN ,_, at_II concentrations_NNS up_II+ to_II 100_MC microM_NN ,_, increased_VVD the_DD activity_NN of_II phospholipase_NN A2_NN toward_II phosphatidylcholine_NN liposomes_NNS ._.
P08917422A07
During_II lactation_NN there_EX was_VBD a_DD dramatic_JJ increase_NN in_II the_DD content_NN of_II dermatan_NN sulfate_NN proteoglycan_NN ._.
P08998082A10
A_DD short-term_NN increase_NN in_II dermatan_NN and_CC chondroitin_NN sulfate_NN content_NN is_VBZ also_RR observed_VVN in_II serum_NN ,_, bronchoalveolar_JJ lavage_NN (_( BAL_NN )_) fluid_NN ,_, and_CC lung_NN tissue_NN ._.
P09202014A06
Using_VVG partially_RR purified_VVNJ heparanase_NN activities_NNS from_II Chinese_NN hamster_NN ovary_NN cells_NNS we_PN examined_VVD whether_CST Abeta_NN (_( 1-40_MC )_) affects_VVZ the_DD catabolism_NN of_II Chinese_NN hamster_NN ovary_NN heparan_NN sulfate_NN glycosaminoglycans_NNS and_CC proteoglycans_NNS in_RR+ vitro_RR ._.
P09270876A06
Only_RR the_DD larger_JJR HS-containing_VVGJ component_NN was_VBD sensitive_JJ to_II alkaline_JJ treatment_NN and_CC was_VBD also_RR found_VVN in_II the_DD medium_NN fraction_NN ._.
P09405101A13
Similar_JJ cell_NN behavior_NN was_VBD also_RR produced_VVN by_II aggrecan_NN and_CC the_DD small_JJ dermatan_NN sulfate_NN proteoglycan_NN decorin_NN ;_: however_RR ,_, 30-fold_NN more_DD aggrecan_NN was_VBD required_VVN to_TO produce_VVI an_DD effect_NN of_II similar_JJ magnitude_NN ._.
P10356257A02
In_II this_DD study_NN ,_, we_PN have_VHB used_VVN a_DD model_NN recombinant_JJ retrovirus_NN encoding_VVG the_DD Escherichia_NN coli_NN lacZ_NN gene_NN ,_, bovine_JJ aorta_NN chondroitin_NN sulfate_NN proteoglycan_NN (_( CSPG_NN )_) ,_, various_JJ free_JJ glycosaminoglycan_NN chains_NNS (_( GAGs_NNS )_) ,_, and_CC quantitative_JJ assays_NNS for_II retrovirus_NN transduction_NN to_TO explore_VVI the_DD mechanism_NN by_II which_PNR proteoglycans_NNS and_CC glycosaminoglycans_NNS inhibit_VVB retroviruses_NNS ._.
P10378482A03
Proteoglycans_NNS metabolically_RR labeled_VVN with_II [_( 35S_NN ]_) sulfate_NN in_II the_DD presence_NN of_II lead_NN were_VBD separated_VVN into_II heparan_NN sulfate_NN proteoglycans_NNS (_( HSPGs_NNS )_) and_CC more_RR highly_RR charged_VVNJ chondroitin_NN /_SYM dermatan_NN sulfate_NN proteoglycans_NNS by_II DEAE-Sephacel_NN ion-exchange_NN chromatography_NN ._.
P10383450A01
Molecules_NNS secreted_VVN by_II potential_JJ target_NN cells_NNS may_VM interfere_VVB with_II cationic_JJ lipid-mediated_VVNJ gene_NN transfer_NN ._.
P10420184A07
RESULTS_NNS ._.
P10704609A10
These_DD findings_NNS were_VBD further_RR supported_VVN by_II using_VVGN mutant_JJ cells_NNS characterized_VVN by_II specific_JJ glycosaminoglycan_NN deficiencies_NNS ._.
P10734086A05
Despite_II distinct_JJ molecular_JJ masses_NNS of_II glypican_NN and_CC syndecan_NN glycosaminoglycans_NNS and_CC minor_JJ differences_NNS in_II disaccharide_NN composition_NN and_CC sulfation_NN pattern_NN ,_, the_DD overall_JJ proportion_NN and_CC distribution_NN of_II sulfated_VVNJ regions_NNS and_CC the_DD affinity_NN for_II the_DD Hep_NN II_MC domain_NN were_VBD similar_JJ ._.
P10864481A09
Sulfated_VVNJ molecules_NNS were_VBD collected_VVN by_II ion-exchange_NN chromatography_NN and_CC then_RR assayed_VVN for_II GAGs_NNS ._.
P10866805A02
In_II order_NN to_TO understand_VVI the_DD regulation_NN of_II midkine_NN signaling_VVGN ,_, we_PN isolated_VVD midkine-binding_VVGJ proteoglycans_NNS from_II day_NN 13_MC mouse_NN embryos_NNS ,_, when_CS midkine_NN is_VBZ intensely_RR expressed_VVN ._.
P11118666A12
As_II a_DD result_NN ,_, versican-poor_JJ extracellular_JJ matrix_NN would_VM be_VBB induced_VVN by_II lead_NN in_II vascular_JJ smooth_JJ muscle_NN cells_NNS ._.
P11573243A09
In_II adhesion_NN assays_NNS performed_VVN on_II matrix-coated_VVNJ titer_NN plates_NNS both_DD cell_NN lines_NNS adhered_VVD to_II types_NNS I_MC and_CC III_MC collagen_NN and_CC cellular_JJ fibronectin_NN ,_, and_CC cell_NN adhesion_NN was_VBD inhibited_VVN by_II preincubation_NN of_II the_DD matrix_NN with_II heparin_NN ,_, heparan_NN sulfate_NN ,_, chondroitin_NN sulfate_NN ,_, dermatan_NN sulfate_NN ,_, or_CC chondroitin_NN glycosaminoglycans_NNS ._.
P11818700A07
At_II 0.4_MC M_NN NaCl_NN ,_, the_DD K_NN (_( d_NN )_) s_NNS of_II beta_NN 2m_NN relative_JJ to_II BSA-anchored_VVNJ columns_NNS for_II HP_NN ,_, HS_NN ,_, CS-A_NN ,_, CS-B_NN ,_, and_CC CS-C_NN were_VBD 94_MC ,_, 620_MC ,_, 130_MC ,_, 660_MC and_CC 190_MC microM_NN ,_, respectively_RR ._.
P11854241A01
We_PN have_VHB previously_RR shown_VVN that_CST enterotoxigenic_JJ invasion_NN protein_NN A_NN (_( Tia_NN )_) ,_, a_DD 25-kDa_NN outer_JJ membrane_NN protein_NN encoded_VVN on_II an_DD apparent_JJ pathogenicity_NN island_NN of_II enterotoxigenic_JJ Escherichia_NN coli_NN (_( ETEC_NN )_) strain_NN H10407_NN ,_, mediates_VVZ attachment_NN to_II and_CC invasion_NN into_II cultured_VVNJ human_NN gastrointestinal_JJ epithelial_JJ cells_NNS ._.P01280674A05
The_DD corresponding_VVGJ figures_NNS in_II the_DD control_NN patients_NNS were_VBD 8_MC and_CC 3_MC days_NNS ,_, respectively_RR (_( P_NN <_SYM .0001_MC )_) ._.
P01281454A02
Interleukin-1_NN (_( IL-1_NN )_) ;_: 4-40_MC ng_NN /_SYM ml_NN and_CC E._NN coli_NN lipopolysaccharide_NN (_( LPS_NN )_) ;_: 0.1-1.00_MC ng_NN /_SYM ml_NN ,_, were_VBD the_DD most_RRT effective_JJ stimuli_NNS and_CC induced_VVD dose-dependent_JJ secretion_NN of_II both_CC GM-CSF_NN and_CC G-CSF_NN ._.
P01281539A03
These_DD survival_NN rates_NNS were_VBD improved_VVN by_II BMT_NN ._.
P01282065A01
Murine_JJ BCL-1_NN B-cell_NN leukemia_NN provides_VVZ a_DD model_NN of_II disseminated_VVNJ human_NN B-lineage_NN acute_JJ lymphoblastic_JJ leukemia_NN (_( ALL_NN )_) and_CC non-Hodgkins_NN lymphoma_NN (_( NHL_NN )_) ._.
P01282573A01
A_DD 9-year-old_JJ boy_NN with_II chronic_JJ granulomatous_JJ disease_NN was_VBD hospitalized_VVN on_II May_NN ,_, 1991_MC ,_, because_II+ of_II continued_VVNJ fever_NN and_CC pain_NN in_II the_DD right_JJ elbow_NN ._.
P01372661A11
This_DD remedy_NN will_VM become_VVB useful_JJ for_II completion_NN of_II the_DD schedule_NN and_CC dose_NN intensification_NN of_II chemotherapy_NN in_II the_DD future_NN ._.
P01375042A02
Dose_NN modification_NN factor_NN was_VBD 1.20_MC when_CS 4.5_MC micrograms_NNS /_SYM mouse_NN of_II rhG-CSF_NN was_VBD given_VVN daily_RR for_II 14_MC days_NNS after_II whole_JJ body_NN irradiation_NN ._.
P01375161A04
Splenic_JJ erythropoiesis_NN effectively_RR compensated_VVD for_II the_DD loss_NN of_II marrow_NN erythropoiesis_NN as_CS indicated_VVN by_II the_DD maintenance_NN of_II a_DD normal_JJ hematocrit_NN ._.
P01379475A06
However_RR ,_, the_DD second_JJ phase_NN of_II aggregation_NN induced_VVN by_II epinephrine_NN was_VBD significantly_RR inhibited_VVN by_II 1.0_MC ng_NN /_SYM ml_NN G-CSF_NN ._.
P01380074A01
We_PN report_VVB a_DD patient_NN with_II congenital_JJ neutropenia_NN or_CC Kostmann_NN 's_GE Syndrome_NN who_PNR suffered_VVD many_DD complications_NNS after_II presenting_VVGN with_II Clostridium_NN septicum_NN enterocolitis_NN ,_, including_VVG absence_NN of_II wound_NN healing_VVGN ._.
P01380571A10
(_( ABSTRACT_NN TRUNCATED_VVN AT_II 250_MC WORDS_NNS )_)
P01381543A01
We_PN tested_VVD the_DD in_JJ+ vitro_JJ effect_NN of_II a_DD novel_JJ granulocyte_NN colony-stimulating_VVGJ factor_NN (_( G-CSF_NN )_) derivative_NN (_( KW-2228_NN )_) on_II the_DD growth_NN of_II G-CSF-dependent_JJ hemopoietic_JJ progenitor_NN cells_NNS :_: granulocyte_NN precursor_NN cells_NNS (_( CFU-G_NN )_) ,_, leukemic_JJ blast_NN progenitors_NNS freshly_RR obtained_VVN from_II 9_MC patients_NNS with_II acute_JJ myeloblastic_JJ leukemia_NN (_( AML_NN )_) and_CC cells_NNS of_II a_DD G-CSF-dependent_JJ human_NN AML_NN cell_NN line_NN (_( OCI_NN /_SYM AML_NN 1a_NN )_) ._.
P01383355A08
No_DD adverse_JJ effects_NNS of_II G-CSF_NN were_VBD observed_VVN ._.
P01384899A11
To_II date_NN ,_, five_MC of_II the_DD patients_NNS have_VHB been_VBN transplanted_VVN with_II autologous_JJ marrow_NN harvested_VVN after_II rhG-CSF_NN treatment_NN ._.
P01696146A05
In_JJ+ vivo_JJ rhIL-3_NN had_VHD no_DD effect_NN on_II the_DD recurrent_JJ neutropenia_NN but_CC was_VBD associated_VVN with_II eosinophilia_NN ,_, rhGM-CSF_NN caused_VVNJ neutrophilia_NN and_CC eosinophilia_NN but_CC cycling_VVGN of_II hematopoiesis_NN persisted_VVD ._.
P01698477A03
GM-CSF_NN stimulated_VVD increased_VVNJ CFU-GM_NN growth_NN in_II the_DD 16_MC patients_NNS with_II abnormal_JJ marrow_NN cytogenetics_NNS in_II comparison_NN with_II the_DD 20_MC patients_NNS who_PNR had_VHD normal_JJ cytogenetics_NNS (_( 52_MC and_CC 30_MC colonies_NNS per_II 10_MC (_( 5_MC )_) NAB_NN ,_, respectively_RR ,_, P_NN less_RR than_CSN .05_MC )_) ,_, whereas_CS no_DB such_DD difference_NN could_VM be_VBB demonstrated_VVN with_II G-CSF_NN (_( 11_MC and_CC 16_MC colonies_NNS per_II 10_MC (_( 5_MC )_) NAB_NN ,_, respectively_RR )_) ._.
P01698896A05
Moreover_RR G-CSF_NN enhanced_VVD a_DD protective_JJ effect_NN to_II pulmonary_JJ and_CC systemic_JJ pseudomonas_NN infections_NNS ._.
P01703795A07
However_RR ,_, three_MC sequential_JJ daily_JJ additions_NNS of_II 150_MC ng_NN /_SYM mL_NN G-CSF_NN did_VDD stimulate_VVB primitive_JJ progenitors_NNS to_TO enter_VVI S-phase_NN and_CC a_DD single_JJ addition_NN of_II 5_MC or_CC 12.5_MC ng_NN /_SYM mL_NN of_II G-CSF_NN together_RR with_II 10_MC ng_NN /_SYM mL_NN GM-CSF_NN was_VBD able_JJ to_TO elicit_VVI the_DD same_JJ effect_NN ._.
P01705433A06
A_DD chemical_JJ cross-linking_VVGJ study_NN revealed_VVD that_CST the_DD G-CSF_NN receptor_NN has_VHZ an_DD approximate_JJ molecular_JJ weight_NN of_II 140,000_MC ._.
P01705636A02
Granulocyte-macrophage_NN colony-stimulating_VVGJ factor_NN (_( GM-CSF_NN )_) stimulated_VVD the_DD proliferation_NN of_II HL-60_NN cells_NNS in_II a_DD dose-dependent_JJ manner_NN at_II concentrations_NNS of_II 0.01-100_MC ng_NN /_SYM ml_NN ;_: however_RR ,_, the_DD proliferation_NN due_II+ to_II GM-CSF_NN was_VBD suppressed_VVN by_II 100_MC nM_NN RA_NN ._.
P01707693A07
GM-CSF_NN and_CC G-CSF_NN (_( 1_MC ng_NN /_SYM mL_NN to_II 1_MC microgram_NN /_SYM mL_NN )_) had_VHD no_DD effect_NN on_II the_DD expression_NN of_II either_CC tissue_NN plasminogen_NN activator_NN (_( tPA_NN )_) or_CC plasminogen_NN activator_NN inhibitor-1_NN (_( PAI-1_NN )_) by_II endothelial_JJ cells_NNS ._.
P01709109A02
We_PN determined_VVD WBC_NN counts_NNS ,_, differentials_NNS ,_, the_DD number_NN of_II total_JJ nucleated_VVNJ cells_NNS ,_, the_DD myeloid_NN mitotic_JJ pool_NN cells_NNS (_( promyelocytes_NNS and_CC myelocytes_NNS )_) ,_, the_DD storage_NN pool_NN cells_NNS (_( metamyelocytes_NNS ,_, bands_NNS ,_, and_CC polymorphonuclear_JJ cells_NNS [_( PMNs_NNS ]_) )_) and_CC the_DD granulocyte-macrophage_NN (_( granulocyte-macrophage_NN colony-forming_VVGJ units_NNS ,_, CFU-GM_NN )_) and_CC macrophage_NN (_( macrophage_NN colony-forming_VVGJ units_NNS ,_, CFU-M_NN )_) progenitor_NN cells_NNS of_II the_DD bone_NN marrow_NN ,_, spleen_NN ,_, and_CC the_DD liver_NN before_II the_DD first_JJ dose_NN of_II rhG-CSF_NN administration_NN and_CC 12_MC h_NN after_II the_DD second_JJ ,_, fourth_JJ ,_, and_CC sixth_JJ dose_NN ._.
P01709372A09
The_DD stimulated_VVNJ monocyte_NN production_NN in_II the_DD case_NN of_II G-CSF_NN required_VVD an_DD additional_JJ five_MC cell_NN cycles_NNS ,_, a_DD level_NN that_PNR might_VM have_VHB repercussions_NNS on_II the_DD progenitor_NN compartments_NNS ._.
P01710148A01
We_PN tested_VVD the_DD ability_NN of_II recombinant_JJ human_NN stem_NN cell_NN factor_NN (_( SCF_NN )_) to_TO stimulate_VVI isolated_VVNJ marrow_NN precursor_NN cells_NNS to_TO form_VVI colonies_NNS in_II semisolid_JJ media_NN and_CC to_TO generate_VVI colony-forming_VVGJ cells_NNS (_( CFC_NN )_) in_II liquid_JJ culture_NN ._.
P01710151A05
Not_RR only_RR was_VBD rG-CSF_NN radioprotective_JJ at_II much_RR smaller_JJR doses_NNS than_CSN rGM-CSF_NN ,_, the_DD survival_NN rate_NN after_II lethal_JJ TBI_NN was_VBD also_RR significantly_RR higher_JJR in_II mice_NNS receiving_VVG optimally_RR radioprotective_JJ doses_NNS of_II rG-CSF_NN as_CS compared_VVN with_II mice_NNS receiving_VVG optimally_RR radioprotective_JJ doses_NNS of_II rGM-CSF_NN ._.
P01712246A08
These_DD data_NNS indicated_VVD that_CST PEG-rhG-CSF_NN administration_NN exerted_VVD a_DD sustained_VVNJ biological_JJ effect_NN on_II peripheral_JJ blood_NN neutrophils_NNS ._.
P01714327A10
The_DD high_JJ expression_NN of_II Fc_NN gamma_NN RI_NN during_II rhG-CSF_NN therapy_NN correlated_VVD with_II enhanced_VVNJ cytotoxicity_NN ._.
P01714401A10
By_II day_NN 19_MC ,_, neutrophil_NN levels_NNS had_VHD dropped_VVN significantly_RR (_( p_NN less_RR than_CSN 0.01_MC )_) from_II the_DD maximum_NN neutrophil_NN levels_NNS ,_, with_II one_MC cat_NN attaining_VVGN a_DD normal_JJ blood_NN neutrophil_NN count_NN by_II day_NN 21_MC of_II rhG-CSF_NN treatment_NN ._.
P01716591A01
Functional_JJ activity_NN of_II peripheral_JJ blood_NN granulocytes_NNS was_VBD assessed_VVN in_II seven_MC patients_NNS and_CC in_II their_PNG normal_JJ donors_NNS following_VVG allogeneic_JJ bone_NN marrow_NN transplantation_NN (_( BMT_NN )_) ._.
P02471275A06
The_DD initial_JJ dose_NN of_II GM-CSF_NN in_II some_DD patients_NNS produced_VVD a_DD reaction_NN that_PNR was_VBD characterized_VVN by_II hypoxia_NN ._.
P07506671A05
In_II sharp_JJ contrast_NN to_II patients_NNS receiving_VVG GM-CSF_NN ,_, however_RR ,_, progenitor_NN cells_NNS from_II patients_NNS off_II G-CSF_NN treatment_NN for_II 2_MC to_II 4_MC days_NNS were_VBD still_RR rapidly_RR proliferating_VVG ._.
P07509223A04
Interestingly_RR ,_, 10_MC out_II+ of_II the_DD 27_MC patients_NNS showed_VVD a_DD dramatic_JJ improvement_NN in_II severe_JJ anemia_NN after_II two_MC to_II ten_MC months_NNS of_II therapy_NN ._.
P07509672A03
There_EX were_VBD no_DD granulocytes_NNS in_II the_DD peripheral_JJ smear_NN and_CC a_DD bone_NN marrow_NN biopsy_NN demonstrated_VVD an_DD absence_NN of_II the_DD entire_JJ myeloid_NN cell_NN line_NN as_CC+ well_CC+ as_CC the_DD presence_NN of_II many_DD granulomas_NNS ._.
P07510423A08
White_JJ blood_NN cells_NNS (_( WBC_NN )_) were_VBD counted_VVN at_II day_NN 2_MC after_II treatment_NN ._.
P07512833A10
The_DD stimulation_NN index_NN of_II marrow_NN mononuclear_JJ cells_NNS cultured_VVN with_II rhG-CSF_NN increased_VVD with_II disease_NN progression_NN ._.
P07520770A02
Such_DD limitations_NNS seem_VVB to_TO predispose_VVI infected_VVNJ newborns_NNS to_II neutropenia_NN from_II an_DD exhaustion_NN of_II the_DD neutrophil_NN reserve_NN ._.
P07520770A15
The_DD rhG-CSF_NN was_VBD well_RR tolerated_VVN at_II all_DD gestational_JJ ages_NNS treated_VVN ._.
P07521347A13
On_II the_DD other_JJ hand_NN ,_, recovery_NN time_NN was_VBD significantly_RR shorter_JJR in_II group_NN C_NN (_( 6.8_MC +/-_SYM 1.2_MC days_NNS mean_NN +/-_SYM SE_NN )_) compared_VVN with_II groups_NNS A_NN and_CC B_NN (_( P_NN <_SYM 0.05_MC )_) ._.
P07521693A06
CTLs_NNS primed_VVN against_II the_DD BM_NN donor_NN suppressed_VVD the_DD formation_NN of_II colonies_NNS consisting_VVG of_II granulocytes_NNS and_CC macrophages_NNS (_( colony-forming_VVGJ unit_NN GM_NN )_) ._.
P07522393A06
When_CS compared_VVN to_II GM-CSF_NN ,_, G-CSF_NN significantly_RR reduced_VVD the_DD duration_NN of_II granulocytopenia_NN (_( P_NN <_SYM .001_MC )_) ._.
P07525173A04
The_DD results_NNS indicated_VVD that_CST rhG-CSF_NN (_( GRAN_NN )_) could_VM elevate_VVB nadirs_NNS of_II WBC_NN and_CC significantly_RR shortened_VVD leukopenic_JJ period_NN with_II WBC_NN below_II 4.0_MC x_SYM 10_MC (_( 9_MC )_) /_SYM L_NN and_CC expedited_VVD the_DD recovery_NN of_II WBC_NN ._.
P07525676A07
We_PN examined_VVD G-CSF_NN and_CC GM-CSF_NN mRNA_NN expressions_NNS in_II peripheral_JJ mononuclear_JJ cells_NNS stimulated_VVN with_II LPS_NN ,_, PMA_NN ,_, and_CC Con_NN A_NN by_II Northern_NN hybridization_NN ._.
P07526017A01
In_II order_NN to_TO evaluate_VVI the_DD mobilization_NN effect_NN of_II recombinant_JJ human_NN granulocyte_NN colony-stimulating_VVGJ factor_NN (_( rhG-CSF_NN )_) on_II peripheral_JJ blood_NN stem_NN cells_NNS (_( PBSCs_NNS )_) ,_, rhG-CSF_NN was_VBD given_VVN to_II patients_NNS with_II urogenital_JJ malignancy_NN before_II chemotherapy_NN ._.
P07528570A06
Parallel_JJ to_II this_DD increase_NN in_II CD34+_NN cells_NNS ,_, clonogenic_JJ assays_NNS showed_VVD a_DD corresponding_VVGJ increase_NN in_II CFU-GM_NN and_CC BFU-E_NN ._.
P07529843A07
However_RR ,_, he_PN relapsed_VVD in_II May_NN ,_, 1991_MC with_II 46XY_NN ,_, 16q-_NN ,_, i_NN (_( 17q_NN )_) chromosome_NN ._.
P07530405A06
A_DD dose_NN of_II 400_MC micrograms_NNS /_SYM m2_NN G-CSF_NN was_VBD sufficient_JJ to_TO cause_VVI an_DD increase_NN in_II neutrophil_NN count_NN and_CC 100_MC IU_NN /_SYM kg_NN rhEPO_NN appeared_VVD to_TO be_VBI sufficient_JJ to_TO cause_VVI an_DD increase_NN in_II erythrocyte_NN count_NN ._.
P07531290A08
The_DD number_NN of_II C._NN albicans_NN colony-forming_VVGJ units_NNS (_( CFU-C._NN albicans_NN )_) in_II the_DD kidney_NN of_II infected_VVNJ mice_NNS was_VBD lower_JJR in_II the_DD rhG-CSF-treated_VVNJ group_NN than_CSN in_II the_DD non-treated_VVNJ control_NN mice_NNS ._.
P07533820A02
The_DD induction_NN of_II Fc_NN gamma_NN RI_NN by_II rhG-CSF_NN has_VHZ previously_RR been_VBN reported_VVN to_TO result_VVI from_II effects_NNS on_II immature_JJ granulocyte_NN progenitors_NNS ._.
P07535143A07
The_DD presence_NN of_II receptors_NNS for_II SCF_NN in_II ALL_NN was_VBD confirmed_VVN by_II polymerase_NN chain_NN reaction_NN for_II c-kit_NN mRNA_NN in_II 19_MC /_SYM 21_MC cases_NNS tested_VVN ._.
P07539959A06
Similar_JJ synergistic_JJ increases_NNS of_II other_JJ hematopoietic_JJ progenitors_NNS ,_, such_II+ as_II colony-forming_VVGJ units_NNS in_II spleen_NN and_CC megakaryocyte_NN colony-forming_VVGJ units_NNS in_II blood_NN ,_, were_VBD also_RR observed_VVN in_II mice_NNS co-administered_VVN rhIL-6_NN and_CC rhG-CSF_NN ._.
P07541325A04
Each_DD patient_NN received_VVD two_MC cycles_NNS treatment_NN ._.
P07541523A01
Recombinant_JJ human_NN granulocyte_NN (_( rhG_NN )_) colony-stimulating_VVGJ factor_NN (_( CSF_NN )_) and_CC recombinant_JJ human_NN granulocyte-macrophage_NN (_( rhGM_NN )_) CSF_NN have_VHB been_VBN used_VVN to_TO enhance_VVI neonatal_JJ neutrophil_NN host_NN defense_NN ._.
P07545214A09
The_DD other_JJ responder_NN had_VHD normal_JJ ALT_NN until_II the_DD first_JJ month_NN of_II follow-up_NN ._.
P07556528A02
The_DD longer_JJR the_DD duration_NN of_II cytokine_NN treatment_NN ,_, the_DD higher_JJR the_DD stimulatory_JJ effect_NN on_II stem_NN cell_NN mobilization_NN ._.
P07584671A01
The_DD influence_NN of_II CSF_NN therapy_NN on_II the_DD superoxide_NN (_( O2-_NN )_) releasing_VVGJ capacity_NN in_II response_NN to_II N-formyl-methionyl-leucyl-phenylalanine_NN (_( FMLP_NN )_) of_II neutrophils_NNS from_II 32_MC patients_NNS with_II testicular_JJ cancer_NN receiving_VVG high-dose_NN chemotherapy_NN followed_VVN by_II autologous_JJ bone_NN marrow_NN transplantation_NN (_( ABMT_NN )_) was_VBD assessed_VVN :_: 8_MC patients_NNS were_VBD treated_VVN as_II control_NN group_NN without_II CSF_NN therapy_NN ,_, 12_MC patients_NNS received_VVD GM-CSF_NN ,_, and_CC 12_MC patients_NNS received_VVD G-CSF_NN ._.
P07678512A01
Interleukin-8_NN (_( IL-8_NN )_) is_VBZ a_DD major_JJ neutrophil_NN chemoattractant_NN and_CC functional_JJ stimulant_NN that_PNR is_VBZ induced_VVN by_II IL-1_NN ,_, tumor_NN necrosis_NN factor_NN alpha_NN (_( TNF_NN alpha_NN )_) ,_, and_CC lipopolysaccharide_NN (_( LPS_NN )_) ._.
P07679062A06
The_DD priming_VVGJ effect_NN of_II rhGM-CSF_NN was_VBD consistently_RR greater_JJR than_CSN that_PND of_II rhG-CSF_NN in_II each_DD patient_NN ._.
P07680373A07
Dose-intensity_NN was_VBD well_RR maintained_VVN through_II three_MC cycles_NNS of_II therapy_NN ,_, after_II which_PNR leukopenia_NN and_CC thrombocytopenia_NN became_VVD dose-limiting_VVGN ._.
P07680849A05
(_( Variant_NN type_NN of_II E._NN coli_NN is_VBZ now_RR in_II trial._NN )_) Difference_NN of_II these_DD two_MC is_VBZ whether_CST carbohydrate_NN chain_VVB primarily_RR seen_VVN in_II molecule_NN of_II natural_JJ form_NN is_VBZ contained_VVN or_CC not_RR ._.
P07681699A01
Two_MC hematopoietic_JJ colony-stimulating_VVGJ factors_NNS ,_, granulocyte_NN colony-stimulating_VVGJ factor_NN (_( G-CSF_NN )_) and_CC granulocyte-macrophage_NN CSF_NN (_( GM-CSF_NN )_) ,_, have_VHB been_VBN shown_VVN to_TO accelerate_VVI leukocyte_NN and_CC neutrophil_NN recovery_NN after_II high-dose_NN chemotherapy_NN and_CC autologous_JJ bone_NN marrow_NN (_( BM_NN )_) support_NN ._.
P07681704A07
GM-CSF_NN priming_VVGN markedly_RR increased_VVD PMN_NN superoxide_NN release_NN (_( sevenfold_NN )_) ,_, but_CC PMN_NN superoxide_NN release_NN was_VBD not_RR further_RR enhanced_VVN by_II the_DD presence_NN of_II MNLs_NNS ._.
P07683484A01
We_PN studied_VVD the_DD long-term_NN in_JJ+ vivo_JJ effect_NN of_II recombinant_JJ human_NN granulocyte_NN colony_NN stimulating_VVGJ factor_NN (_( rhG-CSF_NN )_) on_II in_JJ+ vitro_JJ growth_NN of_II granulocyte_NN /_SYM macrophage_NN colony_NN forming_VVGJ cells_NNS (_( GM-CFC_NN )_) in_II bone_NN marrow_NN and_CC peripheral_JJ blood_NN obtained_VVN from_II two_MC patients_NNS with_II autoimmune_JJ neutropenia_NN ,_, who_PNR received_VVD rhG-CSF_NN ._.
P07685198A01
The_DD bromodeoxyuridine_NN (_( BrdU_NN )_) -Hoechst_NN flow_NN cytometric_JJ technique_NN was_VBD applied_VVN to_TO study_VVI the_DD immediate_JJ cell_NN kinetic_JJ response_NN of_II highly_RR purified_VVNJ human_NN (_( h_NN )_) bone_NN marrow_NN progenitor_NN cells_NNS (_( CD_NN (_( 34+_MC )_) -sorted_VVNJ fraction_NN )_) to_II h_NN granulocyte_NN colony-stimulating_VVGJ factor_NN (_( G-CSF_NN )_) and/or_CC h_NN granulocyte-macrophage_NN colony-stimulating_VVGJ factor_NN (_( GM-CSF_NN )_) ._.
P07687221A02
In_II addition_NN ,_, the_DD possibility_NN of_II synergism_NN between_II erythropoietin_NN (_( Epo_NN )_) and_CC G-CSF_NN in_II blood_NN stem_NN cell_NN mobilization_NN was_VBD studied_VVN ._.
P07689123A03
In_II the_DD 1st_JJ course_NN ,_, when_CS no_DD rhG-CSF_NN was_VBD administered_VVN ,_, the_DD neutrophil_NN function_NN declined_VVD significantly_RR (_( p_NN <_SYM 0.01_MC )_) as_CS the_DD peripheral_JJ neutrophil_NN count_NN (_( PNC_NN )_) decreased_VVD ,_, reached_VVD the_DD minimum_NN almost_RR at_II the_DD same_JJ day_NN as_CS PNC_NN reached_VVD the_DD nadir_NN ,_, and_CC returned_VVD to_II the_DD normal_JJ level_NN at_II the_DD beginning_VVGN of_II the_DD next_JJ course_NN ._.
P07691244A08
An_DD average_NN of_II 3.04_MC x_SYM 10_MC (_( 10_MC )_) CD3+_NN cells_NNS were_VBD collected_VVN per_II pheresis_NN ._.
P07691413A01
Granulocyte_NN colony-stimulating_VVGJ factor_NN (_( G-CSF_NN )_) is_VBZ a_DD cytokine_NN that_PNR regulates_VVZ the_DD proliferation_NN and_CC differentiation_NN of_II neutrophils_NNS ._.
P07693032A07
Despite_II an_DD abnormal_JJ responsiveness_NN of_II mature_JJ myeloid_NN progenitors_NNS to_II G-CSF_NN in_II this_DD SCN_NN patient_NN ,_, myeloid_NN progenitors_NNS responsive_JJ to_II the_DD combination_NN of_II stem_NN cell_NN factor_NN (_( SCF_NN )_) and_CC G-CSF_NN showed_VVD normal_JJ dose-response_NN ._.
P08542941A13
Our_PNG results_NNS demonstrated_VVD that_CST pretreatment_NN with_II G-CSF_NN modified_VVD the_DD response_NN of_II BM_NN cells_NNS to_II subsequent_JJ stimulation_NN with_II additional_JJ CSFs_NNS ._.
P08605651A04
The_DD leukocyte_NN count_NN was_VBD 1,100_MC /_SYM mm3_NN with_II 23_MC %_SYM granulocytes_NNS ,_, 76_MC %_SYM lymphocytes_NNS and_CC 1_MC %_SYM monocytes_NNS ._.
P08610118A09
These_DD findings_NNS support_VVB a_DD model_NN whereby_CST binding_VVGN of_II E21R_NN to_II the_DD alpha_NN chain_NN leads_VVZ to_II apoptosis_NN ,_, while_CS beta_NN (_( c_NN )_) plays_VVZ an_DD important_JJ role_NN in_II cell_NN survival_NN ._.
P08632675A05
Receptor_NN binding_VVGJ analysis_NN revealed_VVD that_CST L-8801_NN cells_NNS expressed_VVD a_DD G-CSF_NN receptor_NN (_( Kd=125_NN pM_NN ,_, 479_MC binding_VVGJ sites_NNS /_SYM cell_NN )_) and_CC L-8057_NN cells_NNS had_VHD no_DD G-CSF_NN receptors_NNS ._.
P08636780A06
No_DD clinically_RR significant_JJ difference_NN was_VBD observed_VVN between_II the_DD two_MC groups_NNS concerning_VVG days_NNS of_II absolute_JJ neutropenia_NN or_CC neutropenic_JJ fever_NN ._.
P08647235A07
On_II day_NN 3_MC ,_, mean_NN CD34+_NN cell_NN counts_NNS of_II the_DD subjects_NNS who_PNR received_VVD sequential_JJ treatment_NN were_VBD markedly_RR higher_JJR than_CSN observed_VVN in_II the_DD other_JJ groups_NNS (_( p_NN <_SYM 0.05_MC )_) and_CC were_VBD estimated_VVN to_TO have_VHI been_VBN sufficient_JJ for_II collection_NN of_II adequate_JJ grafts_NNS by_II single_JJ 10-L_NN leukapheresis_NN procedures_NNS in_II 60_MC %_SYM of_II subjects_NNS ._.
P08749950A02
Reduction_NN of_II leukopenia_NN during_II chemotherapy_NN has_VHZ been_VBN demonstrated_VVN by_II the_DD combined_VVNJ administration_NN of_II granulocyte_NN colony-stimulating_VVGJ factor_NN (_( G-CSF_NN )_) in_II various_JJ malignancies_NNS ._.
P08757506A02
This_DD study_NN investigated_VVD whether_CST G-CSF_NN is_VBZ able_JJ to_TO directly_RR influence_VVI the_DD transendothelial_JJ migration_NN of_II neutrophils_NNS ,_, and_CC how_CST such_DD effects_NNS might_VM be_VBB related_VVN to_II other_JJ effects_NNS on_II neutrophil_NN adhesive_JJ properties_NNS ._.
P08843219A04
Free_JJ radical_NN formation_NN in_II defective_JJ PMNL_NN was_VBD enhanced_VVN by_II rhG-CSF_NN to_II a_DD level_NN similar_JJ to_II that_PND found_VVN in_II normal_JJ PMNL_NN primed_VVN by_II rhG-CSF_NN ._.
P08918500A10
Pooled_VVN together_RR ,_, patients_NNS who_PNR received_VVD IL-3_NN showed_VVD a_DD median_JJ time_NN to_TO achieve_VVI a_DD granulocyte_NN count_NN greater_JJR than_CSN 0.1_MC and_CC greater_JJR than_CSN 0.5_MC x_SYM 10_MC (_( 9_MC )_) /_SYM L_NN of_II 8_MC and_CC 11_MC days_NNS ,_, respectively_RR ._.
P08973623A08
Pretreatment_NN with_II rhG-CSF_NN resulted_VVD in_II increased_VVNJ tissue_NN myeloperoxidase_NN levels_NNS ,_, despite_II a_DD histologically_RR similar_JJ mucosal_JJ polymorphonuclear_JJ cell_NN infiltrate_NN between_II treated_VVNJ and_CC control_NN colitis_NN groups_NNS ._.
P09028941A13
Moreover_RR ,_, G-CSF_NN administration_NN prevented_VVD apoptosis_NN in_II a_DD small_JJ but_CC significant_JJ proportion_NN of_II mobilized_VVNJ CD34+_NN cells_NNS ._.
P09218602A03
Only_RR rhGM-CSF_NN affected_VVD mast_JJ cell_NN development_NN ._.
P09326222A01
Thrombopoietin_NN (_( TPO_NN )_) was_VBD evaluated_VVN for_II efficacy_NN in_II a_DD placebo-controlled_VVNJ study_NN in_II rhesus_NN monkeys_NNS with_II concurrent_JJ administration_NN of_II either_CC granulocyte_NN /_SYM macrophage_NN colony-stimulating_VVGJ factor_NN (_( GM-CSF_NN )_) or_CC granulocyte_NN CSF_NN ,_, (_( G-CSF_NN )_) ._.
P09326222A14
administration_NN of_II TPO_NN is_VBZ sufficient_JJ to_TO prevent_VVI severe_JJ thrombocytopenia_NN following_VVG myelosuppression_NN ,_, (_( 2_MC )_) TPO_NN /_SYM G-CSF_NN and_CC TPO_NN /_SYM GM-CSF_NN treatment_NN result_VVB in_II distinct_JJ response_NN patterns_NNS ,_, with_II TPO_NN /_SYM GM-CSF_NN being_VVGN superior_JJ to_II TPO_NN /_SYM G-CSF_NN in_II stimulating_VVGJ thrombocyte_NN and_CC erythrocyte_NN recovery_NN while_CS being_VBG equivalent_JJ in_II stimulating_VVGN neutrophil_NN recovery_NN ;_: and_CC (_( 3_MC )_) TPO_NN significantly_RR improves_VVZ the_DD performance_NN of_II CSFs_NNS in_II alleviating_VVGN severe_JJ neutropenia_NN ._.
P09339749A04
No_DD changes_NNS of_II lymphocyte_NN response_NN to_II pokeweed_NN mitogen_NN were_VBD observed_VVN ._.
P09345066A08
While_CS GM-CSF_NN and_CC G-CSF_NN alone_JJ had_VHD little_DD effect_NN on_II BM_NN CFU_NN over_II time_NN ,_, FL_NN alone_JJ increased_VVD CFU-GM_NN and_CC CFU-GEMM_NN threefold_NN and_CC fivefold_NN ,_, respectively_RR ._.
P09365526A09
Circulating_VVGJ anti-G-CSF_NN antibodies_NNS did_VDD not_RR seem_VVB to_TO affect_VVI hematological_JJ recovery_NN ._.
P09377071A10
We_PN conclude_VVB that_CST PIXY321_NN and_CC G-CSF_NN act_VVB synergistically_RR on_II the_DD in_JJ+ vitro_JJ proliferation_NN and_CC neutrophil_NN differentiation_NN of_II BM_NN and_CC PB_NN CD34+_NN cells_NNS and_CC that_CST frequent_JJ supplements_NNS of_II G-CSF_NN facilitate_VVB neutrophil_NN differentiation_NN ._.
P09528829A01
The_DD effects_NNS of_II altering_VVGN the_DD timing_VVGN of_II recombinant_JJ human_NN granulocyte_NN colony-stimulating_VVGJ factor_NN (_( rhG-CSF_NN )_) administration_NN on_II neutropenia_NN induced_VVN by_II cyclophosphamide_NN (_( CPA_NN )_) were_VBD studied_VVN experimentally_RR in_II a_DD mouse_NN model_NN ._.
P09544974A05
RhG-CSF_NN was_VBD infused_VVN continuously_RR at_II a_DD dose_NN of_II 5_MC microg_NN /_SYM kg_NN /_SYM day_NN ,_, starting_VVG 24_MC hr_NN before_II the_DD initial_JJ dose_NN of_II total_JJ body_NN irradiation_NN (_( TBI_NN )_) until_II the_DD end_NN of_II AraC_NN therapy_NN ._.
P09592847A06
The_DD contribution_NN of_II rhG-CSF_NN to_II clinical_JJ recovery_NN warrants_VVZ further_JJ investigation_NN ._.
P09818688A06
The_DD patients_NNS received_VVD dexamethasone_NN 24_MC mg_NN days_NNS 1-7_MC ,_, melphalan_NN 30_MC mg_NN /_SYM m2_NN day_NN 3_MC ,_, BCNU_NN 60_MC mg_NN /_SYM m2_NN day_NN 3_MC ,_, etoposide_NN 75_MC mg_NN /_SYM m2_NN days_NNS 4-7_MC ,_, Ara-C_NN 100_MC mg_NN /_SYM m2_NN twice_RR daily_JJ days_NNS 4-7_MC (_( Dexa-BEAM_NN )_) ._.
P10473803A04
The_DD main_JJ findings_NNS were_VBD that_CST (_( a_NN )_) granulocyte_NN and_CC lymphocyte_NN recovery_NN rates_NNS were_VBD faster_JJR in_II the_DD patients_NNS receiving_VVG G-CSF_NN ;_: (_( b_NN )_) looking_VVG at_II the_DD lymphocyte_NN compartment_NN ,_, this_DD difference_NN was_VBD restricted_VVN to_II the_DD CD3_NN (_( +_SYM )_) /_SYM CD8_NN (_( +_SYM )_) and_CC CD56_NN (_( +_SYM )_) lymphocyte_NN subsets_NNS ;_: (_( c_NN )_) the_DD reconstitution_NN rate_NN of_II CD19_NN (_( +_SYM )_) lymphocytes_NNS was_VBD slow_JJ in_II both_DD groups_NNS ;_: (_( d_NN )_) at_II the_DD end_NN of_II follow-up_NN HLA-DR_NN expression_NN by_II CD3_NN (_( +_SYM )_) lymphocytes_NNS was_VBD higher_JJR in_II the_DD GM-CSF_NN group_NN ;_: (_( e_NN )_) the_DD lymphocyte_NN proliferative_JJ capacity_NN was_VBD restored_VVN at_II a_DD faster_JJR rate_NN in_II the_DD GM-CSF_NN group_NN ,_, whereas_CS cytotoxic_JJ activities_NNS recovered_VVD better_RRR in_II the_DD G-CSF_NN group_NN ;_: (_( f_NN )_) the_DD early_JJ repopulating_VVGJ phase_NN was_VBD characterized_VVN by_II higher_JJR interleukin-6_NN serum_NN levels_NNS in_II the_DD GM-CSF_NN group_NN ._.
P10550313A03
G-CSF_NN ,_, GM-CSF_NN ,_, and/or_CC their_PNG receptors_NNS were_VBD expressed_VVN in_II all_DD tumors_NNS and_CC derived_VVNJ cell_NN cultures_NNS ,_, but_CC coexpression_NN of_II both_CC factors_NNS and_CC receptors_NNS was_VBD almost_RR exclusively_RR found_VVN in_II grade_NN IV_MC glioblastomas_NNS and_CC thus_RR correlated_VVD with_II advanced_VVNJ tumor_NN stage_NN ._.
P10708106A01
BACKGROUND_NN :_: Leukopenia_NN due_II+ to_II immunosuppressive_JJ drugs_NNS represents_VVZ a_DD well-known_VVNJ complication_NN in_II graft_NN recipients_NNS ,_, which_PNR might_VM put_VVB patients_NNS at_II an_DD increased_VVNJ risk_NN for_II infections_NNS ._.
P10708106A14
CONCLUSION_NN :_: rhG-CSF_NN was_VBD safe_JJ and_CC effective_JJ in_II leukopenic_JJ kidney_NN graft_NN recipients_NNS ._.
P10784622A10
Three_MC of_II the_DD seven_MC patients_NNS in_II whom_PNR mobilization_NN was_VBD poor_JJ after_II G1_NN had_VHD >_SYM or_CC =2x10_NN (_( 6_MC )_) CD34_NN (_( +_SYM )_) cells_NNS /_SYM kg_NN with_II two_MC leukaphereses_NNS after_II C2_NN ._.
P11146160A08
In_II contrast_NN ,_, inclusion_NN of_II both_CC G-CSF_NN and_CC hydrocortisone_NN in_II the_DD cytokine_NN "_`` cocktail_NN "_'' markedly_RR increased_VVD the_DD neutrophil_NN numbers_NNS ._.
P11283939A06
METHODS_NNS :_: In_II this_DD study_NN ,_, 10_MC ovarian_JJ carcinoma_NN biopsies_NNS were_VBD characterized_VVN for_II the_DD presence_NN of_II G-CSF_NN and_CC G-CSF_NN receptor_NN by_II reverse_JJ transcription-polymerase_NN chain_NN reaction_NN (_( RT-PCR_NN )_) and_CC immunohistochemical_JJ analysis_NN ._.
P11440552A03
The_DD purpose_NN of_II this_DD study_NN was_VBD to_TO test_VVI that_DD hypothesis_NN ._.
P11740262A11
However_RR ,_, RI_NN ,_, LIS_NN ,_, and_CC TM_NN did_VDD not_RR change_VVB ,_, suggesting_VVG that_CST no_DD patient_NN developed_VVD lung_NN injury_NN ._.P01537998A02
The_DD fifth_JJ strategy_NN involved_VVD a_DD combination_NN of_II accelerated_VVNJ rt-PA_NN and_CC intravenous_JJ urokinase_NN (_( regimen_NN E_NN )_) ._.
P01555101A04
Successful_JJ lysis_NN was_VBD achieved_VVN in_II 40_MC of_II 98_MC patients_NNS (_( 41_MC per_II cent_MC )_) receiving_VVG streptokinase_NN and_CC 40_MC of_II 69_MC patients_NNS (_( 58_MC per_II cent_MC )_) receiving_VVG rtPA_NN (_( P_NN less_RR than_CSN 0.05_MC )_) ._.
P01729881A03
Recombinant_JJ tissue_NN plasminogen_NN activator_NN (_( rt-PA_NN )_) is_VBZ more_RR potent_JJ for_II coronary_JJ arterial_JJ thrombolysis_NN ,_, producing_VVG both_CC more_RR rapid_JJ and_CC more_RR frequent_JJ recanalization_NN (_( approximately_RR 75_MC %_SYM patency_NN at_II 90_MC minutes_NNS )_) with_II a_DD dose_NN of_II 100_MC mg_NN given_VVN over_II 3_MC hours_NNS ._.
P01828324A07
Thrombolysis_NN was_VBD successful_JJ in_II 30_MC and_CC unsuccessful_JJ in_II 11_MC patients_NNS ._.
P01899546A08
Fourth_RR ,_, lysis_NN at_II 90_MC minutes_NNS is_VBZ of_II minimal_JJ relevance_NN for_II myocardial_JJ salvage_NN unless_CS observed_VVN within_II the_DD time_NN frame_NN when_PNR infarction_NN size_NN can_VM be_VBB limited_VVN significantly_RR ,_, which_PNR is_VBZ generally_RR less_RR than_CSN 4_MC hours_NNS between_II symptom_NN onset_NN and_CC the_DD time_NN that_CST reperfusion_NN is_VBZ accomplished_VVN ._.
P01900225A09
CONCLUSION_NN ._.
P01900313A04
In_II the_DD rt-PA_NN group_NN ,_, this_DD activity_NN decreased_VVD significantly_RR (_( p_NN less_RR than_CSN 0.001_MC )_) after_II the_DD infusion_NN and_CC remained_VVD depressed_VVN throughout_II the_DD 1st_JJ 4_MC days_NNS ._.
P01902439A06
A_DD second_JJ group_NN was_VBD evaluated_VVN for_II reocclusion_NN up_II+ to_II one_MC month_NN ._.
P01903167A02
All_DD patients_NNS entered_VVD the_DD trial_NN within_II 6_MC h_NN of_II the_DD onset_NN of_II symptoms_NNS and_CC underwent_VVD baseline_NN coronary_JJ angiography_NN of_II the_DD infarct-related_VVNJ coronary_JJ artery_NN before_CS thrombolytic_JJ therapy_NN was_VBD instituted_VVN ._.
P01903404A07
In_II group_NN B_NN ,_, 10_MC day_NN patency_NN of_II the_DD infarct-related_VVNJ artery_NN was_VBD 67_MC %_SYM ;_: there_EX was_VBD no_DD difference_NN in_II patency_NN by_II treatment_NN assignment_NN or_CC in_II left_JJ ventricular_JJ function_NN or_CC infarct_NN size_NN between_II patients_NNS with_II and_CC without_II infarct-related_VVNJ artery_NN patency_NN ._.
P01904028A02
Electrocardiograms_NNS (_( ECG_NN )_) obtained_VVN at_II admission_NN ,_, 6_MC h_NN and_CC 10_MC to_II 22_MC days_NNS after_II the_DD start_NN of_II therapy_NN were_VBD analysed_VVN ._.
P01904629A06
The_DD results_NNS of_II this_DD study_NN show_VVB that_CST even_RR a_DD dosage_NN of_II lower_JJR than_CSN 0.5_MC mg_NN /_SYM kg_NN /_SYM 24_MC hr_NN might_VM prove_VVB to_TO be_VBI effective_JJ ._.
P01905875A02
Patients_NNS were_VBD treated_VVN 2.1_MC +/-_SYM 0.8_MC hours_NNS after_II the_DD onset_NN of_II symptoms_NNS ._.
P01909760A01
A_DD comparison_NN was_VBD made_VVN between_II several_JJ characteristics_NNS of_II tissue-type_NN plasminogen_NN activator_NN (_( t-PA_NN )_) and_CC urokinase_NN (_( UK_NN )_) ,_, potentially_RR useful_JJ in_II microsurgery_NN to_TO restore_VVI perfusion_NN to_II ischemic_JJ free-tissue_NN transfers_NNS ._.
P01913123A05
The_DD median_JJ (_( confidence_NN interval_NN )_) increase_NN in_II ankle_NN :_: brachial_JJ pressure_NN index_NN following_VVG IA_NN rt-PA_NN of_II 0.57_MC (_( 0.33-0.82_MC )_) was_VBD significantly_RR higher_JJR than_CSN for_II either_CC Sk_NN of_II 0.24_MC (_( 0-0.57_MC )_) or_CC for_II IV_NN rt-PA_NN of_II 0.18_MC (_( 0-0.41_MC )_) ._.
P01974704A06
In_II two_MC patients_NNS the_DD thrombolytic_JJ treatment_NN was_VBD successful_JJ (_( the_DD patients_NNS improved_VVD clinically_RR )_) ;_: the_DD third_JJ patient_NN died_VVD of_II massive_JJ cerebral_JJ infarct-related_VVNJ oedema_NN ._.
P02105682A11
These_DD results_NNS indicate_VVB ,_, at_RR+ least_RR in_II the_DD model_NN employed_VVN ,_, that_CST compared_VVN with_II treatment_NN with_II UK_NN ,_, pulmonary_JJ thrombolysis_NN and_CC corresponding_VVGJ hemodynamic_JJ improvement_NN are_VBB greatest_JJT with_II rtPA_NN ._.
P02106403A01
The_DD effects_NNS of_II simultaneous_JJ intravenous_JJ infusions_NNS of_II 12_MC mg_NN recombinant_JJ tissue-type_NN plasminogen_NN activator_NN (_( rt-PA_NN )_) over_II 30_MC minutes_NNS and_CC 48_MC mg_NN single-chain_NN urokinase-type_NN plasminogen_NN activator_NN (_( scuPA_NN )_) over_II 40_MC minutes_NNS were_VBD studied_VVN in_II 38_MC patients_NNS with_II acute_JJ myocardial_JJ infarction_NN ._.
P02107957A08
In_II two_MC patients_NNS following_VVG t-PA_NN alone_JJ ,_, rethrombosis_NN occurred_VVD after_II 2_MC and_CC 11_MC days_NNS ._.
P02108851A09
Other_JJ factors_NNS such_II+ as_II patient_NN age_NN ,_, the_DD likelihood_NN of_II the_DD diagnosis_NN of_II MI_NN ,_, and_CC the_DD estimated_VVNJ risk_NN of_II bleeding_VVGN should_VM also_RR be_VBB considered_VVN ._.
P02110271A03
Nineteen_MC patients_NNS were_VBD excluded_VVN as_CS they_PN did_VDD not_RR meet_VVB the_DD inclusion_NN criteria_NNS ._.
P02119673A05
The_DD different_JJ dosage_NN regimens_NNS of_II rt-PA_NN recently_RR evaluated_VVN (_( 0.71_MC to_II 1.76_MC mg_NN /_SYM kg_NN /_SYM 24_MC h_NN for_II 2-4_MC days_NNS )_) in_II DVT_NN have_VHB caused_VVN consistent_JJ thrombolysis_NN but_CC also_RR excessive_JJ bleeding_VVGN ._.
P02120309A01
When_CS conventional_JJ treatment_NN of_II patients_NNS with_II early_JJ clinical_JJ reinfarction_NN after_II thrombolytic_JJ therapy_NN fails_VVZ ,_, mechanical_JJ revascularization_NN may_VM be_VBB attempted_VVN ._.
P02121073A03
The_DD test_NN revealed_VVD activation_NN of_II platelets_NNS and_CC coagulation_NN by_II SK_NN and_CC rt-PA_NN ._.
P02129372A12
Therefore_RR ,_, thrombolytic_JJ therapy_NN will_VM probably_RR become_VVB routine_JJ therapy_NN for_II early_JJ acute_JJ myocardial_JJ infarction_NN ._.
P02495318A03
In_II the_DD absence_NN of_II stenosis_NN ,_, intravenous_JJ infusion_NN of_II 750,000_MC U_NN of_II streptokinase_NN over_II 1_MC h_NN caused_VVD reperfusion_NN in_II five_MC of_II six_MC dogs_NNS in_II 34_MC +/-_SYM 25_MC min_NN (_( mean_NN +/-_SYM SD_NN )_) ._.
P02501898A03
Successful_JJ lysis_NN was_VBD seen_VVN in_II 18_MC (_( 86_MC %_SYM )_) patients_NNS following_VVG r-tPA_NN and_CC in_II 15_MC (_( 65_MC %_SYM )_) patients_NNS following_VVG streptokinase_NN ._.
P02508227A03
The_DD development_NN of_II persistent_JJ antibodies_NNS or_CC direct_JJ induction_NN of_II hypotension_NN has_VHZ not_RR been_VBN reported_VVN ,_, nor_CC has_VHZ significant_JJ activation_NN of_II the_DD complement_NN system_NN ._.
P02512687A03
"_`` In_JJ+ vitro_JJ "_'' clot_NN lysis_NN assays_NNS with_II fibrinogen-I125_NN were_VBD also_RR evaluated_VVN with_II the_DD same_JJ agents_NNS at_II 1_MC ,_, 3_MC and_CC 7_MC days_NNS ._.
P02953761A05
Patients_NNS treated_VVN with_II SK_NN showed_VVD extensive_JJ further_JJ plasmin_NN degradation_NN of_II fragment_NN X_NN to_II fragments_NNS Y_NN and_CC D_NN ._.
P03109764A07
The_DD occurrence_NN of_II bleeding_VVGJ events_NNS ,_, administration_NN of_II blood_NN transfusions_NNS ,_, and_CC reocclusion_NN of_II the_DD infarct-related_VVNJ artery_NN was_VBD comparable_JJ in_II the_DD two_MC groups_NNS ._.
P03115077A01
The_DD effect_NN of_II combined_VVNJ intravenous_JJ infusion_NN of_II 10_MC mg_NN of_II recombinant_JJ tissue-type_NN plasminogen_NN activator_NN (_( rt-PA_NN )_) and_CC 10_MC mg_NN of_II recombinant_JJ single-chain_NN urokinase-type_NN plasminogen_NN activator_NN over_II 1_MC hour_NN on_II coronary_JJ artery_NN recanalization_NN and_CC on_II the_DD blood_NN fibrinolytic_JJ system_NN was_VBD studied_VVN in_II 9_MC patients_NNS with_II acute_JJ myocardial_JJ infarction_NN and_CC angiographically_RR confirmed_VVN coronary_JJ artery_NN occlusion_NN ._.
P03117859A02
Although_CS originally_RR isolated_VVN from_II urine_NN ,_, pro-urokinase_NN is_VBZ also_RR found_VVN in_II blood_NN ,_, where_PNR it_PN is_VBZ believed_VVN to_TO participate_VVI in_II natural_JJ fibrinolysis_NN alongside_II tissue_NN plasminogen_NN activator_NN (_( t-PA_NN )_) ._.
P07474300A02
The_DD frequency_NN of_II PVC_NN and_CC the_DD mortality_NN rate_NN were_VBD evaluated_VVN in_II anesthetized_VVNJ dogs_NNS which_PNR had_VHD 1-_MC ,_, 3-_MC or_CC 6-h-old_JJ thrombi_NNS induced_VVN by_II a_DD copper_NN coil_NN in_II the_DD coronary_JJ artery_NN ._.
P07494361A01
PURPOSE_NN :_: Presumed_VVNJ differences_NNS in_II the_DD thrombolytic_JJ activity_NN and_CC fibrinolytic_JJ specificity_NN of_II the_DD three_MC commonly_RR used_VVNJ thrombolytic_JJ agents_NNS ,_, streptokinase_NN ,_, urokinase_NN ,_, and_CC recombinant_JJ tissue_NN plasminogen_NN activator_NN (_( rt-PA_NN )_) ,_, are_VBB based_VVN on_II clinical_JJ study_NN results_NNS ,_, where_PNR variability_NN renders_VVZ meaningful_JJ comparisons_NNS difficult_JJ ._.
P07563451A03
SETTING_VVGN --_: A_DD total_NN of_II 75_MC hospitals_NNS in_II 14_MC European_NN countries_NNS ._.
P07563451A17
There_EX were_VBD no_DD statistically_RR significant_JJ differences_NNS in_II the_DD mortality_NN rate_NN at_II 30_MC days_NNS or_CC in_II the_DD overall_JJ incidence_NN of_II intracerebral_JJ hemorrhages_NNS among_II the_DD rt-PA_NN and_CC placebo_NN treatment_NN arms_NNS in_II either_DD analysis_NN ._.
P07594099A10
The_DD median_JJ hospital_NN stay_NN was_VBD 7_MC days_NNS ,_, 2_MC fewer_JJR than_CSN the_DD overall_JJ stay_NN in_II GUSTO-I_NN ._.
P07608437A09
All_DD patients_NNS received_VVD intravenous_JJ heparin_NN and_CC oral_JJ aspirin_NN ._.
P07723799A06
Our_PNG primary_JJ ,_, or_CC base-case_NN ,_, analysis_NN of_II cost_NN effectiveness_NN used_VVD data_NNS from_II the_DD GUSTO_NN study_NN and_CC life_NN expectancy_NN projected_VVN on_II the_DD basis_NN of_II the_DD records_NNS of_II survivors_NNS of_II myocardial_JJ infarction_NN in_II the_DD Duke_NN Cardiovascular_JJ Disease_NN Database_NN ._.
P07745771A01
OBJECTIVE_NN --_: To_TO examine_VVI differences_NNS in_II outcomes_NNS and_CC patient_NN management_NN between_II patients_NNS in_II the_DD United_VVNJ States_NNS and_CC outside_II the_DD United_VVNJ States_NNS undergoing_VVG thrombolysis_NN for_II acute_JJ myocardial_JJ infarction_NN ._.
P07851482A09
It_PN is_VBZ concluded_VVN that_CST thromboxane_NN A2_NN ,_, thrombin_NN and_CC leucocytes_NNS are_VBB involved_VVN in_II reocclusion_NN after_II thrombolysis_NN ._.
P07878629A05
Radiographic_JJ contrast_NN injection_NN showed_VVD 7_MC catheters_NNS randomized_VVN to_II UK_NN had_VHD complete_JJ resolution_NN of_II the_DD thrombus_NN compared_VVN to_II 17_MC randomized_VVN to_II t-PA_NN (_( p_NN =_SYM 0.042_MC )_) ._.
P07963104A01
OBJECTIVES_NNS ._.
P07994806A12
CONCLUSIONS_NNS :_: Our_PNG results_NNS show_VVB that_CST both_DD thrombolytic_JJ agents_NNS activate_VVB the_DD classic_JJ complement_NN pathway_NN and_CC that_CST plasmin_NN could_VM be_VBB the_DD common_JJ trigger_NN for_II this_DD phenomenon_NN ._.
P08092895A05
Additional_JJ endpoints_NNS were_VBD reduction_NN in_II surgical_JJ procedure_NN ,_, clinical_JJ outcome_NN classification_NN ,_, length_NN of_II hospitalization_NN ,_, and_CC outcome_NN by_II duration_NN of_II ischemia_NN ._.
P08092895A19
Patients_NNS with_II acute_JJ ischemia_NN (_( 0-14_MC days_NNS )_) who_PNR were_VBD treated_VVN with_II thrombolysis_NN had_VHD improved_VVNJ amputation-free_JJ survival_NN and_CC shorter_JJR hospital_NN stays_NNS ._.
P08213579A01
A_DD blinded_VVNJ ,_, randomized_VVNJ trial_NN compared_VVD the_DD effects_NNS of_II front-loaded_VVNJ streptokinase_NN with_II those_PND of_II the_DD conventional_JJ dose_NN of_II intravenous_JJ recombinant_JJ tissue-type_NN plasminogen_NN activator_NN (_( rt-PA_NN )_) on_II left_JJ ventricular_JJ (_( LV_NN )_) function_NN after_II acute_JJ myocardial_JJ infarction_NN (_( AMI_NN )_) ._.
P08250455A02
DESIGN_NN :_: Uncontrolled_VVNJ randomized_VVNJ study_NN ._.
P08281367A09
Four_MC patients_NNS underwent_VVD successful_JJ ,_, semiurgent_JJ percutaneous_JJ transluminal_JJ coronary_JJ angioplasty_NN ;_: three_MC received_VVD an_DD elective_JJ and_CC two_MC an_DD urgent_JJ coronary_JJ artery_NN bypass_NN graft_NN ._.
P08328203A04
Thirty_MC ,_, 60_MC ,_, 90_MC ,_, and_CC 120_MC min_NN after_II initiation_NN of_II rt-PA_NN infusion_NN ,_, specific_JJ t-PA_NN activities_NNS in_II plasma_NN of_II responders_NNS were_VBD 0.62_MC ,_, 0.63_MC ,_, 0.62_MC ,_, and_CC 0.57_MC (_( IU_NN /_SYM ng_NN /_SYM ml_NN )_) ,_, respectively_RR ,_, as_CS compared_VVN to_II 0.42_MC ,_, 0.42_MC ,_, 0.40_MC ,_, and_CC 0.32_MC (_( IU_NN /_SYM ng_NN /_SYM ml_NN )_) in_II nonresponders_NNS (_( p_NN <_SYM 0.001_MC )_) ._.
P08354802A11
Bleeding_VVGN and_CC hemorrhagic_JJ and_CC ischemic_JJ stroke_NN rates_NNS were_VBD similar_JJ among_II diabetic_JJ and_CC nondiabetic_JJ patients_NNS ._.
P08370015A01
Catheter-directed_VVNJ thrombolytic_JJ therapy_NN has_VHZ become_VVB an_DD important_JJ part_NN of_II the_DD treatment_NN of_II patients_NNS with_II acute_JJ arterial_JJ and_CC graft_NN occlusion_NN ._.
P08470843A01
STUDY_NN OBJECTIVE_NN :_: To_TO assess_VVI the_DD choice_NN of_II thrombolytic_JJ agents_NNS in_II emergency_NN departments_NNS and_CC whether_CST administrators_NNS and_CC third-party_NN payers_NNS are_VBB influencing_VVGJ choices_NNS because_II+ of_II cost_NN differences_NNS ._.
P08544674A01
PURPOSE_NN ._.
P08544674A16
When_CS the_DD chances_NNS of_II MI_NN and_CC death_NN are_VBB known_VVN ,_, decision_NN analysis_NN can_VM be_VBB a_DD useful_JJ bedside_NN tool_NN to_TO guide_VVI thrombolytic_JJ therapy_NN and_CC subsequently_RR ,_, if_CS needed_VVN ,_, to_TO review_VVI and_CC defend_VVI the_DD treatment_NN decisions_NNS made_VVN ._.
P08554022A09
A_DD transient_JJ decrease_NN occurred_VVD in_II the_DD type_NN I_MC propeptide_NN concentration_NN at_II postinfarction_NN day_NN 2_MC ,_, and_CC this_DD decrease_NN was_VBD followed_VVN by_II a_DD secondary_JJ increase_NN at_II days_NNS 4_MC to_II 6_MC in_II both_DD patient_NN groups_NNS studied_VVN ._.
P08598594A01
OBJECTIVE_NN :_: To_TO compare_VVI baseline_NN characteristics_NNS ,_, complications_NNS ,_, and_CC treatment-specific_JJ outcomes_NNS of_II women_NNS and_CC men_NNS with_II acute_JJ myocardial_JJ infarction_NN treated_VVN with_II thrombolytic_JJ therapy_NN ._.
P08632624A05
Accelerated_VVNJ idioventricular_JJ rhythms_NNS (_( p_NN <_SYM 0.05_MC )_) occurred_VVD sooner_RRR following_VVG rtPA_NN than_CSN UK_NN treatment_NN ._.
P08696906A01
OBJECTIVE_NN :_: To_TO study_VVI the_DD efficacy_NN and_CC risks_NNS of_II local_JJ thrombolytic_JJ therapy_NN of_II peripheral_JJ arterial_JJ occlusions_NNS using_VVG rt-PA_NN ._.
P08732377A06
The_DD activity_NN of_II alpha-hydroxybutyrate_NN dehydrogenase_NN (_( HBDH_NN )_) in_II plasma_NN was_VBD centrally_RR analysed_VVN and_CC infarct_NN size_NN was_VBD defined_VVN as_II cumulative_JJ HBDH_NN release_NN per_II litre_NN of_II plasma_NN within_II 72_MC h_NN of_II the_DD first_JJ symptoms_NNS (_( Q_NN (_( 72_MC )_) )_) ._.
P08737217A09
Conversely_RR ,_, in_II patients_NNS undergoing_VVG thrombolysis_NN the_DD incidence_NN of_II left_JJ ventricular_JJ thrombosis_NN was_VBD lower_JJR when_CS the_DD left_JJ anterior_JJ descending_VVGJ coronary_JJ artery_NN was_VBD patent_JJ ,_, and_CC especially_RR when_CS an_DD early_JJ creatine_NN kinase_NN peak_NN ,_, suggestive_JJ of_II reperfusion_NN ,_, was_VBD recorded_VVN (_( 7_MC %_SYM )_) ._.
P08770844A04
Also_RR discussed_VVN are_VBB new_JJ thrombolytic_JJ agents_NNS and_CC the_DD effects_NNS of_II concomitant_JJ use_NN of_II other_JJ drugs_NNS as_II part_NN of_II the_DD treatment_NN regimen_NN ._.
P08793432A06
Large_JJ local_JJ haematomas_NNS occurred_VVD in_II 8_MC %_SYM of_II cases_NNS in_II the_DD urokinase_NN group_NN and_CC 15_MC %_SYM in_II the_DD rt-PA_NN group_NN ._.
P08795509A01
PURPOSE_NN :_: The_DD purpose_NN of_II this_DD study_NN was_VBD to_TO prospectively_RR evaluate_VVI the_DD treatment_NN of_II patients_NNS with_II occluded_VVNJ lower_JJR extremity_NN bypass_NN grafts_NNS ,_, comparing_VVG surgical_JJ revascularization_NN with_II catheter-directed_VVNJ thrombolysis_NN ._.
P08905435A03
rt-PA_NN therapy_NN was_VBD administered_VVN over_II a_DD 10-day_NN period_NN ._.
P08950493A02
It_PN has_VHZ also_RR been_VBN used_VVN to_TO treat_VVI thrombotic_JJ closure_NN complicating_VVG angioplasty_NN ,_, to_TO treat_VVI nonocclusive_JJ thrombosis_NN observed_VVN during_II angioplasty_NN ,_, and_CC to_TO pretreat_VVI patients_NNS with_II nonacute_JJ total_JJ occlusions_NNS before_II angioplasty_NN ._.
P08990404A04
An_DD accelerated_VVNJ dosage_NN regimen_NN was_VBD later_RR devised_VVN to_TO allow_VVI the_DD administration_NN of_II t-PA_NN over_II a_DD shorter_JJR period_NN of_II time_NN ._.
P08990407A02
As_II a_DD result_NN ,_, it_PN is_VBZ no_RR longer_RR ethical_JJ to_TO test_VVI a_DD new_JJ thrombolytic_JJ regimen_NN against_II placebo_NN ._.
P09052962A10
Two_MC major_JJ categories_NNS of_II patients_NNS were_VBD not_RR treated_VVN with_II thrombolysis_NN :_: 1_MC )_) patients_NNS presented_VVN more_RR than_CSN 12_MC hours_NNS after_II pain_NN onset_NN (_( 38_MC %_SYM )_) ;_: 2_MC )_) patients_NNS without_II ST_NN segment_NN elevation_NN or_CC LBBB_NN on_II the_DD ECG_NN presented_VVN (_( 37_MC %_SYM )_) ._.
P09061735A04
One_MC patient_NN presented_VVD mild_JJ respiratory_JJ distress_NN probably_RR from_II a_DD pulmonary_JJ microembolism_NN that_PNR disappeared_VVD in_II a_DD few_JJ days_NNS ._.
P09091523A05
In-hospital_NN clinical_JJ events_NNS and_CC mortality_NN at_II 30_MC days_NNS and_CC 1_MC year_NN were_VBD assessed_VVN ._.
P09127024A02
METHODS_NNS :_: Nine_MC patients_NNS were_VBD treated_VVN during_II a_DD 2-year_NN period_NN for_II intracranial_JJ dural_JJ sinus_NN thrombosis_NN ._.
P09134650A07
The_DD observation_NN that_CST neutralization_NN of_II PAI-1_NN by_II specific_JJ antibodies_NNS ,_, both_CC in_II plasma_NN and_CC within_II the_DD clot_NN ,_, did_VDD not_RR potentiate_VVB clot_NN lysis_NN indicates_VVZ that_CST the_DD inhibitor_NN ,_, including_VVG the_DD platelet-derived_VVNJ form_NN ,_, is_VBZ insufficient_JJ to_TO attenuate_VVI the_DD thrombolytic_JJ activity_NN of_II a_DD pharmacological_JJ concentration_NN of_II rt-PA_NN and_CC that_CST its_PNG elevation_NN ,_, similarly_RR to_II the_DD elevation_NN of_II plasminogen_NN ,_, is_VBZ not_RR the_DD cause_NN of_II clot_NN resistance_NN but_CC rather_RR a_DD coincident_JJ finding_VVGN ._.
P09134838A08
Eight_MC of_II ten_MC patients_NNS in_II the_DD thrombolysis_NN group_NN and_CC seven_MC of_II eight_MC with_II PTA_NN had_VHD clinical_JJ improvement_NN after_II the_DD procedure_NN ._.
P09173270A05
RESULTS_NNS :_: The_DD incidence_NN of_II the_DD primary_JJ end_NN point_NN in_II the_DD angioplasty_NN and_CC t-PA_NN groups_NNS was_VBD 9.6_MC percent_NN and_CC 13.7_MC percent_NN ,_, respectively_RR (_( odds_NNS ratio_NN ,_, 0.67_MC ;_: 95_MC percent_NN confidence_NN interval_NN ,_, 0.47_MC to_II 0.97_MC ;_: P_NN =_SYM 0.033_MC )_) ._.
P09207639A07
Mortality_NN was_VBD lowest_JJT among_II those_PND with_II diabetes_NN receiving_VVG accelerated_VVNJ t-PA_NN ,_, which_PNR is_VBZ consistent_JJ with_II the_DD results_NNS of_II the_DD overall_JJ patient_NN cohort_NN ._.
P09232304A13
CONCLUSION_NN :_: This_DD case_NN provides_VVZ evidence_NN for_II the_DD efficacy_NN and_CC relative_JJ safety_NN of_II rtPA_NN as_II thrombolytic_JJ therapy_NN in_II the_DD treatment_NN of_II haemodynamically_RR compromised_VVNJ valve_NN heart_NN thrombosis_NN in_II pregnancy_NN ._.
P09243149A07
CONCLUSION_NN :_: These_DD results_NNS proved_VVD that_CST ,_, when_CS the_DD full_JJ dose_NN of_II streptokinase_NN has_VHZ been_VBN given_VVN over_II 12_MC h_NN ,_, its_PNG efficacy_NN is_VBZ as_RR good_JJ as_CSN that_PND of_II 2_MC h_NN of_II recombinant_JJ tissue_NN plasminogen_NN ._.
P09284041A10
These_DD treatments_NNS may_VM reverse_VVB some_DD or_CC all_DD acute_JJ stroke_NN symptoms_NNS and_CC improve_VVB functional_JJ outcomes_NNS ._.
P09288042A04
METHODS_NNS :_: From_II all_DD available_JJ completed_VVNJ randomised_VVNJ trials_NNS of_II thrombolytic_JJ therapy_NN compared_VVN with_II control_NN in_II acute_JJ ischaemic_JJ stroke_NN (_( with_II prerandomisation_NN CT_NN )_) ,_, we_PN checked_VVD tabular_JJ data_NNS on_II deaths_NNS during_II roughly_RR the_DD first_JJ 2_MC weeks_NNS ,_, deaths_NNS from_II all_DD causes_NNS and_CC functional_JJ outcome_NN (_( disability_NN )_) at_II the_DD end_NN of_II the_DD trial_NN follow-up_NN period_NN ,_, and_CC early_JJ symptomatic_JJ and_CC fatal_JJ intracranial_JJ haemorrhages_NNS ._.
P09454430A04
The_DD results_NNS show_VVB that_CST thrombolysis_NN of_II acute_JJ carotid_JJ territory_NN strokes_NNS (_( European_NN Cooperative_NN Acute_JJ Stroke_NN Study_NN )_) and_CC of_II strokes_NNS with_II a_DD deficit_NN measurable_JJ on_II the_DD NIH_NN Stroke_NN Scale_NN (_( National_JJ Institute_NN of_II Neurological_JJ Disorders_NNS and_CC Stroke_NN rt-PA_NN Stroke_NN Study_NN )_) improves_VVZ clinical_JJ and_CC economic_JJ outcome_NN parameters_NNS in_II patients_NNS who_PNR were_VBD treated_VVN within_II 6_MC hours_NNS of_II the_DD onset_NN of_II symptoms_NNS and_CC had_VHD that_CST no_DD signs_NNS of_II extended_VVNJ early_JJ infarction_NN on_II the_DD initial_JJ CT-scan_NN ._.
P09491947A09
Some_DD patients_NNS were_VBD predicted_VVN to_TO benefit_VVI considerably_RR from_II thrombolysis_NN with_II little_DD extra_JJ risk_NN of_II stroke_NN and_CC vice_RR+ versa_RR :_: all_DD cases_NNS must_VM ,_, therefore_RR ,_, be_VBB assessed_VVN individually_RR ._.
P09525545A06
RESULTS_NNS :_: There_EX was_VBD no_DD difference_NN in_II baseline_NN clinical_JJ or_CC angiographic_JJ characteristics_NNS according_II+ to_II the_DD timing_VVGN or_CC nature_NN of_II treatment_NN ._.
P09576210A03
The_DD thrombolytic_JJ therapy_NN protocol_NN consisted_VVN of_II streptokinase_NN (_( 1,500,000_MC IU_NN in_II 90_MC minutes_NNS )_) (_( n_NN =_SYM 18_MC )_) in_II one_MC (_( n_NN =_SYM 7_MC )_) or_CC two_MC (_( n_NN =_SYM 11_MC )_) cycles_NNS or_CC recombinant_JJ tissue-type_NN plasminogen_NN activator_NN (_( 100_MC mg_NN in_II 90_MC minutes_NNS )_) (_( n_NN =_SYM 4_MC )_) ._.
P09626825A04
METHODS_NNS :_: Patients_NNS with_II symptoms_NNS of_II acute_JJ myocardial_JJ infarction_NN and_CC electrocardiographic_JJ ST_NN segment_NN elevation_NN were_VBD treated_VVN with_II thrombolytic_JJ therapy_NN and_CC randomly_RR assigned_VVN to_TO receive_VVI hirudin_NN or_CC heparin_NN ._.
P09631890A02
The_DD coronary_JJ endothelium_NN was_VBD removed_VVN and_CC thrombus_NN formation_NN was_VBD confirmed_VVN by_II angioscopy_NN ._.
P09878934A02
Therefore_RR there_EX might_VM be_VBB a_DD difference_NN in_II the_DD effect_NN of_II time_NN to_II treatment_NN on_II the_DD efficacy_NN of_II these_DD fibrinolytics_NNS with_II different_JJ fibrin_NN specificity_NN in_II patients_NNS with_II acute_JJ myocardial_JJ infarction_NN ._.
P10365238A10
Postthrombolisis_NN arrhythmias_NNS was_VBD observed_VVN in_II 64.7_MC %_SYM ._.
P10469440A09
In_II such_DD situations_NNS ,_, injection_NN of_II rt-PA_NN in_II the_DD pulp_NN soft_JJ tissues_NNS may_VM result_VVB in_II successful_JJ salvage_NN ._.
P10506849A07
Plasma_NN levels_NNS of_II lipid_NN peroxides_NNS (_( LPO_NN )_) were_VBD found_VVN to_TO increase_VVI 90_MC minutes_NNS after_II thrombolytic_JJ therapy_NN in_II each_DD group_NN ,_, while_CS the_DD levels_NNS of_II vitamins_NNS E_NN and_CC C_NN showed_VVD significant_JJ decreases_NNS ._.
P10545680A04
The_DD model_NN included_VVD three_MC outcome_NN states_NNS :_: death_NN ,_, nonfatal_JJ yet_RR disabling_VVGJ stroke_NN ,_, and_CC survival_NN with_II no_DD disabling_VVGJ stroke_NN ._.
P10572811A09
There_EX is_VBZ an_DD increased_VVNJ incidence_NN of_II stroke_NN with_II t-PA_NN ._.
P10695499A11
Controlled_VVNJ prospective_JJ multicentre_NN studies_NNS on_II thrombolytic_JJ therapy_NN in_II neonates_NNS and_CC infants_NNS are_VBB recommended_VVN to_TO evaluate_VVI patency_NN rates_NNS and_CC adverse_JJ effects_NNS for_II the_DD different_JJ thrombolytic_JJ agents_NNS used_VVN ._.
P10716384A09
These_DD risks_NNS appear_VVB similar_JJ to_II those_PND of_II urokinase_NN ._.
P10850102A06
Nevertheless_RR ,_, she_PN recovered_VVD well_RR from_II her_PNG hemiplegia_NN after_II a_DD few_JJ days_NNS ._.
P10865025A03
Thrombolysis_NN offers_VVZ a_DD promising_VVGJ alternative_NN to_II surgery_NN ._.
P11041123A07
After_II 24_MC hours_NNS the_DD t-PA_NN and_CC DD_NN plasma_NN levels_NNS remained_VVD significantly_RR higher_JJR (_( p_NN <_SYM 0.001_MC )_) while_CS the_DD PAI-1_NN plasma_NN levels_NNS returned_VVD to_II the_DD pre-therapy_NN levels_NNS ._.
P11315578A04
The_DD initial_JJ rt-PA_NN dose_NN was_VBD 0.4_MC mg_NN /_SYM kg_NN given_VVN over_II 15_MC min_NN and_CC followed_VVN by_II a_DD continuous_JJ daily_JJ infusion_NN of_II 1.6_MC to_II 2.0_MC mg_NN /_SYM kg_NN ._.
P11907772A05
RESULTS_NNS :_: Successful_JJ lysis_NN was_VBD achieved_VVN in_II all_DD patients_NNS ._.P01371078A01
The_DD cytogenetic_JJ hallmark_NN of_II chronic_JJ myelogenous_JJ leukemia_NN (_( CML_NN )_) is_VBZ the_DD Philadelphia_NN chromosome_NN (_( Ph1_NN )_) ,_, which_PNR reflects_VVZ a_DD chromosomal_JJ translocation_NN t_NN (_( 9_MC ;_: 22_MC )_) and_CC a_DD rearrangement_NN of_II the_DD ABL_NN and_CC bcr_NN genes_NNS ._.
P01482658A05
Of_II the_DD remaining_VVGJ 13_MC PCR-positive_JJ patients_NNS ,_, only_RR one_MC (_( 8_MC %_SYM )_) relapsed_VVD after_II 23_MC months_NNS ;_: the_DD other_JJ 12_MC were_VBD alive_JJ and_CC still_RR in_II remission_NN after_II a_DD median_JJ follow-up_NN of_II 16+_MC months_NNS (_( ranging_VVG 5+_MC to_II 29+_MC months_NNS )_) ._.
P01518306A02
The_DD relationship_NN between_II the_DD fusion_NN pattern_NN of_II BCR_NN /_SYM ABL_NN mRNA_NN and_CC the_DD clinical_JJ outcome_NN was_VBD also_RR analysed_VVN ._.
P01674385A05
Twelve_MC of_II these_DD patients_NNS have_VHB remained_VVN in_II remission_NN by_II morphologic_JJ and_CC karyotypic_JJ criteria_NNS from_II 16.6_MC to_II 63.7_MC months_NNS following_VVG BMT_NN ._.
P01728316A09
The_DD pattern_NN of_II bcr_NN /_SYM abl_NN PCR_NN detection_NN after_II transplant_NN may_VM aid_VVB in_II the_DD development_NN of_II trials_NNS designed_VVN to_TO reduce_VVI the_DD risk_NN of_II relapse_NN ,_, or_CC allow_VVB for_II early_JJ intervention_NN in_II patients_NNS who_PNR fail_VVB to_TO clear_VVI the_DD malignant_JJ clone_NN ._.
P01763047A04
These_DD data_NNS show_VVB that_CST murine_JJ CML_NN can_VM result_VVB from_II retroviral_JJ transfer_NN of_II the_DD bcr_NN /_SYM abl_NN gene_NN into_II pluripotent_JJ hematopoietic_JJ stem_NN cells_NNS ,_, that_CST infected_VVNJ clones_NNS repopulate_VVB poorly_RR after_II adoptive_JJ transfer_NN ,_, and_CC that_CST these_DD clones_NNS can_VM give_VVB rise_NN to_II acute_JJ leukemia_NN ,_, reflecting_VVG evolution_NN to_II a_DD phase_NN resembling_VVG blast_NN crisis_NN in_II the_DD human_NN disease_NN ._.
P01824268A06
Patients_NNS in_II whom_PNR PCR_NN positivity_NN was_VBD sustained_VVN over_II time_NN had_VHD a_DD higher_JJR probability_NN of_II CML_NN relapse_NN than_CSN patients_NNS in_II whom_PNR PCR_NN was_VBD intermittently_RR negative_JJ (_( P_NN =_SYM .0095_MC ,_, log_NN rank_NN test_NN )_) ._.
P01932296A03
Eight_MC of_II 16_MC patients_NNS were_VBD negative_JJ by_II two-step_NN PCR_NN 1-39_MC months_NNS after_II BMT_NN ,_, suggesting_VVG an_DD elimination_NN of_II Ph-positive_JJ cells_NNS or_CC a_DD decrease_NN below_II the_DD threshold_NN of_II detection_NN ._.
P01932752A08
However_RR ,_, mRNA_NN processing_VVGN in_II children_NNS may_VM preferentially_RR splice_VVB Mbcr_NN exon_NN 2_MC to_II ABL_NN exon_NN II_MC ._.
P01961034A09
The_DD second_JJ cluster_NN occurred_VVD within_II two_MC sub-zones_NNS that_PNR spanned_VVD an_DD Alu_NN sequence_NN ,_, and_CC 90_MC %_SYM of_II this_DD cluster_NN exhibited_VVD b3-a2_NN spliced_VVNJ RNA_NN ._.
P02013978A06
In_II two_MC of_II these_DD three_MC patients_NNS ,_, samples_NNS were_VBD available_JJ from_II the_DD time_NN of_II initial_JJ diagnosis_NN ._.
P02032243A08
Also_RR ,_, one_MC chronic_JJ phase_NN patient_NN analyzed_VVN on_II three_MC separate_JJ occasions_NNS lacked_VVD P210_NN BCR-ABL_NN and_CC exhibited_VVD only_RR the_DD Mr_NN 190,000_MC form_NN ._.
P02065312A03
The_DD presence_NN of_II a_DD rearrangement_NN involving_VVG the_DD major_JJ breakpoint_NN cluster_NN region_NN (_( mbcr_NN )_) on_II chromosome_NN 22_MC was_VBD confirmed_VVN by_II Southern_NN blotting_VVGJ techniques_NNS ._.
P02157692A02
Molecular_JJ analysis_NN was_VBD performed_VVN on_II 25_MC patients_NNS with_II Ph-positive_JJ CML_NN using_VVG 2_MC breakpoint_NN cluster_NN region_NN (_( bcr_NN )_) probes_NNS within_II the_DD M-BCR-1_NN DNA_NN sequences_NNS ,_, and_CC two_MC of_II them_PN did_VDD not_RR contain_VVB either_CC detectable_JJ rearranged_VVNJ DNA_NN homologous_JJ to_II the_DD 5_MC '_SYM side_NN bcr_NN probe_NN or_CC ABL-related_VVNJ fusion_NN mRNA_NN ._.
P02197265A04
From_II molecular_JJ studies_NNS ,_, it_PN seemed_VVD that_CST Ph-_NN CML_NN with_II features_NNS of_II true_JJ CML_NN always_RR have_VHB the_DD bcr_NN rearrangement_NN ,_, while_CS Ph-_NN patients_NNS ,_, lacking_VVG such_DD rearrangement_NN ,_, have_VHB atypical_JJ forms_NNS of_II CML_NN ._.
P02198962A03
Furthermore_RR ,_, breakpoints_NNS in_II this_DD intron_NN clustered_VVD in_II three_MC regions_NNS ,_, approximately_RR 30_MC +/-_SYM 5_MC ,_, 100_MC +/-_SYM 13_MC ,_, and_CC 135_MC +/-_SYM 8_MC kb_NN downstream_JJ from_II exon_NN 1b_NN ._.
P02201832A01
A_DD modified_VVNJ polymerase_NN chain_NN reaction_NN (_( PCR_NN )_) procedure_NN was_VBD used_VVN to_TO study_VVI the_DD expression_NN of_II bcr-abl_NN fusion_NN transcripts_NNS following_VVG allogeneic_JJ bone_NN marrow_NN transplantation_NN (_( BMT_NN )_) for_II Philadelphia_NN chromosome_NN (_( Ph1_NN )_) positive_JJ acute_JJ and_CC chronic_JJ leukemias_NNS ._.
P02223646A07
In_II the_DD series_NN analysed_VVN by_II ethidium_NN bromide_NN stained_VVNJ gels_NNS ,_, there_EX was_VBD ,_, however_RR ,_, an_DD increase_NN in_II the_DD percentage_NN of_II cases_NNS expressing_VVG the_DD b3a2_NN junction_NN in_II the_DD mononuclear_JJ cells_NNS of_II blast_NN crisis_NN patients_NNS as_CS compared_VVN to_II the_DD white_JJ blood_NN cells_NNS of_II patients_NNS in_II chronic_JJ phase_NN ._.
P02403827A02
These_DD molecular_JJ phenomena_NNS may_VM occur_VVB even_RR in_II the_DD absence_NN of_II cytogenetic_JJ evidence_NN of_II the_DD Ph_NN translocation_NN ._.
P02407300A04
Cloning_VVGN and_CC sequencing_VVGN of_II the_DD chimeric_JJ part_NN of_II bcr-abl_NN cDNAs_NNS from_II two_MC Ph-positive_JJ CML_NN patients_NNS in_II chronic_JJ phase_NN showed_VVD that_CST in_II one_MC patient_NN ,_, as_CS in_II the_DD Ph-positive_JJ ALL_NN ,_, all_DD central_JJ bcr_NN sequences_NNS are_VBB absent_JJ ,_, while_CS in_II the_DD other_JJ patient_NN ,_, part_NN of_II the_DD bcr_NN central_JJ sequences_NNS are_VBB deleted_VVN ._.
P02684296A04
Seven_MC of_II 13_MC ,_, or_CC 54_MC %_SYM of_II patients_NNS with_II bcr_NN /_SYM abl_NN rearrangement_NN negative_JJ chronic_JJ phase_NN CML_NN (_( atypical_JJ CML_NN )_) harbored_VVD mutations_NNS in_II ras_NN ,_, however_RR ._.
P02730954A03
Among_II the_DD 21_MC samples_NNS obtained_VVN in_II chronic_JJ phase_NN ,_, eight_MC patients_NNS had_VHD the_DD L-6_NN mRNA_NN ,_, 11_MC had_VHD the_DD K-28_NN mRNA_NN ,_, and_CC two_MC had_VHD both_CC the_DD L-6_NN and_CC K-28_NN mRNAs_NNS ._.
P02848601A04
Therefore_RR ,_, it_PN can_VM be_VBB hypothesized_VVN that_CST the_DD transition_NN from_II chronic_JJ to_II blast_NN phase_NN in_II CML_NN is_VBZ accompanied_VVN by_II an_DD alternative_JJ splice_NN in_II the_DD bcr-abl_NN mRNA_NN ,_, which_PNR results_VVZ in_II a_DD switch_NN of_II the_DD production_NN of_II P210bcr-abl_NN into_II P190bcr-abl_NN ._.
P07509222A07
These_DD results_NNS indicated_VVD that_CST normal_JJ clones_NNS can_VM persist_VVB in_II CD34+DR-_NN progenitors_NNS in_II some_DD patients_NNS with_II CML_NN ,_, even_RR when_CS chromosome_NN analysis_NN detects_VVZ the_DD Ph_NN chromosome_NN in_II all_DD metaphases_NNS of_II bone_NN marrow_NN cells_NNS ._.
P07520786A03
Quantification_NN of_II the_DD autoradiographic_JJ signals_NNS of_II amplified_VVNJ products_NNS was_VBD estimated_VVN using_VVG an_DD MCID_NN image_NN analysis_NN system_NN ._.
P07662984A02
Cell_NN lines_NNS established_VVN from_II CML_NN patients_NNS in_II blast_NN crisis_NN show_VVB higher_JJR expression_NN of_II this_DD aberrant_JJ bcr-abl_NN transcript_NN than_CSN cells_NNS from_II patients_NNS in_II chronic_JJ phase_NN of_II the_DD disease_NN ._.
P07701913A03
A_DD sensitive_JJ two-step_NN reverse-transcription_NN polymerase_NN chain_NN reaction_NN (_( RT-PCR_NN )_) was_VBD done_VDN to_TO score_VVI BCR-ABL-mRNA-positive_JJ leukemic_JJ cells_NNS in_II frozen_VVNJ bone_NN marrow_NN samples_NNS of_II 15_MC CML_NN patients_NNS retrospectively_RR ._.
P07817701A01
A_DD patient_NN with_II myasthenia_NN gravis_NN and_CC a_DD thymoma_NN did_VDD not_RR respond_VVB to_II thymectomy_NN ._.
P07857690A08
The_DD products_NNS were_VBD characterized_VVN using_VVG agarose_NN gel_NN electrophoresis_NN ._.
P07938018A01
De_JJ+ novo_JJ methylation_NN of_II CpG_NN islands_NNS is_VBZ a_DD rare_JJ event_NN in_II mammalian_JJ cells_NNS ._.
P07967054A07
Bcr-abl_NN mRNA_NN was_VBD detectable_JJ in_II 6_MC of_II 7_MC cases_NNS (_( 6_MC /_SYM 7_MC )_) within_II 6_MC months_NNS after_II BMT_NN ,_, all_DD five_MC cases_NNS from_II 6_MC months_NNS to_II 1_MC year_NN (_( 1Y_NN )_) ,_, 2_MC /_SYM 8_MC at_II 1Y_NN ,_, 3_MC /_SYM 7_MC at_II 2Y_NN ,_, and_CC 3_MC /_SYM 7_MC over_II 3Y_NN ._.
P08035612A05
In_II each_DD CML_NN patient_NN the_DD incidence_NN of_II '_`` positive_JJ '_'' T_NN cells_NNS was_VBD much_RR less_RR than_CSN in_II positive_JJ controls_NNS and_CC similar_JJ to_II that_PND found_VVN in_II negative_JJ controls_NNS (_( mean_NN values_NNS +/-_SYM 1_MC SD_NN :_: 7.7_MC +/-_SYM 3.6_MC ;_: 91.2_MC +/-_SYM 3.1_MC ,_, and_CC 5.6_MC +/-_SYM 2.2_MC ,_, respectively_RR )_) ._.
P08204887A07
Of_II interest_NN ,_, six_MC Ph1-negative_JJ CML_NN patients_NNS were_VBD BCR-ABL_NN protein-positive_JJ ._.
P08231244A07
Hematological_JJ relapse_NN occurred_VVD in_II five_MC of_II the_DD latter_JJ patients_NNS ._.
P08251917A05
No_DD different_JJ mobility_NN shifts_NNS of_II single_JJ stranded_VVNJ PCR_NN products_NNS were_VBD found_VVN in_II the_DD other_JJ amplified_VVNJ fragments_NNS ._.
P08289478A02
Little_PND is_VBZ known_VVN about_II the_DD mechanism_NN of_II this_DD inhibition_NN ._.
P08295258A06
Both_DD bands_NNS were_VBD seen_VVN more_RR frequently_RR in_II blast_NN crisis_NN than_CSN in_II remission_NN and_CC chronic_JJ phase_NN ._.
P08374529A08
The_DD mean_NN number_NN of_II megakaryocyte_NN progenitor_NN cells_NNS assayed_VVN by_II in_JJ+ vitro_JJ cloning_VVGN was_VBD 128.3_MC /_SYM 2_MC x_SYM 10_MC (_( 5_MC )_) bone_NN marrow_NN cells_NNS for_II 3_MC '_SYM patients_NNS (_( n_NN =_SYM 7_MC )_) compared_VVN with_II 46.3_MC for_II 5_MC '_SYM patients_NNS (_( n_NN =_SYM 4_MC )_) ._.
P08417787A07
Direct_JJ sequencing_VVGN of_II PCR_NN fragments_NNS representing_VVG the_DD full-length_NN coding_VVGJ sequence_NN of_II ABL-BCR_NN cDNAs_NNS type_NN Ib-b3_NN ,_, Ia-b3_NN ,_, Ib-b4_NN ,_, and_CC Ia-b4_NN showed_VVD an_DD open_JJ reading_VVGJ frame_NN predicted_VVN to_TO encode_VVI fusion_NN proteins_NNS of_II 370_MC to_II 414_MC amino-acids_NNS ._.
P08427990A08
If_CS only_RR patients_NNS in_II chronic_JJ phase_NN are_VBB compared_VVN ,_, the_DD t-test_NN showed_VVD significant_JJ correlation_NN between_II leukocyte_NN count_NN just_RR before_II BMT_NN and_CC sustained_VVNJ bcr-abl_NN transcript_NN (_( P_NN <_SYM .05_MC )_) ._.
P08475126A10
The_DD late-onset_NN CML-like_JJ disease_NN and_CC transfer_NN to_II secondary_JJ recipients_NNS provides_VVZ a_DD useful_JJ murine_JJ model_NN with_II features_NNS of_II the_DD chronic_JJ and_CC acute_JJ phases_NNS of_II human_NN CML_NN ._.
P08507874A01
Fluorescence_NN in_JJ+ situ_JJ hybridization_NN (_( FISH_NN )_) has_VHZ become_VVN an_DD increasingly_RR important_JJ method_NN for_II assessing_VVGN chromosome_NN rearrangement_NN ._.
P08542954A07
This_DD ASO_NN had_VHD a_DD hairpin-like_JJ secondary_JJ structure_NN and_CC was_VBD found_VVN to_TO be_VBI much_RR more_RR resistant_JJ to_II the_DD action_NN of_II nucleases_NNS than_CSN control_NN 18-mer_NN standard_JJ oligonucleotides_NNS ._.
P08590842A01
Antisense_NN oligonucleotides_NNS were_VBD used_VVN to_TO determine_VVI the_DD role_NN of_II the_DD BCR-ABL_NN gene_NN in_II the_DD proliferation_NN of_II chronic_JJ myeloid_NN leukaemia_NN (_( CML_NN )_) clonogenic_JJ cells_NNS ._.
P08625225A08
Among_II patients_NNS in_II the_DD early_JJ chronic_JJ phase_NN ,_, thrombocytosis_NN was_VBD significantly_RR associated_VVN with_II the_DD 3_MC '_SYM breakpoint_NN site_NN (_( P_NN =_SYM 0.02_MC )_) ,_, whereas_CS peripheral_JJ basophilia_NN occurred_VVD more_RR frequently_RR with_II the_DD 5_MC '_SYM breakpoint_NN site_NN (_( P_NN =_SYM 0.05_MC )_) ._.
P08639848A07
In_II contrast_NN to_II NL_NN marrow_NN ,_, 34+DR+_NN cells_NNS from_II CML_NN marrow_NN ,_, irrespective_II+ of_II clinical_JJ stage_NN ,_, contained_VVD large_JJ numbers_NNS of_II LTC-IC_NN ._.
P08652835A03
Neither_CC p210_NN nor_CC p190_NN BCR-ABL_NN transcripts_NNS were_VBD detected_VVN in_II normal_JJ healthy_JJ adults_NNS (_( n_NN =_SYM 20_MC )_) ._.
P08656674A04
We_PN analyzed_VVD routine_JJ blood_NN and_CC marrow_NN specimens_NNS from_II eight_MC patients_NNS who_PNR presented_VVD with_II Ph+_NN lymphoblastic_JJ leukemia_NN and_CC found_VVD that_CST FISH_NN recognized_VVD the_DD 9_MC ;_: 22_MC translocation_NN ,_, distinguished_VVD between_II the_DD two_MC common_JJ molecular_JJ variants_NNS ,_, and_CC readily_RR identified_VVD multilineage_NN vs_CC lymphoblast-restricted_VVNJ disease_NN ._.
P08659451A06
Fifty_MC of_II 53_MC pre-BMT_NN samples_NNS were_VBD positive_JJ by_II RT-PCR_NN ._.
P08659451A18
Furthermore_RR ,_, RT-PCR_NN can_VM be_VBB successfully_RR performed_VVN on_II peripheral_JJ blood_NN ,_, yielding_VVG excellent_JJ correlation_NN with_II bone_NN marrow_NN samples_NNS ._.
P08697426A04
This_PND could_VM be_VBB caused_VVN by_II duplication_NN of_II the_DD rearranged_VVNJ chromosome_NN 9_MC ,_, which_PNR may_VM have_VHB a_DD significance_NN similar_JJ to_II a_DD double_JJ Ph_NN chromosome_NN ._.
P08704208A06
Compared_VVN with_II mice_NNS treated_VVN with_II individual_JJ compounds_NNS ,_, the_DD disease_NN process_NN was_VBD significantly_RR retarded_VVN in_II the_DD group_NN treated_VVN with_II both_DD [_( S_NN ]_) ODNs_NNS as_CS revealed_VVN by_II flow_NN cytometry_NN ,_, clonogenic_JJ assay_NN ,_, and_CC RT-PCR_NN analysis_NN to_TO detect_VVI leukemic_JJ cells_NNS in_II mouse_NN tissue_NN cell_NN suspensions_NNS ._.
P08795691A06
The_DD appearance_NN of_II minor_JJ bcr_NN /_SYM abl_NN fusion_NN mRNA_NN was_VBD associated_VVN with_II the_DD lymphoblastic_JJ immunophenotype_NN of_II the_DD blast_NN cells_NNS ._.
P08853030A07
A_DD decreasing_VVGJ ratio_NN was_VBD found_VVN in_II patients_NNS with_II decreasing_VVGJ percentages_NNS of_II Ph_NN ._.
P08874208A06
Analysis_NN of_II individual_JJ CML_NN colonies_NNS for_II the_DD presence_NN of_II the_DD hybrid_NN BCR_NN /_SYM ABL_NN mRNA_NN by_II reverse_JJ transcription-polymerase_NN chain_NN reaction_NN (_( RT-PCR_NN )_) showed_VVD that_CST genistein_NN treatment_NN significantly_RR reduced_VVD the_DD mean_NN +/-_SYM SD_NN percentage_NN of_II marrow_NN BCR_NN /_SYM ABL+_NN progenitors_NNS both_CC by_II continuous_JJ exposure_NN (_( 76_MC %_SYM +/-_SYM 18_MC %_SYM v_NN 24_MC %_SYM +/-_SYM 12_MC %_SYM ,_, P_NN <_SYM or_CC =_SYM .004_MC )_) or_CC preincubation_NN (_( 75_MC %_SYM +/-_SYM 16_MC %_SYM v_NN 21_MC %_SYM +/-_SYM 10_MC %_SYM ,_, P_NN <_SYM or_CC =_SYM .002_MC )_) experiments_NNS ._.
P09028165A03
Either_DD bcr-abl_NN is_VBZ normally_RR expressed_VVN ,_, but_CC both_DD types_NNS of_II bcr-abl_NN mRNA_NN can_VM be_VBB expressed_VVN at_II the_DD same_JJ time_NN in_II a_DD patient_NN ._.
P09168938A03
To_TO elucidate_VVI the_DD mechanism_NN of_II hLH-2_NN transcriptional_JJ activation_NN ,_, we_PN studied_VVD the_DD methylation_NN status_NN of_II hLH-2_NN in_II normal_JJ bone_NN marrow_NN and_CC CML_NN cells_NNS ._.
P09177433A08
Experiments_NNS aimed_VVN at_II evaluating_VVGN the_DD effect_NN of_II the_DD incubation_NN time_NN showed_VVD a_DD significant_JJ increase_NN in_II anti-leukaemic_JJ effect_NN after_II a_DD 120_MC h_NN incubation_NN period_NN compared_VVN to_II that_PND measured_VVN after_II a_DD 24_MC h_NN incubation_NN period_NN ;_: this_PND was_VBD parallelled_VVN by_II a_DD progressive_JJ increase_NN in_II the_DD intracellular_JJ concentrations_NNS of_II [_( S_NN ]_) ODNs_NNS from_II day_NN 1_MC to_II day_NN 5_MC ._.
P09305602A07
Using_VVG fluorescence_NN in_JJ+ situ_JJ hybridization_NN (_( FISH_NN )_) in_II conjunction_NN with_II BCR_NN and_CC ABL_NN probes_NNS we_PN detected_VVD Ph+_NN and_CC Ph-_NN cells_NNS in_II both_CC adherent_JJ and_CC non-adherent_JJ CD34+_NN cell_NN fractions_NNS of_II 15_MC /_SYM 15_MC patients_NNS studied_VVN and_CC in_II the_DD HLA-DR_NN (_( lo_NN )_) or_CC CD38_NN (_( lo_NN )_) sorted_VVNJ CD34+_NN cell_NN fractions_NNS ._.
P09311272A04
Administration_NN of_II hydroxycarbamide_NN was_VBD initiated_VVN ,_, but_CC in_II May_NN she_PN developed_VVD high_JJ fever_NN and_CC severe_JJ left_JJ hypochondralgia_NN ._.
P09389369A01
We_PN present_VVB the_DD case_NN of_II a_DD two-year-old_JJ child_NN with_II an_DD atypical_JJ presentation_NN of_II chronic_JJ myeloid_NN leukemia_NN ._.
P09426513A11
We_PN conclude_VVB the_DD utility_NN of_II FISH_NN and_CC RT-PCR_NN is_VBZ associated_VVN with_II certain_JJ limitations_NNS ,_, such_II+ as_II insufficient_JJ RNA_NN for_II RT-PCR_NN and_CC the_DD occasional_JJ absence_NN of_II internal_JJ positive_JJ FISH_NN control_NN signals_NNS ._.
P09494617A06
The_DD use_NN of_II dual_JJ color_NN FISH_NN in_II the_DD diagnosis_NN of_II CML_NN is_VBZ extremely_RR valuable_JJ not_RR only_RR in_II identifying_VVGN cases_NNS of_II Ph-negative_JJ CML_NN ,_, but_CC also_RR in_II quantifying_VVGN the_DD proportion_NN of_II transformed_VVNJ cell_NN populations_NNS ._.
P09530344A06
The_DD present_JJ case_NN suggests_VVZ that_CST p190_NN BCR_NN /_SYM ABL_NN is_VBZ associated_VVN with_II the_DD aggressive_JJ course_NN of_II the_DD disease_NN ._.
P09613984A04
Of_II the_DD 15_MC patients_NNS ,_, 9_MC are_VBB alive_JJ and_CC in_II complete_JJ remission_NN (_( CR_NN )_) ,_, 4_MC have_VHB died_VVN in_II CR_NN and_CC 2_MC are_VBB alive_JJ but_CC suffered_VVD relapse_NN at_II +_SYM 19_MC and_CC +26_MC months_NNS post-BMT_NN ._.
P09665193A03
FISH_NN detected_VVD 9-16_MC %_SYM nuclei_NNS with_II a_DD BCR-ABL_NN fusion_NN gene_NN ,_, contrasting_VVG with_II RT-PCR_NN ,_, performed_VVN in_II two_MC cases_NNS ,_, which_PNR was_VBD negative_JJ in_II one_MC case_NN and_CC weakly_RR positive_JJ in_II the_DD other_PND ._.
P09808572A07
Analysis_NN of_II the_DD proviral_JJ integration_NN pattern_NN shows_VVZ that_CST ,_, in_II some_DD mice_NNS ,_, the_DD myeloproliferative_JJ disease_NN is_VBZ clonal_JJ ._.
P09834240A04
Furthermore_RR ,_, the_DD 2-5A-antisense_NN chimeras_NNS suppressed_VVD growth_NN of_II K562_NN ,_, while_CS having_VHG substantially_RR reduced_VVNJ effects_NNS on_II the_DD promyelocytic_JJ leukemia_NN cell_NN line_NN ,_, HL60_NN ._.
P09858221A04
We_PN performed_VVD RT-PCR_NN on_II samples_NNS from_II CML_NN patients_NNS in_II chronic_JJ phase_NN to_TO determine_VVI the_DD frequency_NN and_CC mechanism_NN of_II p190_NN and_CC p210_NN co-expression_NN and_CC to_TO see_VVI if_CST this_PND correlated_VVD with_II clinical_JJ indices_NNS ._.
P10087949A04
When_CS promyelocytic_JJ blast_NN crisis_NN was_VBD diagnosed_VVN according_II+ to_II the_DD French-American-British_JJ classification_NN ,_, cytogenetic_JJ studies_NNS revealed_VVD an_DD i_NN (_( 17q_NN )_) as_II a_DD new_JJ feature_NN in_II our_PNG patient_NN ._.
P10200527A06
Inhibition_NN of_II caspase_NN suppressed_VVD apoptosis_NN and_CC the_DD cleavage_NN of_II pRB_NN ,_, and_CC in_II turn_NN arrested_VVD cells_NNS in_II the_DD G1_NN phase_NN ._.
P10222655A07
The_DD literature_NN provides_VVZ support_NN for_II the_DD existence_NN of_II a_DD relationship_NN between_II multiple_JJ myelomas_NNS and_CC CML_NN ._.
P10349111A04
Median_JJ age_NN was_VBD 32_MC years_NNS (_( range_NN 9_MC to_II 47_MC )_) ;_: 15_MC of_II them_PN were_VBD in_II chronic_JJ phase_NN (_( CP_NN )_) ,_, and_CC 4_MC in_II accelerated_VVNJ phase_NN (_( AP_NN )_) ._.
P10374889A09
We_PN used_VVD in_JJ+ situ_JJ RT-PCR_NN by_II comparison_NN to_II cytogenetics_NNS (_( at_RR+ least_RR 30_MC mitoses_NNS examined_VVD )_) ,_, and_CC two-step_NN RT-PCR_NN (_( 10_MC (_( -6_MC )_) sensitivity_NN in_II our_PNG hands_NNS )_) in_II bone_NN marrow_NN samples_NNS from_II 13_MC CML_NN patients_NNS :_: two_MC patients_NNS at_II diagnosis_NN and_CC 11_MC patients_NNS in_II hematological_JJ remission_NN after_II alpha_NN interferon_NN (_( three_MC patients_NNS )_) ,_, hydroxyurea_NN (_( one_MC patient_NN )_) autologous_JJ bone_NN marrow_NN transplantation_NN (_( BMT_NN )_) (_( one_MC patient_NN )_) and_CC allogeneic_JJ BMT_NN (_( six_MC patients_NNS )_) ._.
P10400414A05
Thirty_MC consecutive_JJ Philadelphia_NN (_( Ph_NN )_) chromosome_NN positive_JJ patients_NNS were_VBD enrolled_VVN in_II this_DD study_NN ._.
P10494184A01
Chronic_JJ myelogenous_JJ leukemia_NN is_VBZ characterized_VVN by_II an_DD abnormal_JJ 22nd_JJ chromosome_NN known_VVN as_II a_DD Philadelphia_NN chromosome_NN ,_, which_PNR can_VM be_VBB detected_VVN in_II 95_MC %_SYM of_II patients_NNS with_II CML_NN ._.
P10498589A02
We_PN used_VVD a_DD very_RR sensitive_JJ quantitative_JJ reverse_JJ transcriptase-polymerase_NN chain_NN reaction_NN to_TO investigate_VVI the_DD levels_NNS of_II hybrid_NN BCR_NN /_SYM ABL_NN mRNA_NN in_II bone_NN marrow_NN cells_NNS of_II 20_MC patients_NNS with_II Philadelphia_NN positive_JJ (_( Ph_NN (_( +_SYM )_) )_) CML_NN treated_VVN with_II interferon-alpha_NN (_( IFN-alpha_NN )_) as_II a_DD single_JJ agent_NN ._.
P10509158A03
The_DD Ph_NN chromosome_NN detection_NN via_II fluorescence_NN in_JJ+ situ_JJ hybridization_NN after_II 24-hour_NN mitotic_JJ arrest_NN of_II bone_NN marrow_NN cultures_NNS resulting_VVG in_II several_JJ hundreds_NNS of_II metaphases_NNS (_( hypermetaphase_NN FISH_NN or_CC HMF_NN )_) was_VBD useful_JJ in_II explaining_VVGN the_DD nature_NN of_II the_DD six_MC cases_NNS ._.
P10549264A04
In_II CML_NN patients_NNS with_II clonal_JJ evolution_NN of_II a_DD simple_JJ Ph_NN ,_, a_DD signal_NN of_II the_DD chromosome_NN 22_MC painting_VVGJ probe_NN was_VBD detected_VVN on_II the_DD der_NN (_( 9_MC )_) of_II the_DD Ph_NN translocation_NN ._.
P10602422A02
The_DD e1a2_NN ,_, b2a2_NN or_CC b3a2_NN and_CC c3a2_NN fusion_NN mRNAs_NNS encode_VVB distinct_JJ fusion_NN proteins_NNS (_( p190_NN ,_, p210_NN and_CC p230_NN ,_, respectively_RR )_) ,_, which_PNR are_VBB associated_VVN with_II different_JJ forms_NNS of_II leukemogenesis_NN in_II humans_NNS and_CC animal_NN models_NNS ._.
P10607685A01
A_DD substantial_JJ minority_NN of_II patients_NNS with_II chronic_JJ myelogenous_JJ leukemia_NN (_( CML_NN )_) achieve_VVB a_DD complete_JJ response_NN (_( CR_NN )_) to_II treatment_NN with_II interferon-alpha_NN (_( IFN_NN )_) ,_, defined_VVN as_II the_DD disappearance_NN of_II Philadelphia_NN chromosome-positive_JJ metaphases_NNS ._.
P10607685A13
(_( Blood._NN 2000_MC ;_: 95_MC :_: 62-66_MC )_)
P10629589A05
DESIGN_NN AND_CC METHODS_NNS :_: Dual-color_NN fluorescence_NN in_JJ+ situ_JJ hybridization_NN (_( FISH_NN )_) can_VM visualize_VVB BCR_NN and_CC ABL_NN genes_NNS and_CC localize_VVB the_DD BCR_NN /_SYM ABL_NN fusion_NN gene_NN ._.
P10666183A06
The_DD blast_NN cells_NNS were_VBD clonal_JJ in_II origin_NN and_CC expressed_VVD p210_NN (_( bcr_NN /_SYM abl_NN )_) with_II an_DD increased_VVNJ kinase_NN activity_NN ._.
P10681725A04
Median_JJ follow-up_NN was_VBD 61_MC months_NNS (_( range_NN 4-92_MC )_) ._.
P10985361A04
However_RR ,_, molecular_JJ relapses_NNS of_II CML_NN after_II transplant_NN were_VBD only_RR safely_RR detectable_JJ when_CS a_DD nested_VVNJ real-time_NN PCR_NN assay_NN was_VBD performed_VVN ,_, which_PNR was_VBD able_JJ to_TO detect_VVI 1-10_MC pg_NN cDNA_NN from_II a_DD tenfold_NN serial_JJ dilution_NN ._.
P11091204A08
Neither_CC NK_NN cells_NNS nor_CC T_NN cells_NNS showed_VVD any_DD positive_JJ BCR-ABL_NN signal_NN with_II the_DD exception_NN of_II one_MC patient_NN who_PNR recovered_VVD from_II a_DD lymphoid_JJ blastic_JJ crisis_NN ._.
P11150599A06
In_II this_DD article_NN ,_, we_PN present_VVB several_JJ quality_NN control_NN and_CC assurance_NN methods_NNS that_PNR can_VM be_VBB useful_JJ in_II providing_VVGN standardization_NN of_II the_DD FISH_NN technique_NN ._.
P11175620A06
DIAGNOSTIC_JJ TEST_NN :_: Karyotyping_VVGN was_VBD done_VDN in_II the_DD usual_JJ way_NN and_CC the_DD BCR_NN /_SYM ABL_NN gene-specific_JJ probe_NN was_VBD used_VVN for_II FISH_NN ._.
P11233781A10
In_II blast_NN crisis_NN (_( 6_MC patients_NNS )_) ,_, all_DD colonies_NNS tested_VVN were_VBD BCR-ABL_NN positive_JJ ._.
P11243401A02
We_PN found_VVD a_DD high_JJ proportion_NN of_II 12.51_MC +/-_SYM 1.19_MC %_SYM of_II CD34+_NN peripheral_JJ blood_NN progenitor_NN cells_NNS (_( PBPC_NN )_) in_II S_NN /_SYM G2M_NN phase_NN ._.
P11287973A02
This_DD enzyme_NN is_VBZ present_JJ in_II virtually_RR all_DD cases_NNS of_II chronic_JJ myeloid_NN leukemia_NN (_( CML_NN )_) throughout_II the_DD course_NN of_II the_DD disease_NN ,_, and_CC in_II 20_MC percent_NN of_II cases_NNS of_II acute_JJ lymphoblastic_JJ leukemia_NN (_( ALL_NN )_) ._.
P11387365A09
Only_RR one_MC of_II 26_MC patients_NNS developed_VVD blast_NN crisis_NN ._.
P11691826A04
Inhibition_NN of_II Bcr-Abl_NN with_II STI571_NN resulted_VVD in_II down-regulation_NN of_II cyclin_NN D2_NN and_CC reduction_NN of_II the_DD number_NN of_II cells_NNS in_II S_NN phase_NN ,_, although_CS complete_JJ G1_NN arrest_NN was_VBD not_RR induced_VVN ._.
P11777957A09
p210-enhanced_VVNJ green_JJ fluorescence_NN protein-transduced_VVNJ cells_NNS gave_VVD rise_NN to_II significantly_RR decreased_VVNJ numbers_NNS of_II NK_NN cells_NNS compared_VVN with_II enhanced_VVNJ green_JJ fluorescence_NN protein_NN transduction_NN alone_JJ ._.
P11801312A02
We_PN report_VVB the_DD frequencies_NNS of_II BCR-ABL_NN transcript_NN variants_NNS studied_VVN in_II chronic_JJ myeloid_NN leukemia_NN (_( CML_NN )_) and_CC acute_JJ lymphoblastic_JJ leukemia_NN (_( ALL_NN )_) patients_NNS in_II the_DD Ecuadorian_NN population_NN ._.
P12094246A03
Patients_NNS were_VBD evaluated_VVN for_II hematologic_JJ ,_, cytogenetic_JJ and_CC molecular_JJ response_NN ,_, survival_NN and_CC toxicity_NN ._.
P12100156A03
Sequencing_VVGJ analysis_NN of_II these_DD products_NNS revealed_VVD BCR-ABL_NN fusion_NN transcripts_NNS with_II e19a2_NN in_II patient_NN 1_MC and_CC e191a_NN in_II patient_NN 2_MC ._.
P12200666A06
Cytogenetic_JJ response_NN was_VBD determined_VVN in_II 3-monthly_JJ intervals_NNS :_: From_II 101_MC evaluable_JJ patients_NNS ,_, 42_MC achieved_VVD a_DD complete_JJ (_( CR_NN ,_, 0_MC %_SYM Philadelphia_NN chromosome_NN (_( Ph_NN )_) -_: positive_JJ metaphases_NNS )_) ,_, 18_MC a_DD partial_JJ (_( PR_NN ,_, 1-34_MC %_SYM Ph+_NN )_) ,_, 13_MC a_DD minor_JJ (_( MR_NN ,_, 35-94_MC %_SYM Ph+_NN )_) ,_, and_CC 26_MC no_DD response_NN (_( NR_NN ,_, >_SYM 94_MC %_SYM Ph+_NN )_) ._.
P12351420A01
Clinical_JJ resistance_NN to_II imatinib_NN mesylate_NN is_VBZ commonly_RR observed_VVN in_II patients_NNS with_II advanced_VVNJ Philadelphia_NN chromosome-_NN positive_JJ (_( Ph_NN (_( +_SYM )_) )_) leukemias_NNS ._.P00006620A05
Todarodes_NN pacificus_NN contains_VVZ much_RR more_DD retinochrome_NN than_CSN Loligo_NN ,_, and_CC it_PN is_VBZ more_RR abundant_JJ in_II the_DD outer_JJ than_CSN in_II the_DD inner_JJ segments_NNS ._.
P00013085A09
Demethylglycodiazin_NN (_( 2-benzolsulfonamid_NN --_: 5-_MC (_( beta-hydroxyethoxy_NN )_) -pyrimidin_NN )_) ,_, which_PNR did_VDD not_RR inhibit_VVB endogenous_JJ ketogenesis_NN in_II isolated_VVNJ liver_NN cells_NNS ,_, did_VDD not_RR affect_VVB lysosomal_JJ lipase_NN activity_NN ._.
P00026908A02
If_CS the_DD theory_NN is_VBZ correct_JJ ,_, it_PN suggests_VVZ that_CST both_CC prophylaxis_NN and_CC management_NN of_II the_DD acute_JJ condition_NN should_VM be_VBB possible_JJ by_II means_NNS of_II selective_JJ alpha-adrenoceptor_NN antagonism_NN ._.
P00042211A05
However_RR ,_, in_II undifferentiated_VVNJ areas_NNS of_II transplanted_VVNJ tissue_NN ,_, we_PN found_VVD ultrastructural_JJ evidence_NN that_CST immature_JJ pericytes_NNS of_II capillaries_NNS can_VM differentiate_VVB into_II preadipocytes_NNS ._.
P00058033A06
Antibodies_NNS in_II sera_NNS from_II rabbits_NNS immunized_VVN with_II normal_JJ spleen_NN cells_NNS bound_VVD small_JJ but_CC significant_JJ amounts_NNS of_II radiolabeled_VVNJ melanoma_NN antigens_NNS ._.
P00065903A11
The_DD similarity_NN between_II the_DD protein_NN concentration_NN of_II interstitial_JJ fluid_NN and_CC lymph_NN indicated_VVD that_CST the_DD endothelial_JJ lining_VVGN of_II the_DD terminal_JJ lymphatics_NNS did_VDD not_RR restrict_VVB the_DD passage_NN of_II macromolecules_NNS into_II the_DD lymphatics_NNS ._.
P00097960A01
The_DD computed_VVNJ tomographic_JJ findings_NNS of_II four_MC patients_NNS with_II neoplastic_JJ disease_NN of_II the_DD global_JJ rim_NN are_VBB discussed_VVN ._.
P00111772A04
S_NN --_: R_NN event_NN units_NNS consisted_VVD of_II three_MC subtypes_NNS :_: stimulus-related_VVNJ ,_, response-related_VVNJ ,_, and_CC stimulus_NN --_: response-related_VVNJ units_NNS ._.
P00125829A03
The_DD survival_NN time_NN after_II the_DD dissection_NN of_II the_DD acoustic_JJ nerve_NN is_VBZ somewhat_RR more_RR than_CSN seven_MC weeks_NNS ._.
P00139889A05
Glycerol-density-gradient_NN centrifugation_NN indicates_VVZ a_DD molecular_JJ weight_NN for_II the_DD intact_JJ complex_NN of_II about_RR 270000_MC ._.
P00163622A04
Consequently_RR ,_, the_DD diazepam-treated_VVNJ cells_NNS had_VHD a_DD higher_JJR chlorophyll_NN /_SYM photosynthesis_NN ratio_NN --_: also_RR with_II regard_NN to_II respiration_NN in_II order_NN to_TO calculate_VVI the_DD gross_JJ photosynthesis_NN ._.
P00187164A02
The_DD pure_JJ mesenchymal_JJ tumor_NN is_VBZ usually_RR present_JJ at_II birth_NN and_CC palpated_VVN as_II a_DD mass_NN in_II the_DD kidney_NN ._.
P00192861A02
The_DD pancreatic_JJ acinar_JJ cells_NNS of_II zinc-deficient_JJ rats_NNS showed_VVD marked_VVNJ cellular_JJ alterations_NNS :_: a_DD reduction_NN in_II zymogen_NN granules_NNS ,_, rupture_NN of_II zymogen_NN granules_NNS ,_, basal_JJ accumulation_NN lipid_NN droplets_NNS ,_, prominent_JJ lysosome-like_JJ bodies_NNS ,_, focal_JJ degradation_NN of_II the_DD cytoplasm_NN ,_, and_CC intracistenal_JJ granules_NNS within_II the_DD dilated_VVNJ cisternae_NN of_II the_DD endoplasmic_JJ reticulum_NN ._.
P00206818A03
The_DD results_NNS indicated_VVD that_CST ,_, (_( 1_MC )_) glucose-6-P_NN is_VBZ compartmentalized_VVN with_II respect_NN to_II the_DD enzymes_NNS involved_VVN in_II glucose-60P_NN ,_, trehalose_NN and_CC glycogen_NN metabolism_NN ,_, (_( 2_MC )_) a_DD differences_NNS of_II approximately_RR 0.6_MC mM_NN /_SYM min_NN in_II maximum_NN specific_JJ activity_NN of_II glucokinase_NN compared_VVN to_II glucose-6-P_NN phosphatase_NN is_VBZ required_VVN in_II order_NN for_II the_DD model_NN to_TO produce_VVI end_NN product_NN carbohydrate_NN levels_NNS consistent_JJ with_II those_PND observed_VVN experimentally_RR ,_, (_( 3_MC )_) the_DD Km_NN of_II glucokinase_NN for_II glucose_NN strongly_RR influences_VVZ the_DD steady_JJ state_NN levels_NNS of_II glucose_NN in_II the_DD absence_NN of_II external_JJ glucose_NN ,_, and_CC (_( 4_MC )_) changing_VVGN the_DD order_NN of_II product_NN removal_NN in_II the_DD reaction_NN catalyzed_VVN by_II glucose-6-P_NN phosphatase_NN influences_VVZ the_DD level_NN of_II glycogen_NN and_CC trehalose_NN ._.
P00219800A02
The_DD herpes_NN infection_NN was_VBD confirmed_VVN by_II isolation_NN of_II herpes_NN virus_NN from_II the_DD CSF_NN (_( one_MC case_NN )_) ,_, from_II the_DD brain_NN (_( one_MC case_NN )_) ,_, and_CC in_II the_DD 5_MC remaining_VVGJ cases_NNS by_II serology_NN ._.
P00263489A01
Computed_VVNJ tomography_NN scanners_NNS can_VM be_VBB calibrated_VVN to_TO provide_VVI reproducible_JJ measurements_NNS for_II a_DD quantitative_JJ analysis_NN of_II lung_NN density_NN ._.
P00284170A07
There_EX was_VBD also_RR no_DD significant_JJ correlation_NN when_CS prognostic_JJ factors_NNS were_VBD compared_VVN to_II uptake_NN in_II the_DD individual_JJ organ_NN systems_NNS except_CS+ that_CS T_NN cell_NN disease_NN was_VBD associated_VVN with_II a_DD significantly_RR greater_JJR propensity_NN for_II lymph_NN node_NN uptake_NN ._.
P00305839A04
These_DD results_NNS support_VVB the_DD assumption_NN that_CST with_II increasing_VVGJ age_NN cellular_JJ immunity_NN is_VBZ clearly_RR reduced_VVN and_CC may_VM possibly_RR be_VBB associated_VVN with_II an_DD increased_VVNJ incidence_NN of_II neoplasia_NN ,_, infection_NN ,_, and_CC auto-immune_JJ disease_NN ._.
P00320526A03
Urinary_JJ tract_NN abnormalities_NNS were_VBD found_VVN in_II 49_MC %_SYM of_II patients_NNS with_II the_DD Rokitansky_NN syndrome_NN ._.
P00338401A05
Maprotiline_NN appeared_VVD to_TO be_VBI superior_JJ to_II viloxazine_NN on_II the_DD sleep_NN and_CC sadness_NN scales_NNS and_CC some_DD evidence_NN to_TO show_VVI it_PN to_TO be_VBI better_JJR also_RR on_II the_DD tension_NN scale_NN ._.
P00367052A05
The_DD results_NNS suggest_VVB that_CST cell-mediated_VVNJ immunology_NN plays_VVZ an_DD important_JJ role_NN for_II the_DD lysozyme_NN synthesis_NN of_II macrophages_NNS in_II granuloma_NN ._.
P00393048A05
The_DD results_NNS indicate_VVB that_CST the_DD blocking_VVGJ action_NN of_II the_DD gestagen_NN on_II the_DD positive_JJ feedback_NN of_II estradiol_NN on_II LH_NN release_NN occurs_VVZ at_II the_DD hypothalamus_NN or_CC higher_JJR CNS_NN centers_NNS ._.
P00422973A04
Many_PND of_II the_DD extra_JJ neurons_NNS are_VBB involved_VVN in_II reproductive_JJ behavior_NN ._.
P00438202A06
The_DD hepatic_JJ heme_NN oxygenase_NN appears_VVZ to_TO have_VHI characteristics_NNS essentially_RR similar_JJ to_II those_PND of_II the_DD splenic_JJ heme_NN oxygenase_NN (_( Yoshida_NNP ,_, T._NNP ,_, and_CC Kikuchi_NNP ,_, G._NNP (_( 1978_MC )_) J._NN Biol._NN Chem._NN 253_MC ,_, 4224_MC and_CC 4230_MC )_) ._.
P00460828A02
Among_II 96_MC patients_NNS who_PNR underwent_VVD arthrotomy_NN ,_, the_DD arthroscopic_JJ diagnosis_NN was_VBD confirmed_VVN in_II 96_MC per_II cent_MC ._.
P00482467A06
Evening_NN cortisol_NN elevation_NN was_VBD twice_RR as_RR common_JJ in_II patients_NNS with_II diagnoses_NNS of_II more_RR severe_JJ psychiatric_JJ illness_NN than_CSN in_II those_PND with_II minor_JJ disorders_NNS ._.
P00513294A03
As_II+ for_II side_NN effect_NN ,_, 1_MC case_NN developed_VVD eosinophilia_NN ,_, and_CC another_DD case_NN with_II impaired_VVNJ liver_NN function_NN as_II underlying_VVGJ disease_NN showed_VVD transitory_JJ exacerbated_VVNJ examination_NN values_NNS ._.
P00539639A01
Manula_NN compression_NN of_II the_DD common_JJ carotid_JJ artery_NN after_II a_DD complication_NN of_II the_DD posterior_JJ approach_NN to_II the_DD internal_JJ jugular_NN vein_NN resulted_VVD in_II progressive_JJ AV_NN block_NN and_CC cardiac_JJ arrest_NN ._.
P00565754A03
The_DD most_RRT frequent_JJ lesions_NNS encountered_VVN included_VVD granuloma_NN in_II 9.5_MC %_SYM ,_, focal_JJ areas_NNS of_II necrosis_NN in_II 14_MC %_SYM ,_, portal_NN triaditis_NN in_II 17_MC %_SYM ,_, and_CC Kupffer_NN cell_NN hyperplasia_NN in_II 33_MC %_SYM ._.
P00590425A02
It_PN was_VBD observed_VVN that_CST the_DD matrix_NN and_CC fibrillary_JJ structure_NN became_VVD more_RR abundant_JJ in_II the_DD mesangial_JJ cells_NNS and_CC also_RR in_II the_DD epicytes_NNS ;_: it_PN was_VBD noted_VVN that_CST the_DD Golgi_NN apparatus_NN was_VBD active_JJ and_CC the_DD granular_JJ endoplasmic_JJ reticulum_NN was_VBD very_RR enlarged_VVN ,_, partially_RR containing_VVG structures_NNS of_II a_DD particular_JJ shape_NN ._.
P00608931A01
According_II+ to_II studies_NNS carried_VVN out_II using_VVG the_DD optical_JJ microscope_NN and_CC the_DD electron_NN microscope_NN quingestanol_NN acetate_NN ,_, which_PNR is_VBZ a_DD powerful_JJ progestagen_NN ,_, modified_VVD significantly_RR the_DD histology_NN and_CC the_DD histochemistry_NN of_II the_DD endometrium_NN ._.
P00634556A04
The_DD cells_NNS contained_VVD coarse_JJ granular_JJ and_CC fibrillar_JJ material_NN in_II the_DD cytoplasm_NN and_CC large_JJ granules_NNS in_II the_DD nuclei_NNS ._.
P00675650A02
100_MC of_II these_DD cases_NNS showed_VVD occlusion_NN in_II the_DD ilio-femoral_JJ area_NN and_CC 6_MC in_II the_DD axillary_JJ area_NN ._.
P00683476A01
Cells_NNS in_II the_DD male_NN fowl_NN brain_NN which_PNR accumulate_VVB radioactivity_NN following_VVG 3H_NN testosterone_NN (_( T_NN )_) administration_NN were_VBD identified_VVN by_II autoradiography_NN ._.
P00690888A15
The_DD data_NNS suggest_VVB that_CST the_DD inhibition_NN of_II net_JJ fluid_NN transport_NN by_II ouabain_NN is_VBZ indirect_JJ and_CC mediated_VVN by_II changes_NNS in_II intracellular_JJ ion_NN concentrations_NNS ._.
P00709534A01
History_NN and_CC clinical_JJ findings_NNS of_II 18_MC cases_NNS of_II adenosquamous_JJ carcinoma_NN of_II the_DD skin_NN appendages_NNS found_VVN among_II 135_MC cases_NNS of_II primary_JJ carcinoma_NN of_II the_DD vulva_NN seen_VVN at_II the_DD University_NN of_II Minnesota_NN Hospital_NN between_II 1951_MC and_CC 1970_MC were_VBD analyzed_VVN ._.
P00735240A03
If_CS other_JJ diagnostic_JJ methods_NNS fail_VVB ,_, to_II the_DD interest_NN of_II an_DD early_JJ ascertainment_NN of_II the_DD diagnosis_NN the_DD performance_NN of_II a_DD test_NN excision_NN should_VM not_RR be_VBB delayed_VVN ._.
P00752233A03
The_DD light_JJ intervals_NNS are_VBB subjectively_RR estimated_VVN as_II longer_JJR than_CSN the_DD dark_JJ ones_NNS ._.
P00785612A05
The_DD Mayo-Smith_NN program_NN had_VHD a_DD much_RR larger_JJR number_NN of_II disagreements_NNS with_II the_DD clinical_JJ cardiologists_NNS ,_, and_CC was_VBD far_RR less_RR acceptable_JJ for_II clinical_JJ use_NN in_II their_PNG opinion_NN ._.
P00812305A03
With_II increase_NN of_II the_DD distance_NN and_CC reduction_NN of_II the_DD time_NN of_II contact_NN the_DD risk_NN of_II meningococcus_NN infection_NN in_II a_DD collective_JJ body_NN falls_VVZ to_II the_DD zero_MC (_( no_DB such_DD phenomenon_NN is_VBZ observed_VVN in_II other_JJ droplet_NN infections_NNS )_) ._.
P00838772A03
A_DD major_JJ portion_NN of_II total_JJ cytochrome_NN c_NN oxidase_NN (_( mitochondrial_JJ marker_NN )_) activity_NN was_VBD also_RR recovered_VVN in_II this_DD fraction_NN ,_, with_II the_DD remainder_NN sedimenting_VVGN between_II 640_MC and_CC 6,000_MC g_NN ._.
P00853493A01
Permits_NNS to_TO maintain_VVI the_DD articular_JJ gape_NN that_PNR is_VBZ necessary_JJ on_II the_DD various_JJ angles_NNS of_II rotation_NN of_II the_DD joint_NN ,_, without_II the_DD intervention_NN of_II an_DD assistant_NN ,_, to_TO examine_VVI on_II a_DD remove-operated_VVNJ table_NN with_II centring_VVGN on_II telescopy_NN and_CC eventually_RR for_II tomo-arthrography_NN ._.
P00869925A03
The_DD content_NN of_II glycine_NN ,_, proline_NN and_CC dicarboxylicamino_JJ acids_NNS accounts_VVZ for_II 83_MC %_SYM of_II the_DD total_JJ resideus_NNS of_II protein_NN C_NN and_CC it_PN contains_VVZ 2.0_MC mol_NN of_II P_NN /_SYM mol_NN of_II protein_NN ,_, most_RRT likely_JJ as_II phosphoserine_NN ._.
P00876697A08
Maternal_JJ nutrition_NN immediately_RR before_II delivery_NN has_VHZ considerable_JJ effect_NN on_II the_DD circulating_VVGJ concentrations_NNS of_II metabolites_NNS and_CC the_DD responses_NNS to_II cold_NN of_II the_DD newborn_NN ._.
P00901702A06
4_MC Following_VVG amphetamine_NN (_( 30_MC mg_NN )_) ,_, two_MC of_II six_MC narcoleptic_JJ subjects_NNS had_VHD an_DD increase_NN in_II plasma_NN growth_NN hormone_NN concentration_NN ._.
P00942722A01
The_DD metaphase_NN spindle_NN of_II haploid_NN Dictyostelium_NN discoideum_NN (_( n_NN =_SYM 7_MC )_) is_VBZ 2_MC mum_NN long_JJ ._.
P00949648A06
The_DD literature_NN on_II extrauterine_JJ pregnancy_NN is_VBZ reviewed_VVN briefly_RR ._.
P00963737A07
The_DD third_JJ type_NN of_II cell_NN is_VBZ small_JJ ,_, and_CC can_VM not_RR yet_RR be_VBB identified_VVN ._.
P01003633A02
Our_PNG report_NN concerns_VVZ its_PNG use_NN in_II 5_MC cases_NNS as_II the_DD sole_JJ medical_JJ agent_NN for_II dissolving_VVGN pelvic_JJ stones_NNS and_CC in_II 6_MC others_NNS to_TO supplement_VVI an_DD operation_NN and_CC dissolve_VVI postoperative_JJ residual_JJ concretions_NNS ._.
P01013679A11
Without_II involving_VVGN a_DD higher_JJR operative_JJ risk_NN ,_, the_DD open_JJ approach_NN to_II mitral_JJ commissurotomy_NN offers_VVZ the_DD following_VVGJ main_JJ advantages_NNS :_: safe_JJ removal_NN of_II intraatrial_JJ thrombi_NNS ,_, precise_JJ and_CC complete_JJ incision_NN of_II the_DD fused_VVNJ commissures_NNS under_II direct_JJ vision_NN ,_, avoidance_NN of_II leaflet_NN tears_NNS ,_, separation_NN of_II fused_VVNJ chordae_NN tendineae_NN and_CC incision_NN of_II papillary_JJ muscles_NNS in_II order_NN to_TO remove_VVI subvalvular_JJ stenosis_NN ,_, debridement_NN of_II calcium_NN from_II leaflets_NNS ,_, and_CC repair_NN of_II concomitant_JJ mitral_JJ regurgitation_NN by_II valvuloplasty_NN ._.
P01035397A13
It_PN was_VBD taken_VVN advantage_NN of_II this_DD situation_NN to_TO remove_VVI the_DD larvae_NNS with_II a_DD pair_NN of_II nippers_NNS ._.
P01067614A02
When_CS such_DD cells_NNS are_VBB pulse-labeled_VVN with_II [_( 3H_NN ]_) thymidine_NN during_II the_DD peak_NN of_II DNA_NN synthesis_NN on_II day_NN 3_MC of_II culture_NN ,_, then_RR cultured_VVN for_II 3_MC more_DD days_NNS in_II the_DD absence_NN of_II isotope_NN ,_, labeled_VVNJ DNA_NN moves_VVZ slowly_RR into_II the_DD Hirt_NN supernatant_NN cell_NN fraction_NN from_II the_DD pellet_NN fraction_NN containing_VVG chromosomal_JJ DNA_NN ,_, and_CC then_RR into_II the_DD culture_NN medium_NN ._.
P01082235A09
It_PN is_VBZ conceivable_JJ that_CST the_DD great_JJ increase_NN in_II resistance_NN duroing_VVG the_DD hypotonic_JJ period_NN was_VBD caused_VVN by_II the_DD occlusion_NN of_II the_DD gland_NN lumina_NNS ._.
P01115102A03
Rather_RR ,_, the_DD data_NNS suggest_VVB that_CST satisfaction_NN with_II the_DD specific_JJ agency_NN is_VBZ the_DD chief_JJ determinant_NN of_II overall_JJ satisfaction_NN ._.
P01141184A02
Celite_NN retains_VVZ all_DD interfering_VVGJ materials_NNS including_VVG Lipids_NNS whereas_CS the_DD chlorinated_VVNJ Insecticides_NNS are_VBB eluted_VVN from_II the_DD column_NN with_II n-hexane_NN ._.
P01164398A04
When_CS the_DD mice_NNS were_VBD injected_VVN intraperitoneally_RR (_( i.p._NN )_) with_II OK-432_NN at_II 2_MC months_NNS of_II age_NN ,_, they_PN produced_VVD natural_JJ antibodies_NNS to_II GCSAs_NNS or_CC to_II PCl_NN antigen_NN ,_, unlike_II untreated_VVNJ mice_NNS of_II the_DD same_JJ strains_NNS at_II the_DD same_JJ ages_NNS (_( negative_JJ controls_NNS )_) ,_, which_PNR produced_VVD no_DD antibodies_NNS ._.
P01180233A06
No_DD appreciable_JJ acidic_JJ mucosubstance_NN was_VBD demonstrated_VVN in_II the_DD submandibular_JJ gland_NN mucous_NN tubules_NNS ._.
P01188237A10
The_DD integrity_NN of_II the_DD postero-median_JJ part_NN of_II the_DD frontal_JJ lobe_NN is_VBZ indespensable_JJ for_II a_DD normal_JJ reaction_NN by_II speech_NN to_II stimuli_NNS received_VVN from_II the_DD sensory_JJ areas_NNS ._.
P01212821A04
If_CS procured_VVN from_II sensitized_VVNJ donors_NNS ,_, macrophage_NN migration_NN was_VBD inhibited_VVN by_II the_DD corresponding_VVGJ antigen_NN ._.
P01243606A01
Recent_JJ progress_NN in_II the_DD field_NN of_II radioimmunology_NN ,_, especially_RR as_CS regards_VVZ prolactin_NN (_( PRL_NN )_) assay_NN ,_, as_CC+ well_CC+ as_CC the_DD use_NN of_II new_JJ drugs_NNS have_VHB opened_VVN new_JJ perspectives_NNS for_II a_DD better_RRR understanding_VVGN of_II the_DD "_`` amenorrhoea-galactorrhea_NN syndrome_NN "_'' both_CC from_II the_DD diagnostic_JJ and_CC therapeutic_JJ points_NNS of_II view_NN ._.
P01273208A02
In_II the_DD present_JJ study_NN five_MC normal_JJ adult_NN men_NNS were_VBD administered_VVN saline_NN and_CC two_MC doses_NNS of_II of_II haloperidol_NN (_( 0.25_MC mg_NN ,_, 0.5_MC mg_NN )_) intramuscularly_RR in_II a_DD double-blind_JJ randomized_VVNJ block_NN design_NN ._.
P01279668A08
In_II contrast_NN ,_, almost_RR all_DD (_( 98_MC %_SYM )_) two-cell_NN embryos_NNS cultured_VVN with_II a_DD modified_VVNJ (_( chimeric_JJ phosphorothioate_NN /_SYM phosphodiester_NN )_) antisense_NN c-myc_NN oligo_NN (_( 7.5_MC microM_NN )_) exhibited_VVD developmental_JJ arrest_NN at_II the_DD eight-cell_NN /_SYM morula_NN stage_NN ,_, whereas_CS no_DD developmental_JJ arrest_NN occurred_VVD following_VVG incubation_NN with_II high_JJ concentrations_NNS of_II the_DD modified_VVNJ sense_NN complement_NN (_( 30_MC microM_NN )_) ._.
P01288403A05
Many_JJ treatments_NNS have_VHB been_VBN proposed_VVN ,_, but_CC the_DD follow-up_NN is_VBZ often_RR inadequate_JJ ._.
P01293316A08
Empirically_RR ,_, we_PN found_VVD L_NN =_SYM constant.LVW-0.28_NN (_( r_NN =_SYM 0.43_MC ,_, P_NN <_SYM 0.01_MC )_) ._.
P01307725A04
However_RR ,_, in_II the_DD work_NN reported_VVN here_RR ,_, we_PN found_VVD that_CST treatment_NN with_II 2-deoxyglucose_NN (_( 2-DOG_NN )_) irreversibly_RR altered_VVD the_DD cells_NNS :_: when_CS poisoned_VVNJ human_NN neutrophils_NNS were_VBD then_RR permeabilized_VVN ,_, the_DD cells_NNS failed_VVD to_TO degranulate_VVI well_RR in_II response_NN to_II Ca2+_NN ,_, and_CC their_PNG sensitivity_NN to_II Ca2+_NN could_VM not_RR be_VBB recovered_VVN by_II the_DD readdition_NN of_II ATP_NN ._.
P01315770A01
The_DD smg-25A_NN /_SYM rab3A_NN protein_NN (_( smg_NN p25A_NN )_) ,_, a_DD member_NN of_II the_DD small_JJ GTP-binding_VVGJ protein_NN superfamily_NN ,_, has_VHZ a_DD C-terminal_JJ structure_NN of_II Cys-Ala-Cys_NNS which_PNR is_VBZ post-translationally_RR processed_VVN :_: both_DD cysteine_NN residues_NNS are_VBB geranylgeranylated_VVN followed_VVN by_II the_DD carboxyl_NN methylation_NN of_II the_DD C-terminal_JJ cysteine_NN residue_NN ._.
P01319709A07
Our_PNG data_NNS suggest_VVB that_CST the_DD incidence_NN of_II angioedema_NN associated_VVN with_II lisinopril_NN is_VBZ greater_JJR than_CSN that_PND associated_VVN with_II captopril_NN or_CC enalapril_NN ._.
P01331546A01
A_DD prospective_JJ study_NN examining_VVG the_DD incidence_NN of_II dimercaptosuccinic_JJ acid_NN (_( DMSA_NN )_) abnormalities_NNS in_II children_NNS at_II the_DD time_NN of_II acute_JJ urinary_JJ tract_NN infection_NN ,_, the_DD progression_NN of_II these_DD abnormalities_NNS following_VVG treatment_NN and_CC their_PNG correlation_NN with_II the_DD presence_NN of_II vesicoureteral_JJ reflux_NN is_VBZ reported_VVN ._.
P01335473A06
This_PND explains_VVZ the_DD inhibition_NN of_II ACTH-stimulated_VVNJ cortisol_NN synthesis_NN by_II midazolam_NN (_( 50_MC %_SYM inhibitor_NN dose_NN (_( IC50_NN )_) 22_MC mumol_NN /_SYM l_NN )_) ._.
P01344159A04
Effectiveness_NN in_II the_DD therapeutic_JJ intervention_NN on_II ischaemic_JJ injury_NN bore_VVB an_DD inverse_JJ relation_NN with_II the_DD degree_NN of_II PIS_NN or_CC the_DD "_`` risk_NN region_NN "_'' ._.
P01358974A03
To_TO evaluate_VVI the_DD immunogenic_JJ potential_NN of_II IL-2-releasing_VVGJ neoplastic_JJ cells_NNS ,_, we_PN used_VVD an_DD expression_NN vector_NN to_TO introduce_VVI the_DD cDNA_NN coding_VVG for_II murine_JJ IL-2_NN into_II TS_NN /_SYM A_NN cells_NNS ._.
P01369116A01
The_DD introduction_NN of_II new_JJ technology_NN and_CC increased_VVNJ effort_NN from_II around_II the_DD world_NN is_VBZ driving_VVG the_DD completion_NN of_II the_DD human_NN gene_NN map_NN ._.
P01376918A07
The_DD phosphorylatable_JJ serines_NNS detected_VVN by_II the_DD SMI_NN antibodies_NNS are_VBB part_NN of_II Ser-Pro_NN motifs_NNS and_CC can_VM be_VBB phosphorylated_VVN by_II a_DD protein_NN kinase_NN activity_NN that_PNR can_VM be_VBB used_VVN to_TO induce_VVI a_DD paired_VVNJ helical_JJ filament-like_JJ state_NN in_II human_NN brain_NN tau_NN in_RR+ vitro_RR ._.
P01384656A03
Two_MC genes_NNS of_II interest_NN are_VBB localized_VVN near_II the_DD breakpoints_NNS ,_, the_DD transferrin_NN receptor_NN gene_NN and_CC the_DD ETS2_NN proto-oncogene_NN ._.
P01388785A08
She_PN died_VVD with_II sepsis_NN after_II several_JJ viral_JJ and_CC bacterial_JJ infections_NNS ._.
P01402199A03
Three_MC days_NNS later_RR ,_, the_DD perforation_NN of_II noncoronary_JJ sinus_NN of_II Valsalva_NN into_II the_DD right_JJ atrium_NN was_VBD noted_VVN and_CC she_PN developed_VVD progressive_JJ heart_NN failure_NN due_II+ to_II the_DD massive_JJ left-to-right_NN shunt_NN ._.
P01406835A08
The_DD two_MC regimens_NNS produced_VVD comparable_JJ objective_NN responses_NNS ,_, but_CC the_DD regimen_NN including_VVG interferon_NN had_VHD a_DD greater_JJR effect_NN in_II prolonging_VVGN the_DD time_NN to_II treatment_NN failure_NN (_( P_NN <_SYM 0.001_MC )_) and_CC the_DD duration_NN of_II complete_JJ response_NN (_( P_NN =_SYM 0.03_MC )_) ._.
P01416824A01
Teicoplanin_NN was_VBD compared_VVN with_II vancomycin_NN for_II the_DD prophylaxis_NN of_II experimental_JJ Enterococcus_NN faecalis_NN endocarditis_NN in_II rats_NNS ._.
P01421106A05
These_DD and_CC other_DD findings_NNS suggest_VVB that_CST kinetic_JJ compression_NN injuries_NNS of_II the_DD adult_NN spinal_JJ cord_NN can_VM result_VVB in_II regeneration-associated_VVNJ gene_NN expression_NN in_II intrinsic_JJ CNS_NN neurons_NNS ._.
P01434269A02
Most_PND of_II the_DD patients_NNS with_II renal_JJ cell_NN carcinoma_NN in_II the_DD last_JJ 10_MC years_NNS were_VBD examined_VVN in_II Chiba_NNP prefecture_NN ,_, which_PNR has_VHZ a_DD population_NN of_II about_RR five_MC million_MC and_CC 25_MC active_JJ urological_JJ offices_NNS ._.
P01439452A08
In_II patients_NNS treated_VVN with_II streptokinase_NN ,_, the_DD hemorrhage_NN was_VBD probably_RR due_II+ to_II a_DD more_RR than_CSN 80_MC %_SYM decrease_NN in_II plasma_NN fibrinogen_NN ._.
P01448457A08
In_II contrast_NN to_II the_DD effect_NN of_II carbohydrate-rich_JJ meals_NNS ,_, an_DD enteric_JJ augmentation_NN of_II insulin_NN release_NN seems_VVZ to_TO be_VBI of_II minor_JJ and_CC possibly_RR of_II no_DD importance_NN during_II ingestion_NN of_II protein-rich_JJ meals_NNS ._.
P01452940A14
Left_JJ ventricular_JJ diastolic_JJ function_NN assessed_VVN by_II the_DD relaxation_NN time_NN constant_NN was_VBD prolonged_VVN ,_, the_DD peak_JJ filling_VVGJ rate_NN was_VBD decreased_VVN and_CC left_JJ ventricular_JJ stiffness_NN was_VBD increased_VVN in_II the_DD supraventricular_JJ tachycardia_NN group_NN ._.
P01457715A09
The_DD patient_NN died_VVD in_II a_DD few_JJ hours_NNS ,_, with_II the_DD diagnosis_NN of_II hypovolaemic_JJ shock_NN caused_VVN by_II a_DD burst_VVNJ AAA_NN ._.
P01467526A06
Of_II the_DD other_JJ 12_MC patients_NNS (_( all_DD sibling_VVGJ donors_NNS )_) ,_, 11_MC received_VVNJ TBI_NN plus_CC Cy_NN plus_CC another_DD agent_NN :_: VP16_NN ,_, carboplatinum_NN ,_, or_CC AZQ_NN ._.
P01472366A04
Median_JJ survival_NN time_NN with_II respect_NN to_II cancer_NN death_NN was_VBD 18_MC months_NNS in_II the_DD take_JJ group_NN ,_, as_CS compared_VVN with_II over_RR 74_MC months_NNS in_II the_DD non-take_NN group_NN (_( p_NN =_SYM 0.06_MC )_) ._.
P01481504A03
Bradyarrhythmia_NN was_VBD found_VVN to_TO occupy_VVI a_DD major_JJ place_NN in_II the_DD pathogenesis_NN of_II cerebrovascular_JJ disorders_NNS ._.
P01486017A13
Interestingly_RR ,_, the_DD number_NN of_II CRF_NN receptors_NNS are_VBB increased_VVN in_II cortical_JJ areas_NNS of_II Alzheimer_NNP brains_NNS ._.
P01490680A07
Preliminary_JJ data_NNS suggest_VVB release_NN after_II oral_JJ glucose_NN despite_II localization_NN of_II the_DD GLPI_NN containing_VVGJ cells_NNS predominantly_RR in_II the_DD ileum_NN and_CC colon_NN ._.
P01505424A02
Risk_NN behaviours_NNS that_PNR could_VM have_VHB predisposed_VVN him_PN to_II HIV_NN infection_NN are_VBB discussed_VVN ._.
P01514474A04
Proper_JJ positioning_VVGN of_II the_DD patient_NN and_CC placement_NN of_II a_DD unilateral_JJ eye_NN shield_NN are_VBB the_DD first_JJ steps_NNS in_II management_NN ._.
P01523257A04
In_II Experiment_NN 2_MC ,_, injections_NNS of_II either_CC 0_MC ,_, 0.25_MC ,_, or_CC 0.50_MC mg_NN /_SYM kg_NN pimozide_NN were_VBD given_VVN every_DD 12_MC hours_NNS to_II rats_NNS subjected_VVN to_II the_DD activity-stress_NN paradigm_NN ._.
P01536727A03
The_DD two_MC groups_NNS of_II patients_NNS did_VDD not_RR differ_VVB significantly_RR in_II sex_NN distribution_NN ,_, age_NN of_II onset_NN of_II disease_NN ,_, duration_NN of_II disease_NN ,_, number_NN of_II relapses_NNS and_CC histological_JJ findings_NNS ._.
P01541558A09
The_DD association_NN is_VBZ apparently_RR not_RR a_DD classic_JJ antibody-antigen_NN interaction_NN but_CC may_VM result_VVB from_II other_JJ mechanisms_NNS ._.
P01555593A02
Its_PNG fate_NN was_VBD then_RR followed_VVN using_VVG a_DD sensitive_JJ enzyme_NN immunoassay_NN for_II cystatin_NN alpha_NN ._.
P01564746A03
In_II addition_NN ,_, the_DD pretrichial_JJ modification_NN of_II it_PN can_VM be_VBB used_VVN without_II alteration_NN in_II the_DD hairline_NN ._.
P01578842A04
The_DD control_NN group_NN consisted_VVD of_II 35_MC volunteers_NNS whose_PNR ages_NNS ranged_VVD from_II 18_MC to_II 50_MC years_NNS ._.
P01583457A12
Under_II conditions_NNS of_II high_JJ input_NN pressure_NN and_CC high_JJ output_NN pressure_NN ,_, power_NN output_NN increased_VVD by_II 20_MC %_SYM compared_VVN to_II hypoxic_JJ hearts_NNS without_II coronary_JJ perfusion_NN ._.
P01592637A06
The_DD remaining_VVGJ 29_MC patients_NNS were_VBD treated_VVN according_II+ to_II the_DD above_JJ protocol_NN ._.
P01597274A08
A_DD conservative_JJ clinical_JJ haemorrhage_NN control_NN attempt_NN is_VBZ possible_JJ in_II exceptional_JJ cases_NNS only_RR ._.
P01606931A05
By_II Week_NN 4_MC of_II conditioning_VVGN ,_, although_CS the_DD insulin_NN and_CC glucose_NN indices_NNS continued_VVD to_TO decrease_VVI in_II the_DD exercised_VVNJ ponies_NNS ,_, there_EX was_VBD no_DD significant_JJ difference_NN between_II the_DD groups_NNS ._.
P01616444A01
The_DD seminiferous_JJ tubular_JJ compartment_NN of_II the_DD human_NN testis_NN occupies_VVZ about_II two_MC thirds_NNS of_II the_DD volume_NN of_II the_DD organ_NN and_CC is_VBZ supported_VVN by_II loose_JJ connective_JJ tissue_NN containing_VVG the_DD Leydig_NN cells_NNS ._.
P01620907A03
Mean_JJ length_NN of_II postoperative_JJ stay_NN was_VBD extended_VVN from_II 7.8_MC to_II 10.7_MC days_NNS in_II those_PND developing_VVG infection_NN (_( P_NN less_RR than_CSN 0.05_MC )_) ._.
P01625403A06
The_DD average_JJ ages_NNS of_II the_DD sources_NNS ,_, those_PND who_PNR were_VBD infected_VVN secondly_RR and_CC those_PND who_PNR had_VHD given_VVN chemoprophylaxis_NN were_VBD 44.8_MC ,_, 32.2_MC and_CC 7.7_MC years_NNS of_II age_NN respectively_RR ._.
P01630025A07
This_DD case_NN was_VBD of_II interest_NN with_II respect_NN to_II blood_NN cell_NN differentiation_NN and_CC immunological_JJ findings_NNS ._.
P01639726A02
Similar_JJ to_II other_JJ mammals_NNS ,_, the_DD input_NN /_SYM output_NN (_( I_NN /_SYM O_NN )_) functions_NNS of_II 2f1-f2_NN show_VVB non-monotonicities_NNS and_CC notches_NNS at_II f1_NN levels_NNS between_II 40-70_MC dB_NN SPL_NN ._.
P01648117A02
The_DD baseline_NN hormonal_JJ pattern_NN revealed_VVD low_JJ glucocorticoid_NN levels_NNS (_( 17-hydroxyprogesterone_NN ,_, plasma_NN and_CC urinary_JJ cortisol_NN ,_, cortisol_NN secretion_NN rate_NN )_) ,_, as_CC+ well_CC+ as_CC androgen_NN (_( testosterone_NN and_CC dehydroepiandrosterone_NN sulfate_NN )_) and_CC estrogen_NN (_( 17-beta-estradiol_NN )_) levels_NNS ,_, since_CS the_DD defect_NN is_VBZ present_JJ at_II both_CC adrenal_JJ and_CC gonadal_JJ levels_NNS ._.
P01652125A07
Both_CC an_DD elevation_NN of_II ambient_JJ osmolality_NN to_II 600-750_MC mOsm_NN /_SYM kg_NN and_CC disruption_NN of_II the_DD cytoskeleton_NN by_II cytochalasin_NN B_NN (_( 0.1_MC mmol_NN /_SYM l_NN )_) reduce_VVB initial_JJ FITC-albumin_NN uptake_NN by_II 50_MC %_SYM -60_MC %_SYM in_II a_DD non-additive_JJ fashion_NN ._.
P01659998A01
The_DD spin-lattice_NN relaxation_NN of_II the_DD tyrosine_NN radical_NN D._NN in_II Photosystem_NN II_MC particles_NNS was_VBD studied_VVN at_II 4.2_MC K_NN in_II samples_NNS in_II which_PNR flash-induced_VVNJ oscillations_NNS of_II the_DD oxidation_NN state_NN of_II the_DD Mn-cluster_NN of_II the_DD oxygen_NN evolving_VVGJ system_NN were_VBD abolished_VVN by_II addition_NN of_II ANT2P_NN ,_, leaving_VVG Fe2+_NN /_SYM Fe3+_NN oscillations_NNS intact_JJ ._.
P01668590A04
The_DD neurosecretory_JJ structures_NNS were_VBD found_VVN only_RR in_II the_DD caudal_JJ portion_NN ._.
P01679042A05
The_DD heat_NN shock_NN response_NN is_VBZ discussed_VVN with_II regard_NN to_II the_DD possible_JJ importance_NN of_II transcriptional_JJ regulation_NN of_II mycobacterial_JJ genes_NNS in_RR+ vivo_RR ._.
P01692303A01
In_II order_NN to_TO elucidate_VVI the_DD relationship_NN between_II the_DD structure_NN and_CC function_NN of_II proteins_NNS encoded_VVN for_II by_II the_DD Ly-6_NN gene_NN complex_NN ,_, a_DD cDNA_NN was_VBD constructed_VVN for_II a_DD Ly-6.2_NN specificity_NN and_CC then_RR monoclonal_JJ antibodies_NNS (_( mAb_NN )_) generated_VVN to_II bacterially_RR synthesized_VVNJ protein_NN ._.
P01700197A01
Migration_NN of_II microvessel_NN endothelial_JJ cells_NNS (_( MEC_NN )_) in_II response_NN to_II angiogenic_JJ stimuli_NNS is_VBZ a_DD key_JJ aspect_NN of_II angiogenesis_NN ,_, whether_CS in_II physiologic_JJ or_CC pathologic_JJ situations_NNS ._.
P01707938A01
The_DD effect_NN of_II interferons_NNS (_( IFNs_NNS )_) on_II growth_NN inhibition_NN and_CC carcinoembryonic_JJ antigen_NN (_( CEA_NN )_) secretion_NN by_II 14_MC established_VVNJ human_NN colorectal_JJ carcinoma_NN cell_NN lines_NNS was_VBD studied_VVN in_RR+ vitro_RR ._.
P01715895A02
We_PN have_VHB now_RR investigated_VVN the_DD intracellular_JJ mechanisms_NNS involved_VVN in_II RVV-stimulated_VVNJ GH_NN release_NN by_II concomitant_JJ administration_NN of_II RVV_NN with_II known_VVNJ intracellular_JJ mediators_NNS in_II rat_NN pituitary_NN cells_NNS ._.
P01719762A06
This_DD change_NN in_II the_DD levels_NNS of_II CFTR_NN mRNA_NN is_VBZ correlated_VVN with_II the_DD morphological_JJ differentiation_NN that_PNR occurs_VVZ in_II Caco2_NN cells_NNS during_II culture_NN ._.
P01728238A07
There_EX have_VHB been_VBN 51_MC late_JJ deaths_NNS ,_, 45_MC cardiac_JJ ._.
P01737343A03
In_II terms_NNS of_II changing_VVGN the_DD R_NN group_NN ,_, maximum_NN cytotoxic_JJ effects_NNS were_VBD conferred_VVN by_II alicyclic_JJ substituents_NNS ._.
P01746895A02
TAG-72_NN was_VBD detected_VVN in_II the_DD serum_NN of_II a_DD significant_JJ percentage_NN of_II patients_NNS whose_PNR CEA_NN levels_NNS were_VBD negative_JJ which_PNR underscores_VVZ the_DD possibility_NN of_II exploiting_VVGN the_DD complementarity_NN of_II the_DD two_MC tumor_NN markers_NNS in_II the_DD diagnosis_NN of_II gastrointestinal_JJ (_( G.I._NN )_) carcinoma_NN ._.
P01756258A01
Deregulated_VVNJ expression_NN of_II the_DD RAS_NN oncogene_NN is_VBZ associated_VVN with_II tumorigenic_JJ transformation_NN of_II mammary_JJ cells_NNS ._.
P01760749A05
On_II a_DD given_VVNJ day_NN ,_, an_DD animal_NN was_VBD infused_VVN with_II methylphenidate_NN ,_, tyrosine_NN ,_, or_CC methylphenidate_NN plus_CC tyrosine_NN ._.
P01765260A09
Intercrosses_NNS of_II heterozygous_JJ females_NNS and_CC hemizygous_JJ males_NNS yielded_VVD 5.5_MC %_SYM aneuploidy_NN for_II Rb_NN (_( X.2_NN )_) 2Ad_NN and_CC 5.4_MC %_SYM for_II Rb_NN (_( X.9_NN )_) 6H_NN ._.
P01783790A04
The_DD older_JJR women_NNS were_VBD more_RR interested_VVN in_II educating_VVGN their_PNG children_NNS ._.
P01793488A08
The_DD resulting_VVGJ cell_NN lines_NNS (_( UV5P1_NN ,_, 5P1R1_NN ,_, and_CC 5P1R3_NN )_) expressed_VVD arylhydrocarbon_NN hydroxylase_NN activity_NN ._.
P01798278A09
Thus_RR ,_, active_JJ O2_NN species_NNS may_VM contribute_VVB to_II vascular_JJ responses_NNS in_II pathophysiological_JJ situations_NNS associated_VVN with_II their_PNG formation_NN (_( e.g._II inflammation_NN ,_, ischemia_NN /_SYM reperfusion_NN ,_, etc._NN )_) and_CC to_II the_DD physiological_JJ regulation_NN of_II vascular_JJ tone_NN produced_VVN by_II changes_NNS in_II O2_NN tension_NN (_( e.g._II reactive_JJ hyperemia_NN ,_, hypoxic_JJ vasoconstriction_NN ,_, etc_NN )_) ._.
P01812676A03
More_RR frequently_RR ,_, however_RR ,_, the_DD behavior_NN is_VBZ associated_VVN with_II additional_JJ behavior_NN problems_NNS or_CC is_VBZ part_NN of_II other_JJ psychopathological_JJ syndromes_NNS ,_, e.g._II conduct_NN disorder_NN ._.
P01822479A02
This_DD article_NN addresses_VVZ the_DD health_NN problems_NNS and_CC care_NN needs_NNS of_II young_JJ children_NNS in_II American_JJ cities_NNS and_CC summarizes_VVZ the_DD nursing_VVGJ knowledge_NN and_CC skills_NNS needed_VVN for_II urban_JJ nursing_VVGJ practice_NN ._.
P01831450A06
These_DD results_NNS demonstrate_VVB advantages_NNS of_II oscillatory_JJ behavior_NN of_II glycolysis_NN in_II the_DD regulation_NN of_II carbohydrate_NN utilization_NN and_CC the_DD maintenance_NN of_II a_DD high_JJ [_( ATP_NN ]_) /_SYM [_( ADP_NN ]_) ratio_NN ._.
P01848936A01
Treatment_NN of_II splenic_JJ leukocytes_NNS from_II Cornell_NN K_NN strain_NN male_NN chickens_NNS (_( homozygous_JJ at_II the_DD B15_NN locus_NN of_II the_DD major_JJ histocompatibility_NN complex_NN )_) with_II ovine_JJ corticotropin-releasing_VVGJ factor_NN (_( oCRF_NN )_) ,_, before_II their_PNG co-incubation_NN with_II naive_JJ chicken_NN adrenal_JJ cells_NNS ,_, resulted_VVD in_II an_DD increase_NN in_II corticosterone_NN production_NN ._.
P01858031A06
When_CS cyclooxygenase_NN blockade_NN with_II indomethacin_NN completely_RR prevented_VVD KC_NN production_NN of_II PGE2_NN in_II (_( -_SYM )_) arginine_NN culture_NN ,_, TNF-alpha_NN production_NN was_VBD upregulated_VVN (_( p_NN less_RR than_CSN 0.001_MC vs_CC (_( -_SYM )_) arginine_NN ;_: p_NN not_RR significant_JJ vs_CC (_( +_SYM )_) arginine_NN )_) ._.
P01867839A08
This_PND indicates_VVZ that_CST the_DD timing_VVGN of_II allowed_VVNJ sleep_NN has_VHZ less_PND of_II an_DD immediate_JJ effect_NN on_II circadian_JJ rhythms_NNS than_CSN the_DD timing_VVGN of_II the_DD external_JJ light-dark_NN cycle_NN ._.
P01881968A02
Beginning_VVG 7_MC to_II 10_MC weeks_NNS after_II the_DD start_NN of_II cohabitation_NN ,_, each_DD female_NN was_VBD tested_VVN for_II aggression_NN toward_II an_DD unfamiliar_JJ female_NN at_II weekly_RR intervals_NNS for_II 3_MC weeks_NNS ._.
P01891364A05
Methylation_NN interference_NN experiments_NNS were_VBD used_VVN to_TO identify_VVI purine_NN residues_NNS involved_VVN in_II this_DD protein-DNA_NN interaction_NN ._.
P01900481A04
Luteinizing_VVGJ hormone_NN (_( LH_NN )_) concentrations_NNS remained_VVD suppressed_VVN ._.
P01909013A05
An_DD additional_JJ eight_MC cases_NNS manifested_VVD otitis_NN media_NNS or_CC eustachian_JJ tube_NN dysfunction_NN ._.
P01917874A07
Our_PNG results_NNS provide_VVB support_NN for_II the_DD existence_NN of_II a_DD cellular_JJ repressor_NN in_II B._NN subtilis_NN that_PNR is_VBZ functionally_RR homologous_JJ to_II the_DD E._NN coli_NN LexA_NN repressor_NN and_CC suggest_VVB that_CST the_DD mechanism_NN by_II which_PNR B._NN subtilis_NN RecA_NN protein_NN (_( like_II RecA_NN of_II E._NN coli_NN )_) becomes_VVZ activated_VVN to_TO promote_VVI the_DD induction_NN of_II the_DD SOS_NN response_NN is_VBZ also_RR conserved_VVN ._.
P01927617A07
Long_JJ term_NN results_NNS are_VBB analyzed_VVN as_RR+ well_RR ._.
P01940987A02
Contrast-enhanced_VVNJ T1-weighted_VVNJ MRI_NN revealed_VVD the_DD characteristic_JJ basal_JJ meningeal_JJ inflammation_NN of_II TbM_NN and_CC its_PNG focal_JJ spreading_VVGN into_II adjacent_JJ brain_NN ._.
P01945815A08
Trauma_NN in_II the_DD maxillary_JJ region_NN have_VHB caused_VVN fracture_NN of_II the_DD implants_NNS in_II 5_MC patients_NNS ._.
P01960280A03
Thresholds_NNS were_VBD estimated_VVN using_VVG two_MC different_JJ adaptive_JJ procedures_NNS and_CC the_DD method_NN of_II constant_JJ stimuli_NNS ._.
P01965027A03
While_CS 204_MC children_NNS presented_VVD gastrointestinal_JJ symptoms_NNS with_II diarrhoea_NN ,_, 12_MC had_VHD subclinical_JJ signs_NNS ,_, 26_MC presented_VVD only_RR respiratory_JJ symptoms_NNS and_CC 22_MC had_VHD no_DD clinical_JJ symptomatology_NN ._.
P01974569A02
TIL_NN were_VBD produced_VVN by_II culturing_VVGN Thy-1-enriched_VVNJ single_JJ cell_NN suspensions_NNS from_II a_DD variety_NN of_II murine_JJ tumors_NNS in_II exogenous_JJ IL-2_NN along_RR with_II irradiated_VVNJ tumor_NN cells_NNS and_CC splenocytes_NNS ._.
P01984233A04
We_PN prospectively_RR studied_VVD 55_MC insulin-dependent_JJ diabetic_JJ patients_NNS enrolled_VVN before_II 9_MC weeks_NNS '_GE gestation_NN through_II two_MC consecutive_JJ pregnancies_NNS :_: sequence_NN 1_MC and_CC sequence_NN 2_MC ._.
P01988764A08
A_DD comprehensive_JJ individualized_VVNJ treatment_NN program_NN is_VBZ often_RR required_VVN in_II the_DD care_NN of_II individuals_NNS with_II tic_NN disorders_NNS ._.
P01998718A07
N-Bromosuccinimide_NN treatment_NN for_II modification_NN of_II tryptophan_NN residues_NNS caused_VVD a_DD loss_NN of_II the_DD activity_NN ,_, although_CS the_DD inhibitory_JJ sugar_NN exhibited_VVD no_DD protective_JJ effect_NN against_II this_DD treatment_NN ._.
P02003809A05
It_PN is_VBZ ,_, however_RR ,_, one_MC simple_JJ but_CC effective_JJ approach_NN ,_, and_CC is_VBZ available_JJ to_II any_DD GP_NN ._.
P02017712A01
A_DD complete_JJ and_CC comprehensive_JJ assessment_NN is_VBZ the_DD first_JJ step_NN towards_II rational_JJ management_NN of_II the_DD elderly_JJ patient_NN ._.
P02032225A06
Addition_NN of_II 1_MC ,_, 25_MC (_( OH_NN )_) 2D3_NN to_II the_DD platinum_NN resulted_VVD in_II marginal_JJ to_II marked_VVNJ enhancement_NN of_II growth_NN inhibition_NN over_II that_PND observed_VVN with_II either_DD platinum_NN alone_JJ ._.
P02046848A01
SEP_NN (_( somatosensory_JJ evoked_VVNJ potential_NN )_) monitoring_VVGN was_VBD carried_VVN out_II on_II seven_MC patients_NNS with_II vertebro-basilar_JJ aneurysms_NNS during_II balloon_NN occlusion_NN test_NN ,_, during_II operation_NN ,_, or_CC after_II operation_NN ._.
P02051572A06
In_II the_DD 6_MC mg.kg-1_NN group_NN ,_, mean_NN arterial_JJ pressure_NN ,_, heart_NN rate_NN and_CC cardiac_JJ index_NN decreased_VVD significantly_RR ,_, but_CC no_DD significant_JJ changes_NNS in_II cardiac_JJ variables_NNS were_VBD observed_VVN in_II the_DD 2_MC mg.kg-1_NN group_NN ._.
P02060914A02
The_DD project_NN incorporated_VVD cooperative_JJ arrangements_NNS between_II the_DD mental_JJ health_NN system_NN and_CC vocational_JJ rehabilitation_NN and_CC occupational_JJ education_NN agencies_NNS ._.
P02070492A05
Analysis_NN of_II polydG*polydC_NN revealed_VVD a_DD similar_JJ adduct_NN pattern_NN to_II that_PND obtained_VVN with_II lucidin-modified_VVNJ DNA_NN ._.
P02085108A01
Test_NN measures_NNS of_II field-dependence-independence_NN and_CC impulsiveness-control_NN were_VBD obtained_VVN from_II two_MC groups_NNS of_II diabetic_JJ children_NNS and_CC their_PNG parents_NNS ,_, the_DD children_NNS being_VBG in_II optimal_JJ (_( O_NN ,_, n_NN =_SYM 12_MC )_) or_CC poor_JJ (_( P._NN n_NN =_SYM 27_MC )_) metabolic_JJ control_NN and_CC ,_, according_II+ to_II the_DD judgment_NN of_II clinicians_NNS ,_, showing_VVG optimal_JJ or_CC poor_JJ psychological_JJ adaptation_NN ._.
P02089961A09
The_DD altered_VVNJ distributions_NNS of_II these_DD metals_NNS suggested_VVD tissue_NN injury_NN and_CC impairment_NN of_II red_JJ cell_NN and_CC vessel_NN wall_NN functions_NNS ._.
P02104950A06
The_DD importance_NN of_II quality_NN as_CC+ well_CC+ as_CC length_NN of_II life_NN as_II health_NN outcomes_NNS has_VHZ led_VVN to_II the_DD development_NN of_II cost-utility_NN analysis_NN ._.
P02114041A07
These_DD data_NNS show_VVB that_CST early_JJ after_II start_NN of_II treatment_NN the_DD proportion_NN of_II tumor_NN cells_NNS remains_VVZ constant_NN in_II contrast_NN to_II radiation_NN alone_JJ where_PNR the_DD fraction_NN of_II tumor_NN cells_NNS decreases_VVZ because_II+ of_II influx_NN of_II granulocytes_NNS and_CC macrophages_NNS into_II the_DD tumor_NN ._.
P02123079A03
Six_MC patients_NNS relapsed_VVD during_II follow-up_NN ,_, all_PND of_II whom_PNR had_VHD been_VBN sober_JJ less_RR than_CSN 5_MC years_NNS ._.
P02132188A09
Alterations_NNS in_II BBM_NN lipid_NN composition_NN may_VM be_VBB related_VVN to_II the_DD enhanced_VVNJ permeability_NN to_II glucose_NN in_II animals_NNS fed_VVN S_NN ,_, while_CS the_DD similarity_NN of_II BBM_NN fatty_JJ acid_NN composition_NN in_II diabetic_JJ and_CC control_NN animals_NNS fed_VVN P_NN may_VM be_VBB related_VVN to_II the_DD similar_JJ glucose_NN uptake_NN ._.
P02145207A02
The_DD agarose_NN technique_NN and_CC electrophoresis_NN on_II cellulose-acetate_NN foil_NN methods_NNS were_VBD chosen_VVN because_CS a_DD small_JJ quantity_NN of_II the_DD maternal_NN available_JJ for_II examination_NN ._.
P02157914A02
Radioligand_NN binding_VVGJ assay_NN using_VVG 3H-prazosin_NN as_II an_DD alpha_NN 1-adrenoceptor_NN ligand_NN and_CC 3H-yohimbine_NN as_II an_DD alpha_NN 2-adrenoceptor_NN ligand_NN ,_, clearly_RR demonstrated_VVD alpha_NN 1_MC and_CC alpha_NN 2_MC receptors_NNS present_JJ in_II both_CC rat_NN and_CC human_NN adrenal_JJ gland_NN membranes_NNS ._.
P02161814A06
Furthermore_RR ,_, double-labeling_VVGJ studies_NNS combining_VVG in_JJ+ situ_JJ hybridization_NN and_CC immunocytochemistry_NN using_VVG CD30_NN (_( BerH2_NN )_) and_CC CD15_NN (_( LeuM1_NN )_) as_II markers_NNS of_II RS_NN cells_NNS ,_, as_CC+ well_CC+ as_CC pan_NN B-marker_NN (_( L26_NN )_) and_CC pan_NN T-marker_NN ,_, CD45RO_NN (_( UCHL1_NN )_) ,_, were_VBD performed_VVN to_TO demonstrate_VVI the_DD phenotype_NN of_II EBV_NN DNA-positive_JJ cells_NNS ,_, confirming_VVG that_CST EBV_NN DNA_NN was_VBD present_JJ in_II RS_NN cells_NNS but_CC not_RR in_II lymphocytes_NNS ._.
P02173930A03
The_DD replicative_JJ form_NN of_II polyoma_NN DNA_NN sequences_NNS was_VBD observed_VVN in_II SEWA_NN tumors_NNS grown_VVN in_II ascites_NN fluids_NNS but_CC not_RR in_II cells_NNS maintained_VVN as_II solid_JJ tumors_NNS ._.
P02182667A02
Isolates_NNS were_VBD identified_VVN by_II serogrouping_VVGN or_CC as_II enterotoxigenic_JJ E._NN coli_NN (_( ETEC_NN )_) ,_, enteroinvasive_JJ E._NN coli_NN (_( EIEC_NN )_) ,_, enteropathogenic_JJ E._NN coli_NN (_( EPEC_NN )_) adhesin_NN factor_NN (_( EAF_NN )_) E._NN coli_NN ,_, or_CC Shiga-like-toxin_NN (_( SLT_NN )_) -producing_VVGJ E._NN coli_NN by_II DNA_NN hybridization_NN ._.
P02187410A07
The_DD dot_NN blot_NN technique_NN yielded_VVD results_NNS within_II 48_MC h_NN and_CC can_VM be_VBB used_VVN as_II a_DD fast_JJ and_CC sensitive_JJ method_NN of_II detection_NN for_II SLTEC_NN in_II foods_NNS and_CC calf_NN fecal_JJ samples_NNS ._.
P02196946A07
Subjects_NNS were_VBD excluded_VVN if_CS they_PN had_VHD damaged_VVNJ target_NN organs_NNS ,_, secondary_JJ hypertension_NN ,_, diabetes_NN mellitus_NN ,_, a_DD cholesterol_NN concentration_NN greater_JJR than_CSN 8_MC mmol_NN /_SYM l_NN ,_, or_CC a_DD history_NN of_II malignant_JJ hypertension_NN ._.
P02201903A04
Maintenance_NN of_II M1_NN and_CC M2_NN is_VBZ dependent_JJ on_II the_DD presence_NN of_II LA_NN ,_, which_PNR provides_VVZ capsid_NN and_CC cap-pol_NN for_II M_NN dsRNA_NN maintenance_NN ._.
P02211417A02
Steers_NNS (_( 530_MC kg_NN )_) were_VBD fed_VVN a_DD 50_MC :_: 50_MC roughage_NN :_: concentrate_NN diet_NN at_II 1.5_MC times_II their_PNG NEm_NN requirement_NN ._.
P02221412A06
We_PN suggest_VVB that_CST preoxygenation_NN with_II 3-min_NN breathing_VVGN of_II 100_MC %_SYM O2_NN offers_VVZ more_DD protection_NN against_II hypoxia_NN due_II+ to_II prolonged_VVNJ apnea_NN after_II induction_NN of_II anesthesia_NN in_II the_DD elderly_NN than_CSN does_VDZ four_MC maximal_JJ breaths_NNS of_II 100_MC %_SYM O2_NN ._.
P02235912A01
A_DD rapid_JJ and_CC reliable_JJ method_NN for_II the_DD purification_NN of_II rat_NN liver_NN glucokinase_NN was_VBD developed_VVN ._.
P02245618A06
Comparing_VVG mean_NN differences_NNS ,_, Qsp_NN /_SYM Qt_NN 1_MC was_VBD significantly_RR different_JJ only_RR from_II Qsp_NN /_SYM Qt_NN 3_MC (_( p_NN less_RR than_CSN .01_MC )_) ._.
P02254843A04
A_DD significant_JJ negative_JJ relationship_NN existed_VVD between_II the_DD amount_NN of_II information_NN received_VVN about_II sex_NN and_CC the_DD experience_NN of_II a_DD pregnancy_NN before_II age_NN 18_MC years_NNS among_II the_DD sample_NN group_NN mothers_NNS only_RR ._.
P02264205A04
It_PN was_VBD found_VVN that_CST in_II group_NN 1_MC patients_NNS the_DD indices_NNS of_II central_JJ (_( mean_NN arterial_JJ pressure_NN ,_, cardiac_JJ and_CC stroke_NN indices_NNS ,_, total_JJ peripheral_JJ vascular_JJ resistance_NN ,_, work_NN of_II the_DD left_JJ ventricle_NN )_) and_CC intracardiac_JJ (_( time_NN of_II circulation_NN of_II blood_NN in_II the_DD heart_NN cavities_NNS and_CC lungs_NNS )_) hemodynamics_NNS were_VBD on_II the_DD upper_JJ normal_JJ values_NNS and_CC in_II occasional_JJ cases_NNS exceeded_VVD it_PN ._.
P02273434A01
A_DD case_NN is_VBZ presented_VVN in_II which_PNR the_DD Nd_NN :_: YAG_NN laser_NN obviated_VVD the_DD need_NN for_II a_DD major_JJ thoracic_JJ procedure_NN ._.
P02283534A05
Rapid_JJ reduction_NN of_II contraction-induced_VVNJ autogenetic_JJ inhibition_NN was_VBD also_RR observed_VVN in_II homonymous_JJ gamma-motoneurons_NNS ._.
P02293226A04
GS_NN also_RR plays_VVZ a_DD role_NN in_II the_DD NKC-IFN-IL-2_NN regulatory_JJ system_NN ,_, inhibits_VVZ the_DD growth_NN of_II tumor_NN cells_NNS ,_, and_CC antagonizes_VVZ the_DD suppression_NN of_II ADCC_NN and_CC NK_NN cytotoxicities_NNS in_II mice_NNS with_II surgical_JJ stress_NN ._.
P02302758A06
For_II HOEtNU_NN O6-_NN (_( 2-hydroxyethyl_NN )_) guanine_NN was_VBD found_VVN to_TO be_VBI 63_MC %_SYM of_II N-7-_NN (_( 2-hydroxyethyl_NN )_) guanine_NN ._.
P02307370A06
In_II contrast_NN to_II the_DD binding_VVGJ data_NNS ,_, no_DD cross_NN activation_NN of_II transcription_NN is_VBZ detectable_JJ in_II cultured_VVNJ cell_NN lines_NNS ._.
P02317180A06
Our_PNG study_NN suggests_VVZ that_CST tympanometry_NN can_VM be_VBB a_DD valuable_JJ tool_NN in_II managing_VVGN aerotitis_NN media_NN in_II the_DD aeromedical_JJ environment_NN ._.
P02326692A01
Spines_NNS from_II 832_MC deceased_VVNJ patients_NNS with_II a_DD terminal_JJ diagnosis_NN of_II malignant_JJ neoplasm_NN were_VBD examined_VVN grossly_RR ,_, microscopically_RR and_CC radiographically_RR for_II evidence_NN of_II tumor_NN ._.
P02335845A01
Exercise_NN electrocardiography_NN with_II or_CC without_II thallium-201_NN scintigraphy_NN was_VBD performed_VVN (_( pre-hospital_NN discharge_NN )_) in_II 66_MC asymptomatic_JJ survivors_NNS of_II a_DD first_JJ inferior_JJ myocardial_JJ infarction_NN (_( IMI_NN )_) ._.
P02340488A07
Careful_JJ cytological_JJ review_NN of_II 51_MC patients_NNS with_II MDS_NN or_CC ANLL_NN and_CC various_JJ cytogenetic_JJ anomalies_NNS was_VBD performed_VVN for_II comparison_NN :_: vacuolated_VVNJ granulocytes_NNS were_VBD a_DD very_JJ uncommon_JJ finding_VVGN ._.
P02349957A03
The_DD interstitial_JJ fibrosis_NN was_VBD proven_VVN to_TO be_VBI the_DD most_RRT important_JJ morphological_JJ parameter_NN ,_, and_CC the_DD most_RRT important_JJ clinical_JJ parameters_NNS were_VBD the_DD serum_NN creatinine_NN concentration_NN and_CC the_DD creatinine_NN clearance_NN ._.
P02364285A01
We_PN studied_VVD whether_CST plasticity-induced_VVNJ callosal_JJ transfer_NN exists_VVZ after_II the_DD critical_JJ period_NN for_II sensitivity_NN of_II visual_JJ cortex_NN cells_NNS in_II kittens_NNS postnatally_RR monocularly_RR deprived_VVN and_CC in_II which_PNR interocular_JJ competition_NN was_VBD cancelled_VVN by_II chiasm_NN transection_NN during_II adulthood_NN ._.
P02369120A05
The_DD 1H_NN assignments_NNS for_II tobramycin_NN are_VBB similar_JJ to_II those_PND previously_RR reported_VVN for_II rings_NNS I_MC and_CC III_MC of_II kanamycin_NN A_NN ._.
P02374058A08
The_DD 6_MC rabbits_NNS (_( 12_MC TMJs_NNS )_) demonstrated_VVD consistent_JJ microvascular_JJ differences_NNS ._.
P02383817A06
Levels_NNS of_II physical_JJ activity_NN during_II leisure_NN time_NN of_II the_DD injured_VVNJ pupils_NNS were_VBD related_VVN to_II activity_NN levels_NNS in_II the_DD whole_JJ population_NN ._.
P02393587A08
Group_NN 2_MC included_VVD patients_NNS with_II ventricular_JJ tachycardia_NN of_II noncoronary_JJ genesis_NN ._.
P02398235A07
A_DD summary_NN score_NN (_( number_NN of_II individual_JJ game_NN scores_NNS above_II the_DD 95th_JJ percentile_NN )_) of_II 4_MC or_CC more_PND detected_VVD 60_MC %_SYM of_II hyperactive_JJ subjects_NNS with_II a_DD false_JJ positive_NN rate_NN of_II 5_MC %_SYM ._.
P02411925A06
In_II the_DD animals_NNS with_II adhesions_NNS adhesiolysis_NN was_VBD performed_VVN and_CC 6_MC %_SYM dextran_NN 70_MC or_CC saline_NN was_VBD left_VVN in_II the_DD peritoneal_JJ cavity_NN ._.
P02420715A05
This_DD conductance_NN was_VBD abrogated_VVN upon_II disaggregating_VVGN the_DD complexes_NNS with_II a_DD monovalent_JJ hapten_NN (_( epsilon-N-DNP-L-lysine_NN )_) ._.
P02429497A01
The_DD frequency_NN of_II occurrence_NN of_II the_DD adrenergic_JJ ,_, cholinergic_JJ ,_, 5-hydroxytryptamine_NN (_( 5-HT_NN )_) -_SYM ,_, substance_NN P_NN (_( SP_NN )_) -_SYM ,_, methionine-enkephalin_NN (_( met-Enk_NN )_) -_: and_CC somatostatin_NN (_( SOM_NN )_) -immunoreactive_JJ fibres_NNS innervating_VVG the_DD smooth_JJ muscle_NN of_II the_DD large_JJ intestine_NN in_II Hirschsprung_NN and_CC control_NN children_NNS was_VBD compared_VVN ._.
P02433793A08
Although_CS no_DD significant_JJ decrease_NN in_II myocardial_JJ ATP_NN took_VVD place_NN ,_, 31_MC of_II 38_MC patients_NNS needed_VVD inotropic_JJ support_NN to_TO wean_VVI them_PN off_II bypass_NN ._.
P02442509A10
The_DD most_RRT common_JJ adverse_JJ effects_NNS are_VBB those_PND expected_VVN from_II a_DD potent_JJ arteriolar_JJ dilator_NN :_: ankle_NN swelling_VVGN ,_, headache_NN ,_, dizziness_NN ,_, flushing_VVGN ,_, etc_NN ._.
P02446859A11
No_DB such_DD lesions_NNS were_VBD present_JJ among_II control_NN rats_NNS ._.
P02455592A03
All_DD three_MC interferons_NNS have_VHB direct_JJ antitumor_NN activity_NN in_RR+ vivo_RR for_II 38C13_NN lymphoma_NN at_II high_JJ doses_NNS ;_: however_RR ,_, none_MC of_II these_DD interferons_NNS has_VHZ independent_JJ antitumor_NN activity_NN for_II SL2_NN in_RR+ vivo_RR ._.
P02459828A07
Addition_NN of_II histamine_NN (_( 10_MC (_( -6_MC )_) -10_MC (_( -5_MC )_) M_NN )_) induced_VVD an_DD increase_NN in_II the_DD frequency_NN of_II contractions_NNS and_CC enhanced_VVD the_DD basal_JJ tone_NN particularly_RR in_II human_NN samples_NNS ._.
P02468677A07
This_DD intercellular_JJ contact-dependent_JJ depolarization_NN (_( ICDD_NN )_) was_VBD unaffected_VVN by_II valinomycin_NN ;_: it_PN was_VBD abolished_VVN by_II substituting_VVGN Na+_NN in_II the_DD external_JJ medium_NN with_II a_DD nondiffusible_JJ cation_NN (_( choline_NN )_) ,_, which_PNR shows_VVZ that_CST ICDD_NN was_VBD sustained_VVN by_II Na+_NN influxes_NNS ,_, probably_RR mediated_VVN by_II stretch-activated_VVNJ (_( s.a._NN )_) cation_NN channels_NNS ._.
P02476870A05
Specific_JJ in_JJ+ vivo_JJ T-lymphocyte_NN subpopulation_NN depletion_NN was_VBD accomplished_VVN by_II multiple_JJ intraperitoneal_JJ administrations_NNS of_II cytotoxic_JJ monoclonal_JJ antibodies_NNS to_II mice_NNS prior_II+ to_II and_CC following_VVG BLM_NN administration_NN ._.
P02480823A09
The_DD variations_NNS observed_VVN with_II pH_NN and_CC ionic_JJ strength_NN can_VM be_VBB primarily_RR attributed_VVN to_II screened_VVNJ coulombic_JJ interactions_NNS ._.
P02489642A07
The_DD glycosaminoglycan_NN chains_NNS after_II chondroitinase_NN AC_NN II_MC hydrolysis_NN were_VBD seen_VVN on_II gel_NN as_II polydispersed_VVNJ ,_, broad_JJ alcian_NN blue_JJ staining_VVGJ material_NN (_( Mr_NN =_SYM 20,000-60,000_MC dalton_NN )_) while_CS chains_NNS were_VBD totally_RR hydrolyzed_VVN by_II chondroitinase_NN ABC_NN ._.
P02499460A02
The_DD patients_NNS were_VBD 52_MC men_NNS who_PNR had_VHD sustained_VVD a_DD myocardial_JJ infarction_NN at_II an_DD age_NN of_II 50_MC years_NNS or_CC less_PND and_CC the_DD controls_NNS ,_, selected_VVN from_II a_DD random_JJ population_NN sample_NN ,_, were_VBD matched_VVN to_II the_DD patients_NNS for_II age_NN and_CC sex_NN ._.
P02508498A06
Arginine_NN vasopressin_NN (_( AVP_NN )_) rose_VVD from_II base_NN line_NN after_II HS_NN (_( P_NN =_SYM 0.11_MC vehicle_NN experiments_NNS ,_, P_NN =_SYM 0.04_MC cortisol_NN experiments_NNS )_) ,_, and_CC AVP_NN responses_NNS were_VBD greater_JJR in_II the_DD cortisol_NN experiments_NNS than_CSN in_II the_DD vehicle_NN experiments_NNS (_( delta_NN AVP_NN =_SYM 21.9_MC +/-_SYM 10.9_MC vs._CC 3.1_MC +/-_SYM 0.9_MC pg_NN /_SYM ml_NN ,_, P_NN =_SYM 0.05_MC )_) ._.
P02517998A02
It_PN is_VBZ administered_VVN by_II the_DD South_NN African_JJ Association_NN of_II Retail_NN Pharmacists_NNS ,_, and_CC directed_VVN at_II all_DD segments_NNS of_II the_DD population_NN ,_, with_II the_DD aim_NN of_II promoting_VVGN a_DD drug-abuse_NN free_JJ society_NN ._.
P02531658A04
U1_NN A_NN protein_NN can_VM also_RR bind_VVB the_DD loop_NN sequence_NN when_CS it_PN is_VBZ part_NN of_II an_DD artificial_JJ RNA_NN which_PNR can_VM not_RR form_VVB a_DD stable_JJ hairpin_NN structure_NN ._.
P02540050A04
In_II order_NN to_TO evaluate_VVI the_DD effect_NN of_II enalapril_NN on_II sympathetic_JJ stimulation_NN 10_MC mild_JJ to_II moderate_JJ hypertensive_JJ patients_NNS were_VBD studied_VVN during_II static_JJ (_( hand_NN grip_NN )_) and_CC dynamic_JJ exercise_NN (_( bicycle_NN ergometer_NN )_) ,_, after_CS 2_MC weeks_NNS of_II placebo_NN and_CC after_II 1_MC month_NN of_II treatment_NN with_II 20-40_MC mg_NN enalapril_NN once_RR daily_RR ._.
P02543984A10
The_DD results_NNS provide_VVB direct_JJ ,_, in_JJ+ vivo_JJ evidence_NN to_TO support_VVI the_DD hypothesis_NN that_CST reactive_JJ oxygen_NN metabolites_NNS play_VVB a_DD causal_JJ role_NN in_II the_DD myocardial_JJ "_`` stunning_VVGN "_'' seen_VVN after_II brief_JJ ischemia_NN ._.
P02555701A07
Analysis_NN of_II a_DD variety_NN of_II E5_NN missense_NN mutants_NNS revealed_VVD a_DD strong_JJ correlation_NN between_II their_PNG phenotypes_NNS in_II the_DD acute_JJ transformation_NN assays_NNS following_VVG infection_NN and_CC in_II the_DD stable_JJ focus-forming_VVGJ assay_NN following_VVG transfection_NN ._.
P02564792A04
Furthermore_RR ,_, we_PN found_VVD no_DD de_JJ+ novo_JJ methylation_NN in_II this_DD region_NN ._.
P02569540A12
Serotonin_NN was_VBD the_DD only_RR transmitter_NN identified_VVN in_II cultured_VVNJ but_CC not_RR in_II freshly_RR dissociated_VVNJ cells_NNS ._.
P02578927A03
The_DD lumbar_JJ response_NN was_VBD abnormal_JJ in_II 2.95_MC %_SYM of_II legs_NNS ,_, while_CS the_DD Erb_NN response_NN was_VBD always_RR within_II normal_JJ limits_NNS ._.
P02583119A07
Insertion_NN of_II a_DD spacer_NN between_II TATAAATA_NN and_CC the_DD cap_NN site_NN resulted_VVD in_II accumulation_NN of_II U2_NN RNA_NN with_II an_DD extended_VVNJ 5_MC '_SYM end_NN ,_, indicating_VVG that_CST the_DD TATAAATA_NN element_NN is_VBZ responsible_JJ for_II selection_NN of_II the_DD initiation_NN site_NN ._.
P02597857A01
A_DD family_NN study_NN was_VBD carried_VVN out_II in_II two_MC groups_NNS of_II patients_NNS fulfilling_VVG RDC_NN for_II schizoaffective_JJ disorder_NN :_: in_II one_MC ,_, a_DD full_JJ affective_JJ and_CC a_DD full_JJ schizophrenic_JJ syndrome_NN were_VBD simultaneously_RR present_JJ ;_: in_II the_DD other_PN ,_, affective_JJ and_CC schizophrenic_JJ features_NNS appeared_VVD within_II a_DD polymorphic_JJ and_CC rapidly_RR changing_VVGJ clinical_JJ picture_NN ,_, with_II depersonalization_NN /_SYM derealization_NN and/or_CC confusion_NN ._.
P02607648A07
The_DD further_JJ analysis_NN of_II C-AP_NN using_VVG this_DD method_NN would_VM promise_VVB the_DD establishment_NN of_II clinical_JJ assessment_NN of_II the_DD enzyme_NN ._.
P02621564A02
One_MC is_VBZ a_DD self-emulsifying_VVGJ type_NN ,_, and_CC the_DD other_PN is_VBZ an_DD oil_NN dispersing_VVGJ type_NN ._.
P02631814A03
The_DD reason_NN for_II this_DD episode_NN was_VBD detected_VVN through_II imaging_VVGJ techniques_NNS --_: echocardiography_NN and_CC isotopic_JJ studies_NNS ,_, and_CC consisted_VVD on_II infarct_NN expansion_NN with_II early_JJ evolution_NN for_II apical_JJ aneurysm_NN ._.
P02641810A01
A_DD retrospective_JJ analysis_NN of_II survival_NN time_NN was_VBD carried_VVN out_II in_II 29_MC progressive_JJ systemic_JJ sclerosis_NN patients_NNS treated_VVN with_II immunosuppressive_JJ drugs_NNS and_CC in_II 15_MC patients_NNS who_PNR underwent_VVD another_DD mode_NN of_II treatment_NN ._.
P02651209A04
The_DD staining_VVGJ intensity_NN ,_, cytoplasmic_JJ granulations_NNS ,_, and_CC length_NN of_II hypophysial_JJ gonadotrophs_NNS (_( B2_NN cells_NNS )_) were_VBD increased_VVN (_( P_NN less_RR than_CSN 0.05_MC )_) due_II+ to_II LHRH_NN treatment_NN ._.
P02656541A06
Seventy-two_MC percent_NN of_II the_DD patients_NNS entered_VVN into_II the_DD study_NN had_VHD confirmed_VVNJ myocardial_JJ infarction_NN (_( 39_MC %_SYM anterior_JJ ,_, 39_MC %_SYM inferior_JJ ,_, 22_MC %_SYM other_JJ locations_NNS )_) and_CC 85_MC %_SYM of_II all_DD individuals_NNS treated_VVN tolerated_VVD the_DD full_JJ intravenous_JJ dose_NN of_II 15_MC mg_NN of_II metoprolol_NN ._.
P02661306A10
Metastasising_VVGN in_II the_DD skeletal_JJ structure_NN can_VM be_VBB overlooked_VVN in_II only_RR 2_MC out_II+ of_II 555_MC patients_NNS (_( 0.36_MC %_SYM )_) ._.
P02670763A08
Less_RR optimal_JJ combinations_NNS of_II sensitivity_NN and_CC specificity_NN were_VBD found_VVN for_II differential_JJ glomerular_JJ filtration_NN rate_NN renography_NN ,_, differential_JJ effective_JJ renal_JJ plasma_NN flow_NN renography_NN ,_, and_CC selective_JJ renal_JJ vein_NN renin_NN ratios_NNS ,_, each_PND performed_VVN after_II a_DD single_JJ dose_NN of_II captopril_NN ._.
P02675648A06
The_DD remaining_VVGJ 10_MC patients_NNS were_VBD pleased_VVN with_II their_PNG operation_NN ._.
P02680518A04
These_DD proteins_NNS potentially_RR modulate_VVB phagocyte_NN function_NN ._.
P02685133A13
Ten_MC patients_NNS had_VHD dissecting_VVGJ aneurysms_NNS and_CC 5_MC had_VHD atherosclerotic_JJ thoracic_JJ aneurysms_NNS ._.
P02690039A05
We_PN are_VBB more_RR likely_RR to_TO develop_VVI a_DD greater_JJR understanding_VVGN for_II the_DD end-stage_NN structure_NN if_CS we_PN have_VHB had_VHD a_DD glimpse_NN of_II the_DD blueprints_NNS for_II its_PNG design_NN ._.
P02700156A04
389_MC serum_NN specimens_NNS of_II suspected_VVNJ Dengue_NN Fever_NN patients_NNS including_VVG 226_MC HI_NN (_( +_SYM )_) paired_VVNJ sera_NNS and_CC 163_MC HI_NN (_( -_SYM )_) paired_VVNJ sera_NNS which_PNR were_VBD collected_VVN from_II 1_MC to_II 150_MC days_NNS after_II onset_NN of_II the_DD disease_NN in_II 1988_MC have_VHB been_VBN assayed_VVN for_II IgM_NN antibodies_NNS to_II Dengue_NN type_NN I_MC virus_NN ._.
P02705576A12
The_DD low_JJ expenditure_NN in_II trained_VVNJ groups_NNS did_VDD not_RR ,_, however_RR ,_, relate_VVB to_II changes_NNS in_II facultative_JJ BAT_NN thermogenesis_NN ._.
P02714623A08
Whole_JJ serum_NN was_VBD separated_VVN over_II a_DD neutral_JJ G-200_NN column_NN ,_, and_CC all_DD activity_NN eluted_VVN at_II the_DD void_JJ volume_NN indicated_VVD an_DD apparent_JJ molecular_JJ weight_NN equal_JJ to_II or_CC greater_JJR than_CSN 250_MC kDa_NN ._.
P02723855A04
Measurement_NN of_II mandibular_JJ opening_VVGN revealed_VVD a_DD mean_NN increase_NN of_II 5.9_MC mm_NN ._.
P02738747A01
Spirometry_NN was_VBD performed_VVN on_II 136_MC male_NN industrial_JJ workers_NNS experienced_VVN in_II undergoing_VVGN pulmonary_JJ function_NN testing_VVGN for_II the_DD purpose_NN of_II studying_VVGN the_DD effects_NNS of_II the_DD use_NN of_II noseclips_NNS on_II forced_VVNJ vital_JJ capacity_NN (_( FVC_NN )_) maneuvers_NNS ._.
P02748331A01
The_DD major_JJ regions_NNS coding_VVG for_II the_DD transfer_NN RNA_NN genes_NNS in_II the_DD mitochondrial_JJ DNA_NN of_II K._NN lactis_NN were_VBD studied_VVN ._.
P02753117A10
It_PN is_VBZ suggested_VVN that_CST muscarinic_JJ cholinergic_JJ mechanisms_NNS in_II the_DD basal_JJ forebrain_NN may_VM be_VBB involved_VVN in_II the_DD pathogenesis_NN of_II neural_JJ dysfunction_NN associated_VVN with_II locomotor_NN activity_NN in_II man_NN ._.
P02767253A07
Peroperative_JJ cultures_NNS revealed_VVD small_JJ numbers_NNS of_II staphylococcus_NN epidermidis_NN in_II eleven_MC patients_NNS ,_, and_CC none_MC of_II them_PN developed_VVD graft_NN infection_NN ._.
P02781562A02
Desethylamiodarone_NN ,_, a_DD metabolite_NN ,_, whose_PNR role_NN in_II the_DD etiology_NN of_II amiodarone-induced_VVNJ pulmonary_JJ toxicity_NN has_VHZ been_VBN unclear_JJ ,_, also_RR possesses_VVZ antiarrhythmic_JJ activity_NN and_CC could_VM potentially_RR be_VBB used_VVN as_II an_DD antiarrhythmic_JJ drug_NN itself_PN ._.
P02785815A06
Results_NNS showed_VVD that_CST this_DD gene_NN was_VBD transiently_RR activated_VVN in_II the_DD very_RR early_JJ embryonic_JJ stage_NN and_CC in_II the_DD pupal_JJ stage_NN ,_, suggesting_VVG that_CST sarcocystatin_NN A_NN participates_VVZ in_II morphogenesis_NN of_II larval_JJ and_CC adult_NN structures_NNS of_II Sarcophaga_NN ._.
P02794326A01
Acute_JJ corneal_JJ hydrops_NN ,_, a_DD condition_NN secondary_JJ to_II keratoconus_NN ,_, can_VM be_VBB difficult_JJ to_TO diagnose_VVI unless_CS examination_NN is_VBZ also_RR performed_VVN on_II the_DD fellow_JJ eye_NN ._.
P02804028A02
Antiretinal_JJ antibodies_NNS were_VBD measured_VVN by_II indirect_JJ immunofluorescence_NN and_CC passive_JJ haemagglutination_NN ,_, and_CC circulating_VVGJ immune_JJ complexes_NNS were_VBD measured_VVN by_II polyethylene_NN glycol_NN precipitation_NN and_CC Clq_NN binding_VVGN ._.
P02808299A08
The_DD results_NNS obtained_VVN indicate_VVB that_CST the_DD menaquinone_NN acts_VVZ between_II the_DD two_MC b-type_NN cytochromes_NNS in_II an_DD electron_NN transport_NN chain_NN ._.
P02822335A03
Computed_VVNJ tomography_NN and_CC magnetic_JJ resonance_NN have_VHB with_II few_JJ exceptions_NNS added_VVN little_JJ to_II the_DD primary_JJ diagnosis_NN ._.
P02830733A04
It_PN is_VBZ concluded_VVN that_CST conservative_JJ management_NN after_II withdrawal_NN of_II hormonal_JJ contraception_NN my_VM be_VBB the_DD preferable_JJ treatment_NN for_II hepatic_JJ adenoma_NN and_CC focal_JJ nodular_JJ hyperplasia_NN ._.
P02839309A03
HDL-Au_NN was_VBD not_RR internalized_VVN ._.
P02847748A01
A_DD quantitative_JJ study_NN of_II the_DD relationship_NN between_II structure_NN and_CC receptor_NN binding_VVGJ affinity_NN of_II a_DD series_NN of_II 16_MC beta-carbolines_NNS showed_VVD the_DD influence_NN of_II lipophilic_JJ character_NN and_CC hydrogen_NN bonding_VVGJ capability_NN of_II substituents_NNS in_II position_NN 3_MC ._.
P02863875A03
If_CS a_DD fetus_NN is_VBZ identified_VVN with_II a_DD treatable_JJ disorder_NN in_RR+ utero_RR ,_, and_CC if_CS that_DD disorder_NN can_VM affect_VVB fetal_JJ development_NN ,_, then_RR treatment_NN during_II fetal_JJ life_NN is_VBZ potentially_RR beneficial_JJ ._.
P02874639A03
The_DD effects_NNS were_VBD quantified_VVN by_II the_DD sister_NN chromatid_NN exchange_NN (_( SCE_NN )_) assay_NN ._.
P02896446A04
The_DD changes_NNS are_VBB essentially_RR reversible_JJ after_II treatment_NN ,_, although_CS recovery_NN may_VM take_VVB several_JJ months_NNS ._.
P02912515A01
Gang_NN formation_NN is_VBZ common_JJ among_II adolescents_NNS ,_, and_CC the_DD sociological_JJ dynamics_NNS of_II this_DD phenomenon_NN have_VHB been_VBN studied_VVN in_II depth_NN ._.
P02917372A10
During_II hemorrhagic_JJ shock_NN arterial_JJ oxygen_NN tension_NN (_( PaO2_NN )_) increased_VVD from_II 78.0_MC to_II 94.0_MC torr_NN (_( P_NN less_RR than_CSN 0.005_MC )_) ,_, lymph_NN flow_NN (_( QL_NN )_) decreased_VVD from_II 7.2_MC to_II 5.2_MC ml_NN /_SYM h_NN (_( P_NN less_RR than_CSN 0.05_MC )_) and_CC lymph_NN protein_NN clearance_NN (_( L_NN /_SYM P.QL_NN )_) from_II 4.6_MC to_II 3.3_MC ml_NN /_SYM h_NN (_( P_NN less_RR than_CSN 0.05_MC )_) ._.
P02921962A05
Conclusions_NNS are_VBB drawn_VVN concerning_VVG the_DD significance_NN of_II these_DD processes_NNS for_II midwife_NN managers_NNS ._.
P02937736A02
In_II the_DD presence_NN of_II oxidizable_JJ substrates_NNS ,_, bacteria_NN reduce_VVB this_DD pigment_NN to_II a_DD colorless_JJ product_NN ,_, leukopyocyanin_NN ._.
P02943618A06
Our_PNG results_NNS ,_, interpreted_VVN in_II light_NN of_II studies_NNS from_II the_DD other_JJ laboratories_NNS ,_, suggest_VVB the_DD existence_NN of_II multiple_JJ abnormalities_NNS in_II the_DD BB_NN rat_NN ,_, including_VVG the_DD presence_NN of_II T_NN cells_NNS as_II effector_NN or_CC helper_NN cells_NNS that_PNR augment_VVB onset_NN of_II disease_NN and_CC the_DD absence_NN of_II a_DD regulatory_JJ T_NN cell_NN circuit_NN that_PNR could_VM prevent_VVB the_DD disease_NN ._.
P02955176A04
Bmax_NN in_II the_DD C57BL_NN /_SYM 6J_NN mice_NNS were_VBD lower_JJR than_CSN in_II the_DD other_JJ strains_NNS of_II young_JJ animals_NNS (_( 7-15_MC weeks_NNS )_) but_CC remained_VVD relatively_RR constant_JJ throughout_II life_NN (_( measured_VVN up_II+ to_II 104_MC weeks_NNS of_II age_NN )_) ._.
P02966134A04
The_DD study_NN represents_VVZ a_DD prospective_JJ assessment_NN and_CC included_VVD 52_MC men_NNS and_CC 32_MC women_NNS with_II a_DD mean_NN age_NN of_II 43_MC years_NNS ._.
P02977341A02
2._MC These_DD proteoglycan_NN preparations_NNS contained_VVN about_II equal_JJ amounts_NNS of_II heparan_NN sulfate_NN and_CC chondroitin_NN sulfates_NNS ._.
P02982847A05
DNase_NN I_MC protection_NN experiments_NNS revealed_VVD that_CST cAMP-CRP_NN binds_VVZ to_II the_DD cya_NN DNA_NN region_NN between_II +11_MC and_CC -20_MC ,_, in_II which_PNR a_DD consensus_NN CRP_NN binding_VVGJ sequence_NN is_VBZ present_JJ ._.
P02986944A13
Clonidine_NN (_( 10_MC (_( -5_MC )_) M_NN )_) ,_, similarly_RR perfused_VVN for_II 15_MC min_NN ,_, had_VHD no_DD effect_NN ._.
P02989238A04
As_II a_DD percentage_NN of_II total_JJ starch_NN intake_NN ,_, total_JJ tract_NN and_CC ruminal_JJ starch_NN digestion_NN increased_VVD (_( linear_JJ ,_, P_NN less_RR than_CSN .01_MC )_) while_CS postruminal_JJ starch_NN digestion_NN decreased_VVD (_( linear_JJ ,_, P_NN less_RR than_CSN .01_MC )_) with_II corn_NN level_NN ._.
P02999437A05
Although_CS the_DD minor_JJ differences_NNS between_II these_DD proteins_NNS may_VM be_VBB sufficient_JJ to_TO account_VVI for_II the_DD poor_JJ growth_NN of_II Ad2+ND5_NN in_II monkey_NN cells_NNS ,_, the_DD most_RRT striking_VVGJ difference_NN between_II helper-competent_JJ Ad2+ND2_NN and_CC helper-defective_JJ Ad2+ND5_NN is_VBZ in_II the_DD production_NN of_II the_DD SV40-specific_JJ protein_NN after_II infection_NN of_II monkey_NN cells_NNS ._.
P03008317A03
Especially_RR the_DD high_JJ incidence_NN of_II reinfection_NN with_II CMV_NN (_( 88.0_MC %_SYM )_) and_CC HSV_NN (_( 81.0_MC )_) at_II high_JJ prednisolone_NN dosage_NN compared_VVN to_II the_DD lower_JJR incidence_NN (_( CMV_NN 54.5_MC %_SYM ,_, HSV_NN 44.1_MC %_SYM )_) at_II low_JJ prednisolone_NN dosage_NN was_VBD apparent_JJ ._.
P03021299A02
This_DD study_NN investigated_VVD the_DD effect_NN ,_, on_II time_NN to_II onset_NN and_CC duration_NN of_II analgesia_NN ,_, of_II pH_NN adjustment_NN of_II 0.25_MC per_II cent_MC bupivacaine_NN immediately_RR prior_II+ to_II injection_NN into_II the_DD epidural_JJ space_NN in_II parturients_NNS ._.
P03029658A01
Previous_JJ studies_NNS with_II neutrophils_NNS from_II newborn_NN infants_NNS compared_VVN to_II neutrophils_NNS from_II healthy_JJ adults_NNS have_VHB documented_VVD increased_VVNJ respiratory_JJ burst_NN activity_NN including_VVG enhanced_VVNJ superoxide_NN anion_NN (_( O2-_NN )_) production_NN ,_, nitroblue_NN tetrazolium_NN dye_NN reduction_NN ,_, and_CC hexose_NN monophosphate_NN shunt_NN activity_NN ._.
P03038195A01
The_DD mechanism_NN of_II respiratory_JJ burst_NN was_VBD studied_VVN by_II modulating_VVGN membrane_NN surfaces_NNS with_II lipophilic_JJ ions_NNS in_II guinea-pig_NN polymorphonuclear_JJ leukocytes_NNS and_CC their_PNG subcellular_JJ membranes_NNS ._.
P03054266A02
It_PN can_VM be_VBB accompanied_VVN by_II acute_JJ diffuse_JJ or_CC localised_VVNJ abdominal_JJ pain_NN and_CC it_PN could_VM also_RR appear_VVB to_TO be_VBI an_DD acute_JJ appendicitis_NN or_CC an_DD intussusception_NN ._.
P03073687A04
No_DD significant_JJ loss_NN of_II adsorption_NN capacity_NN was_VBD observed_VVN after_II sterilization_NN and_CC storage_NN of_II immunoadsorbents_NNS ._.
P03086582A06
These_DD findings_NNS show_VVB that_CST it_PN is_VBZ safe_JJ to_TO administer_VVI undiluted_VVNJ hypertonic_JJ elemental_JJ diets_NNS by_II constant_JJ nasogastric_JJ infusion_NN to_II patients_NNS with_II inflammatory_JJ bowel_NN disease_NN ._.
P03107356A01
Methylcobalamin_NN (_( CH3-B12_NN )_) was_VBD administrated_VVN in_II a_DD dose_NN of_II 6_MC mg_NN per_II day_NN (_( group_NN A_NN ,_, 16_MC cases_NNS )_) or_CC 12_MC mg_NN per_II day_NN (_( group_NN B_NN ,_, 23_MC cases_NNS )_) for_II 16_MC weeks_NNS to_II patients_NNS with_II oligozoospermia_NN ._.
P03112430A06
The_DD daily_JJ caloric_JJ intake_NN was_VBD 0.21_MC to_II 0.22_MC kcal_NN /_SYM g_NN body_NN weight_NN ._.
P03122751A03
In_II the_DD particulate_JJ fraction_NN ,_, IFN-gamma_NN decreased_VVD protein_NN kinase_NN C_NN activity_NN within_II 1_MC hr_NN but_CC it_PN reappeared_VVD after_II 24_MC hr_NN ,_, whereas_CS IFN-beta_NN decreased_VVD the_DD activity_NN during_II the_DD inhibition_NN of_II cell_NN growth_NN ._.
P03133111A07
Neutralization_NN (_( Winn_NN type_NN )_) tests_NNS showed_VVD that_CST peritoneal_JJ T_NN lymphocytes_NNS possessed_VVD tumor_NN cytotoxicity_NN and_CC that_CST the_DD antitumor_NN capacity_NN was_VBD reduced_VVN by_II in_JJ+ vivo_JJ treatment_NN with_II anti_JJ I-Ad_NN monoclonal_JJ antibody_NN simultaneously_RR with_II and_CC 1_MC day_NN prior_II+ to_II MMC-Meth_NN A_NN injection_NN ._.
P03143388A07
There_EX were_VBD no_DD statistically_RR significant_JJ differences_NNS among_II the_DD three_MC groups_NNS for_II any_PND of_II the_DD quantitative_JJ parameters_NNS ._.
P03149527A12
Sequencing_VVGN of_II purified_VVNJ lectins_NNS and_CC cDNA_NN clones_NNS indicates_VVZ that_CST at_RR+ least_RR 4_MC distinct_JJ genes_NNS code_VVB for_II what_PND appears_VVZ to_TO be_VBI a_DD family_NN of_II HL-14_NN ._.
P03168884A01
The_DD author_NN provides_VVZ some_DD material_NN for_II reflection_NN on_II the_DD issue_NN of_II developing_VVGN leadership_NN in_II the_DD health_NN sector_NN ;_: in_II this_DD case_NN ,_, in_II the_DD specific_JJ area_NN of_II nursing_VVGN ._.
P03180204A04
She_PN had_VHD marked_VVNJ symptomatic_JJ improvement_NN ,_, no_DD further_JJ heart_NN failure_NN ,_, and_CC a_DD full-term_NN ,_, normal_JJ delivery_NN ._.
P03191946A02
A_DD number_NN of_II monoclonal_JJ antibodies_NNS which_PNR have_VHB been_VBN shown_VVN to_TO be_VBI capable_JJ of_II inducing_VVGN T_NN cell_NN activation_NN and_CC which_PNR have_VHB been_VBN previously_RR considered_VVN to_TO recognize_VVI distinct_JJ proteins_NNS all_PND reacted_VVN with_II the_DD same_JJ transfected_VVNJ gene_NN product_NN ._.
P03204008A09
There_EX were_VBD five_MC instances_NNS of_II leukopenia_NN and_CC fever_NN ._.
P03219063A04
A_DD factor_NN analysis_NN was_VBD performed_VVN on_II the_DD SDMI_NN and_CC six_MC levels_NNS of_II sexual_JJ decision_NN making_VVGN were_VBD defined_VVN :_: Object_NN Constancy_NN ,_, Ambivalence_NN ,_, Need_NN for_II Merger_NN ,_, Need_NN Gratification_NN ,_, Low_JJ Self-esteem_NN ,_, and_CC Narcissistic_JJ Gratification_NN ._.
P03231884A04
We_PN suggest_VVB that_CST the_DD total_JJ sum_NN of_II other_JJ anions_NNS such_II+ as_II proteins_NNS ,_, phosphate_NN ,_, pyruvate_NN ,_, citrate_NN ,_, free_JJ fatty_JJ acids_NNS and_CC aminoacids_NNS ,_, as_CC+ well_CC+ as_CC sodium-hydrogen_NN exchange_NN could_VM account_VVB for_II this_DD acidosis_NN ._.
P03261110A02
In_II most_DD thymic_JJ tissues_NNS from_II patients_NNS with_II MG_NN ,_, a_DD maturating_VVGJ tendency_NN of_II lymphocytes_NNS was_VBD generally_RR observed_VVN ._.
P03280907A01
Imipenem_NN is_VBZ a_DD new_JJ carbapenem_NN antibiotic_NN that_CST has_VHZ an_DD extremely_RR broad_JJ spectrum_NN of_II antibacterial_JJ activity_NN ._.
P03292334A04
Two_MC proteolytic_JJ bands_NNS in_II rat_NN gastric_JJ mucosa_NN that_PNR migrated_VVD concurrently_RR with_II human_NN slow-moving_VVGJ proteinase_NN reacted_VVD with_II antihuman_NN slow-moving_VVGJ proteinase_NN reacted_VVD with_II antihuman_NN slow-moving_VVGJ proteinase_NN ._.
P03304329A01
A_DD method_NN is_VBZ described_VVN for_II the_DD preparation_NN of_II monolayer_NN smears_NNS from_II paraffin-embedded_VVNJ tissue_NN ._.
P03315639A03
There_EX was_VBD no_DD significant_JJ correlation_NN between_II concentrations_NNS of_II serum_NN Tg_NN and_CC triiodothyronine_NN (_( T3_NN )_) ,_, thyroxine_NN (_( T4_NN )_) ,_, fasting_VVGJ plasma_NN glucose_NN (_( FPG_NN )_) ,_, and_CC hemoglobin_NN A1c_NN (_( HbA1c_NN )_) ._.
P03328560A01
Considerable_JJ progress_NN has_VHZ been_VBN made_VVN in_II the_DD morphologic_JJ study_NN of_II pituitary_NN due_II+ to_II the_DD availability_NN of_II angioscan_NN programs_NNS ._.
P03341541A05
A_DD positive_JJ test_NN result_NN was_VBD defined_VVN as_II pain_NN with_II sodium_NN hydroxide_NN but_CC not_RR with_II saline_JJ solution_NN or_CC hydrochloric_JJ acid_NN infusion_NN ._.
P03351882A02
This_DD brief_JJ article_NN attempts_VVZ to_TO explain_VVI how_CST to_TO decode_VVI such_DD references_NNS and_CC thus_RR get_VVI to_II the_DD reports_NNS ._.
P03362871A08
Distinct_JJ mechanisms_NNS ,_, therefore_RR ,_, regulate_VVB the_DD expression_NN of_II proenkephalin_NN mRNA_NN and_CC prodynorphin_NN mRNA_NN in_II rat_NN hippocampus_NN ._.
P03374408A08
This_DD method_NN will_VM be_VBB applicable_JJ routinely_RR for_II the_DD definite_JJ identification_NN of_II atypical_JJ strains_NNS of_II Campylobacter_NN species_NNS and_CC other_JJ gram-negative_JJ bacteria_NN difficult_JJ to_TO identify_VVI biochemically_RR ._.
P03385813A05
Sixteen_MC mongrel_NN dogs_NNS were_VBD anesthetized_VVN and_CC bled_VVN by_II increments_NNS of_II 3_MC %_SYM of_II their_PNG total_JJ blood_NN volume_NN until_II the_DD onset_NN of_II sustained_VVNJ hypotension_NN or_CC a_DD 25_MC %_SYM blood_NN loss_NN ._.
P03397743A01
The_DD authors_NNS reviewed_VVD the_DD clinical_JJ and_CC radiographic_JJ results_NNS of_II 31_MC bipolar_JJ hip_NN arthroplasties_NNS performed_VVN for_II avascular_JJ necrosis_NN in_II 24_MC patients_NNS ._.
P03403456A06
R_NN resulted_VVD in_II increased_VVNJ arterial_JJ lactate_NN concentrations_NNS compared_VVN with_II C_NN and_CC SW_NN at_II base_NN line_NN but_CC was_VBD not_RR different_JJ from_II SW_NN at_II 4_MC wk_NN ._.
P03409486A11
Further_JJ biochemical_JJ investigations_NNS revealed_VVD that_CST the_DD antioxidative_JJ enzyme_NN ,_, catalase_NN ,_, was_VBD significantly_RR increased_VVN to_II 137_MC +/-_SYM 12.7_MC U_NN /_SYM mg_NN protein_NN in_II the_DD heat-shocked_VVNJ hearts_NNS while_CS the_DD control_NN value_NN was_VBD 64.8_MC +/-_SYM 8.3_MC U_NN /_SYM mg_NN protein_NN ._.
P03421612A07
The_DD implications_NNS of_II these_DD findings_NNS for_II ethical_JJ practice_NN and_CC for_II the_DD theoretical_JJ interpretation_NN of_II phallometric_JJ assessment_NN data_NNS were_VBD discussed_VVN ._.
P03440467A02
No_DD differences_NNS between_II the_DD relative_JJ peak_JJ areas_NNS of_II the_DD various_JJ fatty_JJ acids_NNS were_VBD observed_VVN as_CS regards_VVZ the_DD two_MC detectors_NNS used_VVN except_CS+ that_CS response_NN of_II the_DD electron_NN capture_NN dectector_NN to_II the_DD hydroxy_NN acid_NN derivatives_NNS exceeded_VVD that_PND to_II the_DD non-hydroxy_NN acid_NN derivatives_NNS by_II 20_MC %_SYM ._.
P03456347A04
The_DD relative_JJ incorporation_NN of_II fibronectin_NN and_CC collagen_NN into_II the_DD matrix_NN also_RR increases_VVZ in_II response_NN to_II TGFbeta_NN ._.
P03480807A04
Only_RR those_DD cells_NNS in_II which_PNR the_DD stimulation_NN evoked_VVD excitation_NN (_( alone_JJ or_CC mixed_VVN with_II inhibition_NN )_) responded_VVD to_II the_DD inhibitors_NNS ._.
P03492926A03
We_PN tested_VVD for_II a_DD specific_JJ interaction_NN of_II albumin_NN with_II the_DD ablumenal_JJ surface_NN of_II the_DD capillary_NN wall_NN ._.
P03503041A01
Actions_NNS of_II muscles_NNS that_PNR pass_VVB over_II more_RR than_CSN one_MC joint_NN are_VBB mainly_RR described_VVN with_II respect_NN to_II movements_NNS in_II the_DD joints_NNS that_PNR are_VBB crossed_VVN ._.
P03511102A06
No_DD positive_JJ correlation_NN was_VBD found_VVN between_II the_DD amount_NN of_II periodontal_JJ tissue_NN support_NN and_CC the_DD magnitude_NN of_II the_DD forces_NNS developed_VVN during_II biting_VVGN with_II maximal_JJ strength_NN in_II habitual_JJ occlusion_NN either_CC totally_RR or_CC locally_RR ,_, although_CS there_EX was_VBD a_DD strong_JJ tendency_NN (_( r_NN =_SYM 0.54_MC ;_: 0.6_MC greater_JJR than_CSN P_NN greater_JJR than_CSN 0.5_MC )_) towards_II decreasing_VVGJ total_JJ maximal_JJ bite_NN force_NN with_II decreasing_VVGJ total_NN remaining_VVGJ periodontal_JJ ligament_NN area_NN ._.
P03521517A04
MTP-1403_NN markedly_RR improved_VVD the_DD oral_JJ glucose_NN tolerance_NN test_NN in_II the_DD genetically_RR diabetic_JJ KK_NN mice_NNS ._.
P03538922A02
Forty-six_MC patients_NNS with_II proved_VVNJ MPV_NN bites_NNS and_CC incoagulable_JJ blood_NN ,_, indicating_VVG systemic_JJ envenoming_VVGN ,_, were_VBD randomly_RR allocated_VVN for_II treatment_NN with_II Thai_JJ Red_JJ Cross_NN (_( TRC_NN )_) ,_, Thai_JJ Government_NN Pharmaceutical_NN Organization_NN (_( GPO_NN )_) ,_, or_CC Twyford_NN Pharmaceutical_NN monospecific_JJ antivenoms_NNS ._.
P03544648A06
The_DD patients_NNS again_RR asked_VVD for_II an_DD analgesic_NN after_II an_DD average_NN of_II 4.6_MC h_NN in_II the_DD oxycodone_NN group_NN and_CC after_II an_DD average_NN of_II 6.1_MC h_NN in_II the_DD diclofenac_NN group_NN ._.
P03550454A10
This_PND suggests_VVZ the_DD importance_NN of_II choosing_VVGN an_DD appropriate_JJ Nt_NN as_CC+ well_CC+ as_CC method_NN for_II the_DD estimation_NN of_II mu_NN ._.
P03556435A04
The_DD species_NN composition_NN bore_VVB considerable_JJ resemblance_NN to_II that_PND of_II house_NN dust_NN (_( although_CS the_DD density_NN of_II mites_NNS was_VBD far_RR lower_JJR )_) and_CC the_DD mites_NNS have_VHB probably_RR been_VBN transported_VVN from_II homes_NNS via_II clothing_VVGN and_CC pets_NNS ._.
P03572797A10
The_DD similarity_NN between_II the_DD behavioral_JJ effects_NNS of_II the_DD beta_NN adrenergic_JJ agonists_NNS and_CC those_PND of_II proven_VVNJ antidepressant_NN drugs_NNS provides_VVZ evidence_NN consistent_JJ with_II the_DD contention_NN that_CST centrally_RR acting_VVGJ beta_NN adrenergic_JJ agonists_NNS might_VM possess_VVB antidepressant_NN activity_NN ._.
P03584468A01
The_DD metabolism_NN of_II human_NN IgE_NN was_VBD studied_VVN in_II normals_NNS ,_, severe_JJ atopics_NNS ,_, and_CC patients_NNS with_II the_DD hyperimmunoglobulin_NN E-recurrent_JJ infection_NN (_( HIE_NN ;_: Job_NN 's_GE )_) syndrome_NN to_TO determine_VVI whether_CST IgE_NN metabolism_NN is_VBZ altered_VVN in_II patients_NNS with_II marked_VVNJ elevation_NN of_II serum_NN IgE_NN ._.
P03595783A05
Vasopressin_NN increased_VVD the_DD excitability_NN of_II impaled_VVNJ neurons_NNS without_II substantially_RR altering_VVGN membrane_NN potential_NN or_CC resistance_NN ._.
P03601381A12
The_DD overall_JJ results_NNS --_: considering_VVG both_CC objective_JJ and_CC subjective_JJ factors_NNS --_: showed_VVD good_JJ to_II excellent_JJ results_NNS in_II 12_MC patients_NNS of_II group_NN I_MC (_( 52_MC %_SYM )_) ,_, in_II 8_MC patients_NNS of_II group_NN II_MC (_( 62_MC %_SYM )_) ,_, and_CC in_II 31_MC patients_NNS of_II group_NN III_MC (_( 84_MC %_SYM )_) ._.
P03619130A01
One_MC hundred_MC and_CC fifty-two_MC children_NNS affected_VVN by_II respiratory_JJ syndromes_NNS ,_, probably_RR due_II+ to_II allergy_NN ,_, underwent_VVD skin_NN testing_VVGN to_II a_DD range_NN of_II extracts_NNS including_VVG several_JJ different_JJ species_NNS of_II mites_NNS ._.
P03651151A01
Effects_NNS of_II oral_JJ administration_NN of_II elastase_NN on_II changes_NNS in_II contractile_JJ responses_NNS of_II smooth_JJ muscle_NN cells_NNS of_II the_DD aorta_NN and_CC pulmonary_JJ artery_NN were_VBD studied_VVN in_II rabbits_NNS fed_VVN a_DD high-cholesterol_NN diet_NN ._.
P03656193A09
Simultaneously_RR gastric_JJ pressure_NN was_VBD increased_VVN primarily_RR by_II a_DD reduction_NN in_II the_DD tonic_JJ vagal_JJ drive_NN to_II the_DD intramural_JJ non-adrenergic_JJ ,_, non-cholinergic_JJ inhibitory_JJ neurones_NNS in_II the_DD corpus_NN region_NN ._.
P03668318A06
An_DD Arrhenius_NN analysis_NN of_II heat_NN survival_NN curves_NNS of_II the_DD different_JJ CFU-S_NN allowed_VVD us_PN to_TO estimate_VVI only_RR one_MC activation_NN energy_NN (_( Ea_NN )_) in_II the_DD inactivation_NN process_NN of_II foetal_JJ liver_NN and_CC regenerating_VVGJ spleen_NN CFU-S_NN ,_, and_CC two_MC Ea_NN in_II the_DD case_NN of_II steady-state_NN marrow_NN and_CC spleen_NN CFU-S_NN and_CC regenerating_VVGJ marrow_NN CFU-S_NN ._.
P03680049A09
(_( 3_MC )_) Phospholipids_NNS were_VBD labeled_VVN with_II [_( 32P_NN ]_) orthophosphate_NN which_PNR was_VBD mostly_RR incorporated_VVN into_II phosphatidylinositol_NN 4_MC ,_, 5-bisphosphate_NN (_( PIP2_NN )_) ,_, phosphatidylinositol_NN 4-phosphate_NN ,_, phosphatidylinositol_NN ,_, and_CC phosphatidic_JJ acid_NN ._.
P03699194A05
The_DD phenol_NN fraction_NN thus_RR obtained_VVN was_VBD subjected_VVN to_II thin_JJ layer_NN chromatography_NN (_( TLC_NN )_) (_( cyclohexane-ethyl_NN acetate_NN =_SYM 2_MC :_: 1_MC ,_, V_NN /_SYM V_NN and_CC chloroform-ethyl_NN ether_NN =_SYM 4_MC :_: 1_MC ,_, V_NN /_SYM V_NN )_) ._.
P03710141A02
The_DD analyses_NNS were_VBD done_VDN separately_RR in_II each_PND of_II the_DD ethnic_JJ groups_NNS categorized_VVN according_II+ to_II the_DD parents_NNS '_GE country_NN of_II birth_NN (_( Europe_NNP ,_, Asia_NNP ,_, North_NN Africa_NNP ,_, and_CC Israel_NNP /_SYM mixed_VVNJ origin_NN )_) in_II order_NN to_TO identify_VVI the_DD nature_NN and_CC sources_NNS of_II any_DD heterogeneity_NN among_II the_DD groups_NNS ._.
P03716018A07
During_II treatment_NN with_II low-strength_NN anthralin_NN ,_, the_DD mast_JJ cell_NN changes_NNS underwent_VVD regression_NN ._.
P03732727A02
Many_JJ patients_NNS had_VHD a_DD poor_JJ left_JJ ventricular_JJ function_NN ._.
P03738742A02
A_DD 3_MC mm_NN thick_JJ ,_, tube-form_NN applicator_NN of_II noble_JJ metal_NN which_PNR is_VBZ closed_VVN at_II the_DD front_NN side_NN is_VBZ implanted_VVN into_II the_DD tumor_NN by_II a_DD stereotaxic_JJ technique_NN and_CC firmly_RR screwed_VVN together_RR with_II the_DD osseous_JJ calotte_NN ._.
P03750242A07
The_DD study_NN also_RR showed_VVD that_CST doctors_NNS had_VHD difficulty_NN in_II identifying_VVGN the_DD reversibility_NN of_II airflow_NN obstruction_NN in_II patients_NNS in_II whom_PNR they_PN correctly_RR predicted_VVD obstruction_NN ._.
P03766705A07
Parotid_NN glands_NNS receiving_VVG 7.5-15.0_MC Gy_NN were_VBD atrophic_JJ at_II 16-22_MC weeks_NNS after_II irradiation_NN and_CC showed_VVD no_DD recovery_NN by_II 40_MC weeks_NNS ._.
P03782626A01
Lying_VVGN in_II 4th-_NN ,_, 7th-_NN ,_, and_CC 10th-grade_NN boys_NNS was_VBD measured_VVN through_II parent_NN and_CC teacher_NN reports_NNS ._.
P03794055A01
After_II a_DD lower_JJR hemi-cervical_JJ spinal_JJ cord_NN injury_NN ,_, a_DD patient_NN presented_VVD with_II a_DD left_JJ hemiplegia_NN and_CC on_II the_DD same_JJ side_NN a_DD unilateral_JJ chest_NN wall_NN paradoxical_JJ motion_NN mimicking_VVG a_DD flail_NN chest_NN ._.
P03805448A06
Two_MC possible_JJ causes_NNS for_II depressed_VVNJ N_NN digestibility_NN of_II 60_MC degrees_NNS C_NN silage_NN were_VBD 1_MC )_) the_DD ratio_NN of_II poorly_RR digested_VVNJ nonamino_JJ acid_NN N_NN to_II highly_RR digested_VVNJ amino_JJ acid_NN N_NN was_VBD higher_JJR in_II 60_MC degrees_NNS C_NN silage_NN than_CSN in_II 35_MC degrees_NNS C_NN or_CC unheated_VVNJ silage_NN ,_, and_CC 2_MC )_) amino_JJ acid_NN N_NN in_II 60_MC degrees_NNS C_NN silage_NN was_VBD digested_VVN less_RR than_CSN amino_JJ acid_NN N_NN in_II 35_MC degrees_NNS C_NN or_CC unheated_VVNJ silage_NN ._.
P03822838A02
Experiments_NNS were_VBD carried_VVN out_II in_II E._NN coli_NN DNA_NN polymerase_NN I_MC Klenow_NN fragment_NN enzyme_NN system_NN ._.
P03836440A01
Computed_VVNJ tomograms_NNS (_( CT_NN )_) in_II twenty_MC cases_NNS of_II renal_JJ tuberculosis_NN (_( TB_NN )_) were_VBD reviewed_VVN in_II comparison_NN with_II intravenous_JJ urograms_NNS ._.
P03858299A04
Enamel_NN demineralization_NN experiments_NNS conducted_VVN in_RR+ vitro_RR confirmed_VVD the_DD significance_NN of_II the_DD results_NNS of_II the_DD computer_NN simulations_NNS ,_, thus_RR providing_VVG evidence_NN for_II a_DD correlation_NN between_II the_DD known_VVNJ metabolic_JJ activity_NN of_II plaque_NN (_( organic_JJ acid_NN composition_NN )_) ,_, physical_JJ chemistry_NN of_II plaque_NN ,_, and_CC caries_NN susceptibility_NN ._.
P03874151A05
IL-1_NN generation_NN was_VBD determined_VVN by_II the_DD ability_NN of_II supernatants_NNS from_II 2-day_NN cultured_VVNJ adherent_JJ cells_NNS stimulated_VVN by_II lipopolysaccharide_NN to_TO enhance_VVI proliferation_NN of_II PHA-stimulated_VVNJ mice_NNS thymocytes_NNS ._.
P03879038A08
Bovine_JJ rhodopsin_NN ,_, on_II the_DD other_JJ hand_NN ,_, had_VHD a_DD single_JJ Mr_NN component_NN and_CC focused_VVD in_II a_DD major_JJ band_NN at_II pH_NN 6.2_MC ._.
P03895372A03
After_II two_MC months_NNS ,_, the_DD resulting_VVGJ porencephalic_JJ cyst_NN had_VHD been_VBN transformed_VVN into_II glial_JJ tissue_NN of_II very_JJ high_JJ echogenicity_NN ._.
P03906866A04
Some_PND of_II the_DD relevant_JJ enzymatic_JJ metabolic_JJ reactions_NNS are_VBB also_RR discussed_VVN ._.
P03920038A09
The_DD investigation_NN demonstrates_VVZ the_DD great_JJ relevance_NN of_II persistent_JJ treatment_NN for_II prevention_NN of_II exacerbations_NNS as_CC+ well_CC+ as_CC for_II interval_NN periods_NNS ._.
P03935156A01
Spectroscopic_JJ studies_NNS on_II the_DD trans-7_NN ,_, 8-dihydroxy-anti-9_NN ,_, 10-epoxy-7_NN ,_, 8_MC ,_, 9_MC ,_, 10-tetrahydrobenzo_NN [_( a_NN ]_) pyrene-_NN (_( anti-BPDE-_NN )_) modified_VVNJ synthetic_JJ polynucleotide_NN solutions_NNS reveal_VVB interesting_VVGJ sequence-dependent_JJ stereoselective_JJ covalent_JJ binding_VVGN of_II anti-BPDE_NN to_II DNA_NN ._.
P03941248A05
Differences_NNS between_II these_DD findings_NNS and_CC those_PND reported_VVN for_II Western_JJ samples_NNS reflect_VVB cultural_JJ differences_NNS between_II Yoruba_NNP and_CC Western_JJ societies_NNS ._.
P03955986A04
Ninety-three_MC percent_NN of_II patients_NNS were_VBD transported_VVN to_II a_DD hospital_NN where_PNR first_JJ treatment_NN was_VBD given_VVN within_II six_MC hours_NNS after_II the_DD accident_NN ._.
P03961186A06
These_DD standards_NNS are_VBB of_II particular_JJ value_NN in_II subtle_JJ or_CC early_JJ cases_NNS in_II which_PNR the_DD thinning_VVGN of_II the_DD epiphysis_NN may_VM not_RR be_VBB apparent_JJ upon_II simple_JJ observation_NN ._.
P03975972A03
The_DD series_NN included_VVD 217_MC cases_NNS of_II cerebral_JJ thrombosis_NN ,_, 54_MC of_II cerebral_JJ hemorrhage_NN ,_, and_CC 35_MC of_II TIA_NN ._.
P03981021A07
None_MC of_II the_DD patients_NNS with_II underlying_VVGJ conditions_NNS survived_VVD after_CS receiving_VVG inappropriate_JJ therapy_NN as_CS compared_VVN with_II 50_MC %_SYM who_PNR were_VBD previously_RR healthy_JJ ._.
P03996727A05
The_DD extent_NN of_II their_PNG action_NN depended_VVD on_II their_PNG structural_JJ similarity_NN to_II the_DD cyclohexyl_NN of_II retinal_NN ._.
P04013578A02
The_DD focus_NN was_VBD manifested_VVN by_II group_NN morbidity_NN among_II the_DD cattle-tending_VVGJ personnel_NN of_II a_DD dairy_NN farm_NN ._.
P04018776A10
Enhanced_VVNJ extramedullary_JJ erythropoiesis_NN was_VBD observed_VVN in_II all_DD cases_NNS ._.
P04029403A05
Biopsies_NNS were_VBD taken_VVN from_II the_DD tumour_NN and_CC from_II adjacent_JJ '_`` normal_JJ '_'' mucosa_NN and_CC from_II both_DD resection_NN edges_NNS ._.
P04040179A04
Nongerm_NN cell_NN malignancies_NNS in_II mixed_VVNJ germ_NN cell_NN tumors_NNS following_VVG chemotherapy_NN may_VM be_VBB more_RR common_JJ than_CSN previously_RR described_VVN ._.
P04050971A07
In_II airways_NNS ,_, the_DD nonciliated_VVNJ bronchiolar_JJ epithelial_JJ (_( Clara_NN )_) cell_NN was_VBD the_DD predominant_JJ cell_NN affected_VVN ._.
P04056049A10
The_DD slopes_NNS of_II the_DD resting_VVGJ heart_NN rate_NN vs._CC the_DD plasma_NN concentration_NN of_II l-pindolol_NN were_VBD significantly_RR less_RR than_CSN zero_MC and_CC were_VBD significantly_RR correlated_VVN to_II the_DD pretreatment_NN heart_NN rate_NN ,_, which_PNR supports_VVZ the_DD hypothesis_NN that_CST intrinsic_JJ sympathetic_JJ tone_NN largely_RR determines_VVZ the_DD effect_NN of_II pindolol_NN on_II the_DD resting_VVGJ heart_NN rate_NN ._.
P04067078A03
The_DD second_JJ tone_NN ,_, F2_NN ,_, was_VBD located_VVN above_II CF_NN ._.
P04073450A05
Hyperventilation_NN ,_, with_II hand_NN bagging_VVGN ,_, was_VBD successful_JJ in_II treating_VVGN five_MC out_II+ of_II six_MC episodes_NNS of_II PFC_NN (_( 83_MC %_SYM )_) ,_, without_II complication_NN ._.
P04091585A01
Follow_NN+ up_NN of_II 40_MC girls_NNS with_II premature_JJ thelarche_NN showed_VVD that_CST where_CS this_DD disorder_NN occurred_VVD before_II age_NN 2_MC years_NNS it_PN usually_RR regressed_VVN completely_RR ,_, thus_RR representing_VVG a_DD transient_JJ and_CC isolated_VVNJ phenomenon_NN ._.
P06091809A02
The_DD so-called_VVNJ "_`` gaiting_VVGJ mechanism_NN "_'' of_II calcium_NN channels_NNS plays_VVZ a_DD more_RR essential_JJ part_NN in_II the_DD changes_NNS in_II the_DD basal_JJ tone_NN of_II precapillary_JJ sphincters_NNS influenced_VVN by_II calcium_NN antagonists_NNS ,_, whereas_CS voltage-controlled_VVNJ and_CC receptor-operated_VVNJ calcium_NN channels_NNS are_VBB responsible_JJ for_II variations_NNS in_II the_DD adrenergic_JJ tone_NN of_II precapillary_JJ sphincters_NNS ._.
P06101125A03
The_DD iris_NN could_VM be_VBB adequately_RR evaluated_VVN and_CC the_DD retina_NN could_VM be_VBB visualized_VVN after_II surgery_NN in_II 36_MC cases_NNS ._.
P06117377A04
Furthermore_RR ,_, propranolol_NN significantly_RR potentiated_VVD the_DD vasoconstriction_NN caused_VVN by_II intra-arterial_JJ norepinephrine_NN and_CC attenuated_VVD the_DD vasodilator_NN action_NN of_II isoproterenol_NN ._.
P06138056A01
The_DD effect_NN of_II vasodilation_NN (_( with_II nifedipine_NN )_) or_CC beta-adrenergic_JJ receptor_NN blockade_NN (_( with_II propranolol_NN ,_, alprenolol_NN or_CC metoprolol_NN )_) on_II the_DD rate_NN of_II rise_NN of_II oxygen_NN uptake_NN and_CC heart_NN rate_NN were_VBD studied_VVN in_II 14_MC healthy_JJ subjects_NNS after_II a_DD step-wise_JJ increase_NN of_II workload_NN from_II a_DD light_JJ to_II a_DD moderate_JJ exercise_NN intensity_NN ._.
P06149528A04
In_II the_DD hyperinsulinemic_JJ hypoglycemic_JJ infants_NNS ,_, an_DD increase_NN in_II total_JJ endocrine_JJ cell_NN volume_NN was_VBD found_VVN ;_: however_RR ,_, the_DD typical_JJ features_NNS of_II nesidioblastosis_NN were_VBD also_RR found_VVN in_II the_DD controls_NNS ._.
P06166392A01
Leukocytes_NNS and_CC mast_JJ cells_NNS of_II rat_NN peritoneal_JJ exudate_NN (_( PE_NN )_) were_VBD fused_VVN in_RR+ vitro_RR with_II actively_RR growing_VVGJ mouse_NN cells_NNS ._.
P06172374A08
Anti-RCGC-PK1_NN serum_NN showed_VVD no_DD reactivity_NN with_II highly_RR purified_VVNJ xenogeneic_JJ mucins_NNS nor_CC with_II syngeneic_JJ small_JJ bowel_NN mucin_NN ._.
P06184021A06
The_DD relevance_NN of_II this_DD observation_NN to_TO be_VBI clinical_JJ features_NNS of_II rheumatoid_JJ arthritis_NN is_VBZ discussed_VVN ._.
P06193901A02
The_DD isomers_NNS of_II HCH_NN were_VBD separated_VVN by_II adsorption_NN chromatography_NN on_II silica_NN gel_NN ._.
P06198531A02
Since_CS there_EX is_VBZ no_DD part_NN of_II the_DD history_NN ,_, physical_JJ examination_NN or_CC noninvasive_JJ laboratory_NN findings_NNS that_PNR is_VBZ specific_JJ ,_, a_DD tentative_JJ criteria_NNS for_II diagnosis_NN of_II pulmonary_JJ thromboembolism_NN is_VBZ proposed_VVN based_VVN a_DD scoring_VVGJ system_NN ._.
P06207601A03
Five_MC had_VHD no_DD symptoms_NNS ,_, nine_MC had_VHD ambiguous_JJ symptoms_NNS ,_, and_CC six_MC had_VHD pericardial_JJ tamponade_NN ._.
P06213410A01
Posttranslational_JJ transfer_NN of_II most_DD precursor_NN proteins_NNS into_II mitochondria_NNS is_VBZ dependent_JJ on_II energization_NN of_II the_DD mitochondria_NNS ._.
P06226696A05
Total_JJ clinical_JJ recovery_NN occurred_VVD at_II the_DD end_NN of_II 6_MC months_NNS ._.
P06245686A03
The_DD pH_NN dependence_NN can_VM be_VBB analysed_VVN in_II terms_NNS of_II a_DD pKa_NN of_II 6.2_MC in_II the_DD oxidised_VVNJ form_NN and_CC a_DD pKa_NN of_II 7.3_MC in_II the_DD reduced_VVNJ form_NN ._.
P06262408A03
The_DD response_NN pattern_NN obtained_VVN with_II optimum_NN concentrations_NNS of_II these_DD preparations_NNS was_VBD very_RR similar_JJ to_II that_PND seen_VVN with_II the_DD B_NN cell_NN mitogen_NN ,_, LPS_NN ._.
P06273649A01
The_DD identification_NN of_II female_NN carriers_NNS of_II Fabry_NN 's_GE disease_NN is_VBZ important_JJ for_II genetic_JJ counselling_VVGN since_CS prenatal_JJ diagnosis_NN of_II affected_VVNJ fetuses_NNS is_VBZ possible_JJ ._.
P06290264A03
It_PN caused_VVD biphasic_JJ kinetics_NNS of_II inhibition_NN which_PNR could_VM be_VBB potentiated_VVN by_II ATP_NN ._.
P06300763A04
The_DD nucleotide_NN sequence_NN of_II the_DD longest_JJT cDNA_NN contained_VVN in_II pGET2_NN was_VBD determined_VVN ._.
P06309961A04
Using_VVG Epstein-Barr_NN virus_NN activation_NN or_CC coculture_NN with_II irradiated_VVNJ adult_NN T_NN cells_NNS in_II the_DD presence_NN of_II influenza_NN virus_NN to_TO identify_VVI precursor_NN B_NN cells_NNS for_II anti-viral_JJ antibody_NN production_NN ,_, newborns_NNS were_VBD found_VVN to_TO have_VHI a_DD decreased_VVNJ number_NN of_II influenza-specific_JJ B_NN cells_NNS as_CS compared_VVN with_II adults_NNS ._.
P06314491A06
Our_PNG more_RR recent_JJ studies_NNS support_VVB the_DD notion_NN that_CST loperamide_NN has_VHZ an_DD effect_NN on_II specific_JJ transport_NN systems_NNS rather_II+ than_II non-specific_JJ passive_JJ diffusional_JJ processes_NNS ._.
P06327443A07
It_PN also_RR may_VM provide_VVB a_DD newer_JJR conceptual_JJ basis_NN for_II a_DD more_RR rational_JJ development_NN of_II future_JJ compounds_NNS to_TO antagonize_VVI the_DD lethal_JJ effects_NNS of_II cyanide_NN ._.
P06337311A07
The_DD vast_JJ majority_NN of_II cutaneous_JJ basal_JJ cell_NN and_CC squamous_JJ cell_NN carcinomas_NNS are_VBB easily_RR cured_VVN no_DD matter_NN what_DB the_DD treatment_NN modality_NN ._.
P06343057A02
Moderate_JJ hyperthyroidism_NN increased_VVD the_DD rate_NN of_II glucose_NN turnover_NN ,_, whereas_CS hypothyroidism_NN was_VBD without_II effect_NN ._.
P06349442A07
The_DD procoagulant_NN material_NN was_VBD identified_VVN as_II a_DD cell-associated_VVNJ tissue_NN thromboplastin_NN ,_, acting_VVG via_II the_DD extrinsic_JJ coagulation_NN pathway_NN ._.
P06361809A01
A_DD multiclinic_JJ ,_, collaborative_JJ study_NN has_VHZ been_VBN designed_VVN to_TO assess_VVI the_DD natural_JJ progression_NN and_CC efficacy_NN of_II treatment_NN of_II Duchenne_NN muscular_JJ dystrophy_NN ._.
P06373787A07
In_II extracts_NNS from_II iliotibialis_NN and_CC posterior_JJ latissimus_NN dorsi_NN muscles_NNS of_II adult_NN chickens_NNS ,_, we_PN detected_VVD a_DD hitherto_RR unidentified_VVNJ protein_NN that_PNR was_VBD very_RR similar_JJ to_II vimentin_NN in_II molecular_JJ weight_NN but_CC did_VDD not_RR react_VVB with_II our_PNG antivimentin_NN antibody_NN ._.
P06399229A02
In_II 33_MC patients_NNS (_( 66_MC eyes_NNS )_) who_PNR had_VHD avascular_JJ grafts_NNS ,_, there_EX was_VBD no_DD significant_JJ increase_NN in_II the_DD incidence_NN of_II allograft_NN rejection_NN reaction_NN after_II corneal_JJ transplantation_NN in_II the_DD second_JJ eye_NN ._.
P06405715A12
There_EX was_VBD also_RR a_DD high_JJ mortality_NN rate_NN with_II reoperation_NN for_II thrombosis_NN (_( 30_MC p._NN 100_MC )_) because_II+ of_II the_DD severe_JJ myocardial_JJ dysfunction_NN in_II thrombosis_NN of_II tricuspid_NN prostheses_NNS and_CC the_DD emergency_NN situation_NN associated_VVN with_II mitral_JJ prosthetic_JJ valve_NN thrombosis_NN ._.
P06416857A05
However_RR ,_, none_MC of_II the_DD blood_NN cells_NNS tested_VVN served_VVD as_II acceptor_NN for_II lipolysis-generated_VVNJ free_JJ cholesterol_NN ,_, whereas_CS HDL_NN did_VDD ._.
P06427616A03
The_DD incidence_NN of_II A._NN flavus_NN in_II drought-stressed_VVNJ ,_, unshelled_VVNJ ,_, sound_JJ mature_JJ kernels_NNS (_( SMK_NN )_) decreased_VVD with_II decreases_NNS in_II the_DD mean_NN 5_MC cm_NN deep_JJ soil_NN temperature_NN ._.
P06438173A04
Clinical_JJ studies_NNS support_VVB these_DD findings_NNS ._.
P06458765A01
The_DD uncoupling_VVGN of_II pituitary_NN stimulation_NN and_CC response_NN observed_VVN in_II adults_NNS during_II administration_NN of_II the_DD luteinizing_VVGJ hormone-releasing_VVGJ hormone_NN analogue_NN ,_, D-Trp6-Pro9-NEt-LHRH_NN (_( LHRHa_NN )_) suggested_VVD that_CST this_DD drug_NN might_VM be_VBB useful_JJ in_II treating_VVGN precocious_JJ puberty_NN ._.
P06465252A07
Maternal_JJ plasma_NN epinephrine_NN levels_NNS remained_VVD relatively_RR constant_JJ ,_, whereas_CS fetal_JJ epinephrine_NN levels_NNS increased_VVD fiftyfold_NN from_II day_NN 17_MC to_II day_NN 22_MC ._.
P06476888A03
Relatively_RR speaking_VVG ,_, more_DD men_NNS than_CSN women_NNS died_VVD of_II a_DD thin_JJ melanoma_NN :_: in_II Group_NN 1_MC (_( deceased_VVN )_) there_EX were_VBD 32_MC men_NNS and_CC 28_MC women_NNS ,_, in_II Group_NN 2_MC (_( alive_JJ )_) 58_MC men_NNS and_CC 242_MC women_NNS ._.
P06488185A02
A_DD microscopic_JJ cancer_NN was_VBD found_VVN by_II 24_MC weeks_NNS ,_, and_CC macroscopic_JJ cancers_NNS were_VBD found_VVN after_II 27_MC weeks_NNS ._.
P06499159A02
We_PN studied_VVD the_DD influence_NN of_II time_NN ,_, temperature_NN ,_, glucose_NN concentration_NN ,_, and_CC pH_NN on_II results_NNS obtained_VVN by_II three_MC commercially_RR available_JJ column_NN chromatographic_JJ procedures_NNS designed_VVN to_TO quantify_VVI glycated_VVNJ hemoglobin_NN ._.
P06504800A04
With_II early_JJ diagnosis_NN of_II neck_NN infections_NNS ,_, serious_JJ complications_NNS such_II+ as_II spread_NN to_II vital_JJ structures_NNS ,_, toxicity_NN ,_, airway_NN compromise_NN ,_, and_CC sepsis_NN can_VM be_VBB prevented_VVN ._.
P06510887A14
They_PN are_VBB the_DD most_RRT frequent_JJ cells_NNS after_II 35_MC days_NNS of_II age_NN ._.
P06517985A12
In_II addition_NN ,_, the_DD eicosanoids_NNS released_VVN by_II the_DD injured_VVNJ cell_NN are_VBB apparently_RR able_JJ to_TO participate_VVI in_II the_DD homeostatic_JJ response_NN of_II the_DD cell_NN to_II the_DD injury_NN ._.
P06530836A05
At_II the_DD angle_NN recess_NN ,_, the_DD blood_NN cells_NNS accumulated_VVD in_II the_DD perivascular_JJ connective_JJ tissue_NN of_II the_DD major_JJ arterial_JJ circle_NN of_II the_DD iris_NN ._.
P06538581A12
Physical_JJ activity_NN was_VBD maximal_JJ on_II day_NN of_II estrus_NN in_II 73_MC %_SYM of_II the_DD estrous_JJ periods_NNS ._.
P06572977A01
Murine_JJ erythroleukemia_NN cells_NNS (_( MELC_NN )_) are_VBB virus-transformed_VVNJ erythroid_NN precursors_NNS that_PNR appear_VVB to_TO be_VBI blocked_VVN at_II an_DD erythroid_NN precursor_NN stage_NN comparable_JJ to_II the_DD erythroid_NN colony-forming_VVGJ unit_NN (_( CFU-e_NN )_) ._.
P06590912A03
Nulliparous_JJ women_NNS showed_VVD increased_VVNJ RR_NN (_( 3.9_MC )_) comparable_JJ to_II the_DD RR_NN among_II women_NNS who_PNR first_RR bore_VVB a_DD child_NN at_II age_NN 25_MC or_CC more_PND ,_, regardless_II+ of_II the_DD number_NN of_II births_NNS ._.
P06606416A04
With_II semi-purified_VVNJ IL-2_NN preparations_NNS ,_, clones_NNS of_II spontaneous_JJ cytotoxic_JJ cells_NNS are_VBB also_RR detectable_JJ in_II nu_NN /_SYM nu_NN spleen_NN cultures_NNS ._.
P06617177A01
Fourteen_MC patients_NNS presenting_VVG with_II lumbar_JJ radiculopathy_NN had_VHD normal_JJ or_CC nondiagnostic_JJ plain_JJ radiographs_NNS ,_, myelograms_NNS and_CC polytomes_NNS of_II lumbar_JJ spine_NN ._.
P06628556A02
The_DD effects_NNS of_II the_DD coexistence_NN of_II different_JJ species_NNS of_II mitochondria_NNS on_II cellular_JJ properties_NNS were_VBD examined_VVN in_II these_DD clones_NNS ._.
P06646815A02
Skin_NN biopsy_NN identified_VVD the_DD causative_JJ organism_NN as_II an_DD atypical_JJ mycobacterium_NN of_II the_DD M._NN avium-intracellulare-scrofulaceum_NN (_( MAIS_NN )_) complex_NN ._.
P06673103A03
The_DD study_NN tested_VVD the_DD hypothesis_NN that_CST an_DD excess_NN of_II lung_NN cancer_NN observed_VVN in_II a_DD small_JJ town_NN of_II the_DD Milano_NNP Province_NN in_II Italy_NNP was_VBD attributable_JJ to_II occupational_JJ exposures_NNS in_II a_DD chemical_JJ plant_NN (_( SISAS_NN )_) producing_VVG mainly_RR acetylene_NN ,_, phthalic_JJ anhydride_NN ,_, and_CC their_PNG derivatives_NNS ._.
P06681578A04
The_DD 830_MC episodes_NNS involved_VVD 677_MC children_NNS aged_VVN 1_MC week_NN to_II 17_MC years_NNS :_: 40_MC %_SYM were_VBD 24_MC months_NNS old_JJ or_CC younger_JJR ,_, and_CC 12_MC %_SYM were_VBD 60_MC months_NNS old_JJ or_CC older_JJR ._.
P06691283A07
During_II control_NN state_NN ,_, SVT_NN could_VM be_VBB induced_VVN in_II all_DD patients_NNS ;_: after_CS i.v._NN administration_NN of_II the_DD drug_NN ,_, SVT_NN was_VBD presented_VVN in_II 6_MC patients_NNS in_II Group_NN I_MC and_CC in_II 8_MC patients_NNS in_II Group_NN II_MC ._.
P06701005A02
The_DD amino-acid_NN composition_NN of_II the_DD collagen_NN did_VDD not_RR differ_VVB significantly_RR between_II control_NN and_CC papain-treated_VVNJ groups_NNS ._.
P06711749A03
In_II addition_NN ,_, 79_MC polyps_NNS in_II 36_MC patients_NNS ,_, the_DD majority_NN of_II which_PNR were_VBD also_RR undetected_VVN by_II barium_NN enema_NN ,_, were_VBD found_VVN and_CC removed_VVN at_II colonoscopy_NN ._.
P06727779A04
It_PN appears_VVZ that_CST the_DD risk_NN for_II developing_VVGN solid_NN tumors_NNS becomes_VVZ greatest_JJT when_CS the_DD population_NN enters_VVZ the_DD age_NN group_NN at_II which_PNR that_DD particular_JJ form_NN of_II cancer_NN most_RRT commonly_RR occurs_VVZ ._.
P06744040A02
We_PN now_RR report_VVB experiments_NNS in_II which_PNR memory_NN states_NNS were_VBD established_VVN by_II behavioral_JJ training_VVGN and_CC read_VVN out_II by_II a_DD test_NN procedure_NN applied_VVN to_II the_DD isolated_VVNJ brains_NNS derived_VVN from_II the_DD trained_VVNJ animals_NNS ._.
P06766341A04
One_MC pathway_NN projected_VVNJ through_II the_DD alveus_NN and_CC stratum_NN oriens_NN ,_, with_II results_NNS suggesting_VVG collateral_JJ input_NN to_II the_DD basal_JJ dendritic_JJ pyramidal_JJ cell_NN region_NN ._.
P06778607A02
A_DD number_NN of_II dose_NN schedules_NNS were_VBD used_VVN ,_, the_DD lowest_JJT dose_NN being_VBG 6_MC mg_NN /_SYM kg_NN every_DD fourth_JJ day_NN and_CC the_DD highest_JJT dose_NN being_VBG 6.0_MC mg_NN /_SYM kg_NN twice_RR daily_RR for_II 9_MC days_NNS ;_: the_DD lowest_JJT and_CC highest_JJT doses_NNS produced_VVD treated_VVNJ versus_CC control_NN ratios_NNS of_II 140_MC and_CC 220_MC %_SYM ,_, respectively_RR ._.
P06798562A01
The_DD kinetic_JJ parameters_NNS of_II azoalbumin_NN hydrolysis_NN by_II alkaline_JJ proteinase_NN from_II Bacillus_NN subtilis_NN were_VBD determined_VVN to_TO be_VBI Km_NN =_SYM 1.2_MC ._.
P06812287A05
Analysis_NN of_II the_DD obtained_VVNJ classification_NN system_NN permits_VVZ sufficiently_RR grounded_VVNJ conclusions_NNS to_TO be_VBI drawn_VVN with_II regard_NN to_II the_DD classification_NN position_NN of_II certain_JJ viruses_NNS ,_, the_DD classification_NN of_II which_PNR has_VHZ not_RR yet_RR been_VBN completed_VVN by_II the_DD ICVT_NN ._.
P06836820A04
We_PN believe_VVB that_CST segmental_JJ resection_NN is_VBZ indicated_VVN for_II all_DD low-grade_NN and_CC low-stage_NN primary_JJ ureteral_JJ tumors_NNS regardless_II+ of_II their_PNG location_NN and_CC with_II a_DD small_JJ change_NN for_II recurrence_NN ._.
P06848491A08
Inhibition_NN of_II O-alkyl_NN lipid_NN synthesis_NN by_II means_NNS of_II magnesium_NN or_CC NADPH_NN inhibited_VVD the_DD unusual_JJ cleavage_NN ._.
P06866035A01
Almost_RR all_DD states_NNS have_VHB enacted_VVN legislation_NN ,_, that_PNR allows_VVZ pharmacists_NNS to_TO substitute_VVI drug_NN products_NNS when_CS filling_VVG prescriptions_NNS ._.
P06872256A09
When_CS the_DD assay_NN was_VBD applied_VVN to_II serum_NN samples_NNS from_II a_DD group_NN of_II 39_MC Type_NN I_MC diabetic_JJ children_NNS more_RR than_CSN 90_MC %_SYM of_II the_DD children_NNS exceeded_VVD the_DD normal_JJ range_NN of_II the_DD assay_NN ._.
P06889654A03
The_DD frequencies_NNS of_II Y_NN /_SYM F_NN indices_NNS for_II these_DD groups_NNS were_VBD 0.0_MC ,_, 3.33_MC ,_, 56.67_MC ,_, 30.00_MC ,_, and_CC 10.00_MC %_SYM ,_, respectively_RR ._.
P06895843A02
Rats_NNS with_II two_MC weeks_NNS of_II PCS_NN underwent_VVD BDL_NN ,_, then_RR were_VBD killed_VVN after_II 0_MC ,_, 5_MC or_CC 20_MC hours_NNS ,_, or_CC two_MC or_CC four_MC days_NNS ;_: rats_NNS undergoing_VVG sham_JJ PCS_NN were_VBD used_VVN as_II controls_NNS ._.
P06927539A16
Thus_RR ,_, as_II adults_NNS ,_, COPD_NN children_NNS had_VHD a_DD greater_JJR inspiratory_JJ neural_JJ drive_NN ._.
P06958056A01
There_EX are_VBB only_RR a_DD very_JJ small_JJ number_NN of_II research_NN reports_NNS on_II the_DD effect_NN of_II regular_JJ physical_JJ activity_NN on_II the_DD nervous_JJ system_NN ._.
P06981357A04
The_DD first_JJ site_NN of_II recurrence_NN was_VBD the_DD central_JJ nervous_JJ system_NN in_II three_MC (_( 42_MC %_SYM )_) cases_NNS ._.
P07010135A01
A_DD strain_NN of_II Saccharomyces_NN cerevisiae_NN (_( MH41-7B_NN /_SYM 011_MC )_) was_VBD resistant_JJ to_II petite_JJ induction_NN by_II ethidium_NN bromide_NN at_II 30_MC degrees_NNS ,_, but_CC was_VBD sensitive_JJ to_II induction_NN by_II photolabeling_VVGN with_II ethidium_NN monoazide_NN ._.
P07033388A03
Fresh_JJ adherent_JJ cells_NNS ,_, when_CS added_VVN to_II 24_MC h_NN incubated_VVNJ MNC_NN cultures_NNS before_II ConA_NN stimulation_NN ,_, decreased_VVD LIF_NN production_NN ,_, in_II contrast_NN to_II in_RR+ vitro_RR irradiated_VVNJ or_CC overnight_RR cultured_VVNJ adherent_JJ cells_NNS ._.
P07055824A01
L-idaro-1_NN ,_, 4-lactone_NN was_VBD synthesized_VVN by_II two_MC different_JJ ,_, published_VVNJ methods_NNS :_: (_( 1_MC )_) epimerization_NN of_II monopotassium_NN D-glucarate_NN by_II refluxing_VVGN in_II aqueous_JJ barium_NN hydroxide_NN ,_, and_CC (_( 2_MC )_) oxidation_NN of_II L-iditol_NN by_II heating_VVGN in_II dilute_JJ nitric_JJ acid_NN ._.
P07068280A04
No_DD growth_NN inhibition_NN of_II other_JJ BALB_NN /_SYM c_NN lymphomas_NNS induced_VVN by_II Moloney_NN virus_NN (_( LSTRA_NN )_) ,_, X-rays_NNS (_( RL_NN male_NN I_MC )_) or_CC urethane_NN (_( UR-1_NN )_) was_VBD evident_JJ in_II alloimmune_JJ mice_NNS ._.
P07080855A02
The_DD CT_NN results_NNS seem_VVB to_TO indicate_VVI a_DD possibility_NN to_TO distinguish_VVI between_II superficially_RR and_CC deeply_RR invasive_JJ tumours_NNS ._.
P07094791A08
Thus_RR ,_, lipids_NNS are_VBB emptied_VVN more_RR slowly_RR than_CSN any_DD other_JJ component_NN of_II an_DD ordinary_JJ meal_NN ,_, and_CC this_PND is_VBZ not_RR due_JJ only_RR to_II layering_VVGN of_II fat_NN above_II water_NN ._.
P07116618A02
The_DD symptom_NN scores_NNS were_VBD related_VVN to_II duration_NN of_II breast-feeding_VVGN ._.
P07130636A02
This_DD paper_NN tests_VVZ the_DD hypothesis_NN for_II black_NN and_CC white_NN differences_NNS by_II age_NN in_II cancer_NN incidence_NN rates_NNS ._.
P07146582A02
The_DD percentage_NN of_II rats_NNS affected_VVN and_CC the_DD bilirubin_NN levels_NNS reached_VVN are_VBB higher_JJR between_II the_DD 3rd_JJ and_CC 6th_JJ day_NN after_II the_DD anoxic_JJ episode_NN ._.
P07171240A02
Preparation_NN of_II a_DD full_JJ length_NN cDNA_NN and_CC its_PNG cloning_VVGN in_II E._NN coli_NN have_VHB lead_VVN to_II the_DD demonstration_NN that_CST the_DD polypeptides_NNS of_II thyroglobulin_NN protomers_NNS were_VBD identical_JJ ._.
P07189159A06
Non-invasive_JJ examination_NN of_II the_DD heart_NN is_VBZ advised_VVN before_II beta-adrenergic_JJ drugs_NNS are_VBB given_VVN ._.
P07206839A04
Continuity_NN consistently_RR increased_VVD with_II patient_NN age_NN ,_, but_CC appeared_VVD unrelated_VVN to_II several_JJ other_JJ variables_NNS ._.
P07221512A05
A_DD ratio_NN of_II specific_JJ cells_NNS to_II connective_JJ tissue_NN below_II 0.2_MC in_II the_DD sinu-atrial_JJ node_NN is_VBZ highly_RR suggestive_JJ of_II nodal_JJ dysfunction_NN ._.
P07235613A05
Both_CC red_JJ cell_NN rigidity_NN (_( 71_MC +/-_SYM 20_MC mmHg_NN )_) and_CC red_JJ cell_NN fragility_NN (_( 142_MC +/-_SYM 95_MC mg_NN /_SYM l_NN )_) were_VBD significantly_RR higher_JJR (_( p_NN les_RR than_CSN 0.0025_MC )_) than_CSN in_II the_DD control_NN group_NN (_( 54_MC +/-_SYM 10_MC mmHg_NN and_CC 63_MC +/-_SYM 29_MC mg_NN /_SYM l_NN ,_, respectively_RR )_) ._.
P07249318A05
Calcification_NN was_VBD noted_VVN in_II 11_MC of_II 18_MC intracardiac_JJ porcine_JJ valves_NNS and_CC in_II none_MC of_II the_DD extracardiac_JJ valved_VVNJ conduits_NNS ._.
P07263709A05
On_II the_DD other_JJ hand_NN ,_, the_DD absorption_NN spectra_NNS of_II alpha_NN 2+_MC beta_NN 3+_MC )_) 2_MC and_CC (_( alpha_NN 3+_MC beta_NN 2+_MC )_) 2_MC changed_VVD with_II excellent_JJ isosbestic_JJ points_NNS during_II th_DD reductive_JJ reaction_NN by_II ferredoxin-NADP_NN reductase_NN system_NN ,_, i.e._II (_( alpha_NN 2+_MC beta_NN 3+_MC )_) 2_MC at_II 526_MC and_CC 601_MC nm_NN and_CC (_( alpha_NN 3+_MC beta_NN 2+_MC )_) 2_MC at_II 529_MC and_CC 599_MC nm_NN ._.
P07279044A05
This_DD inhibition_NN depended_VVD on_II the_DD grating_VVGJ spatial_JJ frequencies_NNS ._.
P07302292A04
The_DD following_VVGJ organelles_NNS ,_, characterised_VVN by_II their_PNG marker_NN enzymes_NNS were_VBD located_VVN in_II the_DD density_NN gradients_NNS ;_: plasma_NN membrane_NN (_( 5'-nucleotidase_NN )_) brush_NN border_NN (_( alpha-glucosidase_NN ,_, pH_NN 6.0_MC )_) mitochondria_NNS (_( particulate_JJ malate_NN dehydrogenase_NN )_) ,_, peroxisomes_NNS (_( catalase_NN )_) ,_, lysosomes_NNS (_( N-acetyl-beta-glucosaminidase_NN )_) ,_, endoplasmic_JJ reticulum_NN (_( alpha-glucosidase_NN ,_, pH_NN 8.0_MC )_) ,_, cytosol_NN (_( lactate_NN dehydrogenase_NN )_) ._.
P07317612A04
The_DD peak_NN of_II the_DD activity_NN curve_NN of_II adrenergic_JJ fibers_NNS has_VHZ been_VBN fond_VVN to_TO coincide_VVI with_II the_DD activity_NN peak_NN at_II 12_MC o'clock_NN ._.
P07333957A09
Amoeboid_JJ microglia_NNS with_II large_JJ vacuoles_NNS were_VBD not_RR present_VVB in_II the_DD prenatal_JJ spinal_JJ cord_NN ._.
P07358752A03
The_DD knees_NNS were_VBD extended_VVN from_II 90_MC to_II zero_MC degrees_NNS by_II applying_VVGN tension_NN to_II the_DD quadriceps_NN tendon_NN with_II the_DD force_NN of_II gravity_NN as_II the_DD only_JJ resistance_NN ,_, and_CC separation_NN of_II the_DD fracture_NN fragments_NNS was_VBD measured_VVN first_RR with_II the_DD retinaculum_NN unrepaired_VVN and_CC then_RR again_RR with_II the_DD retinaculum_NN repaired_VVN ._.
P07380851A05
The_DD greater_JJR average_NN improvement_NN (_( 36_MC points_NNS )_) in_II this_DD group_NN was_VBD due_JJ primarily_RR to_II the_DD absence_NN of_II any_DD major_JJ complications_NNS ._.
P07396827A03
Labelling_VVGJ experiments_NNS with_II [_( 35S_NN ]_) methionine_NN followed_VVN by_II radioautography_NN or_CC gel_NN electrophoresis_NN and_CC fluorography_NN showed_VVD the_DD presence_NN of_II label_NN only_RR in_II epithelial_JJ proteins_NNS ._.
P07404165A06
Just_CS+ as_CS appendicitis_NN is_VBZ a_DD marker_NN of_II westernization_NN in_II young_JJ urban_JJ Blacks_NNS ,_, hiatus_NN hernia_NN may_VM be_VBB regarded_VVN as_II a_DD marker_NN in_II the_DD middle-aged_NN and_CC elderly_NN ._.
P07425225A01
The_DD technique_NN of_II preservation_NN of_II the_DD antral_JJ vagal_JJ nerve_NN supply_NN of_II the_DD stomach_NN and_CC division_NN of_II the_DD gastric_JJ branches_NNS of_II the_DD nerves_NNS of_II Latarjet_NN remains_VVZ unchanged_VVN ._.
P07437995A01
The_DD population_NN of_II 42_MC adolescents_NNS admitted_VVN to_II the_DD Sunnybrook_NNP Adolescent_NN Unit_NN in_II 1977_MC is_VBZ described_VVN and_CC compared_VVN with_II other_JJ populations_NNS of_II general_JJ hospital_NN units_NNS previously_RR presented_VVN in_II the_DD literature_NN ,_, in_II order_NN to_TO derive_VVI implications_NNS for_II patient_NN selection_NN ,_, treatment_NN techniques_NNS and_CC outcome_NN ._.
P07457757A02
The_DD histopathology_NN in_II two_MC additional_JJ cases_NNS ,_, in_II which_PNR the_DD disease_NN process_NN was_VBD advanced_VVN and_CC uncontrolled_VVN ,_, is_VBZ presented_VVN to_TO illustrate_VVI the_DD unique_JJ progression_NN of_II temporal_JJ bone_NN osteomyelitis_NN due_II+ to_II the_DD Pseudomonas_NN organism_NN ._.
P07464093A07
The_DD model_NN was_VBD found_VVN useful_JJ for_II test_NN and_CC calibration_NN of_II detecting_VVGN cells_NNS and_CC for_II teaching_VVGJ purposes_NNS ._.
P07480533A01
Genetic_JJ differences_NNS in_II ethanol_NN 's_GE ability_NN to_TO induce_VVI conditioned_VVNJ place_NN preference_NN were_VBD studied_VVN in_II 20_MC BXD_NN Recombinant_JJ Inbred_VVNJ (_( RI_NN )_) mouse_NN strains_NNS and_CC in_II the_DD C57BL_NN /_SYM 6J_NN and_CC DBA_NN /_SYM 2J_NN progenitor_NN strains_NNS ._.
P07485344A02
STUDY_NN DESIGN_NN :_: Women_NNS with_II intact_JJ membranes_NNS participating_VVG in_II a_DD National_NN Institute_NN of_II Child_NN Health_NN and_CC Human_NN Development_NN multicenter_NN randomized_VVNJ trial_NN of_II adjunctive_JJ antibiotic_JJ therapy_NN for_II preterm_NN labor_NN (_( 24_MC to_II 34_MC weeks_NNS )_) were_VBD studied_VVN (_( n_NN =_SYM 275_MC )_) ._.
P07489792A05
Oxidation_NN of_II GSH_NN to_II glutathione_NN disulphide_NN (_( GSSG_NN )_) by_II BA-cell_NN derived_VVNJ oxidants_NNS was_VBD detected_VVN as_II a_DD decline_NN of_II GSH_NN in_II the_DD supernatants_NNS ._.
P07494154A03
A_DD generalized_VVNJ interface_NN condition_NN is_VBZ derived_VVN to_TO replace_VVI the_DD usual_JJ condition_NN of_II continuity_NN of_II intensity_NN ._.
P07498682A15
Therefore_RR ,_, permanent_JJ biliary_JJ stenting_VVGN should_VM preferably_RR be_VBB restricted_VVN to_II patients_NNS unfit_JJ for_II elective_JJ treatment_NN at_II a_DD later_JJR stage_NN and_CC with_II a_DD short_JJ life_NN expectancy_NN ._.
P07507261A03
The_DD obstructive_JJ symptoms_NNS were_VBD relieved_VVN in_II all_DD patients_NNS ;_: however_RR ,_, 6_MC patients_NNS had_VHD lasting_VVGJ irritative_JJ symptoms_NNS ,_, 2_MC of_II whom_PNR were_VBD cured_VVN after_II TURP_NN ._.
P07514976A04
Furthermore_RR ,_, cefepime_NN was_VBD as_RR effective_JJ as_CSN ceftazidime_NN and_CC piperacillin_NN or_CC mezlocillin_NN in_II combination_NN with_II gentamicin_NN when_CS administered_VVN as_II empirical_JJ treatment_NN for_II fever_NN in_II patients_NNS with_II neutropenia_NN ._.
P07519025A06
We_PN propose_VVB that_CST p75LNTR_NN normally_RR acts_VVZ to_TO increase_VVI binding_VVGN of_II NGF_NN to_II TrkA_NN ,_, possibly_RR by_II increasing_VVGN the_DD local_JJ NGF_NN concentration_NN in_II the_DD microenvironment_NN surrounding_VVG the_DD cell_NN surface_NN TrkA_NN receptor_NN ._.
P07522948A14
Maximum_NN mobilization_NN was_VBD recorded_VVN at_II day_NN 11_MC of_II the_DD first_JJ cycle_NN ._.
P07530803A04
Given_VVN the_DD low_JJ (_( micromolar_JJ )_) potency_NN of_II SP_NN analogs_NNS at_II displacing_VVGN [_( 3H_NN ]_) -DTG_NN binding_VVGN in_II the_DD present_JJ series_NN of_II experiments_NNS ,_, it_PN is_VBZ unlikely_RR that_CST the_DD similar_JJ behavioral_JJ effects_NNS we_PN have_VHB previously_RR observed_VVN elicited_VVN by_II SP_NN (_( 1-7_MC )_) and_CC DTG_NN in_II the_DD adult_JJ mouse_NN are_VBB a_DD result_NN of_II a_DD direct_JJ action_NN of_II SP_NN (_( 1-7_MC )_) at_II the_DD sigma_NN binding_VVGJ site_NN ._.
P07534827A17
The_DD others_NNS either_CC showed_VVD regular_JJ spontaneous_JJ activity_NN ,_, or_CC their_PNG time-interval_NN histograms_NNS showed_VVD longer_JJR modes_NNS than_CSN ascending_VVGJ fibers_NNS ._.
P07542701A04
However_RR ,_, since_CS none_MC of_II the_DD receptor_NN antagonists_NNS nor_CC transport_NN blockers_NNS tested_VVN could_VM inhibit_VVB dopamine_NN 's_GE action_NN ,_, the_DD mechanism_NN remains_VVZ obscure_JJ ._.
P07551121A03
Specifically_RR ,_, neuropsychological_JJ deficits_NNS regularly_RR occur_VVB on_II measures_NNS of_II recent_JJ memory_NN ,_, attention_NN ,_, information-processing_VVGJ speed_NN ,_, executive_JJ functions_NNS ,_, and_CC visuospatial_JJ perception_NN ._.
P07559742A02
For_II the_DD preparation_NN of_II a_DD GM-CSF_NN gene-modified_VVNJ tumor_NN vaccine_NN ,_, it_PN is_VBZ important_JJ to_TO achieve_VVI efficient_JJ genetic_JJ transduction_NN of_II tumor_NN cells_NNS ,_, leading_VVG to_II an_DD appropriate_JJ expression_NN of_II the_DD induced_VVNJ gene_NN ._.
P07564268A09
Apoptotic_JJ cells_NNS were_VBD recognized_VVN by_II their_PNG characteristic_JJ histologic_JJ and_CC ultrastructural_JJ features_NNS and_CC by_II in_JJ+ situ_JJ detection_NN of_II nuclear_JJ DNA_NN fragmentation_NN ._.
P07573781A03
The_DD amplitudes_NNS of_II N1_NN ,_, P2_NN ,_, and_CC the_DD mismatch_JJ negativity_NN (_( MMN_NN )_) were_VBD significantly_RR diminished_VVN by_II alcohol_NN ._.
P07578022A10
Values_NNS of_II delta_NN GU_NN zero_MC obtained_VVN with_II Gdn-HCl_NN and_CC urea_NN were_VBD in_II good_JJ agreement_NN ,_, as_CS were_VBD values_NNS obtained_VVN from_II linear_JJ extrapolation_NN and_CC nonlinear_JJ regression_NN fitting_VVGN to_II a_DD two-state_NN equilibrium_NN ._.
P07582551A13
Acute_JJ antihypertensive_JJ calcium_NN blockade_NN with_II a_DD single_JJ isradipine_NN dose_NN (_( 2.6_MC mg_NN kg-1_NN day-1_NN )_) caused_VVD a_DD similar_JJ shift_NN in_II the_DD pressure-distensibility_NN curve_NN toward_II the_DD WKY_NN curve_NN although_CS the_DD histomorphometric_JJ composition_NN of_II the_DD arterial_JJ wall_NN differed_VVD significantly_RR from_II that_PND of_II chronically_RR treated_VVNJ animals_NNS ._.
P07590877A08
The_DD oestrogen-mediated_VVNJ effects_NNS on_II serum_NN IL-6_NN were_VBD consistent_JJ with_II a_DD reduction_NN in_II IL-6_NN mRNA_NN in_II peritoneal_JJ macrophages_NNS from_II oestrogen-treated_VVNJ mice_NNS ._.
P07599250A04
Copper_NN deficiency_NN decreased_VVD the_DD activity_NN level_NN of_II ceruloplasmin_NN in_II the_DD serum_NN of_II young_JJ and_CC old_JJ rats_NNS by_II 95_MC %_SYM ,_, and_CC the_DD copper_NN /_SYM zinc_NN superoxide_NN dismutase_NN (_( CuZn-SOD_NN )_) activity_NN levels_NNS of_II cerebrums_NNS ,_, lungs_NNS ,_, and_CC livers_NNS of_II young_JJ rats_NNS by_II 16_MC ,_, 36_MC ,_, and_CC 34_MC %_SYM ,_, respectively_RR ,_, but_CC did_VDD not_RR change_VVB the_DD CuZn-SOD_NN activity_NN levels_NNS of_II tissues_NNS of_II old_JJ rats_NNS ._.
P07608159A01
The_DD major_JJ apurinic_NN /_SYM apyrimidinic_NN (_( AP_NN )_) endonuclease_NN of_II human_NN cells_NNS ,_, the_DD Ape_NN protein_NN ,_, incises_VVZ DNA_NN adjacent_JJ to_II abasic_JJ sites_NNS to_TO initiate_VVI DNA_NN repair_NN and_CC counteract_VVI the_DD cytotoxic_JJ and_CC mutagenic_JJ effects_NNS of_II AP_NN sites_NNS ._.
P07612608A04
In_II the_DD present_JJ study_NN ,_, chromogranin_NN B_NN was_VBD purified_VVN to_TO complete_VVI homogeneity_NN in_II its_PNG native_JJ state_NN from_II the_DD secretory_JJ vesicle_NN lysates_NNS of_II bovine_JJ adrenal_JJ chromaffin_NN cells_NNS using_VVG several_JJ chromatographic_JJ and_CC electrophoresis_NN steps_NNS ._.
P07617168A09
Oxytocin-induced_VVNJ Ca2+_NN transients_NNS (_( 0.32-1000_MC nM_NN )_) ,_, which_PNR were_VBD observed_VVN in_II 32_MC %_SYM (_( 63_MC %_SYM )_) or_CC organum_NN vasculosum_NN laminae_NN terminalis_NN and_CC in_II 54_MC %_SYM (_( 42_MC %_SYM )_) of_II subfornical_JJ organ_NN neurons_NNS (_( astrocytes_NNS )_) ,_, were_VBD not_RR affected_VVN by_II the_DD V1-specific_JJ antagonist_NN ._.
P07626088A03
However_RR ,_, it_PN is_VBZ still_RR unknown_VVN whether_CST G_NN beta_NN gamma_NN directly_RR interacts_VVZ with_II GIRK1_NN ._.
P07635327A04
Depression_NN is_VBZ a_DD modifiable_JJ risk_NN factor_NN for_II suicide_NN in_II old_JJ age_NN ._.
P07639957A11
Systemic_JJ blood_NN pressure_NN and_CC benzylamine_NN oxidase_NN activity_NN were_VBD not_RR significantly_RR affected_VVN by_II allylamine_NN or_CC by_II ethanol_NN ._.
P07644388A13
At_II any_DD dose_NN ,_, the_DD control_NN diet_NN group_NN maintained_VVD a_DD greater_JJR intake_NN on_II Day_NN 1_MC than_CSN the_DD other_JJ two_MC diet_NN groups_NNS ._.
P07654020A07
4MA_NN was_VBD administered_VVN to_II male_NN Copenhagen_NN rats_NNS bearing_VVG R3327-H_NN androgen_NN dependent_JJ prostate_NN tumors_NNS and_CC levels_NNS of_II different_JJ androgens_NNS in_II serum_NN and_CC prostate_NN tumor_NN were_VBD measured_VVN using_VVG reversed_VVNJ phase_NN HPLC_NN and_CC radioimmunoassay_NN ._.
P07667811A02
We_PN conducted_VVD a_DD cross-sectional_JJ survey_NN in_II which_PNR 1072_MC French_JJ general_JJ practitioners_NNS (_( GPs_NNS )_) were_VBD evaluated_VVN for_II their_PNG basic_JJ pharmacological_JJ knowledge_NN and_CC practice_NN of_II NSAIDs_NNS prescription_NN ._.
P07672527A10
CONCLUSIONS_NNS --_: We_PN demonstrated_VVD a_DD significative_JJ difference_NN of_II therapeutic_JJ modalities_NNS between_II these_DD different_JJ french_JJ geographic_JJ areas_NNS concerning_VVG adjuvant_NN radiotherapy_NN and_CC chemotherapy_NN ._.
P07681036A08
Finally_RR ,_, no_DD apparent_JJ direct_JJ correlation_NN was_VBD found_VVN between_II the_DD ability_NN of_II individual_JJ anti-CD23_NN mAb_NN to_TO alter_VVI IgE_NN binding_VVGN to_II cell-associated_VVNJ CD23_NN and_CC their_PNG ability_NN to_TO modulate_VVI IgE_NN production_NN by_II PBMNC_NN ._.
P07684800A11
This_DD methodology_NN can_VM be_VBB used_VVN to_TO purify_VVI other_JJ cell_NN types_NNS ,_, including_VVG T_NN and_CC B_NN lymphocytes_NNS ._.
P07692657A12
One_MC hundred-sixty_MC patients_NNS underwent_VVD radical_JJ prostatectomy_NN and_CC pathologic_JJ staging_VVGN ._.
P07701466A02
This_PND was_VBD an_DD unexpected_VVNJ finding_VVGN but_CC explained_VVD the_DD progressive_JJ airflow_NN limitation_NN which_PNR characterised_VVD the_DD patient_NN 's_GE clinical_JJ course_NN ._.
P07715104A01
To_TO examine_VVI crosstalks_NNS (_( CRs_NNS )_) between_II 99mTc-methoxyisobutyl_NN isonitrile_NN (_( MIBI_NN )_) and_CC beta-methyl-p-_NN (_( 123I_NN )_) iodophenyl-pentadecanoic_JJ acid_NN (_( BMIPP_NN )_) ,_, myocardial_JJ phantom_NN studies_NNS of_II simultaneous_JJ acquisition_NN were_VBD performed_VVN with_II three_MC window_NN widths_NNS and_CC four_MC energies_NNS where_PNR the_DD window_NN located_VVN ._.
P07724307A04
All_DD male_NN newborns_NNS born_VVN in_II a_DD community_NN hospital_NN between_II November_NN 1_MC ,_, 1989_MC and_CC August_NN 31_MC ,_, 1990_MC ,_, and_CC circumcised_VVN after_II DPNB_NN were_VBD evaluated_VVN ._.
P07733788A02
Pregnant_JJ rats_NNS fed_VVN omega_NN 3_MC deficient_JJ diets_NNS were_VBD divided_VVN at_II parturition_NN into_II three_MC groups_NNS ._.
P07738246A07
Simultaneous_JJ isolation_NN of_II other_JJ mastitis_NN pathogens_NNS was_VBD not_RR significantly_RR associated_VVN with_II occurrence_NN of_II Staph_NN ._.
P07742853A01
Urologic_JJ problems_NNS are_VBB a_DD major_JJ source_NN of_II morbidity_NN for_II patients_NNS with_II multiple_JJ sclerosis_NN (_( MS_NN )_) ._.
P07747411A05
The_DD procedure_NN was_VBD repeated_VVN on_II day_NN 28_MC ._.
P07751814A07
The_DD elongated_VVNJ and_CC desaturated_VVNJ metabolites_NNS of_II oleate_NN were_VBD preferentially_RR esterified_VVN in_II cellular_JJ triglyceride_NN when_CS oleate_NN was_VBD delivered_VVN as_II free_JJ oleate_NN ,_, but_CC they_PN were_VBD preferentially_RR esterified_VVN in_II phospholipids_NNS when_CS oleate_NN was_VBD delivered_VVN as_II triolein_NN in_II LDL_NN ._.
P07765360A01
The_DD inhibition_NN of_II wheat_NN Ca_NN (_( 2+_MC )_) -dependent_JJ protein_NN kinase_NN (_( CDPK_NN )_) by_II substituted_VVNJ acridines_NNS and_CC substituted_VVNJ 5-_MC ,_, 6-_MC ,_, 7-_MC and_CC 8-azaacridines_NNS (_( 5-AA_NN ,_, 6-AA_NN ,_, 7-AA_NN and_CC 8-AA_NN )_) was_VBD examined_VVN ._.
P07774109A04
No_DD differences_NNS in_II the_DD capillaroscopic_JJ pattern_NN were_VBD found_VVN between_II rheumatoid_JJ factor_NN positive_JJ and_CC rheumatoid_JJ factor_NN negative_JJ patients_NNS ._.
P07783062A06
Concomitant_JJ administration_NN of_II nonsteroidal_JJ antiinflammatories_NNS ,_, corticosteroids_NNS ,_, or_CC antimalarials_NNS was_VBD not_RR permitted_VVN ._.
P07787842A06
Rapamycin_NN inhibited_VVD PTTH-stimulated_VVNJ synthesis_NN of_II p50_NN and_CC p70_NN ,_, suggesting_VVG that_CST specific_JJ protein_NN synthesis_NN is_VBZ also_RR required_VVN for_II PTTH-stimulated_VVNJ ecdysteroidogenesis_NN ,_, confirming_VVG the_DD results_NNS of_II Rybczynski_NNP and_CC Gilbert_NNP [_( (_( 1994_MC )_) Insect_NN Biochem._NN Molec._NN Biol._NN 24_MC ,_, 175-189_MC ]_) ,_, and_CC that_CST p34_NN phosphorylation_NN may_VM regulate_VVB the_DD downstream_JJ synthesis_NN of_II p50_NN and_CC p70_NN ,_, possible_JJ key_JJ regulatory_JJ proteins_NNS leading_VVG to_II ecdysteroidogenesis_NN ._.
P07797013A03
METHODS_NNS :_: HLA-B27_NN rats_NNS and_CC Fisher_NN 344_MC male_NN controls_NNS were_VBD used_VVN for_II these_DD studies_NNS ._.
P07811113A02
Nine_MC years_NNS later_RR ,_, he_PN presented_VVD with_II an_DD intracerebral_JJ germ_NN cell_NN tumor_NN affecting_VVG both_CC the_DD suprasellar_JJ ventricles_NNS and_CC the_DD pineal_JJ area_NN ._.
P07815223A10
Clinical_JJ evidence_NN of_II thrombosis_NN was_VBD found_VVN in_II 69_MC %_SYM of_II patients_NNS with_II ,_, versus_CC 27_MC %_SYM of_II patients_NNS without_II ,_, ultrasound-proved_VVNJ thrombosis_NN (_( p_NN =_SYM 0.007_MC )_) ._.
P07824541A06
Increased_VVNJ standing_VVGN with_II clonidine_NN and_CC the_DD medium_JJ dose_NN of_II yohimbine_NN may_VM also_RR reflect_VVB sedation_NN ._.
P07833902A01
The_DD purpose_NN of_II this_DD article_NN is_VBZ to_TO highlight_VVI the_DD complex_JJ interrelationship_NN between_II the_DD family_NN and_CC psychoactive_JJ substance_NN dependence_NN and_CC the_DD important_JJ role_NN of_II the_DD family_NN in_II the_DD prevention_NN ,_, treatment_NN ,_, rehabilitation_NN and_CC social_JJ reintegration_NN of_II substance-dependent_JJ persons_NNS ._.
P07838631A18
123_MC (_( 57_MC %_SYM )_) saw_VVD their_PNG MAC_NN provider_NN within_II one_MC week_NN of_II the_DD denied_VVNJ PED_NN visit_NN ._.
P07843062A02
The_DD instrumentation_NN systems_NNS tested_VVN were_VBD the_DD Canal_NN Master_NN and_CC a_DD standard_JJ circumferential_JJ filing_VVGJ technique_NN in_II which_PNR conventional_JJ K-files_NNS were_VBD used_VVN ._.
P07847520A15
Oral_JJ contraceptive_JJ pills_NNS should_VM not_RR be_VBB contraindicated_VVN in_II normotensive_JJ women_NNS ._.
P07856748A09
In_II senile_JJ plaques_NNS ,_, copper_NN ,_, zinc-superoxide_NN dismutase-positive_JJ globular_JJ structures_NNS were_VBD surrounded_VVN by_II astrocytes_NNS highly_RR enriched_VVN in_II manganese-superoxide_NN dismutase_NN ._.
P07865772A01
Antisense_NN oligodeoxynucleotide_NN complementary_JJ to_II the_DD start_NN coding_VVGJ region_NN of_II rat_NN corticotropin_NN releasing_VVGJ hormone_NN (_( CRH_NN )_) mRNA_NN was_VBD intracerebroventricularly_RR infused_VVN into_II rats_NNS three_MC times_NNS at_II 12-h_NN intervals_NNS ._.
P07870183A09
Removal_NN of_II extracellular_JJ Ca2+_NN from_II the_DD medium_NN reduced_VVD ATP-_NN and_CC electrically_RR induced_VVD overflow_NN by_II about_RR 95_MC %_SYM ._.
P07879604A04
This_DD rare_JJ subtype_NN occurring_VVG in_II very_JJ old_JJ (_( over_RR 80_MC years_NNS of_II age_NN )_) subjects_NNS that_PNR does_VDZ not_RR fall_VVB within_II the_DD currently_RR used_VVNJ neuropathological_JJ criteria_NNS for_II diagnosis_NN of_II AD_NN warrants_VVZ further_RR clinico-pathological_JJ documentation_NN ._.
P07888933A04
SUBJECTS_NNS --_: 2004_MC subjects_NNS aged_VVN 35-64_MC years_NNS were_VBD screened_VVN for_II hypercholesterolaemia_NN ;_: 163_MC men_NNS and_CC 146_MC women_NNS with_II a_DD repeat_NN total_JJ cholesterol_NN concentration_NN of_II 6.0-8.5_MC mmol_NN /_SYM l_NN entered_VVD the_DD trial_NN ._.
P07893188A06
The_DD epimerization_NN of_II morphine_NN and_CC dihydromorphine_NN and_CC their_PNG N-substituted_VVNJ derivatives_NNS evoked_VVD only_RR slight_JJ changes_NNS in_II opioid_NN activities_NNS in_RR+ vitro_RR ._.
P07901963A02
Plasma_NN atrial_JJ natriuretic_JJ factor_NN (_( ANF_NN )_) ,_, vasopressin_NN (_( Vas_NN )_) ,_, and_CC dynorphin_NN A_NN (_( Dyn_NN A_NN )_) were_VBD measured_VVN by_II radioimmunoassay_NN ._.
P07911484A04
They_PN all_PND harboured_VVD C._NN difficile_NN in_II their_PNG stools_NNS ._.
P07920572A02
Several_JJ works_NNS demonstrated_VVD that_CST acetylated_VVNJ carbohydrate_NN derivatives_NNS derived_VVN from_II hemicellulose_NN played_VVD a_DD primary_JJ role_NN in_II the_DD outbreak_NN and_CC that_CST uronic_JJ acid_NN residues_NNS were_VBD present_JJ in_II the_DD carbohydrate_NN derivatives_NNS ._.
P07925018A05
A_DD maximal_JJ inhibition_NN of_II 50_MC %_SYM was_VBD observed_VVN ._.
P07929195A06
Binding_VVGN of_II LPS_NN to_II Hb_NN also_RR was_VBD demonstrated_VVN wiht_II a_DD radiolabeled_VVNJ LPS_NN photoaffinity_NN probe_NN ._.
P07933217A08
We_PN recommend_VVB that_CST all_DD users_NNS of_II such_DD lasers_NNS acquire_VVB a_DD laser_NN meter_NN to_TO allow_VVI monitoring_VVGN of_II the_DD energy_NN delivered_VVN by_II the_DD fiber_NN tip_NN ._.
P07947529A02
To_TO investigate_VVI the_DD efficacy_NN of_II 800_MC micrograms_NNS misoprostol_NN (_( a_DD PGE1_NN analogue_NN )_) when_CS administered_VVN to_II women_NNS pretreated_VVN with_II mifepristone_NN for_II early_JJ pregnancy_NN termination_NN ._.
P07952114A01
An_DD improved_VVNJ method_NN for_II the_DD simultaneous_JJ determination_NN of_II cocaine_NN and_CC benzoylecgonine_NN by_II means_NNS of_II gas_NN chromatography_NN with_II nitrogen-phosphorus_NN detection_NN is_VBZ described_VVN ._.
P07965042A02
We_PN have_VHB made_VVN a_DD polyclonal_JJ antiserum_NN to_II the_DD protein_NN product_NN of_II the_DD Dlx-2_NN gene_NN ._.
P07969805A06
These_DD data_NNS suggest_VVB that_CST metabotropic_JJ glutamate_NN receptors_NNS are_VBB involved_VVN in_II NTS_NN and_CC NRA_NN regulation_NN of_II cardiorespiratory_JJ functions_NNS ._.
P07983470A01
When_CS Ss_NNS are_VBB required_VVN to_TO recall_VVI lists_NNS containing_VVG both_CC words_NNS and_CC digits_NNS ,_, memory_NN span_NN is_VBZ higher_JJR when_CS the_DD digits_NNS precede_VVB the_DD words_NNS than_CSN when_CS the_DD words_NNS precede_VVB the_DD digits_NNS ._.
P07988197A08
Further_JJ studies_NNS seem_VVB justified_VVN to_TO investigate_VVI the_DD role_NN of_II the_DD surfactant_NN system_NN in_II interstitial_JJ lung_NN diseases_NNS as_CC+ well_CC+ as_CC the_DD potential_JJ clinical_JJ usefulness_NN of_II SP-A_NN measurements_NNS in_II BAL_NN ._.
P07997241A05
Our_PNG data_NNS suggest_VVB that_CST p56lck_NN contains_VVZ both_CC positive_JJ and_CC negative_JJ regulatory_JJ sites_NNS which_PNR are_VBB constantly_RR dephosphorylated_VVN at_II an_DD unexpectedly_RR high_JJ rate_NN by_II cellular_JJ phosphotyrosine_NN phosphatases_NNS ._.
P08006339A04
Transsphenoidal_JJ resection_NN of_II the_DD pituitary_NN adenomas_NNS were_VBD performed_VVN in_II all_DD patients_NNS ._.
P08011632A06
Fluorescence_NN studies_NNS indicated_VVD that_CST GS-alpha-lactalbumin_NN showed_VVD a_DD [_( NaCl_NN ]_) -dependent_JJ partial_JJ shift_NN toward_II a_DD more_RR nativelike_JJ state_NN ,_, which_PNR was_VBD enhanced_VVN by_II the_DD presence_NN of_II Ca2+_NN ions_NNS ._.
P08016025A12
These_DD results_NNS suggest_VVB that_CST increasing_VVGJ age_NN does_VDZ not_RR diminish_VVB the_DD relation_NN between_II health_NN beliefs_NNS and_CC health_NN behaviors_NNS ._.
P08025020A06
3_MC )_) Sensitivity_NN to_II anticancer_NN agents_NNS on_II NUTLC-1_NN and_CC NUTLC-3_NN cells_NNS differed_VVD individually_RR according_II+ to_II methylthiazol_NN tetrazorium_NN (_( bromide_NN )_) (_( MTT_NN )_) colorimetric_JJ assay_NN ._.
P08029499A09
A_DD key_JJ first_JJ step_NN is_VBZ the_DD determination_NN of_II a_DD skin-to-air_NN or_CC skin-to-medium_NN partition_NN coefficient_NN to_TO estimate_VVI a_DD potential_NN for_II dermal_JJ absorption_NN ._.
P08043519A06
Although_CS the_DD detailed_VVNJ molecular_JJ mechanisms_NNS of_II drug_NN action_NN are_VBB not_RR known_VVN ,_, protein_NN phosphorylations_NNS may_VM be_VBB involved_VVN ,_, since_CS drug-induced_VVNJ stimulation_NN could_VM be_VBB abrogated_VVN by_II several_JJ protein_NN kinase_NN inhibitors_NNS ._.
P08056658A05
Significant_JJ differences_NNS were_VBD observed_VVN among_II breeds_NNS in_II all_DD measures_NNS of_II gain_NN efficiency_NN ._.
P08061263A08
Compared_VVN to_II hemodynamics_NNS at_II induction_NN ,_, there_EX were_VBD no_DD clinically_RR significant_JJ changes_NNS following_VVG administration_NN of_II pipecuronium_NN or_CC doxacurium_NN ._.
P08070317A10
p-Hydroxyamphetamine_NN was_VBD primarily_RR excreted_VVN into_II urine_NN as_II the_DD conjugated_VVNJ form_NN ._.
P08079104A10
RESULTS_NNS :_: Three_MC patients_NNS in_II group_NN B_NN were_VBD lost_VVN to_II follow-up_NN for_II various_JJ reasons_NNS ,_, and_CC only_RR seven_MC remained_VVD eligible_JJ for_II final_JJ analysis_NN ._.
P08083751A07
The_DD Ca2+_NN flux_NN through_II neuronal_JJ nAChRs_NNS of_II adrenal_JJ chromaffin_NN cells_NNS is_VBZ insensitive_JJ to_II alpha-bungarotoxin_NN ._.
P08092929A01
Exposure_NN of_II rat_NN pheochromocytoma_NN (_( PC12_NN )_) cells_NNS to_II cyanide_NN produces_VVZ elevation_NN of_II cytosolic_JJ calcium_NN ,_, impaired_VVNJ Na_NN (_( +_SYM )_) -H+_NN exchange_NN ,_, membrane_NN lipid_NN peroxidation_NN and_CC release_NN of_II neurotransmitters_NNS ._.
P08103064A03
CD30_NN is_VBZ inducible_JJ on_II approximately_RR 15_MC %_SYM of_II normal_JJ PBMC_NN stimulated_VVN with_II any_PND of_II a_DD variety_NN of_II nonspecific_JJ T_NN cell_NN activators_NNS ,_, including_VVG PHA_NN ,_, Con_NN A_NN ,_, anti-T11_NN (_( 2_MC )_) +_SYM T11_NN (_( 3_MC )_) ,_, and_CC anti-CD3_NN ;_: ionomycin_NN alone_JJ induced_VVD lower_JJR percentages_NNS of_II CD30+_NN T_NN cells_NNS (_( 3_MC +/-_SYM 2_MC %_SYM )_) compared_VVN to_II other_JJ stimuli_NNS ._.
P08107567A06
Proteins_NNS of_II Hsp70_NN and_CC Hsp90_NN families_NNS as_CC+ well_CC+ as_CC ubiquitin_NN belong_VVB to_II the_DD same_JJ group_NN ._.
P08121683A01
We_PN investigated_VVD the_DD postcaloric_JJ nystagmus_NN related_VVN to_II positional_JJ change_NN ._.
P08130881A01
Methods_NNS for_II the_DD synthesis_NN and_CC quantitation_NN of_II the_DD novel_JJ choline_NN analogues_NNS ,_, telluronium_NN choline_NN and_CC acetyltelluronium_NN choline_NN ,_, are_VBB described_VVN ._.
P08140024A02
Symptoms_NNS and_CC signs_NNS usually_RR respond_VVB to_II the_DD institution_NN of_II a_DD gluten-free_JJ diet_NN ._.
P08149070A03
Eighteen_MC patients_NNS with_II these_DD two_MC conditions_NNS from_II an_DD area_NN with_II 750,000_MC inhabitants_NNS in_II Valencia_NNP (_( Spain_NNP )_) ,_, were_VBD studied_VVN for_II 2_MC years_NNS ._.
P08158508A02
Clinical_JJ measurements_NNS included_VVD plaque_NN index_NN ,_, gingival_JJ index_NN ,_, bleeding_VVGN on_II probing_VVGN ,_, suppuration_NN ,_, probing_VVGJ depth_NN ,_, clinical_JJ attachment_NN level_NN ,_, and_CC relative_JJ attachment_NN level_NN measured_VVN with_II an_DD automated_VVNJ disk_NN probe_NN ._.
P08162969A07
These_DD results_NNS suggest_VVB that_CST TSMCs_NNS can_VM promote_VVB the_DD growth_NN of_II TSMCs_NNS and_CC SMCs_NNS in_II either_CC an_DD autocrine_JJ or_CC paracrine_JJ manner_NN and_CC that_CST they_PN proliferate_VVB independently_RR of_II the_DD collagen_NN matrices_NNS ._.
P08176674A01
We_PN studied_VVD 20_MC normal_JJ subjects_NNS and_CC 20_MC suffering_VVG from_II sacro-iliitis_NN ._.
P08181293A08
Overall_JJ daily_JJ losses_NNS of_II catecholamines_NNS in_II the_DD ultradiafiltrate_NN were_VBD small_JJ (_( dopamine_NN 404_MC micrograms_NNS ;_: epinephrine_NN 32_MC micrograms_NNS ;_: norepinephrine_NN 29_MC micrograms_NNS )_) ._.
P08185817A08
Additionally_RR ,_, we_PN found_VVD that_CST C140_NN mRNA_NN was_VBD also_RR increased_VVN in_II the_DD thyroid_NN tissue_NN of_II a_DD patient_NN with_II Graves_NN '_GE disease_NN ._.
P08190109A13
Ratios_NNS of_II organ_NN to_II blood_NN concentrations_NNS at_II 2_MC hr_NN for_II all_DD organs_NNS were_VBD 5_MC :_: 1_MC or_CC greater_JJR ._.
P08199276A01
The_DD production_NN of_II the_DD allylic_JJ regulatory_JJ steroid_NN 3_MC alpha-hydroxy-4-pregnen-20-one_NN (_( 3_MC alpha_NN HP_NN )_) in_II the_DD rat_NN ovary_NN was_VBD examined_VVN and_CC compared_VVN to_II progesterone_NN levels_NNS through_II use_NN of_II specific_JJ RIAs_NNS that_PNR had_VHD been_VBN validated_VVN by_II capillary_NN gas_NN chromatography-mass_NN spectrometry_NN (_( GC_NN /_SYM MS_NN )_) ._.
P08203696A05
A_DD computerized_VVNJ personal_JJ interview_NN was_VBD administered_VVN to_II 300_MC African-American_JJ 9-_MC to_II 15-year-old_JJ children_NNS living_VVG in_II six_MC public_JJ housing_VVGJ developments_NNS in_II a_DD large_JJ US_NNP city_NN ._.
P08213081A01
Recently_RR tau_NN immunoreactivity_NN has_VHZ been_VBN observed_VVN in_II astrocytes_NNS in_II Alzheimer_NNP 's_GE disease_NN and_CC other_JJ neurological_JJ diseases_NNS ._.
P08222097A02
Antiplatelet_NN therapy_NN with_II aspirin_NN and_CC antithrombotic_JJ therapy_NN with_II heparin_NN both_CC prevent_VVB the_DD complications_NNS of_II unstable_JJ angina_NN ;_: however_RR ,_, no_DD definitive_JJ data_NNS exist_VVB on_II the_DD relative_JJ clinical_JJ efficacy_NN of_II the_DD two_MC drugs_NNS ._.
P08226432A05
Both_CC Cmax_NN and_CC AUC_NN were_VBD shown_VVN to_TO be_VBI factors_NNS determining_VVG antibacterial_JJ activity_NN ;_: however_RR Cmax_NN independently_RR represented_VVD some_DD 35_MC %_SYM of_II total_JJ exposure_NN effect_NN ._.
P08235385A04
In_II patients_NNS with_II chronic_JJ pure_JJ red_JJ cell_NN aplasia_NN the_DD in_JJ+ vitro_JJ study_NN of_II erythroid_NN precursors_NNS has_VHZ a_DD prognostic_JJ value_NN ._.
P08248763A03
The_DD subjects_NNS had_VHD moderately_RR reduced_VVNJ lung_NN function_NN of_II restrictive_JJ type_NN ,_, and_CC none_MC of_II the_DD subjects_NNS had_VHD forced_VVNJ expiratory_JJ volume_NN for_II one_MC second_NN (_( FEV1_NN )_) below_II 30_MC %_SYM of_II predicted_VVNJ value_NN ,_, indicating_VVG that_CST hypoventilation_NN would_VM probably_RR not_RR occur_VVB ._.
P08257700A01
To_TO study_VVI the_DD effects_NNS of_II methylation_NN damage_NN on_II DNA_NN replication_NN in_RR+ vitro_RR ,_, the_DD plasmid_NN pSVori_NN containing_VVG the_DD SV40_NN origin_NN of_II replication_NN was_VBD reacted_VVN with_II N-methyl-N-nitrosourea_NN and_CC used_VVN as_II a_DD substrate_NN for_II SV40_NN T_NN antigen_NN dependent_JJ replication_NN by_II HeLa_NN cell_NN extracts_NNS ._.
P08262267A05
Evolutionary_JJ implications_NNS of_II these_DD results_NNS are_VBB discussed_VVN ._.
P08280852A01
Patterns_NNS of_II neural_JJ degeneration_NN were_VBD compared_VVN following_VVG continuous_JJ administration_NN of_II four_MC drugs_NNS of_II addiction_NN ,_, each_PND of_II which_PNR induces_VVZ model_NN psychoses_NNS in_II chronic_JJ addicts_NNS ._.
P08285272A08
The_DD apparent_JJ volume_NN of_II TTW_NN participating_VVG in_II the_DD fluid_NN shift_NN averaged_VVD 65_MC +/-_SYM 1_MC ml_NN /_SYM 100_MC g_NN (_( SE_NN )_) over_II a_DD wide_JJ range_NN of_II osmolality_NN increases_NNS ._.
P08294223A08
Both_DD patient_NN collectives_NNS had_VHD similar_JJ initial_JJ factors_NNS ._.
P08298814A08
Conversely_RR ,_, ionomycin_NN could_VM stimulate_VVB IPs_NNS accumulation_NN and_CC elevate_VVB [_( Ca2+_NN ]_) i_NN ._.
P08307958A05
The_DD data_NNS also_RR indicated_VVD that_CST Tus_NN existed_VVN as_II a_DD monomeric_JJ protein_NN in_II solution_NN and_CC when_CS complexed_VVN with_II its_PNG cognate_NN DNA_NN binding_VVGJ site_NN ._.
P08312437A11
ACTH_NN administration_NN (_( i.v._NN )_) induced_VVD a_DD similar_JJ cortisol_NN pulse_NN in_II 4_MC of_II 8_MC growth-restricted_VVNJ lambs_NNS and_CC in_II 5_MC of_II 6_MC ad_II libitum-fed_VVNJ lambs_NNS ._.
P08326025A03
Losses_NNS of_II alpha-tocopherol_NN occurred_VVD in_II UHT_NN milk_NN after_II 1_MC mo_NN of_II storage_NN at_II 30_MC degrees_NNS C_NN ;_: losses_NNS increased_VVD as_CS storage_NN time_NN increased_VVD ._.
P08330625A10
Therefore_RR ,_, when_CS the_DD alpha_NN chain_NN is_VBZ part_NN of_II high-affinity_NN receptors_NNS ,_, it_PN is_VBZ endocytosed_VVN ,_, as_CS opposed_VVN to_II when_CS it_PN is_VBZ part_NN of_II low-affinity_NN receptors_NNS and_CC is_VBZ not_RR endocytosed_VVN ._.
P08339784A07
In_II conclusion_NN ,_, these_DD data_NNS show_VVB a_DD distinct_JJ functional_JJ specificity_NN of_II intrahippocampal_JJ LC_NN grafts_NNS in_II the_DD kindling_VVGJ model_NN of_II epilepsy_NN ._.
P08358223A01
The_DD importance_NN and_CC requirements_NNS for_II catalytic_JJ activation_NN of_II sialyl_NN donors_NNS are_VBB discussed_VVN ,_, leading_VVG to_II the_DD acid_NN sensitive_JJ phosphite_NN and_CC phosphate_NN moiety_NN ,_, respectively_RR ,_, as_II leaving_VVGJ group_NN and_CC nitriles_NNS as_II solvent_NN ._.
P08362985A02
These_DD agents_NNS kill_VVB hepatocytes_NNS by_II a_DD process_NN readily_RR distinguished_VVN from_II two_MC well-known_VVNJ pathways_NNS that_PNR lead_VVB to_II a_DD loss_NN of_II viability_NN ,_, namely_RR ,_, oxidative_JJ stress_NN and_CC inhibition_NN of_II mitochondrial_JJ electron_NN transport_NN ._.
P08367730A16
Eight_MC patients_NNS had_VHD neurological_JJ deficits_NNS ,_, some_PND of_II them_PN minor_JJ ._.
P08376776A03
After_II affinity_NN purification_NN ,_, this_DD antibody_NN ,_, anti-mMCP-2_NN (_( 56-71_MC )_) IgG_NN ,_, reacted_VVD in_II SDS-PAGE_NN /_SYM immunoblots_NNS against_II a_DD 28-kDa_NN protein_NN in_II BMMCW+IL-10_NN that_PNR had_VHD the_DD N-terminal_JJ amino_JJ acid_NN sequence_NN of_II mMCP-2_NN ._.
P08381160A01
Using_VVG GC_NN /_SYM MS_NN in_II scanning_VVGJ mode_NN as_II a_DD screening_VVGJ and_CC definitive_JJ identification_NN methodology_NN for_II substance_NN abuse_NN testing_VVGN ,_, 4500_MC urine_NN samples_NNS have_VHB been_VBN analyzed_VVN ._.
P08385008A17
The_DD Ki_NN for_II the_DD first_JJ product_NN off_RR (_( inositol_NN )_) was_VBD ,_, however_RR ,_, unaltered_VVN by_II Li+_NN ._.
P08392740A02
Sonography_NN can_VM also_RR establish_VVB the_DD diagnosis_NN of_II nerve_NN sheath_NN tumors_NNS when_CS the_DD normal_JJ nerve_NN is_VBZ visualized_VVN ._.
P08396637A07
Both_CC nocturnal_JJ administration_NN of_II melatonin_NN for_II 2_MC consecutive_JJ days_NNS (_( 9_MC mg_NN /_SYM kg_NN /_SYM day_NN ,_, s.c._NN )_) and_CC melatonin_NN incubation_NN (_( 100_MC pg_NN /_SYM ml_NN ,_, 4_MC h_NN )_) of_II the_DD vas_NN deferens_NN from_II old_JJ rats_NNS sacrificed_VVN at_II 15_MC :_: 00_MC h_NN significantly_RR potentiated_VVD the_DD ACh-induced_VVNJ contraction_NN ._.
P08405342A04
Abortion_NN attitudes_NNS vary_VVB little_JJ by_II race_NN after_II other_JJ social_JJ background_NN factors_NNS are_VBB controlled_VVN ._.
P08414171A03
The_DD subcutaneous_JJ injections_NNS were_VBD given_VVN during_II either_CC the_DD diurnal_JJ or_CC nocturnal_JJ period_NN ._.
P08418920A11
However_RR ,_, the_DD 4.0-mg_NN /_SYM kg_NN BW_NN dose_NN of_II progesterone_NN decreased_VVD ER_NN mRNA_NN levels_NNS ._.
P08428211A04
Tension_NN developed_VVD slowly_RR but_CC was_VBD sustained_VVN during_II the_DD application_NN of_II sarafotoxin_NN ._.
P08432738A05
Amongst_II these_PND ,_, endopeptidase_NN activity_NN produces_VVZ a_DD similar_JJ product_NN profile_NN from_II the_DD nonapeptide_NN substrate_NN to_II that_PND of_II human_NN leukocyte_NN elastase_NN ,_, an_DD enzyme_NN previously_RR shown_VVN to_TO be_VBI capable_JJ of_II releasing_VVGN a_DD bioactive_JJ ,_, mature_JJ form_NN of_II TGF_NN alpha_NN from_II its_PNG cell-bound_VVNJ precursor_NN ._.
P08437202A02
Thoracolumbar_JJ spine_NN films_NNS were_VBD obtained_VVN on_II 106_MC patients_NNS ._.
P08442409A08
AIDS_NN patients_NNS with_II progressive_JJ dementia_NN and_CC brains_NNS with_II HIV-specific_JJ neuropathology_NN showed_VVD no_DD difference_NN in_II neuronal_JJ densities_NNS as_CS compared_VVN to_II those_PND without_II such_DD features_NNS ._.
P08451331A06
These_DD results_NNS provide_VVB compelling_VVGJ evidence_NN that_CST multisynaptic_JJ neural_JJ pathways_NNS linking_VVG the_DD chemosensory_JJ systems_NNS of_II the_DD olfactory_NN bulbs_NNS with_II the_DD rostral_JJ hypothalamus_NN are_VBB involved_VVN in_II the_DD regulation_NN of_II intermale_JJ aggression_NN in_II mice_NNS ._.
P08460391A08
Advocates_NNS of_II magnesium_NN criticize_VVB the_DD limited_VVNJ number_NN of_II patients_NNS in_II our_PNG study_NN as_CC+ well_CC+ as_CC the_DD administration_NN of_II the_DD magnesium_NN substitute_NN ._.
P08474119A04
In_II this_DD study_NN ,_, the_DD morphological_JJ and_CC cell-surface_NN characteristics_NNS of_II the_DD avirulent_JJ parental_JJ strain_NN were_VBD compared_VVN with_II those_PND of_II the_DD more_RR virulent_JJ variants_NNS to_TO determine_VVI whether_CST pathogenicity_NN was_VBD associated_VVN with_II one_MC or_CC more_DD cell-surface_NN constituents_NNS ._.
P08483260A05
Two_MC types_NNS of_II scavenger_NN receptor_NN mRNA_NN were_VBD shown_VVN to_TO result_VVI from_II alternative_JJ splicing_VVGN of_II exon_NN 9_MC for_II type_NN II_MC or_CC 10_MC and_CC 11_MC for_II type_NN I_MC to_II the_DD common_JJ exon_NN 1-8_MC ._.
P08492479A05
Serum_NN 1_MC ,_, 25-dihydroxyvitamin-D_NN [_( 1_MC ,_, 25_MC (_( OH_NN )_) 2D_NN ]_) ,_, which_PNR is_VBZ produced_VVN in_II the_DD proximal_JJ tubules_NNS through_II 1_MC alpha-hydroxylation_NN from_II 25-hydroxyvitamin-D_NN [_( 25OHD_NN ]_) ,_, was_VBD normal_JJ or_CC increased_VVN to_II more_RR than_CSN 60pg_NN /_SYM ml_NN ._.
P08497432A09
Of_II those_DD patients_NNS receiving_VVG thrombolysis_NN ,_, the_DD average_JJ time_NN delay_NN from_II the_DD general_JJ practitioner_NN referring_VVGN the_DD patient_NN to_II hospital_NN to_II the_DD patient_NN being_VVGN treated_VVN was_VBD 107_MC minutes_NNS ._.
P08511438A03
Peripheral_JJ somatosensory_JJ input_NN seems_VVZ to_TO modulate_VVI tremor_NN and_CC central_JJ nervous_JJ system_NN activity_NN related_VVN to_II tremor_NN ._.
P08525333A03
Treatment_NN and_CC diagnostic_JJ guidelines_NNS in_II different_JJ clinical_JJ entities_NNS have_VHB been_VBN based_VVN on_II the_DD pillars_NNS of_II medicine_NN -_: controlled_VVNJ studies_NNS and/or_CC a_DD common_JJ consensus_NN among_II specialists_NNS and_CC practitioners_NNS ._.
P08529845A08
Damage_NN was_VBD inferred_VVN to_TO be_VBI caused_VVN by_II the_DD picolinate_NN ligand_NN because_CS picolinic_JJ acid_NN in_II the_DD absence_NN of_II chromium_NN was_VBD clastogenic_JJ ._.
P08539079A09
On_II the_DD other_JJ hand_NN ,_, restrictions_NNS to_II the_DD product_NN use_NN are_VBB a_DD less_RR constant_JJ activity_NN against_II Neisseria_NN gonorrhoeae_NN and_CC a_DD lack_NN of_II efficacy_NN on_II Mycoplasma_NN hominis_NN ._.
P08548611A02
We_PN present_VVB the_DD case_NN of_II a_DD young_JJ patient_NN whose_PNR case_NN began_VVD ,_, four_MC years_NNS ago_RR ,_, with_II depressive-type_NN manifestations_NNS ,_, with_II diagnosis_NN only_RR being_VVGN made_VVN now_RR ._.
P08557486A06
For_II example_NN ,_, the_DD lamins_NNS form_VVB nucleoplasmic_JJ foci_NNS ,_, distinct_JJ from_II the_DD peripheral_JJ lamina_NN ,_, which_PNR vary_VVB in_II their_PNG patterns_NNS of_II distribution_NN as_CC+ well_CC+ as_CC their_PNG composition_NN in_II a_DD cell_NN cycle-dependent_JJ manner_NN ._.
P08566217A03
AChE_NN was_VBD further_RR found_VVN to_TO be_VBI expressed_VVN in_II the_DD HMC-1_NN the_DD human_NN mast_JJ cell_NN precursor_NN line_NN ._.
P08579088A01
PURPOSE_NN :_: Chronic_JJ fatigue_NN syndrome_NN (_( CFS_NN )_) currently_RR is_VBZ defined_VVN by_II a_DD working_VVGJ case_NN definition_NN developed_VVN under_II the_DD leadership_NN of_II the_DD United_VVNJ States_NNS Centers_NNS for_II Disease_NN Control_NN and_CC Prevention_NN (_( CDC_NN )_) based_VVN on_II a_DD consensus_NN among_II experienced_VVNJ clinicians_NNS ._.
P08583242A05
Analysis_NN of_II the_DD tumor_NN by_II confocal_JJ laser_NN scanning_VVGJ microscopy_NN revealed_VVD that_CST labeled_VVNJ LCM_NN were_VBD inside_II the_DD tumor_NN cells_NNS ._.
P08587485A10
These_DD results_NNS demonstrate_VVB that_CST changes_NNS in_II myosin_NN heavy_JJ chain_NN expression_NN ,_, but_CC not_RR myosin_NN light_JJ chain_NN expression_NN accompany_VVB stretch-induced_VVNJ hypertrophy_NN in_II the_DD quail_NN ALD_NN ._.
P08600841A06
This_DD report_NN presents_VVZ a_DD case_NN of_II a_DD 2-year-old_JJ male_NN with_II a_DD groin_NN superficial_JJ angiomyxoma_NN mimicking_VVG an_DD inguinal_JJ hernia_NN ._.
P08609917A01
Recording_VVGJ site_NN is_VBZ an_DD important_JJ cause_NN of_II variability_NN of_II compound_JJ muscle_NN action_NN potential_NN (_( CMAP_NN )_) and_CC conduction_NN parameters_NNS ,_, which_PNR can_VM be_VBB reduced_VVN by_II using_VVGN large_JJ electrodes_NNS ._.
P08614556A07
In_II contrast_NN to_II weaver_NN (_( wv_NN /_SYM +_SYM )_) mice_NNS ,_, the_DD number_NN of_II apoptotic_JJ cells_NNS in_II the_DD external_JJ granule_NN cell_NN layer_NN was_VBD not_RR increased_VVN ._.
P08623731A06
For_II 99_MC %_SYM to_II 100_MC %_SYM occlusions_NNS ,_, predictors_NNS were_VBD shorter_JJR duration_NN of_II occlusion_NN and_CC more_RR jeopardized_VVNJ myocardium_NN ._.
P08632210A02
gamma-Tocotrienol_NN also_RR suppresses_VVZ tumor_NN growth_NN ._.
P08636514A05
Mercury_NN vapor_NN detection_NN ,_, sample_NN mass_NN changes_NNS and_CC x-ray_NN fluorescence_NN data_NNS were_VBD collected_VVN from_II experimental_JJ steam_NN autoclave_NN sterilization_NN of_II amalgam_NN samples_NNS sealed_VVN in_II autoclave_NN bags_NNS ._.
P08640974A09
The_DD coefficient_NN of_II variation_NN as_II an_DD index_NN of_II the_DD observed_VVNJ heterogeneity_NN of_II myocardial_JJ blood_NN flow_NN averaged_VVD ,_, for_II [_( 13N_NN ]_) ammonia_NN ,_, 9_MC +/-_SYM 4_MC %_SYM at_II rest_NN and_CC 12_MC +/-_SYM 7_MC %_SYM during_II stress_NN and_CC ,_, for_II [_( 15O_NN ]_) water_NN ,_, 14_MC +/-_SYM 11_MC %_SYM at_II rest_NN and_CC 16_MC +/-_SYM 9_MC %_SYM during_II stress_NN ._.
P08645558A11
When_CS the_DD first_JJ step_NN in_II the_DD polyamine_NN biosynthetic_JJ pathway_NN is_VBZ blocked_VVN ,_, F9_NN teratocarcinoma_NN stem_NN cells_NNS accumulate_VVB large_JJ amounts_NNS of_II decarboxylated_VVNJ AdoMet_NN ,_, the_DD aminopropyl_NN group_NN donor_NN in_II polyamine_NN synthesis_NN ,_, and_CC go_VVB through_II terminal_JJ differentiation_NN into_II parietal_JJ endoderm_NN cells_NNS ._.
P08649990A09
The_DD enhancement_NN of_II mutation_NN rate_NN was_VBD caused_VVN by_II the_DD appearance_NN of_II mutations_NNS at_II three_MC new_JJ locations_NNS that_PNR correlated_VVD with_II likely_JJ recombination_NN sites_NNS ._.
P08659938A01
An_DD unusual_JJ case_NN of_II unilateral_JJ delayed_VVNJ and_CC progressive_JJ hearing_VVGJ loss_NN following_VVG a_DD microvascular_JJ decompression_NN operation_NN on_II cranial_JJ nerves_NNS V_MC ,_, VII_MC ,_, and_CC VIII_MC on_II the_DD left_JJ side_NN is_VBZ reported_VVN ._.
P08664513A03
From_II this_DD group_NN of_II patients_NNS we_PN identified_VVD 7_MC patients_NNS with_II primary_JJ gastrointestinal_JJ tract_NN (_( GIT_NN )_) CMV_NN disease_NN who_PNR received_VVD treatment_NN with_II GAN_NN ._.
P08669182A15
Discrepancies_NNS in_II immunocytochemical_JJ staining_VVGJ results_NNS may_VM be_VBB caused_VVN partly_RR by_II differences_NNS in_II cell_NN preparation_NN ._.
P08678493A04
An_DD EO-RTC_NN questionnaire_NN system_NN was_VBD translated_VVN into_II Japanese_NN and_CC its_PNG reproducibility_NN was_VBD assessed_VVN before_II the_DD study_NN ._.
P08688228A05
Lung_NN lesions_NNS were_VBD demonstrated_VVN in_II 214_MC patients_NNS ._.
P08692733A07
The_DD test_NN system_NN used_VVD a_DD CHO_NN cell_NN line_NN expressing_VVG the_DD enzyme_NN chloramphenicol_NN acetyl-transferase_NN (_( CAT_NN )_) under_II the_DD control_NN of_II an_DD inducible_JJ promoter_NN ._.
P08697750A05
The_DD aphasic_NN showed_VVD an_DD exactly_RR similar_JJ pattern_NN of_II ERP_NN components_NNS as_CSN the_DD controls_NNS did_VDD ,_, but_CC his_PNG performance_NN in_II a_DD task_NN demanding_VVG explicit_NN differentiation_NN between_II semantically_RR congruous_JJ and_CC incongruous_JJ sentences_NNS was_VBD at_II the_DD chance_NN level_NN ._.
P08707007A06
METHODS_NNS :_: At_II first_NN ,_, we_PN studied_VVD 28_MC patients_NNS (_( pts_NNS )_) ,_, which_PNR we_PN divided_VVD in_II two_MC groups_NNS :_: Group_NN A_NN ,_, 18_MC pts_NNS 59.38_MC +/-_SYM 8.23_MC mean_NN age_NN ,_, 15_MC M._NN and_CC 3_MC F._NN ,_, with_II anterior_JJ descending_VVGJ disease_NN ;_: Group_NN B_NN 10_MC pts_NNS ,_, 59.20_MC +/-_SYM 8.48_MC mean_NN age_NN ,_, 7_MC M._NN and_CC 3_MC F_NN ,_, without_II significant_JJ stenosis_NN (_( >_SYM 75_MC %_SYM )_) ._.
P08718031A01
Over_II the_DD past_JJ 10_MC years_NNS ,_, people_NNS with_II learning_VVGJ disabilities_NNS have_VHB moved_VVN out_II+ of_II institutions_NNS and_CC into_II the_DD community_NN ._.
P08726588A04
Improved_VVNJ antiemetics_NNS have_VHB led_VVN to_II increased_VVNJ patient_NN tolerance_NN of_II the_DD most_RRT acute_JJ symptoms_NNS of_II aggressive_JJ chemotherapeutic_JJ dosing_VVGN ._.
P08730767A04
Of_II the_DD 38_MC children_NNS not_RR identifying_VVG the_DD perpetrator_NN at_II the_DD screening_VVGJ interview_NN ,_, 17_MC (_( 45_MC %_SYM )_) made_VVD disclosure_NN at_II the_DD investigative_JJ interview_NN ._.
P08739132A02
From_II an_DD experimental_JJ point_NN of_II view_NN ,_, the_DD freezing_VVGJ water_NN was_VBD determined_VVN by_II DSC_NN when_CS the_DD total_JJ sorbed_VVNJ water_NN was_VBD obtained_VVN from_II thermogravimetry_NN ._.
P08743195A09
The_DD increase_NN in_II [_( Ca2+_NN ]_) i_NN may_VM act_VVB as_II an_DD intracellular_JJ message_NN and_CC cause_VVB the_DD activation_NN of_II the_DD GP_NN IIb-IIIa_NN complex_NN ._.
P08751720A02
Based_VVN on_II its_PNG effects_NNS on_II tumor_NN and_CC endothelial_JJ cell_NN behavior_NN ,_, this_DD member_NN of_II the_DD thrombospondin_NN gene_NN family_NN has_VHZ attracted_VVN interest_NN as_II a_DD potential_JJ regulator_NN of_II tumor_NN growth_NN and_CC metastasis_NN ._.
P08756561A04
Their_PNG pubic_JJ symphysial_JJ tissues_NNS were_VBD then_RR removed_VVN and_CC analyzed_VVN for_II collagen_NN content_NN and_CC solubility_NN ,_, whereas_CS collagen_NN composition_NN was_VBD determined_VVN by_II SDS-PAGE_NN ._.
P08760820A08
Intraperitoneal_JJ administration_NN into_II mice_NNS of_II living_VVGJ S._NN pyogenes_NN bacteria_NN producing_VVG the_DD cysteine_NN proteinase_NN induced_VVD a_DD rapid_JJ breakdown_NN of_II endogenous_JJ plasma_NN kininogens_NNS and_CC release_NN of_II kinins_NNS ._.
P08765133A12
Both_CC BSA_NN and_CC lysozyme_NN were_VBD completely_RR partitioned_VVN to_II the_DD water_NN phase_NN formed_VVN above_II the_DD cloud_NN point_NN of_II EO30_NN /_SYM PO70_NN ._.
P08778553A02
Seven_MC sedentary_JJ subjects_NNS ,_, 10_MC endurance_NN runners_NNS ,_, and_CC seven_MC elite_JJ gymnasts_NNS of_II similar_JJ height_NN and_CC weight_NN were_VBD investigated_VVN ._.
P08787405A02
Fifty-gram_NN oyster_NN samples_NNS were_VBD processed_VVN by_II an_DD adsorption-elution_NN -precipitation_NN method_NN and_CC then_RR seeded_VVN with_II 10_MC (_( 1_MC )_) to_II 10_MC (_( 5_MC )_) PFU_NN of_II poliovirus_NN type_NN 1_MC (_( PV1_NN )_) or_CC hepatitis_NN A_NN virus_NN (_( HAV_NN )_) ._.
P08792061A05
In_II spite_NN of_II the_DD limitations_NNS ,_, the_DD studies_NNS have_VHB been_VBN critical_JJ in_II helping_VVGN determine_VVI the_DD pathogenesis_NN of_II sepsis_NN in_II humans_NNS ._.
P08800818A06
In_II palliative_JJ care_NN ,_, clinical_JJ and_CC academic_JJ approaches_NNS need_VVB greater_JJR integration_NN ._.
P08811029A05
Secondly_RR ,_, TAP_NN molecules_NNS fail_VVB to_TO associate_VVI with_II MHC_NN class_NN I_MC heavy_JJ chains_NNS indicating_VVG that_CST HCMV_NN early_JJ gene_NN expression_NN also_RR interferes_VVZ with_II MHC_NN class_NN I_MC maturation_NN ._.
P08819791A08
The_DD biological_JJ implication_NN of_II SCEs_NNS was_VBD discussed_VVN in_II connection_NN with_II the_DD generation_NN of_II heteromorphism_NN ._.
P08828419A06
Major_JJ histocompatibility_NN complex_NN class_NN I_MC and_CC class_NN II_MC and_CC intercellular_JJ adhesion_NN molecule-1_NN cell_NN surface_NN antigens_NNS were_VBD determined_VVN by_II fluorescence-activated_VVNJ cell_NN sorting_VVGJ analysis_NN ._.
P08836667A01
Recipients_NNS of_II heart-lung_NN transplantation_NN (_( HLT_NN )_) show_VVB reduced_VVNJ exercise_NN capacity_NN due_II+ to_II several_JJ pre-_JJ and_CC postsurgical_JJ factors_NNS ._.
P08844780A01
Although_CS physiological_JJ processes_NNS related_VVN to_II vascular_JJ function_NN differ_VVB greatly_RR between_II resistance_NN arteries_NNS and_CC conduit_NN arteries_NNS ,_, it_PN is_VBZ not_RR known_VVN whether_CST the_DD effects_NNS of_II calcitonin_NN gene-related_VVNJ peptide_NN (_( CGRP_NN )_) ,_, a_DD vasodilator_NN neuropeptide_NN ,_, on_II these_DD arteries_NNS differ_VVB in_II humans_NNS ._.
P08853414A02
This_DD 15.5-kDa_NN protein_NN binds_VVZ fatty_JJ acids_NNS in_RR+ vitro_RR and_CC has_VHZ identity_NN with_II amino_JJ acids_NNS 10-117_MC of_II alpha_NN 2_MC mu-globulin_NN (_( A2_NN fragment_NN )_) ,_, a_DD 19-kDa_NN protein_NN synthesized_VVN predominantly_RR in_II the_DD male_NN liver_NN ._.
P08858021A07
The_DD other_JJ group_NN received_VVD vehicle_NN alone_JJ ._.
P08867358A04
Here_RR we_PN report_VVB the_DD occurrence_NN of_II HSE_NN in_II a_DD 52_MC years_NNS old_JJ woman_NN two_MC months_NNS after_II brain_NN irradiation_NN (_( 40_MC Gray_NN in_II 20_MC fractions_NNS )_) and_CC dexamethasone_NN administration_NN for_II a_DD metastatic_JJ brain_NN tumor_NN ._.
P08876014A07
Rotating_VVGN to_II anterior-posterior_JJ commissure_NN points_NNS was_VBD the_DD best_NN of_II the_DD tested_VVNJ two-point_NN registrations_NNS ,_, although_CS an_DD average_JJ angular_JJ rotation_NN was_VBD better_JJR ._.
P08884442A05
Radiographic_JJ loosening_VVGN of_II one_MC or_CC both_DD components_NNS was_VBD evident_JJ in_II 3_MC hips_NNS ._.
P08896813A03
Similarly_RR ,_, CGP_NN 39551_MC attenuated_VVD the_DD clonic_JJ and_CC tonic_JJ phases_NNS of_II audiogenic_JJ seizures_NNS 120_MC min_NN after_II acute_JJ treatment_NN with_II ED50_NN values_NNS of_II 17.2_MC and_CC 8.8_MC mumol_NN kg-1_NN ,_, respectively_RR ._.
P08901010A03
Intranigral_JJ application_NN of_II the_DD non-competitive_JJ NMDA_NN receptor_NN antagonist_NN dizocilpine_NN (_( 150_MC nM_NN )_) ,_, or_CC the_DD competitive_JJ NMDA_NN receptor_NN antagonist_NN R-DL-_NN (_( E_NN )_) -2-amino-4-methyl-5-phosphono-3-pentanoate_NN (_( CGP_NN 40116_MC ,_, 10_MC microM_NN )_) ,_, via_II the_DD dialysis_NN probe_NN ,_, did_VDD not_RR affect_VVB the_DD release_NN of_II dopamine_NN or_CC its_PNG metabolites_NNS in_II intact_JJ rats_NNS ,_, but_CC further_RR suppressed_VVD these_DD releases_NNS in_II reserpine_NN plus_CC alpha-methyl-p-tyrosine-treated_VVNJ animals_NNS ._.
P08909990A05
5._MC The_DD longitudinal_JJ muscle_NN strips_NNS showed_VVD higher_JJR spontaneous_JJ and_CC evoked_VVNJ contractions_NNS ._.
P08918119A05
Sexual_JJ abuse_NN was_VBD most_RRT common_JJ (_( 55_MC %_SYM )_) ,_, followed_VVN by_II physical_JJ abuse_NN (_( 48_MC %_SYM )_) ,_, and_CC rape_NN (_( 41_MC %_SYM )_) ._.
P08922531A11
Fibrillar_JJ and_CC basement_NN membrane_NN collagen_NN gene_NN expressions_NNS ,_, their_PNG protein_NN syntheses_NNS ,_, and_CC the_DD processing_VVGN of_II these_DD procollagens_NNS seems_VVZ to_TO be_VBI developmentally_RR regulated_VVN in_II the_DD invasive_JJ cytotrophoblasts_NNS during_II the_DD organization_NN of_II feto-maternal_JJ placental_JJ tissue_NN ._.
P08935861A04
Two_MC studies_NNS were_VBD conducted_VVN ._.
P08940291A01
As_II a_DD participant_NN of_II the_DD endogenous_JJ arachidonic_JJ acid_NN metabolic_JJ cascade_NN ,_, microsomal_JJ cytochrome_NN P450_NN metabolizes_VVZ the_DD fatty_JJ acid_NN to_II biologically_RR active_JJ hydroxyeicosatetraenoic_JJ and_CC epoxyeicosatrienoic_JJ acids_NNS ._.
P08944651A10
It_PN is_VBZ concluded_VVN that_CST an_DD endogenous_JJ PKG_NN activates_VVZ BKCa_NN by_II decreasing_VVGN the_DD Ca2+_NN and_CC voltage_NN activation_NN thresholds_NNS independently_RR of_II sensitivities_NNS ._.
P08953633A08
Poor_JJ outcome_NN was_VBD not_RR predicted_VVN by_II early_JJ gestation_NN at_II diagnosis_NN ,_, the_DD hernial_JJ contents_NNS ,_, or_CC the_DD presence_NN of_II polyhydramnios_NN ._.
P08967972A02
The_DD magnitude_NN of_II these_DD depletions_NNS was_VBD similar_JJ to_II those_PND reported_VVN previously_RR in_II Swiss_NN Webster_NN and_CC C57BL_NN /_SYM 6_MC mice_NNS given_VVN 4_MC x_SYM 20_MC mg_NN /_SYM kg_NN 2'-NH2-MPTP_NN ,_, and_CC in_II keeping_VVGN with_II these_DD prior_JJ studies_NNS ,_, striatal_JJ dopamine_NN levels_NNS were_VBD unchanged_VVN by_II 2'-NH2-MPTP_NN treatment_NN in_II CD-1_NN mice_NNS ._.
P08976926A06
CT_NN revealed_VVD subsegmental_JJ atelectasis_NN in_II other_JJ lobes_NNS adjacent_JJ to_II the_DD bullous_JJ lung_NN in_II six_MC patients_NNS ._.
P08985690A03
Rats_NNS were_VBD subjected_VVN to_II a_DD fluid_NN percussion_NN brain_NN injury_NN one_MC week_NN prior_II+ to_II experimentation_NN ,_, and_CC in_JJ+ vitro_JJ electrophysiological_JJ recording_VVGJ studies_NNS were_VBD conducted_VVN using_VVG combined_VVNJ hippocampal-entorhinal_JJ cortical_JJ slices_NNS (_( HEC_NN slices_NNS )_) ._.
P08989768A05
In_II general_NN ,_, membrane_NN contours_NNS are_VBB smoother_JJR and_CC intracellular_JJ organelles_NNS more_RR regular_JJ in_II shape_NN in_II HPF_NN /_SYM FS_NN samples_NNS as_CS compared_VVN with_II the_DD chemically_RR fixed_VVNJ specimens_NNS ._.
P08999449A07
Signal_NN intensity_NN in_II the_DD FLASH_NN sequence_NN decreased_VVD during_II LITT_NN ,_, both_CC in_II the_DD prostate_NN in_RR+ vivo_RR and_CC in_II specimens_NNS of_II bovine_JJ prostate_NN and_CC seminal_JJ vesicles_NNS in_RR+ vitro_RR ,_, with_II signal_NN developments_NNS running_VVGN in_II parallel_NN ._.
P09008386A01
The_DD promoters_NNS of_II the_DD hemoglobin_NN genes_NNS from_II the_DD nitrogen-fixing_VVGJ tree_NN Parasponia_NN andersonii_NN and_CC the_DD related_VVNJ nonnitrogen-fixing_VVGJ Trema_NN tomentosa_NN both_CC confer_VVB beta-glucuronidase_NN reporter_NN gene_NN expression_NN to_II the_DD central_JJ zone_NN of_II the_DD nodules_NNS of_II a_DD transgenic_JJ legume_NN ,_, Lotus_NN corniculatus_NN ._.
P09012838A06
RF_NN B_NN cells_NNS exposed_VVN to_II tolerogen_NN remain_VVB competent_JJ to_TO secrete_VVI RF_NN in_RR+ vitro_RR if_CS provided_VVN with_II an_DD appropriate_JJ antigenic_JJ stimulus_NN and_CC T_NN cell_NN help_NN ._.
P09022275A07
Our_PNG results_NNS show_VVB that_CST outer_JJ ear_NN temperature_NN measurement_NN is_VBZ the_DD method_NN which_PNR provides_VVZ the_DD best_JJT simplicity_NN /_SYM quality_NN ratio_NN and_CC should_VM therefore_RR be_VBB proposed_VVN for_II use_NN at_II the_DD scene_NN when_CS conditions_NNS are_VBB similar_JJ to_II those_PND of_II our_PNG experiment_NN (_( within_II buildings_NNS )_) ._.
P09037104A03
The_DD cysteine_NN motifs_NNS involved_VVN in_II binding_VVGN two_MC iron-sulfur_NN clusters_NNS are_VBB conserved_VVN in_II the_DD plant_NN protein_NN sequences_NNS ._.
P09046287A02
DESIGN_NN :_: An_DD electrophysiological_JJ evaluation_NN of_II the_DD sensory_JJ nerve_NN to_II the_DD lip_NN and_CC chin_NN was_VBD performed_VVN ._.
P09051095A06
In_II 16_MC of_II 30_MC seroconversion_NN samples_NNS ,_, both_DD immunoblot_NN assays_NNS produced_VVD HIV-1-positive_JJ results_NNS ._.
P09060661A07
However_RR ,_, infected_VVNJ cells_NNS were_VBD not_RR detected_VVN in_II SCID_NN mice_NNS (_( deficient_JJ in_II mature_JJ T_NN and_CC B_NN cells_NNS )_) inoculated_VVN with_II the_DD same_JJ virus_NN ,_, indicating_VVG that_CST precursor_NN B_NN cells_NNS are_VBB not_RR a_DD target_NN of_II the_DD virus_NN in_II the_DD absence_NN of_II mature_JJ CD4+_NN T_NN cells_NNS ._.
P09070126A07
Relative_JJ risks_NNS ,_, derived_VVN from_II Cox_NN 's_GE proportional_JJ hazards_NNS model_NN ,_, describing_VVG the_DD effect_NN on_II survival_NN of_II surgeons_NNS vs_CC gynaecologists_NNS as_II baseline_NN ,_, high_JJ volume_NN vs_CC low_JJ volume_NN operators_NNS and_CC referral_NN vs_CC nonreferral_JJ to_II an_DD oncologist_NN ._.
P09080555A04
Both_CC sensorineural_JJ threshold_NN elevation_NN and_CC tinnitus_NN (_( n_NN =_SYM 16_MC )_) diminished_VVD with_II time_NN ._.
P09090743A02
Hispanics_NNS ,_, the_DD second_JJ largest_JJT of_II these_DD groups_NNS ,_, face_VVB problems_NNS of_II access_NN to_II care_NN ,_, high_JJ rates_NNS of_II substance_NN abuse_NN and_CC HIV_NN ,_, and_CC shortages_NNS of_II Hispanic_JJ psychiatric_JJ professionals_NNS ._.
P09101131A04
This_PND should_VM help_VVB improve_VVI our_PNG patients_NNS '_GE quality_NN of_II life_NN and_CC should_VM have_VHB a_DD positive_JJ economic_JJ impact_NN on_II the_DD long-term_NN treatment_NN of_II peptic_JJ ulcer_NN by_II reducing_VVGN the_DD requirement_NN for_II continuous_JJ medical_JJ treatment_NN ._.
P09110582A01
Edible_JJ mushrooms_NNS such_II+ as_II shiitake_NN may_VM have_VHB important_JJ salutary_JJ effects_NNS on_II health_NN or_CC even_RR in_II treating_VVGN disease_NN ._.
P09119812A04
Histologically_RR ,_, the_DD valves_NNS showed_VVD thickening_VVGN and_CC hyalinization_NN of_II the_DD collagen_NN fibers_NNS ,_, and_CC the_DD presence_NN of_II foamy_JJ cells_NNS that_PNR contained_VVD a_DD large_JJ quantity_NN of_II pure_JJ acid_NN mucopolysaccharide_NN ._.
P09129178A03
Retrogradely_RR labelled_VVNJ cells_NNS were_VBD quantitatively_RR recorded_VVN ._.
P09133667A06
The_DD immortalization_NN of_II human_NN adipocytes_NNS will_VM permit_VVB pharmacological_JJ analysis_NN of_II the_DD human_NN beta3-adrenoceptor_NN function_NN in_II adipose_JJ cells_NNS and_CC will_VM allow_VVB detailed_VVNJ studies_NNS of_II human_NN adipocyte_NN differentiation_NN ._.
P09142854A09
Trifluoperazine_NN ,_, which_PNR inhibits_VVZ MPT_NN ,_, did_VDD not_RR block_VVB the_DD initial_JJ oxidation_NN of_II NAD_NN (_( P_NN )_) H_NN but_CC prevented_VVD the_DD second_JJ phase_NN of_II oxidation_NN ,_, partially_RR blocked_VVD ROS_NN formation_NN ,_, and_CC preserved_VVD cell_NN viability_NN ._.
P09151518A03
Some_PND of_II these_DD diseases_NNS are_VBB of_II known_VVNJ aetiology_NN ,_, whereas_CS others_NNS are_VBB not_RR ._.
P09160407A06
Undigested_VVNJ ,_, gastric_JJ digested_VVNJ and_CC combined_VVNJ gastric_JJ and_CC intestinal_JJ digested_VVNJ G115_NN significantly_RR dilated_VVD lungs_NNS (_( 44_MC %_SYM ,_, undigested_VVN ;_: 26_MC %_SYM ,_, gastric_JJ digested_VVN ;_: 45_MC %_SYM ,_, gastric_JJ and_CC intestinal_JJ digested_VVN )_) ._.
P09169305A03
A_DD series_NN of_II studies_NNS has_VHZ shown_VVN that_CST interruption_NN of_II serotonin_NN synthesis_NN compromises_VVZ the_DD efficacy_NN of_II serotonin_NN but_CC not_RR noradrenaline_NN reuptake_NN inhibitors_NNS ,_, and_CC interruption_NN of_II noradrenaline_NN synthesis_NN compromises_VVZ the_DD efficacy_NN of_II noradrenaline_NN but_CC not_RR serotonin_NN reuptake_NN inhibitors_NNS (_( SSRIs_NNS )_) ._.
P09173958A10
Increased_VVNJ endurance_NN capacity_NN was_VBD not_RR directly_RR associated_VVN with_II the_DD elevated_VVNJ levels_NNS of_II muscle_NN glycogen_NN ,_, oxygen_NN transport_NN capacity_NN of_II blood_NN ,_, or_CC VO2max_NN ._.
P09186818A03
As_II control_NN ,_, 7_MC healthy_JJ adult_NN subjects_NNS (_( 3M_NN ,_, 4F_NN ;_: 26-50_MC yr_NN old_JJ )_) were_VBD studied_VVN in_II basal_JJ condition_NN over_II a_DD 24-h_NN span_NN ._.
P09191838A02
A_DD series_NN of_II internal_JJ deletion_NN mutants_NNS of_II DI_NN cDNA_NN was_VBD generated_VVN to_TO obtain_VVI DI_NN genomic_JJ RNAs_NNS that_PNR differed_VVD from_II one_MC another_PND by_II the_DD presence_NN of_II different_JJ lengths_NNS of_II 3'-terminal_JJ and/or_CC 5'-terminal_JJ sequences_NNS ._.
P09200771A01
A_DD simple_JJ and_CC rapid_JJ procedure_NN to_TO determine_VVI felbamate_NN (_( 2-phenyl-1_NN ,_, 3-propanediol_NN dicarbamate_NN )_) concentrations_NNS in_II human_NN plasma_NN /_SYM serum_NN by_II high-performance_NN liquid_NN chromatography_NN is_VBZ described_VVN ._.
P09204962A04
The_DD spatial_JJ expression_NN of_II MMP-13_NN differed_VVN from_II that_PND of_II collagenase-1_NN (_( MMP-1_NN )_) ,_, which_PNR was_VBD prominently_RR expressed_VVN by_II migrating_VVGJ keratinocytes_NNS and_CC dermal_JJ cells_NNS located_VVN just_RR beneath_II the_DD wound_NN surface_NN ._.
P09213427A04
Using_VVG this_DD panel_NN of_II mAbs_NNS against_II multiple_JJ epitopes_NNS ,_, only_RR alpha-calponin_NN was_VBD detected_VVN in_II adult_JJ chicken_NN smooth_JJ muscles_NNS and_CC throughout_II development_NN of_II the_DD gizzard_NN ._.
P09218245A11
Similar_JJ systems_NNS are_VBB used_VVN to_II scale_NN the_DD response_NN to_II one_MC stimulus_NN feature_NN with_II respect_NN to_II a_DD second_JJ feature_NN ._.
P09222574A08
For_II most_PND of_II the_DD cases_NNS ,_, participants_NNS believed_VVD that_CST they_PN knew_VVD how_CST to_TO deal_VVI with_II the_DD problem_NN ,_, that_CST the_DD clinical_JJ situation_NN was_VBD realistic_JJ ,_, that_CST the_DD simulated_VVNJ patient_NN was_VBD believable_JJ ,_, and_CC that_CST the_DD case_NN duration_NN was_VBD adequate_JJ ._.
P09235646A04
In_II RA_NN patients_NNS the_DD above_JJ symptoms_NNS were_VBD absent_JJ ._.
P09240173A08
On_II multivariate_JJ analysis_NN ,_, MDR-1_NN and_CC tumour_NN stage_NN were_VBD significant_JJ factors_NNS for_II predicting_VVGN the_DD disease-free_JJ period_NN ,_, whereas_CS tumour_NN stage_NN and_CC malignancy_NN grade_NN were_VBD the_DD most_RRT relevant_JJ factors_NNS for_II survival_NN time_NN ._.
P09253647A01
We_PN have_VHB developed_VVN a_DD method_NN for_II representing_VVGN biological_JJ pathways_NNS and_CC simulating_VVGN their_PNG behavior_NN based_VVN on_II the_DD use_NN of_II stochastic_JJ activity_NN networks_NNS (_( SANs_NNS )_) ._.
P09258295A04
This_DD paper_NN presents_VVZ some_PND of_II the_DD arguments_NNS for_II and_CC against_II two-tiered_VVNJ health_NN care_NN ._.
P09262254A19
The_DD suppression_NN occurred_VVD without_II detectable_JJ amounts_NNS of_II aspirin_NN or_CC salicylic_JJ acid_NN in_II the_DD plasma_NN at_II the_DD time_NN points_NNS studied_VVN ._.
P09276168A02
Some_DD pathologic_JJ conditions_NNS may_VM predispose_VVB to_II sudden_JJ death_NN during_II exercise_NN in_II young_JJ athletes_NNS ._.
P09286099A03
Force_NN platform_NN and_CC kinematic_JJ measurements_NNS revealed_VVD that_CST two_MC species_NNS of_II lizards_NNS ,_, Coleonyx_NN variegatus_NN and_CC Eumeces_NN skiltonianus_NN ,_, used_VVD two_MC basic_JJ gaits_NNS similar_JJ to_II mammalian_JJ walking_VVGJ and_CC trotting_VVGJ gaits_NNS ._.
P09291163A07
An_DD important_JJ role_NN for_II neurosteroids_NNS in_II myelin_NN repair_NN has_VHZ been_VBN demonstrated_VVN in_II the_DD rodent_NN sciatic_JJ nerve_NN ,_, where_PNR progesterone_NN and_CC its_PNG direct_JJ precursor_NN pregnenolone_NN are_VBB synthesized_VVN by_II Schwann_NN cells_NNS ._.
P09305011A03
Home_NN health_NN agencies_NNS were_VBD less_RR likely_RR to_TO have_VHI had_VHD programs_NNS in_II the_DD past_NN and_CC more_RR likely_RR to_TO have_VHI recently_RR established_VVN diabetes_NN education_NN programs_NNS ._.
P09314824A01
Needle_NN biopsy_NN of_II the_DD prostate_NN plays_VVZ a_DD central_JJ role_NN in_II the_DD diagnosis_NN of_II prostate_NN cancer_NN and_CC the_DD prediction_NN of_II outcome_NN ._.
P09327504A04
In_II contrast_NN to_II epilepsy_NN ,_, in_II which_PNR a_DD proliferation_NN of_II excitatory_JJ pathways_NNS or_CC inadequate_JJ inhibitory_JJ factors_NNS are_VBB paramount_JJ ,_, schizophrenia_NN may_VM represent_VVB a_DD genetically_RR and_CC age-determined_VVNJ elaboration_NN of_II one_MC or_CC more_DD inhibitory_JJ networks_NNS in_II response_NN to_II specific_JJ physiological_JJ events_NNS (_( e.g._II ,_, the_DD increased_VVNJ neuronal_JJ activity_NN in_II limbic_JJ and_CC hypothalamic_JJ structures_NNS during_II the_DD physiological_JJ events_NNS of_II puberty_NN )_) or_CC to_II brain_NN injury_NN or_CC defect_NN ._.
P09338094A06
Not_RR surprisingly_RR ,_, many_DD components_NNS of_II the_DD cell_NN cycle_NN regulatory_JJ machinery_NN ,_, including_VVG CDKs_NNS ,_, CDK_NN inhibitors_NNS and_CC CDK_NN substrates_NNS ,_, are_VBB important_JJ targets_NNS of_II mutations_NNS that_PNR lead_VVB to_II human_NN malignancy_NN ._.
P09348251A09
CONCLUSION_NN :_: Using_VVG active_JJ expectant_JJ management_NN and_CC strict_JJ routines_NNS it_PN seems_VVZ possible_JJ to_TO minimize_VVI the_DD risk_NN for_II perinatal_JJ asphyxia_NN and_CC mortality_NN ._.
P09361499A03
The_DD mean_NN failure_NN rate_NN was_VBD lowest_JJT in_II Medicine_NN between_II 1975_MC and_CC 1981_MC ,_, in_II Obstetrics_NNS &_CC Gynaecology_NN between_II 1982_MC and_CC 1989_MC and_CC in_II Surgery_NN during_II the_DD last_JJ 7_MC years_NNS ._.
P09370343A07
For_II both_CC the_DD aqua-monoadduct_NN and_CC chloro-monoadduct_NN ,_, cis-_JJ [_( Pt_NN (_( NH3_NN )_) 2_MC (_( N7G_NN )_) (_( H2O_NN or_CC Cl_NN )_) ]_) ,_, the_DD 5'-G_NN monoadduct_NN is_VBZ much_RR longer_JJR lived_VVN (_( t1_NN /_SYM 2_MC approximately_RR 4_MC h_NN at_II 288_MC K_NN for_II aqua_NN ,_, 80_MC h_NN at_II 298_MC K_NN for_II chloro_NN )_) than_CSN the_DD 3'-G_NN monoadduct_NN (_( t1_NN /_SYM 2_MC <_SYM or_CC =_SYM 45_MC min_NN at_II 288_MC K_NN for_II aqua_NN ,_, 6_MC h_NN at_II 298_MC K_NN for_II chloro_NN )_) ._.
P09374561A12
Although_CS use_NN of_II barrier_NN methods_NNS varies_VVZ ,_, all_DD sites_NNS cohort_VVB or_CC isolate_VVB RSV-positive_JJ patients_NNS in_II single_JJ rooms_NNS ._.
P09383880A03
CDE_NN signals_NNS were_VBD recorded_VVN in_II 20_MC singleton_NN pregnancies_NNS with_II appropriate_JJ growth_NN and_CC imminent_JJ preterm_NN delivery_NN between_II 26_MC and_CC 33_MC weeks_NNS of_II gestation_NN ._.
P09393434A01
In_II Saccharomyces_NN cerevisiae_NN ,_, entry_NN into_II S_NN phase_NN requires_VVZ the_DD activation_NN of_II the_DD protein_NN kinase_NN Cdc28p_NN through_II binding_VVGN with_II cyclin_NN Clb5p_NN or_CC Clb6p_NN ,_, as_CC+ well_CC+ as_CC the_DD destruction_NN of_II the_DD cyclin-dependent_JJ kinase_NN inhibitor_NN Sic1p_NN ._.
P09397539A07
The_DD two_MC other_JJ subsets_NNS were_VBD subset_NN V_NN ,_, which_PNR contains_VVZ only_RR the_DD restriction_NN site_NN for_II VspI_NN ,_, and_CC subset_NN N_NN ,_, which_PNR lacks_VVZ all_DD three_MC restriction_NN sites_NNS ._.
P09402084A10
It_PN was_VBD observed_VVN that_CST luminal_JJ U37883A_NN (_( 100_MC microM_NN )_) significantly_RR attenuated_VVD TGF_NN ._.
P09410406A03
The_DD outcome_NN is_VBZ favorable_JJ under_II corticotherapy_NN ._.
P09420353A04
Descriptions_NNS of_II and_CC psychometric_JJ findings_NNS for_II over_RR 2_MC dozen_NN measures_NNS are_VBB summarized_VVN ,_, including_VVG measures_NNS for_II depression_NN ,_, anxiety_NN ,_, eating_VVGJ disorders_NNS ,_, pain_NN ,_, and_CC applications_NNS with_II children_NNS and_CC adolescents_NNS ,_, and_CC conclusions_NNS and_CC future_JJ directions_NNS are_VBB suggested_VVN ._.
P09434208A01
The_DD responsiveness_NN of_II the_DD parabrachial_JJ region_NN to_II electrical_JJ stimulation_NN of_II the_DD superior_JJ laryngeal_JJ nerve_NN was_VBD first_RR examined_VVN in_II anesthetized_VVNJ rats_NNS ._.
P09438564A05
Of_II the_DD medium-SES_NN 6-_MC and_CC 12-year-old_JJ children_NNS ,_, 79_MC and_CC 89_MC %_SYM were_VBD caries-free_JJ ,_, respectively_RR ;_: in_II the_DD high-SES_NN children_NNS the_DD respective_JJ figures_NNS were_VBD 84_MC and_CC 86_MC %_SYM ._.
P09447740A01
The_DD concentration_NN of_II fluoride_NN was_VBD determined_VVN in_II water_NN ,_, forage_NN and_CC urine_NN and_CC serum_NN samples_NNS of_II buffaloes_NNS from_II the_DD Unnao_NNP district_NN of_II India_NNP ._.
P09452452A09
Possible_JJ molecular_JJ mechanisms_NNS are_VBB discussed_VVN ._.
P09457262A14
After_II a_DD mean_NN 6.5_MC year_NN follow-up_NN period_NN ,_, 13_MC patients_NNS (_( 45_MC %_SYM )_) are_VBB neurologically_RR intact_JJ ,_, 8_MC patients_NNS (_( 27.5_MC %_SYM )_) have_VHB a_DD moderate_JJ disability_NN ,_, without_II evidence_NN of_II tumor_NN recurrence_NN ._.
P09466264A07
Transformation_NN efficiencies_NNS of_II recA+_NN (_( Ind-_NN )_) and_CC of_II wild-type_NN cells_NNS were_VBD compared_VVN under_II various_JJ conditions_NNS and_CC with_II different_JJ donor_NN DNA_NN ._.
P09475172A02
A_DD cDNA_NN for_II a_DD rat_NN liver_NN enzyme_NN hydrolyzing_VVG anandamide_NN as_CC+ well_CC+ as_CC oleamide_NN was_VBD overexpressed_VVN in_II COS-7_NN cells_NNS ._.
P09484480A01
A_DD cDNA_NN encoding_VVG the_DD multifunctional_JJ cytochrome_NN P450_NN ,_, CYP71E1_NN ,_, involved_VVN in_II the_DD biosynthesis_NN of_II the_DD cyanogenic_JJ glucoside_NN dhurrin_NN from_II Sorghum_NN bicolor_JJ (_( L._NN )_) Moench_NN was_VBD isolated_VVN ._.
P09488940A06
Left_JJ intraabdominal_JJ testis_NN was_VBD also_RR identified_VVN ._.
P09497501A07
Third_RR ,_, the_DD tissue_NN distribution_NN of_II IF1_NN is_VBZ very_RR suggestive_JJ ._.
P09501857A09
Interestingly_RR ,_, SCFs_NNS produced_VVD and_CC secreted_VVD an_DD 18-kDa_NN extracellular_JJ isoform_NN of_II FGF-2_NN ,_, the_DD synthesis_NN of_II which_PNR is_VBZ further_RR stimulated_VVN by_II TGF-beta_NN 1_MC and_CC TGF-beta_NN 3_MC ,_, respectively_RR ,_, whereas_CS the_DD neutralizing_VVGJ antibody_NN to_II FGF-2_NN and_CC the_DD FGF-2-specific_JJ antisense_NN oligonucleotide_NN primers_NNS inhibited_VVD the_DD stimulatory_JJ activities_NNS of_II TGF-beta_NN 1_MC in_II SCFs_NNS ._.
P09506584A13
Also_RR ,_, anticentrosomal_JJ sera_NNS contained_VVD antibodies_NNS to_II previously_RR undetected_VVNJ centrosomal_JJ components_NNS ._.
P09515719A06
The_DD expression_NN of_II CD14_NN and_CC CD64_NN on_II monocytes_NNS in_II blood_NN was_VBD also_RR investigated_VVN ._.
P09524746A01
Infrastructure_NN of_II 29_MC P._NN shigelloides_NN strains_NNS isolated_VVN as_II the_DD only_RR positive_JJ finding_VVGN from_II children_NNS with_II diarrhea_NN (_( biochemical_JJ properties_NNS ,_, antigenic_JJ structure_NN ,_, antigenic_JJ relationship_NN to_II shigellae_NN ,_, ATB_NN susceptibility_NN and_CC plasmids_NNS )_) were_VBD described_VVN ._.
P09529345A01
Family-based_VVNJ tests_NNS of_II association_NN provide_VVB the_DD opportunity_NN to_TO test_VVI for_II an_DD association_NN between_II a_DD disease_NN and_CC a_DD genetic_JJ marker_NN ._.
P09533829A15
Inhibition_NN of_II phosphatase_NN by_II calyculin_NN (_( 10_MC nm_NN )_) in_II the_DD perforated-patch_NN configuration_NN did_VDD not_RR change_VVB membrane_NN conductance_NN ._.
P09543147A06
Our_PNG data_NNS demonstrate_VVB that_CST 1_MC )_) the_DD release_NN of_II PI_NN provides_VVZ an_DD extracellular_JJ index_NN for_II the_DD hormone_NN biosynthetic_JJ activity_NN of_II human_NN beta-cells_NNS ;_: 2_MC )_) an_DD acute_JJ rise_NN in_II glucose_NN exerts_VVZ a_DD stronger_JJR amplification_NN of_II the_DD release_NN of_II converted_VVNJ hormone_NN than_CSN in_II that_PND of_II nonconverted_VVNJ hormone_NN ;_: and_CC 3_MC )_) prolonged_VVNJ exposure_NN to_II high_JJ glucose_NN levels_NNS results_VVZ in_II an_DD elevated_VVNJ basal_JJ release_NN of_II converted_VVNJ and_CC nonconverted_VVNJ PI_NN ;_: this_DD elevation_NN is_VBZ not_RR associated_VVN with_II a_DD delay_NN in_II PI_NN conversion_NN ,_, but_CC is_VBZ attributed_VVN to_II the_DD hyperactivated_VVNJ state_NN of_II the_DD human_NN beta-cell_NN population_NN ,_, which_PNR was_VBD recently_RR found_VVN to_TO be_VBI responsible_JJ for_II an_DD elevation_NN in_II basal_JJ rates_NNS of_II hormone_NN synthesis_NN ._.
P09551992A06
Photocinematography_NN confirmed_VVD that_CST macrophages_NNS first_RR phagocytosized_VVD and_CC then_RR lysed_VVD the_DD internalized_VVNJ mM-CSF_NN transfectant_NN cells_NNS ._.
P09557038A13
The_DD number_NN of_II visits_NNS rose_VVD by_II 10_MC %_SYM to_II 7.8_MC (_( 3.7_MC )_) and_CC the_DD number_NN of_II diagnostic_JJ laboratory_NN procedures_NNS by_II 25_MC %_SYM to_II 956_MC ._.
P09570690A01
To_TO study_VVI peripheral_JJ nerves_NNS changes_NNS in_II chronic_JJ alcoholism_NN and_CC in_II malnutrition_NN ,_, we_PN examined_VVD ultrastructurally_RR the_DD distal_JJ nerve_NN branches_NNS of_II the_DD digits_NNS of_II rats_NNS treated_VVN with_II four_MC different_JJ dietary_JJ schemes_NNS ,_, as_CS follows_VVZ :_: controls_NNS (_( n_NN =_SYM 22_MC )_) ,_, fed_VVN standard_JJ rodent_NN diet_NN plus_CC water_NN ad_RR+ libitum_RR ;_: alcoholism_NN (_( n_NN =_SYM 12_MC )_) ,_, fed_VVN the_DD standard_JJ diet_NN and_CC 2-12_MC %_SYM ethanol_NN in_II drinking_VVGJ water_NN ;_: malnutrition_NN (_( n_NN =_SYM 21_MC )_) ,_, fed_VVN with_II corn_NN tortillas_NNS instead_II+ of_II standard_JJ diet_NN ;_: and_CC alcoholism_NN and_CC malnutrition_NN combined_VVN (_( n_NN =_SYM 22_MC )_) ._.
P09574886A06
In_II distinguishing_VVGN between_II children_NNS with_II and_CC without_II asthma_NN or_CC in_II assessing_VVGN asthma_NN severity_NN ,_, serum_NN ECP_NN is_VBZ not_RR superior_JJ to_II the_DD peripheral_JJ blood_NN eosinophil_NN count_NN ._.
P09583651A08
This_DD ratio_NN measure_NN was_VBD used_VVN to_TO estimate_VVI the_DD projected_VVNJ unit_NN sales_NNS for_II top-selling_VVGJ premium_NN brands_NNS in_II 1993_MC and_CC was_VBD compared_VVN with_II actual_JJ unit_NN sales_NNS for_II the_DD same_JJ year_NN ._.
P09587995A06
An_DD algorithm_NN that_PNR uses_VVZ a_JJ+ priori_JJ knowledge_NN of_II the_DD correlation_NN coefficient_NN function_NN was_VBD applied_VVN to_TO filter_VVI the_DD obtained_VVNJ strain_NN data_NNS ._.
P09596808A05
Variable_JJ changes_NNS in_II left_JJ ventricular_JJ dP_NN /_SYM dt_NN max_NN occurred_VVD ,_, the_DD predominant_JJ response_NN being_VBG an_DD increase_NN ._.
P09601755A05
After_II occupying_VVGN Bosnia_NNP and_CC Herzegovina_NNP ,_, Austro-Hungarian_JJ Monarchy_NN found_VVD only_RR "_`` Vakuf_NNP Hospital_NN "_'' and_CC Turkish_JJ Military_NN Hospital_NN ,_, in_II 1866_MC ._.
P09606026A04
2-Amino-ethylphosphonic_JJ acid_NN (_( 2-AEPA_NN )_) increased_VVD the_DD overflow_NN of_II [_( 3H_NN ]_) by_II 46.8_MC +/-_SYM 10.9_MC %_SYM at_II the_DD highest_JJT concentration_NN tested_VVN (_( 3_MC mmol_NN /_SYM l_NN )_) ._.
P09610423A11
Two_MC women_NNS achieved_VVD a_DD second_JJ pregnancy_NN ._.
P09619422A03
To_TO test_VVI this_DD hypothesis_NN ,_, adult_JJ females_NNS of_II the_DD hymenopteran_NN ,_, Chrysis_NN ignita_NN were_VBD treated_VVN with_II a_DD microtubule-assemble_NN inhibitor_NN ,_, colchicine_NN ._.
P09627921A02
The_DD author_NN spoke_VVD with_II hospital_NN cleaners_NNS about_II their_PNG jobs_NNS and_CC their_PNG health_NN ._.
P09637220A01
The_DD anthelmintic_JJ efficacy_NN of_II benzimidazoles_NNS ,_, levamisole_NN ,_, rafoxanide_NN and_CC ivermectin_NN was_VBD evaluated_VVN on_II an_DD institutional_JJ farm_NN in_II Kenya_NNP using_VVG faecal_JJ egg_NN count_NN reduction_NN test_NN ,_, larval_JJ cultures_NNS and_CC a_DD controlled_VVNJ slaughter_NN trial_NN ._.
P09641359A11
In_II conclusion_NN ,_, this_DD new_JJ fully_RR automated_VVNJ immunofluorimetric_JJ Lp_NN (_( a_RR )_) assay_NN enables_VVZ to_II the_DD rapid_JJ ,_, accurate_JJ and_CC reliable_JJ determination_NN of_II Lp_NN (_( a_NN )_) in_II blood_NN samples_NNS ._.
P09650556A06
In_II stratified_VVNJ analysis_NN ,_, significantly_RR higher_JJR risk_NN were_VBD found_VVN in_II OC_NN use_NN before_II 25_MC years_NNS old_JJ and_CC in_II duration_NN of_II use_NN less_RR than_CSN one_MC year_NN among_II post-menopausal_JJ subjects_NNS ._.
P09659302A07
These_DD results_NNS suggest_VVB that_CST healing_VVGN may_VM be_VBB an_DD effective_JJ adjunct_NN for_II the_DD treatment_NN of_II chronically_RR ill_JJ patients_NNS presenting_VVG in_II general_JJ practice_NN ._.
P09663739A13
The_DD foreign_JJ body_NN reaction_NN could_VM be_VBB seen_VVN as_II a_DD moderate_JJ accumulation_NN of_II white_JJ blood_NN cells_NNS ._.
P09672958A09
Whether_CST this_DD change_NN is_VBZ sufficient_JJ to_TO increase_VVI the_DD rates_NNS of_II preventive_JJ services_NNS remains_VVZ to_TO be_VBI documented_VVN ._.
P09681652A02
There_EX were_VBD significant_JJ alterations_NNS in_II testicular_JJ sorbitol_NN dehydrogenase_NN ,_, lactic_JJ dehydrogenase_NN ,_, glucose-6-phosphate_NN dehydrogenase_NN ,_, gamma_NN glutamyl_NN transpeptidase_NN ;_: reduced_VVNJ quality_NN of_II sperm_NN and_CC marked_VVNJ pathological_JJ changes_NNS in_II the_DD testis_NN of_II rats_NNS given_VVN aflatoxin_NN B1_NN alone_JJ ._.
P09685710A17
Our_PNG estimates_NNS for_II the_DD rate_NN of_II initiation_NN and_CC progression_NN mutation_NN rates_NNS show_VVB no_DD significant_JJ historical_JJ shifts_NNS and_CC are_VBB approximately_RR 1-2x10-7_MC events_NNS per_II cell_NN division_NN ._.
P09698325A04
Several_JJ findings_NNS suggest_VVB that_CST this_DD decrease_NN in_II AChR_NN clustering_VVGN is_VBZ likely_RR not_RR because_II+ of_II a_DD defect_NN in_II agrin_NN signaling_VVGN through_II the_DD MuSK_NN receptor_NN tyrosine_NN kinase_NN ._.
P09702434A10
CONCLUSIONS_NNS :_: The_DD results_NNS of_II this_DD study_NN provide_VVB some_DD evidence_NN that_CST PCP_NN self-reported_VVNJ attitudes_NNS ,_, knowledge_NN ,_, and_CC practice_NN patterns_NNS in_II delivering_VVGN diabetes_NN care_NN for_II elderly_JJ patients_NNS in_II the_DD office_NN setting_VVGN more_RR closely_RR reflect_VVB current_JJ recommended_VVNJ practice_NN than_CSN reported_VVN in_II previous_JJ physician_NN surveys_NNS ._.
P09711080A04
Human_NN peripheral_JJ blood_NN mononuclear_JJ cells_NNS (_( PBMC_NN )_) cultured_VVN in_II medium_NN containing_VVG the_DD culture_NN supernatant_NN of_II KB_NN /_SYM IL-2_NN cells_NNS showed_VVD stronger_JJR cytotoxic_JJ activity_NN against_II KB_NN cells_NNS than_CSN the_DD control_NN ._.
P09719941A02
A_DD diagnosis_NN of_II a_DD right_JJ renal_JJ tumor_NN was_VBD made_VVN after_II several_JJ radiographic_JJ examinations_NNS and_CC right_JJ radical_JJ nephrectomy_NN was_VBD performed_VVN ._.
P09733110A01
Myoblasts_NNS and_CC myotubes_NNS are_VBB heterogeneous_JJ ,_, but_CC what_PND is_VBZ the_DD significance_NN of_II this_DD heterogeneity_NN ?_.
P09737582A04
It_PN has_VHZ also_RR been_VBN suggested_VVN that_CST variability_NN in_II DC_NN expression_NN of_II coreceptors_NNS for_II M-tropic_JJ versus_CC T-tropic_JJ virus_NN could_VM explain_VVB the_DD restriction_NN in_II the_DD transmitting_VVGJ virus_NN ._.
P09746482A03
The_DD mechanism_NN of_II action_NN of_II this_DD factor_NN does_VDZ not_RR involve_VVB inhibition_NN of_II nitric_JJ oxide_NN (_( NO_NN )_) ,_, production_NN of_II cyclooxygenase_NN metabolites_NNS ,_, 5-hydroxytryptamine_NN ,_, or_CC endothelin_NN ,_, or_CC the_DD activation_NN of_II alpha-adrenoceptors_NNS but_CC is_VBZ a_DD Ca2+-dependent_JJ process_NN ,_, because_CS the_DD constriction_NN is_VBZ inhibited_VVN by_II the_DD Ca2+-channel_NN blocker_NN amlodipine_NN ._.
P09755233A02
The_DD expression_NN of_II TGF-alpha_NN ,_, EGFr_NN ,_, p53_NN nuclear_JJ protein_NN ,_, and_CC proliferation_NN rate_NN was_VBD correlated_VVN with_II clinicopathological_JJ characteristics_NNS and_CC survival_NN after_II partial_JJ liver_NN resection_NN ._.
P09759536A05
This_DD heterogeneity_NN in_II the_DD chemoarchitecture_NN of_II the_DD AOB_NN may_VM reflect_VVB a_DD fundamental_JJ organizational_JJ dichotomy_NN within_II the_DD vomeronasal_JJ system_NN that_PNR corresponds_VVZ to_II a_DD functional_JJ dichotomy_NN ._.
P09768675A02
Patients_NNS with_II acromegaly_NN show_VVB an_DD exuberant_JJ GH_NN response_NN to_II GHSs_NNS ,_, whereas_CS patients_NNS with_II pituitary-dependent_JJ ACTH-secreting_VVGJ tumors_NNS show_VVB an_DD exaggerated_VVNJ rise_NN in_II ACTH_NN and_CC cortisol_NN ._.
P09773286A02
Ninety-one_MC fewer_JJR positions_NNS were_VBD filled_VVN in_II family_NN practice_NN residency_NN programs_NNS in_II 1998_MC ,_, as_CC+ well_CC+ as_CC 21_MC fewer_JJR in_II primary_JJ care_NN internal_JJ medicine_NN ,_, 12_MC fewer_JJR in_II primary_JJ care_NN pediatrics_NNS ,_, and_CC 13_MC fewer_JJR in_II internal_JJ medicine-pediatric_JJ programs_NNS ._.
P09782225A04
A_DD skin_NN patch_NN test_NN to_II chromium_NN was_VBD negative_JJ ._.
P09791021A02
However_RR ,_, recombinant_JJ G_NN protein_NN never_RR matches_VVZ intact_JJ viral_JJ particles_NNS for_II immunogenicity_NN ._.
P09795353A07
The_DD magnitude_NN of_II this_DD effect_NN increased_VVD with_II increased_VVNJ dose_NN of_II initial_JJ irradiation_NN ._.
P09804276A03
Two_MC weeks_NNS after_II grafting_VVGN ,_, the_DD success_NN of_II implantation_NN and_CC recovery_NN of_II dopamine_NN function_NN were_VBD assessed_VVN by_II tyrosine_NN hydroxylase_NN immunocytochemistry_NN (_( TH_NN )_) and_CC the_DD measurement_NN of_II striatal_JJ dopamine_NN content_NN ._.
P09808591A09
Interleukin_NN (_( IL_NN )_) -10_MC but_CC not_RR IL-2_NN messenger_NN RNA_NN was_VBD expressed_VVN in_II NBB_NN cells_NNS as_CS opposed_VVN to_II BM_NN cells_NNS ._.
P09817083A08
This_DD metabolic_JJ reaction_NN was_VBD ,_, however_RR ,_, insensitive_JJ to_II a_DD specific_JJ anti-CYP2B1_NN sera_NNS that_PNR had_VHD been_VBN shown_VVN to_TO inhibit_VVI enzyme_NN activities_NNS attributed_VVN only_RR to_II CYP2BI_NN suggesting_VVG that_CST the_DD CYP2B2_NN pathway_NN is_VBZ predominant_JJ in_II NP_NN metabolism_NN ._.
P09825423A09
The_DD associations_NNS with_II occupational_JJ status_NN and_CC educational_JJ level_NN were_VBD steeper_JJR than_CSN those_PND with_II neighbourhood_NN income_NN ._.
P09829643A10
However_RR ,_, mechanisms_NNS other_II+ than_II viral_JJ persistence_NN may_VM be_VBB more_RR important_JJ in_II the_DD progression_NN of_II IDCM_NN to_II end-stage_NN heart_NN failure_NN in_II this_DD age_NN group_NN ._.
P09844067A02
MATERIALS_NNS AND_CC METHODS_NNS :_: Helicobacter_NN heilmannii_NN infected_VVNJ and_CC uninfected_VVNJ mice_NNS were_VBD treated_VVN with_II 150_MC microg_NN /_SYM ml_NN N-methyl-N'-nitro-N-nitrosoguanidine_NN in_II drinking_VVGJ water_NN for_II either_CC 20_MC or_CC 38_MC weeks_NNS ._.
P09848430A05
OBJECTIVES_NNS :_: We_PN aimed_VVD to_TO ascertain_VVI the_DD views_NNS of_II GPs_NNS on_II service_NN provision_NN for_II people_NNS with_II epilepsy_NN in_II primary_JJ care_NN and_CC on_II specific_JJ initiatives_NNS to_TO improve_VVI care_NN ._.
P09852884A04
Patients_NNS had_VHD a_DD left_JJ ventricular_JJ ejection_NN fraction_NN (_( LVEF_NN )_) of_II >_SYM 25_MC %_SYM and_CC were_VBD not_RR amenable_JJ to_II CABG_NN or_CC PTCA_NN ._.
P09857236A03
No_DD differences_NNS in_II the_DD four_MC angiogenic_JJ factor_NN levels_NNS were_VBD found_VVN between_II the_DD follicular_JJ and_CC luteal_JJ phases_NNS of_II normal_JJ menstruation_NN ._.
P09862128A07
The_DD hydroxyl_NN hydrogens_NNS of_II Tyr33_NN and_CC Ser78_NN are_VBB clearly_RR observed_VVN indicating_VVG that_CST these_DD residues_NNS are_VBB buried_VVN and_CC hydrogen_NN bonded_VVN ._.
P09871450A05
A_DD model_NN is_VBZ proposed_VVN suggesting_VVG that_CST NO_NN protects_VVZ SFO-neurons_NNS from_II overexcitability_NN by_II excitatory_JJ neurotransmitters_NNS ._.
P09884330A01
The_DD adapter_NN protein_NN SLP-76_NN is_VBZ expressed_VVN in_II T_NN lymphocytes_NNS and_CC hematopoietic_JJ cells_NNS of_II the_DD myeloid_NN lineage_NN ,_, and_CC is_VBZ known_VVN to_TO be_VBI a_DD substrate_NN of_II the_DD protein_NN tyrosine_NN kinases_NNS that_PNR are_VBB activated_VVN after_II ligation_NN of_II the_DD T-cell_NN antigen_NN receptor_NN ._.
P09888596A07
The_DD complete_JJ potential_NN of_II the_DD system_NN will_VM become_VVB apparent_JJ as_II new_JJ uses_NNS of_II the_DD technique_NN are_VBB devised_VVN ,_, particularly_RR with_II respect_NN to_II human_NN adrenocortical_JJ cells_NNS and_CC to_II genetically_RR modified_VVNJ cells_NNS ._.
P09920526A01
The_DD local_JJ distribution_NN of_II laser_NN Doppler_NN flux_NN (_( mainly_RR thermoregulatory_JJ perfusion_NN )_) and_CC capillary_NN density_NN (_( nutritive_JJ circulation_NN )_) within_II 25_MC ischemic_JJ leg_NN ulcers_NNS and_CC their_PNG adjacent_JJ skin_NN were_VBD investigated_VVN ._.
P09925216A03
Hemangiosarcomas_NNS were_VBD the_DD most_RRT frequent_JJ primary_JJ neoplasms_NNS ,_, followed_VVN by_II chemodectomas_NNS ._.
P09933960A05
This_DD QSAR_NN represented_VVD the_DD amine_NN narcosis_NN mechanism_NN of_II toxic_JJ action_NN ._.
P09988057A03
Valproate_NN is_VBZ also_RR being_VBG increasingly_RR used_VVN in_II disorders_NNS with_II aggressive_JJ or_CC agitated_VVNJ features_NNS ,_, such_II+ as_II the_DD behavioral_JJ disorders_NNS of_II dementia_NN ;_: yet_RR ,_, few_JJ studies_NNS have_VHB documented_VVN the_DD utility_NN of_II valproate_NN in_II geriatric_JJ patients_NNS ._.
P10022932A07
The_DD percentage_NN of_II surface_NN area_NN operated_VVN upon_II rather_II+ than_II the_DD amount_NN of_II fat_NN removed_VVN was_VBD the_DD most_RRT important_JJ relevant_JJ factor_NN ._.
P10037316A05
RESULTS_NNS :_: The_DD average_JJ mean_NN teaching_VVGJ evaluation_NN score_NN was_VBD associated_VVN with_II the_DD scores_NNS on_II the_DD NBME_NN surgery_NN subject_NN examination_NN (_( P_NN =_SYM 0.0005_MC )_) ._.
P10065864A05
The_DD expression_NN of_II both_CC mRNA_NN and_CC protein_NN appear_VVB to_TO be_VBI decreased_VVN in_II hyperplastic_JJ Leydig_NN cells_NNS ,_, whereas_CS in_II the_DD Leydig_NN cell_NN adenomas_NNS studied_VVN ,_, large_JJ central_JJ areas_NNS of_II the_DD adenoma_NN were_VBD devoid_II+ of_II RLF_NN mRNA_NN and_CC protein_NN ._.
P10074558A03
These_DD results_NNS revealed_VVD that_CST the_DD HGV_NN genome_NN can_VM be_VBB classified_VVN into_II at_RR+ least_RR four_MC major_JJ genotypes_NNS ._.
P10084062A08
The_DD increase_NN in_II low-frequency_NN power_NN was_VBD more_RR evident_JJ in_II Group_NN C_NN patients_NNS than_CSN in_II the_DD other_JJ two_MC groups_NNS (_( p_NN <_SYM 0.005_MC )_) ._.
P10097868A02
Manual_JJ dissection_NN can_VM compromise_VVB the_DD heart_NN and_CC reduce_VVB blood_NN pressure_NN ._.
P10101885A11
CONCLUSIONS_NNS :_: The_DD locoregional_JJ tumor_NN control_NN and_CC disease-free_JJ survival_NN rates_NNS for_II this_DD group_NN of_II 23_MC patients_NNS who_PNR received_VVD combined_VVNJ therapy_NN with_II external_JJ irradiation_NN and_CC radioactive_JJ gold_NN grain_NN implantation_NN (_( Au198_NN )_) were_VBD slightly_RR lower_JJR than_CSN those_PND obtained_VVN in_II another_DD group_NN of_II 104_MC patients_NNS treated_VVN at_II our_PNG Service_NN of_II Radiotherapeutic_JJ Oncology_NN with_II radical_JJ external_JJ radiation_NN therapy_NN and_CC can_VM be_VBB ascribed_VVN mainly_RR to_II poor_JJ patient_NN selection_NN and_CC inadequate_JJ radiation_NN dose_NN ._.
P10132072A05
MAIN_JJ MEASURES_NNS --_: Treatment_NN of_II oesophagectomy_NN ,_, mortality_NN within_II 30_MC days_NNS of_II oesophagectomy_NN ,_, and_CC duration_NN of_II survival_NN from_II date_NN of_II diagnosis_NN to_II death_NN ,_, according_II+ to_II patient_NN and_CC tumour_NN characteristics_NNS ._.
P10143699A07
The_DD patient-focused_VVNJ evaluation_NN of_II large_JJ scale_NN systems_NNS and_CC the_DD hospital-focused_VVNJ evaluation_NN of_II all_DD PACS_NN systems_NNS could_VM feasibly_RR be_VBB conducted_VVN as_II contemporaneous_JJ experimental_JJ comparisons_NNS between_II hospitals_NNS but_CC the_DD large_JJ research_NN costs_NNS implied_VVN by_II such_DB a_DD design_NN almost_RR certainly_RR mean_VVB that_CST non-contemporaneous_JJ ,_, non-experimental_JJ comparisons_NNS within_II hospitals_NNS are_VBB more_RR realistic_JJ ._.
P10179363A02
While_CS the_DD frequency_NN of_II hospital_NN mergers_NNS is_VBZ growing_VVG at_II tremendous_JJ rates_NNS ,_, the_DD actual_JJ consolidation_NN of_II services_NNS following_VVG mergers_NNS is_VBZ slow_JJ ._.
P10192456A04
However_RR ,_, it_PN is_VBZ not_RR clear_VVB if_CST all_DD haematological_JJ cells_NNS expressing_VVG the_DD mutant_JJ WASP_NN allele_NN are_VBB eliminated_VVN in_II WAS_NN carriers_NNS ._.
P10201301A02
Additionally_RR ,_, we_PN sought_VVD to_TO determine_VVI which_DD findings_NNS had_VHD predictive_JJ value_NN for_II surgical_JJ outcome_NN ._.
P10205776A02
METHODS_NNS :_: This_DD study_NN comprised_VVD 52_MC normal_JJ pregnant_JJ women_NNS ,_, including_VVG 11_MC in_II the_DD first_JJ ,_, 19_MC in_II the_DD second_JJ ,_, and_CC 22_MC in_II the_DD third_JJ trimester_NN ,_, in_II addition_NN to_II 30_MC healthy_JJ ,_, fertile_JJ nonpregnant_JJ women_NNS of_II comparable_JJ age_NN and_CC with_II normal_JJ body_NN mass_NN index_NN (_( BMI_NN )_) ._.
P10210179A09
Despite_II presenting_VVGN little_JJ or_CC no_DD sequence_NN similarity_NN ,_, an_DD analysis_NN of_II the_DD beta-prism_NN reveals_VVZ a_DD canonical_JJ feature_NN repeatedly_RR present_JJ in_II all_DB such_DD structures_NNS ,_, which_PNR is_VBZ based_VVN on_II six_MC largely_RR hydrophobic_JJ residues_NNS within_II a_DD beta-hairpin_NN containing_VVG two_MC classic-type_NN beta-bulges_NNS ._.
P10218998A09
These_DD data_NNS indicate_VVB that_CST relaxin-induced_VVNJ uterine_JJ edema_NN and_CC growth_NN is_VBZ mediated_VVN by_II ERs_NNS ._.
P10223220A14
Absolute_JJ eosinophilia_NN is_VBZ a_DD putative_JJ cause_NN of_II EMF_NN ,_, a_DD finding_VVGN not_RR explained_VVN by_II parasitism_NN ._.
P10231718A04
It_PN appears_VVZ that_CST inclusion_NN of_II HOTic_NN in_II place_NN of_II Tyr_NN to_TO introduce_VVI conformational_JJ constrain_NN to_II peptide_NN analogs_NNS can_VM cause_VVB or_CC augment_VVB a_DD tendency_NN towards_II conformations_NNS with_II increasing_VVGJ occlusion_NN of_II N-terminal_JJ amino_JJ groups_NNS and_CC result_VVB in_II the_DD need_NN for_II altered_VVNJ coupling_VVGJ strategies_NNS for_II completion_NN of_II analog_NN synthesis_NN ._.
P10287713A02
The_DD authors_NNS discuss_VVB case-management_NN services_NNS as_CS they_PN apply_VVB to_II persons_NNS with_II AIDS_NN and_CC AIDS-related_VVNJ complex_NN ._.
P10319780A05
Continuous_JJ model-simulated_VVNJ cardiac_JJ output_NN (_( MCO_NN )_) was_VBD computed_VVN from_II radial_JJ or_CC femoral_JJ artery_NN pressure_NN ._.
P10325418A06
V81x_NN RSS_NN mediated_VVD recombination_NN at_II rates_NNS significantly_RR higher_JJR than_CSN another_DD VHRSS_NN ._.
P10334500A04
The_DD results_NNS showed_VVD that_CST the_DD regions_NNS with_II metabolic_JJ change_NN are_VBB somewhat_RR different_JJ from_II those_DD results_NNS studied_VVN with_II microdialysis_NN and_CC the_DD Fos_NN immunohistochemistry_NN ._.
P10349838A01
We_PN investigated_VVD the_DD effects_NNS of_II nerve_NN growth_NN factor_NN (_( NGF_NN )_) and_CC NGF_NN withdrawal_NN on_II expression_NN of_II members_NNS of_II the_DD bcl-2_NN family_NN of_II genes_NNS and_CC caspase-3_NN in_II PC12_NN cells_NNS ._.
P10354845A05
An_DD oncological_JJ resection_NN was_VBD performed_VVN in_II 55_MC patients_NNS ._.
P10359345A03
One_MC day_NN later_RR the_DD epithelium_NN was_VBD removed_VVN from_II the_DD central_JJ cornea_NN and_CC a_DD standardized_VVNJ inoculum_NN of_II Candida_NN albicans_NN blastoconidia_NN was_VBD placed_VVN on_II the_DD corneal_JJ surface_NN and_CC covered_VVN with_II a_DD contact_NN lens_NN ._.
P10363585A04
The_DD IC50_NN of_II SW480_NN /_SYM dThdPase_NN was_VBD lower_JJR than_CSN that_PND of_II SW480_NN or_CC SW480_NN /_SYM V1_NN ,_, although_CS the_DD differences_NNS were_VBD not_RR statistically_RR significant_JJ ._.
P10367847A09
The_DD ultrafiltrate_NN contained_VVD 100_MC %_SYM fPSA_NN in_II high-flux_NN membranes_NNS and_CC no_DD fPSA_NN in_II low-flux_NN membranes_NNS ._.
P10372401A09
The_DD human_NN h-APJ_NN receptor_NN is_VBZ a_DD co-receptor_NN for_II entry_NN of_II the_DD HIV_NN into_II T_NN cells_NNS ,_, a_DD property_NN associated_VVD only_RR with_II CXC_NN chemokine_NN receptors_NNS in_II the_DD lymphocyte_NN population_NN ._.
P10380904A03
Anti-inflammatory_JJ cytokines_NNS ,_, IL-10_NN ,_, and_CC transforming_VVGJ growth_NN factor_NN (_( TGF_NN )_) -beta_NN sequentially_RR inhibited_VVD LPS-_NN and_CC cytokine-induced_VVNJ microglial_JJ cell_NN NF-kappaB_NN activation_NN ,_, RANTES_NN mRNA_NN expression_NN ,_, and_CC protein_NN release_NN ._.
P10389993A03
All_DB the_DD 158_MC women_NNS (_( 159_MC tumours_NNS )_) were_VBD treated_VVN with_II breast_NN conserving_VVGJ surgery_NN and_CC postoperative_JJ radiotherapy_NN ._.
P10394292A05
It_PN is_VBZ necessary_JJ to_TO make_VVI a_DD strict_JJ government_NN surveillance_NN over_II the_DD design_NN ,_, testing_VVGN of_II these_DD agents_NNS ._.
P10407139A05
These_PND include_VVB its_PNG role_NN in_II membrane_NN fusion_NN ,_, microtubule_NN bundling_VVGN ,_, phosphotransferase_NN activity_NN ,_, nuclear_JJ RNA_NN export_NN ,_, DNA_NN replication_NN and_CC DNA_NN repair_NN ._.
P10411582A08
The_DD selective_JJ inhibitor_NN of_II MAPK_NN ,_, PD98059_NN ,_, diminished_VVNJ PAH_NN uptake_NN at_II 5_MC x_SYM 10_MC (_( -5_MC )_) M_NN by_II 23.2_MC +/-_SYM 6.8_MC %_SYM and_CC at_II 10_MC (_( -4_MC )_) M_NN by_II 18.3_MC +/-_SYM 5.2_MC %_SYM ._.
P10420138A06
Atopic_JJ skin_NN had_VHD significantly_RR reduced_VVNJ trypsin_NN activity_NN ,_, increased_VVNJ acid_NN phosphatase_NN and_CC no_DD change_NN in_II the_DD activities_NNS of_II three_MC other_JJ studied_VVNJ enzymes_NNS ._.
P10428948A01
The_DD integrin_NN alpha6beta4_NN is_VBZ an_DD essential_JJ component_NN of_II hemidesmosomes_NNS but_CC it_PN also_RR plays_VVZ a_DD dynamic_JJ role_NN in_II invasive_JJ carcinoma_NN cells_NNS ._.
P10433418A10
With_II regard_NN to_II the_DD force_NN magnitudes_NNS and_CC their_PNG directions_NNS ,_, sheep_NN seem_VVB to_TO be_VBI a_DD good_JJ model_NN for_II testing_VVGN human_NN implant_NN at_II the_DD proximal_JJ femur_NN ._.
P10442113A04
Thermophilic_JJ campylobacters_NNS were_VBD identified_VVN and_CC characterised_VVN using_VVG standard_JJ physical_JJ and_CC biochemical_JJ tests_NNS ._.
P10446389A07
We_PN hypothesise_VVB that_CST in_II the_DD presence_NN of_II an_DD electron_NN carrier_NN the_DD electron_NN donors_NNS active_JJ in_II the_DD reduction_NN of_II CTC_NN are_VBB located_VVN in_II the_DD intracellular_JJ compartment_NN ,_, as_CC+ well_CC+ as_CC in_II plasma_NN membranes_NNS ._.
P10455107A01
Malonyl-CoA_NN decarboxylase_NN (_( MCD_NN )_) catalyzes_VVZ the_DD proton-consuming_VVGJ conversion_NN of_II malonyl-CoA_NN to_II acetyl-CoA_NN and_CC CO_NN (_( 2_MC )_) ._.
P10459558A06
Body_NN fat_NN distribution_NN was_VBD evaluated_VVN by_II the_DD waist_NN circumference_NN and_CC the_DD waist_NN to_II hip_NN ratio_NN (_( WHR_NN )_) ._.
P10463853A07
The_DD meningeal_JJ markers_NNS cystatin-C_NN and_CC beta-trace_NN protein_NN as_CC+ well_CC+ as_CC total_JJ protein_NN did_VDD not_RR differ_VVB in_II TLE_NN and_CC TN_NN ._.
P10472638A06
However_RR ,_, things_NNS are_VBB moving_VVG ,_, and_CC the_DD general_JJ tendency_NN now_RR is_VBZ to_TO reduce_VVI the_DD total_JJ number_NN of_II beds_NNS in_II the_DD Swiss_JJ hospitals_NNS ,_, and_CC to_TO open_VVI some_DD specialised_VVNJ wards_NNS under_II the_DD direct_JJ supervision_NN of_II specialists_NNS ,_, including_VVG pneumologists_NNS ._.
P10481442A02
Magnetic_JJ resonance_NN imaging_VVGN revealed_VVD dilated_VVNJ perimedullary_JJ veins_NNS around_II the_DD spinal_JJ cord_NN at_II C-1_NN and_CC C-2_NN levels_NNS ,_, as_CC+ well_CC+ as_CC high_JJ intensity_NN signals_NNS in_II the_DD spinal_JJ cord_NN on_II T2-weighted_VVNJ images_NNS ._.
P10489996A09
However_RR ,_, these_DD data_NNS do_VDB not_RR suggest_VVB an_DD independent_JJ effect_NN of_II weight_NN cycling_VVGN on_II risk_NN of_II hypertension_NN ._.
P10498804A06
On_II the_DD other_JJ hand_NN ,_, it_PN stimulates_VVZ the_DD metabolism_NN of_II phosphatidylinositol_NN ,_, thus_RR causing_VVG accumulation_NN of_II diacylglycerol_NN and_CC inositol-1_NN ,_, 4_MC ,_, 5-triphosphate_NN ,_, which_PNR in_II turn_NN activate_VVB protein_NN kinase_NN C_NN ._.
P10508084A05
Plants_NNS in_II this_DD family_NN are_VBB considered_VVN to_TO be_VBI promiscuous_JJ hosts_NNS because_CS several_JJ species_NNS are_VBB effectively_RR nodulated_VVN by_II most_DD isolated_VVNJ strains_NNS of_II Frankia_NN in_II the_DD greenhouse_NN ._.
P10512254A10
Stress_NN testing_VVGN alone_JJ was_VBD associated_VVN with_II reduced_VVNJ long-term_NN mortality_NN in_II patients_NNS undergoing_VVG infrainguinal_JJ revascularization_NN ._.
P10521060A02
Its_PNG cardiotoxic_JJ potential_NN is_VBZ known_VVN ,_, but_CC considered_VVNJ uncommon_JJ and_CC usually_RR not_RR life_NN threatening_VVGN ,_, although_CS some_DD cases_NNS of_II severe_JJ cardiotoxicity_NN related_VVN to_II 5-FU_NN have_VHB been_VBN reported_VVN ._.
P10525492A09
The_DD strong_JJ parallelism_NN to_II the_DD experimental_JJ data_NNS obtained_VVN in_II the_DD stroke-prone_JJ animal_NN model_NN provides_VVZ assurance_NN for_II the_DD relevance_NN of_II our_PNG observation_NN ._.
P10534322A02
Radiolabeled_VVNJ tirofiban_NN was_VBD synthesized_VVN with_II either_CC (_( 3_MC )_) H-label_NN incorporated_VVN into_II the_DD phenyl_NN ring_NN of_II the_DD tyrosinyl_NN residue_NN or_CC (_( 14_MC )_) C-label_NN in_II the_DD butane_NN sulfonyl_NN moiety_NN ._.
P10540061A01
A_DD survey_NN of_II 35_MC hospitals_NNS in_II the_DD United_VVNJ Kingdom_NN has_VHZ uncovered_VVN a_DD wide_JJ variety_NN of_II syringe_NN drug_NN labels_NNS ._.
P10544963A10
The_DD remaining_VVGJ 81_MC %_SYM of_II DNA-protein_NN crosslinks_NNS appear_VVB to_TO be_VBI oxidatively_RR crosslinked_VVN out_II+ of_II which_PNR about_RR 45_MC %_SYM appear_VVB to_TO be_VBI through_II sulfhydryl_NN groups_NNS and_CC another_DD 36_MC %_SYM appear_VVB to_TO be_VBI through_II non-sulfhydryl_NN groups_NNS ._.
P10558291A03
The_DD prediction_NN for_II physician_NN executives_NNS ?_.
P10562976A10
The_DD increased_VVNJ risk_NN attributable_JJ to_II advanced_VVNJ donor_NN age_NN was_VBD also_RR supported_VVN by_II the_DD UNOS_NN data_NNS ._.
P10571753A07
Many_JJ questions_NNS about_II partial_JJ liquid_NN ventilation_NN remain_VVB unanswered_VVN particularly_RR with_II regard_NN to_II the_DD dose_NN of_II PFC_NN required_VVN ,_, its_PNG ideal_JJ method_NN of_II administration_NN and_CC the_DD long-term_NN effects_NNS ._.
P10585420A03
Amino_JJ acid_NN sequencing_VVGN allowed_VVD the_DD cloning_VVGN of_II a_DD full-length_NN cDNA_NN encoding_VVG the_DD glucosyltransferase_NN ._.
P10589804A08
Our_PNG results_NNS show_VVB that_CST this_DD single_JJ primer_NN pair_NN AA1416_NN can_VM be_VBB used_VVN in_II PCR_NN to_TO identify_VVI A._NN actinomycetemcomitans_NN isolates_NNS and_CC differentiate_VVB them_PN from_II other_JJ periodontal_JJ bacteria_NN ._.
P10598863A02
We_PN have_VHB developed_VVN an_DD electroporation_NN technique_NN that_CST efficiently_RR transfers_VVZ RNA_NN ,_, DNA_NN and_CC other_JJ large_JJ membrane-impermeant_JJ molecules_NNS into_II adherent_JJ hippocampal_JJ neurons_NNS ._.
P10602912A07
When_CS viewed_VVN through_II the_DD necessarily_RR coarse_JJ filter_NN of_II ecological_JJ data_NNS acquisition_NN ,_, and_CC regardless_II+ of_II their_PNG detailed_VVNJ topology_NN ,_, these_DD attractors_NNS are_VBB often_RR indistinguishable_JJ from_II multi-annual_JJ cycles_NNS ._.
P10607457A08
The_DD precipitated_VVNJ CaF_NN (_( 2_MC )_) may_VM act_VVB as_II a_DD reservoir_NN for_II the_DD subsequent_JJ fluoridation_NN of_II the_DD mineral_NN and_CC may_VM inhibit_VVB bacterial_JJ action_NN in_II the_DD mouth_NN ._.
P10622204A02
The_DD number_NN of_II eligible_JJ subjects_NNS was_VBD 1673_MC ._.
P10626851A07
Part_NN 2_MC :_: Twenty-two_MC SD_NN and_CC 17_MC TS_NN rats_NNS (_( day_NN 0_MC )_) were_VBD injected_VVN with_II either_CC capsaicin_NN or_CC vehicle_NN ._.
P10631090A05
In_II addition_NN ,_, DEPC_NN treatment_NN abolished_VVD the_DD ability_NN of_II PDK_NN to_TO trans-phosphorylate_VVI and_CC inactivate_VVI PDC_NN ._.
P10644761A02
BCP_NN showed_VVD a_DD thioredoxin-dependent_JJ thiol_NN peroxidase_NN activity_NN ._.
P10653619A02
The_DD EEG_NN activity_NN was_VBD recorded_VVN simultaneously_RR from_II intracranial_JJ electrodes_NNS inserted_VVN through_II the_DD foramen_NN ovale_NN (_( FO_NN )_) and_CC scalp_NN electrodes_NNS ._.
P10662748A03
The_DD present_JJ study_NN examined_VVD arrhythmic_JJ risk_NN in_II patients_NNS with_II overt_JJ and_CC concealed_VVNJ forms_NNS of_II the_DD disease_NN and_CC the_DD effectiveness_NN of_II sodium_NN channel_NN blockers_NNS to_TO unmask_VVI the_DD syndrome_NN and_CC ,_, thus_RR ,_, identify_VVI patients_NNS at_II risk_NN ._.
P10667500A09
In_II addition_NN ,_, the_DD personnel_NN were_VBD instructed_VVN to_TO be_VBI more_RR vigilant_JJ and_CC specific_JJ measures_NNS aimed_VVN at_II reducing_VVGN the_DD accidental_JJ removal_NN were_VBD introduced_VVN ._.
P10671843A06
No_DD in-line_NN temperatures_NNS reached_VVD 40_MC degrees_NNS C_MC ._.
P10680483A07
RESULT_NN :_: Totally_RR 151_MC cases_NNS of_II unilateral_JJ and_CC bilateral_JJ cleft_NN palate_NN have_VHB been_VBN repaired_VVN with_II this_DD method_NN ._.
P10689116A02
These_DD algorithms_NNS consist_VVB of_II blocks_NNS of_II 8_MC amino_JJ acids_NNS containing_VVG an_DD amino_JJ acid_NN anchor_NN (_( Tyr_NN ,_, Phe_NN ,_, Trp_NN ,_, Leu_NN ,_, Ile_NN ,_, or_CC Val_NN )_) at_II position_NN i_NN and_CC different_JJ amino_JJ acid_NN combinations_NNS at_II positions_NNS i+2_NN to_II i+7_NN depending_VVG on_II the_DD class_NN II_MC molecule_NN ._.
P10693940A07
Together_RR ,_, these_DD results_NNS indicate_VVB that_CST pooled_VVNJ samples_NNS of_II amperometric_JJ spike_NN characteristics_NNS can_VM give_VVB results_NNS that_PNR may_VM confound_VVB the_DD interpretation_NN of_II amperometric_JJ data_NNS ._.
P10702737A04
The_DD animals_NNS were_VBD divided_VVN into_II three_MC groups_NNS of_II 20_MC rats_NNS each_PND and_CC received_VVD either_CC normal_JJ saline_NN ,_, heparin_NN 100_MC U_NN /_SYM kg_NN body_NN weight_NN ,_, or_CC rt-PA_NN 3.5_MC mg_NN /_SYM kg_NN body_NN weight_NN intravenously_RR ._.
P10706876A11
Finally_RR ,_, our_PNG results_NNS suggest_VVB that_CST a_DD cellular_JJ model_NN with_II doxycycline-inducible_JJ IkappaBalpha_NN (_( 32_MC /_SYM 36A_NN )_) may_VM be_VBB useful_JJ in_II the_DD identification_NN of_II genuine_JJ NF-kappaB_NN target_NN genes_NNS in_II EBV-infected_VVNJ B_NN cells_NNS ._.
P10715614A03
This_DD discussion_NN features_VVZ several_JJ examples_NNS of_II regulations_NNS and_CC judicial_JJ decisions_NNS that_PNR have_VHB begun_VVN to_TO recognize_VVI hormetic_JJ effects_NNS ._.
P10724325A01
The_DD authors_NNS of_II this_DD article_NN ,_, who_PNR were_VBD the_DD members_NNS and_CC staff_NN of_II a_DD research_NN panel_NN formed_VVN by_II the_DD AAMC_NN as_II part_NN of_II its_PNG mission-based_VVNJ management_NN initiative_NN ,_, reflect_VVB on_II the_DD growing_VVGJ interest_NN in_II quantitative_JJ information_NN in_II the_DD management_NN of_II the_DD research_NN mission_NN of_II medical_JJ schools_NNS ._.
P10732943A04
Full-scan_NN mass_NN spectra_NNS of_II drugs_NNS examined_VVN by_II means_NNS of_II APCI_NN with_II collision-induced_VVNJ dissociation_NN showed_VVD protonated_VVNJ molecular_JJ ions_NNS and_CC fragments_NNS typical_JJ for_II particular_JJ drugs_NNS ._.
P10737485A08
Median_JJ time_NN from_II the_DD diagnosis_NN to_II orchiectomy_NN was_VBD 23_MC months_NNS ._.
P10746726A05
We_PN interrupted_VVD motion_NN viewing_VVGN with_II electrical_JJ microstimulation_NN of_II the_DD frontal_JJ eye_NN field_NN and_CC analysed_VVD the_DD resulting_VVGJ ,_, evoked_VVNJ eye_NN movements_NNS for_II evidence_NN of_II ongoing_VVGJ activity_NN associated_VVN with_II the_DD oculomotor_NN response_NN ._.
P10755366A02
Therefore_RR ,_, searching_VVGN for_II sensitive_JJ indicators_NNS of_II nephrotoxic_JJ action_NN is_VBZ well_RR worth_II the_DD effort_NN ._.
P10764021A01
Gastro-oesophageal_JJ reflux_NN disease_NN (_( GORD_NN )_) occurs_VVZ more_RR frequently_RR in_II Europe_NNP and_CC North_NN America_NNP than_CSN in_II Asia_NNP but_CC its_PNG prevalence_NN is_VBZ now_RR increasing_VVG in_II many_DD Asian_JJ countries_NNS ._.
P10772578A04
The_DD recombinant_JJ protein_NN expressed_VVN from_II the_DD plasmid_NN has_VHZ been_VBN used_VVN to_TO develop_VVI an_DD indirect_JJ ELISA_NN for_II IgM_NN antibody_NN detection_NN ._.
P10776948A08
Four_MC (_( 27_MC %_SYM )_) of_II 15_MC patients_NNS with_II chronic_JJ HCV_NN ,_, receiving_VVG treatment_NN with_II interferon_NN ,_, were_VBD coinfected_VVN by_II HGV_NN and_CC became_VVD HGV-RNA_NN negative_JJ during_II therapy_NN ._.
P10781656A04
RESULTS_NNS :_: 14_MC of_II the_DD 26_MC patients_NNS (_( 54_MC %_SYM )_) showed_VVD a_DD significant_JJ vasodilation_NN (_( i.e._II a_DD decrease_NN of_II R_NN (_( fa_NN )_) of_II more_RR than_CSN 10_MC %_SYM )_) ._.
P10786642A01
Dopamine_NN (_( DA_NN )_) release_NN (_( r_NN )_) from_II the_DD carotid_JJ body_NN (_( CB_NN )_) is_VBZ thought_VVN to_TO be_VBI modulated_VVN by_II feedback_NN inhibition_NN mediated_VVN by_II DA_NN D2_NN autoreceptors_NNS ._.
P10796081A15
The_DD length_NN of_II time_NN taken_VVN for_II the_DD synthetic_JJ material_NN to_TO be_VBI absorbed_VVN is_VBZ of_II concern_NN ._.
P10805219A06
The_DD health_NN control_NN patients_NNS had_VHD levels_NNS of_II 25_MC pg_NN /_SYM ml_NN (_( 95_MC percent_NN confidence_NN interval_NN ,_, 10-35_MC )_) ._.
P10809682A10
Analysis_NN of_II a_DD codY_NN mutant_NN bearing_VVG a_DD hag-lacZ_NN reporter_NN revealed_VVD that_CST flagellin_NN expression_NN is_VBZ released_VVN from_II nutritional_JJ repression_NN in_II this_DD strain_NN ,_, whereas_CS mutations_NNS in_II the_DD transition_NN state_NN preventor_NN genes_NNS abrB_NN ,_, hpr_NN ,_, and_CC sinR_NN failed_VVD to_TO elicit_VVI a_DD similar_JJ effect_NN during_II growth_NN in_II complex_JJ medium_NN ._.
P10818427A08
No_DD treatment_NN to_TO restore_VVI fertility_NN in_II patients_NNS with_II premature_JJ ovarian_JJ failure_NN has_VHZ proved_VVN to_TO be_VBI safe_JJ and_CC effective_JJ in_II prospective_JJ controlled_VVNJ studies_NNS ._.
P10827197A08
Mutations_NNS at_II residues_NNS K68A_NN and_CC K309A_NN reduced_VVD the_DD potency_NN of_II ATP_NN by_II >_SYM 1400-fold_NN and_CC prolonged_VVD the_DD time_NN course_NN of_II the_DD P2X_NN (_( 1_MC )_) receptor_NN current_NN but_CC had_VHD no_DD effect_NN on_II suramin_NN antagonism_NN ._.
P10840302A04
METHODS_NNS :_: We_PN removed_VVD 56_MC sessile_JJ colorectal_JJ polyps_NNS 2_MC cm_NN or_CC greater_JJR in_II diameter_NN in_II 56_MC patients_NNS by_II using_VVGN an_DD endoscopic_JJ submucosal_JJ saline_NN injection_NN technique_NN ._.
P10844817A07
Kappa_NN showed_VVD values_NNS of_II 0.85_MC and_CC 0.78_MC ,_, which_PNR can_VM be_VBB described_VVN as_II excellent_JJ ._.
P10853977A04
RESULTS_NNS :_: Seventy-three_MC subjects_NNS (_( 54_MC %_SYM )_) achieved_VVD suppression_NN of_II plasma_NN HIV-1_NN RNA_NN to_II levels_NNS below_II 400_MC copies_NNS /_SYM ml_NN during_II the_DD observation_NN period_NN ,_, 31_MC individuals_NNS (_( 23_MC %_SYM )_) had_VHD detectable_JJ plasma_NN HIV-1_NN RNA_NN below_II 10,000_MC copies_NNS /_SYM ml_NN and_CC 31_MC subjects_NNS (_( 23_MC %_SYM )_) had_VHD virological_JJ failures_NNS with_II viral_JJ loads_NNS above_II 10,000_MC copies_NNS /_SYM mL_NN ._.
P10858386A06
We_PN found_VVD two_MC significant_JJ predictive_JJ factors_NNS of_II N2_NN disease_NN on_II the_DD basis_NN of_II multivariable_JJ analysis_NN :_: maximum_NN tumor_NN dimension_NN and_CC serum_NN carcinoembryonic_JJ antigen_NN (_( CEA_NN )_) concentrations_NNS ._.
P10867250A05
On_II the_DD basis_NN of_II the_DD calculated_VVNJ binding_VVGJ capacity_NN ,_, the_DD complex_NN was_VBD prepared_VVN ,_, dried_VVN and_CC milled_VVN ._.
P10875558A05
Patients_NNS with_II suspected_VVNJ sleep_NN disorders_NNS underwent_VVD physical_JJ and_CC psychiatric_JJ assessment_NN as_CC+ well_CC+ as_CC sleep_NN studies_NNS ._.
P10880117A04
Ethylene_NN oxide_NN and_CC Sterrad_NN (_( R_NN )_) sterilization_NN techniques_NNS did_VDD not_RR modify_VVB the_DD corrosion_NN resistance_NN of_II electropolished_VVNJ NiTi_NN ,_, whereas_CS a_DD steam_NN autoclave_NN and_CC ,_, to_II a_DD lesser_JJR extent_NN ,_, peracetic_JJ acid_NN sterilization_NN produced_VVD scattered_VVNJ breakdown_NN potential_NN ._.
P10884478A10
Brain_NN mRNA_NN levels_NNS of_II the_DD other_JJ proinflammatory_JJ cytokines_NNS ,_, including_VVG tumor_NN necrosis_NN factor-alpha_NN ,_, IL-1beta_NN ,_, and_CC IL-1_NN receptor_NN antagonist_NN ,_, were_VBD 50_MC %_SYM lower_JJR in_II IL-6-deficient_JJ ischemic_JJ animals_NNS than_CSN in_II normal_JJ animals_NNS ._.
P10888979A10
Most_PND of_II these_DD events_NNS occurred_VVD after_II initiation_NN of_II PI_NN therapy_NN ._.
P10898533A03
Both_DD inhibitors_NNS reduced_VVD and_CC then_RR abolished_VVD uterine_JJ force_NN ,_, irrespective_II+ of_II how_CST it_PN was_VBD produced_VVN ;_: this_PND was_VBD the_DD case_NN for_II both_CC human_NN and_CC rat_NN myometrium_NN ,_, and_CC pregnant_JJ and_CC non-pregnant_JJ tissue_NN ._.
P10902715A11
Thus_RR ,_, it_PN was_VBD concluded_VVN that_CST Ncc-tmp1A_NN is_VBZ not_RR required_VVN for_II compatibility_NN with_II its_PNG own_JJ cytoplasm_NN ._.
P10907554A13
In_II yeast_NN ,_, this_PND is_VBZ catalysed_VVN by_II an_DD NADPH-linked_VVNJ transmembrane_JJ reductase_NN ,_, which_PNR has_VHZ homology_NN with_II the_DD NADPH_NN oxidase_NN of_II neutrophils_NNS ._.
P10912630A04
The_DD determination_NN of_II the_DD levels_NNS of_II adenosine_NN deaminase_NN (_( ADA_NN )_) in_II pleural_JJ fluid_NN offers_VVZ high_JJ performance_NN in_II its_PNG discriminating_VVGJ capacity_NN to_TO identify_VVI TP_NN (_( sensitivity_NN 87_MC to_II 100_MC %_SYM ,_, specificity_NN 81_MC to_II 97_MC %_SYM )_) ._.
P10921701A03
METHODS_NNS :_: One_MC hundred_MC forty_MC patients_NNS were_VBD randomly_RR divided_VVN into_II two_MC groups_NNS :_: an_DD amiodarone_NN group_NN (_( n_NN =_SYM 74_MC )_) receiving_VVG intravenous_JJ amiadarone_NN in_II a_DD loading_VVGJ dose_NN of_II 150_MC mg_NN and_CC maintenance_NN dose_NN of_II 0.4_MC mg_NN x_SYM kg_NN (_( -1_MC )_) x_SYM h_NN (_( -1_MC )_) for_II 3_MC days_NNS before_II and_CC 5_MC days_NNS after_II operation_NN and_CC a_DD control_NN group_NN (_( n_NN =_SYM 76_MC )_) receiving_VVG matching_VVGJ infusions_NNS of_II 5_MC %_SYM glucose_NN solution_NN ._.
P10926291A07
Iron_NN staining_VVGN and_CC CytOx_NN activity_NN of_II 20_MC brain_NN structures_NNS were_VBD mapped_VVN histochemically_RR in_II 25_MC rats_NNS from_II each_DD group_NN ._.
P10930832A10
Although_CS the_DD contributions_NNS to_II bond_NN valency_NN or_CC bonding_VVGJ energy_NN of_II such_DD interactions_NNS may_VM not_RR be_VBB great_JJ ,_, their_PNG effect_NN on_II geometry_NN can_VM be_VBB considerable_JJ ;_: they_PN can_VM ,_, for_II example_NN ,_, cause_VVB much_RR larger_JJR distortions_NNS of_II tetrahedral_JJ Zn_NN complexes_NNS than_CSN indicated_VVN above_RR ._.
P10939481A11
Cerales-D_NN proves_VVZ to_TO be_VBI an_DD efficient_JJ tool_NN for_II CT-guided_VVNJ PLDD_NN on_II non-sequestered_VVNJ herniated_VVNJ lumbar_JJ discs_NNS ._.
P10953053A04
The_DD effect_NN of_II retigabine_NN was_VBD associated_VVN with_II a_DD slowing_VVGN of_II M-like_JJ tail_NN current_NN deactivation_NN in_II these_DD cells_NNS ._.
P10958337A08
LKATP_NN was_VBD sensitive_JJ to_II intracellular_JJ Ca2+_NN but_CC insensitive_JJ to_II iberiotoxin_NN ._.
P10966810A03
The_DD membrane_NN fragments_NNS were_VBD obtained_VVN by_II a_DD short_JJ treatment_NN of_II thylakoid_NN membranes_NNS with_II the_DD mild_JJ detergent_NN n-dodecyl-alpha_NN ,_, d-maltoside_NN and_CC are_VBB thought_VVN to_TO reflect_VVI the_DD grana_NN membranes_NNS in_II a_DD native_JJ state_NN ._.
P10971038A08
IIX_NN fibers_NNS were_VBD not_RR identified_VVN until_II P40_NN in_II the_DD TA_NN ._.
P10980289A07
These_DD results_NNS demonstrate_VVB a_DD shelf-life_NN of_II 5_MC months_NNS for_II S._NN carpocapsae_NN at_II 25_MC degrees_NNS C_MC and_CC 9_MC months_NNS at_II 5_MC degrees_NNS C_MC in_II WG_NN with_II over_RR 90_MC %_SYM IJ_NN survival_NN ._.
P10993945A02
These_DD viruses_NNS lack_VVB about_RR 25_MC kbp_NN of_II sequence_NN information_NN and_CC are_VBB no_RR longer_RR infectious_JJ for_II insects_NNS ._.
P10998311A04
It_PN is_VBZ shown_VVN that_CST D_NN (_( e_NN )_) increases_VVZ (_( up_II+ to_II the_DD relative_JJ adsorption_NN equal_JJ to_II approximately_RR 0.6_MC )_) with_II rise_NN in_II the_DD magnitude_NN of_II the_DD enthalpy_NN of_II immersion_NN of_II carbons_NNS in_II water_NN ._.
P11012475A01
BACKGROUND_NN :_: Intestinal_JJ type_NN metaplasia_NN plays_VVZ a_DD role_NN in_II intestinal_JJ type_NN gastric_JJ carcinoma_NN development_NN ._.
P11016868A03
Using_VVG [_( 3H_NN ]_) -inulin_NN we_PN measured_VVD the_DD Glomerular_JJ Inulin_NN Space_NN (_( GIS_NN )_) ,_, (_( that_PNR reflects_VVZ mainly_RR glomerular_JJ intracapillary_JJ volume_NN )_) ,_, in_II the_DD presence_NN of_II ATP_NN and_CC its_PNG analogues_NNS e.g._II 2-methylthio-ATP_NN (_( P2Y-receptor_NN agonist_NN )_) and_CC beta_NN ,_, gamma-methylene-ATP_NN (_( P2X-receptor_NN agonist_NN )_) ._.
P11020986A10
The_DD respiratory_JJ failure_NN was_VBD dramatically_RR improved_VVN ,_, resulting_VVG in_II disappearance_NN of_II the_DD abnormal_JJ lymphoid_JJ cells_NNS from_II the_DD bone_NN marrow_NN ._.
P11030627A04
The_DD mechanism_NN linking_VVG the_DD action_NN of_II SYT_NN /_SYM p300_NN complexes_NNS to_II adhesion_NN function_NN is_VBZ ,_, at_RR+ least_RR in_II part_NN ,_, transcription_NN activation-independent_JJ and_CC results_VVZ in_II proper_JJ activation_NN of_II beta1_NN integrin_NN ,_, a_DD major_JJ adhesion_NN receptor_NN ._.
P11039598A05
These_DD immunoglobulin_NN isotypes_NNS and_CC subisotypes_NNS were_VBD found_VVN in_II lymphocytes_NNS and_CC plasma_NN cells_NNS ._.
P11054633A02
The_DD drug_NN is_VBZ widely_RR used_VVN to_TO improve_VVI symptoms_NNS of_II benign_JJ prostatic_JJ hyperplasia_NN in_II man_NN ._.
P11059298A07
This_DD question_NN is_VBZ currently_RR under_II investigation_NN in_II two_MC global_JJ phase_NN III_MC trials_NNS ,_, namely_RR the_DD SILCAAT_NN and_CC the_DD ESPRIT_NN studies_NNS ._.
P11074216A01
In_II a_DD prospective_JJ study_NN of_II 98_MC persons_NNS >_SYM or_CC =_SYM 65_MC years_NNS of_II age_NN with_II chronic_JJ renal_JJ insufficiency_NN (_( serum_NN creatinine_NN >_SYM 3.0_MC mg_NN /_SYM dl_NN )_) for_II >_SYM 1_MC year_NN and_CC 98_MC age-_NN and_CC sex-matched_VVNJ persons_NNS with_II normal_JJ renal_JJ function_NN (_( serum_NN creatinine_NN <_SYM or_CC =_SYM 1.2_MC mg_NN /_SYM dl_NN )_) ,_, new_JJ coronary_JJ events_NNS developed_VVN at_II 23-month_NN follow-up_NN in_II 69_MC persons_NNS (_( 70_MC %_SYM )_) with_II chronic_JJ renal_JJ insufficiency_NN and_CC at_II 48-month_NN follow-up_NN in_II 24_MC persons_NNS (_( 24_MC %_SYM )_) with_II normal_JJ renal_JJ function_NN (_( p_NN <_SYM 0.0001_MC )_) ._.
P11078840A13
Decreased_VVNJ air_NN pressure_NN reduced_VVD the_DD occurrence_NN of_II visual_JJ field_NN defects_NNS significantly_RR (_( 24_MC %_SYM in_II group_NN A_NN versus_CC 4_MC %_SYM in_II group_NN C_NN ,_, P_NN =_SYM .011_MC )_) ._.
P11083045A11
The_DD additional_JJ decrease_NN in_II hazard_NN observed_VVN for_II the_DD 1990_MC cohort_NN may_VM be_VBB attributed_VVN to_II the_DD effect_NN of_II the_DD Specified_VVNJ Bovine_JJ Offal_NN ban_NN instituted_VVN in_II September_NN 1990_MC ._.
P11091492A09
Although_CS all_DB the_DD transplanted_VVNJ fetal_JJ sheep_NN showed_VVD the_DD presence_NN of_II human_NN cells_NNS in_II their_PNG bone_NN marrow_NN (_( BM_NN )_) ,_, the_DD highest_JJT levels_NNS of_II long-term_NN engraftment_NN in_II primary_JJ recipients_NNS were_VBD obtained_VVN with_II the_DD fraction_NN of_II cells_NNS cultured_VVN for_II 3_MC days_NNS followed_VVN by_II 7_MC days_NNS in_II the_DD absence_NN of_II serum_NN ._.
P11095653A13
The_DD developmental_JJ expression_NN of_II beta-galactosidase_NN in_II transgenic_JJ embryos_NNS was_VBD also_RR analyzed_VVN ._.
P11104765A08
Coimmunoprecipitation_NN experiments_NNS from_II yeast_NN cell_NN lysates_NNS resulted_VVD in_II the_DD isolation_NN of_II a_DD Mex67p-Nup116p_NN complex_NN ._.
P11113534A02
However_RR ,_, behavioral_JJ evidence_NN for_II altered_VVNJ mnemonic_JJ function_NN due_II+ to_II altered_VVNJ PAC1_NN activity_NN is_VBZ missing_VVG ._.
P11118176A10
Private_JJ maternity_NN patients_NNS are_VBB a_DD lucrative_JJ source_NN of_II income_NN ._.
P11127268A03
In_II this_DD study_NN ,_, 91_MC sera_NNS were_VBD used_VVN to_TO assess_VVI the_DD reliability_NN of_II the_DD Widal_NN agglutination_NN assay_NN based_VVN on_II antibodies_NNS to_II the_DD Vi_NN antigens_NNS ._.
P11131512A06
However_RR ,_, this_PND was_VBD observed_VVN only_RR for_II a_DD few_JJ individual_JJ cases_NNS and_CC its_PNG amplitude_NN was_VBD small_JJ ._.
P11140087A01
This_DD study_NN was_VBD carried_VVN out_II to_TO know_VVI the_DD prevalence_NN and_CC determinants_NNS of_II tuberculin_NN reactors_NNS and_CC the_DD size_NN of_II booster_NN phenomenon_NN in_II 211_MC Japanese_JJ residents_NNS of_II a_DD provincial_JJ nursing_VVGJ home_NN for_II elderly_NN ._.
P11144920A08
They_PN suggest_VVB that_CST the_DD extraordinary_JJ therapeutic_JJ effects_NNS of_II antibiotics_NNS ,_, coupled_VVN with_II the_DD problems_NNS that_PNR may_VM arise_VVB when_CS they_PN are_VBB inappropriately_RR used_VVN and_CC with_II the_DD extraordinary_JJ amount_NN of_II resources_NNS spent_VVN on_II antibiotics_NNS worldwide_RR justify_VVB a_DD global_JJ effort_NN to_TO reduce_VVI their_PNG inappropriate_JJ use_NN and_CC promote_VVB their_PNG adequate_JJ administration_NN ._.
P11153569A09
Induced_VVNJ sputum_NN and_CC exhaled_VVNJ gases_NNS are_VBB important_JJ markers_NNS of_II inflammation_NN in_II childhood_NN asthma_NN ._.
P11161972A05
Receptor_NN modulation_NN was_VBD observed_VVN at_II the_DD two_MC highest_JJT doses_NNS ,_, but_CC no_DD depletion_NN of_II T_NN cells_NNS at_II any_DD dose_NN ._.
P11170035A03
In_II accordance_NN with_II previously_RR reported_VVNJ data_NNS in_II the_DD bis_JJ (_( SATE_NN )_) prodrug_NN series_NN ,_, the_DD present_JJ results_NNS demonstrate_VVB that_CST the_DD studied_VVNJ bis_JJ (_( hydroxytBuSATE_NN )_) phosphotriester_NN exerts_VVZ its_PNG biological_JJ effects_NNS via_II intracellular_JJ delivery_NN of_II the_DD 5'-monophosphate_NN of_II AZT_NN ._.
P11174003A01
There_EX is_VBZ evidence_NN that_CST crescentic_JJ glomerulonephritis_NN initiated_VVN in_II rodents_NNS by_II heterologous_JJ antibodies_NNS against_II the_DD glomerular_JJ basement_NN membrane_NN (_( anti-GBM_NN glomerulonephritis_NN )_) depends_VVZ on_II a_DD Th1-type_NN immune_JJ reaction_NN ._.
P11178779A15
This_PND might_VM result_VVB from_II inhibition_NN of_II the_DD local_JJ release_NN of_II PAF_NN ._.
P11195272A03
This_DD document_NN represents_VVZ the_DD consensus_NN achieved_VVN at_II that_DD meeting_VVGN as_CS agreed_VVN upon_II by_II the_DD participants_NNS at_II the_DD final_JJ "_`` consensus_NN achieving_VVGJ "_'' session_NN ._.
P11199721A02
Pure_JJ cultures_NNS of_II P._NN endodontalis_NN were_VBD grown_VVN in_II TYP_NN medium_NN ,_, in_II an_DD anaerobic_JJ chamber_NN ._.
P11204621A06
Broken_VVNJ ,_, oblique_JJ ,_, and_CC loss_NN of_II stereocilia_NNS ,_, denuded_VVNJ epithelial_JJ cells_NNS ,_, and_CC flattening_VVGN of_II the_DD tubule_NN were_VBD observed_VVN ._.
P11218585A18
Their_PNG treatment_NN is_VBZ surgical_JJ and_CC should_VM be_VBB undertaken_VVN before_II the_DD appearance_NN of_II complications_NNS ._.
P11227586A08
Persistent_JJ damage_NN of_II the_DD already_RR implanted_VVNJ pacing_VVGJ system_NN was_VBD not_RR observed_VVN ._.
P11237093A04
The_DD half-life_NN for_II decomposition_NN (_( tau_NN (_( 1_MC /_SYM 2_MC )_) )_) of_II the_DD unsymmetrical_JJ initiators_NNS at_II 37_MC degrees_NNS C_MC in_II methanol_NN covered_VVD a_DD range_NN of_II 121_MC hours_NNS for_II SA-1_NN ,_, 77_MC hours_NNS for_II SA-2_NN ,_, and_CC approximately_RR 25_MC hours_NNS for_II the_DD series_NNS C-16_NN ,_, C-12_NN ,_, and_CC C-8_NN ._.
P11245760A04
SETTING_VVGN :_: Community_NN in_II northern_JJ California_NNP after_II inpatient_NN rehabilitation_NN ._.
P11254728A01
We_PN recently_RR showed_VVD that_CST a_DD class_NN of_II novel_JJ carboxylated_VVNJ N_NN :_: -glycans_NNS was_VBD constitutively_RR expressed_VVN on_II endothelial_JJ cells_NNS ._.
P11259340A05
These_DD genes_NNS have_VHB been_VBN cloned_VVN and_CC their_PNG functions_NNS elucidated_VVN ._.
P11263824A07
A_DD meat_NN sample_NN was_VBD taken_VVN from_II the_DD longissimus_NN thoracis_NN muscle_NN for_II physical_JJ ,_, chemical_JJ ,_, and_CC sensory_JJ analysis_NN ._.
P11269488A03
METHODS_NNS :_: The_DD analysis_NN is_VBZ designed_VVN to_TO determine_VVI the_DD cost-effectiveness_NN of_II LVRS_NN versus_CC medical_JJ therapy_NN for_II those_PND who_PNR are_VBB eligible_JJ for_II the_DD procedure_NN ._.
P11274020A16
Because_CS it_PN is_VBZ convenient_JJ to_TO use_VVI and_CC has_VHZ high_JJ throughput_NN ,_, this_DD serum_NN bone_NN resorption_NN marker_NN may_VM be_VBB useful_JJ for_II the_DD investigation_NN of_II patients_NNS with_II osteoporosis_NN ._.
P11282493A07
These_DD changes_NNS were_VBD prevented_VVN by_II treatment_NN with_II UDCA_NN ._.
P11291392A01
In_II 1998_MC the_DD Faculty_NN of_II Pharmacy_NN and_CC Pharmaceutical_JJ Sciences_NNS at_II the_DD University_NN of_II Alberta_NNP ,_, Canada_NNP ,_, introduced_VVD a_DD new_JJ elective_JJ semester_NN course_NN entitled_VVN "_`` The_DD Pain_NN Module_NN "_'' for_II pharmacy_NN students_NNS in_II their_PNG final_JJ year_NN of_II undergraduate_NN training_VVGN ._.
P11295616A02
Recent_JJ advances_NNS in_II the_DD fields_NNS of_II genomics_NNS and_CC biotechnology_NN have_VHB dramatically_RR increased_VVN the_DD quantity_NN and_CC accessibility_NN of_II molecular_JJ information_NN that_PNR is_VBZ relevant_JJ to_II the_DD study_NN of_II prostate_NN carcinogenesis_NN ._.
P11304547A07
The_DD behavior_NN of_II the_DD double_JJ mutant_NN is_VBZ dominated_VVN by_II the_DD G83A_NN mutation_NN ._.
P11313077A10
The_DD SF-36_NN values_NNS of_II the_DD ARDS_NN survivors_NNS indicated_VVD impaired_VVNJ health_NN status_NN on_II seven_MC out_II+ of_II eight_MC domains_NNS when_CS compared_VVN to_II normative_JJ population_NN data_NNS ._.
P11321732A02
We_PN describe_VVB a_DD case_NN of_II pulmonary_JJ spindle-cell_NN tumor_NN with_II features_NNS of_II infantile_JJ fibrosarcoma_NN and_CC discuss_VVB the_DD differential_JJ diagnosis_NN of_II spindle-cell_NN lesions_NNS in_II this_DD location_NN ._.
P11334903A04
PATIENT_NN (_( S_NNS )_) :_: 1388_MC patients_NNS undergoing_VVG long_JJ protocol_NN in_JJ+ vitro_JJ fertilization_NN /_SYM embryo_NN transfer_NN (_( IVF-ET_NN )_) using_VVG buserelin_NN acetate_NN from_II day_NN 2_MC of_II the_DD cycle_NN and_CC either_CC rFSH_NN (_( follitropin_NN beta_NN )_) (_( n_NN =_SYM 694_MC )_) or_CC uFSH_NN (_( n_NN =_SYM 694_MC )_) with_II equal_JJ number_NN of_II ampules_NNS started_VVN (_( rFSH_NN :_: 50_MC IU_NN ,_, uFSH_NN :_: 75_MC IU_NN )_) ._.
P11339688A06
The_DD concept_NN of_II salt-sensitivity_NN is_VBZ a_DD novel_JJ biological_JJ component_NN that_PNR might_VM contribute_VVB to_II reactivity_NN research_NN in_II subjects_NNS at_II high_JJ risk_NN for_II essential_JJ hypertension_NN ._.
P11348819A12
Induration_NN results_NNS were_VBD 0_MC mm_NN ,_, 216_MC tests_NNS ;_: 1-9_MC mm_NN ,_, 9_MC tests_NNS ;_: >_SYM or_CC =10_MC mm_NN ,_, 2_MC tests_NNS ._.
P11367678A02
The_DD results_NNS are_VBB as_CS follows_VVZ :_: (_( 1_MC )_) Tau_NN acted_VVD on_II strychnine-sensitive_JJ glycine_NN (_( Gly_NN )_) receptors_NNS and_CC elicited_VVD inward_JJ currents_NNS at_II a_DD holding_VVGJ potential_NN (_( VH_NN )_) of_II -40_MC mV_NN in_II SDCN_NN neurons_NNS ;_: (_( 2_MC )_) in_II a_DD range_NN of_II 0.01_MC to_II 100_MC mumol_NN /_SYM L_NN ,_, 5-HT_NN enhanced_VVD ITau_NN in_II a_DD concentration-dependent_JJ manner_NN ;_: (_( 3_MC )_) both_CC the_DD reversal_NN potential_NN of_II Tau_NN and_CC the_DD binding_VVGJ affinity_NN of_II Tau_NN to_II Gly_NN receptor_NN were_VBD not_RR affected_VVN by_II 5-HT_NN ;_: (_( 4_MC )_) when_CS the_DD neurons_NNS were_VBD loaded_VVN with_II 3_MC mumol_NN /_SYM L_NN chelerythrine_NN ,_, application_NN of_II 1_MC mumol_NN /_SYM L_NN 5-HT_NN failed_VVD to_TO enhance_VVI ITau_NN ._.
P11376516A02
Then_RR ,_, it_PN was_VBD used_VVN during_II acute_JJ respiratory_JJ failure_NN to_TO improve_VVI gas_NN exchange_NN ._.
P11381130A01
Type_NN IV_MC pili_NNS are_VBB thin_JJ filaments_NNS that_PNR extend_VVB from_II the_DD poles_NNS of_II a_DD diverse_JJ group_NN of_II bacteria_NN ,_, enabling_VVG them_PN to_TO move_VVI at_II speeds_NNS of_II a_DD few_JJ tenths_NNS of_II a_DD micrometer_NN per_II second_NN ._.
P11390215A02
In_II the_DD microphysiometer_NN ,_, different_JJ sensitive_JJ membranes_NNS are_VBB illuminated_VVN in_II parallel_NN with_II n_NN light_NN sources_NNS at_II different_JJ frequencies_NNS ,_, the_DD response_NN amplitudes_NNS of_II each_DD frequency_NN component_NN can_VM be_VBB measured_VVN on-line_NN by_II parallel_JJ processing_VVGJ algorithm_NN ._.
P11399116A02
A_DD low_JJ serum_NN phosphate_NN (_( S-P_NN )_) level_NN may_VM be_VBB a_DD limiting_VVGJ factor_NN for_II glucose_NN metabolism_NN and_CC may_VM account_VVB for_II hyperglycaemia_NN ,_, with_II an_DD increased_VVNJ risk_NN of_II NIDDM_NN and_CC hypertension_NN and_CC consequent_JJ increased_VVNJ risk_NN of_II stroke_NN ._.
P11407815A02
Its_PNG structure_NN was_VBD elucidated_VVN by_II spectroscopic_JJ methods_NNS ._.
P11416509A07
The_DD only_JJ in-hospital_NN complications_NNS was_VBD the_DD death_NN of_II 1_MC patient_NN (_( 3.8_MC %_SYM )_) after_II an_DD abrupt_JJ closure_NN ,_, and_CC a_DD dissection_NN of_II 1_MC lesion_NN of_II another_DD patient_NN ,_, with_II a_DD favorable_JJ subsequent_JJ outcome_NN ._.
P11421369A06
Both_PND affected_VVD children_NNS more_RR than_CSN adults_NNS ,_, but_CC Cryptosporidium_NN affected_VVD children_NNS at_II a_DD younger_JJR age_NN than_CSN Cyclospora_NN (_( median_NN age_NN 2_MC years_NNS versus_CC 5_MC years_NNS ;_: P_NN <_SYM 0.001_MC )_) ._.
P11430088A02
Nucleophilic_JJ attack_NN leads_VVZ to_II at_RR+ least_RR two_MC reaction_NN channels_NNS ,_, one_MC of_II which_PNR has_VHZ been_VBN previously_RR detected_VVN (_( pathway_NN a_NN )_) and_CC leads_VVZ to_II novel_JJ aminals_NNS 19_MC ._.
P11439290A02
However_RR ,_, these_DD investigations_NNS used_VVD supraphysiological_JJ doses_NNS ._.
P11443913A02
It_PN is_VBZ assumed_VVN that_CST the_DD success_NN in_II plant_NN genomics_NNS will_VM result_VVB in_II revolutionary_JJ changes_NNS in_II biotechnology_NN and_CC plant_NN breeding_VVGN ._.
P11452990A01
An_DD ion_NN chromatography_NN method_NN was_VBD developed_VVN to_TO determine_VVI trace_JJ anionic_JJ contamination_NN in_II matrices_NNS that_PNR have_VHB a_DD high_JJ concentration_NN of_II nitrate_NN ion_NN ._.
P11457220A06
Incorporation_NN of_II this_DD analogue_NN into_II peptides_NNS or_CC proteins_NNS should_VM allow_VVB for_II even_RR more_RR specific_JJ interactions_NNS between_II the_DD photoactivatable_JJ isoprenoid_NN and_CC any_DD number_NN of_II isoprenoid_NN binding_VVGJ proteins_NNS ._.
P11471071A04
Chimeric_JJ receptors_NNS were_VBD expressed_VVN in_II 3T3-L1_NN pre-adipocytes_NNS ,_, which_PNR do_VDB not_RR show_VVB insulin-specific_JJ responses_NNS upon_II EGF_NN stimulation_NN ._.
P11484586A02
The_DD sample_NN consisted_VVD of_II panoramic_JJ radiographs_NNS from_II 70_MC subjects_NNS ._.
P11488890A10
The_DD histopathologic_JJ extent_NN of_II the_DD reaction_NN to_II either_DD type_NN of_II electrodes_NNS could_VM not_RR be_VBB precisely_RR defined_VVN because_II+ of_II the_DD retrospective_JJ nature_NN of_II this_DD study_NN ._.
P11494592A12
2._MC The_DD most_RRT popular_JJ method_NN of_II infant_NN nutrition_NN was_VBD breast-feeding_VVGN ,_, utilized_VVN by_II 60.1_MC %_SYM ._.
P11499048A03
However_RR ,_, in_II the_DD absence_NN of_II clear_JJ guidelines_NNS ,_, continuous_JJ monitoring_VVGN and_CC an_DD adequate_JJ supply_NN of_II financial_JJ and_CC human_NN resources_NNS ,_, decentralization_NN processes_NNS are_VBB more_RR likely_RR to_TO have_VHI a_DD low_JJ impact_NN on_II the_DD process_NN of_II health_NN care_NN reform_NN and_CC can_VM ,_, to_II a_DD certain_JJ extent_NN ,_, provoke_VVB inequalities_NNS between_II regions_NNS in_II the_DD same_JJ country_NN ._.
P11512310A04
Graft_NN survival_NN was_VBD significantly_RR improved_VVN using_VVG Tacrolimus_NN immunosuppression_NN ._.
P11520780A08
No_DD serious_JJ adverse_JJ events_NNS were_VBD reported_VVN ;_: nor_CC were_VBD there_EX events_NNS that_PNR met_VVD the_DD criteria_NNS for_II dose-limiting_VVGJ toxicity_NN ._.
P11530183A06
This_DD system_NN is_VBZ based_VVN on_II the_DD self_PN replication_NN of_II engineered_VVNJ HCV_NN minigenomes_NNS (_( replicons_NNS )_) in_II a_DD transfected_VVNJ human_NN hepatoma_NN cell_NN line_NN ._.
P11547838A05
The_DD femur_NN and_CC tibia_NN were_VBD then_RR excised_VVN ,_, cleaned_VVN ,_, and_CC scanned_VVN in_II triplicate_NN ,_, with_II repositioning_VVGN ._.
P11556744A02
Collagen_NN sponges_NNS of_II different_JJ biodegradabilities_NNS were_VBD prepared_VVN through_II chemical_JJ cross-linking_VVGN of_II Type_NN I_MC collagen_NN with_II glutaraldehyde_NN (_( GA_NN )_) at_II concentrations_NNS of_II 0.2_MC ,_, 1.0_MC ,_, and_CC 2.0_MC wt_NN %_SYM ._.
P11561143A02
This_PND is_VBZ mediated_VVN by_II an_DD effect_NN on_II the_DD endothelium_NN analogous_JJ to_II other_JJ endothelial_JJ responses_NNS ,_, and_CC insulin_NN resistance_NN is_VBZ reflected_VVN in_II ,_, and_CC in_II part_NN due_II+ to_II ,_, impaired_VVNJ vasodilatory_JJ actions_NNS of_II insulin_NN ._.
P11569866A05
On_II dilution_NN Rh_NN (_( III_MC )_) tends_VVZ to_TO be_VBI readily_RR hydrolyzed_VVN ,_, giving_VVG rise_NN to_II a_DD wider_JJR variety_NN (_( and_CC a_DD varied_VVNJ distribution_NN )_) of_II complexed_VVNJ forms_NNS ._.
P11579072A05
After_II confounding_VVGJ factors_NNS had_VHD been_VBN controlled_VVN for_II ,_, the_DD exercise_NN group_NN did_VDD not_RR make_VVB significant_JJ gains_NNS compared_VVN with_II their_PNG control_NN counterparts_NNS ,_, although_CS there_EX were_VBD consistent_JJ trends_NNS toward_II greater_JJR improvement_NN in_II all_DD three_MC primary_JJ outcome_NN measures_NNS ._.
P11584254A11
The_DD group_NN that_PNR receives_VVZ education_NN about_II universal_JJ precautions_NNS has_VHZ a_DD higher_JJR level_NN of_II knowledge_NN and_CC performance_NN of_II the_DD universal_JJ precautions_NNS than_CSN that_DD group_NN that_PNR receives_VVZ no_DB such_DD education_NN ._.
P11593455A06
Tree_NN shrews_NNS can_VM be_VBB regarded_VVN as_II a_DD suitable_JJ animal_NN model_NN to_TO investigate_VVI the_DD neurobiological_JJ basis_NN of_II affective_JJ disorders_NNS since_CS (_( 1_MC )_) behavioral_JJ and_CC endocrine_JJ symptoms_NNS of_II subordinates_NNS resemble_VVB those_PND of_II depressive_JJ patients_NNS ,_, (_( 2_MC )_) antidepressant_NN treatments_NNS lead_VVB to_II an_DD improvement_NN of_II symptoms_NNS ,_, and_CC (_( 3_MC )_) also_RR in_II humans_NNS chronic_JJ stress_NN can_VM lead_VVB to_II depression_NN ._.
P11598036A11
An_DD important_JJ component_NN of_II our_PNG study_NN was_VBD the_DD use_NN of_II heparin_NN to_TO prevent_VVI reinfection_NN of_II cells_NNS and_CC thus_RR enable_VVI the_DD infection_NN to_TO be_VBI followed_VVN from_II a_DD discrete_JJ time_NN point_NN ._.
P11606558A03
General_JJ diploid_NN selection_NN is_VBZ allowed_VVN ,_, but_CC the_DD approach_NN is_VBZ currently_RR restricted_VVN to_II models_NNS ,_, such_II+ as_II the_DD infinite_JJ alleles_NNS model_NN and_CC certain_JJ K-models_NNS ,_, in_II which_PNR the_DD type_NN of_II a_DD mutant_JJ allele_NN does_VDZ not_RR depend_VVB on_II the_DD type_NN of_II its_PNG progenitor_NN allele_NN ._.
P11669999A02
The_DD halide_NN Re_NN (_( 3_MC )_) (_( &mgr;_NN -Cl_NN )_) (_( 3_MC )_) Cl_NN (_( 6_MC )_) (_( THF_NN )_) (_( 3_MC )_) reacts_VVZ at_II room_NN temperature_NN in_II THF_NN with_II 9_MC equiv_NN of_II NaOCH_NN (_( 2_MC )_) CMe_NN (_( 3_MC )_) to_TO give_VVI Re_NN (_( 3_MC )_) (_( &mgr;_NN -OCH_NN (_( 2_MC )_) CMe_NN (_( 3_MC )_) )_) (_( 3_MC )_) (_( OCH_NN (_( 2_MC )_) CMe_NN (_( 3_MC )_) )_) (_( 6_MC )_) ._.
P11674532A05
Optimization_NN of_II binding_VVGN was_VBD achieved_VVN by_II changing_VVGN polymerization_NN conditions_NNS (_( thermal_JJ versus_CC photochemical_JJ polymerization_NN ,_, monomer_NN :_: template_NN ratio_NN )_) for_II t-BOC-phenylalanine_NN imprinted_VVNJ polymers_NNS employing_VVG the_DD N-_NN (_( 2-aminopyridine_NN )_) methacrylamide_NN monomer_NN ._.
P11683809A06
An_DD asymmetric_JJ index_NN (_( AI_NN )_) was_VBD designed_VVN ._.
P11688318A08
The_DD mortality_NN rate_NN varies_VVZ according_II+ to_II the_DD causes_NNS and_CC the_DD age_NN ._.
P11693764A06
The_DD presence_NN of_II SCIs_NNS was_VBD associated_VVN with_II older_JJR age_NN ,_, higher_JJR levels_NNS of_II 24-h_NN systolic_JJ blood_NN pressure_NN ,_, 2-h_NN insulin_NN ,_, thrombin-generation_NN markers_NNS (_( prothrombin_NN fragment_NN 1+2_MC and_CC thrombin-antithrombin_NN complexes_NNS )_) ,_, plasminogen_NN activator_NN inhibitor-1_NN (_( PAI-1_NN )_) ,_, D-dimer_NN and_CC von_II Willebrand_NN factor_NN (_( vWF_NN )_) ,_, but_CC not_RR with_II plasmin-alpha2-plasmin_NN complex_NN (_( PIC_NN )_) levels_NNS ._.
P11707065A02
Using_VVG stereotactic_JJ techniques_NNS ,_, it_PN is_VBZ possible_JJ to_TO characterize_VVI neuroanatomical_JJ relationships_NNS through_II the_DD delivery_NN of_II neurotropic_JJ viral_JJ vectors_NNS to_II specific_JJ brain_NN regions_NNS ._.
P11716155A05
Non-classic_JJ CAH-21_NN OHD_NN may_VM be_VBB detected_VVN in_II up_RR+ to_RR 1-3_MC %_SYM of_II certain_JJ populations_NNS ,_, and_CC is_VBZ often_RR mistaken_VVN for_II idiopathic_JJ precocious_JJ pubarche_NN in_II children_NNS or_CC polycystic_JJ ovary_NN syndrome_NN in_II young_JJ women_NNS ._.
P11724819A05
Raver1_NN colocalizes_VVZ with_II polypyrimidine_NN tract_NN binding_VVGJ protein_NN (_( PTB_NN )_) /_SYM hnRNPI_NN ,_, a_DD protein_NN involved_VVN in_II RNA_NN splicing_VVGN of_II microfilament_NN proteins_NNS ,_, in_II the_DD perinucleolar_JJ compartment_NN and_CC forms_VVZ complexes_NNS with_II PTB_NN /_SYM hnRNPI_NN ._.
P11729241A11
Further_JJ experiments_NNS are_VBB required_VVN to_TO establish_VVI whether_CST these_DD events_NNS are_VBB functionally_RR related_VVN ._.
P11742329A01
BACKGROUND_NN :_: Different_JJ minimally_RR invasive_JJ techniques_NNS of_II parathyroidectomy_NN have_VHB been_VBN described_VVN ._.
P11746443A02
Sciatic_JJ nerve_NN crush_NN was_VBD performed_VVN in_II 2-day-old_JJ rats_NNS ,_, and_CC reinnervation_NN of_II the_DD extensor_NN digitorum_NN longus_NN muscle_NN was_VBD monitored_VVN ._.
P11755384A02
The_DD present_JJ study_NN aims_VVZ to_TO demonstrate_VVI a_DD quantitative_JJ use_NN of_II these_DD devices_NNS in_II pharmacological_JJ bioassays_NNS ._.
P11759993A03
ANIMALS_NNS :_: 17_MC neutered_VVNJ cats_NNS >_SYM 1_MC year_NN old_NN with_II objectionable_JJ urine_NN spraying_VVGJ behavior_NN ._.
P11764572A04
All_DD stages_NNS of_II performance_NN of_II the_DD access_NN ,_, including_VVG trepanation_NN of_II the_DD internal_JJ acoustic_JJ meatus_NN ,_, are_VBB considered_VVN in_II detail_NN ._.
P11769320A11
The_DD amount_NN of_II ions_NNS (_( P_NN ,_, K_NN ,_, Mg_NN and_CC Ca_NN )_) often_RR showed_VVD negative_JJ correlations_NNS with_II the_DD developmental_JJ rate_NN ,_, particularly_RR of_II earlier_JJR phenophases_NNS of_II both_CC native_JJ and_CC cultivated_VVNJ plants_NNS (_( except_II+ for_II the_DD apple_NN '_`` Gravenstein_NN '_'' and_CC pear_NN '_`` Moltke_NN '_'' )_) ,_, possibly_RR ,_, indicating_VVG that_CST a_DD high_JJ nutrient_NN level_NN delayed_VVD plant_NN development_NN ._.
P11778117A03
Loco-regional_JJ techniques_NNS together_RR with_II an_DD effective_JJ pain_NN management_NN should_VM accelerate_VVB rehabilitation_NN ,_, decrease_VVB risk_NN of_II postoperative_JJ complications_NNS and_CC speed_VVB return_NN to_II normal_JJ activities_NNS ._.
P11782348A06
These_DD tissues_NNS showed_VVD a_DD significant_JJ increase_NN in_II apoptosis_NN as_CS determined_VVN by_II in_JJ+ situ_JJ end-labeling_VVGN for_II both_DD ITC-NAC-treated_VVNJ groups_NNS ._.
P11786823A06
Also_RR ,_, the_DD global_JJ rating_VVGJ score_NN for_II appearance_NN and_CC quality_NN of_II the_DD final_JJ surgical_JJ product_NN significantly_RR improved_VVD from_II 2.7_MC to_II 3.3_MC after_II the_DD practice_NN session_NN (_( p_NN <_SYM 0.01_MC )_) ._.
P11795867A06
Pleiotrophin_NN is_VBZ the_DD first_JJ ligand_NN of_II any_PND of_II the_DD known_VVNJ transmembrane_JJ tyrosine_NN phosphatases_NNS ._.
P11800366A09
In_II 8_MC cases_NNS ,_, one_MC or_CC both_PND of_II the_DD vocal_JJ cords_NNS became_VVD mobile_JJ 3_MC to_II 4_MC months_NNS after_II the_DD operation_NN ._.
P11813784A01
Domestic_JJ abuse_NN is_VBZ the_DD leading_VVGJ cause_NN of_II injuries_NNS and_CC death_NN among_II women_NNS of_II childbearing_VVGJ age_NN in_II the_DD United_VVNJ States_NNS ._.
P11818410A09
We_PN conclude_VVB that_CST the_DD circadian_JJ clock_NN generates_VVZ a_DD rhythm_NN of_II luminal_JJ acidification_NN by_II regulating_VVGN the_DD levels_NNS and_CC subcellular_JJ distribution_NN of_II V-ATPase_NN in_II the_DD UVD_NN epithelium_NN ._.
P11827397A03
When_CS the_DD arsenosugar_NN in_II the_DD oyster_NN was_VBD quantified_VVN using_VVG the_DD two_MC detection_NN methods_NNS and_CC external_JJ calibration_NN with_II standard_JJ arsenosugar_NN ,_, there_EX was_VBD a_DD large_JJ discrepancy_NN between_II the_DD two_MC sets_NNS of_II results_NNS ._.
P11832091A09
The_DD median_JJ survival_NN was_VBD 26.5_MC months_NNS in_II Group_NN 1_MC and_CC 57.0_MC months_NNS in_II Group_NN 2_MC (_( P_NN <_SYM 0.01_MC )_) ._.
P11836425A02
All_DD sequenced_VVNJ gammaherpesviruses_NNS encode_VVB a_DD BCL-2_NN homologue_NN that_CST potently_RR inhibits_VVZ apoptosis_NN and_CC apparently_RR escapes_VVZ some_PND of_II the_DD regulatory_JJ mechanisms_NNS that_PNR govern_VVB the_DD functions_NNS of_II their_PNG cellular_JJ counterparts_NNS ._.
P11850165A11
The_DD majority_NN (_( 98_MC %_SYM )_) of_II M._NN catarrhalis_NN isolates_NNS was_VBD found_VVN to_TO be_VBI beta-lactamase-positive_JJ and_CC resistant_JJ to_II penicillins_NNS ,_, however_RR ,_, resistance_NN to_II erythromycin_NN and_CC tetracycline_NN was_VBD also_RR low_JJ at_II 1.8_MC %_SYM ._.
P11854657A13
Fetal_JJ blood_NN gases_NNS and_CC pH_NN were_VBD unchanged_VVN with_II time_NN in_II all_DD 3_MC groups_NNS ._.
P11863688A05
The_DD same_JJ property_NN holds_VVZ for_II the_DD approximate_JJ wave_NN functions_NNS ._.
P11872968A05
The_DD isolated_VVNJ systolic_JJ hypertension_NN and_CC large_JJ pulse_NN pressure_NN that_PNR predominate_VVB in_II the_DD elderly_NN is_VBZ now_RR recognized_VVN as_II a_DD coronary_JJ disease_NN hazard_NN ._.
P11877563A01
Microalbuminuria_NN (_( MA_NN )_) is_VBZ associated_VVN with_II adverse_JJ health_NN outcomes_NNS in_II diabetic_JJ and_CC hypertensive_JJ adults_NNS ._.
P11882196A02
The_DD research_NN question_NN arose_VVD when_CS professional_JJ preunderstandings_NNS about_II schizophrenia_NN as_II a_DD biological_JJ disturbance_NN were_VBD bracketed_VVN as_CS a_DD Husserlian_NN form_NN of_II phenomenology_NN was_VBD adopted_VVN ._.
P11886711A05
Sixty_MC percent_NN of_II our_PNG patients_NNS had_VHD chronic_JJ myelocytic_JJ leukemia_NN (_( CML_NN )_) ._.
P11891134A05
Both_DD deduced_VVNJ amino_JJ acid_NN sequences_NNS show_VVB substantial_JJ similarity_NN to_II human_NN IRP1_NN and_CC Drosophila_NN IRP1A_NN and_CC IRP1B_NN ,_, and_CC all_PND of_II the_DD residues_NNS thought_VVN to_TO be_VBI involved_VVN in_II aconitase_NN activity_NN and_CC iron-sulfur_NN cluster_NN formation_NN are_VBB conserved_VVN ._.
P11900689A01
OBJECTIVES_NNS :_: To_TO analyze_VVI the_DD influence_NN of_II routine_JJ imaging_VVGN of_II the_DD upper_JJ abdomen_NN by_II conventional_JJ computed_VVNJ tomography_NN (_( CT_NN )_) to_TO stage_VVI bronchopulmonary_JJ carcinoma_NN and_CC to_TO detect_VVI liver_NN or_CC adrenal_JJ metastasis_NN ._.
P11905619A05
The_DD need_NN for_II dedicated_VVNJ services_NNS for_II these_DD patients_NNS has_VHZ been_VBN accepted_VVN ,_, but_CC the_DD resources_NNS to_TO meet_VVI this_DD need_NN have_VHB rarely_RR been_VBN identified_VVN ._.
P11920197A01
INTRODUCTION_NN :_: Reduced_VVNJ glutathione_NN is_VBZ an_DD important_JJ antioxidant_NN in_II red_JJ cells_NNS whose_PNR depletion_NN may_VM contribute_VVB to_II the_DD pathophysiology_NN of_II sickle_JJ cell_NN disease_NN ._.
P11924694A04
Results_NNS indicate_VVB that_CST moving_VVGN in_II the_DD past_JJ 12_MC months_NNS is_VBZ positively_RR associated_VVN with_II a_DD nearly_RR lethal_JJ suicide_NN attempt_NN (_( adjusted_VVNJ odds_NNS ratio_NN of_II 2.1_MC ,_, with_II 95_MC %_SYM confidence_NN interval_NN of_II 1.4-3.3_MC )_) ,_, as_CS are_VBB specific_JJ characteristics_NNS of_II the_DD move_NN (_( e.g._II ,_, frequency_NN ,_, recency_NN ,_, distance_NN ,_, and_CC difficulty_NN staying_VVGN in_II touch_NN )_) ._.
P11929207A04
Unrecognized_VVNJ saphenous_JJ neuritis_NN can_VM confuse_VVB the_DD patient_NN 's_GE clinical_JJ picture_NN ,_, complicate_VVB treatment_NN ,_, and_CC compromise_VVB results_NNS ._.
P11933551A17
Surgical_JJ acts_NNS which_PNR do_VDB not_RR impose_VVB major_JJ constraints_NNS on_II the_DD cardiocirculatory_JJ apparatus_NN (_( ophthalmic_JJ surgery_NN for_II example_NN )_) do_VDB not_RR require_VVB supplementary_JJ examinations_NNS ._.
P11943839A04
We_PN therefore_RR developed_VVD a_DD mathematical_JJ model_NN to_TO estimate_VVI life_NN expectancy_NN in_II patients_NNS with_II a_DD body_NN mass_NN index_NN (_( BMI_NN )_) >_SYM or_CC =40_MC kg_NN /_SYM m_NN (_( 2_MC )_) undergoing_VVG bariatric_JJ surgery_NN ._.
P11951099A07
With_II arteriography_NN as_II the_DD "_`` gold_JJ standard_NN ,_, "_'' B-mode_NN image_NN (_( BMI_NN )_) measurement_NN of_II the_DD maximal_JJ ICA_NN luminal_JJ narrowing_VVGN relative_JJ to_II the_DD carotid_JJ bulb_NN (_( n=162_NN )_) as_CC+ well_CC+ as_CC the_DD peak_JJ systolic_JJ velocity_NN in_II the_DD internal_JJ carotid_JJ artery_NN (_( PSVICA_NN )_) (_( n=330_NN )_) ,_, end-diastolic_JJ velocity_NN in_II the_DD internal_JJ carotid_JJ artery_NN (_( EDV_NN (_( ICA_NN )_) )_) (_( n=198_NN )_) ,_, and_CC the_DD ratio_NN of_II the_DD PSVs_NNS in_II both_CC the_DD ICA_NN and_CC the_DD CCA_NN (_( PSVICA_NN /_SYM CCA_NN )_) ratio_NN (_( n=319_NN )_) were_VBD subjected_VVN to_II receiver_NN operator_NN characteristics_NNS (_( ROC_NN )_) curves_NNS for_II 3_MC clinically_RR relevant_JJ stenoses_NNS thresholds_NNS :_: 50-99_MC %_SYM ,_, 60-99_MC %_SYM ,_, and_CC 70-99_MC %_SYM ._.
P11956156A07
Consistent_JJ with_II the_DD reduction_NN in_II expression_NN of_II acetyl_NN CoA_NN carboxylase_NN 2_MC ,_, liver_NN triglyceride_NN levels_NNS were_VBD reduced_VVN ._.
P11967096A03
No_DD other_JJ nitrilase_NN genes_NNS respond_VVB to_II sulphur_NN supply_NN /_SYM deficiency_NN ._.
P11977166A03
The_DD dearth_NN of_II archaeological_JJ cases_NNS may_VM be_VBB due_II+ to_II lack_NN of_II definite_JJ skeletal_JJ changes_NNS or_CC as_II a_DD result_NN of_II the_DD remains_NNS being_VVGN denied_VVN burial_NN within_II consecrated_VVNJ ground_NN ._.
P11987685A05
Patients_NNS were_VBD classified_VVN as_II planned_VVNJ (_( PL-D_NN )_) or_CC unplanned_VVNJ dialysis_NN (_( UNPL-D_NN )_) ,_, depending_VVG on_II whether_CST or_CC not_RR the_DD patient_NN had_VHD a_DD vascular_JJ or_CC peritoneal_JJ access_NN ready_JJ to_TO use_VVI for_II initiating_VVGN RRT_NN ._.
P11992638A06
In_II CFSC-2G_NN cultures_NNS ,_, MeAIB_NN selectively_RR inhibited_VVD the_DD incorporation_NN of_II proline_NN into_II cellular_JJ macromolecules_NNS by_II 43_MC +/-_SYM 4_MC %_SYM ,_, while_CS the_DD synthesis_NN of_II proteins_NNS containing_VVG leucine_NN was_VBD not_RR affected_VVN ._.
P12002346A03
We_PN used_VVD a_DD model_NN that_PNR considers_VVZ variations_NNS in_II skull_NN thicknesses_NNS to_TO determine_VVI the_DD conductivity_NN of_II the_DD tri-layer_NN skull_NN and_CC its_PNG individual_JJ anatomical_JJ structures_NNS ._.
P12011480A05
The_DD doses_NNS of_II the_DD mixture_NN that_PNR were_VBD administered_VVN were_VBD related_VVN to_II minimum_NN risk_NN levels_NNS or_CC tolerable_JJ daily_JJ intakes_NNS of_II these_DD substances_NNS ,_, as_CS derived_VVN by_II risk_NN assessment_NN with_II the_DD 1x_NN ,_, 10x_NN ,_, 100x_NN ,_, and_CC 1000x_NN groups_NNS receiving_VVG mixture_NN components_NNS at_II doses_NNS equivalent_JJ to_II 1x_NN ,_, 10x_NN ,_, 100x_NN ,_, or_CC 1000x_NN the_DD minimum_NN risk_NN level_NN (_( or_CC tolerable_JJ daily_JJ intake_NN ,_, reference_NN dose_NN )_) ,_, respectively_RR ._.
P12016505A08
However_RR ,_, the_DD long-term_NN effect_NN of_II postoperative_JJ bandaging_VVGN remains_VVZ unknown_VVN ._.
P12026051A04
Four_MC histologic_JJ sections_NNS of_II 12_MC specimens_NNS from_II each_DD age_NN group_NN were_VBD stained_VVN with_II toluidine_NN blue_JJ to_TO identify_VVI the_DD MCs_NNS ,_, which_PNR were_VBD counted_VVN using_VVG a_DD computer-assisted_VVNJ image_NN analysis_NN system_NN ._.
P12035538A03
These_DD antibodies_NNS have_VHB recognized_VVN glycine_NN conjugated_VVN with_II proteins_NNS by_II glutaraldehyde_NN and_CC glycine_NN conjugated_VVN with_II glycogen_NN by_II bis-oxyran_NN ,_, however_RR they_PN have_VHB failed_VVN to_TO recognized_VVI others_NNS amino_JJ acids_NNS in_II the_DD analogical_JJ conjugates_NNS ._.
P12045762A01
This_DD prospective_JJ clinical_JJ study_NN assessed_VVD the_DD effect_NN of_II the_DD Frankel_NN Functional_JJ Regulator-II_NN (_( FR-II_NN )_) treatment_NN on_II the_DD position_NN and_CC shape_NN of_II the_DD articular_JJ disc_NN of_II the_DD temporomandibular_JJ joint_NN ._.
P12050378A04
Following_VVG gene_NN gun_NN bombardments_NNS of_II DNA_NN ,_, both_PND were_VBD biased_VVN towards_II type_NN 2_MC immune_JJ responses_NNS and_CC the_DD production_NN of_II interleukin-4_NN ._.
P12059479A01
Compressional_JJ pulses_NNS were_VBD launched_VVN in_II a_DD two-dimensional_JJ Yukawa_NN lattice_NN ,_, a_DD hexagonal_JJ monolayer_NN of_II polymer_NN microspheres_NNS suspended_VVN in_II a_DD plasma_NN ._.
P12068149A04
Hence_RR ,_, this_DD association_NN should_VM be_VBB considered_VVN in_II cases_NNS with_II brain_NN abscesses_NNS of_II undetermined_VVNJ etiologic_JJ factors_NNS ._.
P12077276A07
Although_CS the_DD arthritic_JJ score_NN of_II the_DD C3_NN (_( -/-_SYM )_) mice_NNS was_VBD low_JJ ,_, the_DD arthritis_NN in_II FB_NN (_( -/-_SYM )_) mice_NNS ranked_VVD intermediate_JJ with_II regard_NN to_II C3_NN (_( -/-_SYM )_) and_CC control_NN mice_NNS ._.
P12086533A06
A_DD pattern_NN of_II water_NN molecules_NNS at_II locations_NNS beyond_II the_DD surface_NN of_II the_DD solute_NN molecules_NNS is_VBZ detected_VVN ,_, evidence_NN of_II an_DD emergent_JJ property_NN in_II this_DD solvent-solute_NN system_NN ._.
P12100511A04
On_II day_NN 15_MC post-transplant_NN ,_, because_CS flow_NN velocity_NN was_VBD remarkably_RR reduced_VVN (_( as_CS shown_VVN by_II Doppler_NN ultrasound_NN )_) the_DD patient_NN underwent_VVD percutaneous_JJ transluminal_JJ angioplasty_NN (_( PTA_NN )_) using_VVG a_DD kit_NN for_II coronary_JJ angioplasty_NN ._.
